Citrus Sinensis ID: 040999

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380--
Protein Sequence
MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKNASATSVTGNSKLCGGISKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLATCKE
Secondary Structure (PSIPRED)
cccccccccccccHHHHHHHcccccccccccccccccHHHcccccEEEccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHcccccccccccccEEEcccccccccEEEEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccccccccccEEEcccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHcccccccccccccccccHHHHHccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccHHHHcccEEEEEEccccccccccHHHHcccccccccccccccccccccccccccccccHHHHHHHHccccHccccccccccEEEEcccccccEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHEEEEEEccccccccEEEEEEEcccccHHHHHccccccHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEcccccccHHHHHcccEcccccHEHHHEEEEEEHcccccccccccccHHHHHHHHHHHcccHHHHccHHHccccccccccHHHccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccccc
Coil and Loop (DISEMBL)
mdfsqnnlSGEILKFLTRLFLDNLNlsynnlegmvptgvyknasatsvtgnsklcggiskfklpkcgskksngkrlPVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLgvdyqgndFKALVYEFIHnrspekwlypiskedetyerprnLNLLRRLNIAIDVASALNylhhdcqpvtahcdlkpsnvlldddmtarvgdfglarflpptrtqtkygvgnevstigdVYSYGILLLELMIrekpsdimfegdmnLHKFAKmalpnhvkdivdsillnddeklvvrgdqkqTQAKINVIIECVISMVRIGVacsmespqdrmkMTNVVHELQSIKntllgpknlatcke
Flexible Loop (DISEMBL)
mdfsqnnlSGEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKNASATSVTGNSKLCGGISKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIhnrspekwlypiskedetyeRPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGlarflpptrtqtkygvgnevstigDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVvrgdqkqtqakiNVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQsikntllgpknlatcke
Low Complexity Region (SEG)
MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKNASATSVTGNSKLCGGISKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPrnlnllrrlnIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLATCKE
Disordered region (IsUnstruct)
*********GEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKNASATSVTGNSKLCGGISKFKLPKCG*****GKRLPVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSM************V*********************
Disordered Region (DISOPRED)
MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKNASATSVTGNSKLCGGISKF******************LNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE****ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLV*********AKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL**********
Disordered Region (DISEMBL)
MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKNASATSVTGNSKLCGGISKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLATCKE
Disordered Region (DISPRO)
****QNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKN*SA**************KFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNL*****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKNASATSVTGNSKLCGGISKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLATCKE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	382	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.926	0.350	0.344	5e-63
C0LGT6	1031	LRR receptor-like serine/	no	no	0.929	0.344	0.344	3e-60
Q9SD62	1025	Putative receptor-like pr	no	no	0.633	0.236	0.44	7e-56
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.636	0.247	0.326	2e-38
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.604	0.193	0.315	8e-28
Q9FII5	1041	Leucine-rich repeat recep	no	no	0.586	0.215	0.316	1e-26
Q9ZPS9	1143	Serine/threonine-protein	no	no	0.630	0.210	0.313	1e-26
C0LGX3	993	LRR receptor-like serine/	no	no	0.947	0.364	0.259	1e-26
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.510	0.161	0.339	2e-26
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.510	0.161	0.339	2e-26

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  241 bits (616), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 157/456 (34%), Positives = 234/456 (51%), Gaps = 102/456 (22%)

Query: 1   MDFSQNNLSGEILKFLTRLF-LDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGI 58
           +D S N+LSG I ++      L+ LNLS+NNLEG VP  G+++NA+  S+ GN+ LCGGI
Sbjct: 557 VDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGI 616

Query: 59  SKFKLPKCGS------KKSNGKRLPVALNLVISIVSGLVGLALALSICFF---------- 102
             F+L  C S      KK + +   V + + + I   L+    ++++ +           
Sbjct: 617 MGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETN 676

Query: 103 -------------------------FGFSHLRHQGAF-KIFKSFIAECKALRNIRHRNL- 135
                                    F  S++   G+F  ++K+ +   K +  ++  N+ 
Sbjct: 677 NPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQ 736

Query: 136 -----------------------IKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPI 172
                                  +K+LTAC  +D+QGN+F+AL+YEF+ N S + WL+P 
Sbjct: 737 RRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHP- 795

Query: 173 SKEDETYERP-RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
            +E E   RP R L LL RLNIAIDVAS L+YLH  C    AHCDLKPSNVLLDDD+TA 
Sbjct: 796 -EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAH 854

Query: 232 VGDFGLARFLPPTRTQT-------------------KYGVGNEVSTIGDVYSYGILLLEL 272
           V DFGLAR L     ++                   +YGVG + S  GDVYS+GILLLE+
Sbjct: 855 VSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEM 914

Query: 273 MIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI 332
              ++P++ +F G+  L+ + K ALP  + DIVD  +L+   ++               +
Sbjct: 915 FTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFP------------V 962

Query: 333 IECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 368
           +EC+  +  +G+ C  ESP +R+  + VV EL SI+
Sbjct: 963 VECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  232 bits (592), Expect = 3e-60,   Method: Compositional matrix adjust.
 Identities = 161/468 (34%), Positives = 225/468 (48%), Gaps = 113/468 (24%)

Query: 1    MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGI 58
            +DFS NNLSG I ++L  L  L NLNLS N  EG VPT GV++NA+A SV GN+ +CGG+
Sbjct: 565  VDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGV 624

Query: 59   SKFKLPKCGSKKSNGKRLPVAL--NLVISIVSGLVGLALAL---SICFF----------- 102
             + +L  C  + S  KR P+++   +V  I  G+  L L +   S+C+F           
Sbjct: 625  REMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASD 684

Query: 103  ---------------------------FGFSHLRHQGAF-KIFKSFIA------ECKALR 128
                                       F  ++L   G F  +FK  +         K L 
Sbjct: 685  GNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLN 744

Query: 129  NIRH------------------RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLY 170
             ++H                  RNL+K++T C  +D +GNDF+ALVYEF+   S + WL 
Sbjct: 745  LLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ 804

Query: 171  PISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA 230
             +   +   +  R+L    +LNIAIDVASAL YLH  C    AHCD+KPSN+LLDDD+TA
Sbjct: 805  -LEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTA 863

Query: 231  RVGDFGLARFLPPTRTQT-------------------KYGVGNEVSTIGDVYSYGILLLE 271
             V DFGLA+ L     ++                   +YG+G + S  GDVYS+GILLLE
Sbjct: 864  HVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLE 923

Query: 272  LMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV 331
            +   +KP+D  F GD NLH + K  L                           +    N 
Sbjct: 924  MFSGKKPTDESFAGDYNLHSYTKSILSGCT-----------------------SSGGSNA 960

Query: 332  IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLAT 379
            I E +  ++++G+ CS E P+DRM+    V EL SI++     K   T
Sbjct: 961  IDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSKTTIT 1008

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  218 bits (555), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 121/275 (44%), Positives = 163/275 (59%), Gaps = 33/275 (12%)

Query: 118  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
            KSFIAEC+AL  IRHRNL+K++T C   D++GNDF+ALVYEF+ N + + WL+P  + +E
Sbjct: 759  KSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP-DEIEE 817

Query: 178  TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
            T    R L L  RLNIAIDVASAL YLH  C    AHCD+KPSN+LLD D+TA V DFGL
Sbjct: 818  TGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGL 877

Query: 238  ARFLPPTRTQT-------------------KYGVGNEVSTIGDVYSYGILLLELMIREKP 278
            A+ L      T                   +YG+G   S +GDVYS+GI+LLE+   ++P
Sbjct: 878  AQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRP 937

Query: 279  SDIMFEGDMNLHKFAKMALPN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI 337
            ++ +F   + LH F K AL      DI D  +L        RG   Q     N ++EC+ 
Sbjct: 938  TNKLFVDGLTLHSFTKSALQKRQALDITDETIL--------RGAYAQ---HFN-MVECLT 985

Query: 338  SMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL 372
             + R+GV+CS ESP +R+ M   + +L SI+ +  
Sbjct: 986  LVFRVGVSCSEESPVNRISMAEAISKLVSIRESFF 1020

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  160 bits (405), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/285 (32%), Positives = 145/285 (50%), Gaps = 42/285 (14%)

Query: 113 AFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPI 172
           A +   SF  EC+ L+  RHRNLI+++T C         F ALV   + N S E+ LYP 
Sbjct: 696 ALEFSGSFKRECQILKRTRHRNLIRIITTC-----SKPGFNALVLPLMPNGSLERHLYPG 750

Query: 173 SKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV 232
                     +NL+L++ +NI  DVA  + YLHH       HCDLKPSN+LLDD+MTA V
Sbjct: 751 EYSS------KNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALV 804

Query: 233 GDFGLARFLPPTRTQT------------------------KYGVGNEVSTIGDVYSYGIL 268
            DFG++R +                               +YG+G   ST GDVYS+G+L
Sbjct: 805 TDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVL 864

Query: 269 LLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAK 328
           LLE++   +P+D++     +LH+F K   P+ ++ I++  L     +   +G  ++ +  
Sbjct: 865 LLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQAL----SRWKPQGKPEKCEK- 919

Query: 329 INVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG 373
             +  E ++ M+ +G+ C+  +P  R  M +V HE+  +K  L  
Sbjct: 920 --LWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFA 962

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  125 bits (313), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 129/276 (46%), Gaps = 45/276 (16%)

Query: 107  HLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
            H+  QG     + F+AE + +  I+HRNL+ +L  C     +  D + LVYEF+   S E
Sbjct: 915  HVSGQGD----REFMAEMETIGKIKHRNLVPLLGYC-----KVGDERLLVYEFMKYGSLE 965

Query: 167  KWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD 226
              L+   K          LN   R  IAI  A  L +LHH+C P   H D+K SNVLLD+
Sbjct: 966  DVLHDPKKAG------VKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDE 1019

Query: 227  DMTARVGDFGLARFLP--------------PTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
            ++ ARV DFG+AR +               P     +Y      ST GDVYSYG++LLEL
Sbjct: 1020 NLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLEL 1079

Query: 273  MIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI 332
            +  ++P+D    GD NL  + K      + D+ D  L+ +D  L +              
Sbjct: 1080 LTGKRPTDSPDFGDNNLVGWVKQHAKLRISDVFDPELMKEDPALEIE------------- 1126

Query: 333  IECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 368
               ++  +++ VAC  +    R  M  V+   + I+
Sbjct: 1127 ---LLQHLKVAVACLDDRAWRRPTMVQVMAMFKEIQ 1159

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1

 Score =  121 bits (303), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 127/259 (49%), Gaps = 35/259 (13%)

Query: 121  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE 180
            +AE   L N+RHRN++++L  C        D   L+YE++ N S +  L+     D+T  
Sbjct: 767  LAEVDVLGNVRHRNIVRLLGCC-----TNRDCTMLLYEYMPNGSLDDLLH---GGDKTMT 818

Query: 181  RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF 240
                   L +  IAI VA  + YLHHDC PV  H DLKPSN+LLD D  ARV DFG+A+ 
Sbjct: 819  AAAEWTALYQ--IAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKL 876

Query: 241  LPPTRTQT-----------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNL 289
            +    + +           +Y    +V    D+YSYG++LLE++  ++  +  F    ++
Sbjct: 877  IQTDESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSI 936

Query: 290  HKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSME 349
              + +  L    K+ V+ +L             K      ++I E +  M+RI + C+  
Sbjct: 937  VDWVRSKL--KTKEDVEEVL------------DKSMGRSCSLIREEMKQMLRIALLCTSR 982

Query: 350  SPQDRMKMTNVVHELQSIK 368
            SP DR  M +V+  LQ  K
Sbjct: 983  SPTDRPPMRDVLLILQEAK 1001

Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1

 Score =  121 bits (303), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 133/268 (49%), Gaps = 27/268 (10%)

Query: 118  KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
            + F+AE + L  I+HRNL+ +L  C     +  + + LVYEF+   S E+ L+       
Sbjct: 877  REFMAEMETLGKIKHRNLVPLLGYC-----KIGEERLLVYEFMQYGSLEEVLH----GPR 927

Query: 178  TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
            T E+ R L    R  IA   A  L +LHH+C P   H D+K SNVLLD DM ARV DFG+
Sbjct: 928  TGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDFGM 987

Query: 238  ARFLP--------------PTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 283
            AR +               P     +Y      +  GDVYS G+++LE++  ++P+D   
Sbjct: 988  ARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSGKRPTDKEE 1047

Query: 284  EGDMNLHKFAKM-ALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI 342
             GD NL  ++KM A      +++D  LL +     +    ++   +  VI++ ++  + I
Sbjct: 1048 FGDTNLVGWSKMKAREGKHMEVIDEDLLKEGSSESL---NEKEGFEGGVIVKEMLRYLEI 1104

Query: 343  GVACSMESPQDRMKMTNVVHELQSIKNT 370
             + C  + P  R  M  VV  L+ ++ +
Sbjct: 1105 ALRCVDDFPSKRPNMLQVVASLRELRGS 1132

Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  121 bits (303), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 114/439 (25%), Positives = 189/439 (43%), Gaps = 77/439 (17%)

Query: 1   MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKNASATSVTGNSKLCGGISK 60
           +D S N L+GEI   L RL L+  N+S N L G +P+G  ++    S  GN  LC     
Sbjct: 560 LDLSNNQLTGEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLD 619

Query: 61  FKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLAL--------------ALSICFFFGFS 106
              P C SK+     LP+++  ++++   LV L +               ++I    GF+
Sbjct: 620 PIRP-CRSKRETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTNKITIFQRVGFT 678

Query: 107 H------------LRHQGAFKIFKSFIAECKAL----------RNIRHRNLIKVLTACLG 144
                        +   G+  +++  +   + L          +     ++ +     LG
Sbjct: 679 EEDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLG 738

Query: 145 VDYQGN-----------DFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNI 193
               GN           +F+ LVYEF+ N S    L+  S+++     P  L+   R +I
Sbjct: 739 RVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLH--SEKEHRAVSP--LDWTTRFSI 794

Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQT----- 248
           A+  A  L+YLHHD  P   H D+K +N+LLD +M  RV DFGLA+  P  R        
Sbjct: 795 AVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAK--PLKREDNDGVSD 852

Query: 249 ---------------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA 293
                          +YG  ++V+   DVYS+G++LLEL+  ++P+D  F  + ++ KFA
Sbjct: 853 VSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFA 912

Query: 294 KMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII---ECVISMVRIGVACSMES 350
             A   +     +   +N D     R   K    K+ +     E +  ++ + + C+   
Sbjct: 913 MEAALCYPSPSAEDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKVLDVALLCTSSF 972

Query: 351 PQDRMKMTNVVHELQSIKN 369
           P +R  M  VV  L+  K+
Sbjct: 973 PINRPTMRKVVELLKEKKS 991

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  120 bits (300), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 115/230 (50%), Gaps = 35/230 (15%)

Query: 107  HLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
            H+  QG     + F AE + +  I+HRNL+ +L  C     +  + + LVYE++   S  
Sbjct: 920  HVSGQGD----REFTAEMETIGKIKHRNLVPLLGYC-----KVGEERLLVYEYMKYGS-- 968

Query: 167  KWLYPISKEDETYERPRN---LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVL 223
                    ED  ++R +    LN   R  IAI  A  L +LHH+C P   H D+K SNVL
Sbjct: 969  -------LEDVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVL 1021

Query: 224  LDDDMTARVGDFGLARFLP--------------PTRTQTKYGVGNEVSTIGDVYSYGILL 269
            LD+++ ARV DFG+AR +               P     +Y      ST GDVYSYG++L
Sbjct: 1022 LDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVL 1081

Query: 270  LELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVR 319
            LEL+  ++P+D    GD NL  + K+     + D+ D  LL +D  + + 
Sbjct: 1082 LELLTGKQPTDSADFGDNNLVGWVKLHAKGKITDVFDRELLKEDASIEIE 1131

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  120 bits (300), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 115/230 (50%), Gaps = 35/230 (15%)

Query: 107  HLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
            H+  QG     + F AE + +  I+HRNL+ +L  C     +  + + LVYE++   S  
Sbjct: 920  HVSGQGD----REFTAEMETIGKIKHRNLVPLLGYC-----KVGEERLLVYEYMKYGS-- 968

Query: 167  KWLYPISKEDETYERPR---NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVL 223
                    ED  ++R +    LN   R  IAI  A  L +LHH+C P   H D+K SNVL
Sbjct: 969  -------LEDVLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVL 1021

Query: 224  LDDDMTARVGDFGLARFLP--------------PTRTQTKYGVGNEVSTIGDVYSYGILL 269
            LD+++ ARV DFG+AR +               P     +Y      ST GDVYSYG++L
Sbjct: 1022 LDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVL 1081

Query: 270  LELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVR 319
            LEL+  ++P+D    GD NL  + K+     + D+ D  LL +D  + + 
Sbjct: 1082 LELLTGKQPTDSADFGDNNLVGWVKLHAKGKITDVFDRELLKEDASIEIE 1131

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	382
359486510	965	PREDICTED: probable LRR receptor-like se	0.973	0.385	0.447	1e-99
359482058	1040	PREDICTED: probable LRR receptor-like se	0.976	0.358	0.436	1e-97
255581223	1015	receptor-kinase, putative [Ricinus commu	0.955	0.359	0.461	2e-96
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.976	0.195	0.432	2e-96
224097752	1025	predicted protein [Populus trichocarpa]	0.973	0.362	0.457	1e-95
224097750	1023	predicted protein [Populus trichocarpa]	0.973	0.363	0.454	1e-94
255586722	936	serine-threonine protein kinase, plant-t	0.960	0.392	0.460	5e-93
224121306	966	predicted protein [Populus trichocarpa]	0.973	0.385	0.439	8e-92
224127492	1022	predicted protein [Populus trichocarpa]	0.979	0.365	0.419	2e-91
224081190	1011	predicted protein [Populus trichocarpa]	0.952	0.360	0.449	6e-90

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  369 bits (948), Expect = 1e-99,   Method: Compositional matrix adjust.
 Identities = 202/451 (44%), Positives = 268/451 (59%), Gaps = 79/451 (17%)

Query: 1   MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGIS 59
           +D S NNLSG+I +FL  +    +NLSYN+ EG++PT GV+KN SATS+ GNSKLCGGI 
Sbjct: 502 LDLSHNNLSGKIPEFLQDIHFQLVNLSYNDFEGILPTEGVFKNVSATSIMGNSKLCGGIP 561

Query: 60  KFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFF---------------- 103
           +F+LPKC  ++   + L +AL ++I+ VSGL+ +   LS   F                 
Sbjct: 562 EFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCVLSFLIFLWLRKKKGEPASSSSEK 621

Query: 104 ---------------GFSH----------------LRHQG---AFKIF--------KSFI 121
                          GFS                 L H G   A K+         KSFI
Sbjct: 622 SLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYKGILDHDGTAIAVKVLNLLRKGASKSFI 681

Query: 122 AECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYER 181
           AEC+ALRNIRHRNL+KVLTAC GVDYQGNDFKA+VYEF+ N S E+WL+P     E    
Sbjct: 682 AECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVNGSLEQWLHPTPTTAEASAP 741

Query: 182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL 241
           PR LN L+RLNIAIDVA AL+YLHH CQ    HCDLKPSNVLLD +MT  VGDFG+A+FL
Sbjct: 742 PRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFL 801

Query: 242 PPTRTQT-------------------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 282
           P   T+                    +YG+G+EVST GDVYS+GILLLE+   ++P++ M
Sbjct: 802 PEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTEDM 861

Query: 283 FEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI 342
           F+  +N+H F K A+P  V +I D +LL +  ++     Q++  +  +   EC+IS+  I
Sbjct: 862 FKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMDNTTSQRRMASSHDA-QECLISIFGI 920

Query: 343 GVACSMESPQDRMKMTNVVHELQSIKNTLLG 373
           G+ACS E P++R  +T+   EL S+++  LG
Sbjct: 921 GLACSAELPRERKNITDAAAELNSVRDIFLG 951

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  362 bits (930), Expect = 1e-97,   Method: Compositional matrix adjust.
 Identities = 199/456 (43%), Positives = 265/456 (58%), Gaps = 83/456 (18%)

Query: 1    MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGIS 59
            +D S+NNLSG+I +FL +L L NLNLS+NN EG +PT GV+ NA++TSV GN+KLCGGI 
Sbjct: 575  LDLSRNNLSGQIPEFLQQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIP 634

Query: 60   KFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFF----------------- 102
            +  LP C   K         L L+I +++G +GL L +S+                    
Sbjct: 635  ELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASS 694

Query: 103  ------------------FGFSHLRHQGAF-KIFKSFI---------------------- 121
                              F  ++L   G F  ++K  +                      
Sbjct: 695  KDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKS 754

Query: 122  --AECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
              AEC+ALRNIRHRNL+KVLT C  VDYQGNDFKALVYEF+ N S E WL+P+   DE  
Sbjct: 755  FKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEIN 814

Query: 180  ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
            +  R L+L +RLNIAIDVASAL+YLHH C     HCDLKPSN+LLD+DMTA VGDFGLAR
Sbjct: 815  DVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLAR 874

Query: 240  FLP-------PTRTQT------------KYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
            F+P       P+++ +            +YG+G +VS +GD YSYGILLLE+   ++P++
Sbjct: 875  FIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTE 934

Query: 281  IMFEGDMNLHKFAKMALPNHVKDIVDSILLND---DEKLVVRGDQKQTQAKINVIIECVI 337
             MF   +NLH F KMALP  + DI+D   L+    +E+            K   + EC+I
Sbjct: 935  SMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLI 994

Query: 338  SMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG 373
            S++RIGV+CS+ESP++RM +T  + ELQ I+  LLG
Sbjct: 995  SILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1030

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis]

 Score =  359 bits (921), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 208/451 (46%), Positives = 274/451 (60%), Gaps = 86/451 (19%)

Query: 1    MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGI 58
            +DFS NNLSGEI +FL     L++LNLSYNN EG VP  G+++NAS T V GN KLCGGI
Sbjct: 567  LDFSSNNLSGEIPEFLQSFDLLESLNLSYNNFEGRVPVEGIFRNASTTLVMGNDKLCGGI 626

Query: 59   SKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFF--------------- 103
             +F L KC +K    K+L + L +VIS +  L+GL+  L     F               
Sbjct: 627  PEFHLAKCNAKSP--KKLTLLLKIVISTICSLLGLSFILIFALTFWLRKKKEEPTSDPYG 684

Query: 104  ----------------GFS--HLRHQGAF-KIFK------------------------SF 120
                            GFS  +L  +G+F  ++K                        SF
Sbjct: 685  HLLLNVSFQSLLRATDGFSSANLIGRGSFGHVYKGFLDEGNVTIAVKVLNLLHHGASTSF 744

Query: 121  IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE 180
            IAEC+ALRNIRHRNL+KVLTAC G+DYQGNDFKALVYE++ N S E+WL+PI + +E  E
Sbjct: 745  IAECEALRNIRHRNLVKVLTACSGIDYQGNDFKALVYEYMVNGSLEEWLHPIPRTEEV-E 803

Query: 181  RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF 240
             PR+LNLL+RLNIAIDVASAL+YLH+ C     HCDLKPSNVLLD +M   V DFGLA+ 
Sbjct: 804  PPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVHCDLKPSNVLLDSEMNGHVSDFGLAKI 863

Query: 241  L-------PPTRTQT------------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 281
            L       P +++ +            +YGVG+ VST GDVYSYGILLLEL   ++P+D 
Sbjct: 864  LSESTNSFPVSQSSSIGVRGTVGFAPPEYGVGSNVSTYGDVYSYGILLLELFTGKRPTDD 923

Query: 282  MFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR 341
            MF+ D+NLH FA++A  + + ++ D ILL +      R + ++ Q     + EC+ SM+R
Sbjct: 924  MFKEDLNLHNFAEIAFRDQLAEVADPILLQETAVRETRLNSRKCQR----LEECLFSMLR 979

Query: 342  IGVACSMESPQDRMKMTNVVHELQSIKNTLL 372
            IGVACS E PQ+RMK+ +VV  L +I++ L+
Sbjct: 980  IGVACSTEMPQERMKINDVVTGLHAIRDKLV 1010

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  358 bits (920), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 197/456 (43%), Positives = 264/456 (57%), Gaps = 83/456 (18%)

Query: 1    MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGIS 59
            +D S+NNLSG+I +FL +L L NLNLS+NN EG +PT GV+ NA++TSV GN+KLCGGI 
Sbjct: 606  LDLSRNNLSGQIPEFLQQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIP 665

Query: 60   KFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFF----------------- 102
            +  LP C   K         L L+I +++G +GL L +S+                    
Sbjct: 666  ELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASS 725

Query: 103  ------------------FGFSHLRHQGAF-KIFKSFIAE-------------------- 123
                              F  ++L   G F  ++K  + +                    
Sbjct: 726  KDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKS 785

Query: 124  ----CKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
                C+ALRNIRHRNL+KVLT C  VDYQGNDFKALVYEF+ N S E WL+P+   DE  
Sbjct: 786  FKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEIN 845

Query: 180  ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
            +  R L+L +RLNIAIDVASAL+YLHH C     HCDLKPSN+LLD+DMTA VGDFGLAR
Sbjct: 846  DVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLAR 905

Query: 240  FLP-------PTRTQT------------KYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
            F+P       P+++ +            +YG+G +VS +GD YSYGILLLE+   ++P++
Sbjct: 906  FIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTE 965

Query: 281  IMFEGDMNLHKFAKMALPNHVKDIVDSILLND---DEKLVVRGDQKQTQAKINVIIECVI 337
             MF   +NLH F KMALP  + DI+D   L+    +E+            K   + EC+I
Sbjct: 966  SMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLI 1025

Query: 338  SMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG 373
            S++RIGV+CS+ESP++RM +T  + ELQ I+  LLG
Sbjct: 1026 SILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1061

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa]

 Score =  356 bits (913), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 208/455 (45%), Positives = 273/455 (60%), Gaps = 83/455 (18%)

Query: 1    MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGI 58
            ++ S NNLSGEI KFL  L  L +L+LS+NNLEG VP  G++  AS  S+ GN KLCGG+
Sbjct: 569  LNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGNKKLCGGM 628

Query: 59   SKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFF--------------- 103
             +  L +C SKKS   +    L L+I+I  G VG+ L +S   FF               
Sbjct: 629  PQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEKKSRPASGSPW 688

Query: 104  -----------------GFSH----------------LRHQGA---FKIF--------KS 119
                             GFS                 LR  GA    K+F        KS
Sbjct: 689  ESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 748

Query: 120  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
            F+AEC AL NIRHRNL+KVLTAC G+D+QGNDFKALVYEF+ N S E+WL+P    DE +
Sbjct: 749  FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEAH 808

Query: 180  ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
             R R+L+LL+RLNIAIDVASAL+YLH+ CQ    HCDLKPSNVLLD D+TA VGDFGLAR
Sbjct: 809  RR-RDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLAR 867

Query: 240  FLPPTRTQ-------------------TKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             LP    Q                    +YG+G+EVS  GDVYSYGILLLE+    +P+D
Sbjct: 868  LLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTD 927

Query: 281  IMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV 340
             +F+  +NLH FAK ALP  V +++D +L+ + E+    GD  +  + I   +EC+ ++V
Sbjct: 928  GLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEE--TSGDASRRMSHIGNHMECLAAIV 985

Query: 341  RIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK 375
            ++GVACS E P++RM++++V  EL+ I++ LLGP+
Sbjct: 986  KVGVACSAEFPRERMEISSVAVELRRIRHILLGPQ 1020

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa]

 Score =  352 bits (904), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 207/455 (45%), Positives = 273/455 (60%), Gaps = 83/455 (18%)

Query: 1    MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGI 58
            ++ S NNLSG+I KFL     L +L+LS+NNLEG VP  GV+  AS  S+ GN KLCGG 
Sbjct: 567  LNLSHNNLSGKIPKFLAEFKLLTSLDLSFNNLEGEVPVQGVFARASGFSMLGNKKLCGGR 626

Query: 59   SKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFF--------------- 103
             +  L +C SKKS   +    + L+I+I  G VG+ L +S   FF               
Sbjct: 627  PQLNLSRCTSKKSRKLKSSTKMKLIIAIPCGFVGIILLVSYMLFFLLKEKKSRPASGSPW 686

Query: 104  -----------------GFSH----------------LRHQGA---FKIF--------KS 119
                             GFS                 LR  GA    K+F        KS
Sbjct: 687  ESTFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 746

Query: 120  FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
            F+AEC AL NIRHRNL+KVLTAC G+D+QGNDFKALVYEF+ N S E+WL+P+   DE +
Sbjct: 747  FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVQISDEAH 806

Query: 180  ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
             R R+L+LL+RLNIAIDVASAL+YLH+ CQ   AHCDLKPSNVLLD DMTA VGDFGLAR
Sbjct: 807  VR-RDLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLDGDMTAHVGDFGLAR 865

Query: 240  FLPPTRTQ-------------------TKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             LP    Q                    +YG+G+EVS  GDVYSYGILLLE+    +P++
Sbjct: 866  LLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTN 925

Query: 281  IMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV 340
             +F+  +NLH FAK ALP  V +++D +L+ + E+    GD  +  + I   +EC+ ++V
Sbjct: 926  GLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEE--TSGDASRRMSHIGNHMECLAAIV 983

Query: 341  RIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK 375
            ++GVACS E P++RM++++V  EL+ I++ LLGP+
Sbjct: 984  KVGVACSAEFPRERMEISSVAVELRRIRHILLGPQ 1018

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255586722|ref|XP_002533985.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526036|gb|EEF28405.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  347 bits (891), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 206/447 (46%), Positives = 263/447 (58%), Gaps = 80/447 (17%)

Query: 1   MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGIS 59
           +D S NNLSG+I +FL+++ L  LNLS+NN EG VP  GV++N SATS+ GN+KLCGGI 
Sbjct: 493 LDLSHNNLSGQIPEFLSQIVLLQLNLSHNNFEGPVPAKGVFRNVSATSLEGNNKLCGGIP 552

Query: 60  KFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALS-ICFFF--------------- 103
           +F L  C S +     L   L +V++ V  LVG+ L L  I  FF               
Sbjct: 553 EFHLAPCISTRHKKSGLTHNLRIVVATVCVLVGVTLLLWVIVVFFLKKKRRKESSSSFSE 612

Query: 104 ----------------GFSHLRHQGA------FK---------------------IFKSF 120
                           GFS     GA      FK                      FKSF
Sbjct: 613 KKALELSYHTLYKATDGFSSANTLGAGSFGTVFKGELGGGETSIAVKVFNLMRHGAFKSF 672

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE 180
           IAEC+ALRNIRHRNL+KVLTAC  VDYQGN+FKALVYEF+ N S E+WL+P    DE   
Sbjct: 673 IAECEALRNIRHRNLVKVLTACSSVDYQGNEFKALVYEFMVNGSLEEWLHP---PDEAKA 729

Query: 181 RPR-NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
            PR NLN+L+RLNIA+DVA AL+YLH+ C+    HCDLKPSN+LLD++MT  VGDFGLA+
Sbjct: 730 IPRNNLNILQRLNIAVDVACALDYLHNHCETPIIHCDLKPSNILLDNEMTGHVGDFGLAK 789

Query: 240 FLPPTRTQT--------------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 285
           F      Q+              +YG GNEVST GDVYSYGILLLE+   ++P D  F  
Sbjct: 790 FYRERSHQSSSIGIRGSLGYAPAEYGTGNEVSTSGDVYSYGILLLEIFTGKRPMDDWFNE 849

Query: 286 DMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA 345
           D++LH + K ALP  V +I+D  L  + E  +     +++ A IN  +EC+IS+  IGVA
Sbjct: 850 DVSLHNYVKNALPEQVVEILDPTLFQEGEGGISL--IRRSNASINRTMECLISICEIGVA 907

Query: 346 CSMESPQDRMKMTNVVHELQSIKNTLL 372
           CS E+P +RM + +V  +L SI+N LL
Sbjct: 908 CSAETPGERMNICDVAGQLVSIRNKLL 934

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121306|ref|XP_002330794.1| predicted protein [Populus trichocarpa] gi|222872596|gb|EEF09727.1| predicted protein [Populus trichocarpa]

 Score =  343 bits (880), Expect = 8e-92,   Method: Compositional matrix adjust.
 Identities = 192/437 (43%), Positives = 266/437 (60%), Gaps = 65/437 (14%)

Query: 1   MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGI 58
           ++ S NNL+G I  F      L  LNLS+NN EG+VPT GV++N+SA SV GNSKLCGGI
Sbjct: 528 LNLSHNNLTGSIPDFFLDFRALATLNLSFNNFEGLVPTDGVFRNSSAVSVVGNSKLCGGI 587

Query: 59  SKFKLPKCGSKKSNGKRLPVALNL-------------------VISIVSGLVGLALALSI 99
           ++F+L +C  K +   RL +A+ L                     S++    G +L  ++
Sbjct: 588 AEFQLLECNFKGTKKGRLTLAMKLRKKVEPTPTSPENSVFQMSYRSLLKATDGFSLT-NL 646

Query: 100 CFFFGFSHLRHQG---------AFKIF--------KSFIAECKALRNIRHRNLIKVLTAC 142
               GF  + ++G         A K+         KSF AEC+ LRN+RHRNL+K+LTAC
Sbjct: 647 LGVGGFGSV-YKGILDNDEKLVAVKVLNLLNPRASKSFKAECEVLRNVRHRNLVKLLTAC 705

Query: 143 LGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE-DETYERPRNLNLLRRLNIAIDVASAL 201
            G DYQGNDFKALVYEF+ N S E+WL+PI+   DE  E  R+LN ++RLNIAID++ AL
Sbjct: 706 SGSDYQGNDFKALVYEFMVNGSLEEWLHPITPGIDEARESSRSLNFVQRLNIAIDISCAL 765

Query: 202 NYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR---------------- 245
            YLH  C+    HCDLKPSNVLLDD+M   VGDFGLARF P                   
Sbjct: 766 EYLHRGCRTPIVHCDLKPSNVLLDDEMIGHVGDFGLARFFPEATNNLSFNRSSTNGVRGT 825

Query: 246 ---TQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
              T  +YG+GNEVST GDV+SYGILLLE+   ++P+D++FE  +NLH + K ALP  V+
Sbjct: 826 IGYTAPEYGMGNEVSTSGDVFSYGILLLEMFSGKRPTDVIFEDSLNLHTYMKAALPGKVE 885

Query: 303 DIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH 362
           +I+D IL+ +     ++G++  +    + + +CV+S+  +G+ACS E P +RM ++ V  
Sbjct: 886 EILDPILVQE-----IKGERSSSYMWNSKVQDCVVSVFEVGIACSAELPSERMDISEVTA 940

Query: 363 ELQSIKNTLLGPKNLAT 379
           ELQ+IK  LL  +++ T
Sbjct: 941 ELQAIKEKLLRSEDMGT 957

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  342 bits (876), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 189/451 (41%), Positives = 266/451 (58%), Gaps = 77/451 (17%)

Query: 1    MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGI 58
            ++ S NNL+G+I +FL     L++LNLS+N+ EG VP  G ++N SA S+ GN KLCGGI
Sbjct: 570  LNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAISIFGNKKLCGGI 629

Query: 59   SKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFF--------------- 103
             +  L +C S +    + P  L  +I  V G +G+ L +S   F+               
Sbjct: 630  PQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIISFLLFYCFRKKKDKPAASQPS 689

Query: 104  ------------------GFS--HLRHQGAF-KIFK------------------------ 118
                              GFS  +L  +G+F  +FK                        
Sbjct: 690  LETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVLNLLRKGASK 749

Query: 119  SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
            SF+AEC+AL++IRHRNL+K+LT C  +D+QGNDFKALVYEF+ N + E+WL+P+   DE 
Sbjct: 750  SFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWLHPVQTSDEA 809

Query: 179  YERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
               P+ L+L+ RLNIAI +ASALNYLHHDCQ    HCDLKPSN+LLD +MTA VGDFGLA
Sbjct: 810  -NGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTAHVGDFGLA 868

Query: 239  RFLPPTRTQT--------------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
            RF      QT              +YG+G +VST GDVYSYGILLLE+   ++P D MF+
Sbjct: 869  RFHSEASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLLEMFTGKRPVDGMFK 928

Query: 285  GDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV 344
              +NLH +AKMALP+ + ++VD +L+ +   +    +        + I  C+++++++GV
Sbjct: 929  DGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPHEISACLMTIIKMGV 988

Query: 345  ACSMESPQDRMKMTNVVHELQSIKNTLLGPK 375
            ACS+E P++RM + +VV EL  IK+TLLG +
Sbjct: 989  ACSVELPRERMDIGDVVTELNRIKDTLLGTR 1019

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa]

 Score =  337 bits (864), Expect = 6e-90,   Method: Compositional matrix adjust.
 Identities = 203/452 (44%), Positives = 260/452 (57%), Gaps = 88/452 (19%)

Query: 3    FSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP-TGVYKNASATSVTGNSKLCGGISK 60
             S NNLSG+I +FL     L+ L+LSYN+ EG VP  GV++N S  SV GN KLCGGI +
Sbjct: 568  LSYNNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGVFENTSRISVQGNKKLCGGIPQ 627

Query: 61   FKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFF----------------- 103
              LPKC S +    +    L L+I+I  G +G+ L  S   F+                 
Sbjct: 628  LDLPKCTSNEPARPKSHTKLILIIAIPCGFLGIVLMTSFLLFYSRKTKDEPASGPSWESS 687

Query: 104  --------------GFS--HLRHQGAF-----------------KIF--------KSFIA 122
                          GFS  +L   GAF                 K+         KSF+A
Sbjct: 688  FQRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDGAVVAVKVLNLLRKGASKSFMA 747

Query: 123  ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
            EC AL NIRHRNL+KV+TAC   D+QGNDFKALVYEF+ N S E+WL+P+   D T E  
Sbjct: 748  ECAALINIRHRNLVKVITACSSNDFQGNDFKALVYEFMVNGSLEEWLHPVHISDVTPET- 806

Query: 183  RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP 242
            RNL+L++RLNIAIDVASAL+YLH+ CQ    HCDLKPSNVLL DDMTA VGDFGLARFLP
Sbjct: 807  RNLDLVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSNVLLGDDMTACVGDFGLARFLP 866

Query: 243  PTRTQ-------------------TKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 283
                Q                    +YG+G+EVST GDVYSYGILLLE+    +P+D MF
Sbjct: 867  EASNQLPADESSSVGLKGTIGYAAPEYGMGSEVSTYGDVYSYGILLLEMFTGRRPTDGMF 926

Query: 284  EGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG 343
            +   NLH +AKM LP++V + VD   L + E++    D  +       ++EC++S++++G
Sbjct: 927  KDGHNLHNYAKMVLPDNVLEFVDPT-LREHEEMNHNDDSHK-------VMECMVSIIKVG 978

Query: 344  VACSMESPQDRMKMTNVVHELQSIKNTLLGPK 375
            +ACS E P +RM + NVV EL  I+  L G K
Sbjct: 979  LACSAELPGERMGIANVVVELHRIREMLDGRK 1010

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	382
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.657	0.244	0.417	1.8e-65
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.659	0.249	0.389	6.6e-55
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.685	0.259	0.371	2.2e-54
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.664	0.246	0.366	2.4e-54
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.646	0.240	0.387	4.7e-52
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.667	0.252	0.363	4e-47
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.698	0.531	0.389	2.4e-37
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.350	0.136	0.396	9.6e-36
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.570	0.193	0.316	1.2e-30
TAIR|locus:2161158	1041	PXY "PHLOEM INTERCALATED WITH	0.615	0.225	0.322	2.3e-30

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 524 (189.5 bits), Expect = 1.8e-65, Sum P(2) = 1.8e-65
 Identities = 116/278 (41%), Positives = 164/278 (58%)

Query:   115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
             K  KSF AEC+ALRN+RHRNL+K++T C  +D +GNDFKA+VY+F+ N S E W++P   
Sbjct:   744 KALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHP-ET 802

Query:   175 EDETYERPXXXXXXXXXXIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVG 233
              D+  +R           I +DVA AL+YLH H  +PV  HCD+K SNVLLD DM A VG
Sbjct:   803 NDQADQR--HLNLHRRVTILLDVACALDYLHRHGPEPVV-HCDIKSSNVLLDSDMVAHVG 859

Query:   234 DFGLARFL--------PPTRTQ----------TKYGVGNEVSTIGDVYSYGILLLELMIR 275
             DFGLAR L          T +            +YGVG   ST GD+YSYGIL+LE++  
Sbjct:   860 DFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTG 919

Query:   276 EKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC 335
             ++P+D  F  D+ L ++ ++ L   V D+VD+ L+ D E  +         +    I EC
Sbjct:   920 KRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWL----NSTNNSPCRRITEC 975

Query:   336 VISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG 373
             ++ ++R+G++CS E P  R    +++ EL +IK  L G
Sbjct:   976 IVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNLSG 1013

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 432 (157.1 bits), Expect = 6.6e-55, Sum P(2) = 6.6e-55
 Identities = 107/275 (38%), Positives = 157/275 (57%)

Query:   107 HLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
             +++ +GA K   SF+AEC++L++IRHRNL+K+LTAC  +D+QGN+F+AL+YEF+ N S +
Sbjct:   734 NMQRRGAMK---SFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLD 790

Query:   167 KWLYPISKEDETYERPXXXXXXXXXX-IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD 225
              WL+P  +E E   RP           IAIDVAS L+YLH  C    AHCDLKPSNVLLD
Sbjct:   791 MWLHP--EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLD 848

Query:   226 DDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPS---DIM 282
             DD+TA V DFGLAR L     ++ +   N++S+ G   + G    E  +  +PS   D+ 
Sbjct:   849 DDLTAHVSDFGLARLLLKFDEESFF---NQLSSAGVRGTIGYAAPEYGVGGQPSINGDVY 905

Query:   283 FEGDMNLHKFAKMALPNHVKDIVDSILLND------DEKLVVRGDQKQTQAKINV---II 333
               G + L  F      N +     +  LN        E+++   D+      + V   ++
Sbjct:   906 SFGILLLEMFTGKRPTNEL--FGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVV 963

Query:   334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 368
             EC+  +  +G+ C  ESP +R+  + VV EL SI+
Sbjct:   964 ECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 431 (156.8 bits), Expect = 2.2e-54, Sum P(2) = 2.2e-54
 Identities = 106/285 (37%), Positives = 160/285 (56%)

Query:   107 HLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
             +++ +GA K   SF+AEC++L++IRHRNL+K+LTAC  +D+QGN+F+AL+YEF+ N S +
Sbjct:   733 NMQRRGAMK---SFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLD 789

Query:   167 KWLYPISKEDETYERPXXXXXXXXXX-IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD 225
             KWL+P  +E E   RP           IAIDVAS L+YLH  C    AHCDLKPSN+LLD
Sbjct:   790 KWLHP--EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLD 847

Query:   226 DDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPS---DIM 282
             DD+TA V DFGLAR L     ++ +   N++S+ G   + G    E  +  +PS   D+ 
Sbjct:   848 DDLTAHVSDFGLARLLLKFDQESFF---NQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVY 904

Query:   283 FEGDMNLHKFAKMALPNHVKDIVDSILLND------DEKLVVRGDQKQTQAKINV---II 333
               G + L  F      N +     +  LN        E+++   D+    + + V   ++
Sbjct:   905 SFGVLVLEMFTGKRPTNEL--FGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPVL 962

Query:   334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLA 378
             EC+  ++ +G+ C  ESP +R+  +    EL SI+      +  A
Sbjct:   963 ECLKGILDVGLRCCEESPLNRLATSEAAKELISIRERFFKTRRTA 1007

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 391 (142.7 bits), Expect = 2.4e-54, Sum P(2) = 2.4e-54
 Identities = 97/265 (36%), Positives = 140/265 (52%)

Query:   118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
             KSF+AEC+  + IRHRNL+K++T C  +D +GNDF+ALVYEF+   S + WL  +   + 
Sbjct:   752 KSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ-LEDLER 810

Query:   178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
               +            IAIDVASAL YLH  C    AHCD+KPSN+LLDDD+TA V DFGL
Sbjct:   811 VNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGL 870

Query:   238 ARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPS---DIMFEGDMNLHKFAK 294
             A+ L     ++     N+ S+ G   + G    E  +  +PS   D+   G + L  F+ 
Sbjct:   871 AQLLYKYDRESFL---NQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSG 927

Query:   295 MALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDR 354
                P   +       L+   K ++ G      +  N I E +  ++++G+ CS E P+DR
Sbjct:   928 KK-PTD-ESFAGDYNLHSYTKSILSGCTSSGGS--NAIDEGLRLVLQVGIKCSEEYPRDR 983

Query:   355 MKMTNVVHELQSIKNTLLGPKNLAT 379
             M+    V EL SI++     K   T
Sbjct:   984 MRTDEAVRELISIRSKFFSSKTTIT 1008

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 397 (144.8 bits), Expect = 4.7e-52, Sum P(2) = 4.7e-52
 Identities = 103/266 (38%), Positives = 146/266 (54%)

Query:   118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
             KSFIAEC+AL  IRHRNL+K++T C   D++GNDF+ALVYEF+ N + + WL+P  + +E
Sbjct:   759 KSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP-DEIEE 817

Query:   178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             T              IAIDVASAL YLH  C    AHCD+KPSN+LLD D+TA V DFGL
Sbjct:   818 TGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGL 877

Query:   238 ARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPS---DIMFEGDMNLHKFAK 294
             A+ L      T + +  + S+ G   + G    E  +   PS   D+   G + L  F  
Sbjct:   878 AQLLLKFDRDT-FHI--QFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTG 934

Query:   295 MALPNHVKDIVDSILLNDDEKLVVRGDQ----------KQTQAKINVIIECVISMVRIGV 344
                 N  K  VD + L+   K  ++  Q          +   A+   ++EC+  + R+GV
Sbjct:   935 KRPTN--KLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGV 992

Query:   345 ACSMESPQDRMKMTNVVHELQSIKNT 370
             +CS ESP +R+ M   + +L SI+ +
Sbjct:   993 SCSEESPVNRISMAEAISKLVSIRES 1018

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 391 (142.7 bits), Expect = 4.0e-47, Sum P(2) = 4.0e-47
 Identities = 99/272 (36%), Positives = 146/272 (53%)

Query:   107 HLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
             +++ +GA K   SF+AEC++L++ RHRNL+K+LTAC   D+QGN+F+AL+YE++ N S +
Sbjct:   735 NMQRRGAMK---SFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVD 791

Query:   167 KWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD 226
              WL+P  + +E    P          I IDVAS L+YLH  C    AHCDLKPSNVLL+D
Sbjct:   792 MWLHP-EEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLED 850

Query:   227 DMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPS---DIMF 283
             D+TA V DFGLAR L       K    N++S+ G   + G    E  +  +PS   D+  
Sbjct:   851 DLTAHVSDFGLARLLLKF---DKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYS 907

Query:   284 EGDMNLHKFAKMALPNHV----KDIVDSILLNDDEKLVVRGDQKQTQAKINV---IIECV 336
              G + L  F      + +      +     L   EK+    D+      + V     EC+
Sbjct:   908 FGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTAECL 967

Query:   337 ISMVRIGVACSMESPQDRMKMTNVVHELQSIK 368
               ++ +G+ C  E P +R+  + V  EL SI+
Sbjct:   968 TLVLEVGLRCCEEYPTNRLATSEVAKELISIR 999

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 401 (146.2 bits), Expect = 2.4e-37, P = 2.4e-37
 Identities = 113/290 (38%), Positives = 150/290 (51%)

Query:    86 IVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGV 145
             +  GL+GL   L          L+H GA K   SFIAEC++ + IRHRNL K++T C  +
Sbjct:   223 VFKGLLGLEEKLVAVKVLNL--LKH-GATK---SFIAECESFKGIRHRNLAKLITVCSSL 276

Query:   146 DYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLH 205
             D QGNDF+ALVYEF+   S + WL P   E                 IAIDVASAL YLH
Sbjct:   277 DSQGNDFRALVYEFMPKGSLDMWLQPEDLESAN-NHSRSLTFAEKVNIAIDVASALEYLH 335

Query:   206 HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSY 265
               C    AHCD+KPSNVLLDDD+TA V DFGLAR L     +T     N+ S+ G   + 
Sbjct:   336 VYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEKTFL---NQFSSAGVRGTI 392

Query:   266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHV-KDIVDSIL-----LNDDEKLVVR 319
             G    E  +  KPS    +GD+  + F  + L     K   D+       L+   K V+ 
Sbjct:   393 GYAAPEYGMGSKPS---IQGDV--YSFGVLLLEMFTGKKPTDNSFGGGYNLHGYTKSVL- 446

Query:   320 GDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 369
                  ++    ++ E +  ++ +G+ CS E P+DRM M   V EL SIK+
Sbjct:   447 -SCSTSRGGRTMVDEWLRLVLEVGIKCSEEYPRDRMGMAEAVRELVSIKS 495

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 223 (83.6 bits), Expect = 9.6e-36, Sum P(3) = 9.6e-36
 Identities = 61/154 (39%), Positives = 78/154 (50%)

Query:   113 AFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPI 172
             A +   SF  EC+ L+  RHRNLI+++T C      G  F ALV   + N S E+ LYP 
Sbjct:   696 ALEFSGSFKRECQILKRTRHRNLIRIITTC---SKPG--FNALVLPLMPNGSLERHLYPG 750

Query:   173 SKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV 232
                 +  +            I  DVA  + YLHH       HCDLKPSN+LLDD+MTA V
Sbjct:   751 EYSSKNLD------LIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALV 804

Query:   233 GDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYG 266
              DFG++R +         GV   VST  D  S+G
Sbjct:   805 TDFGISRLVQ--------GVEETVST-DDSVSFG 829

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 268 (99.4 bits), Expect = 1.2e-30, Sum P(2) = 1.2e-30
 Identities = 81/256 (31%), Positives = 136/256 (53%)

Query:   119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
             SF AE   L  IRHRN++++ + C    +QG++   L+YE++   S  + L+    +  +
Sbjct:   866 SFRAEILTLGKIRHRNIVRLYSFCY---HQGSNSNLLLYEYMSRGSLGELLH--GGKSHS 920

Query:   179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
              + P          IA+  A  L YLHHDC+P   H D+K +N+L+D++  A VGDFGLA
Sbjct:   921 MDWPTRFA------IALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLA 974

Query:   239 RFL--PPTRTQT----KYG-VGNE------VSTIGDVYSYGILLLELMIREKPSDIMFEG 285
             + +  P +++ +     YG +  E      V+   D+YS+G++LLEL+  + P   + +G
Sbjct:   975 KVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQG 1034

Query:   286 DMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA 345
               +L  + +    NH++D   S+     E L    D   T+ + +VI+  +I++ +I V 
Sbjct:  1035 G-DLATWTR----NHIRD--HSLT---SEIL----DPYLTKVEDDVILNHMITVTKIAVL 1080

Query:   346 CSMESPQDRMKMTNVV 361
             C+  SP DR  M  VV
Sbjct:  1081 CTKSSPSDRPTMREVV 1096

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)]

 Score = 283 (104.7 bits), Expect = 2.3e-30, Sum P(2) = 2.3e-30
 Identities = 88/273 (32%), Positives = 136/273 (49%)

Query:   109 RHQGAFKIFKS-FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
             +  G  +  KS  +AE   L N+RHRN++++L  C        D   L+YE++ N S + 
Sbjct:   754 KENGKIRRRKSGVLAEVDVLGNVRHRNIVRLLGCCTN-----RDCTMLLYEYMPNGSLDD 808

Query:   168 WLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
              L+     D+T              IAI VA  + YLHHDC PV  H DLKPSN+LLD D
Sbjct:   809 LLHG---GDKTMT--AAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDAD 863

Query:   228 MTARVGDFGLARFLPPTRTQT----KYG-VGNEVS-TI-----GDVYSYGILLLELMIRE 276
               ARV DFG+A+ +    + +     YG +  E + T+      D+YSYG++LLE++  +
Sbjct:   864 FEARVADFGVAKLIQTDESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGK 923

Query:   277 KPSDIMF-EGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC 335
             +  +  F EG+ ++  + +  L    K+ V+ +L             K      ++I E 
Sbjct:   924 RSVEPEFGEGN-SIVDWVRSKLKT--KEDVEEVL------------DKSMGRSCSLIREE 968

Query:   336 VISMVRIGVACSMESPQDRMKMTNVVHELQSIK 368
             +  M+RI + C+  SP DR  M +V+  LQ  K
Sbjct:   969 MKQMLRIALLCTSRSPTDRPPMRDVLLILQEAK 1001

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010089 "xylem development" evidence=IMP

GO:0010223 "secondary shoot formation" evidence=IMP

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00080287 hypothetical protein (1025 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	382
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-21
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-20
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-18
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-18
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-18
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-17
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-12
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-11
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-10
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-10
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-10
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-10
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-08
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-08
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-08
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-08
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-08
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-07
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-07
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-07
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-07
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-07
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-06
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-06
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-06
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-06
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-06
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-06
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-06
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-05
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-05
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-05
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-05
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-05
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-05
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-05
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-05
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-05
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-05
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-05
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-05
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-04
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-04
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-04
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-04
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-04
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-04
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-04
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-04
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-04
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-04
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-04
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-04
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-04
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-04
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-04
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-04
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-04
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.001
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.001
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	0.001
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	0.001
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	0.001
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	0.001
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	0.002
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.002
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.002
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	0.002
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	0.002
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.002
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.002
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.002
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	0.002
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	0.002
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	0.002
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	0.002
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.003
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	0.003
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	0.003
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.003
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.003
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	0.004
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	0.004
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	0.004
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	0.004
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	0.004
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	0.004
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.004
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	0.004
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	0.004
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.004
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	0.004
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 93.1 bits (232), Expect = 4e-22
 Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 31/179 (17%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           ++ + +  + +  + E + L+ + H N++K+     GV ++  +   LV E+    S + 
Sbjct: 26  IKKEDSSSLLEELLREIEILKKLNHPNIVKLY----GV-FEDENHLYLVMEYCEGGSLKD 80

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD-D 226
            L          E    L+    L I + +   L YLH     +  H DLKP N+LLD D
Sbjct: 81  LLK---------ENEGKLSEDEILRILLQILEGLEYLHS--NGI-IHRDLKPENILLDSD 128

Query: 227 DMTARVGDFGLARFLPPTRTQTKYGVGN-------------EVSTIGDVYSYGILLLEL 272
           +   ++ DFGL++ L   ++  K  VG                S   D++S G++L EL
Sbjct: 129 NGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 95.3 bits (237), Expect = 4e-21
 Identities = 111/429 (25%), Positives = 180/429 (41%), Gaps = 93/429 (21%)

Query: 1   MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP-TGVYKNASATSVTGNSKLCGGI 58
           +D SQN LSGEI K L  +  L  +N+S+N+L G +P TG +   +A++V GN  LCGG 
Sbjct: 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD 611

Query: 59  SKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLAL-ALSICFFFGFSHL------RHQ 111
           +   LP C   +      P     +   +   + LAL A    F  G ++L         
Sbjct: 612 TTSGLPPCKRVRKT----PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENED 667

Query: 112 GAF-------KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQG--------------N 150
           G +       K+ KS       L +++  N+I       G  Y+G              N
Sbjct: 668 GTWELQFFDSKVSKSITIN-DILSSLKEENVIS--RGKKGASYKGKSIKNGMQFVVKEIN 724

Query: 151 DFKALVYEFIHN----------------RSPEKWLYPISKEDE---TYERPRNLNLLRRL 191
           D  ++    I +                RS EK  Y I +  E     E  RNL+  RR 
Sbjct: 725 DVNSIPSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIHEYIEGKNLSEVLRNLSWERRR 783

Query: 192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD--DDMTARVGDFGL-----------A 238
            IAI +A AL +LH  C P     +L P  +++D  D+   R+   GL           A
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA 843

Query: 239 RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALP 298
              P TR +TK     +++   D+Y +G++L+EL+  + P+D  F    ++ ++A+    
Sbjct: 844 YVAPETR-ETK-----DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS 897

Query: 299 N-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKM 357
           + H+   +D           +RGD    Q +I       + ++ + + C+   P  R   
Sbjct: 898 DCHLDMWIDPS---------IRGDVSVNQNEI-------VEVMNLALHCTATDPTARPCA 941

Query: 358 TNVVHELQS 366
            +V+  L+S
Sbjct: 942 NDVLKTLES 950

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 35/225 (15%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           ++ +   K  +  + E K L+ ++H N++++        ++  D   LV E+        
Sbjct: 32  IKKKKIKKDRERILREIKILKKLKHPNIVRLYDV-----FEDEDKLYLVMEYCEGGDLFD 86

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
            L          ++   L+          + SAL YLH   + +  H DLKP N+LLD+D
Sbjct: 87  LL----------KKRGRLSEDEARFYLRQILSALEYLH--SKGI-VHRDLKPENILLDED 133

Query: 228 MTARVGDFGLARFLPPTRTQTKYGVG------------NEVSTIGDVYSYGILLLELMIR 275
              ++ DFGLAR L P    T + VG                   D++S G++L EL+  
Sbjct: 134 GHVKLADFGLARQLDPGEKLTTF-VGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG 192

Query: 276 EKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRG 320
           + P    F GD  L +  K               ++ + K ++R 
Sbjct: 193 KPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 84.1 bits (209), Expect = 1e-18
 Identities = 40/173 (23%), Positives = 73/173 (42%), Gaps = 37/173 (21%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ + H N+++     LGV  QG     +V E++        L        
Sbjct: 46  EEFLEEASIMKKLSHPNIVR----LLGVCTQGEPLY-IVTEYMPGGD----LL------- 89

Query: 178 TY--ERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
            +  +    L L   L +A+ +A  + YL   +   V  H DL   N L+ +++  ++ D
Sbjct: 90  DFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNF--V--HRDLAARNCLVTENLVVKISD 145

Query: 235 FGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
           FGL+R +       K G G               + ++  DV+S+G+LL E+ 
Sbjct: 146 FGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 29/173 (16%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           K F+ E + ++ + H N+++     LGV  +      LV E++       +L   S+   
Sbjct: 41  KDFLKEARVMKKLGHPNVVR----LLGVCTEEEPLY-LVLEYMEGGDLLDYLR-KSRPVF 94

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                  L+L   L+ AI +A  + YL    +    H DL   N L+ +D+  ++ DFGL
Sbjct: 95  PSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFV-HRDLAARNCLVGEDLVVKISDFGL 151

Query: 238 ARFLPP-----TRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           +R +        +T  K             G+    S   DV+S+G+LL E+ 
Sbjct: 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS---DVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 82.6 bits (205), Expect = 4e-18
 Identities = 41/172 (23%), Positives = 72/172 (41%), Gaps = 35/172 (20%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E + +R + H N++K+L  C   +        +V E++       +L        
Sbjct: 46  EEFLREARIMRKLDHPNIVKLLGVCTEEEPL-----MIVMEYMPGGDLLDYL-------- 92

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
              RP+ L+L   L+ A+ +A  + YL    +    H DL   N L+ +++  ++ DFGL
Sbjct: 93  RKNRPKELSLSDLLSFALQIARGMEYLES--KNFI-HRDLAARNCLVGENLVVKISDFGL 149

Query: 238 ARFLPPTRTQT----------------KYGVGNEVSTIGDVYSYGILLLELM 273
           +R L                       K G     S   DV+S+G+LL E+ 
Sbjct: 150 SRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 79.1 bits (196), Expect = 7e-17
 Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 32/170 (18%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E + +R + H N++K+L  C   +        +V E++       +L        
Sbjct: 46  EEFLREARIMRKLDHPNVVKLLGVCTEEEPL-----YIVMEYMEGGDLLSYLR------- 93

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             +    L+L   L+ A+ +A  + YL    +    H DL   N L+ +++  ++ DFGL
Sbjct: 94  --KNRPKLSLSDLLSFALQIARGMEYLES--KNFI-HRDLAARNCLVGENLVVKISDFGL 148

Query: 238 ARFLPPTRTQTKYGVGN--------EVSTIG------DVYSYGILLLELM 273
           +R L       K G G         E    G      DV+S+G+LL E+ 
Sbjct: 149 SRDLYDDDYYRKRG-GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 76.5 bits (189), Expect = 6e-16
 Identities = 43/177 (24%), Positives = 72/177 (40%), Gaps = 31/177 (17%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           K  ++   E + LR + H N+++++          +    LV E+         L+    
Sbjct: 40  KKDQTARREIRILRRLSHPNIVRLI----DAFEDKDHL-YLVMEYCEGGD----LFDYLS 90

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                     L+      IA+ +   L YLH     +  H DLKP N+LLD++   ++ D
Sbjct: 91  RG------GPLSEDEAKKIALQILRGLEYLHS--NGI-IHRDLKPENILLDENGVVKIAD 141

Query: 235 FGLARFLPPTRTQTKYGVG-------------NEVSTIGDVYSYGILLLELMIREKP 278
           FGLA+ L  + +     VG             N      DV+S G++L EL+  + P
Sbjct: 142 FGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 6e-13
 Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 31/166 (18%)

Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   +  +RH NL+++L    GV  QGN    +V E++   S   +L         
Sbjct: 46  AFLAEASVMTTLRHPNLVQLL----GVVLQGNPL-YIVTEYMAKGSLVDYL--------- 91

Query: 179 YERPRN---LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
             R R    + L ++L  A+DV   + YL      V  H DL   NVL+ +D+ A+V DF
Sbjct: 92  --RSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFV--HRDLAARNVLVSEDLVAKVSDF 146

Query: 236 GLARFLPPTRTQTKYGVG---------NEVSTIGDVYSYGILLLEL 272
           GLA+     +   K  V           + ST  DV+S+GILL E+
Sbjct: 147 GLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 48/202 (23%)

Query: 113 AFKIFKS--------FIAECKALRNIRHRNLIKVLTACLGVD--YQGNDF--KALVYEFI 160
           A KI KS        F  E +AL+ +RH++LI +   C   +  Y   +   K  +  F+
Sbjct: 34  AIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL 93

Query: 161 HNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPS 220
             RSPE                + L +   +++A  VA  + YL    +  + H DL   
Sbjct: 94  --RSPEG---------------QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAAR 133

Query: 221 NVLLDDDMTARVGDFGLARFL------------PPTRTQTKYGVGNEVSTIGDVYSYGIL 268
           N+L+ +D+  +V DFGLAR +            P   T  +       ST  DV+S+GIL
Sbjct: 134 NILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGIL 193

Query: 269 LLELMIREKPSDIMFEGDMNLH 290
           L E+    +   + + G MN H
Sbjct: 194 LYEMFTYGQ---VPYPG-MNNH 211

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 30/167 (17%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   +  +RH NL+++L    GV  +      +V E++   S   +L        
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLL----GVIVEEKGGLYIVTEYMAKGSLVDYL-------- 91

Query: 178 TYERPRNLNLL---RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
              R R  ++L     L  ++DV  A+ YL  +      H DL   NVL+ +D  A+V D
Sbjct: 92  ---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSD 145

Query: 235 FGLARFLPPTRTQTKYGVG---------NEVSTIGDVYSYGILLLEL 272
           FGL +    T+   K  V           + ST  DV+S+GILL E+
Sbjct: 146 FGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 65.9 bits (159), Expect = 7e-12
 Identities = 53/228 (23%), Positives = 78/228 (34%), Gaps = 39/228 (17%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           K  + F+ E + L ++ H   I  L       +Q      LV E++   S E  L  I  
Sbjct: 39  KEVERFLREIQILASLNHPPNIVKLYDF----FQDEGSLYLVMEYVDGGSLEDLLKKIG- 93

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVG 233
                 R   L+    L I   + SAL YLH        H D+KP N+LLD D    ++ 
Sbjct: 94  ------RKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLI 144

Query: 234 DFGLARFLPPTRT---------------------QTKYGVGNEVSTIGDVYSYGILLLEL 272
           DFGLA+ LP   +                               S+  D++S GI L EL
Sbjct: 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204

Query: 273 MIREKP---SDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLV 317
           +    P             L    ++  P+    +  S      +   
Sbjct: 205 LTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAAS 252

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 33/171 (19%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVD--YQGNDFKALVYEFIHNRSPEKWLYPISKE 175
           K F+AE + ++ +RH  LI++   C   +  Y       +V E +   S  ++L      
Sbjct: 46  KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY-------IVTELMKYGSLLEYL------ 92

Query: 176 DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
                  R L L + +++A  VAS + YL         H DL   NVL+ ++   +V DF
Sbjct: 93  --QGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADF 147

Query: 236 GLARFLPP----TRTQTKYGVG---------NEVSTIGDVYSYGILLLELM 273
           GLAR +       R   K+ +          N  S   DV+S+GILL E++
Sbjct: 148 GLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 47/185 (25%), Positives = 73/185 (39%), Gaps = 61/185 (32%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPI-------- 172
           ++E   LR ++H N+++         Y         Y+ I +RS +  LY +        
Sbjct: 47  VSEVNILRELKHPNIVR---------Y---------YDRIIDRSNQT-LYIVMEYCEGGD 87

Query: 173 --------SKEDETYERPRNLNLLRRLNIAIDVASALNYLHH--DCQPVTAHCDLKPSNV 222
                    KE +  E      +L +L        AL   H+  D      H DLKP+N+
Sbjct: 88  LAQLIQKCKKERKYIEEEFIWRILTQL------LLALYECHNRSDPGNTVLHRDLKPANI 141

Query: 223 LLDDDMTARVGDFGLARFLPPTRTQTKYGVG---------------NEVSTIGDVYSYGI 267
            LD +   ++GDFGLA+ L    +  K  VG               +E S   D++S G 
Sbjct: 142 FLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKS---DIWSLGC 198

Query: 268 LLLEL 272
           L+ EL
Sbjct: 199 LIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 28/165 (16%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E   +  + H+NL+++L   L   + G     +V E +   +   +L        
Sbjct: 44  QAFLEETAVMTKLHHKNLVRLLGVIL---HNG---LYIVMELMSKGNLVNFLR------- 90

Query: 178 TYERPRNL-NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
              R R L ++++ L  ++DVA  + YL         H DL   N+L+ +D  A+V DFG
Sbjct: 91  --TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFG 145

Query: 237 LARFLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLEL 272
           LAR        +K  V           + S+  DV+SYG+LL E+
Sbjct: 146 LARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 42/171 (24%), Positives = 79/171 (46%), Gaps = 33/171 (19%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVD--YQGNDFKALVYEFIHNRSPEKWLYPISKE 175
           ++F+ E + ++ +RH  L+++   C   +  Y       +V E++   S   +L    K 
Sbjct: 46  EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY-------IVTEYMSKGSLLDFL----KS 94

Query: 176 DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
            E     + L L + +++A  +A  + YL         H DL   N+L+ +++  ++ DF
Sbjct: 95  GEG----KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADF 147

Query: 236 GLARFLPP----TRTQTKYGV---GNEVSTIG------DVYSYGILLLELM 273
           GLAR +       R   K+ +     E +  G      DV+S+GILL E++
Sbjct: 148 GLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.5 bits (144), Expect = 5e-10
 Identities = 48/177 (27%), Positives = 73/177 (41%), Gaps = 34/177 (19%)

Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
            +  E   L+ + H N++K    C     QG     L+ E++   S   +L         
Sbjct: 52  GWKKEINILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYL--------- 99

Query: 179 YERPRN-LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
              P++ LNL + L  A  +   + YLH        H DL   NVLLD+D   ++GDFGL
Sbjct: 100 ---PKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGL 153

Query: 238 ARFLPPTRTQTK-----------YGV----GNEVSTIGDVYSYGILLLELMIREKPS 279
           A+ +P      +           Y V     N+ S   DV+S+G+ L EL+      
Sbjct: 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 59.4 bits (145), Expect = 5e-10
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 45/198 (22%)

Query: 116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE 175
           I  + + E   L+ ++H N++K+L               LV+E+  +   +K+L      
Sbjct: 41  IPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYLVFEYC-DMDLKKYL------ 88

Query: 176 DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
            +    P + NL++   I   +   L Y H        H DLKP N+L++ D   ++ DF
Sbjct: 89  -DKRPGPLSPNLIKS--IMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADF 142

Query: 236 GLAR-FLPPTRTQTKYGVGNEVSTI---------G--------DVYSYGILLLELMIREK 277
           GLAR F  P RT T      EV T+         G        D++S G +  E MI  K
Sbjct: 143 GLARAFGIPLRTYTH-----EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAE-MITGK 196

Query: 278 PSDIMFEGDMNLHKFAKM 295
           P   +F GD  + +  K+
Sbjct: 197 P---LFPGDSEIDQLFKI 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 50/232 (21%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           L H G  +    F  E + LR + H N++K    C   +  G     L+ E++ + S   
Sbjct: 41  LNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVC---EKPGGRSLRLIMEYLPSGSLRD 97

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
           +L    ++         +NL R L  +  +   ++YL    + +  H DL   N+L++ +
Sbjct: 98  YL-QRHRD--------QINLKRLLLFSSQICKGMDYLG-SQRYI--HRDLAARNILVESE 145

Query: 228 MTARVGDFGLARFLPPTRTQTKYGVGNE------------------VSTIGDVYSYGILL 269
              ++ DFGLA+ LP  +    Y    E                   S+  DV+S+G+ L
Sbjct: 146 DLVKISDFGLAKVLPEDK---DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202

Query: 270 LELMIREKPSDIMFEGDMNLH---KFAKMALPNHVKDIVDSI--LLNDDEKL 316
            EL            GD +     +F +M      + IV  +  LL + E+L
Sbjct: 203 YELFTY---------GDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 58.3 bits (142), Expect = 9e-10
 Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 37/145 (25%)

Query: 191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKY 250
           L+  + +  AL YLH   + +  H D+KP N+ L  +   ++GDFG+++ L  T    K 
Sbjct: 106 LDWFVQLCLALKYLHS--RKIL-HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT 162

Query: 251 GVG---------------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
            VG               N  S   D++S G +L EL   + P    FEG+ NL + A  
Sbjct: 163 VVGTPYYLSPELCQNKPYNYKS---DIWSLGCVLYELCTLKHP----FEGE-NLLELALK 214

Query: 296 -------ALPNHV----KDIVDSIL 309
                   +P+      +++V S+L
Sbjct: 215 ILKGQYPPIPSQYSSELRNLVSSLL 239

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 56.1 bits (136), Expect = 6e-09
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 14/98 (14%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           IA  +   L+YLH     +  H D+KPSN+L++     ++ DFG+++ L  T  Q    V
Sbjct: 104 IARQILKGLDYLHTKRHII--HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV 161

Query: 253 G------------NEVSTIGDVYSYGILLLELMIREKP 278
           G               S   D++S G+ LLE  + + P
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 46/166 (27%), Positives = 73/166 (43%), Gaps = 30/166 (18%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           FI E K +  + H NL+++   C     Q   F  +V E++ N     +L          
Sbjct: 46  FIEEAKVMMKLSHPNLVQLYGVCT---KQRPIF--IVTEYMANGCLLNYLR--------- 91

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           ER   L     L++  DV  A+ YL  +      H DL   N L+ +D   +V DFGLAR
Sbjct: 92  ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148

Query: 240 FLP----PTRTQTKYGVG---------NEVSTIGDVYSYGILLLEL 272
           ++      +   TK+ V          +  S+  DV+S+G+L+ E+
Sbjct: 149 YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 40/168 (23%), Positives = 77/168 (45%), Gaps = 29/168 (17%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 47  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 100

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                  +N +  L +A  ++SA+ YL         H DL   N L+ ++   +V DFGL
Sbjct: 101 -------VNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL 150

Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 151 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 40/130 (30%), Positives = 60/130 (46%), Gaps = 21/130 (16%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E K L+ + H N+IK+L     V     D   LV+EF+        LY + K     +R 
Sbjct: 48  EIKLLKELNHPNIIKLLD----VFRHKGDL-YLVFEFMDTD-----LYKLIK---DRQRG 94

Query: 183 RNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-F 240
              +L++  +    +   L + H H       H DLKP N+L++ +   ++ DFGLAR F
Sbjct: 95  LPESLIK--SYLYQLLQGLAFCHSHGI----LHRDLKPENLLINTEGVLKLADFGLARSF 148

Query: 241 LPPTRTQTKY 250
             P R  T Y
Sbjct: 149 GSPVRPYTHY 158

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 54.1 bits (131), Expect = 3e-08
 Identities = 26/125 (20%), Positives = 55/125 (44%), Gaps = 18/125 (14%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQ-GNDFKALVYEFIHNRSPEKWLYPISKED 176
           ++   E + L +++H N+++      G +     +   +  E++   S       +S   
Sbjct: 44  EALEREIRILSSLQHPNIVR----YYGSERDEEKNTLNIFLEYVSGGS-------LSSLL 92

Query: 177 ETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           + + +     ++R+      +   L YLH     V  H D+K +N+L+D D   ++ DFG
Sbjct: 93  KKFGKL-PEPVIRKY--TRQILEGLAYLH-SNGIV--HRDIKGANILVDSDGVVKLADFG 146

Query: 237 LARFL 241
            A+ L
Sbjct: 147 CAKRL 151

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 41/165 (24%), Positives = 66/165 (40%), Gaps = 38/165 (23%)

Query: 126 ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL 185
           A+ ++ H  ++++L  C G   Q      LV +     SP   L      D   +   +L
Sbjct: 62  AMGSLDHAYIVRLLGICPGASLQ------LVTQL----SPLGSLL-----DHVRQHRDSL 106

Query: 186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR 245
           +  R LN  + +A  + YL         H +L   N+LL  D   ++ DFG+A  L P  
Sbjct: 107 DPQRLLNWCVQIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163

Query: 246 TQTKYGVGNEVSTI-----------------GDVYSYGILLLELM 273
            +  Y   +E  T                   DV+SYG+ + E+M
Sbjct: 164 KKYFY---SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 53.0 bits (128), Expect = 7e-08
 Identities = 52/200 (26%), Positives = 74/200 (37%), Gaps = 79/200 (39%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF--------IHNRSP------- 165
           + E K L+ ++H N+I  L    G          LV+EF        I ++S        
Sbjct: 50  LREIKLLQELKHPNIIG-LLDVFGHK----SNINLVFEFMETDLEKVIKDKSIVLTPADI 104

Query: 166 EKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD 225
           + ++               L  LR           L YLH +      H DLKP+N+L+ 
Sbjct: 105 KSYM---------------LMTLR----------GLEYLHSN---WILHRDLKPNNLLIA 136

Query: 226 DDMTARVGDFGLARFLP-PTRTQT------------------KYGVGNEVSTIGDVYSYG 266
            D   ++ DFGLAR    P R  T                   YGVG       D++S G
Sbjct: 137 SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVG------VDMWSVG 190

Query: 267 ILLLELMIREKP-----SDI 281
            +  EL++R  P     SDI
Sbjct: 191 CIFAELLLR-VPFLPGDSDI 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 53.3 bits (129), Expect = 8e-08
 Identities = 38/130 (29%), Positives = 57/130 (43%), Gaps = 36/130 (27%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL--VYEF----IHNRSPEKWLYPISKED 176
           E K LR++RH N+I +L           DF  +  V E     +H     K +   S + 
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSP--EDFNDVYIVTELMETDLH-----KVIK--SPQP 99

Query: 177 ETYERPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTAR 231
            T +  +     +LR           L YLH      +A   H DLKPSN+L++ +   +
Sbjct: 100 LTDDHIQYFLYQILR----------GLKYLH------SANVIHRDLKPSNILVNSNCDLK 143

Query: 232 VGDFGLARFL 241
           + DFGLAR +
Sbjct: 144 ICDFGLARGV 153

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 48/175 (27%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E + LRN+ H N++K    C   +  GN  K L+ EF+ + S +++L            P
Sbjct: 56  EIEILRNLYHENIVKYKGIC--TEDGGNGIK-LIMEFLPSGSLKEYL------------P 100

Query: 183 RN---LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           RN   +NL ++L  A+ +   ++YL    Q V  H DL   NVL++ +   ++GDFGL +
Sbjct: 101 RNKNKINLKQQLKYAVQICKGMDYLGSR-QYV--HRDLAARNVLVESEHQVKIGDFGLTK 157

Query: 240 ---------------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
                                + P    Q+K+ + +      DV+S+G+ L EL+
Sbjct: 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS------DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 41/171 (23%), Positives = 78/171 (45%), Gaps = 30/171 (17%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E + ++ +RH  L+++            +   +V E++   S   +L     E  
Sbjct: 46  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGEMG 96

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
            Y     L L + +++A  +AS + Y+    +    H DL+ +N+L+ +++  +V DFGL
Sbjct: 97  KY-----LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGL 148

Query: 238 ARFLPPTRTQTKYG-------VGNEVSTIG------DVYSYGILLLELMIR 275
           AR +       + G          E +  G      DV+S+GILL EL  +
Sbjct: 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 199

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 52.1 bits (126), Expect = 9e-08
 Identities = 39/140 (27%), Positives = 57/140 (40%), Gaps = 31/140 (22%)

Query: 196 DVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGN 254
           ++  AL YLH         + DLKP N+LLD D   ++ DFGLA+ L    ++T    G 
Sbjct: 101 EIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT 156

Query: 255 ------EVSTIG------DVYSYGILLLELMIREKPSDIMFEGD-----MNLHKFAKMAL 297
                 EV          D +S G+LL E M+  KP    F  +             +  
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYE-MLTGKPP---FYAEDRKEIYEKILKDPLRF 212

Query: 298 PNHV----KDIVDSILLNDD 313
           P  +    +D++   LL  D
Sbjct: 213 PEFLSPEARDLISG-LLQKD 231

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 34/188 (18%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY----EFIHNR 163
           L+     K+ + F  E + + +++H N++ +L  C         F+ L +    EF+   
Sbjct: 43  LKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRN 102

Query: 164 SPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYL--HHDCQPVTAHCDLKPSN 221
           SP      +  E        +L+    L+IAI +A+ + YL  HH       H DL   N
Sbjct: 103 SPHS---DVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFV-----HRDLAARN 154

Query: 222 VLLDDDMTARVGDFGLARFLPPT---RTQTK--------------YGVGNEVSTIGDVYS 264
            L+ + +T ++ DFGL+R +      R Q+K              YG   + +T  D++S
Sbjct: 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG---KFTTESDIWS 211

Query: 265 YGILLLEL 272
           +G++L E+
Sbjct: 212 FGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 12/96 (12%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG- 251
           IA+ V   L YLH   + +  H D+KPSN+L++     ++ DFG++  L  +  +T  G 
Sbjct: 105 IAVAVLKGLTYLHEKHKII--HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGT 162

Query: 252 ---------VGNEVSTIGDVYSYGILLLELMIREKP 278
                     GN+ S   D++S G+ L+EL     P
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 55/192 (28%), Positives = 83/192 (43%), Gaps = 48/192 (25%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFIHNRSPEKWLYPI--SKEDET 178
           E K LR+ +H N+I +          G DFK   +V + +     E  L+ I  S +  T
Sbjct: 54  ELKILRHFKHDNIIAIRDILRP---PGADFKDVYVVMDLM-----ESDLHHIIHSDQPLT 105

Query: 179 YERPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
            E  R     LLR           L Y+H        H DLKPSN+L+++D   R+GDFG
Sbjct: 106 EEHIRYFLYQLLR----------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFG 152

Query: 237 LARFLPPTRTQTKYG-----------------VGNEVSTIGDVYSYGILLLELMIREKPS 279
           +AR L  + T+ KY                     E +T  D++S G +  E++ R +  
Sbjct: 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-- 210

Query: 280 DIMFEGDMNLHK 291
             +F G   +H+
Sbjct: 211 --LFPGKNYVHQ 220

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 43/183 (23%), Positives = 71/183 (38%), Gaps = 35/183 (19%)

Query: 115 KIFKSFIAECKALRNI-RHRNLIKVLTACLG-------VDY--QGNDFKALVYEFIHNRS 164
           K     ++E + ++ I +H+N+I +L  C         V+Y   GN     + +F+  R 
Sbjct: 57  KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN-----LRDFLRARR 111

Query: 165 PEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL 224
           P          D+       L     ++ A  VA  + +L         H DL   NVL+
Sbjct: 112 PPGEYA---SPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLV 165

Query: 225 DDDMTARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLL 270
            +D   ++ DFGLAR +       K   G                 +   DV+S+G+LL 
Sbjct: 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225

Query: 271 ELM 273
           E+ 
Sbjct: 226 EIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 36/192 (18%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY----EFIHNR 163
           L+ + +  +   F  E   +    H N++K+L  C         F+ + Y    EF+ +R
Sbjct: 43  LKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHR 102

Query: 164 SPEKWLYPISKEDETY----ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKP 219
           SP +    +S    +       P  L+   +L IA  VA+ + YL    +    H DL  
Sbjct: 103 SP-RAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLAT 158

Query: 220 SNVLLDDDMTARVGDFGLA-------------------RFLPPTRTQTKYGVGNEVSTIG 260
            N L+ ++M  ++ DFGL+                   R++PP          N  +T  
Sbjct: 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-----FYNRYTTES 213

Query: 261 DVYSYGILLLEL 272
           DV++YG++L E+
Sbjct: 214 DVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 44/212 (20%), Positives = 84/212 (39%), Gaps = 50/212 (23%)

Query: 123 ECKALRNIRHRNLIKVL-------TACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE 175
           E   L+N+ H ++I++          C+ + +    + + +Y ++  RS           
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH----YSSDLYTYLTKRS----------- 151

Query: 176 DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
                  R L + + L I   +   L YLH        H D+K  N+ ++D     +GD 
Sbjct: 152 -------RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDL 201

Query: 236 GLARFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREKPSDIM 282
           G A+F  P       G+   V T               D++S GI+L E++    PS I 
Sbjct: 202 GAAQF--PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML--AYPSTIF 257

Query: 283 FEGDMNLHKFAKMALPNHVKDIVDSILLNDDE 314
            +      ++ K    +H+  I+ ++ ++ +E
Sbjct: 258 EDPPSTPEEYVKSC-HSHLLKIISTLKVHPEE 288

Length = 357

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 34/133 (25%), Positives = 53/133 (39%), Gaps = 26/133 (19%)

Query: 123 ECKALRNIRHRNLIKVLTACL--GVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE 180
           E K LR +RH N++ +  A    G  Y       LV+E++            +  +    
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLY-------LVFEYVER----------TLLELLEA 92

Query: 181 RPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
            P  L      +    +  A+ Y H H+      H D+KP N+L+ +    ++ DFG AR
Sbjct: 93  SPGGLPPDAVRSYIWQLLQAIAYCHSHNI----IHRDIKPENILVSESGVLKLCDFGFAR 148

Query: 240 FL--PPTRTQTKY 250
            L   P    T Y
Sbjct: 149 ALRARPASPLTDY 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 30/171 (17%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           +SF+ E + ++ +RH  L+++            +   +V E++   S    L    K+ E
Sbjct: 46  ESFLEEAQIMKKLRHDKLVQLYAVV------SEEPIYIVTEYMSKGS----LLDFLKDGE 95

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                R L L   +++A  VA+ + Y+    +    H DL+ +N+L+ D +  ++ DFGL
Sbjct: 96  G----RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGL 148

Query: 238 ARFLPPTRTQTKYG-------VGNEVSTIG------DVYSYGILLLELMIR 275
           AR +       + G          E +  G      DV+S+GILL EL+ +
Sbjct: 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 51.4 bits (124), Expect = 3e-07
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 74/208 (35%)

Query: 121 IAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           I E K L+ +RH N+++   ++T+      +G+ +  +V+E++                 
Sbjct: 46  IREIKLLQKLRHPNIVRLKEIVTSKG----KGSIY--MVFEYM----------------- 82

Query: 178 TYERPRNLN-LLRRLNIAIDVA----------SALNYLHHDCQPVTAHCDLKPSNVLLDD 226
                 +L  LL    +    +            L YLH     +  H D+K SN+L+++
Sbjct: 83  ----DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-NGIL--HRDIKGSNILINN 135

Query: 227 DMTARVGDFGLARFLPPTRTQ--------------------TKYGVGNEVSTIGDVYSYG 266
           D   ++ DFGLAR      +                     T+Y  G EV    D++S G
Sbjct: 136 DGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY--GPEV----DMWSVG 189

Query: 267 ILLLELMIREKPSDIMFEGDMNLHKFAK 294
            +L EL +  KP   +F+G   L +  K
Sbjct: 190 CILAELFLG-KP---IFQGSTELEQLEK 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 44/180 (24%), Positives = 65/180 (36%), Gaps = 50/180 (27%)

Query: 67  GSKKSNGKRLPVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKSFIAECKA 126
               S GK +PVA+  + S           LS                 I   F+ E   
Sbjct: 15  EWSTSGGKVIPVAVKCLKSDK---------LS----------------DIMDDFLKEAAI 49

Query: 127 LRNIRHRNLIK----VLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           + ++ H NLI+    VLT  L           +V E     S    L    ++D      
Sbjct: 50  MHSLDHENLIRLYGVVLTHPL----------MMVTELAPLGS----LLDRLRKD----AL 91

Query: 183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP 242
            +  +    + A+ +A+ + YL         H DL   N+LL  D   ++GDFGL R LP
Sbjct: 92  GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALP 148

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 39/183 (21%), Positives = 70/183 (38%), Gaps = 38/183 (20%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           LR + + K  K  + E   + ++ H +++++L  CL    Q      L+ + +       
Sbjct: 44  LREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQ------LITQLM------- 90

Query: 168 WLYPISKEDETYERPR-NLNLLRRLNIAIDVASALNYL--HHDCQPVTAHCDLKPSNVLL 224
              P+    +     + N+     LN  + +A  ++YL           H DL   NVL+
Sbjct: 91  ---PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR-----LVHRDLAARNVLV 142

Query: 225 DDDMTARVGDFGLARFLPPTRTQTKYGVGN--------------EVSTIGDVYSYGILLL 270
                 ++ DFGLA+ L     +     G                 +   DV+SYG+ + 
Sbjct: 143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202

Query: 271 ELM 273
           ELM
Sbjct: 203 ELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 40/180 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           K F  E + L N +H N++K    C     +G D   +V+E++ +    K+L     +  
Sbjct: 53  KDFEREAELLTNFQHENIVKFYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAA 107

Query: 178 TYERPRN----LNLLRRLNIAIDVASALNYL--HHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             + P +    L L + L IA+ +AS + YL   H       H DL   N L+  D+  +
Sbjct: 108 FLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVK 162

Query: 232 VGDFGLA-------------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +GDFG++                   R++PP      Y    + +T  DV+S+G++L E+
Sbjct: 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP--ESIMYR---KFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 27/102 (26%), Positives = 47/102 (46%), Gaps = 21/102 (20%)

Query: 187 LLRRLNIAIDVASALNYLH--HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT 244
           L + + +A ++A  + YL           H DL   N ++ +D+T ++GDFG+ R +  T
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFV-----HRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172

Query: 245 RTQTKYGVG--------------NEVSTIGDVYSYGILLLEL 272
               K G G                 +T  DV+S+G++L E+
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 36/170 (21%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           KS + E   L+N++H N++K + +      + +D   ++ E+  N S    L  I K+  
Sbjct: 44  KSIMQEIDLLKNLKHPNIVKYIGS-----IETSDSLYIILEYAENGS----LRQIIKKFG 94

Query: 178 TYERPRNLNLLRRLNIAIDVA---SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
            +  P +L       +A+ V      L YLH   Q V  H D+K +N+L   D   ++ D
Sbjct: 95  PF--PESL-------VAVYVYQVLQGLAYLHE--QGVI-HRDIKAANILTTKDGVVKLAD 142

Query: 235 FGLARFLPPTRTQTKYGVG------------NEVSTIGDVYSYGILLLEL 272
           FG+A  L          VG            +  ST  D++S G  ++EL
Sbjct: 143 FGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIEL 192

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 49/178 (27%), Positives = 72/178 (40%), Gaps = 47/178 (26%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWL---YPI-SKED 176
           I E + L+ +RH N I         +Y+G           + R    WL   Y + S  D
Sbjct: 63  IKEVRFLQQLRHPNTI---------EYKG----------CYLREHTAWLVMEYCLGSASD 103

Query: 177 --ETYERPRNLNLLRRLNIAI---DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             E +++P     L+ + IA         L YLH        H D+K  N+LL +  T +
Sbjct: 104 ILEVHKKP-----LQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVK 155

Query: 232 VGDFGLARFLPPTRT--QTKYGVGNEV---------STIGDVYSYGILLLELMIREKP 278
           + DFG A  + P  +   T Y +  EV             DV+S GI  +EL  R+ P
Sbjct: 156 LADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 34/179 (18%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE 180
           I E   L+ + H N++++L     V +  N    LV+EF+ +   +K++      D +  
Sbjct: 46  IREISLLKELNHPNIVRLLD----VVHSENKL-YLVFEFL-DLDLKKYM------DSSPL 93

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR- 239
              +  L++     +     + Y H        H DLKP N+L+D +   ++ DFGLAR 
Sbjct: 94  TGLDPPLIKSYLYQL--LQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARA 148

Query: 240 FLPPTRTQTKYGV------------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
           F  P RT T   V              + ST  D++S G +  E M+  +P   +F GD
Sbjct: 149 FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAE-MVNRRP---LFPGD 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 41/182 (22%)

Query: 118 KSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           + F++E   +    H N+I    V+T    V         ++ EF+ N + + +L    +
Sbjct: 50  RDFLSEASIMGQFDHPNIIHLEGVVTKSRPV--------MIITEFMENGALDSFL---RQ 98

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
            D  +   + + +LR +   +   S +NY+H D         L   N+L++ ++  +V D
Sbjct: 99  NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRD---------LAARNILVNSNLVCKVSD 149

Query: 235 FGLARFLPPTRTQTKY--GVGNEV---------------STIGDVYSYGILLLELM-IRE 276
           FGL+RFL    +   Y   +G ++               ++  DV+SYGI++ E+M   E
Sbjct: 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 209

Query: 277 KP 278
           +P
Sbjct: 210 RP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 49.5 bits (119), Expect = 8e-07
 Identities = 43/181 (23%), Positives = 72/181 (39%), Gaps = 40/181 (22%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           +  +  I E + L+  +H N++K   +     Y   D   +V EF    S    L  + K
Sbjct: 39  EKKEKIINEIQILKKCKHPNIVKYYGS-----YLKKDELWIVMEFCSGGS----LKDLLK 89

Query: 175 EDETYERPRNLNLLRRLN------IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM 228
                      +  + L       +  ++   L YLH +      H D+K +N+LL  D 
Sbjct: 90  -----------STNQTLTESQIAYVCKELLKGLEYLHSNGI---IHRDIKAANILLTSDG 135

Query: 229 TARVGDFGLARFLPPTRTQ-----TKYGVGNEV------STIGDVYSYGILLLELMIREK 277
             ++ DFGL+  L  T+ +     T Y +  EV          D++S GI  +EL   + 
Sbjct: 136 EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKP 195

Query: 278 P 278
           P
Sbjct: 196 P 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 49.5 bits (118), Expect = 9e-07
 Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 30/166 (18%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           FI E K +  + H  L+++   C     Q   +  +V E++ N     +L       E  
Sbjct: 46  FIEEAKVMMKLSHEKLVQLYGVC---TKQRPIY--IVTEYMSNGCLLNYL------REHG 94

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           +R +   LL    +  DV   + YL    Q +  H DL   N L+DD    +V DFGL+R
Sbjct: 95  KRFQPSQLLE---MCKDVCEGMAYLESK-QFI--HRDLAARNCLVDDQGCVKVSDFGLSR 148

Query: 240 FLPPTRTQTKYGVGNEV-------------STIGDVYSYGILLLEL 272
           ++      +  G    V             S+  DV+++G+L+ E+
Sbjct: 149 YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 50/185 (27%), Positives = 77/185 (41%), Gaps = 30/185 (16%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           LR     +  K F+ E   + N  H N++K+L  CL      N+ + ++ E +       
Sbjct: 34  LRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQYIIMELMEGGD--- 85

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL--- 224
            L  +         P  L L   L+I +DVA    YL    Q    H DL   N L+   
Sbjct: 86  LLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEK 142

Query: 225 --DDDMTARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGIL 268
             D D   ++GDFGLAR +  +    K G G               + +T  DV+S+G+L
Sbjct: 143 GYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVL 202

Query: 269 LLELM 273
           + E++
Sbjct: 203 MWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 28/101 (27%), Positives = 43/101 (42%), Gaps = 16/101 (15%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
              ++  AL YLH   + +  H D+KP N+LLD+     + DF +A  + P  T T    
Sbjct: 105 WICEIVLALEYLHS--KGII-HRDIKPDNILLDEQGHVHITDFNIATKVTP-DTLTTSTS 160

Query: 253 GN------EV------STIGDVYSYGILLLELMIREKPSDI 281
           G       EV      S   D +S G+   E +  ++P   
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 38/180 (21%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYP------ 171
           K F  E + L N++H +++K    C   D    D   +V+E++ +    K+L        
Sbjct: 52  KDFQREAELLTNLQHEHIVKFYGVC--GD---GDPLIMVFEYMKHGDLNKFLRAHGPDAM 106

Query: 172 ISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
           I  + +  +    L L + L+IA  +AS + YL         H DL   N L+  ++  +
Sbjct: 107 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVK 163

Query: 232 VGDFGLA-------------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +GDFG++                   R++PP     +     + +T  DV+S+G++L E+
Sbjct: 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-----KFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 53/218 (24%), Positives = 87/218 (39%), Gaps = 48/218 (22%)

Query: 77  PVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKS-------FIAECKALRN 129
           P  L LV  I SG  GL        + G+   + + A K  +        FI E + +  
Sbjct: 3   PSELTLVQEIGSGQFGLV-------WLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMK 55

Query: 130 IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLR 189
           + H  L+++   C            LV+EF+ +     +L           R +     +
Sbjct: 56  LSHPKLVQLYGVCTE-----RSPICLVFEFMEHGCLSDYL-----------RAQRGKFSQ 99

Query: 190 R--LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP----P 243
              L + +DV   + YL         H DL   N L+ ++   +V DFG+ RF+      
Sbjct: 100 ETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156

Query: 244 TRTQTKYGV---GNEV------STIGDVYSYGILLLEL 272
           + T TK+ V     EV      S+  DV+S+G+L+ E+
Sbjct: 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 41/180 (22%), Positives = 76/180 (42%), Gaps = 44/180 (24%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E   +    H N+I++     GV  +      ++ E++ N S +K+L    +E++  
Sbjct: 52  FLTEASIMGQFDHPNIIRLE----GVVTKSRPV-MIITEYMENGSLDKFL----RENDGK 102

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
                L     + +   +AS + YL         H DL   N+L++ ++  +V DFGL+R
Sbjct: 103 FTVGQL-----VGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154

Query: 240 FL--------------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLELM-IREKP 278
            L                    P      K+      ++  DV+S+GI++ E+M   E+P
Sbjct: 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKF------TSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 41/231 (17%)

Query: 116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE 175
           I K+ +   KA R I          A L   +Q  D+  LV E+++       +  +   
Sbjct: 35  IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL 94

Query: 176 DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
            E + +              +V   +  LH        H D+KP N+L+D     ++ DF
Sbjct: 95  PEDWAK----------QYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDF 141

Query: 236 GLAR-------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKP---- 278
           GL+R             +L P   +T  GVG+    + D +S G ++ E +    P    
Sbjct: 142 GLSRNGLENKKFVGTPDYLAP---ETILGVGD--DKMSDWWSLGCVIFEFLFGYPPFHAE 196

Query: 279 -SDIMFE----GDMNLHKFAKMALPNHVKDIVDSILLND-DEKLVVRGDQK 323
             D +F+      +N  +  K        D+++ +L  D  ++L   G Q+
Sbjct: 197 TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 29/81 (35%), Positives = 38/81 (46%), Gaps = 16/81 (19%)

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-------FLPPTRTQTKYGVG---------NEVS 257
           H DL   N +LD+  T +V DFGLAR       +     T  K  V           + +
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFT 180

Query: 258 TIGDVYSYGILLLELMIREKP 278
           T  DV+S+G+LL ELM R  P
Sbjct: 181 TKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 48.3 bits (116), Expect = 3e-06
 Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 9/43 (20%)

Query: 200 ALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDFGLAR 239
           AL Y+H      +    H DLKPSN+LL+ D   ++ DFGLAR
Sbjct: 119 ALKYIH------SGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 14/126 (11%)

Query: 115 KIFKSFIAECKALR-NIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPIS 173
           K     ++E   ++  +RH N+++     L      ND   +V + I      +    + 
Sbjct: 50  KSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-----NDRLYIVMDLIEGAPLGEHFNSLK 104

Query: 174 KEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVG 233
           ++ + +   R        NI + +  AL YLH + + V  H DL P+N++L +D    + 
Sbjct: 105 EKKQRFTEER------IWNIFVQMVLALRYLHKEKRIV--HRDLTPNNIMLGEDDKVTIT 156

Query: 234 DFGLAR 239
           DFGLA+
Sbjct: 157 DFGLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 41/171 (23%), Positives = 78/171 (45%), Gaps = 30/171 (17%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E + ++ +RH  L+ +            +   +V EF+   S    L    KE +
Sbjct: 46  EAFLQEAQIMKKLRHDKLVPLYAVV------SEEPIYIVTEFMGKGS----LLDFLKEGD 95

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                + L L + +++A  +A  + Y+    +    H DL+ +N+L+ D++  ++ DFGL
Sbjct: 96  G----KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGL 148

Query: 238 ARFLPPTRTQTKYG-------VGNEVSTIG------DVYSYGILLLELMIR 275
           AR +       + G          E +  G      DV+S+GILL EL+ +
Sbjct: 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 38/172 (22%), Positives = 79/172 (45%), Gaps = 31/172 (18%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
            + E   L  + H+N++ +L  C+    +  +   ++Y +++  + + +L      +   
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCI----EDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN- 109

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
             P+ L+  + +++AI +A  ++YLH   +    H D+   N ++D+++  ++ D  L+R
Sbjct: 110 -NPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Query: 240 FLPPTRTQTKYG------------------VGNEVSTIGDVYSYGILLLELM 273
            L P      Y                   V  E S+  DV+S+G+LL ELM
Sbjct: 166 DLFP----MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 50/187 (26%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA-LVYEFIHNRSPEKWLYPISKEDETY 179
           I E   L+ + H N++K+L      D    + K  LV+EF+H +  +K++      D + 
Sbjct: 47  IREISLLKELNHPNIVKLL------DVIHTENKLYLVFEFLH-QDLKKFM------DASP 93

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVT-------AHCDLKPSNVLLDDDMTARV 232
                L L++            +YL    Q +         H DLKP N+L++ +   ++
Sbjct: 94  LSGIPLPLIK------------SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKL 141

Query: 233 GDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIGDVYSYGILLLELMIREKPS 279
            DFGLAR F  P RT T   V       E+       ST  D++S G +  E++ R    
Sbjct: 142 ADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA-- 199

Query: 280 DIMFEGD 286
             +F GD
Sbjct: 200 --LFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 47.9 bits (115), Expect = 3e-06
 Identities = 56/231 (24%), Positives = 90/231 (38%), Gaps = 76/231 (32%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIH-----------NRSPEKW- 168
           + E + L++IRH  L+ +  +     +Q +    LV E++             R PE   
Sbjct: 49  LNEKRILQSIRHPFLVNLYGS-----FQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA 103

Query: 169 -LYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
             Y                       A  V  AL YLH     V  + DLKP N+LLD D
Sbjct: 104 RFY-----------------------AAQVVLALEYLHS-LDIV--YRDLKPENLLLDSD 137

Query: 228 MTARVGDFGLARFLPPTRTQT-----KY---------GVGNEVSTIGDVYSYGILLLELM 273
              ++ DFG A+ +   RT T     +Y         G G  V    D ++ GIL+ E++
Sbjct: 138 GYIKITDFGFAKRV-KGRTYTLCGTPEYLAPEIILSKGYGKAV----DWWALGILIYEML 192

Query: 274 IREKPSDIMF--EGDMNLHKF---AKMALPNHV----KDIVDSILLNDDEK 315
               P    F  +  + +++     K+  P+      KD++ ++L  D  K
Sbjct: 193 AGYPP----FFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTK 239

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 45/194 (23%)

Query: 105 FSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTA-------CLGVDY--QGNDFKAL 155
            ++ +  G F+   S +AE      + H N++ +L         C+  +Y  QG+     
Sbjct: 45  INNPQQWGEFQQEASLMAE------LHHPNIVCLLGVVTQEQPVCMLFEYLNQGD----- 93

Query: 156 VYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHC 215
           ++EF+  RSP   +   S ED T +   +L+    L+IAI +A+ + YL         H 
Sbjct: 94  LHEFLIMRSPHSDVGCSSDEDGTVKS--SLDHGDFLHIAIQIAAGMEYL---SSHFFVHK 148

Query: 216 DLKPSNVLLDDDMTARVGDFGLARFLPPT---RTQTK--------------YGVGNEVST 258
           DL   N+L+ + +  ++ D GL+R +      R Q K              YG   + S+
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG---KFSS 205

Query: 259 IGDVYSYGILLLEL 272
             D++S+G++L E+
Sbjct: 206 DSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 13/119 (10%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E +  R+++H NL++ L  C  V         LV EF      + +L    K +   
Sbjct: 42  FLEEAQPYRSLQHSNLLQCLGQCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMT 96

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             P  L       +A ++A  L +LH +      H DL   N LL  D+T ++GD+GL+
Sbjct: 97  PDPTTLQ-----RMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 36/171 (21%), Positives = 68/171 (39%), Gaps = 22/171 (12%)

Query: 120 FIAECKALRNIRHRNLIKVLTACL-GVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           F++E   +++  H N++K++  C      Q      ++  F+ +     +L         
Sbjct: 48  FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL- 106

Query: 179 YERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
              P  L L   L   +D+A  + YL +       H DL   N +L +DMT  V DFGL+
Sbjct: 107 ---PEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLS 160

Query: 239 RF--------------LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           +               +P      +       ++  DV+++G+ + E+  R
Sbjct: 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 42/175 (24%), Positives = 80/175 (45%), Gaps = 33/175 (18%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F++E   +    H N+I++     GV  +      ++ E++ N + +K+L      D  +
Sbjct: 53  FLSEASIMGQFSHHNIIRLE----GVVTKFKPA-MIITEYMENGALDKYL---RDHDGEF 104

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
              + + +LR +   +   S +NY+H D         L   N+L++ ++  +V DFGL+R
Sbjct: 105 SSYQLVGMLRGIAAGMKYLSDMNYVHRD---------LAARNILVNSNLECKVSDFGLSR 155

Query: 240 FLP--PTRTQTKYG-------------VGNEVSTIGDVYSYGILLLELM-IREKP 278
            L   P  T T  G                + ++  DV+S+GI++ E+M   E+P
Sbjct: 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 34/113 (30%), Positives = 50/113 (44%), Gaps = 20/113 (17%)

Query: 195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ------T 248
           + + SAL ++H        H D+KP+NV +      ++GD GL RF     T       T
Sbjct: 113 VQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 249 KYGVGNEV------STIGDVYSYGILLLELMIREKPSDIMFEGD-MNLHKFAK 294
            Y +  E       +   D++S G LL E+   + P    F GD MNL+   K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 32/177 (18%)

Query: 118 KSFIAECKALRNI-RHRNLIKVLTAC-------LGVDYQ--GNDFKALVYEFIHNRSPEK 167
           + F  E + L  +  H N+I +L AC       + ++Y   GN    L    +    P  
Sbjct: 47  RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDP-- 104

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
                +KE  T     +  LL+    A DVA+ + YL  + Q +  H DL   NVL+ ++
Sbjct: 105 ---AFAKEHGTASTLTSQQLLQ---FASDVATGMQYLS-EKQFI--HRDLAARNVLVGEN 155

Query: 228 MTARVGDFGLARFLP----------PTRTQTKYGVGNEV-STIGDVYSYGILLLELM 273
           + +++ DFGL+R             P R      +   V +T  DV+S+G+LL E++
Sbjct: 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 35/189 (18%)

Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTAC-------LGVDYQGNDFKALVYEF 159
           L+     K     ++E + ++ I +H+N+I +L AC       + V+Y     K  + E+
Sbjct: 52  LKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYAS---KGNLREY 108

Query: 160 IHNRSPEKWLYPISKEDETYERP-RNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDL 217
           +  R P    Y      +T + P   L     ++ A  VA  + YL    C     H DL
Sbjct: 109 LRARRPPGMDYSF----DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDL 160

Query: 218 KPSNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVY 263
              NVL+ +D   ++ DFGLAR +              P +      + + V T   DV+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220

Query: 264 SYGILLLEL 272
           S+G+LL E+
Sbjct: 221 SFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 42/174 (24%), Positives = 76/174 (43%), Gaps = 38/174 (21%)

Query: 118 KSFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           + F++E   +    H N+I    V+T    V         +V E++ N S + +L    K
Sbjct: 50  RDFLSEASIMGQFDHPNIIHLEGVVTKSKPV--------MIVTEYMENGSLDAFL---RK 98

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
            D  +   + + +LR +   +   S + Y+H D         L   N+L++ ++  +V D
Sbjct: 99  HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNILVNSNLVCKVSD 149

Query: 235 FGLARFL---PPTRTQTKYG------------VGNEVSTIGDVYSYGILLLELM 273
           FGL+R L   P     T+ G               + ++  DV+SYGI++ E+M
Sbjct: 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 40/118 (33%), Positives = 56/118 (47%), Gaps = 25/118 (21%)

Query: 173 SKEDETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTAR 231
           SK++E  E    L+L   L  +  VA  +++L   +C     H D+   NVLL D   A+
Sbjct: 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAK 252

Query: 232 VGDFGLARFLPPTRTQTKYGV-GNE---------------VSTI-GDVYSYGILLLEL 272
           + DFGLAR +      + Y V GN                V T+  DV+SYGILL E+
Sbjct: 253 ICDFGLARDI---MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 39/142 (27%), Positives = 61/142 (42%), Gaps = 35/142 (24%)

Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-------------- 239
           A ++  AL YLH        + DLKP N+LLD +   ++ DFG A+              
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE 163

Query: 240 FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKF-----AK 294
           +L P   Q+K G    V    D ++ GIL+ E+++   P    F  D     +      K
Sbjct: 164 YLAPEVIQSK-GHNKAV----DWWALGILIYEMLVGYPP----FFDDNPFGIYEKILAGK 214

Query: 295 MALPNH----VKDIVDSILLND 312
           +  P H     KD++  +L+ D
Sbjct: 215 LEFPRHLDLYAKDLIKKLLVVD 236

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 32/90 (35%), Positives = 42/90 (46%), Gaps = 13/90 (14%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG----LARFLPPTRTQT 248
           IA  V   L+YLH        H D+KPSN+LL      ++ DFG    L   L  T T T
Sbjct: 110 IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGT 166

Query: 249 KYGV------GNEVSTIGDVYSYGILLLEL 272
            + +      G   S   DV+S G+ LLE+
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 20/99 (20%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL--PPTRTQ------- 247
           V   L YLH + Q    H D+K  N+LL +D + ++ DFG++  L     RT+       
Sbjct: 111 VLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167

Query: 248 -TKYGVGNEVSTIG-------DVYSYGILLLELMIREKP 278
            T   +  EV           D++S+GI  +EL     P
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 38/171 (22%), Positives = 79/171 (46%), Gaps = 36/171 (21%)

Query: 119 SFIAECKALRNIRHRNLIK---VLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE 175
           +F+AE   ++ ++H  L++   V+T          +   ++ E++ N S   +L    K 
Sbjct: 47  AFLAEANLMKQLQHPRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL----KT 93

Query: 176 DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
            E  +    L + + +++A  +A  + ++    +    H DL+ +N+L+ + +  ++ DF
Sbjct: 94  PEGIK----LTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADF 146

Query: 236 GLARFLPPTRTQTKYG------------VGNEVSTI-GDVYSYGILLLELM 273
           GLAR +       + G            +     TI  DV+S+GILL E++
Sbjct: 147 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 31/126 (24%)

Query: 201 LNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------TR-------- 245
           L Y+H        H DLKPSN+L++++   ++ DFGLAR   P       TR        
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIM 177

Query: 246 -TQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--LPNHVK 302
            T  KY V  EV    D++S G +  E M+  KP   +F G  ++++F+ +   L     
Sbjct: 178 LTWQKYDV--EV----DIWSAGCIFAE-MLEGKP---LFPGKDHVNQFSIITDLLGTPPD 227

Query: 303 DIVDSI 308
           D++++I
Sbjct: 228 DVINTI 233

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 40/158 (25%), Positives = 59/158 (37%), Gaps = 48/158 (30%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------- 244
            AL YLH        H DLKP N+LLD DM  ++ DFG A+ L P               
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 245 ------RTQTKYGVG------------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                 R +    VG                   D+++ G ++ + M+  KP    F G 
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQ-MLTGKP---PFRGS 225

Query: 287 MNLHKFAK-MAL--------PNHVKDIVDSILLNDDEK 315
                F K + L        P   KD+++ +L+ D + 
Sbjct: 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQD 263

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 52/222 (23%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           K  + E K +R + H N++KV    LG    G+D    V       S    +Y + +  E
Sbjct: 47  KHALREIKIIRRLDHDNIVKVYEV-LGP--SGSDLTEDVGSLTELNS----VYIVQEYME 99

Query: 178 TYERPRNLNLLRRLNIAIDVAS--------ALNYLHHDCQPVTAHCDLKPSNVLLD-DDM 228
           T       N+L +  ++ + A          L Y+H        H DLKP+NV ++ +D+
Sbjct: 100 TDLA----NVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDL 152

Query: 229 TARVGDFGLARFLPPTRTQTKYGVGNEVST----------------IGDVYSYGILLLEL 272
             ++GDFGLAR + P  +   Y     V+                   D+++ G +  E 
Sbjct: 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE- 211

Query: 273 MIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDE 314
           M+  KP   +F G    H+  +M L      I++S+ +  +E
Sbjct: 212 MLTGKP---LFAGA---HELEQMQL------ILESVPVVREE 241

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 34/178 (19%)

Query: 118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
           + F  E + L  +  H N+I +L AC   +++G  + A+ Y      +P   L    ++ 
Sbjct: 52  RDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAIEY------APHGNLLDFLRKS 102

Query: 177 ETYERPRNLNLLRR----------LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD 226
              E      +             L+ A DVA  ++YL    Q    H DL   N+L+ +
Sbjct: 103 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGE 159

Query: 227 DMTARVGDFGLARFLP----------PTRTQTKYGVGNEV-STIGDVYSYGILLLELM 273
           +  A++ DFGL+R             P R      +   V +T  DV+SYG+LL E++
Sbjct: 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 42/178 (23%), Positives = 80/178 (44%), Gaps = 35/178 (19%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLY---PISK 174
           K F  E + L N++H +++K    C+    +G+    +V+E++ +    K+L    P + 
Sbjct: 52  KDFHREAELLTNLQHEHIVKFYGVCV----EGDPL-IMVFEYMKHGDLNKFLRAHGPDAV 106

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                 RP  L   + L+IA  +A+ + YL         H DL   N L+ +++  ++GD
Sbjct: 107 LMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGD 163

Query: 235 FGLA-------------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
           FG++                   R++PP     +     + +T  DV+S G++L E+ 
Sbjct: 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-----KFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 34/126 (26%), Positives = 54/126 (42%), Gaps = 26/126 (20%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIH-------NRSPEKWLYPIS 173
           IA  K L +  H N++++L  C G          LV+E +        ++ P+  L P  
Sbjct: 49  IALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPP-- 106

Query: 174 KEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVG 233
                       +L+R+L         +++LH        H DLKP N+L+  D   ++ 
Sbjct: 107 --------ETIKDLMRQL------LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIA 149

Query: 234 DFGLAR 239
           DFGLAR
Sbjct: 150 DFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 21/158 (13%)

Query: 185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLP 242
            +L R    A ++   L +LH        + DLK  N+LLD D   ++ DFG+ +   L 
Sbjct: 93  FDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG 149

Query: 243 PTRTQTKYG----------VGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDM 287
             +T T  G          +G + +T  D +S+G+LL E++I + P      + +F+   
Sbjct: 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209

Query: 288 NLHKFAKMALPNHVKDIVDSILLNDDEK-LVVRGDQKQ 324
             +      L    KDI+  + + + E+ L V+GD +Q
Sbjct: 210 MDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 54/206 (26%), Positives = 82/206 (39%), Gaps = 57/206 (27%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPI-------- 172
           I E   L+ ++H N++++                   + +H+   EK LY +        
Sbjct: 49  IREISLLKEMQHGNIVRL------------------QDVVHS---EKRLYLVFEYLDLDL 87

Query: 173 -SKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA- 230
               D + +  +N  L++     I     + Y H        H DLKP N+L+D    A 
Sbjct: 88  KKHMDSSPDFAKNPRLIKTYLYQI--LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNAL 142

Query: 231 RVGDFGLAR-FLPPTRTQTKYGV------------GNEVSTIGDVYSYGILLLELMIREK 277
           ++ DFGLAR F  P RT T   V                ST  D++S G +  E M+ +K
Sbjct: 143 KLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAE-MVNQK 201

Query: 278 PSDIMFEGDM---NLHK-FAKMALPN 299
           P   +F GD     L K F  +  PN
Sbjct: 202 P---LFPGDSEIDELFKIFRILGTPN 224

Length = 294

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 32/110 (29%), Positives = 49/110 (44%), Gaps = 17/110 (15%)

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           E P  L L   +   ID+AS + YL         H DL   N +L+++MT  V DFGL++
Sbjct: 105 EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSK 161

Query: 240 --------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
                          LP      +    N  +T  DV+++G+ + E+M R
Sbjct: 162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 33/86 (38%), Positives = 43/86 (50%), Gaps = 17/86 (19%)

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L+D+    ++ DFGLAR F  P R  T   V       EV       ST  
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPV 183

Query: 261 DVYSYGILLLELMIREKPSDIMFEGD 286
           D++S G +  E M  +KP   +F GD
Sbjct: 184 DIWSIGTIFAE-MATKKP---LFHGD 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 39/181 (21%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E + LR++ H N++K    C  +     + + L+ EF+   S E     I+ E    +  
Sbjct: 122 EIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADEQFLAD-- 172

Query: 183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL- 241
                     +A  + S + YLH   +    H D+KPSN+L++     ++ DFG++R L 
Sbjct: 173 ----------VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219

Query: 242 ----------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 285
                            P R  T    G      GD++S G+ +LE  +   P  +  +G
Sbjct: 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG 279

Query: 286 D 286
           D
Sbjct: 280 D 280

Length = 353

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 32/117 (27%), Positives = 54/117 (46%), Gaps = 18/117 (15%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E KAL+  +H  ++K+L         G+ F  LV E++ +      L  + ++    ERP
Sbjct: 49  EIKALQACQHPYVVKLLDVFP----HGSGF-VLVMEYMPSD-----LSEVLRD---EERP 95

Query: 183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
                ++     +     + Y+H        H DLKP+N+L+  D   ++ DFGLAR
Sbjct: 96  LPEAQVKSYMRML--LKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLAR 147

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 31/187 (16%)

Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACL--GVDYQGNDF--KALVYEFIHN 162
           L+     K     I+E + ++ I +H+N+I +L AC   G  Y   ++  K  + E++  
Sbjct: 58  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 117

Query: 163 RSPEKWLY---PISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKP 219
           R P    Y   P    +E       L+    ++ A  VA  + YL         H DL  
Sbjct: 118 RRPPGMEYCYNPTQVPEE------QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168

Query: 220 SNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYSY 265
            NVL+ +D   ++ DFGLAR +              P +      + + + T   DV+S+
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228

Query: 266 GILLLEL 272
           G+LL E+
Sbjct: 229 GVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 34/113 (30%), Positives = 49/113 (43%), Gaps = 20/113 (17%)

Query: 195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVG- 253
           + + SAL ++H        H D+KP+NV +      ++GD GL RF     T     VG 
Sbjct: 113 VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 254 -----------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-MNLHKFAK 294
                      N  +   D++S G LL E+   + P    F GD MNL+   K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 21/130 (16%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E + L+ ++H NL+ ++       ++      LV+E+  +          +  +E  + P
Sbjct: 50  EIRMLKQLKHPNLVNLIEV-----FRRKRKLHLVFEYCDH----------TVLNELEKNP 94

Query: 183 RNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL 241
           R +       I      A+N+ H H+C     H D+KP N+L+      ++ DFG AR L
Sbjct: 95  RGVPEHLIKKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL 150

Query: 242 -PPTRTQTKY 250
             P    T Y
Sbjct: 151 TGPGDDYTDY 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 15/84 (17%)

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEV------STIGDV 262
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV          D+
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 200

Query: 263 YSYGILLLELMIREKPSDIMFEGD 286
           +S G ++ E MIR     ++F G 
Sbjct: 201 WSVGCIMGE-MIRGT---VLFPGT 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 20/96 (20%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           IA+    ALNYL  + + +  H D+KPSN+LLD +   ++ DFG++  L           
Sbjct: 112 IAVATVKALNYLKEELKII--HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG 169

Query: 242 -----PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
                 P R       G +V +  DV+S GI L E+
Sbjct: 170 CRPYMAPERIDPSARDGYDVRS--DVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 40/182 (21%), Positives = 82/182 (45%), Gaps = 28/182 (15%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E K +  +++ N+I++L  C+      +D   ++ E++ N    ++L     E  T+
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIE-STF 117

Query: 180 ERPRNLNLLRRLNI---AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
               N+  +   N+   A+ +AS + YL         H DL   N L+ +  T ++ DFG
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFG 174

Query: 237 LAR--------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMI--REKPSD 280
           ++R               LP      +  +  + +T  DV+++G+ L E+    +E+P  
Sbjct: 175 MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234

Query: 281 IM 282
           ++
Sbjct: 235 LL 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 40/135 (29%), Positives = 53/135 (39%), Gaps = 24/135 (17%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY---EFIHNRSPEKWLYP 171
           K  K    E K L  ++H NL+K      GV+         VY   E+    + E+ L  
Sbjct: 41  KTIKEIADEMKVLELLKHPNLVK----YYGVEVHREK----VYIFMEYCSGGTLEELLEH 92

Query: 172 ISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
               DE   R   L LL            L YLH        H D+KP+N+ LD +   +
Sbjct: 93  GRILDEHVIRVYTLQLLE----------GLAYLH---SHGIVHRDIKPANIFLDHNGVIK 139

Query: 232 VGDFGLARFLPPTRT 246
           +GDFG A  L    T
Sbjct: 140 LGDFGCAVKLKNNTT 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 56/190 (29%), Positives = 80/190 (42%), Gaps = 47/190 (24%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEF----IHN--RSPEKWLYPISK 174
           E K LR++ H N+I +             F    +VYE     +H   RS +     +S 
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPP--HREAFNDVYIVYELMDTDLHQIIRSSQ----TLSD 107

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
           +   Y       LLR L     + SA N LH D         LKPSN+LL+ +   ++ D
Sbjct: 108 DHCQYFL---YQLLRGLKY---IHSA-NVLHRD---------LKPSNLLLNANCDLKICD 151

Query: 235 FGLARFLPPTRTQ-TKYGVG------------NEVSTIGDVYSYGILLLELMIREKPSDI 281
           FGLAR         T+Y V             +E +T  DV+S G +  EL+ R KP   
Sbjct: 152 FGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR-KP--- 207

Query: 282 MFEGDMNLHK 291
           +F G   +H+
Sbjct: 208 LFPGKDYVHQ 217

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 45/192 (23%), Positives = 77/192 (40%), Gaps = 39/192 (20%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE 180
           +A  K L    H N+++++  C            LV+E + ++    +L  +       E
Sbjct: 50  VALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAE 108

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF 240
             ++L  +R+          L++LH +C     H DLKP N+L+      ++ DFGLAR 
Sbjct: 109 TIKDL--MRQF------LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157

Query: 241 L-----------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 283
                             P    Q+ Y      +T  D++S G +  E M R KP   +F
Sbjct: 158 YSCQMALTPVVVTLWYRAPEVLLQSTY------ATPVDMWSVGCIFAE-MFRRKP---LF 207

Query: 284 EGDMNLHKFAKM 295
            G+    +  K+
Sbjct: 208 CGNSEADQLGKI 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 44.8 bits (107), Expect = 4e-05
 Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 29/140 (20%)

Query: 123 ECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYER 181
           E K+LR +  H N++K+        ++ ND    V+E++     E  LY + K+ +   +
Sbjct: 47  EVKSLRKLNEHPNIVKLKEV-----FRENDELYFVFEYM-----EGNLYQLMKDRK--GK 94

Query: 182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDFGLA 238
           P + +++R  +I   +   L ++H           H DLKP N+L+      ++ DFGLA
Sbjct: 95  PFSESVIR--SIIYQILQGLAHIHK------HGFFHRDLKPENLLVSGPEVVKIADFGLA 146

Query: 239 RFLPPTRTQTKYGVGNEVST 258
           R +      T Y     VST
Sbjct: 147 REIRSRPPYTDY-----VST 161

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 35/122 (28%), Positives = 53/122 (43%), Gaps = 21/122 (17%)

Query: 169 LYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM 228
           +Y + +E+  +  PR             + S L +LH   Q    + DLKP NVLLD+D 
Sbjct: 84  IYNVDEENPGFPEPRACFY------TAQIISGLEHLH---QRRIIYRDLKPENVLLDNDG 134

Query: 229 TARVGDFGLARFLPPTRTQTK-YG-----------VGNEVSTIGDVYSYGILLLELMIRE 276
             R+ D GLA  L   +++TK Y             G E     D ++ G+ L E++   
Sbjct: 135 NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Query: 277 KP 278
            P
Sbjct: 195 GP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 33/109 (30%), Positives = 49/109 (44%), Gaps = 29/109 (26%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           IA+ +  AL YLH     +  H D+KPSNVL++ +   ++ DFG++ +L           
Sbjct: 108 IAVSIVKALEYLHSKLSVI--HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165

Query: 242 -----PPTR-----TQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
                 P R      Q  Y V +      DV+S GI ++EL     P D
Sbjct: 166 CKPYMAPERINPELNQKGYDVKS------DVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 28/98 (28%), Positives = 44/98 (44%), Gaps = 18/98 (18%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTK-- 249
           + + +   L YLH +      H DLK SN+LL D    ++ DFGLAR +  P +  T   
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169

Query: 250 -----------YGVGNEVSTIGDVYSYGILLLELMIRE 276
                       G     + I D+++ G +L EL+  +
Sbjct: 170 VTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 35/143 (24%), Positives = 66/143 (46%), Gaps = 22/143 (15%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA---LVYEFI-HNRSPEKWLYPISKEDET 178
           E K L+ ++H N++ ++  C       N +K    LV+EF  H+ +       +S ++  
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGL-----LSNKNVK 115

Query: 179 YERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
           +       +++ L       + L Y+H +      H D+K +N+L+  D   ++ DFGLA
Sbjct: 116 FTLSEIKKVMKML------LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166

Query: 239 R-FLPPTRTQ-TKYGVGNEVSTI 259
           R F     ++  +Y   N V T+
Sbjct: 167 RAFSLSKNSKPNRY--TNRVVTL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 29/105 (27%), Positives = 45/105 (42%), Gaps = 19/105 (18%)

Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTKYG 251
           A ++   L +LH   +    + DLK  NVLLD +   ++ DFG+ +   L    T T  G
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158

Query: 252 V----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                              D ++ G+LL E++  + P    FEGD
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEGD 199

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 44.1 bits (105), Expect = 5e-05
 Identities = 30/109 (27%), Positives = 48/109 (44%), Gaps = 21/109 (19%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +  +V   L YLH   Q V  H D+K  N+LL  D + ++ DFG A  L   +++    V
Sbjct: 121 VCREVLQGLEYLHS--QNVI-HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177

Query: 253 G------------NEVSTIGDVYSYGILLLELM------IREKPSDIMF 283
           G             +     D++S GI+ +E+       +RE P   +F
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 31/117 (26%), Positives = 52/117 (44%), Gaps = 27/117 (23%)

Query: 187 LLRRLN----------IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           LL+R+           + + +  AL+YL      +  H D+KPSN+LLD     ++ DFG
Sbjct: 103 LLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVI--HRDVKPSNILLDASGNVKLCDFG 160

Query: 237 LARFLPPTRTQTKYG-----VGNEVSTI----------GDVYSYGILLLELMIREKP 278
           ++  L  ++ +T+       +  E               DV+S GI L+EL   + P
Sbjct: 161 ISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 41/178 (23%), Positives = 67/178 (37%), Gaps = 52/178 (29%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           K F+ E   +  + H  +++++  C G      +   LV E        K+L        
Sbjct: 41  KEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVMELAPLGPLLKYL-------- 86

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             ++ R + +     +A  VA  + YL      V  H DL   NVLL +   A++ DFG+
Sbjct: 87  --KKRREIPVSDLKELAHQVAMGMAYLE-SKHFV--HRDLAARNVLLVNRHQAKISDFGM 141

Query: 238 ARFLPPTRTQTKYGVGNE------------------------VSTIGDVYSYGILLLE 271
           +R L         G G++                         S+  DV+SYG+ L E
Sbjct: 142 SRAL---------GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWE 190

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 44/158 (27%), Positives = 58/158 (36%), Gaps = 40/158 (25%)

Query: 185 LNLLRR-----------LNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARV 232
           LN LRR           L+ +  VA  + +L   +C     H DL   NVLL      ++
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKI 182

Query: 233 GDFGLAR--------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLE---LMIR 275
            DFGLAR               LP      +       +   DV+SYGILL E   L   
Sbjct: 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN 242

Query: 276 EKPSDIMFEGDMNLHKFAK----MALPNHVKDIVDSIL 309
             P   +   D   +K  K    MA P H    +  I+
Sbjct: 243 PYPGMPV---DSKFYKLIKEGYRMAQPEHAPAEIYDIM 277

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 34/103 (33%), Positives = 45/103 (43%), Gaps = 19/103 (18%)

Query: 185 LNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR---- 239
           L  L  L+    VA  + +L   +C     H DL   NVLL      ++ DFGLAR    
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMH 289

Query: 240 ----------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
                     FLP      +    N  +T+ DV+SYGILL E+
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 40/174 (22%), Positives = 78/174 (44%), Gaps = 23/174 (13%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E   ++     +++++L    GV  QG     ++ E +     + +L  +  E E  
Sbjct: 56  FLNEASVMKEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENN 110

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
                 +L + + +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R
Sbjct: 111 PVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Query: 240 FLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
            +  T    K G G                 +T  DV+S+G++L E+  + E+P
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 39/180 (21%), Positives = 75/180 (41%), Gaps = 43/180 (23%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLY---PISK-- 174
           F  E + L  ++H+++++    C            +V+E++ +    ++L    P +K  
Sbjct: 54  FQREAELLTVLQHQHIVRFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKIL 108

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYL---HHDCQPVTAHCDLKPSNVLLDDDMTAR 231
                  P  L L + L IA  +AS + YL   H        H DL   N L+   +  +
Sbjct: 109 AGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVK 162

Query: 232 VGDFGLA-------------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +GDFG++                   R++PP     +     + +T  D++S+G++L E+
Sbjct: 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-----KFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 24/154 (15%)

Query: 191 LNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR---------- 239
           +  +  VA+ + +L   +C     H DL   NVL+ +    ++ DFGLAR          
Sbjct: 242 VGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS 297

Query: 240 ----FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMI---REKPSDIMFEGDMN-LHK 291
               FLP      +    N  +T+ DV+S+GILL E+        P   M E   N + +
Sbjct: 298 KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357

Query: 292 FAKMALPNHVKDIVDSILLND-DEKLVVRGDQKQ 324
             +MA P H  D +  I+    +EK  +R D  Q
Sbjct: 358 GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 50/192 (26%), Positives = 73/192 (38%), Gaps = 50/192 (26%)

Query: 191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKY 250
           LN  + +A  ++YL  + + V  H DL   NVL+      ++ DFGLAR L    T+   
Sbjct: 112 LNWCVQIAKGMSYLE-EVRLV--HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 168

Query: 251 GVGN--------------EVSTIGDVYSYGILLLELM-IREKPSDIMFEGDMNLHKFAKM 295
             G                 +   DV+SYG+ + ELM    KP D               
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD--------------- 213

Query: 296 ALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRM 355
            +P   ++I D  LL   E+L         Q  I     C I +  I V C M   + R 
Sbjct: 214 GIP--AREIPD--LLEKGERL--------PQPPI-----CTIDVYMIMVKCWMIDSECRP 256

Query: 356 KMTNVVHELQSI 367
           +   +V E   +
Sbjct: 257 RFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 46/159 (28%)

Query: 193 IAIDVASALNYL---HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL------------ 237
           IA+ V   L YL   H        H D+KPSN+L++     ++ DFG+            
Sbjct: 108 IAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF 162

Query: 238 ---ARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKP---SDIMFEGDMN--- 288
              + ++ P R Q     G + +   DV+S GI ++EL + + P   S+I  +G  +   
Sbjct: 163 VGTSTYMSPERIQ-----GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG 217

Query: 289 ----LH--------KFAKMALPNHVKDIVDSILLNDDEK 315
               L         +      P  ++D VD+ LL D  +
Sbjct: 218 ILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 34/112 (30%), Positives = 52/112 (46%), Gaps = 16/112 (14%)

Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTKYG 251
           A ++  ALN+LH   +    + DLK  NVLLD D   ++ D+G+ +    P   T T  G
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158

Query: 252 V----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEG-DMNLHKF 292
                      G E     D ++ G+L+ E+M    P DI+ +  DMN   +
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 54/184 (29%)

Query: 120 FIAECKALRNIRHRNLIKVLTACL-GVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           F+ E +  R + H N+++ L  C+  + Y       LV EF      + +L         
Sbjct: 42  FLQEVQPYRELNHPNVLQCLGQCIESIPY------LLVLEFCPLGDLKNYL---RSNRGM 92

Query: 179 YERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +    ++L+R+  A +VAS L +LH   Q    H DL   N  L  D++ ++GD+GLA
Sbjct: 93  VAQMAQKDVLQRM--ACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Query: 239 -------------------RFLPP-----------TRTQTKYGVGNEVSTIGDVYSYGIL 268
                              R+L P            + QTK           +++S G+ 
Sbjct: 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK---------SNIWSLGVT 198

Query: 269 LLEL 272
           + EL
Sbjct: 199 MWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 14/101 (13%)

Query: 189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRT-Q 247
           R +  A ++   L  LH   Q    + DLKP N+LLDD    R+ D GLA  +P  +T +
Sbjct: 103 RAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159

Query: 248 TKYG---------VGNEVSTIG-DVYSYGILLLELMIREKP 278
            + G         V NE  T   D ++ G LL E++  + P
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 35/131 (26%), Positives = 55/131 (41%), Gaps = 31/131 (23%)

Query: 195 IDVASALNYLHHDCQPVTAHC--------DLKPSNVLLDDD-MTARVGDFGLAR-FLPPT 244
           +   +  ++++   + V AHC        DLKP N+L+D      ++ D GL R F  P 
Sbjct: 107 LPAKTIKSFMYQLLKGV-AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165

Query: 245 RTQTKYGV------------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMN---- 288
           ++ T   V                ST  D++S G +  E M R++P   +F GD      
Sbjct: 166 KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAE-MSRKQP---LFPGDSELQQL 221

Query: 289 LHKFAKMALPN 299
           LH F  +  P 
Sbjct: 222 LHIFKLLGTPT 232

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 39/184 (21%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           L+H  A +  + F  E + L++++H N++K    C      G     LV E++   S   
Sbjct: 41  LQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLRLVMEYLPYGSLRD 96

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
           +L    K  E  +  + L    ++   ++   +  Y+H D         L   N+L++ +
Sbjct: 97  YL---QKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRD---------LATRNILVESE 144

Query: 228 MTARVGDFGLARFLPPTRTQTK--YGV-----------------GNEVSTIGDVYSYGIL 268
              ++GDFGL + LP    Q K  Y V                  ++ S   DV+S+G++
Sbjct: 145 NRVKIGDFGLTKVLP----QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVV 200

Query: 269 LLEL 272
           L EL
Sbjct: 201 LYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.8 bits (100), Expect = 2e-04
 Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 32/177 (18%)

Query: 118 KSFIAECKALRNI-RHRNLIKVLTAC-------LGVDYQ--GNDFKALVYEFIHNRSPEK 167
           + F  E + L  +  H N+I +L AC       L ++Y   GN    L    +    P  
Sbjct: 40  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP-- 97

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
                +  + T     +  LL     A DVA  ++YL    Q    H DL   N+L+ ++
Sbjct: 98  ---AFAIANSTASTLSSQQLLH---FAADVARGMDYLS---QKQFIHRDLAARNILVGEN 148

Query: 228 MTARVGDFGLARFLP----------PTRTQTKYGVGNEV-STIGDVYSYGILLLELM 273
             A++ DFGL+R             P R      +   V +T  DV+SYG+LL E++
Sbjct: 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 17/42 (40%), Positives = 25/42 (59%), Gaps = 5/42 (11%)

Query: 200 ALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF 240
           AL YLH +       H DLKP N+L+D +   ++ DFGL++ 
Sbjct: 105 ALEYLHSNGI----IHRDLKPDNILIDSNGHLKLTDFGLSKV 142

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 43/193 (22%), Positives = 72/193 (37%), Gaps = 53/193 (27%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           FI E K +  + H  L+++   C                     + +K LY ++   E  
Sbjct: 46  FIEEAKVMMKLSHPKLVQLYGVC---------------------TQQKPLYIVT---EFM 81

Query: 180 ERPRNLNLLRR----------LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT 229
           E    LN LR+          L++  DV   + YL    +    H DL   N L+     
Sbjct: 82  ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGV 138

Query: 230 ARVGDFGLARFLPPTRTQTKYGVG-------------NEVSTIGDVYSYGILLLELMIRE 276
            +V DFG+ R++      +  G               ++ S+  DV+S+G+L+ E+    
Sbjct: 139 VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198

Query: 277 KPSDIMFEGDMNL 289
           K   + FE   N 
Sbjct: 199 K---MPFEKKSNY 208

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 32/108 (29%), Positives = 47/108 (43%), Gaps = 20/108 (18%)

Query: 195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVG- 253
           + + SA+ ++H        H D+KP+NV +      ++GD GL RF     T     VG 
Sbjct: 113 VQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 254 -----------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-MNL 289
                      N  +   D++S G LL E+   + P    F GD MNL
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 32/120 (26%), Positives = 48/120 (40%), Gaps = 23/120 (19%)

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF 240
           RP   + + R  I I +   L +LH        H D+K  N+ LD     ++GD G+A+ 
Sbjct: 96  RPLPEDQVWRFFIQILLG--LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150

Query: 241 LPPTRTQTKYGVG---------------NEVSTIGDVYSYGILLLELMIREKPSDIMFEG 285
           L          VG               NE S   DV++ G++L E    + P D   +G
Sbjct: 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEKS---DVWALGVVLYECCTGKHPFDANNQG 207

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 50/188 (26%), Positives = 79/188 (42%), Gaps = 33/188 (17%)

Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTAC-------LGVDYQGNDFKALVYEF 159
           L+     K     I+E + ++ I +H+N+I +L  C       + V+Y     K  + EF
Sbjct: 52  LKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAA---KGNLREF 108

Query: 160 IHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLK 218
           +  R P     P    D T      L+    ++ A  VA  + YL    C     H DL 
Sbjct: 109 LRARRPPG---PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLA 161

Query: 219 PSNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYS 264
             NVL+ +D   ++ DFGLAR +              P +      + + V T   DV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221

Query: 265 YGILLLEL 272
           +GIL+ E+
Sbjct: 222 FGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 28/89 (31%), Positives = 41/89 (46%), Gaps = 21/89 (23%)

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG------------- 260
           H DLKP N+L++ D   ++ DFGLAR       +    +   V+T               
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187

Query: 261 ----DVYSYGILLLELMIREKPSDIMFEG 285
               DV+S G +L EL+ R KP   +F+G
Sbjct: 188 TKAIDVWSVGCILAELLGR-KP---VFKG 212

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 14/91 (15%)

Query: 204 LHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------RT--QTKYGVGNE 255
           +HH       H D+K +N+LL  +   ++GDFG ++    T      RT   T Y V  E
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 256 V------STIGDVYSYGILLLELMIREKPSD 280
           +      S   D++S G+LL EL+  ++P D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 40/143 (27%), Positives = 59/143 (41%), Gaps = 35/143 (24%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--------------FL 241
           ++  A  YLH     +  + DLKP N+LLD+    +V DFG A+              +L
Sbjct: 126 ELVLAFEYLH-SKDII--YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYL 182

Query: 242 PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK-----MA 296
            P   Q+K G G  V    D ++ G+LL E +    P    F  D     + K     + 
Sbjct: 183 APEVIQSK-GHGKAV----DWWTMGVLLYEFIAGYPP----FFDDTPFRIYEKILAGRLK 233

Query: 297 LPNHV----KDIVDSILLNDDEK 315
            PN      +D+V  +L  D  K
Sbjct: 234 FPNWFDGRARDLVKGLLQTDHTK 256

Length = 329

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 23/126 (18%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQ 247
           +   ++YLH +   +  H D+K +N+L D     ++GDFG ++ L           + T 
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171

Query: 248 TKYGVGNEVST------IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM----AL 297
           T Y +  EV +        D++S G  ++E M+ EKP    FE    + K A       L
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVE-MLTEKPPWAEFEAMAAIFKIATQPTNPVL 230

Query: 298 PNHVKD 303
           P HV D
Sbjct: 231 PPHVSD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.5 bits (95), Expect = 3e-04
 Identities = 29/138 (21%), Positives = 54/138 (39%), Gaps = 24/138 (17%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLI--KVLTACLGVDYQGNDFKALVYEFIHNRSP 165
           L+   + +       E   L+ +  + L   KVL +      + + +  L+ E+I   + 
Sbjct: 26  LKINPSREKGADREREVAILQLLARKGLPVPKVLAS-----GESDGWSYLLMEWIEGETL 80

Query: 166 EKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD 225
           ++                 ++   + +IA  +A  L  LH     V  H DL P N+L+D
Sbjct: 81  DE-----------------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123

Query: 226 DDMTARVGDFGLARFLPP 243
           D     + D+  A + PP
Sbjct: 124 DGKILGIIDWEYAGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 45/207 (21%), Positives = 84/207 (40%), Gaps = 35/207 (16%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F++E + L+   H N++K++  C          +  +Y  +       +L  + K+ +  
Sbjct: 39  FLSEARILKQYDHPNIVKLIGVCTQ--------RQPIYIVMELVPGGDFLSFLRKKKD-- 88

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
                L   + +  A+D A+ + YL   +C     H DL   N L+ ++   ++ DFG++
Sbjct: 89  ----ELKTKQLVKFALDAAAGMAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMS 140

Query: 239 R-------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLE---LMIREKPSDIM 282
           R              +P   T  +       S+  DV+SYGILL E   L +   P    
Sbjct: 141 RQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN 200

Query: 283 FEGDMNLHKFAKMALPNHVKDIVDSIL 309
            +    + K  +M+ P    D V  ++
Sbjct: 201 QQAREQVEKGYRMSCPQKCPDDVYKVM 227

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 45/199 (22%), Positives = 76/199 (38%), Gaps = 53/199 (26%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIH-------NRSPEKWLYPIS 173
           +A  + L    H N++++   C            LV+E +        ++ PE  +   +
Sbjct: 52  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 111

Query: 174 KEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVG 233
            +D  ++      LLR           L++LH        H DLKP N+L+      ++ 
Sbjct: 112 IKDMMFQ------LLR----------GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152

Query: 234 DFGLARFL-----------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIRE 276
           DFGLAR                   P    Q+ Y      +T  D++S G +  E M R 
Sbjct: 153 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY------ATPVDLWSVGCIFAE-MFRR 205

Query: 277 KPSDIMFEGDMNLHKFAKM 295
           KP   +F G  ++ +  K+
Sbjct: 206 KP---LFRGSSDVDQLGKI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 30/96 (31%), Positives = 41/96 (42%), Gaps = 20/96 (20%)

Query: 200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ------TKYGVG 253
           ALN+LH        H DLK  N+LL  D   ++ DFG++     T  +      T Y + 
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171

Query: 254 NEV-----------STIGDVYSYGILLLELMIREKP 278
            EV               D++S GI L+EL   E P
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 39/149 (26%), Positives = 63/149 (42%), Gaps = 21/149 (14%)

Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTKYG 251
           A ++   L +LH        + DLK  NVLLD D   ++ DFG+ +       +  T  G
Sbjct: 102 AAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158

Query: 252 V----------GNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDMNLHKFAKMA 296
                      G + +   D +S+G+LL E++I + P      D +F+  +N        
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRW 218

Query: 297 LPNHVKDIVDSILLNDDEK-LVVRGDQKQ 324
           +    KD +  +   D  K L V GD +Q
Sbjct: 219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 50/181 (27%), Positives = 74/181 (40%), Gaps = 45/181 (24%)

Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA----LVYEFIHNRSPEKWLYPI 172
           ++  I E + L+ +RH N I          Y+G   +     LV E+         L   
Sbjct: 59  WQDIIKEVRFLQKLRHPNTI---------QYRGCYLREHTAWLVMEYC--------LGSA 101

Query: 173 SKEDETYERPRNLNLLRRLNIAIDVASALN---YLH-HDCQPVTAHCDLKPSNVLLDDDM 228
           S   E +++P     L+ + IA     AL    YLH H+      H D+K  N+LL +  
Sbjct: 102 SDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPG 152

Query: 229 TARVGDFGLARFLPPTRT--QTKYGVGNEVSTIG---------DVYSYGILLLELMIREK 277
             ++GDFG A  + P      T Y +  EV             DV+S GI  +EL  R+ 
Sbjct: 153 LVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Query: 278 P 278
           P
Sbjct: 213 P 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 27/96 (28%), Positives = 36/96 (37%), Gaps = 14/96 (14%)

Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG-- 251
           A  +   L +LH   Q    + DLKP NVLLDD    R+ D GLA  L   +        
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157

Query: 252 ---------VGNEVSTIGDVYSYGILLLELMIREKP 278
                     G       D ++ G  L E++    P
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 36/200 (18%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E + L+N++H  +++    CL    +      +  E++   S +  L       E+  R 
Sbjct: 54  EIQLLKNLQHERIVQYY-GCL--RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK 110

Query: 183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP 242
               +L            ++YLH +   +  H D+K +N+L D     ++GDFG ++ L 
Sbjct: 111 YTRQILE----------GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157

Query: 243 P---------TRTQTKYGVGNEVST------IGDVYSYGILLLELMIREKPSDIMFEGDM 287
                     + T T Y +  EV +        DV+S G  ++E M+ EKP    +E   
Sbjct: 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVE-MLTEKPPWAEYEAMA 216

Query: 288 NLHKFAKM----ALPNHVKD 303
            + K A       LP+H+ +
Sbjct: 217 AIFKIATQPTNPQLPSHISE 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 22/54 (40%), Positives = 29/54 (53%), Gaps = 3/54 (5%)

Query: 189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP 242
           R L  A ++   L  LH   +  T + DLKP N+LLDD    R+ D GLA  +P
Sbjct: 103 RALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 16/96 (16%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ------TK 249
           +V  AL Y+H     V  H D+K +N+L+ +    ++ DFG+A  L    ++      T 
Sbjct: 109 EVLVALKYIHKV--GVI-HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP 165

Query: 250 YGVGNEVSTIG-------DVYSYGILLLELMIREKP 278
           Y +  EV T G       D++S GI + E+     P
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 49/180 (27%), Positives = 72/180 (40%), Gaps = 43/180 (23%)

Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA----LVYEFIHNRSPEKWLYPI 172
           ++  I E K L+ ++H N I         +Y+G   K     LV E+         L   
Sbjct: 65  WQDIIKEVKFLQQLKHPNTI---------EYKGCYLKEHTAWLVMEYC--------LGSA 107

Query: 173 SKEDETYERPRNLNLLRRLNIAIDVASALN---YLHHDCQPVTAHCDLKPSNVLLDDDMT 229
           S   E +++P     L+ + IA     AL    YLH        H D+K  N+LL +   
Sbjct: 108 SDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQ 159

Query: 230 ARVGDFGLARFLPPTRT--QTKYGVGNEVSTIG---------DVYSYGILLLELMIREKP 278
            ++ DFG A    P  +   T Y +  EV             DV+S GI  +EL  R+ P
Sbjct: 160 VKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 36/123 (29%), Positives = 54/123 (43%), Gaps = 23/123 (18%)

Query: 201 LNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ---------TKYG 251
           + YLH +   +  H D+K +N+L D     ++GDFG ++ L    +          T Y 
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 252 VGNEV---STIG---DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM----ALPNHV 301
           +  EV      G   DV+S G  ++E M+ EKP    FE    + K A       LP+HV
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVE-MLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV 232

Query: 302 KDI 304
              
Sbjct: 233 SPD 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 6e-04
 Identities = 33/136 (24%), Positives = 55/136 (40%), Gaps = 36/136 (26%)

Query: 119 SFIAECKALRNIRHRNLIKVLTACLG---------VDYQGNDFKALVYEFIH-NRSPEKW 168
           S   E   LR ++H N++ ++   L           DY  +D     ++ I  +R  ++ 
Sbjct: 48  SACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDL----WQIIKFHRQAKRV 103

Query: 169 LYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL--DD 226
             P S             +++ L   I   + ++YLH        H DLKP+N+L+  + 
Sbjct: 104 SIPPS-------------MVKSLLWQI--LNGVHYLH---SNWVLHRDLKPANILVMGEG 145

Query: 227 DMTARV--GDFGLARF 240
                V  GD GLAR 
Sbjct: 146 PERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 20/46 (43%), Positives = 26/46 (56%), Gaps = 3/46 (6%)

Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           A ++ASAL YLH        + DLKP N+LLD      + DFGL +
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 15/99 (15%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGN- 254
           ++   L+YLH + +    H D+K +NVLL +    ++ DFG+A  L  T+ +    VG  
Sbjct: 109 EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 165

Query: 255 -----EV------STIGDVYSYGILLLELMIREKPSDIM 282
                EV       +  D++S GI  +EL   E P+  M
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 13/92 (14%)

Query: 192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG 251
            I I +   L  LH + + +  H DLK +N+LL  +   ++GD G+++ L     +T+ G
Sbjct: 107 RIFIQLLRGLQALH-EQKIL--HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIG 163

Query: 252 ----VGNEV------STIGDVYSYGILLLELM 273
               +  EV      S   D++S G LL E+ 
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA 195

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 31/84 (36%), Positives = 45/84 (53%), Gaps = 17/84 (20%)

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 200

Query: 262 VYSYGILLLELMIREKPSDIMFEG 285
           ++S G ++ E M+R K   I+F G
Sbjct: 201 IWSVGCIMGE-MVRHK---ILFPG 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 45/176 (25%), Positives = 70/176 (39%), Gaps = 33/176 (18%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E   + ++ H +L+++L  CL    Q      LV + +    P   L      D  +
Sbjct: 56  FMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLM----PHGCLL-----DYVH 100

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           E   N+     LN  + +A  + YL    +    H DL   NVL+      ++ DFGLAR
Sbjct: 101 EHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157

Query: 240 FLPPTRTQTKYGVGN--------------EVSTIGDVYSYGILLLELM-IREKPSD 280
            L     +     G               + +   DV+SYG+ + ELM    KP D
Sbjct: 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 40.4 bits (94), Expect = 8e-04
 Identities = 41/169 (24%), Positives = 79/169 (46%), Gaps = 30/169 (17%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   ++ ++H  L+K L A +       +   ++ EF+   S    L    K DE
Sbjct: 46  EAFLAEANVMKTLQHDKLVK-LHAVVT-----KEPIYIITEFMAKGS----LLDFLKSDE 95

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             ++P    L + ++ +  +A  + ++    Q    H DL+ +N+L+   +  ++ DFGL
Sbjct: 96  GSKQP----LPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGL 148

Query: 238 ARFLPPTRTQTKYGVGNEVS------------TI-GDVYSYGILLLELM 273
           AR +       + G    +             TI  DV+S+GILL+E++
Sbjct: 149 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 40.4 bits (94), Expect = 9e-04
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 19/149 (12%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG----LARFLPPTRT-- 246
           + + V  AL+YLH+  Q V  H D+K  ++LL  D   ++ DFG    +++ +P  ++  
Sbjct: 123 VCLSVLRALSYLHN--QGVI-HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179

Query: 247 QTKYGVGNEV------STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNH 300
            T Y +  EV       T  D++S GI+++E++  E P     E  +   +  +  LP  
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP--YFNEPPLQAMRRIRDNLPPR 237

Query: 301 VKDI--VDSILLNDDEKLVVRGDQKQTQA 327
           VKD   V S+L    + ++VR   ++  A
Sbjct: 238 VKDSHKVSSVLRGFLDLMLVREPSQRATA 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 40.5 bits (95), Expect = 9e-04
 Identities = 30/130 (23%), Positives = 55/130 (42%), Gaps = 21/130 (16%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E + L+ +RH NL+ ++        +      LV+EF+ +         +  + E Y   
Sbjct: 50  EIRMLKQLRHENLVNLIEVF-----RRKKRLYLVFEFVDH--------TVLDDLEKYPNG 96

Query: 183 RNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL 241
            + + +R+      +   + + H H+      H D+KP N+L+      ++ DFG AR L
Sbjct: 97  LDESRVRK--YLFQILRGIEFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTL 150

Query: 242 P-PTRTQTKY 250
             P    T Y
Sbjct: 151 AAPGEVYTDY 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 17/94 (18%)

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 146 HRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV-ILGMGYKENVD 204

Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ EL+       ++F+G  ++ ++ K+
Sbjct: 205 IWSVGCIMGELV----KGSVIFQGTDHIDQWNKV 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 33/133 (24%), Positives = 56/133 (42%), Gaps = 24/133 (18%)

Query: 156 VYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYL--HHDCQPVTA 213
           ++EF+  RSP      +   D+       L     ++I   +A+ + +L  HH       
Sbjct: 95  LHEFLVMRSPHS---DVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV----- 146

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-------------FLPPTRTQTKYGVG-NEVSTI 259
           H DL   NVL+ D +  ++ D GL R              L P R  +   +   + S  
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID 206

Query: 260 GDVYSYGILLLEL 272
            D++SYG++L E+
Sbjct: 207 SDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 32/110 (29%), Positives = 51/110 (46%), Gaps = 19/110 (17%)

Query: 178 TY--ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
           TY   R R L L +   +A  + SA++Y+H   + +  H D+K  NVL++      +GDF
Sbjct: 248 TYLGARLRPLGLAQVTAVARQLLSAIDYIH--GEGII-HRDIKTENVLVNGPEDICLGDF 304

Query: 236 GLARFLPPTR-TQTKYGVGNEVSTIG-------------DVYSYGILLLE 271
           G A F   +  T   YG+   V T               D++S G+++ E
Sbjct: 305 GAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 7/91 (7%)

Query: 1   MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT---GVYKNASATSVTGNSKLCG 56
           +D S N+ +G I + L +L  L  LNL+ N+L G VP    G   + ++ + T N+ LCG
Sbjct: 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530

Query: 57  GISKFKLPKCGSKKSNGKRLPVALNLVISIV 87
                 L  CG   S G ++ +A  + ++ +
Sbjct: 531 IPG---LRACGPHLSVGAKIGIAFGVSVAFL 558

Length = 623

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 39.9 bits (94), Expect = 0.001
 Identities = 31/88 (35%), Positives = 42/88 (47%), Gaps = 14/88 (15%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL-PPTRTQTKYG---- 251
           V  A  YLH+       + DLKP N+LLD +   ++ DFG A+ L    +T T  G    
Sbjct: 102 VVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY 158

Query: 252 VGNEV------STIGDVYSYGILLLELM 273
           V  E+          D +S GILL EL+
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 39.9 bits (94), Expect = 0.001
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 16/91 (17%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV----- 252
           S + +LH +      H DLK SN+LL++    ++ DFGLAR +  P +  T+  V     
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173

Query: 253 -------GNEVSTIGDVYSYGILLLELMIRE 276
                    E ST  D++S G +  EL+ ++
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 25/91 (27%), Positives = 40/91 (43%), Gaps = 16/91 (17%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVST 258
            A+ Y+H        H D+K  N+ L+ D    +GDFG A      R    YG    V+T
Sbjct: 278 CAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334

Query: 259 -------------IGDVYSYGILLLELMIRE 276
                        I D++S G++LL+++  +
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDMLSHD 365

Length = 501

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 23/73 (31%), Positives = 36/73 (49%), Gaps = 13/73 (17%)

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG-------VGNEVSTIG------ 260
           H DL+ +NVL+ + +  ++ DFGLAR +       + G          E    G      
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 261 DVYSYGILLLELM 273
           DV+S+GILL E++
Sbjct: 186 DVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 25/100 (25%)

Query: 191 LNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK 249
           L+ +  VA  +++L   +C     H DL   N+LL      ++ DFGLAR +   R  + 
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI---RNDSN 269

Query: 250 YGV-GNE---------------VSTI-GDVYSYGILLLEL 272
           Y V GN                V T   DV+SYGILL E+
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 22/101 (21%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA-------------- 238
           ++I V   L YL    Q    H D+KPSN+L++     ++ DFG++              
Sbjct: 108 VSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 165

Query: 239 -RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKP 278
             ++ P R Q     G   S   D++S G+ L+EL I   P
Sbjct: 166 RSYMSPERLQ-----GTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 34/118 (28%), Positives = 50/118 (42%), Gaps = 21/118 (17%)

Query: 183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP 242
           RN+ +   L I   V  A+ YLH +      H D+K  N+ ++      +GDFG A F P
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF-P 232

Query: 243 PTRTQTK-YGVGNEVSTIG-------------DVYSYGILLLELMIREKPSDIMFEGD 286
                 K YG    ++T               D++S GI+L E+       D +FE D
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKD 287

Length = 391

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 45/190 (23%), Positives = 84/190 (44%), Gaps = 37/190 (19%)

Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTAC-------LGVDYQGNDFKALVYEF 159
           L+     K     ++E + ++ I +H+N+I +L AC       + V+Y     K  + E+
Sbjct: 55  LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLREY 111

Query: 160 IHNRSPE--KWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCD 216
           +  R P   ++ Y I++  +     ++L     ++    VA  + YL    C     H D
Sbjct: 112 LRARRPPGMEYSYDIARVPDEQMTFKDL-----VSCTYQVARGMEYLASQKC----IHRD 162

Query: 217 LKPSNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDV 262
           L   NVL+ ++   ++ DFGLAR +              P +      + + V T   DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222

Query: 263 YSYGILLLEL 272
           +S+G+L+ E+
Sbjct: 223 WSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 24/131 (18%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGN- 254
           ++A AL++LH        + DLKP N+LLD++   ++ DFGL++       +     G  
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162

Query: 255 -----EV------STIGDVYSYGILLLELMIREKPSDIMFEGD-----MNLHKFAKMALP 298
                EV      +   D +S+G+L+ E++    P    F+G      M +   AK+ +P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTMILKAKLGMP 218

Query: 299 NHVKDIVDSIL 309
             +     S+L
Sbjct: 219 QFLSPEAQSLL 229

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 39.9 bits (94), Expect = 0.001
 Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 24/118 (20%)

Query: 185 LNLLR--RLN---IAI---DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           L+LL+  +L+   IA    +V   L YLH +      H D+K +N+LL ++   ++ DFG
Sbjct: 87  LDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFG 143

Query: 237 LARFLPPTRTQTKYGVGN------EV------STIGDVYSYGILLLELMIREKP-SDI 281
           ++  L  T ++    VG       EV          D++S GI  +EL   E P SD+
Sbjct: 144 VSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 36/174 (20%), Positives = 62/174 (35%), Gaps = 47/174 (27%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVD--------YQGNDFKALVYEFIHNRSPEKWLYP 171
           F+ E + L+   H N+++++  C             QG DF      F+    P      
Sbjct: 40  FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT----FLRTEGP------ 89

Query: 172 ISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
                        L +   + +  + A+ + YL         H DL   N L+ +    +
Sbjct: 90  ------------RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLK 134

Query: 232 VGDFGLAR--------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLE 271
           + DFG++R               +P   T  +       S+  DV+S+GILL E
Sbjct: 135 ISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 18/103 (17%)

Query: 191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKY 250
           + +A ++A  + YL+        H DL   N ++  D T ++GDFG+ R +  T    K 
Sbjct: 122 IQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 251 GVG--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G G                 +T  D++S+G++L E+  + E+P
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 39/177 (22%), Positives = 76/177 (42%), Gaps = 30/177 (16%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACL-GVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
           + F++E   ++   H N+++++  CL  V+ +G     ++  F+ +     +L       
Sbjct: 45  EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL------ 98

Query: 177 ETYER----PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV 232
             Y R    P+ L     +    D+AS + YL         H DL   N +L+++M   V
Sbjct: 99  --YSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCV 153

Query: 233 GDFGLARFL-------------PPTRTQTKYGVGNEV-STIGDVYSYGILLLELMIR 275
            DFGL++ +              P +      + + V +T  DV+S+G+ + E+  R
Sbjct: 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 41/186 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E K L  +   N+ ++L  C       +    ++ E++ N    ++L       E
Sbjct: 64  EDFLKEVKILSRLSDPNIARLLGVCT-----VDPPLCMIMEYMENGDLNQFLQ--KHVAE 116

Query: 178 TYERPRNLNLLRR---LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
           T     N   L     L +A  +AS + YL         H DL   N L+  + T ++ D
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIAD 173

Query: 235 FGLARFL-------------PPTR-------TQTKYGVGNEVSTIGDVYSYGILLLELMI 274
           FG++R L              P R          K+      +T  DV+++G+ L E++ 
Sbjct: 174 FGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF------TTKSDVWAFGVTLWEILT 227

Query: 275 --REKP 278
             RE+P
Sbjct: 228 LCREQP 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 15/109 (13%)

Query: 182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL 241
           P  L+  +   I  ++   L+YLH + +    H D+K +NVLL +    ++ DFG+A  L
Sbjct: 95  PGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL 151

Query: 242 PPTRTQTKYGVGN------EV------STIGDVYSYGILLLELMIREKP 278
             T+ +    VG       EV       +  D++S GI  +EL   E P
Sbjct: 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 41/184 (22%), Positives = 82/184 (44%), Gaps = 33/184 (17%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E K L  ++  N+I++L  C+       D   ++ E++ N    ++L     +D+  
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEE 120

Query: 180 E----RPRNLNLL-----RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA 230
                 P    L        L++A+ +AS + YL         H DL   N L+ +++T 
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTI 177

Query: 231 RVGDFGLAR--------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMI-- 274
           ++ DFG++R               LP      +  +  + +T  DV+++G+ L E+++  
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237

Query: 275 REKP 278
           +E+P
Sbjct: 238 KEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 39.2 bits (92), Expect = 0.002
 Identities = 18/43 (41%), Positives = 26/43 (60%), Gaps = 9/43 (20%)

Query: 200 ALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDFGLAR 239
            L Y+H      +A   H DLKPSN+ +++D   ++ DFGLAR
Sbjct: 130 GLKYIH------SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 17/94 (18%)

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 207

Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E MI+     ++F G  ++ ++ K+
Sbjct: 208 IWSVGCIMGE-MIKGG---VLFPGTDHIDQWNKV 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 45/181 (24%), Positives = 71/181 (39%), Gaps = 41/181 (22%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE 180
           I E   L+N++H N++ +                  ++ IH       ++     D    
Sbjct: 51  IREVSLLKNLKHANIVTL------------------HDIIHTERCLTLVFEYLDSDLKQY 92

Query: 181 RPRNLNLLRRLNIAI---DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                NL+   N+ I    +   L+Y H        H DLKP N+L+++    ++ DFGL
Sbjct: 93  LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGL 149

Query: 238 ARFLP-PTRTQTKYGV------------GNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           AR    PT+T +   V              E ST  D++  G +L E M   +P   MF 
Sbjct: 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYE-MATGRP---MFP 205

Query: 285 G 285
           G
Sbjct: 206 G 206

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 36/139 (25%), Positives = 58/139 (41%), Gaps = 22/139 (15%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE 180
           I E   L+ ++H N++      L       +   LV+E++H       L     +     
Sbjct: 51  IREASLLKGLKHANIV-----LLHDIIHTKETLTLVFEYVHTD-----LCQYMDKHPGGL 100

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF 240
            P N+ L         +   L+Y+H   Q    H DLKP N+L+ D    ++ DFGLAR 
Sbjct: 101 HPENVKLF-----LFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR- 151

Query: 241 LPPTRTQTKYGVGNEVSTI 259
               ++   +   NEV T+
Sbjct: 152 ---AKSVPSHTYSNEVVTL 167

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 28/96 (29%), Positives = 43/96 (44%), Gaps = 13/96 (13%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           IA+ V   L YL         H D+KPSN+L++     ++ DFG++  L  +  +T  G 
Sbjct: 100 IAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT 156

Query: 253 ----------GNEVSTIGDVYSYGILLLELMIREKP 278
                     G +     DV+S GI  +EL +   P
Sbjct: 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 31/93 (33%), Positives = 42/93 (45%), Gaps = 27/93 (29%)

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGVGNEV---------------- 256
           H DLKP N+L++     ++ DFGLAR F  P  T       NEV                
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-----FSNEVVTLWYRAPDVLLGSRT 177

Query: 257 -STIGDVYSYGILLLELMIREKPSDIMFEGDMN 288
            ST  D++S G ++ E MI  +P   +F G  N
Sbjct: 178 YSTSIDIWSVGCIMAE-MITGRP---LFPGTNN 206

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 22/107 (20%)

Query: 191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKY 250
           LN  + +A  +NYL    +    H DL   NVL+      ++ DFGLA+ L     + +Y
Sbjct: 112 LNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEY 166

Query: 251 GV-GNEV---------------STIGDVYSYGILLLELM-IREKPSD 280
              G +V               +   DV+SYG+ + ELM    KP D
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 40/126 (31%), Positives = 59/126 (46%), Gaps = 32/126 (25%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL--VYEFIHNRSPEKWLYPISK--EDET 178
           E K LR +RH +++++    L       +FK +  V+E +     E  L+ + K  +D T
Sbjct: 49  EIKLLRLLRHPDIVEIKHIMLPPSR--REFKDIYVVFELM-----ESDLHQVIKANDDLT 101

Query: 179 YERPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVG 233
            E  +     LLR          AL Y+H      TA   H DLKP N+L + D   ++ 
Sbjct: 102 PEHHQFFLYQLLR----------ALKYIH------TANVFHRDLKPKNILANADCKLKIC 145

Query: 234 DFGLAR 239
           DFGLAR
Sbjct: 146 DFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 15/91 (16%)

Query: 200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ------TKYGVG 253
           AL++LH +      H D+K  N+LL  D + ++ DFG    + P +++      T Y + 
Sbjct: 127 ALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 254 NEVSTIG------DVYSYGILLLELMIREKP 278
            EV T        D++S GI+ +E++  E P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 38/145 (26%), Positives = 61/145 (42%), Gaps = 32/145 (22%)

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           +R R  +  R    A +V  AL +LH   +    + DLK  N+LLD +   ++ DFG+ +
Sbjct: 88  QRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Query: 240 --FLPPTRTQTKYGVGN----------EVSTIGDVYSYGILLLELMIREKPSDIMFEGDM 287
              L    T T  G  +          E     D ++ G+L+ E+M  + P    FE D 
Sbjct: 145 EGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP----FEAD- 199

Query: 288 NLHKFAKMALPNHVKDIVDSILLND 312
                       +  D+ +SIL +D
Sbjct: 200 ------------NEDDLFESILHDD 212

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 55/276 (19%), Positives = 95/276 (34%), Gaps = 85/276 (30%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQ------------GNDFKALVYEFIHNRSPEK 167
           F+ E   +    H+N+++     +GV ++            G D K+ + E   NR    
Sbjct: 56  FLMEALIMSKFNHQNIVR----LIGVSFERLPRFILLELMAGGDLKSFLRE---NRP--- 105

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD- 226
                       ERP +L +   L  A DVA    YL  +      H D+   N LL   
Sbjct: 106 ----------RPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK 152

Query: 227 --DMTARVGDFGLAR--------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLL 270
                A++ DFG+AR               LP      +  +    ++  DV+S+G+LL 
Sbjct: 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLW 212

Query: 271 ELMIREKPSDIMFEGDMNLHKFAKMALPN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKI 329
           E+                      M  P    +++++          V  G       ++
Sbjct: 213 EIF-----------------SLGYMPYPGRTNQEVME---------FVTGG------GRL 240

Query: 330 NVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQ 365
           +    C   + RI   C   +P+DR     ++  +Q
Sbjct: 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 15/103 (14%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKY-GVG 253
           +++ ALNYLH   +    + DLK  NVLLD +   ++ D+G+ +  L P  T + + G  
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160

Query: 254 NEVST---IGDVYSY-------GILLLELMIREKPSDIMFEGD 286
           N ++     G+ Y +       G+L+ E+M    P DI+   D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 15/95 (15%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------TRTQTK 249
           +   AL +LH +      H D+K  N+LL  D + ++ DFG    + P      T   T 
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179

Query: 250 YGVGNEVSTIG------DVYSYGILLLELMIREKP 278
           Y +  EV T        D++S GI+ +E++  E P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 32/114 (28%), Positives = 50/114 (43%), Gaps = 19/114 (16%)

Query: 185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLP 242
            +L R    A ++   L +LH        + DLK  NV+LD D   ++ DFG+ +     
Sbjct: 93  FDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149

Query: 243 PTRTQTKYGV----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
             R  T  G           G + +   D +S+G+LL E++I + P    F GD
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----FHGD 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 38.8 bits (91), Expect = 0.004
 Identities = 18/41 (43%), Positives = 24/41 (58%), Gaps = 4/41 (9%)

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLARFL----PPTRTQTKY 250
           H DLKPSN+LL+ +   ++ DFGLAR        T   T+Y
Sbjct: 129 HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 18/113 (15%)

Query: 127 LRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN 186
           L+N++H  L+      L   +Q  +    V +F++     +  + + +E  ++  PR   
Sbjct: 50  LKNVKHPFLVG-----LHYSFQTTEKLYFVLDFVNG---GELFFHLQRE-RSFPEPR--- 97

Query: 187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
              R   A ++ASAL YLH        + DLKP N+LLD      + DFGL +
Sbjct: 98  --ARFYAA-EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 38.4 bits (90), Expect = 0.004
 Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 18/95 (18%)

Query: 193 IAIDVASALN---YLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK 249
           IA  +   L    YLH        H D+K  N+LL+++  A++ DFG++  L  T  +  
Sbjct: 101 IAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157

Query: 250 YGVGN------EV-STIG-----DVYSYGILLLEL 272
             +G       EV   IG     D++S GI  +E+
Sbjct: 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 41/190 (21%), Positives = 69/190 (36%), Gaps = 48/190 (25%)

Query: 107 HLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
               +     F+   A C  L    H N++ +L +  G           V+E++  R+  
Sbjct: 15  APEEEHQRARFRRETALCARLY---HPNIVALLDS--GE--APPGLLFAVFEYVPGRTLR 67

Query: 167 KWLY---PISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVL 223
           + L     +   +                + + V  AL   H+  Q +  H DLKP N++
Sbjct: 68  EVLAADGALPAGETG-------------RLMLQVLDALACAHN--QGIV-HRDLKPQNIM 111

Query: 224 L---DDDMTARVGDFGLARFLPP---------TRTQTKYGV----------GNEVSTIGD 261
           +        A+V DFG+   LP          TRT    G           G  V+   D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 262 VYSYGILLLE 271
           +Y++G++ LE
Sbjct: 172 LYAWGLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.5 bits (90), Expect = 0.004
 Identities = 19/58 (32%), Positives = 26/58 (44%), Gaps = 9/58 (15%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKY 250
           +AID    L Y+H D         +KP N+LLD     ++ DFGL   L  +     Y
Sbjct: 112 LAIDSIHKLGYIHRD---------IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 38.6 bits (89), Expect = 0.004
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 15/91 (16%)

Query: 200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ------TKYGVG 253
           AL +LH +      H D+K  N+LL  D + ++ DFG    + P +++      T Y + 
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 254 NEVSTIG------DVYSYGILLLELMIREKP 278
            EV T        D++S GI+ +E++  E P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 40/187 (21%), Positives = 73/187 (39%), Gaps = 40/187 (21%)

Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWL------- 169
            +  ++E   L+ + H ++IK+  AC       +    L+ E+    S   +L       
Sbjct: 47  LRDLLSEFNLLKQVNHPHVIKLYGAC-----SQDGPLLLIVEYAKYGSLRSFLRESRKVG 101

Query: 170 ---------YPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPS 220
                       S  D   ER   +  L  ++ A  ++  + YL    +    H DL   
Sbjct: 102 PSYLGSDGNRNSSYLDNPDERALTMGDL--ISFAWQISRGMQYL---AEMKLVHRDLAAR 156

Query: 221 NVLLDDDMTARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYG 266
           NVL+ +    ++ DFGL+R +    +  K   G              +  +T  DV+S+G
Sbjct: 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG 216

Query: 267 ILLLELM 273
           +LL E++
Sbjct: 217 VLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 35/133 (26%), Positives = 63/133 (47%), Gaps = 22/133 (16%)

Query: 120 FIAECKALRNIRHRNLIKVLTACL-GVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           F+ +    R ++H N+++ L  C+  + Y       LV+E+      + +L   S+E   
Sbjct: 42  FLQQGDPYRILQHPNILQCLGQCVEAIPY------LLVFEYCELGDLKSYL---SQEQWH 92

Query: 179 YERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
               RN  LL    +A ++A+ + ++H H+      H DL   N  L  D+T +VGD+G+
Sbjct: 93  R---RNSQLLLLQRMACEIAAGVTHMHKHN----FLHSDLALRNCFLTSDLTVKVGDYGI 145

Query: 238 ARFLPPTRTQTKY 250
                P+R +  Y
Sbjct: 146 G----PSRYKEDY 154

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 37/177 (20%)

Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA----LVYEFIHNRSPEKWLYPI 172
           ++  I E K L+ I+H N          ++Y+G   +     LV E+         L   
Sbjct: 69  WQDIIKEVKFLQRIKHPN---------SIEYKGCYLREHTAWLVMEYC--------LGSA 111

Query: 173 SKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV 232
           S   E +++P     L+ + IA     AL  L +       H D+K  N+LL +    ++
Sbjct: 112 SDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKL 166

Query: 233 GDFGLARFLPPTRT--QTKYGVGNEVSTIG---------DVYSYGILLLELMIREKP 278
            DFG A    P  +   T Y +  EV             DV+S GI  +EL  R+ P
Sbjct: 167 ADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 18/119 (15%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE 180
           + E + L+N RH  L       L   +Q +D    V E+ +     +  + +S+E   + 
Sbjct: 43  LTESRVLQNTRHPFLTA-----LKYSFQTHDRLCFVMEYANG---GELFFHLSRE-RVFS 93

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
             R      R   A ++ SAL YLH  C  V  + DLK  N++LD D   ++ DFGL +
Sbjct: 94  EDRA-----RFYGA-EIVSALGYLH-SCDVV--YRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	382
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.98
PHA03212	391	serine/threonine kinase US3; Provisional	99.98
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.98
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.98
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.98
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.98
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.98
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.98
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.98
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.98
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.98
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.98
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.98
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.98
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.98
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.98
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.98
KOG0589	426	consensus Serine/threonine protein kinase [General	99.98
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.98
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.98
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.98
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.98
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.98
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.98
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.98
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.98
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.98
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.98
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.98
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.98
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.98
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.98
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
PTZ00284	467	protein kinase; Provisional	99.96
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.96
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.96
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
PLN00009	294	cyclin-dependent kinase A; Provisional	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.94
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.94
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.93
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.92
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.91
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.91
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.91
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.9
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.88
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.88
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.88
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.87
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.87
KOG1152	772	consensus Signal transduction serine/threonine kin	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.83
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.81
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.75
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.74
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.69
PRK12274	218	serine/threonine protein kinase; Provisional	99.69
PRK09188	365	serine/threonine protein kinase; Provisional	99.66
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.64
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.62
PRK10345	210	hypothetical protein; Provisional	99.62
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.6
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.59
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.52
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.51
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.5
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.48
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.47
PRK14879	211	serine/threonine protein kinase; Provisional	99.45
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.45
smart00090	237	RIO RIO-like kinase.	99.44
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.42
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.4
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.34
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.3
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.29
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.23
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.18
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.1
KOG1243	690	consensus Protein kinase [General function predict	99.02
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.93
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.89
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.88
PLN03150	623	hypothetical protein; Provisional	98.84
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.82
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.75
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.66
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.62
KOG3087	229	consensus Serine/threonine protein kinase [General	98.61
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.56
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.54
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.49
COG4248	637	Uncharacterized protein with protein kinase and he	98.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.42
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.38
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.23
PRK09902	216	hypothetical protein; Provisional	98.1
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.09
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.91
PLN03150	623	hypothetical protein; Provisional	97.76
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.76
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	97.69
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.53
PLN02876	822	acyl-CoA dehydrogenase	97.3
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.3
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.23
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.23
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.17
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.12
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.09
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.97
PF01636	239	APH: Phosphotransferase enzyme family This family	96.91
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.87
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	96.82
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.8
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.48
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	96.24
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	96.23
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	96.2
PRK10593	297	hypothetical protein; Provisional	96.05
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.92
KOG0472	565	consensus Leucine-rich repeat protein [Function un	95.55
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	95.46
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	95.23
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.96
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	94.71
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	94.7
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.14
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	94.12
KOG0617	264	consensus Ras suppressor protein (contains leucine	94.0
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.81
KOG0617	264	consensus Ras suppressor protein (contains leucine	93.75
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	93.47
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.35
PRK05231	319	homoserine kinase; Provisional	93.15
PHA03111	444	Ser/Thr kinase; Provisional	92.95
PF13504	17	LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO	92.82
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	92.77
PRK10271	188	thiK thiamine kinase; Provisional	92.27
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	91.95
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	91.89
COG2334	331	Putative homoserine kinase type II (protein kinase	91.76

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-46  Score=398.48  Aligned_cols=331  Identities=25%  Similarity=0.442  Sum_probs=241.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCccccccCCCCCCCCCCCCCcCCCCCCCCCCCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGISKFKLPKCGSKKSNGKRLPV   78 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn~~lcg~~~~~~~~~c~~~~~~~~~~~~   78 (382)
                      ||||+|+|+|.+|..+.++ +|+.||+|+|+|+|.+|. +.+..+...++.||+.+||+.+....++|....   .....
T Consensus       552 L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~---~~~~~  628 (968)
T PLN00113        552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR---KTPSW  628 (968)
T ss_pred             EECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc---cccee
Confidence            6889999999999999988 899999999999999998 667788888999999999987655667785321   11111


Q ss_pred             chhhhhHHHHHHHHHHHHHHHHHhhhccc-----------------------------------------c---------
Q 040999           79 ALNLVISIVSGLVGLALALSICFFFGFSH-----------------------------------------L---------  108 (382)
Q Consensus        79 ~~~~~i~i~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~---------  108 (382)
                      . .++++++++++.++++++++++...++                                         +         
T Consensus       629 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy  707 (968)
T PLN00113        629 W-FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASY  707 (968)
T ss_pred             e-eehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEE
Confidence            1 112222222211111111111111000                                         0         


Q ss_pred             -----ccCC--chhhHH----HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc
Q 040999          109 -----RHQG--AFKIFK----SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE  177 (382)
Q Consensus       109 -----~~~~--avK~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~  177 (382)
                           ..+.  |+|.++    ...+|++.+++++|||||+++++|..     .+..++||||+++|+|.++++       
T Consensus       708 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~-------  775 (968)
T PLN00113        708 KGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVLR-------  775 (968)
T ss_pred             EEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCCCCCcHHHHHh-------
Confidence                 0011  555552    23567999999999999999999764     567899999999999999983       


Q ss_pred             cccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC--------CCCCCCc
Q 040999          178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP--------PTRTQTK  249 (382)
Q Consensus       178 ~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~--------~~~~~~~  249 (382)
                            .++|..+.+++.|+++||+|||+.++++|+||||||+||+++.++.+++. ||.+....        ..+.+||
T Consensus       776 ------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE  848 (968)
T PLN00113        776 ------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPE  848 (968)
T ss_pred             ------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcc
Confidence                  27899999999999999999998878899999999999999999888775 55543321        3456799


Q ss_pred             cccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC-chhhhhhcccccchhhhhhccccchhhhh
Q 040999          250 YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN-HVKDIVDSILLNDDEKLVVRGDQKQTQAK  328 (382)
Q Consensus       250 ~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (382)
                      +..+..++.++|||||||++|||+||+.||+..+........|.+..... ....++++.+....               
T Consensus       849 ~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------  913 (968)
T PLN00113        849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV---------------  913 (968)
T ss_pred             cccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC---------------
Confidence            88888999999999999999999999999976655556666676654433 23344444332211               


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          329 INVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       329 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                       ....++..++.+++.+||+.+|++||||+||+++|+++.+.
T Consensus       914 -~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        914 -SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             -CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence             01124566889999999999999999999999999988664

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=343.97  Aligned_cols=234  Identities=35%  Similarity=0.573  Sum_probs=194.9

Q ss_pred             cccCC--chhhH--------HHHHHHHHHHhhcccccceeeeeeeeecccCCCc-eeEEEEecccCCCccccccCCCCCC
Q 040999          108 LRHQG--AFKIF--------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGND-FKALVYEFIHNRSPEKWLYPISKED  176 (382)
Q Consensus       108 ~~~~~--avK~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~  176 (382)
                      +.++.  |||.+        ++|.+|++++.+++|||+|+++|||.+     .+ ..+||||||++|+|.++|+...   
T Consensus        96 l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e-----~~~~~~LVYEym~nGsL~d~L~~~~---  167 (361)
T KOG1187|consen   96 LSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLE-----GGEHRLLVYEYMPNGSLEDHLHGKK---  167 (361)
T ss_pred             ECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEec-----CCceEEEEEEccCCCCHHHHhCCCC---
Confidence            55543  77755        469999999999999999999999975     34 5899999999999999997532   


Q ss_pred             ccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------C---
Q 040999          177 ETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------T---  244 (382)
Q Consensus       177 ~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~---  244 (382)
                          .. .++|..|++|+.++|+||+|||+.+.+.|+||||||+|||+|+++++||+|||+|+..+.         .   
T Consensus       168 ----~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~  242 (361)
T KOG1187|consen  168 ----GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTF  242 (361)
T ss_pred             ----CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCC
Confidence                11 789999999999999999999998888999999999999999999999999999987764         1   


Q ss_pred             -CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccc-cCCchHHHHHHHhcCC-chhhhhhcccccchhhhhhccc
Q 040999          245 -RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF-EGDMNLHKFAKMALPN-HVKDIVDSILLNDDEKLVVRGD  321 (382)
Q Consensus       245 -~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  321 (382)
                       ...|||...+..++|+|||||||+++|++||+.|.+... .+...+..|.+..+.. .+.+++|+.+......      
T Consensus       243 gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~------  316 (361)
T KOG1187|consen  243 GYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYP------  316 (361)
T ss_pred             ccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCC------
Confidence             234888888899999999999999999999999987543 3445588888766655 7888999887532111      


Q ss_pred             cchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          322 QKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                                ..+++..+.+++.+|++.+|++||+|.||+++|+.+...
T Consensus       317 ----------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  317 ----------DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             ----------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence                      014677899999999999999999999999999666543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-42  Score=316.59  Aligned_cols=209  Identities=30%  Similarity=0.402  Sum_probs=169.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCc-eeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGND-FKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ++|.+|+.+|.+++|||||+|+|+|..     +. ..++|||||++|+|.++++..        ....+++..+++|+.|
T Consensus        84 ~~f~~E~~il~~l~HpNIV~f~G~~~~-----~~~~~~iVtEy~~~GsL~~~l~~~--------~~~~l~~~~~l~~ald  150 (362)
T KOG0192|consen   84 KAFRREASLLSRLRHPNIVQFYGACTS-----PPGSLCIVTEYMPGGSLSVLLHKK--------RKRKLPLKVRLRIALD  150 (362)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCceEEEEEeCCCCcHHHHHhhc--------ccCCCCHHHHHHHHHH
Confidence            489999999999999999999999875     23 689999999999999999642        3567999999999999


Q ss_pred             HHHHHhHHhhcCCCc-eeecCCCCCceeeCCCC-cEEEccccccccCCC------------CCCCCcccc--CCCCCccc
Q 040999          197 VASALNYLHHDCQPV-TAHCDLKPSNVLLDDDM-TARVGDFGLARFLPP------------TRTQTKYGV--GNEVSTIG  260 (382)
Q Consensus       197 i~~~L~~lH~~~~~~-ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~------------~~~~~~~~~--~~~~~~~~  260 (382)
                      ||+|+.|||   +.+ ||||||||+|||++.++ ++||+|||+++....            .+.+||...  ...++.|+
T Consensus       151 iArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~  227 (362)
T KOG0192|consen  151 IARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKS  227 (362)
T ss_pred             HHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccc
Confidence            999999999   556 99999999999999997 999999999976543            234588877  56899999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||+++|||+||+.||.....     .+....        ++........+                  ..+...+.
T Consensus       228 DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~--------v~~~~~Rp~~p------------------~~~~~~l~  276 (362)
T KOG0192|consen  228 DVYSFGIVLWELLTGEIPFEDLAP-----VQVASA--------VVVGGLRPPIP------------------KECPPHLS  276 (362)
T ss_pred             hhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHH--------HHhcCCCCCCC------------------ccCCHHHH
Confidence            999999999999999999875422     111110        11111111100                  13556778


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      .++.+||+.||++||++.+++..|+.+...+..
T Consensus       277 ~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  277 SLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             HHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            888899999999999999999999999887665

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-42  Score=316.96  Aligned_cols=210  Identities=25%  Similarity=0.403  Sum_probs=173.3

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+       ++|.+|+++|++|+|+|||+++|+|..     ++.++||||||+.|+|.+||..        .....+
T Consensus       234 avk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVtE~m~~GsLl~yLr~--------~~~~~l  300 (468)
T KOG0197|consen  234 AVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVTEYMPKGSLLDYLRT--------REGGLL  300 (468)
T ss_pred             cceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEEEecccCcHHHHhhh--------cCCCcc
Confidence            66665       789999999999999999999999964     4579999999999999999953        235678


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~  252 (382)
                      ...+.+.++.|||+|++||+   ++++|||||.++||||+++..+||+|||+|+...+             .+++||...
T Consensus       301 ~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~  377 (468)
T KOG0197|consen  301 NLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALN  377 (468)
T ss_pred             chHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHh
Confidence            89999999999999999999   88999999999999999999999999999995433             244588888


Q ss_pred             CCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 GNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      ...++.|||||||||+||||+| |+.|+..+.     ..+.         -+.+++......+                 
T Consensus       378 ~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~ev---------~~~le~GyRlp~P-----------------  426 (468)
T KOG0197|consen  378 YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEEV---------LELLERGYRLPRP-----------------  426 (468)
T ss_pred             hCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHHH---------HHHHhccCcCCCC-----------------
Confidence            8999999999999999999998 777766431     1111         1122221111111                 


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                       ..|+.++.+++..||+.+|++|||++.+...|+.+...
T Consensus       427 -~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  427 -EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             -CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence             26888999999999999999999999999999888664

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=300.76  Aligned_cols=202  Identities=22%  Similarity=0.284  Sum_probs=164.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCc-eeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGND-FKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +++.+|+++++..+||+||++||.|..     +. .+.++||||.+|||++++.          ..+.+++...-+++.+
T Consensus       122 ~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~isI~mEYMDgGSLd~~~k----------~~g~i~E~~L~~ia~~  186 (364)
T KOG0581|consen  122 KQILRELEILRSCQSPYIVGFYGAFYS-----NGEEISICMEYMDGGSLDDILK----------RVGRIPEPVLGKIARA  186 (364)
T ss_pred             HHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceEEeehhhcCCCCHHHHHh----------hcCCCCHHHHHHHHHH
Confidence            789999999999999999999999764     44 6999999999999999983          3466999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      |++||.|||+  ..+||||||||+|||++..|++||+|||.++.+..          ..++||...+..|+.++||||||
T Consensus       187 VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLG  264 (364)
T KOG0581|consen  187 VLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLG  264 (364)
T ss_pred             HHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceeccc
Confidence            9999999995  37999999999999999999999999999987643          34559999999999999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      ++++|+.+|+.||.......            ..+-++++.+....++..           ..   ..+..++..++..|
T Consensus       265 LsllE~a~GrfP~~~~~~~~------------~~~~~Ll~~Iv~~ppP~l-----------P~---~~fS~ef~~FV~~C  318 (364)
T KOG0581|consen  265 LSLLELAIGRFPYPPPNPPY------------LDIFELLCAIVDEPPPRL-----------PE---GEFSPEFRSFVSCC  318 (364)
T ss_pred             HHHHHHhhCCCCCCCcCCCC------------CCHHHHHHHHhcCCCCCC-----------Cc---ccCCHHHHHHHHHH
Confidence            99999999999986431111            123333343333222110           00   02456788888899


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      +++||.+|||++|+++
T Consensus       319 L~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  319 LRKDPSERPSAKQLLQ  334 (364)
T ss_pred             hcCCcccCCCHHHHhc
Confidence            9999999999999885

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-39  Score=316.47  Aligned_cols=217  Identities=24%  Similarity=0.425  Sum_probs=178.4

Q ss_pred             chhhH---------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcccc---
Q 040999          113 AFKIF---------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE---  180 (382)
Q Consensus       113 avK~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~---  180 (382)
                      |||.+         ++|++|+++|..++|||||+++|+|..     ++..++|+|||..|||.+||...........   
T Consensus       520 AVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~  594 (774)
T KOG1026|consen  520 AVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQ  594 (774)
T ss_pred             hHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----CCeeEEEEEecccccHHHHHHhhCCccccccCCC
Confidence            78887         689999999999999999999999975     7789999999999999999965443222111   


Q ss_pred             -CCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC--------------CCCC
Q 040999          181 -RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL--------------PPTR  245 (382)
Q Consensus       181 -~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~--------------~~~~  245 (382)
                       .+.+++..+.+.|+.|||.|+.||-   +..+|||||-.+|+||.++..+||+|||+++..              +-.+
T Consensus       595 ~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRW  671 (774)
T KOG1026|consen  595 DTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRW  671 (774)
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeec
Confidence             1455999999999999999999999   779999999999999999999999999999843              3345


Q ss_pred             CCCccccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhh-cccccchhhhhhccccc
Q 040999          246 TQTKYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVD-SILLNDDEKLVVRGDQK  323 (382)
Q Consensus       246 ~~~~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  323 (382)
                      +.||....+++|++||||||||+|||+++ |+.||.+....              ++-+.+. ..+..            
T Consensus       672 MppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--------------EVIe~i~~g~lL~------------  725 (774)
T KOG1026|consen  672 MPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--------------EVIECIRAGQLLS------------  725 (774)
T ss_pred             CCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--------------HHHHHHHcCCccc------------
Confidence            66899999999999999999999999997 89997653211              1111111 11111            


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          324 QTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                             ..++|+.++.+|++.||+.+|++||+++||-..|++....
T Consensus       726 -------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  726 -------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                   1237889999999999999999999999999999987654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-38  Score=298.31  Aligned_cols=195  Identities=22%  Similarity=0.319  Sum_probs=159.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +...+||++.++|+|||||+++++     +++.++.|+|+|+|++++|..++          ++.+++++.++..++.||
T Consensus        63 eKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~nVYivLELC~~~sL~el~----------Krrk~ltEpEary~l~QI  127 (592)
T KOG0575|consen   63 EKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNNVYIVLELCHRGSLMELL----------KRRKPLTEPEARYFLRQI  127 (592)
T ss_pred             HHHHHHHHHHHhcCCCcEEeeeeE-----eecCCceEEEEEecCCccHHHHH----------HhcCCCCcHHHHHHHHHH
Confidence            678899999999999999999999     56799999999999999999988          456789999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+|+|||||..|++++++.++||+|||+|..+...            ..+||.......+..+||||+
T Consensus       128 v~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSl  204 (592)
T KOG0575|consen  128 VEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSL  204 (592)
T ss_pred             HHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhh
Confidence            99999999   789999999999999999999999999999887532            334777777778899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|-|++|++||+..                 .+++..+..-..+...                ......+..+|+.+
T Consensus       205 GcvmYtLL~G~PPFetk-----------------~vkety~~Ik~~~Y~~----------------P~~ls~~A~dLI~~  251 (592)
T KOG0575|consen  205 GCVMYTLLVGRPPFETK-----------------TVKETYNKIKLNEYSM----------------PSHLSAEAKDLIRK  251 (592)
T ss_pred             hhHHHhhhhCCCCcccc-----------------hHHHHHHHHHhcCccc----------------ccccCHHHHHHHHH
Confidence            99999999999998732                 1222222222111100                00122345677779


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      +|+.+|.+|||+++|+..
T Consensus       252 lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  252 LLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             HhcCCcccCCCHHHHhcC
Confidence            999999999999999853

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-39  Score=286.59  Aligned_cols=198  Identities=17%  Similarity=0.189  Sum_probs=154.8

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      ...+|+++|++++|||||++++++     ...++.|+||||+.+|+|.+++-          ..+.+.+..-..++.|++
T Consensus       222 ~v~~EieILkkL~HP~IV~~~d~f-----~~~ds~YmVlE~v~GGeLfd~vv----------~nk~l~ed~~K~~f~Qll  286 (475)
T KOG0615|consen  222 DVQNEIEILKKLSHPNIVRIKDFF-----EVPDSSYMVLEYVEGGELFDKVV----------ANKYLREDLGKLLFKQLL  286 (475)
T ss_pred             hhHHHHHHHHhcCCCCEEEEeeee-----ecCCceEEEEEEecCccHHHHHH----------hccccccchhHHHHHHHH
Confidence            357999999999999999999994     45788899999999999999983          455677788889999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCC---CcEEEccccccccCCC-----------CCCCCccccCCC--C-Cccch
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDD---MTARVGDFGLARFLPP-----------TRTQTKYGVGNE--V-STIGD  261 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~--~-~~~~D  261 (382)
                      .|+.|||   +.||+||||||+|||+..+   ..+||+|||+|+....           ...+||...+..  + ..++|
T Consensus       287 ~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVD  363 (475)
T KOG0615|consen  287 TAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVD  363 (475)
T ss_pred             HHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchhe
Confidence            9999999   8899999999999999766   7799999999998743           334477655432  2 34889


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      +||+||+||-+++|.+||...........+..+..+...            +                ..+.+...+.+.
T Consensus       364 iWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~------------p----------------~~w~~Iseea~d  415 (475)
T KOG0615|consen  364 IWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG------------P----------------LQWDRISEEALD  415 (475)
T ss_pred             eeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc------------C----------------hhhhhhhHHHHH
Confidence            999999999999999999764433322223222222110            0                011244556788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.++|..||++|||+.|+++
T Consensus       416 lI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  416 LINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHHhhEeCcccCcCHHHHhc
Confidence            888999999999999999985

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-38  Score=291.21  Aligned_cols=212  Identities=22%  Similarity=0.302  Sum_probs=174.2

Q ss_pred             chhhHHHHH-HHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHH
Q 040999          113 AFKIFKSFI-AECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRL  191 (382)
Q Consensus       113 avK~~~~~~-~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~  191 (382)
                      |||+++++. .+|+-|++|+|+||+.|.|+|..     ..-+|||||||+.|-|+..|.          ....++.....
T Consensus       151 AVKKV~elkETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiMEfCa~GqL~~VLk----------a~~~itp~llv  215 (904)
T KOG4721|consen  151 AVKKVRELKETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIMEFCAQGQLYEVLK----------AGRPITPSLLV  215 (904)
T ss_pred             hhHHHhhhhhhhHHHHHhccCcceeeEeeeecC-----CceeEEeeeccccccHHHHHh----------ccCccCHHHHH
Confidence            999997765 58999999999999999999974     567899999999999999993          45678888999


Q ss_pred             HHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccc
Q 040999          192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIG  260 (382)
Q Consensus       192 ~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~  260 (382)
                      .|..+||.|+.|||   .+.|||||||.-||||..+..+||+|||.++.+...           +++||.......++|+
T Consensus       216 ~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKV  292 (904)
T KOG4721|consen  216 DWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKV  292 (904)
T ss_pred             HHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCccccc
Confidence            99999999999999   779999999999999999999999999999876443           4558999999999999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||||||||+||..||......     ..+|....+.+.-                          .....|+..+.
T Consensus       293 DIwSfGVVLWEmLT~EiPYkdVdss-----AIIwGVGsNsL~L--------------------------pvPstcP~Gfk  341 (904)
T KOG4721|consen  293 DIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWGVGSNSLHL--------------------------PVPSTCPDGFK  341 (904)
T ss_pred             ceehhHHHHHHHHhcCCCccccchh-----eeEEeccCCcccc--------------------------cCcccCchHHH
Confidence            9999999999999999998643211     1111111111110                          11126777888


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      -|+.+||+..|..||++++++..|+-....+++
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~HldIa~pell~  374 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHLDIASPELLS  374 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence            888899999999999999999999877766554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-37  Score=264.49  Aligned_cols=209  Identities=21%  Similarity=0.289  Sum_probs=162.3

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      -++...|+.+|++|+|||||++++.-+   .++....++|||||..|+|.+.+....      ...+.+++..+++++.|
T Consensus        62 rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evlnivmE~c~~GDLsqmIk~~K------~qkr~ipE~~Vwk~f~Q  132 (375)
T KOG0591|consen   62 RQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVLNIVMELCDAGDLSQMIKHFK------KQKRLIPEKTVWKYFVQ  132 (375)
T ss_pred             HHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhhHHHHHhhcccCHHHHHHHHH------hccccCchHHHHHHHHH
Confidence            377899999999999999999998533   233445899999999999999996544      44667999999999999


Q ss_pred             HHHHHhHHhhcCCCc--eeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPV--TAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~--ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||..+|... ++  |+||||||.||+++.+|.+||+|||+++.+...            ..+||...+..|+.|+||
T Consensus       133 L~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDi  211 (375)
T KOG0591|consen  133 LCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDI  211 (375)
T ss_pred             HHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhH
Confidence            999999999531 44  999999999999999999999999999987543            344777788899999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||+||++|||..-++||...     ++.+..+..-            ..+.+.         .     ...-....+.++
T Consensus       212 WslGCllyEMcaL~~PF~g~-----n~~~L~~KI~------------qgd~~~---------~-----p~~~YS~~l~~l  260 (375)
T KOG0591|consen  212 WSLGCLLYEMCALQSPFYGD-----NLLSLCKKIE------------QGDYPP---------L-----PDEHYSTDLREL  260 (375)
T ss_pred             HHHHHHHHHHHhcCCCcccc-----cHHHHHHHHH------------cCCCCC---------C-----cHHHhhhHHHHH
Confidence            99999999999999998642     2322222111            111100         0     001455678889


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      +..|+..||..||+.-.+++.+++
T Consensus       261 i~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  261 INMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHccCCcccCCCcchHHHHHHH
Confidence            999999999999996555555544

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=272.69  Aligned_cols=146  Identities=28%  Similarity=0.492  Sum_probs=132.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +-+..|+++|+.++|||||++++++.     ..++.|+|||||.+|+|.+|++          ..+.+++.....++.|+
T Consensus        54 e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~~~i~lVMEyC~gGDLs~yi~----------~~~~l~e~t~r~Fm~QL  118 (429)
T KOG0595|consen   54 ELLLSEIKILKELKHPNIVRLLDCIE-----DDDFIYLVMEYCNGGDLSDYIR----------RRGRLPEATARHFMQQL  118 (429)
T ss_pred             HHHHHHHHHHHhcCCcceeeEEEEEe-----cCCeEEEEEEeCCCCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            56789999999999999999999965     4789999999999999999994          34579999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCC------CcEEEccccccccCCCC-----------CCCCccccCCCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDD------MTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~------~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~  260 (382)
                      |.||++||   +++||||||||+|||++..      -.+||+|||+|+.+.+.           .++||.....+|+.|+
T Consensus       119 A~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKA  195 (429)
T KOG0595|consen  119 ASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKA  195 (429)
T ss_pred             HHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchh
Confidence            99999999   8899999999999999765      46899999999988654           3458888899999999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCc
Q 040999          261 DVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~  281 (382)
                      |+||.|+|+|+|++|+.||+.
T Consensus       196 DLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  196 DLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hHHHHHHHHHHHHhCCCCccc
Confidence            999999999999999999874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.3e-36  Score=273.99  Aligned_cols=209  Identities=18%  Similarity=0.259  Sum_probs=160.7

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ++.|.+|+++|++++|||||++++++... .......++||||+++|+|.+++..          ...+++....+++.|
T Consensus        62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~Ey~~~g~L~~~l~~----------~~~~~~~~~~~i~~~  130 (283)
T PHA02988         62 IDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLILEYCTRGYLREVLDK----------EKDLSFKTKLDMAID  130 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEEEeCCCCcHHHHHhh----------CCCCChhHHHHHHHH
Confidence            46788999999999999999999997541 1234568999999999999999942          346889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------CCCCCccccC--CCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQTKYGVG--NEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~--~~~~~~~Dv~S~  265 (382)
                      ++.||.|||.  ..+++||||||+|||+++++.+||+|||+++....         ...+||...+  ..++.++|||||
T Consensus       131 i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~Sl  208 (283)
T PHA02988        131 CCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSL  208 (283)
T ss_pred             HHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHH
Confidence            9999999994  24788999999999999999999999999885432         2234666544  678999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||....     ............        .....                  ...++..+.+++.+
T Consensus       209 Gvil~el~~g~~Pf~~~~-----~~~~~~~i~~~~--------~~~~~------------------~~~~~~~l~~li~~  257 (283)
T PHA02988        209 GVVLWEIFTGKIPFENLT-----TKEIYDLIINKN--------NSLKL------------------PLDCPLEIKCIVEA  257 (283)
T ss_pred             HHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcC--------CCCCC------------------CCcCcHHHHHHHHH
Confidence            999999999999987421     111111110000        00000                  00234467888889


Q ss_pred             cCCCCccCCCCHHHHHHHHHHhhh
Q 040999          346 CSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      ||+.||++|||+.|+++.|+.++.
T Consensus       258 cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        258 CTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HhcCCcccCcCHHHHHHHHHHHHh
Confidence            999999999999999999998764

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=305.95  Aligned_cols=215  Identities=25%  Similarity=0.395  Sum_probs=175.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+|.+|..+|++++|||||+++|+|+.     ....++++|||++|+|..||.+.+..   ......++..+.+.++.||
T Consensus       740 ~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~~~~~i~leyM~gGDL~sflr~~r~~---~~~~~~L~~~dLl~~a~dv  811 (1025)
T KOG1095|consen  740 SDFLKEALLMSKFDHPNIVSLIGVCLD-----SGPPLILLEYMEGGDLLSFLRESRPA---PFQPSNLSMRDLLAFALDV  811 (1025)
T ss_pred             HHHHHHHHHHhcCCCcceeeEEEeecC-----CCCcEEEehhcccCcHHHHHHhcccc---cCCCCCCCHHHHHHHHHHH
Confidence            689999999999999999999999975     67789999999999999999765432   1235679999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEcccccccc--------------CCCCCCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF--------------LPPTRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~--------------~~~~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      |+|+.||+   ++++|||||..+|+|++....+||+|||+|+.              ++-.++.||......+++|+|||
T Consensus       812 A~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvW  888 (1025)
T KOG1095|consen  812 AKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVW  888 (1025)
T ss_pred             hhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchh
Confidence            99999999   88999999999999999999999999999983              23345668888889999999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||++||++| |..||.....  ......           +.... ..++                  ...|+..+.++
T Consensus       889 sFGVllWEifslG~~PY~~~~n--~~v~~~-----------~~~gg-RL~~------------------P~~CP~~ly~l  936 (1025)
T KOG1095|consen  889 SFGVLLWEIFSLGATPYPSRSN--FEVLLD-----------VLEGG-RLDP------------------PSYCPEKLYQL  936 (1025)
T ss_pred             hhHHHHHHHHhCCCCCCCCcch--HHHHHH-----------HHhCC-ccCC------------------CCCCChHHHHH
Confidence            99999999998 7788754211  111110           00100 0011                  12688899999


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhhhhcCCC
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  375 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~  375 (382)
                      +..||+.+|++||++.++++++..+.+...+..
T Consensus       937 M~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~  969 (1025)
T KOG1095|consen  937 MLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI  969 (1025)
T ss_pred             HHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence            999999999999999999999999988765543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-35  Score=278.85  Aligned_cols=214  Identities=23%  Similarity=0.316  Sum_probs=161.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc-------------------
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE-------------------  177 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------  177 (382)
                      +.+.+|++++.++ +||||++++++|..    .....++||||+++|+|.+++........                   
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (338)
T cd05102          55 KALMSELKILIHIGNHLNVVNLLGACTK----PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ  130 (338)
T ss_pred             HHHHHHHHHHHHhccCcceeeEEeEecC----CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhh
Confidence            5689999999999 89999999998753    24568999999999999988864211000                   


Q ss_pred             ---------------------------------cccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceee
Q 040999          178 ---------------------------------TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL  224 (382)
Q Consensus       178 ---------------------------------~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl  224 (382)
                                                       .......+++..+..++.||++||+|||   +.+|+||||||+|||+
T Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~  207 (338)
T cd05102         131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILL  207 (338)
T ss_pred             hccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEE
Confidence                                             0001245888999999999999999999   7799999999999999


Q ss_pred             CCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchH
Q 040999          225 DDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNL  289 (382)
Q Consensus       225 ~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~  289 (382)
                      +.++.+||+|||+++....              ....||...+..++.++|||||||++|||++ |..||...... .  
T Consensus       208 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~--  284 (338)
T cd05102         208 SENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-E--  284 (338)
T ss_pred             cCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-H--
Confidence            9999999999999975421              2345777777788999999999999999997 99998642111 0  


Q ss_pred             HHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          290 HKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                       .+.....        +......+                   ..+...+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       285 -~~~~~~~--------~~~~~~~~-------------------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         285 -EFCQRLK--------DGTRMRAP-------------------ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             -HHHHHHh--------cCCCCCCC-------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             1111000        00000000                   0223467889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=285.30  Aligned_cols=207  Identities=22%  Similarity=0.329  Sum_probs=168.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|++|+++|++++|||||++||++..     ...+++|||+|+||+|.++|..         ....++..++++++.+.
T Consensus       206 ~e~m~EArvMr~l~H~NVVr~yGVa~~-----~~Pl~ivmEl~~gGsL~~~L~k---------~~~~v~~~ek~~~~~~A  271 (474)
T KOG0194|consen  206 KEFMKEARVMRQLNHPNVVRFYGVAVL-----EEPLMLVMELCNGGSLDDYLKK---------NKKSLPTLEKLRFCYDA  271 (474)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEcC-----CCccEEEEEecCCCcHHHHHHh---------CCCCCCHHHHHHHHHHH
Confidence            789999999999999999999999764     7789999999999999999953         33469999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      |.||+|||   +++++||||-.+|+|++.++.+||+|||+++.-.            -.+.+||......+++++|||||
T Consensus       272 A~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sf  348 (474)
T KOG0194|consen  272 ARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSF  348 (474)
T ss_pred             HhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhhe
Confidence            99999999   8899999999999999999999999999997542            34556898888899999999999


Q ss_pred             HHHHHHHHh-cCCCCCccccCCchHHHHH-HHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          266 GILLLELMI-REKPSDIMFEGDMNLHKFA-KMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       266 Gvil~ellt-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||++||+++ |..||..+...  ....++ ...++.            ..+                  ...+..+..++
T Consensus       349 GV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~------------~~~------------------~~~p~~~~~~~  396 (474)
T KOG0194|consen  349 GVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRM------------PIP------------------SKTPKELAKVM  396 (474)
T ss_pred             eeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccC------------CCC------------------CCCHHHHHHHH
Confidence            999999998 78897643211  111111 111110            000                  02345667777


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      .+||..+|++||+|.++.+.++.+......
T Consensus       397 ~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  397 KQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            799999999999999999999999877554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.7e-36  Score=259.63  Aligned_cols=220  Identities=20%  Similarity=0.288  Sum_probs=158.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +-.+||+++|++++|+|+|.++++|.     .....+||+|||+.- +.+-|.         .....++...+.+++.|+
T Consensus        46 KIAlREIrmLKqLkH~NLVnLiEVFr-----rkrklhLVFE~~dhT-vL~eLe---------~~p~G~~~~~vk~~l~Q~  110 (396)
T KOG0593|consen   46 KIALREIRMLKQLKHENLVNLIEVFR-----RKRKLHLVFEYCDHT-VLHELE---------RYPNGVPSELVKKYLYQL  110 (396)
T ss_pred             HHHHHHHHHHHhcccchHHHHHHHHH-----hcceeEEEeeecchH-HHHHHH---------hccCCCCHHHHHHHHHHH
Confidence            34689999999999999999999954     478899999999764 333332         344568889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC-CCCC-----------CCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-PTRT-----------QTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~-~~~~-----------~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++|+.|+|   +++++||||||+|||++.++.+||||||+|+.+. ++..           +||...+ ..|+..+||||
T Consensus       111 l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWA  187 (396)
T KOG0593|consen  111 LKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWA  187 (396)
T ss_pred             HHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchh
Confidence            99999999   8899999999999999999999999999999887 3322           2666666 78899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHH--h---cCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKM--A---LPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +||++.||+||.+-|.    +..++.+....  .   +......++...-   ......-+....+............-+
T Consensus       188 iGCv~aEl~~G~pL~P----G~SDiDQLy~I~ktLG~L~prhq~iF~~N~---~F~Gv~lP~~~~~epLe~k~p~~s~~~  260 (396)
T KOG0593|consen  188 IGCVFAELLTGEPLWP----GRSDIDQLYLIRKTLGNLIPRHQSIFSSNP---FFHGVRLPEPEHPEPLERKYPKISNVL  260 (396)
T ss_pred             hhHHHHHHhcCCcCCC----CcchHHHHHHHHHHHcccCHHHHHHhccCC---ceeeeecCCCCCccchhhhcccchHHH
Confidence            9999999999998865    34444433221  1   1112222222210   000000011111122222222334467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++++..|++.||.+|++-+|++.
T Consensus       261 ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  261 LDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHHHHhcCCccccccHHHHhc
Confidence            88889999999999999999873

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=270.90  Aligned_cols=205  Identities=20%  Similarity=0.278  Sum_probs=153.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||+.+|....  .+ ....+++|||+++|+|.+++...         ...+++..+.++..||
T Consensus        59 ~~l~~Ei~iL~~l~~p~IV~~~G~~~~--~~-~~~~~i~mEy~~~GsL~~~~~~~---------g~~l~E~~v~~ytr~i  126 (313)
T KOG0198|consen   59 ESLEREIRILSRLNHPNIVQYYGSSSS--RE-NDEYNIFMEYAPGGSLSDLIKRY---------GGKLPEPLVRRYTRQI  126 (313)
T ss_pred             HHHHHHHHHHHhCCCCCEEeeCCcccc--cc-CeeeEeeeeccCCCcHHHHHHHc---------CCCCCHHHHHHHHHHH
Confidence            458999999999999999999997332  11 13689999999999999999432         2269999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCC---------------CCCCCccccCC-CCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPP---------------TRTQTKYGVGN-EVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~---------------~~~~~~~~~~~-~~~~~~  260 (382)
                      ++||+|||   +++|+||||||+|||++. ++.+||+|||+++....               ...+||....+ ....++
T Consensus       127 L~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~s  203 (313)
T KOG0198|consen  127 LEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRES  203 (313)
T ss_pred             HHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccc
Confidence            99999999   889999999999999999 79999999999986542               12336766633 334599


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||+||++.||+||+.||.....   ................+-                           .....+..
T Consensus       204 DiWSlGCtVvEM~Tg~~PW~~~~~---~~~~~~~ig~~~~~P~ip---------------------------~~ls~~a~  253 (313)
T KOG0198|consen  204 DIWSLGCTVVEMLTGKPPWSEFFE---EAEALLLIGREDSLPEIP---------------------------DSLSDEAK  253 (313)
T ss_pred             hhhhcCCEEEeccCCCCcchhhcc---hHHHHHHHhccCCCCCCC---------------------------cccCHHHH
Confidence            999999999999999999875311   111111111111000000                           02233556


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +++..|++.+|++|||+.++++.--..
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhChhhh
Confidence            777799999999999999999765443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=281.01  Aligned_cols=213  Identities=26%  Similarity=0.423  Sum_probs=169.0

Q ss_pred             chhhH----------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCC
Q 040999          113 AFKIF----------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP  182 (382)
Q Consensus       113 avK~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  182 (382)
                      |||++          +.|.+|+.++++-||.||+-|.|+|..      +...+|..+|++-+|+.+++         ...
T Consensus       418 AVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~------p~~AIiTqwCeGsSLY~hlH---------v~e  482 (678)
T KOG0193|consen  418 AVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN------PPLAIITQWCEGSSLYTHLH---------VQE  482 (678)
T ss_pred             EEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC------CceeeeehhccCchhhhhcc---------chh
Confidence            88877          789999999999999999999999863      34499999999999999996         345


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCC
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQT  248 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~  248 (382)
                      ..++....+.|+.|||+|+.|||   .++|||||||..||++.+++++||+|||++..-..              -+.+|
T Consensus       483 tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAP  559 (678)
T KOG0193|consen  483 TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAP  559 (678)
T ss_pred             hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcH
Confidence            67999999999999999999999   88999999999999999999999999999864211              01235


Q ss_pred             cccc---CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchh
Q 040999          249 KYGV---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQT  325 (382)
Q Consensus       249 ~~~~---~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (382)
                      |...   ...|++.+||||||+|+|||+||..||...     .-++.+++.....        +..+             
T Consensus       560 EvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-----~~dqIifmVGrG~--------l~pd-------------  613 (678)
T KOG0193|consen  560 EVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-----NRDQIIFMVGRGY--------LMPD-------------  613 (678)
T ss_pred             HHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-----ChhheEEEecccc--------cCcc-------------
Confidence            5543   357899999999999999999999998621     1111222111110        0000             


Q ss_pred             hhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          326 QAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                        .......++.++.+|+..||..++++||.+.+|+..|+.+...+
T Consensus       614 --~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  614 --LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             --chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence              01122367788999999999999999999999999999887754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=287.83  Aligned_cols=204  Identities=22%  Similarity=0.395  Sum_probs=170.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+|+.|+.||.++.||||+++-|+..     ......+|.|||++|+|+.||.         .+...+++.+...++++|
T Consensus       675 rdFL~EAsIMGQFdHPNIIrLEGVVT-----ks~PvMIiTEyMENGsLDsFLR---------~~DGqftviQLVgMLrGI  740 (996)
T KOG0196|consen  675 RDFLSEASIMGQFDHPNIIRLEGVVT-----KSKPVMIITEYMENGSLDSFLR---------QNDGQFTVIQLVGMLRGI  740 (996)
T ss_pred             hhhhhhhhhcccCCCCcEEEEEEEEe-----cCceeEEEhhhhhCCcHHHHHh---------hcCCceEeehHHHHHHHH
Confidence            68999999999999999999999954     3677899999999999999995         455679999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      |.|+.||-   +.++|||||..+|||++.+-.+|++|||+++.+.++               +++||....+++|.++||
T Consensus       741 AsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDV  817 (996)
T KOG0196|consen  741 ASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDV  817 (996)
T ss_pred             HHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhc
Confidence            99999999   889999999999999999999999999999987443               234777788899999999


Q ss_pred             HHHHHHHHHHH-hcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELM-IREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||+++||.+ .|.+||-++...              ++...++.-....+                  ..+|+..+.+
T Consensus       818 WSyGIVmWEVmSyGERPYWdmSNQ--------------dVIkaIe~gyRLPp------------------PmDCP~aL~q  865 (996)
T KOG0196|consen  818 WSYGIVMWEVMSYGERPYWDMSNQ--------------DVIKAIEQGYRLPP------------------PMDCPAALYQ  865 (996)
T ss_pred             cccceEEEEecccCCCcccccchH--------------HHHHHHHhccCCCC------------------CCCCcHHHHH
Confidence            99999999977 499997654221              11111121111111                  1279999999


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      |++.||++|..+||++.|++..|+++..+
T Consensus       866 LMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  866 LMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            99999999999999999999999998653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=271.20  Aligned_cols=200  Identities=23%  Similarity=0.323  Sum_probs=158.2

Q ss_pred             chhhH-----------HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcccc
Q 040999          113 AFKIF-----------KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE  180 (382)
Q Consensus       113 avK~~-----------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~  180 (382)
                      |+|++           +...+|-.+|.+| .||.||+++-.     ++++..+|.|+||+++|+|.+++.          
T Consensus       102 AiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQD~~sLYFvLe~A~nGdll~~i~----------  166 (604)
T KOG0592|consen  102 AIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQDEESLYFVLEYAPNGDLLDLIK----------  166 (604)
T ss_pred             eHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----eecccceEEEEEecCCCcHHHHHH----------
Confidence            88887           4567788999999 89999999876     678999999999999999999994          


Q ss_pred             CCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCC-------------
Q 040999          181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ-------------  247 (382)
Q Consensus       181 ~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-------------  247 (382)
                      +.+.+++.....++.+|+.||+|||   +.|||||||||+|||+|++|++||+|||.|+.+.+....             
T Consensus       167 K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~  243 (604)
T KOG0592|consen  167 KYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSR  243 (604)
T ss_pred             HhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCc
Confidence            4567999999999999999999999   889999999999999999999999999999987543221             


Q ss_pred             ------------CccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhh
Q 040999          248 ------------TKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEK  315 (382)
Q Consensus       248 ------------~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (382)
                                  ||.......+..+|+|+||||+|.|+.|++||..    ...+..+.+..         +-    +...
T Consensus       244 ~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra----~NeyliFqkI~---------~l----~y~f  306 (604)
T KOG0592|consen  244 RSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA----ANEYLIFQKIQ---------AL----DYEF  306 (604)
T ss_pred             ccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc----ccHHHHHHHHH---------Hh----cccC
Confidence                        5555566778899999999999999999999763    22222222111         00    0000


Q ss_pred             hhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          316 LVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                                      ....+..+.+|+.+.|..||.+|+|..++.+.
T Consensus       307 ----------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  307 ----------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ----------------CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                            00122345666778899999999999887754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-35  Score=266.93  Aligned_cols=232  Identities=22%  Similarity=0.252  Sum_probs=165.5

Q ss_pred             cccCC--chhhH----------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCC
Q 040999          108 LRHQG--AFKIF----------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE  175 (382)
Q Consensus       108 ~~~~~--avK~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~  175 (382)
                      +..+.  |+|++          ....|||.+|++|+||||+++.+...+   .....+|||+|||++ +|..++.     
T Consensus       139 ~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~---~~~~siYlVFeYMdh-DL~GLl~-----  209 (560)
T KOG0600|consen  139 LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS---KLSGSIYLVFEYMDH-DLSGLLS-----  209 (560)
T ss_pred             cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe---cCCceEEEEEecccc-hhhhhhc-----
Confidence            44443  77776          457899999999999999999999764   235789999999976 7877773     


Q ss_pred             CccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCC--------
Q 040999          176 DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ--------  247 (382)
Q Consensus       176 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--------  247 (382)
                          ...-.++..++..++.|++.||.|+|   ..+|+|||||.+|||||.+|.+||+|||+|+++......        
T Consensus       210 ----~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvT  282 (560)
T KOG0600|consen  210 ----SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVT  282 (560)
T ss_pred             ----CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEE
Confidence                34567999999999999999999999   789999999999999999999999999999977655432        


Q ss_pred             -----CccccC-CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHH---HHHHHhcCCchhhhhhcccccchhhhhh
Q 040999          248 -----TKYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH---KFAKMALPNHVKDIVDSILLNDDEKLVV  318 (382)
Q Consensus       248 -----~~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (382)
                           ||...| ..|+.++|+||.|||+.||++|++.|..    ...+.   ...+...+..-..+-...+. .  ....
T Consensus       283 LWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G----~tEveQl~kIfklcGSP~e~~W~~~kLP-~--~~~~  355 (560)
T KOG0600|consen  283 LWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG----RTEVEQLHKIFKLCGSPTEDYWPVSKLP-H--ATIF  355 (560)
T ss_pred             eeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC----ccHHHHHHHHHHHhCCCChhccccccCC-c--cccc
Confidence                 555444 5789999999999999999999999653    33333   22322222111110000000 0  0000


Q ss_pred             ccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          319 RGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .....-.....+.........++|+..+|..||.+|.|+.++++
T Consensus       356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            00000000111123344556788888999999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.6e-35  Score=268.80  Aligned_cols=215  Identities=20%  Similarity=0.386  Sum_probs=157.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcc---------ccCCcccCHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET---------YERPRNLNLL  188 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------~~~~~~l~~~  188 (382)
                      ++|.+|++++.+++||||+++++++..     .+..++||||+++|+|.+++.........         ......+++.
T Consensus        64 ~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (304)
T cd05096          64 NDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYS  138 (304)
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHH
Confidence            578999999999999999999999654     56789999999999999988543211100         1122457889


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGN  254 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~  254 (382)
                      ...+++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....              ....||...+.
T Consensus       139 ~~~~i~~~i~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  215 (304)
T cd05096         139 SLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG  215 (304)
T ss_pred             HHHHHHHHHHHHHHHHH---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC
Confidence            99999999999999999   77999999999999999999999999999975422              23446766677


Q ss_pred             CCCccchhHHHHHHHHHHHh--cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          255 EVSTIGDVYSYGILLLELMI--REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      .++.++||||||+++|||++  +..||.....  ..................    ....+                   
T Consensus       216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~-------------------  270 (304)
T cd05096         216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTD--EQVIENAGEFFRDQGRQV----YLFRP-------------------  270 (304)
T ss_pred             CCCchhhhHHHHHHHHHHHHccCCCCCCcCCH--HHHHHHHHHHhhhccccc----cccCC-------------------
Confidence            88999999999999999997  4566653211  111111111100000000    00000                   


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      ..++..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus       271 ~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         271 PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            023456888999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=277.45  Aligned_cols=209  Identities=24%  Similarity=0.386  Sum_probs=173.3

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |||.+       ++|+.|+.+|+.++|||+|+++|+|..     +...|||.|||.+|+|.+||.+.        ....+
T Consensus       296 AVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYIiTEfM~yGNLLdYLRec--------nr~ev  362 (1157)
T KOG4278|consen  296 AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYIITEFMCYGNLLDYLREC--------NRSEV  362 (1157)
T ss_pred             ehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEEEEecccCccHHHHHHHh--------chhhc
Confidence            88887       689999999999999999999999976     67789999999999999999643        23446


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~  252 (382)
                      +--..+.++.||+.|+.||.   .+++|||||-..|+|+.++..+|++|||+++.+..+             ++.||...
T Consensus       363 ~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA  439 (1157)
T KOG4278|consen  363 PAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  439 (1157)
T ss_pred             chhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCccccc
Confidence            66677889999999999999   889999999999999999999999999999987543             44577777


Q ss_pred             CCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 GNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      ...++.|+|||+|||+|||+.| |-.||...     ++.         .+.+++++-...+..                 
T Consensus       440 yNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlS---------qVY~LLEkgyRM~~P-----------------  488 (1157)
T KOG4278|consen  440 YNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLS---------QVYGLLEKGYRMDGP-----------------  488 (1157)
T ss_pred             ccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHH---------HHHHHHhccccccCC-----------------
Confidence            7888999999999999999997 66776532     221         223444433322222                 


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                       +.|+..+.+|++.||+++|.+||++.|+-+.++.+..
T Consensus       489 -eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  489 -EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             -CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence             2788999999999999999999999999999987644

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-35  Score=263.19  Aligned_cols=211  Identities=23%  Similarity=0.270  Sum_probs=160.5

Q ss_pred             chhhH---------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCc
Q 040999          113 AFKIF---------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPR  183 (382)
Q Consensus       113 avK~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~  183 (382)
                      |||++         +.+.+|+..|+.++||||++++..+..     +..+|+||.||.+||+.+.+....        ..
T Consensus        55 AIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-----~~~LWvVmpfMa~GS~ldIik~~~--------~~  121 (516)
T KOG0582|consen   55 AIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-----DSELWVVMPFMAGGSLLDIIKTYY--------PD  121 (516)
T ss_pred             EEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-----cceeEEeehhhcCCcHHHHHHHHc--------cc
Confidence            88876         678999999999999999999888654     788999999999999999996432        34


Q ss_pred             ccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCC
Q 040999          184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQ  247 (382)
Q Consensus       184 ~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~  247 (382)
                      .+++..+..|.+++++||.|||   ..|.||||||+.|||++.+|.+||+|||.+..+...                +.+
T Consensus       122 Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmA  198 (516)
T KOG0582|consen  122 GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMA  198 (516)
T ss_pred             cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccC
Confidence            4889999999999999999999   789999999999999999999999999987654322                233


Q ss_pred             Cccc--cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchh
Q 040999          248 TKYG--VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQT  325 (382)
Q Consensus       248 ~~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (382)
                      ||..  ....|+.|+||||||++..||.+|..||..+......+     ..+.+.........+..              
T Consensus       199 PEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-----~tLqn~pp~~~t~~~~~--------------  259 (516)
T KOG0582|consen  199 PEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-----LTLQNDPPTLLTSGLDK--------------  259 (516)
T ss_pred             hHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-----HHhcCCCCCcccccCCh--------------
Confidence            5542  23467999999999999999999999987543222111     11111111000000000              


Q ss_pred             hhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          326 QAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                          +........+.+++-.|+++||.+|||++++++
T Consensus       260 ----d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  260 ----DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ----HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                111233457888888999999999999999984

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-35  Score=277.46  Aligned_cols=195  Identities=19%  Similarity=0.269  Sum_probs=159.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+-+|+-|.|||++++|++     ++...+.|+|.||+++|.|.+++          ...+++++.+..+++.||
T Consensus        57 ~~IerEIviMkLi~HpnVl~LydV-----we~~~~lylvlEyv~gGELFdyl----------v~kG~l~e~eaa~ff~QI  121 (786)
T KOG0588|consen   57 AGIEREIVIMKLIEHPNVLRLYDV-----WENKQHLYLVLEYVPGGELFDYL----------VRKGPLPEREAAHFFRQI  121 (786)
T ss_pred             cchhhhhHHHHHhcCCCeeeeeee-----eccCceEEEEEEecCCchhHHHH----------HhhCCCCCHHHHHHHHHH
Confidence            458899999999999999999999     55688999999999999999999          456789999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCC-CccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEV-STIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~-~~~~Dv~S~  265 (382)
                      ..|+.|+|   ..+|+|||+||+|+|+|.++++||+|||.|....++           +..||...|..| +.++||||.
T Consensus       122 i~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSC  198 (786)
T KOG0588|consen  122 LDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSC  198 (786)
T ss_pred             HHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchh
Confidence            99999999   779999999999999999999999999999865443           234777777777 689999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |||||.|+||+.||++     .++.........            ..         +..       ......+..+|+.+
T Consensus       199 GVILfALLtG~LPFdD-----dNir~LLlKV~~------------G~---------f~M-------Ps~Is~eaQdLLr~  245 (786)
T KOG0588|consen  199 GVILFALLTGKLPFDD-----DNIRVLLLKVQR------------GV---------FEM-------PSNISSEAQDLLRR  245 (786)
T ss_pred             HHHHHHHHhCCCCCCC-----ccHHHHHHHHHc------------Cc---------ccC-------CCcCCHHHHHHHHH
Confidence            9999999999999983     233332221111            00         000       01334467788889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      |+..||++|.|++||++.
T Consensus       246 ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKH  263 (786)
T ss_pred             HhccCccccccHHHHhhC
Confidence            999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=274.23  Aligned_cols=201  Identities=18%  Similarity=0.250  Sum_probs=160.6

Q ss_pred             chhhH--------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc
Q 040999          113 AFKIF--------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN  184 (382)
Q Consensus       113 avK~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~  184 (382)
                      |+|.+        +-+.+|+.+|+..+|+|||++++.++.     .+.+|+|||||++|+|.+.+.           ...
T Consensus       302 aiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-----~deLWVVMEym~ggsLTDvVt-----------~~~  365 (550)
T KOG0578|consen  302 AIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-----GDELWVVMEYMEGGSLTDVVT-----------KTR  365 (550)
T ss_pred             EEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-----cceeEEEEeecCCCchhhhhh-----------ccc
Confidence            77776        457899999999999999999998654     588999999999999999884           334


Q ss_pred             cCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCcccc
Q 040999          185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGV  252 (382)
Q Consensus       185 l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~  252 (382)
                      +++.++..|++++++||+|||   ..+|+|||||.+|||++.+|.+||+|||++..+..            .+.+||...
T Consensus       366 ~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvt  442 (550)
T KOG0578|consen  366 MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVT  442 (550)
T ss_pred             ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhh
Confidence            899999999999999999999   88999999999999999999999999999976543            345577777


Q ss_pred             CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      ...|++|+||||||++++||+-|.+||-.    +..+.......-.. ..++     .                    ..
T Consensus       443 rk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng-~P~l-----k--------------------~~  492 (550)
T KOG0578|consen  443 RKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNG-TPKL-----K--------------------NP  492 (550)
T ss_pred             hcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcC-CCCc-----C--------------------Cc
Confidence            88999999999999999999999999742    22222221111100 0000     0                    00


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ......+.++..+||+.|+++||++.|+++
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            123346777888999999999999999985

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-34  Score=263.86  Aligned_cols=213  Identities=23%  Similarity=0.337  Sum_probs=160.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|++++++++||||+++++++..   ......++||||+++++|.+++..           ..+++..+..++.|+
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l  116 (283)
T cd05080          51 SGWKKEINILKTLYHENIVKYKGCCSE---QGGKGLQLIMEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQI  116 (283)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec---CCCceEEEEecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHH
Confidence            568899999999999999999998753   234568999999999999998832           248999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++||.|||   +.+++||||||+||+++.++.+||+|||+++.....               ...||...+..++.++||
T Consensus       117 ~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di  193 (283)
T cd05080         117 CEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDV  193 (283)
T ss_pred             HHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCccccc
Confidence            99999999   779999999999999999999999999999765321               123666666778999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcC----CchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALP----NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ||||+++|||+||+.|+......   +.........    ....+.++.......                  ...++..
T Consensus       194 ~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~  252 (283)
T cd05080         194 WSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQGQMTVVRLIELLERGMRLPC------------------PKNCPQE  252 (283)
T ss_pred             HHHHHHHHHHHhCCCCCCCCcch---hhhhhcccccccchhhhhhhhhcCCCCCC------------------CCCCCHH
Confidence            99999999999999997532111   1111100000    011111111100000                  0123457


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      +.+++.+||+.+|++|||++++++.|+++.
T Consensus       253 ~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         253 VYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             HHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            888999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-34  Score=274.37  Aligned_cols=212  Identities=23%  Similarity=0.325  Sum_probs=160.0

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCC---------------------
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE---------------------  175 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------  175 (382)
                      +.+.+|+++++.+ +|+|||+++++|..     .+..++||||+++|+|.+++......                     
T Consensus        86 ~~~~~E~~il~~l~~h~nIv~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (374)
T cd05106          86 EALMSELKILSHLGQHKNIVNLLGACTH-----GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNI  160 (374)
T ss_pred             HHHHHHHHHHHhhccCCceeeEeeEecC-----CCCeEEeHhhccCCcHHHHHHhhhhhhcccccccccccccccccccc
Confidence            5688999999999 89999999999653     67889999999999999988532100                     


Q ss_pred             ---------------------------------------CccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecC
Q 040999          176 ---------------------------------------DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCD  216 (382)
Q Consensus       176 ---------------------------------------~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~d  216 (382)
                                                             .........+++..+++++.||+.||+|||   +.+|+|||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrD  237 (374)
T cd05106         161 TLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRD  237 (374)
T ss_pred             chhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEecc
Confidence                                                   000012245888999999999999999999   77999999


Q ss_pred             CCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhHHHHHHHHHHHh-cCCCCCc
Q 040999          217 LKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVYSYGILLLELMI-REKPSDI  281 (382)
Q Consensus       217 lkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~  281 (382)
                      |||+|||+++++.+||+|||+++....              ...+||...+..++.++|||||||++|||++ |+.||..
T Consensus       238 Lkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~  317 (374)
T cd05106         238 VAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG  317 (374)
T ss_pred             CchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999875422              1334676667788999999999999999997 9999864


Q ss_pred             cccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHH
Q 040999          282 MFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVV  361 (382)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl  361 (382)
                      ..... .+.........            .....                  ..+.++.+++.+||+.||++|||+.+|+
T Consensus       318 ~~~~~-~~~~~~~~~~~------------~~~~~------------------~~~~~l~~li~~cl~~dp~~RPs~~~l~  366 (374)
T cd05106         318 ILVNS-KFYKMVKRGYQ------------MSRPD------------------FAPPEIYSIMKMCWNLEPTERPTFSQIS  366 (374)
T ss_pred             ccccH-HHHHHHHcccC------------ccCCC------------------CCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            32111 11111110000            00000                  1124677888899999999999999999


Q ss_pred             HHHHHhh
Q 040999          362 HELQSIK  368 (382)
Q Consensus       362 ~~L~~i~  368 (382)
                      +.|+++.
T Consensus       367 ~~l~~~~  373 (374)
T cd05106         367 QLIQRQL  373 (374)
T ss_pred             HHHHHHh
Confidence            9998863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-35  Score=265.80  Aligned_cols=226  Identities=21%  Similarity=0.252  Sum_probs=163.8

Q ss_pred             chhhHH-------H--HHHHHHHHhhcc-cccceeeeeeeeecccCCCc-eeEEEEecccCCCccccccCCCCCCccccC
Q 040999          113 AFKIFK-------S--FIAECKALRNIR-HRNLIKVLTACLGVDYQGND-FKALVYEFIHNRSPEKWLYPISKEDETYER  181 (382)
Q Consensus       113 avK~~~-------~--~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  181 (382)
                      |+|.++       +  =.||++.|++|+ |||||++.+++.+     .+ .+++|||||+. +|++++.         .+
T Consensus        39 AIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d-----~~~~L~fVfE~Md~-NLYqLmK---------~R  103 (538)
T KOG0661|consen   39 AIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD-----NDRILYFVFEFMDC-NLYQLMK---------DR  103 (538)
T ss_pred             eHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc-----cCceEeeeHHhhhh-hHHHHHh---------hc
Confidence            888883       2  368999999998 9999999999643     44 89999999965 8999994         45


Q ss_pred             CcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCC-----------Ccc
Q 040999          182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ-----------TKY  250 (382)
Q Consensus       182 ~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-----------~~~  250 (382)
                      .+.+++..+..|+.||++||+|+|   .+|+.|||+||+|||+.....+||+|||+|+........           ||.
T Consensus       104 ~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEv  180 (538)
T KOG0661|consen  104 NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEV  180 (538)
T ss_pred             CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHH
Confidence            678999999999999999999999   889999999999999999999999999999987655433           333


Q ss_pred             c-cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHH---hcCCchhhhhhc-ccccchhhhhhccccchh
Q 040999          251 G-VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM---ALPNHVKDIVDS-ILLNDDEKLVVRGDQKQT  325 (382)
Q Consensus       251 ~-~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  325 (382)
                      . ....|+.++|+||+|||++|+.+-++.|.    +..++.+..+.   .......++... .+..   ....+-....+
T Consensus       181 LLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP----G~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~---~mnf~~P~~~~  253 (538)
T KOG0661|consen  181 LLRSGYYSSPVDMWAVGCIMAELYSLRPLFP----GASEIDQIYKICEVLGTPDKDSWPEGYNLAS---AMNFRFPQVKP  253 (538)
T ss_pred             hhhccccCCchHHHHHHHHHHHHHHhcccCC----CCcHHHHHHHHHHHhCCCccccchhHHHHHH---HhccCCCcCCC
Confidence            2 34678999999999999999999988854    44444444332   221111111110 0000   00000000011


Q ss_pred             hhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          326 QAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      .........+..+.++++.+|+++||.+|||+.+.++.
T Consensus       254 ~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  254 SPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             CChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11111222456678889999999999999999999864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.8e-34  Score=271.95  Aligned_cols=211  Identities=22%  Similarity=0.257  Sum_probs=159.3

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc-------------------
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE-------------------  177 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------  177 (382)
                      +.+.+|++++..+ +|||||+++++|..     .+..++|||||++|+|.+++........                   
T Consensus        83 ~~~~~Ei~il~~l~~HpnIv~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (375)
T cd05104          83 EALMSELKVLSYLGNHINIVNLLGACTV-----GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQ  157 (375)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeeeeecc-----CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhh
Confidence            4688999999999 89999999999654     6778999999999999988854221000                   


Q ss_pred             ----------------------------------------------cccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCc
Q 040999          178 ----------------------------------------------TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPV  211 (382)
Q Consensus       178 ----------------------------------------------~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~  211 (382)
                                                                    .......+++..+..++.||++||+|||   +.+
T Consensus       158 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~  234 (375)
T cd05104         158 REMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKN  234 (375)
T ss_pred             hcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence                                                          0011235789999999999999999999   779


Q ss_pred             eeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhHHHHHHHHHHHh-cC
Q 040999          212 TAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVYSYGILLLELMI-RE  276 (382)
Q Consensus       212 ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~S~Gvil~ellt-g~  276 (382)
                      |+||||||+|||++.++.+||+|||+++....              ....||...+..++.++|||||||++|||++ |.
T Consensus       235 ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~  314 (375)
T cd05104         235 CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS  314 (375)
T ss_pred             eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence            99999999999999999999999999875422              1344777777788999999999999999998 88


Q ss_pred             CCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCC
Q 040999          277 KPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMK  356 (382)
Q Consensus       277 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs  356 (382)
                      .||...... ............            ....                  ...+.++.+++.+||+.||++|||
T Consensus       315 ~p~~~~~~~-~~~~~~~~~~~~------------~~~~------------------~~~~~~l~~li~~cl~~dP~~RPs  363 (375)
T cd05104         315 SPYPGMPVD-SKFYKMIKEGYR------------MLSP------------------ECAPSEMYDIMKSCWDADPLKRPT  363 (375)
T ss_pred             CCCCCCCch-HHHHHHHHhCcc------------CCCC------------------CCCCHHHHHHHHHHccCChhHCcC
Confidence            887643211 111111111000            0000                  012236788889999999999999


Q ss_pred             HHHHHHHHHHh
Q 040999          357 MTNVVHELQSI  367 (382)
Q Consensus       357 ~~evl~~L~~i  367 (382)
                      +.||++.|++.
T Consensus       364 ~~eil~~l~~~  374 (375)
T cd05104         364 FKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHHHHhh
Confidence            99999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=246.80  Aligned_cols=215  Identities=17%  Similarity=0.232  Sum_probs=166.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +..++|++.-++++|||++++++++....-......|++++|...|+|.+.+....      .+...+++.+.+.|+.+|
T Consensus        63 e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k------~kg~~~sE~~iL~if~gi  136 (302)
T KOG2345|consen   63 EEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLK------IKGNFVSEAQILWIFLGI  136 (302)
T ss_pred             HHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHh------hcCCccCHHHHHHHHHHH
Confidence            77899999999999999999999987543445677999999999999999986543      334579999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------------CCCCccc---cC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------------RTQTKYG---VG  253 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------------~~~~~~~---~~  253 (382)
                      ++||.+||.. .+++.||||||.|||+.+.+.+++.|||.+...+..                     ..+||..   .+
T Consensus       137 c~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~  215 (302)
T KOG2345|consen  137 CRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSH  215 (302)
T ss_pred             HHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccC
Confidence            9999999954 456999999999999999999999999999755321                     1225543   35


Q ss_pred             CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHH
Q 040999          254 NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII  333 (382)
Q Consensus       254 ~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (382)
                      ...++++|||||||+||+|+.|..||+..++.+..+.-.+           ....+. -+.+                 .
T Consensus       216 ~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv-----------~n~q~s-~P~~-----------------~  266 (302)
T KOG2345|consen  216 CTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV-----------QNAQIS-IPNS-----------------S  266 (302)
T ss_pred             cccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee-----------eccccc-cCCC-----------------C
Confidence            6679999999999999999999999986554332211100           000000 0000                 0


Q ss_pred             HHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       334 ~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      ...+.+.+++..|++.||.+||++.+++..++.+.
T Consensus       267 ~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  267 RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            13456788888999999999999999999998763

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=256.02  Aligned_cols=146  Identities=26%  Similarity=0.346  Sum_probs=131.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +..+.|..+|.+++||.||+++-.     +++.+..|+|+||+.||.|...|          .+.+.+++..+..++.+|
T Consensus        70 ~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~kLylVld~~~GGeLf~hL----------~~eg~F~E~~arfYlaEi  134 (357)
T KOG0598|consen   70 RHTKAERNILSKIKHPFIVKLIYS-----FQTEEKLYLVLDYLNGGELFYHL----------QREGRFSEDRARFYLAEI  134 (357)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeEEe-----cccCCeEEEEEeccCCccHHHHH----------HhcCCcchhHHHHHHHHH
Confidence            567889999999999999999776     67899999999999999999999          456679999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +++||||||||+|||+|.+|+++|+|||+++....            ...+||...+..++..+|+||+
T Consensus       135 ~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL  211 (357)
T KOG0598|consen  135 VLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSL  211 (357)
T ss_pred             HHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhH
Confidence            99999999   88999999999999999999999999999985422            2344777788899999999999


Q ss_pred             HHHHHHHHhcCCCCCc
Q 040999          266 GILLLELMIREKPSDI  281 (382)
Q Consensus       266 Gvil~elltg~~p~~~  281 (382)
                      |+++|||++|.+||..
T Consensus       212 GillYeML~G~pPF~~  227 (357)
T KOG0598|consen  212 GILLYEMLTGKPPFYA  227 (357)
T ss_pred             HHHHHHHhhCCCCCcC
Confidence            9999999999999863

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-34  Score=259.99  Aligned_cols=201  Identities=28%  Similarity=0.446  Sum_probs=150.4

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.|.+|++.+++++||||++++|+|..     .+..++|+||+++|+|.+++...        ....+++..+..|+.
T Consensus        44 ~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~lv~e~~~~g~L~~~L~~~--------~~~~~~~~~~~~i~~  110 (259)
T PF07714_consen   44 EEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLFLVMEYCPGGSLDDYLKSK--------NKEPLSEQQRLSIAI  110 (259)
T ss_dssp             HHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEEEEEE--TTEBHHHHHHHT--------CTTTSBHHHHHHHHH
T ss_pred             cceeeeecccccccccccccccccccccc-----ccccccccccccccccccccccc--------ccccccccccccccc
Confidence            35789999999999999999999999873     45589999999999999999532        245689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccch
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~D  261 (382)
                      ||++||.|||   +.+++|+||+++||+++.++.+||+|||++......              ...||......++.++|
T Consensus       111 ~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksD  187 (259)
T PF07714_consen  111 QIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSD  187 (259)
T ss_dssp             HHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHH
T ss_pred             cccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999   668999999999999999999999999999876211              12355555667899999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||+++|||+| |+.||...     ....+.........        ...+                   ..+...+.
T Consensus       188 VysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~~~~~~--------~~~~-------------------~~~~~~~~  235 (259)
T PF07714_consen  188 VYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKLKQGQR--------LPIP-------------------DNCPKDIY  235 (259)
T ss_dssp             HHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHHHTTEE--------TTSB-------------------TTSBHHHH
T ss_pred             cccccccccccccccccccccc-----cccccccccccccc--------ceec-------------------cchhHHHH
Confidence            9999999999999 67887542     11111111111000        0000                   02344677


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                      +++..||+.+|++|||+.++++.|
T Consensus       236 ~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  236 SLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHhcC
Confidence            888899999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-33  Score=256.23  Aligned_cols=203  Identities=19%  Similarity=0.283  Sum_probs=158.8

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.|.+|+.++++++||||+++++++..     .+..++||||+++|+|.+++..         ....+++..++.++.
T Consensus        49 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~  114 (266)
T cd05064          49 QRRGFLAEALTLGQFDHSNIVRLEGVITR-----GNTMMIVTEYMSNGALDSFLRK---------HEGQLVAGQLMGMLP  114 (266)
T ss_pred             HHHHHHHHHHHHhcCCCCCcCeEEEEEec-----CCCcEEEEEeCCCCcHHHHHHh---------CCCCCCHHHHHHHHH
Confidence            34678999999999999999999998643     6788999999999999999842         234689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchh
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      |++.||+|||   +.+++||||||+||+++.++.+|++|||.+.....             ...+||...+..++.++||
T Consensus       115 ~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  191 (266)
T cd05064         115 GLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDV  191 (266)
T ss_pred             HHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHH
Confidence            9999999999   77999999999999999999999999998754321             1234676667788999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++||+++ |+.||.....  ........           +......+                   ..++..+.+
T Consensus       192 ~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~-----------~~~~~~~~-------------------~~~~~~~~~  239 (266)
T cd05064         192 WSFGIVMWEVMSYGERPYWDMSG--QDVIKAVE-----------DGFRLPAP-------------------RNCPNLLHQ  239 (266)
T ss_pred             HHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHH-----------CCCCCCCC-------------------CCCCHHHHH
Confidence            999999999775 9999864211  01111110           00000000                   134456788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      ++.+||+.+|.+||++.++.+.|.++
T Consensus       240 li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            88999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.9e-34  Score=267.02  Aligned_cols=230  Identities=17%  Similarity=0.195  Sum_probs=153.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||+++++++...........++||||+. ++|.+++.          ....+++..+..++.|+
T Consensus        44 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----------~~~~~~~~~~~~i~~qi  112 (338)
T cd07859          44 TRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK----------ANDDLTPEHHQFFLYQL  112 (338)
T ss_pred             HHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHH----------hcccCCHHHHHHHHHHH
Confidence            45889999999999999999999976533333456899999995 68888873          23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccC--CCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVG--NEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~--~~~~~~~  260 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....               ..+||...+  ..++.++
T Consensus       113 ~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~  189 (338)
T cd07859         113 LRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAI  189 (338)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchh
Confidence            99999999   779999999999999999999999999999754211               233555433  5678899


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||||++|||+||+.||.....  ................+.....................+.............+.
T Consensus       190 DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (338)
T cd07859         190 DIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLAL  267 (338)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHH
Confidence            999999999999999999864211  111111111111100010000000000000000000000000000012234577


Q ss_pred             HHhhccCCCCccCCCCHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +++.+||+.+|++|||++|+++.
T Consensus       268 ~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         268 RLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHHcCcCcccCCCHHHHhcC
Confidence            88999999999999999999954

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.7e-34  Score=264.80  Aligned_cols=205  Identities=22%  Similarity=0.327  Sum_probs=159.8

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+++.+|+.+++.++||||++++++|..      ...++++||+++|+|.+++..         ....+++...+.++.
T Consensus        52 ~~~~~~~e~~~l~~l~h~niv~~~g~~~~------~~~~~v~e~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~  116 (316)
T cd05108          52 ANKEILDEAYVMASVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCV  116 (316)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEcC------CCceeeeecCCCCCHHHHHHh---------ccccCCHHHHHHHHH
Confidence            34678999999999999999999999753      346799999999999999842         234588899999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccch
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~D  261 (382)
                      ||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....              ...||...+..++.++|
T Consensus       117 qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D  193 (316)
T cd05108         117 QIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSD  193 (316)
T ss_pred             HHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhh
Confidence            9999999999   779999999999999999999999999999865321              23466666677899999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||+| |+.||+....  ..+.....            ........                  ..+...+.
T Consensus       194 i~slGv~l~el~t~g~~p~~~~~~--~~~~~~~~------------~~~~~~~~------------------~~~~~~~~  241 (316)
T cd05108         194 VWSYGVTVWELMTFGSKPYDGIPA--SEISSILE------------KGERLPQP------------------PICTIDVY  241 (316)
T ss_pred             hHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHh------------CCCCCCCC------------------CCCCHHHH
Confidence            9999999999998 9999764211  11111111            00000000                  01234678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +++..||+.+|.+||++.+++..+..+...
T Consensus       242 ~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         242 MIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            889999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=268.79  Aligned_cols=214  Identities=22%  Similarity=0.381  Sum_probs=165.5

Q ss_pred             chhhH---------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCc
Q 040999          113 AFKIF---------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPR  183 (382)
Q Consensus       113 avK~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~  183 (382)
                      |||.+         ++|.+|+++|.+++|||||+++|+|..     ++.+++++|||++|+|.+|+....        ..
T Consensus       566 AVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePicmI~EYmEnGDLnqFl~ahe--------ap  632 (807)
T KOG1094|consen  566 AVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPLCMITEYMENGDLNQFLSAHE--------LP  632 (807)
T ss_pred             EEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCchHHHHHHHhcCcHHHHHHhcc--------Cc
Confidence            67766         689999999999999999999999986     677899999999999999996432        11


Q ss_pred             ccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCc
Q 040999          184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTK  249 (382)
Q Consensus       184 ~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~  249 (382)
                      .+.-....+|+.||+.|++||.   +.++||||+.+.|+|+|.++++||+|||.++.+-.              .+.++|
T Consensus       633 t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawE  709 (807)
T KOG1094|consen  633 TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWE  709 (807)
T ss_pred             ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHH
Confidence            2455566789999999999999   77999999999999999999999999999985422              334467


Q ss_pred             cccCCCCCccchhHHHHHHHHHHHh--cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhh
Q 040999          250 YGVGNEVSTIGDVYSYGILLLELMI--REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQA  327 (382)
Q Consensus       250 ~~~~~~~~~~~Dv~S~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (382)
                      ....+++++++|||+||+++||+++  ...||.....++  ..+-.....+..-...                       
T Consensus       710 sillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~~~-----------------------  764 (807)
T KOG1094|consen  710 SILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGRQV-----------------------  764 (807)
T ss_pred             HHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCcce-----------------------
Confidence            7778899999999999999999875  678876432211  1111111111100000                       


Q ss_pred             hhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          328 KINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       328 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      ......-|+..+.+++++||..+.++||+++++...|++.
T Consensus       765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            0001124677899999999999999999999999998764

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-33  Score=258.11  Aligned_cols=214  Identities=22%  Similarity=0.393  Sum_probs=164.1

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC------ccccCCcccCHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED------ETYERPRNLNLLRR  190 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~  190 (382)
                      .+.+.+|++++++++|+||+++++++..     .+..++||||+++++|.+++.......      ........+++..+
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  125 (291)
T cd05094          51 RKDFQREAELLTNLQHEHIVKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM  125 (291)
T ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEcc-----CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHH
Confidence            3678899999999999999999999643     667899999999999999986432110      00112345899999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEV  256 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~  256 (382)
                      +.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....              ....||...+..+
T Consensus       126 ~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  202 (291)
T cd05094         126 LHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF  202 (291)
T ss_pred             HHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC
Confidence            999999999999999   77999999999999999999999999999865422              1234777777788


Q ss_pred             CccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          257 STIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      +.++|||||||++|||+| |+.||.....     ..............        ..                   ..+
T Consensus       203 ~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~~--------~~-------------------~~~  250 (291)
T cd05094         203 TTESDVWSFGVILWEIFTYGKQPWFQLSN-----TEVIECITQGRVLE--------RP-------------------RVC  250 (291)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhCCCCCC--------CC-------------------ccC
Confidence            999999999999999999 9999753211     11111000000000        00                   022


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +..+.+++.+||+.+|++|||+++|+++|+++...
T Consensus       251 ~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         251 PKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            34678899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=264.50  Aligned_cols=200  Identities=21%  Similarity=0.289  Sum_probs=157.0

Q ss_pred             hHHHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ..+.+.+|+.+++.++ ||||+++++++.     .....++||||+.+|+|.+++.          ..+++.+....+++
T Consensus        62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~-----t~~~~~ivmEy~~gGdL~~~i~----------~~g~l~E~~ar~~F  126 (370)
T KOG0583|consen   62 LDELIKREISILRRLRSHPNIIRLLEVFA-----TPTKIYIVMEYCSGGDLFDYIV----------NKGRLKEDEARKYF  126 (370)
T ss_pred             cchhhHHHHHHHHHhccCCCEeEEEEEEe-----cCCeEEEEEEecCCccHHHHHH----------HcCCCChHHHHHHH
Confidence            3455668999999998 999999999954     4667999999999999999994          35678889999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCC-CC-----------CCCCccccCCC-C-Ccc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLP-PT-----------RTQTKYGVGNE-V-STI  259 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~-~~-----------~~~~~~~~~~~-~-~~~  259 (382)
                      .|++.|++|+|   +.+|+||||||+|||++.+ +++||+|||++.... ..           ..+||...+.. | +.+
T Consensus       127 ~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~  203 (370)
T KOG0583|consen  127 RQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKA  203 (370)
T ss_pred             HHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCch
Confidence            99999999999   8899999999999999999 999999999999773 21           23377776655 6 489


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC--chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN--HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      +||||+||+||.|++|+.||+.     .+.....+.....  .+...+                            . ..
T Consensus       204 aDvWS~GViLy~ml~G~~PF~d-----~~~~~l~~ki~~~~~~~p~~~----------------------------~-S~  249 (370)
T KOG0583|consen  204 ADVWSLGVILYVLLCGRLPFDD-----SNVPNLYRKIRKGEFKIPSYL----------------------------L-SP  249 (370)
T ss_pred             hhhhhhHHHHHHHHhCCCCCCC-----ccHHHHHHHHhcCCccCCCCc----------------------------C-CH
Confidence            9999999999999999999985     1111111111110  011110                            0 34


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      ++..++.+|+..+|.+|+|+.+++ .-.-++
T Consensus       250 ~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  250 EARSLIEKMLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence            677888899999999999999999 433333

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-33  Score=256.95  Aligned_cols=206  Identities=21%  Similarity=0.324  Sum_probs=159.1

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +.++++..|+..+++++||||+++++++.      ....++++||+++|+|.+++..         ....+++..+..++
T Consensus        51 ~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~~~~~~i~e~~~~gsL~~~l~~---------~~~~~~~~~~~~i~  115 (279)
T cd05111          51 QTFQEITDHMLAMGSLDHAYIVRLLGICP------GASLQLVTQLSPLGSLLDHVRQ---------HRDSLDPQRLLNWC  115 (279)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceEEEEEC------CCccEEEEEeCCCCcHHHHHHh---------cccCCCHHHHHHHH
Confidence            34467888999999999999999999863      3456789999999999999942         23468999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIG  260 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~  260 (382)
                      .||+.||+|||   +.+++||||||+|||++.++.+||+|||.++.....              ...||...+..++.++
T Consensus       116 ~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~  192 (279)
T cd05111         116 VQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQS  192 (279)
T ss_pred             HHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchh
Confidence            99999999999   778999999999999999999999999999764321              2236666667789999


Q ss_pred             hhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          261 DVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       261 Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      |||||||++||++| |+.||.....  ....            +++.........                  ..+...+
T Consensus       193 Dv~slG~il~el~t~g~~p~~~~~~--~~~~------------~~~~~~~~~~~~------------------~~~~~~~  240 (279)
T cd05111         193 DVWSYGVTVWEMMSYGAEPYAGMRP--HEVP------------DLLEKGERLAQP------------------QICTIDV  240 (279)
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCH--HHHH------------HHHHCCCcCCCC------------------CCCCHHH
Confidence            99999999999998 9999764211  1111            111110000000                  0123356


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+++.+||..+|++|||+.|+++.|..+.+.
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            7788899999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2e-33  Score=256.82  Aligned_cols=211  Identities=21%  Similarity=0.367  Sum_probs=161.7

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcc------ccCCcccCHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET------YERPRNLNLLRR  190 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~  190 (382)
                      .++|.+|++++++++||||+++++++..     ....+++|||+++|+|.+++.........      ......+++..+
T Consensus        52 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  126 (283)
T cd05048          52 QQEFRQEAELMSDLQHPNIVCLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF  126 (283)
T ss_pred             HHHHHHHHHHHHhcCCcccceEEEEEcC-----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHH
Confidence            3578999999999999999999998643     56789999999999999998643211100      011246889999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEV  256 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~  256 (382)
                      +.++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++....              ...+||...+..+
T Consensus       127 ~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  203 (283)
T cd05048         127 LHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF  203 (283)
T ss_pred             HHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC
Confidence            999999999999999   77999999999999999999999999999875321              1344777777788


Q ss_pred             CccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          257 STIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      +.++|||||||++|||++ |..||.....     .+....         +........                  ...+
T Consensus       204 ~~~sDv~slG~il~el~~~g~~p~~~~~~-----~~~~~~---------i~~~~~~~~------------------~~~~  251 (283)
T cd05048         204 TTESDIWSFGVVLWEIFSYGLQPYYGFSN-----QEVIEM---------IRSRQLLPC------------------PEDC  251 (283)
T ss_pred             chhhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH---------HHcCCcCCC------------------cccC
Confidence            999999999999999998 9999864211     111110         100000000                  0134


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +.++.+++.+||+.+|.+||++.||++.|+++
T Consensus       252 ~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         252 PARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            56788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6e-34  Score=277.88  Aligned_cols=214  Identities=20%  Similarity=0.216  Sum_probs=164.8

Q ss_pred             chhhH--------HHHHHHHHHHhhcc-cccceeeeee-eeecccCC-CceeEEEEecccCCCccccccCCCCCCccccC
Q 040999          113 AFKIF--------KSFIAECKALRNIR-HRNLIKVLTA-CLGVDYQG-NDFKALVYEFIHNRSPEKWLYPISKEDETYER  181 (382)
Q Consensus       113 avK~~--------~~~~~E~~~l~~l~-h~niv~~~~~-~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  181 (382)
                      |+|++        +..++|+++|++|+ |+|||.+++. ........ ..+.+|.||||++|+|-+++....        
T Consensus        66 AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl--------  137 (738)
T KOG1989|consen   66 ALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRL--------  137 (738)
T ss_pred             eeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHH--------
Confidence            66665        78899999999996 9999999993 22211222 356789999999999999995322        


Q ss_pred             CcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------------
Q 040999          182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------------  244 (382)
Q Consensus       182 ~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------------  244 (382)
                      ...|++.++++|+.|+++|+++||.. .++|||||||-+||||+.++..||||||.|......                 
T Consensus       138 q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~  216 (738)
T KOG1989|consen  138 QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKY  216 (738)
T ss_pred             hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhh
Confidence            33499999999999999999999965 889999999999999999999999999999643211                 


Q ss_pred             ----CCCCcc---ccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhh
Q 040999          245 ----RTQTKY---GVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLV  317 (382)
Q Consensus       245 ----~~~~~~---~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (382)
                          +..||.   +.+..+++|+||||+||+||-|+....||+..-.                 -.++.....-.+    
T Consensus       217 TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------------laIlng~Y~~P~----  275 (738)
T KOG1989|consen  217 TTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------------LAILNGNYSFPP----  275 (738)
T ss_pred             CCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------------eeEEeccccCCC----
Confidence                111332   3467789999999999999999999999874210                 011111110000    


Q ss_pred             hccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          318 VRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                                    .......+..|+..||+.+|.+||++-+|+..+.++...
T Consensus       276 --------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  276 --------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             --------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                          014556788889999999999999999999999988764

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-33  Score=254.79  Aligned_cols=202  Identities=23%  Similarity=0.393  Sum_probs=159.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++++.++|+||++++++|..     .+..+++|||+++++|.+++...        ....+++..++.++.|+
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~ql  113 (263)
T cd05052          47 EEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLREC--------NRQEVNAVVLLYMATQI  113 (263)
T ss_pred             HHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEEEEEeCCCCcHHHHHHhC--------CCCCCCHHHHHHHHHHH
Confidence            578999999999999999999998653     56789999999999999988431        23458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+++||||||+||++++++.+||+|||.+.....             ....||...+..++.++||||
T Consensus       114 ~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  190 (263)
T cd05052         114 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA  190 (263)
T ss_pred             HHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHH
Confidence            99999999   77999999999999999999999999999876532             134477777778899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||++|||++ |..||...     .........         .........                  ...+..+.+++
T Consensus       191 lG~il~el~t~g~~p~~~~-----~~~~~~~~~---------~~~~~~~~~------------------~~~~~~~~~li  238 (263)
T cd05052         191 FGVLLWEIATYGMSPYPGI-----DLSQVYELL---------EKGYRMERP------------------EGCPPKVYELM  238 (263)
T ss_pred             HHHHHHHHHcCCCCCCCCC-----CHHHHHHHH---------HCCCCCCCC------------------CCCCHHHHHHH
Confidence            9999999998 89997532     111111110         100000000                  02334678888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      .+||+.+|++|||+.++++.|+++
T Consensus       239 ~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         239 RACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHccCCcccCCCHHHHHHHHHhh
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.4e-33  Score=257.11  Aligned_cols=214  Identities=22%  Similarity=0.398  Sum_probs=163.8

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc---cccCCcccCHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE---TYERPRNLNLLRRLNI  193 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~~~~l~~~~~~~i  193 (382)
                      .+.+.+|++++++++|+||+++++++..     .+..++||||+++++|.+++........   .......+++..++.+
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~  125 (288)
T cd05093          51 RKDFHREAELLTNLQHEHIVKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI  125 (288)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEec-----CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHH
Confidence            3578999999999999999999999653     6778999999999999998853321100   0112345899999999


Q ss_pred             HHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCcc
Q 040999          194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTI  259 (382)
Q Consensus       194 ~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~  259 (382)
                      +.|++.||+|||   +.+++||||||+||++++++.+||+|||.++....              ...+||...+..++.+
T Consensus       126 ~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  202 (288)
T cd05093         126 AQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE  202 (288)
T ss_pred             HHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch
Confidence            999999999999   77999999999999999999999999999875421              2344777777788999


Q ss_pred             chhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +|||||||++|||+| |..||.....     ...........        ....+                   .....+
T Consensus       203 sDiwslG~il~~l~t~g~~p~~~~~~-----~~~~~~i~~~~--------~~~~~-------------------~~~~~~  250 (288)
T cd05093         203 SDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIECITQGR--------VLQRP-------------------RTCPKE  250 (288)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCC--------cCCCC-------------------CCCCHH
Confidence            999999999999998 8999753211     11111100000        00000                   012346


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +.+++.+||+.+|.+|||+.+|.+.|+++...
T Consensus       251 l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         251 VYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            78899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-34  Score=251.15  Aligned_cols=234  Identities=21%  Similarity=0.264  Sum_probs=164.4

Q ss_pred             CchhhH----------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccC
Q 040999          112 GAFKIF----------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYER  181 (382)
Q Consensus       112 ~avK~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  181 (382)
                      .|+|++          ++-.||+++|+.++|+||+.++++........-...|+|+|+| .-+|.+.++          .
T Consensus        50 VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik----------~  118 (359)
T KOG0660|consen   50 VAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIK----------S  118 (359)
T ss_pred             eehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHH----------c
Confidence            377776          6778999999999999999999997653344556789999999 558888883          3


Q ss_pred             CcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---CCC-----------
Q 040999          182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---RTQ-----------  247 (382)
Q Consensus       182 ~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---~~~-----------  247 (382)
                      ...++......++.|+++||.|+|   +.+|+|||+||+|+|++.+..+||+|||+|+.....   ...           
T Consensus       119 ~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRA  195 (359)
T KOG0660|consen  119 QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRA  195 (359)
T ss_pred             CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecC
Confidence            445889999999999999999999   889999999999999999999999999999988532   111           


Q ss_pred             Cccc-cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHH--HhcCCchhhhhhcccccchhhhhhccccch
Q 040999          248 TKYG-VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK--MALPNHVKDIVDSILLNDDEKLVVRGDQKQ  324 (382)
Q Consensus       248 ~~~~-~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (382)
                      ||.. ....|+.+.||||.|||+.||++|++-|.    +...+++...  ......-.+.+...-......-.......+
T Consensus       196 PElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp----G~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p  271 (359)
T KOG0660|consen  196 PELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP----GKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIP  271 (359)
T ss_pred             HHHHhccccccchhhhhhhhHHHHHHHcCCCCCC----CCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCC
Confidence            3332 24678999999999999999999999865    3333333221  111111111111111000000000011111


Q ss_pred             hhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          325 TQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +..............++|..+++..||.+|+|++|.++.
T Consensus       272 ~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  272 KQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            222222333444566777789999999999999999864

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.8e-33  Score=253.62  Aligned_cols=200  Identities=22%  Similarity=0.323  Sum_probs=156.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||++++++|.      .+..++||||+++++|.+++..         ....+++..+++++.|+
T Consensus        40 ~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i  104 (257)
T cd05115          40 DEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEMASGGPLNKFLSG---------KKDEITVSNVVELMHQV  104 (257)
T ss_pred             HHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEeCCCCCHHHHHHh---------CCCCCCHHHHHHHHHHH
Confidence            56899999999999999999999863      3467999999999999998842         23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||+|||   +.+++||||||+||+++.++.+||+|||+++.....               ...||...+..++.++||
T Consensus       105 ~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  181 (257)
T cd05115         105 SMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV  181 (257)
T ss_pred             HHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhH
Confidence            99999999   779999999999999999999999999998754221               233565556678889999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++||+++ |..||.....  .......            .........                  ..+..++.+
T Consensus       182 ~slG~~l~el~~~g~~p~~~~~~--~~~~~~~------------~~~~~~~~~------------------~~~~~~l~~  229 (257)
T cd05115         182 WSYGITMWEAFSYGQKPYKKMKG--PEVMSFI------------EQGKRLDCP------------------AECPPEMYA  229 (257)
T ss_pred             HHHHHHHHHHhcCCCCCcCcCCH--HHHHHHH------------HCCCCCCCC------------------CCCCHHHHH
Confidence            999999999996 9999864311  0111111            110000000                  023446778


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      ++.+||+.+|++||++.+|.+.|+.+
T Consensus       230 li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         230 LMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            88999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.9e-33  Score=252.03  Aligned_cols=198  Identities=22%  Similarity=0.371  Sum_probs=154.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|++++++++||||+++++++..     ....++||||+++|+|.+++..         ....+++..++.++.|+
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i  109 (256)
T cd05114          44 EDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPLYIVTEFMENGCLLNYLRQ---------RQGKLSKDMLLSMCQDV  109 (256)
T ss_pred             HHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCEEEEEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHH
Confidence            578899999999999999999998643     6678999999999999998842         22358899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||.++....             ....||...+..++.++||||
T Consensus       110 ~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  186 (256)
T cd05114         110 CEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS  186 (256)
T ss_pred             HHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHH
Confidence            99999999   77999999999999999999999999999875421             123467666677889999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||++ |+.||....  .   .+.........        ....+ .                  .....+.+++
T Consensus       187 ~G~~l~el~~~g~~p~~~~~--~---~~~~~~i~~~~--------~~~~~-~------------------~~~~~~~~li  234 (256)
T cd05114         187 FGVLMWEVFTEGKMPFEKKS--N---YEVVEMISRGF--------RLYRP-K------------------LASMTVYEVM  234 (256)
T ss_pred             HHHHHHHHHcCCCCCCCCCC--H---HHHHHHHHCCC--------CCCCC-C------------------CCCHHHHHHH
Confidence            9999999999 899976321  1   11111110000        00000 0                  1123578889


Q ss_pred             hccCCCCccCCCCHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L  364 (382)
                      .+||+.+|++||++.++++.|
T Consensus       235 ~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHccCCcccCcCHHHHHHhh
Confidence            999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-33  Score=258.94  Aligned_cols=215  Identities=23%  Similarity=0.401  Sum_probs=159.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   .+....++|+||+++|+|.+++..         ....+++..+..++.|+
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~l  117 (284)
T cd05081          50 RDFEREIEILKSLQHDNIVKYKGVCYS---AGRRNLRLVMEYLPYGSLRDYLQK---------HRERLDHRKLLLYASQI  117 (284)
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCCceEEEEEecCCCCHHHHHHh---------cCcCCCHHHHHHHHHHH
Confidence            678999999999999999999998753   234568999999999999999842         22458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||+|||   +.+++||||||+||+++.++.+||+|||+++.....               ...||...+..++.++||
T Consensus       118 ~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  194 (284)
T cd05081         118 CKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDV  194 (284)
T ss_pred             HHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHH
Confidence            99999999   779999999999999999999999999999865322               123666666778899999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC-----chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN-----HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      |||||++|||++|..|+....      ..+.......     ....+.+. +...        . ..+     .......
T Consensus       195 ~slG~~l~el~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------~-~~~-----~~~~~~~  253 (284)
T cd05081         195 WSFGVVLYELFTYSDKSCSPP------AEFMRMMGNDKQGQMIVYHLIEL-LKNN--------G-RLP-----APPGCPA  253 (284)
T ss_pred             HHHHHHHHHHhhcCCcCCCcc------hhhhhhcccccccccchHHHHHH-HhcC--------C-cCC-----CCCCCCH
Confidence            999999999999887753211      0111110000     00000000 0000        0 000     0012345


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      .+.+++.+||+.+|++|||+.||++.|++++
T Consensus       254 ~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         254 EIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            6888999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2e-33  Score=257.83  Aligned_cols=213  Identities=21%  Similarity=0.350  Sum_probs=162.3

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC--------------ccccCC
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED--------------ETYERP  182 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~  182 (382)
                      .+++.+|+++++.++||||+++++.|..     .+..++++||+++|+|.+++.......              ......
T Consensus        47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (290)
T cd05045          47 LRDLLSEFNLLKQVNHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE  121 (290)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccc
Confidence            4678999999999999999999998643     567899999999999999886432111              001223


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCC
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQT  248 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~  248 (382)
                      ..+++..++.++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++....              ....|
T Consensus       122 ~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap  198 (290)
T cd05045         122 RALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI  198 (290)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence            46889999999999999999999   77999999999999999999999999999875421              12336


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhh
Q 040999          249 KYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQA  327 (382)
Q Consensus       249 ~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (382)
                      |...+..++.++||||||+++|||+| |+.||....     .....         +.+.........             
T Consensus       199 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~---------~~~~~~~~~~~~-------------  251 (290)
T cd05045         199 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-----PERLF---------NLLKTGYRMERP-------------  251 (290)
T ss_pred             HHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHH---------HHHhCCCCCCCC-------------
Confidence            66666778999999999999999998 999975321     11111         111110000000             


Q ss_pred             hhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          328 KINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       328 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                           .....++.+++.+||+.+|++||++.++++.|+++..
T Consensus       252 -----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         252 -----ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                 0233467888999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.8e-33  Score=253.61  Aligned_cols=200  Identities=20%  Similarity=0.281  Sum_probs=155.7

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+++.+|+.+++.++|+||+++++++.      .+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        40 ~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~q  103 (257)
T cd05116          40 KDELLREANVMQQLDNPYIVRMIGICE------AESWMLVMELAELGPLNKFLQ----------KNKHVTEKNITELVHQ  103 (257)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            367899999999999999999999853      345689999999999999883          2345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~D  261 (382)
                      ++.||+|||   +.+++||||||+||+++.++.+||+|||+++.+...               ...||......++.++|
T Consensus       104 i~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  180 (257)
T cd05116         104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSD  180 (257)
T ss_pred             HHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhH
Confidence            999999999   789999999999999999999999999999755321               22355555566788999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||+| |+.||.....  .......            +........                  ..+..++.
T Consensus       181 i~slG~~l~el~t~g~~p~~~~~~--~~~~~~i------------~~~~~~~~~------------------~~~~~~l~  228 (257)
T cd05116         181 VWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMI------------ESGERMECP------------------QRCPPEMY  228 (257)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH------------HCCCCCCCC------------------CCCCHHHH
Confidence            9999999999998 9999864211  1111111            110000000                  02334677


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +++.+||+.+|++||++.+|.+.|++.
T Consensus       229 ~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         229 DLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=256.72  Aligned_cols=202  Identities=22%  Similarity=0.268  Sum_probs=151.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc-cCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN-LNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~~  196 (382)
                      +...+||.+|++++|||||+++++.-   ....+.+|||+|||..|.+...-           ..++ ++..++.+++.+
T Consensus       153 ekv~~EIailKkl~H~nVV~LiEvLD---DP~s~~~YlVley~s~G~v~w~p-----------~d~~els~~~Ar~ylrD  218 (576)
T KOG0585|consen  153 EKVRREIAILKKLHHPNVVKLIEVLD---DPESDKLYLVLEYCSKGEVKWCP-----------PDKPELSEQQARKYLRD  218 (576)
T ss_pred             HHHHHHHHHHHhcCCcCeeEEEEeec---CcccCceEEEEEeccCCccccCC-----------CCcccccHHHHHHHHHH
Confidence            68899999999999999999999854   34467899999999988764322           2334 999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------------CCCCCccccCC----C
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------------TRTQTKYGVGN----E  255 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------------~~~~~~~~~~~----~  255 (382)
                      +..||.|||   .++|+||||||+|+|++.+|++||+|||.+.....                 ...+||...++    .
T Consensus       219 vv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~  295 (576)
T KOG0585|consen  219 VVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSY  295 (576)
T ss_pred             HHHHHHHHH---hcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccc
Confidence            999999999   88999999999999999999999999999975522                 22235554432    2


Q ss_pred             CCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          256 VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      .+.+.||||+||+||.|+.|+.||-..+    .+.-+-         .++..-+.-..                  ..+.
T Consensus       296 ~g~a~DiWalGVTLYCllfG~~PF~~~~----~~~l~~---------KIvn~pL~fP~------------------~pe~  344 (576)
T KOG0585|consen  296 SGFALDIWALGVTLYCLLFGQLPFFDDF----ELELFD---------KIVNDPLEFPE------------------NPEI  344 (576)
T ss_pred             cchhhhhhhhhhhHHHhhhccCCcccch----HHHHHH---------HHhcCcccCCC------------------cccc
Confidence            3678999999999999999999975321    111111         11111110000                  0133


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      -..+.+|+.++|.+||++|.+..+|....=-.
T Consensus       345 ~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  345 NEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             cHHHHHHHHHHhhcChhheeehhhheecceec
Confidence            45677888899999999999999987665333

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.7e-33  Score=251.52  Aligned_cols=199  Identities=21%  Similarity=0.319  Sum_probs=156.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++|+||++++++|..     ....++||||+++++|.+++..         ....+++..++.++.|+
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~qi  103 (252)
T cd05084          38 AKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELVQGGDFLTFLRT---------EGPRLKVKELIQMVENA  103 (252)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeeccCCcHHHHHHh---------CCCCCCHHHHHHHHHHH
Confidence            568999999999999999999999653     6678999999999999999842         23458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||.+.....              ....||...+..++.++|||
T Consensus       104 ~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~  180 (252)
T cd05084         104 AAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVW  180 (252)
T ss_pred             HHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHH
Confidence            99999999   77999999999999999999999999999875332              13346766677788999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||++|||++ |..||.....  ....            ..+.........                  ...+..+.++
T Consensus       181 slG~il~e~~~~~~~p~~~~~~--~~~~------------~~~~~~~~~~~~------------------~~~~~~~~~l  228 (252)
T cd05084         181 SFGILLWEAFSLGAVPYANLSN--QQTR------------EAIEQGVRLPCP------------------ELCPDAVYRL  228 (252)
T ss_pred             HHHHHHHHHHhCCCCCccccCH--HHHH------------HHHHcCCCCCCc------------------ccCCHHHHHH
Confidence            99999999998 8888753211  0000            111100000000                  0223467888


Q ss_pred             hhccCCCCccCCCCHHHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      +.+||+.+|++|||+.+|.++|+
T Consensus       229 i~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         229 MERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHh
Confidence            89999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.2e-33  Score=254.79  Aligned_cols=210  Identities=18%  Similarity=0.332  Sum_probs=158.1

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ..++.+|+.+++.++|+||+++++++.     .....++||||+++|+|.+++...............+++..+..++.|
T Consensus        53 ~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  127 (277)
T cd05062          53 RIEFLNEASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE  127 (277)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHH
Confidence            356889999999999999999999864     366789999999999999998543211111111235688899999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      +++||+|||   +.+++||||||+||++++++.+||+|||+++....              ....||...+..++.++||
T Consensus       128 l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  204 (277)
T cd05062         128 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV  204 (277)
T ss_pred             HHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHH
Confidence            999999999   77999999999999999999999999999864321              1334777667778999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||++ |..||....     ...............        .+                   ..++..+.+
T Consensus       205 ~slG~~l~el~~~~~~p~~~~~-----~~~~~~~~~~~~~~~--------~~-------------------~~~~~~~~~  252 (277)
T cd05062         205 WSFGVVLWEIATLAEQPYQGMS-----NEQVLRFVMEGGLLD--------KP-------------------DNCPDMLFE  252 (277)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHcCCcCC--------CC-------------------CCCCHHHHH
Confidence            999999999999 688875321     111111100000000        00                   023346788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      ++.+||+.+|++|||+.|+++.|++
T Consensus       253 li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         253 LMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHhhC
Confidence            9999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.2e-33  Score=252.48  Aligned_cols=212  Identities=20%  Similarity=0.373  Sum_probs=158.4

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+.+|+++++.++|+||++++++|..... ......+++|||+++|+|.+++.....    ......+++.....++.
T Consensus        44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~~  119 (272)
T cd05075          44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRL----GDCPQYLPTQMLVKFMT  119 (272)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcc----cCCcccCCHHHHHHHHH
Confidence            4678999999999999999999998764211 123357899999999999988742211    12234589999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccch
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~D  261 (382)
                      |++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....              ...||...+..++.++|
T Consensus       120 ~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D  196 (272)
T cd05075         120 DIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSD  196 (272)
T ss_pred             HHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHH
Confidence            9999999999   779999999999999999999999999999865321              12245555667889999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||+++|||++ |+.||.....  ..+.....   ....        ....                   ......+.
T Consensus       197 i~slG~il~el~~~g~~p~~~~~~--~~~~~~~~---~~~~--------~~~~-------------------~~~~~~~~  244 (272)
T cd05075         197 VWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLR---QGNR--------LKQP-------------------PDCLDGLY  244 (272)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH---cCCC--------CCCC-------------------CCCCHHHH
Confidence            9999999999999 7888763211  11111110   0000        0000                   02234578


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +++.+||+.+|++|||+.++++.|+++
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         245 SLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            888899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.5e-33  Score=258.89  Aligned_cols=147  Identities=22%  Similarity=0.308  Sum_probs=128.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++||||+++++++..     .+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i  112 (331)
T cd06649          48 NQIIRELQVLHECNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLK----------EAKRIPEEILGKVSIAV  112 (331)
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEEEEEeecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            578999999999999999999999654     678999999999999999984          23458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      +.||.|||+  ..+|+||||||+|||++.++.+||+|||+++....          ....||...+..++.++|||||||
T Consensus       113 ~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~  190 (331)
T cd06649         113 LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL  190 (331)
T ss_pred             HHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHH
Confidence            999999994  23699999999999999999999999999875432          234477777788899999999999


Q ss_pred             HHHHHHhcCCCCCc
Q 040999          268 LLLELMIREKPSDI  281 (382)
Q Consensus       268 il~elltg~~p~~~  281 (382)
                      ++|||+||+.||..
T Consensus       191 il~el~tg~~p~~~  204 (331)
T cd06649         191 SLVELAIGRYPIPP  204 (331)
T ss_pred             HHHHHHhCCCCCCC
Confidence            99999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.9e-33  Score=267.11  Aligned_cols=213  Identities=23%  Similarity=0.299  Sum_probs=160.6

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc-------------------
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE-------------------  177 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------  177 (382)
                      +.+.+|+++++++. |||||+++++|..     .+..++|||||++|+|.+++........                   
T Consensus        85 ~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (400)
T cd05105          85 QALMSELKIMTHLGPHLNIVNLLGACTK-----SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPA  159 (400)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcc
Confidence            57899999999996 9999999999743     6789999999999999988854211000                   


Q ss_pred             -------------------------------------------------------------------cccCCcccCHHHH
Q 040999          178 -------------------------------------------------------------------TYERPRNLNLLRR  190 (382)
Q Consensus       178 -------------------------------------------------------------------~~~~~~~l~~~~~  190 (382)
                                                                                         .......+++..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~  239 (400)
T cd05105         160 DESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDL  239 (400)
T ss_pred             cccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHH
Confidence                                                                               0001235888899


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEV  256 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~  256 (382)
                      +.++.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++....              ....||...+..+
T Consensus       240 ~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  316 (400)
T cd05105         240 LSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY  316 (400)
T ss_pred             HHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC
Confidence            999999999999999   77999999999999999999999999999875422              1234676667778


Q ss_pred             CccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          257 STIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      +.++|||||||++|||++ |..||........ ........            .....                  ...+
T Consensus       317 ~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~~~~~~~------------~~~~~------------------~~~~  365 (400)
T cd05105         317 TTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYNKIKSG------------YRMAK------------------PDHA  365 (400)
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HHHHHhcC------------CCCCC------------------CccC
Confidence            999999999999999997 9999764321110 00000000            00000                  0123


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      +..+.+++.+||+.+|++|||+.+|.+.|+++.+
T Consensus       366 ~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         366 TQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             CHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            4567889999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.1e-33  Score=251.14  Aligned_cols=199  Identities=21%  Similarity=0.354  Sum_probs=154.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|++++++++||||++++++|..     ....++||||+++|+|.+++..         ....+++..++.++.||
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~i~~---------~~~~~~~~~~~~~~~~i  109 (256)
T cd05113          44 DEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYIVTEYMSNGCLLNYLRE---------HGKRFQPSQLLEMCKDV  109 (256)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEEEEEcCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            568999999999999999999999643     5668999999999999998842         22358999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+++|+||||+||+++.++.+||+|||.++.....             ...||...+..++.++||||
T Consensus       110 ~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~s  186 (256)
T cd05113         110 CEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA  186 (256)
T ss_pred             HHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHH
Confidence            99999999   779999999999999999999999999998754321             23366666667889999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||++|||+| |+.||.....  ............           ...+                   ......+.+++
T Consensus       187 lG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~-----------~~~~-------------------~~~~~~~~~li  234 (256)
T cd05113         187 FGVLMWEVYSLGKMPYERFNN--SETVEKVSQGLR-----------LYRP-------------------HLASEKVYAIM  234 (256)
T ss_pred             HHHHHHHHhcCCCCCcCcCCH--HHHHHHHhcCCC-----------CCCC-------------------CCCCHHHHHHH
Confidence            9999999999 9999753211  001010000000           0000                   01234678888


Q ss_pred             hccCCCCccCCCCHHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      .+||+.+|.+||++.++++.|+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHhhC
Confidence            9999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-33  Score=251.08  Aligned_cols=212  Identities=23%  Similarity=0.331  Sum_probs=160.0

Q ss_pred             HHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------cccCCcccCHHH
Q 040999          117 FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------TYERPRNLNLLR  189 (382)
Q Consensus       117 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~  189 (382)
                      .+.+.+|++++.++ +||||+++++++..     ....++||||+++|+|.+++........      .......+++..
T Consensus        39 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~  113 (270)
T cd05047          39 HRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ  113 (270)
T ss_pred             HHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHH
Confidence            35788999999999 79999999999654     5678999999999999999864321100      011223588999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC-----------CCCCCCccccCCCCCc
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-----------PTRTQTKYGVGNEVST  258 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~-----------~~~~~~~~~~~~~~~~  258 (382)
                      +..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++....           .....||+..+..++.
T Consensus       114 ~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~  190 (270)
T cd05047         114 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT  190 (270)
T ss_pred             HHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCc
Confidence            9999999999999999   7799999999999999999999999999985221           1134467666777899


Q ss_pred             cchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          259 IGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       259 ~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      ++|||||||++|||++ |..||....     ...........         ......                  .....
T Consensus       191 ~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~~~~~---------~~~~~~------------------~~~~~  238 (270)
T cd05047         191 NSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEKLPQG---------YRLEKP------------------LNCDD  238 (270)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCccccC-----HHHHHHHHhCC---------CCCCCC------------------CcCCH
Confidence            9999999999999997 999985321     11111111000         000000                  01234


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      .+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         239 EVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            6788899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.4e-33  Score=259.84  Aligned_cols=215  Identities=21%  Similarity=0.291  Sum_probs=161.9

Q ss_pred             HHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC-------------------
Q 040999          117 FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED-------------------  176 (382)
Q Consensus       117 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------  176 (382)
                      .+.+.+|++++.++ +|+||++++++|..    .....+++|||+++++|.+++.......                   
T Consensus        54 ~~~~~~E~~~~~~l~~h~niv~~~~~~~~----~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  129 (337)
T cd05054          54 YKALMTELKILIHIGHHLNVVNLLGACTK----PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK  129 (337)
T ss_pred             HHHHHHHHHHHHhhccCcchhheeeeEec----CCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccc
Confidence            35678899999999 89999999998753    3567889999999999998885322100                   


Q ss_pred             --------------------------------ccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceee
Q 040999          177 --------------------------------ETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL  224 (382)
Q Consensus       177 --------------------------------~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl  224 (382)
                                                      ........+++..+..++.||+.||+|||   +.+|+||||||+|||+
T Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill  206 (337)
T cd05054         130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILL  206 (337)
T ss_pred             ccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEE
Confidence                                            00001236899999999999999999999   7799999999999999


Q ss_pred             CCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchH
Q 040999          225 DDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNL  289 (382)
Q Consensus       225 ~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~  289 (382)
                      +.++.+||+|||+++.+..              ....||+..+..++.++|||||||++|||++ |..||...... ..+
T Consensus       207 ~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~  285 (337)
T cd05054         207 SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEF  285 (337)
T ss_pred             eCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHH
Confidence            9999999999999986421              2345777777889999999999999999998 99998642111 111


Q ss_pred             HHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          290 HKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      ....    ......       ..+                   .....++.+++.+||+.+|++||++.|+++.|+++..
T Consensus       286 ~~~~----~~~~~~-------~~~-------------------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         286 CRRL----KEGTRM-------RAP-------------------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHH----hccCCC-------CCC-------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1100    000000       000                   0223467889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.1e-33  Score=272.72  Aligned_cols=199  Identities=17%  Similarity=0.164  Sum_probs=154.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+++|+.++|||||++++++..     .+..++||||+++|+|.+++....      .....+++..+..++.|+
T Consensus       110 ~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~l~~~~~~~i~~qi  178 (478)
T PTZ00267        110 AYARSELHCLAACDHFGIVKHFDDFKS-----DDKLLLIMEYGSGGDLNKQIKQRL------KEHLPFQEYEVGLLFYQI  178 (478)
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEEEEEEECCCCCCHHHHHHHHH------hccCCCCHHHHHHHHHHH
Confidence            567889999999999999999999654     678999999999999998874321      223468889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....              ...||...+..++.++|||
T Consensus       179 ~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~  255 (478)
T PTZ00267        179 VLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW  255 (478)
T ss_pred             HHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHH
Confidence            99999999   779999999999999999999999999999865321              2347766677889999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||||++|||+||+.||....     ............        ....+                   ......+.+++
T Consensus       256 slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~~~--------~~~~~-------------------~~~s~~~~~li  303 (478)
T PTZ00267        256 SLGVILYELLTLHRPFKGPS-----QREIMQQVLYGK--------YDPFP-------------------CPVSSGMKALL  303 (478)
T ss_pred             HHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC--------CCCCC-------------------ccCCHHHHHHH
Confidence            99999999999999986321     111111110000        00000                   01223577888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.+|++||++.+++.
T Consensus       304 ~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        304 DPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHhccChhhCcCHHHHHh
Confidence            8999999999999999874

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-34  Score=256.13  Aligned_cols=233  Identities=19%  Similarity=0.186  Sum_probs=163.8

Q ss_pred             chhhH----HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHH
Q 040999          113 AFKIF----KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLL  188 (382)
Q Consensus       113 avK~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~  188 (382)
                      |+|+.    +.--+|.++|+.+.|||||++.-++......++-...+||||||. +|.+++....      .....++..
T Consensus        53 AIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~------~~~~~mp~~  125 (364)
T KOG0658|consen   53 AIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYT------RANQRMPLL  125 (364)
T ss_pred             EEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHh------hcCCCCcee
Confidence            88887    334579999999999999999888765332223456789999987 7888885432      234567778


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCCCCCCC-----------CccccC-CC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLPPTRTQ-----------TKYGVG-NE  255 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~~~~~~-----------~~~~~~-~~  255 (382)
                      .+.-+..||.+||+|||   ..+|+||||||.|+|+|.+ |.+||||||.|+.+..+...           ||...| .+
T Consensus       126 ~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~  202 (364)
T KOG0658|consen  126 EIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE  202 (364)
T ss_pred             eeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccc
Confidence            88889999999999999   7899999999999999976 89999999999988665443           555443 57


Q ss_pred             CCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccc---cchhhhhhccccchhhhhhhhH
Q 040999          256 VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILL---NDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      |+.+.||||.|||+.||+-|++-|.+. .+...+....+........++-.-...   ...+.. ....     ...-..
T Consensus       203 Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~i-k~~~-----~~~~~~  275 (364)
T KOG0658|consen  203 YTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQI-KAHP-----WHKVFF  275 (364)
T ss_pred             cCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHHHHhhcCcccccccCccc-cccc-----ceeecc
Confidence            899999999999999999999987642 222233444444333222222111110   000000 0000     000011


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .....+.++++.++++.+|.+|.++.|++.
T Consensus       276 ~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  276 KRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            134456788888999999999999999874

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-33  Score=250.69  Aligned_cols=212  Identities=21%  Similarity=0.378  Sum_probs=160.8

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ++.+.+|++.++.++|+||+++++++..... ......++++||+++|+|..++......    .....+++.....++.
T Consensus        45 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~~~  120 (273)
T cd05035          45 IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG----GLPEKLPLQTLLKFMV  120 (273)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhcc----CCcccCCHHHHHHHHH
Confidence            4678999999999999999999998764322 2334579999999999999888543211    1234689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccch
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~D  261 (382)
                      |++.||+|||   +.+++||||||+||++++++.+||+|||+++.....              ...||...+..++.++|
T Consensus       121 ~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D  197 (273)
T cd05035         121 DIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSD  197 (273)
T ss_pred             HHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccc
Confidence            9999999999   779999999999999999999999999999764321              23366666677899999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||++ |..||.....  ........           .......+                   ..+...+.
T Consensus       198 v~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~-----------~~~~~~~~-------------------~~~~~~~~  245 (273)
T cd05035         198 VWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLR-----------HGNRLKQP-------------------EDCLDELY  245 (273)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH-----------cCCCCCCC-------------------cCCCHHHH
Confidence            9999999999999 8888753211  11111110           00000000                   02344678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +++.+||+.||++|||+.|+++.|+++
T Consensus       246 ~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         246 DLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-33  Score=250.61  Aligned_cols=201  Identities=22%  Similarity=0.383  Sum_probs=158.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|+.++++++|+||+++++++.     ..+..++||||+++++|.+++..         ....+++..+..++.|+
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l  115 (266)
T cd05033          50 LDFLTEASIMGQFDHPNIIRLEGVVT-----KSRPVMIITEYMENGSLDKFLRE---------NDGKFTVGQLVGMLRGI  115 (266)
T ss_pred             HHHHHHHHHHHhCCCCCcceEeEEEe-----cCCceEEEEEcCCCCCHHHHHHh---------ccCCCCHHHHHHHHHHH
Confidence            56889999999999999999999854     36778999999999999999842         23368999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||+|||   +.+|+|+||||+||+++.++.+||+|||+++....              ....||...+..++.++|||
T Consensus       116 ~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~  192 (266)
T cd05033         116 ASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVW  192 (266)
T ss_pred             HHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchH
Confidence            99999999   78999999999999999999999999999986631              12346766677889999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||+++|||++ |..||.....  ...........           ....+                   ..++..+.++
T Consensus       193 slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~-----------~~~~~-------------------~~~~~~l~~l  240 (266)
T cd05033         193 SFGIVMWEVMSYGERPYWDMSN--QDVIKAVEDGY-----------RLPPP-------------------MDCPSALYQL  240 (266)
T ss_pred             HHHHHHHHHHccCCCCCCCCCH--HHHHHHHHcCC-----------CCCCC-------------------CCCCHHHHHH
Confidence            99999999998 9999753211  11111110000           00000                   0233467889


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +.+||+.+|++||++.+|++.|+++
T Consensus       241 i~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         241 MLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHcCCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-32  Score=253.42  Aligned_cols=217  Identities=21%  Similarity=0.292  Sum_probs=164.2

Q ss_pred             HHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------cccCCcccCHHH
Q 040999          117 FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------TYERPRNLNLLR  189 (382)
Q Consensus       117 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~  189 (382)
                      .+.+.+|++++.++ +||||+++++++..     .+..++|+||+++++|.+++........      .......+++..
T Consensus        46 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~  120 (297)
T cd05089          46 HRDFAGELEVLCKLGHHPNIINLLGACEN-----RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ  120 (297)
T ss_pred             HHHHHHHHHHHHhhcCCCchhheEEEEcc-----CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHH
Confidence            35789999999999 79999999998643     5678999999999999999864321100      011224588999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC-----------CCCCCCccccCCCCCc
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-----------PTRTQTKYGVGNEVST  258 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~-----------~~~~~~~~~~~~~~~~  258 (382)
                      +..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++....           .....||...+..++.
T Consensus       121 ~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  197 (297)
T cd05089         121 LLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTT  197 (297)
T ss_pred             HHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCc
Confidence            9999999999999999   7799999999999999999999999999986321           1134477776777899


Q ss_pred             cchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          259 IGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       259 ~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      ++|||||||++|||++ |..||....     ........         .........                  ..+..
T Consensus       198 ~~DvwSlG~il~el~t~g~~pf~~~~-----~~~~~~~~---------~~~~~~~~~------------------~~~~~  245 (297)
T cd05089         198 KSDVWSFGVLLWEIVSLGGTPYCGMT-----CAELYEKL---------PQGYRMEKP------------------RNCDD  245 (297)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH---------hcCCCCCCC------------------CCCCH
Confidence            9999999999999997 999986321     11111110         000000000                  02234


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      .+.+++.+||+.+|.+|||+.++++.|+.+.+....
T Consensus       246 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         246 EVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            678888999999999999999999999999886644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.6e-33  Score=248.95  Aligned_cols=203  Identities=25%  Similarity=0.331  Sum_probs=158.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++++++|+|++++++++..    .....++|+||+++++|.+++...        ....+++..++.++.|+
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i  111 (256)
T cd05082          44 QAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDV  111 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEEECCCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHH
Confidence            568899999999999999999998542    356689999999999999998531        22358899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------CCCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||+|||   +.+++||||||+||++++++.+||+|||+++....         ....||...+..++.++|||||||+
T Consensus       112 ~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i  188 (256)
T cd05082         112 CEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL  188 (256)
T ss_pred             HHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHH
Confidence            99999999   77999999999999999999999999999875432         2334777677788999999999999


Q ss_pred             HHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          269 LLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       269 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      +|||++ |+.||...     ............         ......                  ..++..+.+++.+||
T Consensus       189 ~~~l~~~g~~p~~~~-----~~~~~~~~~~~~---------~~~~~~------------------~~~~~~~~~li~~~l  236 (256)
T cd05082         189 LWEIYSFGRVPYPRI-----PLKDVVPRVEKG---------YKMDAP------------------DGCPPVVYDVMKQCW  236 (256)
T ss_pred             HHHHHhCCCCCCCCC-----CHHHHHHHHhcC---------CCCCCC------------------CCCCHHHHHHHHHHh
Confidence            999998 99997531     111111111000         000000                  023446788889999


Q ss_pred             CCCccCCCCHHHHHHHHHHh
Q 040999          348 MESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       348 ~~~p~~RPs~~evl~~L~~i  367 (382)
                      +.+|++|||+.++++.|+++
T Consensus       237 ~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         237 HLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             cCChhhCcCHHHHHHHHhcC
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-32  Score=248.86  Aligned_cols=205  Identities=23%  Similarity=0.389  Sum_probs=156.0

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+.+++.++||||++++++|..    .++..++|+||+++|+|.+++..         .....++..+..++.|
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~  106 (262)
T cd05058          40 VEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVLPYMKHGDLRNFIRS---------ETHNPTVKDLIGFGLQ  106 (262)
T ss_pred             HHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEEecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHH
Confidence            4678899999999999999999998653    24567899999999999999842         2234677788899999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------------CCCCCccccCCCCCccc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------------TRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------------~~~~~~~~~~~~~~~~~  260 (382)
                      +++||+|||   +.+++||||||+|||++.++.+||+|||+++....                ....||...+..++.++
T Consensus       107 i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  183 (262)
T cd05058         107 VAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKS  183 (262)
T ss_pred             HHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHH
Confidence            999999999   77999999999999999999999999999875421                12346666667789999


Q ss_pred             hhHHHHHHHHHHHhc-CCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          261 DVYSYGILLLELMIR-EKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       261 Dv~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      |||||||++|||++| .+||...     ............        .....+                   ...+..+
T Consensus       184 Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~~~~~~--------~~~~~~-------------------~~~~~~~  231 (262)
T cd05058         184 DVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYLLQG--------RRLLQP-------------------EYCPDPL  231 (262)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHhcC--------CCCCCC-------------------CcCCHHH
Confidence            999999999999995 4555421     111111110000        000000                   0123467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      .+++.+||+.+|++||++.|+++.|+++..
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.8e-33  Score=254.38  Aligned_cols=216  Identities=19%  Similarity=0.331  Sum_probs=157.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC-ccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED-ETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ++|.+|+++++.++|+||+++++++..     .+..++||||+++|+|.+++....... ........+++.....++.|
T Consensus        64 ~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (296)
T cd05095          64 NDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ  138 (296)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHH
Confidence            578999999999999999999998643     567899999999999999986432111 01122345888999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||+|||   +.+++||||||+||+++.++.+||+|||+++.+..              ....||...+..++.++||
T Consensus       139 i~~al~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di  215 (296)
T cd05095         139 IASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDV  215 (296)
T ss_pred             HHHHHHHHH---HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhh
Confidence            999999999   77999999999999999999999999999975422              1223555556678999999


Q ss_pred             HHHHHHHHHHHh--cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          263 YSYGILLLELMI--REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       263 ~S~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||++|||+|  |..||.....     .+.....     ..............               ....++..+.
T Consensus       216 wSlG~~l~el~~~~~~~p~~~~~~-----~~~~~~~-----~~~~~~~~~~~~~~---------------~~~~~~~~~~  270 (296)
T cd05095         216 WAFGVTLWEILTLCKEQPYSQLSD-----EQVIENT-----GEFFRDQGRQVYLP---------------KPALCPDSLY  270 (296)
T ss_pred             hHHHHHHHHHHHhCCCCCccccCh-----HHHHHHH-----HHHHhhccccccCC---------------CCCCCCHHHH
Confidence            999999999998  6778753211     1111100     00000000000000               0002335678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      +++.+||+.||++||++.+|++.|++
T Consensus       271 ~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         271 KLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            89999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-33  Score=250.81  Aligned_cols=193  Identities=19%  Similarity=0.310  Sum_probs=155.3

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+||++|+.|+||||+++|.+     ++..+.+.+||||..+|.|++|+.          ....+++.+...+++||.
T Consensus        99 hIRREIeIMSsLNHPhII~IyEV-----FENkdKIvivMEYaS~GeLYDYiS----------er~~LsErEaRhfFRQIv  163 (668)
T KOG0611|consen   99 HIRREIEIMSSLNHPHIIQIYEV-----FENKDKIVIVMEYASGGELYDYIS----------ERGSLSEREARHFFRQIV  163 (668)
T ss_pred             HHHHHHHHHhhcCCCceeehhhh-----hcCCceEEEEEEecCCccHHHHHH----------HhccccHHHHHHHHHHHH
Confidence            57899999999999999999999     566889999999999999999994          456799999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-----------CCCccccCCCC-CccchhHHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-----------TQTKYGVGNEV-STIGDVYSYG  266 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~~~~~-~~~~Dv~S~G  266 (382)
                      .|+.|+|   ..+++|||||.+|||+|.++++||+|||++.++....           ..||...|..| ++.+|-||+|
T Consensus       164 SAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLG  240 (668)
T KOG0611|consen  164 SAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLG  240 (668)
T ss_pred             HHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHH
Confidence            9999999   8899999999999999999999999999998764432           33666555555 6889999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |+||-|+.|..||+..     +....+++.-.....         ++                    +.+....-|++++
T Consensus       241 vLLYtLVyGtMPFDG~-----Dhk~lvrQIs~GaYr---------EP--------------------~~PSdA~gLIRwm  286 (668)
T KOG0611|consen  241 VLLYTLVYGTMPFDGR-----DHKRLVRQISRGAYR---------EP--------------------ETPSDASGLIRWM  286 (668)
T ss_pred             HHHHHHhhcccccCCc-----hHHHHHHHhhccccc---------CC--------------------CCCchHHHHHHHH
Confidence            9999999999999842     222222222111100         01                    1123445677799


Q ss_pred             CCCCccCCCCHHHHHHH
Q 040999          347 SMESPQDRMKMTNVVHE  363 (382)
Q Consensus       347 l~~~p~~RPs~~evl~~  363 (382)
                      +..+|++|.|+.||...
T Consensus       287 LmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  287 LMVNPERRATIEDIASH  303 (668)
T ss_pred             HhcCcccchhHHHHhhh
Confidence            99999999999999754

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.3e-33  Score=252.13  Aligned_cols=196  Identities=20%  Similarity=0.271  Sum_probs=149.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|+.+++.++||||++++++|..     ....++||||+++|+|..++..         ....+++..++.++.|+
T Consensus        61 ~~~~~~~~~~~~l~h~niv~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~qi  126 (274)
T cd05076          61 LAFFETASLMSQVSHIHLAFVHGVCVR-----GSENIMVEEFVEHGPLDVCLRK---------EKGRVPVAWKITVAQQL  126 (274)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEEe-----CCceEEEEecCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            568889999999999999999999764     5678999999999999988842         23468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCC-------cEEEccccccccCC--------CCCCCCccccC-CCCCccch
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-------TARVGDFGLARFLP--------PTRTQTKYGVG-NEVSTIGD  261 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-------~~kl~Dfg~a~~~~--------~~~~~~~~~~~-~~~~~~~D  261 (382)
                      ++||+|||   +.+|+||||||+|||+++.+       .+|++|||.+....        .....||...+ ..++.++|
T Consensus       127 ~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~D  203 (274)
T cd05076         127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAAD  203 (274)
T ss_pred             HHHHHHHH---cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHH
Confidence            99999999   78999999999999997643       47999999876432        12334665543 56789999


Q ss_pred             hHHHHHHHHHHH-hcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELM-IREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||+ +|+.||.....  .....+.            ..... .+.                   .....+.
T Consensus       204 v~slG~~l~el~~~g~~p~~~~~~--~~~~~~~------------~~~~~-~~~-------------------~~~~~~~  249 (274)
T cd05076         204 KWSFGTTLLEICFDGEVPLKERTP--SEKERFY------------EKKHR-LPE-------------------PSCKELA  249 (274)
T ss_pred             HHHHHHHHHHHHhCCCCCccccCh--HHHHHHH------------HhccC-CCC-------------------CCChHHH
Confidence            999999999995 78998764211  1111111            00000 000                   0112577


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                      +++.+||+.+|++|||+.+|++.|
T Consensus       250 ~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         250 TLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHHHcccChhhCcCHHHHHHhh
Confidence            888899999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-32  Score=249.25  Aligned_cols=209  Identities=19%  Similarity=0.254  Sum_probs=161.1

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ...+.+|+++++.++||||+++++++..     .+..++|+||+++|+|.+++....      .....+++..+..++.|
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~  114 (267)
T cd08228          46 RQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNELNIVLELADAGDLSQMIKYFK------KQKRLIPERTVWKYFVQ  114 (267)
T ss_pred             HHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCeEEEEEEecCCCcHHHHHHHhh------hccCCCCHHHHHHHHHH
Confidence            3578899999999999999999998653     578899999999999998884321      12345788899999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +++||+|||   +.+++|+||||+||+++.++.++|+|||.+.....            ....||...+..++.++||||
T Consensus       115 i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s  191 (267)
T cd08228         115 LCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS  191 (267)
T ss_pred             HHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHH
Confidence            999999999   77999999999999999999999999999876532            123477766777889999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|||++|+.||....   .....+........        .....                  .......+.+++.
T Consensus       192 lG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~~~--------~~~~~------------------~~~~~~~~~~li~  242 (267)
T cd08228         192 LGCLLYEMAALQSPFYGDK---MNLFSLCQKIEQCD--------YPPLP------------------TEHYSEKLRELVS  242 (267)
T ss_pred             HHHHHHHHhcCCCCCcccc---ccHHHHHHHHhcCC--------CCCCC------------------hhhcCHHHHHHHH
Confidence            9999999999999975321   11111111100000        00000                  0123356788888


Q ss_pred             ccCCCCccCCCCHHHHHHHHHHhh
Q 040999          345 ACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      +||+.+|++||++.+|++.+++++
T Consensus       243 ~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         243 MCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HHCCCCcccCcCHHHHHHHHHHhc
Confidence            999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.4e-33  Score=237.35  Aligned_cols=225  Identities=21%  Similarity=0.305  Sum_probs=164.8

Q ss_pred             chhhH----------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCC
Q 040999          113 AFKIF----------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP  182 (382)
Q Consensus       113 avK~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  182 (382)
                      |+|++          ....||++.|+.++|+||+.+++++     ...+...||+|||+. +|+..+.         +..
T Consensus        31 AIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l~lVfEfm~t-dLe~vIk---------d~~   95 (318)
T KOG0659|consen   31 AIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNLSLVFEFMPT-DLEVVIK---------DKN   95 (318)
T ss_pred             EEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCceEEEEEeccc-cHHHHhc---------ccc
Confidence            77776          4678999999999999999999994     447888999999976 7888884         455


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCC------------CCcc
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRT------------QTKY  250 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~------------~~~~  250 (382)
                      ..++..++..++.++.+||+|||   .+.|+||||||.|+|++.+|.+||+|||+|+...+...            +||.
T Consensus        96 i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPEL  172 (318)
T KOG0659|consen   96 IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPEL  172 (318)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHH
Confidence            67999999999999999999999   88999999999999999999999999999998764332            2554


Q ss_pred             ccC-CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHh---cCCchhhhhhcccccchhhhhhccccchhh
Q 040999          251 GVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA---LPNHVKDIVDSILLNDDEKLVVRGDQKQTQ  326 (382)
Q Consensus       251 ~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (382)
                      ..| ..|+..+|+||.|||+.||+-|.+-|    .+..++.+.....   ......++-+-.-.++..+....+    ..
T Consensus       173 LfGsr~Yg~~VDmWavGCI~AELllr~P~f----pG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P----~~  244 (318)
T KOG0659|consen  173 LFGSRQYGTGVDMWAVGCIFAELLLRVPFF----PGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFP----KP  244 (318)
T ss_pred             hccchhcCCcchhhhHHHHHHHHHccCCCC----CCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCC----CC
Confidence            443 67899999999999999999987764    4555565544321   111111111111111111110000    00


Q ss_pred             hhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          327 AKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ........+....++++..++..||.+|.|+.|++++
T Consensus       245 ~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  245 PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0111222445566888999999999999999999864

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-33  Score=249.18  Aligned_cols=198  Identities=24%  Similarity=0.362  Sum_probs=155.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++|+||+++++++.     ..+..++||||+++++|.+++..         ....+++..+..++.|+
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi  109 (256)
T cd05059          44 DDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIVTEYMANGCLLNYLRE---------RKGKLGTEWLLDMCSDV  109 (256)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEEEecCCCCCHHHHHHh---------cccCCCHHHHHHHHHHH
Confidence            46889999999999999999999854     36678999999999999998842         22368899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+++||||||+||+++.++.+||+|||.++....             ....||...+..++.++||||
T Consensus       110 ~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s  186 (256)
T cd05059         110 CEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS  186 (256)
T ss_pred             HHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHH
Confidence            99999999   77999999999999999999999999999875432             133466666778899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||+| |+.||+....  ..........            ......                  ..++..+.+++
T Consensus       187 lG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~------------~~~~~~------------------~~~~~~~~~li  234 (256)
T cd05059         187 FGVLMWEVFSEGKMPYERFSN--SEVVESVSAG------------YRLYRP------------------KLAPTEVYTIM  234 (256)
T ss_pred             HHHHHHHHhccCCCCCCCCCH--HHHHHHHHcC------------CcCCCC------------------CCCCHHHHHHH
Confidence            9999999999 8999763211  1110000000            000000                  02344688899


Q ss_pred             hccCCCCccCCCCHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L  364 (382)
                      .+||+.+|++|||+.|+++.|
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHHh
Confidence            999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.4e-33  Score=253.06  Aligned_cols=204  Identities=22%  Similarity=0.320  Sum_probs=158.9

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+.+++.++|+||++++++|..      ...++++||+++|+|.+++..         ....+++..++.++.|
T Consensus        53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~l~~~~~~~g~l~~~l~~---------~~~~~~~~~~~~~~~q  117 (279)
T cd05109          53 NKEILDEAYVMAGVGSPYVCRLLGICLT------STVQLVTQLMPYGCLLDYVRE---------NKDRIGSQDLLNWCVQ  117 (279)
T ss_pred             HHHHHHHHHHHHhcCCCCCceEEEEEcC------CCcEEEEEcCCCCCHHHHHhh---------ccCCCCHHHHHHHHHH
Confidence            3678899999999999999999999752      346799999999999998842         2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....              ....||...+..++.++||
T Consensus       118 i~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di  194 (279)
T cd05109         118 IAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDV  194 (279)
T ss_pred             HHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHH
Confidence            999999999   77999999999999999999999999999976532              1234666667778999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||+| |..||+....  .....+..            ........                  ..+...+.+
T Consensus       195 ~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~------------~~~~~~~~------------------~~~~~~~~~  242 (279)
T cd05109         195 WSYGVTVWELMTFGAKPYDGIPA--REIPDLLE------------KGERLPQP------------------PICTIDVYM  242 (279)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH------------CCCcCCCC------------------ccCCHHHHH
Confidence            999999999998 8899764211  11111111            10000000                  023346778


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      ++.+||+.||++||++.++++.|+.+...
T Consensus       243 li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         243 IMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            88899999999999999999999877544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-32  Score=247.69  Aligned_cols=201  Identities=23%  Similarity=0.322  Sum_probs=158.3

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+++.+|+++++.+.|+||+++++++.      ....++||||+++|+|.+++..          ...+++..+..++.|
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~q  103 (257)
T cd05060          40 KKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVMELAPLGPLLKYLKK----------RREIPVSDLKELAHQ  103 (257)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEEEeCCCCcHHHHHHh----------CCCCCHHHHHHHHHH
Confidence            367899999999999999999999853      3457899999999999999942          236889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~D  261 (382)
                      ++.||+|||   ..+++|+||||+||+++.++.+||+|||.++.....               ...||...+..++.++|
T Consensus       104 i~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  180 (257)
T cd05060         104 VAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSD  180 (257)
T ss_pred             HHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccch
Confidence            999999999   678999999999999999999999999998754221               23366666677899999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||+++|||++ |..||....  ............+.            ...                  ..++..+.
T Consensus       181 i~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~------------~~~------------------~~~~~~l~  228 (257)
T cd05060         181 VWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESGERL------------PRP------------------EECPQEIY  228 (257)
T ss_pred             HHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcCCcC------------CCC------------------CCCCHHHH
Confidence            9999999999998 999986421  11111111110000            000                  02234678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      +++.+||+.+|++||++.++++.|+++.
T Consensus       229 ~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         229 SIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            8999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.4e-33  Score=260.30  Aligned_cols=194  Identities=21%  Similarity=0.238  Sum_probs=152.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        40 ~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  104 (323)
T cd05571          40 AHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLS----------RERVFSEDRARFYGAEI  104 (323)
T ss_pred             HHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            46788999999999999999998854     4778999999999999988883          33468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++|||||
T Consensus       105 ~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  181 (323)
T cd05571         105 VSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  181 (323)
T ss_pred             HHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCccc
Confidence            99999999   7799999999999999999999999999987531            12344777777888999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||....     .............      ..   +                   .....++.+++.+
T Consensus       182 G~il~elltg~~Pf~~~~-----~~~~~~~~~~~~~------~~---p-------------------~~~~~~~~~li~~  228 (323)
T cd05571         182 GVVMYEMMCGRLPFYNQD-----HEKLFELILMEEI------RF---P-------------------RTLSPEAKSLLAG  228 (323)
T ss_pred             chhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCC------CC---C-------------------CCCCHHHHHHHHH
Confidence            999999999999986321     1111111100000      00   0                   0122356778889


Q ss_pred             cCCCCccCCC-----CHHHHHH
Q 040999          346 CSMESPQDRM-----KMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RP-----s~~evl~  362 (382)
                      ||+.||++||     ++.++++
T Consensus       229 ~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         229 LLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HccCCHHHcCCCCCCCHHHHHc
Confidence            9999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.8e-33  Score=250.22  Aligned_cols=202  Identities=21%  Similarity=0.380  Sum_probs=158.8

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++.+++.     ..+..++||||+++++|.+++..         ....+++..+..++.|
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~  115 (268)
T cd05063          50 RQDFLSEASIMGQFSHHNIIRLEGVVT-----KFKPAMIITEYMENGALDKYLRD---------HDGEFSSYQLVGMLRG  115 (268)
T ss_pred             HHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCCCcEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHH
Confidence            356889999999999999999999864     36678999999999999998842         2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~D  261 (382)
                      ++.||+|||   +.+++||||||+||+++.++.+|++|||++......               ...||...+..++.++|
T Consensus       116 l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D  192 (268)
T cd05063         116 IAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASD  192 (268)
T ss_pred             HHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhH
Confidence            999999999   779999999999999999999999999998755321               23466666677889999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||+| |+.||.....     .......         ........                  ..+++..+.
T Consensus       193 v~slG~il~ell~~g~~p~~~~~~-----~~~~~~i---------~~~~~~~~------------------~~~~~~~~~  240 (268)
T cd05063         193 VWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAI---------NDGFRLPA------------------PMDCPSAVY  240 (268)
T ss_pred             HHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHH---------hcCCCCCC------------------CCCCCHHHH
Confidence            9999999999998 9999853211     1111110         00000000                  002345678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +++.+||+.+|++||++.+|++.|+++
T Consensus       241 ~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         241 QLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-32  Score=248.47  Aligned_cols=202  Identities=29%  Similarity=0.421  Sum_probs=158.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++|+||+++++++..     .+..++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i  112 (261)
T cd05068          46 KDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIYIVTELMKYGSLLEYLQGG--------AGRALKLPQLIDMAAQV  112 (261)
T ss_pred             HHHHHHHHHHHHCCCCCccceeEEEec-----CCCeeeeeecccCCcHHHHHhcc--------CCCCCCHHHHHHHHHHH
Confidence            568899999999999999999998643     66789999999999999998431        13468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||+++....             ....||...+..++.++||||
T Consensus       113 ~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  189 (261)
T cd05068         113 ASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS  189 (261)
T ss_pred             HHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHH
Confidence            99999999   77999999999999999999999999999875432             123477777778899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||+| |+.||....    . ......         +.........                  ......+.+++
T Consensus       190 lG~~l~el~t~g~~p~~~~~----~-~~~~~~---------~~~~~~~~~~------------------~~~~~~~~~li  237 (261)
T cd05068         190 FGILLTEIVTYGRMPYPGMT----N-AEVLQQ---------VDQGYRMPCP------------------PGCPKELYDIM  237 (261)
T ss_pred             HHHHHHHHHhcCCCCCCCCC----H-HHHHHH---------HHcCCCCCCC------------------CcCCHHHHHHH
Confidence            9999999999 999976321    1 000000         0000000000                  02334678889


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      .+|++.+|.+||++.++++.|+++
T Consensus       238 ~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         238 LDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHhhcCcccCCCHHHHHHHHhcC
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1e-32  Score=249.08  Aligned_cols=202  Identities=19%  Similarity=0.343  Sum_probs=157.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++++++|+||+++++++.     ..+..+++|||+++++|.+++...        ....+++..+..++.|+
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~l  112 (261)
T cd05072          46 QAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYIITEYMAKGSLLDFLKSD--------EGGKVLLPKLIDFSAQI  112 (261)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEEEEecCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHH
Confidence            57899999999999999999998853     367789999999999999998531        23457888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++||+|||   ..+++||||||+||+++.++.+||+|||++......             ...||+..+..++.++||||
T Consensus       113 ~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  189 (261)
T cd05072         113 AEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS  189 (261)
T ss_pred             HHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhh
Confidence            99999999   779999999999999999999999999999865321             23366666677888999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||++|||+| |+.||.....  ............            ...                  ....+.++.+++
T Consensus       190 lG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~------------~~~------------------~~~~~~~~~~li  237 (261)
T cd05072         190 FGILLYEIVTYGKIPYPGMSN--SDVMSALQRGYR------------MPR------------------MENCPDELYDIM  237 (261)
T ss_pred             hHHHHHHHHccCCCCCCCCCH--HHHHHHHHcCCC------------CCC------------------CCCCCHHHHHHH
Confidence            9999999998 9999853211  111111100000            000                  002234678889


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      .+||+.+|++||+++++.+.|+++
T Consensus       238 ~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         238 KTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHccCCcccCcCHHHHHHHHhcC
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-32  Score=252.41  Aligned_cols=200  Identities=19%  Similarity=0.234  Sum_probs=153.3

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|++++++++|+||+++++++.     ..+..++||||+++|+|.+++...        ....+++..+..++.|++
T Consensus        46 ~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~~~~~--------~~~~~~~~~~~~~~~qi~  112 (285)
T cd05631          46 MALNEKRILEKVNSRFVVSLAYAYE-----TKDALCLVLTIMNGGDLKFHIYNM--------GNPGFDEQRAIFYAAELC  112 (285)
T ss_pred             HHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeEEEEEEecCCCcHHHHHHhh--------CCCCCCHHHHHHHHHHHH
Confidence            5778999999999999999998854     367899999999999998877421        223588999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCccchhHHHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      .||+|||   +.+|+||||||+|||+++++.+||+|||++.....           ...+||...+..++.++|||||||
T Consensus       113 ~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGv  189 (285)
T cd05631         113 CGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGC  189 (285)
T ss_pred             HHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHH
Confidence            9999999   78999999999999999999999999999976432           223477777888999999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ++|||++|+.||....... ....... ........         .                  .......+.+++.+||
T Consensus       190 il~el~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~~---------~------------------~~~~s~~~~~li~~~l  240 (285)
T cd05631         190 LIYEMIQGQSPFRKRKERV-KREEVDR-RVKEDQEE---------Y------------------SEKFSEDAKSICRMLL  240 (285)
T ss_pred             HHHHHHhCCCCCCCCCcch-hHHHHHH-Hhhccccc---------C------------------CccCCHHHHHHHHHHh
Confidence            9999999999987432111 0011100 00000000         0                  0012335678888999


Q ss_pred             CCCccCCCC-----HHHHHHH
Q 040999          348 MESPQDRMK-----MTNVVHE  363 (382)
Q Consensus       348 ~~~p~~RPs-----~~evl~~  363 (382)
                      +.||++||+     ++++++.
T Consensus       241 ~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         241 TKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             hcCHHHhcCCCCCCHHHHhcC
Confidence            999999997     7888863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-32  Score=248.88  Aligned_cols=202  Identities=26%  Similarity=0.436  Sum_probs=158.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|+||+++++++..     ....++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i  113 (261)
T cd05148          47 QDFQKEVQALKRLRHKHLISLFAVCSV-----GEPVYIITELMEKGSLLAFLRSP--------EGQVLPVASLIDMACQV  113 (261)
T ss_pred             HHHHHHHHHHhcCCCcchhheeeeEec-----CCCeEEEEeecccCCHHHHHhcC--------CCCCCCHHHHHHHHHHH
Confidence            568899999999999999999998643     67789999999999999999532        23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+++|+||||+||+++.++.+||+|||.+......            ...||...+..++.++|||||
T Consensus       114 ~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl  190 (261)
T cd05148         114 AEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSF  190 (261)
T ss_pred             HHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHH
Confidence            99999999   779999999999999999999999999999765322            233666666778899999999


Q ss_pred             HHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          266 GILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       266 Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |+++|+|++ |+.||....  .............            ....                  ..++..+.+++.
T Consensus       191 G~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~------------~~~~------------------~~~~~~~~~~i~  238 (261)
T cd05148         191 GILLYEMFTYGQVPYPGMN--NHEVYDQITAGYR------------MPCP------------------AKCPQEIYKIML  238 (261)
T ss_pred             HHHHHHHHcCCCCCCCcCC--HHHHHHHHHhCCc------------CCCC------------------CCCCHHHHHHHH
Confidence            999999998 899986421  1111111100000            0000                  023346788899


Q ss_pred             ccCCCCccCCCCHHHHHHHHHHh
Q 040999          345 ACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +||+.+|++|||++++++.|+++
T Consensus       239 ~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         239 ECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHcCCCchhCcCHHHHHHHHhcC
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-32  Score=252.99  Aligned_cols=203  Identities=23%  Similarity=0.296  Sum_probs=157.7

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++++++ +|+||+++++++..     .+..++||||+++|+|.+++...        ....+++.++..++.|
T Consensus        83 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~--------~~~~l~~~~~~~i~~~  149 (302)
T cd05055          83 EALMSELKIMSHLGNHENIVNLLGACTI-----GGPILVITEYCCYGDLLNFLRRK--------RESFLTLEDLLSFSYQ  149 (302)
T ss_pred             HHHHHHHHHHHhccCCCCcceEEEEEec-----CCceEEEEEcCCCCcHHHHHHhC--------CCCCCCHHHHHHHHHH
Confidence            5689999999999 79999999998653     56789999999999999998531        1233899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||+|||   +.+|+|+||||+|||++.++.+|++|||+++.....              ...||...+..++.++||
T Consensus       150 i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  226 (302)
T cd05055         150 VAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV  226 (302)
T ss_pred             HHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHH
Confidence            999999999   779999999999999999999999999999754321              234666666778899999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||+| |+.||...... ..+...            ++.........                  .....+.+
T Consensus       227 wslGvil~el~t~g~~p~~~~~~~-~~~~~~------------~~~~~~~~~~~------------------~~~~~~~~  275 (302)
T cd05055         227 WSYGILLWEIFSLGSNPYPGMPVD-SKFYKL------------IKEGYRMAQPE------------------HAPAEIYD  275 (302)
T ss_pred             HHHHHHHHHHHhCCCCCcCCCCch-HHHHHH------------HHcCCcCCCCC------------------CCCHHHHH
Confidence            999999999998 99997643211 011111            11000000000                  11236788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      ++.+||+.+|++|||+.|+++.|++.
T Consensus       276 li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         276 IMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            88899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-33  Score=239.17  Aligned_cols=204  Identities=20%  Similarity=0.285  Sum_probs=159.6

Q ss_pred             chhhHHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHH
Q 040999          113 AFKIFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRL  191 (382)
Q Consensus       113 avK~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~  191 (382)
                      +....+.-.+|+.+|+++ .||+|+++.++     |+.+.+.++|+|.|+.|.|.++|.          ....+++....
T Consensus        62 ~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~-----yes~sF~FlVFdl~prGELFDyLt----------s~VtlSEK~tR  126 (411)
T KOG0599|consen   62 PYEMREATRQEISILRQVMGHPYIIDLQDV-----YESDAFVFLVFDLMPRGELFDYLT----------SKVTLSEKETR  126 (411)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCcEEEeeee-----ccCcchhhhhhhhcccchHHHHhh----------hheeecHHHHH
Confidence            444557788999999998 69999999999     566889999999999999999994          45679999999


Q ss_pred             HHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-----------CCCccc------cCC
Q 040999          192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-----------TQTKYG------VGN  254 (382)
Q Consensus       192 ~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~------~~~  254 (382)
                      +|+.|+.+|+.|||   ..+||||||||+|||+|++.++||+|||+|+.+.++.           .+||..      ..+
T Consensus       127 ~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~p  203 (411)
T KOG0599|consen  127 RIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHP  203 (411)
T ss_pred             HHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCC
Confidence            99999999999999   7899999999999999999999999999999876543           224432      245


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      .|+..+|+||.|||+|-|+.|.+||..-  .+..+.               .-++.....       ++     .+++.+
T Consensus       204 GYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlML---------------R~ImeGkyq-------F~-----speWad  254 (411)
T KOG0599|consen  204 GYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLML---------------RMIMEGKYQ-------FR-----SPEWAD  254 (411)
T ss_pred             CccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHH---------------HHHHhcccc-------cC-----Ccchhh
Confidence            6788999999999999999999997421  000000               000000000       00     011224


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ...++.+|+.+|++.||.+|.|++|+++.
T Consensus       255 is~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  255 ISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             ccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            55677888889999999999999999853

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.8e-32  Score=250.09  Aligned_cols=209  Identities=25%  Similarity=0.414  Sum_probs=160.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc----cccCCcccCHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE----TYERPRNLNLLRRLNI  193 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~l~~~~~~~i  193 (382)
                      +.+.+|++++++++|+||+++++++..     ....++||||+++++|.+++........    .......+++..+..+
T Consensus        53 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~  127 (280)
T cd05049          53 KDFEREAELLTNFQHENIVKFYGVCTE-----GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI  127 (280)
T ss_pred             HHHHHHHHHHHhcCCCCchheeeEEec-----CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHH
Confidence            678999999999999999999999654     5778999999999999999864321100    0122345889999999


Q ss_pred             HHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCcc
Q 040999          194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTI  259 (382)
Q Consensus       194 ~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~  259 (382)
                      +.|++.||.|||   +.+++||||||+||+++.++.+||+|||.++....              ...+||...+..++.+
T Consensus       128 ~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (280)
T cd05049         128 AVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE  204 (280)
T ss_pred             HHHHHHHHHHHh---hCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchh
Confidence            999999999999   77999999999999999999999999999874321              1345777777888999


Q ss_pred             chhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +|||||||++|||++ |+.||.....  ........   .        .... ...                  ......
T Consensus       205 ~Di~slG~il~e~~~~g~~p~~~~~~--~~~~~~~~---~--------~~~~-~~~------------------~~~~~~  252 (280)
T cd05049         205 SDVWSFGVVLWEIFTYGKQPWYGLSN--EEVIECIT---Q--------GRLL-QRP------------------RTCPSE  252 (280)
T ss_pred             hhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHH---c--------CCcC-CCC------------------CCCCHH
Confidence            999999999999998 9999753211  11111110   0        0000 000                  023346


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      +.+++.+||+.+|++||++.||++.|++
T Consensus       253 ~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         253 VYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            7889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-32  Score=252.44  Aligned_cols=224  Identities=19%  Similarity=0.191  Sum_probs=154.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++.     ..+..++||||++++.+..+.          .....+++..+..++.|+
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~~qi  109 (287)
T cd07848          45 ETTLRELKMLRTLKQENIVELKEAFR-----RRGKLYLVFEYVEKNMLELLE----------EMPNGVPPEKVRSYIYQL  109 (287)
T ss_pred             hhHHHHHHHHHhCCCccccchhhhEe-----cCCEEEEEEecCCCCHHHHHH----------hcCCCCCHHHHHHHHHHH
Confidence            56789999999999999999999854     367899999999988765443          223458889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....             ...||...+..++.++||||
T Consensus       110 ~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  186 (287)
T cd07848         110 IKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWS  186 (287)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHh
Confidence            99999999   779999999999999999999999999999765321             23477777778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcC--CchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALP--NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||++|||++|+.||...... ...........+  ..........  ............................+.++
T Consensus       187 lGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl  263 (287)
T cd07848         187 VGCILGELSDGQPLFPGESEI-DQLFTIQKVLGPLPAEQMKLFYSN--PRFHGLRFPAVNHPQSLERRYLGILSGVLLDL  263 (287)
T ss_pred             HHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhCCCCHHHHHhhhcc--chhcccccCcccCcccHHHhhhcccCHHHHHH
Confidence            999999999999998642111 111111111111  0000000000  00000000000000000000011234568899


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||++|+++
T Consensus       264 l~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         264 MKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHHHccCCcccCCCHHHHhc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-32  Score=251.64  Aligned_cols=213  Identities=21%  Similarity=0.340  Sum_probs=162.1

Q ss_pred             hHHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC------ccccCCcccCHH
Q 040999          116 IFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED------ETYERPRNLNLL  188 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~  188 (382)
                      ...++.+|++++.++ +|+||+++++++..     .+..+++|||+++|+|.+++.......      ........+++.
T Consensus        58 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~  132 (293)
T cd05053          58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK  132 (293)
T ss_pred             HHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-----CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHH
Confidence            345688999999999 89999999998643     667899999999999999986432110      001234568999


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGN  254 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~  254 (382)
                      .++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..              ....||...+.
T Consensus       133 ~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  209 (293)
T cd05053         133 DLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR  209 (293)
T ss_pred             HHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC
Confidence            99999999999999999   77999999999999999999999999999975432              12347776777


Q ss_pred             CCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHH
Q 040999          255 EVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII  333 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (382)
                      .++.++|||||||++|||++ |..||....     ..+.....         ........                  ..
T Consensus       210 ~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~~---------~~~~~~~~------------------~~  257 (293)
T cd05053         210 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VEELFKLL---------KEGYRMEK------------------PQ  257 (293)
T ss_pred             CcCcccceeehhhHHHHHhcCCCCCCCCCC-----HHHHHHHH---------HcCCcCCC------------------CC
Confidence            88999999999999999997 888875321     11111100         00000000                  00


Q ss_pred             HHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       334 ~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      .+...+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       258 ~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         258 NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            22346788999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-32  Score=259.40  Aligned_cols=195  Identities=21%  Similarity=0.294  Sum_probs=145.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|+||+++++++.     ..+..++||||+++|+|.+..              ..++..+..++.||
T Consensus       117 ~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi  177 (353)
T PLN00034        117 RQICREIEILRDVNHPNVVKCHDMFD-----HNGEIQVLLEFMDGGSLEGTH--------------IADEQFLADVARQI  177 (353)
T ss_pred             HHHHHHHHHHHhCCCCCcceeeeEec-----cCCeEEEEEecCCCCcccccc--------------cCCHHHHHHHHHHH
Confidence            56889999999999999999999853     467889999999999986533              24566778899999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc-----CCCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV-----GNEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~-----~~~~~~~~  260 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....            ...||...     +...+.++
T Consensus       178 ~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  254 (353)
T PLN00034        178 LSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAG  254 (353)
T ss_pred             HHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcch
Confidence            99999999   779999999999999999999999999999765322            22355432     23345689


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||||++|||++|+.||....  ...............         ....                  ......++.
T Consensus       255 DvwslGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~---------~~~~------------------~~~~~~~l~  305 (353)
T PLN00034        255 DIWSLGVSILEFYLGRFPFGVGR--QGDWASLMCAICMSQ---------PPEA------------------PATASREFR  305 (353)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCC--CccHHHHHHHHhccC---------CCCC------------------CCccCHHHH
Confidence            99999999999999999986221  111111111000000         0000                  002334678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +++.+||+.||++|||+.|+++.
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcC
Confidence            88889999999999999999875

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2e-32  Score=252.86  Aligned_cols=216  Identities=23%  Similarity=0.323  Sum_probs=161.9

Q ss_pred             HHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------cccCCcccCHHH
Q 040999          117 FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------TYERPRNLNLLR  189 (382)
Q Consensus       117 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~  189 (382)
                      .+.+.+|++++.++ +|+||+++++++.     ..+..++||||+++|+|.+++........      .......+++..
T Consensus        51 ~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~  125 (303)
T cd05088          51 HRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ  125 (303)
T ss_pred             HHHHHHHHHHHHHhcCCCCcceEEEEEC-----CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHH
Confidence            35788999999999 8999999999964     36778999999999999999864321100      001224688999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC-----------CCCCCCccccCCCCCc
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-----------PTRTQTKYGVGNEVST  258 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~-----------~~~~~~~~~~~~~~~~  258 (382)
                      ++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...           .....||...+..++.
T Consensus       126 ~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  202 (303)
T cd05088         126 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT  202 (303)
T ss_pred             HHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcc
Confidence            9999999999999999   7799999999999999999999999999986321           1133466666677889


Q ss_pred             cchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          259 IGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       259 ~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      ++|||||||++|||+| |..||.....     ....... +.        ......                  ......
T Consensus       203 ~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~-~~--------~~~~~~------------------~~~~~~  250 (303)
T cd05088         203 NSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKL-PQ--------GYRLEK------------------PLNCDD  250 (303)
T ss_pred             cccchhhhhHHHHHHhcCCCCcccCCh-----HHHHHHH-hc--------CCcCCC------------------CCCCCH
Confidence            9999999999999998 9999853211     1111100 00        000000                  001223


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhc
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  372 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~  372 (382)
                      .+.+++.+||+.+|++||++.++++.|.++.+...
T Consensus       251 ~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         251 EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            57788889999999999999999999998766543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-32  Score=251.27  Aligned_cols=210  Identities=20%  Similarity=0.360  Sum_probs=158.0

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC-------ccccCCcccCHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED-------ETYERPRNLNLLR  189 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~~l~~~~  189 (382)
                      .+.+.+|++++++++||||+++++++.     .....++||||+++++|.+++.......       ........+++..
T Consensus        51 ~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  125 (283)
T cd05090          51 WGEFQQEASLMAELHHPNIVCLLGVVT-----QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD  125 (283)
T ss_pred             HHHHHHHHHHHhhCCCCCeeeEEEEEe-----cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHH
Confidence            357889999999999999999999854     3677899999999999999885322100       0001123588899


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCC
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNE  255 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~  255 (382)
                      .+.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....              ...||+..+..
T Consensus       126 ~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  202 (283)
T cd05090         126 FLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK  202 (283)
T ss_pred             HHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCC
Confidence            9999999999999999   779999999999999999999999999999754221              23466666677


Q ss_pred             CCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          256 VSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ++.++|||||||++|||++ |..||....  .....+.....   .        ....+                   ..
T Consensus       203 ~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~---~--------~~~~~-------------------~~  250 (283)
T cd05090         203 FSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQEVIEMVRKR---Q--------LLPCS-------------------ED  250 (283)
T ss_pred             CCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcC---C--------cCCCC-------------------CC
Confidence            8999999999999999998 888975321  11111111100   0        00000                   02


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      +...+.+++.+||+.+|++||++.++.++|+.
T Consensus       251 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         251 CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            23467788889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=258.56  Aligned_cols=194  Identities=20%  Similarity=0.212  Sum_probs=150.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        38 ~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi  102 (312)
T cd05585          38 THTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFINGGELFHHLQ----------REGRFDLSRARFYTAEL  102 (312)
T ss_pred             HHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            56788999999999999999998854     3678999999999999999884          23458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++....            ...+||...+..++.++|||||
T Consensus       103 ~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  179 (312)
T cd05585         103 LCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL  179 (312)
T ss_pred             HHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceech
Confidence            99999999   78999999999999999999999999999875321            2234777777788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||...     .............        .. .+                   ......+.+++.+
T Consensus       180 Gvil~el~tg~~pf~~~-----~~~~~~~~~~~~~--------~~-~~-------------------~~~~~~~~~li~~  226 (312)
T cd05585         180 GVLLYEMLTGLPPFYDE-----NVNEMYRKILQEP--------LR-FP-------------------DGFDRDAKDLLIG  226 (312)
T ss_pred             hHHHHHHHhCCCCcCCC-----CHHHHHHHHHcCC--------CC-CC-------------------CcCCHHHHHHHHH
Confidence            99999999999998632     1111111111100        00 00                   0122356778889


Q ss_pred             cCCCCccCCCC---HHHHHH
Q 040999          346 CSMESPQDRMK---MTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs---~~evl~  362 (382)
                      ||+.||++||+   +.|++.
T Consensus       227 ~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         227 LLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HcCCCHHHcCCCCCHHHHHc
Confidence            99999999985   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.8e-32  Score=256.43  Aligned_cols=147  Identities=22%  Similarity=0.308  Sum_probs=128.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||++++++|..     .+..++||||+++|+|.+++.          ....+++.....++.|+
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~l  112 (333)
T cd06650          48 NQIIRELQVLHECNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIAV  112 (333)
T ss_pred             HHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            568999999999999999999999754     678999999999999999983          23457888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      +.||.|||+  ..+|+||||||+|||++.++.+||+|||++.....          ...+||...+..++.++|||||||
T Consensus       113 ~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~  190 (333)
T cd06650         113 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL  190 (333)
T ss_pred             HHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHH
Confidence            999999994  24799999999999999999999999999875422          234477777778899999999999


Q ss_pred             HHHHHHhcCCCCCc
Q 040999          268 LLLELMIREKPSDI  281 (382)
Q Consensus       268 il~elltg~~p~~~  281 (382)
                      ++|||++|+.||..
T Consensus       191 il~~l~~g~~p~~~  204 (333)
T cd06650         191 SLVEMAIGRYPIPP  204 (333)
T ss_pred             HHHHHHHCCCCCCC
Confidence            99999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-33  Score=262.89  Aligned_cols=204  Identities=18%  Similarity=0.325  Sum_probs=160.4

Q ss_pred             chhhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHH
Q 040999          113 AFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLN  192 (382)
Q Consensus       113 avK~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~  192 (382)
                      +-+-+++|..|+++|+.|+|+|||++|.++.+.   .....-+|+|.+..|+|..|+          .+.+.++......
T Consensus        81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~in~iTEL~TSGtLr~Y~----------kk~~~vn~kaik~  147 (632)
T KOG0584|consen   81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTINFITELFTSGTLREYR----------KKHRRVNIKAIKS  147 (632)
T ss_pred             ChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCceeeeeeecccCCcHHHHH----------HHhccCCHHHHHH
Confidence            444558899999999999999999999997652   245678999999999999999          3456788899999


Q ss_pred             HHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCCCC----------CCCCccccCCCCCccch
Q 040999          193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLPPT----------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       193 i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~~~~~~D  261 (382)
                      |++||++||.|||++ .++|+|||||-+||+|+.+ |.+||+|+|+|..+...          .++||.. ...|++.+|
T Consensus       148 W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmY-EE~YnE~VD  225 (632)
T KOG0584|consen  148 WCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMY-EENYNELVD  225 (632)
T ss_pred             HHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHH-hhhcchhhh
Confidence            999999999999987 8999999999999999875 89999999999876433          2234433 378899999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++++||+|+..||..    ..+..+..+...+..-.+.+.+.-                          -.++.+
T Consensus       226 VYaFGMCmLEMvT~eYPYsE----C~n~AQIYKKV~SGiKP~sl~kV~--------------------------dPevr~  275 (632)
T KOG0584|consen  226 VYAFGMCMLEMVTSEYPYSE----CTNPAQIYKKVTSGIKPAALSKVK--------------------------DPEVRE  275 (632)
T ss_pred             hhhhhHHHHHHHhccCChhh----hCCHHHHHHHHHcCCCHHHhhccC--------------------------CHHHHH
Confidence            99999999999999999763    344444444433332111111110                          125677


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+|+.. .++|||+.|++.
T Consensus       276 fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  276 FIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHHhcC-chhccCHHHHhh
Confidence            77799999 999999999985

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9e-33  Score=255.18  Aligned_cols=147  Identities=25%  Similarity=0.377  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+++++.++||||+++++++.     +....++||||++ ++|.+++.         .....+++..+..++.|+
T Consensus        48 ~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi  112 (303)
T cd07869          48 FTAIREASLLKGLKHANIVLLHDIIH-----TKETLTLVFEYVH-TDLCQYMD---------KHPGGLHPENVKLFLFQL  112 (303)
T ss_pred             hhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeEEEEEECCC-cCHHHHHH---------hCCCCCCHHHHHHHHHHH
Confidence            35788999999999999999999854     3678999999995 67777773         223458888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++....            ...+||...+ ..++.++||||
T Consensus       113 ~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  189 (303)
T cd07869         113 LRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWG  189 (303)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHH
Confidence            99999999   77999999999999999999999999999874321            1233665443 45788999999


Q ss_pred             HHHHHHHHHhcCCCCCcc
Q 040999          265 YGILLLELMIREKPSDIM  282 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~  282 (382)
                      +||++|||+||+.||...
T Consensus       190 lG~il~~l~~g~~pf~~~  207 (303)
T cd07869         190 VGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             HHHHHHHHHhCCCCCCCC
Confidence            999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.5e-32  Score=247.55  Aligned_cols=202  Identities=23%  Similarity=0.400  Sum_probs=158.6

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+.++++++||||+++++++.     ..+..++||||+++++|.+++..         ....+++..+..++.|
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~~  114 (267)
T cd05066          49 RRDFLSEASIMGQFDHPNIIHLEGVVT-----KSKPVMIVTEYMENGSLDAFLRK---------HDGQFTVIQLVGMLRG  114 (267)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCccEEEEEcCCCCCHHHHHHh---------cCCCCCHHHHHHHHHH
Confidence            467899999999999999999999864     36778999999999999999842         2345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~D  261 (382)
                      ++.||+|||   +.+++||||||+||+++.++.+|++|||.+......               ...||...+..++.++|
T Consensus       115 i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~D  191 (267)
T cd05066         115 IASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASD  191 (267)
T ss_pred             HHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhh
Confidence            999999999   789999999999999999999999999998754321               23466666677899999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||+++||+++ |+.||.....  ............           ....                   ...+..+.
T Consensus       192 v~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~~~~-----------~~~~-------------------~~~~~~~~  239 (267)
T cd05066         192 VWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIEEGYR-----------LPAP-------------------MDCPAALH  239 (267)
T ss_pred             hHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHhCCCc-----------CCCC-------------------CCCCHHHH
Confidence            9999999999886 9999764211  111111110000           0000                   02234678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +++.+||+.+|.+||+|.++++.|+++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-32  Score=250.92  Aligned_cols=205  Identities=22%  Similarity=0.327  Sum_probs=156.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..|.+|+.++++++|+||+++++++..     ....++||||+++++|.+++......   ......+++..++.++.||
T Consensus        54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~g~~L~~~i~~~~~~---~~~~~~~~~~~~~~~~~qi  125 (277)
T cd05036          54 SDFLMEALIMSKFNHQNIVRLIGVSFE-----RLPRFILLELMAGGDLKSFLRENRPR---PERPSSLTMKDLLFCARDV  125 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCcEEEEecCCCCCHHHHHHHhCCC---CCCCCCCCHHHHHHHHHHH
Confidence            468999999999999999999998643     56678999999999999998643211   1123468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCC---cEEEccccccccCCC--------------CCCCCccccCCCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDM---TARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~  260 (382)
                      +.||+|||   +.+++||||||+||+++.++   .+||+|||+++....              ....||...+..++.++
T Consensus       126 ~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  202 (277)
T cd05036         126 AKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKT  202 (277)
T ss_pred             HHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchh
Confidence            99999999   77999999999999998754   599999999975421              12347777777899999


Q ss_pred             hhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          261 DVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       261 Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      |||||||++|||++ |+.||+....     .....         .+.........                  ...+..+
T Consensus       203 DiwslG~il~el~~~g~~pf~~~~~-----~~~~~---------~~~~~~~~~~~------------------~~~~~~~  250 (277)
T cd05036         203 DVWSFGVLLWEIFSLGYMPYPGRTN-----QEVME---------FVTGGGRLDPP------------------KGCPGPV  250 (277)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH---------HHHcCCcCCCC------------------CCCCHHH
Confidence            99999999999997 9999864211     11111         01000000000                  0223467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      .+++.+||+.+|++|||+.+|++.|+
T Consensus       251 ~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         251 YRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            88889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.8e-32  Score=251.62  Aligned_cols=215  Identities=22%  Similarity=0.352  Sum_probs=163.3

Q ss_pred             HHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------cccCCcccCHHH
Q 040999          117 FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------TYERPRNLNLLR  189 (382)
Q Consensus       117 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~  189 (382)
                      ..++.+|+++++++ +||||++++++|..     ....++||||+++|+|.+++........      .......+++..
T Consensus        61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~  135 (314)
T cd05099          61 LADLISEMELMKLIGKHKNIINLLGVCTQ-----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD  135 (314)
T ss_pred             HHHHHHHHHHHHhccCCCCeeeEEEEEcc-----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHH
Confidence            45788999999999 69999999998653     5678999999999999999864321100      011234689999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCC
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNE  255 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~  255 (382)
                      +..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||.++....              ....||...+..
T Consensus       136 ~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  212 (314)
T cd05099         136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV  212 (314)
T ss_pred             HHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC
Confidence            9999999999999999   77999999999999999999999999999975432              133466666777


Q ss_pred             CCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          256 VSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ++.++|||||||++|||++ |..||....     ..............+        .+                   ..
T Consensus       213 ~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~~~~--------~~-------------------~~  260 (314)
T cd05099         213 YTHQSDVWSFGILMWEIFTLGGSPYPGIP-----VEELFKLLREGHRMD--------KP-------------------SN  260 (314)
T ss_pred             cCccchhhHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCCCC--------CC-------------------CC
Confidence            8999999999999999999 888875321     111111100000000        00                   02


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      +..++.+++.+||+.+|++|||+.|+++.|+++....
T Consensus       261 ~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         261 CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            2346778889999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.7e-32  Score=250.70  Aligned_cols=209  Identities=18%  Similarity=0.271  Sum_probs=158.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC------ccccCCcccCHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED------ETYERPRNLNLLRRL  191 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~  191 (382)
                      +.+.+|+.++++++||||+++++++..     ....++++||+++++|.+++.......      ........+++..+.
T Consensus        53 ~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  127 (283)
T cd05091          53 EEFKHEAMMRSRLQHPNIVCLLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV  127 (283)
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEcC-----CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHH
Confidence            568899999999999999999999643     567899999999999999985321110      001123458889999


Q ss_pred             HHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCC
Q 040999          192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVS  257 (382)
Q Consensus       192 ~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~  257 (382)
                      .++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....              ....||...+..++
T Consensus       128 ~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  204 (283)
T cd05091         128 HIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS  204 (283)
T ss_pred             HHHHHHHHHHHHHH---HcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC
Confidence            99999999999999   77999999999999999999999999999875421              23346666677789


Q ss_pred             ccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          258 TIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       258 ~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      .++|||||||++|||+| |..||....     ...+..........         ..                  ..+++
T Consensus       205 ~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~i~~~~~~---------~~------------------~~~~~  252 (283)
T cd05091         205 IDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVIEMIRNRQVL---------PC------------------PDDCP  252 (283)
T ss_pred             cchhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHcCCcC---------CC------------------CCCCC
Confidence            99999999999999998 888875321     11111111110000         00                  01344


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHHHHHH
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      ..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       253 ~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         253 AWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-32  Score=249.62  Aligned_cols=208  Identities=20%  Similarity=0.340  Sum_probs=158.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+++++.++|+||+++++++..     ....++||||+++|+|.+++...............+++..++.++.|+
T Consensus        54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i  128 (277)
T cd05032          54 IEFLNEASVMKEFNCHHVVRLLGVVST-----GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI  128 (277)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEcC-----CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHH
Confidence            568899999999999999999999643     577899999999999999986433211111123457899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||+++....              ....||...+..++.++|||
T Consensus       129 ~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  205 (277)
T cd05032         129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVW  205 (277)
T ss_pred             HHHHHHHH---hCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchH
Confidence            99999999   78999999999999999999999999999875422              12346666667789999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||++||++| |+.||....  .........   ...        ....+                   ..+...+.++
T Consensus       206 slG~il~el~t~g~~p~~~~~--~~~~~~~~~---~~~--------~~~~~-------------------~~~~~~~~~l  253 (277)
T cd05032         206 SFGVVLWEMATLAEQPYQGLS--NEEVLKFVI---DGG--------HLDLP-------------------ENCPDKLLEL  253 (277)
T ss_pred             HHHHHHHHhhccCCCCCccCC--HHHHHHHHh---cCC--------CCCCC-------------------CCCCHHHHHH
Confidence            99999999998 898975321  111111111   000        00000                   0123467889


Q ss_pred             hhccCCCCccCCCCHHHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      +.+||+.+|++|||+.++++.|+
T Consensus       254 i~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         254 MRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHcCCChhhCCCHHHHHHHhc
Confidence            99999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.3e-32  Score=248.05  Aligned_cols=202  Identities=21%  Similarity=0.388  Sum_probs=158.6

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .++|..|++++++++||||+++++++.     .....++||||+++++|.+++..         ....+++..++.++.|
T Consensus        49 ~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~  114 (269)
T cd05065          49 RRDFLSEASIMGQFDHPNIIHLEGVVT-----KSRPVMIITEFMENGALDSFLRQ---------NDGQFTVIQLVGMLRG  114 (269)
T ss_pred             HHHHHHHHHHHHhCCCcCcceEEEEEC-----CCCceEEEEecCCCCcHHHHHhh---------CCCCCCHHHHHHHHHH
Confidence            367999999999999999999999854     36778999999999999998842         2345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------------CCCCccccCCCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------------RTQTKYGVGNEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------------~~~~~~~~~~~~~~~  259 (382)
                      ++.||+|||   +.+++|+||||+||+++.++.+||+|||++......                 ...||...+..++.+
T Consensus       115 l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  191 (269)
T cd05065         115 IAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA  191 (269)
T ss_pred             HHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccch
Confidence            999999999   779999999999999999999999999998754321                 234666667778999


Q ss_pred             chhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +|||||||++||+++ |..||.....  ...........            ....                  ..+++..
T Consensus       192 ~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~------------~~~~------------------~~~~~~~  239 (269)
T cd05065         192 SDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDY------------RLPP------------------PMDCPTA  239 (269)
T ss_pred             hhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCC------------cCCC------------------cccCCHH
Confidence            999999999999886 9999764211  11111111000            0000                  0133456


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +.+++.+||+.+|.+||++++|+..|+++
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            78889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.5e-32  Score=248.29  Aligned_cols=216  Identities=21%  Similarity=0.377  Sum_probs=165.4

Q ss_pred             hhhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHH
Q 040999          114 FKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNI  193 (382)
Q Consensus       114 vK~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i  193 (382)
                      .+..+.+.+|+.++++++|+||+++++++..    .....++++||+++|+|.+++.......  ......+++..++.+
T Consensus        49 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i  122 (280)
T cd05043          49 EIQVTLLLQESCLLYGLSHQNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHM  122 (280)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----CCCCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHH
Confidence            3445778999999999999999999998753    3567899999999999999985432110  112356899999999


Q ss_pred             HHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCcc
Q 040999          194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTI  259 (382)
Q Consensus       194 ~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~  259 (382)
                      +.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.+...              ...||...+..++.+
T Consensus       123 ~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~  199 (280)
T cd05043         123 AIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA  199 (280)
T ss_pred             HHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch
Confidence            999999999999   779999999999999999999999999999855321              234666666778999


Q ss_pred             chhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +|||||||++||+++ |+.||....  ...+..+.......            ..                  ...++..
T Consensus       200 ~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~------------~~------------------~~~~~~~  247 (280)
T cd05043         200 SDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLKDGYRL------------AQ------------------PINCPDE  247 (280)
T ss_pred             hhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHHcCCCC------------CC------------------CCcCCHH
Confidence            999999999999999 999986421  11111111110000            00                  0022346


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +.+++.+||+.+|++|||+.++++.|+++...
T Consensus       248 ~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         248 LFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            78889999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-32  Score=251.88  Aligned_cols=220  Identities=23%  Similarity=0.373  Sum_probs=163.0

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.|.+|+++++.++|+||+++++++..   .+....++||||+++++|.+++..         ....+++..+..++.
T Consensus        49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~l~~---------~~~~~~~~~~~~~~~  116 (284)
T cd05038          49 HRSDFEREIEILRTLDHENIVKYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQR---------HRDQINLKRLLLFSS  116 (284)
T ss_pred             HHHHHHHHHHHHHhCCCCChheEEeeeec---CCCCceEEEEecCCCCCHHHHHHh---------CccccCHHHHHHHHH
Confidence            45689999999999999999999998643   335678999999999999999842         223589999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIG  260 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~  260 (382)
                      |++.||+|||   +.+++|+||||+||+++.++.+||+|||.+......               ...||...+..++.++
T Consensus       117 ~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~  193 (284)
T cd05038         117 QICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSAS  193 (284)
T ss_pred             HHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCccc
Confidence            9999999999   779999999999999999999999999999876521               2236666667788999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC-chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      ||||||+++|||+||+.|+.........   +....... ....+.+ .+....         ..     .....++.++
T Consensus       194 Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~---------~~-----~~~~~~~~~~  255 (284)
T cd05038         194 DVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE-LLKEGE---------RL-----PRPPSCPDEV  255 (284)
T ss_pred             chHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH-HHHcCC---------cC-----CCCccCCHHH
Confidence            9999999999999999997542211100   00000000 0001100 000000         00     0001234578


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      .+++.+||+.+|++||||.||+++|++++
T Consensus       256 ~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         256 YDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            89999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.8e-33  Score=259.57  Aligned_cols=203  Identities=26%  Similarity=0.358  Sum_probs=166.4

Q ss_pred             cccCCchhhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCH
Q 040999          108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNL  187 (382)
Q Consensus       108 ~~~~~avK~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~  187 (382)
                      .+.+++-|-++.+.+|++++++++|||||.++++     |+...+.|+|.|||.+ +|..+|          ...+.+++
T Consensus        36 ~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~~vVte~a~g-~L~~il----------~~d~~lpE   99 (808)
T KOG0597|consen   36 DKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHLWVVTEYAVG-DLFTIL----------EQDGKLPE   99 (808)
T ss_pred             hhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceEEEEehhhhh-hHHHHH----------HhccCCCH
Confidence            3556677888999999999999999999999998     5668999999999976 999999          45677999


Q ss_pred             HHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCC
Q 040999          188 LRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNE  255 (382)
Q Consensus       188 ~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~  255 (382)
                      +.+..++.|++.||.|||   +.+|+|||+||.|||+++.+.+|++|||+|+.+...            +++||...+..
T Consensus       100 e~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~p  176 (808)
T KOG0597|consen  100 EQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQP  176 (808)
T ss_pred             HHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCC
Confidence            999999999999999999   889999999999999999999999999999976432            34577778889


Q ss_pred             CCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          256 VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      |+..+|.||+|||+||+++|++||..                 ..+..++..++..+...                ....
T Consensus       177 yd~~sDlWslGcilYE~~~G~PPF~a-----------------~si~~Lv~~I~~d~v~~----------------p~~~  223 (808)
T KOG0597|consen  177 YDHTSDLWSLGCILYELYVGQPPFYA-----------------RSITQLVKSILKDPVKP----------------PSTA  223 (808)
T ss_pred             ccchhhHHHHHHHHHHHhcCCCCchH-----------------HHHHHHHHHHhcCCCCC----------------cccc
Confidence            99999999999999999999999852                 12222333322221110                0133


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ...+..+....+++||.+|.|..+++.
T Consensus       224 S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  224 SSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            446677777999999999999999874

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-32  Score=251.24  Aligned_cols=215  Identities=24%  Similarity=0.410  Sum_probs=158.6

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++++..   .+....++||||+++++|.+++..         ....+++..+..++.|
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~~  117 (284)
T cd05079          50 IADLKKEIEILRNLYHENIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPR---------NKNKINLKQQLKYAVQ  117 (284)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCCceEEEEEccCCCCHHHHHHh---------ccCCCCHHHHHHHHHH
Confidence            3678999999999999999999998753   224568999999999999999842         2235899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~D  261 (382)
                      ++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....               ...||...+..++.++|
T Consensus       118 i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D  194 (284)
T cd05079         118 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASD  194 (284)
T ss_pred             HHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCcccc
Confidence            999999999   779999999999999999999999999998754321               23366666677889999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC----chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN----HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      ||||||++|||+|++.|......      .......+.    .....+.....         +...+      ....+..
T Consensus       195 i~slG~il~ellt~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~------~~~~~~~  253 (284)
T cd05079         195 VWSFGVTLYELLTYCDSESSPMT------LFLKMIGPTHGQMTVTRLVRVLEE---------GKRLP------RPPNCPE  253 (284)
T ss_pred             chhhhhhhhhhhcCCCCCccccc------hhhhhcccccccccHHHHHHHHHc---------CccCC------CCCCCCH
Confidence            99999999999998876432111      000000000    00000000000         00000      0012345


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      .+.+++.+||+.+|++|||+.++++.|+++
T Consensus       254 ~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         254 EVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            788899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.8e-33  Score=259.28  Aligned_cols=195  Identities=21%  Similarity=0.258  Sum_probs=152.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++.     ..+..++||||+++|+|..++.          ....+++..+..++.||
T Consensus        40 ~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~----------~~~~l~~~~~~~~~~qi  104 (328)
T cd05593          40 AHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVMEYVNGGELFFHLS----------RERVFSEDRTRFYGAEI  104 (328)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            56788999999999999999998854     4778999999999999988873          33468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++...            .....||...+..++.++|||||
T Consensus       105 ~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  181 (328)
T cd05593         105 VSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  181 (328)
T ss_pred             HHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCcccc
Confidence            99999999   7899999999999999999999999999987532            12334777777788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....     .............      .+.                      .....++.+++.+
T Consensus       182 Gvil~elltG~~Pf~~~~-----~~~~~~~~~~~~~------~~p----------------------~~~~~~~~~li~~  228 (328)
T cd05593         182 GVVMYEMMCGRLPFYNQD-----HEKLFELILMEDI------KFP----------------------RTLSADAKSLLSG  228 (328)
T ss_pred             chHHHHHhhCCCCCCCCC-----HHHHHHHhccCCc------cCC----------------------CCCCHHHHHHHHH
Confidence            999999999999985321     1111111110000      000                      0122356778889


Q ss_pred             cCCCCccCCC-----CHHHHHHH
Q 040999          346 CSMESPQDRM-----KMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RP-----s~~evl~~  363 (382)
                      ||+.||++||     ++.|+++.
T Consensus       229 ~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         229 LLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HcCCCHHHcCCCCCCCHHHHhcC
Confidence            9999999997     88998854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.8e-32  Score=250.46  Aligned_cols=214  Identities=20%  Similarity=0.345  Sum_probs=162.4

Q ss_pred             HHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcc------ccCCcccCHHH
Q 040999          117 FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET------YERPRNLNLLR  189 (382)
Q Consensus       117 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~  189 (382)
                      .+++.+|+++++.+ +||||+++++++..     ....++||||+++|+|.+++.........      ......+++..
T Consensus        64 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (304)
T cd05101          64 LSDLVSEMEMMKMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD  138 (304)
T ss_pred             HHHHHHHHHHHHhhccCCCchheeEEEec-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHH
Confidence            46789999999999 89999999998643     66789999999999999998643211100      01234688999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCC
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNE  255 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~  255 (382)
                      +..++.||++||.|||   +.+++||||||+||+++.++.+||+|||.++....              ....||...+..
T Consensus       139 ~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  215 (304)
T cd05101         139 LVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV  215 (304)
T ss_pred             HHHHHHHHHHHHHHHH---HCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC
Confidence            9999999999999999   77999999999999999999999999999875432              123466666777


Q ss_pred             CCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          256 VSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ++.++||||||+++|||++ |..||...     ....+........         ....                  ...
T Consensus       216 ~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~~~~~---------~~~~------------------~~~  263 (304)
T cd05101         216 YTHQSDVWSFGVLMWEIFTLGGSPYPGI-----PVEELFKLLKEGH---------RMDK------------------PAN  263 (304)
T ss_pred             CCchhhHHHHHHHHHHHHcCCCCCcccC-----CHHHHHHHHHcCC---------cCCC------------------CCC
Confidence            8999999999999999998 77886532     1111111110000         0000                  002


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +...+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus       264 ~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         264 CTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            345678888899999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-32  Score=246.59  Aligned_cols=208  Identities=21%  Similarity=0.268  Sum_probs=149.2

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ...|.+|+++++.++|+||+++++.|..     ....++||||+++|+|.+++.....     ......++.....++.|
T Consensus        39 ~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~q  108 (269)
T cd05042          39 QLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLEFCPLGDLKNYLRSNRG-----MVAQMAQKDVLQRMACE  108 (269)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEEeCCCCcHHHHHHhccc-----cccccccHHHHHHHHHH
Confidence            3568899999999999999999998653     6778999999999999999854321     11233567888999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCcccc-------CCC
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGV-------GNE  255 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~-------~~~  255 (382)
                      |+.||+|||   +.+|+||||||+|||++.++.+||+|||++......              ...||...       ...
T Consensus       109 i~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~  185 (269)
T cd05042         109 VASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKD  185 (269)
T ss_pred             HHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccc
Confidence            999999999   779999999999999999999999999998643211              22344421       235


Q ss_pred             CCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          256 VSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ++.++|||||||++|||++ |..||.....    .... ..........+..+...                      ..
T Consensus       186 ~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~-~~~~~~~~~~~~~~~~~----------------------~~  238 (269)
T cd05042         186 QTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQVL-KQVVREQDIKLPKPQLD----------------------LK  238 (269)
T ss_pred             cchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHH-HHHhhccCccCCCCccc----------------------cc
Confidence            6789999999999999999 7788753211    1110 00000000000010000                      02


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      ....+.+++..|| .||++|||+++|++.|.
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2334566777898 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.5e-32  Score=245.03  Aligned_cols=210  Identities=20%  Similarity=0.275  Sum_probs=150.1

Q ss_pred             hhhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHH
Q 040999          114 FKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNI  193 (382)
Q Consensus       114 vK~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i  193 (382)
                      .+..+.|.+|+.+++.++||||+++++.|..     ....++||||+++|+|.+++....      ......++.....+
T Consensus        36 ~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~  104 (268)
T cd05086          36 SKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFEYCELGDLKSYLSQEQ------WHRRNSQLLLLQRM  104 (268)
T ss_pred             hHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEecCCCCcHHHHHHhhh------cccccccHHHHHHH
Confidence            3445789999999999999999999999753     567899999999999999985421      11234677788899


Q ss_pred             HHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC--------------CCCCCCcccc-------
Q 040999          194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP--------------PTRTQTKYGV-------  252 (382)
Q Consensus       194 ~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~--------------~~~~~~~~~~-------  252 (382)
                      +.||++||+|||   +.+++||||||+|||++.++.+||+|||++....              .....||...       
T Consensus       105 ~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  181 (268)
T cd05086         105 ACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLI  181 (268)
T ss_pred             HHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccc
Confidence            999999999999   7799999999999999999999999999986421              1123355432       


Q ss_pred             CCCCCccchhHHHHHHHHHHHhc-CCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 GNEVSTIGDVYSYGILLLELMIR-EKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      ...++.++|||||||++|||+++ ..||....    . ..............+.++.+..                    
T Consensus       182 ~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~--------------------  236 (268)
T cd05086         182 TAEQTKPSNVWALGVTLWELFENAAQPYSHLS----D-REVLNHVIKDQQVKLFKPQLEL--------------------  236 (268)
T ss_pred             cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC----H-HHHHHHHHhhcccccCCCccCC--------------------
Confidence            22457899999999999999974 66765321    1 1111111111111111111110                    


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                        .....+.+++..|| .+|.+||++++|++.|.
T Consensus       237 --~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         237 --PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             --CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence              11234566777899 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.7e-32  Score=251.60  Aligned_cols=214  Identities=22%  Similarity=0.347  Sum_probs=162.7

Q ss_pred             HHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------cccCCcccCHHH
Q 040999          117 FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------TYERPRNLNLLR  189 (382)
Q Consensus       117 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~  189 (382)
                      .+++.+|+++++++ +|+||++++++|..     .+..++||||+++|+|.+++........      .......+++..
T Consensus        67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~  141 (307)
T cd05098          67 LSDLISEMEMMKMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD  141 (307)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHH
Confidence            45788999999999 79999999999653     5678999999999999999964321100      001224589999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCC
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNE  255 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~  255 (382)
                      ++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||.++....              ....||...+..
T Consensus       142 ~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  218 (307)
T cd05098         142 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI  218 (307)
T ss_pred             HHHHHHHHHHHHHHHH---HCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC
Confidence            9999999999999999   77999999999999999999999999999875421              233466666777


Q ss_pred             CCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          256 VSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ++.++|||||||++|||++ |..||...     ............         .....                  ...
T Consensus       219 ~~~~~DvwslG~~l~el~~~g~~p~~~~-----~~~~~~~~~~~~---------~~~~~------------------~~~  266 (307)
T cd05098         219 YTHQSDVWSFGVLLWEIFTLGGSPYPGV-----PVEELFKLLKEG---------HRMDK------------------PSN  266 (307)
T ss_pred             CCcHHHHHHHHHHHHHHHcCCCCCCCcC-----CHHHHHHHHHcC---------CCCCC------------------CCc
Confidence            8999999999999999998 88887531     111111111000         00000                  002


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      ...++.+++.+||+.+|++|||+.+|++.|+++...
T Consensus       267 ~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         267 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            334677888999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=252.73  Aligned_cols=196  Identities=19%  Similarity=0.217  Sum_probs=152.9

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++     .+....++||||+++|+|.+++.          ....+++.....++.|
T Consensus        45 ~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~q  109 (291)
T cd05612          45 EQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFLYMLMEYVPGGELFSYLR----------NSGRFSNSTGLFYASE  109 (291)
T ss_pred             HHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeEEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            35688999999999999999999884     34678999999999999999983          2346888999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccCCCCCccchhHHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....         ..+||...+..++.++|||||||
T Consensus       110 i~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~  186 (291)
T cd05612         110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGI  186 (291)
T ss_pred             HHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHH
Confidence            999999999   789999999999999999999999999998865332         33477777777899999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ++|||+||+.||....     ...........        ...  ...                  .....+.+++.+||
T Consensus       187 il~~l~~g~~pf~~~~-----~~~~~~~i~~~--------~~~--~~~------------------~~~~~~~~li~~~l  233 (291)
T cd05612         187 LIYEMLVGYPPFFDDN-----PFGIYEKILAG--------KLE--FPR------------------HLDLYAKDLIKKLL  233 (291)
T ss_pred             HHHHHHhCCCCCCCCC-----HHHHHHHHHhC--------CcC--CCc------------------cCCHHHHHHHHHHc
Confidence            9999999999986421     11111111000        000  000                  11235677888999


Q ss_pred             CCCccCCCC-----HHHHHHH
Q 040999          348 MESPQDRMK-----MTNVVHE  363 (382)
Q Consensus       348 ~~~p~~RPs-----~~evl~~  363 (382)
                      +.||.+||+     ++|+++.
T Consensus       234 ~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         234 VVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCCHHHccCCccCCHHHHhcC
Confidence            999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-32  Score=249.04  Aligned_cols=216  Identities=21%  Similarity=0.397  Sum_probs=156.7

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC--ccccCCcccCHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED--ETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~l~~~~~~~i~  194 (382)
                      .+.|.+|++++++++|+||+++++++..     ....++||||+++++|.+++.......  ........+++..++.++
T Consensus        61 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~  135 (295)
T cd05097          61 RNDFLKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMA  135 (295)
T ss_pred             HHHHHHHHHHHHhCCCCCcCeEEEEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHH
Confidence            3568999999999999999999999653     667899999999999999885321100  001112347889999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~  260 (382)
                      .|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....              ....||...+..++.++
T Consensus       136 ~~i~~al~~lH---~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  212 (295)
T cd05097         136 VQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS  212 (295)
T ss_pred             HHHHHHHHHHH---hcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchh
Confidence            99999999999   77999999999999999999999999999875422              12346666667789999


Q ss_pred             hhHHHHHHHHHHHh--cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          261 DVYSYGILLLELMI--REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       261 Dv~S~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      |||||||++|||++  +..||..... ......... ......    ........                   ...+..
T Consensus       213 DvwSlG~~l~el~~~~~~~p~~~~~~-~~~~~~~~~-~~~~~~----~~~~~~~~-------------------~~~~~~  267 (295)
T cd05097         213 DVWAFGVTLWEMFTLCKEQPYSLLSD-EQVIENTGE-FFRNQG----RQIYLSQT-------------------PLCPSP  267 (295)
T ss_pred             hHHHHHHHHHHHHHcCCCCCCcccCh-HHHHHHHHH-hhhhcc----ccccCCCC-------------------CCCCHH
Confidence            99999999999998  5667653211 000111000 000000    00000000                   012347


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      +.+++.+||+.+|++|||+.+|++.|+
T Consensus       268 l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         268 VFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-32  Score=249.06  Aligned_cols=208  Identities=22%  Similarity=0.373  Sum_probs=157.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC-----ccccCCcccCHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED-----ETYERPRNLNLLRRLN  192 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~l~~~~~~~  192 (382)
                      +.+.+|+++++.++|+||+++++++..     .+..+++|||+++++|.+++.......     ........+++..++.
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~  126 (280)
T cd05092          52 QDFQREAELLTVLQHQHIVRFYGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA  126 (280)
T ss_pred             HHHHHHHHHHhcCCCCCCceEEEEEec-----CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHH
Confidence            579999999999999999999998643     567899999999999999986432110     0011224588999999


Q ss_pred             HHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCc
Q 040999          193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVST  258 (382)
Q Consensus       193 i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~  258 (382)
                      ++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....              ....||...+..++.
T Consensus       127 ~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (280)
T cd05092         127 IASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT  203 (280)
T ss_pred             HHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCc
Confidence            9999999999999   77999999999999999999999999999864421              234477667778899


Q ss_pred             cchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          259 IGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       259 ~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      ++|||||||++|||++ |+.||.....  ........           .......+                   ..++.
T Consensus       204 ~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~-----------~~~~~~~~-------------------~~~~~  251 (280)
T cd05092         204 ESDIWSFGVVLWEIFTYGKQPWYQLSN--TEAIECIT-----------QGRELERP-------------------RTCPP  251 (280)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCccCCH--HHHHHHHH-----------cCccCCCC-------------------CCCCH
Confidence            9999999999999998 8999753211  01100000           00000000                   02234


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      .+.+++.+||+.||++||++.||++.|+
T Consensus       252 ~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         252 EVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            5778888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.98  E-value=2.6e-32  Score=255.03  Aligned_cols=145  Identities=21%  Similarity=0.263  Sum_probs=128.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        63 ~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  127 (329)
T PTZ00263         63 QHVAQEKSILMELSHPFIVNMMCSFQ-----DENRVYFLLEFVVGGELFTHLR----------KAGRFPNDVAKFYHAEL  127 (329)
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEE-----cCCEEEEEEcCCCCChHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            56889999999999999999999854     3778999999999999999884          23457888899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....         ..+||...+..++.++|||||||+
T Consensus       128 ~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  204 (329)
T PTZ00263        128 VLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVL  204 (329)
T ss_pred             HHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHH
Confidence            99999999   789999999999999999999999999999865432         234777777788999999999999


Q ss_pred             HHHHHhcCCCCC
Q 040999          269 LLELMIREKPSD  280 (382)
Q Consensus       269 l~elltg~~p~~  280 (382)
                      +|||+||+.||.
T Consensus       205 l~elltg~~pf~  216 (329)
T PTZ00263        205 LYEFIAGYPPFF  216 (329)
T ss_pred             HHHHHcCCCCCC
Confidence            999999999985

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=2.8e-32  Score=259.96  Aligned_cols=228  Identities=19%  Similarity=0.222  Sum_probs=157.7

Q ss_pred             chhhH--HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHH
Q 040999          113 AFKIF--KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRR  190 (382)
Q Consensus       113 avK~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~  190 (382)
                      |+|..  +.+.+|++++++++|||||++++++..     ....++|+|++. ++|..++.          ....+++..+
T Consensus       121 aiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e~~~-~~L~~~l~----------~~~~l~~~~~  184 (391)
T PHA03212        121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLILPRYK-TDLYCYLA----------AKRNIAICDI  184 (391)
T ss_pred             EEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEEecCC-CCHHHHHH----------hcCCCCHHHH
Confidence            77766  468899999999999999999998643     677899999995 68887773          2345889999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVS  257 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~  257 (382)
                      +.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....             ...+||...+..++
T Consensus       185 ~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  261 (391)
T PHA03212        185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYG  261 (391)
T ss_pred             HHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCC
Confidence            999999999999999   77999999999999999999999999999964321             12347777777889


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCcccc--CC----chHHHHHHHhcC------Cchhhhhhcccccchhhhhhccccchh
Q 040999          258 TIGDVYSYGILLLELMIREKPSDIMFE--GD----MNLHKFAKMALP------NHVKDIVDSILLNDDEKLVVRGDQKQT  325 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~~~~--~~----~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (382)
                      .++|||||||++|||+||+.||-....  +.    ..+.........      ......++................+  
T Consensus       262 ~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  339 (391)
T PHA03212        262 PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSR--  339 (391)
T ss_pred             cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCC--
Confidence            999999999999999999988642111  11    111111111110      0000000000000000000000000  


Q ss_pred             hhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          326 QAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                       .........+.++.+++.+||+.||++|||++|+++
T Consensus       340 -~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        340 -PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             -CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             001111234557888999999999999999999985

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=4.1e-32  Score=244.48  Aligned_cols=203  Identities=26%  Similarity=0.379  Sum_probs=159.2

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+++.+|+.++++++|+||+++++++..     ....++||||+++++|.+++...        ....+++..+..++.|
T Consensus        44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~q  110 (256)
T cd05039          44 AQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIVTEYMAKGSLVDYLRSR--------GRAVITLAQQLGFALD  110 (256)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHH
Confidence            3678999999999999999999999643     67789999999999999998431        1236899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccCCCCCccchhHHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      ++.||.|||   ..+++|+||||+||+++.++.+||+|||.++.....         ...||+..+..++.++||||||+
T Consensus       111 i~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~  187 (256)
T cd05039         111 VCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGI  187 (256)
T ss_pred             HHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHH
Confidence            999999999   779999999999999999999999999998865322         23477766777889999999999


Q ss_pred             HHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          268 LLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       268 il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      ++||+++ |..||....  ...+.........            ....                  ...+..+.+++.+|
T Consensus       188 il~~l~~~g~~p~~~~~--~~~~~~~~~~~~~------------~~~~------------------~~~~~~~~~li~~~  235 (256)
T cd05039         188 LLWEIYSFGRVPYPRIP--LKDVVPHVEKGYR------------MEAP------------------EGCPPEVYKVMKDC  235 (256)
T ss_pred             HHHHHHhcCCCCCCCCC--HHHHHHHHhcCCC------------CCCc------------------cCCCHHHHHHHHHH
Confidence            9999997 999975321  0111111100000            0000                  02234678888899


Q ss_pred             CCCCccCCCCHHHHHHHHHHh
Q 040999          347 SMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       347 l~~~p~~RPs~~evl~~L~~i  367 (382)
                      |..+|++|||++|++++|+++
T Consensus       236 l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         236 WELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             hccChhhCcCHHHHHHHHhcC
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.98  E-value=4.9e-32  Score=245.71  Aligned_cols=207  Identities=25%  Similarity=0.395  Sum_probs=157.9

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ...+.+|+++++.++||||++++++|..     ....++||||+++++|.+++.......   .....+++..++.++.|
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~  114 (269)
T cd05044          43 KKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLD  114 (269)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeEEEEeccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHH
Confidence            3578899999999999999999999653     567899999999999999985432110   12345789999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCC-----cEEEccccccccCCC--------------CCCCCccccCCCCC
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-----TARVGDFGLARFLPP--------------TRTQTKYGVGNEVS  257 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-----~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~  257 (382)
                      ++.||+|||   +.+++|+||||+||+++.++     .+|++|||+++....              ....||...+..++
T Consensus       115 l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  191 (269)
T cd05044         115 VAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT  191 (269)
T ss_pred             HHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcc
Confidence            999999999   77999999999999999877     899999999875421              12347777777889


Q ss_pred             ccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          258 TIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       258 ~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      .++|||||||++|||+| |+.||....  .........   ...         ....                  ....+
T Consensus       192 ~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~~---~~~---------~~~~------------------~~~~~  239 (269)
T cd05044         192 TQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHVT---AGG---------RLQK------------------PENCP  239 (269)
T ss_pred             cchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHHh---cCC---------ccCC------------------cccch
Confidence            99999999999999998 999975321  111111100   000         0000                  00234


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHHHHHH
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      ..+.+++.+||+.+|++||++.++++.|++
T Consensus       240 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         240 DKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            467888899999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.98  E-value=3e-32  Score=249.74  Aligned_cols=210  Identities=23%  Similarity=0.350  Sum_probs=158.0

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------------cccCCcc
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------------TYERPRN  184 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~  184 (382)
                      .+.+.+|++++++++||||++++++|..     ....++|+||+++|+|.+++........            .......
T Consensus        52 ~~~~~~ei~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  126 (288)
T cd05050          52 QADFQREAALMAEFDHPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP  126 (288)
T ss_pred             HHHHHHHHHHHHhcCCCchheEEEEEcC-----CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccc
Confidence            3678999999999999999999998643     5678999999999999999864321100            0112245


Q ss_pred             cCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCcc
Q 040999          185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKY  250 (382)
Q Consensus       185 l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~  250 (382)
                      +++..++.++.|++.||+|||   ..+++||||||+||+++.++.+||+|||.+......              ...||.
T Consensus       127 l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  203 (288)
T cd05050         127 LSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPES  203 (288)
T ss_pred             cCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHH
Confidence            889999999999999999999   779999999999999999999999999998753211              233666


Q ss_pred             ccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhh
Q 040999          251 GVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKI  329 (382)
Q Consensus       251 ~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (382)
                      ..+..++.++|||||||++|||++ |..||....     ..+.........        ....+                
T Consensus       204 ~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-----~~~~~~~~~~~~--------~~~~~----------------  254 (288)
T cd05050         204 IFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-----HEEVIYYVRDGN--------VLSCP----------------  254 (288)
T ss_pred             HhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhcCC--------CCCCC----------------
Confidence            666788999999999999999997 888875321     111111110000        00000                


Q ss_pred             hhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHH
Q 040999          330 NVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       330 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                         ...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       255 ---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         255 ---DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               0223467889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.98  E-value=7.5e-32  Score=244.04  Aligned_cols=209  Identities=21%  Similarity=0.271  Sum_probs=161.4

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++++..     .+..++||||+++|+|.+++....      .....+++..+..++.+
T Consensus        46 ~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~  114 (267)
T cd08224          46 RQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNELNIVLELADAGDLSRMIKHFK------KQKRLIPERTIWKYFVQ  114 (267)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCeEEEEEecCCCCCHHHHHHHhc------ccCCCcCHHHHHHHHHH
Confidence            3578899999999999999999999653     677899999999999998885322      22345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +++||+|||   +.+++||||||+||+++.++.++|+|||.+......            ...||...+..++.++||||
T Consensus       115 l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s  191 (267)
T cd08224         115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS  191 (267)
T ss_pred             HHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHH
Confidence            999999999   779999999999999999999999999998754321            23367666777889999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||...   ..............        .....+                  .......+.+++.
T Consensus       192 lG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~~--------~~~~~~------------------~~~~~~~~~~~i~  242 (267)
T cd08224         192 LGCLLYEMAALQSPFYGD---KMNLYSLCKKIEKC--------DYPPLP------------------ADHYSEELRDLVS  242 (267)
T ss_pred             HHHHHHHHHHCCCCcccC---CccHHHHHhhhhcC--------CCCCCC------------------hhhcCHHHHHHHH
Confidence            999999999999997532   11111111110000        000000                  0023346778888


Q ss_pred             ccCCCCccCCCCHHHHHHHHHHhh
Q 040999          345 ACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      +||..+|++|||+.+|+++|+++.
T Consensus       243 ~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         243 RCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHcCCCcccCCCHHHHHHHHHHhc
Confidence            999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.98  E-value=4.1e-32  Score=245.96  Aligned_cols=208  Identities=21%  Similarity=0.269  Sum_probs=159.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++++.++|+||+++++++..     .+..+++|||+++++|.+++....      .....+++..++.++.|+
T Consensus        47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~i  115 (267)
T cd08229          47 ADCIKEIDLLKQLNHPNVIKYYASFIE-----DNELNIVLELADAGDLSRMIKHFK------KQKRLIPEKTVWKYFVQL  115 (267)
T ss_pred             HHHHHHHHHHHHccCCchhhhhheeEe-----CCeEEEEEEecCCCCHHHHHHHhh------ccCCCCCHHHHHHHHHHH
Confidence            578899999999999999999998654     678899999999999999884321      123468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+++|+||||+||+++.++.++|+|||.+......            ...||...+..++.++|||||
T Consensus       116 ~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl  192 (267)
T cd08229         116 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL  192 (267)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHH
Confidence            99999999   779999999999999999999999999998754321            234666666778889999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|||++|..||....   ..........     .....+   ...                  .......+.+++.+
T Consensus       193 G~il~~l~~g~~p~~~~~---~~~~~~~~~~-----~~~~~~---~~~------------------~~~~~~~~~~li~~  243 (267)
T cd08229         193 GCLLYEMAALQSPFYGDK---MNLYSLCKKI-----EQCDYP---PLP------------------SDHYSEELRQLVNM  243 (267)
T ss_pred             HHHHHHHHhCCCCccccc---chHHHHhhhh-----hcCCCC---CCC------------------cccccHHHHHHHHH
Confidence            999999999999975321   1111111100     000000   000                  00234467888889


Q ss_pred             cCCCCccCCCCHHHHHHHHHHhh
Q 040999          346 CSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      ||+.+|++||||.+|++.++++.
T Consensus       244 ~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         244 CINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hcCCCcccCCCHHHHHHHHhhhc
Confidence            99999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-32  Score=258.09  Aligned_cols=203  Identities=17%  Similarity=0.195  Sum_probs=155.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++..++||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        46 ~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~qi  110 (333)
T cd05600          46 RHVLTERDILTTTKSEWLVKLLYAFQ-----DDEYLYLAMEYVPGGDFRTLLN----------NLGVLSEDHARFYMAEM  110 (333)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEE-----cCCEEEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            56888999999999999999999854     4778999999999999999983          23468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------CCCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++....         ....||...+..++.++|||||||+
T Consensus       111 ~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i  187 (333)
T cd05600         111 FEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCM  187 (333)
T ss_pred             HHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHH
Confidence            99999999   77999999999999999999999999999975432         2345787777889999999999999


Q ss_pred             HHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCC
Q 040999          269 LLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSM  348 (382)
Q Consensus       269 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~  348 (382)
                      +|||++|+.||.....    ...+.....  . ...+.........                  .....++.+++.+||.
T Consensus       188 l~ell~g~~pf~~~~~----~~~~~~i~~--~-~~~~~~~~~~~~~------------------~~~s~~~~~li~~~l~  242 (333)
T cd05600         188 LYEFLCGFPPFSGSTP----NETWENLKY--W-KETLQRPVYDDPR------------------FNLSDEAWDLITKLIN  242 (333)
T ss_pred             HhhhhhCCCCCCCCCH----HHHHHHHHh--c-cccccCCCCCccc------------------cccCHHHHHHHHHHhh
Confidence            9999999999864211    111100000  0 0000000000000                  0223456778889999


Q ss_pred             CCccCCCCHHHHHHH
Q 040999          349 ESPQDRMKMTNVVHE  363 (382)
Q Consensus       349 ~~p~~RPs~~evl~~  363 (382)
                      .+|.+||+++++++.
T Consensus       243 ~~~~rr~s~~~ll~h  257 (333)
T cd05600         243 DPSRRFGSLEDIKNH  257 (333)
T ss_pred             ChhhhcCCHHHHHhC
Confidence            999999999999964

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.98  E-value=4.6e-32  Score=243.22  Aligned_cols=199  Identities=23%  Similarity=0.333  Sum_probs=155.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||++++++|..     ....++||||+++++|.+++..         ....+++..+..++.|+
T Consensus        37 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i  102 (250)
T cd05085          37 IKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELVPGGDFLSFLRK---------KKDELKTKQLVKFALDA  102 (250)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            468899999999999999999999653     5678999999999999998842         23357899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|+|   +.+++||||||+||+++.++.+||+|||++.....             ....||+..+..++.++||||
T Consensus       103 ~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  179 (250)
T cd05085         103 AAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS  179 (250)
T ss_pred             HHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHH
Confidence            99999999   78999999999999999999999999999864322             133467666777899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++||+++ |..||.....  ...........            .....                  ...+..+.+++
T Consensus       180 lG~ll~~~~~~g~~p~~~~~~--~~~~~~~~~~~------------~~~~~------------------~~~~~~~~~li  227 (250)
T cd05085         180 YGILLWETFSLGVCPYPGMTN--QQAREQVEKGY------------RMSCP------------------QKCPDDVYKVM  227 (250)
T ss_pred             HHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCC------------CCCCC------------------CCCCHHHHHHH
Confidence            9999999998 9999863211  01101000000            00000                  02234678889


Q ss_pred             hccCCCCccCCCCHHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      .+||+.+|++||++.|++++|.
T Consensus       228 ~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         228 QRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHcccCcccCCCHHHHHHHhc
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.98  E-value=6.7e-32  Score=244.97  Aligned_cols=207  Identities=21%  Similarity=0.263  Sum_probs=149.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+.++++++||||+++++++..     ....++||||+++|+|.+++.....     ......++..+..++.|+
T Consensus        40 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~qi  109 (269)
T cd05087          40 MKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVMEFCPLGDLKGYLRSCRK-----AELMTPDPTTLQRMACEI  109 (269)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEECCCCCcHHHHHHHhhh-----cccccccHHHHHHHHHHH
Confidence            468899999999999999999998643     5678999999999999999854221     122346777888999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccC-------CCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVG-------NEV  256 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~-------~~~  256 (382)
                      +.||+|||   +.+++||||||+||+++.++.+||+|||.++.....              ...||...+       ..+
T Consensus       110 ~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~  186 (269)
T cd05087         110 ALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQ  186 (269)
T ss_pred             HHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCC
Confidence            99999999   779999999999999999999999999998643221              233554432       135


Q ss_pred             CccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          257 STIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      +.++||||||+++|||++ |+.||......  ....+.   .........++.+..                      ..
T Consensus       187 ~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~----------------------~~  239 (269)
T cd05087         187 TKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTYT---VREQQLKLPKPRLKL----------------------PL  239 (269)
T ss_pred             CccchhHHHHHHHHHHHhCCCCCCCCCChH--HHHHHH---hhcccCCCCCCccCC----------------------CC
Confidence            789999999999999996 99998642211  111110   000000001111000                      11


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      ...+.+++..|| .+|++|||++||++.|+
T Consensus       240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         240 SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            224566777998 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.98  E-value=1.8e-32  Score=255.46  Aligned_cols=194  Identities=21%  Similarity=0.244  Sum_probs=151.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+++++.++||||+++++++.     ..+..++||||+++|+|..++.          ....+++..+..++.||
T Consensus        40 ~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  104 (323)
T cd05595          40 AHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLS----------RERVFTEERARFYGAEI  104 (323)
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            46778999999999999999998854     3678999999999999988873          33468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++...            .....||...+..++.++|||||
T Consensus       105 ~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  181 (323)
T cd05595         105 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  181 (323)
T ss_pred             HHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhh
Confidence            99999999   7799999999999999999999999999986421            12345787777888999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....     .............      ..   +                   .....++.+++.+
T Consensus       182 Gvil~ell~g~~Pf~~~~-----~~~~~~~~~~~~~------~~---p-------------------~~~~~~~~~li~~  228 (323)
T cd05595         182 GVVMYEMMCGRLPFYNQD-----HERLFELILMEEI------RF---P-------------------RTLSPEAKSLLAG  228 (323)
T ss_pred             HHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCC------CC---C-------------------CCCCHHHHHHHHH
Confidence            999999999999985321     1111111100000      00   0                   0122356778889


Q ss_pred             cCCCCccCCC-----CHHHHHH
Q 040999          346 CSMESPQDRM-----KMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RP-----s~~evl~  362 (382)
                      ||+.||++||     ++.++++
T Consensus       229 ~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         229 LLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HccCCHHHhCCCCCCCHHHHHc
Confidence            9999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.98  E-value=5.8e-32  Score=247.95  Aligned_cols=211  Identities=19%  Similarity=0.330  Sum_probs=158.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+.+++.++|+||+++++++..     ....++||||+++|+|.+++................++..+..++.|+
T Consensus        54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l  128 (288)
T cd05061          54 IEFLNEASVMKGFTCHHVVRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI  128 (288)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHH
Confidence            468889999999999999999998543     567899999999999999996432111111123446778889999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||+|||   +++|+||||||+||+++.++.+||+|||+++....              ....||...+..++.++|||
T Consensus       129 ~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dvw  205 (288)
T cd05061         129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMW  205 (288)
T ss_pred             HHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHH
Confidence            99999999   78999999999999999999999999999874321              13346666667789999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||++|||++ |..||.....     .......        .+......+                   ..+...+.++
T Consensus       206 slG~~l~el~~~~~~p~~~~~~-----~~~~~~~--------~~~~~~~~~-------------------~~~~~~~~~l  253 (288)
T cd05061         206 SFGVVLWEITSLAEQPYQGLSN-----EQVLKFV--------MDGGYLDQP-------------------DNCPERVTDL  253 (288)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH--------HcCCCCCCC-------------------CCCCHHHHHH
Confidence            99999999998 7888753211     1111110        000000000                   0223468888


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      +.+||+.+|++|||+.++++.|++..
T Consensus       254 i~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         254 MRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            99999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=257.60  Aligned_cols=202  Identities=21%  Similarity=0.357  Sum_probs=168.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|+.|.-+|++++|||||+++|+|.      ....|+|||.++-|.|..||.         .+...++......++.||
T Consensus       436 ekflqEa~iMrnfdHphIikLIGv~~------e~P~WivmEL~~~GELr~yLq---------~nk~sL~l~tL~ly~~Qi  500 (974)
T KOG4257|consen  436 EKFLQEASIMRNFDHPHIIKLIGVCV------EQPMWIVMELAPLGELREYLQ---------QNKDSLPLRTLTLYCYQI  500 (974)
T ss_pred             HHHHHHHHHHHhCCCcchhheeeeee------ccceeEEEecccchhHHHHHH---------hccccchHHHHHHHHHHH
Confidence            67999999999999999999999986      467899999999999999995         345668889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.++|||||..+|||+.....+||+|||+++++...             +.+||...-..+++++|||-
T Consensus       501 ~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWM  577 (974)
T KOG4257|consen  501 CTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWM  577 (974)
T ss_pred             HHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHH
Confidence            99999999   889999999999999999999999999999987543             44588877889999999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||++||++. |..||......                 +++...-..+.               ......|+..+..++
T Consensus       578 FgVCmWEIl~lGvkPfqgvkNs-----------------DVI~~iEnGeR---------------lP~P~nCPp~LYslm  625 (974)
T KOG4257|consen  578 FGVCMWEILSLGVKPFQGVKNS-----------------DVIGHIENGER---------------LPCPPNCPPALYSLM  625 (974)
T ss_pred             HHHHHHHHHHhcCCcccccccc-----------------ceEEEecCCCC---------------CCCCCCCChHHHHHH
Confidence            9999999875 99998753221                 11111111000               011126888999999


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      .+||..+|.+||++.++...|..+..
T Consensus       626 skcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  626 SKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             HHHhccCcccCCcHHHHHHHHHHHHH
Confidence            99999999999999999999988765

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.98  E-value=5.1e-32  Score=244.86  Aligned_cols=201  Identities=23%  Similarity=0.377  Sum_probs=156.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|++++++++|+||+++++++.      ....++||||+++|+|.+++...        ....+++..+..++.|+
T Consensus        46 ~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l  111 (262)
T cd05071          46 EAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGE--------MGKYLRLPQLVDMAAQI  111 (262)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEEEEEcCCCCcHHHHHhhc--------cccCCCHHHHHHHHHHH
Confidence            56899999999999999999998742      34578999999999999999531        23457899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+++||||||+||+++.++.+||+|||.++.....             ...||...+..++.++||||
T Consensus       112 ~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvws  188 (262)
T cd05071         112 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS  188 (262)
T ss_pred             HHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHH
Confidence            99999999   779999999999999999999999999998754321             23466666677899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||+| |+.||......     ......         ........                  ..+.+..+.+++
T Consensus       189 lG~~l~ellt~g~~p~~~~~~~-----~~~~~~---------~~~~~~~~------------------~~~~~~~l~~li  236 (262)
T cd05071         189 FGILLTELTTKGRVPYPGMVNR-----EVLDQV---------ERGYRMPC------------------PPECPESLHDLM  236 (262)
T ss_pred             HHHHHHHHHcCCCCCCCCCChH-----HHHHHH---------hcCCCCCC------------------ccccCHHHHHHH
Confidence            9999999999 88887642110     000000         00000000                  013445678899


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      .+|++.+|++||++.++++.|+..
T Consensus       237 ~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         237 CQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HHHccCCcccCCCHHHHHHHHHHh
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.98  E-value=3.8e-32  Score=249.96  Aligned_cols=217  Identities=22%  Similarity=0.349  Sum_probs=159.3

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcc-ccCCcccCHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET-YERPRNLNLLRRLNIA  194 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~  194 (382)
                      ..+++.+|++++++++|+||+++++++..     .+..++++||+++++|.+++......... ......+++..++.++
T Consensus        62 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (296)
T cd05051          62 AREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMA  136 (296)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeEEEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHH
Confidence            34678999999999999999999999653     57889999999999999998543211000 1123468999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~  260 (382)
                      .|++.||+|||   +.+++||||||+||+++.++.++|+|||+++....              ....||...+..++.++
T Consensus       137 ~~i~~al~~LH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  213 (296)
T cd05051         137 TQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKS  213 (296)
T ss_pred             HHHHHHHHHHH---HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccc
Confidence            99999999999   77999999999999999999999999999875421              13346766667889999


Q ss_pred             hhHHHHHHHHHHHh--cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          261 DVYSYGILLLELMI--REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       261 Dv~S~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      |||||||++|||++  +..||.....  ..................    ....                   ...++.+
T Consensus       214 Dv~slG~~l~el~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~-------------------~~~~~~~  268 (296)
T cd05051         214 DVWAFGVTLWEILTLCREQPYEHLTD--QQVIENAGHFFRDDGRQI----YLPR-------------------PPNCPKD  268 (296)
T ss_pred             hhhhhHHHHHHHHhcCCCCCCCCcCh--HHHHHHHHhccccccccc----cCCC-------------------ccCCCHH
Confidence            99999999999998  6677653211  111111110000000000    0000                   0022357


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      +.+++.+||+.+|++|||+.||++.|+
T Consensus       269 l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         269 IYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.98  E-value=4.4e-32  Score=248.77  Aligned_cols=224  Identities=19%  Similarity=0.246  Sum_probs=150.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||+++++++.     ..+..++||||+++ +|.+++..         ....+++..+..++.||
T Consensus        48 ~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~qi  112 (288)
T cd07871          48 CTAIREVSLLKNLKHANIVTLHDIIH-----TERCLTLVFEYLDS-DLKQYLDN---------CGNLMSMHNVKIFMFQL  112 (288)
T ss_pred             hhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEEEEEeCCCc-CHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            35789999999999999999999853     36778999999974 88888732         23357888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....            ..+||...+ ..++.++||||
T Consensus       113 ~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  189 (288)
T cd07871         113 LRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWG  189 (288)
T ss_pred             HHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHH
Confidence            99999999   789999999999999999999999999998754221            233665544 56789999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      +||++|||+||+.||...... ..+...... ......+..................... ............+..+++.
T Consensus       190 lG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~dll~  266 (288)
T cd07871         190 VGCILYEMATGRPMFPGSTVK-EELHLIFRL-LGTPTEETWPGITSNEEFRSYLFPQYRA-QPLINHAPRLDTDGIDLLS  266 (288)
T ss_pred             HHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-hCCCChHHhhccccchhhhccccCccCC-CchHHhCCCCCHHHHHHHH
Confidence            999999999999998642111 111111111 1110011100000000000000000000 0000000012335678888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +|++.||.+|||++|+++
T Consensus       267 ~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         267 SLLLYETKSRISAEAALR  284 (288)
T ss_pred             HhcCcCcccCCCHHHHhc
Confidence            999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=5.1e-32  Score=244.93  Aligned_cols=196  Identities=17%  Similarity=0.280  Sum_probs=150.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|+.+++.++||||+++++++..     ....++||||+++|+|..++..         ....+++..++.++.||
T Consensus        49 ~~~~~~~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~i~~qi  114 (262)
T cd05077          49 LAFFETASMMRQVSHKHIVLLYGVCVR-----DVENIMVEEFVEFGPLDLFMHR---------KSDVLTTPWKFKVAKQL  114 (262)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec-----CCCCEEEEecccCCCHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            568889999999999999999999754     5677999999999999888742         23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCc-------EEEccccccccCCC--------CCCCCcccc-CCCCCccch
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT-------ARVGDFGLARFLPP--------TRTQTKYGV-GNEVSTIGD  261 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~-------~kl~Dfg~a~~~~~--------~~~~~~~~~-~~~~~~~~D  261 (382)
                      ++||+|||   +.+|+||||||+|||++.++.       +|++|||++.....        ...+||... +..++.++|
T Consensus       115 ~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  191 (262)
T cd05077         115 ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAAD  191 (262)
T ss_pred             HHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCcccccccccccChhhhcCCCCCCchhH
Confidence            99999999   789999999999999987654       89999999875432        234577654 466888999


Q ss_pred             hHHHHHHHHHHH-hcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELM-IREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||+ +|..|+.....  ......            .........                    .....+.
T Consensus       192 iwslG~~l~el~~~~~~p~~~~~~--~~~~~~------------~~~~~~~~~--------------------~~~~~~~  237 (262)
T cd05077         192 KWSFGTTLWEICYNGEIPLKDKTL--AEKERF------------YEGQCMLVT--------------------PSCKELA  237 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCcch--hHHHHH------------HhcCccCCC--------------------CChHHHH
Confidence            999999999998 58888653210  000000            000000000                    1123567


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                      +++.+||+.||.+||++.++++.+
T Consensus       238 ~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         238 DLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHhc
Confidence            888899999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.98  E-value=3.2e-32  Score=248.27  Aligned_cols=202  Identities=19%  Similarity=0.227  Sum_probs=152.0

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+..|++++++++||||+++++++.     .....++||||+++++|.+++...        ....+++..+..++.|++
T Consensus        39 ~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~~g~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~  105 (277)
T cd05607          39 MALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLMNGGDLKYHIYNV--------GERGLEMERVIHYSAQIT  105 (277)
T ss_pred             HHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecCCCCCHHHHHHhc--------cccCCCHHHHHHHHHHHH
Confidence            4567999999999999999998853     467899999999999998887421        234588999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCccchhHHHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      .||+|||   +.+|+||||||+||+++.++.+||+|||++.....           ....||...+..++.++||||+||
T Consensus       106 ~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv  182 (277)
T cd05607         106 CGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGC  182 (277)
T ss_pred             HHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHH
Confidence            9999999   78999999999999999999999999999875432           233477777777899999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ++|||++|+.||..... .................        ..                   ......++.+++..||
T Consensus       183 ~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~--------~~-------------------~~~~~~~~~~li~~~L  234 (277)
T cd05607         183 SIYEMVAGRTPFKDHKE-KVAKEELKRRTLEDEVK--------FE-------------------HQNFTEESKDICRLFL  234 (277)
T ss_pred             HHHHHHhCCCCCCCCcc-hhhHHHHHHHhhccccc--------cc-------------------cccCCHHHHHHHHHHh
Confidence            99999999999864211 11111111111110000        00                   0012335678888999


Q ss_pred             CCCccCCCCHHHHHHHH
Q 040999          348 MESPQDRMKMTNVVHEL  364 (382)
Q Consensus       348 ~~~p~~RPs~~evl~~L  364 (382)
                      +.||++||+++|+++.+
T Consensus       235 ~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         235 AKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccCHhhCCCCccchhhh
Confidence            99999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=8.2e-33  Score=255.81  Aligned_cols=199  Identities=19%  Similarity=0.257  Sum_probs=160.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +..+.|+.++++++|||||.+++.+..    +....+|||+||+||++.+.+..        .+...+++..+.+|+.|+
T Consensus        48 ~~A~~E~~lis~~~hP~iv~y~ds~~~----~~~~l~Ivm~Y~eGg~l~~~i~~--------~k~~~f~E~~i~~~~~Q~  115 (426)
T KOG0589|consen   48 RSAIQEMDLLSKLLHPNIVEYKDSFEE----DGQLLCIVMEYCEGGDLAQLIKE--------QKGVLFPEERILKWFVQI  115 (426)
T ss_pred             HHHHHHHHHHHhccCCCeeeeccchhc----CCceEEEEEeecCCCCHHHHHHH--------HhhccccHHHHHHHHHHH
Confidence            467899999999999999999998543    34449999999999999999953        224678999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC------------CCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR------------TQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.|+.|||   +..|+|||||+.||+++++..+||+|||+|+.+.+..            ..||...+..|+.|+||||+
T Consensus       116 ~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsL  192 (426)
T KOG0589|consen  116 LLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSL  192 (426)
T ss_pred             HHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhh
Confidence            99999999   7899999999999999999999999999999886653            22677778899999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++-+++|...     ++...+...        ........+                   .....++..++..
T Consensus       193 GC~~yEm~~lk~aF~a~-----~m~~Li~ki--------~~~~~~Plp-------------------~~ys~el~~lv~~  240 (426)
T KOG0589|consen  193 GCCLYEMCTLKPAFKAS-----NMSELILKI--------NRGLYSPLP-------------------SMYSSELRSLVKS  240 (426)
T ss_pred             cchHHHHHhcccccCcc-----chHHHHHHH--------hhccCCCCC-------------------ccccHHHHHHHHH
Confidence            99999999999998732     122221111        111111111                   1344577888889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      |++.+|+.||++.+++.+
T Consensus       241 ~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  241 MLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HhhcCCccCCCHHHHhhC
Confidence            999999999999999976

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.98  E-value=4.9e-32  Score=248.58  Aligned_cols=226  Identities=19%  Similarity=0.248  Sum_probs=152.6

Q ss_pred             HHHHHHHHHhhc---ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNI---RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+|+++++.+   +||||++++++|...........++||||++ ++|.+++...        ....+++..+..++.
T Consensus        47 ~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~i~~  117 (290)
T cd07862          47 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMF  117 (290)
T ss_pred             HHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC--------CCCCCCHHHHHHHHH
Confidence            456677777665   6999999999986433344567899999996 6888888432        234588999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...+..++.++||||
T Consensus       118 qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  194 (290)
T cd07862         118 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS  194 (290)
T ss_pred             HHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHH
Confidence            9999999999   779999999999999999999999999999764322           23477666778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||...... ..+.............++-.. ..... . ....  ...........+....+.+++.
T Consensus       195 lG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~~~~~-~~~~~-~-~~~~--~~~~~~~~~~~~~~~~~~~li~  268 (290)
T cd07862         195 VGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEEDWPRD-VALPR-Q-AFHS--KSAQPIEKFVTDIDELGKDLLL  268 (290)
T ss_pred             HHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhchhh-hcccc-h-hccC--CCCCCHHHHccCCCHHHHHHHH
Confidence            999999999999998642111 111111111100000000000 00000 0 0000  0000000011123345678889


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +|++.||++|||+.|+++
T Consensus       269 ~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         269 KCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHhccCchhcCCHHHHhc
Confidence            999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.98  E-value=5e-32  Score=247.37  Aligned_cols=202  Identities=21%  Similarity=0.226  Sum_probs=153.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+..|++++++++|+||+++.+++.     .....++||||+++|+|.+++....      .....+++..+..++.||
T Consensus        38 ~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi  106 (280)
T cd05608          38 EGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIMNGGDLRYHIYNVD------EENPGFPEPRACFYTAQI  106 (280)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCCCCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHH
Confidence            45778999999999999999988853     3677999999999999988774322      233568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+||+++.++.+||+|||++.....            ....||...+..++.++|||||
T Consensus       107 ~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl  183 (280)
T cd05608         107 ISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFAL  183 (280)
T ss_pred             HHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHH
Confidence            99999999   77999999999999999999999999999975432            2334777777888999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....... .............        .  ..                  .......+.+++.+
T Consensus       184 G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~--------~--~~------------------~~~~~~~~~~li~~  234 (280)
T cd05608         184 GVTLYEMIAARGPFRARGEKV-ENKELKQRILNDS--------V--TY------------------PDKFSPASKSFCEA  234 (280)
T ss_pred             HHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccC--------C--CC------------------cccCCHHHHHHHHH
Confidence            999999999999986421110 0011111000000        0  00                  00233467788889


Q ss_pred             cCCCCccCCC-----CHHHHHH
Q 040999          346 CSMESPQDRM-----KMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RP-----s~~evl~  362 (382)
                      ||+.||++||     +++++++
T Consensus       235 ~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         235 LLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HhcCCHHHhcCCCCCCHHHHhc
Confidence            9999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.98  E-value=3.3e-32  Score=259.79  Aligned_cols=212  Identities=20%  Similarity=0.281  Sum_probs=158.1

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC--------------------
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED--------------------  176 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------  176 (382)
                      +.+.+|+++|.++. |||||+++++|..     ....++||||+++|+|.++++......                    
T Consensus        85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~-----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (401)
T cd05107          85 QALMSELKIMSHLGPHLNIVNLLGACTK-----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGST  159 (401)
T ss_pred             HHHHHHHHHHHhcCCCCCeEEEEEEEcc-----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccc
Confidence            46889999999997 9999999999754     567899999999999999986432100                    


Q ss_pred             --------------------------------------------------------------------ccccCCcccCHH
Q 040999          177 --------------------------------------------------------------------ETYERPRNLNLL  188 (382)
Q Consensus       177 --------------------------------------------------------------------~~~~~~~~l~~~  188 (382)
                                                                                          ........+++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  239 (401)
T cd05107         160 PLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYM  239 (401)
T ss_pred             cccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHH
Confidence                                                                                000112357888


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGN  254 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~  254 (382)
                      ..+.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....              ....||...+.
T Consensus       240 ~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  316 (401)
T cd05107         240 DLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN  316 (401)
T ss_pred             HHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC
Confidence            89999999999999999   78999999999999999999999999999975421              12335555566


Q ss_pred             CCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHH
Q 040999          255 EVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII  333 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (382)
                      .++.++|||||||++|||++ |..||....... .....            +.........                  .
T Consensus       317 ~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-~~~~~------------~~~~~~~~~p------------------~  365 (401)
T cd05107         317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-QFYNA------------IKRGYRMAKP------------------A  365 (401)
T ss_pred             CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-HHHHH------------HHcCCCCCCC------------------C
Confidence            77899999999999999998 888975321100 00010            0000000000                  0


Q ss_pred             HHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       334 ~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      .+..++.+++.+||+.+|.+||+++||++.|+++.
T Consensus       366 ~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         366 HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            12346788888999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.98  E-value=9.4e-32  Score=242.78  Aligned_cols=200  Identities=23%  Similarity=0.380  Sum_probs=155.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+|++++++++.      .+..++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        46 ~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l  111 (260)
T cd05069          46 EAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYIVTEFMGKGSLLDFLKEG--------DGKYLKLPQLVDMAAQI  111 (260)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEEEEEcCCCCCHHHHHhhC--------CCCCCCHHHHHHHHHHH
Confidence            56889999999999999999998742      34578999999999999998531        23457899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+++|+||||+||++++++.+||+|||.++.....             ...||...+..++.++||||
T Consensus       112 ~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s  188 (260)
T cd05069         112 ADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS  188 (260)
T ss_pred             HHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHH
Confidence            99999999   779999999999999999999999999999754321             23366656677889999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||+| |+.||......  ............            ..                  ....+..+.+++
T Consensus       189 lG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~------------~~------------------~~~~~~~~~~li  236 (260)
T cd05069         189 FGILLTELVTKGRVPYPGMVNR--EVLEQVERGYRM------------PC------------------PQGCPESLHELM  236 (260)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC------------CC------------------CcccCHHHHHHH
Confidence            9999999999 89997642110  111110000000            00                  002334678888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      .+||+.+|++||++++|++.|++
T Consensus       237 ~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         237 KLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHccCCcccCcCHHHHHHHHhc
Confidence            89999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.98  E-value=7.8e-32  Score=242.38  Aligned_cols=199  Identities=19%  Similarity=0.240  Sum_probs=156.1

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++..     .+..++||||+++++|.+++...        ....+++..+..++.|
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~~  109 (256)
T cd08529          43 REEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLNIVMEYAENGDLHKLLKMQ--------RGRPLPEDQVWRFFIQ  109 (256)
T ss_pred             HHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEEEEEEeCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHH
Confidence            3678899999999999999999998653     67899999999999999998532        2346889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.....            ...||+..+..++.++||||
T Consensus       110 l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  186 (256)
T cd08529         110 ILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWA  186 (256)
T ss_pred             HHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHH
Confidence            999999999   779999999999999999999999999998765332            23477777777889999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....    . ........        ..... ..                  .......+.+++.
T Consensus       187 lG~il~~l~~g~~p~~~~~----~-~~~~~~~~--------~~~~~-~~------------------~~~~~~~~~~~i~  234 (256)
T cd08529         187 LGVVLYECCTGKHPFDANN----Q-GALILKII--------RGVFP-PV------------------SQMYSQQLAQLID  234 (256)
T ss_pred             HHHHHHHHHhCCCCCCCCC----H-HHHHHHHH--------cCCCC-CC------------------ccccCHHHHHHHH
Confidence            9999999999999986421    1 11111100        00000 00                  0023346788888


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.+|++||++.++++.
T Consensus       235 ~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         235 QCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHccCCcccCcCHHHHhhC
Confidence            9999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=3.7e-32  Score=245.21  Aligned_cols=197  Identities=19%  Similarity=0.279  Sum_probs=149.7

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+.+++.++||||+++++++..     ....++||||+++|+|.+++..         ....+++..++.++.|
T Consensus        43 ~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~q  108 (258)
T cd05078          43 SESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESIMVQEYVKFGSLDTYLKK---------NKNLINISWKLEVAKQ  108 (258)
T ss_pred             HHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcEEEEecCCCCcHHHHHhc---------CCCCCCHHHHHHHHHH
Confidence            3678899999999999999999999754     5678999999999999999842         2235889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCc--------EEEccccccccCCCC--------CCCCccccC-CCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT--------ARVGDFGLARFLPPT--------RTQTKYGVG-NEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~--------~kl~Dfg~a~~~~~~--------~~~~~~~~~-~~~~~~  259 (382)
                      |+.||+|||   +.+|+||||||+||+++.++.        +|++|||.+......        ...||...+ ..++.+
T Consensus       109 i~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  185 (258)
T cd05078         109 LAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLA  185 (258)
T ss_pred             HHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccccCCchhccccCCccCchhccCCCCCCch
Confidence            999999999   789999999999999987764        699999998754332        234676654 457889


Q ss_pred             chhHHHHHHHHHHHhcC-CCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMIRE-KPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +|||||||++|||++|. .|+....    .. ....         ....... .+ .                  ....+
T Consensus       186 ~DiwslG~~l~~l~~g~~~~~~~~~----~~-~~~~---------~~~~~~~-~~-~------------------~~~~~  231 (258)
T cd05078         186 ADKWSFGTTLWEIFSGGDKPLSALD----SQ-KKLQ---------FYEDRHQ-LP-A------------------PKWTE  231 (258)
T ss_pred             hhHHHHHHHHHHHHcCCCCChhhcc----HH-HHHH---------HHHcccc-CC-C------------------CCcHH
Confidence            99999999999999995 5543211    00 0000         0000000 00 0                  11235


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                      +.+++.+||+.+|++|||++++++.|
T Consensus       232 ~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         232 LANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHHHHHhccChhhCCCHHHHHHhc
Confidence            77888899999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.98  E-value=7.8e-32  Score=253.24  Aligned_cols=215  Identities=21%  Similarity=0.282  Sum_probs=158.7

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc-------------------
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE-------------------  177 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------  177 (382)
                      +.+.+|++++.++ +|+||++++++|..    .....++||||+++|+|.+++........                   
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (343)
T cd05103          55 RALMSELKILIHIGHHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDI  130 (343)
T ss_pred             HHHHHHHHHHHhccCCccHhhhcceeec----CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccch
Confidence            5688999999999 68999999998753    24567899999999999988854211000                   


Q ss_pred             --------------------------------------cccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCC
Q 040999          178 --------------------------------------TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKP  219 (382)
Q Consensus       178 --------------------------------------~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp  219 (382)
                                                            .......+++..+..++.|+++||+|||   +.+|+||||||
T Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp  207 (343)
T cd05103         131 SEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAA  207 (343)
T ss_pred             hhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCcc
Confidence                                                  0001134788899999999999999999   78999999999


Q ss_pred             CceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhHHHHHHHHHHHh-cCCCCCcccc
Q 040999          220 SNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFE  284 (382)
Q Consensus       220 ~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~  284 (382)
                      +||+++.++.+||+|||+++....              ....||...+..++.++||||||+++|||++ |..||.....
T Consensus       208 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  287 (343)
T cd05103         208 RNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  287 (343)
T ss_pred             CeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence            999999999999999999875421              1234666667778999999999999999997 8999764211


Q ss_pred             CCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHH
Q 040999          285 GDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                      . ...........           ....+ .                  ....++.+++..||+.+|++|||+.||++.|
T Consensus       288 ~-~~~~~~~~~~~-----------~~~~~-~------------------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l  336 (343)
T cd05103         288 D-EEFCRRLKEGT-----------RMRAP-D------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  336 (343)
T ss_pred             c-HHHHHHHhccC-----------CCCCC-C------------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            1 01100000000           00000 0                  1123578888999999999999999999999


Q ss_pred             HHhhhh
Q 040999          365 QSIKNT  370 (382)
Q Consensus       365 ~~i~~~  370 (382)
                      +.+.+.
T Consensus       337 ~~~~~~  342 (343)
T cd05103         337 GNLLQA  342 (343)
T ss_pred             HHHHhc
Confidence            988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.98  E-value=1e-31  Score=243.83  Aligned_cols=205  Identities=20%  Similarity=0.317  Sum_probs=159.9

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|+.++++++|+||+++++++.      ....++||||+++|+|.+++..         ....+++..+..++.
T Consensus        50 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~  114 (270)
T cd05056          50 VREKFLQEAYIMRQFDHPHIVKLIGVIT------ENPVWIVMELAPLGELRSYLQV---------NKYSLDLASLILYSY  114 (270)
T ss_pred             HHHHHHHHHHHHHhCCCCchhceeEEEc------CCCcEEEEEcCCCCcHHHHHHh---------CCCCCCHHHHHHHHH
Confidence            3467899999999999999999999864      3456899999999999999842         233589999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchh
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      |++.||+|||   +.+++|+||||+||+++.++.+||+|||+++....             ....||......++.++||
T Consensus       115 ~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  191 (270)
T cd05056         115 QLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDV  191 (270)
T ss_pred             HHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhh
Confidence            9999999999   77999999999999999999999999999875422             1234666666778899999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||+++||+++ |+.||......  ........  ...        . ..+                   ..++..+.+
T Consensus       192 ~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~--~~~--------~-~~~-------------------~~~~~~~~~  239 (270)
T cd05056         192 WMFGVCMWEILMLGVKPFQGVKNN--DVIGRIEN--GER--------L-PMP-------------------PNCPPTLYS  239 (270)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHc--CCc--------C-CCC-------------------CCCCHHHHH
Confidence            999999999996 99998643211  11010000  000        0 000                   023346788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      ++.+|+..+|.+|||+.++++.|+++..+
T Consensus       240 li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            88899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.98  E-value=1.4e-31  Score=250.66  Aligned_cols=214  Identities=22%  Similarity=0.362  Sum_probs=162.8

Q ss_pred             HHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------cccCCcccCHHH
Q 040999          117 FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------TYERPRNLNLLR  189 (382)
Q Consensus       117 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~  189 (382)
                      .+++.+|+++++++ +|+||++++++|..     .+..++++||+++|+|.+++........      .......+++..
T Consensus        61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~  135 (334)
T cd05100          61 LSDLVSEMEMMKMIGKHKNIINLLGACTQ-----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD  135 (334)
T ss_pred             HHHHHHHHHHHHhhcCCCCeeeeeEEEcc-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHH
Confidence            46789999999999 79999999999753     5678999999999999999864321100      001234588999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCC
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNE  255 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~  255 (382)
                      ++.++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++....              ....||...+..
T Consensus       136 ~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  212 (334)
T cd05100         136 LVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV  212 (334)
T ss_pred             HHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC
Confidence            9999999999999999   78999999999999999999999999999875432              123466666777


Q ss_pred             CCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          256 VSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ++.++||||||+++|||++ |..||...     ....+..........+        .+                   ..
T Consensus       213 ~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~~~~~~~~~--------~~-------------------~~  260 (334)
T cd05100         213 YTHQSDVWSFGVLLWEIFTLGGSPYPGI-----PVEELFKLLKEGHRMD--------KP-------------------AN  260 (334)
T ss_pred             cCchhhhHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCCCC--------CC-------------------CC
Confidence            8899999999999999998 88887532     1111111110000000        00                   02


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +...+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus       261 ~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         261 CTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            234678889999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.98  E-value=9.6e-32  Score=242.68  Aligned_cols=200  Identities=25%  Similarity=0.409  Sum_probs=155.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++|+|++++++++.      ....+++|||+++++|.+++...        ....+++..+..++.|+
T Consensus        46 ~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l  111 (260)
T cd05070          46 ESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKDG--------EGRALKLPNLVDMAAQV  111 (260)
T ss_pred             HHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEEEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHH
Confidence            56899999999999999999998742      34578999999999999988531        23458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+++||||||+||++++++.+||+|||.+......             ..+||...+..++.++||||
T Consensus       112 ~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  188 (260)
T cd05070         112 AAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS  188 (260)
T ss_pred             HHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHH
Confidence            99999999   779999999999999999999999999998754321             33466666677889999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||++ |+.||.....     ......         +........                  .......+.+++
T Consensus       189 lG~~l~~l~~~g~~p~~~~~~-----~~~~~~---------~~~~~~~~~------------------~~~~~~~~~~li  236 (260)
T cd05070         189 FGILLTELVTKGRVPYPGMNN-----REVLEQ---------VERGYRMPC------------------PQDCPISLHELM  236 (260)
T ss_pred             HHHHHHHHHhcCCCCCCCCCH-----HHHHHH---------HHcCCCCCC------------------CCcCCHHHHHHH
Confidence            9999999999 8889864211     111110         000000000                  002334688899


Q ss_pred             hccCCCCccCCCCHHHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      .+|++.+|++|||+.++.+.|++
T Consensus       237 ~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         237 LQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.98  E-value=1.1e-31  Score=241.86  Aligned_cols=203  Identities=23%  Similarity=0.327  Sum_probs=157.5

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +..+++.+|++++++++|+||+++++++.     + ...++|+||+++++|.+++....        ...+++.....++
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~  103 (257)
T cd05040          38 DIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVTELAPLGSLLDRLRKDA--------LGHFLISTLCDYA  103 (257)
T ss_pred             HHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEEEecCCCcHHHHHHhcc--------cccCcHHHHHHHH
Confidence            44578999999999999999999999853     2 67899999999999999985321        1468999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------------CCCCCccccCCCCCcc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------------TRTQTKYGVGNEVSTI  259 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~~~~~~~~~~  259 (382)
                      .|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++....               ....||+..+..++.+
T Consensus       104 ~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~  180 (257)
T cd05040         104 VQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHA  180 (257)
T ss_pred             HHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCch
Confidence            99999999999   78999999999999999999999999999876533               1233666666778899


Q ss_pred             chhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +|||||||++|||+| |+.||.....  .........  ..       .... .+                   ...+..
T Consensus       181 ~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~--~~-------~~~~-~~-------------------~~~~~~  229 (257)
T cd05040         181 SDVWMFGVTLWEMFTYGEEPWAGLSG--SQILKKIDK--EG-------ERLE-RP-------------------EACPQD  229 (257)
T ss_pred             hhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHh--cC-------CcCC-CC-------------------ccCCHH
Confidence            999999999999998 9999863211  011111000  00       0000 00                   022346


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      +.+++.+||+.+|++|||+.++++.|.
T Consensus       230 ~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         230 IYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            788888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.98  E-value=5.2e-32  Score=250.14  Aligned_cols=203  Identities=23%  Similarity=0.351  Sum_probs=157.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .++.+|+.+++.++||||++++++|..      ...++++||+++|+|.+++..         ....+++..+..++.|+
T Consensus        54 ~~~~~e~~~~~~l~h~niv~~~~~~~~------~~~~~v~e~~~~g~l~~~~~~---------~~~~~~~~~~~~~~~qi  118 (303)
T cd05110          54 VEFMDEALIMASMDHPHLVRLLGVCLS------PTIQLVTQLMPHGCLLDYVHE---------HKDNIGSQLLLNWCVQI  118 (303)
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEcC------CCceeeehhcCCCCHHHHHHh---------cccCCCHHHHHHHHHHH
Confidence            468899999999999999999998753      345799999999999998842         23458889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....              ...||...+..++.++|||
T Consensus       119 ~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diw  195 (303)
T cd05110         119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVW  195 (303)
T ss_pred             HHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHH
Confidence            99999999   779999999999999999999999999999864321              2235555667788999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||++|||++ |+.||.....  .....+.            .........                  ..+...+.++
T Consensus       196 slG~~l~el~t~g~~p~~~~~~--~~~~~~~------------~~~~~~~~~------------------~~~~~~~~~l  243 (303)
T cd05110         196 SYGVTIWELMTFGGKPYDGIPT--REIPDLL------------EKGERLPQP------------------PICTIDVYMV  243 (303)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCH--HHHHHHH------------HCCCCCCCC------------------CCCCHHHHHH
Confidence            99999999997 8899764211  1111111            100000000                  0123467788


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +..||..+|++||+++++++.|+++.+.
T Consensus       244 i~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         244 MVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            8899999999999999999999987654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.98  E-value=5.8e-32  Score=233.16  Aligned_cols=146  Identities=22%  Similarity=0.295  Sum_probs=132.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +...+|..+|+.+.||.++++++.|     .+..+.++||||+++|.|.++++          +.+++++..+..++.||
T Consensus        89 eH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~~lymvmeyv~GGElFS~Lr----------k~~rF~e~~arFYAAei  153 (355)
T KOG0616|consen   89 EHTHNEKRVLKAVSHPFLVKLYGTF-----KDNSNLYMVMEYVPGGELFSYLR----------KSGRFSEPHARFYAAEI  153 (355)
T ss_pred             HHHhhHHHHHhhccCceeEEEEEee-----ccCCeEEEEEeccCCccHHHHHH----------hcCCCCchhHHHHHHHH
Confidence            6788999999999999999999884     45889999999999999999994          44579999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------CCCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||+|||   +.+|++||+||+|||+|.+|.+||+|||+|+....         +..+||...+..++.++|.|||||+
T Consensus       154 vlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVL  230 (355)
T KOG0616|consen  154 VLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVL  230 (355)
T ss_pred             HHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHH
Confidence            99999999   78999999999999999999999999999997643         4455777888899999999999999


Q ss_pred             HHHHHhcCCCCCc
Q 040999          269 LLELMIREKPSDI  281 (382)
Q Consensus       269 l~elltg~~p~~~  281 (382)
                      +|||+.|.+||..
T Consensus       231 IYEMlaG~pPF~~  243 (355)
T KOG0616|consen  231 IYEMLAGYPPFYD  243 (355)
T ss_pred             HHHHHcCCCCCcC
Confidence            9999999999864

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.2e-31  Score=242.19  Aligned_cols=199  Identities=17%  Similarity=0.241  Sum_probs=154.6

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++||||+++++++.     ..+..++|+||+++++|.+++.          ....+++.....++.
T Consensus        47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~  111 (263)
T cd06625          47 EVNALECEIQLLKNLQHERIVQYYGCLR-----DDETLSIFMEYMPGGSVKDQLK----------AYGALTETVTRKYTR  111 (263)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cCCeEEEEEEECCCCcHHHHHH----------HhCCCCHHHHHHHHH
Confidence            3467899999999999999999999964     3668999999999999998883          234578889999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------------CCCCCccccCCCCCccc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------------TRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~~~~~~~~~~~  260 (382)
                      |++.||.|||   +.+++||||||+||+++.++.+||+|||+++....               ....||...+..++.++
T Consensus       112 ~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  188 (263)
T cd06625         112 QILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKA  188 (263)
T ss_pred             HHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchh
Confidence            9999999999   77999999999999999999999999999875422               12347777777788999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||+++|||++|+.||...    .................     +                      .......+.
T Consensus       189 Di~slG~il~el~~g~~p~~~~----~~~~~~~~~~~~~~~~~-----~----------------------~~~~~~~~~  237 (263)
T cd06625         189 DVWSVGCTVVEMLTEKPPWAEF----EAMAAIFKIATQPTNPQ-----L----------------------PSHVSPDAR  237 (263)
T ss_pred             hhHHHHHHHHHHHhCCCCcccc----chHHHHHHHhccCCCCC-----C----------------------CccCCHHHH
Confidence            9999999999999999997532    11111111110000000     0                      002234567


Q ss_pred             HHhhccCCCCccCCCCHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +++.+||..+|++|||+.|+++.
T Consensus       238 ~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         238 NFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHHHHhhcCcccCCCHHHHhhC
Confidence            88889999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=7.2e-32  Score=252.87  Aligned_cols=195  Identities=20%  Similarity=0.215  Sum_probs=152.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++..     .+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        76 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi  140 (340)
T PTZ00426         76 DHVFSERKILNYINHPFCVNLYGSFKD-----ESYLYLVLEFVIGGEFFTFLR----------RNKRFPNDVGCFYAAQI  140 (340)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEe-----CCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            567889999999999999999999643     678999999999999999983          33468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....         ..+||...+..++.++|||||||+
T Consensus       141 ~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  217 (340)
T PTZ00426        141 VLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIF  217 (340)
T ss_pred             HHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhH
Confidence            99999999   789999999999999999999999999999865432         334777667778999999999999


Q ss_pred             HHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCC
Q 040999          269 LLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSM  348 (382)
Q Consensus       269 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~  348 (382)
                      +|||+||+.||...    .... ....        +...... .+ .                  .....+.+++.+|++
T Consensus       218 l~ell~G~~Pf~~~----~~~~-~~~~--------i~~~~~~-~p-~------------------~~~~~~~~li~~~l~  264 (340)
T PTZ00426        218 IYEILVGCPPFYAN----EPLL-IYQK--------ILEGIIY-FP-K------------------FLDNNCKHLMKKLLS  264 (340)
T ss_pred             HHHHhcCCCCCCCC----CHHH-HHHH--------HhcCCCC-CC-C------------------CCCHHHHHHHHHHcc
Confidence            99999999998632    1111 1111        0110000 00 0                  112245677889999


Q ss_pred             CCccCCC-----CHHHHHHH
Q 040999          349 ESPQDRM-----KMTNVVHE  363 (382)
Q Consensus       349 ~~p~~RP-----s~~evl~~  363 (382)
                      .+|++|+     +++++++.
T Consensus       265 ~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        265 HDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             cCHHHcCCCCCCCHHHHHcC
Confidence            9999995     88888754

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=3e-32  Score=253.97  Aligned_cols=194  Identities=19%  Similarity=0.146  Sum_probs=150.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+++|+.++||||+++++++.     .++..++||||+++|+|.+++.          ....+.+..+..++.|+
T Consensus        45 ~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi  109 (323)
T cd05584          45 AHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLYLILEYLSGGELFMHLE----------REGIFMEDTACFYLSEI  109 (323)
T ss_pred             HHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEEEEEeCCCCchHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            45678999999999999999999854     3678999999999999998883          23457788888999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++...            .....||...+..++.++|||||
T Consensus       110 ~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  186 (323)
T cd05584         110 SLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSL  186 (323)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceeccc
Confidence            99999999   7799999999999999999999999999986431            12344777777778899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....     .........        ..... .+                   ......+.+++.+
T Consensus       187 G~il~ell~G~~pf~~~~-----~~~~~~~~~--------~~~~~-~~-------------------~~~~~~~~~li~~  233 (323)
T cd05584         187 GALMYDMLTGAPPFTAEN-----RKKTIDKIL--------KGKLN-LP-------------------PYLTPEARDLLKK  233 (323)
T ss_pred             HHHHHHHhcCCCCCCCCC-----HHHHHHHHH--------cCCCC-CC-------------------CCCCHHHHHHHHH
Confidence            999999999999986421     111111111        10000 00                   0122356788889


Q ss_pred             cCCCCccCCC-----CHHHHHH
Q 040999          346 CSMESPQDRM-----KMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RP-----s~~evl~  362 (382)
                      ||+.+|++||     ++.++++
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhc
Confidence            9999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.2e-31  Score=242.92  Aligned_cols=204  Identities=21%  Similarity=0.342  Sum_probs=159.5

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ...+.+|+.++++++|+||++++++|..      ...++|+||+++|+|.+++..         ....+++..+..++.|
T Consensus        53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~q  117 (279)
T cd05057          53 NKEILDEAYVMASVDHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRN---------HKDNIGSQYLLNWCVQ  117 (279)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEec------CceEEEEecCCCCcHHHHHHh---------ccCCCCHHHHHHHHHH
Confidence            3678899999999999999999999753      578999999999999999842         2345899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||+|||   +.+++||||||+||+++.++.+||+|||.++.....              ...||......++.++||
T Consensus       118 i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di  194 (279)
T cd05057         118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDV  194 (279)
T ss_pred             HHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhH
Confidence            999999999   779999999999999999999999999999765321              233666666778899999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||+++||++| |+.||+...     ...+...         +.........                  ..+...+.+
T Consensus       195 ~slG~~l~el~~~g~~p~~~~~-----~~~~~~~---------~~~~~~~~~~------------------~~~~~~~~~  242 (279)
T cd05057         195 WSYGVTVWELMTFGAKPYEGIP-----AVEIPDL---------LEKGERLPQP------------------PICTIDVYM  242 (279)
T ss_pred             HHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH---------HhCCCCCCCC------------------CCCCHHHHH
Confidence            999999999998 999986421     1111110         1000000000                  012235678


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      ++.+||..+|++||++.++++.|.++...
T Consensus       243 ~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         243 VLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             HHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            88899999999999999999999988553

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.9e-33  Score=231.83  Aligned_cols=197  Identities=20%  Similarity=0.273  Sum_probs=158.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++-+.|+||||+++|+++     .+....||++||.++|++...|...        ....+++.....+..|+
T Consensus        67 ~qlrREiEIqs~L~hpnilrlY~~f-----hd~~riyLilEya~~gel~k~L~~~--------~~~~f~e~~~a~Yi~q~  133 (281)
T KOG0580|consen   67 HQLRREIEIQSHLRHPNILRLYGYF-----HDSKRIYLILEYAPRGELYKDLQEG--------RMKRFDEQRAATYIKQL  133 (281)
T ss_pred             hhhhheeEeecccCCccHHhhhhhe-----eccceeEEEEEecCCchHHHHHHhc--------ccccccccchhHHHHHH
Confidence            6799999999999999999999994     4588999999999999999999532        34568888899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC----------CCCccccCCCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR----------TQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~----------~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      |.||.|+|   .++|+||||||+|+|++..+..|++|||.+..-+...          ..||...+...+.++|+|++|+
T Consensus       134 A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgv  210 (281)
T KOG0580|consen  134 ANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGV  210 (281)
T ss_pred             HHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHH
Confidence            99999999   8999999999999999999999999999987654322          2377778888999999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ..||++.|.+||+... .+..+....+..+.       .+                         ........+++.+|+
T Consensus       211 l~yeflvg~ppFes~~-~~etYkrI~k~~~~-------~p-------------------------~~is~~a~dlI~~ll  257 (281)
T KOG0580|consen  211 LCYEFLVGLPPFESQS-HSETYKRIRKVDLK-------FP-------------------------STISGGAADLISRLL  257 (281)
T ss_pred             HHHHHHhcCCchhhhh-hHHHHHHHHHcccc-------CC-------------------------cccChhHHHHHHHHh
Confidence            9999999999987533 11122222111110       00                         012235677888999


Q ss_pred             CCCccCCCCHHHHHHH
Q 040999          348 MESPQDRMKMTNVVHE  363 (382)
Q Consensus       348 ~~~p~~RPs~~evl~~  363 (382)
                      ..+|.+|.+..||+..
T Consensus       258 ~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  258 VKNPIERLALTEVMDH  273 (281)
T ss_pred             ccCccccccHHHHhhh
Confidence            9999999999998753

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=3.6e-32  Score=254.05  Aligned_cols=146  Identities=23%  Similarity=0.293  Sum_probs=126.6

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|..++.++ +||||+++++++.     .....++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        40 ~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~~~----------~~~~l~~~~~~~~~~q  104 (329)
T cd05588          40 DWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVIEFVSGGDLMFHMQ----------RQRKLPEEHARFYSAE  104 (329)
T ss_pred             HHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            4577899999998 7999999999854     3678999999999999988873          2356899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++||||
T Consensus       105 i~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  181 (329)
T cd05588         105 ISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA  181 (329)
T ss_pred             HHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceec
Confidence            999999999   7899999999999999999999999999987421            1233477777788899999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      |||++|||+||+.||+.
T Consensus       182 lG~~l~el~~g~~Pf~~  198 (329)
T cd05588         182 LGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             hHHHHHHHHHCCCCccc
Confidence            99999999999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=7.1e-33  Score=257.65  Aligned_cols=191  Identities=19%  Similarity=0.161  Sum_probs=148.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        43 ~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi  107 (318)
T cd05582          43 VRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAEL  107 (318)
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            35678999999999999999999854     3678999999999999998883          23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....            ...||...+..++.++|||||
T Consensus       108 ~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  184 (318)
T cd05582         108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF  184 (318)
T ss_pred             HHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceecc
Confidence            99999999   779999999999999999999999999998754322            223666666778899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||....    . ...........        .. .+                   ......+.+++.+
T Consensus       185 G~il~el~tg~~p~~~~~----~-~~~~~~i~~~~--------~~-~p-------------------~~~~~~~~~li~~  231 (318)
T cd05582         185 GVLMFEMLTGSLPFQGKD----R-KETMTMILKAK--------LG-MP-------------------QFLSPEAQSLLRA  231 (318)
T ss_pred             ceEeeeeccCCCCCCCCC----H-HHHHHHHHcCC--------CC-CC-------------------CCCCHHHHHHHHH
Confidence            999999999999986421    1 11111110000        00 00                   0122356778889


Q ss_pred             cCCCCccCCCCHHH
Q 040999          346 CSMESPQDRMKMTN  359 (382)
Q Consensus       346 Cl~~~p~~RPs~~e  359 (382)
                      ||+.||++||++.+
T Consensus       232 ~l~~~P~~R~~a~~  245 (318)
T cd05582         232 LFKRNPANRLGAGP  245 (318)
T ss_pred             HhhcCHhHcCCCCC
Confidence            99999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=9.2e-32  Score=242.81  Aligned_cols=200  Identities=20%  Similarity=0.364  Sum_probs=155.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+.++++++|+||+++++++.      .+..+++|||+++++|.+++..        .....+++..+..++.|+
T Consensus        46 ~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~~i  111 (260)
T cd05067          46 EAFLAEANLMKQLQHPRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKT--------PEGIKLTINKLIDMAAQI  111 (260)
T ss_pred             HHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcEEEEEcCCCCCHHHHHHh--------cCCCCCCHHHHHHHHHHH
Confidence            57899999999999999999998742      4568999999999999998842        123468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+++||||||+||+++.++.++|+|||++.....             ....||...+..++.++||||
T Consensus       112 ~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~s  188 (260)
T cd05067         112 AEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS  188 (260)
T ss_pred             HHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHH
Confidence            99999999   77999999999999999999999999999975541             123356555667788999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++||+++ |+.||.....  .............           ..+                   ...+.++.+++
T Consensus       189 lG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~-----------~~~-------------------~~~~~~~~~li  236 (260)
T cd05067         189 FGILLTEIVTYGRIPYPGMTN--PEVIQNLERGYRM-----------PRP-------------------DNCPEELYELM  236 (260)
T ss_pred             HHHHHHHHHhCCCCCCCCCCh--HHHHHHHHcCCCC-----------CCC-------------------CCCCHHHHHHH
Confidence            9999999999 9999864211  1111110000000           000                   01234688888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      .+||+.+|++|||+++++..|+.
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         237 RLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHccCChhhCCCHHHHHHHhhc
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=1.7e-31  Score=240.25  Aligned_cols=200  Identities=25%  Similarity=0.391  Sum_probs=155.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++++++||||+++++++..      +..++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi  109 (254)
T cd05083          44 QAFLEETAVMTKLHHKNLVRLLGVILH------NGLYIVMELMSKGNLVNFLRTR--------GRALVSVIQLLQFSLDV  109 (254)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEEEEECCCCCCHHHHHHhc--------CcCCCCHHHHHHHHHHH
Confidence            568999999999999999999998642      3468999999999999998532        22357899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||.+......         ...||...+..++.++|||||||+
T Consensus       110 ~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~  186 (254)
T cd05083         110 AEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVL  186 (254)
T ss_pred             HHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHH
Confidence            99999999   779999999999999999999999999998754321         234666666788899999999999


Q ss_pred             HHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          269 LLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       269 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      +|||++ |+.||....     .......         +.........                  ...+..+.+++.+||
T Consensus       187 l~el~~~g~~p~~~~~-----~~~~~~~---------~~~~~~~~~~------------------~~~~~~~~~li~~~l  234 (254)
T cd05083         187 LWEVFSYGRAPYPKMS-----LKEVKEC---------VEKGYRMEPP------------------EGCPADVYVLMTSCW  234 (254)
T ss_pred             HHHHHhCCCCCCccCC-----HHHHHHH---------HhCCCCCCCC------------------CcCCHHHHHHHHHHc
Confidence            999998 999976321     1111110         1100000000                  023346778888999


Q ss_pred             CCCccCCCCHHHHHHHHHH
Q 040999          348 MESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       348 ~~~p~~RPs~~evl~~L~~  366 (382)
                      +.+|++||+++++++.|++
T Consensus       235 ~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         235 ETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCChhhCcCHHHHHHHHcc
Confidence            9999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=8.5e-32  Score=251.38  Aligned_cols=148  Identities=18%  Similarity=0.158  Sum_probs=123.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++..     ++..++||||+++|+|.+++...        ....+++..+..++.|+
T Consensus        44 ~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~--------~~~~l~~~~~~~i~~qi  110 (327)
T cd08227          44 TFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWVVTSFMAYGSAKDLICTH--------FMDGMSELAIAYILQGV  110 (327)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEEEEeccCCCcHHHHHHhh--------ccCCCCHHHHHHHHHHH
Confidence            457789999999999999999999754     67889999999999999988421        12358899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------------CCCCCccccC--CCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------------TRTQTKYGVG--NEV  256 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------------~~~~~~~~~~--~~~  256 (382)
                      +.||+|||   +.+|+||||||+|||++.++.++++||+.+.....                   ....||...+  ..+
T Consensus       111 ~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  187 (327)
T cd08227         111 LKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGY  187 (327)
T ss_pred             HHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCC
Confidence            99999999   77999999999999999999999999986432210                   1234666544  357


Q ss_pred             CccchhHHHHHHHHHHHhcCCCCCc
Q 040999          257 STIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      +.++|||||||++|||++|+.||..
T Consensus       188 ~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         188 DAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCC
Confidence            8999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.9e-31  Score=246.99  Aligned_cols=148  Identities=22%  Similarity=0.298  Sum_probs=128.1

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+++.+|++++++++||||+++++++..     .+..++||||+++++|.+++.          ....+++..+..++.|
T Consensus        43 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ey~~~~~L~~~l~----------~~~~~~~~~~~~~~~~  107 (308)
T cd06615          43 RNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLK----------KAGRIPENILGKISIA  107 (308)
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEEEeeccCCCcHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            3568899999999999999999999654     678999999999999999984          2345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      +++||.|||+  ..+++||||||+||+++.++.+||+|||++.....          ....||...+..++.++||||||
T Consensus       108 i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG  185 (308)
T cd06615         108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLG  185 (308)
T ss_pred             HHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHH
Confidence            9999999994  24899999999999999999999999999875432          23347776677789999999999


Q ss_pred             HHHHHHHhcCCCCCc
Q 040999          267 ILLLELMIREKPSDI  281 (382)
Q Consensus       267 vil~elltg~~p~~~  281 (382)
                      |++|||+||+.||..
T Consensus       186 ~~l~~l~~g~~p~~~  200 (308)
T cd06615         186 LSLVEMAIGRYPIPP  200 (308)
T ss_pred             HHHHHHHhCCCCCCC
Confidence            999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.2e-31  Score=241.54  Aligned_cols=197  Identities=20%  Similarity=0.319  Sum_probs=152.0

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ...|.+|++++++++|+||+++++++..      ...++||||+++|+|.+++..         ....+++..+..++.|
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~  109 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR------DENIMVEEYVKFGPLDVFLHR---------EKNNVSLHWKLDVAKQ  109 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec------CCcEEEEEcCCCCcHHHHHHh---------hccCCCHHHHHHHHHH
Confidence            3678999999999999999999998653      456899999999999999842         2226889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCC-------cEEEccccccccCCC--------CCCCCccccCC--CCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-------TARVGDFGLARFLPP--------TRTQTKYGVGN--EVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-------~~kl~Dfg~a~~~~~--------~~~~~~~~~~~--~~~~~  259 (382)
                      ++.||+|||   +.+|+||||||+||+++.++       .+||+|||++.....        ....||+..+.  .++.+
T Consensus       110 i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  186 (259)
T cd05037         110 LASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIA  186 (259)
T ss_pred             HHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcccccccccccccCCCccChhhhcCCCCCcchh
Confidence            999999999   78999999999999999887       799999999986432        23447776555  78899


Q ss_pred             chhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +|||||||++|||++ |..||.....  .....+..           .......                     .....
T Consensus       187 ~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~-----------~~~~~~~---------------------~~~~~  232 (259)
T cd05037         187 ADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQ-----------DQHRLPM---------------------PDCAE  232 (259)
T ss_pred             hHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHh-----------cCCCCCC---------------------CCchH
Confidence            999999999999999 5677653211  00001000           0000000                     00146


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      +.+++.+||..+|.+|||+.+|++.|+
T Consensus       233 ~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         233 LANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            778888999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=2e-31  Score=240.10  Aligned_cols=208  Identities=22%  Similarity=0.363  Sum_probs=159.5

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++.+..++|+||+++++++..     ....++||||+++++|.+++....... .......+++..+..++.|
T Consensus        40 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~  113 (262)
T cd00192          40 RKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVLEYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQ  113 (262)
T ss_pred             HHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEEEeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHH
Confidence            4678899999999999999999998643     678899999999999999985421000 0001366899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +++||+|||   +.+++|+||||+||+++.++.+||+|||.+......              ...||...+..++.++||
T Consensus       114 l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  190 (262)
T cd00192         114 IAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDV  190 (262)
T ss_pred             HHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhcc
Confidence            999999999   789999999999999999999999999999866542              233666666678899999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||+|+++|||++ |..||....     .........        +......+                   .....++.+
T Consensus       191 ~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~--------~~~~~~~~-------------------~~~~~~~~~  238 (262)
T cd00192         191 WSFGVLLWEIFTLGATPYPGLS-----NEEVLEYLR--------KGYRLPKP-------------------EYCPDELYE  238 (262)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHH--------cCCCCCCC-------------------ccCChHHHH
Confidence            999999999999 599986431     111111100        00000000                   022456788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      ++.+||+.+|++|||+.|+++.|+
T Consensus       239 li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         239 LMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHccCCcccCcCHHHHHHhhC
Confidence            888999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=7.5e-32  Score=251.87  Aligned_cols=146  Identities=23%  Similarity=0.301  Sum_probs=125.9

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+.++.++ +||||+++++++.     ..+..++||||+++|+|..++.          ....+++..+..++.|
T Consensus        40 ~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~E~~~~~~L~~~~~----------~~~~l~~~~~~~i~~q  104 (329)
T cd05618          40 DWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAE  104 (329)
T ss_pred             HHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            4577888888877 7999999999854     3678999999999999988773          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...            ....+||...+..++.++||||
T Consensus       105 i~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  181 (329)
T cd05618         105 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA  181 (329)
T ss_pred             HHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceec
Confidence            999999999   7799999999999999999999999999987531            1233477777788899999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      |||++|||+||+.||+.
T Consensus       182 lG~il~el~~g~~Pf~~  198 (329)
T cd05618         182 LGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccHHHHHHhhCCCCCcc
Confidence            99999999999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=5.9e-32  Score=256.92  Aligned_cols=229  Identities=19%  Similarity=0.250  Sum_probs=152.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++++.++|+||+++++++...........++|+||+. ++|.+++.          ....+++..+..++.||
T Consensus        44 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----------~~~~l~~~~~~~~~~qi  112 (372)
T cd07853          44 KRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIV----------SPQPLSSDHVKVFLYQI  112 (372)
T ss_pred             HHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHh----------cCCCCCHHHHHHHHHHH
Confidence            56889999999999999999999975422222237899999996 57777662          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccC-CCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVG-NEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~-~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....             ...||...+ ..++.++|||
T Consensus       113 ~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  189 (372)
T cd07853         113 LRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIW  189 (372)
T ss_pred             HHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHH
Confidence            99999999   779999999999999999999999999999754321             233555444 3478899999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhh--hhhhhHHHHHHHHHH
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQ--AKINVIIECVISMVR  341 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  341 (382)
                      ||||++|||++|+.||...... ..+.............++... .. .............+.  .......+...++.+
T Consensus       190 slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (372)
T cd07853         190 SVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSA-CE-GARAHILRGPHKPPSLPVLYTLSSQATHEAVH  266 (372)
T ss_pred             hHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHh-hH-HHHHHHHhCCCCCCchHHhcccCCCCCHHHHH
Confidence            9999999999999998642110 111111111111111110000 00 000000000000000  000000122346788


Q ss_pred             HhhccCCCCccCCCCHHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ++.+|++.||++|||+.|+++.
T Consensus       267 li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         267 LLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHhCCCChhhCcCHHHHhcC
Confidence            8999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1e-31  Score=263.25  Aligned_cols=205  Identities=20%  Similarity=0.216  Sum_probs=154.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc---CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY---QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ..+.+|+..+..++|+||+++++.+...+.   ......++||||+++|+|.+++....      .....+++..+..++
T Consensus        76 ~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~------~~~~~l~e~~~~~i~  149 (496)
T PTZ00283         76 NRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRA------KTNRTFREHEAGLLF  149 (496)
T ss_pred             HHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhh------ccCCCCCHHHHHHHH
Confidence            568889999999999999998877543211   11124689999999999999885322      223568899999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~  260 (382)
                      .|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....              ....||...+..++.++
T Consensus       150 ~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~  226 (496)
T PTZ00283        150 IQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA  226 (496)
T ss_pred             HHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHH
Confidence            99999999999   77999999999999999999999999999875432              12347777777889999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||||++|||++|+.||...     ..............        ...+                   .....++.
T Consensus       227 DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~~~~~~~~--------~~~~-------------------~~~~~~l~  274 (496)
T PTZ00283        227 DMFSLGVLLYELLTLKRPFDGE-----NMEEVMHKTLAGRY--------DPLP-------------------PSISPEMQ  274 (496)
T ss_pred             HHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHhcCCC--------CCCC-------------------CCCCHHHH
Confidence            9999999999999999998632     11111111111000        0000                   02234677


Q ss_pred             HHhhccCCCCccCCCCHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +++.+||+.+|.+||++.++++.
T Consensus       275 ~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        275 EIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHHcccChhhCcCHHHHHhC
Confidence            88889999999999999999864

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=4.1e-32  Score=252.73  Aligned_cols=189  Identities=21%  Similarity=0.219  Sum_probs=146.2

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|.+++..+ +||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        40 ~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~Ey~~~g~L~~~i~----------~~~~l~~~~~~~~~~q  104 (320)
T cd05590          40 ECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVMEFVNGGDLMFHIQ----------KSRRFDEARARFYAAE  104 (320)
T ss_pred             HHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEEcCCCCchHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            4567888888877 6999999999854     4778999999999999998883          2346889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++||||
T Consensus       105 l~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  181 (320)
T cd05590         105 ITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWA  181 (320)
T ss_pred             HHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhh
Confidence            999999999   7899999999999999999999999999987531            1233477767778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....     ............        .. .+ .                  ....++.+++.
T Consensus       182 lG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~~--------~~-~~-~------------------~~~~~~~~li~  228 (320)
T cd05590         182 MGVLLYEMLCGHAPFEAEN-----EDDLFEAILNDE--------VV-YP-T------------------WLSQDAVDILK  228 (320)
T ss_pred             hHHHHHHHhhCCCCCCCCC-----HHHHHHHHhcCC--------CC-CC-C------------------CCCHHHHHHHH
Confidence            9999999999999986321     111111111100        00 00 0                  12235677888


Q ss_pred             ccCCCCccCCCCH
Q 040999          345 ACSMESPQDRMKM  357 (382)
Q Consensus       345 ~Cl~~~p~~RPs~  357 (382)
                      +|++.||++||++
T Consensus       229 ~~L~~dP~~R~~~  241 (320)
T cd05590         229 AFMTKNPTMRLGS  241 (320)
T ss_pred             HHcccCHHHCCCC
Confidence            9999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=3e-31  Score=238.06  Aligned_cols=200  Identities=24%  Similarity=0.374  Sum_probs=156.5

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++++..     ....++||||+++++|.+++..         ....+++..+..++.+
T Consensus        36 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~l~~~l~~---------~~~~~~~~~~~~~~~~  101 (251)
T cd05041          36 KRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELVPGGSLLTFLRK---------KKNRLTVKKLLQMSLD  101 (251)
T ss_pred             HHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcCCCCcHHHHHHh---------cCCCCCHHHHHHHHHH
Confidence            3578999999999999999999998643     6778999999999999998842         2235788899999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||+|||   +.+++||||||+||+++.++.+||+|||.++....              ....||...+..++.++||
T Consensus       102 ~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di  178 (251)
T cd05041         102 AAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV  178 (251)
T ss_pred             HHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhH
Confidence            999999999   77999999999999999999999999999875431              1344776666778999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||+| |..||.....  .......            .........                  ...+..+.+
T Consensus       179 ~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~------------~~~~~~~~~------------------~~~~~~~~~  226 (251)
T cd05041         179 WSYGILLWETFSLGDTPYPGMSN--QQTRERI------------ESGYRMPAP------------------QLCPEEIYR  226 (251)
T ss_pred             HHHHHHHHHHHhccCCCCccCCH--HHHHHHH------------hcCCCCCCC------------------ccCCHHHHH
Confidence            999999999999 8888754211  0111111            000000000                  023446888


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      ++.+||+.+|++|||+.|+++.|+
T Consensus       227 li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         227 LMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHhccChhhCcCHHHHHHHhh
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=5.9e-32  Score=252.25  Aligned_cols=196  Identities=21%  Similarity=0.250  Sum_probs=151.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++..++||||+++++++.     ..+..++||||+++|+|..++.          ....+++..+..++.||
T Consensus        40 ~~~~~e~~~l~~~~hp~i~~~~~~~~-----~~~~~~lv~E~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi  104 (325)
T cd05594          40 AHTLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLS----------RERVFSEDRARFYGAEI  104 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEE-----cCCEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            46788999999999999999998854     3678999999999999988873          33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||+  ..+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++|||||
T Consensus       105 ~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (325)
T cd05594         105 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  182 (325)
T ss_pred             HHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccc
Confidence            999999993  2699999999999999999999999999986432            12334777777788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||....     .............      .+   + .                  ....++.+++.+
T Consensus       183 G~il~el~tG~~Pf~~~~-----~~~~~~~i~~~~~------~~---p-~------------------~~~~~~~~li~~  229 (325)
T cd05594         183 GVVMYEMMCGRLPFYNQD-----HEKLFELILMEEI------RF---P-R------------------TLSPEAKSLLSG  229 (325)
T ss_pred             cceeeeeccCCCCCCCCC-----HHHHHHHHhcCCC------CC---C-C------------------CCCHHHHHHHHH
Confidence            999999999999985321     1111111100000      00   0 0                  112356778889


Q ss_pred             cCCCCccCCC-----CHHHHHHH
Q 040999          346 CSMESPQDRM-----KMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RP-----s~~evl~~  363 (382)
                      ||+.||++|+     ++.++++.
T Consensus       230 ~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         230 LLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HhhcCHHHhCCCCCCCHHHHhcC
Confidence            9999999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=2e-31  Score=242.24  Aligned_cols=213  Identities=22%  Similarity=0.371  Sum_probs=156.5

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCC-ceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGN-DFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+++.+|++++++++||||+++++++......+. ...+++++|+++|+|.+++......    .....+++.....++.
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~  120 (273)
T cd05074          45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMI  120 (273)
T ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHH
Confidence            3578899999999999999999998764221111 2347889999999998887432211    1223578899999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccch
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~D  261 (382)
                      |++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....              ...||......++.++|
T Consensus       121 ~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sD  197 (273)
T cd05074         121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSD  197 (273)
T ss_pred             HHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhh
Confidence            9999999999   779999999999999999999999999998865321              11244445566788999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||++ |+.||.....  .....+...   ..       .....                    ......+.
T Consensus       198 i~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~---~~-------~~~~~--------------------~~~~~~~~  245 (273)
T cd05074         198 VWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIK---GN-------RLKQP--------------------PDCLEDVY  245 (273)
T ss_pred             hHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHc---CC-------cCCCC--------------------CCCCHHHH
Confidence            9999999999999 8888753211  111111110   00       00000                    02234788


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      +++.+||+.+|++|||+.++++.|+++.
T Consensus       246 ~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         246 ELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            8999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=1.7e-31  Score=240.20  Aligned_cols=199  Identities=19%  Similarity=0.244  Sum_probs=154.9

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++++..     ....++++||+++++|.+++..         ....+++..+..++.|
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~~  107 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIMKI---------TNKTLTEEEIAAILYQ  107 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEEecCCCCcHHHHHHh---------CccCCCHHHHHHHHHH
Confidence            4679999999999999999999998653     6788999999999999998842         2356899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......            ...||...+..++.++||||
T Consensus       108 l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  184 (256)
T cd06612         108 TLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS  184 (256)
T ss_pred             HHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHH
Confidence            999999999   779999999999999999999999999998865432            23366666677889999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|||+||+.||.......    .... . ....    .....                    ........+.+++.
T Consensus       185 ~G~il~~l~~g~~p~~~~~~~~----~~~~-~-~~~~----~~~~~--------------------~~~~~~~~~~~~i~  234 (256)
T cd06612         185 LGITAIEMAEGKPPYSDIHPMR----AIFM-I-PNKP----PPTLS--------------------DPEKWSPEFNDFVK  234 (256)
T ss_pred             HHHHHHHHHhCCCCCCCcchhh----hhhh-h-ccCC----CCCCC--------------------chhhcCHHHHHHHH
Confidence            9999999999999986421110    0000 0 0000    00000                    00022346788888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.+|++|||+.||++
T Consensus       235 ~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHhcChhhCcCHHHHhc
Confidence            999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=1.1e-31  Score=249.57  Aligned_cols=194  Identities=18%  Similarity=0.189  Sum_probs=150.8

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|.+++..+ +||||+++++++.     ..+..++||||+++|+|..++.          ....+++..+..++.|
T Consensus        40 ~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~q  104 (318)
T cd05570          40 ECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVMEYVNGGDLMFHIQ----------RSGRFDEPRARFYAAE  104 (318)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEEcCCCCCCHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            4567888999888 6999999999854     3678999999999999988873          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...            .....||...+..++.++||||
T Consensus       105 i~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws  181 (318)
T cd05570         105 IVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWA  181 (318)
T ss_pred             HHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhh
Confidence            999999999   7899999999999999999999999999986421            1233477777788899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||....     ...........        ... .+                   ......+.+++.
T Consensus       182 lGvil~~l~~G~~pf~~~~-----~~~~~~~i~~~--------~~~-~~-------------------~~~~~~~~~li~  228 (318)
T cd05570         182 LGVLLYEMLAGQSPFEGDD-----EDELFQSILED--------EVR-YP-------------------RWLSKEAKSILK  228 (318)
T ss_pred             HHHHHHHHhhCCCCCCCCC-----HHHHHHHHHcC--------CCC-CC-------------------CcCCHHHHHHHH
Confidence            9999999999999986321     11111111000        000 00                   012235678888


Q ss_pred             ccCCCCccCCCCH-----HHHHH
Q 040999          345 ACSMESPQDRMKM-----TNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~-----~evl~  362 (382)
                      +||+.||++||++     .++++
T Consensus       229 ~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         229 SFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHccCCHHHcCCCCCCCHHHHhc
Confidence            9999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=2.6e-31  Score=240.69  Aligned_cols=197  Identities=18%  Similarity=0.277  Sum_probs=153.5

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++||||+++++++..     .+..++|+||+++++|.+++.          ....+++..+..++.
T Consensus        49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~  113 (267)
T cd06628          49 MLDALAREIALLKELQHENIVQYLGSSLD-----ADHLNIFLEYVPGGSVAALLN----------NYGAFEETLVRNFVR  113 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----CCccEEEEEecCCCCHHHHHH----------hccCccHHHHHHHHH
Confidence            34678999999999999999999998653     678899999999999999983          234688889999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------------CCCCccccCCCCC
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------------RTQTKYGVGNEVS  257 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------------~~~~~~~~~~~~~  257 (382)
                      |++.||+|||   +.+++||||+|+||+++.++.+||+|||.++.....                  ...||...+..++
T Consensus       114 ~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~  190 (267)
T cd06628         114 QILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT  190 (267)
T ss_pred             HHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCC
Confidence            9999999999   779999999999999999999999999998765421                  1236655566778


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          258 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      .++|||||||++|||++|+.||....    .........      ....+...                      .....
T Consensus       191 ~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~------~~~~~~~~----------------------~~~~~  238 (267)
T cd06628         191 RKADIWSLGCLVVEMLTGKHPFPDCT----QLQAIFKIG------ENASPEIP----------------------SNISS  238 (267)
T ss_pred             chhhhHHHHHHHHHHhhCCCCCCCcc----HHHHHHHHh------ccCCCcCC----------------------cccCH
Confidence            89999999999999999999986421    111111000      00000000                      02234


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHH
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+.+++.+||+.+|.+||++.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhh
Confidence            6778888999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-32  Score=259.02  Aligned_cols=203  Identities=22%  Similarity=0.358  Sum_probs=166.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+-+|.+++|||+++++|+|..      ....||++|||.|+|.+|++.         ...++..+..+.|+.||
T Consensus       743 ~e~LdeAl~masldHpnl~RLLgvc~~------s~~qlvtq~mP~G~LlDyvr~---------hr~~igsq~lLnw~~QI  807 (1177)
T KOG1025|consen  743 IELLDEALRMASLDHPNLLRLLGVCML------STLQLVTQLMPLGCLLDYVRE---------HRDNIGSQDLLNWCYQI  807 (1177)
T ss_pred             HHHHHHHHHHhcCCCchHHHHhhhccc------chHHHHHHhcccchHHHHHHH---------hhccccHHHHHHHHHHH
Confidence            789999999999999999999999975      337799999999999999953         45678889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCC--------------CccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ--------------TKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--------------~~~~~~~~~~~~~Dv~  263 (382)
                      |+|+.|||   +++++||||-.+|+|+.....+||.|||+|+.+.++...              -|......++.++|||
T Consensus       808 AkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVW  884 (1177)
T KOG1025|consen  808 AKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVW  884 (1177)
T ss_pred             HHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhh
Confidence            99999999   889999999999999999999999999999988665432              1233456789999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||++||++| |..|++.+..              +++.++++.-....                  ...-|..++..+
T Consensus       885 sfGVtiWElmTFGa~Py~gi~~--------------~eI~dlle~geRLs------------------qPpiCtiDVy~~  932 (1177)
T KOG1025|consen  885 SFGVTIWELMTFGAKPYDGIPA--------------EEIPDLLEKGERLS------------------QPPICTIDVYMV  932 (1177)
T ss_pred             hhhhhHHHHHhcCCCccCCCCH--------------HHhhHHHhccccCC------------------CCCCccHHHHHH
Confidence            99999999997 8889775422              12333333211111                  112577889999


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +.+||..|+..||+++++..++.+....
T Consensus       933 mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  933 MVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             HHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            9999999999999999999999877553

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=1.7e-31  Score=233.72  Aligned_cols=153  Identities=24%  Similarity=0.303  Sum_probs=130.1

Q ss_pred             chhhHH----------HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCC
Q 040999          113 AFKIFK----------SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP  182 (382)
Q Consensus       113 avK~~~----------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  182 (382)
                      |.|+++          .-.|||.+|.+++|||||.+..+..+.   .-+.+|+|||||+. +|...+.         ...
T Consensus       105 ALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~iy~VMe~~Eh-DLksl~d---------~m~  171 (419)
T KOG0663|consen  105 ALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDKIYIVMEYVEH-DLKSLME---------TMK  171 (419)
T ss_pred             EeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccceeeeeHHHHHh-hHHHHHH---------hcc
Confidence            778772          468999999999999999999997763   35669999999976 7888884         334


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCC------------CCcc
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRT------------QTKY  250 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~------------~~~~  250 (382)
                      .++...++..++.|+++|++|||   ...|+||||||+|+|++..|.+||+|||+|+.+.....            +||.
T Consensus       172 q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPEL  248 (419)
T KOG0663|consen  172 QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPEL  248 (419)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHH
Confidence            57899999999999999999999   77899999999999999999999999999997765421            2554


Q ss_pred             cc-CCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          251 GV-GNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       251 ~~-~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      .. ...|++.+|+||+|||+.||+++++-|.+
T Consensus       249 LLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G  280 (419)
T KOG0663|consen  249 LLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG  280 (419)
T ss_pred             hcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence            44 35789999999999999999999998654

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=2.1e-31  Score=245.25  Aligned_cols=197  Identities=19%  Similarity=0.240  Sum_probs=152.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|+||+++++.+..     ....++||||+++++|.+++..           ..+++.++..++.|+
T Consensus        62 ~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~ql  125 (296)
T cd06654          62 ELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCREC  125 (296)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEEeecccCCCCHHHHHHh-----------cCCCHHHHHHHHHHH
Confidence            578899999999999999999998654     6789999999999999998832           247888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   ..+|+||||||+||+++.++.+||+|||.+......            ...||...+..++.++|||||
T Consensus       126 ~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~  202 (296)
T cd06654         126 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (296)
T ss_pred             HHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHH
Confidence            99999999   779999999999999999999999999998754321            233676666778899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||.....    ...+.... ....     +.+. .+                   ......+.+++.+
T Consensus       203 Gvil~~l~~g~~pf~~~~~----~~~~~~~~-~~~~-----~~~~-~~-------------------~~~~~~l~~li~~  252 (296)
T cd06654         203 GIMAIEMIEGEPPYLNENP----LRALYLIA-TNGT-----PELQ-NP-------------------EKLSAIFRDFLNR  252 (296)
T ss_pred             HHHHHHHHhCCCCCCCCCH----HHhHHHHh-cCCC-----CCCC-Cc-------------------cccCHHHHHHHHH
Confidence            9999999999999864211    11111000 0000     0000 00                   0223457788889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||..+|++|||+.++++.
T Consensus       253 ~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         253 CLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HCcCCcccCcCHHHHhhC
Confidence            999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=5.3e-31  Score=241.46  Aligned_cols=213  Identities=20%  Similarity=0.223  Sum_probs=156.4

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ..++.+|++++++++||||++++++|..   ......++||||+++++|.+++....      .....+++.....++.|
T Consensus        43 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~~  113 (287)
T cd06621          43 QKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIGIAMEYCEGGSLDSIYKKVK------KRGGRIGEKVLGKIAES  113 (287)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEEEEEEecCCCCHHHHHHHHH------hcCCCCCHHHHHHHHHH
Confidence            3678999999999999999999998753   23456899999999999988874321      12345788899999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------CCCCccccCCCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------RTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      ++.||+|||   ..+++|+||+|+||+++.++.++|+|||++......          ...||...+..++.++||||+|
T Consensus       114 i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG  190 (287)
T cd06621         114 VLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLG  190 (287)
T ss_pred             HHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHH
Confidence            999999999   779999999999999999999999999998754321          2346666677889999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||+..........+............     +.....                ........+.+++.+|
T Consensus       191 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~----------------~~~~~~~~~~~li~~~  249 (287)
T cd06621         191 LTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE-----LKDEPG----------------NGIKWSEEFKDFIKQC  249 (287)
T ss_pred             HHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh-----hccCCC----------------CCCchHHHHHHHHHHH
Confidence            9999999999998743211111111111100000000     000000                0001234678899999


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      |+.+|++|||+.|+++
T Consensus       250 l~~~p~~Rpt~~eil~  265 (287)
T cd06621         250 LEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cCCCcccCCCHHHHHh
Confidence            9999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=4.4e-31  Score=241.54  Aligned_cols=222  Identities=19%  Similarity=0.256  Sum_probs=153.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++..     ....++||||+++++|..++.          ....+++..+..++.|+
T Consensus        45 ~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~ql  109 (286)
T cd07847          45 KIALREIRMLKQLKHPNLVNLIEVFRR-----KRKLHLVFEYCDHTVLNELEK----------NPRGVPEHLIKKIIWQT  109 (286)
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEEEEEEeccCccHHHHHHh----------CCCCCCHHHHHHHHHHH
Confidence            457899999999999999999998643     678899999999988877662          23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC------------CCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR------------TQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||++.......            ..||...+ ..++.++||||
T Consensus       110 ~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s  186 (286)
T cd07847         110 LQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWA  186 (286)
T ss_pred             HHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHH
Confidence            99999999   7899999999999999999999999999998654322            23555443 45688999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC---chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN---HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||+++|||++|+.||...... ........ ....   ...+..+....   .........................+.+
T Consensus       187 lG~i~~~l~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (286)
T cd07847         187 IGCVFAELLTGQPLWPGKSDV-DQLYLIRK-TLGDLIPRHQQIFSTNQF---FKGLSIPEPETREPLESKFPNISSPALS  261 (286)
T ss_pred             HHHHHHHHHhCCCCCCCCChH-HHHHHHHH-HhCCCChHHhhhcccccc---cccccCCCcccccCHHHHhccCCHHHHH
Confidence            999999999999998642211 11111111 1100   00111100000   0000000000000000011123456788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.+|++||++.|++.
T Consensus       262 li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         262 FLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HHHHHhcCCccccCCHHHHhc
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-31  Score=243.38  Aligned_cols=201  Identities=19%  Similarity=0.210  Sum_probs=153.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+++++.++|+||+++++.+.     ..+..++||||+++|+|.+++...        ....+++..+..++.|+
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi  111 (285)
T cd05605          45 AMALNEKQILEKVNSRFVVSLAYAYE-----TKDALCLVLTLMNGGDLKFHIYNM--------GNPGFDEERAVFYAAEI  111 (285)
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeEEEEEeccCCCcHHHHHHhc--------CcCCCCHHHHHHHHHHH
Confidence            34778999999999999999999854     367899999999999998887421        22458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      +.||.|||   +.+++||||||+||++++++.++|+|||++.....           ....||...+..++.++||||+|
T Consensus       112 ~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G  188 (285)
T cd05605         112 TCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLG  188 (285)
T ss_pred             HHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHH
Confidence            99999999   77999999999999999999999999999976532           12347777777889999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||..... .........         .+..... ..                  .......+.+++.+|
T Consensus       189 ~~l~el~~g~~pf~~~~~-~~~~~~~~~---------~~~~~~~-~~------------------~~~~~~~~~~li~~~  239 (285)
T cd05605         189 CLIYEMIEGKSPFRQRKE-KVKREEVER---------RVKEDQE-EY------------------SEKFSEAARSICRQL  239 (285)
T ss_pred             HHHHHHHHCCCCCCCCch-hhHHHHHHH---------Hhhhccc-cc------------------CcccCHHHHHHHHHH
Confidence            999999999999864211 000011100         0000000 00                  002234577888899


Q ss_pred             CCCCccCCC-----CHHHHHHH
Q 040999          347 SMESPQDRM-----KMTNVVHE  363 (382)
Q Consensus       347 l~~~p~~RP-----s~~evl~~  363 (382)
                      |+.||++||     +++++++.
T Consensus       240 l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         240 LTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ccCCHHHhcCCCCCCHHHHhcC
Confidence            999999999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=3.3e-31  Score=241.78  Aligned_cols=198  Identities=21%  Similarity=0.257  Sum_probs=151.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++||||+++++++..     .+..++||||+++++|..+.              .+++.....++.|+
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi  104 (279)
T cd06619          44 KQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISICTEFMDGGSLDVYR--------------KIPEHVLGRIAVAV  104 (279)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEEEEecCCCCChHHhh--------------cCCHHHHHHHHHHH
Confidence            578999999999999999999999754     66788999999999886442              36778888999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      +.||.|||   +.+|+|+||||+||+++.++.+||+|||++.....          ....||...+..++.++||||||+
T Consensus       105 ~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~  181 (279)
T cd06619         105 VKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGI  181 (279)
T ss_pred             HHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHH
Confidence            99999999   77999999999999999999999999999875432          223477777778899999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchH--HHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          268 LLLELMIREKPSDIMFEGDMNL--HKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ++|||++|+.||..........  .......        .+........                  .....++.+++.+
T Consensus       182 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~------------------~~~~~~~~~li~~  235 (279)
T cd06619         182 SFMELALGRFPYPQIQKNQGSLMPLQLLQCI--------VDEDPPVLPV------------------GQFSEKFVHFITQ  235 (279)
T ss_pred             HHHHHHhCCCCchhhcccccccchHHHHHHH--------hccCCCCCCC------------------CcCCHHHHHHHHH
Confidence            9999999999986532211110  0100000        0000000000                  0122357788889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.+|++||+++|+++.
T Consensus       236 ~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         236 CMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HhhCChhhCCCHHHHhcC
Confidence            999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.4e-31  Score=239.05  Aligned_cols=201  Identities=21%  Similarity=0.398  Sum_probs=157.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++|+||+++++++.     .....++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~i~~~--------~~~~~~~~~~~~~~~~i  112 (261)
T cd05034          46 EAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYIVTEYMSKGSLLDFLKSG--------EGKKLRLPQLVDMAAQI  112 (261)
T ss_pred             HHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEEEEeccCCCCHHHHHhcc--------ccCCCCHHHHHHHHHHH
Confidence            57899999999999999999999854     356789999999999999998531        22468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+++|+||||+||+++.++.+||+|||.++....             ....||...+..++.++||||
T Consensus       113 ~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  189 (261)
T cd05034         113 AEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWS  189 (261)
T ss_pred             HHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHH
Confidence            99999999   77999999999999999999999999999876532             233467666777899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++||++| |+.||.....     .......        ........+                   ...+..+.+++
T Consensus       190 lG~il~~l~t~g~~p~~~~~~-----~~~~~~~--------~~~~~~~~~-------------------~~~~~~~~~~i  237 (261)
T cd05034         190 FGILLTEIVTYGRVPYPGMTN-----REVLEQV--------ERGYRMPRP-------------------PNCPEELYDLM  237 (261)
T ss_pred             HHHHHHHHHhCCCCCCCCCCH-----HHHHHHH--------HcCCCCCCC-------------------CCCCHHHHHHH
Confidence            9999999999 9999753211     0111100        000000000                   01234678889


Q ss_pred             hccCCCCccCCCCHHHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      .+|++.+|++||+++++.+.|+.
T Consensus       238 ~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         238 LQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHcccCcccCCCHHHHHHHHhc
Confidence            99999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=3.5e-31  Score=245.25  Aligned_cols=224  Identities=18%  Similarity=0.225  Sum_probs=150.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||+++++++..     ++..++||||+++ +|.+++..         ....+++..+..++.|+
T Consensus        49 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi  113 (309)
T cd07872          49 CTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLTLVFEYLDK-DLKQYMDD---------CGNIMSMHNVKIFLYQI  113 (309)
T ss_pred             hhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEEEEEeCCCC-CHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            357789999999999999999999653     6788999999975 78777732         23457888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....            ...||...+ ..++.++||||
T Consensus       114 ~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  190 (309)
T cd07872         114 LRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWG  190 (309)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHH
Confidence            99999999   779999999999999999999999999998753221            223665433 45788999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||...... ..+....... .....+............. .......+............++.+++.
T Consensus       191 lG~il~el~tg~~pf~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~  267 (309)
T cd07872         191 VGCIFFEMASGRPLFPGSTVE-DELHLIFRLL-GTPTEETWPGISSNDEFKN-YNFPKYKPQPLINHAPRLDTEGIELLT  267 (309)
T ss_pred             HHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh-CCCCHHHHhhhcchhhhhh-hhcCccCCCchhhhccCCCHHHHHHHH
Confidence            999999999999998642111 1111111111 1100000000000000000 000000000000001122345678888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +|++.||.+|||+.|+++
T Consensus       268 ~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         268 KFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HhccCChhhCCCHHHHhc
Confidence            999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=2.5e-31  Score=251.73  Aligned_cols=146  Identities=21%  Similarity=0.242  Sum_probs=127.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++.+++|+||+++++.+.     +....++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        46 ~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi  110 (363)
T cd05628          46 GHIRAERDILVEADSLWVVKMFYSFQ-----DKLNLYLIMEFLPGGDMMTLLM----------KKDTLTEEETQFYIAET  110 (363)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEe-----cCCeEEEEEcCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            46788999999999999999999854     4778999999999999999984          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------------------------------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------------------------------  243 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------------------------------  243 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++....                                  
T Consensus       111 ~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (363)
T cd05628         111 VLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKR  187 (363)
T ss_pred             HHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhh
Confidence            99999999   78999999999999999999999999999875321                                  


Q ss_pred             -------------CCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          244 -------------TRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       244 -------------~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                                   ...+||...+..++.++|||||||++|||++|+.||..
T Consensus       188 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         188 NRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                         12346666677789999999999999999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=1e-31  Score=256.06  Aligned_cols=146  Identities=21%  Similarity=0.275  Sum_probs=125.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++.     +.+..++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        46 ~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----------~~~~~~e~~~~~~~~qi  110 (381)
T cd05626          46 AHVKAERDILAEADNEWVVKLYYSFQ-----DKDNLYFVMDYIPGGDMMSLLI----------RMEVFPEVLARFYIAEL  110 (381)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            46889999999999999999999864     3678999999999999999884          23458888899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC-----------------------------------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-----------------------------------  242 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~-----------------------------------  242 (382)
                      +.||+|||   ..+|+||||||+|||++.++.+||+|||+++...                                   
T Consensus       111 ~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (381)
T cd05626         111 TLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD  187 (381)
T ss_pred             HHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccccccccccccccc
Confidence            99999999   7799999999999999999999999999875321                                   


Q ss_pred             ------------------------CCCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          243 ------------------------PTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       243 ------------------------~~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                                              ....+||...+..++.++|||||||++|||+||+.||..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~  250 (381)
T cd05626         188 RLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLA  250 (381)
T ss_pred             ccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcC
Confidence                                    112336666667789999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=5.5e-31  Score=237.06  Aligned_cols=199  Identities=16%  Similarity=0.226  Sum_probs=154.9

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+++.+|++++++++|+||+++++++..     .+..+++|||+++++|.+++...        ....+++..+..++.|
T Consensus        43 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~  109 (256)
T cd08221          43 RRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLLIEMEYANGGTLYDKIVRQ--------KGQLFEEEMVLWYLFQ  109 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEEEEEEecCCCcHHHHHHhc--------cccCCCHHHHHHHHHH
Confidence            3568899999999999999999999653     67899999999999999988421        1345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC------------CCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR------------TQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||.|||   +.+++|+||||+||+++.++.+||+|||.+.......            ..||...+..++.++||||
T Consensus       110 l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~s  186 (256)
T cd08221         110 IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWA  186 (256)
T ss_pred             HHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHH
Confidence            999999999   6799999999999999999999999999987653322            2366666667788999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|||++|..||+...     ............        .....                   ......+.+++.
T Consensus       187 lG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~--------~~~~~-------------------~~~~~~~~~~i~  234 (256)
T cd08221         187 LGCVLYELLTLKRTFDATN-----PLNLVVKIVQGN--------YTPVV-------------------SVYSSELISLVH  234 (256)
T ss_pred             HHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCC--------CCCCc-------------------cccCHHHHHHHH
Confidence            9999999999999976321     111111111000        00000                   022346778888


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.+|.+||+++|+++.
T Consensus       235 ~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         235 SLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHcccCcccCCCHHHHhhC
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=3.3e-31  Score=242.41  Aligned_cols=211  Identities=20%  Similarity=0.269  Sum_probs=157.6

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+++++.++||||+++++++..     ....++||||+++++|.+++.          ....+++.....++.+
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~  111 (284)
T cd06620          47 RKQILRELQIMHECRSPYIVSFYGAFLN-----ENNICMCMEFMDCGSLDRIYK----------KGGPIPVEILGKIAVA  111 (284)
T ss_pred             HHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEEEEEecCCCCCHHHHHH----------hccCCCHHHHHHHHHH
Confidence            3678999999999999999999999654     578899999999999998873          2346889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      ++.||.|||+  ..+++||||||+||+++.++.++|+|||++.....          ....||...+..++.++||||||
T Consensus       112 i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG  189 (284)
T cd06620         112 VVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLG  189 (284)
T ss_pred             HHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHH
Confidence            9999999994  25899999999999999999999999999865421          22346766667888999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++||++||+.||+........      ...+..+.+.+..........          ..    ..+.+..+.+++.+|
T Consensus       190 ~~l~~l~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~----------~~----~~~~~~~~~~li~~~  249 (284)
T cd06620         190 ISIIELALGKFPFAFSNIDDDG------QDDPMGILDLLQQIVQEPPPR----------LP----SSDFPEDLRDFVDAC  249 (284)
T ss_pred             HHHHHHHhCCCCCcccchhhhh------hhhhhHHHHHHHHHhhccCCC----------CC----chhcCHHHHHHHHHH
Confidence            9999999999998753221100      000001111111111100000          00    002345678888899


Q ss_pred             CCCCccCCCCHHHHHHHH
Q 040999          347 SMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       347 l~~~p~~RPs~~evl~~L  364 (382)
                      |+.||++|||+.|+++..
T Consensus       250 l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         250 LLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hcCCcccCcCHHHHhcCc
Confidence            999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=5.3e-31  Score=237.15  Aligned_cols=199  Identities=22%  Similarity=0.393  Sum_probs=154.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+|.+|++++++++||||+++++++.     .....++||||+++++|.+++..         ....+++..+..++.|+
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~l  109 (256)
T cd05112          44 EDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRA---------QRGKFSQETLLGMCLDV  109 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEEEEcCCCCcHHHHHHh---------CccCCCHHHHHHHHHHH
Confidence            46889999999999999999999854     35678999999999999988842         23457899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+++|+||||+||+++.++.+||+|||.+.....             ....||...+..++.++||||
T Consensus       110 ~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~s  186 (256)
T cd05112         110 CEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS  186 (256)
T ss_pred             HHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHH
Confidence            99999999   77999999999999999999999999999874422             123477767778889999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||++ |+.||.....     ..........         .......                  .....+.+++
T Consensus       187 lG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~---------~~~~~~~------------------~~~~~~~~l~  234 (256)
T cd05112         187 FGVLMWEVFSEGKTPYENRSN-----SEVVETINAG---------FRLYKPR------------------LASQSVYELM  234 (256)
T ss_pred             HHHHHHHHHcCCCCCCCcCCH-----HHHHHHHhCC---------CCCCCCC------------------CCCHHHHHHH
Confidence            9999999998 9999763211     1111110000         0000000                  1124678889


Q ss_pred             hccCCCCccCCCCHHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      .+||+.+|++|||+.+++++|+
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHcccChhhCCCHHHHHHhhC
Confidence            9999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=4e-31  Score=239.25  Aligned_cols=199  Identities=19%  Similarity=0.264  Sum_probs=153.3

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++|+||++++++|..     .+..++|+||+++++|.+++.          ....+++..+..++.
T Consensus        45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~  109 (265)
T cd06631          45 EYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----DNTISIFMEFVPGGSISSILN----------RFGPLPEPVFCKYTK  109 (265)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeEeeEeec-----CCeEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHH
Confidence            34678999999999999999999999653     678999999999999999983          234578899999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------------CCCCCccccCCCCC
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------------TRTQTKYGVGNEVS  257 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------------~~~~~~~~~~~~~~  257 (382)
                      |++.||+|||   +.+++|+||||+||+++.++.+||+|||.+.....                  ....||...+..++
T Consensus       110 qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~  186 (265)
T cd06631         110 QILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG  186 (265)
T ss_pred             HHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCc
Confidence            9999999999   77899999999999999999999999999875421                  12336766677788


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          258 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      .++|||||||++|||++|+.||.....    ............   .. +...                      .....
T Consensus       187 ~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~---~~-~~~~----------------------~~~~~  236 (265)
T cd06631         187 RKSDIWSIGCTVFEMATGKPPLASMDR----LAAMFYIGAHRG---LM-PRLP----------------------DSFSA  236 (265)
T ss_pred             chhhHHHHHHHHHHHHhCCCccccCCh----HHHHHHhhhccC---CC-CCCC----------------------CCCCH
Confidence            999999999999999999999864211    111100000000   00 0000                      01234


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHH
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         237 AAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhc
Confidence            5678888999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=5e-31  Score=239.95  Aligned_cols=209  Identities=19%  Similarity=0.323  Sum_probs=157.1

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++++.     +....++||||+++|+|.+++........ ......+++..+..++.|
T Consensus        52 ~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~-~~~~~~l~~~~~~~~~~~  125 (275)
T cd05046          52 QSEFRRELDMFRKLSHKNVVRLLGLCR-----EAEPHYMILEYTDLGDLKQFLRATKSKDE-KLKPPPLSTKQKVALCTQ  125 (275)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeEEEEC-----CCCcceEEEEecCCCcHHHHHHhcccccc-cccccCCCHHHHHHHHHH
Confidence            467899999999999999999999864     35678999999999999999853321100 011236899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      ++.||+|||   +.+|+||||||+||+++.++.++++|||+++....             ....||...+..++.++|||
T Consensus       126 l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~  202 (275)
T cd05046         126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVW  202 (275)
T ss_pred             HHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHH
Confidence            999999999   77999999999999999999999999999864321             13346666667788999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||+++|||++ |..||.....     ............. .       ...                  ...+..+.++
T Consensus       203 slG~~l~~l~~~~~~p~~~~~~-----~~~~~~~~~~~~~-~-------~~~------------------~~~~~~l~~~  251 (275)
T cd05046         203 SFGVLMWEVFTQGELPFYGLSD-----EEVLNRLQAGKLE-L-------PVP------------------EGCPSRLYKL  251 (275)
T ss_pred             HHHHHHHHHHhCCCCCccccch-----HHHHHHHHcCCcC-C-------CCC------------------CCCCHHHHHH
Confidence            99999999999 7888753211     1111110000000 0       000                  0223467888


Q ss_pred             hhccCCCCccCCCCHHHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      +.+||+.+|++|||+.|+++.|.
T Consensus       252 i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         252 MTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHcCCCcccCCCHHHHHHHhc
Confidence            99999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=3.7e-31  Score=241.17  Aligned_cols=195  Identities=19%  Similarity=0.224  Sum_probs=153.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++.     .....++||||+++++|.+++.           ...+++..+..++.|+
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~~i  110 (277)
T cd06642          47 EDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWIIMEYLGGGSALDLLK-----------PGPLEETYIATILREI  110 (277)
T ss_pred             HHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEEEEEccCCCcHHHHhh-----------cCCCCHHHHHHHHHHH
Confidence            57899999999999999999999864     3678899999999999998883           2357889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++|+.|||   ..+++|+||+|+||+++.++.+|++|||++..+...            ...||...+..++.++|||||
T Consensus       111 ~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  187 (277)
T cd06642         111 LKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL  187 (277)
T ss_pred             HHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHH
Confidence            99999999   779999999999999999999999999999764322            234677667778999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.|+.......  ....            +........                  .......+.+++.+
T Consensus       188 G~il~el~tg~~p~~~~~~~~--~~~~------------~~~~~~~~~------------------~~~~~~~~~~li~~  235 (277)
T cd06642         188 GITAIELAKGEPPNSDLHPMR--VLFL------------IPKNSPPTL------------------EGQYSKPFKEFVEA  235 (277)
T ss_pred             HHHHHHHHhCCCCCcccchhh--HHhh------------hhcCCCCCC------------------CcccCHHHHHHHHH
Confidence            999999999999976432111  0000            000000000                  00233467888889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.+|++||+|.++++.
T Consensus       236 ~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         236 CLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HccCCcccCcCHHHHHHh
Confidence            999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=2.3e-31  Score=247.23  Aligned_cols=192  Identities=18%  Similarity=0.206  Sum_probs=145.3

Q ss_pred             HHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+..|.+++... +||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        41 ~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~e~~~gg~L~~~~~----------~~~~~~~~~~~~~~~qi  105 (316)
T cd05592          41 CTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVMEYLNGGDLMFHIQ----------SSGRFDEARARFYAAEI  105 (316)
T ss_pred             HHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            455677777654 8999999998853     4678999999999999998883          23458889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++....            ....||...+..++.++|||||
T Consensus       106 ~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (316)
T cd05592         106 ICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSF  182 (316)
T ss_pred             HHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhH
Confidence            99999999   77999999999999999999999999999875321            2234777777788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....     ...........      .+..   +                   .....++.+++.+
T Consensus       183 G~il~ell~G~~Pf~~~~-----~~~~~~~i~~~------~~~~---~-------------------~~~~~~~~~ll~~  229 (316)
T cd05592         183 GVLLYEMLIGQSPFHGED-----EDELFDSILND------RPHF---P-------------------RWISKEAKDCLSK  229 (316)
T ss_pred             HHHHHHHHhCCCCCCCCC-----HHHHHHHHHcC------CCCC---C-------------------CCCCHHHHHHHHH
Confidence            999999999999986421     11111111000      0000   0                   0122345677889


Q ss_pred             cCCCCccCCCCHH-HHH
Q 040999          346 CSMESPQDRMKMT-NVV  361 (382)
Q Consensus       346 Cl~~~p~~RPs~~-evl  361 (382)
                      ||+.+|++||++. +++
T Consensus       230 ~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         230 LFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HccCCHHHcCCChHHHH
Confidence            9999999999975 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=7.2e-32  Score=251.42  Aligned_cols=189  Identities=22%  Similarity=0.213  Sum_probs=144.3

Q ss_pred             HHHHHHH-HHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++.+|.. +++.++||||+++++++.     ..+..++||||+++|+|..++.          ....+++..+..++.||
T Consensus        41 ~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi  105 (323)
T cd05575          41 HIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVLDYVNGGELFFHLQ----------RERSFPEPRARFYAAEI  105 (323)
T ss_pred             HHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEEcCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            3455554 457789999999998854     3678999999999999988883          23468889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++||.|||   +.+|+||||||+|||++.++.+||+|||+++....            ....||...+..++.++|||||
T Consensus       106 ~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (323)
T cd05575         106 ASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL  182 (323)
T ss_pred             HHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCcccccccc
Confidence            99999999   77999999999999999999999999999874311            2234777777888999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||...     ..........        .......+                    .....+.+++.+
T Consensus       183 G~il~ell~g~~pf~~~-----~~~~~~~~i~--------~~~~~~~~--------------------~~~~~~~~li~~  229 (323)
T cd05575         183 GAVLYEMLYGLPPFYSR-----DTAEMYDNIL--------NKPLRLKP--------------------NISVSARHLLEG  229 (323)
T ss_pred             chhhhhhhcCCCCCCCC-----CHHHHHHHHH--------cCCCCCCC--------------------CCCHHHHHHHHH
Confidence            99999999999998632     1111111111        00000000                    112356778889


Q ss_pred             cCCCCccCCCCHH
Q 040999          346 CSMESPQDRMKMT  358 (382)
Q Consensus       346 Cl~~~p~~RPs~~  358 (382)
                      |++.||.+||++.
T Consensus       230 ~l~~~p~~R~~~~  242 (323)
T cd05575         230 LLQKDRTKRLGAK  242 (323)
T ss_pred             HhhcCHHhCCCCC
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=1.1e-30  Score=238.10  Aligned_cols=196  Identities=19%  Similarity=0.238  Sum_probs=155.2

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++++..     ....++||||+++|+|.+++.           ...+++.....++.|
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~-----------~~~l~~~~~~~~~~~  109 (277)
T cd06640          46 IEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLWIIMEYLGGGSALDLLR-----------AGPFDEFQIATMLKE  109 (277)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEEEEEecCCCCcHHHHHh-----------cCCCCHHHHHHHHHH
Confidence            3678999999999999999999999654     678999999999999999883           134788889999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||+|||   ..+++|+||+|+||+++.++.++++|||++......            ...||...+..++.++||||
T Consensus       110 l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~s  186 (277)
T cd06640         110 ILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWS  186 (277)
T ss_pred             HHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHH
Confidence            999999999   779999999999999999999999999999655331            23467666777899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||.......     ...         .+.......                  .....+..+.+++.
T Consensus       187 lG~il~el~tg~~p~~~~~~~~-----~~~---------~~~~~~~~~------------------~~~~~~~~~~~li~  234 (277)
T cd06640         187 LGITAIELAKGEPPNSDMHPMR-----VLF---------LIPKNNPPT------------------LTGEFSKPFKEFID  234 (277)
T ss_pred             HHHHHHHHHHCCCCCCCcChHh-----Hhh---------hhhcCCCCC------------------CchhhhHHHHHHHH
Confidence            9999999999999986432110     000         000000000                  01134557888999


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.+|++||++.++++.
T Consensus       235 ~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         235 ACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHcccCcccCcCHHHHHhC
Confidence            9999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.6e-31  Score=254.00  Aligned_cols=150  Identities=25%  Similarity=0.295  Sum_probs=127.5

Q ss_pred             chhhH---HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHH
Q 040999          113 AFKIF---KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLR  189 (382)
Q Consensus       113 avK~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~  189 (382)
                      |+|.+   +...+|+++|++++|||||++++++.     .....++|||++. ++|.+++.          ....+++..
T Consensus       123 ~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~-~~l~~~l~----------~~~~l~~~~  186 (392)
T PHA03207        123 IVKAVTGGKTPGREIDILKTISHRAIINLIHAYR-----WKSTVCMVMPKYK-CDLFTYVD----------RSGPLPLEQ  186 (392)
T ss_pred             EEEeccccccHHHHHHHHHhcCCCCccceeeeEe-----eCCEEEEEehhcC-CCHHHHHH----------hcCCCCHHH
Confidence            55655   45688999999999999999998854     3678899999995 67888772          235689999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCC
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNE  255 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~  255 (382)
                      ++.++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++.....              ..+||...+..
T Consensus       187 ~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  263 (392)
T PHA03207        187 AITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP  263 (392)
T ss_pred             HHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCC
Confidence            9999999999999999   779999999999999999999999999998754321              22467777778


Q ss_pred             CCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          256 VSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      ++.++|||||||++|||++|+.||..
T Consensus       264 ~~~~~DvwslGvil~el~~g~~pf~~  289 (392)
T PHA03207        264 YCAKTDIWSAGLVLFEMSVKNVTLFG  289 (392)
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            89999999999999999999999864

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=4.2e-31  Score=237.71  Aligned_cols=199  Identities=16%  Similarity=0.206  Sum_probs=154.2

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+.+++.++|+||+++++.+.     +.+..++||||+++|+|.+++...        ....+++.....++.|
T Consensus        42 ~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~  108 (255)
T cd08219          42 VEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYIVMEYCDGGDLMQKIKLQ--------RGKLFPEDTILQWFVQ  108 (255)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEEEEeeCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHH
Confidence            467889999999999999999999854     377899999999999998887421        2345788999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||.|||   +.+|+|+||||+||++++++.++++|||.+......            ...||...+..++.++||||
T Consensus       109 i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s  185 (255)
T cd08219         109 MCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWS  185 (255)
T ss_pred             HHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhh
Confidence            999999999   789999999999999999999999999998765332            23366666677889999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|+|++|+.||...     ...............        ..+                   ......+.+++.
T Consensus       186 lG~i~~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~--------~~~-------------------~~~~~~~~~li~  233 (255)
T cd08219         186 LGCILYELCTLKHPFQAN-----SWKNLILKVCQGSYK--------PLP-------------------SHYSYELRSLIK  233 (255)
T ss_pred             hchhheehhhccCCCCCC-----CHHHHHHHHhcCCCC--------CCC-------------------cccCHHHHHHHH
Confidence            999999999999998632     111111111000000        000                   012235678888


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.+|++|||+.+++..
T Consensus       234 ~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         234 QMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHhCCcccCCCHHHHhhc
Confidence            9999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=4.7e-31  Score=245.27  Aligned_cols=156  Identities=20%  Similarity=0.321  Sum_probs=123.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||+++++++..   ......+++|||+. ++|.+++....... .......+++..+..++.|+
T Consensus        43 ~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi  117 (317)
T cd07868          43 MSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYAE-HDLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQI  117 (317)
T ss_pred             HHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEeccC-CCHHHHHHhccccc-ccCCcccCCHHHHHHHHHHH
Confidence            457899999999999999999998653   23567899999985 47777764322110 01223458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee----CCCCcEEEccccccccCCCC---------------CCCCccccC-CCCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMTARVGDFGLARFLPPT---------------RTQTKYGVG-NEVS  257 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl----~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~-~~~~  257 (382)
                      +.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.....               ..+||...+ ..++
T Consensus       118 ~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  194 (317)
T cd07868         118 LDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT  194 (317)
T ss_pred             HHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcC
Confidence            99999999   7799999999999999    45678999999999764321               234676655 4578


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCc
Q 040999          258 TIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      .++||||+||++|||++|++||..
T Consensus       195 ~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         195 KAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             chhhHHHHHHHHHHHHhCCCCccC
Confidence            999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=2.1e-31  Score=249.25  Aligned_cols=198  Identities=19%  Similarity=0.193  Sum_probs=148.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++..+ +|+||+++++++     ...+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~q  113 (332)
T cd05614          49 EHTRTERNVLEHVRQSPFLVTLHYAF-----QTEAKLHLILDYVSGGEMFTHLY----------QRDNFSEDEVRFYSGE  113 (332)
T ss_pred             HHHHHHHHHHHhccCCCCcccEEEEE-----ecCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            5678899999999 599999999884     34678899999999999999884          2345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCC-CCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGN-EVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~-~~~~~~Dv  262 (382)
                      |+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....             ....||...+. .++.++||
T Consensus       114 i~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  190 (332)
T cd05614         114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDW  190 (332)
T ss_pred             HHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCcccc
Confidence            999999999   77999999999999999999999999999875422             12236655443 46889999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||+||+.||....... ....+.......      +....                      ......+.++
T Consensus       191 wslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~------~~~~~----------------------~~~~~~~~~l  241 (332)
T cd05614         191 WSLGILIFELLTGASPFTLEGERN-TQSEVSRRILKC------DPPFP----------------------SFIGPEAQDL  241 (332)
T ss_pred             ccchhhhhhhhcCCCCCCCCCCCC-CHHHHHHHHhcC------CCCCC----------------------CCCCHHHHHH
Confidence            999999999999999986422111 111111110000      00000                      0122356778


Q ss_pred             hhccCCCCccCCC-----CHHHHHH
Q 040999          343 GVACSMESPQDRM-----KMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RP-----s~~evl~  362 (382)
                      +.+||+.||++||     +++++++
T Consensus       242 i~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         242 LHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            8899999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=1.9e-31  Score=248.96  Aligned_cols=146  Identities=25%  Similarity=0.294  Sum_probs=126.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+.++.++ +|+||+++++++.     .....++||||+++|+|..++.          ....+++..+..++.|
T Consensus        40 ~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~q  104 (327)
T cd05617          40 DWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYAAE  104 (327)
T ss_pred             HHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            4578899999888 6999999999854     3678999999999999988773          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++||||
T Consensus       105 i~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  181 (327)
T cd05617         105 ICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA  181 (327)
T ss_pred             HHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeeh
Confidence            999999999   7799999999999999999999999999987421            1233477777788899999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      |||++|||+||+.||+.
T Consensus       182 lGvil~ell~g~~pf~~  198 (327)
T cd05617         182 LGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             hHHHHHHHHhCCCCCCc
Confidence            99999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=1e-30  Score=238.91  Aligned_cols=201  Identities=21%  Similarity=0.266  Sum_probs=151.9

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +..+.+.+|+++++.++|+||+++++++..     ....++|+||+++++|..++..         ....+++..+..++
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~  109 (282)
T cd06643          44 EELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVMLE---------LERPLTEPQIRVVC  109 (282)
T ss_pred             HHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHH
Confidence            344678999999999999999999998654     6788999999999999887742         23468999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccc-----cCCCCC
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYG-----VGNEVS  257 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~-----~~~~~~  257 (382)
                      .|+++||.|||   +.+++||||||+||+++.++.+||+|||++......            ...||..     .+..++
T Consensus       110 ~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~  186 (282)
T cd06643         110 KQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD  186 (282)
T ss_pred             HHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCC
Confidence            99999999999   779999999999999999999999999998654221            2235543     234567


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          258 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      .++|||||||++|||++|+.||....    ............ .....      .+                   .....
T Consensus       187 ~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~~~~~~-~~~~~------~~-------------------~~~~~  236 (282)
T cd06643         187 YKADVWSLGITLIEMAQIEPPHHELN----PMRVLLKIAKSE-PPTLA------QP-------------------SRWSS  236 (282)
T ss_pred             ccchhhhHHHHHHHHccCCCCccccC----HHHHHHHHhhcC-CCCCC------Cc-------------------cccCH
Confidence            89999999999999999999976421    111111110000 00000      00                   01234


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHH
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+++.+||+.+|.+||++.++++
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            6778888999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=2.9e-31  Score=247.42  Aligned_cols=145  Identities=23%  Similarity=0.304  Sum_probs=122.2

Q ss_pred             HHHHHHHHHH---hhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKAL---RNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +.+.+|++++   +.++||||+++++++.     ..+..++||||+++|+|..++.           ...+++..+..++
T Consensus        44 ~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~~~~lv~E~~~~~~L~~~~~-----------~~~l~~~~~~~~~  107 (324)
T cd05589          44 ESLMCEKRIFETANSERHPFLVNLFACFQ-----TEDHVCFVMEYAAGGDLMMHIH-----------TDVFSEPRAVFYA  107 (324)
T ss_pred             HHHHHHHHHHHhccccCCCChhceeeEEE-----cCCEEEEEEcCCCCCcHHHHhh-----------cCCCCHHHHHHHH
Confidence            3455565554   5678999999999854     4678999999999999988773           2358999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchh
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv  262 (382)
                      .|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...            .....||...+..++.++||
T Consensus       108 ~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di  184 (324)
T cd05589         108 ACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDW  184 (324)
T ss_pred             HHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccch
Confidence            99999999999   7899999999999999999999999999986432            12334777777788999999


Q ss_pred             HHHHHHHHHHHhcCCCCCc
Q 040999          263 YSYGILLLELMIREKPSDI  281 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~  281 (382)
                      |||||++|||++|+.||..
T Consensus       185 wslG~il~el~~G~~pf~~  203 (324)
T cd05589         185 WGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             hhHHHHHHHHHhCCCCCCC
Confidence            9999999999999999863

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.8e-31  Score=248.66  Aligned_cols=229  Identities=17%  Similarity=0.178  Sum_probs=151.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++++++|+||+++++++..... ......+++++++ +++|.+++.           ...+++..+..++.|
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-----------~~~l~~~~~~~i~~q  126 (343)
T cd07878          59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-----------CQKLSDEHVQFLIYQ  126 (343)
T ss_pred             HHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-----------cCCCCHHHHHHHHHH
Confidence            457789999999999999999988643211 2234578999988 778887763           235889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccC-CCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVG-NEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~-~~~~~~~Dv~S~G  266 (382)
                      ++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....         ..+||...+ ..++.++||||||
T Consensus       127 i~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  203 (343)
T cd07878         127 LLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG  203 (343)
T ss_pred             HHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHH
Confidence            999999999   779999999999999999999999999999865432         234666554 4678899999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||..... ...+..+...... ...+...................................+.+++.+|
T Consensus       204 ~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m  281 (343)
T cd07878         204 CIMAELLKGKALFPGNDY-IDQLKRIMEVVGT-PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM  281 (343)
T ss_pred             HHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCC-CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHH
Confidence            999999999999853210 0111111111100 01111111000000000000000000000000011223467888899


Q ss_pred             CCCCccCCCCHHHHHHH
Q 040999          347 SMESPQDRMKMTNVVHE  363 (382)
Q Consensus       347 l~~~p~~RPs~~evl~~  363 (382)
                      ++.||.+|||+.|+++.
T Consensus       282 L~~dp~~R~s~~ell~h  298 (343)
T cd07878         282 LVLDSDKRISASEALAH  298 (343)
T ss_pred             cCCChhhCCCHHHHhcC
Confidence            99999999999999954

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=2.2e-31  Score=257.70  Aligned_cols=240  Identities=19%  Similarity=0.217  Sum_probs=156.7

Q ss_pred             chhhH----HHHHHHHHHHhhcccccceeeeeeeeeccc---CCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF----KSFIAECKALRNIRHRNLIKVLTACLGVDY---QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+    ....+|+.+|+.++|+|||++++++....+   ......++||||+++ ++.+++....      .....+
T Consensus        95 AiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~------~~~~~l  167 (440)
T PTZ00036         95 AIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYA------RNNHAL  167 (440)
T ss_pred             EEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHh------hcCCCC
Confidence            77765    345679999999999999999988654222   123357799999975 6766663221      234568


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC-cEEEccccccccCCCC-----------CCCCccccC
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPPT-----------RTQTKYGVG  253 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~~-----------~~~~~~~~~  253 (382)
                      ++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+|+.+...           ..+||...+
T Consensus       168 ~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~  244 (440)
T PTZ00036        168 PLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG  244 (440)
T ss_pred             CHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcC
Confidence            89999999999999999999   77999999999999998665 6999999999865321           234666544


Q ss_pred             -CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhh--hhcccccchhhhhhccccchhhhhhh
Q 040999          254 -NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDI--VDSILLNDDEKLVVRGDQKQTQAKIN  330 (382)
Q Consensus       254 -~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (382)
                       ..++.++|||||||++|||+||.+||..... ...+..............+  ..+...    ... ............
T Consensus       245 ~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~p~~~~~~~~~~~~~----~~~-~~~~~~~~l~~~  318 (440)
T PTZ00036        245 ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQLVRIIQVLGTPTEDQLKEMNPNYA----DIK-FPDVKPKDLKKV  318 (440)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhchhhh----ccc-CCccCchhHHHH
Confidence             4689999999999999999999999864211 1111121111111110000  000000    000 000000000000


Q ss_pred             hHHHHHHHHHHHhhccCCCCccCCCCHHHHHH--HHHHhh
Q 040999          331 VIIECVISMVRIGVACSMESPQDRMKMTNVVH--ELQSIK  368 (382)
Q Consensus       331 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~--~L~~i~  368 (382)
                      .....+.++.+++.+||+.||.+|||+.|+++  .++.+.
T Consensus       319 ~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        319 FPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             hccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            00112346788999999999999999999983  344443

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=6.8e-31  Score=240.66  Aligned_cols=226  Identities=19%  Similarity=0.234  Sum_probs=152.5

Q ss_pred             HHHHHHHHHhhc---ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNI---RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+|+++++.+   +||||+++++++...........++||||+++ +|.+++...        ....+++..+..++.
T Consensus        45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--------~~~~~~~~~~~~~~~  115 (288)
T cd07863          45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV--------PPPGLPAETIKDLMR  115 (288)
T ss_pred             HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhc--------CCCCCCHHHHHHHHH
Confidence            456777777665   69999999998765333445678999999974 888877421        223589999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....           ..+||...+..++.++||||
T Consensus       116 qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  192 (288)
T cd07863         116 QFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWS  192 (288)
T ss_pred             HHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhh
Confidence            9999999999   779999999999999999999999999999765321           34477777778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      +||++|||++|++||..... ...+..............+-. ...... .   ...............+....+.+++.
T Consensus       193 lG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~li~  266 (288)
T cd07863         193 VGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDDWPR-DVTLPR-G---AFSPRGPRPVQSVVPEIEESGAQLLL  266 (288)
T ss_pred             HHHHHHHHHhCCcCcCCCCH-HHHHHHHHHHhCCCChhhCcc-cccccc-c---ccCCCCCCchHHhCcCcCHHHHHHHH
Confidence            99999999999999853211 111111111110000000000 000000 0   00000000000011123446778888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +|++.||++|||+.|++.
T Consensus       267 ~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         267 EMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHhccCcccCCCHHHHhc
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.6e-32  Score=255.51  Aligned_cols=198  Identities=18%  Similarity=0.207  Sum_probs=152.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++..++|+||+++++++.     +.+..++||||+++|+|.+++..          ...+++..+..++.|+
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~i~~qi  110 (350)
T cd05573          46 AHVRAERDILADADSPWIVKLYYSFQ-----DEEHLYLVMEYMPGGDLMNLLIR----------KDVFPEETARFYIAEL  110 (350)
T ss_pred             HHHHHHHHHHHhcCCCCccchhhhee-----cCCeEEEEEcCCCCCCHHHHHHH----------cCCCCHHHHHHHHHHH
Confidence            46888999999999999999998853     47789999999999999999842          2568899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC--------------------------------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR--------------------------------  245 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~--------------------------------  245 (382)
                      +.||+|||   ..+|+||||||+|||++.++.+||+|||+++......                                
T Consensus       111 ~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (350)
T cd05573         111 VLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA  187 (350)
T ss_pred             HHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccc
Confidence            99999999   7899999999999999999999999999997654322                                


Q ss_pred             ---------CCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhh
Q 040999          246 ---------TQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKL  316 (382)
Q Consensus       246 ---------~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (382)
                               ..||...+..++.++|||||||++|||++|+.||....    ....+.. ... ..     ......... 
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~----~~~~~~~-i~~-~~-----~~~~~p~~~-  255 (350)
T cd05573         188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT----LQETYNK-IIN-WK-----ESLRFPPDP-  255 (350)
T ss_pred             cccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC----HHHHHHH-Hhc-cC-----CcccCCCCC-
Confidence                     23666666788999999999999999999999986421    1111110 000 00     000000000 


Q ss_pred             hhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCC-HHHHHHH
Q 040999          317 VVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMK-MTNVVHE  363 (382)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-~~evl~~  363 (382)
                                       .....+.+++.+|+. +|.+||+ ++++++.
T Consensus       256 -----------------~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         256 -----------------PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             -----------------CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                             123456777889997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=8e-31  Score=237.73  Aligned_cols=198  Identities=18%  Similarity=0.213  Sum_probs=148.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc--CHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL--NLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~  195 (382)
                      +.+.+|++++++++|+||+++++++..     .+..++|+||+++++|.+++...         ...+  ++..+..++.
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~~  115 (268)
T cd06624          50 QPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFFKIFMEQVPGGSLSALLRSK---------WGPLKDNEQTIIFYTK  115 (268)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEEEEEEecCCCCCHHHHHHHh---------cccCCCcHHHHHHHHH
Confidence            578999999999999999999999653     67889999999999999998421         1234  7788889999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCC------------CCCCCccccCC--CCCccc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPP------------TRTQTKYGVGN--EVSTIG  260 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~--~~~~~~  260 (382)
                      |++.||+|||   ..+|+||||||+||+++. ++.+||+|||.+.....            ....||...+.  .++.++
T Consensus       116 qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~  192 (268)
T cd06624         116 QILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPA  192 (268)
T ss_pred             HHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchh
Confidence            9999999999   779999999999999976 67899999999865422            12236654332  368899


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||+++|||++|+.||.......  ...+.......      .+.+                      ......++.
T Consensus       193 Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~~~~------~~~~----------------------~~~~~~~~~  242 (268)
T cd06624         193 DIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMFKI------HPEI----------------------PESLSAEAK  242 (268)
T ss_pred             hhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhhhcc------CCCC----------------------CcccCHHHH
Confidence            99999999999999999986321110  00000000000      0000                      002234577


Q ss_pred             HHhhccCCCCccCCCCHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +++.+||+.+|++|||+.|+++
T Consensus       243 ~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         243 NFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHHHcCCCchhCCCHHHHHh
Confidence            8888999999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=1.3e-31  Score=249.43  Aligned_cols=195  Identities=22%  Similarity=0.231  Sum_probs=149.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+..|.+++..+ +||||+++++++.     ..+..++||||+++|+|..++.          ....+++..+..++.|
T Consensus        40 ~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~E~~~~~~L~~~l~----------~~~~~~~~~~~~~~~q  104 (321)
T cd05591          40 DCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVMEYVNGGDLMFQIQ----------RSRKFDEPRSRFYAAE  104 (321)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            3567888888876 7999999999854     3678999999999999988883          2345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++||||
T Consensus       105 i~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  181 (321)
T cd05591         105 VTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWA  181 (321)
T ss_pred             HHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceec
Confidence            999999999   7799999999999999999999999999987432            1233467666778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||.....     ...........        .. .+ .                  ....++.+++.
T Consensus       182 lG~il~el~tg~~Pf~~~~~-----~~~~~~i~~~~--------~~-~p-~------------------~~~~~~~~ll~  228 (321)
T cd05591         182 LGVLMYEMMAGQPPFEADNE-----DDLFESILHDD--------VL-YP-V------------------WLSKEAVSILK  228 (321)
T ss_pred             hhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC--------CC-CC-C------------------CCCHHHHHHHH
Confidence            99999999999999864211     11111110000        00 00 0                  11235677888


Q ss_pred             ccCCCCccCCC-------CHHHHHHH
Q 040999          345 ACSMESPQDRM-------KMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RP-------s~~evl~~  363 (382)
                      +|++.||++||       ++.++++.
T Consensus       229 ~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         229 AFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             HHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            99999999999       77777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=7.6e-31  Score=243.75  Aligned_cols=156  Identities=20%  Similarity=0.327  Sum_probs=123.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||+++++++..   ......++|+||+.+ +|.+++....... .......+++..+..++.|+
T Consensus        43 ~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi  117 (317)
T cd07867          43 MSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDYAEH-DLWHIIKFHRASK-ANKKPMQLPRSMVKSLLYQI  117 (317)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEeeeCC-cHHHHHHhhhccc-cCCCCccCCHHHHHHHHHHH
Confidence            367899999999999999999998753   335678999999865 6777664221110 01223458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee----CCCCcEEEccccccccCCCC---------------CCCCccccC-CCCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMTARVGDFGLARFLPPT---------------RTQTKYGVG-NEVS  257 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl----~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~-~~~~  257 (382)
                      +.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++.....               ..+||...+ ..++
T Consensus       118 ~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  194 (317)
T cd07867         118 LDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT  194 (317)
T ss_pred             HHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccC
Confidence            99999999   7799999999999999    56678999999999764321               234666544 4578


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCc
Q 040999          258 TIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      .++|||||||++|||+||+.||..
T Consensus       195 ~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         195 KAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cHHHHHhHHHHHHHHHhCCCCccc
Confidence            999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=6e-31  Score=244.37  Aligned_cols=194  Identities=20%  Similarity=0.248  Sum_probs=148.0

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+..|..++... +||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        40 ~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ey~~~g~L~~~l~----------~~~~~~~~~~~~~~~q  104 (316)
T cd05619          40 ECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVMEYLNGGDLMFHIQ----------SCHKFDLPRATFYAAE  104 (316)
T ss_pred             HHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            3466788888764 8999999999854     3678999999999999998883          2345888999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++||||
T Consensus       105 i~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  181 (316)
T cd05619         105 IICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWS  181 (316)
T ss_pred             HHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhh
Confidence            999999999   7799999999999999999999999999987421            1234577777778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....     ...........      ....   +                   ......+.+++.
T Consensus       182 lG~il~el~~G~~pf~~~~-----~~~~~~~i~~~------~~~~---~-------------------~~~~~~~~~li~  228 (316)
T cd05619         182 FGVLLYEMLIGQSPFHGHD-----EEELFQSIRMD------NPCY---P-------------------RWLTREAKDILV  228 (316)
T ss_pred             HHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC------CCCC---C-------------------ccCCHHHHHHHH
Confidence            9999999999999986421     11111100000      0000   0                   011234677788


Q ss_pred             ccCCCCccCCCCHH-HHHH
Q 040999          345 ACSMESPQDRMKMT-NVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~-evl~  362 (382)
                      +||+.+|++||++. ++.+
T Consensus       229 ~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         229 KLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHhccCHhhcCCChHHHHc
Confidence            99999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=4.3e-31  Score=245.40  Aligned_cols=193  Identities=19%  Similarity=0.216  Sum_probs=147.0

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+..|.+++... +||||+++++++.     ..+..++||||+++|+|..++.          ....+++..+..++.|
T Consensus        40 ~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~i~----------~~~~~~~~~~~~~~~q  104 (316)
T cd05620          40 ECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVMEFLNGGDLMFHIQ----------DKGRFDLYRATFYAAE  104 (316)
T ss_pred             HHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEECCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            3466778888764 8999999999854     4778999999999999988883          2345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +++||+|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++||||
T Consensus       105 i~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  181 (316)
T cd05620         105 IVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWS  181 (316)
T ss_pred             HHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhh
Confidence            999999999   7799999999999999999999999999986421            1233477777788899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....     ...........      .+..   + .                  ....++.+++.
T Consensus       182 lGvil~el~~g~~Pf~~~~-----~~~~~~~~~~~------~~~~---~-~------------------~~~~~~~~li~  228 (316)
T cd05620         182 FGVLLYEMLIGQSPFHGDD-----EDELFESIRVD------TPHY---P-R------------------WITKESKDILE  228 (316)
T ss_pred             hHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC------CCCC---C-C------------------CCCHHHHHHHH
Confidence            9999999999999986321     11111110000      0000   0 0                  11235667888


Q ss_pred             ccCCCCccCCCCHH-HHH
Q 040999          345 ACSMESPQDRMKMT-NVV  361 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~-evl  361 (382)
                      +||+.||++||++. ++.
T Consensus       229 ~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         229 KLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHccCCHHHcCCChHHHH
Confidence            99999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=248.01  Aligned_cols=202  Identities=21%  Similarity=0.242  Sum_probs=159.0

Q ss_pred             CCchhhH---------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccC
Q 040999          111 QGAFKIF---------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYER  181 (382)
Q Consensus       111 ~~avK~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  181 (382)
                      ..|+|++         +++.+|+.+|.+++++||.++|+.++.     +..++++||||.+|++.+.|.          .
T Consensus        40 ~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-----g~~LwiiMey~~gGsv~~lL~----------~  104 (467)
T KOG0201|consen   40 VVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-----GTKLWIIMEYCGGGSVLDLLK----------S  104 (467)
T ss_pred             eEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-----cccHHHHHHHhcCcchhhhhc----------c
Confidence            3377765         678899999999999999999998664     778999999999999999984          2


Q ss_pred             CcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCc
Q 040999          182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTK  249 (382)
Q Consensus       182 ~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~  249 (382)
                      ...+++....-+++++..||.|||   ..+.+|||||+.|||+..+|.+|++|||.+..+.            +-+++||
T Consensus       105 ~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPE  181 (467)
T KOG0201|consen  105 GNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPE  181 (467)
T ss_pred             CCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchh
Confidence            334467777778999999999999   7799999999999999999999999999997653            3345688


Q ss_pred             cccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhh
Q 040999          250 YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKI  329 (382)
Q Consensus       250 ~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (382)
                      +.....|+.|+||||+|++.+||.+|.+|+......              .+.-++.+.-   ++.            . 
T Consensus       182 VI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------------rvlflIpk~~---PP~------------L-  231 (467)
T KOG0201|consen  182 VIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------------RVLFLIPKSA---PPR------------L-  231 (467)
T ss_pred             hhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------------eEEEeccCCC---CCc------------c-
Confidence            888889999999999999999999999997643220              0001111100   000            0 


Q ss_pred             hhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          330 NVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       330 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                        ...+...+.+++..|+.++|+.||++.++++
T Consensus       232 --~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 --DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             --ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence              0023346778888999999999999999875

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-31  Score=252.34  Aligned_cols=146  Identities=18%  Similarity=0.247  Sum_probs=126.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++..++|+||+++++++.     +.+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        46 ~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~~lv~E~~~~g~L~~~l~----------~~~~l~~~~~~~~~~qi  110 (364)
T cd05599          46 AHVRAERDILAEADNPWVVKLYYSFQ-----DENYLYLIMEYLPGGDMMTLLM----------KKDTFTEEETRFYIAET  110 (364)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEE-----cCCeEEEEECCCCCcHHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            45788999999999999999999854     4788999999999999999884          23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------------------------------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------------------------------  243 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------------------------------  243 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..                                  
T Consensus       111 ~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (364)
T cd05599         111 ILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET  187 (364)
T ss_pred             HHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccc
Confidence            99999999   77999999999999999999999999999864321                                  


Q ss_pred             ----------------CCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          244 ----------------TRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       244 ----------------~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                                      ...+||...+..++.++|||||||++|||++|..||..
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~  241 (364)
T cd05599         188 WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS  241 (364)
T ss_pred             hhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCC
Confidence                            12346666667789999999999999999999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=235.72  Aligned_cols=201  Identities=20%  Similarity=0.262  Sum_probs=153.7

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++..     ....+++|||+++++|.+++..         ....+++..+..++.|
T Consensus        44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l~~e~~~~~~l~~~~~~---------~~~~l~~~~~~~~~~q  109 (262)
T cd06613          44 FEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWIVMEYCGGGSLQDIYQV---------TRGPLSELQIAYVCRE  109 (262)
T ss_pred             HHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEEEEeCCCCCcHHHHHHh---------hccCCCHHHHHHHHHH
Confidence            3678999999999999999999998543     6789999999999999998842         2246889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCC---CCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGN---EVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~---~~~~~~D  261 (382)
                      ++.||+|||   +.+++|+||||+||+++.++.+||+|||.+......            ...||...+.   .++.++|
T Consensus       110 l~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~D  186 (262)
T cd06613         110 TLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCD  186 (262)
T ss_pred             HHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhh
Confidence            999999999   779999999999999999999999999998754321            2346666555   7888999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||+++|||+||+.||.....    ..........    ..-...+.                    .......++.+
T Consensus       187 i~slG~~l~~~~tg~~p~~~~~~----~~~~~~~~~~----~~~~~~~~--------------------~~~~~~~~~~~  238 (262)
T cd06613         187 IWALGITAIELAELQPPMFDLHP----MRALFLISKS----NFPPPKLK--------------------DKEKWSPVFHD  238 (262)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc----cCCCcccc--------------------chhhhhHHHHH
Confidence            99999999999999999864211    1110000000    00000000                    00123446788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.+|.+|||+.+|+.
T Consensus       239 li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         239 FIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHhc
Confidence            899999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=8.6e-31  Score=237.59  Aligned_cols=206  Identities=21%  Similarity=0.346  Sum_probs=156.1

Q ss_pred             hHHHHHHHHHHHhh-cccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          116 IFKSFIAECKALRN-IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       116 ~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      .++++.+|++++.+ ++|+||+++++++..     .+..+++|||+++++|.+++....      .....+++..++.++
T Consensus        51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~~  119 (269)
T cd08528          51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-----NDRLYIVMDLIEGAPLGEHFNSLK------EKKQRFTEERIWNIF  119 (269)
T ss_pred             HHHHHHHHHHHHhhcCCCCCeeeEEeeEcc-----CCeEEEEEecCCCCcHHHHHHHHH------hccCCCCHHHHHHHH
Confidence            34668889998875 799999999999653     678999999999999998874321      223468889999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      .|++.||.|||+  ..+++|+||||+||+++.++.+||+|||.+......           ...||...+..++.++|||
T Consensus       120 ~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~  197 (269)
T cd08528         120 VQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVW  197 (269)
T ss_pred             HHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHH
Confidence            999999999994  257999999999999999999999999999764432           2336766677789999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||+++|||++|+.||...     .........        .+........                  ......+.+++
T Consensus       198 slG~ll~~l~~g~~p~~~~-----~~~~~~~~~--------~~~~~~~~~~------------------~~~~~~l~~li  246 (269)
T cd08528         198 AFGCILYQMCTLQPPFYST-----NMLSLATKI--------VEAVYEPLPE------------------GMYSEDVTDVI  246 (269)
T ss_pred             HHHHHHHHHHhCCCccccc-----CHHHHHHHH--------hhccCCcCCc------------------ccCCHHHHHHH
Confidence            9999999999999997531     111111110        0000000000                  01224577888


Q ss_pred             hccCCCCccCCCCHHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      .+||+.||++||++.||.+++.
T Consensus       247 ~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         247 TSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHCCCCCccCCCHHHHHHHhc
Confidence            8999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=1e-30  Score=236.81  Aligned_cols=151  Identities=20%  Similarity=0.312  Sum_probs=127.7

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +..+.+.+|++++++++|+||+++++++..   ......++++||+++++|.+++.          ....+++.....++
T Consensus        46 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~~~l~~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~  112 (266)
T cd06651          46 KEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEKTLTIFMEYMPGGSVKDQLK----------AYGALTESVTRKYT  112 (266)
T ss_pred             HHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHH
Confidence            344678999999999999999999998542   22467789999999999999884          23357889999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------------CCCCCccccCCCCCcc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------------TRTQTKYGVGNEVSTI  259 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~~~~~~~~~~  259 (382)
                      .|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.+..               ....||...+..++.+
T Consensus       113 ~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  189 (266)
T cd06651         113 RQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK  189 (266)
T ss_pred             HHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCch
Confidence            99999999999   77999999999999999999999999999875421               1234676667778899


Q ss_pred             chhHHHHHHHHHHHhcCCCCCc
Q 040999          260 GDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      +|||||||++|||++|+.||..
T Consensus       190 ~Dv~slG~i~~el~~g~~pf~~  211 (266)
T cd06651         190 ADVWSLGCTVVEMLTEKPPWAE  211 (266)
T ss_pred             hhhHHHHHHHHHHHHCCCCccc
Confidence            9999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=9.2e-31  Score=237.72  Aligned_cols=203  Identities=20%  Similarity=0.219  Sum_probs=151.6

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccC-CCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQ-GNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+|+.++.++ +|+||+++++++...... .....++||||+++++|.+++...        ....+++..+..++.
T Consensus        47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--------~~~~l~~~~~~~~~~  118 (272)
T cd06637          47 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICR  118 (272)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc--------cCCCCCHHHHHHHHH
Confidence            5688999999998 699999999997653221 135689999999999999988531        234588999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc-----CCCCCc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV-----GNEVST  258 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~-----~~~~~~  258 (382)
                      |++.||+|||   +.+|+||||||+||++++++.+||+|||++......            ...||...     ...++.
T Consensus       119 qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~  195 (272)
T cd06637         119 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF  195 (272)
T ss_pred             HHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCc
Confidence            9999999999   679999999999999999999999999999754321            22356543     345788


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ++|||||||++|||++|+.||....    ........ ..........                          ......
T Consensus       196 ~~Dv~slGv~l~el~~g~~p~~~~~----~~~~~~~~-~~~~~~~~~~--------------------------~~~~~~  244 (272)
T cd06637         196 KSDLWSLGITAIEMAEGAPPLCDMH----PMRALFLI-PRNPAPRLKS--------------------------KKWSKK  244 (272)
T ss_pred             hhhHHHHHHHHHHHHhCCCCccccC----HHHHHHHH-hcCCCCCCCC--------------------------CCcCHH
Confidence            9999999999999999999986321    11111100 0000000000                          012335


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+++.+||+.+|.+|||+.++++
T Consensus       245 ~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         245 FQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhh
Confidence            778888999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=1.1e-30  Score=235.75  Aligned_cols=200  Identities=21%  Similarity=0.352  Sum_probs=155.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++.     . ...+++|||+++++|.+++...        ....+++..+..++.|+
T Consensus        46 ~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l  111 (260)
T cd05073          46 EAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIYIITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQI  111 (260)
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeEEEEEeCCCCcHHHHHHhC--------CccccCHHHHHHHHHHH
Confidence            56889999999999999999998853     2 5679999999999999998531        23457888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   ..+++|+||||+||+++.++.+||+|||.+......             ...||...+..++.++||||
T Consensus       112 ~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  188 (260)
T cd05073         112 AEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS  188 (260)
T ss_pred             HHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchH
Confidence            99999999   679999999999999999999999999998754321             23366666677888999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||++||++| |+.||....  ..............            ..                  ....+..+.+++
T Consensus       189 lG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~~~------------~~------------------~~~~~~~~~~~i  236 (260)
T cd05073         189 FGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRM------------PR------------------PENCPEELYNIM  236 (260)
T ss_pred             HHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCCC------------CC------------------cccCCHHHHHHH
Confidence            9999999999 899976321  11111111100000            00                  002234678888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                      .+||+.+|++||++.++.+.|+.
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         237 MRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHcccCcccCcCHHHHHHHHhc
Confidence            89999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=1e-30  Score=247.25  Aligned_cols=148  Identities=24%  Similarity=0.251  Sum_probs=122.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+.+++.++||||+++++++.... .......++||||+.+ +|.+.+.            ..+++..+..++.|
T Consensus        65 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~q  131 (359)
T cd07876          65 KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQ  131 (359)
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHH
Confidence            56789999999999999999999865321 1122457999999965 5555542            23778888999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....           ...+||...+..++.++|||||
T Consensus       132 i~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl  208 (359)
T cd07876         132 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  208 (359)
T ss_pred             HHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHH
Confidence            999999999   77999999999999999999999999999975422           2345787778889999999999


Q ss_pred             HHHHHHHHhcCCCCCc
Q 040999          266 GILLLELMIREKPSDI  281 (382)
Q Consensus       266 Gvil~elltg~~p~~~  281 (382)
                      ||++|||+||+.||..
T Consensus       209 G~il~el~tg~~pf~~  224 (359)
T cd07876         209 GCIMGELVKGSVIFQG  224 (359)
T ss_pred             HHHHHHHHhCCCCCCC
Confidence            9999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=3.5e-31  Score=239.88  Aligned_cols=200  Identities=17%  Similarity=0.206  Sum_probs=149.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++++++|+||+++++++..     .+..++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        51 ~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~iv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi  115 (267)
T cd06646          51 SLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRET  115 (267)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            457889999999999999999998654     678899999999999999883          23458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc---CCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV---GNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~---~~~~~~~~Dv  262 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||++......            ...||...   ...++.++||
T Consensus       116 ~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dv  192 (267)
T cd06646         116 LQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI  192 (267)
T ss_pred             HHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhH
Confidence            99999999   779999999999999999999999999998754321            12355432   3446789999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||++|+.||.......    ...         .+...........               ........+.++
T Consensus       193 ws~G~il~el~~g~~p~~~~~~~~----~~~---------~~~~~~~~~~~~~---------------~~~~~~~~~~~l  244 (267)
T cd06646         193 WAVGITAIELAELQPPMFDLHPMR----ALF---------LMSKSNFQPPKLK---------------DKTKWSSTFHNF  244 (267)
T ss_pred             HHHHHHHHHHHhCCCCccccchhh----hhe---------eeecCCCCCCCCc---------------cccccCHHHHHH
Confidence            999999999999999975321100    000         0000000000000               000223467788


Q ss_pred             hhccCCCCccCCCCHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +.+||+.+|++|||++++++.
T Consensus       245 i~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         245 VKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             HHHHhhCChhhCcCHHHHhcC
Confidence            889999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=2.3e-31  Score=253.28  Aligned_cols=146  Identities=21%  Similarity=0.272  Sum_probs=125.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|+||+++++.+.     +++..++||||+++|+|.+++.          ....+++.....++.||
T Consensus        46 ~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~~lv~E~~~~g~L~~~i~----------~~~~~~~~~~~~~~~qi  110 (376)
T cd05598          46 AHVKAERDILAEADNEWVVKLYYSFQ-----DKDNLYFVMDYIPGGDMMSLLI----------RLGIFEEDLARFYIAEL  110 (376)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEE-----cCCEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            45788999999999999999999854     4788999999999999999984          23457888889999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC------------------------------------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL------------------------------------  241 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~------------------------------------  241 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+|..+                                    
T Consensus       111 ~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (376)
T cd05598         111 TCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP  187 (376)
T ss_pred             HHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccc
Confidence            99999999   789999999999999999999999999997422                                    


Q ss_pred             -------------------CCCCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          242 -------------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       242 -------------------~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                                         .....+||...+..++.++|||||||++|||+||+.||..
T Consensus       188 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  246 (376)
T cd05598         188 LERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA  246 (376)
T ss_pred             hhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCC
Confidence                               1123346666667788999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=254.31  Aligned_cols=203  Identities=24%  Similarity=0.320  Sum_probs=162.9

Q ss_pred             chhhH---------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCc
Q 040999          113 AFKIF---------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPR  183 (382)
Q Consensus       113 avK~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~  183 (382)
                      |||.+         .+|++|+.+|.+|+|+|+|++||+..+      ....+|+|+++.|||.+.|+.        ....
T Consensus       142 AVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~mMV~ELaplGSLldrLrk--------a~~~  207 (1039)
T KOG0199|consen  142 AVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPAMMVFELAPLGSLLDRLRK--------AKKA  207 (1039)
T ss_pred             EEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chhhHHhhhcccchHHHHHhh--------cccc
Confidence            77766         789999999999999999999999652      567899999999999999964        1344


Q ss_pred             ccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCC
Q 040999          184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQT  248 (382)
Q Consensus       184 ~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~  248 (382)
                      .|-......++.|||.|+.||.   .+++|||||-..|+|+-....+||+|||+.+.+...               +..|
T Consensus       208 ~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaP  284 (1039)
T KOG0199|consen  208 ILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAP  284 (1039)
T ss_pred             ceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCH
Confidence            6778888899999999999999   889999999999999999999999999999876543               2337


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhh
Q 040999          249 KYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQA  327 (382)
Q Consensus       249 ~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (382)
                      |......++.++|||+|||++|||+| |..||-....  .            .+-+.+|..-..                
T Consensus       285 EsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~------------qIL~~iD~~erL----------------  334 (1039)
T KOG0199|consen  285 ESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--I------------QILKNIDAGERL----------------  334 (1039)
T ss_pred             hHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--H------------HHHHhccccccC----------------
Confidence            77788899999999999999999998 6778653210  0            111112211000                


Q ss_pred             hhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHH
Q 040999          328 KINVIIECVISMVRIGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       328 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                        .....|..++.+++..||..+|++|||+.++.+.+
T Consensus       335 --pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  335 --PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             --CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence              01126788999999999999999999999997544

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=1e-30  Score=239.04  Aligned_cols=148  Identities=22%  Similarity=0.334  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++++++||||+++++++..     +...++||||++ ++|.+++....       ....+++..+..++.|+
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~~~qi  110 (285)
T cd07861          44 STAIREISLLKELQHPNIVCLQDVLMQ-----ESRLYLIFEFLS-MDLKKYLDSLP-------KGQYMDAELVKSYLYQI  110 (285)
T ss_pred             HHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEEEEEecCC-CCHHHHHhcCC-------CCCcCCHHHHHHHHHHH
Confidence            567889999999999999999999653     678899999997 68888774321       23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+++||||||+||+++.++.+||+|||++.....            ....||...+ ..++.++||||
T Consensus       111 ~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s  187 (285)
T cd07861         111 LQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWS  187 (285)
T ss_pred             HHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHH
Confidence            99999999   77999999999999999999999999999875421            1234665443 34688999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      |||++|||+||+.||..
T Consensus       188 lG~il~~l~tg~~~~~~  204 (285)
T cd07861         188 IGTIFAEMATKKPLFHG  204 (285)
T ss_pred             HHHHHHHHHHCCCCCCC
Confidence            99999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.9e-31  Score=251.05  Aligned_cols=146  Identities=18%  Similarity=0.215  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|||||++++++.     +....++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        46 ~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~ql  110 (377)
T cd05629          46 AHVKAERDVLAESDSPWVVSLYYSFQ-----DAQYLYLIMEFLPGGDLMTMLI----------KYDTFSEDVTRFYMAEC  110 (377)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEE-----cCCeeEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            56788999999999999999999854     4778999999999999999884          23458888899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC-----------------------------------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-----------------------------------  242 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~-----------------------------------  242 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++...                                   
T Consensus       111 ~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (377)
T cd05629         111 VLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLT  187 (377)
T ss_pred             HHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999   7799999999999999999999999999985221                                   


Q ss_pred             ------------------------CCCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          243 ------------------------PTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       243 ------------------------~~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                                              ....+||...+..++.++|||||||++|||+||+.||..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~  250 (377)
T cd05629         188 MSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCS  250 (377)
T ss_pred             ccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCC
Confidence                                    112346666667789999999999999999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=5.6e-31  Score=254.52  Aligned_cols=149  Identities=24%  Similarity=0.344  Sum_probs=126.6

Q ss_pred             chhhH--HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHH
Q 040999          113 AFKIF--KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRR  190 (382)
Q Consensus       113 avK~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~  190 (382)
                      |+|..  ..+.+|+++|++++|+|||++++++..     .+..++|||++. ++|.+++.         .....+++..+
T Consensus       198 avK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e~~~-~~L~~~l~---------~~~~~l~~~~~  262 (461)
T PHA03211        198 VVKAGWYASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLPKYR-SDLYTYLG---------ARLRPLGLAQV  262 (461)
T ss_pred             EEecccccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEEccC-CCHHHHHH---------hcCCCCCHHHH
Confidence            66654  567899999999999999999998654     677899999994 68888773         22346899999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEV  256 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~  256 (382)
                      +.++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++....              ....||...+..+
T Consensus       263 ~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~  339 (461)
T PHA03211        263 TAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY  339 (461)
T ss_pred             HHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCC
Confidence            999999999999999   77999999999999999999999999999975432              1233677777788


Q ss_pred             CccchhHHHHHHHHHHHhcCCCC
Q 040999          257 STIGDVYSYGILLLELMIREKPS  279 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~elltg~~p~  279 (382)
                      +.++|||||||++|||++|..|+
T Consensus       340 ~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        340 TPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             CchHHHHHHHHHHHHHHHcCCCc
Confidence            99999999999999999988764

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=6.7e-31  Score=265.73  Aligned_cols=215  Identities=19%  Similarity=0.266  Sum_probs=159.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc-cccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE-TYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~l~~~~~~~i~~~  196 (382)
                      ++|.+|++++++++||||+++++++..     .+..++||||+++|+|.+++........ .......+++..++.++.|
T Consensus        47 ~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~Q  121 (932)
T PRK13184         47 KRFLREAKIAADLIHPGIVPVYSICSD-----GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK  121 (932)
T ss_pred             HHHHHHHHHHHhCCCcCcCeEEEEEee-----CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHH
Confidence            578999999999999999999998653     6788999999999999998854221110 0112345678888999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------------------------CCCC
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------------------------PTRT  246 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------------------------~~~~  246 (382)
                      |++||+|||   +.+|+||||||+||+++.++.+||+|||+++...                              ....
T Consensus       122 Ia~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~Ym  198 (932)
T PRK13184        122 ICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYM  198 (932)
T ss_pred             HHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCC
Confidence            999999999   7799999999999999999999999999997651                              1123


Q ss_pred             CCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhh
Q 040999          247 QTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQ  326 (382)
Q Consensus       247 ~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (382)
                      +||...+..++.++|||||||++|||+||+.||.......  .  .......       .      +...          
T Consensus       199 APE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k--i--~~~~~i~-------~------P~~~----------  251 (932)
T PRK13184        199 APERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK--I--SYRDVIL-------S------PIEV----------  251 (932)
T ss_pred             CHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh--h--hhhhhcc-------C------hhhc----------
Confidence            3666667788999999999999999999999986421100  0  0000000       0      0000          


Q ss_pred             hhhhhHHHHHHHHHHHhhccCCCCccCCC-CHHHHHHHHHHhhhh
Q 040999          327 AKINVIIECVISMVRIGVACSMESPQDRM-KMTNVVHELQSIKNT  370 (382)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-s~~evl~~L~~i~~~  370 (382)
                         ....+.+..+.+++.+|++.||++|| +++++.+.|+.....
T Consensus       252 ---~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        252 ---APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             ---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence               00012334577888899999999996 578888888877553

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=8.3e-31  Score=239.87  Aligned_cols=207  Identities=20%  Similarity=0.219  Sum_probs=153.7

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ..+.+|+.+++++ +|+||+++++++........+..++||||+++++|.+++....      .....+++..+..++.|
T Consensus        59 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~  132 (286)
T cd06638          59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL------KRGERMEEPIIAYILHE  132 (286)
T ss_pred             HHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhh------ccCccccHHHHHHHHHH
Confidence            4678899999999 6999999999986544455678899999999999998874321      12345888999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc-----CCCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV-----GNEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~-----~~~~~~~  259 (382)
                      +++||.|||   +.+++||||||+||+++.++.+||+|||+++.....            ...||...     +..++.+
T Consensus       133 i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~  209 (286)
T cd06638         133 ALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDAR  209 (286)
T ss_pred             HHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccch
Confidence            999999999   779999999999999999999999999998764321            12355432     2446889


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +|||||||++|||++|+.||....    ......... ...     ..... .+                   ......+
T Consensus       210 ~Dv~slGvi~~el~~g~~p~~~~~----~~~~~~~~~-~~~-----~~~~~-~~-------------------~~~~~~~  259 (286)
T cd06638         210 CDVWSLGITAIELGDGDPPLADLH----PMRALFKIP-RNP-----PPTLH-QP-------------------ELWSNEF  259 (286)
T ss_pred             hhhhhHHHHHHHHhcCCCCCCCCc----hhHHHhhcc-ccC-----CCccc-CC-------------------CCcCHHH
Confidence            999999999999999999976321    111111000 000     00000 00                   0112357


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      .+++.+||+.+|++|||+.|+++.
T Consensus       260 ~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         260 NDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhc
Confidence            788889999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=9.9e-32  Score=250.72  Aligned_cols=195  Identities=22%  Similarity=0.212  Sum_probs=146.6

Q ss_pred             HHHHHHH-HHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+.+|.. +++.++||||+++++++.     ..+..++||||+++|+|..++.          ....+++..+..++.||
T Consensus        41 ~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  105 (325)
T cd05604          41 HIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVLDFVNGGELFFHLQ----------RERSFPEPRARFYAAEI  105 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEEcCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            4555554 467789999999998854     3778999999999999988873          33468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++....            ....||...+..++.++|||||
T Consensus       106 ~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (325)
T cd05604         106 ASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCL  182 (325)
T ss_pred             HHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccc
Confidence            99999999   77999999999999999999999999999874321            1234777777788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....     .........        ...+...+                    .....+.+++.+
T Consensus       183 G~il~el~~G~~pf~~~~-----~~~~~~~~~--------~~~~~~~~--------------------~~~~~~~~ll~~  229 (325)
T cd05604         183 GAVLYEMLYGLPPFYCRD-----VAEMYDNIL--------HKPLVLRP--------------------GASLTAWSILEE  229 (325)
T ss_pred             cceehhhhcCCCCCCCCC-----HHHHHHHHH--------cCCccCCC--------------------CCCHHHHHHHHH
Confidence            999999999999986321     111111111        00000000                    112346677889


Q ss_pred             cCCCCccCCCCHHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~L  364 (382)
                      |++.+|.+||++++.++.+
T Consensus       230 ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         230 LLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             HhccCHHhcCCCCCCHHHH
Confidence            9999999999986444433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-30  Score=236.06  Aligned_cols=195  Identities=20%  Similarity=0.230  Sum_probs=153.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+++++.++|+||+++++++..     ....++|+||+++++|.+++..           ..+++..+..++.|+
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql  107 (274)
T cd06609          44 EDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLWIIMEYCGGGSCLDLLKP-----------GKLDETYIAFILREV  107 (274)
T ss_pred             HHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEEEEEEeeCCCcHHHHHhh-----------cCCCHHHHHHHHHHH
Confidence            568899999999999999999998654     5789999999999999998842           268999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+++|+||+|+||++++++.++|+|||+++.....            ...||...+..++.++|||||
T Consensus       108 ~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~sl  184 (274)
T cd06609         108 LLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSL  184 (274)
T ss_pred             HHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHH
Confidence            99999999   779999999999999999999999999999765432            234777777778999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|||+||+.||.....     .......         ..........                 ......+.+++.+
T Consensus       185 G~il~~l~tg~~p~~~~~~-----~~~~~~~---------~~~~~~~~~~-----------------~~~~~~~~~~l~~  233 (274)
T cd06609         185 GITAIELAKGEPPLSDLHP-----MRVLFLI---------PKNNPPSLEG-----------------NKFSKPFKDFVSL  233 (274)
T ss_pred             HHHHHHHHhCCCCcccCch-----HHHHHHh---------hhcCCCCCcc-----------------cccCHHHHHHHHH
Confidence            9999999999999864211     0000000         0000000000                 0123357788889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||..+|++|||++++++
T Consensus       234 ~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         234 CLNKDPKERPSAKELLK  250 (274)
T ss_pred             HhhCChhhCcCHHHHhh
Confidence            99999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=6.6e-31  Score=245.04  Aligned_cols=146  Identities=20%  Similarity=0.241  Sum_probs=124.0

Q ss_pred             HHHHHHHHHHhhcccc-cceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+..|++++..++|+ +|+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~~~----------~~~~~~~~~~~~~~~q  109 (324)
T cd05587          45 ECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDRLYFVMEYVNGGDLMYHIQ----------QVGKFKEPHAVFYAAE  109 (324)
T ss_pred             HHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCEEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            4678899999999765 5778877743     3678999999999999998883          2345888999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC------------CCCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL------------PPTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~------------~~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..            ......||...+..++.++||||
T Consensus       110 i~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  186 (324)
T cd05587         110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA  186 (324)
T ss_pred             HHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhh
Confidence            999999999   779999999999999999999999999998642            12234577777778899999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      |||++|||+||+.||..
T Consensus       187 lGvil~elltG~~pf~~  203 (324)
T cd05587         187 FGVLLYEMLAGQPPFDG  203 (324)
T ss_pred             hHHHHHHHHhCCCCCCC
Confidence            99999999999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=1.1e-30  Score=240.48  Aligned_cols=196  Identities=19%  Similarity=0.258  Sum_probs=152.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|+||+++++++..     .+..++|+||+++++|..++.           ...+++.++..++.|+
T Consensus        61 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----------~~~l~~~~~~~i~~~l  124 (296)
T cd06655          61 ELIINEILVMKELKNPNIVNFLDSFLV-----GDELFVVMEYLAGGSLTDVVT-----------ETCMDEAQIAAVCREC  124 (296)
T ss_pred             HHHHHHHHHHHhcCCCceeeeeeeEec-----CceEEEEEEecCCCcHHHHHH-----------hcCCCHHHHHHHHHHH
Confidence            568899999999999999999999653     678999999999999998883           2348899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+++||||||+||+++.++.+||+|||++......            ...||...+..++.++|||||
T Consensus       125 ~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  201 (296)
T cd06655         125 LQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (296)
T ss_pred             HHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHH
Confidence            99999999   779999999999999999999999999998754322            233676666778899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||.....    ......... .....     +. .+                   ......+.+++.+
T Consensus       202 Gvil~~lltg~~pf~~~~~----~~~~~~~~~-~~~~~-----~~-~~-------------------~~~~~~~~~li~~  251 (296)
T cd06655         202 GIMAIEMVEGEPPYLNENP----LRALYLIAT-NGTPE-----LQ-NP-------------------EKLSPIFRDFLNR  251 (296)
T ss_pred             HHHHHHHHhCCCCCCCCCH----HHHHHHHHh-cCCcc-----cC-Cc-------------------ccCCHHHHHHHHH
Confidence            9999999999999864211    111110000 00000     00 00                   0223356778889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.+|++||++.+++.
T Consensus       252 ~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         252 CLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HhhcChhhCCCHHHHhh
Confidence            99999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=1.1e-30  Score=239.82  Aligned_cols=207  Identities=20%  Similarity=0.198  Sum_probs=152.9

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ..+.+|+.++.++ +|||++++++++...+.......++|+||+++++|.+++....      .....+++..+..++.|
T Consensus        63 ~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~------~~~~~~~~~~~~~~~~q  136 (291)
T cd06639          63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL------ICGQRLDEAMISYILYG  136 (291)
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhh------hcCCCCCHHHHHHHHHH
Confidence            4677899999999 7999999999987543334467899999999999998874321      12346889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-----CCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-----NEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-----~~~~~~  259 (382)
                      ++.||.|||   ..+++||||||+||+++.++.+||+|||++......            ...||....     ..++.+
T Consensus       137 i~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~  213 (291)
T cd06639         137 ALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDAR  213 (291)
T ss_pred             HHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCc
Confidence            999999999   779999999999999999999999999998754321            123554322     235789


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +|||||||++|||++|+.||.....    ........ ......+..      .                   ......+
T Consensus       214 ~Di~slGvi~~el~~g~~p~~~~~~----~~~~~~~~-~~~~~~~~~------~-------------------~~~~~~l  263 (291)
T cd06639         214 CDVWSLGITAIELGDGDPPLFDMHP----VKTLFKIP-RNPPPTLLH------P-------------------EKWCRSF  263 (291)
T ss_pred             cchHHHHHHHHHHhhCCCCCCCCcH----HHHHHHHh-cCCCCCCCc------c-------------------cccCHHH
Confidence            9999999999999999999864211    11111100 000000000      0                   0223457


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      .+++.+||+.+|++||++.|+++.
T Consensus       264 ~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         264 NHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHHHHHhhcChhhCcCHHHHhcC
Confidence            888899999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=8.1e-31  Score=247.58  Aligned_cols=148  Identities=22%  Similarity=0.259  Sum_probs=122.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+.+++.++||||+++++++.... .......++||||+++ ++.+++.            ..+++..+..++.|
T Consensus        61 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~q  127 (355)
T cd07874          61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQ  127 (355)
T ss_pred             HHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHH
Confidence            56788999999999999999999865321 1233457999999965 5655552            24788889999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...+..++.++|||||
T Consensus       128 i~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl  204 (355)
T cd07874         128 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  204 (355)
T ss_pred             HHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHH
Confidence            999999999   789999999999999999999999999999764332           234777777788999999999


Q ss_pred             HHHHHHHHhcCCCCCc
Q 040999          266 GILLLELMIREKPSDI  281 (382)
Q Consensus       266 Gvil~elltg~~p~~~  281 (382)
                      ||++|||++|+.||..
T Consensus       205 G~il~el~~g~~pf~~  220 (355)
T cd07874         205 GCIMGEMVRHKILFPG  220 (355)
T ss_pred             HHHHHHHHhCCCCCCC
Confidence            9999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=5.8e-31  Score=249.67  Aligned_cols=197  Identities=17%  Similarity=0.217  Sum_probs=147.4

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|+++++.++||||+++++++.     +....++||||+++|+|.+++..           ..+++..+..++.|++
T Consensus        89 ~~~~e~~il~~~~h~~iv~~~~~~~-----~~~~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~  152 (370)
T cd05596          89 FFWEERDIMAHANSEWIVQLHYAFQ-----DDKYLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVV  152 (370)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEe-----cCCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHH
Confidence            4778999999999999999998854     47789999999999999998832           2477888889999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccC----CCCCccch
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVG----NEVSTIGD  261 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~----~~~~~~~D  261 (382)
                      .||+|||   +.+|+||||||+|||++.++.+||+|||++......             ..+||...+    ..++.++|
T Consensus       153 ~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~D  229 (370)
T cd05596         153 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD  229 (370)
T ss_pred             HHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCcee
Confidence            9999999   779999999999999999999999999998765322             123554332    24788999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||++|+.||....    ....+.. .....     ........                   .....++.+
T Consensus       230 iwSlGvilyelltG~~Pf~~~~----~~~~~~~-i~~~~-----~~~~~~~~-------------------~~~s~~~~~  280 (370)
T cd05596         230 WWSVGVFLYEMLVGDTPFYADS----LVGTYSK-IMDHK-----NSLTFPDD-------------------IEISKQAKD  280 (370)
T ss_pred             eeehhHHHHHHHhCCCCcCCCC----HHHHHHH-HHcCC-----CcCCCCCc-------------------CCCCHHHHH
Confidence            9999999999999999986321    1111111 00000     00000000                   012345677


Q ss_pred             HhhccCCCCccC--CCCHHHHHHH
Q 040999          342 IGVACSMESPQD--RMKMTNVVHE  363 (382)
Q Consensus       342 l~~~Cl~~~p~~--RPs~~evl~~  363 (382)
                      ++.+|++.+|.+  |||+.|+++.
T Consensus       281 li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         281 LICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHHccChhhccCCCCHHHHhcC
Confidence            888999999988  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=1.2e-30  Score=236.48  Aligned_cols=199  Identities=18%  Similarity=0.239  Sum_probs=149.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+.+++.++||||+++++++..     .+..++|+||+++++|.+++.          ....+++..+..++.|+
T Consensus        51 ~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~~i  115 (267)
T cd06645          51 AVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWICMEFCGGGSLQDIYH----------VTGPLSESQIAYVSRET  115 (267)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEEEEeccCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            467889999999999999999998643     678899999999999999883          23468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc---CCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV---GNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~---~~~~~~~~Dv  262 (382)
                      +.||.|||   ..+++|+||||+||+++.++.+||+|||++......            ..+||...   ...++.++||
T Consensus       116 ~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv  192 (267)
T cd06645         116 LQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI  192 (267)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhh
Confidence            99999999   779999999999999999999999999998654321            23355542   3457889999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||++|+.||....... ...........       .+....                    .......+.++
T Consensus       193 wSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~~-------~~~~~~--------------------~~~~~~~~~~l  244 (267)
T cd06645         193 WAVGITAIELAELQPPMFDLHPMR-ALFLMTKSNFQ-------PPKLKD--------------------KMKWSNSFHHF  244 (267)
T ss_pred             HHHHHHHHHHhcCCCCcccccchh-hHHhhhccCCC-------CCcccc--------------------cCCCCHHHHHH
Confidence            999999999999999975321110 00000000000       000000                    00122356788


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+|++.+|++||+++++++
T Consensus       245 i~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHccCCchhCcCHHHHhc
Confidence            88999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=1.7e-30  Score=234.59  Aligned_cols=206  Identities=18%  Similarity=0.236  Sum_probs=158.0

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++++..   ......+++|||+++++|.+++....      .....+++..++.++.|
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~~~~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~  113 (265)
T cd08217          43 KQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLYIVMEYCEGGDLAQLIQKCK------KERKYIEEEFIWRILTQ  113 (265)
T ss_pred             HHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEEEEehhccCCCHHHHHHHHh------hcccCCCHHHHHHHHHH
Confidence            4678899999999999999999998653   23566899999999999999985322      22456899999999999


Q ss_pred             HHHHHhHHhhcC--CCceeecCCCCCceeeCCCCcEEEccccccccCCCCC------------CCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDC--QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR------------TQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~--~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||+|||..+  +.+++|+||||+||+++.++.+||+|||++.......            ..||...+..++.++||
T Consensus       114 i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv  193 (265)
T cd08217         114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDI  193 (265)
T ss_pred             HHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHH
Confidence            999999999554  6689999999999999999999999999998654322            23666666778899999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||+++|+|++|+.||....     ........         ........                  .......+.++
T Consensus       194 ~slG~il~~l~~g~~p~~~~~-----~~~~~~~~---------~~~~~~~~------------------~~~~~~~~~~l  241 (265)
T cd08217         194 WSLGCLIYELCALSPPFTARN-----QLQLASKI---------KEGKFRRI------------------PYRYSSELNEV  241 (265)
T ss_pred             HHHHHHHHHHHHCCCcccCcC-----HHHHHHHH---------hcCCCCCC------------------ccccCHHHHHH
Confidence            999999999999999986421     11111110         00000000                  00233467888


Q ss_pred             hhccCCCCccCCCCHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +.+|++.+|++||++.+|++.
T Consensus       242 ~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         242 IKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHccCCcccCCCHHHHhhC
Confidence            889999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=2.1e-30  Score=237.32  Aligned_cols=201  Identities=20%  Similarity=0.231  Sum_probs=151.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++.+.     ..+..++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~ql  111 (285)
T cd05632          45 SMALNEKQILEKVNSQFVVNLAYAYE-----TKDALCLVLTIMNGGDLKFHIYNM--------GNPGFEEERALFYAAEI  111 (285)
T ss_pred             HHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEEEEEEeccCccHHHHHHHh--------cCCCCCHHHHHHHHHHH
Confidence            34778999999999999999988854     367899999999999998887421        23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||++.....           ....||...+..++.++||||||
T Consensus       112 ~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG  188 (285)
T cd05632         112 LCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLG  188 (285)
T ss_pred             HHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHH
Confidence            99999999   78999999999999999999999999999865422           22347777777889999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||+||+.||...... .............. ..     ..                      ......+.+++..|
T Consensus       189 ~~l~~l~~g~~P~~~~~~~-~~~~~~~~~~~~~~-~~-----~~----------------------~~~~~~~~~li~~~  239 (285)
T cd05632         189 CLIYEMIEGQSPFRGRKEK-VKREEVDRRVLETE-EV-----YS----------------------AKFSEEAKSICKML  239 (285)
T ss_pred             HHHHHHHhCCCCCCCCCHH-HHHHHHHHhhhccc-cc-----cC----------------------ccCCHHHHHHHHHH
Confidence            9999999999998632110 00111110000000 00     00                      01223567788899


Q ss_pred             CCCCccCCCC-----HHHHHHH
Q 040999          347 SMESPQDRMK-----MTNVVHE  363 (382)
Q Consensus       347 l~~~p~~RPs-----~~evl~~  363 (382)
                      ++.+|++||+     +++++..
T Consensus       240 l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         240 LTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccCCHhHcCCCcccChHHHHcC
Confidence            9999999999     6676653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-31  Score=249.66  Aligned_cols=193  Identities=22%  Similarity=0.285  Sum_probs=155.3

Q ss_pred             chhhH-----------HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcccc
Q 040999          113 AFKIF-----------KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE  180 (382)
Q Consensus       113 avK~~-----------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~  180 (382)
                      |||++           +..+.|.+++... +||.+++++..     ++.+++.|.||||+.||++..+.+          
T Consensus       397 AIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT~~~l~fvmey~~Ggdm~~~~~----------  461 (694)
T KOG0694|consen  397 AIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQTKEHLFFVMEYVAGGDLMHHIH----------  461 (694)
T ss_pred             EEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----cccCCeEEEEEEecCCCcEEEEEe----------
Confidence            77776           6788999999888 59999999987     677999999999999999665553          


Q ss_pred             CCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCC
Q 040999          181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQT  248 (382)
Q Consensus       181 ~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~  248 (382)
                       ...+++..+..++..|+.||.|||   +++||+||||.+|||+|.+|.+||+|||+++...            +...+|
T Consensus       462 -~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aP  537 (694)
T KOG0694|consen  462 -TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAP  537 (694)
T ss_pred             -cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcCh
Confidence             356999999999999999999999   8899999999999999999999999999998542            233447


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhh
Q 040999          249 KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAK  328 (382)
Q Consensus       249 ~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (382)
                      |...+..|+..+|+|||||++|||+.|..||....+                 .++.+.++..++.-             
T Consensus       538 Eil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-----------------ee~FdsI~~d~~~y-------------  587 (694)
T KOG0694|consen  538 EVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-----------------EEVFDSIVNDEVRY-------------  587 (694)
T ss_pred             hhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-----------------HHHHHHHhcCCCCC-------------
Confidence            888889999999999999999999999999874211                 22333333222110             


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCccCCCCH
Q 040999          329 INVIIECVISMVRIGVACSMESPQDRMKM  357 (382)
Q Consensus       329 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~  357 (382)
                         ......+.+.++.+.+.++|++|--+
T Consensus       588 ---P~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  588 ---PRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---CCcccHHHHHHHHHHhccCcccccCC
Confidence               01334566777789999999999766

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=1.4e-30  Score=248.34  Aligned_cols=146  Identities=20%  Similarity=0.264  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+|||++++.+.     +.+..++|||||++|+|.+++.          ....+++.....++.||
T Consensus        46 ~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----------~~~~~~e~~~~~~~~qi  110 (382)
T cd05625          46 AHVKAERDILAEADNEWVVRLYYSFQ-----DKDNLYFVMDYIPGGDMMSLLI----------RMGIFPEDLARFYIAEL  110 (382)
T ss_pred             HHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            56889999999999999999999864     3778999999999999999883          23457888899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC------------------------------------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL------------------------------------  241 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~------------------------------------  241 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++..                                    
T Consensus       111 ~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (382)
T cd05625         111 TCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD  187 (382)
T ss_pred             HHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccc
Confidence            99999999   779999999999999999999999999997421                                    


Q ss_pred             -----------------------CCCCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          242 -----------------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       242 -----------------------~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                                             .....+||...+..++.++|||||||++|||+||+.||..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~  250 (382)
T cd05625         188 RLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             cccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence                                   1123346766677889999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=8.1e-31  Score=248.42  Aligned_cols=148  Identities=22%  Similarity=0.249  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+.+++.++||||+++++++.... .......++||||+++ +|.+++.            ..+++..+..++.|
T Consensus        68 ~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~q  134 (364)
T cd07875          68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQ  134 (364)
T ss_pred             HHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH------------hcCCHHHHHHHHHH
Confidence            56788999999999999999999865321 1233567999999965 6666552            23778889999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....           ..+||...+..++.++|||||
T Consensus       135 i~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl  211 (364)
T cd07875         135 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  211 (364)
T ss_pred             HHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhH
Confidence            999999999   779999999999999999999999999999754322           234777777788999999999


Q ss_pred             HHHHHHHHhcCCCCCc
Q 040999          266 GILLLELMIREKPSDI  281 (382)
Q Consensus       266 Gvil~elltg~~p~~~  281 (382)
                      ||++|||++|+.||..
T Consensus       212 G~il~ell~g~~pf~~  227 (364)
T cd07875         212 GCIMGEMIKGGVLFPG  227 (364)
T ss_pred             HHHHHHHHhCCCCCCC
Confidence            9999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=1.3e-30  Score=235.69  Aligned_cols=203  Identities=20%  Similarity=0.250  Sum_probs=156.5

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+++.+|++++++++||||+++++.+..     ....++++||+++++|.+++..         ....+++.....++.|
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~  108 (265)
T cd06605          43 QKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISICMEYMDGGSLDKILKE---------VQGRIPERILGKIAVA  108 (265)
T ss_pred             HHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEEEEEecCCCcHHHHHHH---------ccCCCCHHHHHHHHHH
Confidence            3678999999999999999999998654     5789999999999999998842         1256888999999999


Q ss_pred             HHHHHhHHhhcCC-CceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQ-PVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~-~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +++||+|||   + .+++|+||||+||+++.++.+||+|||.+.....          ....||...+..++.++|||||
T Consensus       109 l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  185 (265)
T cd06605         109 VLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSL  185 (265)
T ss_pred             HHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHH
Confidence            999999999   6 7999999999999999999999999999865421          2344777777788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|+|++|+.||.....................        ....+ .                 ......+.+++.+
T Consensus       186 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-~-----------------~~~~~~~~~li~~  239 (265)
T cd06605         186 GLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--------PPRLP-S-----------------GKFSPDFQDFVNL  239 (265)
T ss_pred             HHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC--------CCCCC-h-----------------hhcCHHHHHHHHH
Confidence            99999999999998643221111111111111000        00000 0                 0133467888889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||..+|++|||+.+++.
T Consensus       240 ~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         240 CLIKDPRERPSYKELLE  256 (265)
T ss_pred             HcCCCchhCcCHHHHhh
Confidence            99999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=4.5e-30  Score=233.23  Aligned_cols=201  Identities=19%  Similarity=0.253  Sum_probs=151.9

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++++..     .+..++||||+++++|.+++..          ...+++..+..++.|
T Consensus        52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~q  116 (272)
T cd06629          52 VKALRSEIETLKDLDHLNIVQYLGFETT-----EEYLSIFLEYVPGGSIGSCLRT----------YGRFEEQLVRFFTEQ  116 (272)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEecc-----CCceEEEEecCCCCcHHHHHhh----------ccCCCHHHHHHHHHH
Confidence            4678899999999999999999998643     6788999999999999998842          246888999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCC--CCCccc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGN--EVSTIG  260 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~--~~~~~~  260 (382)
                      ++.||.|||   +.+++||||||+||+++.++.+|++|||+++.....              ...||.....  .++.++
T Consensus       117 i~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~  193 (272)
T cd06629         117 VLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKV  193 (272)
T ss_pred             HHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccc
Confidence            999999999   779999999999999999999999999998754321              1235554433  378899


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||+++||+++|..||...    ........... ......+...                      ...+....+.
T Consensus       194 Dv~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~-~~~~~~~~~~----------------------~~~~~~~~~~  246 (272)
T cd06629         194 DIWSLGCVVLEMFAGRRPWSDE----EAIAAMFKLGN-KRSAPPIPPD----------------------VSMNLSPVAL  246 (272)
T ss_pred             hhHHHHHHHHHHHhCCCCCcCc----chHHHHHHhhc-cccCCcCCcc----------------------ccccCCHHHH
Confidence            9999999999999999997531    11111111000 0000000000                      0012345678


Q ss_pred             HHhhccCCCCccCCCCHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +++.+||+.+|.+|||+++|++
T Consensus       247 ~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         247 DFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHHHHhcCChhhCCCHHHHhh
Confidence            8888999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=3.9e-31  Score=246.27  Aligned_cols=189  Identities=22%  Similarity=0.224  Sum_probs=143.1

Q ss_pred             HHHHHHH-HHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+.+|.. +++.++||||+++++++.     +.+..++||||+++|+|..++.          ....+++..+..++.||
T Consensus        41 ~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  105 (321)
T cd05603          41 HIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVLDYVNGGELFFHLQ----------RERCFLEPRARFYAAEV  105 (321)
T ss_pred             HHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEEcCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            4555554 578899999999998854     3678999999999999988773          23457888899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++||.|||   +.+|+||||||+||+++.++.+||+|||+++...            .....||...+..++.++|||||
T Consensus       106 ~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (321)
T cd05603         106 ASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCL  182 (321)
T ss_pred             HHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCccccc
Confidence            99999999   7799999999999999999999999999987531            12234676667778999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||...     +..........        .......                    .....+.+++.+
T Consensus       183 G~il~el~~g~~pf~~~-----~~~~~~~~i~~--------~~~~~~~--------------------~~~~~~~~li~~  229 (321)
T cd05603         183 GAVLYEMLYGLPPFYSR-----DVSQMYDNILH--------KPLQLPG--------------------GKTVAACDLLVG  229 (321)
T ss_pred             chhhhhhhcCCCCCCCC-----CHHHHHHHHhc--------CCCCCCC--------------------CCCHHHHHHHHH
Confidence            99999999999998632     11111111110        0000000                    122356788889


Q ss_pred             cCCCCccCCCCHH
Q 040999          346 CSMESPQDRMKMT  358 (382)
Q Consensus       346 Cl~~~p~~RPs~~  358 (382)
                      |++.+|.+||++.
T Consensus       230 ~l~~~p~~R~~~~  242 (321)
T cd05603         230 LLHKDQRRRLGAK  242 (321)
T ss_pred             HccCCHhhcCCCC
Confidence            9999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.1e-30  Score=246.76  Aligned_cols=149  Identities=23%  Similarity=0.367  Sum_probs=125.3

Q ss_pred             chhhH--HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHH
Q 040999          113 AFKIF--KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRR  190 (382)
Q Consensus       113 avK~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~  190 (382)
                      |+|..  .....|+.++++++|+||+++++++..     ....++|+||+. ++|.+++.         .....+++..+
T Consensus        95 alK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~---------~~~~~~~~~~~  159 (357)
T PHA03209         95 VLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPHYS-SDLYTYLT---------KRSRPLPIDQA  159 (357)
T ss_pred             EEEeCCccccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEEccC-CcHHHHHH---------hccCCCCHHHH
Confidence            56654  445679999999999999999999654     667899999994 68888873         23456899999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCcc
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTI  259 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~  259 (382)
                      ..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++....           ....||...+..++.+
T Consensus       160 ~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  236 (357)
T PHA03209        160 LIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK  236 (357)
T ss_pred             HHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCch
Confidence            999999999999999   77999999999999999999999999999974321           2345888778889999


Q ss_pred             chhHHHHHHHHHHHhcCCCC
Q 040999          260 GDVYSYGILLLELMIREKPS  279 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~  279 (382)
                      +|||||||++|||+++..|+
T Consensus       237 ~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        237 ADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             hhHHHHHHHHHHHHHcCCcc
Confidence            99999999999999866553

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=3.2e-30  Score=232.09  Aligned_cols=200  Identities=19%  Similarity=0.234  Sum_probs=154.0

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+|++++++.+..    .....+++|||+++++|.+++...        ....+++.++..++.|
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~e~~~~~~l~~~l~~~--------~~~~l~~~~~~~~~~~  110 (257)
T cd08223          43 RKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLYIVMGFCEGGDLYHKLKEQ--------KGKLLPENQVVEWFVQ  110 (257)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEEEEecccCCCcHHHHHHHh--------cCCCCCHHHHHHHHHH
Confidence            3568899999999999999999887432    245678999999999999988531        2345899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||+|||   +.+++||||||+||+++.++.++|+|||++.....            ....||...+..++.++||||
T Consensus       111 l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  187 (257)
T cd08223         111 IAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA  187 (257)
T ss_pred             HHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHH
Confidence            999999999   77999999999999999999999999999875532            123477777778889999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||++++||++|+.||+...     ............        +. ...                  ......+.+++.
T Consensus       188 lG~il~~l~~g~~~~~~~~-----~~~~~~~~~~~~--------~~-~~~------------------~~~~~~~~~li~  235 (257)
T cd08223         188 LGCCVYEMATLKHAFNAKD-----MNSLVYRIIEGK--------LP-PMP------------------KDYSPELGELIA  235 (257)
T ss_pred             HHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcC--------CC-CCc------------------cccCHHHHHHHH
Confidence            9999999999999976321     111111111100        00 000                  022346778888


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.+|++|||+.++++.
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHhccCcccCCCHHHHhcC
Confidence            9999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=1.3e-30  Score=240.14  Aligned_cols=196  Identities=18%  Similarity=0.215  Sum_probs=151.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.+++.++|+||+++++++..     .+..++||||+++++|.+++..           ..+++..+..++.|+
T Consensus        61 ~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~l  124 (297)
T cd06656          61 ELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCREC  124 (297)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEEEeecccCCCCHHHHHHh-----------CCCCHHHHHHHHHHH
Confidence            568899999999999999999999653     6788999999999999998832           347888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||.+......            ...||...+..++.++|||||
T Consensus       125 ~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  201 (297)
T cd06656         125 LQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (297)
T ss_pred             HHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHH
Confidence            99999999   779999999999999999999999999998754322            223666666778899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|+|++|+.||.......    ..... ....     .+... .                   .......+.+++.+
T Consensus       202 Gvil~~l~tg~~pf~~~~~~~----~~~~~-~~~~-----~~~~~-~-------------------~~~~~~~~~~li~~  251 (297)
T cd06656         202 GIMAIEMVEGEPPYLNENPLR----ALYLI-ATNG-----TPELQ-N-------------------PERLSAVFRDFLNR  251 (297)
T ss_pred             HHHHHHHHhCCCCCCCCCcch----heeee-ccCC-----CCCCC-C-------------------ccccCHHHHHHHHH
Confidence            999999999999985321100    00000 0000     00000 0                   00123356778889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.+|++||+++++++
T Consensus       252 ~l~~~p~~Rps~~~il~  268 (297)
T cd06656         252 CLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HccCChhhCcCHHHHhc
Confidence            99999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=2.5e-30  Score=239.95  Aligned_cols=224  Identities=19%  Similarity=0.172  Sum_probs=153.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|+||+++++++.     ..+..+++|||+++|+|.+++...        ....+++.....++.|+
T Consensus        44 ~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l~~~l~~~--------~~~~~~~~~~~~~~~~l  110 (314)
T cd08216          44 KLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSCEDLLKTH--------FPEGLPELAIAFILKDV  110 (314)
T ss_pred             HHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCHHHHHHHh--------cccCCCHHHHHHHHHHH
Confidence            67899999999999999999999854     367789999999999999988532        12357888899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------------CCCCccccC--CCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------------RTQTKYGVG--NEV  256 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~~~~~--~~~  256 (382)
                      ++||.|||   +.+|+||||||+||+++.++.+|++|||.+......                   ...||....  ..+
T Consensus       111 ~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  187 (314)
T cd08216         111 LNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY  187 (314)
T ss_pred             HHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCC
Confidence            99999999   779999999999999999999999999988644211                   123554433  347


Q ss_pred             CccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhh-----ccccc-hhhhhhh
Q 040999          257 STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVV-----RGDQK-QTQAKIN  330 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~  330 (382)
                      +.++|||||||++|||++|+.||....... ...+......+    ..++............     ..... .......
T Consensus       188 ~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (314)
T cd08216         188 NEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVP----CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHP  262 (314)
T ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCc----cccccCchhhhcCCcCcccccccccchhhhhhcc
Confidence            889999999999999999999987432111 11111111111    0110000000000000     00000 0000000


Q ss_pred             hHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          331 VIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       331 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .......++.+++.+||+.+|++|||++++++
T Consensus       263 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         263 YTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            11123346788889999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=5.8e-30  Score=235.13  Aligned_cols=200  Identities=21%  Similarity=0.248  Sum_probs=150.7

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|+++++.++|+||+++++.+..     ....++||||+++++|..++.         .....+++..+..++.
T Consensus        52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~---------~~~~~l~~~~~~~~~~  117 (292)
T cd06644          52 ELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWIMIEFCPGGAVDAIML---------ELDRGLTEPQIQVICR  117 (292)
T ss_pred             HHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEEEEecCCCCcHHHHHH---------hhcCCCCHHHHHHHHH
Confidence            34678899999999999999999998653     568899999999999988773         2234588999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCcccc-----CCCCCc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGV-----GNEVST  258 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~-----~~~~~~  258 (382)
                      |++.||.|||   +.+++||||||+||+++.++.+||+|||.+.....            ....||...     ...++.
T Consensus       118 ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~  194 (292)
T cd06644         118 QMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY  194 (292)
T ss_pred             HHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCc
Confidence            9999999999   78999999999999999999999999998864322            123366543     344678


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ++|||||||++|||++|+.||....    ........ .....     +... .                   ......+
T Consensus       195 ~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~~-~~~~~-----~~~~-~-------------------~~~~~~~  244 (292)
T cd06644         195 KADIWSLGITLIEMAQIEPPHHELN----PMRVLLKI-AKSEP-----PTLS-Q-------------------PSKWSME  244 (292)
T ss_pred             hhhhHhHHHHHHHHhcCCCCCcccc----HHHHHHHH-hcCCC-----ccCC-C-------------------CcccCHH
Confidence            9999999999999999999975321    11111110 00000     0000 0                   0022345


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+++.+||+.+|++||+++++++
T Consensus       245 ~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         245 FRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhc
Confidence            778888999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=3e-30  Score=232.28  Aligned_cols=198  Identities=19%  Similarity=0.264  Sum_probs=154.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++|+||+++++++.     ..+..++|+||+++++|.+++...        ....+++..+..++.|+
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~l  110 (256)
T cd08218          44 EESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLYIVMDYCEGGDLYKKINAQ--------RGVLFPEDQILDWFVQI  110 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEEEEEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHH
Confidence            57899999999999999999999853     467899999999999999888421        12357889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+++|+||+|+||+++.++.++|+|||.+......            ...||...+..++.++|||||
T Consensus       111 ~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl  187 (256)
T cd08218         111 CLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWAL  187 (256)
T ss_pred             HHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHH
Confidence            99999999   779999999999999999999999999999755321            234676667778899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||+++||+||+.||...     ......            +.........               ........+.+++.+
T Consensus       188 G~i~~~l~~g~~~~~~~-----~~~~~~------------~~~~~~~~~~---------------~~~~~~~~~~~li~~  235 (256)
T cd08218         188 GCVLYEMCTLKHAFEAG-----NMKNLV------------LKIIRGSYPP---------------VSSHYSYDLRNLVSQ  235 (256)
T ss_pred             HHHHHHHHcCCCCccCC-----CHHHHH------------HHHhcCCCCC---------------CcccCCHHHHHHHHH
Confidence            99999999999997531     111111            1111000000               000223467888889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.+|.+||++.||++.
T Consensus       236 ~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         236 LFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HhhCChhhCcCHHHHhhC
Confidence            999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=2.1e-30  Score=237.27  Aligned_cols=200  Identities=20%  Similarity=0.241  Sum_probs=152.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++++++|+||+++++.+..     .+..++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~--------~~~~l~~~~~~~~~~qi  111 (285)
T cd05630          45 SMALNEKQILEKVNSRFVVSLAYAYET-----KDALCLVLTLMNGGDLKFHIYHM--------GEAGFEEGRAVFYAAEI  111 (285)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEEEEEEEecCCCcHHHHHHHh--------cccCCCHHHHHHHHHHH
Confidence            356789999999999999999988643     67899999999999999888421        22358899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      +.||.|||   +.+|+||||||+||+++.++.++|+|||++.....           ....||...+..++.++||||||
T Consensus       112 ~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG  188 (285)
T cd05630         112 CCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALG  188 (285)
T ss_pred             HHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHH
Confidence            99999999   78999999999999999999999999999875432           22347777777889999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||....... ..... ..... ....    ...                      ......+.+++.+|
T Consensus       189 ~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~~~~-~~~~----~~~----------------------~~~~~~~~~li~~~  239 (285)
T cd05630         189 CLLYEMIAGQSPFQQRKKKI-KREEV-ERLVK-EVQE----EYS----------------------EKFSPDARSLCKML  239 (285)
T ss_pred             HHHHHHHhCCCCCCCCCccc-hHHHH-Hhhhh-hhhh----hcC----------------------ccCCHHHHHHHHHH
Confidence            99999999999986432110 00000 00000 0000    000                      01223567888899


Q ss_pred             CCCCccCCCC-----HHHHHH
Q 040999          347 SMESPQDRMK-----MTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs-----~~evl~  362 (382)
                      |+.||++|||     ++|+++
T Consensus       240 l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         240 LCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhcCHHHccCCCCCchHHHHc
Confidence            9999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=1.2e-30  Score=238.74  Aligned_cols=223  Identities=20%  Similarity=0.274  Sum_probs=152.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++.     +....++|+||+++++|..+..          ....+++..++.++.|+
T Consensus        45 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i  109 (286)
T cd07846          45 KIAMREIRMLKQLRHENLVNLIEVFR-----RKKRLYLVFEFVDHTVLDDLEK----------YPNGLDESRVRKYLFQI  109 (286)
T ss_pred             HHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeEEEEEecCCccHHHHHHh----------ccCCCCHHHHHHHHHHH
Confidence            46789999999999999999999954     4778999999999988887662          23358999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+++|+||+|+||++++++.+||+|||++......            ...||...+ ..++.++||||
T Consensus       110 ~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s  186 (286)
T cd07846         110 LRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWA  186 (286)
T ss_pred             HHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHH
Confidence            99999999   779999999999999999999999999998754321            123565443 34678999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHh--cCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMA--LPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||+++|||++|+.||..... ...........  .........+.....   ........................+.++
T Consensus       187 lG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l  262 (286)
T cd07846         187 VGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNPLF---AGMRLPEVKEIEPLEKRFPKLSGLVLDL  262 (286)
T ss_pred             HHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccchHh---hccccccccCcchHHHhCCCcCHHHHHH
Confidence            99999999999998753211 00111111100  000111111000000   0000000000000000111335578889


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.+|++||++.++++
T Consensus       263 i~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         263 AKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHHhcCCcccchhHHHHhc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=5.1e-31  Score=245.90  Aligned_cols=194  Identities=22%  Similarity=0.203  Sum_probs=145.0

Q ss_pred             HHHHHHH-HHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+.+|.. +++.++|+||+++++++.     ..+..++||||+++|+|.+++.          ....++......++.||
T Consensus        41 ~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi  105 (325)
T cd05602          41 HIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVLDYINGGELFYHLQ----------RERCFLEPRARFYAAEI  105 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            3444443 467789999999998854     3678999999999999998884          23457788888899999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++||.|||   +.+|+||||||+|||++.++.+||+|||+++...            .....||...+..++.++|||||
T Consensus       106 ~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (325)
T cd05602         106 ASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL  182 (325)
T ss_pred             HHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccc
Confidence            99999999   7799999999999999999999999999987432            12234777777788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....     .........        .......+                    .....+.+++.+
T Consensus       183 G~il~el~~g~~pf~~~~-----~~~~~~~i~--------~~~~~~~~--------------------~~~~~~~~li~~  229 (325)
T cd05602         183 GAVLYEMLYGLPPFYSRN-----TAEMYDNIL--------NKPLQLKP--------------------NITNSARHLLEG  229 (325)
T ss_pred             cHHHHHHhcCCCCCCCCC-----HHHHHHHHH--------hCCcCCCC--------------------CCCHHHHHHHHH
Confidence            999999999999986321     111111110        00000000                    122356777789


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      |++.+|.+||++.+.+.+
T Consensus       230 ~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         230 LLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             HcccCHHHCCCCCCCHHH
Confidence            999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.97  E-value=2e-30  Score=230.35  Aligned_cols=231  Identities=19%  Similarity=0.277  Sum_probs=157.7

Q ss_pred             HHHHHHHHHHhhccccc-ceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRN-LIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ....+|+.+|+.++|+| ||++++++.... +......++|+||+.. +|.+++......      ...++...+..++.
T Consensus        55 ~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~------~~g~~~~~ik~~m~  127 (323)
T KOG0594|consen   55 STAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKK------PQGLPPRLIKSFMR  127 (323)
T ss_pred             chhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhcccc------ccCCCHHHHHHHHH
Confidence            34689999999999999 999999986522 1223478899999954 899888543311      13566788999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-C-----------CCCccccCC-CCCccchh
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-R-----------TQTKYGVGN-EVSTIGDV  262 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-~-----------~~~~~~~~~-~~~~~~Dv  262 (382)
                      ||++||+|||   +++|+||||||+|||++++|.+||+|||+|+...-. .           ..||...+. .|++.+||
T Consensus       128 Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDi  204 (323)
T KOG0594|consen  128 QLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDI  204 (323)
T ss_pred             HHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcch
Confidence            9999999999   789999999999999999999999999999865421 1           126665554 78999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHH---h-cCC--chhhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKM---A-LPN--HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~---~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      ||+|||+.||++++.-|...    .+..+....   . .|+  .+.....-   .+...  .......+...........
T Consensus       205 Ws~GcIfaEm~~~~~LFpG~----se~~ql~~If~~lGtP~e~~Wp~v~~~---~~~k~--~f~~~~~~~~l~~~~~~~~  275 (323)
T KOG0594|consen  205 WSLGCIFAEMFTRRPLFPGD----SEIDQLFRIFRLLGTPNEKDWPGVSSL---PDYKA--PFPKWPGPKDLSSILPKLD  275 (323)
T ss_pred             HhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHHHcCCCCccCCCCcccc---ccccc--cCcCCCCccchHHhccccC
Confidence            99999999999998887643    333332221   1 111  11111000   00000  0000000011111111112


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHHH--HHHh
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVHE--LQSI  367 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~~--L~~i  367 (382)
                      ....+++..|++.+|.+|.|++.++.+  ++.+
T Consensus       276 ~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  276 PDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             ccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            367788889999999999999999976  5544

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=242.98  Aligned_cols=236  Identities=18%  Similarity=0.223  Sum_probs=157.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++|+||+++++++...++......++|+||+++ +|.+++.           ...+++..+..++.|+
T Consensus        48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----------~~~l~~~~~~~i~~ql  115 (336)
T cd07849          48 QRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK-----------TQHLSNDHIQYFLYQI  115 (336)
T ss_pred             HHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHh-----------cCCCCHHHHHHHHHHH
Confidence            567889999999999999999998765444455678999999964 7776662           2358899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccC-CCCCccch
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVG-NEVSTIGD  261 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~-~~~~~~~D  261 (382)
                      ++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....               ...||...+ ..++.++|
T Consensus       116 ~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  192 (336)
T cd07849         116 LRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAID  192 (336)
T ss_pred             HHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHH
Confidence            99999999   779999999999999999999999999998754321               233554333 45788999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||++|+.||....  .................+..+...............................++.+
T Consensus       193 vwslGvil~el~~G~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (336)
T cd07849         193 IWSVGCILAEMLSNRPLFPGKD--YLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALD  270 (336)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHH
Confidence            9999999999999999985321  10111111111111100111110000000000000000000000001123456889


Q ss_pred             HhhccCCCCccCCCCHHHHHHH--HHHhhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHE--LQSIKNT  370 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~--L~~i~~~  370 (382)
                      ++.+||+.+|++|||+.|+++.  ++.....
T Consensus       271 li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         271 LLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            9999999999999999999986  6655544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=2.6e-30  Score=238.95  Aligned_cols=201  Identities=16%  Similarity=0.160  Sum_probs=152.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++.+.     ..++.++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~~i  110 (305)
T cd05609          46 QQVFVERDILTFAENPFVVSMFCSFE-----TKRHLCMVMEYVEGGDCATLLK----------NIGALPVDMARMYFAET  110 (305)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCEEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            56889999999999999999998854     3678899999999999999983          23458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC---------------------------CCCCCCcc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP---------------------------PTRTQTKY  250 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~---------------------------~~~~~~~~  250 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||.++...                           .....||.
T Consensus       111 ~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  187 (305)
T cd05609         111 VLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV  187 (305)
T ss_pred             HHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchh
Confidence            99999999   7799999999999999999999999999986310                           11234676


Q ss_pred             ccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhh
Q 040999          251 GVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN  330 (382)
Q Consensus       251 ~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (382)
                      ..+..++.++|||||||++|||++|+.||....     ..++..........   .+    ..                 
T Consensus       188 ~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----~~~~~~~~~~~~~~---~~----~~-----------------  238 (305)
T cd05609         188 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----PEELFGQVISDDIE---WP----EG-----------------  238 (305)
T ss_pred             ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcccC---CC----Cc-----------------
Confidence            666778999999999999999999999975321     11111111000000   00    00                 


Q ss_pred             hHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHH
Q 040999          331 VIIECVISMVRIGVACSMESPQDRMKMTNVVHELQS  366 (382)
Q Consensus       331 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~  366 (382)
                       .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus       239 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         239 -DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             00123457888889999999999997666655544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=2.5e-30  Score=238.58  Aligned_cols=231  Identities=18%  Similarity=0.208  Sum_probs=153.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++|+||+++++++.     .....++||||++ ++|.+++..         ....+++..+..++.|+
T Consensus        49 ~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi  113 (301)
T cd07873          49 CTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLTLVFEYLD-KDLKQYLDD---------CGNSINMHNVKLFLFQL  113 (301)
T ss_pred             hHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeEEEEEeccc-cCHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            35778999999999999999999964     3678999999997 588888742         23457889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+|+|+||||+||+++.++.+||+|||++......            ...||...+ ..++.++||||
T Consensus       114 ~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~s  190 (301)
T cd07873         114 LRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWG  190 (301)
T ss_pred             HHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHH
Confidence            99999999   789999999999999999999999999998754211            223554433 34688999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||.....  ......................+............... .............+.+++.
T Consensus       191 lG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  267 (301)
T cd07873         191 VGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRA-DCLHNHAPRLDSDGAELLS  267 (301)
T ss_pred             HHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhchhhhccccccccccCcccc-ccHHhhcCCCCHHHHHHHH
Confidence            99999999999999864211  11111111111111011111100000000000000000 0000000122345678889


Q ss_pred             ccCCCCccCCCCHHHHHH--HHHHhhh
Q 040999          345 ACSMESPQDRMKMTNVVH--ELQSIKN  369 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~--~L~~i~~  369 (382)
                      +|++.||.+|||+.|+++  .++.+.+
T Consensus       268 ~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         268 KLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             HHhcCCcccCcCHHHHhcCcccccccc
Confidence            999999999999999986  4444433

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=7e-31  Score=245.52  Aligned_cols=198  Identities=17%  Similarity=0.139  Sum_probs=149.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|+||+++++++.     ..+..++||||+++|+|.+++..         ....+++..+..++.|+
T Consensus        46 ~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~~~~qi  111 (330)
T cd05601          46 SFFEEERDILSISNSPWIPQLQYAFQ-----DKDNLYLVMEYQPGGDLLSLLNR---------YEDQFDEDMAQFYLAEL  111 (330)
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeEEEEECCCCCCCHHHHHHH---------hcCCCCHHHHHHHHHHH
Confidence            45788999999999999999998854     36789999999999999999842         23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCcccc------CCCCCc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGV------GNEVST  258 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~------~~~~~~  258 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||++......             ..+||...      ...++.
T Consensus       112 ~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  188 (330)
T cd05601         112 VLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV  188 (330)
T ss_pred             HHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCC
Confidence            99999999   789999999999999999999999999999765322             22355543      456788


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ++|||||||++|||++|+.||....    ....+ ......      ..... .+..                 ......
T Consensus       189 ~~DiwslG~il~el~~g~~Pf~~~~----~~~~~-~~i~~~------~~~~~-~~~~-----------------~~~~~~  239 (330)
T cd05601         189 ECDWWSLGVIAYEMIYGRSPFHEGT----SAKTY-NNIMNF------QRFLK-FPED-----------------PKVSSD  239 (330)
T ss_pred             cceeecccceeeeeccCCCCCCCCC----HHHHH-HHHHcC------CCccC-CCCC-----------------CCCCHH
Confidence            9999999999999999999986321    11111 110000      00000 0000                 012235


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+++..|++ +|.+|||+.++++
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhC
Confidence            6677778997 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=8.4e-31  Score=242.52  Aligned_cols=151  Identities=23%  Similarity=0.306  Sum_probs=132.0

Q ss_pred             chhhH-----------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccC
Q 040999          113 AFKIF-----------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYER  181 (382)
Q Consensus       113 avK~~-----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  181 (382)
                      |.|++           +..+.|-.+|....+|+||++|-.     +++.+++||||||.+||++..+|          .+
T Consensus       170 AmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~~~LYLiMEylPGGD~mTLL----------~~  234 (550)
T KOG0605|consen  170 AMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDKEYLYLIMEYLPGGDMMTLL----------MR  234 (550)
T ss_pred             eeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCCCeeEEEEEecCCccHHHHH----------Hh
Confidence            77776           567889999999999999999877     67899999999999999999999          45


Q ss_pred             CcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------------
Q 040999          182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------------  243 (382)
Q Consensus       182 ~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------------  243 (382)
                      ...|++..+..++.+++-|+.-+|   ..|+|||||||+|+|||..|++||+|||++.-+..                  
T Consensus       235 ~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~  311 (550)
T KOG0605|consen  235 KDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLS  311 (550)
T ss_pred             cCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhc
Confidence            678999999999999999999999   88999999999999999999999999999853210                  


Q ss_pred             -----------------------------------------CCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          244 -----------------------------------------TRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       244 -----------------------------------------~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                                                               +..+||+..+..|+..+|+||+|||+|||+.|.+||..
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s  390 (550)
T KOG0605|consen  312 EAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCS  390 (550)
T ss_pred             cCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence                                                     00116666777889999999999999999999999864

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=2.8e-30  Score=232.46  Aligned_cols=199  Identities=18%  Similarity=0.231  Sum_probs=152.3

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +..+.+.+|+++++.++|+||+++++++.     +....++++||+++++|.+++.          ....+++..+..++
T Consensus        44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~  108 (258)
T cd06632          44 EAVKQLEQEIALLSKLQHPNIVQYLGTER-----EEDNLYIFLELVPGGSLAKLLK----------KYGSFPEPVIRLYT  108 (258)
T ss_pred             HHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCCeEEEEEEecCCCcHHHHHH----------hcCCCCHHHHHHHH
Confidence            34577999999999999999999999864     3678899999999999999883          23458899999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-----------CCCccccCCC-CCccchh
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-----------TQTKYGVGNE-VSTIGDV  262 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~~~~-~~~~~Dv  262 (382)
                      .|+++||+|||   +.+++|+||+|+||+++.++.+||+|||.+.......           ..||...... ++.++|+
T Consensus       109 ~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~  185 (258)
T cd06632         109 RQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI  185 (258)
T ss_pred             HHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhh
Confidence            99999999999   7799999999999999999999999999987543221           2355544444 7889999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||+++|+|++|+.||....    ................     .   +                   ......+.++
T Consensus       186 ~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~-----~---~-------------------~~~~~~~~~l  234 (258)
T cd06632         186 WSLGCTVLEMATGKPPWSQLE----GVAAVFKIGRSKELPP-----I---P-------------------DHLSDEAKDF  234 (258)
T ss_pred             HHHHHHHHHHHhCCCCcccCc----HHHHHHHHHhcccCCC-----c---C-------------------CCcCHHHHHH
Confidence            999999999999999986432    1111110000000000     0   0                   0122456778


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.+|.+||++.+++.
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhc
Confidence            88999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-30  Score=236.14  Aligned_cols=221  Identities=21%  Similarity=0.265  Sum_probs=153.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++..     .+..++||||++++.+..+.          .....+++..+..++.|+
T Consensus        45 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~iv~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~~~i  109 (288)
T cd07833          45 KTALREVKVLRQLRHENIVNLKEAFRR-----KGRLYLVFEYVERTLLELLE----------ASPGGLPPDAVRSYIWQL  109 (288)
T ss_pred             hHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEEEEEecCCCCHHHHHH----------hcCCCCCHHHHHHHHHHH
Confidence            568999999999999999999999754     67899999999987766554          223458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCC-CCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGN-EVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~-~~~~~~Dv~  263 (382)
                      +.||+|||   ..+++|+||+|+||++++++.+||+|||.+......             ...||...+. .++.++|||
T Consensus       110 ~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~  186 (288)
T cd07833         110 LQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVW  186 (288)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHH
Confidence            99999999   779999999999999999999999999998765432             2336666566 778999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHh--cCCchhhhhh--cccccchhhhhhccccchhhhhh-hhHHHHHHH
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--LPNHVKDIVD--SILLNDDEKLVVRGDQKQTQAKI-NVIIECVIS  338 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  338 (382)
                      |||+++|||++|+.||...... ..+.......  .+........  .......     ......+.... ........+
T Consensus       187 slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  260 (288)
T cd07833         187 AIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSNPRFAGVA-----FPEPSQPESLERRYPGKVSSP  260 (288)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHhhhcccCccccccc-----cCCCCCcHHHHHhcCCccchH
Confidence            9999999999999998642111 0011100100  0000000000  0000000     00000000000 000122567


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+++.+||..+|++|||++++++
T Consensus       261 ~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         261 ALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHHHHHHHhccCchhcccHHHHhc
Confidence            889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-30  Score=237.17  Aligned_cols=145  Identities=23%  Similarity=0.333  Sum_probs=121.9

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|++++++++|+||+++++++.     ..+..++||||+++ +|.+++..         ....+++.....++.|++
T Consensus        49 ~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~-~L~~~~~~---------~~~~~~~~~~~~~~~ql~  113 (291)
T cd07844          49 TAIREASLLKDLKHANIVTLHDIIH-----TKKTLTLVFEYLDT-DLKQYMDD---------CGGGLSMHNVRLFLFQLL  113 (291)
T ss_pred             hHHHHHHHHhhCCCcceeeEEEEEe-----cCCeEEEEEecCCC-CHHHHHHh---------CCCCCCHHHHHHHHHHHH
Confidence            4678999999999999999999954     36789999999974 89888742         234688999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccC-CCCCccchhHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVG-NEVSTIGDVYSY  265 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~-~~~~~~~Dv~S~  265 (382)
                      +||.|||   +.+|+||||||+||+++.++.+||+|||+++....            ....||...+ ..++.++||||+
T Consensus       114 ~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl  190 (291)
T cd07844         114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV  190 (291)
T ss_pred             HHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHH
Confidence            9999999   77999999999999999999999999999864321            1233665543 457889999999


Q ss_pred             HHHHHHHHhcCCCCCc
Q 040999          266 GILLLELMIREKPSDI  281 (382)
Q Consensus       266 Gvil~elltg~~p~~~  281 (382)
                      |+++|||++|+.||..
T Consensus       191 G~il~~l~~g~~~~~~  206 (291)
T cd07844         191 GCIFYEMATGRPLFPG  206 (291)
T ss_pred             HHHHHHHHhCCCCCCC
Confidence            9999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=239.19  Aligned_cols=200  Identities=19%  Similarity=0.302  Sum_probs=160.4

Q ss_pred             chhhH----------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCC
Q 040999          113 AFKIF----------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP  182 (382)
Q Consensus       113 avK~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  182 (382)
                      |||++          ..+..|++-|+-++|||||++|++     ......+|||+|+=.+|+|++|+-         +..
T Consensus        47 AVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTKlyLiLELGD~GDl~DyIm---------KHe  112 (864)
T KOG4717|consen   47 AVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTKLYLILELGDGGDLFDYIM---------KHE  112 (864)
T ss_pred             EEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccceEEEEEEecCCchHHHHHH---------hhh
Confidence            78877          468899999999999999999999     455778999999999999999994         456


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeC-CCCcEEEccccccccCCCCC-----------CCCcc
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVGDFGLARFLPPTR-----------TQTKY  250 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfg~a~~~~~~~-----------~~~~~  250 (382)
                      ..+.+....+++.||..|+.|+|   ...+|||||||+|+.+- +-|-+||.|||++..+.++.           .+||.
T Consensus       113 ~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEI  189 (864)
T KOG4717|consen  113 EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEI  189 (864)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchh
Confidence            67999999999999999999999   78999999999999774 56889999999997765543           34787


Q ss_pred             ccCCCCC-ccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhh
Q 040999          251 GVGNEVS-TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKI  329 (382)
Q Consensus       251 ~~~~~~~-~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (382)
                      ..|..|+ +++||||+|||||.|+.|+.||+.....+             .+.-++|-..                    
T Consensus       190 LLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------TLTmImDCKY--------------------  236 (864)
T KOG4717|consen  190 LLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------TLTMIMDCKY--------------------  236 (864)
T ss_pred             hhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------hhhhhhcccc--------------------
Confidence            7777774 78999999999999999999987421111             0111111100                    


Q ss_pred             hhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          330 NVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       330 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ........++.+|+.+|+..||++|.+.++++.
T Consensus       237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            011244567889999999999999999999874

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=2.3e-30  Score=241.25  Aligned_cols=146  Identities=19%  Similarity=0.234  Sum_probs=124.6

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+..|.+++..+ +|++|+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~~~----------~~~~~~~~~~~~~~~q  109 (323)
T cd05616          45 ECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDRLYFVMEYVNGGDLMYQIQ----------QVGRFKEPHAVFYAAE  109 (323)
T ss_pred             HHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCEEEEEEcCCCCCCHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            3567788888877 5889999988854     3678999999999999998883          2345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++||||
T Consensus       110 i~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  186 (323)
T cd05616         110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA  186 (323)
T ss_pred             HHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhc
Confidence            999999999   7799999999999999999999999999987532            1234477777788899999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      |||++|||+||+.||..
T Consensus       187 lGvil~elltg~~Pf~~  203 (323)
T cd05616         187 FGVLLYEMLAGQAPFEG  203 (323)
T ss_pred             hhHHHHHHHhCCCCCCC
Confidence            99999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=4e-30  Score=235.39  Aligned_cols=203  Identities=18%  Similarity=0.207  Sum_probs=151.6

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++.+..     .+..++||||+++++|.+++....       ....+++..+..++.|
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~  110 (286)
T cd06622          43 FNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVYMCMEYMDAGSLDKLYAGGV-------ATEGIPEDVLRRITYA  110 (286)
T ss_pred             HHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEEEEEeecCCCCHHHHHHhcc-------ccCCCCHHHHHHHHHH
Confidence            3578899999999999999999998543     678999999999999988884321       1236899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCccccC------CCCCccc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGVG------NEVSTIG  260 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~------~~~~~~~  260 (382)
                      +++||.|||+  ..+++||||||+||+++.++.+||+|||.+.....          ....||...+      ..++.++
T Consensus       111 i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~  188 (286)
T cd06622         111 VVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQS  188 (286)
T ss_pred             HHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCccc
Confidence            9999999994  35899999999999999999999999999875422          1233555433      2357899


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||||++|||++|+.||.....  ........        .+.......                   .......++.
T Consensus       189 DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~--------~~~~~~~~~-------------------~~~~~~~~~~  239 (286)
T cd06622         189 DVWSLGLSILEMALGRYPYPPETY--ANIFAQLS--------AIVDGDPPT-------------------LPSGYSDDAQ  239 (286)
T ss_pred             chHhHHHHHHHHHhCCCCCCCcch--hhHHHHHH--------HHhhcCCCC-------------------CCcccCHHHH
Confidence            999999999999999999863211  00000000        000000000                   0012344677


Q ss_pred             HHhhccCCCCccCCCCHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +++.+||+.+|++||++.+++.
T Consensus       240 ~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         240 DFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHcccCcccCCCHHHHhc
Confidence            8888999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=1.7e-30  Score=238.72  Aligned_cols=197  Identities=19%  Similarity=0.272  Sum_probs=151.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++++++|+||+++++.+..     .+..++||||+++++|.+++.           ...+++..+..++.||
T Consensus        64 ~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----------~~~l~~~~~~~~~~qi  127 (292)
T cd06658          64 ELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIATVCLSV  127 (292)
T ss_pred             HHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEEEEeCCCCCcHHHHHh-----------cCCCCHHHHHHHHHHH
Confidence            568899999999999999999998643     678899999999999998873           1347889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+||+++.++.+||+|||++.....            ....||...+..++.++|||||
T Consensus       128 ~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  204 (292)
T cd06658         128 LRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSL  204 (292)
T ss_pred             HHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHH
Confidence            99999999   77999999999999999999999999999864321            1234666666678899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|||++|+.||...    ........      +...........                    ......+..++..
T Consensus       205 Gvil~el~~g~~p~~~~----~~~~~~~~------~~~~~~~~~~~~--------------------~~~~~~~~~li~~  254 (292)
T cd06658         205 GIMVIEMIDGEPPYFNE----PPLQAMRR------IRDNLPPRVKDS--------------------HKVSSVLRGFLDL  254 (292)
T ss_pred             HHHHHHHHhCCCCCCCC----CHHHHHHH------HHhcCCCccccc--------------------cccCHHHHHHHHH
Confidence            99999999999997631    11111100      000000000000                    0122356677789


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||..+|++|||++++++.
T Consensus       255 ~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         255 MLVREPSQRATAQELLQH  272 (292)
T ss_pred             HccCChhHCcCHHHHhhC
Confidence            999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-30  Score=234.34  Aligned_cols=199  Identities=23%  Similarity=0.309  Sum_probs=151.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|++++++++|+||+++++++..     ....++||||+++++|.+++..         ....+++..+..++.|+
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~---------~~~~l~~~~~~~~~~ql  112 (280)
T cd06611          47 EDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLWILIEFCDGGALDSIMLE---------LERGLTEPQIRYVCRQM  112 (280)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEEEEeeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHH
Confidence            678999999999999999999999653     6788999999999999998842         23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc-----CCCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV-----GNEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~-----~~~~~~~~  260 (382)
                      +.||.|||   +.+|+|+||||+||+++.++.++|+|||.+......            ...||...     +..++.++
T Consensus       113 ~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~s  189 (280)
T cd06611         113 LEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA  189 (280)
T ss_pred             HHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccc
Confidence            99999999   779999999999999999999999999988654321            22354432     34467899


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||+++|||++|+.||.....    ...... ......     +.+..                    .......+.
T Consensus       190 Di~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~-----~~~~~--------------------~~~~~~~~~  239 (280)
T cd06611         190 DIWSLGITLIELAQMEPPHHELNP----MRVLLK-ILKSEP-----PTLDQ--------------------PSKWSSSFN  239 (280)
T ss_pred             cHHHHHHHHHHHHhCCCCcccCCH----HHHHHH-HhcCCC-----CCcCC--------------------cccCCHHHH
Confidence            999999999999999999864211    111100 000000     00000                    002234567


Q ss_pred             HHhhccCCCCccCCCCHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +++.+||+.+|.+||++.++++.
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         240 DFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HHHHHHhccChhhCcCHHHHhcC
Confidence            88889999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=1.3e-30  Score=234.90  Aligned_cols=200  Identities=24%  Similarity=0.340  Sum_probs=152.1

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      ...+|+.++++++||||+++++++..     ....++||||+++++|.+++.          ....+++..+..++.|++
T Consensus        44 ~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~v~~~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi~  108 (260)
T PF00069_consen   44 ENIREIKILRRLRHPNIVQILDVFQD-----DNYLYIVMEYCPGGSLQDYLQ----------KNKPLSEEEILKIAYQIL  108 (260)
T ss_dssp             HHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEEEEEEETTEBHHHHHH----------HHSSBBHHHHHHHHHHHH
T ss_pred             hhhhhhhccccccccccccccccccc-----ccccccccccccccccccccc----------cccccccccccccccccc
Confidence            34569999999999999999999654     778899999999999999994          345689999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCcccc-CCCCCccchhHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGV-GNEVSTIGDVYSY  265 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~-~~~~~~~~Dv~S~  265 (382)
                      +||+|||   +.+++|+||||+||+++.++.++|+|||.+.....            ....||... +...+.++||||+
T Consensus       109 ~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  185 (260)
T PF00069_consen  109 EALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSL  185 (260)
T ss_dssp             HHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHH
T ss_pred             ccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999   67999999999999999999999999999974211            123366666 6788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|+|++|..||...  ................    ......                    ........+.+++..
T Consensus       186 G~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~----~~~~~~--------------------~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  186 GIILYELLTGKLPFEES--NSDDQLEIIEKILKRP----LPSSSQ--------------------QSREKSEELRDLIKK  239 (260)
T ss_dssp             HHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHHTH----HHHHTT--------------------SHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccc--cchhhhhhhhhccccc----cccccc--------------------ccchhHHHHHHHHHH
Confidence            99999999999998743  0001111111000000    000000                    000112578889999


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.||++|||+.++++
T Consensus       240 ~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HSSSSGGGSTTHHHHHT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=5.3e-30  Score=230.50  Aligned_cols=201  Identities=24%  Similarity=0.428  Sum_probs=154.4

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+..|++.+..++|+||+++++++..     .+..+++|||+++++|.+++....        ...+++..+..++.
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~i~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~  110 (258)
T smart00219       44 QIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEPLMIVMEYMEGGDLLDYLRKNR--------PKELSLSDLLSFAL  110 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCeeEEEEeccCCCCHHHHHHhhh--------hccCCHHHHHHHHH
Confidence            34678999999999999999999999653     578899999999999999984211        11289999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchh
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      |++.||+|||   +.+++|+||||+||+++.++.++|+|||.++.....             ...||...+..++.++||
T Consensus       111 ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di  187 (258)
T smart00219      111 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDV  187 (258)
T ss_pred             HHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhH
Confidence            9999999999   779999999999999999999999999999755322             233555556778899999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||+|++++||++ |..||...     ..............         ....                  ......+.+
T Consensus       188 ~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~---------~~~~------------------~~~~~~~~~  235 (258)
T smart00219      188 WSFGVLLWEIFTLGESPYPGM-----SNEEVLEYLKKGYR---------LPKP------------------ENCPPEIYK  235 (258)
T ss_pred             HHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCCC---------CCCC------------------CcCCHHHHH
Confidence            999999999998 78887531     11111111000000         0000                  013346788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                      ++.+|+..+|++|||+.|+++.|
T Consensus       236 ~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      236 LMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHCcCChhhCcCHHHHHhhC
Confidence            88899999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=1.7e-30  Score=237.48  Aligned_cols=222  Identities=18%  Similarity=0.237  Sum_probs=149.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++     .+....++|+||++ ++|.+++..         ....+++..+..++.||
T Consensus        44 ~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~~~~qi  108 (284)
T cd07839          44 SSALREICLLKELKHKNIVRLYDVL-----HSDKKLTLVFEYCD-QDLKKYFDS---------CNGDIDPEIVKSFMFQL  108 (284)
T ss_pred             cchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceEEEEecCC-CCHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            4577899999999999999999984     34678999999997 577777632         23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||.|||   ..+++||||||+||+++.++.+||+|||+++.....            ...||...+ ..++.++||||
T Consensus       109 ~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  185 (284)
T cd07839         109 LKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS  185 (284)
T ss_pred             HHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHH
Confidence            99999999   779999999999999999999999999998754321            233665544 34688999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhh--hhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDI--VDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||++|||+||..|+.........+...............  +.......... ......    ...........++.++
T Consensus       186 lG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~l  260 (284)
T cd07839         186 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP-MYPATT----SLVNVVPKLNSTGRDL  260 (284)
T ss_pred             HHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC-CCCCcc----hhhhhcccCCHHHHHH
Confidence            9999999999999864322111111111111110000000  00000000000 000000    0000001233467788


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||.+|||++++++
T Consensus       261 i~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         261 LQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHHHhcCChhhcCCHHHHhc
Confidence            88999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=4.4e-30  Score=232.65  Aligned_cols=202  Identities=20%  Similarity=0.274  Sum_probs=153.8

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +..+++.+|++++++++|+||+++++++.     +.+..++|+||+++++|.+++.          ....+++..+..++
T Consensus        45 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~~v~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~  109 (268)
T cd06630          45 EVVEALRKEIRLMARLNHPHIIRMLGATC-----EDSHFNLFVEWMAGGSVSHLLS----------KYGAFKEAVIINYT  109 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCceehhhceec-----cCCeEEEEEeccCCCcHHHHHH----------HhCCCCHHHHHHHH
Confidence            34578999999999999999999999964     3678899999999999999883          23468899999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC-cEEEccccccccCCCC----------------CCCCccccCCCCC
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPPT----------------RTQTKYGVGNEVS  257 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~~----------------~~~~~~~~~~~~~  257 (382)
                      .|++.||.|||   +.+++|+||||+||+++.++ .+||+|||.+......                ...||...+..++
T Consensus       110 ~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~  186 (268)
T cd06630         110 EQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG  186 (268)
T ss_pred             HHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCC
Confidence            99999999999   77999999999999998776 5999999998765321                2236666667788


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          258 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      .++||||+|+++|||++|+.||..... ............         .......                  ......
T Consensus       187 ~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~---------~~~~~~~------------------~~~~~~  238 (268)
T cd06630         187 RSCDVWSVGCVIIEMATAKPPWNAEKH-SNHLALIFKIAS---------ATTAPSI------------------PEHLSP  238 (268)
T ss_pred             cccchHHHHHHHHHHHhCCCCCCCCCC-cchHHHHHHHhc---------cCCCCCC------------------chhhCH
Confidence            999999999999999999999863211 111111100000         0000000                  012334


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHH
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+.+++.+|++.+|.+||++.++++
T Consensus       239 ~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         239 GLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhc
Confidence            6778888999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=6.8e-31  Score=220.90  Aligned_cols=198  Identities=18%  Similarity=0.216  Sum_probs=148.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++.+.++|||||++.+.     +....+.|+|+|+|.+++|..-+-          ....+++..+-.++.||
T Consensus        55 e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~~ylvFe~m~G~dl~~eIV----------~R~~ySEa~aSH~~rQi  119 (355)
T KOG0033|consen   55 QKLEREARICRKLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQI  119 (355)
T ss_pred             HHHHHHHHHHHhcCCCcEeehhhh-----hcccceeEEEEecccchHHHHHHH----------HHHHHHHHHHHHHHHHH
Confidence            788999999999999999999887     556889999999999999864441          22456778888899999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCC---CcEEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDD---MTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +++|+|+|   ..+|||||+||+|+|+...   --+||+|||+|..+..+           ...||......|+..+|||
T Consensus       120 Leal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW  196 (355)
T KOG0033|consen  120 LEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW  196 (355)
T ss_pred             HHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhh
Confidence            99999999   7799999999999999543   45899999999876532           2347777778899999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      +.|||||-|+.|.+||....     -+...+.            +......-       ..     ..+.....+...|+
T Consensus       197 ~cGViLfiLL~G~~PF~~~~-----~~rlye~------------I~~g~yd~-------~~-----~~w~~is~~Ak~Lv  247 (355)
T KOG0033|consen  197 ACGVILYILLVGYPPFWDED-----QHRLYEQ------------IKAGAYDY-------PS-----PEWDTVTPEAKSLI  247 (355)
T ss_pred             hhhHHHHHHHhCCCCCCCcc-----HHHHHHH------------HhccccCC-------CC-----cccCcCCHHHHHHH
Confidence            99999999999999986411     1111111            11100000       00     00012223456677


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+|+..||.+|.|+.|.++
T Consensus       248 rrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  248 RRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHhccChhhhccHHHHhC
Confidence            7999999999999988764

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=9.5e-30  Score=235.44  Aligned_cols=200  Identities=24%  Similarity=0.304  Sum_probs=150.8

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +..+++.+|+++++.++||||++++++|..     .+..++|+||++ |++.+++.         .....+++..+..++
T Consensus        57 ~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~-g~l~~~~~---------~~~~~l~~~~~~~~~  121 (307)
T cd06607          57 EKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHTAWLVMEYCL-GSASDILE---------VHKKPLQEVEIAAIC  121 (307)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCeEEEEHHhhC-CCHHHHHH---------HcccCCCHHHHHHHH
Confidence            344678999999999999999999999764     667899999996 56766653         123458999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------CCCCcccc---CCCCCccchhH
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------RTQTKYGV---GNEVSTIGDVY  263 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~---~~~~~~~~Dv~  263 (382)
                      .|++.||.|||   +.+++||||+|+||+++.++.+||+|||++......        ...||...   ...++.++|||
T Consensus       122 ~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~  198 (307)
T cd06607         122 HGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW  198 (307)
T ss_pred             HHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCccCCccccCceeeeccCCCCCCcccchH
Confidence            99999999999   779999999999999999999999999999765432        23366542   35678899999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||+++|||+||+.||....    ....... ......     +..   .                  .......+.+++
T Consensus       199 s~G~il~el~tg~~p~~~~~----~~~~~~~-~~~~~~-----~~~---~------------------~~~~~~~~~~li  247 (307)
T cd06607         199 SLGITCIELAERKPPLFNMN----AMSALYH-IAQNDS-----PTL---S------------------SNDWSDYFRNFV  247 (307)
T ss_pred             HHHHHHHHHHcCCCCCCCcc----HHHHHHH-HhcCCC-----CCC---C------------------chhhCHHHHHHH
Confidence            99999999999999975321    1110000 000000     000   0                  012344678888


Q ss_pred             hccCCCCccCCCCHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~  363 (382)
                      .+||+.+|++||++.+++..
T Consensus       248 ~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         248 DSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHhcCChhhCcCHHHHhcC
Confidence            89999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=4.1e-30  Score=231.02  Aligned_cols=200  Identities=20%  Similarity=0.237  Sum_probs=151.6

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      |++.+...|-+||+.+.||.+..+|..     ++...+.|+|||||+||+|....+.        ...+.+++..+..++
T Consensus       119 kKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~~cl~meyCpGGdL~~Lrqk--------Qp~~~fse~~aRFYa  185 (459)
T KOG0610|consen  119 KKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKYSCLVMEYCPGGDLHSLRQK--------QPGKRFSESAARFYA  185 (459)
T ss_pred             hHHHHHHHHHHHHHhcCCCccchhhhe-----eeccceeEEEEecCCCccHHHHHhh--------CCCCccchhhHHHHH
Confidence            444678889999999999999999998     5568999999999999999988863        346779999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------------------------
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------------------------  244 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------------------------  244 (382)
                      .+++-||+|||   ..|||.|||||+||||.++|++-|+||.++......                              
T Consensus       186 AEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~  262 (459)
T KOG0610|consen  186 AEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRC  262 (459)
T ss_pred             HHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccch
Confidence            99999999999   889999999999999999999999999987532100                              


Q ss_pred             ----C----------------------------------CCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCC
Q 040999          245 ----R----------------------------------TQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD  286 (382)
Q Consensus       245 ----~----------------------------------~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~  286 (382)
                          .                                  .+||...|...+.++|+|+|||++|||+.|+.||..... .
T Consensus       263 ~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~-~  341 (459)
T KOG0610|consen  263 LSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN-K  341 (459)
T ss_pred             hccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc-h
Confidence                0                                  004444455557789999999999999999999864321 1


Q ss_pred             chHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCC----HHHHH
Q 040999          287 MNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMK----MTNVV  361 (382)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs----~~evl  361 (382)
                      ..+...+            .+.+.-..                  ..+......+|+.+.|.+||++|-.    +.||-
T Consensus       342 ~Tl~NIv------------~~~l~Fp~------------------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  342 ETLRNIV------------GQPLKFPE------------------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             hhHHHHh------------cCCCcCCC------------------CCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            1222221            11110000                  0023446777888899999999987    55554

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=6.2e-30  Score=235.51  Aligned_cols=222  Identities=21%  Similarity=0.216  Sum_probs=152.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++|+||+++++++..     .+..++||||+ +|+|.+++..         ....+++..+..++.||
T Consensus        47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~-~~~L~~~i~~---------~~~~~~~~~~~~~~~qi  111 (298)
T cd07841          47 FTALREIKLLQELKHPNIIGLLDVFGH-----KSNINLVFEFM-ETDLEKVIKD---------KSIVLTPADIKSYMLMT  111 (298)
T ss_pred             HHHHHHHHHHhhcCCCCChhhhheeec-----CCEEEEEEccc-CCCHHHHHhc---------cCCCCCHHHHHHHHHHH
Confidence            457789999999999999999999643     67899999999 9999999842         12368999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+++|+||||+||+++.++.+||+|||+++.....            ...||...+ ..++.++||||
T Consensus       112 ~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s  188 (298)
T cd07841         112 LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWS  188 (298)
T ss_pred             HHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHH
Confidence            99999999   779999999999999999999999999999865432            122454332 45688999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|.+||..... ...+..... ....................   ......+.............+.+++.
T Consensus       189 lG~il~e~~~g~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~  263 (298)
T cd07841         189 VGCIFAELLLRVPFLPGDSD-IDQLGKIFE-ALGTPTEENWPGVTSLPDYV---EFKPFPPTPLKQIFPAASDDALDLLQ  263 (298)
T ss_pred             HHHHHHHHHcCCccccCCcc-HHHHHHHHH-HcCCCchhhhhhcccccccc---cccccCCcchhhhcccccHHHHHHHH
Confidence            99999999999877653211 111111111 11000000000000000000   00000000000111233457889999


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.+|++|||+.|+++
T Consensus       264 ~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         264 RLLTLNPNKRITARQALE  281 (298)
T ss_pred             HHhcCCcccCcCHHHHhh
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=6.1e-30  Score=230.03  Aligned_cols=199  Identities=19%  Similarity=0.311  Sum_probs=153.1

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++.+.     ..+..++||||+++++|.+++...        ....+++..+..++.+
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~  109 (256)
T cd08220          43 RLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKR--------CNSLLDEDTILHFFVQ  109 (256)
T ss_pred             HHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEEEEEecCCCCCHHHHHHHh--------cccCCCHHHHHHHHHH
Confidence            467899999999999999999998854     367899999999999999998431        1345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +++||+|||   +.+++|+||||+||+++.+ +.+||+|||.+......           ...||...+..++.++||||
T Consensus       110 i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  186 (256)
T cd08220         110 ILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWA  186 (256)
T ss_pred             HHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHH
Confidence            999999999   7799999999999999865 46899999999765422           33477766677889999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|+|++|+.||....     ...............+        +                   ......+.+++.
T Consensus       187 lG~~l~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~--------~-------------------~~~~~~l~~li~  234 (256)
T cd08220         187 LGCVLYELASLKRAFEAAN-----LPALVLKIMSGTFAPI--------S-------------------DRYSPDLRQLIL  234 (256)
T ss_pred             HHHHHHHHHhCCCCcccCc-----hHHHHHHHHhcCCCCC--------C-------------------CCcCHHHHHHHH
Confidence            9999999999999976321     1111111000000000        0                   012346778888


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.+|++|||+.|+++.
T Consensus       235 ~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         235 SMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHccCChhhCCCHHHHhhC
Confidence            9999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=1e-29  Score=229.58  Aligned_cols=202  Identities=21%  Similarity=0.278  Sum_probs=157.7

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +..+.+.+|++.+.+++|+||+++++++..     ....++|+||+++++|.+++.          ....+++..+..++
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~  105 (264)
T cd06623          41 EFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEISIVLEYMDGGSLADLLK----------KVGKIPEPVLAYIA  105 (264)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEEEEEEecCCCcHHHHHH----------HcCCCCHHHHHHHH
Confidence            345779999999999999999999999654     678999999999999999984          22568999999999


Q ss_pred             HHHHHHHhHHhhcCC-CceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccch
Q 040999          195 IDVASALNYLHHDCQ-PVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~-~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~D  261 (382)
                      .|+++|++|||   + .+++|+||+|+||+++.++.++|+|||.+......            ...||...+..++.++|
T Consensus       106 ~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~D  182 (264)
T cd06623         106 RQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAAD  182 (264)
T ss_pred             HHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhh
Confidence            99999999999   7 89999999999999999999999999998865322            22366666677889999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH-HHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE-CVISMV  340 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  340 (382)
                      |||||+++|||+||+.||.....  ....+........        ......                   .. .+..+.
T Consensus       183 v~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~--------~~~~~~-------------------~~~~~~~l~  233 (264)
T cd06623         183 IWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDG--------PPPSLP-------------------AEEFSPEFR  233 (264)
T ss_pred             HHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcC--------CCCCCC-------------------cccCCHHHH
Confidence            99999999999999999865322  0111111111000        000000                   01 345678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +++.+||+.+|++||++.++++.
T Consensus       234 ~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         234 DFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHHHHHccCChhhCCCHHHHHhC
Confidence            88889999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=5.5e-30  Score=239.26  Aligned_cols=150  Identities=22%  Similarity=0.224  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+.+++.++||||+++++++..     .+..++|+||+.++++.+++....        ...+++..+..++.|
T Consensus        43 ~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~e~~~~~~l~~~l~~~~--------~~~~~~~~~~~~~~q  109 (328)
T cd08226          43 LKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVISPFMAYGSANSLLKTYF--------PEGMSEALIGNILFG  109 (328)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEEecccCCCHHHHHHhhc--------ccCCCHHHHHHHHHH
Confidence            4678899999999999999999999653     678899999999999999885321        235888999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC-------------------CCCCCCccccC--CC
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------------PTRTQTKYGVG--NE  255 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~~~~--~~  255 (382)
                      ++.||+|||   +.+++||||||+||+++.++.+|++||+.+....                   .....||...+  ..
T Consensus       110 i~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  186 (328)
T cd08226         110 ALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG  186 (328)
T ss_pred             HHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCC
Confidence            999999999   7799999999999999999999999997543211                   01234665544  34


Q ss_pred             CCccchhHHHHHHHHHHHhcCCCCCcc
Q 040999          256 VSTIGDVYSYGILLLELMIREKPSDIM  282 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~elltg~~p~~~~  282 (382)
                      ++.++|||||||++|||++|+.||...
T Consensus       187 ~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         187 YNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            678999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=4.1e-30  Score=240.72  Aligned_cols=229  Identities=20%  Similarity=0.243  Sum_probs=153.4

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+.++++++|+||+++++++.... ......++||||+. ++|.+++.          ....+++..+..++.|
T Consensus        48 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~i~~q  115 (334)
T cd07855          48 AKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDVYVVMDLME-SDLHHIIH----------SDQPLTEEHIRYFLYQ  115 (334)
T ss_pred             hHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceEEEEEehhh-hhHHHHhc----------cCCCCCHHHHHHHHHH
Confidence            356788999999999999999998764321 23467899999995 68888873          2345899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccC-CCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVG-NEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~-~~~~~~  259 (382)
                      ++.||.|||   ..+|+||||||+||+++.++.+||+|||+++.....                ...||...+ ..++.+
T Consensus       116 i~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~  192 (334)
T cd07855         116 LLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTA  192 (334)
T ss_pred             HHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccc
Confidence            999999999   779999999999999999999999999998754321                122554333 457889


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +|||||||++|||++|+.||.....  ................++.+................................+
T Consensus       193 ~Di~slG~~l~el~~g~~pf~~~~~--~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (334)
T cd07855         193 IDMWSVGCIFAEMLGRRQLFPGKNY--VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEA  270 (334)
T ss_pred             cchHHHHHHHHHHHcCCCccCCCCh--HHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHH
Confidence            9999999999999999999864211  11111111111111111111100000000000000000000001111235678


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+++.+||+.+|.+|||+.+++.
T Consensus       271 ~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         271 LDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HHHHHHHccCChhhCcCHHHHHh
Confidence            88999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=9.4e-30  Score=233.56  Aligned_cols=145  Identities=21%  Similarity=0.362  Sum_probs=120.0

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|+++++.++|+||+++++++.     ..+..++|+||+. +++.+++.         .....+++..+..++.|++
T Consensus        49 ~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~  113 (291)
T cd07870          49 TAIREASLLKGLKHANIVLLHDIIH-----TKETLTFVFEYMH-TDLAQYMI---------QHPGGLHPYNVRLFMFQLL  113 (291)
T ss_pred             HHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeEEEEEeccc-CCHHHHHH---------hCCCCCCHHHHHHHHHHHH
Confidence            5678999999999999999999864     3678899999995 67776663         1224577888889999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccC-CCCCccchhHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVG-NEVSTIGDVYSY  265 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~-~~~~~~~Dv~S~  265 (382)
                      .||.|||   ..+|+|+||||+||+++.++.+||+|||+++....            ....||...+ ..++.++|||||
T Consensus       114 ~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  190 (291)
T cd07870         114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA  190 (291)
T ss_pred             HHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHH
Confidence            9999999   67999999999999999999999999999875322            1233665543 346889999999


Q ss_pred             HHHHHHHHhcCCCCCc
Q 040999          266 GILLLELMIREKPSDI  281 (382)
Q Consensus       266 Gvil~elltg~~p~~~  281 (382)
                      ||++|||+||+.||+.
T Consensus       191 G~~l~~l~~g~~~f~~  206 (291)
T cd07870         191 GCIFIEMLQGQPAFPG  206 (291)
T ss_pred             HHHHHHHHhCCCCCCC
Confidence            9999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.3e-30  Score=232.75  Aligned_cols=206  Identities=21%  Similarity=0.229  Sum_probs=153.1

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      +++.+|+++++++ +|+||+++++++..... ......++||||+++++|.+++....      .....+++..+..++.
T Consensus        47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~  120 (275)
T cd06608          47 EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR------KKGKRLKEEWIAYILR  120 (275)
T ss_pred             HHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHh------hcCCCCCHHHHHHHHH
Confidence            5789999999999 69999999999865322 23566899999999999998884321      1235688999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc-----CCCCCc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV-----GNEVST  258 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~-----~~~~~~  258 (382)
                      |+++||.|||   +.+++|+||+|+||+++.++.+||+|||.+......            ..+||...     ...++.
T Consensus       121 ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~  197 (275)
T cd06608         121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDA  197 (275)
T ss_pred             HHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccc
Confidence            9999999999   789999999999999999999999999998654321            22355432     235678


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ++|||||||++|||+||+.||..... ........    ....     +.+.                    ........
T Consensus       198 ~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~----~~~~-----~~~~--------------------~~~~~~~~  247 (275)
T cd06608         198 RSDVWSLGITAIELADGKPPLCDMHP-MRALFKIP----RNPP-----PTLK--------------------SPENWSKK  247 (275)
T ss_pred             cccHHHhHHHHHHHHhCCCCccccch-HHHHHHhh----ccCC-----CCCC--------------------chhhcCHH
Confidence            99999999999999999999863211 01111100    0000     0000                    00123446


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+++.+||..||++|||+.|+++
T Consensus       248 ~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         248 FNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHHHHHHHhhcChhhCcCHHHHhc
Confidence            778888999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=4.8e-30  Score=260.64  Aligned_cols=204  Identities=17%  Similarity=0.221  Sum_probs=151.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..|..|+.++++++|||||++++++..   ......++||||+++|+|.+++....      .....+++..++.|+.||
T Consensus        57 ~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~~~lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QI  127 (1021)
T PTZ00266         57 SQLVIEVNVMRELKHKNIVRYIDRFLN---KANQKLYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQL  127 (1021)
T ss_pred             HHHHHHHHHHHHcCCCCcCeEEEEEEe---cCCCEEEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHH
Confidence            578899999999999999999998653   23567899999999999999885321      123468999999999999


Q ss_pred             HHHHhHHhhcC----CCceeecCCCCCceeeCC-----------------CCcEEEccccccccCCC-----------CC
Q 040999          198 ASALNYLHHDC----QPVTAHCDLKPSNVLLDD-----------------DMTARVGDFGLARFLPP-----------TR  245 (382)
Q Consensus       198 ~~~L~~lH~~~----~~~ivH~dlkp~NILl~~-----------------~~~~kl~Dfg~a~~~~~-----------~~  245 (382)
                      +.||+|||...    ..+|+||||||+|||++.                 ...+||+|||++..+..           ..
T Consensus       128 L~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~Y  207 (1021)
T PTZ00266        128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYY  207 (1021)
T ss_pred             HHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccc
Confidence            99999999532    146999999999999964                 23489999999976532           22


Q ss_pred             CCCcccc--CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccc
Q 040999          246 TQTKYGV--GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQK  323 (382)
Q Consensus       246 ~~~~~~~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (382)
                      .+||...  ...++.++|||||||++|||+||+.||...    .....+.......       +.+..            
T Consensus       208 mAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~----~~~~qli~~lk~~-------p~lpi------------  264 (1021)
T PTZ00266        208 WSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA----NNFSQLISELKRG-------PDLPI------------  264 (1021)
T ss_pred             cCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC----CcHHHHHHHHhcC-------CCCCc------------
Confidence            3466553  345789999999999999999999998632    1222221111000       00000            


Q ss_pred             hhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          324 QTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                               ......+.+|+..||+.+|.+||++.|++.
T Consensus       265 ---------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        265 ---------KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             ---------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence                     012345778888999999999999999984

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=1.4e-29  Score=229.19  Aligned_cols=200  Identities=17%  Similarity=0.199  Sum_probs=149.7

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +..+.+.+|++++++++|+||+++++++..   ......++||||+++++|.+++.          ....+++....+++
T Consensus        46 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~~~~v~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~  112 (265)
T cd06652          46 KEVNALECEIQLLKNLLHERIVQYYGCLRD---PMERTLSIFMEHMPGGSIKDQLK----------SYGALTENVTRKYT  112 (265)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCceEEEEEEecCCCcHHHHHH----------HcCCCCHHHHHHHH
Confidence            345678999999999999999999997532   12356789999999999999883          23457888899999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------------CCCCCccccCCCCCcc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------------TRTQTKYGVGNEVSTI  259 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~~~~~~~~~~  259 (382)
                      .|++.||.|||   +.+++|+||||+||+++.++.+||+|||.++....               ....||...+..++.+
T Consensus       113 ~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  189 (265)
T cd06652         113 RQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRK  189 (265)
T ss_pred             HHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcc
Confidence            99999999999   77999999999999999999999999999874321               1234676667778899


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +|||||||++|||++|+.||...    ..............     ....                      .......+
T Consensus       190 ~Dv~slG~il~el~~g~~p~~~~----~~~~~~~~~~~~~~-----~~~~----------------------~~~~~~~~  238 (265)
T cd06652         190 ADIWSVGCTVVEMLTEKPPWAEF----EAMAAIFKIATQPT-----NPVL----------------------PPHVSDHC  238 (265)
T ss_pred             hhHHHHHHHHHHHhhCCCCCCcc----chHHHHHHHhcCCC-----CCCC----------------------chhhCHHH
Confidence            99999999999999999998532    11111111110000     0000                      00222355


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ..++.+|+. +|++||+++|+++
T Consensus       239 ~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         239 RDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHHHhc-ChhhCCCHHHHhc
Confidence            667778884 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-30  Score=257.02  Aligned_cols=212  Identities=22%  Similarity=0.333  Sum_probs=165.1

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcccc----CC--cccCHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE----RP--RNLNLLRR  190 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~----~~--~~l~~~~~  190 (382)
                      +.+..|+++|+.+ +|+||+.++|+|..     .+..++|.||+..|+|.++|...+.......    ..  ..++..+.
T Consensus       346 ~~~~~El~~m~~~g~H~niv~llG~~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dL  420 (609)
T KOG0200|consen  346 KDLMSELNVLKELGKHPNIVNLLGACTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDL  420 (609)
T ss_pred             HHHHHHHHHHHHhcCCcchhhheeeecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHH
Confidence            6899999999999 69999999999864     6788999999999999999976551100000    01  24899999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC---------------CCCCCCCccccCCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL---------------PPTRTQTKYGVGNE  255 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~---------------~~~~~~~~~~~~~~  255 (382)
                      +.++.|||.|++||+   +.+++|||+-.+|||+.++..+||+|||+|+..               +-.+.+||......
T Consensus       421 lsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~  497 (609)
T KOG0200|consen  421 LSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV  497 (609)
T ss_pred             HHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc
Confidence            999999999999999   789999999999999999999999999999832               22244577777789


Q ss_pred             CCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          256 VSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ++.|+|||||||+|||++| |..||.... ...++.++.+....            ..                  ....
T Consensus       498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~l~~~l~~G~r------------~~------------------~P~~  546 (609)
T KOG0200|consen  498 FTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEELLEFLKEGNR------------ME------------------QPEH  546 (609)
T ss_pred             ccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHHHHHHHhcCCC------------CC------------------CCCC
Confidence            9999999999999999998 777875411 01111111111111            00                  0114


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      |..++.+++..||+.+|++||++.++.+.++...
T Consensus       547 c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  547 CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            5668889999999999999999999999998853

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=3.1e-30  Score=244.49  Aligned_cols=145  Identities=19%  Similarity=0.241  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++.     ++...++||||+++|+|.+++..           ..+++..+..++.||
T Consensus        88 ~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~~~~~lv~Ey~~gg~L~~~l~~-----------~~~~~~~~~~~~~qi  151 (370)
T cd05621          88 AFFWEERDIMAFANSPWVVQLFCAFQ-----DDKYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWAKFYTAEV  151 (370)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHH
Confidence            34778999999999999999999854     47789999999999999998832           247888899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccC----CCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVG----NEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~----~~~~~~~  260 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....             ..+||...+    ..++.++
T Consensus       152 l~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~  228 (370)
T cd05621         152 VLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC  228 (370)
T ss_pred             HHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCccc
Confidence            99999999   779999999999999999999999999999765321             123554433    2378899


Q ss_pred             hhHHHHHHHHHHHhcCCCCCc
Q 040999          261 DVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~  281 (382)
                      ||||+||++|||+||+.||..
T Consensus       229 DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         229 DWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             CEEeehHHHHHHHhCCCCCCC
Confidence            999999999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=3.8e-30  Score=239.80  Aligned_cols=146  Identities=20%  Similarity=0.248  Sum_probs=123.5

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+..|.+++..+. |++|+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~i~----------~~~~l~~~~~~~i~~q  109 (323)
T cd05615          45 ECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDRLYFVMEYVNGGDLMYHIQ----------QVGKFKEPQAVFYAAE  109 (323)
T ss_pred             HHHHHHHHHHHhccCCCchhheeeEEe-----cCCEEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            45778888988885 567778887743     3678999999999999998883          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++||||
T Consensus       110 i~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  186 (323)
T cd05615         110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA  186 (323)
T ss_pred             HHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhh
Confidence            999999999   7799999999999999999999999999987532            1233477777778899999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      |||++|||+||+.||..
T Consensus       187 lGvil~elltG~~pf~~  203 (323)
T cd05615         187 YGVLLYEMLAGQPPFDG  203 (323)
T ss_pred             hHHHHHHHHhCCCCCCC
Confidence            99999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-31  Score=248.88  Aligned_cols=203  Identities=19%  Similarity=0.248  Sum_probs=155.1

Q ss_pred             chhhH--------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc
Q 040999          113 AFKIF--------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN  184 (382)
Q Consensus       113 avK~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~  184 (382)
                      |+|-+        +-+.+||..-++++|.|||+++|.|.     .+++.-+.||.+|||||.+.|..         .-++
T Consensus       604 aIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-----enGf~kIFMEqVPGGSLSsLLrs---------kWGP  669 (1226)
T KOG4279|consen  604 AIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-----ENGFFKIFMEQVPGGSLSSLLRS---------KWGP  669 (1226)
T ss_pred             EeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-----CCCeEEEEeecCCCCcHHHHHHh---------ccCC
Confidence            67666        56889999999999999999999964     36788899999999999999953         2234


Q ss_pred             c--CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCCCC------------CCCc
Q 040999          185 L--NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPPTR------------TQTK  249 (382)
Q Consensus       185 l--~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~------------~~~~  249 (382)
                      +  .+...-.+..||++||.|||   +..|||||||-+|+|++. .|.+||+|||.++.+..-.            .+||
T Consensus       670 lKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPE  746 (1226)
T KOG4279|consen  670 LKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE  746 (1226)
T ss_pred             CccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChH
Confidence            4  56777788999999999999   889999999999999965 6899999999998764322            2244


Q ss_pred             ccc--CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhh
Q 040999          250 YGV--GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQA  327 (382)
Q Consensus       250 ~~~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (382)
                      ..-  ...|+.++|||||||++.||.||++||...-....   .+++..            +.+..              
T Consensus       747 vIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFkVG------------myKvH--------------  797 (1226)
T KOG4279|consen  747 VIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFKVG------------MYKVH--------------  797 (1226)
T ss_pred             hhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhhhc------------ceecC--------------
Confidence            432  24678899999999999999999999875422211   111110            00000              


Q ss_pred             hhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          328 KINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       328 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                       .+..++...+...++++|...||.+||+++++++
T Consensus       798 -P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  798 -PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             -CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence             0011245567788999999999999999999985

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-29  Score=229.56  Aligned_cols=236  Identities=24%  Similarity=0.274  Sum_probs=161.4

Q ss_pred             chhhH-----HHHHHHHHHHhh--cccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-----KSFIAECKALRN--IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |||++     ++|.+|-++.+.  ++|+||++|+++-...+. ..-..+||++|.+.|+|.+||..           ..+
T Consensus       237 AVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eywLVt~fh~kGsL~dyL~~-----------nti  304 (534)
T KOG3653|consen  237 AVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYWLVTEFHPKGSLCDYLKA-----------NTI  304 (534)
T ss_pred             EEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccceeEEeeeccCCcHHHHHHh-----------ccc
Confidence            89998     789999888876  589999999998432211 14478999999999999999943           459


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhc------CCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCC------------
Q 040999          186 NLLRRLNIAIDVASALNYLHHD------CQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ------------  247 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~------~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~------------  247 (382)
                      +|....+++..+++||+|||++      .+++|+|||||++|||+..|+.+.|+|||+|..+.+....            
T Consensus       305 sw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RY  384 (534)
T KOG3653|consen  305 SWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRY  384 (534)
T ss_pred             cHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhh
Confidence            9999999999999999999974      4678999999999999999999999999999887654322            


Q ss_pred             --CccccCC------CCCccchhHHHHHHHHHHHhcCCCCCc--cccCCchHHHHHHHhcCCchhhhhhcccccchhhhh
Q 040999          248 --TKYGVGN------EVSTIGDVYSYGILLLELMIREKPSDI--MFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLV  317 (382)
Q Consensus       248 --~~~~~~~------~~~~~~Dv~S~Gvil~elltg~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (382)
                        ||...+.      ..-.+.||||+|.|||||+++..-++.  ..+-...+..-+...  ..+.++-+-..        
T Consensus       385 MAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h--Pt~e~mq~~VV--------  454 (534)
T KOG3653|consen  385 MAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH--PTLEEMQELVV--------  454 (534)
T ss_pred             cCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC--CCHHHHHHHHH--------
Confidence              4433221      112368999999999999987554321  000011111111111  11111111000        


Q ss_pred             hccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          318 VRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                       +...++.....-.....+.-+.+.+..||..||+.|-|+.=|-+++.++...-
T Consensus       455 -~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  455 -RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             -hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence             00000000101111134556777777999999999999999999988876544

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=9.8e-30  Score=229.74  Aligned_cols=198  Identities=19%  Similarity=0.173  Sum_probs=152.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|+||+++++++.     ++...++|+||+++++|.+++..          ...+++..+..++.|+
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~~~~~~~~i  102 (262)
T cd05572          38 EHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYCLGGELWTILRD----------RGLFDEYTARFYIACV  102 (262)
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecCCCCcHHHHHhh----------cCCCCHHHHHHHHHHH
Confidence            56889999999999999999999854     36778999999999999999842          3358889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      ++||+|||   +.+++|+||||+||+++.++.+||+|||.++.....           ...||...+..++.++|+||||
T Consensus       103 ~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG  179 (262)
T cd05572         103 VLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLG  179 (262)
T ss_pred             HHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhH
Confidence            99999999   789999999999999999999999999999866442           2346666667788999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      +++|||++|+.||......   .......        +..........                  ......+.+++.+|
T Consensus       180 ~il~~l~~g~~p~~~~~~~---~~~~~~~--------~~~~~~~~~~~------------------~~~~~~~~~~i~~~  230 (262)
T cd05572         180 ILLYELLTGRPPFGEDDED---PMEIYND--------ILKGNGKLEFP------------------NYIDKAAKDLIKQL  230 (262)
T ss_pred             HHHHHHHhCCCCcCCCCCC---HHHHHHH--------HhccCCCCCCC------------------cccCHHHHHHHHHH
Confidence            9999999999998643211   1111110        00000000000                  01234678888899


Q ss_pred             CCCCccCCCC-----HHHHHH
Q 040999          347 SMESPQDRMK-----MTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs-----~~evl~  362 (382)
                      |+.+|++||+     ++|+++
T Consensus       231 l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         231 LRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCChhhCcCCcccCHHHHhc
Confidence            9999999999     566554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=1.8e-29  Score=230.06  Aligned_cols=196  Identities=21%  Similarity=0.268  Sum_probs=153.8

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++++..     ....++||||+++++|.+++.           ...+++..+..++.|
T Consensus        46 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~i~-----------~~~~~~~~~~~~~~~  109 (277)
T cd06641          46 IEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLWIIMEYLGGGSALDLLE-----------PGPLDETQIATILRE  109 (277)
T ss_pred             HHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEEEEEEeCCCCcHHHHHh-----------cCCCCHHHHHHHHHH
Confidence            3678899999999999999999999653     678899999999999998883           235789999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.|+.|||   +.+++|+||||+||+++.++.++|+|||++......            ...||...+...+.++||||
T Consensus       110 l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s  186 (277)
T cd06641         110 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS  186 (277)
T ss_pred             HHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHH
Confidence            999999999   789999999999999999999999999998754332            23466666677788999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|..||.....     ............     +.+                      ......++.+++.
T Consensus       187 lG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~-----~~~----------------------~~~~~~~~~~~i~  234 (277)
T cd06641         187 LGITAIELAKGEPPHSELHP-----MKVLFLIPKNNP-----PTL----------------------EGNYSKPLKEFVE  234 (277)
T ss_pred             HHHHHHHHHcCCCCCCccch-----HHHHHHHhcCCC-----CCC----------------------CcccCHHHHHHHH
Confidence            99999999999999763211     011110000000     000                      0023346778888


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.+|.+||++.++++.
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHccCChhhCcCHHHHHhC
Confidence            9999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=1.1e-29  Score=229.51  Aligned_cols=200  Identities=21%  Similarity=0.304  Sum_probs=151.8

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|+++++.++|+||+++++++.     ..+..++|+||+++++|.+++.          ....+++..+..++.
T Consensus        42 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~  106 (264)
T cd06626          42 TIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVYIFMEYCSGGTLEELLE----------HGRILDEHVIRVYTL  106 (264)
T ss_pred             HHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEEEEEecCCCCcHHHHHh----------hcCCCChHHHHHHHH
Confidence            4578999999999999999999999854     3678899999999999999884          233578889999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccCCC---C
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVGNE---V  256 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~~~---~  256 (382)
                      |+++||.|||   +.+++|+||+|+||+++.++.+||+|||.+......                ...||...+..   .
T Consensus       107 ~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~  183 (264)
T cd06626         107 QLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH  183 (264)
T ss_pred             HHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCC
Confidence            9999999999   779999999999999999999999999998765322                22355554444   7


Q ss_pred             CccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          257 STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      +.++||||||+++||+++|+.||.....   .......... ..     .+.+..                    .....
T Consensus       184 ~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~~~~~~~~~~-~~-----~~~~~~--------------------~~~~~  234 (264)
T cd06626         184 GRAADIWSLGCVVLEMATGKRPWSELDN---EFQIMFHVGA-GH-----KPPIPD--------------------SLQLS  234 (264)
T ss_pred             CcccchHHHHHHHHHHHhCCCCccCCcc---hHHHHHHHhc-CC-----CCCCCc--------------------ccccC
Confidence            8899999999999999999999864211   1000000000 00     000000                    00123


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ..+.+++.+||+.+|++|||+.|++.
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhc
Confidence            45678888999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=6.9e-30  Score=239.50  Aligned_cols=236  Identities=20%  Similarity=0.223  Sum_probs=156.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.+++.++|+||+++++++...........++|+||+. ++|.+++.          ....+++..+..++.|+
T Consensus        49 ~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qi  117 (337)
T cd07858          49 KRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIR----------SSQTLSDDHCQYFLYQL  117 (337)
T ss_pred             HHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHh----------cCCCCCHHHHHHHHHHH
Confidence            45778999999999999999999865432223346899999996 67887773          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||+++.....            ...||.... ..++.++||||
T Consensus       118 ~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  194 (337)
T cd07858         118 LRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWS  194 (337)
T ss_pred             HHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHH
Confidence            99999999   779999999999999999999999999999865332            123554432 45788999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....  .................+..+...............................++.+++.
T Consensus       195 lG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  272 (337)
T cd07858         195 VGCIFAELLGRKPLFPGKD--YVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLE  272 (337)
T ss_pred             HHHHHHHHHcCCCCCCCCC--hHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHH
Confidence            9999999999999986421  11111111111100000000000000000000000000000000011134456789999


Q ss_pred             ccCCCCccCCCCHHHHHHH--HHHhhh
Q 040999          345 ACSMESPQDRMKMTNVVHE--LQSIKN  369 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~--L~~i~~  369 (382)
                      +||+.+|++|||++++++.  +..+..
T Consensus       273 ~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         273 KMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             HHhcCChhhccCHHHHHcCcchhhhcC
Confidence            9999999999999999976  665543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=5.5e-30  Score=235.93  Aligned_cols=197  Identities=18%  Similarity=0.248  Sum_probs=151.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.+++.++||||+++++++..     .+..++|+||+++++|.+++.           ...+++..+..++.|+
T Consensus        63 ~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~qi  126 (297)
T cd06659          63 ELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVS-----------QTRLNEEQIATVCESV  126 (297)
T ss_pred             HHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEEecCCCCCHHHHHh-----------hcCCCHHHHHHHHHHH
Confidence            568899999999999999999998643     678899999999999988772           2357899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+++||||||+||+++.++.+||+|||++.....            ....||...+..++.++|||||
T Consensus       127 ~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  203 (297)
T cd06659         127 LQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSL  203 (297)
T ss_pred             HHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHH
Confidence            99999999   77999999999999999999999999999864432            1234666666778999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....    ......... ...     ..... .                   .......+.+++.+
T Consensus       204 G~il~el~~g~~p~~~~~----~~~~~~~~~-~~~-----~~~~~-~-------------------~~~~~~~l~~~i~~  253 (297)
T cd06659         204 GIMVIEMVDGEPPYFSDS----PVQAMKRLR-DSP-----PPKLK-N-------------------AHKISPVLRDFLER  253 (297)
T ss_pred             HHHHHHHHhCCCCCCCCC----HHHHHHHHh-ccC-----CCCcc-c-------------------cCCCCHHHHHHHHH
Confidence            999999999999986321    111111000 000     00000 0                   00112356778889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.+|++||+++++++.
T Consensus       254 ~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         254 MLTREPQERATAQELLDH  271 (297)
T ss_pred             HhcCCcccCcCHHHHhhC
Confidence            999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PTZ00284 protein kinase; Provisional

Probab=99.96  E-value=1.6e-29  Score=247.12  Aligned_cols=152  Identities=20%  Similarity=0.270  Sum_probs=123.0

Q ss_pred             chhhH-------HHHHHHHHHHhhcccc------cceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHR------NLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY  179 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~  179 (382)
                      |+|++       +++..|+++++.++|.      +++++++++..    ...+.++|||++ +++|.+++.         
T Consensus       158 AvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~~~~~~iv~~~~-g~~l~~~l~---------  223 (467)
T PTZ00284        158 AVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----ETGHMCIVMPKY-GPCLLDWIM---------  223 (467)
T ss_pred             EEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----CCceEEEEEecc-CCCHHHHHH---------
Confidence            78865       3567788888888765      47888887542    345789999988 678888773         


Q ss_pred             cCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC----------------cEEEccccccccCC-
Q 040999          180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM----------------TARVGDFGLARFLP-  242 (382)
Q Consensus       180 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~----------------~~kl~Dfg~a~~~~-  242 (382)
                       ....+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++                .+||+|||.+.... 
T Consensus       224 -~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~  300 (467)
T PTZ00284        224 -KHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH  300 (467)
T ss_pred             -HcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc
Confidence             23468999999999999999999993  15999999999999998765                49999999875432 


Q ss_pred             --------CCCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          243 --------PTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       243 --------~~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                              .....||...+..++.++|||||||++|||+||+.||+.
T Consensus       301 ~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        301 SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                    234558888888899999999999999999999999864

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=8.6e-30  Score=232.90  Aligned_cols=224  Identities=20%  Similarity=0.199  Sum_probs=150.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     +.+..++||||+. ++|.+++...        ....+++..+..++.|+
T Consensus        44 ~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~-~~l~~~~~~~--------~~~~l~~~~~~~~~~~i  109 (284)
T cd07860          44 STAIREISLLKELNHPNIVKLLDVIH-----TENKLYLVFEFLH-QDLKKFMDAS--------PLSGIPLPLIKSYLFQL  109 (284)
T ss_pred             hHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEEEEeeccc-cCHHHHHHhC--------CCCCCCHHHHHHHHHHH
Confidence            46889999999999999999999854     4678999999995 6788877431        23468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||+|||   ..+++|+||+|+||+++.++.+||+|||++......            ...||...+ ..++.++||||
T Consensus       110 ~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s  186 (284)
T cd07860         110 LQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS  186 (284)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHH
Confidence            99999999   779999999999999999999999999998754321            233665444 33578899999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||..... .....+......... .. ..+.....+.......... .............++.+++.
T Consensus       187 lG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  262 (284)
T cd07860         187 LGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPD-EV-VWPGVTSLPDYKPSFPKWA-RQDFSKVVPPLDEDGRDLLS  262 (284)
T ss_pred             HHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCC-hh-hhhhhhHHHHHHhhccccc-ccCHHHHcccCCHHHHHHHH
Confidence            99999999999999863211 111111111111000 00 0000000000000000000 00000000112345678888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||++|||++++++
T Consensus       263 ~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         263 QMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhcCCCcccCCCHHHHhc
Confidence            999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=2.4e-29  Score=233.82  Aligned_cols=201  Identities=25%  Similarity=0.282  Sum_probs=151.8

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++|+|++++++++..     ....++||||++ |++.+.+.         .....+++..+..++.
T Consensus        68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-g~l~~~~~---------~~~~~l~~~~~~~i~~  132 (317)
T cd06635          68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTAWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAITH  132 (317)
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeEEEEEeCCC-CCHHHHHH---------HhcCCCCHHHHHHHHH
Confidence            34678999999999999999999999754     667899999996 57777663         2234589999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------CCCCcccc---CCCCCccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------RTQTKYGV---GNEVSTIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~---~~~~~~~~Dv~S  264 (382)
                      |++.||.|||   ..+++||||+|+||+++.++.+||+|||++......        ...||...   ...++.++||||
T Consensus       133 ~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~s  209 (317)
T cd06635         133 GALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  209 (317)
T ss_pred             HHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccccCCccccChhhhhcCCCCCCCccccHHH
Confidence            9999999999   779999999999999999999999999998755432        23466542   356788999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||..... ......+.....+            ...                  .......+.+++.
T Consensus       210 lGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~------------~~~------------------~~~~~~~l~~li~  258 (317)
T cd06635         210 LGITCIELAERKPPLFNMNA-MSALYHIAQNESP------------TLQ------------------SNEWSDYFRNFVD  258 (317)
T ss_pred             HHHHHHHHHhCCCCCCCccH-HHHHHHHHhccCC------------CCC------------------CccccHHHHHHHH
Confidence            99999999999999753210 0001111100000            000                  0022345778888


Q ss_pred             ccCCCCccCCCCHHHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      +||+.+|.+||++.++++.+-
T Consensus       259 ~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         259 SCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             HHccCCcccCcCHHHHHhChh
Confidence            999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.96  E-value=7.8e-30  Score=229.49  Aligned_cols=198  Identities=20%  Similarity=0.256  Sum_probs=152.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++.+.     .....++|+||+++++|.+++...        ....+++..+..++.|+
T Consensus        44 ~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l  110 (257)
T cd08225          44 EASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLFIVMEYCDGGDLMKRINRQ--------RGVLFSEDQILSWFVQI  110 (257)
T ss_pred             HHHHHHHHHHHhCCCCChhhhhheec-----cCCeEEEEEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHH
Confidence            56789999999999999999999854     367899999999999999988531        22357899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCC-cEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++||.|||   ..+++|+||||+||++++++ .+||+|||.+......            ...||...+..++.++||||
T Consensus       111 ~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~s  187 (257)
T cd08225         111 SLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWS  187 (257)
T ss_pred             HHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHH
Confidence            99999999   67999999999999999885 4699999998765332            22366666667889999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|||++|..||...     ...+............        ..                   ......+.+++.
T Consensus       188 lG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~--------~~-------------------~~~~~~~~~~i~  235 (257)
T cd08225         188 LGCVLYELCTLKHPFEGN-----NLHQLVLKICQGYFAP--------IS-------------------PNFSRDLRSLIS  235 (257)
T ss_pred             HHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcccCCC--------CC-------------------CCCCHHHHHHHH
Confidence            999999999999997632     1122221111111000        00                   012235778888


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.+|++|||+.|+++.
T Consensus       236 ~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         236 QLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             HHhccChhhCcCHHHHhhC
Confidence            9999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.96  E-value=4.4e-30  Score=243.00  Aligned_cols=146  Identities=21%  Similarity=0.249  Sum_probs=126.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++..++|+||+++++.+.     +.+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        46 ~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi  110 (360)
T cd05627          46 AHIRAERDILVEADGAWVVKMFYSFQ-----DKRNLYLIMEFLPGGDMMTLLM----------KKDTLSEEATQFYIAET  110 (360)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCEEEEEEeCCCCccHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            56788999999999999999998853     4778999999999999999983          23468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------------------------------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------------------------------  243 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------------------------------  243 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..                                  
T Consensus       111 ~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (360)
T cd05627         111 VLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK  187 (360)
T ss_pred             HHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccc
Confidence            99999999   78999999999999999999999999999864321                                  


Q ss_pred             -------------CCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          244 -------------TRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       244 -------------~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                                   ...+||...+..++.++|||||||++|||+||+.||..
T Consensus       188 ~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         188 NRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                         12336666677789999999999999999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=1.8e-29  Score=231.18  Aligned_cols=196  Identities=20%  Similarity=0.246  Sum_probs=151.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.+++.++|+||+++++++..     .+..++++||+++++|.+++..           ..+++..+..++.|+
T Consensus        61 ~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql  124 (285)
T cd06648          61 ELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVVMEFLEGGALTDIVTH-----------TRMNEEQIATVCLAV  124 (285)
T ss_pred             HHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEEEeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHH
Confidence            568899999999999999999998643     6788999999999999998832           358889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+++||||+|+||+++.++.++|+|||.+.....            ....||...+..++.++|||||
T Consensus       125 ~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  201 (285)
T cd06648         125 LKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSL  201 (285)
T ss_pred             HHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHH
Confidence            99999999   77999999999999999999999999998764322            1234666666678899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||...    ... ..........     .+.....                    ......+.+++.+
T Consensus       202 Gv~l~ell~g~~p~~~~----~~~-~~~~~~~~~~-----~~~~~~~--------------------~~~~~~l~~li~~  251 (285)
T cd06648         202 GIMVIEMVDGEPPYFNE----PPL-QAMKRIRDNL-----PPKLKNL--------------------HKVSPRLRSFLDR  251 (285)
T ss_pred             HHHHHHHHhCCCCCcCC----CHH-HHHHHHHhcC-----CCCCccc--------------------ccCCHHHHHHHHH
Confidence            99999999999997531    111 1111000000     0000000                    0123467888899


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.+|++||++.++++
T Consensus       252 ~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         252 MLVRDPAQRATAAELLN  268 (285)
T ss_pred             HcccChhhCcCHHHHcc
Confidence            99999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.1e-29  Score=249.43  Aligned_cols=148  Identities=20%  Similarity=0.287  Sum_probs=119.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|+|||++++++..     .+..++|++++. ++|..++.....     .............++.|+
T Consensus       208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~ql  276 (501)
T PHA03210        208 IQLENEILALGRLNHENILKIEEILRS-----EANTYMITQKYD-FDLYSFMYDEAF-----DWKDRPLLKQTRAIMKQL  276 (501)
T ss_pred             HHHHHHHHHHHhCCCCCcCcEeEEEEE-----CCeeEEEEeccc-cCHHHHHhhccc-----cccccccHHHHHHHHHHH
Confidence            568899999999999999999999643     677899999984 567776643221     111223456677899999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...             ...||...+..++.++||||
T Consensus       277 ~~aL~yLH---~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  353 (501)
T PHA03210        277 LCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS  353 (501)
T ss_pred             HHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHH
Confidence            99999999   789999999999999999999999999999765321             22477777778899999999


Q ss_pred             HHHHHHHHHhcCCCC
Q 040999          265 YGILLLELMIREKPS  279 (382)
Q Consensus       265 ~Gvil~elltg~~p~  279 (382)
                      |||++|||++|..++
T Consensus       354 lGvil~ell~~~~~p  368 (501)
T PHA03210        354 CGLILLDMLSHDFCP  368 (501)
T ss_pred             HHHHHHHHHHCCCCC
Confidence            999999999998643

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=2.3e-29  Score=230.46  Aligned_cols=199  Identities=19%  Similarity=0.247  Sum_probs=154.6

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++.++.++|+||+++++++..     ....++|+||+++++|.+++..         ....+++..+..++.|
T Consensus        59 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---------~~~~l~~~~~~~i~~~  124 (286)
T cd06614          59 KELIINEILIMKDCKHPNIVDYYDSYLV-----GDELWVVMEYMDGGSLTDIITQ---------NFVRMNEPQIAYVCRE  124 (286)
T ss_pred             HHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEEEEEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHH
Confidence            3578899999999999999999998754     5789999999999999999942         1136899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||.|||   ..+++|+||+|+||+++.++.+||+|||.+......            ...||...+..++.++||||
T Consensus       125 i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s  201 (286)
T cd06614         125 VLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWS  201 (286)
T ss_pred             HHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHH
Confidence            999999999   789999999999999999999999999987654321            33467666677899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|+|++|+.||...    ......... .......        ..                 ........+.+++.
T Consensus       202 lGvil~~l~~g~~p~~~~----~~~~~~~~~-~~~~~~~--------~~-----------------~~~~~~~~l~~li~  251 (286)
T cd06614         202 LGIMCIEMAEGEPPYLRE----PPLRALFLI-TTKGIPP--------LK-----------------NPEKWSPEFKDFLN  251 (286)
T ss_pred             HHHHHHHHHhCCCCCCCC----CHHHHHHHH-HhcCCCC--------Cc-----------------chhhCCHHHHHHHH
Confidence            999999999999997532    111111100 0000000        00                 00013346788889


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.+|.+|||+.++++
T Consensus       252 ~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         252 KCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHhccChhhCcCHHHHhh
Confidence            999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=1.7e-29  Score=232.14  Aligned_cols=148  Identities=24%  Similarity=0.306  Sum_probs=123.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||+++++++..   ......++|+||++ ++|.+++..         ....+++..+..++.|+
T Consensus        49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~~~lv~e~~~-~~L~~~~~~---------~~~~l~~~~~~~i~~qi  115 (293)
T cd07843          49 ITSLREINILLKLQHPNIVTVKEVVVG---SNLDKIYMVMEYVE-HDLKSLMET---------MKQPFLQSEVKCLMLQL  115 (293)
T ss_pred             hhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCcEEEEehhcC-cCHHHHHHh---------ccCCCCHHHHHHHHHHH
Confidence            356789999999999999999998764   12378999999997 488888742         22358999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+++|+||||+||+++.++.+||+|||+++.....            ...||...+ ...+.++||||
T Consensus       116 ~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s  192 (293)
T cd07843         116 LSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWS  192 (293)
T ss_pred             HHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHH
Confidence            99999999   779999999999999999999999999998865432            233565443 34588999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      ||+++|||++|+.||..
T Consensus       193 lG~~l~~l~~g~~~f~~  209 (293)
T cd07843         193 VGCIFAELLTKKPLFPG  209 (293)
T ss_pred             HHHHHHHHHhCCCCCCC
Confidence            99999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=5e-30  Score=221.45  Aligned_cols=214  Identities=17%  Similarity=0.183  Sum_probs=162.7

Q ss_pred             chhhH---HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHH
Q 040999          113 AFKIF---KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLL  188 (382)
Q Consensus       113 avK~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~  188 (382)
                      |.|++   ...++|++.--.. .|||||++++++.. .+++...+.+|||.|+||.|.+.+..        .....+++.
T Consensus        91 ALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rkcLLiVmE~meGGeLfsriq~--------~g~~afTEr  161 (400)
T KOG0604|consen   91 ALKVLLDSPKARREVELHWMASGHPHIVSIIDVYEN-SYQGRKCLLIVMECMEGGELFSRIQD--------RGDQAFTER  161 (400)
T ss_pred             HHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCceeeEeeeecccchHHHHHHHH--------cccccchHH
Confidence            99998   5688999886666 69999999999754 35667778899999999999999864        335679999


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC---CCcEEEccccccccCCC-----------CCCCCccccCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD---DMTARVGDFGLARFLPP-----------TRTQTKYGVGN  254 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~  254 (382)
                      ++-.|+.||+.|+.|||   +.+|.||||||+|+|...   +-.+||+|||+|+.-..           -...||.....
T Consensus       162 ea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~e  238 (400)
T KOG0604|consen  162 EASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPE  238 (400)
T ss_pred             HHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCch
Confidence            99999999999999999   889999999999999965   45699999999986442           22336666667


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      .|+..+|+||+||++|-|+.|.+||...-..          .++...+.-+...-..-+               .+++.+
T Consensus       239 KydkscdmwSlgVimYIlLCGyPPFYS~hg~----------aispgMk~rI~~gqy~FP---------------~pEWs~  293 (400)
T KOG0604|consen  239 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----------AISPGMKRRIRTGQYEFP---------------EPEWSC  293 (400)
T ss_pred             hcCCCCCccchhHHHHHhhcCCCcccccCCc----------cCChhHHhHhhccCccCC---------------ChhHhH
Confidence            8899999999999999999999998753221          112222221111111001               012234


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ......++++..+..+|.+|-|+.+++..
T Consensus       294 VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  294 VSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             HHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            55567778889999999999999998753

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=1.5e-29  Score=228.94  Aligned_cols=205  Identities=20%  Similarity=0.230  Sum_probs=154.0

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++.++.++|+||+++++.+..     ....++|+||+++++|.+++....       ....+++.....++.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~iv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~  109 (267)
T cd06610          42 SVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELWLVMPYLSGGSLLDIMKSSY-------PRGGLDEAIIATVLK  109 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEEEEEeccCCCcHHHHHHHhc-------ccCCCCHHHHHHHHH
Confidence            44678999999999999999999988543     678899999999999999984321       124588999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccCC-CCCc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVGN-EVST  258 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~~-~~~~  258 (382)
                      |++.||+|||   +.+++||||||+||++++++.+||+|||++..+...                ...||..... ..+.
T Consensus       110 ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~  186 (267)
T cd06610         110 EVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF  186 (267)
T ss_pred             HHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCc
Confidence            9999999999   779999999999999999999999999998754432                1225554444 6788


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ++|+|||||++|||++|+.||...... .......... +        .......                 ........
T Consensus       187 ~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~-~--------~~~~~~~-----------------~~~~~~~~  239 (267)
T cd06610         187 KADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQND-P--------PSLETGA-----------------DYKKYSKS  239 (267)
T ss_pred             ccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCC-C--------CCcCCcc-----------------ccccccHH
Confidence            999999999999999999998643111 0111111000 0        0000000                 00123456


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         240 FRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhh
Confidence            788888999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=1.2e-29  Score=233.33  Aligned_cols=197  Identities=19%  Similarity=0.212  Sum_probs=151.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++++++||||+++++++..     .+..++|+||+++++|.+++..           ..+++..+..++.|+
T Consensus        61 ~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l  124 (293)
T cd06647          61 ELIINEILVMRENKHPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCREC  124 (293)
T ss_pred             HHHHHHHHHHhhcCCCCeeehhheeee-----CCcEEEEEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHH
Confidence            568899999999999999999998653     6778999999999999998832           247888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+++|+||||+||+++.++.+||+|||++......            ...||...+..++.++|||||
T Consensus       125 ~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  201 (293)
T cd06647         125 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (293)
T ss_pred             HHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHH
Confidence            99999999   779999999999999999999999999987654322            233676666778899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++||+++|+.||.......    ........ .     .+...                    ........+.+++.+
T Consensus       202 G~ll~~ll~g~~pf~~~~~~~----~~~~~~~~-~-----~~~~~--------------------~~~~~~~~l~~li~~  251 (293)
T cd06647         202 GIMAIEMVEGEPPYLNENPLR----ALYLIATN-G-----TPELQ--------------------NPEKLSAIFRDFLNR  251 (293)
T ss_pred             HHHHHHHHhCCCCCCCCChhh----heeehhcC-C-----CCCCC--------------------CccccCHHHHHHHHH
Confidence            999999999999986421100    00000000 0     00000                    000223457788889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.+|++||++.+++..
T Consensus       252 ~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         252 CLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HccCChhhCcCHHHHhcC
Confidence            999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=2.7e-29  Score=229.69  Aligned_cols=222  Identities=18%  Similarity=0.233  Sum_probs=153.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++..     ....++|+||+ +++|.+++..         ....+++..+..++.|+
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~v~e~~-~~~L~~~~~~---------~~~~~~~~~~~~~~~~i  108 (286)
T cd07832          44 NQALREIKALQACQHPYVVKLLDVFPH-----GSGFVLVMEYM-PSDLSEVLRD---------EERPLPEAQVKSYMRML  108 (286)
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeEEEeccc-CCCHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            578999999999999999999998643     67889999999 9999998842         23568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-------------CCCccccC-CCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-------------TQTKYGVG-NEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~~-~~~~~~~Dv~  263 (382)
                      ++||.|||   +.+++|+||||+||+++.++.++|+|||.+.......             ..||...+ ..++.++|||
T Consensus       109 ~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  185 (286)
T cd07832         109 LKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLW  185 (286)
T ss_pred             HHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHH
Confidence            99999999   7799999999999999999999999999988654321             23565443 3458899999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHH--HHhcCCchhhhhhcccc-cchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFA--KMALPNHVKDIVDSILL-NDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |+|+++|||+||.+||...    .....+.  ................. .+......  .............+....+.
T Consensus       186 slG~~l~~l~tg~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  259 (286)
T cd07832         186 AVGCIFAELLNGSPLFPGE----NDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF--PESKPIPLEEIFPDASPEAL  259 (286)
T ss_pred             HHHHHHHHHHcCCcCcCCC----CHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC--CCCCcchHHHhCCCccHHHH
Confidence            9999999999998776532    1111111  11111000000000000 00000000  00000000011112346788


Q ss_pred             HHhhccCCCCccCCCCHHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +++.+|++.+|++|||++++++.
T Consensus       260 ~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         260 DLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHHHHHhccChhhCCCHHHHhhC
Confidence            89999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-31  Score=228.61  Aligned_cols=204  Identities=20%  Similarity=0.245  Sum_probs=162.9

Q ss_pred             chhhH------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|.+      +++++|+.+|+++..+++|++||.++.     ...+|+|||||..|+..+.+.         .+.++++
T Consensus        62 AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLWIVMEYCGAGSiSDI~R---------~R~K~L~  127 (502)
T KOG0574|consen   62 AIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLWIVMEYCGAGSISDIMR---------ARRKPLS  127 (502)
T ss_pred             EEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceEeehhhcCCCcHHHHHH---------HhcCCcc
Confidence            77765      899999999999999999999998653     667899999999999999994         4567899


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCC
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGN  254 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~  254 (382)
                      +.++..++.+.++||+|||   ...-+|||||..|||++.+|.+||+|||.|..+.+            -+..||+...-
T Consensus       128 E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EI  204 (502)
T KOG0574|consen  128 EQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEI  204 (502)
T ss_pred             HHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHh
Confidence            9999999999999999999   67889999999999999999999999999986643            23446766667


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      .|+.++||||+|++..||..|++||...-.-                +.++.-  ...            +++.....+.
T Consensus       205 GY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMI--PT~------------PPPTF~KPE~  254 (502)
T KOG0574|consen  205 GYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMI--PTK------------PPPTFKKPEE  254 (502)
T ss_pred             ccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEec--cCC------------CCCCCCChHh
Confidence            7899999999999999999999998643110                000000  000            0111112234


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ...++-+++.+|+-++|++|.|+-++++.
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            55678888889999999999999887653

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.96  E-value=5.1e-30  Score=243.19  Aligned_cols=151  Identities=28%  Similarity=0.384  Sum_probs=129.8

Q ss_pred             chhhH-------HHHHHHHHHHhhcc-c-----ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIR-H-----RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY  179 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~  179 (382)
                      |+|++       ++-..|+.+|..++ |     -|+|++++++..     .++.|||+|.+. -+|++++..        
T Consensus       215 AIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-----r~HlciVfELL~-~NLYellK~--------  280 (586)
T KOG0667|consen  215 AIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-----RNHLCIVFELLS-TNLYELLKN--------  280 (586)
T ss_pred             EEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-----ccceeeeehhhh-hhHHHHHHh--------
Confidence            88887       45677999999997 4     399999999654     889999999995 489999964        


Q ss_pred             cCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC--cEEEccccccccCCCC---------CCCC
Q 040999          180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM--TARVGDFGLARFLPPT---------RTQT  248 (382)
Q Consensus       180 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~--~~kl~Dfg~a~~~~~~---------~~~~  248 (382)
                      .+...++...+..++.||+.||.+||   +.+|||+||||+||||.+..  .+||+|||.|......         ..+|
T Consensus       281 n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAP  357 (586)
T KOG0667|consen  281 NKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAP  357 (586)
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccCCcceeeeeccccccc
Confidence            33456999999999999999999999   88999999999999997543  6999999999876543         3459


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHHhcCCCCC
Q 040999          249 KYGVGNEVSTIGDVYSYGILLLELMIREKPSD  280 (382)
Q Consensus       249 ~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~  280 (382)
                      |...|..|+++.||||||||+.||+||.+-|.
T Consensus       358 EVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  358 EVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             hhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            99999999999999999999999999977654

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-29  Score=235.36  Aligned_cols=200  Identities=20%  Similarity=0.199  Sum_probs=152.6

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|+++++.++|+||+++++.+.     .....++||||+.+++|.+++...        ....+++..+..++.
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~  110 (316)
T cd05574          44 KVKRVLTEQEILATLDHPFLPTLYASFQ-----TETYLCLVMDYCPGGELFRLLQRQ--------PGKCLSEEVARFYAA  110 (316)
T ss_pred             HHHHHHHHHHHHHhCCCCCchhheeeee-----cCCEEEEEEEecCCCCHHHHHHhC--------CCCccCHHHHHHHHH
Confidence            3467899999999999999999999854     367889999999999999988421        234688999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------------------------
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------------------------  244 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------------------------  244 (382)
                      |+++||+|||   +.+++|+||||+||+++.++.++|+|||++......                               
T Consensus       111 qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (316)
T cd05574         111 EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF  187 (316)
T ss_pred             HHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccC
Confidence            9999999999   779999999999999999999999999998654211                               


Q ss_pred             ----------CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchh
Q 040999          245 ----------RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDE  314 (382)
Q Consensus       245 ----------~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (382)
                                ...||...+..++.++||||||+++|+|++|+.||.....    ...+..         +......... 
T Consensus       188 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~---------~~~~~~~~~~-  253 (316)
T cd05574         188 RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR----DETFSN---------ILKKEVTFPG-  253 (316)
T ss_pred             CCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch----HHHHHH---------HhcCCccCCC-
Confidence                      2335555566678899999999999999999999864211    111111         1110000000 


Q ss_pred             hhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCC----HHHHHH
Q 040999          315 KLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMK----MTNVVH  362 (382)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs----~~evl~  362 (382)
                                       .......+.+++.+||+.+|++|||    ++|+++
T Consensus       254 -----------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         254 -----------------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             -----------------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence                             0013346788888999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.2e-29  Score=229.38  Aligned_cols=195  Identities=19%  Similarity=0.265  Sum_probs=149.7

Q ss_pred             HHHHHHHHHHhhcc---cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKALRNIR---HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +++.+|++++++++   |||++++++++..     ....++||||+++++|.+++..           ..+++.....++
T Consensus        44 ~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~  107 (277)
T cd06917          44 SDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPRLWIIMEYAEGGSVRTLMKA-----------GPIAEKYISVII  107 (277)
T ss_pred             HHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCEEEEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHH
Confidence            56889999999997   9999999998653     6778999999999999988731           258899999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC------------CCCccccC-CCCCccch
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR------------TQTKYGVG-NEVSTIGD  261 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~-~~~~~~~D  261 (382)
                      .|+++||.|||   ..+++|+||+|+||+++.++.++|+|||.+.......            ..||...+ ..++.++|
T Consensus       108 ~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  184 (277)
T cd06917         108 REVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKAD  184 (277)
T ss_pred             HHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchh
Confidence            99999999999   7799999999999999999999999999987654321            23554433 34688999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|+|++|+.||.....     ...... ...    ...+.+..                     .....++.+
T Consensus       185 v~slG~~l~~ll~g~~p~~~~~~-----~~~~~~-~~~----~~~~~~~~---------------------~~~~~~~~~  233 (277)
T cd06917         185 IWSLGITIYEMATGNPPYSDVDA-----FRAMML-IPK----SKPPRLED---------------------NGYSKLLRE  233 (277)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCh-----hhhhhc-ccc----CCCCCCCc---------------------ccCCHHHHH
Confidence            99999999999999999864211     111000 000    00000000                     012346788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.+|++||++.|++.
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhh
Confidence            888999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=9.5e-30  Score=229.32  Aligned_cols=199  Identities=18%  Similarity=0.186  Sum_probs=153.4

Q ss_pred             hhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       115 K~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +..+.+.+|++++++++||||+++++.+     .+....++|+||+.+++|.+++.          ....+++..+..++
T Consensus        42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~  106 (258)
T cd05578          42 GSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENMYLVVDLLLGGDLRYHLS----------QKVKFSEEQVKFWI  106 (258)
T ss_pred             hHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeEEEEEeCCCCCCHHHHHH----------hcCCcCHHHHHHHH
Confidence            3456789999999999999999999884     44778999999999999999883          22468899999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      .|+++||.|||   +.+++|+||||+||++++++.++|+|||.+......           ...||...+..++.++|+|
T Consensus       107 ~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~  183 (258)
T cd05578         107 CEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWW  183 (258)
T ss_pred             HHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccch
Confidence            99999999999   779999999999999999999999999998765432           1236666666689999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||+++|+|++|+.||......  ....+... ....     ..    ..                  .......+.+++
T Consensus       184 slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-~~~~-----~~----~~------------------~~~~~~~~~~~i  233 (258)
T cd05578         184 SLGVTAYECLRGKRPYRGHSRT--IRDQIRAK-QETA-----DV----LY------------------PATWSTEAIDAI  233 (258)
T ss_pred             hhHHHHHHHHhCCCCCCCCCcc--HHHHHHHH-hccc-----cc----cC------------------cccCcHHHHHHH
Confidence            9999999999999998743211  11111110 0000     00    00                  002235677888


Q ss_pred             hccCCCCccCCCCH--HHHH
Q 040999          344 VACSMESPQDRMKM--TNVV  361 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~--~evl  361 (382)
                      .+||+.+|.+||++  +|++
T Consensus       234 ~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         234 NKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHHccCChhHcCCccHHHHh
Confidence            89999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=1.8e-29  Score=230.03  Aligned_cols=148  Identities=25%  Similarity=0.290  Sum_probs=126.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     ..+..++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        38 ~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~ql  104 (277)
T cd05577          38 QMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLMNGGDLKYHIYNV--------GEPGFPEARAIFYAAQI  104 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecCCCCcHHHHHHHc--------CcCCCCHHHHHHHHHHH
Confidence            45678999999999999999998853     367889999999999999988532        12368899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      +.||.|||   ..+++||||+|+||+++.++.+||+|||.+.....           ....||...+..++.++||||||
T Consensus       105 ~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG  181 (277)
T cd05577         105 ICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALG  181 (277)
T ss_pred             HHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHH
Confidence            99999999   77999999999999999999999999999875431           22346766667788999999999


Q ss_pred             HHHHHHHhcCCCCCc
Q 040999          267 ILLLELMIREKPSDI  281 (382)
Q Consensus       267 vil~elltg~~p~~~  281 (382)
                      |++|+|++|+.||..
T Consensus       182 ~il~~l~~g~~p~~~  196 (277)
T cd05577         182 CTLYEMIAGRSPFRQ  196 (277)
T ss_pred             HHHHHHhhCCCCCCC
Confidence            999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=241.58  Aligned_cols=201  Identities=24%  Similarity=0.292  Sum_probs=156.7

Q ss_pred             chhhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHH
Q 040999          113 AFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLN  192 (382)
Q Consensus       113 avK~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~  192 (382)
                      +..+.+++++|++.|.+++|||+|.+.|+|+.     +...||||||| -||-.+++.         ...+++.+..+..
T Consensus        66 s~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~TaWLVMEYC-lGSAsDlle---------VhkKplqEvEIAA  130 (948)
T KOG0577|consen   66 SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTAWLVMEYC-LGSASDLLE---------VHKKPLQEVEIAA  130 (948)
T ss_pred             cHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchHHHHHHHH-hccHHHHHH---------HHhccchHHHHHH
Confidence            55666899999999999999999999999664     67789999999 557777773         4567899999999


Q ss_pred             HHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC--------CCCcccc---CCCCCccch
Q 040999          193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR--------TQTKYGV---GNEVSTIGD  261 (382)
Q Consensus       193 i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~---~~~~~~~~D  261 (382)
                      |+.+.+.||+|||   +.+.||||||..|||+++.|.+||+|||.|.+..+..        ..||+..   .+.|+-|+|
T Consensus       131 i~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvD  207 (948)
T KOG0577|consen  131 ITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVD  207 (948)
T ss_pred             HHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccc
Confidence            9999999999999   7899999999999999999999999999998876543        3455543   468899999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||+|+++.||..+++|.-.+..-. .+........         +.+..                     -+....+..
T Consensus       208 vWSLGITCIELAERkPPlFnMNAMS-ALYHIAQNes---------PtLqs---------------------~eWS~~F~~  256 (948)
T KOG0577|consen  208 VWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES---------PTLQS---------------------NEWSDYFRN  256 (948)
T ss_pred             eeeccchhhhhhhcCCCccCchHHH-HHHHHHhcCC---------CCCCC---------------------chhHHHHHH
Confidence            9999999999999999954321100 0001110000         01100                     034456777


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++..|+++-|.+|||.++++.
T Consensus       257 Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  257 FVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHHHHhhCcccCCcHHHHhh
Confidence            888999999999999988765

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.6e-29  Score=236.22  Aligned_cols=236  Identities=19%  Similarity=0.251  Sum_probs=159.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|+||+++++++...........+++|||++ ++|.+++.          ....+++..+..++.|+
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~----------~~~~l~~~~~~~i~~~l  112 (330)
T cd07834          44 KRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIK----------SPQPLTDDHIQYFLYQI  112 (330)
T ss_pred             hhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHh----------CCCCCCHHHHHHHHHHH
Confidence            57889999999999999999999875432222347899999997 47888873          23378999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC---------------CCCccccCC-CCCccch
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR---------------TQTKYGVGN-EVSTIGD  261 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~~~-~~~~~~D  261 (382)
                      ++||+|||   +.+|+||||||+||+++.++.++|+|||.+.......               ..||...+. .++.++|
T Consensus       113 ~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sD  189 (330)
T cd07834         113 LRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAID  189 (330)
T ss_pred             HHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchh
Confidence            99999999   7799999999999999999999999999998664432               236665555 7889999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||+++|+|++|+.||.....  ................+...................................+.+
T Consensus       190 i~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (330)
T cd07834         190 IWSVGCIFAELLTRKPLFPGRDY--IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAID  267 (330)
T ss_pred             HHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHH
Confidence            99999999999999999864321  1101111111110000000000000000000000000000000011123456788


Q ss_pred             HhhccCCCCccCCCCHHHHHHH--HHHhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHE--LQSIKN  369 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~--L~~i~~  369 (382)
                      ++.+||+.+|++|||+.++++.  ++++..
T Consensus       268 li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         268 LLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             HHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            9999999999999999999974  665544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.2e-30  Score=240.26  Aligned_cols=145  Identities=20%  Similarity=0.175  Sum_probs=120.2

Q ss_pred             HHHHHHHHHhhc---ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNI---RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+..|..++...   +||||+++++++.     .....++||||+++|+|.+++.          ....+++..+..++.
T Consensus        39 ~~~~e~~~l~~~~~~~~p~i~~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~~~~  103 (330)
T cd05586          39 HTIGERNILVRTLLDESPFIVGLKFSFQ-----TDSDLYLVTDYMSGGELFWHLQ----------KEGRFSEDRAKFYIA  103 (330)
T ss_pred             HHHHHHHHHHHhccCCCCcCcceEEEEe-----cCCeEEEEEcCCCCChHHHHHH----------hcCCCCHHHHHHHHH
Confidence            345566777665   6999999998854     4678999999999999988883          334688999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCC-CCCccchh
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGN-EVSTIGDV  262 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~-~~~~~~Dv  262 (382)
                      ||++||+|||   +.+|+||||||+|||++.++.+||+|||+++....            ....||...+. .++.++||
T Consensus       104 qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv  180 (330)
T cd05586         104 ELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF  180 (330)
T ss_pred             HHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccce
Confidence            9999999999   77999999999999999999999999999875321            12336655443 47899999


Q ss_pred             HHHHHHHHHHHhcCCCCCc
Q 040999          263 YSYGILLLELMIREKPSDI  281 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~  281 (382)
                      |||||++|||+||+.||..
T Consensus       181 wslGvil~elltG~~Pf~~  199 (330)
T cd05586         181 WSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             eccccEEEEeccCCCCCCC
Confidence            9999999999999999863

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.96  E-value=3e-29  Score=230.15  Aligned_cols=148  Identities=24%  Similarity=0.283  Sum_probs=128.7

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++||||+++++++.     .....++||||+++++|.+++.          ....+++..+..++.
T Consensus        44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~  108 (290)
T cd05580          44 QVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNLYLVMEYVPGGELFSHLR----------KSGRFPEPVARFYAA  108 (290)
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeEEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHH
Confidence            3467889999999999999999999854     3678999999999999999883          235688999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccCCCCCccchhHHHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      |+++||.|||   +.+++|+||+|+||+++.++.+||+|||+++.....         ...||...+...+.++||||||
T Consensus       109 qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  185 (290)
T cd05580         109 QVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALG  185 (290)
T ss_pred             HHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHH
Confidence            9999999999   789999999999999999999999999999865332         2346666666778899999999


Q ss_pred             HHHHHHHhcCCCCCc
Q 040999          267 ILLLELMIREKPSDI  281 (382)
Q Consensus       267 vil~elltg~~p~~~  281 (382)
                      +++|+|++|+.||..
T Consensus       186 ~il~~l~~g~~p~~~  200 (290)
T cd05580         186 ILIYEMLAGYPPFFD  200 (290)
T ss_pred             HHHHHHHhCCCCCCC
Confidence            999999999999863

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=2.5e-29  Score=229.65  Aligned_cols=203  Identities=19%  Similarity=0.187  Sum_probs=150.7

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .++..|+.+++++ +|+||+++++++..... ......+++|||+++|+|.+++...        ....+++..+..++.
T Consensus        57 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~  128 (282)
T cd06636          57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--------KGNALKEDWIAYICR  128 (282)
T ss_pred             HHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--------cCCCCCHHHHHHHHH
Confidence            5678899999998 69999999999754211 2356789999999999999988431        223477888899999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCcccc-----CCCCCc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGV-----GNEVST  258 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~-----~~~~~~  258 (382)
                      |++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....            ....||...     ...++.
T Consensus       129 qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~  205 (282)
T cd06636         129 EILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDY  205 (282)
T ss_pred             HHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCc
Confidence            9999999999   77999999999999999999999999999875421            123355433     345788


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ++|||||||++|||++|+.||.....    .......      .........                     .......
T Consensus       206 ~~DvwslG~~l~el~~g~~p~~~~~~----~~~~~~~------~~~~~~~~~---------------------~~~~~~~  254 (282)
T cd06636         206 RSDIWSLGITAIEMAEGAPPLCDMHP----MRALFLI------PRNPPPKLK---------------------SKKWSKK  254 (282)
T ss_pred             ccchhHHHHHHHHHHhCCCCccccCH----HhhhhhH------hhCCCCCCc---------------------ccccCHH
Confidence            99999999999999999999853211    1111000      000000000                     0023346


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+++.+||+.||.+|||+.|+++
T Consensus       255 ~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         255 FIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HHHHHHHHhCCChhhCcCHHHHhc
Confidence            788888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=3.2e-29  Score=228.75  Aligned_cols=187  Identities=18%  Similarity=0.182  Sum_probs=140.2

Q ss_pred             hcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcC
Q 040999          129 NIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDC  208 (382)
Q Consensus       129 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~  208 (382)
                      ..+|+||+.+++++..     .+..++||||+++|+|.+++.          ....+++..+..++.|++.||+|||   
T Consensus        53 ~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~----------~~~~l~~~~~~~i~~qi~~al~~lH---  114 (279)
T cd05633          53 TGDCPFIVCMTYAFHT-----PDKLCFILDLMNGGDLHYHLS----------QHGVFSEKEMRFYATEIILGLEHMH---  114 (279)
T ss_pred             hCCCCcEeEEEEEEec-----CCeEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence            3479999999888543     668899999999999998883          2346899999999999999999999   


Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCcccc-CCCCCccchhHHHHHHHHHHHhcCC
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGV-GNEVSTIGDVYSYGILLLELMIREK  277 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~-~~~~~~~~Dv~S~Gvil~elltg~~  277 (382)
                      +.+|+||||||+||+++.++.+||+|||++.....          ....||... +..++.++|||||||++|||++|+.
T Consensus       115 ~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~  194 (279)
T cd05633         115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHS  194 (279)
T ss_pred             HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence            77999999999999999999999999999864422          123366544 3557889999999999999999999


Q ss_pred             CCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCC--
Q 040999          278 PSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRM--  355 (382)
Q Consensus       278 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP--  355 (382)
                      ||........  ..........      ...+.                      .....++.+++.+||+.||++||  
T Consensus       195 pf~~~~~~~~--~~~~~~~~~~------~~~~~----------------------~~~~~~~~~li~~~l~~~p~~R~~~  244 (279)
T cd05633         195 PFRQHKTKDK--HEIDRMTLTV------NVELP----------------------DSFSPELKSLLEGLLQRDVSKRLGC  244 (279)
T ss_pred             CcCCCCCcCH--HHHHHHhhcC------CcCCc----------------------cccCHHHHHHHHHHhcCCHHHhcCC
Confidence            9864322111  1111100000      00000                      02234677788899999999999  


Q ss_pred             ---CHHHHHHH
Q 040999          356 ---KMTNVVHE  363 (382)
Q Consensus       356 ---s~~evl~~  363 (382)
                         |++++++.
T Consensus       245 ~~~~~~~~~~h  255 (279)
T cd05633         245 LGRGAQEVKEH  255 (279)
T ss_pred             CCCCHHHHHhC
Confidence               59998874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=241.50  Aligned_cols=160  Identities=27%  Similarity=0.321  Sum_probs=130.4

Q ss_pred             chhhH---------HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCC
Q 040999          113 AFKIF---------KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP  182 (382)
Q Consensus       113 avK~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  182 (382)
                      |||.+         +...+|+++|++++|+|||+++++-.+.. +.......+|||||.+|||+..|...       ++.
T Consensus        42 AvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P-------EN~  114 (732)
T KOG4250|consen   42 AVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP-------ENA  114 (732)
T ss_pred             hHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCc-------ccc
Confidence            77766         67899999999999999999998832210 11134568999999999999999642       355


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeC--CCC--cEEEccccccccCCCCCC-----------C
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD--DDM--TARVGDFGLARFLPPTRT-----------Q  247 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~--~~~--~~kl~Dfg~a~~~~~~~~-----------~  247 (382)
                      ..+++...+.+..+++.||.|||   +.+|+||||||.||++-  .+|  .-||+|||.|+-+++...           +
T Consensus       115 ~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLh  191 (732)
T KOG4250|consen  115 YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLH  191 (732)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcC
Confidence            67999999999999999999999   78999999999999983  334  479999999998876542           2


Q ss_pred             Ccccc-CCCCCccchhHHHHHHHHHHHhcCCCCCcc
Q 040999          248 TKYGV-GNEVSTIGDVYSYGILLLELMIREKPSDIM  282 (382)
Q Consensus       248 ~~~~~-~~~~~~~~Dv~S~Gvil~elltg~~p~~~~  282 (382)
                      |+... ...|+..+|.|||||++||.+||..||...
T Consensus       192 Pel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  192 PELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             hHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            44444 367888999999999999999999999753

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=5.3e-29  Score=222.80  Aligned_cols=200  Identities=23%  Similarity=0.302  Sum_probs=155.0

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++.+++++|+|++++++++..     ....++++||+++++|.+++..         ....+++..+..++.
T Consensus        40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~  105 (253)
T cd05122          40 KKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIVMEFCSGGSLKDLLKS---------TNQTLTESQIAYVCK  105 (253)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEEEecCCCCcHHHHHhh---------cCCCCCHHHHHHHHH
Confidence            44678999999999999999999998653     5778999999999999998842         225689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-----------CCCccccCCCCCccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-----------TQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+++||.|||   ..+++|+||+|+||+++.++.++|+|||.+.......           ..||...+...+.++||||
T Consensus       106 ~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s  182 (253)
T cd05122         106 ELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWS  182 (253)
T ss_pred             HHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHH
Confidence            9999999999   7899999999999999999999999999997765432           3366666666789999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|+|++|+.||....    ......... .........     .                    ......+.+++.
T Consensus       183 lG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~~~~~~-----~--------------------~~~~~~~~~~i~  232 (253)
T cd05122         183 LGITAIELAEGKPPYSELP----PMKALFKIA-TNGPPGLRN-----P--------------------EKWSDEFKDFLK  232 (253)
T ss_pred             HHHHHHHHHhCCCCCCCCc----hHHHHHHHH-hcCCCCcCc-----c--------------------cccCHHHHHHHH
Confidence            9999999999999976321    011100000 000000000     0                    011346788888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.+|++|||+.|+++
T Consensus       233 ~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHccCChhhCCCHHHHhc
Confidence            999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-29  Score=227.41  Aligned_cols=224  Identities=22%  Similarity=0.316  Sum_probs=166.3

Q ss_pred             chhhH-----HHHHHHHHHHhhc--ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-----KSFIAECKALRNI--RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |||++     +++.+|.++.+..  ||+||+.|++.-... -..-...|||.+|-+.|||++||.           ...+
T Consensus       238 AVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQLwLvTdYHe~GSL~DyL~-----------r~tv  305 (513)
T KOG2052|consen  238 AVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQLWLVTDYHEHGSLYDYLN-----------RNTV  305 (513)
T ss_pred             EEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEEEEEeeecccCCcHHHHHh-----------hccC
Confidence            99999     7899999999874  999999999874321 122345799999999999999994           2568


Q ss_pred             CHHHHHHHHHHHHHHHhHHhh-----cCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCC--------------
Q 040999          186 NLLRRLNIAIDVASALNYLHH-----DCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRT--------------  246 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~-----~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~--------------  246 (382)
                      +....++++..+|.||++||.     ..++.|.|||||+.|||+.+++.+.|+|+|+|-.......              
T Consensus       306 ~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKR  385 (513)
T KOG2052|consen  306 TTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKR  385 (513)
T ss_pred             CHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceee
Confidence            999999999999999999996     3578999999999999999999999999999975443321              


Q ss_pred             --CCccccCC------CCCccchhHHHHHHHHHHHhc----------CCCCCccccCCchHHHHHHHhcCCchhhhhhcc
Q 040999          247 --QTKYGVGN------EVSTIGDVYSYGILLLELMIR----------EKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSI  308 (382)
Q Consensus       247 --~~~~~~~~------~~~~~~Dv~S~Gvil~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (382)
                        +||.....      +.-..+||||||.|+||+.-+          +.||.+....+..+.++.+..--...+..+...
T Consensus       386 YMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr  465 (513)
T KOG2052|consen  386 YMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR  465 (513)
T ss_pred             ccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcc
Confidence              13322110      012358999999999999854          467766655555554443322111111111111


Q ss_pred             cccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          309 LLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      .                     ...+++..+.+++..||..+|.-|-|+=.+.+.|.++.+
T Consensus       466 W---------------------~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  466 W---------------------KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             c---------------------ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            1                     112677889999999999999999999999999988875

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.96  E-value=2.2e-29  Score=238.81  Aligned_cols=145  Identities=18%  Similarity=0.222  Sum_probs=122.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++.     +....++||||+++|+|.+++..           ..++...+..++.||
T Consensus        88 ~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~~~~~lv~Ey~~gg~L~~~~~~-----------~~~~~~~~~~~~~qi  151 (371)
T cd05622          88 AFFWEERDIMAFANSPWVVQLFYAFQ-----DDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEV  151 (371)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEE-----cCCEEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHH
Confidence            34778999999999999999998854     46789999999999999998832           247888889999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccC----CCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVG----NEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~----~~~~~~~  260 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....             ..+||...+    ..++.++
T Consensus       152 ~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~  228 (371)
T cd05622         152 VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC  228 (371)
T ss_pred             HHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCcc
Confidence            99999999   789999999999999999999999999999765321             223555433    2378899


Q ss_pred             hhHHHHHHHHHHHhcCCCCCc
Q 040999          261 DVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~  281 (382)
                      |||||||++|||++|+.||..
T Consensus       229 DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         229 DWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             ceeehhHHHHHHHhCCCCCCC
Confidence            999999999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=2.6e-29  Score=229.55  Aligned_cols=199  Identities=18%  Similarity=0.259  Sum_probs=144.5

Q ss_pred             HHHHHHHH-HhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECKA-LRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++..|+.. ++..+|+||+++++++..     ....+++|||++ |+|.+++....      .....+++..++.++.|+
T Consensus        45 ~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~~~~qi  112 (283)
T cd06617          45 RLLMDLDISMRSVDCPYTVTFYGALFR-----EGDVWICMEVMD-TSLDKFYKKVY------DKGLTIPEDILGKIAVSI  112 (283)
T ss_pred             HHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcEEEEhhhhc-ccHHHHHHHhc------cCCCCCCHHHHHHHHHHH
Confidence            45556665 556689999999999653     667899999996 67877774322      123568999999999999


Q ss_pred             HHHHhHHhhcCCC-ceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccC----CCCCccch
Q 040999          198 ASALNYLHHDCQP-VTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVG----NEVSTIGD  261 (382)
Q Consensus       198 ~~~L~~lH~~~~~-~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~----~~~~~~~D  261 (382)
                      +.||+|||   +. +++||||||+||+++.++.+||+|||.+......           ...||...+    ..++.++|
T Consensus       113 ~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~D  189 (283)
T cd06617         113 VKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSD  189 (283)
T ss_pred             HHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCcccc
Confidence            99999999   54 8999999999999999999999999998754321           223554432    34578999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      +|||||++|||++|+.||......   .....         ..........+.                  .....++.+
T Consensus       190 i~slG~~l~~l~~g~~p~~~~~~~---~~~~~---------~~~~~~~~~~~~------------------~~~~~~l~~  239 (283)
T cd06617         190 VWSLGITMIELATGRFPYDSWKTP---FQQLK---------QVVEEPSPQLPA------------------EKFSPEFQD  239 (283)
T ss_pred             chhhHHHHHHHHhCCCCCCccccC---HHHHH---------HHHhcCCCCCCc------------------cccCHHHHH
Confidence            999999999999999998632111   11110         000000000000                  012346788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.+|++||++.++++
T Consensus       240 li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         240 FVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            888999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=4e-29  Score=234.34  Aligned_cols=226  Identities=19%  Similarity=0.253  Sum_probs=150.7

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ..+.+|+.+++++ +|+||++++++|..   .+....++||||++ ++|..++..           ..+++..+..++.|
T Consensus        51 ~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~q  115 (337)
T cd07852          51 QRTFREIMFLQELGDHPNIVKLLNVIKA---ENDKDIYLVFEYME-TDLHAVIRA-----------NILEDVHKRYIMYQ  115 (337)
T ss_pred             hhhhHHHHHHHHhcCCCCccceeeeecc---CCCceEEEEecccc-cCHHHHHhc-----------CCCCHHHHHHHHHH
Confidence            4577899999999 99999999998643   23456899999997 588887731           25788899999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------------CCCCcccc-CCCCCc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------------RTQTKYGV-GNEVST  258 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------------~~~~~~~~-~~~~~~  258 (382)
                      ++.||+|||   +.+|+||||||+||+++.++.+||+|||.++.....                 ...||... ...++.
T Consensus       116 i~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  192 (337)
T cd07852         116 LLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTK  192 (337)
T ss_pred             HHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccc
Confidence            999999999   779999999999999999999999999999755332                 12255433 245678


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ++||||||+++|||+||+.||...... .............. .+.+.................................
T Consensus       193 ~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (337)
T cd07852         193 GVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEKIIEVIGPPS-AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDD  270 (337)
T ss_pred             cchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC-HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHH
Confidence            999999999999999999998632111 11111111110000 0000000000000000000000000000111123457


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +.+++.+||+.+|++|||+.++++.
T Consensus       271 l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         271 ALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhccCCcccccCHHHHhhC
Confidence            8889999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=5.7e-29  Score=230.90  Aligned_cols=153  Identities=20%  Similarity=0.324  Sum_probs=123.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   ......++||||+++ ++.+++.....     .....++...+..++.|+
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~i~~qi  117 (316)
T cd07842          47 QSACREIALLRELKHENVVSLVEVFLE---HADKSVYLLFDYAEH-DLWQIIKFHRQ-----AKRVSIPPSMVKSLLWQI  117 (316)
T ss_pred             HHHHHHHHHHHhcCCCCccceEEEEeC---CCCceEEEEEeCCCc-CHHHHHHhhcc-----CCCcCcCHHHHHHHHHHH
Confidence            567889999999999999999999754   223779999999975 66666532211     122368899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCC----CCcEEEccccccccCCCC---------------CCCCccccC-CCCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDD----DMTARVGDFGLARFLPPT---------------RTQTKYGVG-NEVS  257 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~----~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~-~~~~  257 (382)
                      +.||.|||   +.+|+||||||+||+++.    ++.+||+|||+++.....               ..+||...+ ..++
T Consensus       118 ~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  194 (316)
T cd07842         118 LNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYT  194 (316)
T ss_pred             HHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCC
Confidence            99999999   779999999999999999    899999999998865321               233555444 3578


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCcc
Q 040999          258 TIGDVYSYGILLLELMIREKPSDIM  282 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~~  282 (382)
                      .++|||||||++|||++|+.||...
T Consensus       195 ~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         195 KAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             cHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            8999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7e-30  Score=236.65  Aligned_cols=197  Identities=20%  Similarity=0.249  Sum_probs=145.2

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ..|..|++.|.++ .|.+||++++|-..     ++++|+||||= .-+|.++|....         ...+-..+..+..|
T Consensus       404 ~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~~lYmvmE~G-d~DL~kiL~k~~---------~~~~~~~lk~ywkq  468 (677)
T KOG0596|consen  404 DGYRNEIALLNKLKGHDKIIQLYDYEVT-----DGYLYMVMECG-DIDLNKILKKKK---------SIDPDWFLKFYWKQ  468 (677)
T ss_pred             HHHHHHHHHHHHhcCCceEEEEeeeecc-----CceEEEEeecc-cccHHHHHHhcc---------CCCchHHHHHHHHH
Confidence            6799999999999 49999999999554     88999999965 558999995322         22332277889999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCC--------------CccccC---------
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ--------------TKYGVG---------  253 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--------------~~~~~~---------  253 (382)
                      ++.++.++|   ..+|||.||||.|+|+ -.|.+||+|||+|..+.+..+.              ||....         
T Consensus       469 ML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~  544 (677)
T KOG0596|consen  469 MLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGK  544 (677)
T ss_pred             HHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCC
Confidence            999999999   7799999999999998 4578999999999877654332              443321         


Q ss_pred             --CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          254 --NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       254 --~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                        ..+++++||||+|||||+|+.|+.||.....      .|.      ++..+.++...-....                
T Consensus       545 ~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~a------Kl~aI~~P~~~Iefp~----------------  596 (677)
T KOG0596|consen  545 SKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIA------KLHAITDPNHEIEFPD----------------  596 (677)
T ss_pred             cceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHH------HHHhhcCCCccccccC----------------
Confidence              2467899999999999999999999864210      111      1222222211100000                


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                       .....++++++..||++||++|||..++++
T Consensus       597 -~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  597 -IPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -CCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence             001123788899999999999999999985

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=6.1e-29  Score=227.26  Aligned_cols=223  Identities=18%  Similarity=0.209  Sum_probs=153.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+|++++++++...   ..+..++|+||+++ +|.+++..         ....+++..++.++.|+
T Consensus        43 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~i~~~i  109 (287)
T cd07840          43 ITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYMVFEYMDH-DLTGLLDS---------PEVKFTESQIKCYMKQL  109 (287)
T ss_pred             HHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEEEeccccc-cHHHHHhc---------cCCCCCHHHHHHHHHHH
Confidence            4688999999999999999999997541   13789999999975 88877732         22468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-------------CCCccccC-CCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-------------TQTKYGVG-NEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~~-~~~~~~~Dv~  263 (382)
                      ++||+|||   ..+++|+||||+||++++++.+||+|||.+.......             ..||...+ ..++.++|||
T Consensus       110 ~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~  186 (287)
T cd07840         110 LEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMW  186 (287)
T ss_pred             HHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHH
Confidence            99999999   6799999999999999999999999999998654331             23554433 3568899999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC---chhhhhhcccccchhhhhhccccchhhhhhhhHHH-HHHHH
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN---HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE-CVISM  339 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  339 (382)
                      |||+++|||+||+.||+.... ..............   ......+.     ...................... +...+
T Consensus       187 slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (287)
T cd07840         187 SVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKL-----PWFENLKPKKPYKRRLREFFKHLIDPSA  260 (287)
T ss_pred             HHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccc-----hhhhhccccccchhHHHHHhcccCCHHH
Confidence            999999999999999864221 11111111111000   00000000     0000000000000000011112 25678


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+++.+||+.+|++||+++++++
T Consensus       261 ~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         261 LDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             HHHHHHHcCCChhhCcCHHHHhh
Confidence            99999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=6.7e-29  Score=223.09  Aligned_cols=201  Identities=17%  Similarity=0.235  Sum_probs=155.1

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++|+||+++++.+...   .....++|+||+++++|.+++.          ....+++..+..++.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~  108 (260)
T cd06606          42 ELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLNIFLEYVSGGSLSSLLK----------KFGKLPEPVIRKYTR  108 (260)
T ss_pred             HHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEEEEEEecCCCcHHHHHH----------HcCCCCHHHHHHHHH
Confidence            346789999999999999999999986531   1277899999999999999984          223789999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC--------------CCCccccCCCCCccch
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR--------------TQTKYGVGNEVSTIGD  261 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~--------------~~~~~~~~~~~~~~~D  261 (382)
                      |+++||.|||   +.+++|+||+|+||+++.++.+||+|||.+.......              ..||...+...+.++|
T Consensus       109 ~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~D  185 (260)
T cd06606         109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD  185 (260)
T ss_pred             HHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhh
Confidence            9999999999   6799999999999999999999999999988665432              2256655666889999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||+++|+|++|..||....   .................         .                  .......+.+
T Consensus       186 v~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~---------~------------------~~~~~~~l~~  235 (260)
T cd06606         186 IWSLGCTVIEMATGKPPWSELG---NPMAALYKIGSSGEPPE---------I------------------PEHLSEEAKD  235 (260)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCC---chHHHHHhccccCCCcC---------C------------------CcccCHHHHH
Confidence            9999999999999999986432   11111100000000000         0                  0022346788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+|++.+|.+||++.|+++
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhh
Confidence            888999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=4.3e-29  Score=227.89  Aligned_cols=222  Identities=21%  Similarity=0.240  Sum_probs=154.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++.     .....++|+||+++ ++.+++..         ....+++..+..++.|+
T Consensus        43 ~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~~-~l~~~l~~---------~~~~~~~~~~~~~~~~i  107 (283)
T cd05118          43 KTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYLVFEFMDT-DLYKLIKD---------RQRGLPESLIKSYLYQL  107 (283)
T ss_pred             HHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEEEEeccCC-CHHHHHHh---------hcccCCHHHHHHHHHHH
Confidence            56888999999999999999999854     36789999999975 88877732         23568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC------------CCCccccCC-CCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR------------TQTKYGVGN-EVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~-~~~~~~Dv~S  264 (382)
                      ++||.|||   ..+++|+||||+||+++.++.+||+|||.+.......            ..||...+. ..+.++||||
T Consensus       108 ~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~s  184 (283)
T cd05118         108 LQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWS  184 (283)
T ss_pred             HHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHH
Confidence            99999999   7799999999999999999999999999987654322            235555444 6788999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHH--HhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAK--MALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||+++|+|+||+.||....    ....+..  ........+.......... ...................+....+.++
T Consensus       185 lG~~l~~l~tg~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (283)
T cd05118         185 VGCIFAELLSRRPLFPGKS----EIDQLFKIFRTLGTPDPEVWPKFTSLAR-NYKFSFPKKAGMPLPKLFPNASPQALDL  259 (283)
T ss_pred             HHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCchHhcccchhhhh-hhhhhhccccccCHHHhhhhhCHHHHHH
Confidence            9999999999999975321    1111111  1110000000000000000 0000000000000111122456678899


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||.+||++.+++.
T Consensus       260 i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         260 LSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             HHHHhccCcccCcCHHHHhh
Confidence            99999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=4.5e-29  Score=226.31  Aligned_cols=185  Identities=18%  Similarity=0.223  Sum_probs=143.4

Q ss_pred             ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCC
Q 040999          131 RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQP  210 (382)
Q Consensus       131 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~  210 (382)
                      +|+||+++++.+..     .+..++||||+++++|.+++.          ....+++..+..++.|+++||.|||   +.
T Consensus        67 ~h~~iv~~~~~~~~-----~~~~~iv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi~~~l~~lH---~~  128 (267)
T PHA03390         67 DNPNFIKLYYSVTT-----LKGHVLIMDYIKDGDLFDLLK----------KEGKLSEAEVKKIIRQLVEALNDLH---KH  128 (267)
T ss_pred             cCCCEEEEEEEEec-----CCeeEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence            69999999999653     668999999999999999983          2237899999999999999999999   77


Q ss_pred             ceeecCCCCCceeeCCCC-cEEEccccccccCCCC--------CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          211 VTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPPT--------RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       211 ~ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~~--------~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      +++||||||+||+++.++ .++|+|||+++.....        ..+||...+..++.++||||||+++|||++|+.||..
T Consensus       129 ~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  208 (267)
T PHA03390        129 NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE  208 (267)
T ss_pred             CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            999999999999999998 9999999998765432        2347777777889999999999999999999999874


Q ss_pred             cccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCC-HHHH
Q 040999          282 MFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMK-MTNV  360 (382)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-~~ev  360 (382)
                      ..........+.... .... ..                           .......+.+++.+||+.+|.+||+ ++++
T Consensus       209 ~~~~~~~~~~~~~~~-~~~~-~~---------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  259 (267)
T PHA03390        209 DEDEELDLESLLKRQ-QKKL-PF---------------------------IKNVSKNANDFVQSMLKYNINYRLTNYNEI  259 (267)
T ss_pred             CCcchhhHHHHHHhh-cccC-Cc---------------------------ccccCHHHHHHHHHHhccChhhCCchHHHH
Confidence            333222222222111 0000 00                           0022345777888999999999996 6888


Q ss_pred             HH
Q 040999          361 VH  362 (382)
Q Consensus       361 l~  362 (382)
                      ++
T Consensus       260 l~  261 (267)
T PHA03390        260 IK  261 (267)
T ss_pred             hc
Confidence            74

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=9e-30  Score=229.82  Aligned_cols=199  Identities=19%  Similarity=0.226  Sum_probs=151.2

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++|+||+++++.+.     .....++++||+++++|.+++.          ....+++..+..++.|
T Consensus        37 ~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~q  101 (265)
T cd05579          37 VDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYLPGGDLASLLE----------NVGSLDEDVARIYIAE  101 (265)
T ss_pred             HHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            467889999999999999999988743     4778899999999999999884          2236899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------------CCCCccccCCCC
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------------RTQTKYGVGNEV  256 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------------~~~~~~~~~~~~  256 (382)
                      +++||+|||   +.+++|+||+|+||+++.++.+||+|||++......                    ...||.......
T Consensus       102 i~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~  178 (265)
T cd05579         102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH  178 (265)
T ss_pred             HHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCC
Confidence            999999999   779999999999999999999999999998754322                    123555555667


Q ss_pred             CccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          257 STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      +.++||||||+++||+++|+.||....     .........        ..... .+ .           .     ....
T Consensus       179 ~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~--------~~~~~-~~-~-----------~-----~~~~  227 (265)
T cd05579         179 SKTVDWWSLGCILYEFLVGIPPFHGET-----PEEIFQNIL--------NGKIE-WP-E-----------D-----VEVS  227 (265)
T ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHh--------cCCcC-CC-c-----------c-----ccCC
Confidence            889999999999999999999986321     111111100        00000 00 0           0     0113


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHHHH
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                      ..+.+++.+||+.+|++|||+.++.+.|
T Consensus       228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         228 DEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             HHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            4678888899999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=6.4e-29  Score=226.76  Aligned_cols=222  Identities=15%  Similarity=0.191  Sum_probs=149.3

Q ss_pred             HHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          120 FIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       120 ~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      ..+|+.++.++. |+||+++++++..   ...+..++|+||++ |++.+++..         ....+++..+..++.|++
T Consensus        44 ~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~lv~e~~~-~~l~~~l~~---------~~~~~~~~~~~~~~~qi~  110 (282)
T cd07831          44 NLREIQALRRLSPHPNILRLIEVLFD---RKTGRLALVFELMD-MNLYELIKG---------RKRPLPEKRVKSYMYQLL  110 (282)
T ss_pred             HHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEEEEecCC-ccHHHHHHh---------ccCCCCHHHHHHHHHHHH
Confidence            457888999885 9999999999754   12367899999996 578777732         234689999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccc-cCCCCCccchhHHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYG-VGNEVSTIGDVYSYG  266 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~-~~~~~~~~~Dv~S~G  266 (382)
                      .||.|||   ..+++||||||+||+++. +.+||+|||.++.....           ...||.. .+..++.++||||||
T Consensus       111 ~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  186 (282)
T cd07831         111 KSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVG  186 (282)
T ss_pred             HHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHH
Confidence            9999999   779999999999999999 99999999999765322           2236643 335568899999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||....  .................++...........  .....................+.+++.+|
T Consensus       187 v~l~el~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~  262 (282)
T cd07831         187 CVFFEILSLFPLFPGTN--ELDQIAKIHDVLGTPDAEVLKKFRKSRHMN--YNFPSKKGTGLRKLLPNASAEGLDLLKKL  262 (282)
T ss_pred             HHHHHHHcCCcCCCCCC--HHHHHHHHHHHcCCCCHHHHHhhccccccc--ccCcccccccHHHHcccccHHHHHHHHHH
Confidence            99999999999986421  111111111111111111100000000000  00000000000001113456789999999


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      |+.+|++||+++++++
T Consensus       263 l~~~P~~R~~~~~~l~  278 (282)
T cd07831         263 LAYDPDERITAKQALR  278 (282)
T ss_pred             hccCcccccCHHHHhh
Confidence            9999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=7e-29  Score=228.13  Aligned_cols=229  Identities=16%  Similarity=0.173  Sum_probs=152.3

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++++++ |+||+++++++......+....++||||+++ +|.+++.....     .....+++..+..++.|
T Consensus        45 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~~q  118 (295)
T cd07837          45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGR-----GPGRPLPAKTIKSFMYQ  118 (295)
T ss_pred             hHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcc-----cCCCCCCHHHHHHHHHH
Confidence            46788999999995 6999999998765322233457999999985 78888753221     11346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCCC------------CCCCccccC-CCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv  262 (382)
                      |++||.|||   +.+++||||||+||+++. ++.+||+|||.++.....            ...||...+ ..++.++||
T Consensus       119 i~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  195 (295)
T cd07837         119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDI  195 (295)
T ss_pred             HHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHH
Confidence            999999999   779999999999999998 889999999998754321            233665443 456889999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHh--cCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--LPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||+++|||++|..||...    ..........  ................. . ...... .+.............+.
T Consensus       196 ~slG~~l~~l~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~-~~~~~~~~~~~~~~~~~  268 (295)
T cd07837         196 WSVGCIFAEMSRKQPLFPGD----SELQQLLHIFKLLGTPTEQVWPGVSKLRD-W-HEFPQW-KPQDLSRAVPDLSPEGL  268 (295)
T ss_pred             HHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHHHhCCCChhhCcchhhccc-h-hhcCcc-cchhHHHhccccCHHHH
Confidence            99999999999999997632    1222111110  00000000000000000 0 000000 00000001112345678


Q ss_pred             HHhhccCCCCccCCCCHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +++.+||+.+|.+||+++|++.
T Consensus       269 ~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         269 DLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHHHHccCChhhcCCHHHHhc
Confidence            8999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.1e-31  Score=264.01  Aligned_cols=147  Identities=24%  Similarity=0.327  Sum_probs=124.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++..++|||+|++||+-.+     .+..+|.||||.+|+|.+.+.          ..+..++.....+..|+
T Consensus      1279 ~~i~eEm~vlE~lnHpNlV~YyGVEvH-----Rekv~IFMEyC~~GsLa~ll~----------~gri~dE~vt~vyt~ql 1343 (1509)
T KOG4645|consen 1279 KLIAEEMKVLEGLNHPNLVRYYGVEVH-----REKVYIFMEYCEGGSLASLLE----------HGRIEDEMVTRVYTKQL 1343 (1509)
T ss_pred             cchHHHHHHHHhccCccccccCceeec-----HHHHHHHHHHhccCcHHHHHH----------hcchhhhhHHHHHHHHH
Confidence            678899999999999999999999544     667899999999999999983          44556777777889999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccCCC---CCc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVGNE---VST  258 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~~~---~~~  258 (382)
                      +.|++|||   +.+||||||||.||+++.+|.+|++|||.|..+...                ..+||..++..   -..
T Consensus      1344 l~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~ 1420 (1509)
T KOG4645|consen 1344 LEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGG 1420 (1509)
T ss_pred             HHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCc
Confidence            99999999   789999999999999999999999999999866433                23366655433   345


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCcc
Q 040999          259 IGDVYSYGILLLELMIREKPSDIM  282 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~  282 (382)
                      ++||||+|||++||+||+.||...
T Consensus      1421 A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1421 AADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred             chhhhcccceEEEeecCCCchhhc
Confidence            789999999999999999998753

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=6.4e-29  Score=230.04  Aligned_cols=200  Identities=25%  Similarity=0.296  Sum_probs=150.1

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+++.+|+++++.++|+|++++++++..     ....++||||+. |++.+++..         ....+++..+..++.
T Consensus        58 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~---------~~~~l~~~~~~~~~~  122 (308)
T cd06634          58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTAWLVMEYCL-GSASDLLEV---------HKKPLQEVEIAAVTH  122 (308)
T ss_pred             HHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCeeEEEEEccC-CCHHHHHHH---------cCCCCCHHHHHHHHH
Confidence            34678899999999999999999999754     677899999996 677776631         234578899999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------CCCCcccc---CCCCCccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------RTQTKYGV---GNEVSTIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~---~~~~~~~~Dv~S  264 (382)
                      |++.||.|||   ..+++||||||+||+++.++.+||+|||++......        ...||...   ...++.++||||
T Consensus       123 ~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~s  199 (308)
T cd06634         123 GALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWS  199 (308)
T ss_pred             HHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccccCCccccCHHHHhhcccCCCCcccchHH
Confidence            9999999999   779999999999999999999999999998765432        23355532   345788999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||..... ......+.....+.         .   .                  .......+.+++.
T Consensus       200 lG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~---------~---~------------------~~~~~~~~~~li~  248 (308)
T cd06634         200 LGITCIELAERKPPLFNMNA-MSALYHIAQNESPA---------L---Q------------------SGHWSEYFRNFVD  248 (308)
T ss_pred             HHHHHHHHHcCCCCCccccH-HHHHHHHhhcCCCC---------c---C------------------cccccHHHHHHHH
Confidence            99999999999999753211 00011111000000         0   0                  0023345778888


Q ss_pred             ccCCCCccCCCCHHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~L  364 (382)
                      +||+.+|++||++.++++.-
T Consensus       249 ~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         249 SCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             HHhhCCcccCCCHHHHhhCc
Confidence            99999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=7.8e-29  Score=229.31  Aligned_cols=150  Identities=21%  Similarity=0.336  Sum_probs=121.3

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeeccc---CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDY---QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+|++++++++||||++++++|.....   ......++||||+.+ +|.+++.         .....+++..+..++.
T Consensus        57 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~i~~  126 (310)
T cd07865          57 TALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS---------NKNVKFTLSEIKKVMK  126 (310)
T ss_pred             HHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHH---------hcccCCCHHHHHHHHH
Confidence            46789999999999999999999865321   123456999999964 7777763         2234689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccCC-CCCc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVGN-EVST  258 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~~-~~~~  258 (382)
                      |++.||.|||   +.+++|+||||+||+++.++.+||+|||.+......                ...||...+. .++.
T Consensus       127 qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  203 (310)
T cd07865         127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGP  203 (310)
T ss_pred             HHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCc
Confidence            9999999999   679999999999999999999999999998754221                2336654443 3678


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCc
Q 040999          259 IGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      ++||||||+++|||+||+.||..
T Consensus       204 ~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         204 PIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             hhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=3.6e-29  Score=228.65  Aligned_cols=223  Identities=20%  Similarity=0.239  Sum_probs=151.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|+|++++++++..     .+..+++|||++ ++|.+++...        ....+++..+..++.|+
T Consensus        43 ~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~iv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~~i  108 (283)
T cd07835          43 STAIREISLLKELNHPNIVRLLDVVHS-----ENKLYLVFEFLD-LDLKKYMDSS--------PLTGLDPPLIKSYLYQL  108 (283)
T ss_pred             hHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEEEEeccC-cCHHHHHhhC--------CCCCCCHHHHHHHHHHH
Confidence            468889999999999999999999643     678999999995 6898888421        11368999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+++||||+|+||+++.++.+||+|||++......            ...||...+ ..++.++||||
T Consensus       109 ~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s  185 (283)
T cd07835         109 LQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWS  185 (283)
T ss_pred             HHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHH
Confidence            99999999   779999999999999999999999999998754311            234665544 34688999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccc-cchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILL-NDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||+||+.||..... .............. .......... .+..........   .............+.+++
T Consensus       186 lG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li  260 (283)
T cd07835         186 IGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGTP-DEDVWPGVTSLPDYKPTFPKWAR---QDLSKVVPNLDEDGLDLL  260 (283)
T ss_pred             HHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCC-ChHHhhhhhhchhhhhhcccccc---cchhhhcCCCCHHHHHHH
Confidence            99999999999999853211 00111111110000 0000000000 000000000000   000000012234678899


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+|++.+|++|||++|+++
T Consensus       261 ~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         261 SKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             HHHhcCChhhCcCHHHHhc
Confidence            9999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=8.2e-29  Score=231.26  Aligned_cols=225  Identities=20%  Similarity=0.255  Sum_probs=151.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..    .....++++||+ +++|.+++.           ...+++.....++.|+
T Consensus        54 ~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~~lv~e~~-~~~L~~~~~-----------~~~~~~~~~~~~~~ql  117 (328)
T cd07856          54 KRTYRELKLLKHLRHENIISLSDIFIS----PLEDIYFVTELL-GTDLHRLLT-----------SRPLEKQFIQYFLYQI  117 (328)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEeeeEec----CCCcEEEEeehh-ccCHHHHHh-----------cCCCCHHHHHHHHHHH
Confidence            568899999999999999999998643    245688999998 568887773           2347788888999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccC-CCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVG-NEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~-~~~~~~~Dv~S~Gv  267 (382)
                      ++||+|||   ..+++||||||+||+++.++.+||+|||.+......         ...||...+ ..++.++|||||||
T Consensus       118 ~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  194 (328)
T cd07856         118 LRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGC  194 (328)
T ss_pred             HHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHH
Confidence            99999999   779999999999999999999999999998754332         233665443 56789999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ++|||+||+.||.....  ................++.+........+.........+.............+.+++.+|+
T Consensus       195 il~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  272 (328)
T cd07856         195 IFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML  272 (328)
T ss_pred             HHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHc
Confidence            99999999999864211  0111111111111111111111100000000000000000000011123457888899999


Q ss_pred             CCCccCCCCHHHHHHH
Q 040999          348 MESPQDRMKMTNVVHE  363 (382)
Q Consensus       348 ~~~p~~RPs~~evl~~  363 (382)
                      +.+|++|||+.+++..
T Consensus       273 ~~~P~~R~t~~ell~~  288 (328)
T cd07856         273 VFDPQKRISAAEALAH  288 (328)
T ss_pred             CCChhhCCCHHHHhcC
Confidence            9999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=1.1e-28  Score=225.62  Aligned_cols=222  Identities=16%  Similarity=0.199  Sum_probs=151.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++..     .+..++||||+++ +|.+++....       ....+++..+..++.|+
T Consensus        43 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~-~l~~~~~~~~-------~~~~~~~~~~~~~~~qi  109 (284)
T cd07836          43 STAIREISLMKELKHENIVRLHDVIHT-----ENKLMLVFEYMDK-DLKKYMDTHG-------VRGALDPNTVKSFTYQL  109 (284)
T ss_pred             HHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEEEEecCCc-cHHHHHHhcC-------CCCCcCHHHHHHHHHHH
Confidence            467789999999999999999999654     6778999999985 7888774321       12458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+++||||||+||+++.++.+||+|||.+......            ...||...+ ..++.++||||
T Consensus       110 ~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~s  186 (284)
T cd07836         110 LKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWS  186 (284)
T ss_pred             HHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHH
Confidence            99999999   779999999999999999999999999998754221            233554433 35688999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC---chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN---HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||++|||++|+.||...... .............   ....+...   ....   .....................+.+
T Consensus       187 lG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  259 (284)
T cd07836         187 VGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQL---PEYK---PTFPRYPPQDLQQLFPHADPLGID  259 (284)
T ss_pred             HHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcC---chhc---ccccCCChHHHHHHhhhcCcHHHH
Confidence            999999999999998643211 1111111111000   01111000   0000   000000000000111123456788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+|++.+|.+||++.++++
T Consensus       260 ~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         260 LLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHHHhcCCcccCCCHHHHhc
Confidence            889999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=6.7e-29  Score=228.12  Aligned_cols=196  Identities=19%  Similarity=0.274  Sum_probs=150.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.+++.++|+||+++++++..     .+..++||||+++++|.+++.           ...+++.....++.|+
T Consensus        62 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~ql  125 (292)
T cd06657          62 ELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIAAVCLAV  125 (292)
T ss_pred             HHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEEecCCCCcHHHHHh-----------cCCCCHHHHHHHHHHH
Confidence            568899999999999999999998653     678999999999999988773           2347889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+++|+||+|+||+++.++.++|+|||.+......            ...||...+..++.++|||||
T Consensus       126 ~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  202 (292)
T cd06657         126 LKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL  202 (292)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHH
Confidence            99999999   779999999999999999999999999987654321            234666556677899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|||++|+.||....  ............+......                            ......+.+++.+
T Consensus       203 Gvil~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~l~~li~~  252 (292)
T cd06657         203 GIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPKLKNL----------------------------HKVSPSLKGFLDR  252 (292)
T ss_pred             HHHHHHHHhCCCCCCCCC--HHHHHHHHHhhCCcccCCc----------------------------ccCCHHHHHHHHH
Confidence            999999999999975311  1111111111111100000                            0122356677889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.+|.+||++.++++
T Consensus       253 ~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         253 LLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHhCCcccCcCHHHHhc
Confidence            99999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=9.2e-29  Score=231.39  Aligned_cols=228  Identities=18%  Similarity=0.182  Sum_probs=149.5

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++++++ +|+||+++++.+... .......++++||+. ++|.+++.          ....+++..+..++.|
T Consensus        46 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~~~~~~~e~~~-~~L~~~l~----------~~~~~~~~~~~~~~~q  113 (332)
T cd07857          46 KRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFNELYLYEELME-ADLHQIIR----------SGQPLTDAHFQSFIYQ  113 (332)
T ss_pred             HHHHHHHHHHHHhcCCCChheeeeeeeec-cccCCcEEEEEeccc-CCHHHHHh----------cCCCCCHHHHHHHHHH
Confidence            5678899999999 599999999875431 123456788999885 68888873          2346889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccC-CCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVG-NEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~-~~~~~~  259 (382)
                      ++.||.|||   ..+++||||||+||+++.++.+||+|||.++.....                ...||...+ ..++.+
T Consensus       114 i~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~  190 (332)
T cd07857         114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKA  190 (332)
T ss_pred             HHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcH
Confidence            999999999   779999999999999999999999999999754321                223564433 457889


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +||||+||++|+|++|+.||..... ...+...... ......+...................................+
T Consensus       191 ~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (332)
T cd07857         191 IDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQV-LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLA  268 (332)
T ss_pred             HHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHH-hCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHH
Confidence            9999999999999999999864211 0011111111 0000011111100000000000000000000000001123467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+++.+|++.+|++|||+.|++.
T Consensus       269 ~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         269 LDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHHHccCCcccCCCHHHHhc
Confidence            88899999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=2.2e-29  Score=230.74  Aligned_cols=206  Identities=21%  Similarity=0.216  Sum_probs=147.2

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ..+.+|+.++.++. |+||+++++++..     +...+++|||+.. ++.++.....     ......+++..+..++.+
T Consensus        47 ~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~~~~e~~~~-~l~~l~~~~~-----~~~~~~l~~~~~~~i~~~  115 (288)
T cd06616          47 KRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCWICMELMDI-SLDKFYKYVY-----EVLKSVIPEEILGKIAVA  115 (288)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEEEEEecccC-CHHHHHHHHH-----HhhcCCCCHHHHHHHHHH
Confidence            56889999999996 9999999998643     5678899999864 5544331100     012356899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCC---CCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGN---EVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~---~~~~~~Dv  262 (382)
                      ++.||+|||+  ..+++||||||+||+++.++.+||+|||+++....           ....||...+.   .++.++||
T Consensus       116 i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di  193 (288)
T cd06616         116 TVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDV  193 (288)
T ss_pred             HHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhh
Confidence            9999999994  34899999999999999999999999999865422           12336655444   67899999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||++|+.||....    ..............     +.+....                  .......+.++
T Consensus       194 ~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~-----~~~~~~~------------------~~~~~~~l~~l  246 (288)
T cd06616         194 WSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDP-----PILSNSE------------------EREFSPSFVNF  246 (288)
T ss_pred             hHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCC-----CcCCCcC------------------CCccCHHHHHH
Confidence            999999999999999986321    11111111100000     0000000                  01234467888


Q ss_pred             hhccCCCCccCCCCHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +.+||+.+|++|||+++|++.
T Consensus       247 i~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         247 INLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HHHHccCChhhCcCHHHHhcC
Confidence            899999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=4e-29  Score=224.65  Aligned_cols=200  Identities=19%  Similarity=0.220  Sum_probs=155.1

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ..++.+|++++++++|+||+++++++..     ....++|+||+++++|.+++....      .....+++..+..++.|
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~~  111 (256)
T cd08530          43 REDAVNEIRILASVNHPNIISYKEAFLD-----GNKLCIVMEYAPFGDLSKAISKRK------KKRKLIPEQEIWRIFIQ  111 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEEEEehhcCCCCHHHHHHHHH------hhcCCCCHHHHHHHHHH
Confidence            3567889999999999999999988543     578999999999999999885321      12356889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------CCCCccccCCCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------RTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      +++||+|||   +.+++|+||+|+||+++.++.+||+|||++......          ...||...+..++.++|+||||
T Consensus       112 l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG  188 (256)
T cd08530         112 LLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLG  188 (256)
T ss_pred             HHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHH
Confidence            999999999   789999999999999999999999999998765432          2235666667788899999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      +++|||++|+.||....     ............        .. .                  .......++.+++.+|
T Consensus       189 ~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~--------~~-~------------------~~~~~~~~~~~li~~~  236 (256)
T cd08530         189 CLLYEMATFAPPFEARS-----MQDLRYKVQRGK--------YP-P------------------IPPIYSQDLQNFIRSM  236 (256)
T ss_pred             HHHHHHHhCCCCCCCCC-----HHHHHHHHhcCC--------CC-C------------------CchhhCHHHHHHHHHH
Confidence            99999999999986421     111111000000        00 0                  0012345678888999


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      ++.+|++||++.++++
T Consensus       237 l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         237 LQVKPKLRPNCDKILA  252 (256)
T ss_pred             cCCCcccCCCHHHHhc
Confidence            9999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=1.9e-28  Score=224.07  Aligned_cols=226  Identities=18%  Similarity=0.216  Sum_probs=153.4

Q ss_pred             HHHHHHHHHhhc---ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNI---RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+|+++++++   +|+||+++++++...........+++|||+.+ +|.+++...        ....+++..+..++.
T Consensus        44 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~--------~~~~l~~~~~~~~~~  114 (287)
T cd07838          44 STLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC--------PKPGLPPETIKDLMR  114 (287)
T ss_pred             hHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHc--------cCCCCCHHHHHHHHH
Confidence            466777777666   59999999999876433333458999999974 788877421        123589999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+++||+|||   +.+++|+||+|+||+++.++.+||+|||.+......           ...||...+..++.++||||
T Consensus       115 ~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s  191 (287)
T cd07838         115 QLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWS  191 (287)
T ss_pred             HHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhh
Confidence            9999999999   779999999999999999999999999998765322           23477777777899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||.... ....+..+.................  ....   ...............+....+.+++.
T Consensus       192 ~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~  265 (287)
T cd07838         192 VGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPRNVS--LPRS---SFPSYTPRSFKSFVPEICEEGLDLLK  265 (287)
T ss_pred             HHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHhcCCCcc--cchh---hcccccccchhhhhhhhhHHHHHHHH
Confidence            9999999999999976421 1111222221111100000000000  0000   00000000111111234466788999


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||++||++.|+++
T Consensus       266 ~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         266 KMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HHhccCCccCCCHHHHhc
Confidence            999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.1e-28  Score=232.95  Aligned_cols=148  Identities=22%  Similarity=0.252  Sum_probs=123.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++++++|+||+++++++.... ..+....++||||+. ++|.+.+.            ..++...+..++.|
T Consensus        60 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------------~~l~~~~~~~~~~q  126 (353)
T cd07850          60 KRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ------------MDLDHERMSYLLYQ  126 (353)
T ss_pred             HHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHh------------hcCCHHHHHHHHHH
Confidence            46778999999999999999999865321 123346799999995 47777662            12788889999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++.||+|||   ..+++||||||+||+++.++.+||+|||+++.....           ...||...+..++.++|||||
T Consensus       127 l~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  203 (353)
T cd07850         127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  203 (353)
T ss_pred             HHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhH
Confidence            999999999   779999999999999999999999999999865332           234676677788999999999


Q ss_pred             HHHHHHHHhcCCCCCc
Q 040999          266 GILLLELMIREKPSDI  281 (382)
Q Consensus       266 Gvil~elltg~~p~~~  281 (382)
                      ||++|+|++|+.||..
T Consensus       204 G~~l~~l~~g~~pf~~  219 (353)
T cd07850         204 GCIMGEMIRGTVLFPG  219 (353)
T ss_pred             HHHHHHHHHCCCCCCC
Confidence            9999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.2e-29  Score=224.27  Aligned_cols=199  Identities=18%  Similarity=0.169  Sum_probs=146.5

Q ss_pred             HHHHHHHHH-hhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECKAL-RNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+..|..++ ...+|+||+++++++.     ..+..++|+||+++++|.+++.          ....+++..+..++.|+
T Consensus        42 ~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi  106 (260)
T cd05611          42 NVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVMEYLNGGDCASLIK----------TLGGLPEDWAKQYIAEV  106 (260)
T ss_pred             HHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEEeccCCCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            344555444 3458999999999964     3678999999999999999883          23458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------CCCCCccccCCCCCccchhHHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------TRTQTKYGVGNEVSTIGDVYSYGILL  269 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------~~~~~~~~~~~~~~~~~Dv~S~Gvil  269 (382)
                      ++||.|||   +.+++|+||+|+||+++.++.+||+|||+++....        ....||...+..++.++||||||+++
T Consensus       107 ~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il  183 (260)
T cd05611         107 VLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVI  183 (260)
T ss_pred             HHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcCccChhhhcCCCCcchhhhHHHHHHH
Confidence            99999999   77999999999999999999999999999875432        23347766666789999999999999


Q ss_pred             HHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCC
Q 040999          270 LELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSME  349 (382)
Q Consensus       270 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~  349 (382)
                      |||+||..||.....     ..........        ......                .....+...+.+++.+||+.
T Consensus       184 ~~l~~g~~p~~~~~~-----~~~~~~~~~~--------~~~~~~----------------~~~~~~~~~~~~~i~~~l~~  234 (260)
T cd05611         184 FEFLFGYPPFHAETP-----DAVFDNILSR--------RINWPE----------------EVKEFCSPEAVDLINRLLCM  234 (260)
T ss_pred             HHHHHCCCCCCCCCH-----HHHHHHHHhc--------ccCCCC----------------cccccCCHHHHHHHHHHccC
Confidence            999999999863211     1111100000        000000                00002344678888899999


Q ss_pred             CccCCCCHHHHHHHH
Q 040999          350 SPQDRMKMTNVVHEL  364 (382)
Q Consensus       350 ~p~~RPs~~evl~~L  364 (382)
                      +|++||++.++.+.|
T Consensus       235 ~p~~R~~~~~~~~~l  249 (260)
T cd05611         235 DPAKRLGANGYQEIK  249 (260)
T ss_pred             CHHHccCCCcHHHHH
Confidence            999999876665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=237.77  Aligned_cols=197  Identities=19%  Similarity=0.169  Sum_probs=151.7

Q ss_pred             chhhH----HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCH
Q 040999          113 AFKIF----KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNL  187 (382)
Q Consensus       113 avK~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~  187 (382)
                      |+|++    .+-.+|+.++... +||||+++.+.+     .+..+.|+|||++.++-+.+.+..          .+... 
T Consensus       351 ~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v~e~l~g~ell~ri~~----------~~~~~-  414 (612)
T KOG0603|consen  351 AVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLVMELLDGGELLRRIRS----------KPEFC-  414 (612)
T ss_pred             hheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeeeehhccccHHHHHHHh----------cchhH-
Confidence            77777    2367788777776 699999999995     458899999999999877666621          12222 


Q ss_pred             HHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceee-CCCCcEEEccccccccCCCC---------CCCCccccCCCCC
Q 040999          188 LRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL-DDDMTARVGDFGLARFLPPT---------RTQTKYGVGNEVS  257 (382)
Q Consensus       188 ~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl-~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~~~~~  257 (382)
                      ..+..|+.+|+.|+.|||   ++++||||+||+|||+ +..++++|+|||.++.....         ..+||......++
T Consensus       415 ~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt  491 (612)
T KOG0603|consen  415 SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYT  491 (612)
T ss_pred             HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccchhhcccChhhhccCCCC
Confidence            677789999999999999   7899999999999999 68899999999999877654         3348888888999


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          258 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      +++||||||++||+|++|+.||.....+    .+...........                              .....
T Consensus       492 ~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~~s------------------------------~~vS~  537 (612)
T KOG0603|consen  492 EACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPKFS------------------------------ECVSD  537 (612)
T ss_pred             cchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCccc------------------------------cccCH
Confidence            9999999999999999999998754332    1111111111111                              02223


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHH
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ...+|+..||+.||.+||+|.++..
T Consensus       538 ~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  538 EAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHHHHHHhccCChhhCcChhhhcc
Confidence            4566777999999999999999875

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=1e-28  Score=228.72  Aligned_cols=226  Identities=21%  Similarity=0.199  Sum_probs=150.2

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|++++++++|+||+++++++..   ...+..++||||+. ++|.+++..         ....+++..+..++.|++
T Consensus        52 ~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~-~~l~~~l~~---------~~~~l~~~~~~~~~~qi~  118 (309)
T cd07845          52 SSLREITLLLNLRHPNIVELKEVVVG---KHLDSIFLVMEYCE-QDLASLLDN---------MPTPFSESQVKCLMLQLL  118 (309)
T ss_pred             hhhHHHHHHHhCCCCCCcceEEEEec---CCCCeEEEEEecCC-CCHHHHHHh---------cccCCCHHHHHHHHHHHH
Confidence            45689999999999999999998653   22356899999996 478877742         225689999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYSY  265 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S~  265 (382)
                      +||+|||   +.+++||||||+||+++.++.+||+|||.+......            ...||...+ ..++.++||||+
T Consensus       119 ~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  195 (309)
T cd07845         119 RGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAV  195 (309)
T ss_pred             HHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHH
Confidence            9999999   779999999999999999999999999999765432            233565443 457889999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||.....  .............................. .....................+.+++.+
T Consensus       196 G~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~  272 (309)
T cd07845         196 GCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWPGFSDLPLVGK-FTLPKQPYNNLKHKFPWLSEAGLRLLNF  272 (309)
T ss_pred             HHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhchhhhccccccc-ccccCCCCCchHHhccccCHHHHHHHHH
Confidence            9999999999999863211  111111111111000000000000000000 0000000000000001124456788889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      |++.||++|||++|+++.
T Consensus       273 ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         273 LLMYDPKKRATAEEALES  290 (309)
T ss_pred             HhcCChhhCcCHHHHhcC
Confidence            999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.1e-29  Score=231.65  Aligned_cols=147  Identities=22%  Similarity=0.198  Sum_probs=123.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++..++|+||+++++++.     ..+..++||||+++|+|.+++..         ....+++..+..++.||
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~~~~qi  111 (331)
T cd05597          46 ACFREERDVLVNGDRRWITNLHYAFQ-----DENNLYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEM  111 (331)
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEe-----cCCeEEEEEecCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHH
Confidence            45788999999999999999999854     47789999999999999999842         23458889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCcccc-----CCCCCcc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGV-----GNEVSTI  259 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~-----~~~~~~~  259 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||++......             ...||...     ...++.+
T Consensus       112 ~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  188 (331)
T cd05597         112 VLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPE  188 (331)
T ss_pred             HHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCc
Confidence            99999999   789999999999999999999999999998654321             22355443     2356789


Q ss_pred             chhHHHHHHHHHHHhcCCCCCc
Q 040999          260 GDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      +|||||||++|||++|+.||..
T Consensus       189 ~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         189 CDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ceeehhhhHHHHHhhCCCCCCC
Confidence            9999999999999999999863

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=1.4e-28  Score=224.48  Aligned_cols=190  Identities=17%  Similarity=0.163  Sum_probs=141.9

Q ss_pred             HHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHH
Q 040999          125 KALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYL  204 (382)
Q Consensus       125 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~l  204 (382)
                      +.++...||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|+++||.||
T Consensus        49 ~~~~~~~~~~i~~~~~~~~-----~~~~~~~v~e~~~g~~L~~~l~----------~~~~l~~~~~~~~~~ql~~~l~~l  113 (278)
T cd05606          49 SLVSTGDCPFIVCMSYAFH-----TPDKLSFILDLMNGGDLHYHLS----------QHGVFSEAEMRFYAAEIILGLEHM  113 (278)
T ss_pred             HHHHhCCCCcEeeeeeeee-----cCCEEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHHHH
Confidence            3444457999999988854     4678999999999999988873          234689999999999999999999


Q ss_pred             hhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCccccC-CCCCccchhHHHHHHHHHHH
Q 040999          205 HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGVG-NEVSTIGDVYSYGILLLELM  273 (382)
Q Consensus       205 H~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~-~~~~~~~Dv~S~Gvil~ell  273 (382)
                      |   +.+++||||||+||+++.++.+||+|||++.....          ....||...+ ..++.++||||+||++|||+
T Consensus       114 H---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~  190 (278)
T cd05606         114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL  190 (278)
T ss_pred             H---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHH
Confidence            9   77999999999999999999999999999875432          1223666543 35789999999999999999


Q ss_pred             hcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccC
Q 040999          274 IREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQD  353 (382)
Q Consensus       274 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~  353 (382)
                      +|+.||........  .........      ....+.                      ......+.+++.+|+..+|.+
T Consensus       191 ~g~~p~~~~~~~~~--~~~~~~~~~------~~~~~~----------------------~~~s~~~~~li~~~l~~~p~~  240 (278)
T cd05606         191 RGHSPFRQHKTKDK--HEIDRMTLT------MAVELP----------------------DSFSPELRSLLEGLLQRDVNR  240 (278)
T ss_pred             hCCCCCCCCCccch--HHHHHHhhc------cCCCCC----------------------CcCCHHHHHHHHHHhhcCHHh
Confidence            99999864321111  110000000      000000                      012346778888999999999


Q ss_pred             CC-----CHHHHHH
Q 040999          354 RM-----KMTNVVH  362 (382)
Q Consensus       354 RP-----s~~evl~  362 (382)
                      ||     ++.++++
T Consensus       241 R~~~~~~~~~~ll~  254 (278)
T cd05606         241 RLGCLGRGAQEVKE  254 (278)
T ss_pred             ccCCCCCCHHHHHh
Confidence            99     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-28  Score=230.22  Aligned_cols=198  Identities=22%  Similarity=0.257  Sum_probs=155.5

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++|+++. |||||++++++     ++....++|||+|.+|.|.+.+..         .  .+++..+..++.|
T Consensus        80 ~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~~~~~lvmEL~~GGeLfd~i~~---------~--~~sE~da~~~~~~  143 (382)
T KOG0032|consen   80 EDVRREVAILQQLSGHPNIVQLKDAF-----EDPDSVYLVMELCEGGELFDRIVK---------K--HYSERDAAGIIRQ  143 (382)
T ss_pred             HHHHHHHHHHHhccCCCCEEEEEEEE-----EcCCeEEEEEEecCCchHHHHHHH---------c--cCCHHHHHHHHHH
Confidence            47899999999998 99999999994     457899999999999999999942         1  3899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCC----CcEEEccccccccCCCC-----------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDD----MTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~----~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~D  261 (382)
                      ++.++.|||   ..+|+|||+||+|+|+...    +.+|++|||+|......           ..+||......|+..+|
T Consensus       144 il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~D  220 (382)
T KOG0032|consen  144 ILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVD  220 (382)
T ss_pred             HHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccc
Confidence            999999999   7899999999999999543    47999999999877652           23377777788999999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||+||++|.|++|..||.....    ...+......+ . ++     ...                  .+........+
T Consensus       221 iWS~Gvi~yiLL~G~~PF~~~~~----~~~~~~i~~~~-~-~f-----~~~------------------~w~~is~~akd  271 (382)
T KOG0032|consen  221 VWSIGVILYILLSGVPPFWGETE----FEIFLAILRGD-F-DF-----TSE------------------PWDDISESAKD  271 (382)
T ss_pred             hhHHHHHHHHHhhCCCCCcCCCh----hHHHHHHHcCC-C-CC-----CCC------------------CccccCHHHHH
Confidence            99999999999999999864321    11111110000 0 00     000                  01133446677


Q ss_pred             HhhccCCCCccCCCCHHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ++..|+..||.+|+|+.++++.
T Consensus       272 ~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  272 FIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHHHhcccCcccCCCHHHHhcC
Confidence            7889999999999999999984

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=1.4e-28  Score=221.07  Aligned_cols=199  Identities=20%  Similarity=0.299  Sum_probs=154.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|+|++++++.+..     ....++|+||+++++|.+++....      .....+++..+..++.++
T Consensus        44 ~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i  112 (258)
T cd08215          44 EDALNEVKILKKLNHPNIIKYYESFEE-----KGKLCIVMEYADGGDLSQKIKKQK------KEGKPFPEEQILDWFVQL  112 (258)
T ss_pred             HHHHHHHHHHHhcCCCChhheEEEEec-----CCEEEEEEEecCCCcHHHHHHHhh------ccCCCcCHHHHHHHHHHH
Confidence            568899999999999999999998543     578899999999999999885322      123678999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+++|+||+|+||+++.++.++|+|||.+......            ...||...+..++.++||||+
T Consensus       113 ~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  189 (258)
T cd08215         113 CLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSL  189 (258)
T ss_pred             HHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHH
Confidence            99999999   779999999999999999999999999998765433            233666566678899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++++|++|+.||+...     ............        ....+                   ......+.+++.+
T Consensus       190 G~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~--------~~~~~-------------------~~~~~~~~~~i~~  237 (258)
T cd08215         190 GCVLYELCTLKHPFEGEN-----LLELALKILKGQ--------YPPIP-------------------SQYSSELRNLVSS  237 (258)
T ss_pred             HHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC--------CCCCC-------------------CCCCHHHHHHHHH
Confidence            999999999999986321     111111111100        00000                   0123467788889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||..+|++|||+.++++
T Consensus       238 ~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         238 LLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HcCCChhhCcCHHHHhc
Confidence            99999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=9.9e-30  Score=239.11  Aligned_cols=194  Identities=19%  Similarity=0.274  Sum_probs=150.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|+.++|||||+++.+.     +.+..+|+||||+.+|.+++++.          .........+..++.|+
T Consensus       100 ~k~~rev~imk~l~HPnIvkl~~v~-----~t~~~lylV~eya~~ge~~~yl~----------~~gr~~e~~ar~~F~q~  164 (596)
T KOG0586|consen  100 QKLGREVDIMKSLNHPNIVKLFSVI-----ETEATLYLVMEYASGGELFDYLV----------KHGRMKEKEARAKFRQI  164 (596)
T ss_pred             HHHHHHHHHHHhcCCcceeeeeeee-----eecceeEEEEEeccCchhHHHHH----------hcccchhhhhhhhhHHH
Confidence            5589999999999999999999994     45889999999999999999994          33445557888999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-----------CCCccccCCCC-CccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-----------TQTKYGVGNEV-STIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~~~~~-~~~~Dv~S~  265 (382)
                      .+|++|||   ++.|+|||||++|||++.++++||+|||++..+....           ..||...+..+ ++++|+||+
T Consensus       165 vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wsl  241 (596)
T KOG0586|consen  165 VSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSL  241 (596)
T ss_pred             HHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhh
Confidence            99999999   8899999999999999999999999999998775432           23666666544 689999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|-|+.|..||+...-                 +++-++.+....         +-+.       -...++-+++.+
T Consensus       242 gvvly~LV~GsLPFDG~~l-----------------k~Lr~rvl~gk~---------rIp~-------~ms~dce~lLrk  288 (596)
T KOG0586|consen  242 GVVLYALVEGSLPFDGQNL-----------------KELRPRVLRGKY---------RIPF-------YMSCDCEDLLRK  288 (596)
T ss_pred             hhhheeeeecccccCCccc-----------------ccccchheeeee---------cccc-------eeechhHHHHHH
Confidence            9999999999999984211                 111111111000         0000       112245667778


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      .+-.+|.+|++++++.+
T Consensus       289 ~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  289 FLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             hhccCccccCCHHHhhh
Confidence            88999999999998864

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=1.4e-28  Score=226.89  Aligned_cols=226  Identities=19%  Similarity=0.212  Sum_probs=150.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-----cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-----YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLN  192 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~  192 (382)
                      ..+.+|++++++++||||+++++++....     ..+....++|+||+++ ++.+++.         .....+++..+..
T Consensus        51 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~  120 (302)
T cd07864          51 ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLE---------SGLVHFSEDHIKS  120 (302)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHh---------cCCCCCCHHHHHH
Confidence            45778999999999999999999875421     1123478999999976 6666663         2234689999999


Q ss_pred             HHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccC-CCCCc
Q 040999          193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVG-NEVST  258 (382)
Q Consensus       193 i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~-~~~~~  258 (382)
                      ++.|++.||+|||   +.+|+|+||||+||++++++.+||+|||.+......             ...||...+ ..++.
T Consensus       121 i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  197 (302)
T cd07864         121 FMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGP  197 (302)
T ss_pred             HHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCc
Confidence            9999999999999   779999999999999999999999999999765322             223554433 34688


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcC---CchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALP---NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      ++|||||||++|||++|+.||.... ....+.........   ....++.........     +................
T Consensus       198 ~~Di~slG~~~~el~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  271 (302)
T cd07864         198 AIDVWSCGCILGELFTKKPIFQANQ-ELAQLELISRLCGSPCPAVWPDVIKLPYFNTM-----KPKKQYRRRLREEFSFI  271 (302)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhccccccccccccc-----ccccccccchhhhcCCC
Confidence            9999999999999999999986321 11111111111100   001111000000000     00000000000000122


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +..+.+++.+||+.+|.+||++++++.
T Consensus       272 ~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         272 PTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=2.9e-28  Score=226.19  Aligned_cols=199  Identities=25%  Similarity=0.293  Sum_probs=149.4

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|+++++.++|+|++++++++..     ....++||||+. |++.+++.         .....+++..+..++.
T Consensus        64 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~---------~~~~~l~~~~~~~~~~  128 (313)
T cd06633          64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAITH  128 (313)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEEEecCC-CCHHHHHH---------hcCCCCCHHHHHHHHH
Confidence            34678899999999999999999999654     677899999995 57777663         2234588999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------CCCCcccc---CCCCCccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------RTQTKYGV---GNEVSTIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~---~~~~~~~~Dv~S  264 (382)
                      |++.||.|||   +.+++|+||||+||+++.++.+||+|||.+......        ...||...   ...++.++||||
T Consensus       129 qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s  205 (313)
T cd06633         129 GALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  205 (313)
T ss_pred             HHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccccccccChhhccccCCCCCCchhhHHH
Confidence            9999999999   779999999999999999999999999998754322        23466642   356788999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|..||....    .......... .....     .   ..                  ......+.+++.
T Consensus       206 lGvil~el~~g~~p~~~~~----~~~~~~~~~~-~~~~~-----~---~~------------------~~~~~~l~~li~  254 (313)
T cd06633         206 LGITCIELAERKPPLFNMN----AMSALYHIAQ-NDSPT-----L---QS------------------NEWTDSFRGFVD  254 (313)
T ss_pred             HHHHHHHHHhCCCCCCCCC----hHHHHHHHHh-cCCCC-----C---Cc------------------cccCHHHHHHHH
Confidence            9999999999999975421    1111111000 00000     0   00                  012235677888


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.+|.+||++.+++..
T Consensus       255 ~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         255 YCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHccCChhhCcCHHHHhcC
Confidence            9999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.4e-28  Score=219.17  Aligned_cols=197  Identities=20%  Similarity=0.274  Sum_probs=153.7

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++|+|++++++++..     ....++++||+++++|.+++.          ....+++..+..++.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~  106 (254)
T cd06627          42 ALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLYIILEYAENGSLRQIIK----------KFGPFPESLVAVYVY  106 (254)
T ss_pred             HHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEEEEEecCCCCcHHHHHH----------hccCCCHHHHHHHHH
Confidence            34678999999999999999999998643     678899999999999999883          235689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC------------CCCccccCCCCCccchhH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR------------TQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~~~~~~~Dv~  263 (382)
                      |++.||.|||   +.+++||||||+||+++.++.+||+|||.+.......            ..||...+..++.++|||
T Consensus       107 ~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~  183 (254)
T cd06627         107 QVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIW  183 (254)
T ss_pred             HHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHH
Confidence            9999999999   7799999999999999999999999999998654322            236655556678899999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |+|+++|+|++|+.||....    .......... ...     ...   +                   ......+.+++
T Consensus       184 ~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~~-~~~-----~~~---~-------------------~~~~~~~~~~i  231 (254)
T cd06627         184 SLGCTVIELLTGNPPYYDLN----PMAALFRIVQ-DDH-----PPL---P-------------------EGISPELKDFL  231 (254)
T ss_pred             HHHHHHHHHHhCCCCCCCcc----HHHHHHHHhc-cCC-----CCC---C-------------------CCCCHHHHHHH
Confidence            99999999999999976321    1111111100 000     000   0                   01234677888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||..+|++|||+.+++.
T Consensus       232 ~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         232 MQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHHhCChhhCcCHHHHhc
Confidence            8999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=5.1e-29  Score=221.92  Aligned_cols=150  Identities=19%  Similarity=0.154  Sum_probs=125.6

Q ss_pred             chhhH---HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHH
Q 040999          113 AFKIF---KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLR  189 (382)
Q Consensus       113 avK~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~  189 (382)
                      |+|.+   ..+.+|...+....||||+++++++.     ..+..++||||+++|+|.+++..          ...+++..
T Consensus        22 ~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----------~~~l~~~~   86 (237)
T cd05576          22 ILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHISK----------FLNIPEEC   86 (237)
T ss_pred             EEEeecchhhhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHHH----------hcCCCHHH
Confidence            66666   23566766666778999999999854     36789999999999999998832          23589999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------CCCCCccccCCCCCccc
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~~~~~~~~  260 (382)
                      ...++.|+++||.|||   +.+++||||||+||+++.++.++++|||.+.....         ....||...+..++.++
T Consensus        87 ~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  163 (237)
T cd05576          87 VKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEAC  163 (237)
T ss_pred             HHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccCCCCCCchh
Confidence            9999999999999999   78999999999999999999999999998754432         23447776667788999


Q ss_pred             hhHHHHHHHHHHHhcCCCCC
Q 040999          261 DVYSYGILLLELMIREKPSD  280 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~  280 (382)
                      ||||+|+++|||++|+.|++
T Consensus       164 DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         164 DWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             hHHHHHHHHHHHHHCcchhh
Confidence            99999999999999998864

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=8.2e-29  Score=231.70  Aligned_cols=147  Identities=20%  Similarity=0.183  Sum_probs=124.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++..++|+||+++++++.     +.+..++||||+++|+|.+++..         ....+++..+..++.|+
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~---------~~~~l~~~~~~~~~~qi  111 (332)
T cd05623          46 ACFREERDVLVNGDNQWITTLHYAFQ-----DENNLYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYLAEM  111 (332)
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCEEEEEEeccCCCcHHHHHHH---------hcCCCCHHHHHHHHHHH
Confidence            34788999999999999999998854     46789999999999999999942         23458889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCcccc-----CCCCCcc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGV-----GNEVSTI  259 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~-----~~~~~~~  259 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++....             ....||...     ...++.+
T Consensus       112 ~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  188 (332)
T cd05623         112 VIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPE  188 (332)
T ss_pred             HHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCc
Confidence            99999999   78999999999999999999999999999864321             123355543     3457889


Q ss_pred             chhHHHHHHHHHHHhcCCCCCc
Q 040999          260 GDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      +|||||||++|||++|+.||..
T Consensus       189 ~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         189 CDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             CCEEeeHHHHHHHhcCCCCCCC
Confidence            9999999999999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=9.8e-29  Score=226.46  Aligned_cols=203  Identities=18%  Similarity=0.165  Sum_probs=150.8

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++.++ +|+||+++++.+     ......++||||+++|+|.+++.          ....+++.....++.|
T Consensus        49 ~~~~~E~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~q  113 (288)
T cd05583          49 EHTRTERQVLEAVRRCPFLVTLHYAF-----QTDTKLHLILDYVNGGELFTHLY----------QREHFTESEVRVYIAE  113 (288)
T ss_pred             HHHHHHHHHHHhccCCcchhhhheee-----ecCCEEEEEEecCCCCcHHHHHh----------hcCCcCHHHHHHHHHH
Confidence            5688999999999 599999999874     34677899999999999998883          2345888999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCC--CCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNE--VSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~--~~~~~D  261 (382)
                      +++||.|||   ..+++||||||+||+++.++.++|+|||+++.....             ...||...+..  .+.++|
T Consensus       114 l~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D  190 (288)
T cd05583         114 IVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVD  190 (288)
T ss_pred             HHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhh
Confidence            999999999   779999999999999999999999999998754322             12244443333  678999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||+++|||+||..||..... ......+....        .... ...+                   ......+.+
T Consensus       191 v~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~--------~~~~-~~~~-------------------~~~~~~l~~  241 (288)
T cd05583         191 WWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRI--------LKSK-PPFP-------------------KTMSAEARD  241 (288)
T ss_pred             hHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHH--------HccC-CCCC-------------------cccCHHHHH
Confidence            99999999999999999853111 11111111110        0000 0000                   012235677


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      ++.+||+.+|++|||++++.+.|+..
T Consensus       242 li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         242 FIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHHHHhcCCHhhccCcchHHHHhcCc
Confidence            88899999999999998887776554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.9e-29  Score=233.98  Aligned_cols=199  Identities=22%  Similarity=0.301  Sum_probs=155.2

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +++|+-||++|..+.||+||++++.|+.     ++.+|++.|||.||.....+.         .-...+++.++.-++.|
T Consensus        73 LEDylVEIeILa~CdHP~ivkLl~ayy~-----enkLwiliEFC~GGAVDaiml---------EL~r~LtE~QIqvvc~q  138 (1187)
T KOG0579|consen   73 LEDYLVEIEILAECDHPVIVKLLSAYYF-----ENKLWILIEFCGGGAVDAIML---------ELGRVLTEDQIQVVCYQ  138 (1187)
T ss_pred             HhhhhhhhhhhhcCCChHHHHHHHHHhc-----cCceEEEEeecCCchHhHHHH---------HhccccchHHHHHHHHH
Confidence            3789999999999999999999998653     678999999999999988874         34567999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC------------CCCCCCCcccc-----CCCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL------------PPTRTQTKYGV-----GNEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~------------~~~~~~~~~~~-----~~~~~~~  259 (382)
                      ++.||.|||   +++|||||||..|||++-+|.++|+|||.+...            .+.+.+||+..     ...|+.+
T Consensus       139 ~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDyk  215 (1187)
T KOG0579|consen  139 VLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYK  215 (1187)
T ss_pred             HHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhh
Confidence            999999999   889999999999999999999999999998532            34445565543     4678999


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +||||||++|.||..+.+|-...    ..+.-..+..-+             +++.             ..........+
T Consensus       216 aDiWSlGITLIEMAqiEPPHhel----npMRVllKiaKS-------------ePPT-------------LlqPS~Ws~~F  265 (1187)
T KOG0579|consen  216 ADIWSLGITLIEMAQIEPPHHEL----NPMRVLLKIAKS-------------EPPT-------------LLQPSHWSRSF  265 (1187)
T ss_pred             hhHHhhhhHHHHHhccCCCcccc----chHHHHHHHhhc-------------CCCc-------------ccCcchhhhHH
Confidence            99999999999999999995432    111111111111             1100             00111344567


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .++...|+.++|..||++.++++
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhh
Confidence            77777999999999999999875

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.4e-28  Score=220.01  Aligned_cols=199  Identities=16%  Similarity=0.200  Sum_probs=150.0

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++|+||+++++++..   ......++|+||+++++|.+++.          ....+++.....++.
T Consensus        47 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~~~~~~v~e~~~~~~L~~~~~----------~~~~l~~~~~~~~~~  113 (264)
T cd06653          47 EVNALECEIQLLKNLRHDRIVQYYGCLRD---PEEKKLSIFVEYMPGGSIKDQLK----------AYGALTENVTRRYTR  113 (264)
T ss_pred             HHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCCCEEEEEEEeCCCCcHHHHHH----------HcCCCCHHHHHHHHH
Confidence            34678999999999999999999998643   22456789999999999998883          223578889999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------------CCCCCccccCCCCCccc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------------TRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~~~~~~~~~~~  260 (382)
                      |++.||.|||   +.+++|+||||+||+++.++.++|+|||+++....               ....||...+..++.++
T Consensus       114 ~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  190 (264)
T cd06653         114 QILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKA  190 (264)
T ss_pred             HHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccc
Confidence            9999999999   77999999999999999999999999999975421               12336666667788999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||||++|||++|+.||...    ............. ....+.                          ......+.
T Consensus       191 Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~-~~~~~p--------------------------~~~~~~~~  239 (264)
T cd06653         191 DVWSVACTVVEMLTEKPPWAEY----EAMAAIFKIATQP-TKPMLP--------------------------DGVSDACR  239 (264)
T ss_pred             cHHHHHHHHHHHHhCCCCCCcc----CHHHHHHHHHcCC-CCCCCC--------------------------cccCHHHH
Confidence            9999999999999999998632    1111111110000 000000                          02234567


Q ss_pred             HHhhccCCCCccCCCCHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +++.+|++ +|.+||++.+++.
T Consensus       240 ~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         240 DFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHHhc-CcccCccHHHHhc
Confidence            77789999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.4e-28  Score=229.50  Aligned_cols=234  Identities=16%  Similarity=0.177  Sum_probs=152.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++++.++|+||+++++++..... ......++|+||+.. +|..+.            ...+++..+..++.|
T Consensus        59 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------------~~~~~~~~~~~~~~q  125 (342)
T cd07879          59 KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM------------GHPLSEDKVQYLVYQ  125 (342)
T ss_pred             hHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHH------------cCCCCHHHHHHHHHH
Confidence            457899999999999999999998754211 123456899999864 555543            124788999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccC-CCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVG-NEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~-~~~~~~~Dv~S~G  266 (382)
                      ++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....         ...||...+ ..++.++||||||
T Consensus       126 i~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  202 (342)
T cd07879         126 MLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVG  202 (342)
T ss_pred             HHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHH
Confidence            999999999   779999999999999999999999999999765332         234665544 4578899999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||..... ...+..... ........+.+................................+.+++.+|
T Consensus       203 vil~el~~g~~pf~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  280 (342)
T cd07879         203 CIMAEMLTGKTLFKGKDY-LDQLTQILK-VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKM  280 (342)
T ss_pred             HHHHHHHhCCCCCCCCCH-HHHHHHHHH-hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHH
Confidence            999999999999863210 001111111 111111111110000000000000000000000000011234577888999


Q ss_pred             CCCCccCCCCHHHHHHH--HHHhhh
Q 040999          347 SMESPQDRMKMTNVVHE--LQSIKN  369 (382)
Q Consensus       347 l~~~p~~RPs~~evl~~--L~~i~~  369 (382)
                      |+.||++||++.+++..  ++..+.
T Consensus       281 l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         281 LELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cCCChhhCcCHHHHhcCcchhhccc
Confidence            99999999999999954  666654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=2.4e-28  Score=228.89  Aligned_cols=217  Identities=18%  Similarity=0.226  Sum_probs=150.3

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|++++++++|+||+++++++..     .+..++||||+. |+|.+++.          ....+++.....++.|++
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~----------~~~~~~~~~~~~~~~ql~  129 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVE-----GDFINLVMDIMA-SDLKKVVD----------RKIRLTESQVKCILLQIL  129 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEec-----CCcEEEEEeccc-cCHHHHHH----------hcCCCCHHHHHHHHHHHH
Confidence            57899999999999999999999653     678999999996 68888873          234588999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------------------CCCCCcccc
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------------------TRTQTKYGV  252 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------------------~~~~~~~~~  252 (382)
                      .||+|||   +.+++|+||||+||+++.++.+||+|||.+.....                          ....||...
T Consensus       130 ~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  206 (335)
T PTZ00024        130 NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM  206 (335)
T ss_pred             HHHHHHH---hCCeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcc
Confidence            9999999   77999999999999999999999999999876540                          122355544


Q ss_pred             CC-CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC---chhhhhhcccccchhhhhhccccchhhhh
Q 040999          253 GN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN---HVKDIVDSILLNDDEKLVVRGDQKQTQAK  328 (382)
Q Consensus       253 ~~-~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (382)
                      +. .++.++|||||||++|||+||+.||...... ..+..........   ......+-......       ....+...
T Consensus       207 ~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~  278 (335)
T PTZ00024        207 GAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-DQLGRIFELLGTPNEDNWPQAKKLPLYTEF-------TPRKPKDL  278 (335)
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCchhhCcchhhccccccc-------CcCCcccH
Confidence            43 4688999999999999999999998642111 1111111100000   00000000000000       00000000


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          329 INVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       329 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ..........+.+++.+||+.+|++|||+.|++.
T Consensus       279 ~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        279 KTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            0011123456788899999999999999999986

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.96  E-value=8.9e-29  Score=231.37  Aligned_cols=147  Identities=21%  Similarity=0.205  Sum_probs=124.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++..++|+||+++++++.     +.+..++||||+++|+|.+++..         ....+++..+..++.|+
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~~~lv~Ey~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi  111 (331)
T cd05624          46 ACFREERNVLVNGDCQWITTLHYAFQ-----DENYLYLVMDYYVGGDLLTLLSK---------FEDRLPEDMARFYIAEM  111 (331)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCEEEEEEeCCCCCcHHHHHHH---------hcCCCCHHHHHHHHHHH
Confidence            44788999999999999999999854     47889999999999999999942         23458888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccC-----CCCCcc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVG-----NEVSTI  259 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~-----~~~~~~  259 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....             ..+||...+     ..++.+
T Consensus       112 ~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  188 (331)
T cd05624         112 VLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE  188 (331)
T ss_pred             HHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCc
Confidence            99999999   789999999999999999999999999998754321             223554433     457889


Q ss_pred             chhHHHHHHHHHHHhcCCCCCc
Q 040999          260 GDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      +|||||||++|||++|+.||..
T Consensus       189 ~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         189 CDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ccEEeeehhhhhhhhCCCCccC
Confidence            9999999999999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=1.5e-28  Score=225.96  Aligned_cols=204  Identities=19%  Similarity=0.175  Sum_probs=140.8

Q ss_pred             HHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHH
Q 040999          121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASA  200 (382)
Q Consensus       121 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~  200 (382)
                      ..+...+..+.|+||+++++++... .......+++++++.. ++.+.+.          .....++..+..++.|+++|
T Consensus        71 ~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~~i~~qi~~~  138 (294)
T PHA02882         71 IALWKNIHNIDHLGIPKYYGCGSFK-RCRMYYRFILLEKLVE-NTKEIFK----------RIKCKNKKLIKNIMKDMLTT  138 (294)
T ss_pred             HHHHHHhccCCCCCCCcEEEeeeEe-cCCceEEEEEEehhcc-CHHHHHH----------hhccCCHHHHHHHHHHHHHH
Confidence            4455566778999999999875431 1112245677777643 4444442          12235677888999999999


Q ss_pred             HhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------------CCCCCccccCCCCCccch
Q 040999          201 LNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------------TRTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       201 L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------------~~~~~~~~~~~~~~~~~D  261 (382)
                      |+|||   +.+|+||||||+|||++.++.+||+|||+|+....                   ...+|+...+..++.++|
T Consensus       139 l~~lH---~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~D  215 (294)
T PHA02882        139 LEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGD  215 (294)
T ss_pred             HHHHH---hCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHH
Confidence            99999   77999999999999999999999999999975421                   112355556677899999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||++|+.||........ .......       +++........                 ....++..+.+
T Consensus       216 iwSlG~~l~el~~g~~P~~~~~~~~~-~~~~~~~-------~~~~~~~~~~~-----------------~~~~~~~~~~~  270 (294)
T PHA02882        216 LESLGYCMLKWAGIKLPWKGFGHNGN-LIHAAKC-------DFIKRLHEGKI-----------------KIKNANKFIYD  270 (294)
T ss_pred             HHHHHHHHHHHHhCCCCCCccccchH-HHHHhHH-------HHHHHhhhhhh-----------------ccCCCCHHHHH
Confidence            99999999999999999875322111 1111110       11111000000                 00123456788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                      ++..||+.+|++||++.++++.+
T Consensus       271 ~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        271 FIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHhCCCCCCCCHHHHHHhh
Confidence            88899999999999999999876

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=1.3e-28  Score=226.73  Aligned_cols=200  Identities=17%  Similarity=0.176  Sum_probs=144.5

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .++.+|++++.+.. |+||++++++|..     ....+++|||++ +++.+++..         ....+++..+..++.|
T Consensus        58 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v~e~~~-~~l~~l~~~---------~~~~l~~~~~~~i~~~  122 (296)
T cd06618          58 KRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSDVFICMELMS-TCLDKLLKR---------IQGPIPEDILGKMTVA  122 (296)
T ss_pred             HHHHHHHHHHHhccCCCchHhhheeeec-----CCeEEEEeeccC-cCHHHHHHH---------hcCCCCHHHHHHHHHH
Confidence            45677887777775 9999999999754     667899999985 466665521         2346889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCC----CCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGN----EVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~----~~~~~~D  261 (382)
                      +++||+|||+  ..+|+||||+|+||++++++.+||+|||++..+..           ....||...+.    .++.++|
T Consensus       123 i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~D  200 (296)
T cd06618         123 IVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRAD  200 (296)
T ss_pred             HHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchh
Confidence            9999999994  25899999999999999999999999999875432           12335554433    3788999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||+++|||++|+.||......   . +.....        +.......+ .                ......++.+
T Consensus       201 i~slG~il~el~~g~~p~~~~~~~---~-~~~~~~--------~~~~~~~~~-~----------------~~~~~~~l~~  251 (296)
T cd06618         201 VWSLGISLVELATGQFPYKNCKTE---F-EVLTKI--------LQEEPPSLP-P----------------NEGFSPDFCS  251 (296)
T ss_pred             HHHHHHHHHHHHhCCCCCCcchhH---H-HHHHHH--------hcCCCCCCC-C----------------CCCCCHHHHH
Confidence            999999999999999998632111   1 111100        000000000 0                0012346788


Q ss_pred             HhhccCCCCccCCCCHHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ++.+||+.+|++||++.++++.
T Consensus       252 li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         252 FVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHHccCChhhCCCHHHHhcC
Confidence            8889999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.7e-28  Score=230.59  Aligned_cols=228  Identities=17%  Similarity=0.196  Sum_probs=150.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++++++|+||+++++++..... ......++|+||+ +++|.+++.           ...+++..+..++.|
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~~~~q  126 (343)
T cd07851          59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK-----------CQKLSDDHIQFLVYQ  126 (343)
T ss_pred             HHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHH
Confidence            567789999999999999999887543211 1223489999998 668888873           235899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccC-CCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVG-NEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~-~~~~~~~Dv~S~G  266 (382)
                      +++||+|||   +.+|+||||||+||+++.++.+||+|||++......         ...||...+ ..++.++||||||
T Consensus       127 l~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG  203 (343)
T cd07851         127 ILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG  203 (343)
T ss_pred             HHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHH
Confidence            999999999   779999999999999999999999999999865332         123444332 3568899999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||+||+.||..... ...+...... .......+..................................+.+++.+|
T Consensus       204 v~l~elltg~~pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~  281 (343)
T cd07851         204 CIMAELLTGKTLFPGSDH-IDQLKRIMNL-VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKM  281 (343)
T ss_pred             HHHHHHHhCCCCCCCCCh-HHHHHHHHHh-cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHh
Confidence            999999999999863211 0011111110 11011111111100000000000000000000001112245788899999


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      ++.+|++|||+.+|++
T Consensus       282 l~~~P~~Rpt~~ell~  297 (343)
T cd07851         282 LVLDPDKRITAAEALA  297 (343)
T ss_pred             CCCChhhCCCHHHHhc
Confidence            9999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=1.7e-28  Score=221.44  Aligned_cols=198  Identities=17%  Similarity=0.199  Sum_probs=149.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .++.+|+.++++++||||+++++++.     +....++|+||+++++|.+++....      .....+++..++.++.|+
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~l  115 (260)
T cd08222          47 VQANQEAQLLSKLDHPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELK------HTGKTLSENQVCEWFIQL  115 (260)
T ss_pred             HHHHHHHHHHHhCCCCcHHHHHHHHh-----cCCceEEEEEeCCCCCHHHHHHHHh------hcccccCHHHHHHHHHHH
Confidence            35678999999999999999999854     3667899999999999998885321      223568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++||.|||   +.+++|+||||+||+++. +.+||+|||.++.....            ...||...+..++.++|+|||
T Consensus       116 ~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl  191 (260)
T cd08222         116 LLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSL  191 (260)
T ss_pred             HHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHH
Confidence            99999999   779999999999999975 56999999998765321            123555555667889999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|+|++|..||...    .. ...........        .. ..                  ......++.+++.+
T Consensus       192 G~~~~~l~~~~~~~~~~----~~-~~~~~~~~~~~--------~~-~~------------------~~~~~~~~~~li~~  239 (260)
T cd08222         192 GCILYEMCCLAHAFEGQ----NF-LSVVLRIVEGP--------TP-SL------------------PETYSRQLNSIMQS  239 (260)
T ss_pred             HHHHHHHHhCCCCCCCc----cH-HHHHHHHHcCC--------CC-CC------------------cchhcHHHHHHHHH
Confidence            99999999999997531    11 11111100000        00 00                  01234467788889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.+|++||++.|+++
T Consensus       240 ~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         240 MLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HhcCChhhCcCHHHHhh
Confidence            99999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.95  E-value=2.8e-28  Score=224.10  Aligned_cols=147  Identities=22%  Similarity=0.307  Sum_probs=119.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++.     +....++||||++ ++|.+++..        .....+++.....++.||
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~~qi  111 (294)
T PLN00009         46 STAIREISLLKEMQHGNIVRLQDVVH-----SEKRLYLVFEYLD-LDLKKHMDS--------SPDFAKNPRLIKTYLYQI  111 (294)
T ss_pred             HHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeEEEEEeccc-ccHHHHHHh--------CCCCCcCHHHHHHHHHHH
Confidence            46889999999999999999999964     3678999999996 577776632        122335778888999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~  263 (382)
                      +.||+|||   +.+++||||||+||+++. ++.+||+|||++......            ...||...+ ..++.++|||
T Consensus       112 ~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~  188 (294)
T PLN00009        112 LRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIW  188 (294)
T ss_pred             HHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHH
Confidence            99999999   779999999999999985 567999999998754211            233565444 3568899999


Q ss_pred             HHHHHHHHHHhcCCCCCc
Q 040999          264 SYGILLLELMIREKPSDI  281 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~  281 (382)
                      ||||++|+|+||+.||..
T Consensus       189 slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        189 SVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             HHHHHHHHHHhCCCCCCC
Confidence            999999999999999864

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=4e-28  Score=224.68  Aligned_cols=229  Identities=16%  Similarity=0.178  Sum_probs=149.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc---CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY---QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ..+.+|++++++++|+||+++++++.....   ......++|+||+.. ++...+.         .....+++..+..++
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~---------~~~~~~~~~~~~~i~  121 (311)
T cd07866          52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE---------NPSVKLTESQIKCYM  121 (311)
T ss_pred             hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHh---------ccccCCCHHHHHHHH
Confidence            356889999999999999999988654211   223467999999965 5666553         223468999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------------------CCCCccc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------------------RTQTKYG  251 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------------------~~~~~~~  251 (382)
                      .|+++||+|||   +.+++|+||||+||++++++.+||+|||+++.....                       ...||..
T Consensus       122 ~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (311)
T cd07866         122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL  198 (311)
T ss_pred             HHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHh
Confidence            99999999999   779999999999999999999999999999754321                       2235544


Q ss_pred             cC-CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhh
Q 040999          252 VG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN  330 (382)
Q Consensus       252 ~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (382)
                      .+ ..++.++|||||||++|||++|+.||..... ..................+...............  ...+.....
T Consensus       199 ~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  275 (311)
T cd07866         199 LGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSF--TNYPRTLEE  275 (311)
T ss_pred             hCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhchhhhhcccccccccC--CCCCccHHH
Confidence            33 3478899999999999999999999863211 1111111111100000000000000000000000  000000000


Q ss_pred             hHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          331 VIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       331 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ........+.+++.+|++.+|++|||+.|++.
T Consensus       276 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         276 RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            11122356788999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=9.2e-28  Score=225.63  Aligned_cols=233  Identities=18%  Similarity=0.191  Sum_probs=152.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++++++|+||+++++++..... ......++||||+ +++|.+++.           ...+++..+..++.|
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~i~~q  126 (343)
T cd07880          59 KRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-----------HEKLSEDRIQFLVYQ  126 (343)
T ss_pred             HHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh-----------cCCCCHHHHHHHHHH
Confidence            468899999999999999999998653211 1123468999999 678887763           235889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC---------CCCccccC-CCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR---------TQTKYGVG-NEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~~~-~~~~~~~Dv~S~G  266 (382)
                      +++||+|||   +.+|+||||||+||+++.++.+||+|||++.......         ..||...+ ..++.++||||||
T Consensus       127 i~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  203 (343)
T cd07880         127 MLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVG  203 (343)
T ss_pred             HHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHH
Confidence            999999999   7799999999999999999999999999997654321         23554433 3578899999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      +++|++++|+.||..... ............. ...++.+................................+.+++.+|
T Consensus       204 ~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  281 (343)
T cd07880         204 CIMAEMLTGKPLFKGHDH-LDQLMEIMKVTGT-PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKM  281 (343)
T ss_pred             HHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCC-CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHH
Confidence            999999999999863211 0011111111100 00111111000000000000000000000001112344678899999


Q ss_pred             CCCCccCCCCHHHHH--HHHHHh
Q 040999          347 SMESPQDRMKMTNVV--HELQSI  367 (382)
Q Consensus       347 l~~~p~~RPs~~evl--~~L~~i  367 (382)
                      ++.||++|||+.+++  ..++..
T Consensus       282 l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         282 LVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             cCCChhhCCCHHHHhcCccHhhh
Confidence            999999999999998  444444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=5.7e-28  Score=221.65  Aligned_cols=145  Identities=21%  Similarity=0.232  Sum_probs=122.0

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++.++ +|+||+++++++.     .....++|+||+++++|.+++.          ....+++.....++.|
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~q  113 (290)
T cd05613          49 EHTRTERQVLEHIRQSPFLVTLHYAFQ-----TDTKLHLILDYINGGELFTHLS----------QRERFKEQEVQIYSGE  113 (290)
T ss_pred             HHHHHHHHHHHhcccCCChhceeeEee-----cCCeEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            5678899999999 5999999988743     3677899999999999999883          2345788889999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccC--CCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVG--NEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~--~~~~~~~D  261 (382)
                      +++||.|||   +.+++||||||+|||++.++.+||+|||++......             ...||...+  ...+.++|
T Consensus       114 i~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D  190 (290)
T cd05613         114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVD  190 (290)
T ss_pred             HHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCcccc
Confidence            999999999   789999999999999999999999999998765332             122554433  23578899


Q ss_pred             hHHHHHHHHHHHhcCCCCC
Q 040999          262 VYSYGILLLELMIREKPSD  280 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~  280 (382)
                      |||||+++|+|+||+.||.
T Consensus       191 v~slG~~l~~ll~g~~p~~  209 (290)
T cd05613         191 WWSMGVLMYELLTGASPFT  209 (290)
T ss_pred             HHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=7e-28  Score=226.60  Aligned_cols=229  Identities=17%  Similarity=0.190  Sum_probs=150.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++++++|+||+++++++.... .......+++++++ +++|.+++.           ...+++..+..++.|
T Consensus        61 ~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-----------~~~l~~~~~~~i~~q  128 (345)
T cd07877          61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-----------CQKLTDDHVQFLIYQ  128 (345)
T ss_pred             HHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh-----------cCCCCHHHHHHHHHH
Confidence            56788999999999999999999865321 12234567888877 778887763           234889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccC-CCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVG-NEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~-~~~~~~~Dv~S~G  266 (382)
                      +++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....         ...||...+ ..++.++||||||
T Consensus       129 i~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG  205 (345)
T cd07877         129 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG  205 (345)
T ss_pred             HHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHH
Confidence            999999999   779999999999999999999999999998765332         223554433 4568899999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||..... ...+....... .....++..................................+.+++.+|
T Consensus       206 ~il~el~~g~~pf~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  283 (345)
T cd07877         206 CIMAELLTGRTLFPGTDH-IDQLKLILRLV-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM  283 (345)
T ss_pred             HHHHHHHhCCCCCCCCCH-HHHHHHHHHHh-CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHH
Confidence            999999999999853211 11111111111 0001111111000000000000000000000000001234577889999


Q ss_pred             CCCCccCCCCHHHHHHH
Q 040999          347 SMESPQDRMKMTNVVHE  363 (382)
Q Consensus       347 l~~~p~~RPs~~evl~~  363 (382)
                      ++.+|.+||++.++++.
T Consensus       284 L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         284 LVLDSDKRITAAQALAH  300 (345)
T ss_pred             cCCChhhcCCHHHHhcC
Confidence            99999999999999865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=6.3e-28  Score=220.07  Aligned_cols=220  Identities=21%  Similarity=0.228  Sum_probs=152.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++.     +.+..++|+||++ ++|.+++..         ....+++..+..++.|+
T Consensus        43 ~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~v~e~~~-~~l~~~i~~---------~~~~~~~~~~~~~~~~i  107 (282)
T cd07829          43 STALREISLLKELKHPNIVKLLDVIH-----TERKLYLVFEYCD-MDLKKYLDK---------RPGPLSPNLIKSIMYQL  107 (282)
T ss_pred             HHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEEEecCcC-cCHHHHHHh---------hccCCCHHHHHHHHHHH
Confidence            56788999999999999999999854     3678999999997 589998842         12468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCC-CCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGN-EVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~-~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||+|+||++++++.+||+|||.++.....            ...||...+. .++.++||||
T Consensus       108 ~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~s  184 (282)
T cd07829         108 LRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWS  184 (282)
T ss_pred             HHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHH
Confidence            99999999   679999999999999999999999999998755332            2235555444 7788999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC---chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN---HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||++|||++|+.||...... ..+..........   ....+.+.........   .....   ............+.+
T Consensus       185 lG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~  257 (282)
T cd07829         185 VGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDYKPTFP---KFPPK---DLEKVLPRLDPEGID  257 (282)
T ss_pred             HHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhccccccccccc---ccCcc---chHHhcccccHHHHH
Confidence            999999999999998642110 0111111110000   0000000000000000   00000   000000112456889


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.+|++||++.+++.
T Consensus       258 ~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         258 LLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHHHhhccCcccCCCHHHHhh
Confidence            999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=7.9e-28  Score=219.71  Aligned_cols=223  Identities=18%  Similarity=0.193  Sum_probs=149.5

Q ss_pred             HHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          120 FIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       120 ~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      ..+|+..+++++ |+||+++++++.     ..+..++||||+ +|+|.+++...        ....+++..+..++.|++
T Consensus        44 ~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~-~~~l~~~~~~~--------~~~~~~~~~~~~~~~~l~  109 (283)
T cd07830          44 NLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYFVFEYM-EGNLYQLMKDR--------KGKPFSESVIRSIIYQIL  109 (283)
T ss_pred             HHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEEEEecC-CCCHHHHHHhc--------ccccCCHHHHHHHHHHHH
Confidence            456899999998 999999999864     377899999999 88998887421        124689999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccc-cCCCCCccchhHHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYG-VGNEVSTIGDVYSYG  266 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~-~~~~~~~~~Dv~S~G  266 (382)
                      .+|.|||   +.+++|+||+|+||+++.++.++|+|||.+......           ...||.. .+..++.++|+||||
T Consensus       110 ~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G  186 (283)
T cd07830         110 QGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALG  186 (283)
T ss_pred             HHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHH
Confidence            9999999   779999999999999999999999999999765432           1235543 234568899999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      ++++||++|+.||..... ............+.......+............  ..................+.+++.+|
T Consensus       187 ~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~c  263 (283)
T cd07830         187 CIMAELYTLRPLFPGSSE-IDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF--PQFAPTSLHQLIPNASPEAIDLIKDM  263 (283)
T ss_pred             HHHHHHHhCCCccCCCCh-HHHHHHHHHhcCCCChhhhhhHhhhhccccccc--cccccccHHHHcccCCHHHHHHHHHh
Confidence            999999999999854211 011111111000000000000000000000000  00000000000011235688999999


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      |+.+|++|||++|++.
T Consensus       264 l~~~p~~Rpt~~ei~~  279 (283)
T cd07830         264 LRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccCcccCCCHHHHhh
Confidence            9999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.3e-28  Score=215.74  Aligned_cols=192  Identities=23%  Similarity=0.241  Sum_probs=149.6

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ...+.+|++++++++|+||+++++.+     +.....++||||+++++|.+++.          ....+++.....++.|
T Consensus        37 ~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~q  101 (250)
T cd05123          37 VEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYAPGGELFSHLS----------KEGRFSEERARFYAAE  101 (250)
T ss_pred             HHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            35789999999999999999999884     34788999999999999999983          2335899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +++||.|||   +.+++|+||+|+||+++.++.++|+|||.+......            ...||...+...+.++|+||
T Consensus       102 i~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~s  178 (250)
T cd05123         102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWS  178 (250)
T ss_pred             HHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHH
Confidence            999999999   779999999999999999999999999998765332            23366666666788999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++||+++|+.||.....     ..........        ... .+ .                  .....+.+++.
T Consensus       179 lG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~--------~~~-~~-~------------------~~~~~l~~~i~  225 (250)
T cd05123         179 LGVLLYEMLTGKPPFYAEDR-----KEIYEKILKD--------PLR-FP-E------------------FLSPEARDLIS  225 (250)
T ss_pred             HHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcC--------CCC-CC-C------------------CCCHHHHHHHH
Confidence            99999999999999863211     1111111100        000 00 0                  11345678888


Q ss_pred             ccCCCCccCCCCHHH
Q 040999          345 ACSMESPQDRMKMTN  359 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~e  359 (382)
                      +||..+|++||++.+
T Consensus       226 ~~l~~~p~~R~~~~~  240 (250)
T cd05123         226 GLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHhcCCHhhCCCccc
Confidence            999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=210.65  Aligned_cols=204  Identities=20%  Similarity=0.245  Sum_probs=145.5

Q ss_pred             chhhH---------HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCC
Q 040999          113 AFKIF---------KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP  182 (382)
Q Consensus       113 avK~~---------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  182 (382)
                      |||.+         +++...++++.+-+ .|.||+.+|++..     +...++.||.|.. -++.++.         .-.
T Consensus       121 AVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-----n~dV~IcMelMs~-C~ekLlk---------rik  185 (391)
T KOG0983|consen  121 AVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-----NTDVFICMELMST-CAEKLLK---------RIK  185 (391)
T ss_pred             EEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-----CchHHHHHHHHHH-HHHHHHH---------Hhc
Confidence            77766         56777777776664 8999999999765     5567888998743 2444442         223


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-----------CCCccc
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-----------TQTKYG  251 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~  251 (382)
                      .++++...-++...+.+||.||..  .++|+|||+||+|||+|+.|++|++|||++..+.+..           .+||..
T Consensus       186 ~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERi  263 (391)
T KOG0983|consen  186 GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERI  263 (391)
T ss_pred             CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCcccc
Confidence            457888888899999999999986  6799999999999999999999999999997664332           224443


Q ss_pred             c---CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhh
Q 040999          252 V---GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAK  328 (382)
Q Consensus       252 ~---~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (382)
                      .   ...|+.++||||||++++||.||..||..-..+...+..... ..|        +.+...                
T Consensus       264 dp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~eP--------P~L~~~----------------  318 (391)
T KOG0983|consen  264 DPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEP--------PLLPGH----------------  318 (391)
T ss_pred             CCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCC--------CCCCcc----------------
Confidence            2   356788999999999999999999998642221111111111 111        011000                


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          329 INVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       329 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                          ......+.+++..|+.+|+.+||...++++
T Consensus       319 ----~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  319 ----MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ----cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                012346778888999999999999887764

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=8.3e-28  Score=225.86  Aligned_cols=228  Identities=18%  Similarity=0.248  Sum_probs=147.4

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecc---------cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVD---------YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNL  187 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~  187 (382)
                      .+.+.+|++++++++||||+++++++....         .......++||||++ ++|.+++.           ...+++
T Consensus        46 ~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~l~~  113 (342)
T cd07854          46 VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE-----------QGPLSE  113 (342)
T ss_pred             HHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH-----------cCCCCH
Confidence            367889999999999999999998754311         111245789999997 58877762           235889


Q ss_pred             HHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCCC---------------CCCCccc
Q 040999          188 LRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPPT---------------RTQTKYG  251 (382)
Q Consensus       188 ~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~~---------------~~~~~~~  251 (382)
                      ..+..++.||++||.|||   +.+++||||||+||+++. ++.+|++|||.++.+...               ..+||..
T Consensus       114 ~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  190 (342)
T cd07854         114 EHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL  190 (342)
T ss_pred             HHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHH
Confidence            999999999999999999   779999999999999974 567899999999754221               1235543


Q ss_pred             c-CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhh
Q 040999          252 V-GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN  330 (382)
Q Consensus       252 ~-~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (382)
                      . +..++.++|||||||++|||++|+.||...... ........ ..+....+.........+ ................
T Consensus       191 ~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  267 (342)
T cd07854         191 LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-EQMQLILE-SVPVVREEDRNELLNVIP-SFVRNDGGEPRRPLRD  267 (342)
T ss_pred             hCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-hcCCCChHHhhhhhhhhh-hhhhhcccccCCCHHH
Confidence            2 345788999999999999999999998642110 01111111 011000000000000000 0000000000000000


Q ss_pred             hHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          331 VIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       331 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .......++.+++.+|++.||++|||+.|++.
T Consensus       268 ~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         268 LLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00123346778899999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.95  E-value=7.3e-28  Score=209.09  Aligned_cols=156  Identities=24%  Similarity=0.337  Sum_probs=129.5

Q ss_pred             chhhH----------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCC
Q 040999          113 AFKIF----------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP  182 (382)
Q Consensus       113 avK~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  182 (382)
                      |+|++          .+..||+..++.++|||||.+..+++.    .+...++++||.+. +|.+.++-.+.     ...
T Consensus        57 AiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~----~d~~v~l~fdYAEh-DL~~II~fHr~-----~~~  126 (438)
T KOG0666|consen   57 AIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS----HDKKVWLLFDYAEH-DLWHIIKFHRA-----SKA  126 (438)
T ss_pred             HHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc----cCceEEEEehhhhh-hHHHHHHHhcc-----chh
Confidence            77776          467899999999999999999998754    26778999999976 78888865442     233


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC----CcEEEccccccccCCCCC-------------
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD----MTARVGDFGLARFLPPTR-------------  245 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~----~~~kl~Dfg~a~~~~~~~-------------  245 (382)
                      +.++...+..|+.||+.|+.|||   +.=|+||||||.|||+..+    |.+||+|||+|+.+....             
T Consensus       127 ~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTi  203 (438)
T KOG0666|consen  127 KQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTI  203 (438)
T ss_pred             ccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEE
Confidence            57888999999999999999999   6679999999999999877    899999999999764322             


Q ss_pred             --CCCccccC-CCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          246 --TQTKYGVG-NEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       246 --~~~~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                        .+||...| ..||.+.||||.|||+.||+|-++.|..
T Consensus       204 WYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  204 WYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             EecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence              12555544 6789999999999999999999888754

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=8.6e-28  Score=218.88  Aligned_cols=194  Identities=23%  Similarity=0.302  Sum_probs=149.8

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++++++ |+||+++++++     .+.+..++||||+++++|.+++.          ....+++..+..++.|
T Consensus        46 ~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~i~~q  110 (280)
T cd05581          46 KYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIR----------KYGSLDEKCTRFYAAE  110 (280)
T ss_pred             HHHHHHHHHHHhcccCCCchhHHHHh-----cCCceEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            56888999999998 99999999884     34678999999999999999983          2336999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-------------------------------
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-------------------------------  245 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-------------------------------  245 (382)
                      ++.||.|||   +.+++|+||||+||+++.++.++++|||++.......                               
T Consensus       111 l~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (280)
T cd05581         111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAE  187 (280)
T ss_pred             HHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCcc
Confidence            999999999   7799999999999999999999999999987653322                               


Q ss_pred             -CCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccch
Q 040999          246 -TQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQ  324 (382)
Q Consensus       246 -~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (382)
                       ..||...+..++.++||||||++++++++|+.||....    ....+..         ......  ...          
T Consensus       188 ~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~---------~~~~~~--~~~----------  242 (280)
T cd05581         188 YVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN----EYLTFQK---------ILKLEY--SFP----------  242 (280)
T ss_pred             ccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHH---------HHhcCC--CCC----------
Confidence             22444445567889999999999999999999986421    1111100         000000  000          


Q ss_pred             hhhhhhhHHHHHHHHHHHhhccCCCCccCCCCH----HHHHH
Q 040999          325 TQAKINVIIECVISMVRIGVACSMESPQDRMKM----TNVVH  362 (382)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~----~evl~  362 (382)
                              ......+.+++.+||+.+|++||++    +++++
T Consensus       243 --------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         243 --------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                    0123457888889999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=1.9e-27  Score=211.23  Aligned_cols=199  Identities=24%  Similarity=0.285  Sum_probs=154.2

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++.+++++|+||+++++++..     ....++++||+++++|.+++..          ...+++..+..++.+
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~~   95 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLFDLLKK----------RGRLSEDEARFYARQ   95 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHHHHHHh----------ccCCCHHHHHHHHHH
Confidence            4688999999999999999999999754     5788999999999999998842          223889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +++++.|||   ..+++|+||+|+||+++.++.++++|||.+......           ...||...+..++.++|||||
T Consensus        96 l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~sl  172 (244)
T smart00220       96 ILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSL  172 (244)
T ss_pred             HHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHH
Confidence            999999999   679999999999999999999999999999866542           223666656778889999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |++++++++|..||....    ............        ........                 .....++.+++.+
T Consensus       173 G~~l~~l~~~~~p~~~~~----~~~~~~~~~~~~--------~~~~~~~~-----------------~~~~~~~~~~i~~  223 (244)
T smart00220      173 GVILYELLTGKPPFPGDD----QLLELFKKIGKP--------KPPFPPPE-----------------WKISPEAKDLIRK  223 (244)
T ss_pred             HHHHHHHHhCCCCCCCCC----cHHHHHHHHhcc--------CCCCcccc-----------------ccCCHHHHHHHHH
Confidence            999999999999986421    111111110000        00000000                 0033568889999


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      |+..+|++||++.++++
T Consensus       224 ~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      224 LLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HccCCchhccCHHHHhh
Confidence            99999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.94  E-value=9e-29  Score=210.45  Aligned_cols=211  Identities=22%  Similarity=0.258  Sum_probs=148.5

Q ss_pred             chhhH---------HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCC
Q 040999          113 AFKIF---------KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP  182 (382)
Q Consensus       113 avK~~---------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  182 (382)
                      |||.+         +++..|.++..+- +.||||++||.++.     ++-.|+.||.|.- |+..+.. ..    .....
T Consensus        93 AVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcWiCMELMd~-SlDklYk-~v----y~vq~  161 (361)
T KOG1006|consen   93 AVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCWICMELMDI-SLDKLYK-RV----YSVQK  161 (361)
T ss_pred             EEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCceeeeHHHHhh-hHHHHHH-HH----HHHHh
Confidence            88776         6788888765554 68999999999865     7779999999954 5543321 00    01234


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccc
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYG  251 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~  251 (382)
                      ..+++...-.|..-.+.||.||-.  ...|+|||+||+|||+|..|.+||+|||++..+..           ...+||..
T Consensus       162 ~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi  239 (361)
T KOG1006|consen  162 SRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERI  239 (361)
T ss_pred             ccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhcc
Confidence            567787777888889999999986  56899999999999999999999999999875532           22335544


Q ss_pred             c--CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhh
Q 040999          252 V--GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKI  329 (382)
Q Consensus       252 ~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (382)
                      .  +..|+.++||||+|++|||+.||+.|+.....   .+.+...             ....+++....          .
T Consensus       240 ~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~-------------Vv~gdpp~l~~----------~  293 (361)
T KOG1006|consen  240 DPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQ-------------VVIGDPPILLF----------D  293 (361)
T ss_pred             CCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHH-------------HHcCCCCeecC----------c
Confidence            2  23478899999999999999999999764211   1111111             11111111000          0


Q ss_pred             hhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          330 NVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       330 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ....+....+.+++..|+.+|.++||+..++.+
T Consensus       294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            011134557888899999999999999998764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-27  Score=205.06  Aligned_cols=154  Identities=21%  Similarity=0.330  Sum_probs=128.0

Q ss_pred             chhhH--------HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCc
Q 040999          113 AFKIF--------KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPR  183 (382)
Q Consensus       113 avK~~--------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~  183 (382)
                      |||++        .+..+|++++.+.+ |+||++++++     ++++...|||||-|.+|+|.+.++          ..+
T Consensus       107 AVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----FEdd~~FYLVfEKm~GGplLshI~----------~~~  171 (463)
T KOG0607|consen  107 AVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----FEDDTRFYLVFEKMRGGPLLSHIQ----------KRK  171 (463)
T ss_pred             hhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----hcccceEEEEEecccCchHHHHHH----------Hhh
Confidence            88888        57899999999994 9999999999     567889999999999999999884          456


Q ss_pred             ccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC---cEEEccccccccCCCC-----CCC--------
Q 040999          184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM---TARVGDFGLARFLPPT-----RTQ--------  247 (382)
Q Consensus       184 ~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfg~a~~~~~~-----~~~--------  247 (382)
                      .+++.++.++..+|+.||+|||   .++|.|||+||+|||-.+..   -+||+||.++.-+...     ...        
T Consensus       172 ~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvG  248 (463)
T KOG0607|consen  172 HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVG  248 (463)
T ss_pred             hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCccc
Confidence            7899999999999999999999   88999999999999986654   4899999887533211     111        


Q ss_pred             ------Ccc-----ccCCCCCccchhHHHHHHHHHHHhcCCCCCcccc
Q 040999          248 ------TKY-----GVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE  284 (382)
Q Consensus       248 ------~~~-----~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~  284 (382)
                            ||.     .....|+.++|.||+|||+|-|+.|.+||...-.
T Consensus       249 SAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  249 SAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             chhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence                  222     1234678899999999999999999999976543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=5.8e-27  Score=198.05  Aligned_cols=151  Identities=22%  Similarity=0.357  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc---cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD---YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ..-.+|+++|..++|+|++.++++|....   .......|+|+++|+. +|...|.         +....++...+.+++
T Consensus        61 italreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLs---------n~~vr~sls~Ikk~M  130 (376)
T KOG0669|consen   61 ITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLS---------NRKVRFSLSEIKKVM  130 (376)
T ss_pred             HHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhc---------CccccccHHHHHHHH
Confidence            35689999999999999999999987532   2234458999999976 7888773         344679999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCC----------------CCcccc-CCCCC
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRT----------------QTKYGV-GNEVS  257 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~----------------~~~~~~-~~~~~  257 (382)
                      .++..||.|+|   ...|+|||+||.|+|++.++.+||+|||+++.+.....                .||... ..+++
T Consensus       131 k~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg  207 (376)
T KOG0669|consen  131 KGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYG  207 (376)
T ss_pred             HHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccC
Confidence            99999999999   77999999999999999999999999999975532211                133322 35789


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCc
Q 040999          258 TIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      ++.|||.-|||+.||+||.+.+..
T Consensus       208 ~~iDiWgAgCimaeMwtrspimqg  231 (376)
T KOG0669|consen  208 PPIDIWGAGCIMAEMWTRSPIMQG  231 (376)
T ss_pred             CcchhHhHHHHHHHHHccCccccC
Confidence            999999999999999999988653

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-26  Score=206.98  Aligned_cols=231  Identities=18%  Similarity=0.183  Sum_probs=160.2

Q ss_pred             chhhH-------HHHHHHHHHHhhccc--c----cceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRH--R----NLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY  179 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h--~----niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~  179 (382)
                      |+|++       +.-+-|+++|+++.+  |    -+|++.++     ++-.++.++|+|.+ |.|+.++|..        
T Consensus       118 AlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----FdyrghiCivfell-G~S~~dFlk~--------  183 (415)
T KOG0671|consen  118 ALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FDYRGHICIVFELL-GLSTFDFLKE--------  183 (415)
T ss_pred             hHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hhccCceEEEEecc-ChhHHHHhcc--------
Confidence            88887       345679999999943  2    46777666     34478899999988 6689999953        


Q ss_pred             cCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC--------------------CCcEEEccccccc
Q 040999          180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD--------------------DMTARVGDFGLAR  239 (382)
Q Consensus       180 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~--------------------~~~~kl~Dfg~a~  239 (382)
                      +...+++...+..++.|++++++|||   +.+++|-||||+|||+..                    +..+||+|||.|.
T Consensus       184 N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAt  260 (415)
T KOG0671|consen  184 NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSAT  260 (415)
T ss_pred             CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcc
Confidence            34567899999999999999999999   789999999999999831                    2358999999998


Q ss_pred             cCCCC---------CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcc--
Q 040999          240 FLPPT---------RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSI--  308 (382)
Q Consensus       240 ~~~~~---------~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  308 (382)
                      .-...         ..+||...+-.++..+||||+||||.|+.||...|..... ...+ .+.+.....--..++.+.  
T Consensus       261 f~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen-~EHL-aMMerIlGp~P~~mi~r~~~  338 (415)
T KOG0671|consen  261 FDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN-LEHL-AMMERILGPIPSRMIKKTRK  338 (415)
T ss_pred             eeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc-HHHH-HHHHHhhCCCcHHHhhhhhh
Confidence            65443         3449999999999999999999999999999998764321 1111 111111111111111111  


Q ss_pred             ---c---ccchhh-------hhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          309 ---L---LNDDEK-------LVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       309 ---~---~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                         .   ..+..+       +.....+.+..........+...+.+|+.+++..||.+|+|++|+++
T Consensus       339 ~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  339 EKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence               0   000000       11111122222222223355667999999999999999999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-26  Score=206.17  Aligned_cols=213  Identities=20%  Similarity=0.295  Sum_probs=167.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+..|.-.+..+.|||+.++.++++.    +....++++.++.-|+|..||.-.+  +........++-.+...++.|+
T Consensus       332 ~~~L~es~lly~~sH~nll~V~~V~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr--~~~~~~aqtvtt~qlV~masQl  405 (563)
T KOG1024|consen  332 NLLLQESMLLYGASHPNLLSVLGVSIE----DYATPFVLYPATGVGNLKSFLQICR--GDDPSYAQTVTTIQLVLMASQL  405 (563)
T ss_pred             HHHHHHHHHHhcCcCCCccceeEEEee----ccCcceEEEeccCcchHHHHHHHhc--cCCCccccchhHHHHHHHHHHH
Confidence            457778888888999999999999875    4667789999999999999996333  1112345667888899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.|++|||   +.++||.||..+|+++|+.-++||+|-.+++.+.+.              +..+|......++.++|||
T Consensus       406 a~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvW  482 (563)
T KOG1024|consen  406 AMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVW  482 (563)
T ss_pred             HHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhH
Confidence            99999999   789999999999999999999999999999876443              3336666778999999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||++|||+| |+.|+-...  ...+..+.+..++     +.                         ..-+|+.++..+
T Consensus       483 sfGVllWELmtlg~~PyaeID--PfEm~~ylkdGyR-----la-------------------------QP~NCPDeLf~v  530 (563)
T KOG1024|consen  483 SFGVLLWELMTLGKLPYAEID--PFEMEHYLKDGYR-----LA-------------------------QPFNCPDELFTV  530 (563)
T ss_pred             HHHHHHHHHHhcCCCCccccC--HHHHHHHHhccce-----ec-------------------------CCCCCcHHHHHH
Confidence            99999999998 888875321  1122222222111     00                         111688899999


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      +.-||...|++||+++|++..|.+.-..+
T Consensus       531 MacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  531 MACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             HHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            99999999999999999999998876554

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.94  E-value=5.5e-27  Score=234.62  Aligned_cols=168  Identities=22%  Similarity=0.291  Sum_probs=112.0

Q ss_pred             eeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEE
Q 040999          152 FKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR  231 (382)
Q Consensus       152 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~k  231 (382)
                      ..||=||||+.-++.+++....         ..-.....++++++|++||+|+|   +++||||||||.||++|.+..+|
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~---------~~~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VK  737 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNH---------FNSQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVK  737 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcc---------cchhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCee
Confidence            3467777777766666663211         00145678899999999999999   88999999999999999999999


Q ss_pred             EccccccccCCC-------------------C-----------CCCCccccCC---CCCccchhHHHHHHHHHHHhcCCC
Q 040999          232 VGDFGLARFLPP-------------------T-----------RTQTKYGVGN---EVSTIGDVYSYGILLLELMIREKP  278 (382)
Q Consensus       232 l~Dfg~a~~~~~-------------------~-----------~~~~~~~~~~---~~~~~~Dv~S~Gvil~elltg~~p  278 (382)
                      |+|||+|+....                   .           +.+||...+.   .|+.|+|+||+|||++||+.   |
T Consensus       738 IGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---P  814 (1351)
T KOG1035|consen  738 IGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---P  814 (1351)
T ss_pred             ecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---c
Confidence            999999986210                   0           0114444332   58999999999999999984   4


Q ss_pred             CCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHH
Q 040999          279 SDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMT  358 (382)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~  358 (382)
                      |....+....+...-...+|.. .++.+                           +....=.+++.++++.||.+|||+.
T Consensus       815 F~TsMERa~iL~~LR~g~iP~~-~~f~~---------------------------~~~~~e~slI~~Ll~hdP~kRPtA~  866 (1351)
T KOG1035|consen  815 FGTSMERASILTNLRKGSIPEP-ADFFD---------------------------PEHPEEASLIRWLLSHDPSKRPTAT  866 (1351)
T ss_pred             CCchHHHHHHHHhcccCCCCCC-ccccc---------------------------ccchHHHHHHHHHhcCCCccCCCHH
Confidence            5432221111111111111211 11111                           1122335667799999999999999


Q ss_pred             HHHH
Q 040999          359 NVVH  362 (382)
Q Consensus       359 evl~  362 (382)
                      |++.
T Consensus       867 eLL~  870 (1351)
T KOG1035|consen  867 ELLN  870 (1351)
T ss_pred             HHhh
Confidence            9874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=6e-27  Score=192.51  Aligned_cols=174  Identities=21%  Similarity=0.283  Sum_probs=134.1

Q ss_pred             cccccCC--chhhH---------HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCC
Q 040999          106 SHLRHQG--AFKIF---------KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPIS  173 (382)
Q Consensus       106 ~~~~~~~--avK~~---------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  173 (382)
                      +....|.  |+|.+         ++..+|+.+..+. ..|.+|.|||..+     .+...++.||.|.. ||..+-... 
T Consensus        66 rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-----regdvwIcME~M~t-Sldkfy~~v-  138 (282)
T KOG0984|consen   66 RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-----REGDVWICMELMDT-SLDKFYRKV-  138 (282)
T ss_pred             eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh-----ccccEEEeHHHhhh-hHHHHHHHH-
Confidence            4444554  77766         5677888776654 7999999999843     47789999999954 676665332 


Q ss_pred             CCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------
Q 040999          174 KEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------  244 (382)
Q Consensus       174 ~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------  244 (382)
                           ......+++...-+|+..+.+||.|||+  ...++|||+||+|||++.+|++|++|||++.++...         
T Consensus       139 -----~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGC  211 (282)
T KOG0984|consen  139 -----LKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGC  211 (282)
T ss_pred             -----HhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCC
Confidence                 2456678999999999999999999997  569999999999999999999999999999876432         


Q ss_pred             --CCCCcccc----CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHH
Q 040999          245 --RTQTKYGV----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA  293 (382)
Q Consensus       245 --~~~~~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~  293 (382)
                        .++||...    ...|+.|+||||+|+++.||.+++.||+..+.....+.+.+
T Consensus       212 kpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV  266 (282)
T KOG0984|consen  212 KPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV  266 (282)
T ss_pred             CccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence              23344332    23788999999999999999999999987655444444433

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.8e-26  Score=206.75  Aligned_cols=147  Identities=23%  Similarity=0.302  Sum_probs=130.2

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .-++|-.+|.+++.+.||.+--.     |+..+.+++|+..|.||+|.-.|+..        ....+++..++.++.+|+
T Consensus       231 maLnEk~iL~kV~s~FiVslaYA-----feTkd~LClVLtlMNGGDLkfHiyn~--------g~~gF~e~ra~FYAAEi~  297 (591)
T KOG0986|consen  231 MALNEKQILEKVSSPFIVSLAYA-----FETKDALCLVLTLMNGGDLKFHIYNH--------GNPGFDEQRARFYAAEII  297 (591)
T ss_pred             HhhHHHHHHHHhccCcEEEEeee-----ecCCCceEEEEEeecCCceeEEeecc--------CCCCCchHHHHHHHHHHH
Confidence            45789999999999999987555     56789999999999999999888643        235799999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCccchhHHHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      .||.+||   ..+||.||+||+|||+|++|+++|+|+|+|..++.           +.++||...+..|+...|.||+||
T Consensus       298 cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGC  374 (591)
T KOG0986|consen  298 CGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGC  374 (591)
T ss_pred             hhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHh
Confidence            9999999   77999999999999999999999999999986644           344588888889999999999999


Q ss_pred             HHHHHHhcCCCCCc
Q 040999          268 LLLELMIREKPSDI  281 (382)
Q Consensus       268 il~elltg~~p~~~  281 (382)
                      ++|||+.|+.||..
T Consensus       375 llYemi~G~sPFr~  388 (591)
T KOG0986|consen  375 LLYEMIAGHSPFRQ  388 (591)
T ss_pred             HHHHHHcccCchhh
Confidence            99999999999864

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=6e-26  Score=229.94  Aligned_cols=104  Identities=25%  Similarity=0.328  Sum_probs=93.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++..++|+||+++++++..     ....++||||+++++|.+++..          ...+++..++.++.||
T Consensus        49 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~~~lVmEy~~g~~L~~li~~----------~~~l~~~~~~~i~~qi  113 (669)
T cd05610          49 HQVQAERDALALSKSPFIVHLYYSLQS-----ANNVYLVMEYLIGGDVKSLLHI----------YGYFDEEMAVKYISEV  113 (669)
T ss_pred             HHHHHHHHHHHhcCCCCcCeEEEEEEE-----CCEEEEEEeCCCCCCHHHHHHh----------cCCCCHHHHHHHHHHH
Confidence            568899999999999999999988543     6789999999999999999842          3357888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR  239 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~  239 (382)
                      +.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus       114 l~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             HHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999   6799999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=207.81  Aligned_cols=149  Identities=23%  Similarity=0.367  Sum_probs=127.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +...+|.++-+.|.||.||++|+++.    -+.+..|-|+|||++.+|.-||          +..+.+++.++..|+.||
T Consensus       512 KHAcREyrIHKeLDHpRIVKlYDyfs----lDtdsFCTVLEYceGNDLDFYL----------KQhklmSEKEARSIiMQi  577 (775)
T KOG1151|consen  512 KHACREYRIHKELDHPRIVKLYDYFS----LDTDSFCTVLEYCEGNDLDFYL----------KQHKLMSEKEARSIIMQI  577 (775)
T ss_pred             HHHHHHHhhhhccCcceeeeeeeeee----eccccceeeeeecCCCchhHHH----------HhhhhhhHHHHHHHHHHH
Confidence            55778999999999999999999964    2467889999999999999888          456779999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCC---CCcEEEccccccccCCCCCCC-------------------Ccccc---
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDD---DMTARVGDFGLARFLPPTRTQ-------------------TKYGV---  252 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfg~a~~~~~~~~~-------------------~~~~~---  252 (382)
                      +.||.||..- +++|||-||||.|||+..   .|.+||.|||+++++..+...                   ||...   
T Consensus       578 VnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk  656 (775)
T KOG1151|consen  578 VNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK  656 (775)
T ss_pred             HHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCC
Confidence            9999999965 899999999999999943   478999999999998654322                   34332   


Q ss_pred             -CCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          253 -GNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       253 -~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                       .+.++.|+||||.|||+|..+.|+.||..
T Consensus       657 ePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  657 EPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             CCCccccceeeEeeehhhhhhhccCCCCCC
Confidence             34678999999999999999999999864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-26  Score=220.76  Aligned_cols=209  Identities=20%  Similarity=0.203  Sum_probs=163.8

Q ss_pred             chhhH-------HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc
Q 040999          113 AFKIF-------KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN  184 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~  184 (382)
                      |+|++       +++..|.++|+.. .|||++.++|++.-.+....+.+|||||||.+||..+++....        ...
T Consensus        48 a~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--------g~r  119 (953)
T KOG0587|consen   48 AIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--------GNR  119 (953)
T ss_pred             eeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--------ccc
Confidence            77776       6788899999988 6999999999998776777899999999999999999985422        567


Q ss_pred             cCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc
Q 040999          185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV  252 (382)
Q Consensus       185 l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~  252 (382)
                      +.|..+..|++.++.||.+||   ...++|||||-.|||++.++.+|+.|||.+..++..            +.+||+..
T Consensus       120 l~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEVia  196 (953)
T KOG0587|consen  120 LKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIA  196 (953)
T ss_pred             hhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeee
Confidence            899999999999999999999   779999999999999999999999999999876433            33355432


Q ss_pred             -----CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhh
Q 040999          253 -----GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQA  327 (382)
Q Consensus       253 -----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (382)
                           ...|+..+|+||+|++..||.-|.+|+-.+-..     .......+                         .|+.
T Consensus       197 c~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-----raLF~IpR-------------------------NPPP  246 (953)
T KOG0587|consen  197 CDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFLIPR-------------------------NPPP  246 (953)
T ss_pred             cccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----hhhccCCC-------------------------CCCc
Confidence                 345677899999999999999999996543110     00000000                         0111


Q ss_pred             hhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          328 KINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       328 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ..........++.+++..|+.+|-++||++.++++
T Consensus       247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            11122345667888999999999999999998874

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=6.6e-26  Score=189.14  Aligned_cols=222  Identities=21%  Similarity=0.285  Sum_probs=152.0

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++|..++ ||||++++++...   .......|++||+.+.+.....             ..++-..+..++.+
T Consensus        77 kKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaLiFE~v~n~Dfk~ly-------------~tl~d~dIryY~~e  140 (338)
T KOG0668|consen   77 KKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSLIFEYVNNTDFKQLY-------------PTLTDYDIRYYIYE  140 (338)
T ss_pred             HHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchhHhhhhccccHHHHh-------------hhhchhhHHHHHHH
Confidence            67899999999997 9999999998553   2345567999999887765544             24666778889999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCCCCCCC-----------Ccccc-CCCCCccchhH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLPPTRTQ-----------TKYGV-GNEVSTIGDVY  263 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~~~~~~-----------~~~~~-~~~~~~~~Dv~  263 (382)
                      +++||.|+|   +.||+|||+||.|+++|.. ..++|+|+|+|.+..++...           ||... -..++..-|+|
T Consensus       141 lLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~W  217 (338)
T KOG0668|consen  141 LLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMW  217 (338)
T ss_pred             HHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHH
Confidence            999999999   8899999999999999875 56999999999887665322           44332 24567889999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHH---HhcCCchhhhhhccc---ccchhhhhhccccchhhhhh--hhHHH-
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAK---MALPNHVKDIVDSIL---LNDDEKLVVRGDQKQTQAKI--NVIIE-  334 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~--~~~~~-  334 (382)
                      ||||++..|+..+.||-   .+..+..+.++   .....+....+.+.-   .+.......+..... ....  ...+. 
T Consensus       218 S~GcmlA~miFrkepFF---hG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~-w~~Fi~~~n~hl  293 (338)
T KOG0668|consen  218 SLGCMLASMIFRKEPFF---HGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKP-WSRFINSENQHL  293 (338)
T ss_pred             HHHHHHHHHHhccCccc---CCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhcccccc-HHHhCCcccccc
Confidence            99999999999999973   44444444433   322333333322211   111111111111000 0000  00001 


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ...+.++++...+..|-++|+|++|...
T Consensus       294 ~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  294 VSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             CChHHHHHHHHHHhhccccccchHHHhc
Confidence            1245677777899999999999999874

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.5e-26  Score=226.56  Aligned_cols=144  Identities=22%  Similarity=0.268  Sum_probs=125.5

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      -|..|-.+|..-+.+.||+++-.     ++++.++|+|||||+||+|-.++.          ....+++..+..++..|+
T Consensus       121 ~F~EERDimv~~ns~Wiv~LhyA-----FQD~~~LYlVMdY~pGGDlltLlS----------k~~~~pE~~ArFY~aEiV  185 (1317)
T KOG0612|consen  121 CFREERDIMVFGNSEWIVQLHYA-----FQDERYLYLVMDYMPGGDLLTLLS----------KFDRLPEDWARFYTAEIV  185 (1317)
T ss_pred             HHHHHhHHHHcCCcHHHHHHHHH-----hcCccceEEEEecccCchHHHHHh----------hcCCChHHHHHHHHHHHH
Confidence            48889999999999999998766     688999999999999999999994          233799999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccc----cC-CCCCccc
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYG----VG-NEVSTIG  260 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~----~~-~~~~~~~  260 (382)
                      -||+-+|   +.|+|||||||+|||+|..|++||+|||.+-.+..+             +.+||..    .+ +.|+..+
T Consensus       186 lAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ec  262 (1317)
T KOG0612|consen  186 LALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGREC  262 (1317)
T ss_pred             HHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCcc
Confidence            9999999   889999999999999999999999999998665422             2234332    23 6889999


Q ss_pred             hhHHHHHHHHHHHhcCCCCC
Q 040999          261 DVYSYGILLLELMIREKPSD  280 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~  280 (382)
                      |+||+||++|||+.|..||.
T Consensus       263 DwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  263 DWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             chhhhHHHHHHHHcCCCcch
Confidence            99999999999999999986

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=5.1e-26  Score=235.59  Aligned_cols=189  Identities=16%  Similarity=0.216  Sum_probs=132.1

Q ss_pred             Hhhccc-ccceeeeeeeeeccc--CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhH
Q 040999          127 LRNIRH-RNLIKVLTACLGVDY--QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNY  203 (382)
Q Consensus       127 l~~l~h-~niv~~~~~~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~  203 (382)
                      .+.++| +||+++++++.....  ........++||+ +++|.+++.         .....+++..++.++.||++||+|
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~---------~~~~~~~~~~~~~i~~qi~~al~~   95 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLD---------NPDRSVDAFECFHVFRQIVEIVNA   95 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHh---------cccccccHHHHHHHHHHHHHHHHH
Confidence            345567 688888887522111  1223466778887 669999994         223458999999999999999999


Q ss_pred             HhhcCCCceeecCCCCCceeeCC-------------------CCcEEEccccccccCCC---------------------
Q 040999          204 LHHDCQPVTAHCDLKPSNVLLDD-------------------DMTARVGDFGLARFLPP---------------------  243 (382)
Q Consensus       204 lH~~~~~~ivH~dlkp~NILl~~-------------------~~~~kl~Dfg~a~~~~~---------------------  243 (382)
                      ||   +.+|+||||||+|||++.                   ++.+|++|||+++....                     
T Consensus        96 lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (793)
T PLN00181         96 AH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQ  172 (793)
T ss_pred             HH---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccc
Confidence            99   789999999999999953                   45678888888764210                     


Q ss_pred             -------CCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhh
Q 040999          244 -------TRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKL  316 (382)
Q Consensus       244 -------~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (382)
                             .+..||...+..++.++|||||||++|||++|..|+....   ..+........+        +    ..   
T Consensus       173 ~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~--------~----~~---  234 (793)
T PLN00181        173 ILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLP--------P----QI---  234 (793)
T ss_pred             cccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcC--------h----hh---
Confidence                   1345888778889999999999999999999988754210   001111000000        0    00   


Q ss_pred             hhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          317 VVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                                      .........++.+||+.+|.+||+|.|+++
T Consensus       235 ----------------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        235 ----------------LLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ----------------hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence                            011123456777999999999999999985

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.92  E-value=4.3e-26  Score=220.71  Aligned_cols=202  Identities=22%  Similarity=0.290  Sum_probs=147.1

Q ss_pred             chhhH-----HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF-----KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |||.+     .-..+|+..|+.- +|||||++++.     .++..+.|+..|.|.. +|.+++.....+.   ..   ..
T Consensus       537 AVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalELC~~-sL~dlie~~~~d~---~~---~~  604 (903)
T KOG1027|consen  537 AVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALELCAC-SLQDLIESSGLDV---EM---QS  604 (903)
T ss_pred             hHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEehHhhh-hHHHHHhccccch---hh---cc
Confidence            88887     4457999999988 69999999877     4568899999999954 8999996431100   01   11


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC---C--CcEEEccccccccCCCCC---------------C
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD---D--MTARVGDFGLARFLPPTR---------------T  246 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~--~~~kl~Dfg~a~~~~~~~---------------~  246 (382)
                      -...+.+..|+++||++||   +.+||||||||.||||+.   +  .+++|+|||+++.+..+.               .
T Consensus       605 ~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~  681 (903)
T KOG1027|consen  605 DIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQ  681 (903)
T ss_pred             cccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCccccc
Confidence            1345678899999999999   779999999999999976   3  478999999999875443               3


Q ss_pred             CCccccCCCCCccchhHHHHHHHHHHHhc-CCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchh
Q 040999          247 QTKYGVGNEVSTIGDVYSYGILLLELMIR-EKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQT  325 (382)
Q Consensus       247 ~~~~~~~~~~~~~~Dv~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (382)
                      +||......-+.++||||+||++|+.++| +.||......+.++..        ....++.  +  .+.           
T Consensus       682 APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L~~--L--~~~-----------  738 (903)
T KOG1027|consen  682 APEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTLVH--L--EPL-----------  738 (903)
T ss_pred             CHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Cccceee--e--ccC-----------
Confidence            36666666667799999999999999997 9998754333222110        0000000  0  000           


Q ss_pred             hhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHH
Q 040999          326 QAKINVIIECVISMVRIGVACSMESPQDRMKMTNVV  361 (382)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl  361 (382)
                             .++  +..+|+.+++..+|..||++.+|+
T Consensus       739 -------~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  739 -------PDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             -------chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence                   022  556777799999999999999997

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=8.2e-26  Score=197.18  Aligned_cols=223  Identities=19%  Similarity=0.219  Sum_probs=155.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ++-.+|...+..+.|+||++++.++.... .......|+||||| .++|.+.+.            ..++-.....++.|
T Consensus        60 kra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~------------~elDH~tis~i~yq  126 (369)
T KOG0665|consen   60 KRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL------------MELDHETISYILYQ  126 (369)
T ss_pred             hhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH------------HhcchHHHHHHHHH
Confidence            56788999999999999999999865321 12234578999999 457777763            23566778899999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++.|++|||   +.+|+||||||+||++..+..+||.|||+|+.-...           ...||...+..+.+.+||||.
T Consensus       127 ~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSv  203 (369)
T KOG0665|consen  127 MLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  203 (369)
T ss_pred             HHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhh
Confidence            999999999   889999999999999999999999999999865544           123777777789999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcC-C--------chhhhhhcccccchh-------hhhhccccchhhhhh
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALP-N--------HVKDIVDSILLNDDE-------KLVVRGDQKQTQAKI  329 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  329 (382)
                      ||++.||++|+.-|.    +...+.+|.+..-. +        .............+.       ....+..+.......
T Consensus       204 Gci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~  279 (369)
T KOG0665|consen  204 GCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS  279 (369)
T ss_pred             hhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCC
Confidence            999999999998754    55666666554311 0        111111111111110       000011111000000


Q ss_pred             hhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          330 NVIIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       330 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                         .-.......++.++|-.+|++|.+++++++.
T Consensus       280 ---~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  280 ---KLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             ---ccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence               0112345667779999999999999999863

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.9e-25  Score=193.24  Aligned_cols=151  Identities=28%  Similarity=0.349  Sum_probs=129.6

Q ss_pred             chhhHH-----------HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccC
Q 040999          113 AFKIFK-----------SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYER  181 (382)
Q Consensus       113 avK~~~-----------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  181 (382)
                      |+|+++           .-..|-++|+..+||.+..+.-.     ++..+.+|.||||..+|.|.-.|          .+
T Consensus       197 AiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~drlCFVMeyanGGeLf~HL----------sr  261 (516)
T KOG0690|consen  197 AIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQDRLCFVMEYANGGELFFHL----------SR  261 (516)
T ss_pred             ehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCceEEEEEEEccCceEeeeh----------hh
Confidence            788772           34678899999999998876544     57789999999999999999888          34


Q ss_pred             CcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC------------CCCCCCCc
Q 040999          182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL------------PPTRTQTK  249 (382)
Q Consensus       182 ~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~------------~~~~~~~~  249 (382)
                      .+.+++.....+-..|..||.|||   +.+||.||+|.+|.|+|++|++||+|||+++.-            .+...+||
T Consensus       262 er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPE  338 (516)
T KOG0690|consen  262 ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPE  338 (516)
T ss_pred             hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCch
Confidence            567889989999999999999999   779999999999999999999999999999742            22333466


Q ss_pred             cccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          250 YGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       250 ~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      ......|+.++|+|.+||++|||+.|+.||..
T Consensus       339 VleDnDYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  339 VLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             hhccccccceeehhhhhHHHHHHHhccCcccc
Confidence            66777889999999999999999999999864

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=3.8e-25  Score=208.02  Aligned_cols=150  Identities=20%  Similarity=0.266  Sum_probs=125.9

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      ....|-.||.....+.||++|-.     +++++.+|+||||++||++-.+|          -+.+-+.+..+..++.++.
T Consensus       675 HVKAERDILAEADn~WVVrLyyS-----FQDkdnLYFVMdYIPGGDmMSLL----------IrmgIFeE~LARFYIAElt  739 (1034)
T KOG0608|consen  675 HVKAERDILAEADNEWVVRLYYS-----FQDKDNLYFVMDYIPGGDMMSLL----------IRMGIFEEDLARFYIAELT  739 (1034)
T ss_pred             hhhhhhhhHhhcCCcceEEEEEE-----eccCCceEEEEeccCCccHHHHH----------HHhccCHHHHHHHHHHHHH
Confidence            46678899999999999999876     67899999999999999998888          3445688888999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC---------C--------------------------
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP---------P--------------------------  243 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~---------~--------------------------  243 (382)
                      .|+++.|   ..|+|||||||+|||||.+|++||.|||++.-+.         .                          
T Consensus       740 cAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~  816 (1034)
T KOG0608|consen  740 CAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLE  816 (1034)
T ss_pred             HHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHH
Confidence            9999999   8899999999999999999999999999985221         0                          


Q ss_pred             -------------------CCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCC
Q 040999          244 -------------------TRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD  286 (382)
Q Consensus       244 -------------------~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~  286 (382)
                                         ....||+.....++..+|+||.|||||||+.|+.||.....++
T Consensus       817 ~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  817 RRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence                               0011455555667888999999999999999999997654443

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.9e-26  Score=194.55  Aligned_cols=149  Identities=23%  Similarity=0.333  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++|..++|.|++..+++.-.....--.++|++.|.|. .+|.+.+          ..+..++.+.+.-+..||
T Consensus        97 krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKII----------VSPQ~Ls~DHvKVFlYQI  165 (449)
T KOG0664|consen   97 KRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKII----------VSPQALTPDHVKVFVYQI  165 (449)
T ss_pred             HHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhhee----------ccCCCCCcchhhhhHHHH
Confidence            78999999999999999999988843221111234678889884 4787777          456678888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCC-------------CCccccC-CCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRT-------------QTKYGVG-NEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~~~-~~~~~~~Dv~  263 (382)
                      ++||.|||   +.+|.||||||.|.|++.+..+||+|||+|+.......             .||..+| ..|+.++|||
T Consensus       166 LRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiW  242 (449)
T KOG0664|consen  166 LRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIW  242 (449)
T ss_pred             HhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCcccee
Confidence            99999999   78999999999999999999999999999997655432             2665554 5789999999


Q ss_pred             HHHHHHHHHHhcCCCCC
Q 040999          264 SYGILLLELMIREKPSD  280 (382)
Q Consensus       264 S~Gvil~elltg~~p~~  280 (382)
                      |.|||+.|++.++..|.
T Consensus       243 SVGCIFaELLgRrILFQ  259 (449)
T KOG0664|consen  243 SVGCIFAELLQRKILFQ  259 (449)
T ss_pred             hhhHHHHHHHhhhhhhh
Confidence            99999999998888765

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.92  E-value=1.2e-24  Score=215.52  Aligned_cols=195  Identities=16%  Similarity=0.130  Sum_probs=119.2

Q ss_pred             CCCceeEEEEecccCCCccccccCCCCCCc----------cccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCC
Q 040999          148 QGNDFKALVYEFIHNRSPEKWLYPISKEDE----------TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDL  217 (382)
Q Consensus       148 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dl  217 (382)
                      ......++|+||+++++|.+++........          ............+..++.|++.||.|||   +.+|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence            346778999999999999998853221000          0000111223445679999999999999   779999999


Q ss_pred             CCCceeeCC-CCcEEEccccccccCCC-------------CCCCCccccC----------------------CCCCccch
Q 040999          218 KPSNVLLDD-DMTARVGDFGLARFLPP-------------TRTQTKYGVG----------------------NEVSTIGD  261 (382)
Q Consensus       218 kp~NILl~~-~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~----------------------~~~~~~~D  261 (382)
                      ||+|||++. ++.+||+|||+|+.+..             ....||....                      ..++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 57899999999975422             2233442211                      12345679


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcC--Cch---hhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALP--NHV---KDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      ||||||++|||+++..|++.      ....+......  ...   ...+.+....+..            ..........
T Consensus       362 VwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~d~~~  423 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLR------------RGFEVLDLDG  423 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhh------------hhhhhccccc
Confidence            99999999999998776442      11111111100  000   0111110000000            0000000112


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ....+|+.+|++.||++|||++|+++.
T Consensus       424 ~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        424 GAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             hHHHHHHHHHccCCcccCCCHHHHhCC
Confidence            234578889999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=2.9e-24  Score=182.19  Aligned_cols=163  Identities=22%  Similarity=0.205  Sum_probs=117.3

Q ss_pred             CCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          163 RSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       163 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      |+|.+++.         .....+++..++.++.|+++||.|||+   .+      ||+|||++.++.+|+  ||.++...
T Consensus         1 GsL~~~l~---------~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~   60 (176)
T smart00750        1 VSLADILE---------VRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKT   60 (176)
T ss_pred             CcHHHHHH---------HhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeec
Confidence            57777773         224569999999999999999999994   34      999999999999999  99987653


Q ss_pred             C-------CCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhh
Q 040999          243 P-------TRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEK  315 (382)
Q Consensus       243 ~-------~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (382)
                      .       ...+||...+..++.++|||||||++|||+||+.||.........+..+.....+.            ....
T Consensus        61 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~  128 (176)
T smart00750       61 PEQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD------------DPRD  128 (176)
T ss_pred             cccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC------------Cccc
Confidence            3       34558888888899999999999999999999999864322111111111111100            0000


Q ss_pred             hhhccccchhhhhhhhHHHHH--HHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          316 LVVRGDQKQTQAKINVIIECV--ISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                             ..      ......  ..+.+++.+||+.+|.+||++.|+++.+..+...
T Consensus       129 -------~~------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      129 -------RS------NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             -------cc------cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence                   00      000111  2588899999999999999999999998776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.91  E-value=9.7e-26  Score=208.05  Aligned_cols=152  Identities=24%  Similarity=0.317  Sum_probs=129.8

Q ss_pred             chhhH----------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCC
Q 040999          113 AFKIF----------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP  182 (382)
Q Consensus       113 avK~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  182 (382)
                      |||++          .++++|+++|++++||.||.+--.|     +..+..++|||-+.+.-|+-.|.         ...
T Consensus       593 AvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVMEKl~GDMLEMILS---------sEk  658 (888)
T KOG4236|consen  593 AVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVMEKLHGDMLEMILS---------SEK  658 (888)
T ss_pred             eeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEehhhcchHHHHHHH---------hhc
Confidence            88887          5789999999999999999987664     55889999999996655555552         445


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC---CcEEEccccccccCCCC-----------CCCC
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD---MTARVGDFGLARFLPPT-----------RTQT  248 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfg~a~~~~~~-----------~~~~  248 (382)
                      ..+++.....+..||+.||.|||   .++|+|+||||+|||+...   -++||+|||+|+++...           ...|
T Consensus       659 gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaP  735 (888)
T KOG4236|consen  659 GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAP  735 (888)
T ss_pred             ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCH
Confidence            67888888999999999999999   7899999999999999654   46999999999987544           3347


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          249 KYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       249 ~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      |......|+..-|+||.|||+|--+.|..||..
T Consensus       736 EVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  736 EVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             HHHhhccccccccceeeeEEEEEEecccccCCC
Confidence            777788899999999999999999999999864

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.6e-25  Score=202.78  Aligned_cols=146  Identities=20%  Similarity=0.271  Sum_probs=129.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +....|-++|...+.|.||++|..     |.+..+.|++||-|-+|.+...|.          ....++......++..+
T Consensus       465 eHv~sEr~Im~~~~s~fIvrLYrT-----frd~kyvYmLmEaClGGElWTiLr----------dRg~Fdd~tarF~~acv  529 (732)
T KOG0614|consen  465 EHVFSERNIMMECRSDFIVRLYRT-----FRDSKYVYMLMEACLGGELWTILR----------DRGSFDDYTARFYVACV  529 (732)
T ss_pred             HHHHhHHHHHHhcCchHHHHHHHH-----hccchhhhhhHHhhcCchhhhhhh----------hcCCcccchhhhhHHHH
Confidence            567889999999999999999987     566889999999999999999994          34568888889999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-----------CCCccccCCCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-----------TQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      .+|++|||   .++||.|||||+|.++|.+|.+||.|||+|+.+..+.           .+||.......+.++|.||+|
T Consensus       530 ~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLG  606 (732)
T KOG0614|consen  530 LEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALG  606 (732)
T ss_pred             HHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHH
Confidence            99999999   8899999999999999999999999999999875443           335666666778899999999


Q ss_pred             HHHHHHHhcCCCCCc
Q 040999          267 ILLLELMIREKPSDI  281 (382)
Q Consensus       267 vil~elltg~~p~~~  281 (382)
                      +++|||+||++||..
T Consensus       607 Ili~ELL~G~pPFs~  621 (732)
T KOG0614|consen  607 ILIYELLTGSPPFSG  621 (732)
T ss_pred             HHHHHHHcCCCCCCC
Confidence            999999999999874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.91  E-value=2.8e-24  Score=173.18  Aligned_cols=143  Identities=24%  Similarity=0.384  Sum_probs=118.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+..+|+-+|+.++|.|||+++++     ...+....+|+|||.. +|..|..         .-.+.++......++.|+
T Consensus        46 ssalreicllkelkhknivrl~dv-----lhsdkkltlvfe~cdq-dlkkyfd---------slng~~d~~~~rsfmlql  110 (292)
T KOG0662|consen   46 SSALREICLLKELKHKNIVRLHDV-----LHSDKKLTLVFEFCDQ-DLKKYFD---------SLNGDLDPEIVRSFMLQL  110 (292)
T ss_pred             HHHHHHHHHHHHhhhcceeehhhh-----hccCceeEEeHHHhhH-HHHHHHH---------hcCCcCCHHHHHHHHHHH
Confidence            467899999999999999999998     4457888999999965 6777663         234568889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC------------CCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR------------TQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||.|+|   ++++.|||+||.|.|++.+|+.|++|||+|+......            ..|....+ .-|++..|+||
T Consensus       111 lrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmws  187 (292)
T KOG0662|consen  111 LRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS  187 (292)
T ss_pred             Hhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhh
Confidence            99999999   7899999999999999999999999999998654321            11333333 45788999999


Q ss_pred             HHHHHHHHHhcCCC
Q 040999          265 YGILLLELMIREKP  278 (382)
Q Consensus       265 ~Gvil~elltg~~p  278 (382)
                      -|||+.|+.....|
T Consensus       188 agcifaelanagrp  201 (292)
T KOG0662|consen  188 AGCIFAELANAGRP  201 (292)
T ss_pred             cchHHHHHhhcCCC
Confidence            99999999976555

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-24  Score=194.39  Aligned_cols=151  Identities=23%  Similarity=0.296  Sum_probs=128.0

Q ss_pred             chhhHH-----------HHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcccc
Q 040999          113 AFKIFK-----------SFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE  180 (382)
Q Consensus       113 avK~~~-----------~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~  180 (382)
                      |||+++           --+.|-++|.-- +-|.+++++.+     ++.-+.+|.||||+.+|+|--.+.          
T Consensus       378 AiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTmDRLyFVMEyvnGGDLMyhiQ----------  442 (683)
T KOG0696|consen  378 AIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTMDRLYFVMEYVNGGDLMYHIQ----------  442 (683)
T ss_pred             hhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhhhheeeEEEEecCchhhhHHH----------
Confidence            888882           245677777776 56788888776     566889999999999999976663          


Q ss_pred             CCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC------------CCCCCCC
Q 040999          181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL------------PPTRTQT  248 (382)
Q Consensus       181 ~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~------------~~~~~~~  248 (382)
                      +-+.+.+..+..++.+||-||-|||   +++|+.||||.+||++|.+|++||+|||+++.-            .+...+|
T Consensus       443 Q~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAP  519 (683)
T KOG0696|consen  443 QVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAP  519 (683)
T ss_pred             HhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCccccc
Confidence            3455778889999999999999999   889999999999999999999999999999742            3344557


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          249 KYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       249 ~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      |......|+..+|+|||||+||||+.|++||+.
T Consensus       520 EIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG  552 (683)
T KOG0696|consen  520 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  552 (683)
T ss_pred             ceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence            777788899999999999999999999999985

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.9e-23  Score=202.39  Aligned_cols=156  Identities=19%  Similarity=0.180  Sum_probs=111.8

Q ss_pred             HHHHHHhhcccccc-----eeeeeeeeeccc---CCCceeEEEEecccCCCccccccCCCCCC-----------c---cc
Q 040999          122 AECKALRNIRHRNL-----IKVLTACLGVDY---QGNDFKALVYEFIHNRSPEKWLYPISKED-----------E---TY  179 (382)
Q Consensus       122 ~E~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~---~~  179 (382)
                      .|+.++.+++|.++     ++++++|.....   ...+..++||||+++++|.++++......           .   ..
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46677777766654     677777653211   12456899999999999999986432100           0   00


Q ss_pred             cCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCC
Q 040999          180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRT  246 (382)
Q Consensus       180 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~  246 (382)
                      .....+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++....             ...
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~  377 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS  377 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence            11234678889999999999999999   77999999999999999999999999999865422             222


Q ss_pred             CCccccCCC----------------------CCccchhHHHHHHHHHHHhcCC-CCC
Q 040999          247 QTKYGVGNE----------------------VSTIGDVYSYGILLLELMIREK-PSD  280 (382)
Q Consensus       247 ~~~~~~~~~----------------------~~~~~Dv~S~Gvil~elltg~~-p~~  280 (382)
                      .||......                      ...+.||||+||++|||++|.. |+.
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            344332211                      1235799999999999999975 654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.90  E-value=5.9e-23  Score=177.93  Aligned_cols=165  Identities=25%  Similarity=0.416  Sum_probs=139.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++.++.++|++++++++++..     ....++++||+++++|.+++...         ...+++..+..++.++
T Consensus        36 ~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~~l  101 (215)
T cd00180          36 EELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEGGSLKDLLKEN---------EGKLSEDEILRILLQI  101 (215)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCCCcHHHHHHhc---------cCCCCHHHHHHHHHHH
Confidence            568999999999999999999999643     57889999999999999988421         1458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCCCC------------CCCccccCC-CCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPPTR------------TQTKYGVGN-EVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~-~~~~~~Dv~  263 (382)
                      ++++.|||   ..+++|+||+|.||+++. ++.++|+|||.+.......            ..|+..... ..+.++|+|
T Consensus       102 ~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~  178 (215)
T cd00180         102 LEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW  178 (215)
T ss_pred             HHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhH
Confidence            99999999   779999999999999999 8999999999998664432            224444444 677899999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ++|++++++                                                                ..+.+++
T Consensus       179 ~lg~~~~~l----------------------------------------------------------------~~~~~~l  194 (215)
T cd00180         179 SLGVILYEL----------------------------------------------------------------PELKDLI  194 (215)
T ss_pred             HHHHHHHHH----------------------------------------------------------------HHHHHHH
Confidence            999999998                                                                0456777


Q ss_pred             hccCCCCccCCCCHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ..|++.+|++||++.++++.
T Consensus       195 ~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         195 RKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHhhCCcccCcCHHHHhhC
Confidence            79999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.9e-23  Score=176.68  Aligned_cols=157  Identities=20%  Similarity=0.270  Sum_probs=120.8

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ++|.+|..---.| .|.||+.-|++-    ++..+....++||+|.|+|.+-+..           ..+.+....+++.|
T Consensus        65 ~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~YvF~qE~aP~gdL~snv~~-----------~GigE~~~K~v~~q  129 (378)
T KOG1345|consen   65 ADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAYVFVQEFAPRGDLRSNVEA-----------AGIGEANTKKVFAQ  129 (378)
T ss_pred             HHHHHHhccceeeccchhhhHHHHHH----hhcCceEEEeeccCccchhhhhcCc-----------ccccHHHHHHHHHH
Confidence            7899998765555 599999988774    5667888899999999999887732           34777888899999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeC--CCCcEEEccccccccCCCCC---------CCCcccc-----CCCCCccc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLD--DDMTARVGDFGLARFLPPTR---------TQTKYGV-----GNEVSTIG  260 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~--~~~~~kl~Dfg~a~~~~~~~---------~~~~~~~-----~~~~~~~~  260 (382)
                      ++.|+.|||   ++++||||||.+|||+-  +..++||+|||..+......         ..||...     .-...+.+
T Consensus       130 l~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~  206 (378)
T KOG1345|consen  130 LLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPST  206 (378)
T ss_pred             HHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccc
Confidence            999999999   88999999999999993  34589999999987543221         1122211     12346789


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKF  292 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~  292 (382)
                      |||.||++++.++||+.||......+..+.+|
T Consensus       207 D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~  238 (378)
T KOG1345|consen  207 DIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW  238 (378)
T ss_pred             cchheeeeeeeeecCCCcchhhhccCchHHHH
Confidence            99999999999999999998544444444444

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-22  Score=177.22  Aligned_cols=145  Identities=23%  Similarity=0.332  Sum_probs=126.1

Q ss_pred             HHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          120 FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       120 ~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.|-.+..+. +||.+|.++.+     ++.+...+.|.||+++|+|--.+          .+.+.+++..+..+...|.
T Consensus       297 vqtek~vfe~asn~pflvglhsc-----fqtesrlffvieyv~ggdlmfhm----------qrqrklpeeharfys~ei~  361 (593)
T KOG0695|consen  297 VQTEKHVFEQASNNPFLVGLHSC-----FQTESRLFFVIEYVNGGDLMFHM----------QRQRKLPEEHARFYSAEIC  361 (593)
T ss_pred             HHhhHHHHHhccCCCeEEehhhh-----hcccceEEEEEEEecCcceeeeh----------hhhhcCcHHHhhhhhHHHH
Confidence            45677777776 69999998877     56788999999999999997666          3456799999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC------------CCCCCCCccccCCCCCccchhHHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL------------PPTRTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~------------~~~~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      -||.|||   +.+|+.||+|.+|+|+|..|++|+.|+|..+.-            .+...+||...+.+|...+|+|++|
T Consensus       362 lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalg  438 (593)
T KOG0695|consen  362 LALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALG  438 (593)
T ss_pred             HHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHH
Confidence            9999999   789999999999999999999999999998742            2233447778899999999999999


Q ss_pred             HHHHHHHhcCCCCCcc
Q 040999          267 ILLLELMIREKPSDIM  282 (382)
Q Consensus       267 vil~elltg~~p~~~~  282 (382)
                      |+++||+.|+.||+..
T Consensus       439 vlmfemmagrspfdiv  454 (593)
T KOG0695|consen  439 VLMFEMMAGRSPFDIV  454 (593)
T ss_pred             HHHHHHHcCCCCccee
Confidence            9999999999999854

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-22  Score=185.44  Aligned_cols=100  Identities=29%  Similarity=0.458  Sum_probs=83.5

Q ss_pred             chhhH-------HHHHHHHHHHhhcc-----c---ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc
Q 040999          113 AFKIF-------KSFIAECKALRNIR-----H---RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE  177 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~  177 (382)
                      |+|+.       +.-+.||++|++++     |   .+||+|++.+.... ....+.++|+|+. |.+|..++..      
T Consensus       107 AlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvL-GdnLLklI~~------  178 (590)
T KOG1290|consen  107 ALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVL-GDNLLKLIKY------  178 (590)
T ss_pred             EEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-CCCcEEEEEehhh-hhHHHHHHHH------
Confidence            77666       56788999999995     2   37999999976533 3467899999999 6688888853      


Q ss_pred             cccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceee
Q 040999          178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL  224 (382)
Q Consensus       178 ~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl  224 (382)
                        ...+.++...+..|+.||+.||.|||..|  +|||-||||+|||+
T Consensus       179 --s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  179 --SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             --hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              34567999999999999999999999976  99999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.87  E-value=4.8e-23  Score=190.06  Aligned_cols=153  Identities=22%  Similarity=0.262  Sum_probs=128.6

Q ss_pred             chhhH-------HHHHHHHHHHhhcc------cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIR------HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY  179 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~  179 (382)
                      |||++       +.=++|+++|++|+      --|+++++..+.     ..+++|||+|-+ ..+|...|....      
T Consensus       461 AiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~-----hknHLClVFE~L-slNLRevLKKyG------  528 (752)
T KOG0670|consen  461 AIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK-----HKNHLCLVFEPL-SLNLREVLKKYG------  528 (752)
T ss_pred             EEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh-----hcceeEEEehhh-hchHHHHHHHhC------
Confidence            99988       55678999999995      348888877743     488999999987 457888886543      


Q ss_pred             cCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCCCCCC----------CC
Q 040999          180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLPPTRT----------QT  248 (382)
Q Consensus       180 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~~~~~----------~~  248 (382)
                       ....|....+..++.|+.-||..|-   ..+|+|.||||+|||+++. ..+||||||.|........          +|
T Consensus       529 -~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaP  604 (752)
T KOG0670|consen  529 -RNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAP  604 (752)
T ss_pred             -cccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccccccccccccHHHHHHhccCc
Confidence             3456788889999999999999999   6699999999999999876 4589999999987765543          38


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          249 KYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       249 ~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      |...|..|+...|+||.||+||||.||+..|.+
T Consensus       605 EIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  605 EIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             ceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            888999999999999999999999999998764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.87  E-value=9.2e-22  Score=172.88  Aligned_cols=148  Identities=27%  Similarity=0.374  Sum_probs=125.9

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc-cCHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN-LNLLRRLNIA  194 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~  194 (382)
                      ..+.+.+|++.+++++|+|++++++++..     ....++++||+++++|.+++..          ... +++.....++
T Consensus        40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~  104 (225)
T smart00221       40 QREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLVMEYCEGGDLFDYLRK----------KGGKLSEEEARFYL  104 (225)
T ss_pred             HHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEEEeccCCCCHHHHHHh----------cccCCCHHHHHHHH
Confidence            45678999999999999999999998643     5778999999999999998842          122 7889999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-------------CCCccc-cCCCCCccc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-------------TQTKYG-VGNEVSTIG  260 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~-~~~~~~~~~  260 (382)
                      .+++.++.|||   ..+++|+|++|+||+++.++.++|+|||.+.......             ..||.. ....++.++
T Consensus       105 ~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~  181 (225)
T smart00221      105 RQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAV  181 (225)
T ss_pred             HHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchh
Confidence            99999999999   6799999999999999999999999999998765432             224544 445667799


Q ss_pred             hhHHHHHHHHHHHhcCCCCCc
Q 040999          261 DVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~  281 (382)
                      ||||||++++||++|+.||+.
T Consensus       182 Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      182 DIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             hHHHHHHHHHHHHHCCCCccc
Confidence            999999999999999999864

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.86  E-value=1.9e-22  Score=188.22  Aligned_cols=143  Identities=22%  Similarity=0.337  Sum_probs=124.5

Q ss_pred             HHHHHHHHhhcc---cccceeeeeeeeecccCCCceeEEEEecc-cCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          120 FIAECKALRNIR---HRNLIKVLTACLGVDYQGNDFKALVYEFI-HNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       120 ~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .-.||++|..++   |+||++++++     ++++++.||+||-- ++-+|.+++          +....+++.....|+.
T Consensus       613 Vp~EIqIla~l~~~sH~NIlKlLdf-----FEddd~yyl~te~hg~gIDLFd~I----------E~kp~m~E~eAk~IFk  677 (772)
T KOG1152|consen  613 VPSEIQILATLNKHSHENILKLLDF-----FEDDDYYYLETEVHGEGIDLFDFI----------EFKPRMDEPEAKLIFK  677 (772)
T ss_pred             cchhHHHHHHhhhcCccchhhhhhe-----eecCCeeEEEecCCCCCcchhhhh----------hccCccchHHHHHHHH
Confidence            456999999997   9999999999     56789999999853 566888888          4556799999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------CCCCccccCCCC-CccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------RTQTKYGVGNEV-STIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~~-~~~~Dv~S  264 (382)
                      ||+.|+++||   +++|||||||-+|+.++.+|-+||+|||.|.+...+          ..+||...|..| +...|||+
T Consensus       678 QV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwa  754 (772)
T KOG1152|consen  678 QVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWA  754 (772)
T ss_pred             HHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhh
Confidence            9999999999   889999999999999999999999999999866443          344787777665 66789999


Q ss_pred             HHHHHHHHHhcCCCCC
Q 040999          265 YGILLLELMIREKPSD  280 (382)
Q Consensus       265 ~Gvil~elltg~~p~~  280 (382)
                      +|++||.++....||.
T Consensus       755 lgillytivykenpyy  770 (772)
T KOG1152|consen  755 LGILLYTIVYKENPYY  770 (772)
T ss_pred             hhheeeEEEeccCCCc
Confidence            9999999999999975

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=2.2e-21  Score=183.71  Aligned_cols=204  Identities=25%  Similarity=0.378  Sum_probs=151.6

Q ss_pred             HhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhh
Q 040999          127 LRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHH  206 (382)
Q Consensus       127 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~  206 (382)
                      |+.+.|.|+.+++|.|+.     ....+.|.+||+.|+|.+.+.         .....+++.....+.++|++||.|+|+
T Consensus         1 l~~l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~---------~~~~~~d~~F~~s~~rdi~~Gl~ylh~   66 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILS---------NEDIKLDYFFILSFIRDISKGLAYLHN   66 (484)
T ss_pred             CcccchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHh---------ccccCccHHHHHHHHHHHHHHHHHHhc
Confidence            467899999999999875     477899999999999999995         345678999999999999999999995


Q ss_pred             cCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCC-------CCCccchhHHH
Q 040999          207 DCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGN-------EVSTIGDVYSY  265 (382)
Q Consensus       207 ~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~-------~~~~~~Dv~S~  265 (382)
                        ++...|+.+++.|+++|....+|++|||+.......              +..||...+.       ..+.++|||||
T Consensus        67 --s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~  144 (484)
T KOG1023|consen   67 --SPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF  144 (484)
T ss_pred             --CcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence              333499999999999999999999999999877421              1224443321       25778999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCch--HHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          266 GILLLELMIREKPSDIMFEGDMN--LHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |++++|+++.+.||+........  +...++....    ....+.+                 ...   .+...++..++
T Consensus       145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~----~~~rP~i-----------------~~~---~e~~~~l~~l~  200 (484)
T KOG1023|consen  145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGS----NPFRPSI-----------------ELL---NELPPELLLLV  200 (484)
T ss_pred             HHHHHHHHhccCccccccccCChHHHHHHHHhcCC----CCcCcch-----------------hhh---hhcchHHHHHH
Confidence            99999999999999864332221  1111111000    0000000                 000   03334688899


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+||..+|++||++++|-..++.+...
T Consensus       201 ~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  201 ARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             HHhcccChhhCccHHHHHhhhhhhccc
Confidence            999999999999999999988877654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.83  E-value=1.1e-21  Score=185.98  Aligned_cols=198  Identities=20%  Similarity=0.277  Sum_probs=148.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +-...|+-+++..+|+|||.++|-+.     ..+..|+.||||.+|+|++..+          ...++++.++..+++..
T Consensus        57 ~~iqqei~~~~dc~h~nivay~gsyl-----r~dklwicMEycgggslQdiy~----------~TgplselqiayvcRet  121 (829)
T KOG0576|consen   57 SGIQQEIGMLRDCRHPNIVAYFGSYL-----RRDKLWICMEYCGGGSLQDIYH----------VTGPLSELQIAYVCRET  121 (829)
T ss_pred             cccccceeeeecCCCcChHHHHhhhh-----hhcCcEEEEEecCCCcccceee----------ecccchhHHHHHHHhhh
Confidence            45678999999999999999999854     3778999999999999998774          35679999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccc---cCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYG---VGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~---~~~~~~~~~Dv  262 (382)
                      .+||+|||   +++-+|||||-.|||+++.|.+|++|||.+..+.            +.+..||..   ..+.|..++||
T Consensus       122 l~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdi  198 (829)
T KOG0576|consen  122 LQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI  198 (829)
T ss_pred             hccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccc
Confidence            99999999   8899999999999999999999999999986442            333445543   24567899999


Q ss_pred             HHHHHHHHHHHhcCCC-CCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKP-SDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |+.|++..|+-.-++| |+.+     .+....-+.-     ...++.-.++..                   .....+-+
T Consensus       199 wa~gitAiel~eLqpplfdlh-----pmr~l~LmTk-----S~~qpp~lkDk~-------------------kws~~fh~  249 (829)
T KOG0576|consen  199 WALGITAIELGELQPPLFDLH-----PMRALFLMTK-----SGFQPPTLKDKT-------------------KWSEFFHN  249 (829)
T ss_pred             cccccchhhhhhcCCcccccc-----hHHHHHHhhc-----cCCCCCcccCCc-------------------cchHHHHH
Confidence            9999999999887777 2211     1111111100     011111111110                   22345677


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++..|+.++|++||+++.+++
T Consensus       250 fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHhcCCCccCCChhhhee
Confidence            778999999999999987664

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.81  E-value=2.9e-20  Score=168.28  Aligned_cols=229  Identities=20%  Similarity=0.234  Sum_probs=152.2

Q ss_pred             chhhH------HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF------KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+      .++.+|++.|..+ .+.||+++.++     +..++...+|+||++.-+..++..             .+
T Consensus        68 alk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~-----~rnnd~v~ivlp~~~H~~f~~l~~-------------~l  129 (418)
T KOG1167|consen   68 ALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGC-----FRNNDQVAIVLPYFEHDRFRDLYR-------------SL  129 (418)
T ss_pred             eeeecccccCchHHHHHHHHHHHhccchhhhcchhh-----hccCCeeEEEecccCccCHHHHHh-------------cC
Confidence            77776      7899999999999 59999999988     455889999999999988887773             46


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCCCCC----------------CC-
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLPPTR----------------TQ-  247 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~~~~----------------~~-  247 (382)
                      +...+..++..+..||+++|   ..|||||||||+|+|.+.. ++-.|.|||+|.......                .. 
T Consensus       130 ~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~  206 (418)
T KOG1167|consen  130 SLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGK  206 (418)
T ss_pred             CHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccC
Confidence            78889999999999999999   8899999999999999865 567899999997211000                00 


Q ss_pred             ---------------------------------------Ccccc-CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCc
Q 040999          248 ---------------------------------------TKYGV-GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM  287 (382)
Q Consensus       248 ---------------------------------------~~~~~-~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~  287 (382)
                                                             ||... .+.-++++||||-|||++-+++++.||-....+-.
T Consensus       207 ~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~  286 (418)
T KOG1167|consen  207 DVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDAD  286 (418)
T ss_pred             cccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccc
Confidence                                                   11100 12337789999999999999999999854333333


Q ss_pred             hHHHHHHHhcCCchhh---hhhc--ccc-----cchhh----hhh-ccccch-hh--hhhhhHHHH-HHHHHHHhhccCC
Q 040999          288 NLHKFAKMALPNHVKD---IVDS--ILL-----NDDEK----LVV-RGDQKQ-TQ--AKINVIIEC-VISMVRIGVACSM  348 (382)
Q Consensus       288 ~~~~~~~~~~~~~~~~---~~~~--~~~-----~~~~~----~~~-~~~~~~-~~--~~~~~~~~~-~~~~~~l~~~Cl~  348 (382)
                      .+.+.+....+..+..   +.+.  ...     ...+.    ... .+.... .+  .......++ +..++++..+|++
T Consensus       287 al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le  366 (418)
T KOG1167|consen  287 ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLE  366 (418)
T ss_pred             hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHcc
Confidence            3333332222211111   0011  000     00000    000 000000 00  011111222 3367888889999


Q ss_pred             CCccCCCCHHHHHH
Q 040999          349 ESPQDRMKMTNVVH  362 (382)
Q Consensus       349 ~~p~~RPs~~evl~  362 (382)
                      .||.+|.|++|.++
T Consensus       367 ~np~kRitAEeALk  380 (418)
T KOG1167|consen  367 LNPQKRITAEDALK  380 (418)
T ss_pred             CChhhcccHHHHhc
Confidence            99999999999884

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.80  E-value=5.5e-20  Score=157.61  Aligned_cols=206  Identities=25%  Similarity=0.354  Sum_probs=152.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|..|.-.|+-+.||||..++|.|-+     +.+..++..||+.|||+..|++..        ....+-.+..+++.+|
T Consensus       232 rdfneefp~lrifshpnilpvlgacns-----ppnlv~isq~mp~gslynvlhe~t--------~vvvd~sqav~faldi  298 (448)
T KOG0195|consen  232 RDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVIISQYMPFGSLYNVLHEQT--------SVVVDHSQAVRFALDI  298 (448)
T ss_pred             chhhhhCcceeeecCCchhhhhhhccC-----CCCceEeeeeccchHHHHHHhcCc--------cEEEecchHHHHHHHH
Confidence            689999999999999999999999865     677889999999999999998533        3456778999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEc--c--ccc---cccCCCCCCCCccccCCCC---CccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVG--D--FGL---ARFLPPTRTQTKYGVGNEV---STIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~--D--fg~---a~~~~~~~~~~~~~~~~~~---~~~~Dv~S~Gv  267 (382)
                      |+|++|||+- ++-|..--+.+..+++|++.+++|+  |  |.+   .+.+.+.+..||......-   -.++|+|||.+
T Consensus       299 argmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfai  377 (448)
T KOG0195|consen  299 ARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAI  377 (448)
T ss_pred             HhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHH
Confidence            9999999975 5556666789999999999887764  3  222   2344556666766554332   34789999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ++||+.|+..||.....-+..    .+..+..     +...+.+                      .....+.+++.-|+
T Consensus       378 llwel~trevpfadlspmecg----mkialeg-----lrv~ipp----------------------gis~hm~klm~icm  426 (448)
T KOG0195|consen  378 LLWELNTREVPFADLSPMECG----MKIALEG-----LRVHIPP----------------------GISRHMNKLMNICM  426 (448)
T ss_pred             HHHHhhccccccccCCchhhh----hhhhhcc-----ccccCCC----------------------CccHHHHHHHHHHh
Confidence            999999999998653221111    1111100     0000000                      22345677888999


Q ss_pred             CCCccCCCCHHHHHHHHHHhh
Q 040999          348 MESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       348 ~~~p~~RPs~~evl~~L~~i~  368 (382)
                      ..||.+||.+..|+-.|+++.
T Consensus       427 nedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  427 NEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cCCCCcCCCcceehhhHHHhc
Confidence            999999999999999988764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=8.9e-20  Score=180.53  Aligned_cols=208  Identities=18%  Similarity=0.185  Sum_probs=151.1

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+..|.-+-..++|+|++..+..+..     .....-+||||++ +|..++.          ....++...+-.++.|+.
T Consensus       367 ~i~sE~~i~~~l~h~~~~e~l~~~~~-----~~~~~~~mE~~~~-Dlf~~~~----------~~~~~~~~e~~c~fKqL~  430 (601)
T KOG0590|consen  367 NITSEFCIGSSLSHPNIIETLDIVQE-----IDGILQSMEYCPY-DLFSLVM----------SNGKLTPLEADCFFKQLL  430 (601)
T ss_pred             hhhhheeecccccCCchhhhHHHHhh-----cccchhhhhcccH-HHHHHHh----------cccccchhhhhHHHHHHH
Confidence            36777777888999999877666432     2333334999999 9999883          234578888889999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------------CCCCCccccCCCCCc-cch
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------------TRTQTKYGVGNEVST-IGD  261 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------------~~~~~~~~~~~~~~~-~~D  261 (382)
                      .|++|+|   ..+|.|||+|++|++++.++.+||+|||.+.....                ...+||...+.+|.+ ..|
T Consensus       431 ~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vD  507 (601)
T KOG0590|consen  431 RGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVD  507 (601)
T ss_pred             HHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhh
Confidence            9999999   78999999999999999999999999999875422                223377777777754 589


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||.|+++..|++|+.||......+..+   .......+....                     .+........+.....
T Consensus       508 iwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~~~---------------------~~~~~~~~~lp~~~~~  563 (601)
T KOG0590|consen  508 VWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRNIF---------------------EGPNRLLSLLPRETRI  563 (601)
T ss_pred             hhhccceEEEEecCCCccccccccccch---hhhccccccccc---------------------cChHHHHHhchhhHHH
Confidence            9999999999999999987543322221   111111111100                     1111223356677888


Q ss_pred             HhhccCCCCccCCCCHHHHHH--HHHHhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVH--ELQSIKN  369 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~--~L~~i~~  369 (382)
                      ++.++++.+|.+|.|+++|++  .++++..
T Consensus       564 ~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  564 IIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             HHHHHccCChhheecHHHHhhChHhhhcce
Confidence            999999999999999999984  4444443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=4.3e-18  Score=153.24  Aligned_cols=188  Identities=21%  Similarity=0.220  Sum_probs=125.7

Q ss_pred             ccccceeeeeeeeec----------------------ccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHH
Q 040999          131 RHRNLIKVLTACLGV----------------------DYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLL  188 (382)
Q Consensus       131 ~h~niv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~  188 (382)
                      +|||||++.+++++.                      .+..+...|+||.-++. +|..++.           ....+..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----------~~~~s~r  341 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----------TRHRSYR  341 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----------cCCCchH
Confidence            599999998886432                      12234567888887754 7888873           2235556


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceee--CCCC--cEEEccccccccCCC------------------CCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL--DDDM--TARVGDFGLARFLPP------------------TRT  246 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl--~~~~--~~kl~Dfg~a~~~~~------------------~~~  246 (382)
                      ...-++.|+++|+.|||   .++|.|||+|++|||+  |+++  .+.|+|||++---..                  ...
T Consensus       342 ~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm  418 (598)
T KOG4158|consen  342 TGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM  418 (598)
T ss_pred             HHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence            67778999999999999   8899999999999999  4443  578999999742111                  011


Q ss_pred             CCccccCC-----C-CCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhcc
Q 040999          247 QTKYGVGN-----E-VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRG  320 (382)
Q Consensus       247 ~~~~~~~~-----~-~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (382)
                      .||.....     . --.|+|.|+.|.+.||+++...||...-+.-.+...+.+..+|.                     
T Consensus       419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa---------------------  477 (598)
T KOG4158|consen  419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA---------------------  477 (598)
T ss_pred             chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC---------------------
Confidence            24433221     1 13589999999999999999999874211111222222222110                     


Q ss_pred             ccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHH
Q 040999          321 DQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                                ..+.++..+.+++...++.||++|++..-....|
T Consensus       478 ----------lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  478 ----------LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             ----------CcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence                      0113455678888899999999999876555444

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.74  E-value=1.7e-18  Score=150.14  Aligned_cols=133  Identities=12%  Similarity=0.147  Sum_probs=104.0

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeeccc---CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDY---QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+|++.+.+++|++|..+..++.....   ......++||||++|.+|.++..              ++.    ....
T Consensus        81 ~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~  142 (232)
T PRK10359         81 YYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKA  142 (232)
T ss_pred             HHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHH
Confidence            37899999999999999999887543211   11346899999999999877641              221    2456


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCCCccccCCCCCccchhHHHHHHHHHHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM  273 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~ell  273 (382)
                      +++.++..+|   ..+++|||+||+||+++.++ ++|+|||..+..........+.....+..++|+||||+++.-..
T Consensus       143 ~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        143 KIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             HHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHHHHHHHhHhcccccccceeEeehHHH
Confidence            9999999999   78999999999999999988 99999999987654444444445556778999999999887654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.69  E-value=5.1e-16  Score=143.47  Aligned_cols=211  Identities=25%  Similarity=0.308  Sum_probs=148.7

Q ss_pred             hHHHHHHHHHHHhhcccc-cceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHR-NLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ....+.+|+.+++.+.|+ +|+++++.+.     .....+++++++.++++.+++.....      . ..++......+.
T Consensus        40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~~~~~~~------~-~~~~~~~~~~~~  107 (384)
T COG0515          40 EVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSLYLVMEYVDGGSLEDLLKKIGR------K-GPLSESEALFIL  107 (384)
T ss_pred             HHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEEEEEEecCCCCcHHHHHHhccc------c-cCCCHHHHHHHH
Confidence            356799999999999988 7999999853     24557999999999999966632110      0 368889999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC-cEEEccccccccCCCCC------------------CCCccccC--
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPPTR------------------TQTKYGVG--  253 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~------------------~~~~~~~~--  253 (382)
                      .|++.++.|+|   ..+++|||+||+||+++... .++++|||.++......                  ..|+...+  
T Consensus       108 ~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~  184 (384)
T COG0515         108 AQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS  184 (384)
T ss_pred             HHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCC
Confidence            99999999999   77899999999999999988 79999999987544321                  12454444  


Q ss_pred             -CCCCccchhHHHHHHHHHHHhcCCCCCccccC--CchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhh
Q 040999          254 -NEVSTIGDVYSYGILLLELMIREKPSDIMFEG--DMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN  330 (382)
Q Consensus       254 -~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (382)
                       ...+...|+||+|++++++++|..||......  ..............        ........       .  ..   
T Consensus       185 ~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~-------~--~~---  244 (384)
T COG0515         185 LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--------SLASPLSP-------S--NP---  244 (384)
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--------ccccccCc-------c--cc---
Confidence             47788999999999999999999996542211  01111111111110        00000000       0  00   


Q ss_pred             hHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          331 VIIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       331 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                        ......+.+++..|+..+|..|.++.+....
T Consensus       245 --~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         245 --ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              1123456777778999999999998887764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.3e-16  Score=135.76  Aligned_cols=133  Identities=22%  Similarity=0.119  Sum_probs=101.1

Q ss_pred             HHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+.+|+++|+++. |+++.+++++         +..+++|||+.+.+|.+.+.          .       ....++.|+
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~---------~~~~lvmeyI~G~~L~~~~~----------~-------~~~~~~~qi  100 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW---------DGRHLDRSYLAGAAMYQRPP----------R-------GDLAYFRAA  100 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE---------cCEEEEEeeecCccHHhhhh----------h-------hhHHHHHHH
Confidence            4789999999995 5889998886         23589999999988764331          0       113477899


Q ss_pred             HHHHhHHhhcCCCceeecCC-CCCceeeCCCCcEEEccccccccCCCCCC--------------------CCccccC---
Q 040999          198 ASALNYLHHDCQPVTAHCDL-KPSNVLLDDDMTARVGDFGLARFLPPTRT--------------------QTKYGVG---  253 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dl-kp~NILl~~~~~~kl~Dfg~a~~~~~~~~--------------------~~~~~~~---  253 (382)
                      +++|.++|   ..+|+|||| ||+|||++.++.++|+|||+|........                    .|++...   
T Consensus       101 ~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~  177 (218)
T PRK12274        101 RRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVER  177 (218)
T ss_pred             HHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHH
Confidence            99999999   789999999 79999999999999999999985543321                    0222111   


Q ss_pred             ---CCCC-ccchhHHHHHHHHHHHhcCCCCC
Q 040999          254 ---NEVS-TIGDVYSYGILLLELMIREKPSD  280 (382)
Q Consensus       254 ---~~~~-~~~Dv~S~Gvil~elltg~~p~~  280 (382)
                         ...+ ...+.++-|.-+|.++|+..+.-
T Consensus       178 ~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        178 RVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             hhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence               0112 34688999999999999998854

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=2.6e-16  Score=146.62  Aligned_cols=97  Identities=27%  Similarity=0.236  Sum_probs=78.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|+++|++++|+|+++.+..        .+..++||||+++++|....           ...      ...++.++
T Consensus        66 ~~~~~E~~iL~~L~h~~iv~~l~~--------~~~~~LVmE~~~G~~L~~~~-----------~~~------~~~~~~~i  120 (365)
T PRK09188         66 HLAAREIRALKTVRGIGVVPQLLA--------TGKDGLVRGWTEGVPLHLAR-----------PHG------DPAWFRSA  120 (365)
T ss_pred             HHHHHHHHHHHhccCCCCCcEEEE--------cCCcEEEEEccCCCCHHHhC-----------ccc------hHHHHHHH
Confidence            458999999999999999853322        13469999999999986211           000      13678899


Q ss_pred             HHHHhHHhhcCCCceeecCC-CCCceeeCCCCcEEEccccccccCC
Q 040999          198 ASALNYLHHDCQPVTAHCDL-KPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dl-kp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      ++||.|||   +.+|+|||| ||+|||++.++.+||+|||+|+...
T Consensus       121 ~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188        121 HRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             HHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            99999999   789999999 9999999999999999999998653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.64  E-value=8.8e-17  Score=160.70  Aligned_cols=197  Identities=17%  Similarity=0.235  Sum_probs=136.0

Q ss_pred             hhhHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHH
Q 040999          114 FKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNI  193 (382)
Q Consensus       114 vK~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i  193 (382)
                      ..-+++-.+|++ ...++|||.+++.-+-     ......|||-+|..+ +|++.+.          ....+...+.+-|
T Consensus        63 L~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kAAylvRqyvkh-nLyDRlS----------TRPFL~~iEKkWi  125 (1431)
T KOG1240|consen   63 LRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKAAYLVRQYVKH-NLYDRLS----------TRPFLVLIEKKWI  125 (1431)
T ss_pred             chHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHHHHHHHHHHhh-hhhhhhc----------cchHHHHHHHHHH
Confidence            333445555666 5667999999876652     235556778888744 7888883          3345677788889


Q ss_pred             HHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEcccccccc--CCCCCC-----------------CCccccC-
Q 040999          194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF--LPPTRT-----------------QTKYGVG-  253 (382)
Q Consensus       194 ~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~--~~~~~~-----------------~~~~~~~-  253 (382)
                      +-|++.||.-+|   ..+|.|+|||.+|||++.-..+.|+||..-+.  ++.+..                 +||.... 
T Consensus       126 aFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~  202 (1431)
T KOG1240|consen  126 AFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSA  202 (1431)
T ss_pred             HHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhcc
Confidence            999999999999   88999999999999999999999999987652  222111                 1333211 


Q ss_pred             ----------CCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhc--CCchhhhhhcccccchhhhhhcc
Q 040999          254 ----------NEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMAL--PNHVKDIVDSILLNDDEKLVVRG  320 (382)
Q Consensus       254 ----------~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  320 (382)
                                ...+++-||||.||++.||++ |++||+.        .+...-.-  ......+++.+            
T Consensus       203 ~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------SQL~aYr~~~~~~~e~~Le~I------------  262 (1431)
T KOG1240|consen  203 LGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------SQLLAYRSGNADDPEQLLEKI------------  262 (1431)
T ss_pred             ccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------HHHHhHhccCccCHHHHHHhC------------
Confidence                      125788999999999999998 5777752        22221110  11111111110            


Q ss_pred             ccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHH
Q 040999          321 DQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L  364 (382)
                                    .-..+..+++.|++.||++|-++++.++.-
T Consensus       263 --------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  263 --------------EDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             --------------cCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence                          012578888899999999999999999873

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.62  E-value=1.3e-15  Score=130.36  Aligned_cols=102  Identities=17%  Similarity=0.092  Sum_probs=79.3

Q ss_pred             HHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHH
Q 040999          120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVAS  199 (382)
Q Consensus       120 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~  199 (382)
                      ..+|++.+.++.++++.....+.       ....++||||++++++.....          ....++......++.|++.
T Consensus        66 ~~~E~~~l~~l~~~~v~~p~~~~-------~~~~~iVmE~i~g~~l~~~~~----------~~~~~~~~~~~~i~~qi~~  128 (190)
T cd05147          66 AEKEMRNLKRLVTAGIPCPEPIL-------LKSHVLVMEFIGDDGWAAPRL----------KDAPLSESKARELYLQVIQ  128 (190)
T ss_pred             HHHHHHHHHHHHHCCCCCCcEEE-------ecCCEEEEEEeCCCCCcchhh----------hcCCCCHHHHHHHHHHHHH
Confidence            45799999999988774433221       112389999999877654431          2245788899999999999


Q ss_pred             HHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       200 ~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      +|.|+||  ..+|+||||||+|||++ ++.++|+|||+|...
T Consensus       129 ~L~~l~H--~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         129 IMRILYQ--DCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HHHHHHH--hCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            9999943  56999999999999998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10345 hypothetical protein; Provisional

Probab=99.62  E-value=1.3e-15  Score=131.79  Aligned_cols=103  Identities=15%  Similarity=0.133  Sum_probs=79.2

Q ss_pred             HHHHHHHHHHhhc-----ccccceeeeeeeeecccCCCce-eEEEEec--ccCCCccccccCCCCCCccccCCcccCHHH
Q 040999          118 KSFIAECKALRNI-----RHRNLIKVLTACLGVDYQGNDF-KALVYEF--IHNRSPEKWLYPISKEDETYERPRNLNLLR  189 (382)
Q Consensus       118 ~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~-~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~  189 (382)
                      +.+.+|+++++.+     .||||++++|++.+  ..+.+. ..+|+||  +++|+|.+++..           ..+++. 
T Consensus        41 ~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et--~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----------~~~~e~-  106 (210)
T PRK10345         41 KEIRRELKYYAHLSRRLIDWSGIPRYYGTVET--DCGTGYVYDVIADFDGKPSITLTEFAEQ-----------CRYEED-  106 (210)
T ss_pred             HHHHHHHHHHHHhhccCCCCcccceeeEEEEe--CCCCeEEEEEEecCCCCcchhHHHHHHc-----------ccccHh-
Confidence            5789999999999     57999999999654  112234 3478999  668999999932           124444 


Q ss_pred             HHHHHHHHHHHH-hHHhhcCCCceeecCCCCCceeeCC----CCcEEEcccccc
Q 040999          190 RLNIAIDVASAL-NYLHHDCQPVTAHCDLKPSNVLLDD----DMTARVGDFGLA  238 (382)
Q Consensus       190 ~~~i~~~i~~~L-~~lH~~~~~~ivH~dlkp~NILl~~----~~~~kl~Dfg~a  238 (382)
                       ..++.+++.++ +|||   +.+|+||||||+|||++.    +..++|+||+.+
T Consensus       107 -~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        107 -VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             -HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence             35678888888 9999   789999999999999974    347999995444

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.60  E-value=3e-15  Score=128.47  Aligned_cols=104  Identities=19%  Similarity=0.119  Sum_probs=81.2

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|.+.+.++.|+++.....+..       ...++||||++++++.....          ....++......++.|++
T Consensus        65 ~~~~E~~~l~~l~~~~i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l----------~~~~~~~~~~~~i~~~l~  127 (190)
T cd05145          65 WAEKEFRNLKRLYEAGVPVPEPILL-------KKNVLVMEFIGDDGSPAPRL----------KDVPLEEEEAEELYEQVV  127 (190)
T ss_pred             HHHHHHHHHHHHHhCCCCCceEEEe-------cCCEEEEEEecCCCchhhhh----------hhccCCHHHHHHHHHHHH
Confidence            3568999999999998754444321       12489999998875533221          123467788899999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      .++.++|+  ..+|+||||||+||+++ ++.++|+|||+++...
T Consensus       128 ~~l~~lH~--~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         128 EQMRRLYQ--EAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             HHHHHHHH--hCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            99999994  17999999999999998 7899999999998664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.59  E-value=2.3e-14  Score=133.36  Aligned_cols=209  Identities=22%  Similarity=0.222  Sum_probs=142.0

Q ss_pred             HHHHHHHHHhhccc----ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          119 SFIAECKALRNIRH----RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       119 ~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      .+..|+.++..+..    +++.++++...    ....+.++||+.+ +.+|.++...        ...+.++..+.++++
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~~~~iVM~l~-G~sL~dl~~~--------~~~~~fs~~T~l~ia  128 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STEDFNFIVMSLL-GPSLEDLRKR--------NPPGRFSRKTVLRIA  128 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCceeEEEEecc-CccHHHHHHh--------CCCCCcCHhHHHHHH
Confidence            57788999988873    57788877731    3467889999988 7789886632        124679999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCC-----CcEEEccccccc--cCCCCC----CC----------------
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-----MTARVGDFGLAR--FLPPTR----TQ----------------  247 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-----~~~kl~Dfg~a~--~~~~~~----~~----------------  247 (382)
                      .|++.+|.++|   +.+++||||||+|+++...     ..+.+.|||+++  ......    ..                
T Consensus       129 ~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S  205 (322)
T KOG1164|consen  129 IQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYAS  205 (322)
T ss_pred             HHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCcccccc
Confidence            99999999999   8899999999999999765     358999999998  321111    00                


Q ss_pred             CccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhh
Q 040999          248 TKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQA  327 (382)
Q Consensus       248 ~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (382)
                      +....+.+.+.+.|+||++-++.|++.|..||........ ...+......    ..... ..                 
T Consensus       206 ~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~~~----~~~~~-~~-----------------  262 (322)
T KOG1164|consen  206 INVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDPRK----LLTDR-FG-----------------  262 (322)
T ss_pred             HHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHhhh----hcccc-cc-----------------
Confidence            0111234557889999999999999999999864322111 1111110000    00000 00                 


Q ss_pred             hhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          328 KINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       328 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                           ...+..+.++...+-..+..++|....+...++......
T Consensus       263 -----~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  263 -----DLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -----CCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                 011233444444555588899999999999988776653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=8.9e-15  Score=129.10  Aligned_cols=146  Identities=20%  Similarity=0.312  Sum_probs=115.1

Q ss_pred             HHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHh
Q 040999          126 ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLH  205 (382)
Q Consensus       126 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH  205 (382)
                      .|-++-|.|||+++.|+.+..+.+.....++.|||..|++.++|..-.      ...+.+......+|+.||..||.|||
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~------~~~~a~~~~~wkkw~tqIlsal~yLh  193 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK------KNQKALFQKAWKKWCTQILSALSYLH  193 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH------HhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence            455667999999999988777777788899999999999999996433      34456777778899999999999999


Q ss_pred             hcCCCceeecCCCCCceeeCCCCcEEEcccccccc----------------CCCCCCCCccccCCCCCccchhHHHHHHH
Q 040999          206 HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF----------------LPPTRTQTKYGVGNEVSTIGDVYSYGILL  269 (382)
Q Consensus       206 ~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~----------------~~~~~~~~~~~~~~~~~~~~Dv~S~Gvil  269 (382)
                      .. ++.|+|+++..+-|++..++-+|++--.-...                ..+....|+++.....+..+|||+||...
T Consensus       194 s~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA  272 (458)
T KOG1266|consen  194 SC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA  272 (458)
T ss_pred             cc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence            76 99999999999999999998888753211110                01222336666667778899999999999


Q ss_pred             HHHHhcCCC
Q 040999          270 LELMIREKP  278 (382)
Q Consensus       270 ~elltg~~p  278 (382)
                      +||..+..-
T Consensus       273 lemailEiq  281 (458)
T KOG1266|consen  273 LEMAILEIQ  281 (458)
T ss_pred             HHHHHheec
Confidence            999887643

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.52  E-value=3.9e-14  Score=119.97  Aligned_cols=152  Identities=24%  Similarity=0.290  Sum_probs=116.4

Q ss_pred             chhhH------HHHHHHHHHHhhccc-ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF------KSFIAECKALRNIRH-RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|+-      ..+..|.++.+.++| ..|..+..+     .....+-.+|||.. +.||++...         --.+.+
T Consensus        44 AiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~ynvlVMdLL-GPsLEdLfn---------fC~R~f  108 (341)
T KOG1163|consen   44 AIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDYNVLVMDLL-GPSLEDLFN---------FCSRRF  108 (341)
T ss_pred             EEEeecccCCCcchhHHHHHHHHhccCCCCchhhhh-----ccccccceeeeecc-CccHHHHHH---------HHhhhh
Confidence            66654      457889999999975 345454444     23467778999988 889988874         234678


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC---CcEEEccccccccCCCCCCC---C-----------
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD---MTARVGDFGLARFLPPTRTQ---T-----------  248 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfg~a~~~~~~~~~---~-----------  248 (382)
                      +..+++.++-|++.-++|+|   ..+++||||||+|+|..-+   .++.++|||+|+..-+..+.   |           
T Consensus       109 tmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTa  185 (341)
T KOG1163|consen  109 TMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTA  185 (341)
T ss_pred             hHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceee
Confidence            99999999999999999999   7789999999999999644   45889999999866443222   0           


Q ss_pred             -----ccccCCCCCccchhHHHHHHHHHHHhcCCCCCcc
Q 040999          249 -----KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM  282 (382)
Q Consensus       249 -----~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~  282 (382)
                           ....+.+-+.+.|+=|+|-+|....-|+.||...
T Consensus       186 RYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  186 RYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             eehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence                 0112234467789999999999999999999865

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.51  E-value=1.2e-14  Score=138.52  Aligned_cols=143  Identities=23%  Similarity=0.210  Sum_probs=118.4

Q ss_pred             HHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ....|..++..++ ||.+|++...     ++.+...+++++|..+|.+...+.          ....++......+...+
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ld~~rgg~lft~l~----------~~~~f~~~~~~~~~ael  106 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLILDFLRGGDLFTRLS----------KEVMFDELDVAFYLAEL  106 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeee-----eccccchhHhhhhcccchhhhccc----------cCCchHHHHHHHHHHHH
Confidence            5667888888887 9999998766     455788899999999999988773          34457777788888999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC--------CCCccccCCCCCccchhHHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR--------TQTKYGVGNEVSTIGDVYSYGILL  269 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~~~~~~~~~Dv~S~Gvil  269 (382)
                      +-+++++|   +.+|+|||+|++||+++.+|.+|+.|||+++..-...        ..||...  .....+|.||||++.
T Consensus       107 aLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~  181 (612)
T KOG0603|consen  107 ALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEYRAPEIIN--GHLSAADWWSFGVLA  181 (612)
T ss_pred             HHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccchhhhhhHhhh--ccCCcccchhhhhhH
Confidence            99999999   8899999999999999999999999999998654322        2233332  346789999999999


Q ss_pred             HHHHhcCCCCCc
Q 040999          270 LELMIREKPSDI  281 (382)
Q Consensus       270 ~elltg~~p~~~  281 (382)
                      +||+||..||..
T Consensus       182 felltg~~pf~~  193 (612)
T KOG0603|consen  182 FELLTGTLPFGG  193 (612)
T ss_pred             HHHhhCCCCCch
Confidence            999999999864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.50  E-value=2.9e-13  Score=119.74  Aligned_cols=152  Identities=20%  Similarity=0.265  Sum_probs=120.7

Q ss_pred             chhhH------HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF------KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.-      -++..|.+..+.|. .++|.++|-+     -+..-+-.||+|.. +.||+++..         --.+.+
T Consensus        57 AIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~NiLVidLL-GPSLEDLFD---------~CgR~F  121 (449)
T KOG1165|consen   57 AIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNILVIDLL-GPSLEDLFD---------LCGRRF  121 (449)
T ss_pred             EEEeccccCCcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhhhhhhhh-CcCHHHHHH---------HhcCcc
Confidence            66654      46888888888884 6888887765     23456678999988 778888773         235679


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC-----cEEEccccccccCCCCCCC-------------
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-----TARVGDFGLARFLPPTRTQ-------------  247 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-----~~kl~Dfg~a~~~~~~~~~-------------  247 (382)
                      +..++..++.|+..-++|+|   ++.+|.|||||+|+||...+     .+.++|||+|+...+..+.             
T Consensus       122 SvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsG  198 (449)
T KOG1165|consen  122 SVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSG  198 (449)
T ss_pred             cHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccccccc
Confidence            99999999999999999999   88999999999999996543     4889999999976443322             


Q ss_pred             ------CccccCCCCCccchhHHHHHHHHHHHhcCCCCCcc
Q 040999          248 ------TKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM  282 (382)
Q Consensus       248 ------~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~  282 (382)
                            -....|.+-+.+-|.=|+|-++++.+-|..||...
T Consensus       199 TARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  199 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             ceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence                  11123566688899999999999999999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.48  E-value=1.1e-14  Score=136.34  Aligned_cols=111  Identities=29%  Similarity=0.449  Sum_probs=94.5

Q ss_pred             ceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcE
Q 040999          151 DFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA  230 (382)
Q Consensus       151 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~  230 (382)
                      .+.++.|++|.-.+|.+|+....       .....++...+.++.|++.|++|      ++.+|||+||.||....+..+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~-------~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~  395 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRR-------TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQL  395 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCC-------cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhh
Confidence            45789999999999999995322       23456788889999999999999      489999999999999999999


Q ss_pred             EEccccccccCCCCC------------------CCCccccCCCCCccchhHHHHHHHHHHHh
Q 040999          231 RVGDFGLARFLPPTR------------------TQTKYGVGNEVSTIGDVYSYGILLLELMI  274 (382)
Q Consensus       231 kl~Dfg~a~~~~~~~------------------~~~~~~~~~~~~~~~Dv~S~Gvil~ellt  274 (382)
                      ||.|||+...+....                  +.||...+..|+.|+||||+|++|+|+++
T Consensus       396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            999999987654332                  23777788999999999999999999987

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.47  E-value=7.2e-14  Score=125.06  Aligned_cols=157  Identities=18%  Similarity=0.161  Sum_probs=96.2

Q ss_pred             EEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEc
Q 040999          154 ALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVG  233 (382)
Q Consensus       154 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~  233 (382)
                      +++|+-+ .+||.+++......   ......+....++.+..|+.+.+++||   ..+++|+||||+|++++.+|.++|+
T Consensus       115 ~~l~P~~-~~dL~~~~~~l~~~---~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg  187 (288)
T PF14531_consen  115 FLLMPRA-QGDLQDLVEALFSR---AQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLG  187 (288)
T ss_dssp             EEEEE---SEEHHHHHHHHHHH---TTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE-
T ss_pred             hhccchh-hhcHHHHHHHHhhc---ccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEc
Confidence            5677766 55777765311100   011233555666778899999999999   6799999999999999999999999


Q ss_pred             cccccccCCCC---------CCCCcccc--------CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHh
Q 040999          234 DFGLARFLPPT---------RTQTKYGV--------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA  296 (382)
Q Consensus       234 Dfg~a~~~~~~---------~~~~~~~~--------~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  296 (382)
                      ||+........         ...||...        ...++.+.|.|++|+++|.|++++.||+..........      
T Consensus       188 ~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------  261 (288)
T PF14531_consen  188 DFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------  261 (288)
T ss_dssp             -GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------
T ss_pred             ChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------
Confidence            99886543221         11222221        12468899999999999999999999875422211100      


Q ss_pred             cCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCC
Q 040999          297 LPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDR  354 (382)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~R  354 (382)
                             .+..                        +.+.+..+..|+...++.+|.+|
T Consensus       262 -------~f~~------------------------C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 -------DFSR------------------------CRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -------GGTT------------------------SS---HHHHHHHHHHT-SSGGGS
T ss_pred             -------cchh------------------------cCCcCHHHHHHHHHHccCCcccC
Confidence                   0110                        11345577888889999999998

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.45  E-value=2.2e-13  Score=118.88  Aligned_cols=100  Identities=20%  Similarity=0.292  Sum_probs=84.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++..++|++|.....++..     ....++||||+++++|.+++..             ..+ .+..++.++
T Consensus        44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~lv~e~~~G~~L~~~~~~-------------~~~-~~~~i~~~i  104 (211)
T PRK14879         44 ERTRREARIMSRARKAGVNVPAVYFVD-----PENFIIVMEYIEGEPLKDLINS-------------NGM-EELELSREI  104 (211)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCCEEEEEEeCCcCHHHHHHh-------------ccH-HHHHHHHHH
Confidence            468899999999999998776666432     4567899999999999988732             111 778899999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      +.+|.++|   ..+++|+|++|.||+++ ++.++++|||.++.
T Consensus       105 ~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        105 GRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999   77999999999999999 78899999999875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.45  E-value=1.7e-13  Score=136.15  Aligned_cols=97  Identities=23%  Similarity=0.299  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++++.++|++++....++..     ....++||||+++++|.+++.                  ....++.++
T Consensus       381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i  437 (535)
T PRK09605        381 ERTRAEARLLSEARRAGVPTPVIYDVD-----PEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKV  437 (535)
T ss_pred             HHHHHHHHHHHhhcccCCCeeEEEEEe-----CCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHH
Confidence            468899999999999999887666443     445689999999999988772                  356789999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      +++|.|||   +.+++|||+||+|||+ .++.++|+|||+++..
T Consensus       438 ~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        438 GEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             HHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999   7899999999999999 6778999999999754

>smart00090 RIO RIO-like kinase

Probab=99.44  E-value=4.5e-13  Score=118.64  Aligned_cols=101  Identities=18%  Similarity=0.121  Sum_probs=78.3

Q ss_pred             HHHHHHHHHhhccccc--ceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRN--LIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+|++++.++.+.+  +.+++++         ...++||||+++++|..+..          ....+.......++.|
T Consensus        96 ~~~~E~~~L~~L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~----------~~~~~~~~~~~~i~~q  156 (237)
T smart00090       96 WAEKEFRNLQRLYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRL----------KDVEPEEEEEFELYDD  156 (237)
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeeEe---------cCceEEEEEecCCccccccc----------ccCCcchHHHHHHHHH
Confidence            4678999999997643  3333432         12479999999988876542          1223455567789999


Q ss_pred             HHHHHhHHhhcCCCc-eeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          197 VASALNYLHHDCQPV-TAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       197 i~~~L~~lH~~~~~~-ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      ++.++.+||   ..+ ++||||||+||+++ ++.++|+|||.+....
T Consensus       157 i~~~l~~LH---~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      157 ILEEMRKLY---KEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             HHHHHHHHH---hcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            999999999   778 99999999999999 8899999999987543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.42  E-value=3.7e-13  Score=116.34  Aligned_cols=98  Identities=20%  Similarity=0.322  Sum_probs=79.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++..++|+++.....++..     ....++||||+++++|.+++..          ...       .++.++
T Consensus        42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~lv~e~~~g~~l~~~~~~----------~~~-------~~~~~i   99 (199)
T TIGR03724        42 ERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKTIVMEYIEGKPLKDVIEE----------GND-------ELLREI   99 (199)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCEEEEEEECCccHHHHHhh----------cHH-------HHHHHH
Confidence            568899999999998876544444322     4456899999999999887731          100       789999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      +++|.++|   ..+++|+|++|.||+++ ++.++++|||+++..
T Consensus       100 ~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724       100 GRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             HHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999999   78999999999999999 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.40  E-value=9.2e-13  Score=116.85  Aligned_cols=105  Identities=20%  Similarity=0.140  Sum_probs=79.8

Q ss_pred             HHHHHHHHHHhhcccccc--eeeeeeeeecccCCCceeEEEEecccC-CCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFIHN-RSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ..+.+|++++.+++|++|  ++.+++.... .......++|+|++++ .+|.+++..           ..++..    .+
T Consensus        85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~-~~~~~~~~lV~e~l~G~~~L~~~l~~-----------~~l~~~----~~  148 (239)
T PRK01723         85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVR-HGLFYRADILIERIEGARDLVALLQE-----------APLSEE----QW  148 (239)
T ss_pred             hHHHHHHHHHHHHHhCCCCCceeEeeeeee-cCcceeeeEEEEecCCCCCHHHHHhc-----------CCCCHH----HH
Confidence            457889999999999885  6666664321 0111223599999997 688877732           123332    35


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      .+++.+|.+||   ..+|+||||||.|||++.++.++|+|||.+...
T Consensus       149 ~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        149 QAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             HHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            78999999999   789999999999999999899999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.34  E-value=4.1e-12  Score=109.74  Aligned_cols=96  Identities=19%  Similarity=0.141  Sum_probs=76.7

Q ss_pred             HHHHHHHHHhhccccc--ceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRN--LIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+|..++.++.|++  +.+.++.         ...++||||+++++|.....                ......++.+
T Consensus        79 ~~~~E~~~l~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~----------------~~~~~~~~~~  133 (198)
T cd05144          79 AAQKEFAALKALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRV----------------LEDPEEVLDE  133 (198)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhccc----------------cccHHHHHHH
Confidence            4678999999998874  3333332         34589999999998866541                0234578899


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      ++.++.++|   ..+++||||||+||++++++.++|+|||.+....
T Consensus       134 i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         134 ILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             HHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            999999999   6799999999999999999999999999996544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.30  E-value=1.7e-11  Score=100.33  Aligned_cols=102  Identities=25%  Similarity=0.294  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHhhccc--ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRH--RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+|+..+..++|  .++.+++++.     ...+..++++||++++++..+                 +......++.
T Consensus        36 ~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~~~g~~~~~~-----------------~~~~~~~~~~   93 (155)
T cd05120          36 ADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEWIEGETLDEV-----------------SEEEKEDIAE   93 (155)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEecCCeecccC-----------------CHHHHHHHHH
Confidence            468999999999987  4888888773     234678999999988765432                 4456677899


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      +++++++++|.....+++|+|++|+||++++.+.+++.|||.++..
T Consensus        94 ~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          94 QLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             HHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            9999999999543368999999999999999899999999998643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=1.5e-11  Score=125.37  Aligned_cols=116  Identities=15%  Similarity=0.133  Sum_probs=96.5

Q ss_pred             CceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC---
Q 040999          150 NDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD---  226 (382)
Q Consensus       150 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~---  226 (382)
                      .+.-++|+||.+.|+|.+++.          ..+.++|..++.++.|++.-++.||   ..+|||+||||+|.||..   
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N----------~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~  832 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLIN----------TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREIC  832 (974)
T ss_pred             CCcceeeeeccccccHHHhhc----------cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccC
Confidence            556689999999999999993          4567899999999999999999999   789999999999999942   


Q ss_pred             ----CCcEEEccccccccCC---CCC-----------CCCccccCCCCCccchhHHHHHHHHHHHhcCCC
Q 040999          227 ----DMTARVGDFGLARFLP---PTR-----------TQTKYGVGNEVSTIGDVYSYGILLLELMIREKP  278 (382)
Q Consensus       227 ----~~~~kl~Dfg~a~~~~---~~~-----------~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p  278 (382)
                          ..-++|+|||.+-.+.   +..           .-.|...|..++..+|-|.+..+++-|+.|+.-
T Consensus       833 ~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  833 ADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             CCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence                2358999999996442   221           114555688999999999999999999999754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.23  E-value=3.2e-12  Score=128.37  Aligned_cols=81  Identities=27%  Similarity=0.346  Sum_probs=68.6

Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC---------------------------CCCCCCcc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP---------------------------PTRTQTKY  250 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~---------------------------~~~~~~~~  250 (382)
                      +.+++|+|   ..+|+|||+||+|.+++.-|++|+.|||+++...                           +.+..|++
T Consensus       153 vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            77999999   7899999999999999999999999999997531                           11222555


Q ss_pred             ccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          251 GVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       251 ~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      .....|+..+|+|++|+|+||.+.|+.||..
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffG  260 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFG  260 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccC
Confidence            5566788899999999999999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=3.9e-12  Score=126.47  Aligned_cols=154  Identities=23%  Similarity=0.268  Sum_probs=117.2

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +....|..+=..+. |+|++++++.     ....+..+++++|..++++...+..        ......+....-.++.|
T Consensus        65 ~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~~~~~~~~~~s~g~~~f~~i~~--------~~~~~~~~~~~~~~~~q  131 (601)
T KOG0590|consen   65 EHIDTETDIQKKLSKHSNTVHMIEP-----SSSPRSYLLSLSYSDGGSLFSKISH--------PDSTGTSSSSASRYLPQ  131 (601)
T ss_pred             hhcCccccccccccccccccccCCc-----cCCCcccccccCccccccccccccc--------CCccCCCCcchhhhhhh
Confidence            34445666666665 9999999998     4457888999999999999887721        11114556667789999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCC-cEEEccccccccCCC-CC---------------CCCccccC-CCCCc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPP-TR---------------TQTKYGVG-NEVST  258 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~-~~---------------~~~~~~~~-~~~~~  258 (382)
                      +..++.|+|.  ..++.|||+||+|.+++..+ ..|++|||+|..... ..               ..||...+ ....+
T Consensus       132 l~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~  209 (601)
T KOG0590|consen  132 LNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGP  209 (601)
T ss_pred             hccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCC
Confidence            9999999995  45899999999999999999 999999999976544 11               11333333 23466


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCC
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGD  286 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~  286 (382)
                      ..|+||.|+++.-+++|..|++......
T Consensus       210 ~~d~~S~g~~l~~~~~g~~p~~~~~~~~  237 (601)
T KOG0590|consen  210 SVDVWSLGIVLSAMLTGELPWDFPSRKD  237 (601)
T ss_pred             CcccccccccccccccCCCCcccccccc
Confidence            7899999999999999999987544333

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.10  E-value=2.6e-10  Score=97.47  Aligned_cols=98  Identities=19%  Similarity=0.137  Sum_probs=71.0

Q ss_pred             HHHHHHHhhccccc--ceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          121 IAECKALRNIRHRN--LIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       121 ~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      ..|.+.+.++.+..  +.+.+++         ...++||||++++++......         . .... .....++.+++
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~---------~-~~~~-~~~~~~~~~~~  124 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDL---------NRHVLVMEFIGGDGIPAPRLK---------D-VRLL-EDPEELYDQIL  124 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEec---------CCCEEEEEEeCCCCccChhhh---------h-hhhc-ccHHHHHHHHH
Confidence            56777777776553  3444432         235899999999654322100         0 0011 55778999999


Q ss_pred             HHHhHHhhcCC-CceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          199 SALNYLHHDCQ-PVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       199 ~~L~~lH~~~~-~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      .++.++|   . .+|+|+||||+||+++ ++.++++|||.+....
T Consensus       125 ~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         125 ELMRKLY---REAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             HHHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            9999999   5 7999999999999999 8899999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.02  E-value=1e-09  Score=106.25  Aligned_cols=138  Identities=20%  Similarity=0.212  Sum_probs=100.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ....+-++.|+.+|||||++++..     ++..+..|+|+|-+.-  |..++.             .+......--+.||
T Consensus        54 ~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~P--l~~~lk-------------~l~~~~v~~Gl~qI  113 (690)
T KOG1243|consen   54 ELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVRP--LETVLK-------------ELGKEEVCLGLFQI  113 (690)
T ss_pred             HHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeecccc--HHHHHH-------------HhHHHHHHHHHHHH
Confidence            345677888999999999999987     4457789999997743  444442             23344455568899


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCC--CccccCC-----CCC---ccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ--TKYGVGN-----EVS---TIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~-----~~~---~~~Dv~S~Gv  267 (382)
                      +.||.|||+.  .+++|++|.-+.|+++..|..||++|.++.........  -.+....     ...   -..|.|-||+
T Consensus       114 l~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~s~D~~~Lg~  191 (690)
T KOG1243|consen  114 LAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEWSIDSWGLGC  191 (690)
T ss_pred             HHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccccchhhhhHHH
Confidence            9999999984  49999999999999999999999999887544332210  0000000     001   2359999999


Q ss_pred             HHHHHHhcCC
Q 040999          268 LLLELMIREK  277 (382)
Q Consensus       268 il~elltg~~  277 (382)
                      +++|++.|..
T Consensus       192 li~el~ng~~  201 (690)
T KOG1243|consen  192 LIEELFNGSL  201 (690)
T ss_pred             HHHHHhCccc
Confidence            9999999943

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.93  E-value=4.3e-09  Score=89.61  Aligned_cols=98  Identities=21%  Similarity=0.134  Sum_probs=71.3

Q ss_pred             HHHHHHHHhhcccc--cceeeeeeeeecccCCCceeEEEEecccCCCccc-cccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          120 FIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK-WLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       120 ~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      -.+|.+.|+++...  ++.+.+++         ...++||||+.+..+.. .+.           ...++......+..+
T Consensus        73 a~kE~r~L~rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lk-----------d~~~~~~~~~~i~~~  132 (197)
T cd05146          73 AEKEMHNLKRMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLK-----------DAKLNDEEMKNAYYQ  132 (197)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhh-----------ccccCHHHHHHHHHH
Confidence            45899999998643  45555554         34579999997654321 121           112444556677899


Q ss_pred             HHHHHhHH-hhcCCCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          197 VASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       197 i~~~L~~l-H~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      ++.+|..| |   ..+++|+|+++.||+++ ++.+.++|||.|...
T Consensus       133 i~~~l~~l~H---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         133 VLSMMKQLYK---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHHHHHHHH---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            99999999 6   66999999999999997 467999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.89  E-value=7.3e-09  Score=86.89  Aligned_cols=96  Identities=22%  Similarity=0.163  Sum_probs=69.4

Q ss_pred             HHHHHHHHHhhccccccee-eeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIK-VLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+.+|+++++.+.+.++++ ++.+.       ....++||||+++.++.+..               .   ....++.++
T Consensus        38 ~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~i~G~~l~~~~---------------~---~~~~~~~~l   92 (170)
T cd05151          38 NRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEFIEGSELLTED---------------F---SDPENLEKI   92 (170)
T ss_pred             CHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEecCCCcccccc---------------c---cCHHHHHHH
Confidence            4678999999997766554 44331       22357999999998765421               0   012356789


Q ss_pred             HHHHhHHhhcC--CCceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          198 ASALNYLHHDC--QPVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       198 ~~~L~~lH~~~--~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      +++|+.||...  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        93 ~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          93 AKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             HHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99999999431  12369999999999999 66899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.88  E-value=3.7e-09  Score=101.98  Aligned_cols=106  Identities=20%  Similarity=0.181  Sum_probs=75.2

Q ss_pred             HHHHHHHHHhhcc----cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          119 SFIAECKALRNIR----HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       119 ~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +|.+|++.+.+++    |.+-+.+-.++..  +  ....++||||+++++|.++.....         ...   .+..++
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~--~--~~~~vLvmE~i~G~~L~~~~~~~~---------~~~---~~~~ia  262 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWD--R--TSERVLTMEWIDGIPLSDIAALDE---------AGL---DRKALA  262 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehh--h--cCCceEEEEeECCcccccHHHHHh---------cCC---CHHHHH
Confidence            4778888888774    3334444444322  1  344689999999999988763210         111   234566


Q ss_pred             HHHHH-HHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC
Q 040999          195 IDVAS-ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP  243 (382)
Q Consensus       195 ~~i~~-~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~  243 (382)
                      ..++. .+..+|   ..+++|+|+||.||+++.++.++++|||++..+.+
T Consensus       263 ~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       263 ENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            66665 467788   67999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=98.84  E-value=2.9e-09  Score=107.30  Aligned_cols=64  Identities=38%  Similarity=0.571  Sum_probs=48.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCccc---ccCCCCccccccCCCCCCCCCCCCCcCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGV---YKNASATSVTGNSKLCGGISKFKLPKCG   67 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~---~~~~~~~~~~gn~~lcg~~~~~~~~~c~   67 (382)
                      ||||+|+|+|.||.+++++ +|+.|||++|+|+|.+|..+   ..+.....+.||+.+||.+.   ++.|.
T Consensus       471 LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~  538 (623)
T PLN03150        471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACG  538 (623)
T ss_pred             EECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCc
Confidence            6888888888888888888 88888888888888888732   23344567889999998542   45675

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.82  E-value=1.3e-08  Score=84.00  Aligned_cols=95  Identities=25%  Similarity=0.324  Sum_probs=74.9

Q ss_pred             HHHHHHHHHHhhcccccc--eeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ++-.+|++++.+++--.|  ..++.+       +.+...++|||+++..|.+.+..          .       ...++.
T Consensus        44 ~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~~~~I~me~I~G~~lkd~l~~----------~-------~~~~~r   99 (204)
T COG3642          44 ERTRREARILAKAREAGVPVPIVYDV-------DPDNGLIVMEYIEGELLKDALEE----------A-------RPDLLR   99 (204)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEE-------cCCCCEEEEEEeCChhHHHHHHh----------c-------chHHHH
Confidence            567889999999875433  334444       35667899999999888888832          1       246778


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      .+-.-+.-||   ..+|+|+|+.++||++..+. +.++|||++..
T Consensus       100 ~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         100 EVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             HHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            8888889999   78999999999999997765 99999999974

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.75  E-value=5.5e-08  Score=91.72  Aligned_cols=149  Identities=17%  Similarity=0.203  Sum_probs=112.1

Q ss_pred             HHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccC-CCccccccCCCCCC-----ccccCCcccCHHHHHHHH
Q 040999          121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHN-RSPEKWLYPISKED-----ETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       121 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~  194 (382)
                      ..-++.++++.|.|+|++.+++....+ +...+++||+|.|+ ++|.++-.......     .........++...+.++
T Consensus       321 t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~  399 (655)
T KOG3741|consen  321 TSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYI  399 (655)
T ss_pred             hHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHH
Confidence            344788999999999999999764333 45678999999986 56665543322211     112334567888999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCCCccccCCCCCccchhHHHHHHHHHHHh
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMI  274 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~ellt  274 (382)
                      .|+..||.++|   +.|+.-+-|.|.+||++.+.+++|+--|....+..+...|     -+--.+-|.-.||.+++-|.|
T Consensus       400 ~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~~-----le~~Qq~D~~~lG~ll~aLAt  471 (655)
T KOG3741|consen  400 SQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTEP-----LESQQQNDLRDLGLLLLALAT  471 (655)
T ss_pred             HHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCCCcc-----hhHHhhhhHHHHHHHHHHHhh
Confidence            99999999999   6688889999999999999999999888877665554222     111346799999999999999


Q ss_pred             cCCC
Q 040999          275 REKP  278 (382)
Q Consensus       275 g~~p  278 (382)
                      |..-
T Consensus       472 ~~~n  475 (655)
T KOG3741|consen  472 GTEN  475 (655)
T ss_pred             cccc
Confidence            9543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.66  E-value=1e-07  Score=85.67  Aligned_cols=111  Identities=14%  Similarity=0.055  Sum_probs=79.3

Q ss_pred             HHHHHHHHHhhcccccce--eeeeeeeecccCCCceeEEEEecccCC-CccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLI--KVLTACLGVDYQGNDFKALVYEFIHNR-SPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+|.+.+.++...+|-  +.+++............++|+|++++- +|.+++....        ....+...+..++.
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--------~~~~~~~~~~~ll~  145 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--------TNPPDPRLKRMLIK  145 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--------ccCCCHHHHHHHHH
Confidence            478899998888654443  334443211111133568999999875 7888773211        12344566778999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCC-------CCcEEEcccccccc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDD-------DMTARVGDFGLARF  240 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-------~~~~kl~Dfg~a~~  240 (382)
                      +++..+.-||   ..+|+|+|++++|||++.       +..+.++||+.+..
T Consensus       146 ~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        146 RVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9999999999   789999999999999975       46789999998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.64  E-value=8.4e-08  Score=81.36  Aligned_cols=100  Identities=20%  Similarity=0.206  Sum_probs=65.1

Q ss_pred             HHHHHHHHHHhhcccc--cceeeeeeeeecccCCCceeEEEEeccc--CCCccccccCCCCCCccccCCcccCHHHHHHH
Q 040999          118 KSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFIH--NRSPEKWLYPISKEDETYERPRNLNLLRRLNI  193 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i  193 (382)
                      ....+|.+.|.++..-  ++.+.+++         ....+||||++  +..+. .+..           ..++......+
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~---------~~~~ivME~I~~~G~~~~-~l~~-----------~~~~~~~~~~~  111 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDY---------NRNVIVMEYIGEDGVPLP-RLKD-----------VDLSPEEPKEL  111 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEE---------ETTEEEEE--EETTEEGG-CHHH-----------CGGGGSTHHHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEE---------eCCEEEEEecCCCccchh-hHHh-----------ccccchhHHHH
Confidence            4678899999999765  45566655         13479999998  43333 2311           11223445667


Q ss_pred             HHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       194 ~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      +.+++..+..+++  ..+|+|+|+.+.||+++++ .+.++|||.+...
T Consensus       112 ~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  112 LEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             HHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             HHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence            7888886666432  6799999999999999888 9999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.62  E-value=3.2e-08  Score=94.90  Aligned_cols=142  Identities=23%  Similarity=0.283  Sum_probs=108.1

Q ss_pred             HHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          120 FIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       120 ~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      =.+|....+++ .|+|.++.+..     +.+.+..++-+|+|. .+|.++.+.         ....++....+....+..
T Consensus       164 k~~~~~s~~~i~~~~~~v~~~~~-----~e~~~~lfiqtE~~~-~sl~~~~~~---------~~~~~p~~~l~~~~~~~~  228 (524)
T KOG0601|consen  164 KLREFLSHHKIDSHENPVRDSPA-----WEGSGILFIQTELCG-ESLQSYCHT---------PCNFLPDNLLWNSLRDWL  228 (524)
T ss_pred             ccchhhcccccCccccccccCcc-----cccCCcceeeecccc-chhHHhhhc---------ccccCCchhhhhHHhhhh
Confidence            45667766777 49999996665     556888899999885 678777743         233466666777777777


Q ss_pred             H----HHhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCCCCCCCCcc----------------ccCCCCC
Q 040999          199 S----ALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLPPTRTQTKY----------------GVGNEVS  257 (382)
Q Consensus       199 ~----~L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~~~~~~~~~----------------~~~~~~~  257 (382)
                      +    ||.++|   ...++|-|+||.||....+ ...+++|||+...+......-.+                ....-++
T Consensus       229 ~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~  305 (524)
T KOG0601|consen  229 SRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT  305 (524)
T ss_pred             hcccccccccC---CCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc
Confidence            7    999999   7799999999999999999 78999999998876554422111                1234557


Q ss_pred             ccchhHHHHHHHHHHHhcCCCC
Q 040999          258 TIGDVYSYGILLLELMIREKPS  279 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~  279 (382)
                      ...|+||+|.+..|..++..+.
T Consensus       306 ~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  306 FASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             hHhhhcchhhhhHhhHhhcccc
Confidence            8899999999999999887653

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.61  E-value=1.2e-07  Score=78.04  Aligned_cols=108  Identities=21%  Similarity=0.218  Sum_probs=74.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccC-CCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHN-RSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ++..+|++.|.+++--.|.--.-+++     +...-.++|||+++ .++.+++...-        ...........++..
T Consensus        55 ~Rt~~Ear~l~k~~~~GI~~P~l~~~-----D~~~~~i~ME~~~g~~~vk~~i~~~~--------~~~~~d~~~~~~~~~  121 (229)
T KOG3087|consen   55 KRTKQEARLLAKCRALGIPAPRLIFI-----DTYGGQIYMEFIDGASTVKDFILSTM--------EDESEDEGLAELARR  121 (229)
T ss_pred             HHHHHHHHHHHHHHHhCCCCceEEEE-----ecCCCeEEEEeccchhHHHHHHHHHc--------cCcccchhHHHHHHH
Confidence            56788999999987544422111211     24445799999976 46777774321        111222223678899


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCC---cEEEccccccccC
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDM---TARVGDFGLARFL  241 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfg~a~~~  241 (382)
                      |-+.+.-||   ..+|+|+||..+||++..++   .+.++|||++...
T Consensus       122 iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  122 IGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999999999   78999999999999996654   3589999998643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.56  E-value=6.6e-08  Score=94.72  Aligned_cols=107  Identities=15%  Similarity=0.084  Sum_probs=67.7

Q ss_pred             HHHHHHHHHhhcc----cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          119 SFIAECKALRNIR----HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       119 ~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +|.+|++.+.+++    +.+.+.+-.++.+    -.....|||||+.|+.+.++-.-...    ......+.......++
T Consensus       202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~----g~d~~~la~~~v~~~~  273 (537)
T PRK04750        202 DLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAA----GTDMKLLAERGVEVFF  273 (537)
T ss_pred             CHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhc----CCCHHHHHHHHHHHHH
Confidence            3666776666664    3444444444322    13456899999999998764211000    0011123333344444


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC----cEEEccccccccCCC
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM----TARVGDFGLARFLPP  243 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfg~a~~~~~  243 (382)
                      .|+.          ..+++|+|+||.||+++.++    ++++.|||++..++.
T Consensus       274 ~Qif----------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVF----------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH----------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4443          34899999999999999888    999999999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.54  E-value=4.1e-07  Score=78.95  Aligned_cols=110  Identities=23%  Similarity=0.247  Sum_probs=80.8

Q ss_pred             HHHHHHHHHhhcccccc--eeeeeeeeecccCCCceeEEEEecccCC-CccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFIHNR-SPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ...+|.+.+..+...+|  .+.+++..... ......++|+|++++. +|.+++...          ...+......++.
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~----------~~~~~~~~~~ll~  125 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQW----------EQLDPSQRRELLR  125 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhh----------cccchhhHHHHHH
Confidence            57788888888764433  34445433211 1124458999999874 788877321          1255667788999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCC---cEEEccccccccCC
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM---TARVGDFGLARFLP  242 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfg~a~~~~  242 (382)
                      ++++.++-||   ..+|+|+|+++.|||++.+.   .+.++||+.++...
T Consensus       126 ~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  126 ALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999999999   78999999999999998887   79999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.49  E-value=9.8e-07  Score=77.22  Aligned_cols=112  Identities=25%  Similarity=0.248  Sum_probs=80.1

Q ss_pred             HHHHHHHHHHHhhccccc--ceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRN--LIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ...+.+|.++++.+++.+  +.+++.++....  ..+..++||||+++.++.+.+..           ..++......++
T Consensus        39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~i~G~~l~~~~~~-----------~~~~~~~~~~i~  105 (223)
T cd05154          39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMERVDGRVLRDRLLR-----------PELSPEERRALA  105 (223)
T ss_pred             cccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEEeCCEecCCCCCC-----------CCCCHHHHHHHH
Confidence            356889999999997643  566666643210  11356899999999888765520           235666677777


Q ss_pred             HHHHHHHhHHhhc-----------------------------------------------------CCCceeecCCCCCc
Q 040999          195 IDVASALNYLHHD-----------------------------------------------------CQPVTAHCDLKPSN  221 (382)
Q Consensus       195 ~~i~~~L~~lH~~-----------------------------------------------------~~~~ivH~dlkp~N  221 (382)
                      .+++++|..||..                                                     ....++|+|++|.|
T Consensus       106 ~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~N  185 (223)
T cd05154         106 RALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGN  185 (223)
T ss_pred             HHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCccc
Confidence            7888888777741                                                     13567999999999


Q ss_pred             eeeCC--CCcEEEccccccccC
Q 040999          222 VLLDD--DMTARVGDFGLARFL  241 (382)
Q Consensus       222 ILl~~--~~~~kl~Dfg~a~~~  241 (382)
                      |+++.  ++.+.|+||+.+...
T Consensus       186 il~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         186 VLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             EEEcCCCCcEEEEEeccccccC
Confidence            99998  567899999988643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.46  E-value=4.4e-06  Score=77.35  Aligned_cols=200  Identities=16%  Similarity=0.145  Sum_probs=117.6

Q ss_pred             eEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEE
Q 040999          153 KALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV  232 (382)
Q Consensus       153 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl  232 (382)
                      ..+.|..+++..--..++...   ..........|+..++.++.++.+.+-||   ..|.+-+|+.++|+|+.+++.+.|
T Consensus        85 iGflmP~v~g~~pI~~~y~p~---tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~L  158 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPA---TRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVL  158 (637)
T ss_pred             eEEecccCCCccchhhhcCch---hhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEE
Confidence            556676665542222222111   11123345789999999999999999999   778899999999999999998888


Q ss_pred             ccccccccCC-----------CCCCCCcc-----ccCCCCCccchhHHHHHHHHHHHhc-CCCCCccccCCchHHHHHHH
Q 040999          233 GDFGLARFLP-----------PTRTQTKY-----GVGNEVSTIGDVYSYGILLLELMIR-EKPSDIMFEGDMNLHKFAKM  295 (382)
Q Consensus       233 ~Dfg~a~~~~-----------~~~~~~~~-----~~~~~~~~~~Dv~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~  295 (382)
                      .|-..-..-.           ...+.||.     ..+-.-+...|-|-+||++++++.| +.||.........       
T Consensus       159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a-------  231 (637)
T COG4248         159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA-------  231 (637)
T ss_pred             EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC-------
Confidence            7632211110           11111222     2344557789999999999999987 9999865432211       


Q ss_pred             hcCCchh-hhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCC--ccCCCCHHHHHHHHHHhhhhh
Q 040999          296 ALPNHVK-DIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMES--PQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       296 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~--p~~RPs~~evl~~L~~i~~~~  371 (382)
                        ++... ++...... ...+   +.....+........-.+..+..+-.+|....  +.-|||++.-+..|.++..++
T Consensus       232 --p~p~E~~Ia~g~f~-ya~~---~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         232 --PNPLETDIAHGRFA-YASD---QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             --CCcchhhhhcceee-echh---ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence              00000 00000000 0000   00000000000111123445666777888754  568999999999998887765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.46  E-value=6.1e-08  Score=92.99  Aligned_cols=139  Identities=22%  Similarity=0.255  Sum_probs=100.9

Q ss_pred             HHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHH
Q 040999          122 AECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASA  200 (382)
Q Consensus       122 ~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~  200 (382)
                      .|+-+...+ .|.+++.....     +...+..++-.|||.++++.....          -...++...++++..|++.+
T Consensus       314 ~ev~l~~~l~~~~~~~g~~~~-----W~~~r~~~ip~e~~~~~s~~l~~~----------~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  314 GEVILEAILGSHLPSVGKNSS-----WSQLRQGYIPLEFCEGGSSSLRSV----------TSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             hhhhHhhHhhcccccCCCCCC-----ccccccccCchhhhcCcchhhhhH----------HHHhcCcchhhhhHHHHHhc
Confidence            344444444 47777775554     233556678899999998776551          22346777889999999999


Q ss_pred             HhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCCCC--------CCC---CccccCCCCCccchhHHHHHH
Q 040999          201 LNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLPPT--------RTQ---TKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       201 L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~~~--------~~~---~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.++|   ++.++|+|+||+||++..+ +..+++|||++..+.-.        ...   +.......+..+.|+||||..
T Consensus       379 l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~  455 (524)
T KOG0601|consen  379 LNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLS  455 (524)
T ss_pred             ccccc---chhhhcccccccceeeccchhhhhccccccccccceecccccccccccccchhhcccccccccccccccccc
Confidence            99999   8999999999999999886 78899999998632211        111   111122345678999999999


Q ss_pred             HHHHHhcCCC
Q 040999          269 LLELMIREKP  278 (382)
Q Consensus       269 l~elltg~~p  278 (382)
                      +.|.+++..-
T Consensus       456 ~~e~~~~~~l  465 (524)
T KOG0601|consen  456 VDEAITGSPL  465 (524)
T ss_pred             ccccccCccc
Confidence            9999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.42  E-value=1.6e-07  Score=95.22  Aligned_cols=121  Identities=20%  Similarity=0.228  Sum_probs=90.7

Q ss_pred             CCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC
Q 040999          149 GNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM  228 (382)
Q Consensus       149 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~  228 (382)
                      .....+||++|..+++|...|+...          ..+..-.......+.++++|||   ...+.|||++|.|+|...++
T Consensus       875 ~rsP~~L~~~~~~~~~~~Skl~~~~----------~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~g  941 (1205)
T KOG0606|consen  875 CRSPLPLVGHYLNGGDLPSKLHNSG----------CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDG  941 (1205)
T ss_pred             CCCCcchhhHHhccCCchhhhhcCC----------CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccC
Confidence            3566789999999999998886433          2333333445667888999999   55699999999999999999


Q ss_pred             cEEEccccccccCCC-------------------------------------------CCCCCccccCCCCCccchhHHH
Q 040999          229 TARVGDFGLARFLPP-------------------------------------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       229 ~~kl~Dfg~a~~~~~-------------------------------------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ..+++|||.......                                           +...||...+......+|+|++
T Consensus       942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen  942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred             CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence            999999984432100                                           0001444445566778999999


Q ss_pred             HHHHHHHHhcCCCCCcc
Q 040999          266 GILLLELMIREKPSDIM  282 (382)
Q Consensus       266 Gvil~elltg~~p~~~~  282 (382)
                      |++++|.++|..||...
T Consensus      1022 g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             hhhhhhhhcCCCCCCCc
Confidence            99999999999998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.38  E-value=9.8e-08  Score=93.07  Aligned_cols=83  Identities=18%  Similarity=0.340  Sum_probs=66.9

Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------------CCCCccccC
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------------RTQTKYGVG  253 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------------~~~~~~~~~  253 (382)
                      .+++.|+.|+|.  +.++||++|.|++|.++..+..||+-|+.+....+.                     ...||+..+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            445589999997  679999999999999999999999999987644331                     122777777


Q ss_pred             CCCCccchhHHHHHHHHHHH-hcCCCC
Q 040999          254 NEVSTIGDVYSYGILLLELM-IREKPS  279 (382)
Q Consensus       254 ~~~~~~~Dv~S~Gvil~ell-tg~~p~  279 (382)
                      ...+.++|+||+||.+|.+. .|+.-+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~  210 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSII  210 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchh
Confidence            77789999999999999998 444443

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.23  E-value=5.4e-06  Score=70.58  Aligned_cols=105  Identities=21%  Similarity=0.202  Sum_probs=81.4

Q ss_pred             HHHHHHHhhccc-ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHH
Q 040999          121 IAECKALRNIRH-RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVAS  199 (382)
Q Consensus       121 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~  199 (382)
                      ..|.-+|+.+++ +++.+++|+|-         .++|.||.+.+++...-..       ...-..-+|..|.+|+.++++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~-------l~~~~~~~w~~R~~iA~~lL~   70 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRP-------LSQFLQSPWEQRAKIALQLLE   70 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccc-------cccccccCHHHHHHHHHHHHH
Confidence            458888888876 69999999972         2679999987765422000       011224689999999999999


Q ss_pred             HHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       200 ~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      .+.++++.....+.-.|++++|+-+++++++|+.|...+...
T Consensus        71 ~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   71 LLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999764456777999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09902 hypothetical protein; Provisional

Probab=98.10  E-value=1.9e-05  Score=67.67  Aligned_cols=111  Identities=16%  Similarity=0.126  Sum_probs=79.6

Q ss_pred             HHHHHHHHHHhhccccc--ceeeeeeeeecccCCCceeEEEEecccC-CCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRN--LIKVLTACLGVDYQGNDFKALVYEFIHN-RSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ..|.+|...|.++...+  +.+.. ++-..........+||+|-+++ -+|.+++...        ...+.+...+..+.
T Consensus        64 ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~--------~~~~~~~~~k~~il  134 (216)
T PRK09902         64 PTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQH--------AVSPYSDEVRQAML  134 (216)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcC--------CcCCcchHHHHHHH
Confidence            46899999999996443  33333 2211111223446799997753 5777777321        12345677788999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCc--EEEcccccccc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT--ARVGDFGLARF  240 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~--~kl~Dfg~a~~  240 (382)
                      .++++.++-||   ..++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       135 ~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        135 KAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             HHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            99999999999   789999999999999986666  99999977653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.09  E-value=2.1e-05  Score=67.72  Aligned_cols=69  Identities=22%  Similarity=0.265  Sum_probs=53.4

Q ss_pred             CceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCc
Q 040999          150 NDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT  229 (382)
Q Consensus       150 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~  229 (382)
                      ....+++|||++|..|.+...              ++.    .+...+.+++.-+|   ..|++|+|..|.|+++++++ 
T Consensus       115 ~~~~~ll~EYIeG~~l~d~~~--------------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  115 TSSYVLLMEYIEGVELNDIED--------------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeEEEEEEEEecCeecccchh--------------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-
Confidence            344568999999988766541              221    24566778899999   78999999999999998654 


Q ss_pred             EEEcccccccc
Q 040999          230 ARVGDFGLARF  240 (382)
Q Consensus       230 ~kl~Dfg~a~~  240 (382)
                      +++.||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987753

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.91  E-value=2.6e-05  Score=68.67  Aligned_cols=95  Identities=20%  Similarity=0.159  Sum_probs=64.8

Q ss_pred             HHHHHHHHHHhhcccc--cceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ....+|.++|.++.-.  .+.+.+++         +...+||||+.+--|...-               ++....-.++.
T Consensus       154 l~A~rEf~~L~~L~~~G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~  209 (304)
T COG0478         154 LAAEREFEALQRLYPEGVKVPKPIAW---------NRHAVVMEYIEGVELYRLR---------------LDVENPDEILD  209 (304)
T ss_pred             HHHHHHHHHHHHhhhcCCCCCCcccc---------ccceeeeehcccceeeccc---------------CcccCHHHHHH
Confidence            3467899999998654  55555544         5568999999885543321               12222333444


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR  239 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~  239 (382)
                      .|.+-+.-.-   ..|+||+|+++-||+++++|.+.++||-.+.
T Consensus       210 ~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         210 KILEEVRKAY---RRGIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             HHHHHHHHHH---HcCccccCCchheEEEecCCCEEEEeCcccc
Confidence            4444444444   4589999999999999999999999995553

>PLN03150 hypothetical protein; Provisional

Probab=97.76  E-value=1.7e-05  Score=80.31  Aligned_cols=52  Identities=33%  Similarity=0.579  Sum_probs=39.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn~   52 (382)
                      ||||+|+|+|.||.+++++ .|+.||||+|+|+|.+|.  +.+.++....+.+|.
T Consensus       447 L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~  501 (623)
T PLN03150        447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS  501 (623)
T ss_pred             EECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence            5788888888888888888 888888888888888887  233444444455553

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.76  E-value=1.5e-05  Score=50.33  Aligned_cols=34  Identities=32%  Similarity=0.518  Sum_probs=29.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP   36 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP   36 (382)
                      |||++|+++ .||+.+++| .|++||+|+|+++ .+|
T Consensus         6 L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~   40 (44)
T PF12799_consen    6 LDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS   40 (44)
T ss_dssp             EEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred             EEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence            689999999 799999999 9999999999998 443

...

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=97.69  E-value=5e-05  Score=81.46  Aligned_cols=52  Identities=31%  Similarity=0.550  Sum_probs=33.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCccc--ccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGV--YKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~--~~~~~~~~~~gn~   52 (382)
                      ||||+|+|+|.+|..+.++ .|+.||||+|+++|.+|..+  ...+....+.+|+
T Consensus       528 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~  582 (968)
T PLN00113        528 LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH  582 (968)
T ss_pred             EECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc
Confidence            5677777777777777777 77777777777777777622  2334444455554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.53  E-value=0.00085  Score=59.00  Aligned_cols=31  Identities=16%  Similarity=0.176  Sum_probs=26.8

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      ...++|+|+.|.||++++++ +.++||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            34678999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.30  E-value=0.0019  Score=67.78  Aligned_cols=47  Identities=19%  Similarity=0.268  Sum_probs=33.2

Q ss_pred             HHHHHHHHHHhhcc-cccc--eeeeeeeeecccCCCceeEEEEecccCCCcc
Q 040999          118 KSFIAECKALRNIR-HRNL--IKVLTACLGVDYQGNDFKALVYEFIHNRSPE  166 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  166 (382)
                      ..+.+|.++|+.+. |.++  .+++.+|...  ...+..|+||||+++..+.
T Consensus        83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~flVME~v~G~~~~  132 (822)
T PLN02876         83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAFYIMEYLEGRIFV  132 (822)
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCceEEEEecCCcccC
Confidence            46889999999995 6665  6777776431  1124568999999876543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.30  E-value=0.00069  Score=66.28  Aligned_cols=108  Identities=17%  Similarity=0.171  Sum_probs=67.8

Q ss_pred             HHHHHHHHHhhc----cccc---ceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHH
Q 040999          119 SFIAECKALRNI----RHRN---LIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRL  191 (382)
Q Consensus       119 ~~~~E~~~l~~l----~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~  191 (382)
                      +|.+|++...++    .|-+   =|.+=.++.    +-.....|+||||+|..+.+.-.-         ....++...+.
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~----~~st~RVLtME~~~G~~i~Dl~~i---------~~~gi~~~~i~  306 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYW----DLSTKRVLTMEYVDGIKINDLDAI---------DKRGISPHDIL  306 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehh----hcCcceEEEEEecCCccCCCHHHH---------HHcCCCHHHHH
Confidence            477777776665    3445   122223322    123467899999999988776421         12234444443


Q ss_pred             HHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC----CCcEEEccccccccCCCC
Q 040999          192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD----DMTARVGDFGLARFLPPT  244 (382)
Q Consensus       192 ~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~----~~~~kl~Dfg~a~~~~~~  244 (382)
                      .-+.+...-.-+-|     |++|+|-.|.||++..    ++.+.+-|||+...+...
T Consensus       307 ~~l~~~~~~qIf~~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  307 NKLVEAYLEQIFKT-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHHHHHHHHHHhc-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            33333333333333     8999999999999984    568999999999866543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.23  E-value=0.0009  Score=69.78  Aligned_cols=147  Identities=21%  Similarity=0.216  Sum_probs=95.8

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCc-eeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGND-FKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      +.....|.+.+.++.|+|++.++.|-....  ..+ ...+..+++..-++.+.++          .-..++......+..
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~--~~g~~~~v~~~~~s~~~~~~~~q----------~v~~i~~~~~r~~~~  293 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERL--FRGIVLDVLQEICSKVELRSLLQ----------SVGSIPLETLRILHQ  293 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhh--cchHHHHHHHhhcCccchHHHHh----------hccccCHHHHHHHHH
Confidence            345666888899999999999988855321  112 2223446777777777663          345678888889999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCC---ceeeCCCCcEEEc--cccccccCCCCCCC-----------CccccCCCC--C
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPS---NVLLDDDMTARVG--DFGLARFLPPTRTQ-----------TKYGVGNEV--S  257 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~---NILl~~~~~~kl~--Dfg~a~~~~~~~~~-----------~~~~~~~~~--~  257 (382)
                      +..+||+|+|.   ....|.-+..+   +--.+.++...++  ||+.++.+......           ++.......  .
T Consensus       294 ~~~~GL~~~h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~  370 (1351)
T KOG1035|consen  294 KLLEGLAYLHS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKS  370 (1351)
T ss_pred             HHhhhHHHHHH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhh
Confidence            99999999994   34444433333   3334555666666  88888766443221           111111222  3


Q ss_pred             ccchhHHHHHHHHHHHhcCCC
Q 040999          258 TIGDVYSYGILLLELMIREKP  278 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p  278 (382)
                      ...|+|.+|.....+..|..+
T Consensus       371 r~~dL~~lgll~~~~~~~~~i  391 (1351)
T KOG1035|consen  371 RLTDLWCLGLLLLQLSQGEDI  391 (1351)
T ss_pred             hhhHHHHHHHHHhhhhhcCcc
Confidence            346999999999999888665

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.23  E-value=0.001  Score=65.24  Aligned_cols=107  Identities=20%  Similarity=0.191  Sum_probs=66.9

Q ss_pred             HHHHHHHHHhhccc----ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          119 SFIAECKALRNIRH----RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       119 ~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ++.+|+..+.++++    ..=+++=.+|.+    -.....|+|||++|-.+.+...-..         ..++..   .++
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we----~t~~~VLtmE~i~Gi~i~d~~~l~~---------~g~d~k---~ia  270 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDVYVPKVYWE----YTTRRVLTMEWIDGIKISDIAALKS---------AGIDRK---ELA  270 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeceeehh----ccCCcEEEEEeeCCEecccHHHHHh---------cCCCHH---HHH
Confidence            46778888888742    222333344322    2455689999999988877742111         122322   222


Q ss_pred             HHHHHHH-hHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC
Q 040999          195 IDVASAL-NYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT  244 (382)
Q Consensus       195 ~~i~~~L-~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~  244 (382)
                      ..++++. .-+-   ..+++|.|.+|.||+++.++++.+.|||+...+++.
T Consensus       271 ~~~~~~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         271 ELLVRAFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHHHHHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            2222221 1111   238999999999999999999999999999866543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.17  E-value=0.0023  Score=56.95  Aligned_cols=32  Identities=22%  Similarity=0.232  Sum_probs=27.9

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      .+.++|+|+.|.|||++++....|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            46689999999999999987788999988753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.12  E-value=0.0022  Score=56.16  Aligned_cols=100  Identities=22%  Similarity=0.218  Sum_probs=66.1

Q ss_pred             HHHHHHHHhhcccc--cceeeeeeeeecccCCCceeEEEEecccCC-CccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          120 FIAECKALRNIRHR--NLIKVLTACLGVDYQGNDFKALVYEFIHNR-SPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       120 ~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      -.+|.+.|+++.--  .+.+-+++         ....|||||+... ...-.|           ....+.......+..+
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g~pAP~L-----------kDv~~e~~e~~~~~~~  174 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDGLPAPRL-----------KDVPLELEEAEGLYED  174 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceee---------cCCeEEEEeccCCCCCCCCc-----------ccCCcCchhHHHHHHH
Confidence            45677777777432  33333333         2346999999653 111112           1122333356677788


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      +++.+.-|-.  ..++||+||+.=|||+. ++.+.++|||.|....
T Consensus       175 ~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         175 VVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            8888887774  36999999999999999 8899999999886443

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.09  E-value=0.0044  Score=54.82  Aligned_cols=32  Identities=41%  Similarity=0.558  Sum_probs=27.0

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      ...++|+|+.+.||+++++...-|.||+.+..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            45699999999999998776667999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.97  E-value=0.00039  Score=68.04  Aligned_cols=140  Identities=17%  Similarity=0.158  Sum_probs=98.2

Q ss_pred             HHHHHHHHHHhhccccc-ceeeeeeeeecccCCCceeEEEEecccCC-CccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRN-LIKVLTACLGVDYQGNDFKALVYEFIHNR-SPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+..-++++|.+++||| .+..++-     ++.+++.+++++++..+ +-..-.         ......+...+...+.+
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~~i~s~~rs~~~~~---------~~se~~~~~~~~~~~~r  343 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPMRICSTGRSSALEM---------TVSEIALEQYQFAYPLR  343 (829)
T ss_pred             hhhHHHHHHHHHccCCCCccccccc-----CCcccccchhhhhhcCCccccccC---------ChhhHhhhhhhhhhhhh
Confidence            34566889999999999 4443333     56688899999999877 221111         01223344445556777


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      .-+++++|+|.   -.-+|||    ||+..+ +..|..||+....++..           ...|+......+..+.|+||
T Consensus       344 ~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~  415 (829)
T KOG0576|consen  344 KETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGS  415 (829)
T ss_pred             hhccccccccc---ccccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccC
Confidence            78889999993   3458888    777655 67899999998766544           22366666777888999999


Q ss_pred             HHHHHHHHHhcCCCC
Q 040999          265 YGILLLELMIREKPS  279 (382)
Q Consensus       265 ~Gvil~elltg~~p~  279 (382)
                      .|+--.++.-|.+|-
T Consensus       416 ~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  416 LAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCcchhhcCCCCCCC
Confidence            998777777777664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.91  E-value=0.0045  Score=54.24  Aligned_cols=33  Identities=39%  Similarity=0.538  Sum_probs=23.0

Q ss_pred             CCceeecCCCCCceeeC-CCCcEEEccccccccC
Q 040999          209 QPVTAHCDLKPSNVLLD-DDMTARVGDFGLARFL  241 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~-~~~~~kl~Dfg~a~~~  241 (382)
                      ...++|+|+.|.||+++ +++.+.|.||+.+...
T Consensus       165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             CEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             CcEEEEeccccccceeeeccceeEEEecccceEC
Confidence            56799999999999999 5666689999887643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.87  E-value=0.007  Score=51.88  Aligned_cols=99  Identities=17%  Similarity=0.171  Sum_probs=62.3

Q ss_pred             HHHHHHHHHHhhcc------cccceeeeeeeeecccCCCceeEEEEecccC--C----CccccccCCCCCCccccCCccc
Q 040999          118 KSFIAECKALRNIR------HRNLIKVLTACLGVDYQGNDFKALVYEFIHN--R----SPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       118 ~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      ++..+|+.-...+.      +.+|.+++|+.     +++....+|+|.+.+  |    +|.+++.           ...+
T Consensus        56 ~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~v-----eT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----------~~~~  119 (199)
T PF10707_consen   56 RQNRRELRYYKQLSLRRGVDWSHIPRFYGFV-----ETNLGLGLVVELIRDADGNISPTLEDYLK-----------EGGL  119 (199)
T ss_pred             HHHHHHHHHHHHHhhccCCcccccccEeEEE-----ecCCceEEEEEEEECCCCCcCccHHHHHH-----------cCCc
Confidence            55666666655555      88999999994     446667899998744  2    3444441           1223


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC----cEEEcc-ccccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM----TARVGD-FGLAR  239 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~----~~kl~D-fg~a~  239 (382)
                      +. .....+.+.   ..||-   +..|+.+|++|.||++....    .+.|+| ||...
T Consensus       120 ~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  120 TE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             cH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence            33 233333333   34554   55799999999999995432    577888 55543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=96.82  E-value=0.00041  Score=47.21  Aligned_cols=49  Identities=35%  Similarity=0.556  Sum_probs=35.3

Q ss_pred             CccCCCccccccc-hhhhhc-cCCeeeccCCcccccCCcccccCC---CCcccccc
Q 040999            1 MDFSQNNLSGEIL-KFLTRL-FLDNLNLSYNNLEGMVPTGVYKNA---SATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP-~~l~~l-~L~~ldls~N~lsG~iP~~~~~~~---~~~~~~gn   51 (382)
                      |+|++|+|+ .|| ..+..+ .|++||+++|+++ .||...|...   ....+.+|
T Consensus         6 L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N   59 (61)
T PF13855_consen    6 LDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNN   59 (61)
T ss_dssp             EEETSSTES-EECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSS
T ss_pred             EECCCCCCC-ccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCC
Confidence            689999999 666 577889 9999999999998 5555444333   33344454

...

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.80  E-value=0.0053  Score=55.08  Aligned_cols=30  Identities=17%  Similarity=0.193  Sum_probs=26.2

Q ss_pred             CceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          210 PVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       210 ~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      ..++|+|+.|.||++++++ ++++||..|..
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            4689999999999999877 78999988754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.48  E-value=0.0059  Score=58.80  Aligned_cols=42  Identities=26%  Similarity=0.297  Sum_probs=31.3

Q ss_pred             HHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCcccccc
Q 040999          124 CKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLY  170 (382)
Q Consensus       124 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  170 (382)
                      .+.++.+.|+|+.+.+.+-.+    ......+|+|++ +-||++++.
T Consensus        33 ~~~lktl~~~~l~~yl~~~r~----~~~r~IVV~e~~-~~Sled~~~   74 (725)
T KOG1093|consen   33 FQYLKSLQHDNLCQYLDFSRG----KHERVIVVMEHY-TMSLEDILK   74 (725)
T ss_pred             hHHHHhhcCccceeeEeeecC----ccceEEEEehhh-ccchHHHHH
Confidence            357888999999998887432    234478899998 668888773

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=96.24  E-value=0.0018  Score=44.01  Aligned_cols=31  Identities=42%  Similarity=0.497  Sum_probs=27.2

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNL   31 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~l   31 (382)
                      |||++|+++.--|..+..+ .|++|++++|+|
T Consensus        30 L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen   30 LDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             EEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             eEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            6899999986656688899 999999999986

...

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=96.23  E-value=0.0014  Score=34.50  Aligned_cols=18  Identities=44%  Similarity=0.617  Sum_probs=13.6

Q ss_pred             cCCeeeccCCcccccCCcc
Q 040999           20 FLDNLNLSYNNLEGMVPTG   38 (382)
Q Consensus        20 ~L~~ldls~N~lsG~iP~~   38 (382)
                      +|++||+|+|+|+ .||..
T Consensus         1 ~L~~Ldls~n~l~-~ip~~   18 (22)
T PF00560_consen    1 NLEYLDLSGNNLT-SIPSS   18 (22)
T ss_dssp             TESEEEETSSEES-EEGTT
T ss_pred             CccEEECCCCcCE-eCChh
Confidence            3678888888888 77763

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=96.20  E-value=0.0012  Score=34.68  Aligned_cols=18  Identities=39%  Similarity=0.571  Sum_probs=15.3

Q ss_pred             CccCCCccccccchhhhhc
Q 040999            1 MDFSQNNLSGEILKFLTRL   19 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l   19 (382)
                      ||||+|+|+ +||+++++|
T Consensus         5 Ldls~n~l~-~ip~~~~~l   22 (22)
T PF00560_consen    5 LDLSGNNLT-SIPSSFSNL   22 (22)
T ss_dssp             EEETSSEES-EEGTTTTT-
T ss_pred             EECCCCcCE-eCChhhcCC
Confidence            799999999 999987654

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>PRK10593 hypothetical protein; Provisional

Probab=96.05  E-value=0.073  Score=48.91  Aligned_cols=46  Identities=15%  Similarity=0.005  Sum_probs=32.9

Q ss_pred             HHHHHHHHHHhhccc---ccceeeeeeeeecccCCCceeEEEEecccCCCc
Q 040999          118 KSFIAECKALRNIRH---RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSP  165 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL  165 (382)
                      ..|.+|.+.|+.+.-   -.+.+++++|..  ....+..++|||+++++++
T Consensus        52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~--~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTH--EQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             hHHHHHHHHHHHHccCCCCCcCcEEEEecc--CCcCCCeEEEEeccCCEec
Confidence            468899999998853   256777777532  1224557999999998765

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.92  E-value=0.052  Score=49.99  Aligned_cols=34  Identities=32%  Similarity=0.510  Sum_probs=29.8

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      ...++|+|+.+.|++++....+-|.||+.+..-+
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            4579999999999999998889999999987544

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=95.55  E-value=0.0062  Score=56.52  Aligned_cols=50  Identities=26%  Similarity=0.418  Sum_probs=41.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn~   52 (382)
                      |||..|+|. +.|+++.-+ +|.+||+|+|.+||-=|+ +-. .+...++.|||
T Consensus       257 LDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  257 LDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             eeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence            799999998 999999999 899999999999976555 322 55556678887

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=95.46  E-value=0.0066  Score=62.49  Aligned_cols=36  Identities=22%  Similarity=0.218  Sum_probs=25.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|+|+ +||.++.++ .|+.|||++|+|+|.+|.
T Consensus       427 L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        427 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             hhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            456666666 677777777 777777777777777776

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=95.23  E-value=0.0056  Score=59.97  Aligned_cols=35  Identities=43%  Similarity=0.560  Sum_probs=18.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      ||||+|+|. +.|..|.+- ++.+||||+|++. .||+
T Consensus       108 lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn  143 (1255)
T KOG0444|consen  108 LDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPN  143 (1255)
T ss_pred             eecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCc
Confidence            455555555 455555444 4455555555554 4554

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.96  E-value=0.12  Score=48.15  Aligned_cols=56  Identities=23%  Similarity=0.239  Sum_probs=47.5

Q ss_pred             ccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       184 ~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      ...+.+...++.+.+.-++-+..  .-..-|||+.-.|||++ +|++.|+||.+++...
T Consensus       317 ~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~~  372 (488)
T COG5072         317 ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence            45688889999888887777765  45789999999999999 9999999999998543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=94.71  E-value=0.0061  Score=65.69  Aligned_cols=151  Identities=9%  Similarity=-0.020  Sum_probs=98.1

Q ss_pred             HHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHH
Q 040999          120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVAS  199 (382)
Q Consensus       120 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~  199 (382)
                      ...|..-++...|++++..+.-   .........+.+++|+..|.+.+.+-....      +...++...+.....+...
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~r---I~ps~s~ee~~r~~~~~~g~~f~iIikg~e------e~~~ld~~~v~~~~kvsvl 1346 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLR---IPPSESTEEYIRSLYVEFGKLFSIIIKGLE------ESPDLDRSPVHLRHKVSVL 1346 (2724)
T ss_pred             hhhhhhhhhhhhceeeeccccc---CCCCCChHHHHHHHHHHHhHHHHHHHhccc------cCCcchhchHHHHHHHHHh
Confidence            3445555666789888765433   223445667899999999999998865442      2222333333333333244


Q ss_pred             HHhHHhh--cCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCC------Cc------cccCCCCCccchhHHH
Q 040999          200 ALNYLHH--DCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ------TK------YGVGNEVSTIGDVYSY  265 (382)
Q Consensus       200 ~L~~lH~--~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~------~~------~~~~~~~~~~~Dv~S~  265 (382)
                      +..-+|.  ..+.-.+|+++|+-|.++..+.++|++++|+.++..+....      |.      ....-.++.++|+|..
T Consensus      1347 ~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1347 NRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRR 1426 (2724)
T ss_pred             ccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHH
Confidence            4444443  22345789999999999999999999999999955443221      11      1112345667999999


Q ss_pred             HHHHHHHHhcCCCC
Q 040999          266 GILLLELMIREKPS  279 (382)
Q Consensus       266 Gvil~elltg~~p~  279 (382)
                      |+-+|+.--|..+|
T Consensus      1427 s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHhcccHHH
Confidence            99999987776654

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=94.70  E-value=0.0086  Score=58.74  Aligned_cols=35  Identities=43%  Similarity=0.503  Sum_probs=25.3

Q ss_pred             CccCCCccccccchhhh-hc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLT-RL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~-~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |+||+|++. +||..+. ++ .|-+||||+|.|. .+|+
T Consensus       131 LNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPP  167 (1255)
T KOG0444|consen  131 LNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPP  167 (1255)
T ss_pred             EEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCH
Confidence            578888887 7887655 55 7778888888887 4554

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.14  E-value=0.12  Score=47.33  Aligned_cols=92  Identities=14%  Similarity=0.110  Sum_probs=59.0

Q ss_pred             HHHHHHHHHhhccc-cc-ceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRH-RN-LIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       119 ~~~~E~~~l~~l~h-~n-iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ...+|...|+.+.. -. +.+.++         .+..++|||++.+..|.+.-+-             .+......-+.+
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpiD---------~~RH~Vvmelv~g~Pl~~v~~v-------------~d~~~ly~~lm~  213 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPID---------HNRHCVVMELVDGYPLRQVRHV-------------EDPPTLYDDLMG  213 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCccc---------ccceeeHHHhhcccceeeeeec-------------CChHHHHHHHHH
Confidence            35678888888843 22 222233         4566899999988776654321             122222222222


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEcccccc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA  238 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a  238 (382)
                      +   +.-|.   ..|+||+|..-=||+++++..++++||-..
T Consensus       214 ~---Iv~la---~~GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  214 L---IVRLA---NHGLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             H---HHHHH---HcCceecccchheeEEecCCCEEEeechHh
Confidence            2   22333   569999999999999999999999999543

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=94.12  E-value=0.015  Score=46.04  Aligned_cols=31  Identities=29%  Similarity=0.569  Sum_probs=21.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLE   32 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~ls   32 (382)
                      |+|++|.++ .+|.+++.+ .|+.||+++|.|+
T Consensus        82 lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~  113 (177)
T KOG4579|consen   82 LNLANNEIS-DVPEELAAMPALRSLNLRFNPLN  113 (177)
T ss_pred             hhcchhhhh-hchHHHhhhHHhhhcccccCccc
Confidence            456667766 677777777 6777777777776

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=94.00  E-value=0.025  Score=46.54  Aligned_cols=35  Identities=37%  Similarity=0.535  Sum_probs=31.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |-||+|.|+ .+|+.++++ +|+.||+++|+++ .+|.
T Consensus        38 LtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~   73 (264)
T KOG0617|consen   38 LTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPT   73 (264)
T ss_pred             hhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcCh
Confidence            568999999 889999999 9999999999998 6665

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.81  E-value=0.15  Score=46.86  Aligned_cols=48  Identities=25%  Similarity=0.247  Sum_probs=37.4

Q ss_pred             CCceeecCCCCCceeeCCC----CcEEEccccccccCCCCCCCCccccCCCCCccchhHHHHHHHHHHHh
Q 040999          209 QPVTAHCDLKPSNVLLDDD----MTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMI  274 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~ellt  274 (382)
                      ...++|+|+.+.||+++++    +.++++||..|....                  =.|-+|..+.|+..
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~------------------p~~DlA~~~~e~~~  229 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY------------------RGFDIANHFCEWMY  229 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC------------------cHHHHHHHHHHHHh
Confidence            5688999999999999985    789999998885332                  14667777777653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=93.75  E-value=0.018  Score=47.29  Aligned_cols=31  Identities=29%  Similarity=0.466  Sum_probs=21.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLE   32 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~ls   32 (382)
                      |+|++|++. .+|.+++.+ .|..||++-|.|.
T Consensus        61 ln~~nnqie-~lp~~issl~klr~lnvgmnrl~   92 (264)
T KOG0617|consen   61 LNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN   92 (264)
T ss_pred             hhcccchhh-hcChhhhhchhhhheecchhhhh
Confidence            466667666 667777777 6777777777766

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=93.47  E-value=0.12  Score=47.56  Aligned_cols=31  Identities=42%  Similarity=0.469  Sum_probs=27.8

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLAR  239 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~  239 (382)
                      ..+++|+|+.+.||+++.++...|.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            5789999999999999988777899998875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.35  E-value=0.14  Score=45.13  Aligned_cols=47  Identities=17%  Similarity=0.241  Sum_probs=36.5

Q ss_pred             CCceeecCCCCCceeeCC-CCcEEEccccccccCCCCCCCCccccCCCCCccchhHHHHHHHHHHH
Q 040999          209 QPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM  273 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~ell  273 (382)
                      ...++|+|+.+.|||++. ++.+.++||..|..-.+                  .|-+|+++.|+.
T Consensus       169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~~------------------~~Dla~~~~e~~  216 (235)
T cd05157         169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNYR------------------AFDIANHFNEWA  216 (235)
T ss_pred             CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCch------------------heeHHHHHHHHc
Confidence            457999999999999998 57899999988753321                  456777777754

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK05231 homoserine kinase; Provisional

Probab=93.15  E-value=0.17  Score=46.84  Aligned_cols=31  Identities=32%  Similarity=0.320  Sum_probs=26.9

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLAR  239 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~  239 (382)
                      ..+++|+|+.|.||+++.+...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4689999999999999877656899999875

>PHA03111 Ser/Thr kinase; Provisional

Probab=92.95  E-value=0.11  Score=47.58  Aligned_cols=37  Identities=27%  Similarity=0.289  Sum_probs=24.8

Q ss_pred             HHHHHHHHHHHHHhHH-hhcCCCceeecCCCCCceeeC
Q 040999          189 RRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLD  225 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~l-H~~~~~~ivH~dlkp~NILl~  225 (382)
                      -...++.||+--.-.+ .-.|-...+|-||||+|||+-
T Consensus       280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            4456778886544233 222245789999999999993

>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D

Probab=92.82  E-value=0.054  Score=26.33  Aligned_cols=13  Identities=46%  Similarity=0.516  Sum_probs=8.6

Q ss_pred             cCCeeeccCCccc
Q 040999           20 FLDNLNLSYNNLE   32 (382)
Q Consensus        20 ~L~~ldls~N~ls   32 (382)
                      +|+.||||+|+|+
T Consensus         2 ~L~~L~l~~n~L~   14 (17)
T PF13504_consen    2 NLRTLDLSNNRLT   14 (17)
T ss_dssp             T-SEEEETSS--S
T ss_pred             ccCEEECCCCCCC
Confidence            4789999999986

...

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=92.77  E-value=0.052  Score=55.73  Aligned_cols=53  Identities=32%  Similarity=0.479  Sum_probs=0.0

Q ss_pred             CccCCCccccccchh----------------------hhhc-cCCeeeccCCccc-ccCCcccc-cCCCCccccccCCC
Q 040999            1 MDFSQNNLSGEILKF----------------------LTRL-FLDNLNLSYNNLE-GMVPTGVY-KNASATSVTGNSKL   54 (382)
Q Consensus         1 LdLs~N~lsG~iP~~----------------------l~~l-~L~~ldls~N~ls-G~iP~~~~-~~~~~~~~~gn~~l   54 (382)
                      |+||+|.|+ .||.+                      +.++ .|+.+|||.|+|+ +.+|..+- +++....++||..+
T Consensus       412 L~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  412 LNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             Hhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.27  E-value=0.11  Score=43.85  Aligned_cols=31  Identities=19%  Similarity=0.206  Sum_probs=26.5

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      ....+|+|+.|.|+++++++ ++++||+.|..
T Consensus        76 ~~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         76 RLAPLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             CeeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            34568999999999998877 89999998864

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=91.95  E-value=0.24  Score=42.93  Aligned_cols=121  Identities=12%  Similarity=0.066  Sum_probs=74.8

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      -|..+.+++++++  .|+++..-       ......++.|+|-...                   -..    ..++.-=.
T Consensus       104 ~y~nky~v~Armh--GilrL~ND-------n~~~yGvIlE~Cy~~~-------------------i~~----~N~i~agi  151 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKND-------NNYKYGVILERCYKIK-------------------INF----SNFITAGI  151 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeecC-------CCceeEEEEeeccCcc-------------------cch----hHHHHHhH
Confidence            3566777777763  46666521       2344568888882211                   011    11222224


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCCCccccCCCCCccchhHHHHHHHHHHHhc
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR  275 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg  275 (382)
                      ++|.-.|++ ..+.+|+|..|+||+-|+.|.+||.|=+.--...-.+...+   ....|.++.+-+|=.-+++++..
T Consensus       152 ~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  152 KDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLENQVNMVNIE---YESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             HHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhheeeEEeee---ccccChHHHHHHHHHHHHHHHHH
Confidence            667778866 78999999999999999999999999665321111111111   12346778888887777877754

The function of this family is unknown.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=91.89  E-value=1.3  Score=38.07  Aligned_cols=90  Identities=23%  Similarity=0.357  Sum_probs=61.7

Q ss_pred             HHHHHHHHHHhhcc---cccc--eeeeeeeeec-------------ccCCCceeEEEEecccCCCccccccCCCCCCccc
Q 040999          118 KSFIAECKALRNIR---HRNL--IKVLTACLGV-------------DYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY  179 (382)
Q Consensus       118 ~~~~~E~~~l~~l~---h~ni--v~~~~~~~~~-------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~  179 (382)
                      ..|..|++...+|+   +.++  |+.+||..-.             .........||.||++...               
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------  163 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------  163 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------
Confidence            57889999888885   4466  8888886321             0112233467888775532               


Q ss_pred             cCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEcccccc
Q 040999          180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA  238 (382)
Q Consensus       180 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a  238 (382)
                          .++    .+-+.+|.+-+..+|   ..+|+-+|+++.|..     .-||+|||.+
T Consensus       164 ----~~~----~~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  164 ----PLQ----IRDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ----ccc----hhHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence                111    233567777788899   789999999999985     4589999865

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=91.76  E-value=0.36  Score=44.90  Aligned_cols=28  Identities=46%  Similarity=0.615  Sum_probs=25.7

Q ss_pred             eeecCCCCCceeeCCCCc-EEEccccccc
Q 040999          212 TAHCDLKPSNVLLDDDMT-ARVGDFGLAR  239 (382)
Q Consensus       212 ivH~dlkp~NILl~~~~~-~kl~Dfg~a~  239 (382)
                      +||+|+.|.||+++.+.. ..+.||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999999875 8899999885

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	382
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-15
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-07
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-06
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-05
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-05
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-05
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-05
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-05
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-05
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-04
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-04
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-04
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-04
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-04
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-04
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-04
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-04
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-04
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-04
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-04
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-04
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-04
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-04
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-04
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-04
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-04
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-04
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-04
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-04
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-04
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-04
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-04
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-04
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-04
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-04
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-04
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-04
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-04
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-04
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-04
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-04
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-04
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-04
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-04
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-04
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-04
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-04
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-04
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-04
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-04
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-04
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-04
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-04
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-04
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-04
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-04
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-04
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-04
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-04
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-04
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-04
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-04
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-04
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-04
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-04
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-04
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-04
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-04
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-04
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-04
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-04
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-04
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-04
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-04
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-04
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-04
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-04
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-04
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-04
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-04
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-04
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-04
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-04
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-04
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-04
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-04
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-04
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-04
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-04
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-04
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-04
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-04
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-04
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-04
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-04
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-04
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-04
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-04
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-04
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-04
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-04
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-04
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-04
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-04
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-04
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-04
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-04
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-04
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-04
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-04
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-04
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-04
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-04
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-04
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-04
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-04
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-04
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-04
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-04
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-04
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-04
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-04
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 50/267 (18%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
            F  E + +    HRNL+++   C+         + LVY ++ N S    L    +    
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQPP 127
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
            + P          IA+  A  L YLH  C P   H D+K +N+LLD++  A VGDFGLA
Sbjct: 128 LDWPKRQR------IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 239 RFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREKPSDIMFEG 285
           + +          V   +  I              DV+ YG++LLEL+  ++  D+    
Sbjct: 182 KLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL---- 237
Query: 286 DMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII------ECVISM 339
                  A++A         D ++L D  K +++  +K+ +A ++V +      E V  +
Sbjct: 238 -------ARLAND-------DDVMLLDWVKGLLK--EKKLEALVDVDLQGNYKDEEVEQL 281
Query: 340 VRIGVACSMESPQDRMKMTNVVHELQS 366
           +++ + C+  SP +R KM+ VV  L+ 
Sbjct: 282 IQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 50/267 (18%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
            F  E + +    HRNL+++   C+         + LVY ++ N S    L    +    
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQPP 135
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
            + P          IA+  A  L YLH  C P   H D+K +N+LLD++  A VGDFGLA
Sbjct: 136 LDWPKRQR------IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 189
Query: 239 RFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREKPSDIMFEG 285
           + +          V   +  I              DV+ YG++LLEL+  ++  D+    
Sbjct: 190 KLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL---- 245
Query: 286 DMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII------ECVISM 339
                  A++A         D ++L D  K +++  +K+ +A ++V +      E V  +
Sbjct: 246 -------ARLAND-------DDVMLLDWVKGLLK--EKKLEALVDVDLQGNYKDEEVEQL 289
Query: 340 VRIGVACSMESPQDRMKMTNVVHELQS 366
           +++ + C+  SP +R KM+ VV  L+ 
Sbjct: 290 IQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 31/174 (17%)
Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E   ++ +RH N++  + A      Q  +  ++V E++   S  + L+     ++  
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 180 ERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           ER           +A DVA  +NYLH+   P+  H +LK  N+L+D   T +V DFGL+R
Sbjct: 136 ER-------RRLSMAYDVAKGMNYLHNRNPPIV-HRNLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 240 FLPPTRTQTKYGVG---------------NEVSTIGDVYSYGILLLELMIREKP 278
               T   +K   G               NE S   DVYS+G++L EL   ++P
Sbjct: 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS---DVYSFGVILWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 31/174 (17%)
Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E   ++ +RH N++  + A      Q  +  ++V E++   S  + L+     ++  
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 180 ERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           ER           +A DVA  +NYLH+   P+  H DLK  N+L+D   T +V DFGL+R
Sbjct: 136 ER-------RRLSMAYDVAKGMNYLHNRNPPIV-HRDLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 240 FLPPTRTQTKYGVG---------------NEVSTIGDVYSYGILLLELMIREKP 278
                   +K   G               NE S   DVYS+G++L EL   ++P
Sbjct: 188 LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS---DVYSFGVILWELATLQQP 238

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 35/179 (19%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
           F++F  E   LR  RH N++      L + Y   D  A+V ++    S  K L+    + 
Sbjct: 76  FQAFRNEVAVLRKTRHVNIL------LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKF 129
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           + ++            IA   A  ++YLH        H D+K +N+ L + +T ++GDFG
Sbjct: 130 QMFQ---------LIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFG 177
Query: 237 LA----RFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMIREKP 278
           LA    R+    + +   G               N  S   DVYSYGI+L ELM  E P
Sbjct: 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  E K +   +H NL+++L    G    G+D   LVY ++ N S    L  +S  D 
Sbjct: 69  QQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGS---LLDRLSCLDG 120
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
           T              IA   A+ +N+LH +      H D+K +N+LLD+  TA++ DFGL
Sbjct: 121 T----PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 173
Query: 238 A-------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
           A             R +  T       +  E++   D+YS+G++LLE++
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEII 222

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  E K +   +H NL+++L    G    G+D   LVY ++ N S    L  +S  D 
Sbjct: 75  QQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGS---LLDRLSCLDG 126
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
           T              IA   A+ +N+LH +      H D+K +N+LLD+  TA++ DFGL
Sbjct: 127 T----PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 238 A-------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
           A             R +  T       +  E++   D+YS+G++LLE++
Sbjct: 180 ARASEKFAQTVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEII 228

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  E K +   +H NL+++L    G    G+D   LVY ++ N S    L  +S  D 
Sbjct: 75  QQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGS---LLDRLSCLDG 126
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
           T              IA   A+ +N+LH +      H D+K +N+LLD+  TA++ DFGL
Sbjct: 127 T----PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 238 A-------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
           A             R +  T       +  E++   D+YS+G++LLE++
Sbjct: 180 ARASEKFAQTVMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEII 228

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 28/169 (16%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  E K     +H NL+++L    G    G+D   LVY +  N S    L  +S  D 
Sbjct: 66  QQFDQEIKVXAKCQHENLVELL----GFSSDGDDL-CLVYVYXPNGS---LLDRLSCLDG 117
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
           T              IA   A+ +N+LH +      H D+K +N+LLD+  TA++ DFGL
Sbjct: 118 T----PPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 170
Query: 238 A-------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
           A             R +  T       +  E++   D+YS+G++LLE++
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEII 219

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    L+ I  + 
Sbjct: 50  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 103
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           E  +            IA   A  ++YLH        H DLK +N+ L +D+T ++GDFG
Sbjct: 104 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 151
Query: 237 LAR-------------------FLPPT--RTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LA                    ++ P   R Q K    N  S   DVY++GI+L ELM  
Sbjct: 152 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMTG 207
Query: 276 EKP 278
           + P
Sbjct: 208 QLP 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    L+ I  + 
Sbjct: 48  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 101
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           E  +            IA   A  ++YLH        H DLK +N+ L +D+T ++GDFG
Sbjct: 102 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 237 LAR-------------------FLPPT--RTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LA                    ++ P   R Q K    N  S   DVY++GI+L ELM  
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMTG 205
Query: 276 EKP 278
           + P
Sbjct: 206 QLP 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    L+ I  + 
Sbjct: 53  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 106
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           E  +            IA   A  ++YLH        H DLK +N+ L +D+T ++GDFG
Sbjct: 107 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 154
Query: 237 LAR-------------------FLPPT--RTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LA                    ++ P   R Q K    N  S   DVY++GI+L ELM  
Sbjct: 155 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMTG 210
Query: 276 EKP 278
           + P
Sbjct: 211 QLP 213

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    L+ I  + 
Sbjct: 48  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 101
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           E  +            IA   A  ++YLH        H DLK +N+ L +D+T ++GDFG
Sbjct: 102 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 237 LAR-------------------FLPPT--RTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LA                    ++ P   R Q K    N  S   DVY++GI+L ELM  
Sbjct: 150 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMTG 205
Query: 276 EKP 278
           + P
Sbjct: 206 QLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    L+ I  + 
Sbjct: 53  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 106
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           E  +            IA   A  ++YLH        H DLK +N+ L +D+T ++GDFG
Sbjct: 107 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 154
Query: 237 LAR-------------------FLPPT--RTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LA                    ++ P   R Q K    N  S   DVY++GI+L ELM  
Sbjct: 155 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMTG 210
Query: 276 EKP 278
           + P
Sbjct: 211 QLP 213

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    L+ I  + 
Sbjct: 76  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 129
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           E  +            IA   A  ++YLH        H DLK +N+ L +D+T ++GDFG
Sbjct: 130 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 177
Query: 237 LAR-------------------FLPPT--RTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LA                    ++ P   R Q K    N  S   DVY++GI+L ELM  
Sbjct: 178 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMTG 233
Query: 276 EKP 278
           + P
Sbjct: 234 QLP 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    L+ I  + 
Sbjct: 75  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 128
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           E  +            IA   A  ++YLH        H DLK +N+ L +D+T ++GDFG
Sbjct: 129 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 176
Query: 237 LAR-------------------FLPPT--RTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LA                    ++ P   R Q K    N  S   DVY++GI+L ELM  
Sbjct: 177 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMTG 232
Query: 276 EKP 278
           + P
Sbjct: 233 QLP 235

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    L+ I  + 
Sbjct: 68  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 121
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           E  +            IA   A  ++YLH        H DLK +N+ L +D+T ++GDFG
Sbjct: 122 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 169
Query: 237 LAR-------------------FLPPT--RTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LA                    ++ P   R Q K    N  S   DVY++GI+L ELM  
Sbjct: 170 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMTG 225
Query: 276 EKP 278
           + P
Sbjct: 226 QLP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    L+ I  + 
Sbjct: 76  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKF 129
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           E  +            IA   A  ++YLH        H DLK +N+ L +D+T ++GDFG
Sbjct: 130 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 177
Query: 237 LAR-------------------FLPPT--RTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LA                    ++ P   R Q K    N  S   DVY++GI+L ELM  
Sbjct: 178 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMTG 233
Query: 276 EKP 278
           + P
Sbjct: 234 QLP 236

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 43/183 (23%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    L+ I  + 
Sbjct: 48  LQAFKNEVGVLRKTRHVNIL------LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKF 101
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           E  +            IA   A  ++YLH        H DLK +N+ L +D+T ++GDFG
Sbjct: 102 EMIK---------LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 237 LAR-------------------FLPPT--RTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LA                    ++ P   R Q K    N  S   DVY++GI+L ELM  
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK----NPYSFQSDVYAFGIVLYELMTG 205
Query: 276 EKP 278
           + P
Sbjct: 206 QLP 208

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 24/164 (14%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   +  +RH NL+++L     V+ +G  +  +V E++   S   +L    +   
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS-- 112
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                           ++DV  A+ YL  +      H DL   NVL+ +D  A+V DFGL
Sbjct: 113 ------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 163
Query: 238 ARFLPPTRTQTKYGVG---------NEVSTIGDVYSYGILLLEL 272
            +    T+   K  V           + ST  DV+S+GILL E+
Sbjct: 164 TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 22/115 (19%)
Query: 206 HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-TQTKY------------GV 252
           HD + V  H D+KP N+L+D + T ++ DFG+A+ L  T  TQT +              
Sbjct: 128 HDMRIV--HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH---KFAKMALPNHVKDI 304
           G       D+YS GI+L E+++ E P    F G+  +    K  + ++PN   D+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKHIQDSVPNVTTDV 236

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 71/173 (41%), Gaps = 24/173 (13%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           K+FI E + L  + H N++K+  ACL       +   LV E+    S    LY +    E
Sbjct: 47  KAFIVELRQLSRVNHPNIVKLYGACL-------NPVCLVMEYAEGGS----LYNVLHGAE 95
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFG 236
                            +  +  + YLH        H DLKP N+LL    T  ++ DFG
Sbjct: 96  PLP---YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 152
Query: 237 LARFLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIREKPSD 280
            A  +    T  K            G+  S   DV+S+GI+L E++ R KP D
Sbjct: 153 TACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 71/173 (41%), Gaps = 24/173 (13%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           K+FI E + L  + H N++K+  ACL       +   LV E+    S    LY +    E
Sbjct: 46  KAFIVELRQLSRVNHPNIVKLYGACL-------NPVCLVMEYAEGGS----LYNVLHGAE 94
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFG 236
                            +  +  + YLH        H DLKP N+LL    T  ++ DFG
Sbjct: 95  PLP---YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151
Query: 237 LARFLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIREKPSD 280
            A  +    T  K            G+  S   DV+S+GI+L E++ R KP D
Sbjct: 152 TACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 24/164 (14%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   +  +RH NL+++L     V+ +G  +  +V E++   S   +L    +   
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS-- 97
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                           ++DV  A+ YL  +      H DL   NVL+ +D  A+V DFGL
Sbjct: 98  ------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 148
Query: 238 ARFLPPTRTQTKYGVG---------NEVSTIGDVYSYGILLLEL 272
            +    T+   K  V           + ST  DV+S+GILL E+
Sbjct: 149 TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 26/173 (15%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  EC  LR   H N++ VL AC           A     I +  P   LY +  E  
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGAC-------QSPPAPHPTLITHWMPYGSLYNVLHEGT 104
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV----- 232
            +              A+D+A  + +LH   +P+     L   +V++D+DMTAR+     
Sbjct: 105 NF----VVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADV 159
Query: 233 -------GDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKP 278
                  G      ++ P   Q K    N  S   D++S+ +LL EL+ RE P
Sbjct: 160 KFSFQSPGRMYAPAWVAPEALQKKPEDTNRRS--ADMWSFAVLLWELVTREVP 210

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 24/164 (14%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   +  +RH NL+++L     V+ +G  +  +V E++   S   +L    +   
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS-- 284
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                           ++DV  A+ YL  +      H DL   NVL+ +D  A+V DFGL
Sbjct: 285 ------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 238 ARFLPPTRTQTKYGVG---------NEVSTIGDVYSYGILLLEL 272
            +    T+   K  V           + ST  DV+S+GILL E+
Sbjct: 336 TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 24/164 (14%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   +  +RH NL+++L     V+ +G  +  +V E++   S   +L    +   
Sbjct: 50  QAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS-- 103
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                           ++DV  A+ YL  +      H DL   NVL+ +D  A+V DFGL
Sbjct: 104 ------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 154
Query: 238 ARFLPPTRTQTKYGVG---------NEVSTIGDVYSYGILLLEL 272
            +    T+   K  V             ST  DV+S+GILL E+
Sbjct: 155 TKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 55/115 (47%), Gaps = 27/115 (23%)
Query: 193 IAIDVASALNYLHHDC--------QPVTAHCDLKPSNVLLDDDMTARVGDFGLA-RF--- 240
           +A  ++  L+YLH D         +P  AH D K  NVLL  D+TA + DFGLA RF   
Sbjct: 117 VAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPG 176
Query: 241 LPPTRTQTKYG----VGNEVSTIG-----------DVYSYGILLLELMIREKPSD 280
            PP  T  + G    +  EV               D+Y+ G++L EL+ R K +D
Sbjct: 177 KPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 18/103 (17%)
Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLL-----DDDMT---ARVGDFGLARFLPPTR 245
           A+ +A  +NYLH +      H DLK SN+L+     + D++    ++ DFGLAR    T 
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT 170
Query: 246 TQTKYGV----------GNEVSTIGDVYSYGILLLELMIREKP 278
             +  G            +  S   DV+SYG+LL EL+  E P
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 253
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 254 FFPK-ARDLVEKLLVLDATK 272

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 116 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 232
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 233 FFPK-ARDLVEKLLVLDATK 251

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 253
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 254 FFPK-ARDLVEKLLVLDATK 272

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 122 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 238
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 239 FFPK-ARDLVEKLLVLDATK 257

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 115 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 172 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 231
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 232 FFPK-ARDLVEKLLVLDATK 250

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 118 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 252 VGNEVST----------IGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 175 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 234
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 235 FFPK-ARDLVEKLLVLDATK 253

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 117 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 174 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 233
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 234 FFPK-ARDLVEKLLVLDATK 252

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 254
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 255 FFPK-ARDLVEKLLVLDATK 273

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 256
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 257 FFPK-ARDLVEKLLVLDATK 275

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 254
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 255 FFPK-ARDLVEKLLVLDATK 273

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 254
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 255 FFPK-ARDLVEKLLVLDATK 273

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 256
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 257 FFPK-ARDLVEKLLVLDATK 275

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 254
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 255 FFPK-ARDLVEKLLVLDATK 273

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 252 VGNEV----------STIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               V          S   D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 197 TAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 256
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 257 FFPK-ARDLVEKLLVLDATK 275

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 63/139 (45%), Gaps = 22/139 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 143 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNLHKFAKMA 296
               VS             D+++ G ++ +L+      R     ++F+  + L      A
Sbjct: 200 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAA 259
Query: 297 LPNHVKDIVDSILLNDDEK 315
                +D+V+ +L+ D  K
Sbjct: 260 FFPKARDLVEKLLVLDATK 278

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 256
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 257 FFPK-ARDLVEKLLVLDATK 275

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 141 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 257
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 258 FFPK-ARDLVEKLLVLDATK 276

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 141 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 257
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 258 FFPK-ARDLVEKLLVLDATK 276

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 145 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F+  + L + F + 
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 261
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 262 FFPK-ARDLVEKLLVLDATK 280

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 72/179 (40%), Gaps = 35/179 (19%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    LY      
Sbjct: 64  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSS----LYHHLHAS 113
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           ET              IA   A  ++YLH        H DLK +N+ L +D T ++GDFG
Sbjct: 114 ET-----KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG 165
Query: 237 LA----RFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMIREKP 278
           LA    R+    + +   G               N  S   DVY++GI+L ELM  + P
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 72/179 (40%), Gaps = 35/179 (19%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            ++F  E   LR  RH N++      L + Y      A+V ++    S    LY      
Sbjct: 52  LQAFKNEVGVLRKTRHVNIL------LFMGYSTKPQLAIVTQWCEGSS----LYHHLHAS 101
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
           ET              IA   A  ++YLH        H DLK +N+ L +D T ++GDFG
Sbjct: 102 ET-----KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG 153
Query: 237 LA----RFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMIREKP 278
           LA    R+    + +   G               N  S   DVY++GI+L ELM  + P
Sbjct: 154 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F   + L + F + 
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEK 256
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 257 FFPK-ARDLVEKLLVLDATK 275

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 24/140 (17%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK----YG 251
           ++ SAL YLH        H DLKP N+LL++DM  ++ DFG A+ L P   Q +     G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 252 VGNEVS----------TIGDVYSYGILLLELM-----IREKPSDIMFEGDMNL-HKFAKM 295
               VS             D+++ G ++ +L+      R     ++F   + L + F + 
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEK 256
Query: 296 ALPNHVKDIVDSILLNDDEK 315
             P   +D+V+ +L+ D  K
Sbjct: 257 FFPK-ARDLVEKLLVLDATK 275

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 20/103 (19%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA----RFLPPTRTQT 248
           IA   A  ++YLH        H DLK +N+ L +D T ++GDFGLA    R+    + + 
Sbjct: 125 IARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181
Query: 249 KYGV-------------GNEVSTIGDVYSYGILLLELMIREKP 278
             G               N  S   DVY++GI+L ELM  + P
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 49/207 (23%)
Query: 193 IAIDVASALNYLHHDC-------QPVTAHCDLKPSNVLLDDDMTARVGDFGLA------- 238
           IA  +A  L YLH D        +P  +H D+K  NVLL +++TA + DFGLA       
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 239 ------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD------ 280
                       R++ P   +       +     D+Y+ G++L EL  R   +D      
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 281 -IMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI-- 337
            + FE ++  H       P+ ++D+   ++++  ++ V+R D  Q  A + ++ E +   
Sbjct: 246 MLPFEEEIGQH-------PS-LEDM-QEVVVHKKKRPVLR-DYWQKHAGMAMLCETIEEC 295
Query: 338 ----SMVRIGVACSMESPQDRMKMTNV 360
               +  R+   C  E      ++TN+
Sbjct: 296 WDHDAEARLSAGCVGERITQMQRLTNI 322

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 49/217 (22%)
Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYPI 172
           F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P 
Sbjct: 97  FLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----PT 150
Query: 173 SKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV 232
            K+                   + VA  + YL         H DL   N +LD+  T +V
Sbjct: 151 VKD--------------LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKV 193
Query: 233 GDFGLAR-------FLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIRE 276
            DFGLAR       +    +T  K  V           + +T  DV+S+G+LL ELM R 
Sbjct: 194 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 253
Query: 277 KP--SDI-MFEGDMNLHKFAKMALPNHVKDIVDSILL 310
            P   D+  F+  + L +  ++  P +  D +  ++L
Sbjct: 254 APPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 290

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 71/182 (39%), Gaps = 46/182 (25%)
Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYPI 172
           F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P 
Sbjct: 96  FLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----PT 149
Query: 173 SKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV 232
            K+                   + VA  + YL         H DL   N +LD+  T +V
Sbjct: 150 VKD--------------LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKV 192
Query: 233 GDFGLAR-------FLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIRE 276
            DFGLAR       +    +T  K  V           + +T  DV+S+G+LL ELM R 
Sbjct: 193 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 252
Query: 277 KP 278
            P
Sbjct: 253 AP 254

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 49/218 (22%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 76  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 129
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + YL         H DL   N +LD+  T +
Sbjct: 130 TVKD--------------LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVK 172
Query: 232 VGDFGLAR-------FLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR       +    +T  K  V           + +T  DV+S+G+LL ELM R
Sbjct: 173 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 232
Query: 276 EKP--SDI-MFEGDMNLHKFAKMALPNHVKDIVDSILL 310
             P   D+  F+  + L +  ++  P +  D +  ++L
Sbjct: 233 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 270

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 71/182 (39%), Gaps = 46/182 (25%)
Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYPI 172
           F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P 
Sbjct: 76  FLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----PT 129
Query: 173 SKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV 232
            K+                   + VA  + YL         H DL   N +LD+  T +V
Sbjct: 130 VKD--------------LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKV 172
Query: 233 GDFGLAR-------FLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIRE 276
            DFGLAR       +    +T  K  V           + +T  DV+S+G+LL ELM R 
Sbjct: 173 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 232
Query: 277 KP 278
            P
Sbjct: 233 AP 234

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 49/217 (22%)
Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYPI 172
           F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P 
Sbjct: 70  FLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----PT 123
Query: 173 SKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV 232
            K+                   + VA  + YL         H DL   N +LD+  T +V
Sbjct: 124 VKD--------------LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKV 166
Query: 233 GDFGLAR-------FLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIRE 276
            DFGLAR       +    +T  K  V           + +T  DV+S+G+LL ELM R 
Sbjct: 167 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 226
Query: 277 KP--SDI-MFEGDMNLHKFAKMALPNHVKDIVDSILL 310
            P   D+  F+  + L +  ++  P +  D +  ++L
Sbjct: 227 APPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 263

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 71/183 (38%), Gaps = 46/183 (25%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 74  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 127
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + YL         H DL   N +LD+  T +
Sbjct: 128 TVKD--------------LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVK 170
Query: 232 VGDFGLAR-------FLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR       +    +T  K  V           + +T  DV+S+G+LL ELM R
Sbjct: 171 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230
Query: 276 EKP 278
             P
Sbjct: 231 GAP 233

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 71/183 (38%), Gaps = 46/183 (25%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 130
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + YL         H DL   N +LD+  T +
Sbjct: 131 TVKD--------------LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVK 173
Query: 232 VGDFGLAR-------FLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR       +    +T  K  V           + +T  DV+S+G+LL ELM R
Sbjct: 174 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 233
Query: 276 EKP 278
             P
Sbjct: 234 GAP 236

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 49/218 (22%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 130
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + YL         H DL   N +LD+  T +
Sbjct: 131 TVKD--------------LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVK 173
Query: 232 VGDFGLAR-------FLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR       +    +T  K  V           + +T  DV+S+G+LL ELM R
Sbjct: 174 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 233
Query: 276 EKP--SDI-MFEGDMNLHKFAKMALPNHVKDIVDSILL 310
             P   D+  F+  + L +  ++  P +  D +  ++L
Sbjct: 234 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 271

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 71/183 (38%), Gaps = 46/183 (25%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 72  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 125
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + YL         H DL   N +LD+  T +
Sbjct: 126 TVKD--------------LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVK 168
Query: 232 VGDFGLAR-------FLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR       +    +T  K  V           + +T  DV+S+G+LL ELM R
Sbjct: 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 228
Query: 276 EKP 278
             P
Sbjct: 229 GAP 231

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 69/183 (37%), Gaps = 46/183 (25%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 76  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 129
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + YL         H DL   N +LD+  T +
Sbjct: 130 TVKD--------------LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVK 172
Query: 232 VGDFGLAR----------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR                 LP      +     + +T  DV+S+G+LL ELM R
Sbjct: 173 VADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 232
Query: 276 EKP 278
             P
Sbjct: 233 GAP 235

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 83/217 (38%), Gaps = 44/217 (20%)
Query: 77  PVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKS-------FIAECKALRN 129
           P  L  V  I SG  GL          G+   + + A K  K        FI E + +  
Sbjct: 26  PSELTFVQEIGSGQFGLV-------HLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMK 78
Query: 130 IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPXXXXXXX 189
           + H  L+++   CL           LV+EF+ +     +L           +        
Sbjct: 79  LSHPKLVQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT---------QRGLFAAET 124
Query: 190 XXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----PPTR 245
              + +DV   + YL   C     H DL   N L+ ++   +V DFG+ RF+      + 
Sbjct: 125 LLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 181
Query: 246 TQTKYGVG---------NEVSTIGDVYSYGILLLELM 273
           T TK+ V          +  S+  DV+S+G+L+ E+ 
Sbjct: 182 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 218

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/176 (22%), Positives = 72/176 (40%), Gaps = 29/176 (16%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F++E   +++  H N+I++L  C+ +  QG     ++  F+       +L        
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-------- 132
Query: 178 TYER----PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVG 233
            Y R    P            +D+A  + YL +       H DL   N +L DDMT  V 
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA 189
Query: 234 DFGLARFL-------------PPTRTQTKYGVGNEVSTI-GDVYSYGILLLELMIR 275
           DFGL++ +              P +      + + V T   DV+++G+ + E+  R
Sbjct: 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 35/200 (17%)
Query: 109 RHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKW 168
           R +    I ++ + E K L+ + H N+I +L A     ++ N   +LV++F+     E  
Sbjct: 48  RSEAKDGINRTALREIKLLQELSHPNIIGLLDA---FGHKSN--ISLVFDFM-----ETD 97
Query: 169 LYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM 228
           L  I K++     P          +       L YLH   Q    H DLKP+N+LLD++ 
Sbjct: 98  LEVIIKDNSLVLTPSHIKAYMLMTL-----QGLEYLH---QHWILHRDLKPNNLLLDENG 149
Query: 229 TARVGDFGLAR-FLPPTRTQTKYGV-----------GNEVSTIG-DVYSYGILLLELMIR 275
             ++ DFGLA+ F  P R      V           G  +  +G D+++ G +L EL++R
Sbjct: 150 VLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
Query: 276 EKPSDIMFEGDMNLHKFAKM 295
                    GD +L +  ++
Sbjct: 210 VP----FLPGDSDLDQLTRI 225

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 44/102 (43%), Gaps = 19/102 (18%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR------------- 239
             + VA  + YL    +    H DL   N +LD+  T +V DFGLAR             
Sbjct: 129 FGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185
Query: 240 ---FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKP 278
               LP   T  +       +T  DV+S+G+LL EL+ R  P
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK-YG---- 251
           + S L +LH   Q    + DLKP NVLLDDD   R+ D GLA  L   +T+TK Y     
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 252 -------VGNEVSTIGDVYSYGILLLELMIREKP 278
                  +G E     D ++ G+ L E++    P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK-YG---- 251
           + S L +LH   Q    + DLKP NVLLDDD   R+ D GLA  L   +T+TK Y     
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 252 -------VGNEVSTIGDVYSYGILLLELMIREKP 278
                  +G E     D ++ G+ L E++    P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK-YG---- 251
           + S L +LH   Q    + DLKP NVLLDDD   R+ D GLA  L   +T+TK Y     
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 252 -------VGNEVSTIGDVYSYGILLLELMIREKP 278
                  +G E     D ++ G+ L E++    P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK-YG---- 251
           + S L +LH   Q    + DLKP NVLLDDD   R+ D GLA  L   +T+TK Y     
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 252 -------VGNEVSTIGDVYSYGILLLELMIREKP 278
                  +G E     D ++ G+ L E++    P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 44/217 (20%)
Query: 77  PVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKS-------FIAECKALRN 129
           P  L  V  I SG  GL          G+   + + A K  +        FI E + +  
Sbjct: 4   PSELTFVQEIGSGQFGLV-------HLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMK 56
Query: 130 IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPXXXXXXX 189
           + H  L+++   CL           LV+EF+ +     +L           +        
Sbjct: 57  LSHPKLVQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT---------QRGLFAAET 102
Query: 190 XXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----PPTR 245
              + +DV   + YL   C     H DL   N L+ ++   +V DFG+ RF+      + 
Sbjct: 103 LLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159
Query: 246 TQTKYGVG---------NEVSTIGDVYSYGILLLELM 273
           T TK+ V          +  S+  DV+S+G+L+ E+ 
Sbjct: 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 44/217 (20%)
Query: 77  PVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKS-------FIAECKALRN 129
           P  L  V  I SG  GL          G+   + + A K  +        FI E + +  
Sbjct: 6   PSELTFVQEIGSGQFGLV-------HLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMK 58
Query: 130 IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPXXXXXXX 189
           + H  L+++   CL           LV+EF+ +     +L           +        
Sbjct: 59  LSHPKLVQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT---------QRGLFAAET 104
Query: 190 XXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----PPTR 245
              + +DV   + YL   C     H DL   N L+ ++   +V DFG+ RF+      + 
Sbjct: 105 LLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 161
Query: 246 TQTKYGVG---------NEVSTIGDVYSYGILLLELM 273
           T TK+ V          +  S+  DV+S+G+L+ E+ 
Sbjct: 162 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 198

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 69/183 (37%), Gaps = 46/183 (25%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 78  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 131
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + +L         H DL   N +LD+  T +
Sbjct: 132 TVKD--------------LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 174
Query: 232 VGDFGLAR----------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR                 LP      +     + +T  DV+S+G+LL ELM R
Sbjct: 175 VADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 234
Query: 276 EKP 278
             P
Sbjct: 235 GAP 237

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 44/217 (20%)
Query: 77  PVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKS-------FIAECKALRN 129
           P  L  V  I SG  GL          G+   + + A K  +        FI E + +  
Sbjct: 9   PSELTFVQEIGSGQFGLV-------HLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMK 61
Query: 130 IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPXXXXXXX 189
           + H  L+++   CL           LV+EF+ +     +L           +        
Sbjct: 62  LSHPKLVQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT---------QRGLFAAET 107
Query: 190 XXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----PPTR 245
              + +DV   + YL   C     H DL   N L+ ++   +V DFG+ RF+      + 
Sbjct: 108 LLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164
Query: 246 TQTKYGVG---------NEVSTIGDVYSYGILLLELM 273
           T TK+ V          +  S+  DV+S+G+L+ E+ 
Sbjct: 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 201

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 24/161 (14%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   ++ ++H  L+K+            +   ++ EF+   S    L    K DE
Sbjct: 222 EAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYIITEFMAKGS----LLDFLKSDE 271
Query: 178 TYERPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
             ++P          IA  +A     NY+H D         L+ +N+L+   +  ++ DF
Sbjct: 272 GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD---------LRAANILVSASLVCKIADF 322
Query: 236 GLARF---LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
           GLAR     P   T  +       +   DV+S+GILL+E++
Sbjct: 323 GLARVGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 363

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTKYG 251
           A ++   L +LH        + DLK  N+LLD D   ++ DFG+ +   L   +T    G
Sbjct: 124 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCG 180
Query: 252 ----------VGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDMNLHKFAKMA 296
                     +G + +   D +S+G+LL E++I + P      + +F      + F    
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 240
Query: 297 LPNHVKDIVDSILLNDDEK-LVVRGDQKQ 324
           L    KD++  + + + EK L VRGD +Q
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 69/183 (37%), Gaps = 46/183 (25%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 78  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 131
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + +L         H DL   N +LD+  T +
Sbjct: 132 TVKD--------------LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 174
Query: 232 VGDFGLAR----------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR                 LP      +     + +T  DV+S+G+LL ELM R
Sbjct: 175 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 234
Query: 276 EKP 278
             P
Sbjct: 235 GAP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 69/183 (37%), Gaps = 46/183 (25%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 82  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 135
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + +L         H DL   N +LD+  T +
Sbjct: 136 TVKD--------------LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 178
Query: 232 VGDFGLAR----------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR                 LP      +     + +T  DV+S+G+LL ELM R
Sbjct: 179 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 238
Query: 276 EKP 278
             P
Sbjct: 239 GAP 241

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQTKYG 251
           A ++   L +LH        + DLK  N+LLD D   ++ DFG+ +   L   +T    G
Sbjct: 125 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCG 181
Query: 252 ----------VGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFEGDMNLHKFAKMA 296
                     +G + +   D +S+G+LL E++I + P      + +F      + F    
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 241
Query: 297 LPNHVKDIVDSILLNDDEK-LVVRGDQKQ 324
           L    KD++  + + + EK L VRGD +Q
Sbjct: 242 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 270

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 69/183 (37%), Gaps = 46/183 (25%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 130
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + +L         H DL   N +LD+  T +
Sbjct: 131 TVKD--------------LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 173
Query: 232 VGDFGLAR----------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR                 LP      +     + +T  DV+S+G+LL ELM R
Sbjct: 174 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 233
Query: 276 EKP 278
             P
Sbjct: 234 GAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 69/182 (37%), Gaps = 46/182 (25%)
Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYPI 172
           F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P 
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----PT 190
Query: 173 SKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV 232
            K+                   + VA  + +L         H DL   N +LD+  T +V
Sbjct: 191 VKD--------------LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKV 233
Query: 233 GDFGLAR----------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIRE 276
            DFGLAR                 LP      +     + +T  DV+S+G+LL ELM R 
Sbjct: 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 293
Query: 277 KP 278
            P
Sbjct: 294 AP 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 69/183 (37%), Gaps = 46/183 (25%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 130
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + +L         H DL   N +LD+  T +
Sbjct: 131 TVKD--------------LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 173
Query: 232 VGDFGLAR----------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR                 LP      +     + +T  DV+S+G+LL ELM R
Sbjct: 174 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 233
Query: 276 EKP 278
             P
Sbjct: 234 GAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 69/183 (37%), Gaps = 46/183 (25%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVY-------EFIHNRSPEKWLYP 171
            F+ E   +++  H N++ +L  CL    +G+    L Y        FI N +      P
Sbjct: 75  QFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPLVVLPYMKHGDLRNFIRNETHN----P 128
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
             K+                   + VA  + +L         H DL   N +LD+  T +
Sbjct: 129 TVKD--------------LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 171
Query: 232 VGDFGLAR----------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           V DFGLAR                 LP      +     + +T  DV+S+G+LL ELM R
Sbjct: 172 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 231
Query: 276 EKP 278
             P
Sbjct: 232 GAP 234

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 34/171 (19%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   ++ ++H  L+K+            +   ++ EF+   S    L    K DE
Sbjct: 55  EAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYIITEFMAKGS----LLDFLKSDE 104
Query: 178 TYERPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
             ++P          IA  +A     NY+H D         L+ +N+L+   +  ++ DF
Sbjct: 105 GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD---------LRAANILVSASLVCKIADF 155
Query: 236 GLARFLPPTRTQTKYG-------VGNEVSTIG------DVYSYGILLLELM 273
           GLAR +       + G          E    G      DV+S+GILL+E++
Sbjct: 156 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 206

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 34/171 (19%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   ++ ++H  L+K+            +   ++ EF+   S    L    K DE
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYIITEFMAKGS----LLDFLKSDE 277
Query: 178 TYERPXXXXXXXXXXIAIDVA--SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
             ++P          IA  +A     NY+H D         L+ +N+L+   +  ++ DF
Sbjct: 278 GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD---------LRAANILVSASLVCKIADF 328
Query: 236 GLARFLPPTRTQTKYG-------VGNEVSTIG------DVYSYGILLLELM 273
           GLAR +       + G          E    G      DV+S+GILL+E++
Sbjct: 329 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 21/100 (21%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-----PTRTQTKYG 251
           +AS + YL    +    H DL   N+L++ ++  +V DFGL+RFL      PT T +  G
Sbjct: 127 IASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGG 183
Query: 252 ------------VGNEVSTIGDVYSYGILLLELM-IREKP 278
                          + ++  D +SYGI++ E+M   E+P
Sbjct: 184 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 31/187 (16%)
Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGNDFKALVYEF 159
           L+     K     I+E + ++ I +H+N+I +L AC         V+Y     K  + E+
Sbjct: 68  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLREY 124
Query: 160 IHNRSPEKWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKP 219
           +  R P    Y  +      E+            A  VA  + YL         H DL  
Sbjct: 125 LQAREPPGLEYSYNPSHNPEEQ---LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 220 SNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYSY 265
            NVL+ +D   ++ DFGLAR +              P +      + + + T   DV+S+
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 266 GILLLEL 272
           G+LL E+
Sbjct: 239 GVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 97/248 (39%), Gaps = 39/248 (15%)
Query: 54  LCGGISKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALALSI-------CFFFGFS 106
           +  G+S+++LP+    +    RL +   L      G V LA A+ +              
Sbjct: 1   MVAGVSEYELPEDPRWELPRDRLVLGKPLGEGAF-GQVVLAEAIGLDKDKPNRVTKVAVK 59
Query: 107 HLRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGNDFKALVYE 158
            L+     K     I+E + ++ I +H+N+I +L AC         V+Y     K  + E
Sbjct: 60  MLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLRE 116
Query: 159 FIHNRSPEKWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLK 218
           ++  R P    Y  +      E+            A  VA  + YL         H DL 
Sbjct: 117 YLQARRPPGLEYSYNPSHNPEEQ---LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLA 170
Query: 219 PSNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYS 264
             NVL+ +D   ++ DFGLAR +              P +      + + + T   DV+S
Sbjct: 171 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 230
Query: 265 YGILLLEL 272
           +G+LL E+
Sbjct: 231 FGVLLWEI 238

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 46/100 (46%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA----------------RF 240
           + SA++Y H   + +  H DLKP NVLLD  M A++ DFGL+                 +
Sbjct: 120 ILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNY 176
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P     +   G EV    D++S G++L  L+    P D
Sbjct: 177 AAPEVISGRLYAGPEV----DIWSCGVILYALLCGTLPFD 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 46/100 (46%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA----------------RF 240
           + SA++Y H   + +  H DLKP NVLLD  M A++ DFGL+                 +
Sbjct: 120 ILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNY 176
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P     +   G EV    D++S G++L  L+    P D
Sbjct: 177 AAPEVISGRLYAGPEV----DIWSCGVILYALLCGTLPFD 212

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 63/171 (36%), Gaps = 22/171 (12%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  EC  LR   H N++ VL AC           A     I +  P   LY +  E  
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGACQSP-------PAPHPTLITHWXPYGSLYNVLHEGT 104
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
            +              A+D A    +LH   +P+     L   +V +D+D TAR+    +
Sbjct: 105 NF----VVDQSQAVKFALDXARGXAFLH-TLEPLIPRHALNSRSVXIDEDXTARISXADV 159
Query: 238 A-RFLPPTRTQTKYGVGNEV---------STIGDVYSYGILLLELMIREKP 278
              F  P R      V  E              D +S+ +LL EL+ RE P
Sbjct: 160 KFSFQSPGRXYAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVP 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/172 (22%), Positives = 71/172 (41%), Gaps = 32/172 (18%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E + ++ +RH  L+++            +   +V E++   S   +L     E  
Sbjct: 48  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIXIVTEYMSKGSLLDFL---KGETG 98
Query: 178 TYER-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 99  KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 149
Query: 237 LARFLPPTRTQTKYG-------VGNEVSTIG------DVYSYGILLLELMIR 275
           LAR +       + G          E +  G      DV+S+GILL EL  +
Sbjct: 150 LARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 201

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 31/187 (16%)
Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGNDFKALVYEF 159
           L+     K     I+E + ++ I +H+N+I +L AC         V+Y     K  + E+
Sbjct: 109 LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLREY 165
Query: 160 IHNRSPEKWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKP 219
           +  R P    Y  +      E+            A  VA  + YL         H DL  
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQ---LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 219
Query: 220 SNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYSY 265
            NVL+ +D   ++ DFGLAR +              P +      + + + T   DV+S+
Sbjct: 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279
Query: 266 GILLLEL 272
           G+LL E+
Sbjct: 280 GVLLWEI 286

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 21/100 (21%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-----PTRTQTKYG 251
           +AS + YL    +    H DL   N+L++ ++  +V DFGL+RFL      PT T +  G
Sbjct: 125 IASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGG 181
Query: 252 ------------VGNEVSTIGDVYSYGILLLELM-IREKP 278
                          + ++  D +SYGI++ E+M   E+P
Sbjct: 182 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 31/187 (16%)
Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGNDFKALVYEF 159
           L+     K     I+E + ++ I +H+N+I +L AC         V+Y     K  + E+
Sbjct: 68  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLREY 124
Query: 160 IHNRSPEKWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKP 219
           +  R P    Y  +      E+            A  VA  + YL         H DL  
Sbjct: 125 LQARRPPGLEYSYNPSHNPEEQ---LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 220 SNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYSY 265
            NVL+ +D   ++ DFGLAR +              P +      + + + T   DV+S+
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 266 GILLLEL 272
           G+LL E+
Sbjct: 239 GVLLWEI 245

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/172 (22%), Positives = 72/172 (41%), Gaps = 32/172 (18%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E + ++ +RH  L+++            +   +V E+++  S   +L     E  
Sbjct: 55  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMNKGSLLDFL---KGETG 105
Query: 178 TYER-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 106 KYLRLPQLVDMSAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 156
Query: 237 LARFLPPTRTQTKYG-------VGNEVSTIG------DVYSYGILLLELMIR 275
           LAR +       + G          E +  G      DV+S+GILL EL  +
Sbjct: 157 LARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 208

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP---------- 242
            A DVA  ++YL    Q    H DL   N+L+ ++  A++ DFGL+R             
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 243 PTRTQTKYGVGNEVSTI-GDVYSYGILLLELM 273
           P R      +   V T   DV+SYG+LL E++
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 49/113 (43%), Gaps = 20/113 (17%)
Query: 195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVG- 253
           + + SAL ++H        H D+KP+NV +      ++GD GL RF     T     VG 
Sbjct: 143 VQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 199
Query: 254 -----------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-MNLHKFAK 294
                      N  +   D++S G LL E+   + P    F GD MNL+   K
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 248

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 31/187 (16%)
Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGNDFKALVYEF 159
           L+     K     I+E + ++ I +H+N+I +L AC         V+Y     K  + E+
Sbjct: 57  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLREY 113
Query: 160 IHNRSPEKWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKP 219
           +  R P    Y  +      E+            A  VA  + YL         H DL  
Sbjct: 114 LQARRPPGLEYSYNPSHNPEEQ---LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 167
Query: 220 SNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYSY 265
            NVL+ +D   ++ DFGLAR +              P +      + + + T   DV+S+
Sbjct: 168 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 227
Query: 266 GILLLEL 272
           G+LL E+
Sbjct: 228 GVLLWEI 234

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 69/179 (38%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ EF+   S  ++L    K  
Sbjct: 58  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEFLPYGSLREYL---QKHK 111
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 112 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 155
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 65/137 (47%), Gaps = 25/137 (18%)
Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ---TKY 250
           A +V  AL YLH        + DLKP N+LLD +   ++ DFG A+++P        T  
Sbjct: 112 AAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPD 168
Query: 251 GVGNEVSTIG------DVYSYGILLLELMIREKP---SDIM--FEGDMNLHKFAKMALP- 298
            +  EV +        D +S+GIL+ E++    P   S+ M  +E  +N    A++  P 
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----AELRFPP 224
Query: 299 ---NHVKDIVDSILLND 312
                VKD++  ++  D
Sbjct: 225 FFNEDVKDLLSRLITRD 241

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP---------- 242
            A DVA  ++YL    Q    H DL   N+L+ ++  A++ DFGL+R             
Sbjct: 137 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 193
Query: 243 PTRTQTKYGVGNEVSTI-GDVYSYGILLLELM 273
           P R      +   V T   DV+SYG+LL E++
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 32/172 (18%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E + ++ +RH  L+++              +  +Y  I   S    L  +  E  
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVV---------SEEPIYIVIEYMSKGSLLDFLKGEMG 108
Query: 178 TYER-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 159
Query: 237 LARFLPPTRTQTKYG-------VGNEVSTIG------DVYSYGILLLELMIR 275
           LAR +       + G          E +  G      DV+S+GILL EL  +
Sbjct: 160 LARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 31/187 (16%)
Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGNDFKALVYEF 159
           L+     K     I+E + ++ I +H+N+I +L AC         V+Y     K  + E+
Sbjct: 60  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLREY 116
Query: 160 IHNRSPEKWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKP 219
           +  R P    Y  +      E+            A  VA  + YL         H DL  
Sbjct: 117 LQARRPPGLEYSYNPSHNPEEQ---LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 170
Query: 220 SNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYSY 265
            NVL+ +D   ++ DFGLAR +              P +      + + + T   DV+S+
Sbjct: 171 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 230
Query: 266 GILLLEL 272
           G+LL E+
Sbjct: 231 GVLLWEI 237

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/172 (22%), Positives = 72/172 (41%), Gaps = 32/172 (18%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E + ++ +RH  L+++            +   +V E+++  S   +L     E  
Sbjct: 55  EAFLQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMNKGSLLDFL---KGETG 105
Query: 178 TYER-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 106 KYLRLPQLVDMSAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 156
Query: 237 LARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LAR +             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 157 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 208

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 44/217 (20%)
Query: 77  PVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKS-------FIAECKALRN 129
           P  L  V  I SG  GL          G+   + + A K  +        FI E + +  
Sbjct: 7   PSELTFVQEIGSGQFGLV-------HLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMK 59
Query: 130 IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPXXXXXXX 189
           + H  L+++   CL           LV EF+ +     +L           +        
Sbjct: 60  LSHPKLVQLYGVCLE-----QAPICLVTEFMEHGCLSDYLRT---------QRGLFAAET 105
Query: 190 XXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----PPTR 245
              + +DV   + YL   C     H DL   N L+ ++   +V DFG+ RF+      + 
Sbjct: 106 LLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162
Query: 246 TQTKYGVG---------NEVSTIGDVYSYGILLLELM 273
           T TK+ V          +  S+  DV+S+G+L+ E+ 
Sbjct: 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/172 (22%), Positives = 71/172 (41%), Gaps = 32/172 (18%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E + ++ IRH  L+++            +   +V E++   S   +L     E  
Sbjct: 58  EAFLQEAQVMKKIRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFL---KGEMG 108
Query: 178 TYER-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 159
Query: 237 LARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LAR +             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 160 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 19/150 (12%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG----LARFLPPTR--T 246
           + + V  AL+YLH+       H D+K  ++LL  D   ++ DFG    +++ +P  +   
Sbjct: 146 VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV 202
Query: 247 QTKYGVGNEV------STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNH 300
            T Y +  EV       T  D++S GI+++E++  E P     E  +   +  + +LP  
Sbjct: 203 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP--YFNEPPLQAMRRIRDSLPPR 260
Query: 301 VKDI--VDSILLNDDEKLVVRGDQKQTQAK 328
           VKD+  V S+L    + ++VR   ++  A+
Sbjct: 261 VKDLHKVSSVLRGFLDLMLVREPSQRATAQ 290

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG- 251
           +A  +AS + Y+    +    H DL+ +N+L+ +++  +V DFGLAR +       + G 
Sbjct: 285 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341
Query: 252 ------VGNEVSTIG------DVYSYGILLLELMIR 275
                    E +  G      DV+S+GILL EL  +
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           +A  +AS + Y+         H DL+ +N+L+ +++  +V DFGLAR +           
Sbjct: 112 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 168
Query: 242 --PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 169 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 204

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG- 251
           +A  +AS + Y+    +    H DL+ +N+L+ +++  +V DFGLAR +       + G 
Sbjct: 285 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341
Query: 252 ------VGNEVSTIG------DVYSYGILLLELMIR 275
                    E +  G      DV+S+GILL EL  +
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           +A  +AS + Y+         H DL+ +N+L+ +++  +V DFGLAR +           
Sbjct: 108 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 164
Query: 242 --PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 165 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 200

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 22/106 (20%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----TRTQTKY 250
           D   ALN+ H +      H D+KP+N+++      +V DFG+AR +       T+T    
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 251 GV----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
           G           G+ V    DVYS G +L E++  E P    F GD
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           +A  +AS + Y+         H DL+ +N+L+ +++  +V DFGLAR +           
Sbjct: 110 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 166
Query: 242 --PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 167 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 202

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 22/106 (20%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----TRTQTKY 250
           D   ALN+ H +      H D+KP+N+++      +V DFG+AR +       T+T    
Sbjct: 141 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 197
Query: 251 GV----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
           G           G+ V    DVYS G +L E++  E P    F GD
Sbjct: 198 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 239

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG- 251
           +A  +AS + Y+    +    H DL+ +N+L+ +++  +V DFGLAR +       + G 
Sbjct: 285 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341
Query: 252 ------VGNEVSTIG------DVYSYGILLLELMIR 275
                    E +  G      DV+S+GILL EL  +
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           +A  +AS + Y+         H DL+ +N+L+ +++  +V DFGLAR +           
Sbjct: 119 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 242 --PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 75/187 (40%), Gaps = 31/187 (16%)
Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGNDFKALVYEF 159
           L+     K     I+E + ++ I +H+N+I +L AC         V+Y     K  + E+
Sbjct: 68  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLREY 124
Query: 160 IHNRSPEKWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKP 219
           +  R P    +  +      E+            A  VA  + YL         H DL  
Sbjct: 125 LQARRPPGLEFSFNPSHNPEEQ---LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 220 SNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYSY 265
            NVL+ +D   ++ DFGLAR +              P +      + + + T   DV+S+
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 266 GILLLEL 272
           G+LL E+
Sbjct: 239 GVLLWEI 245

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           +A  +AS + Y+         H DL+ +N+L+ +++  +V DFGLAR +           
Sbjct: 119 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 242 --PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 84/201 (41%), Gaps = 49/201 (24%)
Query: 121 IAECKALRNIRHRNLIKVLTA-----CLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE 175
           I E   L+ + H N++ ++       CL           LV+EF+     EK L  +  E
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCL----------TLVFEFM-----EKDLKKVLDE 111
Query: 176 DETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
           ++T              I I +   L  + H  Q    H DLKP N+L++ D   ++ DF
Sbjct: 112 NKT--------GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADF 163
Query: 236 GLAR-FLPPTRTQTKYGV------------GNEVSTIGDVYSYGILLLELMIREKPSDIM 282
           GLAR F  P R+ T   V              + ST  D++S G +  E MI  KP   +
Sbjct: 164 GLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE-MITGKP---L 219
Query: 283 FEG---DMNLHK-FAKMALPN 299
           F G   D  L K F+ +  PN
Sbjct: 220 FPGVTDDDQLPKIFSILGTPN 240

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/172 (22%), Positives = 69/172 (40%), Gaps = 32/172 (18%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E + ++ +RH  L+++              +  +Y  I   S    L  +  E  
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVV---------SEEPIYIVIEYMSKGSLLDFLKGEMG 108
Query: 178 TYER-PXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
            Y R P            +     +NY+H D         L+ +N+L+ +++  +V DFG
Sbjct: 109 KYLRLPQLVDMAAQIASGMAYVERMNYVHRD---------LRAANILVGENLVCKVADFG 159
Query: 237 LARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           LAR +             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 160 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           +A  +AS + Y+         H DL+ +N+L+ +++  +V DFGLAR +           
Sbjct: 119 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 242 --PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           +A  +AS + Y+         H DL+ +N+L+ +++  +V DFGLAR +           
Sbjct: 119 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 242 --PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 22/106 (20%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR---TQT---- 248
           D   ALN+ H +      H D+KP+N+++      +V DFG+AR +  +    TQT    
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                   +   G+ V    DVYS G +L E++  E P    F GD
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGLAR L               
Sbjct: 156 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI 212
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA----------------RF 240
           + SA+ Y H   +    H DLKP N+LLD+ +  ++ DFGL+                 +
Sbjct: 121 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNY 177
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P     K   G EV    DV+S G++L  ++ R  P D
Sbjct: 178 AAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 213

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 84/201 (41%), Gaps = 49/201 (24%)
Query: 121 IAECKALRNIRHRNLIKVLTA-----CLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE 175
           I E   L+ + H N++ ++       CL           LV+EF+     EK L  +  E
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCL----------TLVFEFM-----EKDLKKVLDE 111
Query: 176 DETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
           ++T              I I +   L  + H  Q    H DLKP N+L++ D   ++ DF
Sbjct: 112 NKT--------GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADF 163
Query: 236 GLAR-FLPPTRTQTKYGV------------GNEVSTIGDVYSYGILLLELMIREKPSDIM 282
           GLAR F  P R+ T   V              + ST  D++S G +  E MI  KP   +
Sbjct: 164 GLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE-MITGKP---L 219
Query: 283 FEG---DMNLHK-FAKMALPN 299
           F G   D  L K F+ +  PN
Sbjct: 220 FPGVTDDDQLPKIFSILGTPN 240

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA----------------RF 240
           + SA+ Y H   +    H DLKP N+LLD+ +  ++ DFGL+                 +
Sbjct: 122 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNY 178
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P     K   G EV    DV+S G++L  ++ R  P D
Sbjct: 179 AAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 22/106 (20%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR---TQT---- 248
           D   ALN+ H +      H D+KP+N+++      +V DFG+AR +  +    TQT    
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                   +   G+ V    DVYS G +L E++  E P    F GD
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 22/106 (20%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR---TQT---- 248
           D   ALN+ H +      H D+KP+N+++      +V DFG+AR +  +    TQT    
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                   +   G+ V    DVYS G +L E++  E P    F GD
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG- 251
           +A  +AS + Y+         H DL+ +N+L+ +++  +V DFGLAR +       + G 
Sbjct: 368 MAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424
Query: 252 ------VGNEVSTIG------DVYSYGILLLELMIR 275
                    E +  G      DV+S+GILL EL  +
Sbjct: 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 44/100 (44%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA----------------RF 240
           + SA+ Y H        H DLKP N+LLD+ +  ++ DFGL+                 +
Sbjct: 112 IISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNY 168
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P     K   G EV    DV+S G++L  ++ R  P D
Sbjct: 169 AAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 204

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 28/101 (27%)
Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------- 243
            A+++LH +      H DLKP N+LLDD+M  R+ DFG +  L P               
Sbjct: 211 EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267
Query: 244 ------TRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKP 278
                 +  +T  G G EV    D+++ G++L  L+    P
Sbjct: 268 PEILKCSMDETHPGYGKEV----DLWACGVILFTLLAGSPP 304

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 156 IASGMKYLS-DMGAV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 31/187 (16%)
Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGNDFKALVYEF 159
           L+     K     I+E + ++ I +H+N+I +L AC         V+Y     K  + E+
Sbjct: 53  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLREY 109
Query: 160 IHNRSPEKWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKP 219
           +  R P    Y  +      E+            A  VA  + YL         H DL  
Sbjct: 110 LQARRPPGLEYCYNPSHNPEEQ---LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 163
Query: 220 SNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYSY 265
            NVL+ +D   ++ DFGLAR +              P +      + + + T   DV+S+
Sbjct: 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223
Query: 266 GILLLEL 272
           G+LL E+
Sbjct: 224 GVLLWEI 230

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA----------------RF 240
           + SA+ Y H   +    H DLKP N+LLD+ +  ++ DFGL+                 +
Sbjct: 116 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNY 172
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P     K   G EV    DV+S G++L  ++ R  P D
Sbjct: 173 AAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLPFD 208

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 31/187 (16%)
Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGNDFKALVYEF 159
           L+     K     I+E + ++ I +H+N+I +L AC         V+Y     K  + E+
Sbjct: 68  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS---KGNLREY 124
Query: 160 IHNRSPEKWLYPISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKP 219
           +  R P    Y  +      E+            A  VA  + YL         H DL  
Sbjct: 125 LQARRPPGLEYCYNPSHNPEEQ---LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 220 SNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVGNEVST-IGDVYSY 265
            NVL+ +D   ++ DFGLAR +              P +      + + + T   DV+S+
Sbjct: 179 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 238
Query: 266 GILLLEL 272
           G+LL E+
Sbjct: 239 GVLLWEI 245

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 137 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 234

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/71 (40%), Positives = 36/71 (50%), Gaps = 12/71 (16%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVG----------NEVS--TIGD 261
           H DLKP+NV LD     ++GDFGLAR L    +  K  VG          N +S     D
Sbjct: 139 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSD 198
Query: 262 VYSYGILLLEL 272
           ++S G LL EL
Sbjct: 199 IWSLGCLLYEL 209

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 128 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 185 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/71 (40%), Positives = 36/71 (50%), Gaps = 12/71 (16%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVG----------NEVS--TIGD 261
           H DLKP+NV LD     ++GDFGLAR L    +  K  VG          N +S     D
Sbjct: 139 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSD 198
Query: 262 VYSYGILLLEL 272
           ++S G LL EL
Sbjct: 199 IWSLGCLLYEL 209

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 31/169 (18%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTAC-LGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
           + F+ E   ++ I+H NL+++L  C L   +       +V E++   +   +L   ++E+
Sbjct: 73  EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFY------IVTEYMPYGNLLDYLRECNREE 126
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
            T              +A  ++SA+ YL    +    H DL   N L+ ++   +V DFG
Sbjct: 127 VT--------AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFG 175
Query: 237 LARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           L+R +             P   T  +    N  S   DV+++G+LL E+
Sbjct: 176 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NVL+D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/268 (21%), Positives = 108/268 (40%), Gaps = 45/268 (16%)
Query: 37  TGVYKNASATSVTGNSKLCGGISKFKLPKCGSKKSNGKRLPVALNLVISIVSGLVGLALA 96
           T + +  +  S T ++ +  G+S+++LP+    +    +L +   L      G V +A A
Sbjct: 44  TPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCF-GQVVMAEA 102
Query: 97  LSI-------CFFFGFSHLRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLG---- 144
           + I               L+     K     ++E + ++ I +H+N+I +L AC      
Sbjct: 103 VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162
Query: 145 ---VDYQGNDFKALVYEFIHNRSPE--KWLYPISKEDETYERPXXXXXXXXXXIAIDVAS 199
              V+Y     K  + E++  R P   ++ Y I++  E                   +A 
Sbjct: 163 YVIVEYAS---KGNLREYLRARRPPGMEYSYDINRVPE-----EQMTFKDLVSCTYQLAR 214
Query: 200 ALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------PTR 245
            + YL    C     H DL   NVL+ ++   ++ DFGLAR +              P +
Sbjct: 215 GMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 270
Query: 246 TQTKYGVGNEVST-IGDVYSYGILLLEL 272
                 + + V T   DV+S+G+L+ E+
Sbjct: 271 WMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 45/103 (43%), Gaps = 23/103 (22%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA----------------RF 240
           +  A+ Y H        H DLKP N+LLDD++  ++ DFGL+                 +
Sbjct: 117 IICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNY 173
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 283
             P     K   G EV    DV+S GI+L  +++   P D  F
Sbjct: 174 AAPEVINGKLYAGPEV----DVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 127 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 48/111 (43%), Gaps = 32/111 (28%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR---------------- 239
           D   ALN+ H +      H D+KP+N+L+      +V DFG+AR                
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVI 180
Query: 240 ----FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
               +L P + +     G+ V    DVYS G +L E++  E P    F GD
Sbjct: 181 GTAQYLSPEQAR-----GDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 127 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 105
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 106 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 155
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 156 SRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 42/172 (24%)
Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E + LRN+ H N++K    C   +  GN  K L+ EF+ + S +++L P +K     ++ 
Sbjct: 61  EIEILRNLYHENIVKYKGIC--TEDGGNGIK-LIMEFLPSGSLKEYL-PKNKNKINLKQ- 115
Query: 183 XXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--- 239
                      A+ +   ++YL         H DL   NVL++ +   ++GDFGL +   
Sbjct: 116 -------QLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 165
Query: 240 ------------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
                             + P    Q+K+ + +      DV+S+G+ L EL+
Sbjct: 166 TDKEXXTVKDDRDSPVFWYAPECLMQSKFYIAS------DVWSFGVTLHELL 211

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 42/172 (24%)
Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E + LRN+ H N++K    C   +  GN  K L+ EF+ + S +++L P +K     ++ 
Sbjct: 73  EIEILRNLYHENIVKYKGIC--TEDGGNGIK-LIMEFLPSGSLKEYL-PKNKNKINLKQ- 127
Query: 183 XXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--- 239
                      A+ +   ++YL         H DL   NVL++ +   ++GDFGL +   
Sbjct: 128 -------QLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 240 ------------------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
                             + P    Q+K+ + +      DV+S+G+ L EL+
Sbjct: 178 TDKEXXTVKDDRDSPVFWYAPECLMQSKFYIAS------DVWSFGVTLHELL 223

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYLRECNRQE- 107
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 108 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYLRECNRQE- 105
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 106 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 155
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 156 SRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYLRECNRQE- 107
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 108 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 144 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 200
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 201 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 232

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 105
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 106 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 155
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 156 SRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/71 (40%), Positives = 35/71 (49%), Gaps = 12/71 (16%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVG----------NEVS--TIGD 261
           H DLKP+NV LD     ++GDFGLAR L       K  VG          N +S     D
Sbjct: 139 HRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSD 198
Query: 262 VYSYGILLLEL 272
           ++S G LL EL
Sbjct: 199 IWSLGCLLYEL 209

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/182 (21%), Positives = 74/182 (40%), Gaps = 35/182 (19%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLY---PISK 174
           K F  E + L N++H +++K    C+       D   +V+E++ +    K+L    P + 
Sbjct: 60  KDFHREAELLTNLQHEHIVKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAV 114
Query: 175 EDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                  P          IA  +A+ + YL         H DL   N L+ +++  ++GD
Sbjct: 115 LMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGD 171
Query: 235 FGLA-------------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
           FG++                   R++PP     +     + +T  DV+S G++L E+   
Sbjct: 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-----KFTTESDVWSLGVVLWEIFTY 226
Query: 276 EK 277
            K
Sbjct: 227 GK 228

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 185 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 225

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 44/217 (20%)
Query: 77  PVALNLVISIVSGLVGLALALSICFFFGFSHLRHQGAFKIFKS-------FIAECKALRN 129
           P  L  V  I SG  GL          G+   + + A K  +        FI E + +  
Sbjct: 6   PSELTFVQEIGSGQFGLV-------HLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMK 58
Query: 130 IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPXXXXXXX 189
           + H  L+++   CL           LV+EF+ +     +L           +        
Sbjct: 59  LSHPKLVQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT---------QRGLFAAET 104
Query: 190 XXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----PPTR 245
              + +DV   + YL    +    H DL   N L+ ++   +V DFG+ RF+      + 
Sbjct: 105 LLGMCLDVCEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 161
Query: 246 TQTKYGVG---------NEVSTIGDVYSYGILLLELM 273
           T TK+ V          +  S+  DV+S+G+L+ E+ 
Sbjct: 162 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 198

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 186 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 226

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 185 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 225

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR----------------F 240
           + SA+ Y H   Q    H DLK  N+LLD DM  ++ DFG +                 +
Sbjct: 115 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPY 171
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P   Q K   G EV    DV+S G++L  L+    P D
Sbjct: 172 AAPELFQGKKYDGPEV----DVWSLGVILYTLVSGSLPFD 207

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 186 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 226

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 107
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 108 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 185 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 225

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 186 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 226

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 20/94 (21%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKY--GVGN 254
           +A+ + YL  D   V  H DL   N+L++ ++  +V DFGL+RFL    +   Y   +G 
Sbjct: 144 IAAGMKYLA-DMNYV--HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 200
Query: 255 EV---------------STIGDVYSYGILLLELM 273
           ++               ++  DV+SYGI++ E+M
Sbjct: 201 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 185 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 225

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 187 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 227

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA----------------RF 240
           + S ++Y H   + +  H DLKP NVLLD  M A++ DFGL+                 +
Sbjct: 125 ILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNY 181
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P     +   G EV    D++S G++L  L+    P D
Sbjct: 182 AAPEVISGRLYAGPEV----DIWSSGVILYALLCGTLPFD 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/178 (23%), Positives = 68/178 (38%), Gaps = 44/178 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 126
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 127 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 170
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLEL 272
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           +A  +AS + Y+         H DL  +N+L+ +++  +V DFGLAR +           
Sbjct: 119 MAAQIASGMAYVERMN---YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 242 --PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIR 275
             P   T  +  +    +   DV+S+GILL EL  +
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 211

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTK-----YGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T      +    E+       ST  
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 186 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 226

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/178 (23%), Positives = 68/178 (38%), Gaps = 44/178 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 126
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 127 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 170
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLEL 272
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 55  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 108
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 109 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 53  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 106
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 107 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 150
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 151 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 209

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 156 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR----------------F 240
           + SA+ Y H   Q    H DLK  N+LLD DM  ++ DFG +                 +
Sbjct: 123 IVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPY 179
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P   Q K   G EV    DV+S G++L  L+    P D
Sbjct: 180 AAPELFQGKKYDGPEV----DVWSLGVILYTLVSGSLPFD 215

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYLRECNRQE- 112
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 113 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 163 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 97/250 (38%), Gaps = 36/250 (14%)
Query: 132 HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPXXXXXXXXX 191
           HR+L           ++ NDF  +V E    RS    L  + K  +    P         
Sbjct: 71  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEARYYLR-- 124
Query: 192 XIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP--PTRTQTK 249
                +     YLH +      H DLK  N+ L++D+  ++GDFGLA  +     R +T 
Sbjct: 125 ----QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL 177
Query: 250 YGVGNEV----------STIGDVYSYGILLLELMIREKPSDIMFEGDMNLH-KFAKMALP 298
            G  N +          S   DV+S G ++  L++ + P +     +  L  K  + ++P
Sbjct: 178 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP 237
Query: 299 NHVKDIVDSI---LLNDDEKLV-----VRGDQKQTQAKI--NVIIECVISMVRIGVACSM 348
            H+  +  S+   +L  D         +  D+  T   I   + I C+    R  +A S 
Sbjct: 238 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSS 297
Query: 349 ESPQDRMKMT 358
             P +R  +T
Sbjct: 298 LDPSNRKPLT 307

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 133 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 192
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 193 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 233

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 73/164 (44%), Gaps = 42/164 (25%)
Query: 131 RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLY--PISKEDETYERPXXXXXX 188
           RH +L+ ++  C        +   L+Y+++ N + ++ LY   +     ++E+       
Sbjct: 93  RHPHLVSLIGFC-----DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ------- 140
Query: 189 XXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--------- 239
               I I  A  L+YLH        H D+K  N+LLD++   ++ DFG+++         
Sbjct: 141 -RLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTH 196
Query: 240 ----------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
                     ++ P     +Y +   ++   DVYS+G++L E++
Sbjct: 197 LXXVVKGTLGYIDP-----EYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 55  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYLRECNRQE- 108
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 109 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 158
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 159 SRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 55  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 108
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 109 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 107
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 108 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 185
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 186 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 226

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 54  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 107
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 108 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 151
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 152 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 210

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 112
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 113 -------VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 163 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR----------------F 240
           + SA+ Y H   Q    H DLK  N+LLD DM  ++ DFG +                 +
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPY 178
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P   Q K   G EV    DV+S G++L  L+    P D
Sbjct: 179 AAPELFQGKKYDGPEV----DVWSLGVILYTLVSGSLPFD 214

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 133 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 192
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 193 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 233

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 156 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 156 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 73/164 (44%), Gaps = 42/164 (25%)
Query: 131 RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLY--PISKEDETYERPXXXXXX 188
           RH +L+ ++  C        +   L+Y+++ N + ++ LY   +     ++E+       
Sbjct: 93  RHPHLVSLIGFC-----DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ------- 140
Query: 189 XXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--------- 239
               I I  A  L+YLH        H D+K  N+LLD++   ++ DFG+++         
Sbjct: 141 -RLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 240 ----------FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
                     ++ P     +Y +   ++   DVYS+G++L E++
Sbjct: 197 LXXVVKGTLGYIDP-----EYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 107
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 108 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 109
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 110 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 159
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 160 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP---------- 242
            A DVA  ++YL    Q    H +L   N+L+ ++  A++ DFGL+R             
Sbjct: 144 FAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 200
Query: 243 PTRTQTKYGVGNEVSTI-GDVYSYGILLLELM 273
           P R      +   V T   DV+SYG+LL E++
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 156 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 67  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 120
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 121 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 170
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 171 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 218

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR----------------F 240
           + SA+ Y H   Q    H DLK  N+LLD DM  ++ DFG +                 +
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPY 178
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P   Q K   G EV    DV+S G++L  L+    P D
Sbjct: 179 AAPELFQGKKYDGPEV----DVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR----------------F 240
           + SA+ Y H   Q    H DLK  N+LLD DM  ++ DFG +                 +
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPY 178
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P   Q K   G EV    DV+S G++L  L+    P D
Sbjct: 179 AAPELFQGKKYDGPEV----DVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR----------------F 240
           + SA+ Y H   Q    H DLK  N+LLD DM  ++ DFG +                 +
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPY 178
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P   Q K   G EV    DV+S G++L  L+    P D
Sbjct: 179 AAPELFQGKKYDGPEV----DVWSLGVILYTLVSGSLPFD 214

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 55  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 108
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 109 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 158
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 159 SRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR----------------F 240
           + SA+ Y H   Q    H DLK  N+LLD DM  ++ DFG +                 +
Sbjct: 122 IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPY 178
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P   Q K   G EV    DV+S G++L  L+    P D
Sbjct: 179 AAPELFQGKKYDGPEV----DVWSLGVILYTLVSGSLPFD 214

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 61  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 114
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 115 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 158
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 159 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 217

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 154 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 210
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 211 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 242

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 86  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 139
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 140 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 183
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 184 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 109
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 110 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 159
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 160 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 109
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 110 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 159
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 160 SRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGV-----GNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT T   V       E+       ST  
Sbjct: 130 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 189
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 190 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 230

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 138 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 194
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 251
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 252 DLYDYI 257

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 156 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 59  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 112
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 113 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 156
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 157 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 215

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 112
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 113 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 163 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 138 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 194
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 251
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 252 DLYDYI 257

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 60  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 113
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 114 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 157
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 158 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 62  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 115
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 116 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 159
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 160 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 218

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 107
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 108 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG- 251
           +A  +AS + Y+    +    H DL+ +N+L+ +++  +V DFGL R +       + G 
Sbjct: 286 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGA 342
Query: 252 ------VGNEVSTIG------DVYSYGILLLELMIR 275
                    E +  G      DV+S+GILL EL  +
Sbjct: 343 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 378

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 36/250 (14%)
Query: 132 HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPXXXXXXXXX 191
           HR+L           ++ NDF  +V E    RS    L  + K  +    P         
Sbjct: 75  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEARYYLR-- 128
Query: 192 XIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP--PTRTQTK 249
                +     YLH +      H DLK  N+ L++D+  ++GDFGLA  +     R +T 
Sbjct: 129 ----QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL 181
Query: 250 YGVGNEV-----STIG-----DVYSYGILLLELMIREKPSDIMFEGDMNLH-KFAKMALP 298
            G  N +     S  G     DV+S G ++  L++ + P +     +  L  K  + ++P
Sbjct: 182 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP 241
Query: 299 NHVKDIVDSI---LLNDDEKL-----VVRGDQKQTQAKI--NVIIECVISMVRIGVACSM 348
            H+  +  S+   +L  D         +  D+  T   I   + I C+    R  +A S 
Sbjct: 242 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSS 301
Query: 349 ESPQDRMKMT 358
             P +R  +T
Sbjct: 302 LDPSNRKPLT 311

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L    K  
Sbjct: 58  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYL---QKHK 111
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
           E                 ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 112 ER----------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 155
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 139 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 195
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 252
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 253 DLYDYI 258

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR----------------F 240
           + SA+ Y H   Q    H DLK  N+LLD DM  ++ DFG +                 +
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPY 179
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P   Q K   G EV    DV+S G++L  L+    P D
Sbjct: 180 AAPELFQGKKYDGPEV----DVWSLGVILYTLVSGSLPFD 215

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 144 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 200
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 201 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 257
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 258 DLYDYI 263

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 112
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 113 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 163 SRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 24/93 (25%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA----------------RF 240
           +   ++Y+H        H DLKPSN+ L D    ++GDFGL                 R+
Sbjct: 145 ITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 201
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM 273
           + P +  ++   G EV    D+Y+ G++L EL+
Sbjct: 202 MSPEQISSQ-DYGKEV----DLYALGLILAELL 229

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 19/126 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-RVGDFGLARFLPP-----TRTQTK 249
           ++  AL+Y H        H D+KP NV++D +    R+ D+GLA F  P      R  ++
Sbjct: 137 EILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 193
Query: 250 YGVGNEVSTIGDVYSY-------GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
           Y  G E+     +Y Y       G +L  ++ R++P    F G  N  +  ++A     +
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTE 250
Query: 303 DIVDSI 308
           D+ D I
Sbjct: 251 DLYDYI 256

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL+R L               
Sbjct: 156 IASGMKYLS-DMGFV--HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 18/107 (16%)
Query: 200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF------LPPTRTQTKYG-- 251
            L++LH +C     H DLKP N+L+    T ++ DFGLAR       L P      Y   
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAP 180
Query: 252 ---VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
              + +  +T  D++S G +  E M R KP   +F G+    +  K+
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAE-MFRRKP---LFCGNSEADQLGKI 223

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 111
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 112 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 161
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 207
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 208 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 237

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/179 (21%), Positives = 68/179 (37%), Gaps = 44/179 (24%)
Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
            + F  E + L++++H N++K    C      G     L+ E++   S   +L   ++  
Sbjct: 58  LRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQAHAER- 113
Query: 177 ETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTA-------HCDLKPSNVLLDDDMT 229
                             ID    L Y    C+ +         H DL   N+L++++  
Sbjct: 114 ------------------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 155
Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNE---------------VSTIGDVYSYGILLLELM 273
            ++GDFGL + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 43/100 (43%), Gaps = 23/100 (23%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR----------------F 240
           + SA+ Y H   Q    H DLK  N+LLD DM  ++ DFG +                 +
Sbjct: 120 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPY 176
Query: 241 LPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
             P   Q K   G EV    DV+S G++L  L+    P D
Sbjct: 177 AAPELFQGKKYDGPEV----DVWSLGVILYTLVSGSLPFD 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C     +   F  ++ EF+   +   +L   ++++ 
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE- 112
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 113 -------VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 162
Query: 238 ARFL-------------PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +R +             P   T  +    N+ S   DV+++G+LL E+
Sbjct: 163 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 165 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 221
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 222 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 262

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 18/92 (19%)
Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------- 242
           +AS + YL  D   V  H DL   N+L++ ++  +V DFGL R L               
Sbjct: 156 IASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 243 PTRTQTKYGVG-NEVSTIGDVYSYGILLLELM 273
           P R  +   +   + ++  DV+SYGI+L E+M
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 16/96 (16%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG- 251
           +A  VA+ + Y+         H DL+ +N+L+ + +  ++ DFGLAR +       + G 
Sbjct: 110 MAAQVAAGMAYIERMN---YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGA 166
Query: 252 ------VGNEVSTIG------DVYSYGILLLELMIR 275
                    E +  G      DV+S+GILL EL+ +
Sbjct: 167 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 202

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/198 (21%), Positives = 84/198 (42%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 49  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 102
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 103 INK--------LLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLA 151
Query: 239 RFLP------------PTRTQTKYGVGNEVSTI-GDVYSYGILLLELMIREK---PSDIM 282
           R +             P +      +     TI  DV+S+GILL E++   +   P    
Sbjct: 152 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 211
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 212 PEVIQNLERGYRMVRPDN 229

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 134 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 191 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 231

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 18/107 (16%)
Query: 200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF------LPPTRTQTKYG-- 251
            L++LH +C     H DLKP N+L+    T ++ DFGLAR       L P      Y   
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 252 ---VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
              + +  +T  D++S G +  E M R KP   +F G+    +  K+
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAE-MFRRKP---LFCGNSEADQLGKI 231

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 130 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 227

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 137 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 142 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 200
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 201 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 230

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 136 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 233

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 207
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 208 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 237

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 186 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 226

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 73/180 (40%), Gaps = 38/180 (21%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYP------ 171
           K F  E + L N++H +++K    C        D   +V+E++ +    K+L        
Sbjct: 62  KDFQREAELLTNLQHEHIVKFYGVC-----GDGDPLIMVFEYMKHGDLNKFLRAHGPDAM 116
Query: 172 ISKEDETYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
           I  + +  +            IA  +AS + YL         H DL   N L+  ++  +
Sbjct: 117 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVK 173
Query: 232 VGDFGLA-------------------RFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
           +GDFG++                   R++PP     +     + +T  DV+S+G++L E+
Sbjct: 174 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-----KFTTESDVWSFGVILWEI 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 136 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 233

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 186 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 226

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 74/184 (40%), Gaps = 43/184 (23%)
Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E K +R + H N++K +    GV Y+       + E+I   +    +  +  +  
Sbjct: 52  RTFLKEVKVMRCLEHPNVLKFI----GVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQYP 106
Query: 178 TYERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             +R            A D+AS + YLH        H DL   N L+ ++    V DFGL
Sbjct: 107 WSQR---------VSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGL 154
Query: 238 ARFLPPTRTQT-------------KYGV-------------GNEVSTIGDVYSYGILLLE 271
           AR +   +TQ              +Y V             G       DV+S+GI+L E
Sbjct: 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214
Query: 272 LMIR 275
           ++ R
Sbjct: 215 IIGR 218

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 127 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 187 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 227

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 133 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 190 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 230

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 207
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 208 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 237

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/198 (20%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 55  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 108
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 109 INK--------LLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLA 157
Query: 239 RFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREK---PSDIM 282
           R +       + G    +                 DV+S+GILL E++   +   P    
Sbjct: 158 RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 217
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 218 PEVIQNLERGYRMVRPDN 235

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 188 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 228

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 186 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 226

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 129 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 189 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 229

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 45/105 (42%), Gaps = 24/105 (22%)
Query: 193 IAIDVASALNYLHHDCQPVTA----------HCDLKPSNVLLDDDMTARVGDFGLARFLP 242
           IA   AS  + LH   Q              H D+   NVLL +   A++GDFGLAR + 
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 243 -------------PTRTQTKYGVGNEVSTI-GDVYSYGILLLELM 273
                        P +      + + V T+  DV+SYGILL E+ 
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 185 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 225

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 127 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 187 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 227

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 207
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 208 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 237

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 188 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 228

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 128 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 188 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 228

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 189 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 229

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 126 HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 186 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 226

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/198 (20%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 56  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 109
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 110 INK--------LLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLA 158
Query: 239 RFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREK---PSDIM 282
           R +       + G    +                 DV+S+GILL E++   +   P    
Sbjct: 159 RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 218
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 219 PEVIQNLERGYRMVRPDN 236

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 189 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 229

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 189 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 229

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 186 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 226

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 187 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 227

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 185 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 225

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 130 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 189
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 190 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 230

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 189 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 229

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 188 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 228

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/198 (20%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 107
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 108 INK--------LLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLA 156
Query: 239 RFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREK---PSDIM 282
           R +       + G    +                 DV+S+GILL E++   +   P    
Sbjct: 157 RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 217 PEVIQNLERGYRMVRPDN 234

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 189 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 229

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/198 (20%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 107
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 108 INK--------LLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 156
Query: 239 RFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREK---PSDIM 282
           R +       + G    +                 DV+S+GILL E++   +   P    
Sbjct: 157 RLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 217 PEVIQNLERGYRMVRPDN 234

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 24/109 (22%)
Query: 201 LNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG 260
           L Y+H   Q +  H DLKPSN+L++++   ++GDFG+AR L  +  + +Y +   V+T  
Sbjct: 171 LKYMH-SAQVI--HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 261 -----------------DVYSYGILLLELMIREKPSDIMFEGDMNLHKF 292
                            D++S G +  E++ R +    +F G   +H+ 
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ----LFPGKNYVHQL 272

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQ-----TKYGVGNEV-------STIG 260
           H DLKP N+L++ +   ++ DFGLAR F  P RT      T +    E+       ST  
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 261 DVYSYGILLLELMIREKPSDIMFEGDMNLHK----FAKMALPNHV 301
           D++S G +  E++ R      +F GD  + +    F  +  P+ V
Sbjct: 187 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEV 227

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 245
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 246 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 275

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/198 (21%), Positives = 84/198 (42%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 107
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 108 INK--------LLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLA 156
Query: 239 RFLP------------PTRTQTKYGVGNEVSTI-GDVYSYGILLLELMIREK---PSDIM 282
           R +             P +      +     TI  DV+S+GILL E++   +   P    
Sbjct: 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 217 PEVIQNLERGYRMVRPDN 234

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 143 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 245
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 246 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 275

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 30/167 (17%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
            FI E K + N+ H  L+++   C     Q   F  ++ E++ N     +L  +    +T
Sbjct: 45  EFIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQT 99
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
            +            +  DV  A+ YL         H DL   N L++D    +V DFGL+
Sbjct: 100 QQ---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 147
Query: 239 RFLPPTRTQTKYG-------------VGNEVSTIGDVYSYGILLLEL 272
           R++      +  G             + ++ S+  D++++G+L+ E+
Sbjct: 148 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 194

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 14/96 (14%)
Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRT-QTKYG- 251
           A ++   L  LH +      + DLKP N+LLDD    R+ D GLA  +P  +T + + G 
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 252 --------VGNEVSTIG-DVYSYGILLLELMIREKP 278
                   V NE  T   D ++ G LL E++  + P
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 26/191 (13%)
Query: 132 HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPXXXXXXXXX 191
           HR+L           ++ NDF  +V E    RS    L  + K  +    P         
Sbjct: 71  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEARYYLR-- 124
Query: 192 XIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP--PTRTQTK 249
                +     YLH +      H DLK  N+ L++D+  ++GDFGLA  +     R +T 
Sbjct: 125 ----QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL 177
Query: 250 YGVGNEV----------STIGDVYSYGILLLELMIREKPSDIMFEGDMNLH-KFAKMALP 298
            G  N +          S   DV+S G ++  L++ + P +     +  L  K  + ++P
Sbjct: 178 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP 237
Query: 299 NHVKDIVDSIL 309
            H+  +  S++
Sbjct: 238 KHINPVAASLI 248

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 18/107 (16%)
Query: 200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF------LPPTRTQTKYG-- 251
            L++LH +C     H DLKP N+L+    T ++ DFGLAR       L P      Y   
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAP 180
Query: 252 ---VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
              + +  +T  D++S G +  E M R KP   +F G+    +  K+
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAE-MFRRKP---LFCGNSEADQLGKI 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +A ++A  + YL+ +      H DL   N ++ +D T ++GDFG+ R +  T    K G 
Sbjct: 143 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 253 G--------------NEVSTIGDVYSYGILLLEL-MIREKP 278
           G                 +T  DV+S+G++L E+  + E+P
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 208
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 209 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 238

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 201
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 202 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 231

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 207
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 208 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 237

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 30/167 (17%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
            FI E K + N+ H  L+++   C     Q   F  ++ E++ N     +L  +    +T
Sbjct: 50  EFIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQT 104
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
            +            +  DV  A+ YL         H DL   N L++D    +V DFGL+
Sbjct: 105 QQ---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 152
Query: 239 RFLPPTRTQTKYG-------------VGNEVSTIGDVYSYGILLLEL 272
           R++      +  G             + ++ S+  D++++G+L+ E+
Sbjct: 153 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 200
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 201 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 230

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 148 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 206
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 207 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 236

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ------TK 249
           ++   L+YLH + +    H D+K +NVLL +    ++ DFG+A  L  T+ +      T 
Sbjct: 128 EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 184
Query: 250 YGVGNEV------STIGDVYSYGILLLELMIREKPSDIM 282
           + +  EV       +  D++S GI  +EL   E P+  M
Sbjct: 185 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 24/109 (22%)
Query: 201 LNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG 260
           L Y+H   Q +  H DLKPSN+L++++   ++GDFG+AR L  +  + +Y +   V+T  
Sbjct: 172 LKYMH-SAQVI--HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 261 -----------------DVYSYGILLLELMIREKPSDIMFEGDMNLHKF 292
                            D++S G +  E++ R +    +F G   +H+ 
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ----LFPGKNYVHQL 273

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/198 (20%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 113
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 114 INK--------LLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 162
Query: 239 RFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREK---PSDIM 282
           R +       + G    +                 DV+S+GILL E++   +   P    
Sbjct: 163 RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 222
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 223 PEVIQNLERGYRMVRPDN 240

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/198 (20%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 62  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 115
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 116 INK--------LLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 164
Query: 239 RFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREK---PSDIM 282
           R +       + G    +                 DV+S+GILL E++   +   P    
Sbjct: 165 RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 224
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 225 PEVIQNLERGYRMVRPDN 242

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 201
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 202 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 231

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 14/96 (14%)
Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRT-QTKYG- 251
           A ++   L  LH +      + DLKP N+LLDD    R+ D GLA  +P  +T + + G 
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 252 --------VGNEVSTIG-DVYSYGILLLELMIREKP 278
                   V NE  T   D ++ G LL E++  + P
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/198 (20%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 63  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 116
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 117 INK--------LLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 165
Query: 239 RFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREK---PSDIM 282
           R +       + G    +                 DV+S+GILL E++   +   P    
Sbjct: 166 RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 225
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 226 PEVIQNLERGYRMVRPDN 243

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 207
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 208 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 237

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 30/166 (18%)
Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           FI E K + N+ H  L+++   C     Q   F  ++ E++ N     +L  +    +T 
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ 120
Query: 180 ERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           +            +  DV  A+ YL         H DL   N L++D    +V DFGL+R
Sbjct: 121 Q---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 240 FLPPTRTQTKYG-------------VGNEVSTIGDVYSYGILLLEL 272
           ++      +  G             + ++ S+  D++++G+L+ E+
Sbjct: 169 YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/198 (21%), Positives = 84/198 (42%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 113
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 114 INK--------LLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 162
Query: 239 RFLP------------PTRTQTKYGVGNEVSTI-GDVYSYGILLLELMIREK---PSDIM 282
           R +             P +      +     TI  DV+S+GILL E++   +   P    
Sbjct: 163 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 222
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 223 PEVIQNLERGYRMVRPDN 240

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/198 (20%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 107
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 108 INK--------LLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 156
Query: 239 RFLPPTRTQTKYGVGNEVSTIG-------------DVYSYGILLLELMIREK---PSDIM 282
           R +       + G    +                 DV+S+GILL E++   +   P    
Sbjct: 157 RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 217 PEVIQNLERGYRMVRPDN 234

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 30/167 (17%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
            FI E K + N+ H  L+++   C     Q   F  ++ E++ N     +L  +    +T
Sbjct: 49  EFIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQT 103
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
            +            +  DV  A+ YL         H DL   N L++D    +V DFGL+
Sbjct: 104 QQ---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 151
Query: 239 RFLPPTRTQTKYG-------------VGNEVSTIGDVYSYGILLLEL 272
           R++      +  G             + ++ S+  D++++G+L+ E+
Sbjct: 152 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 198

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 208
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G ++ E M+R K   I+F G   + ++ K+
Sbjct: 209 IWSVGCIMGE-MVRHK---ILFPGRDYIDQWNKV 238

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/198 (21%), Positives = 84/198 (42%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 59  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 112
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 113 INK--------LLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 161
Query: 239 RFLP------------PTRTQTKYGVGNEVSTI-GDVYSYGILLLELMIREK---PSDIM 282
           R +             P +      +     TI  DV+S+GILL E++   +   P    
Sbjct: 162 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 221
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 222 PEVIQNLERGYRMVRPDN 239

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/198 (21%), Positives = 84/198 (42%), Gaps = 33/198 (16%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L   S    T
Sbjct: 64  AFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLT 117
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
             +           +A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 118 INK--------LLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 166
Query: 239 RFLP------------PTRTQTKYGVGNEVSTI-GDVYSYGILLLELMIREK---PSDIM 282
           R +             P +      +     TI  DV+S+GILL E++   +   P    
Sbjct: 167 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 226
Query: 283 FEGDMNLHKFAKMALPNH 300
            E   NL +  +M  P++
Sbjct: 227 PEVIQNLERGYRMVRPDN 244

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 30/167 (17%)
Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
            FI E K + N+ H  L+++   C     Q   F  ++ E++ N     +L  +    +T
Sbjct: 50  EFIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQT 104
Query: 179 YERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
            +            +  DV  A+ YL         H DL   N L++D    +V DFGL+
Sbjct: 105 QQ---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 152
Query: 239 RFLPPTRTQTKYG-------------VGNEVSTIGDVYSYGILLLEL 272
           R++      +  G             + ++ S+  D++++G+L+ E+
Sbjct: 153 RYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 30/166 (18%)
Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           FI E K + N+ H  L+++   C     Q   F  ++ E++ N     +L  +    +T 
Sbjct: 57  FIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQ 111
Query: 180 ERPXXXXXXXXXXIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           +            +  DV  A+ YL         H DL   N L++D    +V DFGL+R
Sbjct: 112 Q---------LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 159
Query: 240 FLPPTRTQTKYG-------------VGNEVSTIGDVYSYGILLLEL 272
           ++      +  G             + ++ S+  D++++G+L+ E+
Sbjct: 160 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 205

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 207
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G+++ E++       ++F G  ++ ++ K+
Sbjct: 208 IWSVGVIMGEMI----KGGVLFPGTDHIDQWNKV 237

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 17/94 (18%)
Query: 214 HCDLKPSNVLLDDDMTARVGDFGLAR-----FLPPTRTQTKYGVGNEVSTIG-------D 261
           H DLKPSN+++  D T ++ DFGLAR     F+      T+Y    EV  +G       D
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVD 207
Query: 262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKM 295
           ++S G+++ E++       ++F G  ++ ++ K+
Sbjct: 208 IWSVGVIMGEMI----KGGVLFPGTDHIDQWNKV 237

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	382
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-46
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-38
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-37
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-32
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-32
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-30
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-29
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-28
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-27
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-26
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-26
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-25
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-04
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-04
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-04
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-16
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-16
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-05
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-04
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-15
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-15
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-15
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-15
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-15
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-15
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-14
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-14
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-14
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-14
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-14
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-13
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-13
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-13
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-13
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-13
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-13
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-13
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-13
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-12
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-12
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-12
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-12
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-12
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-12
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-12
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-12
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-12
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-12
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-12
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-12
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-12
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-12
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-12
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-12
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-12
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-12
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-12
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-12
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-12
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-12
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-11
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-11
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-11
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-11
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-11
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-11
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-11
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-11
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-11
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-11
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-11
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-10
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-10
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-10
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-10
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-10
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-10
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-09
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-09
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-09
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-09
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-09
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-09
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-09
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-09
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-09
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-08
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-08
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-08
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-08
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-08
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-08
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-08
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-07
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-07
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-07
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-07
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-07
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-07
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-07
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-07
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-07
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-07
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-07
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-07
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-07
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-07
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-07
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-07
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-07
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-07
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-07
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-07
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-07
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-07
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-07
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-06
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-06
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-06
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-06
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-06
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-06
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-06
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-06
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-06
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-06
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-06
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-06
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-06
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-06
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-06
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-06
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-06
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-06
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-06
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-06
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-06
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-06
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-06
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-06
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-06
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-06
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-06
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-05
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-05
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-05
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-05
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-05
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-05
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-05
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-05
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-05
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-05
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-05
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-05
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-05
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-05
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-05
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-05
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-05
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-05
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-05
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-05
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-05
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-05
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-04
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-04
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-04
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-04
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-04
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-04
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	3e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-04
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-04
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  158 bits (403), Expect = 8e-46
 Identities = 72/264 (27%), Positives = 117/264 (44%), Gaps = 46/264 (17%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F  E + +    HRNL+++   C+       + + LVY ++ N S    L       E  
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR------ERP 122

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           E    L+  +R  IA+  A  L YLH  C P   H D+K +N+LLD++  A VGDFGLA+
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

Query: 240 FLPPTRT--QTK-----------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF--- 283
            +    T   T            Y    + S   DV+ YG++LLEL+  ++  D+     
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

Query: 284 EGDMNLHKFAKMALPN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI 342
           + D+ L  + K  L    ++ +VD  L  + +                   E V  ++++
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKD------------------EEVEQLIQV 284

Query: 343 GVACSMESPQDRMKMTNVVHELQS 366
            + C+  SP +R KM+ VV  L+ 
Sbjct: 285 ALLCTQSSPMERPKMSEVVRMLEG 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  138 bits (351), Expect = 2e-38
 Identities = 62/280 (22%), Positives = 101/280 (36%), Gaps = 68/280 (24%)

Query: 110 HQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWL 169
            +      + F  E K +   +H NL+++L         G+D   LVY ++ N S    L
Sbjct: 71  EEL----KQQFDQEIKVMAKCQHENLVELLGFSS----DGDD-LCLVYVYMPNGSLLDRL 121

Query: 170 YPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT 229
             +            L+   R  IA   A+ +N+LH +      H D+K +N+LLD+  T
Sbjct: 122 SCLDGT-------PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFT 171

Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNEVS-----TIG---------------DVYSYGILL 269
           A++ DFGLAR       QT       ++     T                 D+YS+G++L
Sbjct: 172 AKISDFGLAR-ASEKFAQT------VMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVL 224

Query: 270 LELMIREKPSDIMFEGDMNLHKFAKMAL--PNHVKDIVDSILLNDDEKLVVRGDQKQTQA 327
           LE++      D   E    L    +        ++D +D  + + D   V          
Sbjct: 225 LEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEA-------- 275

Query: 328 KINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 367
                      M  +   C  E    R  +  V   LQ +
Sbjct: 276 -----------MYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  135 bits (341), Expect = 8e-37
 Identities = 64/281 (22%), Positives = 112/281 (39%), Gaps = 66/281 (23%)

Query: 110 HQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWL 169
            QG     + F  E + L   RH +L+ ++  C   +        L+Y+++ N + ++ L
Sbjct: 76  SQG----IEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHL 126

Query: 170 YPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT 229
           Y       +     +++  +RL I I  A  L+YLH        H D+K  N+LLD++  
Sbjct: 127 Y------GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177

Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNEVST-----IG----------------DVYSYGIL 268
            ++ DFG+++       QT       +ST     +G                DVYS+G++
Sbjct: 178 PKITDFGISK-KGTELDQTH------LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230

Query: 269 LLELMIREKPSDIMF-EGDMNLHKFAKMALPN-HVKDIVDSILLNDDEKLVVRGDQKQTQ 326
           L E++              +NL ++A  +  N  ++ IVD  L                 
Sbjct: 231 LFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL----------------A 274

Query: 327 AKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 367
            KI    E +       V C   S +DR  M +V+ +L+  
Sbjct: 275 DKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  134 bits (340), Expect = 1e-36
 Identities = 58/288 (20%), Positives = 101/288 (35%), Gaps = 55/288 (19%)

Query: 113 AFKIFKS-------FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSP 165
           A KIF            E  +L  ++H N+++ + A         D   L+  F    S 
Sbjct: 51  AVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSL 109

Query: 166 EKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHD-------CQPVTAHCDLK 218
             +L           +   ++     +IA  +A  L YLH D        +P  +H D+K
Sbjct: 110 SDFL-----------KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK 158

Query: 219 PSNVLLDDDMTARVGDFGLARFLPPTRTQ--TKYGVG-----------------NEVSTI 259
             NVLL +++TA + DFGLA      ++   T   VG                  +    
Sbjct: 159 SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 218

Query: 260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVR 319
            D+Y+ G++L EL  R   +D   +  M    F +  +  H         L D +++VV 
Sbjct: 219 IDMYAMGLVLWELASRCTAADGPVDEYM--LPFEEE-IGQHPS-------LEDMQEVVVH 268

Query: 320 GDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 367
             ++            +  +      C     + R+    V   +  +
Sbjct: 269 KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  126 bits (319), Expect = 8e-34
 Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 25/176 (14%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           +    F+ E   ++ +RH N++  + A      Q  +  ++V E++   S  + L+    
Sbjct: 76  ERVNEFLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVTEYLSRGSLYRLLH---- 126

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                     L+  RRL++A DVA  +NYLH+   P   H +LK  N+L+D   T +V D
Sbjct: 127 ---KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCD 182

Query: 235 FGLARFLPPTRTQTKYGVGN------EV------STIGDVYSYGILLLELMIREKP 278
           FGL+R    T   +K   G       EV      +   DVYS+G++L EL   ++P
Sbjct: 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  120 bits (303), Expect = 8e-32
 Identities = 39/177 (22%), Positives = 70/177 (39%), Gaps = 28/177 (15%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           +  + F  EC  LR   H N++ VL AC            L+  ++   S    LY +  
Sbjct: 49  RKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPHPTLITHWMPYGS----LYNVLH 101

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
           E         ++  + +  A+D+A  + +LH   +P+     L   +V++D+DMTAR+  
Sbjct: 102 EG----TNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISM 156

Query: 235 FGLARFLPPTRT-------------QTKYGVGNEVSTIGDVYSYGILLLELMIREKP 278
             +                      +         +   D++S+ +LL EL+ RE P
Sbjct: 157 ADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  121 bits (306), Expect = 9e-32
 Identities = 61/307 (19%), Positives = 104/307 (33%), Gaps = 60/307 (19%)

Query: 113 AFKIF-----KSFIAECK--ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSP 165
           A K+F     ++FI E     +  + H N+ + +     V   G     LV E+  N S 
Sbjct: 40  AVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSL 99

Query: 166 EKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHD------CQPVTAHCDLKP 219
            K+L                + +    +A  V   L YLH +       +P  +H DL  
Sbjct: 100 XKYL-----------SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS 148

Query: 220 SNVLLDDDMTARVGDFGLARFLPPTRTQ--------TKYGVGN------EV--------- 256
            NVL+ +D T  + DFGL+  L   R              VG       EV         
Sbjct: 149 RNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRD 208

Query: 257 ----STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLND 312
                   D+Y+ G++  E+ +R   +D+     +  +   +MA    V +        D
Sbjct: 209 XESALKQVDMYALGLIYWEIFMR--CTDLFPGESVPEY---QMAFQTEVGNHPT---FED 260

Query: 313 DEKLVVRGDQKQT-QAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL 371
            + LV R  Q+             V S+      C  +  + R+        +  +    
Sbjct: 261 MQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320

Query: 372 LGPKNLA 378
              K+++
Sbjct: 321 ERNKSVS 327

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  117 bits (294), Expect = 3e-30
 Identities = 51/185 (27%), Positives = 74/185 (40%), Gaps = 36/185 (19%)

Query: 113 AFKIFKS------FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
           A K  +S      FI E + L  + H N++K+  ACL      N    LV E+    S  
Sbjct: 35  AIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL------NPV-CLVMEYAEGGSLY 87

Query: 167 KWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD 226
             L+         E          ++  +  +  + YLH        H DLKP N+LL  
Sbjct: 88  NVLH-------GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 140

Query: 227 DMT-ARVGDFGLARFLPPTRTQTKYGVGN------EV------STIGDVYSYGILLLELM 273
             T  ++ DFG A  +    T      G+      EV      S   DV+S+GI+L E++
Sbjct: 141 GGTVLKICDFGTACDIQTHMTN---NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI 197

Query: 274 IREKP 278
            R KP
Sbjct: 198 TRRKP 202

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  114 bits (287), Expect = 1e-29
 Identities = 46/182 (25%), Positives = 72/182 (39%), Gaps = 34/182 (18%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           +  ++   E K    ++H N+I +   CL    +  +   LV EF         L     
Sbjct: 48  QTIENVRQEAKLFAMLKHPNIIALRGVCL----KEPNL-CLVMEFARGGP----LN---- 94

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD--------D 226
                   + +     +N A+ +A  +NYLH +      H DLK SN+L+          
Sbjct: 95  ---RVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151

Query: 227 DMTARVGDFGLARFLPPTRTQTKYG----------VGNEVSTIGDVYSYGILLLELMIRE 276
           +   ++ DFGLAR    T   +  G            +  S   DV+SYG+LL EL+  E
Sbjct: 152 NKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

Query: 277 KP 278
            P
Sbjct: 212 VP 213

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  112 bits (282), Expect = 9e-29
 Identities = 33/180 (18%), Positives = 67/180 (37%), Gaps = 33/180 (18%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           + F+ F  E   + N+ H N++K+            +   +V EF+        L     
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMH-------NPPRMVMEFVPCGDLYHRLL---- 113

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD-----DDMT 229
                ++   +    +L + +D+A  + Y+ +   P   H DL+  N+ L        + 
Sbjct: 114 -----DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVC 167

Query: 230 ARVGDFGLARFLPPTRTQTK-----------YGVGNEVSTIGDVYSYGILLLELMIREKP 278
           A+V DFGL++    + +                     +   D YS+ ++L  ++  E P
Sbjct: 168 AKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  112 bits (281), Expect = 2e-28
 Identities = 45/206 (21%), Positives = 79/206 (38%), Gaps = 46/206 (22%)

Query: 113 AFKIF-----KSFIAECK--ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSP 165
           A KIF     KS+  E +      +RH N++  + + +   +       L+  +    S 
Sbjct: 35  AVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL-WLITHYHEMGS- 92

Query: 166 EKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHD-----CQPVTAHCDLKPS 220
              LY        Y +   L+ +  L I + +AS L +LH +      +P  AH DLK  
Sbjct: 93  ---LY-------DYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 142

Query: 221 NVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG-------------------- 260
           N+L+  +    + D GLA     +  Q   G    V T                      
Sbjct: 143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYK 202

Query: 261 --DVYSYGILLLELMIREKPSDIMFE 284
             D++++G++L E+  R   + I+ +
Sbjct: 203 RVDIWAFGLVLWEVARRMVSNGIVED 228

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  111 bits (280), Expect = 5e-28
 Identities = 55/293 (18%), Positives = 97/293 (33%), Gaps = 57/293 (19%)

Query: 113 AFKIFK-----SFIAECK--ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSP 165
           A K+F      S+  E +      +RH N++  + A +           L+ ++  N S 
Sbjct: 64  AVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL-YLITDYHENGS- 121

Query: 166 EKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLH-----HDCQPVTAHCDLKPS 220
              LY        Y +   L+    L +A    S L +LH        +P  AH DLK  
Sbjct: 122 ---LY-------DYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171

Query: 221 NVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG-------------------- 260
           N+L+  + T  + D GLA        +        V T                      
Sbjct: 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYI 231

Query: 261 --DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVV 318
             D+YS+G++L E+  R     I+ E  +    +  +   +   + +  I+     +   
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQL---PYHDLVPSDPSYEDMREIVCIKKLRPSF 288

Query: 319 RGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL 371
                          EC+  M ++   C   +P  R+    V   L  +  + 
Sbjct: 289 PNRWSSD--------ECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  106 bits (268), Expect = 1e-26
 Identities = 45/183 (24%), Positives = 74/183 (40%), Gaps = 39/183 (21%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           +  ++F  E   LR  RH N++  +              A+V ++    S    LY    
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL------AIVTQWCEGSS----LYHHLH 111

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
             E         + + ++IA   A  ++YLH   + +  H DLK +N+ L +D T ++GD
Sbjct: 112 ASE-----TKFEMKKLIDIARQTARGMDYLH--AKSII-HRDLKSNNIFLHEDNTVKIGD 163

Query: 235 FGLARFLPPTRTQTKYGVGNEVSTIG-------------------DVYSYGILLLELMIR 275
           FGLA     +R    +       +I                    DVY++GI+L ELM  
Sbjct: 164 FGLATEK--SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221

Query: 276 EKP 278
           + P
Sbjct: 222 QLP 224

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  107 bits (269), Expect = 2e-26
 Identities = 42/204 (20%), Positives = 71/204 (34%), Gaps = 46/204 (22%)

Query: 113 AFKIFK-----SFIAECK--ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSP 165
           A KIF      S+  E +      +RH N++  + A    +        LV ++  + S 
Sbjct: 69  AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHEHGS- 126

Query: 166 EKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHD-----CQPVTAHCDLKPS 220
              L+        Y     + +   + +A+  AS L +LH +      +P  AH DLK  
Sbjct: 127 ---LF-------DYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176

Query: 221 NVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG-------------------- 260
           N+L+  + T  + D GLA               + V T                      
Sbjct: 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236

Query: 261 --DVYSYGILLLELMIREKPSDIM 282
             D+Y+ G++  E+  R     I 
Sbjct: 237 RADIYAMGLVFWEIARRCSIGGIH 260

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  103 bits (260), Expect = 2e-25
 Identities = 43/187 (22%), Positives = 73/187 (39%), Gaps = 43/187 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E K +R + H N++K +       Y+       + E+I   +    L  I K   
Sbjct: 52  RTFLKEVKVMRCLEHPNVLKFIGVL----YKDKRL-NFITEYIKGGT----LRGIIKS-- 100

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                      +R++ A D+AS + YLH     +  H DL   N L+ ++    V DFGL
Sbjct: 101 ---MDSQYPWSQRVSFAKDIASGMAYLH--SMNII-HRDLNSHNCLVRENKNVVVADFGL 154

Query: 238 ARFLPPTRTQTKYGVGNEVSTIG--------------------------DVYSYGILLLE 271
           AR +   +TQ +     +                               DV+S+GI+L E
Sbjct: 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214

Query: 272 LMIREKP 278
           ++ R   
Sbjct: 215 IIGRVNA 221

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  102 bits (256), Expect = 8e-25
 Identities = 39/190 (20%), Positives = 65/190 (34%), Gaps = 44/190 (23%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
              K+F  E  A R  RH N++  + AC+          A++      R+    LY    
Sbjct: 71  DQLKAFKREVMAYRQTRHENVVLFMGACM----SPPHL-AIITSLCKGRT----LY---- 117

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                +    L++ +   IA ++   + YLH   + +  H DLK  NV   D+    + D
Sbjct: 118 -SVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGIL-HKDLKSKNVFY-DNGKVVITD 172

Query: 235 FGLARFLPPTRTQTKYGV-GNEVSTIG-------------------------DVYSYGIL 268
           FGL       +   +      +   +                          DV++ G +
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232

Query: 269 LLELMIREKP 278
             EL  RE P
Sbjct: 233 WYELHAREWP 242

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 37/192 (19%), Positives = 72/192 (37%), Gaps = 31/192 (16%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           L H G  +     +AE + L  + H +++++       D  G+    +V E++  +S   
Sbjct: 114 LVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQS--- 170

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
            L    K      + + L +   +   +++  AL+YLH     +  + DLKP N++L ++
Sbjct: 171 -L----KR----SKGQKLPVAEAIAYLLEILPALSYLHS--IGL-VYNDLKPENIMLTEE 218

Query: 228 MTARVGDFGLARFLPPTRTQTKYG---------VGNEVSTIGDVYSYGILLLELMIREKP 278
              ++ D G    +        YG         V    +   D+Y+ G  L  L +    
Sbjct: 219 -QLKLIDLGAVSRI--NSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPT 275

Query: 279 SDIMFEGDMNLH 290
                 G     
Sbjct: 276 ----RNGRYVDG 283

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 80.9 bits (199), Expect = 6e-17
 Identities = 31/228 (13%), Positives = 68/228 (29%), Gaps = 37/228 (16%)

Query: 105 FSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRS 164
              +++Q   K+   FI     +++ + + +I+V            D   L   F++ R 
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD-------ERDMWVLSRFFLYPRM 187

Query: 165 PEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL 224
                             ++L    RL + + V   L  LHH    +  H  L+P +++L
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGL-VHTYLRPVDIVL 244

Query: 225 DDDMTARVGDFGLAR------------------FLPPTRTQTKYGVGNEVSTIGDVYSYG 266
           D      +  F                                      ++   D ++ G
Sbjct: 245 DQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304

Query: 267 ILLLELMIREKPSDIMFEGD-----MNLHKFAKMALPNHVKDIVDSIL 309
           + +  +   + P       D           +   +P  V+ +++  L
Sbjct: 305 LAIYWIWCADLP----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFL 348

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 23/76 (30%), Positives = 36/76 (47%), Gaps = 6/76 (7%)

Query: 1   MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG-VYKNASATSVTGNSKLCGGI 58
           +D S N L G I + ++ L  L  ++LS NNL G +P    ++         N  LCG  
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG-- 742

Query: 59  SKFKLPKCGSKKSNGK 74
             + LP+C    ++G 
Sbjct: 743 --YPLPRCDPSNADGY 756

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 14/44 (31%), Positives = 23/44 (52%), Gaps = 1/44 (2%)

Query: 2   DFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKNAS 44
               N L GEI + L  +  L+ L L +N+L G +P+G+    +
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN 491

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 41.4 bits (98), Expect = 4e-04
 Identities = 8/37 (21%), Positives = 14/37 (37%), Gaps = 1/37 (2%)

Query: 1   MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP 36
            + +     G           +  L++SYN L G +P
Sbjct: 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 16/36 (44%), Positives = 18/36 (50%), Gaps = 1/36 (2%)

Query: 2   DFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP 36
             S N LSG I   L  L  L +L L  N LEG +P
Sbjct: 424 HLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 32/169 (18%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   +  +RH NL+++L   +    +      +V E++   S   +L        
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYL-------- 278

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
                  L     L  ++DV  A+ YL  ++      H DL   NVL+ +D  A+V DFG
Sbjct: 279 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFG 334

Query: 237 LARFLPPTRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           L +    T+   K                   ST  DV+S+GILL E+ 
Sbjct: 335 LTKEASSTQDTGKLPVKWTAPEALREKK---FSTKSDVWSFGILLWEIY 380

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 77.6 bits (192), Expect = 3e-16
 Identities = 24/68 (35%), Positives = 36/68 (52%), Gaps = 6/68 (8%)

Query: 1   MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGI 58
           +D   N + G + + LT+L FL +LN+S+NNL G +P  G  +    ++   N  LCG  
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

Query: 59  SKFKLPKC 66
               LP C
Sbjct: 309 ----LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 43.3 bits (103), Expect = 6e-05
 Identities = 20/67 (29%), Positives = 29/67 (43%), Gaps = 3/67 (4%)

Query: 1   MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKNASATSV--TGNSKLCGGI 58
           M  S+N L+G+I      L L  ++LS N LEG        + +   +    NS L   +
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS-LAFDL 237

Query: 59  SKFKLPK 65
            K  L K
Sbjct: 238 GKVGLSK 244

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 40.6 bits (96), Expect = 5e-04
 Identities = 14/37 (37%), Positives = 21/37 (56%), Gaps = 1/37 (2%)

Query: 2   DFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT 37
             +  N+SG I  FL+++  L  L+ SYN L G +P 
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 37/229 (16%), Positives = 75/229 (32%), Gaps = 38/229 (16%)

Query: 105 FSHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRS 164
              +++Q   K+   FI     +++ + + +I+V            D   L   F++ R 
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD-------ERDMWVLSRFFLYPRM 182

Query: 165 PEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL 224
                             ++L    RL + + V   L  LHH    +  H  L+P +++L
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGL-VHTYLRPVDIVL 239

Query: 225 DDDMTARVGDFGLAR-------------FLPP---TRTQTKYGVGNEVSTIG---DVYSY 265
           D      +  F                 F PP    R  T     +  + +    D ++ 
Sbjct: 240 DQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299

Query: 266 GILLLELMIREKPSDIMFEGDMNLHKFAK-----MALPNHVKDIVDSIL 309
           G+++  +   + P       D  L            +P  V+ +++  L
Sbjct: 300 GLVIYWIWCADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGFL 344

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 36/171 (21%), Positives = 73/171 (42%), Gaps = 23/171 (13%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F++E   +++  H N+I++L  C+ +  QG     ++  F+       +L        
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----LYSR 136

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
               P+++ L   L   +D+A  + YL + +      H DL   N +L DDMT  V DFG
Sbjct: 137 LETGPKHIPLQTLLKFMVDIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFG 192

Query: 237 LARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
           L++ +       +  +                  ++  DV+++G+ + E+ 
Sbjct: 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 31/168 (18%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E   ++ I+H NL++     LGV  +   F  ++ EF+   +   +L          
Sbjct: 263 FLKEAAVMKEIKHPNLVQ----LLGVCTREPPFY-IITEFMTYGNLLDYL--------RE 309

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
              + ++ +  L +A  ++SA+ YL   +      H +L   N L+ ++   +V DFGL+
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLS 365

Query: 239 RFLP----PTRTQTKYGVG---------NEVSTIGDVYSYGILLLELM 273
           R +           K+ +          N+ S   DV+++G+LL E+ 
Sbjct: 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 73.5 bits (181), Expect = 5e-15
 Identities = 46/220 (20%), Positives = 77/220 (35%), Gaps = 42/220 (19%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPI----SKED-E 177
           E KAL  + H N++          + G D+         +RS  K L+       K   E
Sbjct: 54  EVKALAKLDHVNIVHYNGC-----WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108

Query: 178 TYERPRNLNLLRR---LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
            +   R    L +   L +   +   ++Y+H        + DLKPSN+ L D    ++GD
Sbjct: 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGD 165

Query: 235 FGLARFLPPTRTQTKYGVG---------------NEVSTIGDVYSYGILLLELMIREKPS 279
           FGL   L     +T+   G                +     D+Y+ G++L EL+      
Sbjct: 166 FGLVTSLKNDGKRTRS-KGTLRYMSPEQISSQDYGKEV---DLYALGLILAELLHVCDT- 220

Query: 280 DIMFEGDMNLHKFAKMALPNHV----KDIVDSILLNDDEK 315
              FE            + +      K ++  +L    E 
Sbjct: 221 --AFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPED 258

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 73.9 bits (182), Expect = 6e-15
 Identities = 37/172 (21%), Positives = 68/172 (39%), Gaps = 24/172 (13%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL-VYEFIHNRSPEKWLYPISKED 176
           + F+ E   ++   H ++ K++   L    +G     + +  F+ +     +L       
Sbjct: 70  EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL----LAS 125

Query: 177 ETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
              E P NL L   +   +D+A  + YL   +      H DL   N +L +DMT  V DF
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADF 181

Query: 236 GLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
           GL+R +       +                  N  +   DV+++G+ + E+M
Sbjct: 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 73.4 bits (181), Expect = 6e-15
 Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 26/112 (23%)

Query: 191 LNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDFGLARFL-PPTRT 246
           +N    +   + + H           H D+KP N+L+D + T ++ DFG+A+ L   + T
Sbjct: 114 INFTNQILDGIKHAHD------MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167

Query: 247 QTKYGVG------------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
           QT + +G                   D+YS GI+L E+++ E P    F G+
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 38/171 (22%), Positives = 62/171 (36%), Gaps = 33/171 (19%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
             F+ E + L+   H N+++     +GV  Q      +V E +       +L        
Sbjct: 157 AKFLQEARILKQYSHPNIVR----LIGVCTQKQPI-YIVMELVQGGDFLTFLR------- 204

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
                  L +   L +  D A+ + YL    C     H DL   N L+ +    ++ DFG
Sbjct: 205 --TEGARLRVKTLLQMVGDAAAGMEYLESKCC----IHRDLAARNCLVTEKNVLKISDFG 258

Query: 237 LARFLPPTRTQTKYGVGN--------EV------STIGDVYSYGILLLELM 273
           ++R           G+          E       S+  DV+S+GILL E  
Sbjct: 259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 39/168 (23%), Positives = 75/168 (44%), Gaps = 32/168 (19%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E + ++ +RH  L+++            +   +V E++   S   +L          
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL--------KG 271

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
           E  + L L + +++A  +AS + Y+   +      H DL+ +N+L+ +++  +V DFGLA
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLA 327

Query: 239 RFLPP----TRTQTKYGV---------GNEVSTIGDVYSYGILLLELM 273
           R +       R   K+ +             +   DV+S+GILL EL 
Sbjct: 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 39/168 (23%), Positives = 75/168 (44%), Gaps = 32/168 (19%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E + ++ +RH  L+++            +   +V E++   S   +L          
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL--------KG 354

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
           E  + L L + +++A  +AS + Y+   +      H DL+ +N+L+ +++  +V DFGLA
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLA 410

Query: 239 RFLPP----TRTQTKYGV---------GNEVSTIGDVYSYGILLLELM 273
           R +       R   K+ +             +   DV+S+GILL EL 
Sbjct: 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 34/171 (19%), Positives = 71/171 (41%), Gaps = 38/171 (22%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+AE   ++ ++H  L+K+            +   ++ EF+   S   +L          
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKS-------- 275

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
           +      L + ++ +  +A  + ++   +      H DL+ +N+L+   +  ++ DFGLA
Sbjct: 276 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNY----IHRDLRAANILVSASLVCKIADFGLA 331

Query: 239 RFLPP----TRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           R +       R   K            +G     +   DV+S+GILL+E++
Sbjct: 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGS---FTIKSDVWSFGILLMEIV 379

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 30/115 (26%), Positives = 46/115 (40%), Gaps = 20/115 (17%)

Query: 185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-P 243
           L   R + I   + SAL+  H        H D+KP N+L+  D  A + DFG+A      
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAA-GAT--HRDVKPENILVSADDFAYLVDFGIASATTDE 187

Query: 244 TRTQTKYGVG------------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
             TQ    VG            +  +   D+Y+   +L E +    P    ++GD
Sbjct: 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 33/114 (28%), Positives = 49/114 (42%), Gaps = 28/114 (24%)

Query: 191 LNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDFGLARFL-----P 242
           + +  D   ALN+ H           H D+KP+N+++      +V DFG+AR +      
Sbjct: 119 IEVIADACQALNFSHQ------NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172

Query: 243 PTRTQTKYG----------VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
            T+T    G           G+ V    DVYS G +L E++  E P    F GD
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 25/238 (10%), Positives = 53/238 (22%), Gaps = 53/238 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTAC-------LGVDYQGNDFKALVYEFIHNRSPEKWLY 170
           +       A   +   +  +                     F  L             L 
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166

Query: 171 ----------PISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPS 220
                       S  D  Y    +  +L    +   +      L    + +  H    P 
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGL-VHGHFTPD 223

Query: 221 NVLLDDDMTARVGDFGLAR--------------FLPP-TRTQTKYGVGNEVSTIGDVYSY 265
           N+ +  D    +GD                   + P      +     + +    + +  
Sbjct: 224 NLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHAL----NAWQL 279

Query: 266 GILLLELMIREKPSDIMFEGDMNLHKFAKMA--------------LPNHVKDIVDSIL 309
           G+ +  +     P  ++  G     K   +               LP+ VK ++   L
Sbjct: 280 GLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL 337

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 40/174 (22%), Positives = 62/174 (35%), Gaps = 33/174 (18%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           +    FI E  A+ ++ HRNLI++    L    +      +V E     S    L     
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLR---- 112

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                +   +  L      A+ VA  + YL    + +  H DL   N+LL      ++GD
Sbjct: 113 -----KHQGHFLLGTLSRYAVQVAEGMGYLE-SKRFI--HRDLAARNLLLATRDLVKIGD 164

Query: 235 FGLARFLPPTRTQTKYGVGNEV---------------STIGDVYSYGILLLELM 273
           FGL R LP            +V               S   D + +G+ L E+ 
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 70.7 bits (174), Expect = 6e-14
 Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 32/169 (18%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+AE   +  +RH NL+++L   +    +      +V E++   S   +L        
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRS------ 108

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
                  L     L  ++DV  A+ YL  ++      H DL   NVL+ +D  A+V DFG
Sbjct: 109 --RGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFG 162

Query: 237 LARFLPPTRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           L +    T+   K                   ST  DV+S+GILL E+ 
Sbjct: 163 LTKEASSTQDTGKLPVKWTAPEALREKK---FSTKSDVWSFGILLWEIY 208

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 35/212 (16%), Positives = 68/212 (32%), Gaps = 54/212 (25%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL--------VYEFIHNRSPEKWLYPISK 174
           E    R   H N+++++  CL      ++   L        ++  I     +        
Sbjct: 76  EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT--- 132

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
           ED+             L + + +   L  +H   +   AH DLKP+N+LL D+    + D
Sbjct: 133 EDQI------------LWLLLGICRGLEAIHA--KGY-AHRDLKPTNILLGDEGQPVLMD 177

Query: 235 FGLARFL--PPTRTQTKYGVGNEVSTIG----------------------DVYSYGILLL 270
            G           ++    + +  +                         DV+S G +L 
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237

Query: 271 ELMIREKPSDIMFEGDMNLHKFAKMALPNHVK 302
            +M  E P    ++          +A+ N + 
Sbjct: 238 AMMFGEGP----YDMVFQKGDSVALAVQNQLS 265

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 42/208 (20%), Positives = 74/208 (35%), Gaps = 48/208 (23%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQG----NDFKALVY---EFIHNRSPEKWLY 170
           +  + E KAL  + H  +++   A L  +       +  K  +Y   +     + + W  
Sbjct: 48  EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDW-- 105

Query: 171 PISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA 230
            ++      ER R++ L    +I + +A A+ +LH        H DLKPSN+    D   
Sbjct: 106 -MNGRCTIEERERSVCL----HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVV 157

Query: 231 RVGDFGLARFLPPTRTQTK-----YGVGNEVSTIG-------------------DVYSYG 266
           +VGDFGL   +     +                +G                   D++S G
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLG 217

Query: 267 ILLLELMIREKPSDIMFEGDMNLHKFAK 294
           ++L EL+         F   M   +   
Sbjct: 218 LILFELLYP-------FSTQMERVRTLT 238

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 35/169 (20%), Positives = 62/169 (36%), Gaps = 34/169 (20%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
            + E   + ++ + ++ ++L  CL    Q      L+ + +       ++          
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR--------- 108

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
           E   N+     LN  + +A  +NYL          H DL   NVL+      ++ DFGLA
Sbjct: 109 EHKDNIGSQYLLNWCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLA 164

Query: 239 RFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
           + L     +     G                 +   DV+SYG+ + ELM
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 52/236 (22%), Positives = 83/236 (35%), Gaps = 65/236 (27%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTA---------CLGVDY-QGNDFKALVYEFIHNRSPEK 167
           +  ++E   LR ++H N+++              + ++Y +G D    +   I   + E+
Sbjct: 50  QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD----LASVITKGTKER 105

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA--HCDLKPSNVLLD 225
                  E+              L +   +  AL   H          H DLKP+NV LD
Sbjct: 106 QYLD---EEFV------------LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150

Query: 226 DDMTARVGDFGLARFLPPTRTQTKYGVG---------------NEVSTIGDVYSYGILLL 270
                ++GDFGLAR L    +  K  VG               NE S   D++S G LL 
Sbjct: 151 GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKS---DIWSLGCLLY 207

Query: 271 ELMIREKPSDIMFEGDMNLHKFAKM-------ALPNH----VKDIVDSILLNDDEK 315
           EL     P    F    +  + A          +P      + +I+  +L   D  
Sbjct: 208 ELCALMPP----FTAF-SQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYH 258

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 41/181 (22%), Positives = 70/181 (38%), Gaps = 34/181 (18%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           +  +   + F++      A+ ++ H +++++L  C G   Q      LV +++   S   
Sbjct: 50  IEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLD 103

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDD 226
            +          +    L     LN  + +A  + YL  H       H +L   NVLL  
Sbjct: 104 HVR---------QHRGALGPQLLLNWGVQIAKGMYYLEEHGM----VHRNLAARNVLLKS 150

Query: 227 DMTARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLEL 272
               +V DFG+A  LPP   Q  Y                  + +   DV+SYG+ + EL
Sbjct: 151 PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 210

Query: 273 M 273
           M
Sbjct: 211 M 211

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 67.2 bits (165), Expect = 7e-13
 Identities = 38/171 (22%), Positives = 76/171 (44%), Gaps = 38/171 (22%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L    K     
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFL----KTP--- 101

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
                L + + L++A  +A  + ++   +      H DL+ +N+L+ D ++ ++ DFGLA
Sbjct: 102 -SGIKLTINKLLDMAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLA 156

Query: 239 RFLPP----TRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           R +       R   K            YG     +   DV+S+GILL E++
Sbjct: 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIV 204

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 37/172 (21%), Positives = 69/172 (40%), Gaps = 32/172 (18%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  E + L++++H N++K    C      G     L+ E++   S   +L        
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQ------- 105

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
             +    ++ ++ L     +   + YL          H DL   N+L++++   ++GDFG
Sbjct: 106 --KHKERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFG 159

Query: 237 LARFLPPTRTQTKYGVGNEV---------------STIGDVYSYGILLLELM 273
           L + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 38/172 (22%), Positives = 70/172 (40%), Gaps = 32/172 (18%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
                E + LRN+ H N++K    C      G +   L+ EF+ + S +++L        
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLP------- 117

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
             +    +NL ++L  A+ +   ++YL          H DL   NVL++ +   ++GDFG
Sbjct: 118 --KNKNKINLKQQLKYAVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFG 171

Query: 237 LARFLPPTRTQTKYGVGNEV---------------STIGDVYSYGILLLELM 273
           L + +   +         +                    DV+S+G+ L EL+
Sbjct: 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 41/172 (23%), Positives = 64/172 (37%), Gaps = 34/172 (19%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
             +  E   LR + H ++IK    C            LV E++   S   +L        
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL---QLVMEYVPLGSLRDYL-------- 126

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
                 ++ L + L  A  +   + YLH         H DL   NVLLD+D   ++GDFG
Sbjct: 127 ---PRHSIGLAQLLLFAQQICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFG 179

Query: 237 LARFLPPTRTQTKYGVGNEV---------------STIGDVYSYGILLLELM 273
           LA+ +P      +     +                    DV+S+G+ L EL+
Sbjct: 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 37/174 (21%), Positives = 64/174 (36%), Gaps = 34/174 (19%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           K  K  + E   + ++ + ++ ++L  CL    Q      L+ + +       ++     
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR---- 108

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVG 233
                E   N+     LN  + +A  +NYL          H DL   NVL+      ++ 
Sbjct: 109 -----EHKDNIGSQYLLNWCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKIT 159

Query: 234 DFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
           DFGLA+ L     +     G                 +   DV+SYG+ + ELM
Sbjct: 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 36/172 (20%), Positives = 63/172 (36%), Gaps = 32/172 (18%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  E + L+ +    ++K      G    G     LV E++ +     +L        
Sbjct: 69  RDFQREIQILKALHSDFIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQ------- 118

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
                  L+  R L  +  +   + YL    C     H DL   N+L++ +   ++ DFG
Sbjct: 119 --RHRARLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFG 172

Query: 237 LARFLPPTRTQTKYGVGNEV---------------STIGDVYSYGILLLELM 273
           LA+ LP  +         +                S   DV+S+G++L EL 
Sbjct: 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 36/172 (20%), Positives = 69/172 (40%), Gaps = 32/172 (18%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  E + L++++H N++K    C     +      L+ E++   S   +L        
Sbjct: 87  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQ------- 136

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
             +    ++ ++ L     +   + YL          H DL   N+L++++   ++GDFG
Sbjct: 137 --KHKERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFG 190

Query: 237 LARFLPPTRTQTKYGVGNEV---------------STIGDVYSYGILLLELM 273
           L + LP  +   K     E                S   DV+S+G++L EL 
Sbjct: 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 66.4 bits (163), Expect = 1e-12
 Identities = 38/168 (22%), Positives = 66/168 (39%), Gaps = 32/168 (19%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F  E + +  + H  L+K      GV  +      +V E+I N     +L          
Sbjct: 50  FFQEAQTMMKLSHPKLVK----FYGVCSKEYPI-YIVTEYISNGCLLNYLR--------- 95

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
              + L   + L +  DV   + +L  H       H DL   N L+D D+  +V DFG+ 
Sbjct: 96  SHGKGLEPSQLLEMCYDVCEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMT 151

Query: 239 RFLPPTRTQTKYG-------------VGNEVSTIGDVYSYGILLLELM 273
           R++   +  +  G                + S+  DV+++GIL+ E+ 
Sbjct: 152 RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 38/173 (21%), Positives = 70/173 (40%), Gaps = 41/173 (23%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVD--YQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           F+ E   ++ I+H NL+++L  C      Y       ++ EF+   +   +L        
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPFY-------IITEFMTYGNLLDYL-------- 100

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
                + ++ +  L +A  ++SA+ YL   +      H DL   N L+ ++   +V DFG
Sbjct: 101 RECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFG 156

Query: 237 LARFLP----PTRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           L+R +           K            Y      S   DV+++G+LL E+ 
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK---FSIKSDVWAFGVLLWEIA 206

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 46/240 (19%), Positives = 84/240 (35%), Gaps = 54/240 (22%)

Query: 118 KSFIAECKALRNIRHRNLIK-----VLTACLGVDYQGNDFKALVY---EFIHNRSPEKWL 169
            + ++E   L ++ H+ +++     +              K+ ++   E+  N +     
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL- 105

Query: 170 YPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT 229
             I  E+   +R     L R       +  AL+Y+H   Q +  H DLKP N+ +D+   
Sbjct: 106 --IHSENLNQQRDEYWRLFR------QILEALSYIHS--QGI-IHRDLKPMNIFIDESRN 154

Query: 230 ARVGDFGLARFLPPTRTQTKYGVGNEV-------STIG--------------------DV 262
            ++GDFGLA+ +  +    K    N         S IG                    D+
Sbjct: 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM 214

Query: 263 YSYGILLLEL-------MIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEK 315
           YS GI+  E+       M R      +    +              K I+  ++ +D  K
Sbjct: 215 YSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK 274

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 37/172 (21%), Positives = 72/172 (41%), Gaps = 30/172 (17%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E   ++     ++++     LGV  QG     ++ E +     + +L  +       
Sbjct: 75  FLNEASVMKEFNCHHVVR----LLGVVSQGQPT-LVIMELMTRGDLKSYLRSLRPAMANN 129

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
                 +L + + +A ++A  + YL+ +       H DL   N ++ +D T ++GDFG+ 
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMT 185

Query: 239 RFLPPT---RTQTK--------------YGVGNEVSTIGDVYSYGILLLELM 273
           R +  T   R   K               GV    +T  DV+S+G++L E+ 
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIA 234

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 33/171 (19%), Positives = 67/171 (39%), Gaps = 22/171 (12%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  E + L+ ++H N+++   +             LV E + + + + +L        
Sbjct: 70  QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI-VLVTELMTSGTLKTYL-------- 120

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVGDFG 236
             +R + + +    +    +   L +LH    P   H DLK  N+ +     + ++GD G
Sbjct: 121 --KRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177

Query: 237 LARFLPPTRTQTKYG---------VGNEVSTIGDVYSYGILLLELMIREKP 278
           LA     +  +   G            +     DVY++G+ +LE+   E P
Sbjct: 178 LATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP 228

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 41/185 (22%), Positives = 73/185 (39%), Gaps = 50/185 (27%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGN------------DFKALVYEFIHNRSPEK 167
           F  E + L N++H +++K      GV   G+            D      +F+    P+ 
Sbjct: 64  FQREAELLTNLQHEHIVK----FYGVCGDGDPLIMVFEYMKHGDLN----KFLRAHGPDA 115

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYL--HHDCQPVTAHCDLKPSNVLLD 225
            +     + +  +    L L + L+IA  +AS + YL   H       H DL   N L+ 
Sbjct: 116 MILV---DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFV-----HRDLATRNCLVG 167

Query: 226 DDMTARVGDFGLARFL---PPTRTQTK--------------YGVGNEVSTIGDVYSYGIL 268
            ++  ++GDFG++R +      R                  Y      +T  DV+S+G++
Sbjct: 168 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVI 224

Query: 269 LLELM 273
           L E+ 
Sbjct: 225 LWEIF 229

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 29/170 (17%), Positives = 60/170 (35%), Gaps = 35/170 (20%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
            + E + +  + +  +++++  C            LV E        K+L          
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVCQAEALM------LVMEMAGGGPLHKFLV--------- 427

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
            +   + +     +   V+  + YL   +      H +L   NVLL +   A++ DFGL+
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLS 483

Query: 239 RFLPPTRTQTKYGVGNEV---------------STIGDVYSYGILLLELM 273
           + L    +        +                S+  DV+SYG+ + E +
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 65.3 bits (160), Expect = 3e-12
 Identities = 38/173 (21%), Positives = 65/173 (37%), Gaps = 42/173 (24%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVD--YQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           FI E + +  + H  L+++   CL             LV EF+ +     +L        
Sbjct: 50  FIEEAEVMMKLSHPKLVQLYGVCLEQAPIC-------LVTEFMEHGCLSDYLR------- 95

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
              +         L + +DV   + YL          H DL   N L+ ++   +V DFG
Sbjct: 96  --TQRGLFAAETLLGMCLDVCEGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFG 149

Query: 237 LARFLP----PTRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           + RF+      + T TK            +      S+  DV+S+G+L+ E+ 
Sbjct: 150 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR---YSSKSDVWSFGVLMWEVF 199

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 26/98 (26%), Positives = 41/98 (41%), Gaps = 13/98 (13%)

Query: 191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL-PPTRTQTK 249
                D   AL +LH        H D+KP+N+ L      ++GDFGL   L      + +
Sbjct: 160 WGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216

Query: 250 YG----VGNEV-----STIGDVYSYGILLLELMIREKP 278
            G    +  E+      T  DV+S G+ +LE+    + 
Sbjct: 217 EGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMEL 254

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 39/171 (22%), Positives = 75/171 (43%), Gaps = 32/171 (18%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
             F+ E   +    H N+I+      GV  +      ++ E++ N + +K+L        
Sbjct: 91  VDFLGEAGIMGQFSHHNIIR----LEGVISKYKPM-MIITEYMENGALDKFLR------- 138

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             E+    ++L+ + +   +A+ + YL  +   V  H DL   N+L++ ++  +V DFGL
Sbjct: 139 --EKDGEFSVLQLVGMLRGIAAGMKYLA-NMNYV--HRDLAARNILVNSNLVCKVSDFGL 193

Query: 238 ARFLPPTRTQTKYGVGN---------EV------STIGDVYSYGILLLELM 273
           +R L      T    G          E       ++  DV+S+GI++ E+M
Sbjct: 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 32/171 (18%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F++E   +    H N+I++     GV  +G     +V E++ N S + +L        
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLE----GVVTRGRLA-MIVTEYMENGSLDTFLR------- 142

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                    +++ + +   V + + YL  D   V  H DL   NVL+D ++  +V DFGL
Sbjct: 143 --THDGQFTIMQLVGMLRGVGAGMRYLS-DLGYV--HRDLAARNVLVDSNLVCKVSDFGL 197

Query: 238 ARFLPPTRTQTKYGVGN---------EV------STIGDVYSYGILLLELM 273
           +R L           G          E       S+  DV+S+G+++ E++
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 38/176 (21%), Positives = 67/176 (38%), Gaps = 40/176 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
             F+ E   +++  H N++ +L  CL    +G+    +V  ++ +     ++        
Sbjct: 135 SQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIR------- 183

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
                 N  +   +   + VA  + +L          H DL   N +LD+  T +V DFG
Sbjct: 184 --NETHNPTVKDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFG 237

Query: 237 LARFL-----PPTRTQTK--------------YGVGNEVSTIGDVYSYGILLLELM 273
           LAR +          +T                      +T  DV+S+G+LL ELM
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELM 290

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 40/176 (22%), Positives = 68/176 (38%), Gaps = 40/176 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
             F+ E   +++  H N++ +L  CL    +G+    +V  ++ +     ++        
Sbjct: 71  SQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIR------- 119

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
                 N  +   +   + VA  + YL          H DL   N +LD+  T +V DFG
Sbjct: 120 --NETHNPTVKDLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFG 173

Query: 237 LARFL-------PPTRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           LAR +          +T  K                   +T  DV+S+G+LL ELM
Sbjct: 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELM 226

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 45/182 (24%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHN---------RSPEKWLY 170
           F  E + L  ++H+++++      GV  +G     +V+E++ +           P+  L 
Sbjct: 90  FQREAELLTMLQHQHIVR----FFGVCTEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLL 144

Query: 171 PISKEDETYERPRNLNLLRRLNIAIDVASALNYL--HHDCQPVTAHCDLKPSNVLLDDDM 228
              ++      P  L L + L +A  VA+ + YL   H       H DL   N L+   +
Sbjct: 145 AGGEDVA----PGPLGLGQLLAVASQVAAGMVYLAGLHFV-----HRDLATRNCLVGQGL 195

Query: 229 TARVGDFGLARFLPPT---RTQTK--------------YGVGNEVSTIGDVYSYGILLLE 271
             ++GDFG++R +  T   R   +              Y      +T  DV+S+G++L E
Sbjct: 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK---FTTESDVWSFGVVLWE 252

Query: 272 LM 273
           + 
Sbjct: 253 IF 254

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 35/176 (19%), Positives = 69/176 (39%), Gaps = 40/176 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E   +R + H N++ ++   L           ++  ++ +    +++    +  +
Sbjct: 67  EAFLREGLLMRGLNHPNVLALIGIML----PPEGLPHVLLPYMCHGDLLQFI----RSPQ 118

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
                RN  +   ++  + VA  + YL          H DL   N +LD+  T +V DFG
Sbjct: 119 -----RNPTVKDLISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFG 169

Query: 237 LAR-------FLPPTRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           LAR       +        +                   +T  DV+S+G+LL EL+
Sbjct: 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYR---FTTKSDVWSFGVLLWELL 222

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 64.9 bits (159), Expect = 5e-12
 Identities = 37/168 (22%), Positives = 68/168 (40%), Gaps = 32/168 (19%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           FI E K + N+ H  L++      GV  +      ++ E++ N     +L          
Sbjct: 66  FIEEAKVMMNLSHEKLVQ----LYGVCTKQRPI-FIITEYMANGCLLNYLR--------- 111

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
           E        + L +  DV  A+ YL          H DL   N L++D    +V DFGL+
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLS 167

Query: 239 RFLPPTRTQTKYG-------------VGNEVSTIGDVYSYGILLLELM 273
           R++      +  G             + ++ S+  D++++G+L+ E+ 
Sbjct: 168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 64.9 bits (159), Expect = 5e-12
 Identities = 40/185 (21%), Positives = 65/185 (35%), Gaps = 50/185 (27%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGN------------DFKALVYEFIHNRSPEK 167
           F  E      ++H N++      LGV  +              D      EF+  RSP  
Sbjct: 59  FRHEAMLRARLQHPNVVC----LLGVVTKDQPLSMIFSYCSHGDLH----EFLVMRSPHS 110

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYL--HHDCQPVTAHCDLKPSNVLLD 225
            +      D+       L     +++   +A+ + YL  HH       H DL   NVL+ 
Sbjct: 111 DVGS---TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVV-----HKDLATRNVLVY 162

Query: 226 DDMTARVGDFGLARFLPPT---RTQTK--------------YGVGNEVSTIGDVYSYGIL 268
           D +  ++ D GL R +      +                  YG     S   D++SYG++
Sbjct: 163 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVV 219

Query: 269 LLELM 273
           L E+ 
Sbjct: 220 LWEVF 224

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 40/185 (21%), Positives = 68/185 (36%), Gaps = 42/185 (22%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLG-------VDY-QGNDFKALVYEFIHNRSPEKWLYP 171
           F  E   +    + N++K+L  C          +Y    D      EF+ + SP      
Sbjct: 97  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN----EFLRSMSPHTVCSL 152

Query: 172 ISKE-----DETYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLD 225
              +       +   P  L+   +L IA  VA+ + YL          H DL   N L+ 
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVG 208

Query: 226 DDMTARVGDFGLARFLPPT---RTQTK--------------YGVGNEVSTIGDVYSYGIL 268
           ++M  ++ DFGL+R +      +                  Y      +T  DV++YG++
Sbjct: 209 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVV 265

Query: 269 LLELM 273
           L E+ 
Sbjct: 266 LWEIF 270

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 40/181 (22%), Positives = 80/181 (44%), Gaps = 25/181 (13%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E + + +I++   +     C G+     D   ++YE++ N S  K+       D+ Y   
Sbjct: 93  ELQIITDIKNEYCLT----CEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP 242
             + +++   I   V ++ +Y+H++      H D+KPSN+L+D +   ++ DFG + ++ 
Sbjct: 148 IPIQVIKC--IIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 243 PTRTQTKYG---------VGNEVSTIG---DVYSYGILLLELMIREKPSDIMFEGDMNLH 290
             + +   G           NE S  G   D++S GI L  +     P    F   ++L 
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259

Query: 291 K 291
           +
Sbjct: 260 E 260

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 64.9 bits (158), Expect = 7e-12
 Identities = 31/139 (22%), Positives = 48/139 (34%), Gaps = 34/139 (24%)

Query: 158 EFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDL 217
           +     + + W+        + E   +   L    I I +A A+ +LH        H DL
Sbjct: 141 QLCRKENLKDWM----NRRCSLEDREHGVCLH---IFIQIAEAVEFLHSKG---LMHRDL 190

Query: 218 KPSNVLLDDDMTARVGDFGLARFL-----PPTRTQTKYGVGNEVSTIG------------ 260
           KPSN+    D   +VGDFGL   +       T              +G            
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250

Query: 261 -------DVYSYGILLLEL 272
                  D++S G++L EL
Sbjct: 251 NNYSHKVDIFSLGLILFEL 269

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 64.6 bits (158), Expect = 7e-12
 Identities = 33/170 (19%), Positives = 64/170 (37%), Gaps = 36/170 (21%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
            +AE   ++ + +  +++++  C    +       LV E        K+L          
Sbjct: 65  LLAEANVMQQLDNPYIVRMIGICEAESWM------LVMEMAELGPLNKYL---------- 108

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
           ++ R++     + +   V+  + YL   +      H DL   NVLL     A++ DFGL+
Sbjct: 109 QQNRHVKDKNIIELVHQVSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLS 164

Query: 239 RFLPPTRTQTKYGVGNEV---------------STIGDVYSYGILLLELM 273
           + L       K     +                S+  DV+S+G+L+ E  
Sbjct: 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 64.8 bits (158), Expect = 9e-12
 Identities = 39/206 (18%), Positives = 67/206 (32%), Gaps = 60/206 (29%)

Query: 123 ECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVY-----------EFIHNRSPEKWLY 170
           E   ++ +  H N+++  +A      + +  +A              EF+        L 
Sbjct: 75  EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL- 133

Query: 171 PISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA 230
                D              L I      A+ ++H   +P   H DLK  N+LL +  T 
Sbjct: 134 ---SCDTV------------LKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTI 177

Query: 231 RVGDFGLARFL--PPTRTQTKYGVG------NEVST----------------IG---DVY 263
           ++ DFG A  +   P  + +              +T                IG   D++
Sbjct: 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237

Query: 264 SYGILLLELMIREKPSDIMFEGDMNL 289
           + G +L  L  R+ P    FE    L
Sbjct: 238 ALGCILYLLCFRQHP----FEDGAKL 259

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 36/182 (19%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLG-------VDYQGN-DFKALVYEFIHNRSPEKWLYP 171
            ++E   L+ + H ++IK+  AC         V+Y      +     F+         Y 
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR----GFLRESRKVGPGYL 128

Query: 172 ISKEDETYER-----PRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLD 225
            S              R L +   ++ A  ++  + YL          H DL   N+L+ 
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVA 184

Query: 226 DDMTARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLE 271
           +    ++ DFGL+R +    +  K   G              +  +T  DV+S+G+LL E
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244

Query: 272 LM 273
           ++
Sbjct: 245 IV 246

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 30/170 (17%), Positives = 60/170 (35%), Gaps = 35/170 (20%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
            + E + +  + +  +++++  C            LV E        K+L          
Sbjct: 57  MMREAQIMHQLDNPYIVRLIGVCQAEALM------LVMEMAGGGPLHKFLV--------- 101

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
            +   + +     +   V+  + YL   +      H DL   NVLL +   A++ DFGL+
Sbjct: 102 GKREEIPVSNVAELLHQVSMGMKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLS 157

Query: 239 RFLPPTRTQTKYGVGNEV---------------STIGDVYSYGILLLELM 273
           + L    +        +                S+  DV+SYG+ + E +
Sbjct: 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 207

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 41/191 (21%), Positives = 79/191 (41%), Gaps = 44/191 (23%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFIHNRSPEKWLYPISKEDETYE 180
           E   ++ + H+N+I +L           +F+   +V E +     +  L  + + +  +E
Sbjct: 74  ELVLMKCVNHKNIIGLLNV-FTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHE 127

Query: 181 RPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDF 235
           R   L   +L            + +LH      +A   H DLKPSN+++  D T ++ DF
Sbjct: 128 RMSYLLYQMLC----------GIKHLH------SAGIIHRDLKPSNIVVKSDCTLKILDF 171

Query: 236 GLARFLPPTRTQTKY-----------GVGNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           GLAR    +   T Y            +G       D++S G ++ E++        +F 
Sbjct: 172 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GV---LFP 227

Query: 285 GDMNLHKFAKM 295
           G  ++ ++ K+
Sbjct: 228 GTDHIDQWNKV 238

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 29/111 (26%), Positives = 46/111 (41%), Gaps = 25/111 (22%)

Query: 191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKY 250
           L+  + +  AL ++H        H D+K  N+ L  D T ++GDFG+AR L  T    + 
Sbjct: 128 LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184

Query: 251 GVG---------------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
            +G               N  S   D+++ G +L EL   +      FE  
Sbjct: 185 CIGTPYYLSPEICENKPYNNKS---DIWALGCVLYELCTLKHA----FEAG 228

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 40/178 (22%), Positives = 65/178 (36%), Gaps = 33/178 (18%)

Query: 120 FIAECKALRNI-RHRNLIKVLTAC-------LGVDYQGN-DFKALVYEFIHNRSPEKWLY 170
            ++E K L  +  H N++ +L AC       +  +Y    D       F+  +     + 
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL----NFLRRKRDSF-IC 127

Query: 171 PISKEDETYERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMT 229
             +      +    L+L   L+ +  VA  + +L   +C     H DL   N+LL     
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRI 183

Query: 230 ARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
            ++ DFGLAR +         G                   +   DV+SYGI L EL 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 34/115 (29%), Positives = 47/115 (40%), Gaps = 26/115 (22%)

Query: 191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKY 250
               + + SAL ++H        H D+KP+NV +      ++GD GL RF     T    
Sbjct: 139 WKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195

Query: 251 GVG---------------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-MNL 289
            VG               N  S   D++S G LL E+   + P    F GD MNL
Sbjct: 196 LVGTPYYMSPERIHENGYNFKS---DIWSLGCLLYEMAALQSP----FYGDKMNL 243

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 39/179 (21%), Positives = 68/179 (37%), Gaps = 36/179 (20%)

Query: 120 FIAECKALRNI-RHRNLIKVLTACLGVDY---------QGNDFKALVYEFIHNRSPEKWL 169
            ++E K L +I  H N++ +L AC              +  +       ++ ++  E   
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS----TYLRSKRNEFVP 132

Query: 170 YPISKEDETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDM 228
           Y ++ ED        L L   +  +  VA  + +L    C     H DL   N+LL +  
Sbjct: 133 YKVAPEDL---YKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKN 185

Query: 229 TARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
             ++ DFGLAR +       + G                   +   DV+S+G+LL E+ 
Sbjct: 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 40/171 (23%), Positives = 71/171 (41%), Gaps = 32/171 (18%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   +    H N+I+      GV  +      +V E++ N S + +L        
Sbjct: 91  RDFLGEASIMGQFDHPNIIR----LEGVVTKSKPV-MIVTEYMENGSLDSFLR------- 138

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             +      +++ + +   +AS + YL  D   V  H DL   N+L++ ++  +V DFGL
Sbjct: 139 --KHDAQFTVIQLVGMLRGIASGMKYLS-DMGYV--HRDLAARNILINSNLVCKVSDFGL 193

Query: 238 ARFLPPTRTQTKYGVG---------------NEVSTIGDVYSYGILLLELM 273
            R L           G                + ++  DV+SYGI+L E+M
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 31/173 (17%), Positives = 67/173 (38%), Gaps = 39/173 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   +R   H +++K++               ++ E         +L        
Sbjct: 61  EKFLQEALTMRQFDHPHIVKLIGVITENPVW------IIMELCTLGELRSFLQ------- 107

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
              R  +L+L   +  A  +++AL YL          H D+   NVL+  +   ++GDFG
Sbjct: 108 --VRKYSLDLASLILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFG 161

Query: 237 LARFLPP----TRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           L+R++        ++ K            +      ++  DV+ +G+ + E++
Sbjct: 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRR---FTSASDVWMFGVCMWEIL 211

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 35/178 (19%)

Query: 120 FIAECKALRNI-RHRNLIKVLTACLG-------VDYQGN-DFKALVYEFIHNRSPEKWLY 170
            I+E + ++ I +H+N+I +L AC         V+Y    + +    E++  R P    Y
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR----EYLQARRPPGLEY 176

Query: 171 PISKEDETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMT 229
             +           L+    ++ A  VA  + YL    C     H DL   NVL+ +D  
Sbjct: 177 SYNPSHNP---EEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNV 229

Query: 230 ARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
            ++ DFGLAR +       K   G                 +   DV+S+G+LL E+ 
Sbjct: 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 28/186 (15%), Positives = 48/186 (25%), Gaps = 41/186 (22%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
            ++    L  I    + +VL     V  +      +V E+I   S    L       E  
Sbjct: 78  TLSRTLRLSRIDKPGVARVLDV---VHTRAGGL--VVAEWIRGGS----L------QEVA 122

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR 239
           +     + +  +     +A+A +  H     V A     PS V +  D    +       
Sbjct: 123 DTS--PSPVGAIRAMQSLAAAADAAHR--AGV-ALSIDHPSRVRVSIDGDVVLAYPA--- 174

Query: 240 FLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN 299
            +P    Q             D+   G  L  L++   P              A      
Sbjct: 175 TMPDANPQD------------DIRGIGASLYALLVNRWP----LPEAGVRSGLA--PAER 216

Query: 300 HVKDIV 305
                 
Sbjct: 217 DTAGQP 222

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 61.8 bits (151), Expect = 4e-11
 Identities = 31/143 (21%), Positives = 58/143 (40%), Gaps = 36/143 (25%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQT------- 248
           +A+AL+Y H         H D+KP N+LL      ++ DFG +   P +R          
Sbjct: 118 LANALSYCHSKRVI----HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDY 173

Query: 249 -------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHK---FAKMA 296
                        +V    D++S G+L  E ++ + P    FE +     +K     +  
Sbjct: 174 LPPEMIEGRMHDEKV----DLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFT 225

Query: 297 LPNHV----KDIVDSILLNDDEK 315
            P+ V    +D++  +L ++  +
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQ 248

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 55/210 (26%)

Query: 113 AFKIFKSFIA-----ECKALRNIR-HRNLIKVLTACLGVDYQGNDFK-ALVYEFIHNRSP 165
             KI K         E K L N+R   N+I +      +         ALV+E ++N   
Sbjct: 65  VVKILKPVKKKKIKREIKILENLRGGPNIITLAD----IVKDPVSRTPALVFEHVNNTDF 120

Query: 166 EKWLYPISKEDE---TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKP 219
           ++    ++  D     YE      +L+          AL+Y H      +    H D+KP
Sbjct: 121 KQLYQTLTDYDIRFYMYE------ILK----------ALDYCH------SMGIMHRDVKP 158

Query: 220 SNVLLD-DDMTARVGDFGLARFLPPTRTQTKYGV-----GNEV-------STIGDVYSYG 266
            NV++D +    R+ D+GLA F  P +            G E+           D++S G
Sbjct: 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 218

Query: 267 ILLLELMIREKPSDIMFEGDMNLHKFAKMA 296
            +L  ++ R++P    F G  N  +  ++A
Sbjct: 219 CMLASMIFRKEP---FFHGHDNYDQLVRIA 245

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 41/178 (23%), Positives = 67/178 (37%), Gaps = 37/178 (20%)

Query: 120 FIAECKALRNI-RHRNLIKVLTACLG-------VDY-QGNDFKALVYEFIHNRSPEKWLY 170
            ++E K + ++ +H N++ +L AC          +Y    D       F+  +S      
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL----NFLRRKSRVLETD 151

Query: 171 PISKEDETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMT 229
           P              +    L+ +  VA  + +L   +C     H D+   NVLL +   
Sbjct: 152 PAFAIA-----NSTASTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHV 202

Query: 230 ARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
           A++GDFGLAR +         G                   +   DV+SYGILL E+ 
Sbjct: 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 39/181 (21%), Positives = 70/181 (38%), Gaps = 35/181 (19%)

Query: 117 FKSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGN-DFKALVYEFIHNRSPEK 167
               ++E + ++ I +H+N+I +L AC         V+Y    + +    E++  R P  
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR----EYLRARRPPG 139

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDD 226
             Y     D        +     ++    +A  + YL    C     H DL   NVL+ +
Sbjct: 140 MEYS---YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTE 192

Query: 227 DMTARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLEL 272
           +   ++ DFGLAR +       K   G                 +   DV+S+G+L+ E+
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

Query: 273 M 273
            
Sbjct: 253 F 253

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 61.9 bits (151), Expect = 7e-11
 Identities = 42/184 (22%), Positives = 67/184 (36%), Gaps = 36/184 (19%)

Query: 118 KSFIAECKALRNI-RHRNLIKVLTACLG-------VDYQGN-DFKALVYEFIHNRSPE-- 166
           ++ ++E K +  +  H N++ +L AC          +Y    D       ++ ++  +  
Sbjct: 93  EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL----NYLRSKREKFS 148

Query: 167 --KWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVL 223
             +  Y   K  E  E    L     L  A  VA  + +L    C     H DL   NVL
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVL 204

Query: 224 LDDDMTARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILL 269
           +      ++ DFGLAR +         G                   +   DV+SYGILL
Sbjct: 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264

Query: 270 LELM 273
            E+ 
Sbjct: 265 WEIF 268

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 61.6 bits (150), Expect = 9e-11
 Identities = 40/173 (23%), Positives = 70/173 (40%), Gaps = 32/173 (18%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E   +    H+N+++    C+GV  Q      ++ E +     + +L          
Sbjct: 80  FLMEALIISKFNHQNIVR----CIGVSLQSLPR-FILMELMAGGDLKSFLRETRPRPS-- 132

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL--HHDCQPVTAHCDLKPSNVLLD---DDMTARVGD 234
            +P +L +L  L++A D+A    YL  +H       H D+   N LL        A++GD
Sbjct: 133 -QPSSLAMLDLLHVARDIACGCQYLEENHFI-----HRDIAARNCLLTCPGPGRVAKIGD 186

Query: 235 FGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
           FG+AR +       K G                   ++  D +S+G+LL E+ 
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 46/191 (24%), Positives = 80/191 (41%), Gaps = 44/191 (23%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFIHNRSPEKWLYPISKEDETYE 180
           E   ++ + H+N+I +L           +F+   LV E +     +  L  + + +  +E
Sbjct: 111 ELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHE 164

Query: 181 RPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDF 235
           R   L   +L            + +LH      +A   H DLKPSN+++  D T ++ DF
Sbjct: 165 RMSYLLYQMLC----------GIKHLH------SAGIIHRDLKPSNIVVKSDCTLKILDF 208

Query: 236 GLARFLPPTRTQTKYGV-----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           GLAR    +   T Y V           G       D++S G ++ E M+R K    +F 
Sbjct: 209 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE-MVRHKI---LFP 264

Query: 285 GDMNLHKFAKM 295
           G   + ++ K+
Sbjct: 265 GRDYIDQWNKV 275

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 39/181 (21%), Positives = 70/181 (38%), Gaps = 35/181 (19%)

Query: 117 FKSFIAECKALRNI-RHRNLIKVLTACLG-------VDY-QGNDFKALVYEFIHNRSPEK 167
               ++E + ++ I +H+N+I +L AC         V+Y    + +    E++  R P  
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR----EYLRARRPPG 185

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDD 226
             Y     D        +     ++    +A  + YL    C     H DL   NVL+ +
Sbjct: 186 MEY---SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTE 238

Query: 227 DMTARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLEL 272
           +   ++ DFGLAR +       K   G                 +   DV+S+G+L+ E+
Sbjct: 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

Query: 273 M 273
            
Sbjct: 299 F 299

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 28/171 (16%), Positives = 68/171 (39%), Gaps = 39/171 (22%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F++E   ++N+ H +++K++           +   ++ E         +L          
Sbjct: 60  FMSEAVIMKNLDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLE--------- 104

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
               +L +L  +  ++ +  A+ YL   +C     H D+   N+L+      ++GDFGL+
Sbjct: 105 RNKNSLKVLTLVLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLS 160

Query: 239 RFLPP----TRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           R++        + T+            +      +T  DV+ + + + E++
Sbjct: 161 RYIEDEDYYKASVTRLPIKWMSPESINFRR---FTTASDVWMFAVCMWEIL 208

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 44/190 (23%), Positives = 80/190 (42%), Gaps = 43/190 (22%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFIHNRSPEKWLYPISKEDETYE 180
           E   L++++H N+I +L           +F    LV  F+     +  L  I     + E
Sbjct: 73  ELLLLKHMQHENVIGLLDV-FTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEE 126

Query: 181 RPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDF 235
           + + L   +L+           L Y+H      +A   H DLKP N+ +++D   ++ DF
Sbjct: 127 KIQYLVYQMLK----------GLKYIH------SAGVVHRDLKPGNLAVNEDCELKILDF 170

Query: 236 GLARFLPPTRTQ---TKYGVGNEV-------STIGDVYSYGILLLELMIREKPSDIMFEG 285
           GLAR      T    T++    EV       +   D++S G ++ E++   K    +F+G
Sbjct: 171 GLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KT---LFKG 226

Query: 286 DMNLHKFAKM 295
              L +  ++
Sbjct: 227 KDYLDQLTQI 236

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 40/173 (23%), Positives = 70/173 (40%), Gaps = 32/173 (18%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E   +    H+N+++    C+GV  Q      ++ E +     + +L          
Sbjct: 121 FLMEALIISKFNHQNIVR----CIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPS-- 173

Query: 180 ERPRNLNLLRRLNIAIDVASALNYL--HHDCQPVTAHCDLKPSNVLLD---DDMTARVGD 234
            +P +L +L  L++A D+A    YL  +H       H D+   N LL        A++GD
Sbjct: 174 -QPSSLAMLDLLHVARDIACGCQYLEENHFI-----HRDIAARNCLLTCPGPGRVAKIGD 227

Query: 235 FGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
           FG+AR +       K G                   ++  D +S+G+LL E+ 
Sbjct: 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 46/179 (25%), Positives = 72/179 (40%), Gaps = 40/179 (22%)

Query: 120 FIAECKALRNI-RHRNLIKVLTACLGVDY---------QGNDFKALVYEFIHNRSPEKWL 169
           F  E + L  +  H N+I +L AC    Y          GN    L+ +F+      +  
Sbjct: 72  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN----LL-DFLRKSRVLETD 126

Query: 170 YPISKEDETYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLDDDM 228
              +  + T     +  LL     A DVA  ++YL          H DL   N+L+ ++ 
Sbjct: 127 PAFAIANSTASTLSSQQLLH---FAADVARGMDYLSQKQF----IHRDLAARNILVGENY 179

Query: 229 TARVGDFGLARFLPPTRTQTK--------------YGVGNEVSTIGDVYSYGILLLELM 273
            A++ DFGL+R       +T               Y V    +T  DV+SYG+LL E++
Sbjct: 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIV 235

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 29/143 (20%), Positives = 52/143 (36%), Gaps = 36/143 (25%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQT------- 248
           +A AL+Y H         H D+KP N+L+      ++ DFG +   P  R +T       
Sbjct: 123 LADALHYCHERKV----IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDY 178

Query: 249 -------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHK---FAKMA 296
                        +V    D++  G+L  E ++   P    F+       H+      + 
Sbjct: 179 LPPEMIEGKTHDEKV----DLWCAGVLCYEFLVGMPP----FDSPSHTETHRRIVNVDLK 230

Query: 297 LPNHV----KDIVDSILLNDDEK 315
            P  +    KD++  +L     +
Sbjct: 231 FPPFLSDGSKDLISKLLRYHPPQ 253

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 39/205 (19%), Positives = 76/205 (37%), Gaps = 49/205 (23%)

Query: 115 KIF--KSF----IAECKALRNIRHRNLIKVLTACLGVDYQGND--FKALVYEFIHNRSPE 166
           K+     F    +   + L  + H N++++ +    +  +     +  +V E++      
Sbjct: 55  KVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----P 109

Query: 167 KWLYPISKEDETYERPRNLN--------LLRRLNIAIDVASALNYLHHDCQPVTAHCDLK 218
             L+   +     +              L+R          ++  LH     V  H D+K
Sbjct: 110 DTLHRCCRNYYRRQVAPPPILIKVFLFQLIR----------SIGCLHLPSVNV-CHRDIK 158

Query: 219 PSNVLLD-DDMTARVGDFGLARFLPPTRTQTKYGV------------GNEVSTIGDVYSY 265
           P NVL++  D T ++ DFG A+ L P+     Y                  +T  D++S 
Sbjct: 159 PHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218

Query: 266 GILLLELMIREKPSDIMFEGDMNLH 290
           G +  E+M+  +P   +F GD +  
Sbjct: 219 GCIFAEMMLG-EP---IFRGDNSAG 239

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 31/171 (18%), Positives = 66/171 (38%), Gaps = 39/171 (22%)

Query: 120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY 179
           F+ E   +R   H +++K++               ++ E         +L          
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITENPVW------IIMELCTLGELRSFLQ--------- 482

Query: 180 ERPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
            R  +L+L   +  A  +++AL YL          H D+   NVL+  +   ++GDFGL+
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLS 538

Query: 239 RFLPP----TRTQTK------------YGVGNEVSTIGDVYSYGILLLELM 273
           R++        ++ K            +      ++  DV+ +G+ + E++
Sbjct: 539 RYMEDSTYYKASKGKLPIKWMAPESINFRR---FTSASDVWMFGVCMWEIL 586

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 38/191 (19%), Positives = 64/191 (33%), Gaps = 51/191 (26%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFI----HN--RSPEKWLYPISK 174
           E + L +  H N++ +    + V ++        LV E +              + P   
Sbjct: 79  EIRLLNHFHHPNILGLRD--IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTAR 231
           +   Y       +L            L+ LH       A   H DL P N+LL D+    
Sbjct: 137 QYFMYH------ILL----------GLHVLH------EAGVVHRDLHPGNILLADNNDIT 174

Query: 232 VGDFGLARFLPPTRTQTKYGV------------GNEVSTIGDVYSYGILLLELMIREKPS 279
           + DF LAR       +T Y                  + + D++S G ++ E+  R K  
Sbjct: 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KA- 232

Query: 280 DIMFEGDMNLH 290
             +F G    +
Sbjct: 233 --LFRGSTFYN 241

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 33/182 (18%), Positives = 58/182 (31%), Gaps = 26/182 (14%)

Query: 106 SHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSP 165
           S       +K   +   + K        +L         +D   +   +    F+  +S 
Sbjct: 120 SKRNEFVPYKTKGARFRQGKDYVGAIPVDL------KRRLDSITSSQSSASSGFVEEKSL 173

Query: 166 EKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD 225
                    E         L L   +  +  VA  + +L    +    H DL   N+LL 
Sbjct: 174 SDVEEE---EAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCI-HRDLAARNILLS 227

Query: 226 DDMTARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLE 271
           +    ++ DFGLAR +       + G                   +   DV+S+G+LL E
Sbjct: 228 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287

Query: 272 LM 273
           + 
Sbjct: 288 IF 289

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 31/178 (17%), Positives = 67/178 (37%), Gaps = 44/178 (24%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           +SF      +  + H++L+       GV   G++   LV EF+   S + +L        
Sbjct: 57  ESFFEAASMMSKLSHKHLVL----NYGVCVCGDEN-ILVQEFVKFGSLDTYLK------- 104

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYL-HHDCQPVTAHCDLKPSNVLLD--------DDM 228
             +    +N+L +L +A  +A+A+++L  +       H ++   N+LL         +  
Sbjct: 105 --KNKNCINILWKLEVAKQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPP 158

Query: 229 TARVGDFGLARFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELM 273
             ++ D G++  +                           ++   D +S+G  L E+ 
Sbjct: 159 FIKLSDPGISITV----LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 34/144 (23%), Positives = 56/144 (38%), Gaps = 36/144 (25%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL--PPTRTQT------ 248
           +     YLH +      H DLK  N+ L++D+  ++GDFGLA  +     R +       
Sbjct: 150 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 206

Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHKFAKMA-- 296
                   K G   EV    DV+S G ++  L++ + P    FE       +   K    
Sbjct: 207 YIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEY 258

Query: 297 -LPNHV----KDIVDSILLNDDEK 315
            +P H+      ++  +L  D   
Sbjct: 259 SIPKHINPVAASLIQKMLQTDPTA 282

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 56.4 bits (137), Expect = 3e-09
 Identities = 35/144 (24%), Positives = 56/144 (38%), Gaps = 36/144 (25%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL--PPTRTQT------ 248
           +     YLH     V  H DLK  N+ L++D+  ++GDFGLA  +     R +       
Sbjct: 124 IVLGCQYLHR--NRV-IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180

Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHKFAKMA-- 296
                   K G   EV    DV+S G ++  L++ + P    FE       +   K    
Sbjct: 181 YIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETSCLKETYLRIKKNEY 232

Query: 297 -LPNHV----KDIVDSILLNDDEK 315
            +P H+      ++  +L  D   
Sbjct: 233 SIPKHINPVAASLIQKMLQTDPTA 256

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 56.4 bits (137), Expect = 4e-09
 Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 36/141 (25%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL--PPTRTQT------ 248
           + + + YLH     +  H DL  SN+LL  +M  ++ DFGLA  L  P  +  T      
Sbjct: 121 IITGMLYLHS--HGI-LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177

Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHK---FAKM 295
                   +   G E     DV+S G +   L+I   P    F+ D   N       A  
Sbjct: 178 YISPEIATRSAHGLES----DVWSLGCMFYTLLIGRPP----FDTDTVKNTLNKVVLADY 229

Query: 296 ALPNHV----KDIVDSILLND 312
            +P+ +    KD++  +L  +
Sbjct: 230 EMPSFLSIEAKDLIHQLLRRN 250

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 56.0 bits (136), Expect = 4e-09
 Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 29/106 (27%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGVGNEV- 256
             L + H        H DLKP N+L++ +   ++ +FGLAR F  P R  +      EV 
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS-----AEVV 163

Query: 257 ----------------STIGDVYSYGILLLELMIREKPSDIMFEGD 286
                           ST  D++S G +  EL    +P   +F G+
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 44/191 (23%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFIHNRSPEKWLYPISKEDE-TY 179
           E + L+++RH N+I +L      D   +DF    LV  F+        L  + K ++   
Sbjct: 74  ELRLLKHMRHENVIGLLDV-FTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGE 127

Query: 180 ERPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGD 234
           +R + L   +L+           L Y+H       A   H DLKP N+ +++D   ++ D
Sbjct: 128 DRIQFLVYQMLK----------GLRYIH------AAGIIHRDLKPGNLAVNEDCELKILD 171

Query: 235 FGLARFLPPTRTQ---TKYGVGNEV-------STIGDVYSYGILLLELMIREKPSDIMFE 284
           FGLAR      T    T++    EV       +   D++S G ++ E++   K    +F+
Sbjct: 172 FGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KT---LFK 227

Query: 285 GDMNLHKFAKM 295
           G  +L +  ++
Sbjct: 228 GSDHLDQLKEI 238

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 44/186 (23%), Positives = 78/186 (41%), Gaps = 44/186 (23%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFIHNRSPEKWLYPISKEDE-TY 179
           E + L++++H N+I +L           +F    LV   +        L  I K  + T 
Sbjct: 78  ELRLLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTD 131

Query: 180 ERPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGD 234
           +  + L   +LR           L Y+H      +A   H DLKPSN+ +++D   ++ D
Sbjct: 132 DHVQFLIYQILR----------GLKYIH------SADIIHRDLKPSNLAVNEDCELKILD 175

Query: 235 FGLARFLPPTRTQ---TKYGVGNEV-------STIGDVYSYGILLLELMIREKPSDIMFE 284
           FGLAR      T    T++    E+       +   D++S G ++ EL+   +    +F 
Sbjct: 176 FGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RT---LFP 231

Query: 285 GDMNLH 290
           G  ++ 
Sbjct: 232 GTDHID 237

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 55.7 bits (135), Expect = 8e-09
 Identities = 33/139 (23%), Positives = 58/139 (41%), Gaps = 28/139 (20%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFI-HNRSPEKWLYPISKEDETYER 181
           E K L+ +RH NL+ +L  C     +      LV+EF+ H          I  + E +  
Sbjct: 74  EIKLLKQLRHENLVNLLEVC-----KKKKRWYLVFEFVDHT---------ILDDLELFPN 119

Query: 182 PRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR- 239
             +  +++       + + + + H H+      H D+KP N+L+      ++ DFG AR 
Sbjct: 120 GLDYQVVQ--KYLFQIINGIGFCHSHNI----IHRDIKPENILVSQSGVVKLCDFGFART 173

Query: 240 FLPPTRTQTKYGVGNEVST 258
              P          +EV+T
Sbjct: 174 LAAPGEVYD-----DEVAT 187

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 42/191 (21%), Positives = 74/191 (38%), Gaps = 46/191 (24%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFIHNRSPEKWLYPISKEDETYE 180
           E + +R ++H N++  L A    +    D     LV E++      + +Y  S+     +
Sbjct: 82  ELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLK 135

Query: 181 RPRNLN--------LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA-R 231
           +   +         LLR          +L Y+H     +  H D+KP N+LLD      +
Sbjct: 136 QTMPMLLIKLYMYQLLR----------SLAYIH--SIGI-CHRDIKPQNLLLDPPSGVLK 182

Query: 232 VGDFGLARFLPPTRTQTKYGV------------GNEVSTIGDVYSYGILLLELMIREKPS 279
           + DFG A+ L        Y                  +T  D++S G ++ ELM   +P 
Sbjct: 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QP- 240

Query: 280 DIMFEGDMNLH 290
             +F G+  + 
Sbjct: 241 --LFPGESGID 249

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 55.3 bits (134), Expect = 9e-09
 Identities = 35/138 (25%), Positives = 63/138 (45%), Gaps = 26/138 (18%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E + L+ ++H NL+ +L     V  +      LV+E+      +  +     E + Y+R 
Sbjct: 52  EIRMLKQLKHPNLVNLL----EVFRRKRRL-HLVFEYC-----DHTVL---HELDRYQRG 98

Query: 183 RNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-F 240
              +L++  +I      A+N+ H H+C     H D+KP N+L+      ++ DFG AR  
Sbjct: 99  VPEHLVK--SITWQTLQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLL 152

Query: 241 LPPTRTQTKYGVGNEVST 258
             P+         +EV+T
Sbjct: 153 TGPSDYYD-----DEVAT 165

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 12/96 (12%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG- 251
           ++I V   L YL    + +  H D+KPSN+L++     ++ DFG++  L  +   +  G 
Sbjct: 136 VSIAVIKGLTYLREKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 193

Query: 252 ---------VGNEVSTIGDVYSYGILLLELMIREKP 278
                     G   S   D++S G+ L+E+ +   P
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 19/47 (40%), Positives = 26/47 (55%), Gaps = 3/47 (6%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP 243
           +   +  LH     +  H DLKP N+LLDDDM  ++ DFG +  L P
Sbjct: 133 LLEVICALHK--LNI-VHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 31/121 (25%), Positives = 52/121 (42%), Gaps = 23/121 (19%)

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD------DMTARVGD 234
           R   L  +++  I+  +   L+Y+H  C  +  H D+KP NVL++        +  ++ D
Sbjct: 126 RGIPLIYVKQ--ISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIAD 181

Query: 235 FGLARFLPPTRT---QTKYGVGNEV------STIGDVYSYGILLLELMIREKPSDIMFEG 285
            G A +     T   QT+     EV          D++S   L+ EL+      D +FE 
Sbjct: 182 LGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEP 237

Query: 286 D 286
           D
Sbjct: 238 D 238

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 54.1 bits (131), Expect = 2e-08
 Identities = 47/184 (25%), Positives = 75/184 (40%), Gaps = 40/184 (21%)

Query: 121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE 180
           I E   ++ ++H N++++      V +  N    LV+EF+     +  L           
Sbjct: 51  IREISLMKELKHENIVRLYD----VIHTENKL-TLVFEFM-----DNDLKKYMDSRTVGN 100

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR- 239
            PR L L         +   L + H +      H DLKP N+L++     ++GDFGLAR 
Sbjct: 101 TPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157

Query: 240 FLPPTRTQTKYGVGNEV-----------------STIGDVYSYGILLLELMIREKPSDIM 282
           F  P  T +     +EV                 ST  D++S G +L E++   KP   +
Sbjct: 158 FGIPVNTFS-----SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KP---L 208

Query: 283 FEGD 286
           F G 
Sbjct: 209 FPGT 212

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 33/148 (22%), Positives = 54/148 (36%), Gaps = 32/148 (21%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA--LVYEFIHNRSPEKWLYPI--SKEDET 178
           E   L  ++   +I++    +  D     F    +V E       +  L  +  +    T
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDL--LKFDELYIVLEIA-----DSDLKKLFKTPIFLT 127

Query: 179 YERPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVG 233
            E  + +  NLL             N++H       +   H DLKP+N LL+ D + +V 
Sbjct: 128 EEHIKTILYNLLL----------GENFIH------ESGIIHRDLKPANCLLNQDCSVKVC 171

Query: 234 DFGLARFLPPTRTQTKYGVGNEVSTIGD 261
           DFGLAR +   +         E    G 
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGP 199

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 18/96 (18%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------- 241
           + + +  AL YL      +  H D+KPSN+LLD+    ++ DFG++  L           
Sbjct: 129 MTVAIVKALYYLKEKHGVI--HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAG 186

Query: 242 -----PPTRTQTKYGVGNEVSTIGDVYSYGILLLEL 272
                 P R         +     DV+S GI L+EL
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 53.7 bits (130), Expect = 3e-08
 Identities = 31/106 (29%), Positives = 46/106 (43%), Gaps = 30/106 (28%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGVGNEV- 256
             + + H        H DLKP N+L++ D   ++ DFGLAR F  P R+ T     +EV 
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT-----HEVV 181

Query: 257 ----------------STIGDVYSYGILLLELMIREKPSDIMFEGD 286
                           ST  D++S G +  E++   KP   +F G 
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KP---LFPGV 223

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 20/48 (41%), Positives = 29/48 (60%), Gaps = 3/48 (6%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT 244
           +  A+++LH     +  H DLKP N+LLDD+M  R+ DFG +  L P 
Sbjct: 209 LLEAVSFLH--ANNI-VHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 53.0 bits (128), Expect = 6e-08
 Identities = 45/198 (22%), Positives = 79/198 (39%), Gaps = 56/198 (28%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYP-ISKEDETYER 181
           E K L++ +H N+I +        ++  +   ++ E +     +  L+  IS +  + + 
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDH 113

Query: 182 PRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDFG 236
            +      LR          A+  LH       +   H DLKPSN+L++ +   +V DFG
Sbjct: 114 IQYFIYQTLR----------AVKVLH------GSNVIHRDLKPSNLLINSNCDLKVCDFG 157

Query: 237 LARFLPPTRTQTKYGVGNE------VST------------------IGDVYSYGILLLEL 272
           LAR +  +        G +      V+T                  + DV+S G +L EL
Sbjct: 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAEL 216

Query: 273 MIREKPSDIMFEGDMNLH 290
            +R +P   +F G    H
Sbjct: 217 FLR-RP---IFPGRDYRH 230

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 53.3 bits (128), Expect = 6e-08
 Identities = 38/143 (26%), Positives = 58/143 (40%), Gaps = 41/143 (28%)

Query: 115 KIFKSF---------IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFI----H 161
           KI + F         + E   L  + H +++KVL   +  D +  D   +V E       
Sbjct: 85  KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFK 144

Query: 162 N--RSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA---HCD 216
              R+P   L  +  +   Y      NLL            + Y+H      +A   H D
Sbjct: 145 KLFRTPVY-LTELHIKTLLY------NLLV----------GVKYVH------SAGILHRD 181

Query: 217 LKPSNVLLDDDMTARVGDFGLAR 239
           LKP+N L++ D + +V DFGLAR
Sbjct: 182 LKPANCLVNQDCSVKVCDFGLAR 204

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 40/192 (20%), Positives = 75/192 (39%), Gaps = 48/192 (25%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKAL--VYEFIHNRSPEKWLYPISKEDETYE 180
           E + +R + H N+++ L        +  D   L  V +++      + +Y +++     +
Sbjct: 97  ELQIMRKLDHCNIVR-LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAK 150

Query: 181 RPRNLN--------LLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTA- 230
           +   +         L R          +L Y+H         H D+KP N+LLD D    
Sbjct: 151 QTLPVIYVKLYMYQLFR----------SLAYIHSFGI----CHRDIKPQNLLLDPDTAVL 196

Query: 231 RVGDFGLARFLPPTRTQTKYGV------------GNEVSTIGDVYSYGILLLELMIREKP 278
           ++ DFG A+ L        Y                + ++  DV+S G +L EL++  +P
Sbjct: 197 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QP 255

Query: 279 SDIMFEGDMNLH 290
              +F GD  + 
Sbjct: 256 ---IFPGDSGVD 264

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 32/126 (25%), Positives = 55/126 (43%), Gaps = 20/126 (15%)

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTA--RVGDFGLA 238
           +  +L L+R+   A  +   L+ LH   + +  HCDLKP N+LL     +  +V DFG +
Sbjct: 195 QGFSLPLVRK--FAHSILQCLDALH-KNRII--HCDLKPENILLKQQGRSGIKVIDFGSS 249

Query: 239 RFLPPTRT---QTKYGVGNEV------STIGDVYSYGILLLELMIREKPSDIMFEGDMNL 289
            +         Q+++    EV          D++S G +L EL+        +  G+   
Sbjct: 250 CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT----GYPLLPGEDEG 305

Query: 290 HKFAKM 295
            + A M
Sbjct: 306 DQLACM 311

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 30/106 (28%), Positives = 43/106 (40%), Gaps = 30/106 (28%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGVGNEV- 256
             L Y H        H DLKP N+L+++    ++ DFGLAR    PT+T       NEV 
Sbjct: 111 RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD-----NEVV 162

Query: 257 ----------------STIGDVYSYGILLLELMIREKPSDIMFEGD 286
                           ST  D++  G +  E+    +P   +F G 
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RP---LFPGS 204

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 51.7 bits (125), Expect = 1e-07
 Identities = 29/106 (27%), Positives = 45/106 (42%), Gaps = 30/106 (28%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGVGNEV- 256
           + + Y H        H DLKP N+L++ +   ++ DFGLAR F  P R  T     +E+ 
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-----HEIV 162

Query: 257 ----------------STIGDVYSYGILLLELMIREKPSDIMFEGD 286
                           ST  D++S G +  E++    P   +F G 
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TP---LFPGV 204

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 41/186 (22%), Positives = 68/186 (36%), Gaps = 53/186 (28%)

Query: 125 KALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIH-------NRSPEKWLYPISKEDE 177
           + L    H N++++   C            LV+E +        ++ PE  +   + +D 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
            ++      LLR           L++LH        H DLKP N+L+      ++ DFGL
Sbjct: 126 MFQ------LLR----------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 166

Query: 238 ARF--LPPTRTQ---------------TKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
           AR        T                + Y      +T  D++S G +  E+  R KP  
Sbjct: 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRR-KP-- 217

Query: 281 IMFEGD 286
            +F G 
Sbjct: 218 -LFRGS 222

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 41/193 (21%), Positives = 71/193 (36%), Gaps = 42/193 (21%)

Query: 119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET 178
           S   E   LR ++H N+I +    L      +    L++++      E  L+ I K    
Sbjct: 64  SACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYA-----EHDLWHIIKFHRA 115

Query: 179 YERPRNLNLLRRLNI---AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR---- 231
            +  +    L R  +      +   ++YLH +      H DLKP+N+L+  +   R    
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172

Query: 232 VGDFGLAR-FLPPTRTQTKYGVGNEVSTI---------G--------DVYSYGILLLELM 273
           + D G AR F  P +          V T          G        D+++ G +  EL+
Sbjct: 173 IADMGFARLFNSPLKPLADL--DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230

Query: 274 IREKPSDIMFEGD 286
              +P   +F   
Sbjct: 231 TS-EP---IFHCR 239

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 18/59 (30%), Positives = 29/59 (49%), Gaps = 6/59 (10%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTKYG 251
           D+ +A+ +LH     + AH D+KP N+L    + D   ++ DFG A+       QT   
Sbjct: 136 DIGTAIQFLHS--HNI-AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY 191

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 32/143 (22%), Positives = 54/143 (37%), Gaps = 36/143 (25%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV---------YEFIHNRSPEKWLYPIS 173
           E + L+ + H+N++K+       +      K L+         Y  +   S    L    
Sbjct: 57  EFEVLKKLNHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL---- 109

Query: 174 KEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMT 229
            E E       L +LR      DV   +N+L      +  H ++KP N++     D    
Sbjct: 110 PESEF------LIVLR------DVVGGMNHLRE--NGI-VHRNIKPGNIMRVIGEDGQSV 154

Query: 230 ARVGDFGLARFLPP-TRTQTKYG 251
            ++ DFG AR L    +  + YG
Sbjct: 155 YKLTDFGAARELEDDEQFVSLYG 177

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 23/136 (16%), Positives = 45/136 (33%), Gaps = 35/136 (25%)

Query: 191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-------------------MTAR 231
            ++ + V   L Y+H        H D+KPSN+ +                      +  +
Sbjct: 118 KDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 232 VGDFGLARFLPPTRTQ--TKYGVGNEV-------STIGDVYSYGILLLELMIREKPSDIM 282
           +GD G    +   + +      + NEV           D+++  + ++     E      
Sbjct: 175 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP--- 231

Query: 283 FEGDMNLHKFAKMALP 298
             GD   H+  +  LP
Sbjct: 232 RNGDQ-WHEIRQGRLP 246

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 19/96 (19%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           IA+ +  AL +LH     +  H D+KPSNVL++     ++ DFG++ +L     +     
Sbjct: 114 IAVSIVKALEHLHSKLSVI--HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-A 170

Query: 253 G-----------NEVSTIG-----DVYSYGILLLEL 272
           G            E++  G     D++S GI ++EL
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 51.0 bits (123), Expect = 2e-07
 Identities = 42/186 (22%), Positives = 71/186 (38%), Gaps = 53/186 (28%)

Query: 125 KALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIH-------NRSPEKWLYPISKEDE 177
           + L    H N+++++  C            LV+E +        +++P   L   + +D 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             +       LR           L++LH +C     H DLKP N+L+    T ++ DFGL
Sbjct: 126 MRQ------FLR----------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL 166

Query: 238 ARF--LPPTRTQ---------------TKYGVGNEVSTIGDVYSYGILLLELMIREKPSD 280
           AR        T                + Y      +T  D++S G +  E+  R KP  
Sbjct: 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRR-KP-- 217

Query: 281 IMFEGD 286
            +F G+
Sbjct: 218 -LFCGN 222

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 30/143 (20%), Positives = 52/143 (36%), Gaps = 36/143 (25%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALV---------YEFIHNRSPEKWLYPIS 173
           E + L+ + H+N++K+       +      K L+         Y  +   S    L    
Sbjct: 57  EFEVLKKLNHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL---- 109

Query: 174 KEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMT 229
            E E             L +  DV   +N+L      +  H ++KP N++     D    
Sbjct: 110 PESEF------------LIVLRDVVGGMNHLRE--NGI-VHRNIKPGNIMRVIGEDGQSV 154

Query: 230 ARVGDFGLARFLPP-TRTQTKYG 251
            ++ DFG AR L    +  + YG
Sbjct: 155 YKLTDFGAARELEDDEQFVSLYG 177

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 27/107 (25%), Positives = 49/107 (45%), Gaps = 26/107 (24%)

Query: 200 ALNYLHHDCQPVTA---HCDLKPSNVLLD-DDMTARVGDFGLARFLPPTRTQTKYGV--- 252
           A+ ++H      +    H D+KP N+L++  D T ++ DFG A+ L P+     Y     
Sbjct: 153 AVGFIH------SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF 206

Query: 253 ---------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH 290
                      E +   D++S G +  EL++  KP   +F G+ ++ 
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILG-KP---LFSGETSID 249

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 32/140 (22%), Positives = 53/140 (37%), Gaps = 34/140 (24%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL--------------- 241
           + SA+ YL         H D+K  N+++ +D T ++ DFG A +L               
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195

Query: 242 --PPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN 299
             P       Y  G E+    +++S G+ L  L+  E P    F       + A +  P 
Sbjct: 196 CAPEVLMGNPY-RGPEL----EMWSLGVTLYTLVFEENP----FCELEETVE-AAIHPPY 245

Query: 300 HV----KDIVDSILLNDDEK 315
            V      +V  +L    E+
Sbjct: 246 LVSKELMSLVSGLLQPVPER 265

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 32/106 (30%), Positives = 47/106 (44%), Gaps = 30/106 (28%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR-FLPPTRTQTKYGVGNEV- 256
             L YLH        H DLKP+N+LLD++   ++ DFGLA+ F  P R  T     ++V 
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT-----HQVV 174

Query: 257 ----------------STIGDVYSYGILLLELMIREKPSDIMFEGD 286
                               D+++ G +L EL++R  P      GD
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VP---FLPGD 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 19/51 (37%), Positives = 30/51 (58%), Gaps = 6/51 (11%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPP 243
            + SA++++H     V  H DLKP N+L    +D++  ++ DFG AR  PP
Sbjct: 114 KLVSAVSHMHD--VGV-VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 33/174 (18%), Positives = 50/174 (28%), Gaps = 37/174 (21%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERP 182
           E  A   +    ++       G   +G     +  E +   S  + +  +    E     
Sbjct: 100 ELVACAGLSSPRIVP----LYGAVREGPWVN-IFMELLEGGSLGQLIKQMGCLPEDRAL- 153

Query: 183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFL 241
                             L YLH        H D+K  NVLL  D   A + DFG A  L
Sbjct: 154 ---------YYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCL 201

Query: 242 PPTRTQTKYGVGN-----------EV------STIGDVYSYGILLLELMIREKP 278
            P         G+           EV          D++S   ++L  M+    
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH-MLNGCH 254

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 19/96 (19%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           I +    ALN+L  + +    H D+KPSN+LLD     ++ DFG++  L  +  +T+   
Sbjct: 130 ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-A 186

Query: 253 G-----------NEVSTIG-----DVYSYGILLLEL 272
           G              S  G     DV+S GI L EL
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 9/65 (13%)

Query: 200 ALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEV 256
            + YLH      +    H D+KPSN+LL+ +   +V DFGL+R     R  T     +  
Sbjct: 121 VIKYLH------SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 257 STIGD 261
               +
Sbjct: 175 ENTEN 179

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 16/47 (34%), Positives = 21/47 (44%), Gaps = 3/47 (6%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR 245
             L YLH        H D+KP N+LL    T ++   G+A  L P  
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 32/138 (23%), Positives = 55/138 (39%), Gaps = 31/138 (22%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKA---LVYEFIH-------NRSPEKWLYPI 172
           E K L+ ++H N++ ++  C       N  K    LV++F         +    K+    
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125

Query: 173 SKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV 232
            K            +++ L       + L Y+H +      H D+K +NVL+  D   ++
Sbjct: 126 IK-----------RVMQMLL------NGLYYIHRNK---ILHRDMKAANVLITRDGVLKL 165

Query: 233 GDFGLAR-FLPPTRTQTK 249
            DFGLAR F     +Q  
Sbjct: 166 ADFGLARAFSLAKNSQPN 183

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 33/165 (20%), Positives = 57/165 (34%), Gaps = 40/165 (24%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFI-----HNRSPEKWLYPISKEDE 177
           E   +  + H  LI +  A     ++      L+ EF+      +R        I+ ED 
Sbjct: 98  EISIMNQLHHPKLINLHDA-----FEDKYEMVLILEFLSGGELFDR--------IAAEDY 144

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV--GDF 235
                  +N +R           L ++H     +  H D+KP N++ +    + V   DF
Sbjct: 145 KMSEAEVINYMR------QACEGLKHMHE--HSI-VHLDIKPENIMCETKKASSVKIIDF 195

Query: 236 GLARFLPPTRT-QTKYG----------VGNEVSTIGDVYSYGILL 269
           GLA  L P    +                  V    D+++ G+L 
Sbjct: 196 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 24/88 (27%), Positives = 37/88 (42%), Gaps = 14/88 (15%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYG----V 252
           +   L ++H        + DLKP+N+LLD+    R+ D GLA      +     G    +
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 357

Query: 253 GNEVSTIGDVY-------SYGILLLELM 273
             EV   G  Y       S G +L +L+
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLL 385

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 45/190 (23%), Positives = 71/190 (37%), Gaps = 47/190 (24%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK-EDETYER 181
           E K L   RH N+I +         +      +V + +     E  LY + K +  + + 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDH 129

Query: 182 PRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLDDDMTARVGDFG 236
                  +LR           L Y+H      +A   H DLKPSN+LL+     ++ DFG
Sbjct: 130 ICYFLYQILR----------GLKYIH------SANVLHRDLKPSNLLLNTTCDLKICDFG 173

Query: 237 LARFLPPTRTQ----TKYGV------------GNEVSTIGDVYSYGILLLELMIREKPSD 280
           LAR   P        T+Y                  +   D++S G +L E++   +P  
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP-- 230

Query: 281 IMFEGDMNLH 290
            +F G   L 
Sbjct: 231 -IFPGKHYLD 239

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 50.5 bits (120), Expect = 6e-07
 Identities = 36/180 (20%), Positives = 60/180 (33%), Gaps = 53/180 (29%)

Query: 123 ECKALRNIRHRNLIKVLTACL--GVDYQGNDFKALV---------YEFIHNRSPEKWLYP 171
           E + ++ + H N++               ND   L           ++++       L  
Sbjct: 62  EIQIMKKLNHPNVVS-AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL-- 118

Query: 172 ISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD---DDM 228
             KE           LL       D++SAL YLH + + +  H DLKP N++L      +
Sbjct: 119 --KEGPI------RTLLS------DISSALRYLH-ENRII--HRDLKPENIVLQPGPQRL 161

Query: 229 TARVGDFGLARFLPP-TRTQTKYG--------------VGNEVSTIGDVYSYGILLLELM 273
             ++ D G A+ L          G                  V    D +S+G L  E +
Sbjct: 162 IHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTV----DYWSFGTLAFECI 217

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 16/46 (34%), Positives = 28/46 (60%), Gaps = 3/46 (6%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL 241
           D+   + YLH+  Q +  H D+KPSN+L+ +D   ++ DFG++   
Sbjct: 145 DLIKGIEYLHY--QKI-IHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 30/111 (27%), Positives = 46/111 (41%), Gaps = 35/111 (31%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVG-----DFGLAR-FLPPTRTQTKYGV 252
           + +N+ H   +    H DLKP N+LL     +        DFGLAR F  P R  T    
Sbjct: 143 NGVNFCHS--RRCL-HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT---- 195

Query: 253 GNEV-----------------STIGDVYSYGILLLELMIREKPSDIMFEGD 286
            +E+                 ST  D++S   +  E++++  P   +F GD
Sbjct: 196 -HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TP---LFPGD 241

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 33/127 (25%), Positives = 59/127 (46%), Gaps = 20/127 (15%)

Query: 181 RPRNLNLLRRLNIAIDVASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTA--RVGDFGL 237
           R  +LNL R+   A  + +AL +L   +   +  HCDLKP N+LL +   +  ++ DFG 
Sbjct: 152 RGVSLNLTRK--FAQQMCTALLFLATPELSII--HCDLKPENILLCNPKRSAIKIVDFGS 207

Query: 238 ARFLPPTRT---QTKYGVGNEV------STIGDVYSYGILLLELMIREKPSDIMFEGDMN 288
           +  L        Q+++    EV          D++S G +L+E+       + +F G   
Sbjct: 208 SCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT----GEPLFSGANE 263

Query: 289 LHKFAKM 295
           + +  K+
Sbjct: 264 VDQMNKI 270

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 26/137 (18%), Positives = 52/137 (37%), Gaps = 30/137 (21%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFI-----HNRSPEKWLYPISKEDE 177
           E + +  +RH  L+ +  A     ++ ++   ++YEF+       +        ++ E  
Sbjct: 204 EIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFEK--------VADEHN 250

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV--GDF 235
                  +  +R       V   L ++H        H DLKP N++     +  +   DF
Sbjct: 251 KMSEDEAVEYMR------QVCKGLCHMHE--NNY-VHLDLKPENIMFTTKRSNELKLIDF 301

Query: 236 GLARFLPPTRT-QTKYG 251
           GL   L P ++ +   G
Sbjct: 302 GLTAHLDPKQSVKVTTG 318

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 49.1 bits (118), Expect = 8e-07
 Identities = 19/58 (32%), Positives = 28/58 (48%), Gaps = 6/58 (10%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTKYG 251
           V SA+ YLH     +  H DLKP N+L    +++    + DFGL++        T  G
Sbjct: 115 VLSAVKYLHE--NGI-VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG 169

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 49.2 bits (118), Expect = 9e-07
 Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 57/200 (28%)

Query: 123 ECKALRNIRHRNLIKVL-------TACLGVDYQGNDFKA--LVYEFIHNRSPEKWLYP-I 172
           E K +R + H N++KV        +          +  +  +V E++     E  L   +
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVL 112

Query: 173 SKEDETYERPRNL--NLLRRLNIAIDVASALNYLHHDCQPVTA---HCDLKPSNVLLD-D 226
            +     E  R     LLR           L Y+H      +A   H DLKP+N+ ++ +
Sbjct: 113 EQGPLLEEHARLFMYQLLR----------GLKYIH------SANVLHRDLKPANLFINTE 156

Query: 227 DMTARVGDFGLARFLPPTRTQ----TKYGV------------GNEVSTIGDVYSYGILLL 270
           D+  ++GDFGLAR + P  +     ++  V             N  +   D+++ G +  
Sbjct: 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 216

Query: 271 ELMIREKPSDIMFEGDMNLH 290
           E++   K    +F G   L 
Sbjct: 217 EMLTG-KT---LFAGAHELE 232

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 49.2 bits (117), Expect = 9e-07
 Identities = 34/225 (15%), Positives = 66/225 (29%), Gaps = 39/225 (17%)

Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
           F       + L+       +K  +A     +   +   LV E     +    L  I+   
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGT---LLNAINLYK 162

Query: 177 ETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL-----------D 225
            T E+     L+     A+ +   +  +H DC+ +  H D+KP N +L           D
Sbjct: 163 NTPEKVMPQGLVIS--FAMRMLYMIEQVH-DCEII--HGDIKPDNFILGNGFLEQDDEDD 217

Query: 226 DDMTARVGDFGLAR----FLPPTRTQTKYG----VGNEV------STIGDVYSYGILLLE 271
                 + D G +     F   T    K         E+      +   D +     +  
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYC 277

Query: 272 LMIREKPSDIMFEGDMNLHK-FAKMALPNHVKDIVDSILLNDDEK 315
           ++           G+      F ++   +   +    +L   D  
Sbjct: 278 MLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 15/51 (29%), Positives = 24/51 (47%), Gaps = 6/51 (11%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPP 243
            +  A+ YLH     + AH D+KP N+L      +   ++ DFG A+    
Sbjct: 169 SIGEAIQYLHS--INI-AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 29/137 (21%), Positives = 52/137 (37%), Gaps = 30/137 (21%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIH-----NRSPEKWLYPISKEDE 177
           E   +  + H NLI++  A     ++  +   LV E++      +R        I  E  
Sbjct: 136 EISVMNQLDHANLIQLYDA-----FESKNDIVLVMEYVDGGELFDR--------IIDESY 182

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL--DDDMTARVGDF 235
                  +  ++       +   + ++H     +  H DLKP N+L    D    ++ DF
Sbjct: 183 NLTELDTILFMK------QICEGIRHMHQ--MYI-LHLDLKPENILCVNRDAKQIKIIDF 233

Query: 236 GLARFLPPTRT-QTKYG 251
           GLAR   P    +  +G
Sbjct: 234 GLARRYKPREKLKVNFG 250

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 17/91 (18%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-TRTQTKYG---- 251
           +  AL+YL +  Q +  H D+KP N+LLD+     + DF +A  LP  T+  T  G    
Sbjct: 124 LVMALDYLQN--QRI-IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPY 180

Query: 252 ----VGNEVSTIG-----DVYSYGILLLELM 273
               + +     G     D +S G+   EL+
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 28/188 (14%), Positives = 66/188 (35%), Gaps = 50/188 (26%)

Query: 172 ISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD------ 225
           +  ++ + E  +       +++   +AS + +LH        H DLKP N+L+       
Sbjct: 99  VESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFT 155

Query: 226 -------DDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG------------------ 260
                  +++   + DFGL + L   ++  +  + N   T G                  
Sbjct: 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRR 215

Query: 261 -----DVYSYGILLLELMIREKP--------SDIMFEGDMNLHKFAKMALPN---HVKDI 304
                D++S G +   ++ + K            +  G  +L +   +   +      D+
Sbjct: 216 LTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDL 275

Query: 305 VDSILLND 312
           +  ++ +D
Sbjct: 276 ISQMIDHD 283

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 20/68 (29%), Positives = 33/68 (48%), Gaps = 6/68 (8%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTKYGV 252
           DVASAL++LH+  + + AH DLKP N+L    +     ++ DF L   +      +    
Sbjct: 119 DVASALDFLHN--KGI-AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 253 GNEVSTIG 260
              ++  G
Sbjct: 176 PELLTPCG 183

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 34/147 (23%), Positives = 60/147 (40%), Gaps = 40/147 (27%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----TRTQT--- 248
           + SAL YLH         H DLKP N+LL++DM  ++ DFG A+ L P     R  +   
Sbjct: 139 IVSALEYLHGKGI----IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 249 -----------KYGVGNEVSTIGDVYSYGILLLELMI-----REKPSDIMFEGDMNLHKF 292
                      +           D+++ G ++ +L+      R     ++F+  +     
Sbjct: 195 TAQYVSPELLTEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK---- 246

Query: 293 AKMALPNHV----KDIVDSILLNDDEK 315
            +   P       +D+V+ +L+ D  K
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLVLDATK 273

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 36/142 (25%), Positives = 56/142 (39%), Gaps = 36/142 (25%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL-ARFLPPTRTQTKYG------ 251
           SA+ Y H        H DLK  N+LLD DM  ++ DFG    F    +     G      
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181

Query: 252 ---------VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHK---FAKMAL 297
                     G EV    DV+S G++L  L+    P    F+G     L +     K  +
Sbjct: 182 PELFQGKKYDGPEV----DVWSLGVILYTLVSGSLP----FDGQNLKELRERVLRGKYRI 233

Query: 298 PNHV----KDIVDSILLNDDEK 315
           P ++    ++++   L+ +  K
Sbjct: 234 PFYMSTDCENLLKRFLVLNPIK 255

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 33/165 (20%), Positives = 63/165 (38%), Gaps = 40/165 (24%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIH-----NRSPEKWLYPISKEDE 177
           E   L   RHRN++ +  +     ++  +   +++EFI       R        I+    
Sbjct: 51  EISILNIARHRNILHLHES-----FESMEELVMIFEFISGLDIFER--------INTSAF 97

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV--GDF 235
                  ++ +        V  AL +LH     +  H D++P N++     ++ +   +F
Sbjct: 98  ELNEREIVSYVH------QVCEALQFLHS--HNI-GHFDIRPENIIYQTRRSSTIKIIEF 148

Query: 236 GLARFLPP-TRTQTKYG----------VGNEVSTIGDVYSYGILL 269
           G AR L P    +  +             + VST  D++S G L+
Sbjct: 149 GQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 28/140 (20%), Positives = 50/140 (35%), Gaps = 34/140 (24%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVGDFGLARFLPPTRTQT------- 248
           V  A+ + H+       H D+K  N+L+D +    ++ DFG    L  T           
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 214

Query: 249 ---------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN 299
                    +Y  G        V+S GILL +++  + P    FE D  + +  ++    
Sbjct: 215 SPPEWIRYHRYH-GRSA----AVWSLGILLYDMVCGDIP----FEHDEEIIR-GQVFFRQ 264

Query: 300 HV----KDIVDSILLNDDEK 315
            V    + ++   L      
Sbjct: 265 RVSSECQHLIRWCLALRPSD 284

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 19/52 (36%), Positives = 26/52 (50%), Gaps = 7/52 (13%)

Query: 196 DVASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMTARVGDFGLARFLPP 243
            +   + YLH   Q V  H DLKPSN+L      +  + R+ DFG A+ L  
Sbjct: 124 TITKTVEYLH--AQGV-VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 22/81 (27%), Positives = 35/81 (43%), Gaps = 16/81 (19%)

Query: 192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQT 248
            I   +  A+ YLH     + AH D+KP N+L      +   ++ DFG A       T  
Sbjct: 121 EIMKSIGEAIQYLH--SINI-AHRDVKPENLLYTSKRPNAILKLTDFGFA----KETTGE 173

Query: 249 KYGVGNEVSTIGDVYSYGILL 269
           KY          D++S G+++
Sbjct: 174 KY--DKSC----DMWSLGVIM 188

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 26/126 (20%), Positives = 45/126 (35%), Gaps = 34/126 (26%)

Query: 172 ISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL-----DD 226
           + ++D  +     + LL+         S L +LH     +  H DLKP N+L+       
Sbjct: 108 VEQKDFAHLGLEPITLLQ------QTTSGLAHLHS--LNI-VHRDLKPHNILISMPNAHG 158

Query: 227 DMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG-------------------DVYSYGI 267
            + A + DFGL + L   R  +         T G                   D++S G 
Sbjct: 159 KIKAMISDFGLCKKLAVGR-HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217

Query: 268 LLLELM 273
           +   ++
Sbjct: 218 VFYYVI 223

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 33/176 (18%), Positives = 64/176 (36%), Gaps = 30/176 (17%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           +    E    ++++H+N+++     LG   +    K +  E +   S    L       +
Sbjct: 64  QPLHEEIALHKHLKHKNIVQ----YLGSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLK 118

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFG 236
             E       +        +   L YLH +      H D+K  NVL++      ++ DFG
Sbjct: 119 DNE-----QTIG--FYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFG 168

Query: 237 LARFLPPTRTQTKYGVGN------EV---STIG-----DVYSYGILLLELMIREKP 278
            ++ L      T+   G       E+      G     D++S G  ++E+   + P
Sbjct: 169 TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 31/134 (23%), Positives = 52/134 (38%), Gaps = 34/134 (25%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPPTRTQT------- 248
           V +A+ + H   + V  H D+K  N+L+D     A++ DFG    L              
Sbjct: 148 VVAAIQHCHS--RGV-VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVY 204

Query: 249 ---------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN 299
                    +Y           V+S GILL +++  + P    FE D  + + A++  P 
Sbjct: 205 SPPEWISRHQYH-ALPA----TVWSLGILLYDMVCGDIP----FERDQEILE-AELHFPA 254

Query: 300 HV----KDIVDSIL 309
           HV      ++   L
Sbjct: 255 HVSPDCCALIRRCL 268

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 18/54 (33%), Positives = 28/54 (51%), Gaps = 6/54 (11%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK 249
           +  A++ +H H       H DLKP+N L+ D M  ++ DFG+A  + P  T   
Sbjct: 136 MLEAVHTIHQHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV 184

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 18/54 (33%), Positives = 28/54 (51%), Gaps = 6/54 (11%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK 249
           +  A++ +H H       H DLKP+N L+ D M  ++ DFG+A  + P  T   
Sbjct: 117 MLEAVHTIHQHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV 165

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 20/104 (19%), Positives = 33/104 (31%), Gaps = 27/104 (25%)

Query: 193 IAI---DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK 249
           IA     V  AL+Y+HH       H  +K S++L+  D    +        +     + +
Sbjct: 130 IAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186

Query: 250 YGVGNEVSTIG---------------------DVYSYGILLLEL 272
                   ++                      D+YS GI   EL
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 30/143 (20%), Positives = 53/143 (37%), Gaps = 35/143 (24%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF---------IHNRSPEKWLYPIS 173
           E      ++H +++++L       Y  +    +V+EF         I  R+   ++Y   
Sbjct: 76  EASICHMLKHPHIVELLET-----YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS-- 128

Query: 174 KEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTA 230
            E            +R       +  AL Y H     +  H D+KP  VLL   ++    
Sbjct: 129 -EAVASH------YMR------QILEALRYCHD--NNI-IHRDVKPHCVLLASKENSAPV 172

Query: 231 RVGDFGLARFLPPTRTQTKYGVG 253
           ++G FG+A  L  +       VG
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRVG 195

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 46.4 bits (111), Expect = 6e-06
 Identities = 14/50 (28%), Positives = 23/50 (46%), Gaps = 6/50 (12%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPP 243
           +  ++ Y H     +  H +LKP N+LL         ++ DFGLA  +  
Sbjct: 114 ILESIAYCHS--NGI-VHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 46.7 bits (111), Expect = 6e-06
 Identities = 19/57 (33%), Positives = 29/57 (50%), Gaps = 5/57 (8%)

Query: 192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV--GDFGLARFLPPTRT 246
           NI   + SAL+YLH+  Q +  H D+KP N L   + +  +   DFGL++       
Sbjct: 172 NIMRQIFSALHYLHN--QGI-CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 18/54 (33%), Positives = 28/54 (51%), Gaps = 6/54 (11%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK 249
           +  A++ +H H       H DLKP+N L+ D M  ++ DFG+A  + P  T   
Sbjct: 164 MLEAVHTIHQHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV 212

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 17/45 (37%), Positives = 25/45 (55%), Gaps = 3/45 (6%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP 243
            A+ Y H        H DLKP N+LLDD++  ++ DFGL+  +  
Sbjct: 119 CAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 28/109 (25%), Positives = 45/109 (41%), Gaps = 27/109 (24%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT------ 248
           + SAL+YLH +   V  + DLK  N++LD D   ++ DFGL +         +T      
Sbjct: 257 IVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 314

Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKP-----SDIMFE 284
                       G  V    D +  G+++ E+M    P      + +FE
Sbjct: 315 YLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 14/51 (27%), Positives = 24/51 (47%), Gaps = 6/51 (11%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPT 244
           +  ++ Y H     +  H +LKP N+LL         ++ DFGLA  +  +
Sbjct: 137 ILESIAYCHS--NGI-VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 19/45 (42%), Positives = 25/45 (55%), Gaps = 3/45 (6%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP 243
           S ++Y H        H DLKP NVLLD  M A++ DFGL+  +  
Sbjct: 127 SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 46.0 bits (110), Expect = 9e-06
 Identities = 20/45 (44%), Positives = 26/45 (57%), Gaps = 3/45 (6%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP 243
           SA++Y H        H DLKP NVLLD  M A++ DFGL+  +  
Sbjct: 122 SAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 45.7 bits (109), Expect = 9e-06
 Identities = 21/56 (37%), Positives = 25/56 (44%), Gaps = 6/56 (10%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTK 249
           V SA+ Y H     V AH DLKP N L      D   ++ DFGLA    P +    
Sbjct: 115 VLSAVAYCHK--LNV-AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 46.1 bits (110), Expect = 9e-06
 Identities = 19/51 (37%), Positives = 28/51 (54%), Gaps = 6/51 (11%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPT 244
           +  A+ YLH     +  H DLKP NVLL   ++D   ++ DFG ++ L  T
Sbjct: 123 MLLAVQYLHE--NGII-HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 16/51 (31%), Positives = 25/51 (49%), Gaps = 6/51 (11%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPT 244
           +  A+ YLH     +  H DLKP N+L      D   ++ DFGL++ +   
Sbjct: 157 ILEAVAYLHE--NGI-VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 15/98 (15%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +  +   AL +LH +      H D+K  N+LL  D + ++ DFG    + P +++    V
Sbjct: 121 VCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177

Query: 253 GN------EVSTIG------DVYSYGILLLELMIREKP 278
           G       EV T        D++S GI+ +E++  E P
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 16/40 (40%), Positives = 24/40 (60%), Gaps = 3/40 (7%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
           + + YLH     +  H D+KP N+LLD+    ++ DFGLA
Sbjct: 116 AGVVYLHG--IGI-THRDIKPENLLLDERDNLKISDFGLA 152

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 24/101 (23%)

Query: 193 IAI---DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK 249
           IA    +V   L YLH + Q    H D+K  N+LL +D + ++ DFG++ FL      T+
Sbjct: 123 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179

Query: 250 YGVGN-----------EVSTIG-------DVYSYGILLLEL 272
             V             EV           D++S+GI  +EL
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 19/56 (33%), Positives = 28/56 (50%), Gaps = 6/56 (10%)

Query: 192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPT 244
                +  A+ YLH     +  H DLKP NVLL   ++D   ++ DFG ++ L  T
Sbjct: 243 LYFYQMLLAVQYLHE--NGII-HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 34/106 (32%), Positives = 45/106 (42%), Gaps = 27/106 (25%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEV 256
           + S L +LH   Q    + DLKP NVLLDDD   R+ D GLA  L   +T+TK   G   
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG--- 351

Query: 257 STIG----------------DVYSYGILLLELMIREKPSDIMFEGD 286
            T G                D ++ G+ L E++    P    F   
Sbjct: 352 -TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP----FRAR 392

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 16/60 (26%), Positives = 25/60 (41%), Gaps = 6/60 (10%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTKYGVG 253
           +  A+ + H     V  H +LKP N+LL         ++ DFGLA  +   +       G
Sbjct: 119 ILEAVLHCHQ--MGV-VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 16/40 (40%), Positives = 24/40 (60%), Gaps = 3/40 (7%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA 238
           + + YLH     +  H D+KP N+LLD+    ++ DFGLA
Sbjct: 116 AGVVYLHG--IGI-THRDIKPENLLLDERDNLKISDFGLA 152

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 18/61 (29%), Positives = 26/61 (42%), Gaps = 6/61 (9%)

Query: 192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQT 248
            I   V S + Y+H     +  H DLKP N+LL   + D   ++ DFGL+          
Sbjct: 125 RIIKQVFSGITYMHK--HNI-VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181

Query: 249 K 249
            
Sbjct: 182 D 182

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 30/100 (30%), Positives = 43/100 (43%), Gaps = 16/100 (16%)

Query: 192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQ- 247
            I   V S + YLH     +  H DLKP N+LL   + D   ++ DFGL+      +   
Sbjct: 140 VIIKQVLSGVTYLHK--HNI-VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196

Query: 248 ----TKYGVGNEV-----STIGDVYSYGILLLELMIREKP 278
               T Y +  EV         DV+S G++L  L+    P
Sbjct: 197 ERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPP 236

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 27/98 (27%), Positives = 43/98 (43%), Gaps = 15/98 (15%)

Query: 193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV 252
           +   V  AL YLH        H D+K  ++LL  D   ++ DFG    +     + K  V
Sbjct: 146 VCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202

Query: 253 GN------EVSTIG------DVYSYGILLLELMIREKP 278
           G       EV +        D++S GI+++E++  E P
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 26/101 (25%), Positives = 41/101 (40%), Gaps = 18/101 (17%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-TRTQTKYG---- 251
           +   L  LH   +    + DLKP N+LLDD    R+ D GLA  +P     + + G    
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351

Query: 252 ------VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                      +   D ++ G LL E++  + P    F+  
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQR 388

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 18/101 (17%)

Query: 193 IAI---DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK 249
           IA    ++   L+YLH + +    H D+K +NVLL +    ++ DFG+A  L  T+ +  
Sbjct: 121 IATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177

Query: 250 YGVGN------EVSTIG------DVYSYGILLLELMIREKP 278
             VG       EV          D++S GI  +EL   E P
Sbjct: 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 26/149 (17%), Positives = 46/149 (30%), Gaps = 34/149 (22%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA-RFLPPTRTQTKYGVG-- 253
           +  A++ +H   +    H D+KP N+LLD     R+ DFG   +       ++   VG  
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227

Query: 254 ----------NEVSTIGDVY-------SYGILLLELMIREKP----------SDIMFEGD 286
                              Y       + G+   E+   + P            I+   +
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287

Query: 287 MNLHKFAKMALPNHVKDIVDSILLNDDEK 315
                     +P   +D +   LL   E 
Sbjct: 288 HLSLPLVDEGVPEEARDFIQR-LLCPPET 315

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 38/141 (26%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQT------- 248
           +     YLH  D      + DLKP N+L+D     +V DFG A+ +   RT T       
Sbjct: 150 IVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTLCGTPEA 204

Query: 249 -------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHK---FAKMA 296
                    G    V    D ++ G+L+ E+     P    F  D  + +++     K+ 
Sbjct: 205 LAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKVR 256

Query: 297 LPNHV----KDIVDSILLNDD 313
            P+H     KD++ + LL  D
Sbjct: 257 FPSHFSSDLKDLLRN-LLQVD 276

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 18/61 (29%), Positives = 26/61 (42%), Gaps = 6/61 (9%)

Query: 192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQT 248
            I   V S + Y+H     +  H DLKP N+LL   + D   ++ DFGL+          
Sbjct: 125 RIIKQVFSGITYMHK--HNI-VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181

Query: 249 K 249
            
Sbjct: 182 D 182

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 33/116 (28%), Positives = 46/116 (39%), Gaps = 20/116 (17%)

Query: 192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQ- 247
            I   V S + Y+H     +  H DLKP N+LL     D   R+ DFGL+     ++   
Sbjct: 130 RIIRQVLSGITYMHK--NKI-VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK 186

Query: 248 ----TKYGVGNEV-----STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAK 294
               T Y +  EV         DV+S G++L  L+    P    F G        K
Sbjct: 187 DKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP----FNGANEYDILKK 238

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 35/173 (20%), Positives = 57/173 (32%), Gaps = 53/173 (30%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEF---------IHNRSPEKWLYPIS 173
           E + L+++ H N+IK+        ++      +V E          I +           
Sbjct: 70  EIEVLKSLDHPNIIKIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQARGKALS-- 122

Query: 174 KEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTA 230
            E    E            +   + +AL Y H   Q V  H DLKP N+L          
Sbjct: 123 -EGYVAE------------LMKQMMNALAYFHS--QHV-VHKDLKPENILFQDTSPHSPI 166

Query: 231 RVGDFGLARFLPPTRTQT--------------KYGVGNEVSTIGDVYSYGILL 269
           ++ DFGLA         T              K  V  +     D++S G+++
Sbjct: 167 KIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKC----DIWSAGVVM 215

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 16/56 (28%), Positives = 26/56 (46%), Gaps = 6/56 (10%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPTRTQTK 249
           + S + YLH     +  H D+KP N+LL   +  +  ++ DFGL+ F         
Sbjct: 155 ILSGICYLHK--HNI-VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 15/50 (30%), Positives = 24/50 (48%), Gaps = 6/50 (12%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPP 243
           +   + YLH     +  H DLKP N+LL         ++ DFG++R +  
Sbjct: 140 ILEGVYYLHQ--NNI-VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 29/148 (19%), Positives = 54/148 (36%), Gaps = 34/148 (22%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA-RFLPPTRTQTKYGVG- 253
           +  A++ +H         H D+KP N+L+D +   R+ DFG   + +     Q+   VG 
Sbjct: 184 MVIAIDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239

Query: 254 -----------NEVSTIG-----DVYSYGILLLELMIREKP-----SDIMFEGDMNLHKF 292
                       E          D +S G+ + E++  E P         +   MN  + 
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299

Query: 293 AKM-----ALPNHVKDIVDSILLNDDEK 315
            +       +  + KD++   L+   E 
Sbjct: 300 FQFPTQVTDVSENAKDLIRR-LICSREH 326

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 32/166 (19%), Positives = 57/166 (34%), Gaps = 40/166 (24%)

Query: 185 LNLLRRLNIAIDVA--------SALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
           +NL+   ++    A         AL+ +H         H D+KP N+LLD     ++ DF
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADF 212

Query: 236 GLA-RFLPPTRTQTKYGVGN------EV-STIGDVYSY---------GILLLELMIREKP 278
           G   +       +    VG       EV  + G    Y         G+ L E+++ + P
Sbjct: 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

Query: 279 -----SDIMFE----GDMNLHKFAKMALPNHVKDIVDSILLNDDEK 315
                    +        +L       +    K+++ +  L D E 
Sbjct: 273 FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREV 317

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 42.9 bits (102), Expect = 8e-05
 Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 24/92 (26%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQT------- 248
           V  AL YLH  D      + DLKP N+LLD +   ++ DFG A+++ P  T T       
Sbjct: 115 VCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYTLCGTPDY 169

Query: 249 -------KYGVGNEVSTIGDVYSYGILLLELM 273
                         +    D +S+GIL+ E++
Sbjct: 170 IAPEVVSTKPYNKSI----DWWSFGILIYEML 197

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 42.9 bits (102), Expect = 8e-05
 Identities = 31/130 (23%), Positives = 52/130 (40%), Gaps = 32/130 (24%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFI-----HNRSPEKWLYPISKEDE 177
           E   LR IRH N+I +        ++      L+ E +      +   EK       EDE
Sbjct: 58  EVNILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLT---EDE 109

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMTARVG 233
             +       L+       +   ++YLH   + + AH DLKP N++L      +   ++ 
Sbjct: 110 ATQ------FLK------QILDGVHYLHS--KRI-AHFDLKPENIMLLDKNVPNPRIKLI 154

Query: 234 DFGLARFLPP 243
           DFG+A  +  
Sbjct: 155 DFGIAHKIEA 164

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 29/130 (22%), Positives = 49/130 (37%), Gaps = 32/130 (24%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFI-----HNRSPEKWLYPISKEDE 177
           E   LR + H N+I +        Y+      L+ E +      +   +K       E+E
Sbjct: 65  EVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLS---EEE 116

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMTARVG 233
                     ++       +   +NYLH   + + AH DLKP N++L          ++ 
Sbjct: 117 ATS------FIK------QILDGVNYLHT--KKI-AHFDLKPENIMLLDKNIPIPHIKLI 161

Query: 234 DFGLARFLPP 243
           DFGLA  +  
Sbjct: 162 DFGLAHEIED 171

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 23/97 (23%), Positives = 36/97 (37%), Gaps = 28/97 (28%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR---FLPPTRTQT---- 248
           +  AL +LH         + D+K  N+LLD +    + DFGL++        R       
Sbjct: 168 IVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223

Query: 249 ------------KYGVGNEVSTIGDVYSYGILLLELM 273
                         G    V    D +S G+L+ EL+
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELL 256

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 29/130 (22%), Positives = 49/130 (37%), Gaps = 32/130 (24%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFI-----HNRSPEKWLYPISKEDE 177
           E   LR + H N+I +        Y+      L+ E +      +   +K       E+E
Sbjct: 65  EVSILRQVLHPNIITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLS---EEE 116

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMTARVG 233
                     ++       +   +NYLH   + + AH DLKP N++L          ++ 
Sbjct: 117 ATS------FIK------QILDGVNYLHT--KKI-AHFDLKPENIMLLDKNIPIPHIKLI 161

Query: 234 DFGLARFLPP 243
           DFGLA  +  
Sbjct: 162 DFGLAHEIED 171

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 27/130 (20%), Positives = 50/130 (38%), Gaps = 32/130 (24%)

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFI-----HNRSPEKWLYPISKEDE 177
           E   L+ I+H N+I +        Y+      L+ E +      +         +++++ 
Sbjct: 64  EVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDF--------LAEKES 110

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMTARVG 233
             E       L+       + + + YLH     + AH DLKP N++L          ++ 
Sbjct: 111 LTEE-EATEFLK------QILNGVYYLHS--LQI-AHFDLKPENIMLLDRNVPKPRIKII 160

Query: 234 DFGLARFLPP 243
           DFGLA  +  
Sbjct: 161 DFGLAHKIDF 170

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 1e-04
 Identities = 47/318 (14%), Positives = 100/318 (31%), Gaps = 82/318 (25%)

Query: 31  LEGMVPTGVYKNASATSVTGNSKL----CGGISKFKLPKCGSKKS--------------- 71
           ++G++ +G  K   A  V  + K+       I    L  C S ++               
Sbjct: 155 IDGVLGSG--KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPN 212

Query: 72  ------NGKRLPVALNLVISIVSGLVGLAL---ALSICFFFGFSHLRHQGAFKIFKSFIA 122
                 +   + + ++ + + +  L+        L +        L +    K + +F  
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV--------LLNVQNAKAWNAFNL 264

Query: 123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE---KWLYPISKEDETY 179
            CK L   R + +   L+A        +           +       K+L     +D   
Sbjct: 265 SCKILLTTRFKQVTDFLSAATTTHISLDHHSM---TLTPDEVKSLLLKYL-DCRPQDLPR 320

Query: 180 E----RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPS-NVLLDDDMTARVGD 234
           E     PR L+++    I   +A+  N+ H +C  +T    ++ S NVL   +       
Sbjct: 321 EVLTTNPRRLSIIAES-IRDGLATWDNWKHVNCDKLTT--IIESSLNVLEPAEYRKMFDR 377

Query: 235 FGLARFLP-----PTRTQTKY---GVGNEVSTI-------------GDVYSYGILLLELM 273
             +    P     PT   +      + ++V  +                 +  I  + L 
Sbjct: 378 LSV---FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE 434

Query: 274 IREKPSDIMFEGDMNLHK 291
           ++ K  +     +  LH+
Sbjct: 435 LKVKLEN-----EYALHR 447

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 2e-04
 Identities = 64/436 (14%), Positives = 119/436 (27%), Gaps = 144/436 (33%)

Query: 1   MDFSQNNLSGEILKFLTRLFLD-----------------NLNLSYNNLEGMVPTGVYKNA 43
           ++    N    +L+ L +L                     ++     L  ++ +  Y+N 
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246

Query: 44  -------SATSVTGNSKLCGGISKFKLPKCGSK-------KSNGKRLPVALNLVISIVSG 89
                         N+K     + F L  C  K       K     L  A    IS+   
Sbjct: 247 LLVLLNVQ------NAKA---WNAFNL-SC--KILLTTRFKQVTDFLSAATTTHISLDHH 294

Query: 90  LVGLALA-----LSICFFFGFSHLRHQGAFKIFK---SFIAECKALR-------NIRHRN 134
            + L        L          L  +          S IAE  ++R       N +H N
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPRE-VLTTNPRRLSIIAE--SIRDGLATWDNWKHVN 351

Query: 135 ---LIKVLTACLGV----DYQGNDFKALVYEFIHNRS---PEK-----WLYPISKEDETY 179
              L  ++ + L V    +Y+   F  L    +   S   P       W   I  +    
Sbjct: 352 CDKLTTIIESSLNVLEPAEYRKM-FDRLS---VFPPSAHIPTILLSLIWFDVIKSDVMVV 407

Query: 180 ERPRNLNLLRRLN-IAIDVASALNYLHHDCQPVTAHCDLKPS--NVLLD----------D 226
                +N L + + +      +   +      +    + + +    ++D          D
Sbjct: 408 -----VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462

Query: 227 DMTARVGD------FG--LA------------------RFLPPTRTQTK--------YGV 252
           D+     D       G  L                   RFL     + K           
Sbjct: 463 DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL-----EQKIRHDSTAWNAS 517

Query: 253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM--NLHKFAKMALPNHVKDIVDSILL 310
           G+ ++T+  +  Y       +    P        +   L K  +  + +   D++   L+
Sbjct: 518 GSILNTLQQLKFYK----PYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM 573

Query: 311 NDDEKLVVRGDQKQTQ 326
            +DE +      KQ Q
Sbjct: 574 AEDEAIFEEA-HKQVQ 588

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 25/100 (25%), Positives = 42/100 (42%), Gaps = 23/100 (23%)

Query: 193 IAI---DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTK 249
           IA    ++   L++LH        H D+K  NVLL ++   ++ DFG++  L  T  +  
Sbjct: 131 IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187

Query: 250 YGVGN------EVSTIG-----------DVYSYGILLLEL 272
             +G       EV               D++S GI  +E+
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 26/91 (28%), Positives = 40/91 (43%), Gaps = 15/91 (16%)

Query: 200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGN----- 254
            L YLH        H D+K  N+LL+ +  A++ DFG+A  L  T  +    +G      
Sbjct: 137 GLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193

Query: 255 -EVSTIG------DVYSYGILLLELMIREKP 278
            EV          D++S GI  +E+   + P
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 27/109 (24%), Positives = 46/109 (42%), Gaps = 27/109 (24%)

Query: 194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT--- 248
           A ++A  L +L         + DLK  NV+LD +   ++ DFG+ +        T+T   
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG 504

Query: 249 -----------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                          G  V    D +++G+LL E++  + P    FEG+
Sbjct: 505 TPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP----FEGE 545

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 28/96 (29%), Positives = 40/96 (41%), Gaps = 20/96 (20%)

Query: 200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGN----- 254
           ALN+LH        H DLK  NVL+  +   R+ DFG++     T  +    +G      
Sbjct: 129 ALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185

Query: 255 -EVSTIG-----------DVYSYGILLLELMIREKP 278
            EV               D++S GI L+E+   E P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 23/98 (23%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT------ 248
           ++ ALNYLH   +    + DLK  NVLLD +   ++ D+G+ +    P   T T      
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 175

Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKP 278
                       G  V    D ++ G+L+ E+M    P
Sbjct: 176 YIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 26/107 (24%), Positives = 40/107 (37%), Gaps = 29/107 (27%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT----- 248
           + SAL YLH  D      + D+K  N++LD D   ++ DFGL +         +T     
Sbjct: 114 IVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169

Query: 249 ---------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                        G  V    D +  G+++ E+M    P    F   
Sbjct: 170 EYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP----FYNQ 208

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* Length = 339

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 18/122 (14%), Positives = 47/122 (38%), Gaps = 4/122 (3%)

Query: 125 KALRNIRHRNLI-KVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPR 183
           K LR I H   +   +   L  +     ++ +V  F +    +     ++   +++    
Sbjct: 123 KVLRQI-HETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQN 181

Query: 184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP 243
           +  + R ++ +  ++  +       + V  H D+   NVL+ ++ +  + D+      P 
Sbjct: 182 SAAIHRLVDTSEKLSKKIQ--PDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK 239

Query: 244 TR 245
            R
Sbjct: 240 ER 241

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 23/98 (23%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT------ 248
           ++ ALNYLH   +    + DLK  NVLLD +   ++ D+G+ +    P   T T      
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 218

Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKP 278
                       G  V    D ++ G+L+ E+M    P
Sbjct: 219 YIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 16/71 (22%), Positives = 25/71 (35%), Gaps = 5/71 (7%)

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF 240
              ++  ++     I++  ALNYL         H DLKP N+LLDD    +         
Sbjct: 132 NGFHIEDIKL--YCIEILKALNYLR-KMSLT--HTDLKPENILLDDPYFEKSLITVRRVT 186

Query: 241 LPPTRTQTKYG 251
                   +  
Sbjct: 187 DGKKIQIYRTK 197

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 26/106 (24%), Positives = 44/106 (41%), Gaps = 27/106 (25%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT------ 248
           +A  L +L         + DLK  NV+LD +   ++ DFG+ +        T+T      
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 186

Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                       G  V    D +++G+LL E++  + P    FEG+
Sbjct: 187 YIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP----FEGE 224

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 29/107 (27%), Positives = 40/107 (37%), Gaps = 29/107 (27%)

Query: 197 VASALNYLH-HDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLAR--FLPPTRTQT----- 248
           +ASAL YLH  +      + DLKP N+LLD      + DFGL +      + T T     
Sbjct: 148 IASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTP 203

Query: 249 ---------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                    K      V    D +  G +L E++    P    F   
Sbjct: 204 EYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP----FYSR 242

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 15/44 (34%), Positives = 24/44 (54%), Gaps = 4/44 (9%)

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL 224
           +   L  +++  I   V   L+YLH  C+ +  H D+KP N+LL
Sbjct: 141 QGLPLPCVKK--IIQQVLQGLDYLHTKCRII--HTDIKPENILL 180

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 29/143 (20%), Positives = 47/143 (32%), Gaps = 37/143 (25%)

Query: 181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARF 240
           +P  L  +R   +A  +  AL +LH + Q    H DLKP N+L  +     + +   +  
Sbjct: 118 QPYPLPHVRH--MAYQLCHALRFLH-ENQLT--HTDLKPENILFVNSEFETLYNEHKSCE 172

Query: 241 LP-PTRTQTK---YG----VGNEVSTI-------------G-------DVYSYGILLLEL 272
                 T  +   +G         +TI                     DV+S G +L E 
Sbjct: 173 EKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232

Query: 273 MIREKPSDIMFEGDMNLHKFAKM 295
                    +F+   N      M
Sbjct: 233 YR----GFTLFQTHENREHLVMM 251

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 28/106 (26%), Positives = 42/106 (39%), Gaps = 27/106 (25%)

Query: 197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLA--RFLPPTRTQT------ 248
           + SAL +LH        + DLK  NVLLD +   ++ DFG+          T T      
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD 189

Query: 249 --------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
                   +   G  V    D ++ G+LL E++    P    FE +
Sbjct: 190 YIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP----FEAE 227

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 40.0 bits (94), Expect = 8e-04
 Identities = 15/44 (34%), Positives = 20/44 (45%), Gaps = 5/44 (11%)

Query: 199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR--VGDFGLARF 240
           S ++Y H        H DLK  N LLD     R  + DFG ++ 
Sbjct: 127 SGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	382
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.98
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.98
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.98
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.98
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.98
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.98
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.98
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.98
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.98
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.98
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.98
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.98
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.98
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.98
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.98
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.98
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.98
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.98
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.98
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.98
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.81
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.64
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.49
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.05
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.81
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.71
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.66
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.56
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.54
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	98.47
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	98.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.97
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.86
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.85
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	97.59
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	97.48
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.46
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	97.45
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	97.42
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	97.39
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.34
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	97.31
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	97.28
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	97.26
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	97.24
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	97.23
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	97.18
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	97.16
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	97.16
3e6j_A	229	Variable lymphocyte receptor diversity region; var	97.15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	97.12
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	97.1
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	97.09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	97.01
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	97.01
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	97.01
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	96.93
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	96.93
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	96.92
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	96.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	96.88
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	96.86
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	96.8
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	96.77
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	96.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	96.72
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	96.69
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	96.68
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.68
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	96.61
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	96.59
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	96.58
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	96.54
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	96.52
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	96.51
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	96.51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	96.5
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	96.49
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	96.48
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	96.47
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	96.46
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	96.46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	96.45
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	96.39
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	96.35
3e6j_A	229	Variable lymphocyte receptor diversity region; var	96.33
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	96.29
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	96.2
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	96.18
3m19_A	251	Variable lymphocyte receptor A diversity region; a	96.18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	96.13
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	96.13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	96.09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	96.08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	96.08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	96.06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	96.04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	96.03
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	96.03
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	95.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	95.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	95.86
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	95.86
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	95.86
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.85
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	95.83
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	95.8
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	95.8
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	95.79
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	95.77
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	95.77
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	95.75
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	95.75
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	95.66
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	95.63
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	95.61
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	95.61
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.6
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	95.49
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	95.47
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	95.47
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	95.41
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	95.39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	95.32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	95.31
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	95.29
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	95.25
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	95.2
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	95.18
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	95.18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	95.15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	95.12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	95.11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	95.06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	95.0
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	94.98
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	94.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	94.86
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	94.86
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	94.86
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	94.8
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	94.8
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	94.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	94.74
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	94.73
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	94.67
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	94.63
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	94.56
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	94.53
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	94.51
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	94.51
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	94.39
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	94.31
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	94.3
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	94.14
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	94.05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	94.05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	93.84
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	93.78
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	93.47
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	93.45
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	93.39
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	93.29
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	93.22
1o6v_A	466	Internalin A; bacterial infection, extracellular r	93.19
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.14
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	92.88
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	92.68
1o6v_A	466	Internalin A; bacterial infection, extracellular r	92.39
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	92.38
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	92.34
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	91.98
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	91.82
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	91.36
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	91.35
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	91.29
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.03
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	90.74
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	90.67
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	90.66
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	90.28
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	88.96
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	88.91
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.83
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	88.47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	88.38
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	88.35
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	87.9
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	85.82
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	84.58
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	84.07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	83.17
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	82.08
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	81.88
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	81.5
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	80.99

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=357.83  Aligned_cols=211  Identities=25%  Similarity=0.390  Sum_probs=164.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|+++|++++|||||+++|+|.      ++..++|||||++|+|.++|+.         ....++|..++.|+.||
T Consensus        77 ~~f~~E~~il~~l~HpNIV~l~g~~~------~~~~~iVmEy~~gGsL~~~l~~---------~~~~l~~~~~~~i~~qi  141 (307)
T 3omv_A           77 QAFRNEVAVLRKTRHVNILLFMGYMT------KDNLAIVTQWCEGSSLYKHLHV---------QETKFQMFQLIDIARQT  141 (307)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCEEEEECCSSCBHHHHHHT---------SCCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEE------CCeEEEEEEcCCCCCHHHHHhh---------cCCCCCHHHHHHHHHHH
Confidence            68999999999999999999999864      3457999999999999999952         34569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCcccc---CCCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGV---GNEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~---~~~~~~~~  260 (382)
                      |+||+|||   +++|+||||||+|||+++++.+||+|||+|+....              .+.+||...   ...++.++
T Consensus       142 a~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ks  218 (307)
T 3omv_A          142 AQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS  218 (307)
T ss_dssp             HHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHH
T ss_pred             HHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHH
Confidence            99999999   67999999999999999999999999999986432              234466653   34589999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||||++|||+||+.||..... ...+.........       .+.+..                   ...+++..+.
T Consensus       219 DVwS~Gvvl~Elltg~~Pf~~~~~-~~~~~~~~~~~~~-------~p~~~~-------------------~~~~~~~~l~  271 (307)
T 3omv_A          219 DVYSYGIVLYELMTGELPYSHINN-RDQIIFMVGRGYA-------SPDLSK-------------------LYKNCPKAMK  271 (307)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHTTCC-------CCCSTT-------------------SCTTSCHHHH
T ss_pred             HhHhHHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCCC-------CCCccc-------------------ccccchHHHH
Confidence            999999999999999999864211 1111111111100       000000                   0013445788


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      +++.+||+.||++||||.||++.|+.++..++.
T Consensus       272 ~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          272 RLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             HHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            899999999999999999999999999877643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=352.80  Aligned_cols=218  Identities=22%  Similarity=0.365  Sum_probs=166.9

Q ss_pred             chhhH--------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc-----cc
Q 040999          113 AFKIF--------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE-----TY  179 (382)
Q Consensus       113 avK~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~  179 (382)
                      |||.+        ++|.+|+++|++++|||||+++|+|..     .+..++|||||++|+|.++++.......     ..
T Consensus        75 AvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~  149 (329)
T 4aoj_A           75 AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED  149 (329)
T ss_dssp             EEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SSSEEEEEECCTTCBHHHHHHTSSCC---------
T ss_pred             EEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEEcCCCCcHHHHHHhcCccccccccccc
Confidence            77765        679999999999999999999999754     6779999999999999999965432211     01


Q ss_pred             cCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CC
Q 040999          180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TR  245 (382)
Q Consensus       180 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~  245 (382)
                      ....+++|.+++.|+.|||+||+|||   +++|+||||||+|||+++++.+||+|||+|+....              .+
T Consensus       150 ~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~y  226 (329)
T 4aoj_A          150 VAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW  226 (329)
T ss_dssp             --CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGG
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccc
Confidence            12457999999999999999999999   67999999999999999999999999999985422              23


Q ss_pred             CCCccccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccch
Q 040999          246 TQTKYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQ  324 (382)
Q Consensus       246 ~~~~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (382)
                      .+||...+..++.++|||||||++|||+| |+.||.....  ......+.....           ...+           
T Consensus       227 mAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i~~g~~-----------~~~p-----------  282 (329)
T 4aoj_A          227 MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAIDCITQGRE-----------LERP-----------  282 (329)
T ss_dssp             CCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHHHHHHTCC-----------CCCC-----------
T ss_pred             cChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCCC-----------CCCc-----------
Confidence            45788888899999999999999999999 8999864311  111111110000           0000           


Q ss_pred             hhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          325 TQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                              ..++.++.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus       283 --------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          283 --------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             --------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                    02345678899999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-47  Score=351.02  Aligned_cols=211  Identities=18%  Similarity=0.269  Sum_probs=165.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------cccCCcccCHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------TYERPRNLNLLRRL  191 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~  191 (382)
                      ++|.+|+++|++++|||||+++|+|..     .+..++|||||++|+|.++|........      .......++|..++
T Consensus        74 ~~f~~E~~il~~l~HpNIV~l~g~~~~-----~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~  148 (308)
T 4gt4_A           74 EEFRHEAMLRARLQHPNVVCLLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV  148 (308)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCcceEEEE-----CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHH
Confidence            689999999999999999999999764     6678999999999999999964332110      01123569999999


Q ss_pred             HHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCC
Q 040999          192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVS  257 (382)
Q Consensus       192 ~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~  257 (382)
                      .|+.|||+||+|||   +.+|+||||||+|||+++++.+||+|||+|+....              .+.+||...+..++
T Consensus       149 ~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s  225 (308)
T 4gt4_A          149 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS  225 (308)
T ss_dssp             HHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC
Confidence            99999999999999   67999999999999999999999999999985421              23457777788999


Q ss_pred             ccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          258 TIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       258 ~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      .++|||||||++|||+| |+.||....     ..+.......        ......+                   .+++
T Consensus       226 ~ksDVwSfGvvl~El~t~g~~Pf~~~~-----~~~~~~~i~~--------~~~~~~p-------------------~~~~  273 (308)
T 4gt4_A          226 IDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVVEMIRN--------RQVLPCP-------------------DDCP  273 (308)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCTTTTCC-----HHHHHHHHHT--------TCCCCCC-------------------TTCC
T ss_pred             ccchhhhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHc--------CCCCCCc-------------------ccch
Confidence            99999999999999999 899986431     1111111100        0000000                   1345


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      ..+.+++.+||+.||++||||.||++.|+++.
T Consensus       274 ~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          274 AWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            57889999999999999999999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-47  Score=350.41  Aligned_cols=214  Identities=21%  Similarity=0.380  Sum_probs=168.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC---ccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED---ETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~~l~~~~~~~i~  194 (382)
                      ++|.+|+++|++++|||||+++|+|..     ++..++|||||++|+|.++|+......   ........++|.+++.++
T Consensus        60 ~~f~~E~~il~~l~HpnIV~l~g~~~~-----~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~  134 (299)
T 4asz_A           60 KDFHREAELLTNLQHEHIVKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA  134 (299)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECS-----SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEee-----CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Confidence            679999999999999999999999754     678999999999999999996432100   001234579999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccc
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~  260 (382)
                      .||++||+|||   +++|+||||||+|||++.++.+||+|||+|+....              .+.+||...+..++.++
T Consensus       135 ~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~  211 (299)
T 4asz_A          135 QQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES  211 (299)
T ss_dssp             HHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchh
Confidence            99999999999   67999999999999999999999999999975422              24557887888999999


Q ss_pred             hhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          261 DVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       261 Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      |||||||++|||+| |+.||.....  ..+...+..           ......+                   ..++.++
T Consensus       212 DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i~~-----------~~~~~~p-------------------~~~~~~~  259 (299)
T 4asz_A          212 DVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECITQ-----------GRVLQRP-------------------RTCPQEV  259 (299)
T ss_dssp             HHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHH-----------TCCCCCC-------------------TTCCHHH
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHc-----------CCCCCCC-------------------ccchHHH
Confidence            99999999999999 8999864311  111111110           0000000                   0344578


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      .+++.+||+.||++||||+||.+.|+++.+..
T Consensus       260 ~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          260 YELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            88999999999999999999999999987763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.7e-45  Score=338.41  Aligned_cols=213  Identities=21%  Similarity=0.249  Sum_probs=168.5

Q ss_pred             chhhH---HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHH
Q 040999          113 AFKIF---KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLR  189 (382)
Q Consensus       113 avK~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~  189 (382)
                      |+|++   ....+|+++|++++|||||++++++..     .+..|+|||||++|+|.+++.          ....+++..
T Consensus        87 AiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~ivmEy~~gg~L~~~l~----------~~~~l~e~~  151 (336)
T 4g3f_A           87 AVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE-----GPWVNIFMELLEGGSLGQLIK----------QMGCLPEDR  151 (336)
T ss_dssp             EEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHH----------HHSSCCHHH
T ss_pred             EEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEeccCCCcHHHHHH----------HcCCCCHHH
Confidence            88887   234689999999999999999999654     778999999999999999993          345699999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC-cEEEccccccccCCC-----------------CCCCCccc
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPP-----------------TRTQTKYG  251 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~-----------------~~~~~~~~  251 (382)
                      +..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+|+.+..                 .+.+||..
T Consensus       152 ~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~  228 (336)
T 4g3f_A          152 ALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV  228 (336)
T ss_dssp             HHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHH
Confidence            9999999999999999   78999999999999999987 699999999986532                 22347777


Q ss_pred             cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          252 VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       252 ~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      .+..++.++|||||||++|||+||+.||........ +....... + ...+                           .
T Consensus       229 ~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~-~-~~~~---------------------------~  278 (336)
T 4g3f_A          229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP-P-PIRE---------------------------I  278 (336)
T ss_dssp             TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC-C-GGGG---------------------------S
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC-C-Cchh---------------------------c
Confidence            888899999999999999999999999975332221 11111100 0 0000                           0


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      ...+...+.+++.+||+.||++|||+.|+++.|.........
T Consensus       279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            002334677888899999999999999999999888776544

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.4e-45  Score=329.84  Aligned_cols=202  Identities=19%  Similarity=0.326  Sum_probs=154.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|+++|++++|||||++++++... ..++...++|||||++|+|.+++.          ....+++..+..|+.||
T Consensus        70 ~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lvmEy~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi  138 (290)
T 3fpq_A           70 QRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQI  138 (290)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEEEeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            6799999999999999999999997542 123466899999999999999994          34568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      +.||+|||+. .++|+||||||+|||++. ++.+||+|||+|+....          ...+||... ..++.++||||||
T Consensus       139 ~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlG  216 (290)
T 3fpq_A          139 LKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFG  216 (290)
T ss_dssp             HHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHH
T ss_pred             HHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcC-CCCCcHHHHHHHH
Confidence            9999999933 223999999999999984 78999999999986432          344588665 4689999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||+||+.||...    ...................+                          .....++.+++.+|
T Consensus       217 vilyelltg~~Pf~~~----~~~~~~~~~i~~~~~~~~~~--------------------------~~~~~~~~~li~~~  266 (290)
T 3fpq_A          217 MCMLEMATSEYPYSEC----QNAAQIYRRVTSGVKPASFD--------------------------KVAIPEVKEIIEGC  266 (290)
T ss_dssp             HHHHHHHHSSCTTTTC----SSHHHHHHHHTTTCCCGGGG--------------------------GCCCHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCCC----CcHHHHHHHHHcCCCCCCCC--------------------------ccCCHHHHHHHHHH
Confidence            9999999999998632    12222221111100000000                          01123567888899


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      |+.||++|||+.|+++
T Consensus       267 L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          267 IRQNKDERYSIKDLLN  282 (290)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999975

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-44  Score=331.67  Aligned_cols=231  Identities=21%  Similarity=0.252  Sum_probs=163.0

Q ss_pred             chhhH-----HHHH--HHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-----KSFI--AECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-----~~~~--~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |||++     +++.  +|+..+.+++|||||+++++|.... ......+||||||++|+|.++++.           ..+
T Consensus        30 AvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~-----------~~l   97 (303)
T 3hmm_A           30 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-----------YTV   97 (303)
T ss_dssp             EEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-----------CCB
T ss_pred             EEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEecCCCCCcHHHHHHh-----------CCC
Confidence            78776     3444  4555667889999999999987521 122467999999999999999942           358


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhc-----CCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------------C
Q 040999          186 NLLRRLNIAIDVASALNYLHHD-----CQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------------T  244 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~-----~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------------~  244 (382)
                      +|..+.+++.|+++||+|||+.     ..++|+||||||+|||++.++.+||+|||+|+....                .
T Consensus        98 ~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~  177 (303)
T 3hmm_A           98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR  177 (303)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccccccc
Confidence            9999999999999999999953     134999999999999999999999999999975432                1


Q ss_pred             CCCCccccCC------CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhh----hhcccccchh
Q 040999          245 RTQTKYGVGN------EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDI----VDSILLNDDE  314 (382)
Q Consensus       245 ~~~~~~~~~~------~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  314 (382)
                      +.+||...+.      .++.++|||||||++|||+||+.||.........+......  .....++    .+..+.+..+
T Consensus       178 ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~rp~~p  255 (303)
T 3hmm_A          178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS--DPSVEEMRKVVCEQKLRPNIP  255 (303)
T ss_dssp             GCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS--SCCHHHHHHHHTTSCCCCCCC
T ss_pred             ccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc--cchHHHHHHHHhcccCCCCCC
Confidence            2336655433      46789999999999999999998875432211111000000  0001111    1111111000


Q ss_pred             hhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          315 KLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .             .....+++..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus       256 ~-------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          256 N-------------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             G-------------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             c-------------cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0             001124566788999999999999999999999999998753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.8e-45  Score=340.40  Aligned_cols=215  Identities=21%  Similarity=0.269  Sum_probs=166.3

Q ss_pred             HHHHHHHHHHhhccc-ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------cccCCcccCHHHH
Q 040999          118 KSFIAECKALRNIRH-RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------TYERPRNLNLLRR  190 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~  190 (382)
                      ++|.+|+++|.+++| ||||+++|+|..    .....++|||||++|+|.++|+.......      .......+++..+
T Consensus       112 ~~~~~E~~il~~l~hhpnIV~l~g~~~~----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~  187 (353)
T 4ase_A          112 RALMSELKILIHIGHHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL  187 (353)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECC----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHH
T ss_pred             HHHHHHHHHHHHcCCCCcEEEEEEEEEe----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHH
Confidence            679999999999965 899999999853    34568999999999999999964321100      0012346899999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEV  256 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~  256 (382)
                      +.++.|||+||+|||   +++||||||||+|||+++++.+||+|||+|+.+...              +.+||...+..+
T Consensus       188 ~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y  264 (353)
T 4ase_A          188 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY  264 (353)
T ss_dssp             HHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHhHh---hCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence            999999999999999   779999999999999999999999999999865332              344777778899


Q ss_pred             CccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          257 STIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      +.++|||||||++|||+| |+.||..... ...+...+......           ..+                   ..+
T Consensus       265 ~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~-~~~~~~~i~~g~~~-----------~~p-------------------~~~  313 (353)
T 4ase_A          265 TIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEGTRM-----------RAP-------------------DYT  313 (353)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHHTCCC-----------CCC-------------------TTC
T ss_pred             CCcccEeehHHHHHHHHhCCCCCCCCCCH-HHHHHHHHHcCCCC-----------CCC-------------------ccC
Confidence            999999999999999998 8999874321 11111111111100           000                   023


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus       314 ~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          314 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            34678889999999999999999999999998664

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-44  Score=335.32  Aligned_cols=197  Identities=18%  Similarity=0.265  Sum_probs=158.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++..     ++..|+|||||++|+|.+++..        .....+++..+..|+.||
T Consensus        68 ~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~~yiVmEy~~gg~L~~~i~~--------~~~~~~~e~~~~~~~~qi  134 (350)
T 4b9d_A           68 EESRREVAVLANMKHPNIVQYRESFEE-----NGSLYIVMDYCEGGDLFKRINA--------QKGVLFQEDQILDWFVQI  134 (350)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHH--------TTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEeCCCCCcHHHHHHH--------cCCCCCCHHHHHHHHHHH
Confidence            679999999999999999999999653     7889999999999999999942        223457899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.            +.+.+||...+..|+.++|||||
T Consensus       135 ~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSl  211 (350)
T 4b9d_A          135 CLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWAL  211 (350)
T ss_dssp             HHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             HHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHH
Confidence            99999999   7799999999999999999999999999998653            34566888888899999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||...    . ........        +.......+                   .....++.+|+.+
T Consensus       212 GvilyemltG~~PF~~~----~-~~~~~~~i--------~~~~~~~~~-------------------~~~s~~~~~li~~  259 (350)
T 4b9d_A          212 GCVLYELCTLKHAFEAG----S-MKNLVLKI--------ISGSFPPVS-------------------LHYSYDLRSLVSQ  259 (350)
T ss_dssp             HHHHHHHHHSSCSCCCS----S-HHHHHHHH--------HHTCCCCCC-------------------TTSCHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCc----C-HHHHHHHH--------HcCCCCCCC-------------------ccCCHHHHHHHHH
Confidence            99999999999998642    1 11111111        000000000                   0123457788889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.||++|||+.|+++
T Consensus       260 ~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          260 LFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HTCSSGGGSCCHHHHHT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.7e-44  Score=331.08  Aligned_cols=201  Identities=20%  Similarity=0.265  Sum_probs=159.8

Q ss_pred             chhhH--------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc
Q 040999          113 AFKIF--------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN  184 (382)
Q Consensus       113 avK~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~  184 (382)
                      |+|++        +.+.+|+++|++++|||||++++++..     ++..|+|||||++|+|.+++.           ...
T Consensus       103 AiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~ivmEy~~gg~L~~~l~-----------~~~  166 (346)
T 4fih_A          103 AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVMEFLEGGALTDIVT-----------HTR  166 (346)
T ss_dssp             EEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEECCCTTEEHHHHHH-----------HSC
T ss_pred             EEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEeCCCCCcHHHHHH-----------cCC
Confidence            88876        568999999999999999999999654     788999999999999999883           235


Q ss_pred             cCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc
Q 040999          185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV  252 (382)
Q Consensus       185 l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~  252 (382)
                      +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...            +.+||...
T Consensus       167 l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~  243 (346)
T 4fih_A          167 MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS  243 (346)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHC
Confidence            899999999999999999999   779999999999999999999999999999876432            23477777


Q ss_pred             CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      +..|+.++||||+||++|||+||+.||....  .......+....+....         ..                   
T Consensus       244 ~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~~---------~~-------------------  293 (346)
T 4fih_A          244 RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLK---------NL-------------------  293 (346)
T ss_dssp             TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCCCS---------CG-------------------
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCCC---------cc-------------------
Confidence            7889999999999999999999999986321  11111111111110000         00                   


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .....++.+++.+||+.||++|||+.|+++
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            022345678888999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.5e-44  Score=325.41  Aligned_cols=193  Identities=17%  Similarity=0.215  Sum_probs=154.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++     ++++..|+|||||++|+|.+++.          ..+.+++..+..++.||
T Consensus        77 ~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~yivmEy~~gG~L~~~i~----------~~~~l~e~~~~~~~~qi  141 (311)
T 4aw0_A           77 PYVTRERDVMSRLDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIR----------KIGSFDETCTRFYTAEI  141 (311)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEEEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            5689999999999999999999995     45788999999999999999993          34569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...              ..+||...+..++.++|||
T Consensus       142 ~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiW  218 (311)
T 4aw0_A          142 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW  218 (311)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHH
T ss_pred             HHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHH
Confidence            99999999   779999999999999999999999999999876422              1236666677899999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |+||++|||+||+.||...    . ........        ...... -+ .                  ....++.+++
T Consensus       219 SlGvilyeml~G~~PF~~~----~-~~~~~~~i--------~~~~~~-~p-~------------------~~s~~~~dli  265 (311)
T 4aw0_A          219 ALGCIIYQLVAGLPPFRAG----N-EGLIFAKI--------IKLEYD-FP-E------------------KFFPKARDLV  265 (311)
T ss_dssp             HHHHHHHHHHHSSCSSCCS----S-HHHHHHHH--------HHTCCC-CC-T------------------TCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCC----C-HHHHHHHH--------HcCCCC-CC-c------------------ccCHHHHHHH
Confidence            9999999999999998632    1 11111110        000000 00 0                  1123567788


Q ss_pred             hccCCCCccCCCCHHHHH
Q 040999          344 VACSMESPQDRMKMTNVV  361 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl  361 (382)
                      .+||+.||++|||++|++
T Consensus       266 ~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGT
T ss_pred             HHHccCCHhHCcChHHHc
Confidence            899999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.2e-43  Score=331.88  Aligned_cols=201  Identities=19%  Similarity=0.253  Sum_probs=160.2

Q ss_pred             chhhH--------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc
Q 040999          113 AFKIF--------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN  184 (382)
Q Consensus       113 avK~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~  184 (382)
                      |+|++        +.+.+|+++|++++|||||++++++..     .+..|+|||||++|+|.+++.           ...
T Consensus       180 AiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~iVmEy~~gG~L~~~i~-----------~~~  243 (423)
T 4fie_A          180 AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVMEFLEGGALTDIVT-----------HTR  243 (423)
T ss_dssp             EEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHH-----------HSC
T ss_pred             EEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEEEEeCCCCCcHHHHHh-----------ccC
Confidence            88876        568999999999999999999999654     778999999999999999883           235


Q ss_pred             cCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCcccc
Q 040999          185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGV  252 (382)
Q Consensus       185 l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~  252 (382)
                      +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+..            .+.+||...
T Consensus       244 l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~  320 (423)
T 4fie_A          244 MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS  320 (423)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHC
Confidence            899999999999999999999   77999999999999999999999999999986533            234477777


Q ss_pred             CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      +..|+.++|||||||++|||++|+.||....  .......+....+...        . ..                   
T Consensus       321 ~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~--------~-~~-------------------  370 (423)
T 4fie_A          321 RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRL--------K-NL-------------------  370 (423)
T ss_dssp             TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCC--------S-CT-------------------
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCC--------c-cc-------------------
Confidence            8889999999999999999999999986321  1111111111111000        0 00                   


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .....++.+|+.+||+.||++|||+.|+++
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            012235678888999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.8e-42  Score=311.52  Aligned_cols=193  Identities=21%  Similarity=0.311  Sum_probs=150.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++.     +++..++||||| +|+|.+++.          ....+++..+..++.||
T Consensus        58 ~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~ivmEy~-~g~L~~~l~----------~~~~l~e~~~~~~~~qi  121 (275)
T 3hyh_A           58 GRIEREISYLRLLRHPHIIKLYDVIK-----SKDEIIMVIEYA-GNELFDYIV----------QRDKMSEQEARRFFQQI  121 (275)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEEECC-CEEHHHHHH----------HSCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEEEEEEeCC-CCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            56899999999999999999999954     478899999999 689999883          34569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCC-CccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEV-STIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~-~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....           ...+||...+..+ +.++||||+
T Consensus       122 ~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSl  198 (275)
T 3hyh_A          122 ISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC  198 (275)
T ss_dssp             HHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHH
T ss_pred             HHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHH
Confidence            99999999   77999999999999999999999999999986532           2344777766665 689999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||...     .........        ...... .+ .                  ....++.+++.+
T Consensus       199 Gvily~lltg~~PF~~~-----~~~~~~~~i--------~~~~~~-~p-~------------------~~s~~~~~li~~  245 (275)
T 3hyh_A          199 GVILYVMLCRRLPFDDE-----SIPVLFKNI--------SNGVYT-LP-K------------------FLSPGAAGLIKR  245 (275)
T ss_dssp             HHHHHHHHHSSCSSCCS-----SHHHHHHHH--------HHTCCC-CC-T------------------TSCHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCC-----CHHHHHHHH--------HcCCCC-CC-C------------------CCCHHHHHHHHH
Confidence            99999999999998632     111111110        000000 00 0                  112356778889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.||++|||++|+++
T Consensus       246 ~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          246 MLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HSCSSGGGSCCHHHHHH
T ss_pred             HccCChhHCcCHHHHHc
Confidence            99999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-43  Score=321.46  Aligned_cols=194  Identities=18%  Similarity=0.159  Sum_probs=147.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .++.+|+++|++++|||||++++++..     ++..|+|||||++|+|.+++.          ....+++..+..++.||
T Consensus        71 ~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~~~~qi  135 (304)
T 3ubd_A           71 VRTKMERDILVEVNHPFIVKLHYAFQT-----EGKLYLILDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAEL  135 (304)
T ss_dssp             C------CCCCCCCCTTEECEEEEEEE-----TTEEEEEECCCTTCEEHHHHH----------HHCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEEEEEEEcCCCCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            468899999999999999999999643     788999999999999999993          34569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....            ...+||...+..++.++||||+
T Consensus       136 ~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl  212 (304)
T 3ubd_A          136 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF  212 (304)
T ss_dssp             HHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred             HHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccch
Confidence            99999999   77999999999999999999999999999986422            1234777777889999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||...    . ..+.....        ...... .+ .                  ....++.+++.+
T Consensus       213 GvilyemltG~~PF~~~----~-~~~~~~~i--------~~~~~~-~p-~------------------~~s~~~~~li~~  259 (304)
T 3ubd_A          213 GVLMFEMLTGTLPFQGK----D-RKETMTMI--------LKAKLG-MP-Q------------------FLSPEAQSLLRM  259 (304)
T ss_dssp             HHHHHHHHHSSCSSCCS----S-HHHHHHHH--------HHCCCC-CC-T------------------TSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCc----C-HHHHHHHH--------HcCCCC-CC-C------------------cCCHHHHHHHHH
Confidence            99999999999998642    1 11111110        000000 00 0                  122356788889


Q ss_pred             cCCCCccCCCCH-----HHHHH
Q 040999          346 CSMESPQDRMKM-----TNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~-----~evl~  362 (382)
                      ||+.||++|||+     +|+++
T Consensus       260 ~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          260 LFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HcccCHHHCCCCCcCCHHHHHc
Confidence            999999999984     56664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.4e-41  Score=309.20  Aligned_cols=201  Identities=21%  Similarity=0.318  Sum_probs=147.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc-------CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY-------QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRR  190 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~  190 (382)
                      +++.+|+++|++++|||||++++++...+.       ....+.|+|||||++|+|.+++....       .....++..+
T Consensus        48 ~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-------~~~~~~~~~~  120 (299)
T 4g31_A           48 EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-------TIEERERSVC  120 (299)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC-------SGGGSCHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC-------CCChhHHHHH
Confidence            678999999999999999999999764221       12345799999999999999995322       1233566778


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------------------CCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------------------TRT  246 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------------------~~~  246 (382)
                      +.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+..                        ...
T Consensus       121 ~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Ym  197 (299)
T 4g31_A          121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYM  197 (299)
T ss_dssp             HHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTS
T ss_pred             HHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCcccc
Confidence            899999999999999   77999999999999999999999999999986532                        244


Q ss_pred             CCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhh
Q 040999          247 QTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQ  326 (382)
Q Consensus       247 ~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (382)
                      +||...+..++.++|||||||++|||++   ||...    .........        +.....   +             
T Consensus       198 APE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----~~~~~~~~~--------~~~~~~---p-------------  246 (299)
T 4g31_A          198 SPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----MERVRTLTD--------VRNLKF---P-------------  246 (299)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHHHHHHH--------HHTTCC---C-------------
T ss_pred             CHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc----cHHHHHHHH--------HhcCCC---C-------------
Confidence            5777778889999999999999999996   76421    111111000        000000   0             


Q ss_pred             hhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          327 AKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                         ....+......+++.+||+.||++|||+.|+++
T Consensus       247 ---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          247 ---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               001122334567888999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-40  Score=312.40  Aligned_cols=229  Identities=17%  Similarity=0.192  Sum_probs=155.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeec-ccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGV-DYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++|++++|||||++++++... .+.+.+..|+|||||. |+|.+++.          ....+++..+..++.|
T Consensus        98 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~----------~~~~l~~~~~~~~~~q  166 (398)
T 4b99_A           98 KRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIH----------SSQPLTLEHVRYFLYQ  166 (398)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHT----------SSSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            5688999999999999999999987542 2345678999999995 67999883          3457999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------------CCCCCccccCC-CCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------------TRTQTKYGVGN-EVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------------~~~~~~~~~~~-~~~~~  259 (382)
                      |+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+..                ...+||...+. .++.+
T Consensus       167 il~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~  243 (398)
T 4b99_A          167 LLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQA  243 (398)
T ss_dssp             HHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTH
T ss_pred             HHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCCh
Confidence            999999999   77999999999999999999999999999986522                12346665554 56899


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +||||+||++|||+||+.||..... ...+............. .....................+............++
T Consensus       244 ~DiWSlG~il~ell~G~~pF~g~~~-~~~l~~I~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  321 (398)
T 4b99_A          244 IDLWSVGCIFGEMLARRQLFPGKNY-VHQLQLIMMVLGTPSPA-VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQA  321 (398)
T ss_dssp             HHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCGG-GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHH
T ss_pred             hheehhHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCChH-HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHH
Confidence            9999999999999999999864211 01111122211111100 000000000000000000000000000001123456


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+|+.+||+.||++|||+.|+++
T Consensus       322 ~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          322 LSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHCcCChhHCcCHHHHhc
Confidence            78888999999999999999886

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.8e-39  Score=302.30  Aligned_cols=148  Identities=24%  Similarity=0.248  Sum_probs=126.6

Q ss_pred             chhhH------HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF------KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+      .++.+|+++|+.+ +|||||++++++.     +.++.++|||||++|+|.+++.             .+
T Consensus        53 AiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~~~~~lvmE~~~g~~L~~~~~-------------~l  114 (361)
T 4f9c_A           53 ALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KNDHVVIAMPYLEHESFLDILN-------------SL  114 (361)
T ss_dssp             EEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ETTEEEEEEECCCCCCHHHHHT-------------TC
T ss_pred             EEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----ECCEEEEEEeCCCcccHHHHHc-------------CC
Confidence            66654      5688999999998 6999999999854     4788999999999999999882             38


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCCC---------------------
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLPP---------------------  243 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~~---------------------  243 (382)
                      ++.++..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+....                     
T Consensus       115 ~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (361)
T 4f9c_A          115 SFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQN  191 (361)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC------------
T ss_pred             CHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccc
Confidence            88999999999999999999   7799999999999999877 7999999999975432                     


Q ss_pred             -------------------CCCCCccccCC-CCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          244 -------------------TRTQTKYGVGN-EVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       244 -------------------~~~~~~~~~~~-~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                                         ...+||...+. .++.++||||+||++|||+||+.||..
T Consensus       192 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          192 KCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             --------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             cccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence                               12336655554 589999999999999999999999853

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.9e-37  Score=285.21  Aligned_cols=222  Identities=25%  Similarity=0.412  Sum_probs=171.4

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++....      .....+++..++.++.|
T Consensus        79 ~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~  147 (321)
T 2qkw_B           79 IEEFETEIETLSFCRHPHLVSLIGFCD-----ERNEMILIYKYMENGNLKRHLYGSD------LPTMSMSWEQRLEICIG  147 (321)
T ss_dssp             HHHHHHHHHGGGSCCCTTBCCEEEECC-----CTTCCEEEEECCTTCBTGGGSSSSC------CCSCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEEEEEEcCCCCcHHHHHhccC------CCccccCHHHHHHHHHH
Confidence            367999999999999999999999964     3678899999999999999995432      22346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      +++||+|||   +.+|+||||||+||+++.++.+||+|||+++....              ....||...+..++.++||
T Consensus       148 i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  224 (321)
T 2qkw_B          148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDV  224 (321)
T ss_dssp             HHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHH
T ss_pred             HHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccch
Confidence            999999999   67999999999999999999999999999975432              1234666666788999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCC-chHHHHHHHhc-CCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGD-MNLHKFAKMAL-PNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||++|||+||+.||....... .....|..... .......+++......                  ..++...+.
T Consensus       225 ~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~l~  286 (321)
T 2qkw_B          225 YSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI------------------RPESLRKFG  286 (321)
T ss_dssp             HHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS------------------CHHHHHHHH
T ss_pred             HhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc------------------CHHHHHHHH
Confidence            999999999999999987543222 22223322111 1122222222221111                  125667889


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +++.+||+.||++|||+.||++.|+.+.+.
T Consensus       287 ~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          287 DTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            999999999999999999999999988653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.4e-38  Score=289.91  Aligned_cols=220  Identities=31%  Similarity=0.514  Sum_probs=170.7

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|++++++++||||++++++|..     ....++||||+++|+|.+++....      .....+++..+..++.|++
T Consensus        73 ~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~  141 (326)
T 3uim_A           73 QFQTEVEMISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERP------ESQPPLDWPKRQRIALGSA  141 (326)
T ss_dssp             HHHHHHHGGGTCCCTTBCCCCEEECC-----SSCCEEEEECCTTCBHHHHHHCCS------TTCCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCccceEEEEec-----CCceEEEEEeccCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHH
Confidence            68999999999999999999999653     667899999999999999996432      2344699999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      .||+|||+.+.++|+||||||+|||++.++.+||+|||+++.....             ..+||...+..++.++|||||
T Consensus       142 ~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  221 (326)
T 3uim_A          142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY  221 (326)
T ss_dssp             HHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHH
T ss_pred             HHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhH
Confidence            9999999544449999999999999999999999999999865322             223555556678999999999


Q ss_pred             HHHHHHHHhcCCCCCcc---ccCCchHHHHHHHhcCC-chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          266 GILLLELMIREKPSDIM---FEGDMNLHKFAKMALPN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       266 Gvil~elltg~~p~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||++|||+||+.||+..   .........+....... ....+.+.......                  ..+....+.+
T Consensus       222 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~l~~  283 (326)
T 3uim_A          222 GVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNY------------------KDEEVEQLIQ  283 (326)
T ss_dssp             HHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSC------------------CHHHHHHHHH
T ss_pred             HHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcccc------------------CHHHHHHHHH
Confidence            99999999999998632   12233344444333322 22222222221111                  1256678999


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      ++.+||+.||++|||+.||++.|+..
T Consensus       284 li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          284 VALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            99999999999999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9e-38  Score=309.91  Aligned_cols=204  Identities=19%  Similarity=0.249  Sum_probs=159.7

Q ss_pred             chhhH--------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc
Q 040999          113 AFKIF--------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN  184 (382)
Q Consensus       113 avK~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~  184 (382)
                      |+|.+        +.+.+|+++|+.++|||||++++++     ++....++|||||++|+|.+++.         .....
T Consensus       186 AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~iv~E~~~gg~L~~~i~---------~~~~~  251 (573)
T 3uto_A          186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVA---------DEHNK  251 (573)
T ss_dssp             EEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEEEEEECCCCCBHHHHHT---------CTTSC
T ss_pred             EEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEeecCCCcHHHHHH---------HhCCC
Confidence            77765        5788999999999999999999995     45789999999999999999884         23456


Q ss_pred             cCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC--CcEEEccccccccCCCC-----------CCCCccc
Q 040999          185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD--MTARVGDFGLARFLPPT-----------RTQTKYG  251 (382)
Q Consensus       185 l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~--~~~kl~Dfg~a~~~~~~-----------~~~~~~~  251 (382)
                      +++..+..++.||+.||.|||   +.+|+||||||+|||++.+  +.+||+|||+|+.+...           ..+||..
T Consensus       252 l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~  328 (573)
T 3uto_A          252 MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA  328 (573)
T ss_dssp             EEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHh
Confidence            999999999999999999999   7799999999999999854  89999999999876543           2347777


Q ss_pred             cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          252 VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       252 ~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      .+..++.++||||+||++|||++|+.||...    .....+ .....        ....... .               .
T Consensus       329 ~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~----~~~~~~-~~i~~--------~~~~~~~-~---------------~  379 (573)
T 3uto_A          329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----NDDETL-RNVKS--------CDWNMDD-S---------------A  379 (573)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHH-HHHHT--------TCCCCCS-G---------------G
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHH-HHHHh--------CCCCCCc-c---------------c
Confidence            7888999999999999999999999998632    111111 11000        0000000 0               0


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ......++.+|+.+||+.||++|||+.|+++
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0012235677888999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.8e-37  Score=283.84  Aligned_cols=209  Identities=25%  Similarity=0.406  Sum_probs=166.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|++++++++||||+++++++..     ....++||||+++|+|.+++..         ....+++..+..++.|+
T Consensus        52 ~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi  117 (310)
T 3s95_A           52 RTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLNFITEYIKGGTLRGIIKS---------MDSQYPWSQRVSFAKDI  117 (310)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHH---------CCTTSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeEEEEEecCCCcHHHHHHh---------ccCCCCHHHHHHHHHHH
Confidence            679999999999999999999999764     6789999999999999999942         24568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------------------CCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------------------RTQTKYG  251 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------------------~~~~~~~  251 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....                          ...||..
T Consensus       118 ~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  194 (310)
T 3s95_A          118 ASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI  194 (310)
T ss_dssp             HHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHH
T ss_pred             HHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHh
Confidence            99999999   679999999999999999999999999999765321                          3346766


Q ss_pred             cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          252 VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       252 ~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      .+..++.++||||||+++|||++|..|+..........        ........+.....                    
T Consensus       195 ~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~--------------------  246 (310)
T 3s95_A          195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--------GLNVRGFLDRYCPP--------------------  246 (310)
T ss_dssp             TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--------SBCHHHHHHHTCCT--------------------
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--------hhhhhccccccCCC--------------------
Confidence            77788999999999999999999999976432211110        00111111111100                    


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                        .++..+.+++.+||+.||++|||+.++++.|++++..+..
T Consensus       247 --~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          247 --NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             --TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence              2233577888899999999999999999999999887654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2e-37  Score=287.39  Aligned_cols=232  Identities=21%  Similarity=0.240  Sum_probs=164.9

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|++       ..+.+|+.++++++|||||++++++.... ......++||||+++|+|.+++..           ..+
T Consensus        51 avK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~  118 (322)
T 3soc_A           51 AVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLWLITAFHEKGSLSDFLKA-----------NVV  118 (322)
T ss_dssp             EEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-----------CCB
T ss_pred             EEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEEEEEecCCCCCHHHHHHh-----------cCC
Confidence            66665       45667899999999999999999976521 113457999999999999999942           348


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCC----------ceeecCCCCCceeeCCCCcEEEccccccccCCCCC----------
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQP----------VTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR----------  245 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~----------~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~----------  245 (382)
                      ++..+..++.|++.||+|||   +.          +|+||||||+|||++.++.+||+|||+++......          
T Consensus       119 ~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~g  195 (322)
T 3soc_A          119 SWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG  195 (322)
T ss_dssp             CHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCC
T ss_pred             CHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCcc
Confidence            99999999999999999999   66          99999999999999999999999999997543221          


Q ss_pred             ----CCCccccC-----CCCCccchhHHHHHHHHHHHhcCCCCCccccCCch-HHHHHHHhcCCchhhhhhcccccchhh
Q 040999          246 ----TQTKYGVG-----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMN-LHKFAKMALPNHVKDIVDSILLNDDEK  315 (382)
Q Consensus       246 ----~~~~~~~~-----~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (382)
                          .+||...+     ..++.++|||||||++|||+||+.||......... .....  .......++.+.......  
T Consensus       196 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~--  271 (322)
T 3soc_A          196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI--GQHPSLEDMQEVVVHKKK--  271 (322)
T ss_dssp             CGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH--CSSCCHHHHHHHHTTSCC--
T ss_pred             CccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh--ccCCchhhhhhhhhcccC--
Confidence                22454443     34567889999999999999999998753322111 11100  000111111111100000  


Q ss_pred             hhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          316 LVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                             .+..........+..++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       272 -------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          272 -------RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             -------CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                   000000000114556789999999999999999999999999999865

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.4e-37  Score=285.20  Aligned_cols=214  Identities=24%  Similarity=0.359  Sum_probs=158.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++||||+++++++.     .....++||||+++|+|.+++....       ....+++..++.++.|+
T Consensus        79 ~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi  146 (309)
T 3p86_A           79 NEFLREVAIMKRLRHPNIVLFMGAVT-----QPPNLSIVTEYLSRGSLYRLLHKSG-------AREQLDERRRLSMAYDV  146 (309)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEC-----STTCCEEEEECCTTCBHHHHHHSTT-------HHHHSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCceEEEEecCCCCcHHHHHhhcC-------CCCCCCHHHHHHHHHHH
Confidence            67999999999999999999999964     3667899999999999999995321       12348999999999999


Q ss_pred             HHHHhHHhhcCCCc--eeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPV--TAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~--ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||+|||   +.+  |+||||||+|||++.++.+||+|||+++....            ...+||...+..++.++|||
T Consensus       147 ~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  223 (309)
T 3p86_A          147 AKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY  223 (309)
T ss_dssp             HHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHH
T ss_pred             HHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHH
Confidence            99999999   667  99999999999999999999999999975432            23447777778889999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||||++|||+||+.||.....    ............         .....                  ......+.+++
T Consensus       224 slG~il~elltg~~Pf~~~~~----~~~~~~~~~~~~---------~~~~~------------------~~~~~~l~~li  272 (309)
T 3p86_A          224 SFGVILWELATLQQPWGNLNP----AQVVAAVGFKCK---------RLEIP------------------RNLNPQVAAII  272 (309)
T ss_dssp             HHHHHHHHHHHCCCTTTTSCH----HHHHHHHHHSCC---------CCCCC------------------TTSCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCC---------CCCCC------------------ccCCHHHHHHH
Confidence            999999999999999864211    111100000000         00000                  02234577888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhhhcCCCCC
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNTLLGPKNL  377 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~~~  377 (382)
                      .+||+.||++|||+.++++.|+.+......|+++
T Consensus       273 ~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~  306 (309)
T 3p86_A          273 EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR  306 (309)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence            8999999999999999999999998876666554

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.8e-38  Score=285.71  Aligned_cols=219  Identities=20%  Similarity=0.374  Sum_probs=162.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   .+....++||||+++|+|.+++..         ....+++..+..++.|+
T Consensus        56 ~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi  123 (295)
T 3ugc_A           56 RDFEREIEILKSLQHDNIVKYKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQI  123 (295)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECH---HHHTSCEEEEECCTTCBHHHHHHH---------CGGGCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec---CCCCceEEEEEeCCCCCHHHHHHh---------cccccCHHHHHHHHHHH
Confidence            678999999999999999999999754   223557999999999999999942         33458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....               ...||...+..++.++||
T Consensus       124 ~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  200 (295)
T 3ugc_A          124 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDV  200 (295)
T ss_dssp             HHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHH
Confidence            99999999   679999999999999999999999999999865332               234666667788999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchh-----hhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK-----DIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      ||||+++|||+||..|+....      ..+..........     .+.+......          ..+     ....++.
T Consensus       201 ~slG~~l~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~-----~~~~~~~  259 (295)
T 3ugc_A          201 WSFGVVLYELFTYIEKSKSPP------AEFMRMIGNDKQGQMIVFHLIELLKNNG----------RLP-----RPDGCPD  259 (295)
T ss_dssp             HHHHHHHHHHHHTTCTTCSHH------HHHHHHHCTTCCTHHHHHHHHHHHHTTC----------CCC-----CCTTCCH
T ss_pred             HHHHHHHHHHHhcccccCCCh------HHHHhhhcCccccchhHHHHHHHHhccC----------cCC-----CCcCcCH
Confidence            999999999999999975321      1111111111000     0000000000          000     0013345


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhc
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  372 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~  372 (382)
                      ++.+++.+||+.||++|||+.|+++.|+++.+.+.
T Consensus       260 ~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          260 EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            78889999999999999999999999999988764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=289.67  Aligned_cols=207  Identities=20%  Similarity=0.368  Sum_probs=163.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|++++++++||||+++++++..     .+..++||||+++|+|.+++..         ....+++..++.++.|+
T Consensus        95 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi  160 (325)
T 3kul_A           95 RDFLSEASIMGQFDHPNIIRLEGVVTR-----GRLAMIVTEYMENGSLDTFLRT---------HDGQFTIMQLVGMLRGV  160 (325)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECG-----GGCCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEe-----CCccEEEeeCCCCCcHHHHHHh---------cccCCCHHHHHHHHHHH
Confidence            679999999999999999999999643     6678999999999999999842         33568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....               ...||...+..++.++||
T Consensus       161 ~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di  237 (325)
T 3kul_A          161 GAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDV  237 (325)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHH
T ss_pred             HHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHH
Confidence            99999999   679999999999999999999999999999865432               334666666778999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||++ |+.||.....  ..........            ......                  ..+...+.+
T Consensus       238 ~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~------------~~~~~~------------------~~~~~~l~~  285 (325)
T 3kul_A          238 WSFGVVMWEVLAYGERPYWNMTN--RDVISSVEEG------------YRLPAP------------------MGCPHALHQ  285 (325)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHTT------------CCCCCC------------------TTCCHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcC------------CCCCCC------------------CCcCHHHHH
Confidence            999999999999 9999864211  0111111000            000000                  023346788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      ++.+||+.||++|||+.+|++.|+++......
T Consensus       286 li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          286 LMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence            88999999999999999999999999876433

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.1e-37  Score=281.49  Aligned_cols=222  Identities=22%  Similarity=0.327  Sum_probs=163.9

Q ss_pred             chhhH-----HHHHHHHHHHhh--cccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-----KSFIAECKALRN--IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|++     +.+.+|.+++..  ++||||+++++++... .......++||||+++|+|.+++.           ...+
T Consensus        35 avK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~-----------~~~~  102 (301)
T 3q4u_A           35 AVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQLWLITHYHEMGSLYDYLQ-----------LTTL  102 (301)
T ss_dssp             EEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEEEEEEECCCTTCBHHHHHT-----------TCCB
T ss_pred             EEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCceeEEehhhccCCCHHHHHh-----------hccc
Confidence            66665     567778887777  7999999999997642 233566899999999999999993           2358


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcC-----CCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------
Q 040999          186 NLLRRLNIAIDVASALNYLHHDC-----QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------  244 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~-----~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------  244 (382)
                      ++..++.++.|++.||+|||+..     +.+|+||||||+|||++.++.+||+|||+++.....                
T Consensus       103 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  182 (301)
T 3q4u_A          103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR  182 (301)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccc
Confidence            99999999999999999999321     569999999999999999999999999999653221                


Q ss_pred             CCCCccccCC------CCCccchhHHHHHHHHHHHhc----------CCCCCccccCCchHHHHHHHhcCCchhhhhhcc
Q 040999          245 RTQTKYGVGN------EVSTIGDVYSYGILLLELMIR----------EKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSI  308 (382)
Q Consensus       245 ~~~~~~~~~~------~~~~~~Dv~S~Gvil~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (382)
                      ..+||...+.      .++.++|||||||++|||+||          +.||........................    .
T Consensus       183 y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~  258 (301)
T 3q4u_A          183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP----N  258 (301)
T ss_dssp             GCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC----C
T ss_pred             eeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCC----C
Confidence            2235554444      455799999999999999999          7777654433333333322211110000    0


Q ss_pred             cccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          309 LLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      ...                 ..........+.+++.+||+.||++|||+.||++.|+++
T Consensus       259 ~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          259 IPN-----------------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCG-----------------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCh-----------------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            000                 000114566889999999999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.1e-37  Score=306.58  Aligned_cols=192  Identities=16%  Similarity=0.172  Sum_probs=148.1

Q ss_pred             HHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHh
Q 040999          123 ECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALN  202 (382)
Q Consensus       123 E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~  202 (382)
                      ++++++.++|||||++++++     ++.+..|+|||||+||+|.+++.          ....+++..+..++.||+.||.
T Consensus       242 ~l~ll~~~~HP~IV~l~~~f-----~~~~~lylVmEy~~GGdL~~~l~----------~~~~l~E~~a~~y~~qIl~aL~  306 (689)
T 3v5w_A          242 MLSLVSTGDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLS----------QHGVFSEADMRFYAAEIILGLE  306 (689)
T ss_dssp             HHHHHSSSCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHH----------HHCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhhCCCCCEeEEEEEE-----EECCEEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHHHHHHH
Confidence            45667778999999999994     45889999999999999999993          3456999999999999999999


Q ss_pred             HHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC----------CCCcccc-CCCCCccchhHHHHHHHHH
Q 040999          203 YLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR----------TQTKYGV-GNEVSTIGDVYSYGILLLE  271 (382)
Q Consensus       203 ~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~----------~~~~~~~-~~~~~~~~Dv~S~Gvil~e  271 (382)
                      |||   +.+|+||||||+|||++.+|.+||+|||+|+......          .+||... +..|+.++||||+||++||
T Consensus       307 yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYE  383 (689)
T 3v5w_A          307 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK  383 (689)
T ss_dssp             HHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHH
T ss_pred             HHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHH
Confidence            999   8899999999999999999999999999998764432          3366664 4578999999999999999


Q ss_pred             HHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCc
Q 040999          272 LMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESP  351 (382)
Q Consensus       272 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p  351 (382)
                      |+||+.||......  ...........        .... .+ .                  ....++.+|+.+||+.||
T Consensus       384 mLtG~~PF~~~~~~--~~~~i~~~i~~--------~~~~-~p-~------------------~~S~~a~dLI~~lL~~dP  433 (689)
T 3v5w_A          384 LLRGHSPFRQHKTK--DKHEIDRMTLT--------MAVE-LP-D------------------SFSPELRSLLEGLLQRDV  433 (689)
T ss_dssp             HHHSSCTTCGGGCC--CHHHHHHHHHH--------CCCC-CC-T------------------TSCHHHHHHHHHHTCSCG
T ss_pred             HHhCCCCCCCCChH--HHHHHHHhhcC--------CCCC-CC-c------------------cCCHHHHHHHHHHccCCH
Confidence            99999999643221  11111111100        0000 00 0                  112356788889999999


Q ss_pred             cCCCC-----HHHHHH
Q 040999          352 QDRMK-----MTNVVH  362 (382)
Q Consensus       352 ~~RPs-----~~evl~  362 (382)
                      ++|++     +.||++
T Consensus       434 ~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          434 NRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             GGCTTCSSSTHHHHTT
T ss_pred             hHCCCCCCCCHHHHhc
Confidence            99998     577764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2e-37  Score=293.12  Aligned_cols=204  Identities=24%  Similarity=0.404  Sum_probs=157.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|++++++++||||+++++++..     ....++||||+++|+|.+++..         ....+++..++.++.||
T Consensus        91 ~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~---------~~~~~~~~~~~~i~~qi  156 (373)
T 2qol_A           91 RDFLGEASIMGQFDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRK---------HDAQFTVIQLVGMLRGI  156 (373)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHT---------TTTCSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEee-----CCceEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHH
Confidence            679999999999999999999999643     6778999999999999999942         33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------------CCCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||+++....               ....||...+..++.++||
T Consensus       157 ~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  233 (373)
T 2qol_A          157 ASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV  233 (373)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcH
Confidence            99999999   67999999999999999999999999999986532               2344666667788999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||++ |+.||.....     .....         .+.........                  ..++..+.+
T Consensus       234 ~SlG~il~ellt~g~~P~~~~~~-----~~~~~---------~i~~~~~~~~~------------------~~~~~~l~~  281 (373)
T 2qol_A          234 WSYGIVLWEVMSYGERPYWEMSN-----QDVIK---------AVDEGYRLPPP------------------MDCPAALYQ  281 (373)
T ss_dssp             HHHHHHHHHHHTTC-CTTTTCCH-----HHHHH---------HHHTTEECCCC------------------TTCBHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCH-----HHHHH---------HHHcCCCCCCC------------------ccccHHHHH
Confidence            999999999998 9999864211     11111         11110000000                  023446788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      ++.+||+.||++||++.+|++.|+++...
T Consensus       282 li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          282 LMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            99999999999999999999999998664

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.5e-37  Score=289.82  Aligned_cols=216  Identities=20%  Similarity=0.329  Sum_probs=165.7

Q ss_pred             HHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------cccCCcccCHHH
Q 040999          117 FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------TYERPRNLNLLR  189 (382)
Q Consensus       117 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~  189 (382)
                      .+.+.+|+++++++ +||||++++++|..     .+..++||||+++|+|.+++........      .......+++..
T Consensus       130 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (370)
T 2psq_A          130 LSDLVSEMEMMKMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD  204 (370)
T ss_dssp             HHHHHHHHHHHHHSCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeEEEEEcc-----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHH
Confidence            36799999999999 89999999999643     6778999999999999999964321100      001234589999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCC
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNE  255 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~  255 (382)
                      ++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....              ...||...+..
T Consensus       205 ~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  281 (370)
T 2psq_A          205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV  281 (370)
T ss_dssp             HHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC
T ss_pred             HHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC
Confidence            9999999999999999   679999999999999999999999999999855321              33466666778


Q ss_pred             CCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          256 VSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ++.++|||||||++|||+| |+.||.....  ..+.........            ....                  ..
T Consensus       282 ~~~~~DvwslG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~------------~~~~------------------~~  329 (370)
T 2psq_A          282 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELFKLLKEGHR------------MDKP------------------AN  329 (370)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCC------------CCCC------------------TT
T ss_pred             CCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCCC------------CCCC------------------CC
Confidence            8999999999999999999 9999864211  111111110000            0000                  02


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhc
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  372 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~  372 (382)
                      +...+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       330 ~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          330 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            33467888889999999999999999999999887543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.3e-38  Score=296.26  Aligned_cols=204  Identities=23%  Similarity=0.334  Sum_probs=162.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|+++|++++||||++++++|..     .+..++||||+++|+|.+++.         .....+++..+..++.|+
T Consensus       157 ~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~---------~~~~~~~~~~~~~~~~qi  222 (377)
T 3cbl_A          157 AKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELVQGGDFLTFLR---------TEGARLRVKTLLQMVGDA  222 (377)
T ss_dssp             TTTTHHHHHHTTCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHH---------HHGGGCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEec-----CCCcEEEEEcCCCCCHHHHHH---------hcCCCCCHHHHHHHHHHH
Confidence            468899999999999999999999743     567899999999999999984         223458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....              ..+||...+..++.++|||
T Consensus       223 ~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  299 (377)
T 3cbl_A          223 AAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVW  299 (377)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHH
T ss_pred             HHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHH
Confidence            99999999   679999999999999999999999999999754321              3446666667789999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||++|||+| |+.||.....  .......            .........                  ..++..+.++
T Consensus       300 slG~il~el~t~g~~p~~~~~~--~~~~~~~------------~~~~~~~~~------------------~~~~~~l~~l  347 (377)
T 3cbl_A          300 SFGILLWETFSLGASPYPNLSN--QQTREFV------------EKGGRLPCP------------------ELCPDAVFRL  347 (377)
T ss_dssp             HHHHHHHHHHTTSCCSSTTSCH--HHHHHHH------------HTTCCCCCC------------------TTCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCH--HHHHHHH------------HcCCCCCCC------------------CCCCHHHHHH
Confidence            99999999998 9999864211  1111111            110000000                  0233467888


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +.+||+.||++|||+.++++.|++++..
T Consensus       348 i~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          348 MEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            8999999999999999999999999765

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=279.65  Aligned_cols=216  Identities=24%  Similarity=0.332  Sum_probs=163.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|++++++++||||+++++++.       +..++||||+++|+|.+++....       ....+++..++.++.|+
T Consensus        46 ~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi  111 (307)
T 2eva_A           46 KAFIVELRQLSRVNHPNIVKLYGACL-------NPVCLVMEYAEGGSLYNVLHGAE-------PLPYYTAAHAMSWCLQC  111 (307)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEEEEECCTTCBHHHHHHCSS-------SEECCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEEEEEcCCCCCHHHHHhccC-------CCCccCHHHHHHHHHHH
Confidence            67999999999999999999999853       34789999999999999995321       12347888999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCc-EEEccccccccCCC---------CCCCCccccCCCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT-ARVGDFGLARFLPP---------TRTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~-~kl~Dfg~a~~~~~---------~~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      ++||+|||+....+|+||||||+||+++.++. +||+|||++.....         ....||...+..++.++||||||+
T Consensus       112 ~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  191 (307)
T 2eva_A          112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI  191 (307)
T ss_dssp             HHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHH
Confidence            99999999532379999999999999988876 79999999975432         234577777788899999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ++|||+||+.||+......  . ...........     ....                      ...+..+.+++.+||
T Consensus       192 il~el~~g~~p~~~~~~~~--~-~~~~~~~~~~~-----~~~~----------------------~~~~~~l~~li~~~l  241 (307)
T 2eva_A          192 ILWEVITRRKPFDEIGGPA--F-RIMWAVHNGTR-----PPLI----------------------KNLPKPIESLMTRCW  241 (307)
T ss_dssp             HHHHHHHTCCTTTTTCSSH--H-HHHHHHHTTCC-----CCCB----------------------TTCCHHHHHHHHHHT
T ss_pred             HHHHHHHCCCCchhhCccH--H-HHHHHHhcCCC-----CCcc----------------------cccCHHHHHHHHHHh
Confidence            9999999999987432111  1 11110000000     0000                      012345778888999


Q ss_pred             CCCccCCCCHHHHHHHHHHhhhhhcCCCCC
Q 040999          348 MESPQDRMKMTNVVHELQSIKNTLLGPKNL  377 (382)
Q Consensus       348 ~~~p~~RPs~~evl~~L~~i~~~~~~~~~~  377 (382)
                      +.||++|||+.++++.|+.+...+....+|
T Consensus       242 ~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  271 (307)
T 2eva_A          242 SKDPSQRPSMEEIVKIMTHLMRYFPGADEP  271 (307)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred             cCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence            999999999999999999999888766554

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-36  Score=274.70  Aligned_cols=204  Identities=22%  Similarity=0.396  Sum_probs=162.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++||||+++++++.     .....++||||+++++|.+++..         ....+++..+..++.|+
T Consensus        50 ~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~~i  115 (269)
T 4hcu_A           50 EDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLVFEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDV  115 (269)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEEEEECCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceEEEEEeCCCCcHHHHHHh---------cCcccCHHHHHHHHHHH
Confidence            67999999999999999999999964     36778999999999999999942         33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+|+||||||+||+++.++.+||+|||+++....             ...+||...+..++.++||||
T Consensus       116 ~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  192 (269)
T 4hcu_A          116 CEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS  192 (269)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHH
Confidence            99999999   67999999999999999999999999999975432             134466666678899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      +|+++|||+| |+.||.....     ........        .......+ .                  .....+.+++
T Consensus       193 lG~~l~~ll~~g~~p~~~~~~-----~~~~~~~~--------~~~~~~~~-~------------------~~~~~~~~li  240 (269)
T 4hcu_A          193 FGVLMWEVFSEGKIPYENRSN-----SEVVEDIS--------TGFRLYKP-R------------------LASTHVYQIM  240 (269)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCH-----HHHHHHHH--------TTCCCCCC-T------------------TSCHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCCCCH-----HHHHHHHh--------cCccCCCC-C------------------cCCHHHHHHH
Confidence            9999999999 9999864211     11111100        00000000 0                  1123577888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+||+.+|++|||+.|+++.|+++.+.
T Consensus       241 ~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          241 NHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            899999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.5e-36  Score=294.02  Aligned_cols=211  Identities=25%  Similarity=0.321  Sum_probs=167.9

Q ss_pred             chhhH------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|.+      +.|.+|+++|++++|||||+++++|..    .....++||||+++|+|.+++...        ....++
T Consensus       220 avK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~--------~~~~~~  287 (450)
T 1k9a_A          220 AVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVTEYMAKGSLVDYLRSR--------GRSVLG  287 (450)
T ss_dssp             EEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEEEEEECCTTCBHHHHHHHH--------CTTTCC
T ss_pred             EEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceEEEEEecCCCcHHHHHHhc--------CCCCCC
Confidence            77766      789999999999999999999999754    244789999999999999999531        223478


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------CCCCCccccCCCCC
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQTKYGVGNEVS  257 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~~~~~  257 (382)
                      +..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++....         ...+||...+..++
T Consensus       288 ~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~  364 (450)
T 1k9a_A          288 GDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFS  364 (450)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------CCCTTTSCHHHHHSSCCC
T ss_pred             HHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCC
Confidence            9999999999999999999   67999999999999999999999999999975432         34457777778899


Q ss_pred             ccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          258 TIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       258 ~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      .++|||||||++|||+| |+.||......  ..........            .....                  ..++
T Consensus       365 ~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~------------~~~~p------------------~~~~  412 (450)
T 1k9a_A          365 TKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY------------KMDAP------------------DGCP  412 (450)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTTC------------CCCCC------------------TTCC
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC------------CCCCC------------------CcCC
Confidence            99999999999999998 99998743211  1111111100            00000                  0234


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      ..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            5778889999999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.4e-36  Score=286.57  Aligned_cols=220  Identities=15%  Similarity=0.195  Sum_probs=168.6

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+..|+..++.++|+||+++++++... ..+....++||||+ +++|.+++.         .....+++..++.++.||+
T Consensus        94 ~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~---------~~~~~l~~~~~~~i~~qi~  162 (364)
T 3op5_A           94 EQIQKWIRTRKLKYLGVPKYWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYE---------ANAKRFSRKTVLQLSLRIL  162 (364)
T ss_dssp             HHHHHHHHHTTCSCCCSCCEEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHH---------HTTSCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhccCCCCCeEEeeeeec-cCCcceEEEEEeCC-CCCHHHHHH---------hccCCCCHHHHHHHHHHHH
Confidence            456677778888999999999998652 22346689999999 999999984         2335699999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeC--CCCcEEEccccccccCCC-------------------CCCCCccccCCCCC
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLD--DDMTARVGDFGLARFLPP-------------------TRTQTKYGVGNEVS  257 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~--~~~~~kl~Dfg~a~~~~~-------------------~~~~~~~~~~~~~~  257 (382)
                      .||+|||   +.+|+||||||+|||++  .++.+||+|||+++.+..                   ....||...+..++
T Consensus       163 ~~l~~lH---~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  239 (364)
T 3op5_A          163 DILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS  239 (364)
T ss_dssp             HHHHHHH---HTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC
T ss_pred             HHHHHHH---HCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC
Confidence            9999999   67999999999999998  889999999999975422                   23346666777889


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          258 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      .++|||||||++|||+||+.||..... ...............+.++++..+...                     .++.
T Consensus       240 ~~~Di~slG~~l~el~~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~  297 (364)
T 3op5_A          240 RRGDLEILGYCMIQWLTGHLPWEDNLK-DPKYVRDSKIRYRENIASLMDKCFPAA---------------------NAPG  297 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCTTGGGTT-CHHHHHHHHHHHHHCHHHHHHHHSCTT---------------------CCCH
T ss_pred             chhhHHHHHHHHHHHHhCCCCcccccc-CHHHHHHHHHHhhhhHHHHHHHhcccc---------------------cCHH
Confidence            999999999999999999999875322 122222222222333444444333211                     2244


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCC
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  374 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~  374 (382)
                      ++.+++..||+.+|++||++.++++.|+++......+
T Consensus       298 ~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  334 (364)
T 3op5_A          298 EIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK  334 (364)
T ss_dssp             HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            6788888999999999999999999999998765443

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.9e-37  Score=284.39  Aligned_cols=203  Identities=22%  Similarity=0.334  Sum_probs=161.7

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.|.+|++++++++||||++++++|..      ...++|+||+++|+|.+++..         ....+++..++.++.|
T Consensus        61 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~~q  125 (327)
T 3poz_A           61 NKEILDEAYVMASVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVRE---------HKDNIGSQYLLNWCVQ  125 (327)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCEEEEEES------SSEEEEEECCTTCBHHHHHHH---------STTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEec------CCeEEEEEecCCCcHHHHHHh---------cCCCCCHHHHHHHHHH
Confidence            3679999999999999999999999753      347899999999999999842         3456899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....              ...||...+..++.++||
T Consensus       126 i~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di  202 (327)
T 3poz_A          126 IAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV  202 (327)
T ss_dssp             HHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhh
Confidence            999999999   679999999999999999999999999999764322              334666667788999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||+| |+.||+....  ..+.....            .........                  .+...+.+
T Consensus       203 ~slG~il~ellt~g~~p~~~~~~--~~~~~~~~------------~~~~~~~~~------------------~~~~~~~~  250 (327)
T 3poz_A          203 WSYGVTVWELMTFGSKPYDGIPA--SEISSILE------------KGERLPQPP------------------ICTIDVYM  250 (327)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH------------TTCCCCCCT------------------TBCHHHHH
T ss_pred             hhhHHHHHHHHhcCCCCccCCCH--HHHHHHHH------------cCCCCCCCc------------------cCCHHHHH
Confidence            999999999999 9999874321  11111111            110000000                  22346788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      ++.+||+.+|++|||+.|+++.|+++..
T Consensus       251 li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          251 IMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            8899999999999999999999998865

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.2e-37  Score=286.56  Aligned_cols=218  Identities=22%  Similarity=0.336  Sum_probs=166.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   .+....++||||+++|+|.+++..           ..+++..++.++.|+
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~i~~~l  143 (318)
T 3lxp_A           78 SGWKQEIDILRTLYHEHIIKYKGCCED---AGAASLQLVMEYVPLGSLRDYLPR-----------HSIGLAQLLLFAQQI  143 (318)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTEEEEEECCCTTCBHHHHGGG-----------SCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcchhhEEEEEec---CCCceEEEEEecccCCcHHHHHhh-----------CCCCHHHHHHHHHHH
Confidence            678999999999999999999999764   235678999999999999999842           248999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....               ...||...+..++.++||
T Consensus       144 ~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  220 (318)
T 3lxp_A          144 CEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV  220 (318)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHH
T ss_pred             HHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHH
Confidence            99999999   679999999999999999999999999999876432               233555556677889999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC------chhhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN------HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      ||||+++|||+||+.||......     .........      ...+.+........                  ...+.
T Consensus       221 ~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~  277 (318)
T 3lxp_A          221 WSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQMTVLRLTELLERGERLPR------------------PDKCP  277 (318)
T ss_dssp             HHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHHHHHHHHHHHHTTCCCCC------------------CTTCC
T ss_pred             HHHHHHHHHHHhCCCcccccchh-----hhhhhcccccchhHHHHHHHHhcccCCCC------------------Ccccc
Confidence            99999999999999997632110     000000110      01111111110000                  01234


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCCC
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  375 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~  375 (382)
                      ..+.+++.+||+.||++|||+.|+++.|+++.+.+..+.
T Consensus       278 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          278 AEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence            578889999999999999999999999999999886543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-36  Score=273.83  Aligned_cols=204  Identities=21%  Similarity=0.359  Sum_probs=160.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++||||+++++++.     .....++||||+++++|.+++.         .....+++..+..++.|+
T Consensus        48 ~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~qi  113 (268)
T 3sxs_A           48 DEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLR---------SHGKGLEPSQLLEMCYDV  113 (268)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEEEEEECCTTCBHHHHHH---------HHGGGCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceEEEEEccCCCcHHHHHH---------HcCCCCCHHHHHHHHHHH
Confidence            67899999999999999999999964     3677899999999999999984         223458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....             ..+||...+..++.++||||
T Consensus       114 ~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  190 (268)
T 3sxs_A          114 CEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA  190 (268)
T ss_dssp             HHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHH
T ss_pred             HHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHH
Confidence            99999999   679999999999999999999999999999865332             33456555667889999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||+| |+.||+....     ........        .......+ .                  .....+.+++
T Consensus       191 lG~il~~l~~~g~~p~~~~~~-----~~~~~~~~--------~~~~~~~~-~------------------~~~~~l~~li  238 (268)
T 3sxs_A          191 FGILMWEVFSLGKMPYDLYTN-----SEVVLKVS--------QGHRLYRP-H------------------LASDTIYQIM  238 (268)
T ss_dssp             HHHHHHHHHTTTCCTTTTSCH-----HHHHHHHH--------TTCCCCCC-T------------------TSCHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCccccCh-----HHHHHHHH--------cCCCCCCC-C------------------cChHHHHHHH
Confidence            9999999999 9999864211     11110000        00000000 0                  1123577888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+||+.+|++|||+.|+++.|+++++.
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          239 YSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            899999999999999999999998764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-36  Score=285.94  Aligned_cols=210  Identities=21%  Similarity=0.373  Sum_probs=159.6

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .++|.+|++++++++||||++++++|..    ..+..++||||+++|+|.+++..         ....+++..++.++.|
T Consensus       134 ~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~q  200 (373)
T 3c1x_A          134 VSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGLQ  200 (373)
T ss_dssp             HHHHHHHHTTSTTCCCTTBCCCCEEECC----CSSCCEEEEECCTTCBHHHHHHC---------TTCCCBHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEc----CCCCeEEEEECCCCCCHHHHHhh---------cccCCCHHHHHHHHHH
Confidence            3779999999999999999999998743    35678999999999999999942         3346889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccCCCCCccc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVGNEVSTIG  260 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~~~~~~~~  260 (382)
                      |++||.|||   +.+|+||||||+|||++.++.+||+|||+++.....                ...||...+..++.++
T Consensus       201 i~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  277 (373)
T 3c1x_A          201 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS  277 (373)
T ss_dssp             HHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHH
Confidence            999999999   679999999999999999999999999999754221                3346666667889999


Q ss_pred             hhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          261 DVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       261 Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      |||||||++|||+| |.+||.....  ............           ...+                   ..++..+
T Consensus       278 DvwSlG~il~ellt~~~~p~~~~~~--~~~~~~~~~~~~-----------~~~p-------------------~~~~~~l  325 (373)
T 3c1x_A          278 DVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRR-----------LLQP-------------------EYCPDPL  325 (373)
T ss_dssp             HHHHHHHHHHHHHTTSCCSCTTSCS--SCHHHHHHTTCC-----------CCCC-------------------TTCCHHH
T ss_pred             HHHHHHHHHHHHHhCcCCCCCCCCH--HHHHHHHHcCCC-----------CCCC-------------------CCCCHHH
Confidence            99999999999999 6777654221  111111111000           0000                   0223467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCC
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  374 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~  374 (382)
                      .+++.+||+.||++|||+.|+++.|+++...+...
T Consensus       326 ~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence            88888999999999999999999999999887654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-36  Score=300.71  Aligned_cols=208  Identities=19%  Similarity=0.296  Sum_probs=166.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|+++|++++|||||+++++|.      .+..++||||+++|+|.+++..         ....+++..+..++.||
T Consensus       381 ~~~~~E~~il~~l~hpniv~l~~~~~------~~~~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi  445 (613)
T 2ozo_A          381 EEMMREAQIMHQLDNPYIVRLIGVCQ------AEALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQV  445 (613)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEE------SSSEEEEEECCTTCBHHHHHTT---------CTTTSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEec------cCCeEEEEEeCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHH
Confidence            68999999999999999999999974      2458999999999999999942         34568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------------CCCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++....               ...+||...+..++.++||
T Consensus       446 ~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDv  522 (613)
T 2ozo_A          446 SMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV  522 (613)
T ss_dssp             HHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHH
Confidence            99999999   67999999999999999999999999999986532               2345676667788999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||+| |+.||.....  ......+....            .....                  ..++..+.+
T Consensus       523 wSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~------------~~~~p------------------~~~~~~l~~  570 (613)
T 2ozo_A          523 WSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGK------------RMECP------------------PECPPELYA  570 (613)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCS--HHHHHHHHTTC------------CCCCC------------------TTCCHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCC------------CCCCC------------------CcCCHHHHH
Confidence            999999999998 9999874321  11111111100            00000                  023457888


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhhhcCCC
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  375 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~  375 (382)
                      ++.+||+.+|++||++.+|++.|+.+........
T Consensus       571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~  604 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  604 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence            9999999999999999999999999988765543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-36  Score=276.67  Aligned_cols=207  Identities=25%  Similarity=0.396  Sum_probs=153.9

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.|.+|++++++++||||+++++++.      ....++||||+++++|.+++.         .....+++..++.++.|
T Consensus        64 ~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~i~~q  128 (289)
T 3og7_A           64 LQAFKNEVGVLRKTRHVNILLFMGYST------APQLAIVTQWCEGSSLYHHLH---------ASETKFEMKKLIDIARQ  128 (289)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCEEEEECCCEEEHHHHHT---------TC---CCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcEEEEEeecc------CCccEEEEEecCCCcHHHHHh---------hccCCCCHHHHHHHHHH
Confidence            367999999999999999999999742      456799999999999999984         23456899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCcccc---CCCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGV---GNEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~---~~~~~~~  259 (382)
                      ++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....              ....||...   +..++.+
T Consensus       129 i~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  205 (289)
T 3og7_A          129 TARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ  205 (289)
T ss_dssp             HHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHH
T ss_pred             HHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcc
Confidence            999999999   67999999999999999999999999999875432              123355543   5567889


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHh-cCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA-LPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +||||||+++|||++|+.||....... ......... .......+                           ...++..
T Consensus       206 ~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~  257 (289)
T 3og7_A          206 SDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSLSPDLSKV---------------------------RSNCPKR  257 (289)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSCCCCTTSS---------------------------CTTSCHH
T ss_pred             cchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccccCcchhhc---------------------------cccCCHH
Confidence            999999999999999999986432111 111111111 11100000                           0023456


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      +.+++.+||+.+|.+|||+.++++.|+++.+
T Consensus       258 l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          258 MKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            8888899999999999999999999998864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.2e-36  Score=276.17  Aligned_cols=196  Identities=19%  Similarity=0.236  Sum_probs=154.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++++++||||+++++++..     .+..++||||+++|+|.+++..           ..+++..+..++.|+
T Consensus        62 ~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi  125 (297)
T 3fxz_A           62 ELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCREC  125 (297)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHH-----------SCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEEEEEECCCCCCHHHHHhh-----------cCCCHHHHHHHHHHH
Confidence            668999999999999999999999654     6788999999999999999842           248899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....            ...||...+..++.++|||||
T Consensus       126 ~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  202 (297)
T 3fxz_A          126 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (297)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHH
T ss_pred             HHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHH
Confidence            99999999   679999999999999999999999999998765432            223666667788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||...    .............      ..... .+                   ......+.+++.+
T Consensus       203 G~il~ell~g~~pf~~~----~~~~~~~~~~~~~------~~~~~-~~-------------------~~~~~~~~~li~~  252 (297)
T 3fxz_A          203 GIMAIEMIEGEPPYLNE----NPLRALYLIATNG------TPELQ-NP-------------------EKLSAIFRDFLNR  252 (297)
T ss_dssp             HHHHHHHHHSSCTTTTS----CHHHHHHHHHHHC------SCCCS-CG-------------------GGSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCC----CHHHHHHHHHhCC------CCCCC-Cc-------------------cccCHHHHHHHHH
Confidence            99999999999998632    1111111100000      00000 00                   0223457788889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.||++|||+.|+++
T Consensus       253 ~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          253 CLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HccCChhHCcCHHHHhh
Confidence            99999999999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.2e-36  Score=274.91  Aligned_cols=212  Identities=20%  Similarity=0.338  Sum_probs=164.3

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++.     ..+..++||||+++++|.+++.          ....+++..+..++.|
T Consensus        55 ~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~q  119 (294)
T 4eqm_A           55 LKRFEREVHNSSQLSHQNIVSMIDVDE-----EDDCYYLVMEYIEGPTLSEYIE----------SHGPLSVDTAINFTNQ  119 (294)
T ss_dssp             HHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCceEEEeee-----eCCeEEEEEeCCCCCCHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            378999999999999999999999964     3778999999999999999983          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      ++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....             ....||...+..++.++|||
T Consensus       120 i~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~  196 (294)
T 4eqm_A          120 ILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIY  196 (294)
T ss_dssp             HHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHH
T ss_pred             HHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHH
Confidence            999999999   67999999999999999999999999999975432             23346766777889999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||+++|||+||+.||...    ......... ...........                       ...+.+..+.+++
T Consensus       197 slG~~l~~ll~g~~pf~~~----~~~~~~~~~-~~~~~~~~~~~-----------------------~~~~~~~~l~~li  248 (294)
T 4eqm_A          197 SIGIVLYEMLVGEPPFNGE----TAVSIAIKH-IQDSVPNVTTD-----------------------VRKDIPQSLSNVI  248 (294)
T ss_dssp             HHHHHHHHHHHSSCSSCSS----CHHHHHHHH-HSSCCCCHHHH-----------------------SCTTSCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCC----ChHHHHHHH-hhccCCCcchh-----------------------cccCCCHHHHHHH
Confidence            9999999999999998642    111111111 11100000000                       0012334678888


Q ss_pred             hccCCCCccCCC-CHHHHHHHHHHhhhhhcCC
Q 040999          344 VACSMESPQDRM-KMTNVVHELQSIKNTLLGP  374 (382)
Q Consensus       344 ~~Cl~~~p~~RP-s~~evl~~L~~i~~~~~~~  374 (382)
                      .+||+.||++|| ++.++.+.|+++...-...
T Consensus       249 ~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~  280 (294)
T 4eqm_A          249 LRATEKDKANRYKTIQEMKDDLSSVLHENRAN  280 (294)
T ss_dssp             HHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred             HHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence            899999999998 8999999999886654433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-36  Score=297.98  Aligned_cols=209  Identities=22%  Similarity=0.356  Sum_probs=165.6

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+       ++|.+|+++|++++|||||+++++|..     ....++||||+++|+|.+++...        ....+
T Consensus       249 avK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~--------~~~~~  315 (495)
T 1opk_A          249 AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLREC--------NRQEV  315 (495)
T ss_dssp             EEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHS--------CTTTS
T ss_pred             EEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEEEEEEccCCCCHHHHHHhc--------CcCCC
Confidence            66655       789999999999999999999999753     56789999999999999999532        23458


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~  252 (382)
                      ++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....             ..+||...
T Consensus       316 ~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  392 (495)
T 1opk_A          316 SAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  392 (495)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHh
Confidence            89999999999999999999   679999999999999999999999999999865322             23466656


Q ss_pred             CCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 GNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      +..++.++|||||||++|||+| |+.||.....  .......            .........                 
T Consensus       393 ~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~~------------~~~~~~~~~-----------------  441 (495)
T 1opk_A          393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELL------------EKDYRMERP-----------------  441 (495)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHH------------HTTCCCCCC-----------------
T ss_pred             cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH------------HcCCCCCCC-----------------
Confidence            6778999999999999999999 9999864321  1111111            111100000                 


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                       ..++..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       442 -~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          442 -EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence             0234567888899999999999999999999998753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7e-36  Score=275.68  Aligned_cols=217  Identities=21%  Similarity=0.372  Sum_probs=161.3

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++...........++||||+++|+|.+++.....    ......+++..++.++.|
T Consensus        80 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~q  155 (313)
T 3brb_A           80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL----ETGPKHIPLQTLLKFMVD  155 (313)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTB----TTSCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhh----hcCCccCCHHHHHHHHHH
Confidence            3678999999999999999999999875333333456999999999999999843221    123456999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....              ...||...+..++.++||
T Consensus       156 i~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  232 (313)
T 3brb_A          156 IALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDV  232 (313)
T ss_dssp             HHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHH
T ss_pred             HHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhh
Confidence            999999999   789999999999999999999999999999765321              233566667778999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||+++|||+| |..||.....  ...........           ....+                   ..+...+.+
T Consensus       233 ~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~-----------~~~~~-------------------~~~~~~l~~  280 (313)
T 3brb_A          233 WAFGVTMWEIATRGMTPYPGVQN--HEMYDYLLHGH-----------RLKQP-------------------EDCLDELYE  280 (313)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTC-----------CCCCB-------------------TTCCHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCccCCH--HHHHHHHHcCC-----------CCCCC-------------------ccccHHHHH
Confidence            999999999999 8889764211  11111111000           00000                   022346788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhhhc
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNTLL  372 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~  372 (382)
                      ++.+||+.||++|||+.++++.|+++.+.++
T Consensus       281 li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          281 IMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            8889999999999999999999999988764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.2e-36  Score=283.25  Aligned_cols=216  Identities=21%  Similarity=0.272  Sum_probs=163.7

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc-------------------
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE-------------------  177 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------  177 (382)
                      +.+.+|++++.++ +||||++++++|..    .....++||||+++|+|.+++........                   
T Consensus        70 ~~~~~E~~~l~~l~~hpniv~~~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (359)
T 3vhe_A           70 RALMSELKILIHIGHHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI  145 (359)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------
T ss_pred             HHHHHHHHHHHhhcCCcceeeeeeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhccccccccc
Confidence            5799999999999 79999999999753    34558999999999999999965432100                   


Q ss_pred             -------------------------------------cccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCC
Q 040999          178 -------------------------------------TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPS  220 (382)
Q Consensus       178 -------------------------------------~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~  220 (382)
                                                           .......+++..++.++.|++.||+|||   +.+|+||||||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~  222 (359)
T 3vhe_A          146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR  222 (359)
T ss_dssp             --------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             chhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChh
Confidence                                                 0000223899999999999999999999   679999999999


Q ss_pred             ceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccC
Q 040999          221 NVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEG  285 (382)
Q Consensus       221 NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~  285 (382)
                      |||++.++.+||+|||+++.....              ...||...+..++.++|||||||++|||+| |+.||......
T Consensus       223 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  302 (359)
T 3vhe_A          223 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  302 (359)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             hEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh
Confidence            999999999999999999865322              234666667788999999999999999998 99998643211


Q ss_pred             CchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          286 DMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      . .............           .+ .                  .....+.+++.+||+.||++|||+.|+++.|+
T Consensus       303 ~-~~~~~~~~~~~~~-----------~~-~------------------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  351 (359)
T 3vhe_A          303 E-EFCRRLKEGTRMR-----------AP-D------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  351 (359)
T ss_dssp             H-HHHHHHHHTCCCC-----------CC-T------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H-HHHHHHHcCCCCC-----------CC-C------------------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            1 1111111110000           00 0                  12235778888999999999999999999999


Q ss_pred             Hhhhhh
Q 040999          366 SIKNTL  371 (382)
Q Consensus       366 ~i~~~~  371 (382)
                      ++.+..
T Consensus       352 ~~~~~~  357 (359)
T 3vhe_A          352 NLLQAN  357 (359)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            987653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.6e-36  Score=272.27  Aligned_cols=204  Identities=20%  Similarity=0.339  Sum_probs=161.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++||||+++++++.     .....++||||+++++|.+++..         ....+++..+..++.|+
T Consensus        64 ~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi  129 (283)
T 3gen_A           64 DEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLRE---------MRHRFQTQQLLEMCKDV  129 (283)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEEEECCCTTCBHHHHHHC---------GGGCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCeEEEEeccCCCcHHHHHHH---------hccCCCHHHHHHHHHHH
Confidence            67999999999999999999999964     36778999999999999999942         23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||+++....             ....||...+..++.++||||
T Consensus       130 ~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  206 (283)
T 3gen_A          130 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA  206 (283)
T ss_dssp             HHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHH
T ss_pred             HHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHH
Confidence            99999999   67999999999999999999999999999975432             134466666678899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||+| |+.||.....  ..........            .......                  .....+.+++
T Consensus       207 lG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~------------~~~~~~~------------------~~~~~l~~li  254 (283)
T 3gen_A          207 FGVLMWEIYSLGKMPYERFTN--SETAEHIAQG------------LRLYRPH------------------LASEKVYTIM  254 (283)
T ss_dssp             HHHHHHHHHTTTCCTTTTSCH--HHHHHHHHTT------------CCCCCCT------------------TCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCccccCh--hHHHHHHhcc------------cCCCCCC------------------cCCHHHHHHH
Confidence            9999999998 9999864211  0111110000            0000000                  1123577888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+||+.+|++|||+.++++.|+++.+.
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          255 YSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            899999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-36  Score=294.50  Aligned_cols=210  Identities=20%  Similarity=0.355  Sum_probs=165.8

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+       +.|.+|+++|++++|||||++++++.      .+..++||||+++|+|.+++...        ....+
T Consensus       216 avK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~  281 (454)
T 1qcf_A          216 AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYIITEFMAKGSLLDFLKSD--------EGSKQ  281 (454)
T ss_dssp             EEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCEEEECCCTTCBHHHHHHSH--------HHHTC
T ss_pred             EEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCccEEEEeecCCCcHHHHHHhc--------cCCCC
Confidence            66655       68999999999999999999999863      45689999999999999999421        12357


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~  252 (382)
                      ++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....             ...+||...
T Consensus       282 ~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  358 (454)
T 1qcf_A          282 PLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN  358 (454)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhc
Confidence            88999999999999999999   67999999999999999999999999999986532             234466666


Q ss_pred             CCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 GNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      ...++.++|||||||++|||+| |+.||.....  ............           ...+                  
T Consensus       359 ~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~-----------~~~~------------------  407 (454)
T 1qcf_A          359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYR-----------MPRP------------------  407 (454)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHHTCC-----------CCCC------------------
T ss_pred             cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC-----------CCCC------------------
Confidence            6788999999999999999999 9999864211  111111111000           0000                  


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                       ..++..+.+++.+||+.||++|||+++|++.|+++....
T Consensus       408 -~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          408 -ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             -CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence             023456788999999999999999999999999987653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-36  Score=284.86  Aligned_cols=215  Identities=22%  Similarity=0.333  Sum_probs=166.1

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC------ccccCCcccCHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED------ETYERPRNLNLLRR  190 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~  190 (382)
                      +++.+|+++++++ +|||||+++++|..     .+..++||||+++|+|.+++.......      ........+++..+
T Consensus       119 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  193 (382)
T 3tt0_A          119 SDLISEMEMMKMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL  193 (382)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHH
T ss_pred             HHHHHHHHHHHHhcCCchhhhheeeecc-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHH
Confidence            6799999999999 99999999999643     677899999999999999996432110      00112346999999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEV  256 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~  256 (382)
                      +.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....              ..+||...+..+
T Consensus       194 ~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  270 (382)
T 3tt0_A          194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY  270 (382)
T ss_dssp             HHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC
T ss_pred             HHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC
Confidence            999999999999999   679999999999999999999999999999865321              234666667788


Q ss_pred             CccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          257 STIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      +.++|||||||++|||+| |+.||....     ...........         ......                  ..+
T Consensus       271 ~~~~DiwslG~il~ellt~g~~p~~~~~-----~~~~~~~~~~~---------~~~~~~------------------~~~  318 (382)
T 3tt0_A          271 THQSDVWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKEG---------HRMDKP------------------SNC  318 (382)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHTT---------CCCCCC------------------SSC
T ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC---------CCCCCC------------------ccC
Confidence            999999999999999999 999986321     11111111000         000000                  022


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhc
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  372 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~  372 (382)
                      ..++.+++.+||+.||++|||+.||++.|+++.....
T Consensus       319 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          319 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            3467888889999999999999999999999987653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7e-36  Score=278.36  Aligned_cols=240  Identities=21%  Similarity=0.221  Sum_probs=163.9

Q ss_pred             chhhH-----HHHHHHHHHH--hhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-----KSFIAECKAL--RNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l--~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|++     +.+..|.+++  ..++|+||+++++.+......+....++||||+++|+|.+++..           ...
T Consensus        40 avK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~  108 (336)
T 3g2f_A           40 AVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----------HTS  108 (336)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----------CCB
T ss_pred             EEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----------ccc
Confidence            67765     4555555554  45899999999987765555666678999999999999999942           235


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCC---------ceeecCCCCCceeeCCCCcEEEccccccccCCCC------------
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQP---------VTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------  244 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~---------~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------  244 (382)
                      ++..+..++.|+++||+|||   +.         +|+||||||+|||++.++.+||+|||+++.....            
T Consensus       109 ~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~  185 (336)
T 3g2f_A          109 DWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA  185 (336)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------
T ss_pred             chhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcccccccc
Confidence            88899999999999999999   66         9999999999999999999999999999765321            


Q ss_pred             --------CCCCccccC-------CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcC-Cchhh---hh
Q 040999          245 --------RTQTKYGVG-------NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALP-NHVKD---IV  305 (382)
Q Consensus       245 --------~~~~~~~~~-------~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~---~~  305 (382)
                              ..+||...+       ..++.++|||||||++|||+||..||............+...... ....+   .+
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (336)
T 3g2f_A          186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV  265 (336)
T ss_dssp             CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHH
T ss_pred             ccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhh
Confidence                    223554443       345678999999999999999987754321111000000000000 00000   00


Q ss_pred             hcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCCCCC
Q 040999          306 DSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNL  377 (382)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~~~  377 (382)
                      ........        .   .........+...+.+++.+||+.||++|||+.|+++.|+++...+.+..+.
T Consensus       266 ~~~~~~~~--------~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~  326 (336)
T 3g2f_A          266 SREKQRPK--------F---PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV  326 (336)
T ss_dssp             TTSCCCCC--------C---CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred             cccccCCC--------C---CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence            00000000        0   0000001135567899999999999999999999999999999887775544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-36  Score=294.22  Aligned_cols=212  Identities=24%  Similarity=0.383  Sum_probs=164.6

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+       +.|.+|+++|++++||||+++++++.      .+..++||||+++|+|.+++..        .....+
T Consensus       212 avK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~~~iv~e~~~~gsL~~~l~~--------~~~~~~  277 (452)
T 1fmk_A          212 AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKG--------ETGKYL  277 (452)
T ss_dssp             EEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEEECCCTTCBHHHHHSH--------HHHTTC
T ss_pred             EEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc------CCceEEEehhhcCCCHHHHHHh--------cCCCCC
Confidence            67665       67999999999999999999999863      2568999999999999999942        122458


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~  252 (382)
                      ++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....             ..+||...
T Consensus       278 ~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  354 (452)
T 1fmk_A          278 RLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  354 (452)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHh
Confidence            99999999999999999999   779999999999999999999999999999865321             33466666


Q ss_pred             CCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 GNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      +..++.++|||||||++|||+| |+.||.....     ......         +.........                 
T Consensus       355 ~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~---------i~~~~~~~~~-----------------  403 (452)
T 1fmk_A          355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQ---------VERGYRMPCP-----------------  403 (452)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHH---------HHTTCCCCCC-----------------
T ss_pred             cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHH---------HHcCCCCCCC-----------------
Confidence            6788999999999999999999 9999864211     111110         0000000000                 


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                       ..++..+.+++.+||+.||++|||++++++.|+.+......
T Consensus       404 -~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          404 -PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             -CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence             02345678889999999999999999999999998766443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.8e-36  Score=276.09  Aligned_cols=215  Identities=21%  Similarity=0.344  Sum_probs=163.4

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc--------------cccC
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE--------------TYER  181 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~  181 (382)
                      ..+.+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++........              ....
T Consensus        69 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (314)
T 2ivs_A           69 ELRDLLSEFNVLKQVNHPHVIKLYGACS-----QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD  143 (314)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC---------------
T ss_pred             HHHHHHHHHHHHhhCCCCceeeEEEEEe-----cCCceEEEEeecCCCCHHHHHHHHhhccCCccccccccccccccccc
Confidence            3477899999999999999999999964     36778999999999999999964321100              0012


Q ss_pred             CcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCC
Q 040999          182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQ  247 (382)
Q Consensus       182 ~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~  247 (382)
                      ...+++..++.++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....              ...
T Consensus       144 ~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  220 (314)
T 2ivs_A          144 ERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMA  220 (314)
T ss_dssp             -CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCC
T ss_pred             ccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccC
Confidence            245899999999999999999999   679999999999999999999999999999765322              233


Q ss_pred             CccccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhh
Q 040999          248 TKYGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQ  326 (382)
Q Consensus       248 ~~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (382)
                      ||...+..++.++|||||||++|||+| |+.||.....  ............            ....            
T Consensus       221 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~------------~~~~------------  274 (314)
T 2ivs_A          221 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP--ERLFNLLKTGHR------------MERP------------  274 (314)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCC------------CCCC------------
T ss_pred             hhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHhhcCCc------------CCCC------------
Confidence            555556678999999999999999999 9999864321  111111111000            0000            


Q ss_pred             hhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          327 AKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                            ......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       275 ------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          275 ------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence                  02234678888899999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.2e-35  Score=270.49  Aligned_cols=217  Identities=27%  Similarity=0.367  Sum_probs=166.2

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++...       .....+++..+..++.|
T Consensus        74 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~~  141 (307)
T 2nru_A           74 KQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCL-------DGTPPLSWHMRCKIAQG  141 (307)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTG-------GGCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhc-------cCCCCCCHHHHHHHHHH
Confidence            467999999999999999999999964     367789999999999999998532       12346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....              ...||... ..++.++||
T Consensus       142 i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv  217 (307)
T 2nru_A          142 AANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDI  217 (307)
T ss_dssp             HHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHH
T ss_pred             HHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchh
Confidence            999999999   679999999999999999999999999998765432              12244332 357889999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHh--cCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--LPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||+++|||+||+.||+...... ....+....  ....+.+.+++.+...                   .......+.
T Consensus       218 ~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~l~  277 (307)
T 2nru_A          218 YSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMNDA-------------------DSTSVEAMY  277 (307)
T ss_dssp             HHHHHHHHHHHHCCCSBCTTBSSS-BTTHHHHHHHTTSCCHHHHSCSSCSCC-------------------CHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCcccCcchH-HHHHHHHHhhhhhhhhhhhcccccccc-------------------chHHHHHHH
Confidence            999999999999999987543222 122222111  1112333333322111                   124566788


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      +++.+||+.+|++|||+.+|++.|+++..
T Consensus       278 ~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          278 SVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            99999999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-35  Score=273.78  Aligned_cols=223  Identities=22%  Similarity=0.305  Sum_probs=161.0

Q ss_pred             chhhH-----HHHHHHHHHHhhc--ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-----KSFIAECKALRNI--RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|++     ..+.+|.+++...  +||||+++++++... .......++||||+++|+|.+++..           ..+
T Consensus        64 avK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~  131 (337)
T 3mdy_A           64 AVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG-TGSWTQLYLITDYHENGSLYDYLKS-----------TTL  131 (337)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-CGGGCEEEEEECCCTTCBHHHHHHH-----------CCB
T ss_pred             EEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccC-CCCCCceEEEEeccCCCcHHHHhhc-----------cCC
Confidence            77765     4566677777665  899999999997642 1112678999999999999999932           358


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCC--------ceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQP--------VTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------  244 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~--------~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------  244 (382)
                      ++..++.++.|++.||.|||   ..        +|+||||||+|||++.++.+||+|||+++.....             
T Consensus       132 ~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g  208 (337)
T 3mdy_A          132 DAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG  208 (337)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCS
T ss_pred             CHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCcc
Confidence            99999999999999999999   55        9999999999999999999999999999754321             


Q ss_pred             ---CCCCccccCCCCCc------cchhHHHHHHHHHHHhc----------CCCCCccccCCchHHHHHHHhcCCchhhhh
Q 040999          245 ---RTQTKYGVGNEVST------IGDVYSYGILLLELMIR----------EKPSDIMFEGDMNLHKFAKMALPNHVKDIV  305 (382)
Q Consensus       245 ---~~~~~~~~~~~~~~------~~Dv~S~Gvil~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (382)
                         ..+||...+...+.      ++|||||||++|||+||          +.||......................    
T Consensus       209 t~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----  284 (337)
T 3mdy_A          209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL----  284 (337)
T ss_dssp             CGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----
T ss_pred             CcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhcc----
Confidence               22355544444444      39999999999999999          55554332222222222211111000    


Q ss_pred             hcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          306 DSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                          .....             ......++...+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus       285 ----~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          285 ----RPSFP-------------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             ----CCCCC-------------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ----Ccccc-------------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence                00000             00011256678899999999999999999999999999998763

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=285.74  Aligned_cols=210  Identities=21%  Similarity=0.345  Sum_probs=161.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .++.+|+.++++++|||||++++++.     .....++||||+++|+|.+++......   ......+++..++.++.||
T Consensus       119 ~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi  190 (367)
T 3l9p_A          119 LDFLMEALIISKFNHQNIVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVARDI  190 (367)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEEEECCTTEEHHHHHHHHSCC---SSSCCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCCCEEEEEeCCCCCHHHHHHhhccc---cCccccccHHHHHHHHHHH
Confidence            57899999999999999999999964     366779999999999999999543211   1223468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCC---cEEEccccccccC--------------CCCCCCCccccCCCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDM---TARVGDFGLARFL--------------PPTRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfg~a~~~--------------~~~~~~~~~~~~~~~~~~~  260 (382)
                      ++||+|||   +.+|+||||||+|||++.++   .+||+|||+++..              +.....||...+..++.++
T Consensus       191 ~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  267 (367)
T 3l9p_A          191 ACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKT  267 (367)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHH
Confidence            99999999   67999999999999999554   5999999999743              1123457766677899999


Q ss_pred             hhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          261 DVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       261 Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      |||||||++|||+| |..||....     ...........         .......                  .+...+
T Consensus       268 DvwslG~il~ellt~g~~pf~~~~-----~~~~~~~i~~~---------~~~~~~~------------------~~~~~l  315 (367)
T 3l9p_A          268 DTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFVTSG---------GRMDPPK------------------NCPGPV  315 (367)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHTT---------CCCCCCT------------------TCCHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC---------CCCCCCc------------------cCCHHH
Confidence            99999999999998 999986421     11111111000         0000000                  223467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+++.+||+.||++|||+.+|++.|+.+...
T Consensus       316 ~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          316 YRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            8888999999999999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9e-36  Score=276.38  Aligned_cols=198  Identities=18%  Similarity=0.211  Sum_probs=153.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        50 ~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi  114 (323)
T 3tki_A           50 ENIKKEICINKMLNHENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQL  114 (323)
T ss_dssp             -CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeEEEEEEcCCCCcHHHHHh----------hcCCCCHHHHHHHHHHH
Confidence            56889999999999999999999964     3678899999999999999983          34468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCC-Cccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEV-STIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~-~~~~Dv  262 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++....              ....||...+..+ +.++||
T Consensus       115 ~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  191 (323)
T 3tki_A          115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV  191 (323)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHH
T ss_pred             HHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccH
Confidence            99999999   67999999999999999999999999999975421              1223555555554 778999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||+||+.||............+......            ....                  ......+.++
T Consensus       192 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------~~~~------------------~~~~~~~~~l  241 (323)
T 3tki_A          192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------LNPW------------------KKIDSAPLAL  241 (323)
T ss_dssp             HHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT------------STTG------------------GGSCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc------------CCcc------------------ccCCHHHHHH
Confidence            999999999999999987533222222222111000            0000                  0123356788


Q ss_pred             hhccCCCCccCCCCHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +.+||+.||++|||+.|+++.
T Consensus       242 i~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHccCChhhCcCHHHHhhC
Confidence            889999999999999999763

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-36  Score=282.24  Aligned_cols=215  Identities=22%  Similarity=0.338  Sum_probs=162.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC--------------ccccCCc
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED--------------ETYERPR  183 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~  183 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++|+|.+++.......              .......
T Consensus        95 ~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (343)
T 1luf_A           95 ADFQREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP  169 (343)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------C
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEcc-----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCC
Confidence            679999999999999999999999643     677899999999999999986432100              0001125


Q ss_pred             ccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCc
Q 040999          184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTK  249 (382)
Q Consensus       184 ~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~  249 (382)
                      .+++..++.++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++....              ....||
T Consensus       170 ~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  246 (343)
T 1luf_A          170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE  246 (343)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChh
Confidence            7899999999999999999999   67999999999999999999999999999875321              133466


Q ss_pred             cccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhh
Q 040999          250 YGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAK  328 (382)
Q Consensus       250 ~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (382)
                      ...+..++.++||||||+++|||+| |+.||....     ...........        .....+               
T Consensus       247 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~~~--------~~~~~~---------------  298 (343)
T 1luf_A          247 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-----HEEVIYYVRDG--------NILACP---------------  298 (343)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHHHTT--------CCCCCC---------------
T ss_pred             hhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC-----hHHHHHHHhCC--------CcCCCC---------------
Confidence            6666778999999999999999999 999986421     11111111000        000000               


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhc
Q 040999          329 INVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  372 (382)
Q Consensus       329 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~  372 (382)
                          ..++..+.+++.+||+.||++|||+.++++.|+++.+.+.
T Consensus       299 ----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          299 ----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             ----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence                0223467888889999999999999999999999987653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-35  Score=270.20  Aligned_cols=202  Identities=20%  Similarity=0.337  Sum_probs=155.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .  .++||||+++|+|.+++.         .....+++..++.++.|+
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~--~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~~~l  131 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHN-----P--PRMVMEFVPCGDLYHRLL---------DKAHPIKWSVKLRLMLDI  131 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETT-----T--TEEEEECCTTCBHHHHHH---------CTTSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecC-----C--CeEEEEecCCCCHHHHHh---------cccCCccHHHHHHHHHHH
Confidence            789999999999999999999998632     2  369999999999988884         334568999999999999


Q ss_pred             HHHHhHHhhcCCCc--eeecCCCCCceeeCCCCc-----EEEccccccccCCC---------CCCCCccc--cCCCCCcc
Q 040999          198 ASALNYLHHDCQPV--TAHCDLKPSNVLLDDDMT-----ARVGDFGLARFLPP---------TRTQTKYG--VGNEVSTI  259 (382)
Q Consensus       198 ~~~L~~lH~~~~~~--ivH~dlkp~NILl~~~~~-----~kl~Dfg~a~~~~~---------~~~~~~~~--~~~~~~~~  259 (382)
                      +.||+|||   +.+  |+||||||+||+++.++.     +||+|||+++....         ....||..  ....++.+
T Consensus       132 ~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~  208 (287)
T 4f0f_A          132 ALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEK  208 (287)
T ss_dssp             HHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHH
T ss_pred             HHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCch
Confidence            99999999   667  999999999999988776     99999999975432         23447765  34557889


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +|||||||++|||++|+.||..................           ......                  ..+...+
T Consensus       209 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------~~~~~~------------------~~~~~~l  259 (287)
T 4f0f_A          209 ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG-----------LRPTIP------------------EDCPPRL  259 (287)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC-----------CCCCCC------------------TTSCHHH
T ss_pred             hhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC-----------CCCCCC------------------cccCHHH
Confidence            99999999999999999998743222111111111100           000000                  0223467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      .+++.+||+.||++|||+.|+++.|+++
T Consensus       260 ~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          260 RNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            8888899999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-35  Score=271.16  Aligned_cols=213  Identities=19%  Similarity=0.284  Sum_probs=168.1

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++.      .+..++||||+++++|.+++..         ....+++..+..++.|
T Consensus        54 ~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~q  118 (287)
T 1u59_A           54 TEEMMREAQIMHQLDNPYIVRLIGVCQ------AEALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQ  118 (287)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEEECCTTEEHHHHHTT---------CTTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEec------CCCcEEEEEeCCCCCHHHHHHh---------CCccCCHHHHHHHHHH
Confidence            367999999999999999999999963      4568999999999999999842         3356899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~D  261 (382)
                      +++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....               ...||...+..++.++|
T Consensus       119 i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  195 (287)
T 1u59_A          119 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD  195 (287)
T ss_dssp             HHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHH
T ss_pred             HHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhh
Confidence            999999999   679999999999999999999999999999865322               22355555567889999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||+++|||+| |+.||.....  ............            ....                  ..++..+.
T Consensus       196 i~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~~~~------------~~~~------------------~~~~~~l~  243 (287)
T 1u59_A          196 VWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKR------------MECP------------------PECPPELY  243 (287)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTCC------------CCCC------------------TTCCHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhcCCc------------CCCC------------------CCcCHHHH
Confidence            9999999999998 9999864211  111111111000            0000                  02234678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCCCCCCC
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNLAT  379 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~~~~~  379 (382)
                      +++.+||+.+|++|||+.++++.|+++..+...+..+.+
T Consensus       244 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~  282 (287)
T 1u59_A          244 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH  282 (287)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCc
Confidence            888899999999999999999999999998877766543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.8e-35  Score=269.67  Aligned_cols=211  Identities=22%  Similarity=0.387  Sum_probs=163.4

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++||||++++++|..    ..+..++||||+++|+|.+++..         ....+++..++.++.
T Consensus        69 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~  135 (298)
T 3f66_A           69 EVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIRN---------ETHNPTVKDLIGFGL  135 (298)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSCCEEEEECCTTCBHHHHHHC---------TTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CCCceEEEEeCCCCCCHHHHHHh---------cccCCCHHHHHHHHH
Confidence            34679999999999999999999998743    35678999999999999999942         345688999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccCCCCCcc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVGNEVSTI  259 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~~~~~~~  259 (382)
                      |++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....                ...||...+..++.+
T Consensus       136 ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  212 (298)
T 3f66_A          136 QVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK  212 (298)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChH
Confidence            9999999999   679999999999999999999999999999755321                233555556778999


Q ss_pred             chhHHHHHHHHHHHhc-CCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMIR-EKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +||||||+++|||++| .+||.....  ............           ...+ .                  .++..
T Consensus       213 ~Di~slG~il~~l~~~~~~~~~~~~~--~~~~~~~~~~~~-----------~~~~-~------------------~~~~~  260 (298)
T 3f66_A          213 SDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRR-----------LLQP-E------------------YCPDP  260 (298)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTSCT--TTHHHHHHTTCC-----------CCCC-T------------------TCCHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhcCCC-----------CCCC-c------------------cCCHH
Confidence            9999999999999995 555543211  111111110000           0000 0                  12235


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCC
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  374 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~  374 (382)
                      +.+++.+||+.+|++|||+.|+++.|+++...+.++
T Consensus       261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~  296 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  296 (298)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            778888999999999999999999999999877553

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-35  Score=274.50  Aligned_cols=199  Identities=22%  Similarity=0.284  Sum_probs=155.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++..     .+..++||||+++|+|.+++..         ....+++..+..++.|+
T Consensus        46 ~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~i~~qi  111 (321)
T 1tki_A           46 VLVKKEISILNIARHRNILHLHESFES-----MEELVMIFEFISGLDIFERINT---------SAFELNEREIVSYVHQV  111 (321)
T ss_dssp             HHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEEECCCCCCBHHHHHTS---------SSCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEEEEEeCCCCCHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            568899999999999999999999654     6789999999999999999842         23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCC--CCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDD--DMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~--~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++.....           ..+||...+..++.++||||
T Consensus       112 ~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  188 (321)
T 1tki_A          112 CEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWS  188 (321)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHH
T ss_pred             HHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHH
Confidence            99999999   679999999999999987  789999999999876433           33466666677899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....    . ......        +.........                ........++.+++.
T Consensus       189 lG~il~~ll~g~~pf~~~~----~-~~~~~~--------i~~~~~~~~~----------------~~~~~~s~~~~~li~  239 (321)
T 1tki_A          189 LGTLVYVLLSGINPFLAET----N-QQIIEN--------IMNAEYTFDE----------------EAFKEISIEAMDFVD  239 (321)
T ss_dssp             HHHHHHHHHHSSCTTCCSS----H-HHHHHH--------HHHTCCCCCH----------------HHHTTSCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCcCCC----H-HHHHHH--------HHcCCCCCCh----------------hhhccCCHHHHHHHH
Confidence            9999999999999986421    1 111110        0010000000                000123346788888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||++|||+.|+++
T Consensus       240 ~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          240 RLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TTSCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHhc
Confidence            999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.8e-37  Score=283.28  Aligned_cols=220  Identities=22%  Similarity=0.321  Sum_probs=162.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   .+....++||||+++++|.+++..         ....+++..++.++.|+
T Consensus        69 ~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi  136 (327)
T 3lxl_A           69 RDFQREIQILKALHSDFIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQR---------HRARLDASRLLLYSSQI  136 (327)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEC---SSSCEEEEEEECCTTCBHHHHHHH---------HGGGCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCceeEEEEEEec---CCCceEEEEEeecCCCCHHHHHHh---------cccCCCHHHHHHHHHHH
Confidence            668999999999999999999998753   346778999999999999999842         23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....               ...||...+..++.++||
T Consensus       137 ~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  213 (327)
T 3lxl_A          137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDV  213 (327)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHH
T ss_pred             HHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhH
Confidence            99999999   679999999999999999999999999999865432               233555556677899999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhc----CCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL----PNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ||||+++|||++|+.||.....      .......    ......+.+.........               ....+...
T Consensus       214 ~slG~il~~ll~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~  272 (327)
T 3lxl_A          214 WSFGVVLYELFTYCDKSCSPSA------EFLRMMGCERDVPALSRLLELLEEGQRLP---------------APPACPAE  272 (327)
T ss_dssp             HHHHHHHHHHHTTTCGGGSHHH------HHHHHCC----CCHHHHHHHHHHTTCCCC---------------CCTTCCHH
T ss_pred             HHHHHHHHHHHhCCCCCccccc------hhhhhcccccccccHHHHHHHhhcccCCC---------------CCCcccHH
Confidence            9999999999999999753211      1111100    001111111100000000               00123456


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      +.+++.+||+.||++|||+.|+++.|+.+......
T Consensus       273 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          273 VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence            78889999999999999999999999999775544

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-35  Score=269.62  Aligned_cols=204  Identities=20%  Similarity=0.323  Sum_probs=154.3

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+.++++++||||+++++++.      .+..++||||+++|+|.+++..         ....+++..+..++.|
T Consensus        60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~q  124 (281)
T 1mp8_A           60 REKFLQEALTMRQFDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQV---------RKYSLDLASLILYAYQ  124 (281)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEC------SSSCEEEEECCTTEEHHHHHHH---------TTTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCccceEEEEEc------cCccEEEEecCCCCCHHHHHHh---------cCCCCCHHHHHHHHHH
Confidence            367899999999999999999999852      4567899999999999999842         2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      ++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....             ..+||...+..++.++|||
T Consensus       125 i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  201 (281)
T 1mp8_A          125 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVW  201 (281)
T ss_dssp             HHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHH
T ss_pred             HHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCch
Confidence            999999999   679999999999999999999999999999765332             3346666667789999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||+++|||++ |..||......  ..........           ....+                   ..++..+.++
T Consensus       202 slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~-----------~~~~~-------------------~~~~~~l~~l  249 (281)
T 1mp8_A          202 MFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGE-----------RLPMP-------------------PNCPPTLYSL  249 (281)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTC-----------CCCCC-------------------TTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCC-----------CCCCC-------------------CCCCHHHHHH
Confidence            99999999997 99998743211  1111111000           00000                   0223467788


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +.+||+.||++|||+.|+++.|+++.+.
T Consensus       250 i~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          250 MTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            8899999999999999999999998765

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-35  Score=269.55  Aligned_cols=213  Identities=24%  Similarity=0.389  Sum_probs=163.5

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++||||+++++++..    .....++||||+.+|+|.+++..         ....+++..+..++.
T Consensus        65 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~~v~e~~~~~~L~~~~~~---------~~~~~~~~~~~~i~~  131 (298)
T 3pls_A           65 QVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGLPHVLLPYMCHGDLLQFIRS---------PQRNPTVKDLISFGL  131 (298)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSCCEEEECCCTTCBHHHHHHC---------TTCCCBHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCCcEEEEecccCCCHHHHHhc---------cccCCCHHHHHHHHH
Confidence            34779999999999999999999999753    23445899999999999999942         345689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccCCCCCcc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVGNEVSTI  259 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~~~~~~~  259 (382)
                      |++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....                ...||...+..++.+
T Consensus       132 qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  208 (298)
T 3pls_A          132 QVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK  208 (298)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHH
T ss_pred             HHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChh
Confidence            9999999999   679999999999999999999999999999754321                223555566778999


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +||||||+++|||+||..|+..... ..............            ....                  .....+
T Consensus       209 ~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~------------~~~~------------------~~~~~l  257 (298)
T 3pls_A          209 SDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRL------------PQPE------------------YCPDSL  257 (298)
T ss_dssp             HHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTCCC------------CCCT------------------TCCHHH
T ss_pred             hchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCCCC------------CCCc------------------cchHHH
Confidence            9999999999999996666432111 11111111111000            0000                  123367


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCCC
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  375 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~  375 (382)
                      .+++.+||+.||.+|||+.++++.|+++...+....
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~  293 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH  293 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence            788889999999999999999999999999876543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.7e-36  Score=279.40  Aligned_cols=195  Identities=19%  Similarity=0.270  Sum_probs=152.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|+.++||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        59 ~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~l~~~~~~~~~~qi  123 (328)
T 3fe3_A           59 QKLFREVRIMKILNHPNIVKLFEVIE-----TEKTLYLIMEYASGGEVFDYLV----------AHGRMKEKEARSKFRQI  123 (328)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEECCCTTCBHHHHHH----------HHCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEEEEECCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            57889999999999999999999964     3778999999999999999983          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCC-CccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEV-STIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~-~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...+..+ +.++||||+
T Consensus       124 ~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  200 (328)
T 3fe3_A          124 VSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSL  200 (328)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHH
T ss_pred             HHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhh
Confidence            99999999   679999999999999999999999999999765432           233665555555 479999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||+..     .........        ...... .+            .       .....+.+++.+
T Consensus       201 G~il~ell~g~~pf~~~-----~~~~~~~~i--------~~~~~~-~p------------~-------~~s~~~~~li~~  247 (328)
T 3fe3_A          201 GVILYTLVSGSLPFDGQ-----NLKELRERV--------LRGKYR-IP------------F-------YMSTDCENLLKR  247 (328)
T ss_dssp             HHHHHHHHHSSCSSCCS-----SHHHHHHHH--------HHCCCC-CC------------T-------TSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCC-----CHHHHHHHH--------HhCCCC-CC------------C-------CCCHHHHHHHHH
Confidence            99999999999998642     111111110        000000 00            0       112356778889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.||.+|||++|+++.
T Consensus       248 ~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          248 FLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HCCSSTTTSCCHHHHTTC
T ss_pred             HCCCChhHCcCHHHHhcC
Confidence            999999999999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-35  Score=267.64  Aligned_cols=204  Identities=22%  Similarity=0.379  Sum_probs=161.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++++|.+++..         ....+++..+..++.|+
T Consensus        48 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~~i  113 (267)
T 3t9t_A           48 EDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVTEFMEHGCLSDYLRT---------QRGLFAAETLLGMCLDV  113 (267)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEEEECCCTTCBHHHHHHH---------TTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEEEEeCCCCCcHHHHHhh---------CcccCCHHHHHHHHHHH
Confidence            679999999999999999999999643     6678999999999999999842         33468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||+++....             ...+||...+..++.++||||
T Consensus       114 ~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  190 (267)
T 3t9t_A          114 CEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS  190 (267)
T ss_dssp             HHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhh
Confidence            99999999   67999999999999999999999999999976432             133466666677899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||++ |+.||....     ...........        .....+ .                  .....+.+++
T Consensus       191 lG~il~~l~~~g~~p~~~~~-----~~~~~~~i~~~--------~~~~~~-~------------------~~~~~l~~li  238 (267)
T 3t9t_A          191 FGVLMWEVFSEGKIPYENRS-----NSEVVEDISTG--------FRLYKP-R------------------LASTHVYQIM  238 (267)
T ss_dssp             HHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTT--------CCCCCC-T------------------TSCHHHHHHH
T ss_pred             hHHHHHHHhccCCCCCCCCC-----HHHHHHHHhcC--------CcCCCC-c------------------cCcHHHHHHH
Confidence            9999999999 899986421     11111110000        000000 0                  1223577888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+||+.||++|||+.++++.|+++.+.
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            899999999999999999999998764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=276.40  Aligned_cols=215  Identities=15%  Similarity=0.167  Sum_probs=162.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+..++.++||||+++++++... +.+....++||||+ +++|.+++.          ....+++..++.++.||
T Consensus        93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~----------~~~~~~~~~~~~i~~qi  160 (345)
T 2v62_A           93 KDCIKKWIERKQLDYLGIPLFYGSGLTE-FKGRSYRFMVMERL-GIDLQKISG----------QNGTFKKSTVLQLGIRM  160 (345)
T ss_dssp             HHHHHHHHHHHTCSCCCCCCEEEEEEEE-SSSCEEEEEEEECE-EEEHHHHCB----------GGGBCCHHHHHHHHHHH
T ss_pred             hHHHHHHHhhccccccCcceeecccccc-cCCCcEEEEEEecc-CCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            4577899999999999999999997642 24467899999999 999999984          23378999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCC--cEEEccccccccCCC-------------------CCCCCccccCCCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDM--TARVGDFGLARFLPP-------------------TRTQTKYGVGNEV  256 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~--~~kl~Dfg~a~~~~~-------------------~~~~~~~~~~~~~  256 (382)
                      +.||+|||   +.+|+||||||+|||++.++  .+||+|||+++.+..                   ...+||...+..+
T Consensus       161 ~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  237 (345)
T 2v62_A          161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL  237 (345)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC
T ss_pred             HHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC
Confidence            99999999   67999999999999998877  999999999975421                   2234666667778


Q ss_pred             CccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          257 STIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      +.++|||||||++|||+||+.||................. .......+......                     ...+
T Consensus       238 ~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---------------------~~~~  295 (345)
T 2v62_A          238 SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNL-LDELPQSVLKWAPS---------------------GSSC  295 (345)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHH-HHTTTHHHHHHSCT---------------------TSCC
T ss_pred             CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhh-cccccHHHHhhccc---------------------cccH
Confidence            9999999999999999999999864322211111111110 00011101000000                     0233


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      ..+.+++.+||+.||++|||+.+|++.|+++.-
T Consensus       296 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          296 CEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            468888889999999999999999999988755

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-35  Score=271.25  Aligned_cols=212  Identities=13%  Similarity=0.125  Sum_probs=163.7

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++++.+ +|+|++++++++..     ....++||||+ +++|.+++..         ....+++..+..++.|
T Consensus        50 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~lv~e~~-~~~L~~~l~~---------~~~~~~~~~~~~i~~q  114 (298)
T 1csn_A           50 PQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNVLVIDLL-GPSLEDLLDL---------CGRKFSVKTVAMAAKQ  114 (298)
T ss_dssp             CCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCCeEEeecCC-----CceeEEEEEec-CCCHHHHHHH---------hccCCCHHHHHHHHHH
Confidence            4688999999999 79999999998643     67889999999 9999999942         2345899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCc-----EEEccccccccCCCC-------------------CCCCcccc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT-----ARVGDFGLARFLPPT-------------------RTQTKYGV  252 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~-----~kl~Dfg~a~~~~~~-------------------~~~~~~~~  252 (382)
                      ++.||+|||   +.+|+||||||+||+++.++.     +||+|||+++.....                   ..+||...
T Consensus       115 i~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  191 (298)
T 1csn_A          115 MLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL  191 (298)
T ss_dssp             HHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred             HHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhc
Confidence            999999999   789999999999999987766     999999999765322                   23366666


Q ss_pred             CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCch--HHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhh
Q 040999          253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMN--LHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN  330 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (382)
                      +..++.++|||||||++|||++|+.||.........  +........+.....                           
T Consensus       192 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------  244 (298)
T 1csn_A          192 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE---------------------------  244 (298)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH---------------------------
T ss_pred             CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH---------------------------
Confidence            777899999999999999999999998753221110  000000000000000                           


Q ss_pred             hHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCC
Q 040999          331 VIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  374 (382)
Q Consensus       331 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~  374 (382)
                      .....+..+.+++.+||+.||++|||+++|++.|+++.+.+...
T Consensus       245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            00123457888899999999999999999999999998876543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-35  Score=272.40  Aligned_cols=215  Identities=22%  Similarity=0.266  Sum_probs=164.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC--------ccccCCcccCHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED--------ETYERPRNLNLL  188 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~~~l~~~  188 (382)
                      +.+.+|+++++++ +||||+++++++..     .+..++||||+++|+|.+++.......        ........+++.
T Consensus        71 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (313)
T 1t46_A           71 EALMSELKVLSYLGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE  145 (313)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHH
T ss_pred             HHHHHHHHHHhhcccCCCeeeEEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHH
Confidence            6799999999999 99999999999643     677899999999999999986432110        000122358999


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGN  254 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~  254 (382)
                      .++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....              ..+||...+.
T Consensus       146 ~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  222 (313)
T 1t46_A          146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC  222 (313)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC
Confidence            99999999999999999   679999999999999999999999999999865432              2335655667


Q ss_pred             CCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHH
Q 040999          255 EVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII  333 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (382)
                      .++.++||||||+++|||+| |+.||...... ............            .....                  
T Consensus       223 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~------------~~~~~------------------  271 (313)
T 1t46_A          223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMIKEGFR------------MLSPE------------------  271 (313)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHHHHHHHTCC------------CCCCT------------------
T ss_pred             CCChHHHHHHHHHHHHHHHhCCCCCCCcccch-hHHHHHhccCCC------------CCCcc------------------
Confidence            78999999999999999999 99998643211 111111111110            00000                  


Q ss_pred             HHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       334 ~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      .....+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus       272 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            12346788888999999999999999999999988764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-36  Score=277.49  Aligned_cols=205  Identities=22%  Similarity=0.399  Sum_probs=158.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++..         ....+++..++.++.|+
T Consensus        91 ~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi  156 (333)
T 1mqb_A           91 VDFLGEAGIMGQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGI  156 (333)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEEEEECCTTEEHHHHHHH---------TTTCSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEe-----cCCCcEEEEeCCCCCcHHHHHHh---------CCCCCCHHHHHHHHHHH
Confidence            57899999999999999999999964     36788999999999999999842         33568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....               ...||...+..++.++||
T Consensus       157 ~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  233 (333)
T 1mqb_A          157 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV  233 (333)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHH
T ss_pred             HHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhh
Confidence            99999999   679999999999999999999999999999865321               334666667788999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||+| |+.||.....     .......        .+......+                   ..+...+.+
T Consensus       234 ~slG~il~ellt~g~~pf~~~~~-----~~~~~~~--------~~~~~~~~~-------------------~~~~~~l~~  281 (333)
T 1mqb_A          234 WSFGIVMWEVMTYGERPYWELSN-----HEVMKAI--------NDGFRLPTP-------------------MDCPSAIYQ  281 (333)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHH--------HTTCCCCCC-------------------TTCBHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCcccCCH-----HHHHHHH--------HCCCcCCCc-------------------ccCCHHHHH
Confidence            999999999999 9999864211     1111100        000000000                   022346788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      ++.+||+.+|++||++.++++.|+++....
T Consensus       282 li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          282 LMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            888999999999999999999999987643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-35  Score=268.82  Aligned_cols=204  Identities=17%  Similarity=0.296  Sum_probs=159.4

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++.      .+..++||||+++++|.+++..         ....+++..+..++.|
T Consensus        57 ~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~  121 (281)
T 3cc6_A           57 KEKFMSEAVIMKNLDHPHIVKLIGIIE------EEPTWIIMELYPYGELGHYLER---------NKNSLKVLTLVLYSLQ  121 (281)
T ss_dssp             HHHHHHHHHHHHHHCCTTBCCEEEEEC------SSSCEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEc------CCCCEEEEecCCCCCHHHHHHh---------ccccCCHHHHHHHHHH
Confidence            467999999999999999999999853      3456899999999999999842         2345899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      ++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....             ..+||...+..++.++|||
T Consensus       122 i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  198 (281)
T 3cc6_A          122 ICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVW  198 (281)
T ss_dssp             HHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccH
Confidence            999999999   679999999999999999999999999999865332             2346655667789999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||+++|||+| |+.||.....  .............           ..+ .                  .+...+.++
T Consensus       199 slG~il~~llt~g~~p~~~~~~--~~~~~~~~~~~~~-----------~~~-~------------------~~~~~l~~l  246 (281)
T 3cc6_A          199 MFAVCMWEILSFGKQPFFWLEN--KDVIGVLEKGDRL-----------PKP-D------------------LCPPVLYTL  246 (281)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCG--GGHHHHHHHTCCC-----------CCC-T------------------TCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCcccCCh--HHHHHHHhcCCCC-----------CCC-C------------------CCCHHHHHH
Confidence            99999999998 9999864221  1111111111000           000 0                  123357788


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +.+||+.||++|||+.|+++.|+++...
T Consensus       247 i~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          247 MTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            8899999999999999999999998664

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-35  Score=277.01  Aligned_cols=216  Identities=23%  Similarity=0.271  Sum_probs=161.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC-------------ccccCCc
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED-------------ETYERPR  183 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~  183 (382)
                      +.+.+|+++++++ +||||+++++++..     .+..++||||+++|+|.+++.......             .......
T Consensus        93 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (344)
T 1rjb_A           93 EALMSELKMMTQLGSHENIVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN  167 (344)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEee-----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccc
Confidence            6789999999999 89999999999643     677899999999999999996432110             0001123


Q ss_pred             ccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCc
Q 040999          184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTK  249 (382)
Q Consensus       184 ~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~  249 (382)
                      .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....              ..+||
T Consensus       168 ~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  244 (344)
T 1rjb_A          168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  244 (344)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence            4899999999999999999999   679999999999999999999999999999754321              33466


Q ss_pred             cccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhh
Q 040999          250 YGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAK  328 (382)
Q Consensus       250 ~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (382)
                      ...+..++.++|||||||++|||+| |+.||..... .............            .....             
T Consensus       245 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~------------~~~~~-------------  298 (344)
T 1rjb_A          245 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-DANFYKLIQNGFK------------MDQPF-------------  298 (344)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHTTCC------------CCCCT-------------
T ss_pred             HhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc-HHHHHHHHhcCCC------------CCCCC-------------
Confidence            6666788999999999999999998 9999864321 1111111111100            00000             


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhc
Q 040999          329 INVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  372 (382)
Q Consensus       329 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~  372 (382)
                           .+...+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus       299 -----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          299 -----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             -----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence                 123467888889999999999999999999999876543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=273.97  Aligned_cols=214  Identities=18%  Similarity=0.226  Sum_probs=163.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++... .......++||||+++|+|.+++....      .....+++..++.++.|+
T Consensus        71 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi  143 (317)
T 2buj_A           71 EEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAWLLLPFFKRGTLWNEIERLK------DKGNFLTEDQILWLLLGI  143 (317)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEEEEEECCTTCBHHHHHHHHH------TTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeEEEEEeCCCCcHHHHHHHHH------hcCCCCCHHHHHHHHHHH
Confidence            6789999999999999999999997632 123457899999999999999885321      134568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC---------------------CCCCCCccccCCC-
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP---------------------PTRTQTKYGVGNE-  255 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~~~~~~-  255 (382)
                      ++||.|||   +.+|+||||||+||+++.++.+||+|||.++...                     .....||...+.. 
T Consensus       144 ~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  220 (317)
T 2buj_A          144 CRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH  220 (317)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSE
T ss_pred             HHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCC
Confidence            99999999   6799999999999999999999999999887542                     2345577665433 


Q ss_pred             --CCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHH
Q 040999          256 --VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII  333 (382)
Q Consensus       256 --~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (382)
                        ++.++||||||+++|||++|+.||+...............            .......                  .
T Consensus       221 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~------------------~  270 (317)
T 2buj_A          221 CVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN------------QLSIPQS------------------P  270 (317)
T ss_dssp             EEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC------------C--CCCC------------------T
T ss_pred             cCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc------------cCCCCcc------------------c
Confidence              6889999999999999999999986432222111111110            0000000                  0


Q ss_pred             HHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       334 ~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      .....+.+++.+||+.||.+|||+.++++.|+++....
T Consensus       271 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          271 RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            12346788888999999999999999999999886543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4e-36  Score=302.10  Aligned_cols=203  Identities=20%  Similarity=0.286  Sum_probs=162.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++|++++|||||+++++|.      .+..++||||+++|+|.+++.          ....+++..++.++.||
T Consensus       415 ~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~E~~~~g~L~~~l~----------~~~~l~~~~~~~i~~qi  478 (635)
T 4fl3_A          415 DELLAEANVMQQLDNPYIVRMIGICE------AESWMLVMEMAELGPLNKYLQ----------QNRHVKDKNIIELVHQV  478 (635)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEEECCTTEEHHHHHH----------HCTTCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEEEccCCCCHHHHHh----------hCCCCCHHHHHHHHHHH
Confidence            67999999999999999999999974      345789999999999999993          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....               ..+||...+..++.++||
T Consensus       479 ~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDv  555 (635)
T 4fl3_A          479 SMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV  555 (635)
T ss_dssp             HHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHH
Confidence            99999999   679999999999999999999999999999865322               334666667788999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||+| |+.||.....  ..........            ......                  ..++.++.+
T Consensus       556 wSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~------------~~~~~p------------------~~~~~~l~~  603 (635)
T 4fl3_A          556 WSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKG------------ERMGCP------------------AGCPREMYD  603 (635)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTT------------CCCCCC------------------TTCCHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC------------CCCCCC------------------CCCCHHHHH
Confidence            999999999998 9999864311  1111111110            000000                  023456788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      ++..||+.||++|||+.+|++.|+++...+
T Consensus       604 li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          604 LMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            899999999999999999999999987664

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.5e-36  Score=273.69  Aligned_cols=206  Identities=19%  Similarity=0.306  Sum_probs=156.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++|+|.+++..         ....+++..+..++.|+
T Consensus        57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi  122 (289)
T 4fvq_A           57 ESFFEAASMMSKLSHKHLVLNYGVCVC-----GDENILVQEFVKFGSLDTYLKK---------NKNCINILWKLEVAKQL  122 (289)
T ss_dssp             HHHHHHHHHHHTSCCTTBCCEEEEECC-----TTCCEEEEECCTTCBHHHHHHH---------TGGGCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEEe-----CCCCEEEEECCCCCCHHHHHHh---------CCCCCCHHHHHHHHHHH
Confidence            679999999999999999999999653     6678999999999999999942         33458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCc--------EEEccccccccCCC--------CCCCCccccC-CCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT--------ARVGDFGLARFLPP--------TRTQTKYGVG-NEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~--------~kl~Dfg~a~~~~~--------~~~~~~~~~~-~~~~~~~  260 (382)
                      +.||.|||   +.+|+||||||+|||++.++.        +||+|||++.....        ....||...+ ..++.++
T Consensus       123 ~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  199 (289)
T 4fvq_A          123 AAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLAT  199 (289)
T ss_dssp             HHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHH
T ss_pred             HHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchh
Confidence            99999999   679999999999999988877        99999999975532        3455777666 6789999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||||++|||+||..|+...... .........  ...        ...                      .....+.
T Consensus       200 DiwslG~il~el~~g~~~~~~~~~~-~~~~~~~~~--~~~--------~~~----------------------~~~~~l~  246 (289)
T 4fvq_A          200 DKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYED--RHQ--------LPA----------------------PKAAELA  246 (289)
T ss_dssp             HHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHT--TCC--------CCC----------------------CSSCTTH
T ss_pred             HHHHHHHHHHHHHcCCCCCccccch-HHHHHHhhc--cCC--------CCC----------------------CCCHHHH
Confidence            9999999999999965553221110 000000000  000        000                      0112467


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      +++.+||+.||++|||+.|+++.|+++...--.
T Consensus       247 ~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          247 NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             HHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence            788899999999999999999999998775433

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-35  Score=274.47  Aligned_cols=202  Identities=21%  Similarity=0.313  Sum_probs=159.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.++++++||||++++++|.      ....++||||+++|+|.+++..         ....+++..+..++.|+
T Consensus        60 ~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi  124 (325)
T 3kex_A           60 QAVTDHMLAIGSLDHAHIVRLLGLCP------GSSLQLVTQYLPLGSLLDHVRQ---------HRGALGPQLLLNWGVQI  124 (325)
T ss_dssp             CSCCHHHHHHHTCCCTTBCCEEEEEC------BSSEEEEEECCTTCBSHHHHHS---------SGGGSCTTHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEc------CCccEEEEEeCCCCCHHHHHHH---------ccccCCHHHHHHHHHHH
Confidence            56788999999999999999999863      4568899999999999999842         23568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....              ...||...+..++.++|||
T Consensus       125 ~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  201 (325)
T 3kex_A          125 AKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVW  201 (325)
T ss_dssp             HHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhH
Confidence            99999999   679999999999999999999999999999865332              2335655667789999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||++|||+| |+.||....  ...........            .......                  .+...+.++
T Consensus       202 slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~------------~~~~~~~------------------~~~~~~~~l  249 (325)
T 3kex_A          202 SYGVTVWELMTFGAEPYAGLR--LAEVPDLLEKG------------ERLAQPQ------------------ICTIDVYMV  249 (325)
T ss_dssp             HHHHHHHHHHTTSCCTTTTSC--TTHHHHHHHTT------------CBCCCCT------------------TBCTTTTHH
T ss_pred             HhHHHHHHHHhCCCCCccccC--HHHHHHHHHcC------------CCCCCCC------------------cCcHHHHHH
Confidence            99999999999 999987431  11111111110            0000000                  112246778


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      +.+||+.||++|||+.++++.|+++..
T Consensus       250 i~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          250 MVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             HHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            889999999999999999999999865

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-35  Score=275.37  Aligned_cols=215  Identities=22%  Similarity=0.355  Sum_probs=157.3

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccC-CCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQ-GNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+++.+|++++++++||||+++++++...... .....++||||+++|+|.+++......    .....+++..++.++.
T Consensus        69 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~  144 (323)
T 3qup_A           69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG----ENPFNLPLQTLVRFMV  144 (323)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcc----ccccccCHHHHHHHHH
Confidence            36799999999999999999999997642111 112238999999999999998532210    1223689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccch
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~D  261 (382)
                      |++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....              ...||...+..++.++|
T Consensus       145 qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  221 (323)
T 3qup_A          145 DIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSD  221 (323)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHH
T ss_pred             HHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccc
Confidence            9999999999   679999999999999999999999999999765321              23356556677899999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||+| |+.||.....  ........           .......+                   ......+.
T Consensus       222 i~slG~il~ell~~g~~p~~~~~~--~~~~~~~~-----------~~~~~~~~-------------------~~~~~~l~  269 (323)
T 3qup_A          222 VWAFGVTMWEIMTRGQTPYAGIEN--AEIYNYLI-----------GGNRLKQP-------------------PECMEEVY  269 (323)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH-----------TTCCCCCC-------------------TTCCHHHH
T ss_pred             hhhHHHHHHHHHhCCCCCccccCh--HHHHHHHh-----------cCCCCCCC-------------------CccCHHHH
Confidence            9999999999999 8999864221  11111110           00000000                   02234678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +++.+||+.||++|||+.++++.|+++...
T Consensus       270 ~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          270 DLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            888999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.4e-36  Score=273.14  Aligned_cols=208  Identities=20%  Similarity=0.274  Sum_probs=163.5

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+++.+|++++++++||||+++++++.      .+..++||||+++++|.+++..          ...+++..+..++.|
T Consensus        62 ~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~i~~q  125 (291)
T 1xbb_A           62 KDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVMEMAELGPLNKYLQQ----------NRHVKDKNIIELVHQ  125 (291)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEE------SSSEEEEEECCTTEEHHHHHHH----------CTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEC------CCCcEEEEEeCCCCCHHHHHHh----------CcCCCHHHHHHHHHH
Confidence            367999999999999999999999962      4568999999999999999942          345889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~D  261 (382)
                      +++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....               ...||...+..++.++|
T Consensus       126 i~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  202 (291)
T 1xbb_A          126 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD  202 (291)
T ss_dssp             HHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHH
T ss_pred             HHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhh
Confidence            999999999   679999999999999999999999999999865432               23355555667788999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||+++|||+| |+.||.....  ............            ....                  ..+...+.
T Consensus       203 i~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~------------~~~~------------------~~~~~~l~  250 (291)
T 1xbb_A          203 VWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGER------------MGCP------------------AGCPREMY  250 (291)
T ss_dssp             HHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCC------------CCCC------------------TTCCHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC------------CCCC------------------CCCCHHHH
Confidence            9999999999999 9999864211  111111110000            0000                  02234678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCCC
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  375 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~  375 (382)
                      +++.+||+.||++|||+.++++.|+++......+.
T Consensus       251 ~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  285 (291)
T 1xbb_A          251 DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG  285 (291)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence            88889999999999999999999999987655433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.6e-35  Score=274.11  Aligned_cols=210  Identities=16%  Similarity=0.133  Sum_probs=162.0

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++++++ +||||+++++++..     ....++||||+ +++|.+++..         ....+++..++.++.|
T Consensus        49 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~q  113 (330)
T 2izr_A           49 PQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMVLELL-GPSLEDLFDL---------CDRTFSLKTVLMIAIQ  113 (330)
T ss_dssp             CCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHH---------TTTCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEEEEeC-CCCHHHHHHH---------cCCCCCHHHHHHHHHH
Confidence            4588999999999 99999999999654     67889999999 9999999842         2356999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCc-----EEEccccccccCCC-------------------CCCCCcccc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT-----ARVGDFGLARFLPP-------------------TRTQTKYGV  252 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~-----~kl~Dfg~a~~~~~-------------------~~~~~~~~~  252 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++....                   ...+||...
T Consensus       114 i~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  190 (330)
T 2izr_A          114 LISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHL  190 (330)
T ss_dssp             HHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred             HHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHc
Confidence            999999999   679999999999999999887     99999999986422                   123366666


Q ss_pred             CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      +..++.++|||||||++|||++|+.||......  .........        .+.......               ....
T Consensus       191 ~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~~~~~~~i--------~~~~~~~~~---------------~~~~  245 (330)
T 2izr_A          191 GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TLKERYQKI--------GDTKRATPI---------------EVLC  245 (330)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SHHHHHHHH--------HHHHHHSCH---------------HHHT
T ss_pred             CCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cHHHHHHHH--------HhhhccCCH---------------HHHh
Confidence            778899999999999999999999998753211  111111100        000000000               0000


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      ...+ ++.+++..||+.+|.+||++.+|.+.|+++....
T Consensus       246 ~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            0123 7888999999999999999999999999987764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.8e-36  Score=278.12  Aligned_cols=215  Identities=23%  Similarity=0.410  Sum_probs=160.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   .+....++||||+++|+|.+++..         ....+++..++.++.|+
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~i  135 (302)
T 4e5w_A           68 ADLKKEIEILRNLYHENIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPK---------NKNKINLKQQLKYAVQI  135 (302)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEC------CCEEEEEECCTTCBHHHHHHH---------HTTTCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeEEec---CCCceEEEEEEeCCCCcHHHHHHh---------ccccCCHHHHHHHHHHH
Confidence            678999999999999999999999764   224668999999999999999842         23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....               ...||...+..++.++||
T Consensus       136 ~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  212 (302)
T 4e5w_A          136 CKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDV  212 (302)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHH
T ss_pred             HHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhH
Confidence            99999999   679999999999999999999999999999865432               233555556677889999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCc----hhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNH----VKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ||||+++|||+||+.|+...      ...+.....+..    ...+.........         ..      ........
T Consensus       213 ~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~------~~~~~~~~  271 (302)
T 4e5w_A          213 WSFGVTLHELLTYCDSDSSP------MALFLKMIGPTHGQMTVTRLVNTLKEGKR---------LP------CPPNCPDE  271 (302)
T ss_dssp             HHHHHHHHHHHTTTCGGGSH------HHHHHHHHCSCCGGGHHHHHHHHHHTTCC---------CC------CCTTCCHH
T ss_pred             HHHHHHHHHHHHccCCCcch------hhHHhhccCCcccccCHHHHHHHHhccCC---------CC------CCCCCCHH
Confidence            99999999999999985421      111111111110    0011110000000         00      00023346


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      +.+++.+||+.||++|||+.|+++.|+++.
T Consensus       272 l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          272 VYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            788899999999999999999999999875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.5e-35  Score=271.42  Aligned_cols=197  Identities=20%  Similarity=0.249  Sum_probs=154.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++|+|.+++.           ...+++..+..++.|+
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~-----------~~~l~~~~~~~i~~qi  150 (321)
T 2c30_A           87 ELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVS-----------QVRLNEEQIATVCEAV  150 (321)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHT-----------TCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHH-----------hcCCCHHHHHHHHHHH
Confidence            678999999999999999999999764     678999999999999999883           2358999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....            ...||...+..++.++|||||
T Consensus       151 ~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl  227 (321)
T 2c30_A          151 LQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSL  227 (321)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             HHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHH
Confidence            99999999   679999999999999999999999999998765432            233666667788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||.....  ...........+..        +...                    ......+.+++.+
T Consensus       228 G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~--------~~~~--------------------~~~~~~l~~li~~  277 (321)
T 2c30_A          228 GIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPK--------LKNS--------------------HKVSPVLRDFLER  277 (321)
T ss_dssp             HHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCCC--------CTTG--------------------GGSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCCCC--------cCcc--------------------ccCCHHHHHHHHH
Confidence            9999999999999863211  01111111100000        0000                    0123357788889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.||++|||+.|+++.
T Consensus       278 ~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          278 MLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HSCSSTTTSCCHHHHHTS
T ss_pred             HccCChhhCcCHHHHhcC
Confidence            999999999999999863

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=274.80  Aligned_cols=216  Identities=20%  Similarity=0.365  Sum_probs=163.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   .+....++||||+++++|.+++..         ....+++..++.++.|+
T Consensus        87 ~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi  154 (326)
T 2w1i_A           87 RDFEREIEILKSLQHDNIVKYKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQK---------HKERIDHIKLLQYTSQI  154 (326)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECC-------CCEEEECCCTTCBHHHHHHH---------STTSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEe---cCCCceEEEEECCCCCCHHHHHHh---------cccCCCHHHHHHHHHHH
Confidence            679999999999999999999998753   224468999999999999999942         23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....               ..+||...+..++.++||
T Consensus       155 ~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  231 (326)
T 2w1i_A          155 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDV  231 (326)
T ss_dssp             HHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHH
T ss_pred             HHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhH
Confidence            99999999   679999999999999999999999999999866432               223555555667899999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCc--------hhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNH--------VKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ||||+++|||+||..|+...      ...+........        +.+.+........                  ...
T Consensus       232 ~slG~il~el~tg~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~  287 (326)
T 2w1i_A          232 WSFGVVLYELFTYIEKSKSP------PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR------------------PDG  287 (326)
T ss_dssp             HHHHHHHHHHHHTTCGGGSH------HHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC------------------CTT
T ss_pred             HHHHHHHHHHHhcCCCCCCC------HHHHHHhhccccchhhhHHHHHHHhhcCCCCCC------------------CCc
Confidence            99999999999999986531      111111111110        0011110000000                  012


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhc
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  372 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~  372 (382)
                      ++.++.+++.+||+.||++|||+.|+++.|+++++.+.
T Consensus       288 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          288 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            34568888999999999999999999999999988764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-35  Score=272.73  Aligned_cols=204  Identities=22%  Similarity=0.334  Sum_probs=158.2

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+.+|++++++++||||++++++|..      ...++|+||+++|+|.+++.         .....+++..++.++.
T Consensus        60 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~~v~~~~~~g~L~~~l~---------~~~~~~~~~~~~~i~~  124 (327)
T 3lzb_A           60 ANKEILDEAYVMASVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCV  124 (327)
T ss_dssp             CHHHHHHHHHHHTTCCBTTBCCCCEEEES------SSEEEEECCCSSCBHHHHHH---------HTTTCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCeeEEEEEEec------CCceEEEEecCCCcHHHHHH---------hcCCCCCHHHHHHHHH
Confidence            34789999999999999999999999753      34789999999999999984         2345689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCccch
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~~~D  261 (382)
                      |++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....              ...||...+..++.++|
T Consensus       125 qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D  201 (327)
T 3lzb_A          125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD  201 (327)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred             HHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHH
Confidence            9999999999   679999999999999999999999999999865321              33466666778899999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||+| |+.||.....  ..+.......            .......                  .+...+.
T Consensus       202 i~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~------------~~~~~~~------------------~~~~~l~  249 (327)
T 3lzb_A          202 VWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKG------------ERLPQPP------------------ICTIDVY  249 (327)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTT------------CCCCCCT------------------TBCHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcC------------CCCCCCc------------------cCCHHHH
Confidence            9999999999999 9999874321  1111111111            0000000                  1233577


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      +++.+||+.||.+|||+.|+++.|+++..
T Consensus       250 ~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          250 MIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            88889999999999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.7e-35  Score=266.31  Aligned_cols=210  Identities=21%  Similarity=0.355  Sum_probs=160.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.      .+..++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        53 ~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi  118 (279)
T 1qpc_A           53 DAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTP--------SGIKLTINKLLDMAAQI  118 (279)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEEEECCTTCBHHHHTTSH--------HHHTCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCcceEEEEEc------CCCcEEEEecCCCCCHHHHHhcC--------CCCCCCHHHHHHHHHHH
Confidence            67899999999999999999999853      34579999999999999998421        12368999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....             ...||...+..++.++||||
T Consensus       119 ~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  195 (279)
T 1qpc_A          119 AEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS  195 (279)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHH
T ss_pred             HHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHH
Confidence            99999999   679999999999999999999999999999865322             23355555567789999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||+| |+.||.....  ............            ....                  ......+.+++
T Consensus       196 lG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~------------~~~~------------------~~~~~~l~~li  243 (279)
T 1qpc_A          196 FGILLTEIVTHGRIPYPGMTN--PEVIQNLERGYR------------MVRP------------------DNCPEELYQLM  243 (279)
T ss_dssp             HHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCC------------CCCC------------------TTCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcccCH--HHHHHHHhcccC------------CCCc------------------ccccHHHHHHH
Confidence            9999999999 8999864211  111111100000            0000                  02234678888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhhhcCCCC
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNTLLGPKN  376 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~~  376 (382)
                      .+||+.+|++|||+.++++.|+++.........
T Consensus       244 ~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~  276 (279)
T 1qpc_A          244 RLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ  276 (279)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHHC-----
T ss_pred             HHHhccChhhCCCHHHHHHHHHHHHHhccCCCC
Confidence            899999999999999999999999887654433

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.4e-35  Score=272.98  Aligned_cols=219  Identities=20%  Similarity=0.318  Sum_probs=164.2

Q ss_pred             hHHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcc------ccCCcccCHH
Q 040999          116 IFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET------YERPRNLNLL  188 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~  188 (382)
                      ..+.+.+|+++++++ +||||+++++++..     .+..++||||+++|+|.+++.........      ......+++.
T Consensus        83 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  157 (334)
T 2pvf_A           83 DLSDLVSEMEMMKMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK  157 (334)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHH
Confidence            346799999999999 89999999999643     67789999999999999999643311000      0112358999


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGN  254 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~  254 (382)
                      .++.++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....              ...||...+.
T Consensus       158 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  234 (334)
T 2pvf_A          158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR  234 (334)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC
Confidence            99999999999999999   679999999999999999999999999999765432              2335555566


Q ss_pred             CCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHH
Q 040999          255 EVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII  333 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (382)
                      .++.++||||||+++|||+| |+.||.....  ..+.........            ....                  .
T Consensus       235 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~------------~~~~------------------~  282 (334)
T 2pvf_A          235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELFKLLKEGHR------------MDKP------------------A  282 (334)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHHTCC------------CCCC------------------T
T ss_pred             CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--HHHHHHHhcCCC------------CCCC------------------c
Confidence            78899999999999999999 9999864211  111111110000            0000                  0


Q ss_pred             HHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCC
Q 040999          334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  374 (382)
Q Consensus       334 ~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~  374 (382)
                      .+...+.+++.+||+.+|.+|||+.|+++.|+++.......
T Consensus       283 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~  323 (334)
T 2pvf_A          283 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE  323 (334)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence            22346788888999999999999999999999998765443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.7e-35  Score=269.80  Aligned_cols=199  Identities=19%  Similarity=0.208  Sum_probs=155.0

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++.     .....++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~q  122 (326)
T 2y0a_A           58 REDIEREVSILKEIQHPNVITLHEVYE-----NKTDVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQ  122 (326)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHT----------TSSCCBHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCCEEEEEEEcCCCCCHHHHHH----------hcCCcCHHHHHHHHHH
Confidence            367899999999999999999999964     3678999999999999999983          3356899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCC----cEEEccccccccCCCC-----------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDM----TARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~D  261 (382)
                      ++.||.|||   +.+|+||||||+|||++.++    .+||+|||+++.....           ..+||...+..++.++|
T Consensus       123 i~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  199 (326)
T 2y0a_A          123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEAD  199 (326)
T ss_dssp             HHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHH
T ss_pred             HHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHH
Confidence            999999999   67999999999999999887    7999999999865422           23466666778899999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||++|+.||....    ........         .........                .........+.+
T Consensus       200 iwslG~il~~ll~g~~pf~~~~----~~~~~~~~---------~~~~~~~~~----------------~~~~~~~~~~~~  250 (326)
T 2y0a_A          200 MWSIGVITYILLSGASPFLGDT----KQETLANV---------SAVNYEFED----------------EYFSNTSALAKD  250 (326)
T ss_dssp             HHHHHHHHHHHHHSCCSSCCSS----HHHHHHHH---------HHTCCCCCH----------------HHHTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHCcCCCCCCC----HHHHHHHH---------HhcCCCcCc----------------cccccCCHHHHH
Confidence            9999999999999999986321    11111000         000000000                000122345778


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||++|||+.|+++
T Consensus       251 li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          251 FIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHhc
Confidence            888999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-35  Score=271.74  Aligned_cols=231  Identities=17%  Similarity=0.158  Sum_probs=163.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   ......++||||+++|+|.+++....       ....+++..++.++.|+
T Consensus        52 ~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi  121 (319)
T 4euu_A           52 DVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKVLIMEFCPCGSLYTVLEEPS-------NAYGLPESEFLIVLRDV  121 (319)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEEEEEECCTTCBHHHHHHSGG-------GTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEeec---CCCceEEEEEeCCCCCCHHHHHHHhc-------cccCCCHHHHHHHHHHH
Confidence            678899999999999999999998753   23457899999999999999995321       22348999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee----CCCCcEEEccccccccCCCCC-----------CCCcccc--------CC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMTARVGDFGLARFLPPTR-----------TQTKYGV--------GN  254 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl----~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~--------~~  254 (382)
                      +.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++......           ..||...        +.
T Consensus       122 ~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  198 (319)
T 4euu_A          122 VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK  198 (319)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCC
T ss_pred             HHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccC
Confidence            99999999   6799999999999999    788889999999998754332           2244432        46


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHH---HHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLH---KFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      .++.++|||||||++|||+||+.||...........   .......+.....+ ........   .......   .....
T Consensus       199 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~~---~~~~~~~---~~~~~  271 (319)
T 4euu_A          199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV-QKAENGPI---DWSGDMP---VSCSL  271 (319)
T ss_dssp             CBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEE-ECSTTCCE---EEESSCC---TTCSS
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhh-hcccCCcc---ccCccCC---ccccc
Confidence            788999999999999999999999864322221111   11111111111100 00000000   0000000   00011


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhh
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK  368 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~  368 (382)
                      .......+.+++.+||+.||++|||++|+++...+..
T Consensus       272 ~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          272 SRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             chhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            1245667888889999999999999999999987654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5e-36  Score=296.35  Aligned_cols=210  Identities=24%  Similarity=0.393  Sum_probs=165.7

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+       ++|.+|+++|++++|+|||++++++.      ....++||||+++|+|.+++..        .....+
T Consensus       295 avK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~--------~~~~~l  360 (535)
T 2h8h_A          295 AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKG--------ETGKYL  360 (535)
T ss_dssp             EEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEEECCCTTEEHHHHHSH--------HHHTTC
T ss_pred             EEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe------eccceEeeehhcCCcHHHHHhh--------cCCCCC
Confidence            67765       67999999999999999999999863      2568999999999999999942        122458


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~  252 (382)
                      ++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....             ....||...
T Consensus       361 ~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~  437 (535)
T 2h8h_A          361 RLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  437 (535)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhc
Confidence            89999999999999999999   77999999999999999999999999999986532             134466666


Q ss_pred             CCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 GNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      +..++.++|||||||++|||+| |+.||.....     .+....         +.........                 
T Consensus       438 ~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----~~~~~~---------i~~~~~~~~~-----------------  486 (535)
T 2h8h_A          438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQ---------VERGYRMPCP-----------------  486 (535)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----HHHHHH---------HHTTCCCCCC-----------------
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH---------HHcCCCCCCC-----------------
Confidence            7788999999999999999999 9999864311     111111         0000000000                 


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                       ..+...+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus       487 -~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          487 -PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             -CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence             023446788889999999999999999999999987654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.5e-35  Score=274.76  Aligned_cols=199  Identities=16%  Similarity=0.183  Sum_probs=153.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     +.+..++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        73 ~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi  137 (362)
T 2bdw_A           73 QKLEREARICRKLQHPNIVRLHDSIQ-----EESFHYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQI  137 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHT----------TCSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEEEEEEecCCCCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            67899999999999999999999964     3778999999999999999883          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCC---cEEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDM---TARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+|||++.++   .+||+|||+++.....           ..+||...+..++.++|||
T Consensus       138 ~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  214 (362)
T 2bdw_A          138 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW  214 (362)
T ss_dssp             HHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHH
T ss_pred             HHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHH
Confidence            99999999   67999999999999998654   5999999999765432           2346666677889999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||||++|||++|+.||....  ...+........           ..... .               .......++.+++
T Consensus       215 slG~il~~ll~g~~Pf~~~~--~~~~~~~i~~~~-----------~~~~~-~---------------~~~~~~~~~~~li  265 (362)
T 2bdw_A          215 ACGVILYILLVGYPPFWDED--QHRLYAQIKAGA-----------YDYPS-P---------------EWDTVTPEAKSLI  265 (362)
T ss_dssp             HHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTC-----------CCCCT-T---------------GGGGSCHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCC-----------CCCCc-c---------------cccCCCHHHHHHH
Confidence            99999999999999986321  111111110000           00000 0               0002234677888


Q ss_pred             hccCCCCccCCCCHHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~  363 (382)
                      .+||+.||++|||+.|+++.
T Consensus       266 ~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          266 DSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHcCCChhhCcCHHHHhcC
Confidence            89999999999999998753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.6e-35  Score=268.49  Aligned_cols=206  Identities=21%  Similarity=0.351  Sum_probs=163.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     .....++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        54 ~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i  120 (288)
T 3kfa_A           54 EEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLREC--------NRQEVSAVVLLYMATQI  120 (288)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEEEEEECCTTEEHHHHHHHC--------CTTTSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCEEEEEEcCCCCcHHHHHHhc--------ccCCccHhHHHHHHHHH
Confidence            67999999999999999999999964     367789999999999999999531        23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....             ...||...+..++.++||||
T Consensus       121 ~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  197 (288)
T 3kfa_A          121 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA  197 (288)
T ss_dssp             HHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHH
Confidence            99999999   669999999999999999999999999999866432             23466666677899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||+++|||++ |..||.....  ..........            ......                  ..++..+.+++
T Consensus       198 lG~il~~ll~~g~~p~~~~~~--~~~~~~~~~~------------~~~~~~------------------~~~~~~l~~li  245 (288)
T 3kfa_A          198 FGVLLWEIATYGMSPYPGIDL--SQVYELLEKD------------YRMERP------------------EGCPEKVYELM  245 (288)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTT------------CCCCCC------------------TTCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcc------------CCCCCC------------------CCCCHHHHHHH
Confidence            9999999999 9999864211  1111111110            000000                  02234678888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      .+||+.||++|||+.++++.|+++....
T Consensus       246 ~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          246 RACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            8999999999999999999999887653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.7e-35  Score=273.16  Aligned_cols=198  Identities=18%  Similarity=0.201  Sum_probs=154.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++||||+++++++.     +....++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        60 ~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~i~~qi  124 (361)
T 2yab_A           60 EEIEREVSILRQVLHPNIITLHDVYE-----NRTDVVLILELVSGGELFDFLA----------QKESLSEEEATSFIKQI  124 (361)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHT----------TCSCCBHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCCCcEEEEEE-----eCCEEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            57899999999999999999999964     4778999999999999999993          33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCC----cEEEccccccccCCCC-----------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDM----TARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||.|||   +.+|+||||||+|||++.++    .+||+|||+++.....           ..+||...+..++.++||
T Consensus       125 ~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  201 (361)
T 2yab_A          125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADM  201 (361)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHH
T ss_pred             HHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccH
Confidence            99999999   67999999999999998876    7999999999865432           233666666788999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||++|..||...    .. .......        .........                .........+.++
T Consensus       202 wslGvil~~ll~g~~Pf~~~----~~-~~~~~~i--------~~~~~~~~~----------------~~~~~~s~~~~~l  252 (361)
T 2yab_A          202 WSIGVITYILLSGASPFLGD----TK-QETLANI--------TAVSYDFDE----------------EFFSQTSELAKDF  252 (361)
T ss_dssp             HHHHHHHHHHHHSCCSSCCS----SH-HHHHHHH--------HTTCCCCCH----------------HHHTTSCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCC----CH-HHHHHHH--------HhcCCCCCc----------------hhccCCCHHHHHH
Confidence            99999999999999998642    11 1111110        000000000                0001223457788


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||..||++|||+.|+++
T Consensus       253 i~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          253 IRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHCCCChhHCcCHHHHhc
Confidence            88999999999999999984

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1e-34  Score=271.06  Aligned_cols=225  Identities=22%  Similarity=0.290  Sum_probs=165.2

Q ss_pred             chhhH-----HHHHHHHHHHhh--cccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-----KSFIAECKALRN--IRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+     +.+.+|++++..  ++||||+++++++.... ......++||||+++|+|.+++..           ..+
T Consensus        69 avK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-----------~~~  136 (342)
T 1b6c_B           69 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-----------YTV  136 (342)
T ss_dssp             EEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEEECCCTTCBHHHHHHH-----------CCB
T ss_pred             EEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEEEeecCCCcHHHHHhc-----------cCc
Confidence            77765     678899999988  78999999999975411 111378999999999999999942           358


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcC-----CCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------
Q 040999          186 NLLRRLNIAIDVASALNYLHHDC-----QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------  244 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~-----~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------  244 (382)
                      ++..++.++.|++.||.|||...     +.+|+||||||+|||++.++.+||+|||+++.....                
T Consensus       137 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~  216 (342)
T 1b6c_B          137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR  216 (342)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGG
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcc
Confidence            99999999999999999999321     458999999999999999999999999999754332                


Q ss_pred             CCCCccccCC------CCCccchhHHHHHHHHHHHhc----------CCCCCccccCCchHHHHHHHhcCCchhhhhhcc
Q 040999          245 RTQTKYGVGN------EVSTIGDVYSYGILLLELMIR----------EKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSI  308 (382)
Q Consensus       245 ~~~~~~~~~~------~~~~~~Dv~S~Gvil~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (382)
                      ..+||...+.      .++.++|||||||++|||+||          +.||............+........        
T Consensus       217 y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------  288 (342)
T 1b6c_B          217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK--------  288 (342)
T ss_dssp             GCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC--------
T ss_pred             cCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHH--------
Confidence            1224544333      234789999999999999999          6676544333333333322221110        


Q ss_pred             cccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          309 LLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .......             .....++...+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       289 ~~~~~~~-------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          289 LRPNIPN-------------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CCCCCCG-------------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hCCCCcc-------------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            0000000             000115566789999999999999999999999999999775

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.7e-35  Score=263.86  Aligned_cols=204  Identities=27%  Similarity=0.364  Sum_probs=151.3

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+++++.++||||+++++++..     .+..++||||+++++|.+++.           ...+++..+..++.|
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~i~~~  113 (271)
T 3dtc_A           50 IENVRQEAKLFAMLKHPNIIALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-----------GKRIPPDILVNWAVQ  113 (271)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECC-----C--CEEEEECCTTEEHHHHHT-----------SSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCceEEEEEcCCCCCHHHHhh-----------cCCCCHHHHHHHHHH
Confidence            3678999999999999999999999643     667899999999999999883           235899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCC--------CCcEEEccccccccCCCC----------CCCCccccCCCCCc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDD--------DMTARVGDFGLARFLPPT----------RTQTKYGVGNEVST  258 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~--------~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~~~~  258 (382)
                      +++||.|||.....+|+||||||+||+++.        ++.+||+|||.++.....          ...||...+..++.
T Consensus       114 l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  193 (271)
T 3dtc_A          114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSK  193 (271)
T ss_dssp             HHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSH
T ss_pred             HHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCc
Confidence            999999999532223999999999999986        678999999999754332          23366666677899


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ++||||||+++|||+||+.||....    ...........         .......                  ..+...
T Consensus       194 ~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~---------~~~~~~~------------------~~~~~~  242 (271)
T 3dtc_A          194 GSDVWSYGVLLWELLTGEVPFRGID----GLAVAYGVAMN---------KLALPIP------------------STCPEP  242 (271)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTTTSC----HHHHHHHHHTS---------CCCCCCC------------------TTCCHH
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHhhhcC---------CCCCCCC------------------cccCHH
Confidence            9999999999999999999986421    11111100000         0000000                  022346


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      +.+++.+||+.||++|||+.|+++.|+++
T Consensus       243 ~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          243 FAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            78888899999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.2e-35  Score=269.96  Aligned_cols=216  Identities=21%  Similarity=0.273  Sum_probs=163.0

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcc------ccCCcccCHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDET------YERPRNLNLLRR  190 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~  190 (382)
                      +.+.+|++++.++ +||||+++++++..    .....++||||+++|+|.+++.........      ......+++..+
T Consensus        75 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (316)
T 2xir_A           75 RALMSELKILIHIGHHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL  150 (316)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHH
T ss_pred             HHHHHHHHHHHhcccCCCeeeEEEEEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHH
Confidence            6789999999999 79999999999753    245689999999999999999643311000      001223889999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEV  256 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~  256 (382)
                      ..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....              ..+||...+..+
T Consensus       151 ~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  227 (316)
T 2xir_A          151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY  227 (316)
T ss_dssp             HHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence            999999999999999   679999999999999999999999999999865332              234666666778


Q ss_pred             CccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          257 STIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      +.++||||||+++|||+| |+.||....... .............           .+ .                  ..
T Consensus       228 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~-----------~~-~------------------~~  276 (316)
T 2xir_A          228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMR-----------AP-D------------------YT  276 (316)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHHHHHHHTCCCC-----------CC-T------------------TC
T ss_pred             cchhHHHHHHHHHHHHHhCCCCCCcccchhH-HHHHHhccCccCC-----------CC-C------------------CC
Confidence            999999999999999998 999986432111 1111111110000           00 0                  12


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      ...+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus       277 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          277 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            235778888999999999999999999999987754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.6e-35  Score=280.23  Aligned_cols=198  Identities=15%  Similarity=0.141  Sum_probs=153.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|||||++++++.     +.+..++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        55 ~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~~~~lv~E~~~gg~L~~~i~----------~~~~~~e~~~~~i~~qi  119 (444)
T 3soa_A           55 QKLEREARICRLLKHPNIVRLHDSIS-----EEGHHYLIFDLVTGGELFEDIV----------AREYYSEADASHCIQQI  119 (444)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCEEEEEE-----CSSEEEEEECCCBCCBHHHHHH----------HCSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCCCeEEEEEE-----ECCEEEEEEEeCCCCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            57899999999999999999999964     4788999999999999999884          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeC---CCCcEEEccccccccCCCC------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLD---DDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~---~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||.|||   +.+|+||||||+|||++   .++.+||+|||+++.....            ..+||...+..++.++||
T Consensus       120 l~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DI  196 (444)
T 3soa_A          120 LEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDL  196 (444)
T ss_dssp             HHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHH
T ss_pred             HHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCcccc
Confidence            99999999   77999999999999998   4678999999999765432            233666667788999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||+||++|||++|+.||....  ...........           ...... .               .......++.++
T Consensus       197 wSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~-----------~~~~~~-~---------------~~~~~s~~~~~l  247 (444)
T 3soa_A          197 WACGVILYILLVGYPPFWDED--QHRLYQQIKAG-----------AYDFPS-P---------------EWDTVTPEAKDL  247 (444)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHT-----------CCCCCT-T---------------TTTTSCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhC-----------CCCCCc-c---------------ccccCCHHHHHH
Confidence            999999999999999986321  11111111000           000000 0               000123457788


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||+.|+++
T Consensus       248 i~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          248 INKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCChhHCCCHHHHhc
Confidence            88999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4e-35  Score=266.03  Aligned_cols=206  Identities=25%  Similarity=0.316  Sum_probs=157.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..    ..+..++||||+++++|.+++...        ....+++..+..++.|+
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~i  126 (278)
T 1byg_A           59 QAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDV  126 (278)
T ss_dssp             HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEEEECCCTTEEHHHHHHHH--------HHHHCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceEEEEecCCCCCHHHHHHhc--------ccccCCHHHHHHHHHHH
Confidence            679999999999999999999998643    345789999999999999998421        12247889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------CCCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||+++....         ....||...+..++.++||||||++
T Consensus       127 ~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  203 (278)
T 1byg_A          127 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL  203 (278)
T ss_dssp             HHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHH
Confidence            99999999   67999999999999999999999999999875432         2344666666788999999999999


Q ss_pred             HHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          269 LLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       269 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      +|||+| |+.||.....  ..........            ......                  ...+..+.+++.+||
T Consensus       204 l~~l~t~g~~p~~~~~~--~~~~~~~~~~------------~~~~~~------------------~~~~~~l~~li~~~l  251 (278)
T 1byg_A          204 LWEIYSFGRVPYPRIPL--KDVVPRVEKG------------YKMDAP------------------DGCPPAVYEVMKNCW  251 (278)
T ss_dssp             HHHHHTTSCCSCTTSCG--GGHHHHHTTT------------CCCCCC------------------TTCCHHHHHHHHHHT
T ss_pred             HHHHHhCCCCCCCCCCH--HHHHHHHhcC------------CCCCCc------------------ccCCHHHHHHHHHHh
Confidence            999998 9999864211  1111111000            000000                  022346788888999


Q ss_pred             CCCccCCCCHHHHHHHHHHhhhh
Q 040999          348 MESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       348 ~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +.||++|||+.|+++.|++++..
T Consensus       252 ~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          252 HLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCChhhCCCHHHHHHHHHHHHhh
Confidence            99999999999999999999765

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.4e-35  Score=274.70  Aligned_cols=199  Identities=20%  Similarity=0.222  Sum_probs=155.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++|+|.+++.         .....+++..+..++.||
T Consensus       131 ~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~E~~~~~~L~~~l~---------~~~~~l~~~~~~~i~~qi  196 (373)
T 2x4f_A          131 EEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLVMEYVDGGELFDRII---------DESYNLTELDTILFMKQI  196 (373)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEEECCTTCEEHHHHH---------HTGGGCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEEeCCCCCcHHHHHH---------hcCCCCCHHHHHHHHHHH
Confidence            679999999999999999999999653     678999999999999998884         233468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee--CCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL--DDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl--~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+|+||||||+|||+  +.++.+||+|||+++.....           ...||...+..++.++||||
T Consensus       197 ~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  273 (373)
T 2x4f_A          197 CEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWS  273 (373)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHH
T ss_pred             HHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHH
Confidence            99999999   6799999999999999  67789999999999865432           33466666778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||..... ...+.......+.            ....                .......++.+++.
T Consensus       274 lG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~------------~~~~----------------~~~~~~~~~~~li~  324 (373)
T 2x4f_A          274 VGVIAYMLLSGLSPFLGDND-AETLNNILACRWD------------LEDE----------------EFQDISEEAKEFIS  324 (373)
T ss_dssp             HHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC------------SCSG----------------GGTTSCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCC------------CChh----------------hhccCCHHHHHHHH
Confidence            99999999999999864211 0011111111000            0000                00022346788888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||++|||+.|+++
T Consensus       325 ~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          325 KLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TTSCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhhCCCHHHHhc
Confidence            999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2e-35  Score=274.98  Aligned_cols=215  Identities=22%  Similarity=0.276  Sum_probs=162.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCC----CccccCCcccCHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE----DETYERPRNLNLLRRLN  192 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~l~~~~~~~  192 (382)
                      +.+.+|+++++++ +||||+++++++..     .+..++||||+++|+|.+++......    .........+++..++.
T Consensus        94 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (333)
T 2i1m_A           94 EALMSELKIMSHLGQHENIVNLLGACTH-----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH  168 (333)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEec-----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHH
Confidence            6789999999999 89999999999643     66789999999999999998532100    00000134578999999


Q ss_pred             HHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCCCc
Q 040999          193 IAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEVST  258 (382)
Q Consensus       193 i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~~~  258 (382)
                      ++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....              ..+||...+..++.
T Consensus       169 ~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  245 (333)
T 2i1m_A          169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV  245 (333)
T ss_dssp             HHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCCh
Confidence            9999999999999   679999999999999999999999999999754221              33466666677899


Q ss_pred             cchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          259 IGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       259 ~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      ++|||||||++|||+| |..||...... .............            ....                  .++.
T Consensus       246 ~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~------------~~~~------------------~~~~  294 (333)
T 2i1m_A          246 QSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKLVKDGYQM------------AQPA------------------FAPK  294 (333)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHHHHHHTCCC------------CCCT------------------TCCH
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHHHHhcCCCC------------CCCC------------------CCCH
Confidence            9999999999999999 99998643211 1111111111110            0000                  1224


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      .+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus       295 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          295 NIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            6778888999999999999999999999987654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.4e-35  Score=266.05  Aligned_cols=218  Identities=18%  Similarity=0.207  Sum_probs=166.0

Q ss_pred             chhhH------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|.+      +++.+|+++++.++|++++..+.++..    .....++||||+ +++|.+++..         ....++
T Consensus        38 avK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv~e~~-~~~L~~~~~~---------~~~~~~  103 (296)
T 3uzp_A           38 AIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVMELL-GPSLEDLFNF---------CSRKFS  103 (296)
T ss_dssp             EEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEEEECC-CCBHHHHHHH---------TTTCCC
T ss_pred             EEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEEEEec-CCCHHHHHHh---------hccCCC
Confidence            66654      578999999999999988887777643    367789999999 9999999842         234689


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceee---CCCCcEEEccccccccCCCC-------------------
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPT-------------------  244 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfg~a~~~~~~-------------------  244 (382)
                      +..+..++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.....                   
T Consensus       104 ~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (296)
T 3uzp_A          104 LKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR  180 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTT
T ss_pred             HHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccc
Confidence            9999999999999999999   6799999999999999   47889999999999764332                   


Q ss_pred             CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCC--chHHHHHHHhcCCchhhhhhcccccchhhhhhcccc
Q 040999          245 RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQ  322 (382)
Q Consensus       245 ~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (382)
                      ..+||...+..++.++|||||||++|||+||+.||.......  ..+..............                   
T Consensus       181 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  241 (296)
T 3uzp_A          181 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-------------------  241 (296)
T ss_dssp             TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-------------------
T ss_pred             cCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH-------------------
Confidence            223666667778999999999999999999999987532211  11111111111000000                   


Q ss_pred             chhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCC
Q 040999          323 KQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  374 (382)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~  374 (382)
                              .....+..+.+++.+||+.||++|||+.++++.|+++......+
T Consensus       242 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          242 --------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             --------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             --------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence                    00123346788889999999999999999999999998876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9e-35  Score=267.89  Aligned_cols=217  Identities=19%  Similarity=0.234  Sum_probs=160.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++++|.+++....      .....+++..++.++.|+
T Consensus        77 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi  145 (310)
T 2wqm_A           77 ADCIKEIDLLKQLNHPNVIKYYASFIE-----DNELNIVLELADAGDLSRMIKHFK------KQKRLIPERTVWKYFVQL  145 (310)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEECCCSCBHHHHHHHHH------HTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCcEEEEEecCCCCCHHHHHHHhc------ccccCCCHHHHHHHHHHH
Confidence            678999999999999999999999764     678899999999999999884321      124568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||+++....            ....||...+..++.++|||||
T Consensus       146 ~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  222 (310)
T 2wqm_A          146 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL  222 (310)
T ss_dssp             HHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHH
T ss_pred             HHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHH
Confidence            99999999   67999999999999999999999999999875432            2334666667788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|||++|+.||.....   .............        ......                  ......+.+++.+
T Consensus       223 G~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~--------~~~~~~------------------~~~~~~l~~li~~  273 (310)
T 2wqm_A          223 GCLLYEMAALQSPFYGDKM---NLYSLCKKIEQCD--------YPPLPS------------------DHYSEELRQLVNM  273 (310)
T ss_dssp             HHHHHHHHHSSCTTC---C---CHHHHHHHHHTTC--------SCCCCT------------------TTSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCcccch---hHHHHHHHhhccc--------CCCCcc------------------cccCHHHHHHHHH
Confidence            9999999999999864211   1111111110000        000000                  0123467788889


Q ss_pred             cCCCCccCCCCHHHHHHHHHHhhhhhcCCCCC
Q 040999          346 CSMESPQDRMKMTNVVHELQSIKNTLLGPKNL  377 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~~~  377 (382)
                      ||+.||++|||+.+|++.|+++.+....|.+.
T Consensus       274 ~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~  305 (310)
T 2wqm_A          274 CINPDPEKRPDVTYVYDVAKRMHACTASSLEH  305 (310)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHHHC-----
T ss_pred             HcCCChhhCCCHHHHHHHHHHHHHhhhhhhhh
Confidence            99999999999999999999999988776654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.6e-35  Score=263.58  Aligned_cols=207  Identities=22%  Similarity=0.279  Sum_probs=156.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   ......++||||+++|+|.+++...        ....+++..++.++.|+
T Consensus        52 ~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~qi  120 (271)
T 3kmu_A           52 RDFNEECPRLRIFSHPNVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEG--------TNFVVDQSQAVKFALDM  120 (271)
T ss_dssp             HHHHHHGGGGCCCSCTTEECEEEEECT---TTSSSCEEEEECCTTCBHHHHHHSC--------SSCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCchhheEEEEcc---CCCCCeEeeecccCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHH
Confidence            679999999999999999999999753   2236789999999999999999532        22358999999999999


Q ss_pred             HHHHhHHhhcCCCc--eeecCCCCCceeeCCCCcEEEccccccccCCC-------CCCCCccccCCCCC---ccchhHHH
Q 040999          198 ASALNYLHHDCQPV--TAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------TRTQTKYGVGNEVS---TIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~--ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~~~~~~---~~~Dv~S~  265 (382)
                      +.||+|||   +.+  ++||||||+||+++.++.++|+|||++.....       ...+||...+...+   .++|||||
T Consensus       121 ~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~sl  197 (271)
T 3kmu_A          121 ARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF  197 (271)
T ss_dssp             HHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHH
T ss_pred             HHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecccCccCCccccChhhhccCCCCCCCchhhHHHH
Confidence            99999999   667  99999999999999999999998887754322       22335655544443   37999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||.....    .......         ..........                  ......+.+++.+
T Consensus       198 G~il~el~~g~~p~~~~~~----~~~~~~~---------~~~~~~~~~~------------------~~~~~~~~~li~~  246 (271)
T 3kmu_A          198 AVLLWELVTREVPFADLSN----MEIGMKV---------ALEGLRPTIP------------------PGISPHVSKLMKI  246 (271)
T ss_dssp             HHHHHHHHHCSCTTTTSCH----HHHHHHH---------HHSCCCCCCC------------------TTCCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCccccCh----HHHHHHH---------HhcCCCCCCC------------------CCCCHHHHHHHHH
Confidence            9999999999999864211    1111000         0000000000                  0223467888889


Q ss_pred             cCCCCccCCCCHHHHHHHHHHhhh
Q 040999          346 CSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      ||+.||++|||+.|+++.|+++.+
T Consensus       247 ~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          247 CMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HcCCChhhCcCHHHHHHHHHHhhc
Confidence            999999999999999999998864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-34  Score=268.90  Aligned_cols=201  Identities=21%  Similarity=0.290  Sum_probs=152.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc--------------------------------------------------
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY--------------------------------------------------  147 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--------------------------------------------------  147 (382)
                      +.+.+|+++|++++|||||++++++.....                                                  
T Consensus        49 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  128 (332)
T 3qd2_B           49 EKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ  128 (332)
T ss_dssp             HHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-----------------------------------------
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccccccc
Confidence            679999999999999999999999754211                                                  


Q ss_pred             --CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeC
Q 040999          148 --QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD  225 (382)
Q Consensus       148 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~  225 (382)
                        ......++||||+++|+|.+++....       .....++..++.++.|++.||+|||   +.+|+||||||+|||++
T Consensus       129 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~  198 (332)
T 3qd2_B          129 PSSPKVYLYIQMQLCRKENLKDWMNRRC-------SLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFT  198 (332)
T ss_dssp             ---CCCEEEEEEECCCSSCHHHHHHTCC-------SGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEC
T ss_pred             CCCCCceEEEEEEecCCCCHHHHHhccc-------CccchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEe
Confidence              11234899999999999999996432       2234567788999999999999999   67999999999999999


Q ss_pred             CCCcEEEccccccccCCCC------------------------CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          226 DDMTARVGDFGLARFLPPT------------------------RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       226 ~~~~~kl~Dfg~a~~~~~~------------------------~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      .++.+||+|||+++.....                        ..+||...+..++.++|||||||++|||++|..|+..
T Consensus       199 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~  278 (332)
T 3qd2_B          199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME  278 (332)
T ss_dssp             TTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH
T ss_pred             CCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH
Confidence            9999999999999866443                        2236666677889999999999999999998776321


Q ss_pred             cccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHH
Q 040999          282 MFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVV  361 (382)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl  361 (382)
                             .........        ....   +                .........+.+++.+||+.||++|||+.|++
T Consensus       279 -------~~~~~~~~~--------~~~~---~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  324 (332)
T 3qd2_B          279 -------RVRIITDVR--------NLKF---P----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDII  324 (332)
T ss_dssp             -------HHHHHHHHH--------TTCC---C----------------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHH
T ss_pred             -------HHHHHHHhh--------ccCC---C----------------cccccCChhHHHHHHHHccCCCCcCCCHHHHh
Confidence                   000000000        0000   0                00113344567888899999999999999998


Q ss_pred             H
Q 040999          362 H  362 (382)
Q Consensus       362 ~  362 (382)
                      +
T Consensus       325 ~  325 (332)
T 3qd2_B          325 E  325 (332)
T ss_dssp             H
T ss_pred             h
Confidence            6

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.9e-35  Score=273.82  Aligned_cols=212  Identities=17%  Similarity=0.316  Sum_probs=160.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++...............+++..++.++.|+
T Consensus        73 ~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi  147 (322)
T 1p4o_A           73 IEFLNEASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI  147 (322)
T ss_dssp             HHHHHHHHHGGGCCCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeeEEEEc-----cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHH
Confidence            57899999999999999999999964     3667899999999999999985321100000112457899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||+++....              ....||...+..++.++|||
T Consensus       148 ~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  224 (322)
T 1p4o_A          148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW  224 (322)
T ss_dssp             HHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHH
Confidence            99999999   67999999999999999999999999999975422              13446666677889999999


Q ss_pred             HHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||+++|||+| |+.||....     ...........        .....+                   ..+...+.++
T Consensus       225 slG~il~el~~~g~~p~~~~~-----~~~~~~~~~~~--------~~~~~~-------------------~~~~~~l~~l  272 (322)
T 1p4o_A          225 SFGVVLWEIATLAEQPYQGLS-----NEQVLRFVMEG--------GLLDKP-------------------DNCPDMLFEL  272 (322)
T ss_dssp             HHHHHHHHHHHTSCCTTTTSC-----HHHHHHHHHTT--------CCCCCC-------------------TTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCCccccCC-----HHHHHHHHHcC--------CcCCCC-------------------CCCCHHHHHH
Confidence            99999999999 889976421     11111111000        000000                   0223467788


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      +.+||+.||++|||+.|+++.|+++..
T Consensus       273 i~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          273 MRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            889999999999999999999988743

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-34  Score=266.97  Aligned_cols=221  Identities=19%  Similarity=0.228  Sum_probs=155.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     +....++||||+++ +|.+++.         .....+++..+..++.|+
T Consensus        64 ~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~~~~qi  128 (311)
T 3niz_A           64 STAIREISLLKELHHPNIVSLIDVIH-----SERCLTLVFEFMEK-DLKKVLD---------ENKTGLQDSQIKIYLYQL  128 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSCEEEEEECCSE-EHHHHHH---------TCTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCEEEEEEcCCCC-CHHHHHH---------hccCCCCHHHHHHHHHHH
Confidence            56889999999999999999999954     46789999999975 7877773         233458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....            ..+||...+ ..++.++||||
T Consensus       129 ~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  205 (311)
T 3niz_A          129 LRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWS  205 (311)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHH
T ss_pred             HHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHH
Confidence            99999999   679999999999999999999999999999865321            233665544 56799999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC---chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN---HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||++|||++|+.||...... ..+..........   ......+.......     ...................++.+
T Consensus       206 lG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  279 (311)
T 3niz_A          206 IGCIFAEMITGKPLFPGVTDD-DQLPKIFSILGTPNPREWPQVQELPLWKQR-----TFQVFEKKPWSSIIPGFCQEGID  279 (311)
T ss_dssp             HHHHHHHHHHSSCSCCCSSTT-THHHHHHHHHCCCCTTTSGGGTTSHHHHSC-----CCCCCCCCCHHHHSTTCCHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHCCCChHHhhhhhccchhhhc-----ccccccCCcHHHhCcccCHHHHH
Confidence            999999999999998753322 2222222222111   11110000000000     00000000000001122346788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||++|||++|+++
T Consensus       280 li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          280 LLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHcCCChhHCCCHHHHhc
Confidence            889999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.1e-35  Score=272.38  Aligned_cols=193  Identities=21%  Similarity=0.298  Sum_probs=151.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++..     ....++||||+ +|+|.+++.          ....+++..+..++.|+
T Consensus        54 ~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~~~lv~E~~-~g~l~~~l~----------~~~~l~~~~~~~i~~qi  117 (336)
T 3h4j_B           54 MRVEREISYLKLLRHPHIIKLYDVITT-----PTDIVMVIEYA-GGELFDYIV----------EKKRMTEDEGRRFFQQI  117 (336)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEECCC-CEEHHHHHH----------HHCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCEEEEEEECC-CCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            468899999999999999999999653     67899999999 788988883          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCC-CccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEV-STIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~-~~~~Dv~S~  265 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...+..+ +.++|||||
T Consensus       118 ~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  194 (336)
T 3h4j_B          118 ICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC  194 (336)
T ss_dssp             HHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred             HHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence            99999999   669999999999999999999999999999865432           334776666655 689999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||+.......             ... +.......+ .                  .....+.+++.+
T Consensus       195 G~il~~ll~g~~Pf~~~~~~~~-------------~~~-i~~~~~~~p-~------------------~~s~~~~~li~~  241 (336)
T 3h4j_B          195 GIVLYVMLVGRLPFDDEFIPNL-------------FKK-VNSCVYVMP-D------------------FLSPGAQSLIRR  241 (336)
T ss_dssp             HHHHHHHHHSSCSSBCSSSTTC-------------BCC-CCSSCCCCC-T------------------TSCHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCCccHHHH-------------HHH-HHcCCCCCc-c------------------cCCHHHHHHHHH
Confidence            9999999999999864221110             000 000000000 0                  122356788889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.||.+|||+.|+++
T Consensus       242 ~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          242 MIVADPMQRITIQEIRR  258 (336)
T ss_dssp             TSCSSGGGSCCHHHHTT
T ss_pred             HcCCChhHCcCHHHHHh
Confidence            99999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-35  Score=274.81  Aligned_cols=224  Identities=14%  Similarity=0.136  Sum_probs=166.9

Q ss_pred             chhhH---HHHHHHHHHHhhccccccee---------------eeeeeeecccCCCceeEEEEecccCCCccccccCCCC
Q 040999          113 AFKIF---KSFIAECKALRNIRHRNLIK---------------VLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK  174 (382)
Q Consensus       113 avK~~---~~~~~E~~~l~~l~h~niv~---------------~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~  174 (382)
                      |+|.+   +.+.+|++++++++||||++               +++++.    ......++||||+ +++|.+++...  
T Consensus        79 avK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~--  151 (352)
T 2jii_A           79 SLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVS--  151 (352)
T ss_dssp             EEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHS--
T ss_pred             EEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhC--
Confidence            77766   56999999999999999998               444433    2357889999999 99999999531  


Q ss_pred             CCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC--cEEEccccccccCCC---------
Q 040999          175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM--TARVGDFGLARFLPP---------  243 (382)
Q Consensus       175 ~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~--~~kl~Dfg~a~~~~~---------  243 (382)
                            ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++  .+||+|||+++....         
T Consensus       152 ------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  222 (352)
T 2jii_A          152 ------PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE  222 (352)
T ss_dssp             ------GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCT
T ss_pred             ------CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccc
Confidence                  1356999999999999999999999   67999999999999999998  899999999975432         


Q ss_pred             ----------CCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccch
Q 040999          244 ----------TRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDD  313 (382)
Q Consensus       244 ----------~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (382)
                                ...+||...+..++.++|||||||++|||+||+.||.........+....... ......+.+.....  
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--  299 (352)
T 2jii_A          223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCGHW--  299 (352)
T ss_dssp             TSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTSCE--
T ss_pred             cccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhc-cCChhhhhhhcccc--
Confidence                      22336666677889999999999999999999999875332221111111110 00000000000000  


Q ss_pred             hhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCC
Q 040999          314 EKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  374 (382)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~  374 (382)
                                         ......+.+++.+||+.||++|||+.++++.|+++.......
T Consensus       300 -------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          300 -------------------IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             -------------------ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             -------------------CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence                               012346788888999999999999999999999998876543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.1e-34  Score=271.48  Aligned_cols=197  Identities=18%  Similarity=0.264  Sum_probs=152.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|+.++|||||++++++.     +....++||||+.+|+|.+++.          ....+++..+..++.||
T Consensus        60 ~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi  124 (384)
T 4fr4_A           60 RNVFKELQIMQGLEHPFLVNLWYSFQ-----DEEDMFMVVDLLLGGDLRYHLQ----------QNVHFKEETVKLFICEL  124 (384)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEEEEECCCTTEEHHHHHH----------TTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEE-----eCCEEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            57889999999999999999999964     4778999999999999999984          34568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCcccc---CCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGV---GNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~---~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...   +..++.++|||
T Consensus       125 ~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~Diw  201 (384)
T 4fr4_A          125 VMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWW  201 (384)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHH
T ss_pred             HHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceee
Confidence            99999999   679999999999999999999999999999865432           23366654   34588999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||||++|||+||+.||......  .........         .......+                   ......+.+++
T Consensus       202 SlG~il~elltG~~Pf~~~~~~--~~~~~~~~~---------~~~~~~~p-------------------~~~s~~~~~li  251 (384)
T 4fr4_A          202 SLGVTAYELLRGRRPYHIRSST--SSKEIVHTF---------ETTVVTYP-------------------SAWSQEMVSLL  251 (384)
T ss_dssp             HHHHHHHHHHHSSCSSCCCTTS--CHHHHHHHH---------HHCCCCCC-------------------TTSCHHHHHHH
T ss_pred             chHHHHHHHHhCCCCCCCCCCc--cHHHHHHHH---------hhcccCCC-------------------CcCCHHHHHHH
Confidence            9999999999999998642211  111111110         00000000                   01224677888


Q ss_pred             hccCCCCccCCCC-HHHHHH
Q 040999          344 VACSMESPQDRMK-MTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs-~~evl~  362 (382)
                      .+||+.||++||+ +.++.+
T Consensus       252 ~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          252 KKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHhcCCHhHhcccHHHHHc
Confidence            8999999999998 666653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.8e-35  Score=282.87  Aligned_cols=144  Identities=26%  Similarity=0.367  Sum_probs=123.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++|++++|||||++++++.....+.....++||||+ +|+|.+++.          ....+++..+..++.||
T Consensus        97 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----------~~~~l~~~~~~~~~~qi  165 (458)
T 3rp9_A           97 KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR----------TPVYLTELHIKTLLYNL  165 (458)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHH----------SSCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcc----------cCCCCCHHHHHHHHHHH
Confidence            6789999999999999999999998664445567899999998 568888883          34568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------------------------------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------------------------------  243 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------------------------------  243 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....                                  
T Consensus       166 ~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (458)
T 3rp9_A          166 LVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG  242 (458)
T ss_dssp             HHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-------------------------
T ss_pred             HHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccC
Confidence            99999999   67999999999999999999999999999986531                                  


Q ss_pred             -----CCCCCccc-cCCCCCccchhHHHHHHHHHHHhc
Q 040999          244 -----TRTQTKYG-VGNEVSTIGDVYSYGILLLELMIR  275 (382)
Q Consensus       244 -----~~~~~~~~-~~~~~~~~~Dv~S~Gvil~elltg  275 (382)
                           ...+||.. .+..++.++|||||||++|||+||
T Consensus       243 ~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          243 HVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             --CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             CcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence                 13446653 456689999999999999999994

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-34  Score=274.14  Aligned_cols=199  Identities=17%  Similarity=0.217  Sum_probs=154.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+++|++++||||+++++++.     +....++||||+++|+|.+++..         ....+++..+..++.||
T Consensus        93 ~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~---------~~~~l~~~~~~~i~~qi  158 (387)
T 1kob_A           93 YTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVLILEFLSGGELFDRIAA---------EDYKMSEAEVINYMRQA  158 (387)
T ss_dssp             HHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEEEEECCCCCBHHHHTTC---------TTCCBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEEEEEEcCCCCcHHHHHHh---------hcCCCCHHHHHHHHHHH
Confidence            46899999999999999999999964     37789999999999999998842         33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCC--CCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDD--DMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~--~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++.....           ..+||...+..++.++||||
T Consensus       159 ~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  235 (387)
T 1kob_A          159 CEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWA  235 (387)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHH
T ss_pred             HHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEee
Confidence            99999999   679999999999999974  477999999999876443           23477777778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||...    ..........         .........                .......++.+++.
T Consensus       236 lG~il~elltg~~Pf~~~----~~~~~~~~i~---------~~~~~~~~~----------------~~~~~s~~~~~li~  286 (387)
T 1kob_A          236 IGVLGYVLLSGLSPFAGE----DDLETLQNVK---------RCDWEFDED----------------AFSSVSPEAKDFIK  286 (387)
T ss_dssp             HHHHHHHHHHSCCSSCCS----SHHHHHHHHH---------HCCCCCCSS----------------TTTTSCHHHHHHHH
T ss_pred             HhHHHHHHHhCCCCCCCC----CHHHHHHHHH---------hCCCCCCcc----------------ccccCCHHHHHHHH
Confidence            999999999999998642    1111111100         000000000                00012346778888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||++|||+.|+++
T Consensus       287 ~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          287 NLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTSCSSGGGSCCHHHHHT
T ss_pred             HHcCCChhHCcCHHHHhh
Confidence            999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.9e-35  Score=272.90  Aligned_cols=204  Identities=19%  Similarity=0.220  Sum_probs=148.4

Q ss_pred             chhhH------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|++      +.+.+|++++++++||||+++++++..     ....++||||+++|+|.+++.          ....++
T Consensus        82 avK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~  146 (349)
T 2w4o_A           82 ALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTEISLVLELVTGGELFDRIV----------EKGYYS  146 (349)
T ss_dssp             EEEEEEC----------CHHHHHCCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHT----------TCSSCC
T ss_pred             EEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCeEEEEEEeCCCCCHHHHHH----------hcCCCC
Confidence            77765      568899999999999999999999653     678999999999999999884          234589


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC---CCcEEEccccccccCCCC-----------CCCCcccc
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD---DMTARVGDFGLARFLPPT-----------RTQTKYGV  252 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~  252 (382)
                      +..+..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.....           ...||...
T Consensus       147 ~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  223 (349)
T 2w4o_A          147 ERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR  223 (349)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhc
Confidence            9999999999999999999   679999999999999975   889999999999865332           33477777


Q ss_pred             CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      +..++.++|||||||++|||++|+.||...................     ...+     .                  .
T Consensus       224 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-----~~~~-----~------------------~  275 (349)
T 2w4o_A          224 GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-----FISP-----W------------------W  275 (349)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-----CCTT-----T------------------T
T ss_pred             CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-----cCCc-----h------------------h
Confidence            7788999999999999999999999986421111011111100000     0000     0                  0


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+....+.+++.+||+.||++|||+.|+++
T Consensus       276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            022346778888999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-34  Score=265.26  Aligned_cols=212  Identities=17%  Similarity=0.203  Sum_probs=162.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|++++..++.+..    ..+..++||||+ +++|.+++..         ....+++..+..++.|+
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv~e~~-~~~L~~~~~~---------~~~~~~~~~~~~i~~qi  114 (296)
T 4hgt_A           49 PQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVMELL-GPSLEDLFNF---------CSRKFSLKTVLLLADQM  114 (296)
T ss_dssp             CCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEEEECC-CCBHHHHHHH---------TTSCCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEEEEcc-CCCHHHHHHH---------hcCCCCHHHHHHHHHHH
Confidence            458899999999999998888877643    367789999999 9999999842         23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee---CCCCcEEEccccccccCCCC-------------------CCCCccccCCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPT-------------------RTQTKYGVGNE  255 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~~~~~~~  255 (382)
                      +.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.....                   ..+||...+..
T Consensus       115 ~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  191 (296)
T 4hgt_A          115 ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE  191 (296)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCC
Confidence            99999999   6799999999999999   78899999999999865332                   12356666677


Q ss_pred             CCccchhHHHHHHHHHHHhcCCCCCccccCC--chHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHH
Q 040999          256 VSTIGDVYSYGILLLELMIREKPSDIMFEGD--MNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII  333 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (382)
                      ++.++|||||||++|||++|+.||.......  ..+........+.....                           ...
T Consensus       192 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~  244 (296)
T 4hgt_A          192 QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV---------------------------LCK  244 (296)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH---------------------------HTT
T ss_pred             CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh---------------------------hhc
Confidence            8999999999999999999999997532211  11111111110000000                           001


Q ss_pred             HHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       334 ~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      ..+..+.+++.+||+.||++|||+.++++.|+++......
T Consensus       245 ~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          245 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            2244688888999999999999999999999999887644

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.7e-34  Score=267.72  Aligned_cols=195  Identities=20%  Similarity=0.218  Sum_probs=154.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        50 ~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi  114 (337)
T 1o6l_A           50 AHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLS----------RERVFTEERARFYGAEI  114 (337)
T ss_dssp             HHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCcCcceEEEEE-----eCCEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            56889999999999999999999954     4778999999999999998883          33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++....            ...+||...+..++.++|||||
T Consensus       115 ~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  191 (337)
T 1o6l_A          115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  191 (337)
T ss_dssp             HHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred             HHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccc
Confidence            99999999   67999999999999999999999999999985322            1334777778889999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....     ........        ...... .+ .                  ....++.+++.+
T Consensus       192 G~il~ell~g~~Pf~~~~-----~~~~~~~i--------~~~~~~-~p-~------------------~~s~~~~~li~~  238 (337)
T 1o6l_A          192 GVVMYEMMCGRLPFYNQD-----HERLFELI--------LMEEIR-FP-R------------------TLSPEAKSLLAG  238 (337)
T ss_dssp             HHHHHHHHHSSCSSCCSS-----HHHHHHHH--------HHCCCC-CC-T------------------TSCHHHHHHHHH
T ss_pred             hhHHHHHhcCCCCCCCCC-----HHHHHHHH--------HcCCCC-CC-C------------------CCCHHHHHHHHH
Confidence            999999999999986321     11111110        000000 00 0                  122356778889


Q ss_pred             cCCCCccCCC-----CHHHHHHH
Q 040999          346 CSMESPQDRM-----KMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RP-----s~~evl~~  363 (382)
                      ||+.||++||     +++|+++.
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcC
Confidence            9999999999     89998753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-34  Score=263.50  Aligned_cols=197  Identities=17%  Similarity=0.215  Sum_probs=151.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   ......++||||+++++|.+++.           ...+++..+..++.|+
T Consensus        81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi  146 (298)
T 2zv2_A           81 EQVYQEIAILKKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPT-----------LKPLSEDQARFYFQDL  146 (298)
T ss_dssp             CHHHHHHHHHHTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSC-----------SSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhh-----------cCCCCHHHHHHHHHHH
Confidence            568999999999999999999999753   23567899999999999988662           2468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCC---CCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNE---VSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~---~~~~~Dv  262 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....            ...||...+..   .+.++||
T Consensus       147 ~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di  223 (298)
T 2zv2_A          147 IKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDV  223 (298)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHH
T ss_pred             HHHHHHHH---HCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhh
Confidence            99999999   679999999999999999999999999999865432            23366655443   3778999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||++|+.||....     ........        ..........                  ......+.++
T Consensus       224 ~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~--------~~~~~~~~~~------------------~~~~~~l~~l  272 (298)
T 2zv2_A          224 WAMGVTLYCFVFGQCPFMDER-----IMCLHSKI--------KSQALEFPDQ------------------PDIAEDLKDL  272 (298)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH--------HHCCCCCCSS------------------SCCCHHHHHH
T ss_pred             HhHHHHHHHHHHCCCCCCCcc-----HHHHHHHH--------hcccCCCCCc------------------cccCHHHHHH
Confidence            999999999999999986321     11111100        0000000000                  0122357788


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||+.|+++
T Consensus       273 i~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          273 ITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHhhcChhhCCCHHHHhc
Confidence            88999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8e-35  Score=264.51  Aligned_cols=215  Identities=23%  Similarity=0.321  Sum_probs=162.7

Q ss_pred             chhhH----HHHHHHHHHHhhcccccceeeeeeeeeccc-----------CCCceeEEEEecccCCCccccccCCCCCCc
Q 040999          113 AFKIF----KSFIAECKALRNIRHRNLIKVLTACLGVDY-----------QGNDFKALVYEFIHNRSPEKWLYPISKEDE  177 (382)
Q Consensus       113 avK~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~  177 (382)
                      |+|.+    +.+.+|++++++++||||+++++++....+           ......++||||+++|+|.+++...     
T Consensus        40 avK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----  114 (284)
T 2a19_B           40 VIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-----  114 (284)
T ss_dssp             EEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG-----
T ss_pred             EEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc-----
Confidence            56655    568899999999999999999998754222           1245579999999999999999531     


Q ss_pred             cccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CC
Q 040999          178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RT  246 (382)
Q Consensus       178 ~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~  246 (382)
                         ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....           ..
T Consensus       115 ---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~  188 (284)
T 2a19_B          115 ---RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM  188 (284)
T ss_dssp             ---GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTS
T ss_pred             ---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCccccc
Confidence               2346899999999999999999999   679999999999999999999999999998765432           23


Q ss_pred             CCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhh
Q 040999          247 QTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQ  326 (382)
Q Consensus       247 ~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (382)
                      .||...+..++.++||||||+++|||++|..|+...       .....        .+.......               
T Consensus       189 aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~--------~~~~~~~~~---------------  238 (284)
T 2a19_B          189 SPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFT--------DLRDGIISD---------------  238 (284)
T ss_dssp             CHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHH--------HHHTTCCCT---------------
T ss_pred             ChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHH--------Hhhcccccc---------------
Confidence            366666677899999999999999999999885311       01111        000100100               


Q ss_pred             hhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCCC
Q 040999          327 AKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  375 (382)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~  375 (382)
                             .....+.+++.+||+.||++|||+.|+++.|..+........
T Consensus       239 -------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~  280 (284)
T 2a19_B          239 -------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE  280 (284)
T ss_dssp             -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred             -------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence                   112346778889999999999999999999999987654443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.4e-35  Score=276.78  Aligned_cols=149  Identities=19%  Similarity=0.176  Sum_probs=128.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|||||++++++..     .+..++|||||++|+|.+++...        ....+++..+..++.||
T Consensus        71 ~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi  137 (389)
T 3gni_B           71 TFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWVVTSFMAYGSAKDLICTH--------FMDGMNELAIAYILQGV  137 (389)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHT--------CTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEeEEEEE-----CCEEEEEEEccCCCCHHHHHhhh--------cccCCCHHHHHHHHHHH
Confidence            678889999999999999999999754     67899999999999999998532        23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------------CCCCCccccC--CCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------------TRTQTKYGVG--NEV  256 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------------~~~~~~~~~~--~~~  256 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||.+.....                   ...+||...+  ..+
T Consensus       138 ~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  214 (389)
T 3gni_B          138 LKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY  214 (389)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB
T ss_pred             HHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCC
Confidence            99999999   67999999999999999999999999998754311                   1244666655  578


Q ss_pred             CccchhHHHHHHHHHHHhcCCCCCcc
Q 040999          257 STIGDVYSYGILLLELMIREKPSDIM  282 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~elltg~~p~~~~  282 (382)
                      +.++|||||||++|||++|+.||...
T Consensus       215 ~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          215 DAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            99999999999999999999998753

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.4e-34  Score=268.65  Aligned_cols=216  Identities=23%  Similarity=0.311  Sum_probs=164.0

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc------cccCCcccCHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE------TYERPRNLNLLRR  190 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~  190 (382)
                      +.+.+|+++++++ +||||+++++++..     .+..++||||+++|+|.+++........      .......+++..+
T Consensus        70 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (327)
T 1fvr_A           70 RDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL  144 (327)
T ss_dssp             CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred             HHHHHHHHHHHhccCCCchhhhceeeee-----CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHH
Confidence            5689999999999 89999999999754     6789999999999999999954210000      0012246899999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC-----------CCCCCCccccCCCCCcc
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-----------PTRTQTKYGVGNEVSTI  259 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~-----------~~~~~~~~~~~~~~~~~  259 (382)
                      +.++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++...           .....||...+..++.+
T Consensus       145 ~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  221 (327)
T 1fvr_A          145 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN  221 (327)
T ss_dssp             HHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred             HHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCch
Confidence            999999999999999   7799999999999999999999999999987432           12344666666778999


Q ss_pred             chhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +|||||||++|||+| |+.||....     .........         ........                  ......
T Consensus       222 ~Di~slG~il~ellt~g~~pf~~~~-----~~~~~~~~~---------~~~~~~~~------------------~~~~~~  269 (327)
T 1fvr_A          222 SDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEKLP---------QGYRLEKP------------------LNCDDE  269 (327)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHGG---------GTCCCCCC------------------TTBCHH
T ss_pred             hcchHHHHHHHHHHcCCCCCCCCCc-----HHHHHHHhh---------cCCCCCCC------------------CCCCHH
Confidence            999999999999998 999986421     111111100         00000000                  012346


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcC
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG  373 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~  373 (382)
                      +.+++.+||+.||.+|||+.|+++.|+++.+....
T Consensus       270 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          270 VYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence            78888899999999999999999999998876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.9e-35  Score=269.40  Aligned_cols=209  Identities=20%  Similarity=0.285  Sum_probs=154.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.... ......++||||+++++|.+++.          ....+++..++.++.|+
T Consensus        57 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~~~~lv~e~~~g~~L~~~l~----------~~~~~~~~~~~~~~~qi  125 (311)
T 3ork_A           57 LRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPLPYIVMEYVDGVTLRDIVH----------TEGPMTPKRAIEVIADA  125 (311)
T ss_dssp             HHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEEEEEEEEECCCEEEHHHHHH----------HHCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCcccEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            57899999999999999999999976421 11234599999999999999984          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------------CCCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++....               ....||...+..++.++||
T Consensus       126 ~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  202 (311)
T 3ork_A          126 CQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV  202 (311)
T ss_dssp             HHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHH
T ss_pred             HHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhH
Confidence            99999999   67999999999999999999999999999975432               2344777777788999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||+||+.||....    ... .....        ....... . .              .........+.++
T Consensus       203 ~slG~~l~~ll~g~~pf~~~~----~~~-~~~~~--------~~~~~~~-~-~--------------~~~~~~~~~l~~l  253 (311)
T 3ork_A          203 YSLGCVLYEVLTGEPPFTGDS----PVS-VAYQH--------VREDPIP-P-S--------------ARHEGLSADLDAV  253 (311)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSS----HHH-HHHHH--------HHCCCCC-H-H--------------HHSTTCCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCC----hHH-HHHHH--------hcCCCCC-c-c--------------cccCCCCHHHHHH
Confidence            999999999999999986421    111 11000        0000000 0 0              0000233467888


Q ss_pred             hhccCCCCccCCCCHHH-HHHHHHHhhh
Q 040999          343 GVACSMESPQDRMKMTN-VVHELQSIKN  369 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~e-vl~~L~~i~~  369 (382)
                      +.+||+.||++||++.+ +.+.+.++..
T Consensus       254 i~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          254 VLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             HHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            88999999999997555 5566665544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-34  Score=270.23  Aligned_cols=201  Identities=16%  Similarity=0.193  Sum_probs=153.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++..     .+..++||||+++|+|.+++....      .....+++..+..++.||
T Consensus        71 ~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi  139 (351)
T 3c0i_A           71 EDLKREASICHMLKHPHIVELLETYSS-----DGMLYMVFEFMDGADLCFEIVKRA------DAGFVYSEAVASHYMRQI  139 (351)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCSSCBHHHHHHHHH------HTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEe-----CCEEEEEEeCCCCCCHHHHHHHhc------ccCCCCCHHHHHHHHHHH
Confidence            568999999999999999999999654     678999999999999988774321      123458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCc---EEEccccccccCCCC------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT---ARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~---~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||.|||   +.+|+||||||+|||++.++.   +||+|||+++.....            ...||...+..++.++||
T Consensus       140 ~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  216 (351)
T 3c0i_A          140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDV  216 (351)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHH
T ss_pred             HHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhh
Confidence            99999999   679999999999999987654   999999999765432            223666667778999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||++|+.||....      .....        .+........+.                ........+.++
T Consensus       217 wslG~il~~ll~g~~pf~~~~------~~~~~--------~i~~~~~~~~~~----------------~~~~~s~~~~~l  266 (351)
T 3c0i_A          217 WGCGVILFILLSGCLPFYGTK------ERLFE--------GIIKGKYKMNPR----------------QWSHISESAKDL  266 (351)
T ss_dssp             HHHHHHHHHHHHSSCSSCSSH------HHHHH--------HHHHTCCCCCHH----------------HHTTSCHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCcH------HHHHH--------HHHcCCCCCCcc----------------ccccCCHHHHHH
Confidence            999999999999999986421      01110        011100000000                001223467888


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||+.|+++
T Consensus       267 i~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          267 VRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHCCCChhHCcCHHHHhc
Confidence            88999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.9e-34  Score=272.94  Aligned_cols=212  Identities=16%  Similarity=0.201  Sum_probs=159.8

Q ss_pred             chhhH---HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHH
Q 040999          113 AFKIF---KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLL  188 (382)
Q Consensus       113 avK~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~  188 (382)
                      |+|++   ..+.+|++++.++ +||||+++++++... +.+....++||||+++|+|.+++...        ....+++.
T Consensus        91 AiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~l~~~  161 (400)
T 1nxk_A           91 ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDR--------GDQAFTER  161 (400)
T ss_dssp             EEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEEEEEEECCCSEEHHHHHHCC-----------CCBHH
T ss_pred             EEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEEEEEEEeCCCCcHHHHHHHh--------CCCCCCHH
Confidence            88877   6788999988554 899999999986531 23456789999999999999999531        23468999


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC---CCcEEEccccccccCCC-----------CCCCCccccCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD---DMTARVGDFGLARFLPP-----------TRTQTKYGVGN  254 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~  254 (382)
                      .+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++....           ....||...+.
T Consensus       162 ~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  238 (400)
T 1nxk_A          162 EASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE  238 (400)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCC
T ss_pred             HHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCC
Confidence            99999999999999999   679999999999999997   78899999999986532           24458888788


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCc--hHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDM--NLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      .++.++|||||||++|||++|+.||........  .........           .......                ..
T Consensus       239 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-----------~~~~~~~----------------~~  291 (400)
T 1nxk_A          239 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-----------QYEFPNP----------------EW  291 (400)
T ss_dssp             CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-----------CCCCCTT----------------TT
T ss_pred             CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-----------cccCCCc----------------cc
Confidence            899999999999999999999999864322111  011111100           0000000                00


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      .....++.+++.+||+.||++|||+.|+++.
T Consensus       292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0223467888889999999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=267.23  Aligned_cols=222  Identities=18%  Similarity=0.246  Sum_probs=155.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        47 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~i~~~l  111 (311)
T 4agu_A           47 KIALREIRMLKQLKHPNLVNLLEVFRR-----KRRLHLVFEYCDHTVLHELDR----------YQRGVPEHLVKSITWQT  111 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHH----------TSSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCccchhheeec-----CCeEEEEEEeCCCchHHHHHh----------hhcCCCHHHHHHHHHHH
Confidence            668899999999999999999999754     678899999999999988773          34568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....            ...||...+ ..++.++||||
T Consensus       112 ~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s  188 (311)
T 4agu_A          112 LQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWA  188 (311)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHH
T ss_pred             HHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHH
Confidence            99999999   679999999999999999999999999999865422            223555544 56799999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC---chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN---HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||+++|||+||+.||......  ............   ................   ....................+.+
T Consensus       189 lG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  263 (311)
T 4agu_A          189 IGCVFAELLSGVPLWPGKSDV--DQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK---IPDPEDMEPLELKFPNISYPALG  263 (311)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC---CCCCSSCCCHHHHCTTCCHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhcccccccccccccccccccCc---CCCccccchhhhhcccccHHHHH
Confidence            999999999999998642211  111111111111   0000000000000000   00000000000001123446788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||++|||++|+++
T Consensus       264 li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          264 LLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHCCSSTTTSCCHHHHHT
T ss_pred             HHHHHccCChhhcCCHHHHhc
Confidence            999999999999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.4e-35  Score=265.41  Aligned_cols=205  Identities=23%  Similarity=0.292  Sum_probs=158.8

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++..      ...++|+||+++++|.+++..         ....+++..+..++.|
T Consensus        65 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~~  129 (291)
T 1u46_A           65 MDDFIREVNAMHSLDHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRK---------HQGHFLLGTLSRYAVQ  129 (291)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHH---------HGGGSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEcc------CCceeeEecccCCCHHHHHHh---------ccCCcCHHHHHHHHHH
Confidence            3678999999999999999999999643      337899999999999999842         2356899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~D  261 (382)
                      +++||.|||   +.+++||||||+||+++.++.+||+|||+++.....               ...||...+..++.++|
T Consensus       130 i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  206 (291)
T 1u46_A          130 VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASD  206 (291)
T ss_dssp             HHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHH
T ss_pred             HHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhh
Confidence            999999999   679999999999999999999999999999865432               23355555667789999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||+++|||++ |+.||....     ............        ......                  ......+.
T Consensus       207 i~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~~--------~~~~~~------------------~~~~~~l~  255 (291)
T 1u46_A          207 TWMFGVTLWEMFTYGQEPWIGLN-----GSQILHKIDKEG--------ERLPRP------------------EDCPQDIY  255 (291)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTSC--------CCCCCC------------------TTCCHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcccCC-----HHHHHHHHHccC--------CCCCCC------------------cCcCHHHH
Confidence            9999999999999 999986421     111111110000        000000                  02234678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +++.+||+.||++|||+.++++.|+++...
T Consensus       256 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          256 NVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            888899999999999999999999988764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.1e-34  Score=256.54  Aligned_cols=197  Identities=18%  Similarity=0.213  Sum_probs=154.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++..     .+..++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~i  114 (276)
T 2yex_A           50 ENIKKEICINKMLNHENVVKFYGHRRE-----GNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQL  114 (276)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEEEEEEEecCCCcHHHHHh----------hccCCCHHHHHHHHHHH
Confidence            678999999999999999999999654     678899999999999999983          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCC-Cccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEV-STIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~-~~~~Dv  262 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||.+.....              ....||...+..+ +.++||
T Consensus       115 ~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  191 (276)
T 2yex_A          115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV  191 (276)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHH
T ss_pred             HHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchH
Confidence            99999999   67999999999999999999999999999975421              1234666655554 779999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||+++|||+||+.||............+.....            .....                  ......+.++
T Consensus       192 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------~~~~~------------------~~~~~~~~~l  241 (276)
T 2yex_A          192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------YLNPW------------------KKIDSAPLAL  241 (276)
T ss_dssp             HHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT------------TSTTG------------------GGSCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc------------ccCch------------------hhcCHHHHHH
Confidence            99999999999999998753322222222211000            00000                  0122356788


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||+.|+++
T Consensus       242 i~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHCCCCchhCCCHHHHhc
Confidence            88999999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-34  Score=271.94  Aligned_cols=206  Identities=19%  Similarity=0.236  Sum_probs=152.7

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+       +.+.+|+.++++++||||+++++++..     ....++||||+++|+|.+++.          ....+
T Consensus        49 avK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~  113 (361)
T 3uc3_A           49 AVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLAIIMEYASGGELYERIC----------NAGRF  113 (361)
T ss_dssp             EEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHH----------HHSSC
T ss_pred             EEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEEEEEEeCCCCCHHHHHH----------hcCCC
Confidence            66655       678999999999999999999999653     678999999999999999883          23468


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCc--EEEccccccccCC-----------CCCCCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT--ARVGDFGLARFLP-----------PTRTQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~--~kl~Dfg~a~~~~-----------~~~~~~~~~~  252 (382)
                      ++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||+++...           ....+||...
T Consensus       114 ~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  190 (361)
T 3uc3_A          114 SEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL  190 (361)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhc
Confidence            99999999999999999999   679999999999999987765  9999999987432           1233466665


Q ss_pred             CCCCCcc-chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 GNEVSTI-GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 ~~~~~~~-~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      +..++.+ +|||||||++|||++|+.||....... ...........        ........                 
T Consensus       191 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~--------~~~~~~~~-----------------  244 (361)
T 3uc3_A          191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILS--------VKYSIPDD-----------------  244 (361)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHT--------TCCCCCTT-----------------
T ss_pred             CCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhc--------CCCCCCCc-----------------
Confidence            6666555 899999999999999999987432211 11111111110        00000000                 


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                       ......+.+++.+||+.||++|||+.|+++.
T Consensus       245 -~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          245 -IRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             0112356788889999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.4e-35  Score=270.47  Aligned_cols=210  Identities=21%  Similarity=0.246  Sum_probs=150.4

Q ss_pred             chhhH-----HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF-----KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|.+     ..+.+|+++++.++ ||||+++++++.     +....++||||+++|+|.+++.          ....++
T Consensus        40 avK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~  104 (325)
T 3kn6_A           40 AVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMELLNGGELFERIK----------KKKHFS  104 (325)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------HCSCCC
T ss_pred             EEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEccCCCcHHHHHH----------hcCCCC
Confidence            66654     67889999999997 999999999964     4778999999999999999984          335689


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC---cEEEccccccccCCCC------------CCCCccc
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM---TARVGDFGLARFLPPT------------RTQTKYG  251 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfg~a~~~~~~------------~~~~~~~  251 (382)
                      +..+..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||+++.....            ...||..
T Consensus       105 ~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~  181 (325)
T 3kn6_A          105 ETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL  181 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------------------
T ss_pred             HHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHh
Confidence            9999999999999999999   77999999999999997665   8999999999865332            3347777


Q ss_pred             cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          252 VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       252 ~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      .+..++.++|||||||++|||++|+.||........          .....++...........         +   ...
T Consensus       182 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~~~~i~~~~~~~---------~---~~~  239 (325)
T 3kn6_A          182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSAVEIMKKIKKGDFSF---------E---GEA  239 (325)
T ss_dssp             --CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHHHHHHHHTTTCCCC---------C---SHH
T ss_pred             cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccHHHHHHHHHcCCCCC---------C---ccc
Confidence            778899999999999999999999999874321100          001111111111100000         0   000


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ......++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1123456788888999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-34  Score=267.54  Aligned_cols=211  Identities=20%  Similarity=0.226  Sum_probs=154.8

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecc---cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVD---YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNI  193 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i  193 (382)
                      +.+.+|++++.++. ||||+++++++....   .......++||||+. |+|.+++...       .....+++..++.+
T Consensus        70 ~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~~~~i  141 (337)
T 3ll6_A           70 RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKM-------ESRGPLSCDTVLKI  141 (337)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHH-------HTTCSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHh-------hccCCCCHHHHHHH
Confidence            67899999999996 999999999975321   134566899999995 7898888431       12346999999999


Q ss_pred             HHHHHHHHhHHhhcCCCc--eeecCCCCCceeeCCCCcEEEccccccccCCCC------------------------CCC
Q 040999          194 AIDVASALNYLHHDCQPV--TAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------------------RTQ  247 (382)
Q Consensus       194 ~~~i~~~L~~lH~~~~~~--ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------------------~~~  247 (382)
                      +.|++.||.|||   ..+  |+||||||+|||++.++.+||+|||+++.....                        ...
T Consensus       142 ~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~a  218 (337)
T 3ll6_A          142 FYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRT  218 (337)
T ss_dssp             HHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------------------
T ss_pred             HHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCC
Confidence            999999999999   667  999999999999999999999999999865321                        234


Q ss_pred             Cccc---cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccch
Q 040999          248 TKYG---VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQ  324 (382)
Q Consensus       248 ~~~~---~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (382)
                      ||..   .+..++.++|||||||++|||+||+.||......     ...            ..........         
T Consensus       219 PE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~------------~~~~~~~~~~---------  272 (337)
T 3ll6_A          219 PEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----RIV------------NGKYSIPPHD---------  272 (337)
T ss_dssp             -----CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------------CCCCTTC---------
T ss_pred             hhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----Hhh------------cCcccCCccc---------
Confidence            6665   4566789999999999999999999998632110     000            0000000000         


Q ss_pred             hhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCC
Q 040999          325 TQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  374 (382)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~  374 (382)
                               .....+.+++.+||+.||++|||+.|+++.|+.+.......
T Consensus       273 ---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          273 ---------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             ---------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             ---------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence                     11123567888999999999999999999999998765443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.8e-34  Score=259.97  Aligned_cols=200  Identities=19%  Similarity=0.321  Sum_probs=153.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++... ..+....++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        70 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  138 (290)
T 1t4h_A           70 QRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQI  138 (290)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceEEEEEEecCCCCHHHHHH----------HccCCCHHHHHHHHHHH
Confidence            6789999999999999999999987542 234567899999999999999993          23468899999999999


Q ss_pred             HHHHhHHhhcCCCc--eeecCCCCCceeeC-CCCcEEEccccccccCCCC----------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPV--TAHCDLKPSNVLLD-DDMTARVGDFGLARFLPPT----------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~--ivH~dlkp~NILl~-~~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+  |+||||||+||+++ .++.+||+|||++......          ..+||... ..++.++||||
T Consensus       139 ~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~s  214 (290)
T 1t4h_A          139 LKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYA  214 (290)
T ss_dssp             HHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHH
T ss_pred             HHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHh-ccCCCcchHHH
Confidence            99999999   666  99999999999998 7899999999999754332          33466544 45899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|||+||+.||...    ...................+                          ......+.+++.
T Consensus       215 lG~~l~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~  264 (290)
T 1t4h_A          215 FGMCMLEMATSEYPYSEC----QNAAQIYRRVTSGVKPASFD--------------------------KVAIPEVKEIIE  264 (290)
T ss_dssp             HHHHHHHHHHSSCTTTTC----SSHHHHHHHHTTTCCCGGGG--------------------------GCCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCc----CcHHHHHHHHhccCCccccC--------------------------CCCCHHHHHHHH
Confidence            999999999999998642    11222211111110000000                          011235788888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||.+|||+.|+++
T Consensus       265 ~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          265 GCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHSCSSGGGSCCHHHHHT
T ss_pred             HHccCChhhCCCHHHHhh
Confidence            999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=275.91  Aligned_cols=234  Identities=18%  Similarity=0.156  Sum_probs=164.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   ......++||||+++|+|.+++....       ....+++..++.++.|+
T Consensus        52 ~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~qi  121 (396)
T 4eut_A           52 DVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKVLIMEFCPCGSLYTVLEEPS-------NAYGLPESEFLIVLRDV  121 (396)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEEEEECCCTTEEHHHHTTSGG-------GTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCeeEEEEecCCCCCHHHHHHhhh-------cccCCCHHHHHHHHHHH
Confidence            678899999999999999999998753   23447899999999999999995321       22348999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee----CCCCcEEEccccccccCCCC-----------CCCCccccC--------C
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMTARVGDFGLARFLPPT-----------RTQTKYGVG--------N  254 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl----~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~--------~  254 (382)
                      +.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.....           ...||...+        .
T Consensus       122 ~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  198 (396)
T 4eut_A          122 VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK  198 (396)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHH
T ss_pred             HHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhcccccccccc
Confidence            99999999   6799999999999999    78888999999999865432           223444322        4


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHh--cCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA--LPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      .++.++|||||||++|||+||+.||.................  .+......+........   .......   ......
T Consensus       199 ~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~---~~~~l~  272 (396)
T 4eut_A          199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI---DWSGDMP---VSCSLS  272 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCE---EEESSCC---TTCSSC
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCc---ccCccCC---cccccc
Confidence            567899999999999999999999875433222222111111  11110000000000000   0000000   000111


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      ......+.+++.+||+.||++|||+.|+++.++++.+.
T Consensus       273 ~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          273 RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            35566788889999999999999999999999988663

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3e-34  Score=276.60  Aligned_cols=149  Identities=23%  Similarity=0.305  Sum_probs=124.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++|++++||||+++++++...........++||||+. |+|.+++.          ....+++..+..++.||
T Consensus        70 ~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----------~~~~l~~~~~~~i~~qi  138 (432)
T 3n9x_A           70 KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK----------TPIFLTEEHIKTILYNL  138 (432)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHH----------SSCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHh----------ccCCCCHHHHHHHHHHH
Confidence            67899999999999999999999976543333467899999986 59998883          34568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------------------------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------------------------  244 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------------------------  244 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....                                 
T Consensus       139 l~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  215 (432)
T 3n9x_A          139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR  215 (432)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCC
T ss_pred             HHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCc
Confidence            99999999   679999999999999999999999999999865321                                 


Q ss_pred             -CCCCccc-cCCCCCccchhHHHHHHHHHHHhcCCCCC
Q 040999          245 -RTQTKYG-VGNEVSTIGDVYSYGILLLELMIREKPSD  280 (382)
Q Consensus       245 -~~~~~~~-~~~~~~~~~Dv~S~Gvil~elltg~~p~~  280 (382)
                       ..+||.. ....++.++||||+||++|||++|..||.
T Consensus       216 ~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          216 WYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence             2336653 45568999999999999999999766654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.9e-34  Score=262.33  Aligned_cols=221  Identities=19%  Similarity=0.226  Sum_probs=152.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     ....++||||+++ ++.+++.         .....+++..+..++.|+
T Consensus        46 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~-~l~~~~~---------~~~~~l~~~~~~~~~~ql  110 (292)
T 3o0g_A           46 SSALREICLLKELKHKNIVRLHDVLHS-----DKKLTLVFEFCDQ-DLKKYFD---------SCNGDLDPEIVKSFLFQL  110 (292)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEEEEECCSE-EHHHHHH---------HTTTCCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEEEEEEecCCC-CHHHHHH---------hCCCCCCHHHHHHHHHHH
Confidence            678899999999999999999999654     6789999999976 5555552         234568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCC-CCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNE-VSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~-~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....            ..+||...+.. ++.++||||
T Consensus       111 ~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  187 (292)
T 3o0g_A          111 LKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS  187 (292)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred             HHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHH
Confidence            99999999   679999999999999999999999999999865422            22355554544 799999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC---chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN---HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||++|||+||..||.........+..........   ....... ........     ..................+.+
T Consensus       188 lG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  261 (292)
T 3o0g_A          188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK-LPDYKPYP-----MYPATTSLVNVVPKLNATGRD  261 (292)
T ss_dssp             HHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG-STTCCCCC-----CCCTTCCCTTTSTTCCHHHHH
T ss_pred             HHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc-cccccccc-----cccCCcchhhcccccChHHHH
Confidence            99999999999988542211111122222211111   0000000 00000000     000000000000123346778


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||++|||++|+++
T Consensus       262 li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          262 LLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccChhhCCCHHHHhc
Confidence            888999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.9e-34  Score=262.99  Aligned_cols=151  Identities=25%  Similarity=0.380  Sum_probs=126.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     ..+..++||||++ |+|.+++.....    ......+++..+..++.||
T Consensus        48 ~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~~~~~qi  117 (317)
T 2pmi_A           48 STAIREISLMKELKHENIVRLYDVIH-----TENKLTLVFEFMD-NDLKKYMDSRTV----GNTPRGLELNLVKYFQWQL  117 (317)
T ss_dssp             HHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEEEEEEECCC-CBHHHHHHHHHS----SSCCCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeEEEEEEecC-CCHHHHHHhccc----cccccCCCHHHHHHHHHHH
Confidence            67889999999999999999999954     4678999999998 689888843211    1123458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....            ..+||...+ ..++.++||||
T Consensus       118 ~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  194 (317)
T 2pmi_A          118 LQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWS  194 (317)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHH
T ss_pred             HHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHH
Confidence            99999999   679999999999999999999999999999865321            233665544 46799999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      |||++|||+||+.||..
T Consensus       195 lG~il~el~~g~~pf~~  211 (317)
T 2pmi_A          195 CGCILAEMITGKPLFPG  211 (317)
T ss_dssp             HHHHHHHHHHSSCSCCC
T ss_pred             HHHHHHHHHhCCCCCCC
Confidence            99999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.2e-34  Score=276.04  Aligned_cols=194  Identities=22%  Similarity=0.316  Sum_probs=153.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++..     ....++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        61 ~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~----------~~~~l~~~~~~~i~~qi  125 (476)
T 2y94_A           61 GKIRREIQNLKLFRHPHIIKLYQVIST-----PSDIFMVMEYVSGGELFDYIC----------KNGRLDEKESRRLFQQI  125 (476)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEEECCSSEEHHHHTT----------SSSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            568899999999999999999999643     678999999999999999984          33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCC-CccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEV-STIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~-~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...+..+ +.++||||+
T Consensus       126 ~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  202 (476)
T 2y94_A          126 LSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSS  202 (476)
T ss_dssp             HHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHH
T ss_pred             HHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhh
Confidence            99999999   789999999999999999999999999999865432           223555555544 689999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||+...  .   ......        +.+.... .+ .                  .....+.+++.+
T Consensus       203 Gvil~elltG~~Pf~~~~--~---~~~~~~--------i~~~~~~-~p-~------------------~~s~~~~~Li~~  249 (476)
T 2y94_A          203 GVILYALLCGTLPFDDDH--V---PTLFKK--------ICDGIFY-TP-Q------------------YLNPSVISLLKH  249 (476)
T ss_dssp             HHHHHHHHHSSCSSCCSS--S---HHHHHH--------HHTTCCC-CC-T------------------TCCHHHHHHHHH
T ss_pred             HHHHHHHhhCCCCCCCCC--H---HHHHHH--------HhcCCcC-CC-c------------------cCCHHHHHHHHH
Confidence            999999999999986421  1   111111        1110000 00 0                  112356788889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.||++|||+.|+++
T Consensus       250 ~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          250 MLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HTCSSTTTSCCHHHHHT
T ss_pred             HcCCCchhCcCHHHHHh
Confidence            99999999999999996

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9.4e-34  Score=266.61  Aligned_cols=152  Identities=26%  Similarity=0.328  Sum_probs=130.5

Q ss_pred             chhhH-------HHHHHHHHHHhhcc-----cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCcccc
Q 040999          113 AFKIF-------KSFIAECKALRNIR-----HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYE  180 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~  180 (382)
                      |+|++       +.+.+|+++++.++     ||||+++++++..     .+..++||||+ +++|.+++...        
T Consensus        64 avK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~--------  129 (360)
T 3llt_A           64 AVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-----YDHMCLIFEPL-GPSLYEIITRN--------  129 (360)
T ss_dssp             EEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-----TTEEEEEECCC-CCBHHHHHHHT--------
T ss_pred             EEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-----CCeeEEEEcCC-CCCHHHHHHhc--------
Confidence            77765       56788999999996     9999999999754     67899999999 99999998532        


Q ss_pred             CCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC-------------------------CCcEEEccc
Q 040999          181 RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD-------------------------DMTARVGDF  235 (382)
Q Consensus       181 ~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-------------------------~~~~kl~Df  235 (382)
                      ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.                         ++.+||+||
T Consensus       130 ~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DF  206 (360)
T 3llt_A          130 NYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF  206 (360)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCC
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEec
Confidence            2345899999999999999999999   779999999999999975                         788999999


Q ss_pred             cccccCCCC---------CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          236 GLARFLPPT---------RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       236 g~a~~~~~~---------~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      |+++.....         ..+||...+..++.++|||||||++|||+||+.||..
T Consensus       207 G~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          207 GCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence            999865432         2347777778899999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.1e-34  Score=262.72  Aligned_cols=219  Identities=18%  Similarity=0.216  Sum_probs=153.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++ +|.+++..         ....+++..+..++.|+
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~~~~qi  109 (288)
T 1ob3_A           45 STTIREISILKELKHSNIVKLYDVIHT-----KKRLVLVFEHLDQ-DLKKLLDV---------CEGGLESVTAKSFLLQL  109 (288)
T ss_dssp             HHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCEEEEEECCSE-EHHHHHHT---------STTCCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeEEEEEEecCC-CHHHHHHh---------cccCCCHHHHHHHHHHH
Confidence            678899999999999999999999643     6789999999975 88888842         23568899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||+++....            ...+||...+ ..++.++||||
T Consensus       110 ~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  186 (288)
T 1ob3_A          110 LNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS  186 (288)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHH
T ss_pred             HHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHH
Confidence            99999999   67999999999999999999999999999875431            2344666544 45899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC---chhhhhhc-ccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN---HVKDIVDS-ILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||++|||+||+.||..... ...+..........   ........ .......       ...+............++.
T Consensus       187 lG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~  258 (288)
T 1ob3_A          187 VGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT-------VYEPLPWESFLKGLDESGI  258 (288)
T ss_dssp             HHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC-------CCCCCCGGGTCCSCCHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHHCCCChhhchhhhcccccccccc-------cccCccHHHHhhhcCHHHH
Confidence            99999999999999864321 11111111111110   00000000 0000000       0000000000012234677


Q ss_pred             HHhhccCCCCccCCCCHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +++.+||+.||++|||+.|+++
T Consensus       259 ~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          259 DLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCcccCCCHHHHhc
Confidence            8888999999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.5e-34  Score=264.86  Aligned_cols=231  Identities=22%  Similarity=0.252  Sum_probs=158.6

Q ss_pred             chhhH-----HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF-----KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|++     +.+.+|++++++++ ||||+++++++..   ......++||||+++++|.+++.             .++
T Consensus        65 avK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~-------------~~~  128 (330)
T 3nsz_A           65 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALVFEHVNNTDFKQLYQ-------------TLT  128 (330)
T ss_dssp             EEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEEEEEECCCCCCHHHHGG-------------GCC
T ss_pred             EEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceEEEEeccCchhHHHHHH-------------hCC
Confidence            77765     78999999999997 9999999999653   23567899999999999988872             378


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC-cEEEccccccccCCCCC-----------CCCccccC-
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPPTR-----------TQTKYGVG-  253 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~-----------~~~~~~~~-  253 (382)
                      +..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++......           ..||...+ 
T Consensus       129 ~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~  205 (330)
T 3nsz_A          129 DYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY  205 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCC
Confidence            8899999999999999999   67999999999999999776 89999999998654322           23555444 


Q ss_pred             CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhh---hhhcccc-ch-hhhh
Q 040999          254 NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEK---LVVRGDQ-KQ-TQAK  328 (382)
Q Consensus       254 ~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-~~-~~~~  328 (382)
                      ..++.++|||||||++|||++|+.||.........+.............+.++.........   ....... .. ....
T Consensus       206 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (330)
T 3nsz_A          206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH  285 (330)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCC
T ss_pred             CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhcc
Confidence            56899999999999999999999998532222112222211111111111111110000000   0000000 00 0000


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          329 INVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       329 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ..........+.+++.+||+.||++|||++|+++
T Consensus       286 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          286 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000113456788899999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.2e-34  Score=258.30  Aligned_cols=195  Identities=18%  Similarity=0.231  Sum_probs=153.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     +....++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        54 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~l~----------~~~~~~~~~~~~~~~qi  118 (279)
T 3fdn_A           54 HQLRREVEIQSHLRHPNILRLYGYFH-----DATRVYLILEYAPLGTVYRELQ----------KLSKFDEQRTATYITEL  118 (279)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCCcchhheEe-----cCCEEEEEEecCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            56889999999999999999999964     3678999999999999999883          23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||++.....          ....||...+..++.++||||||+
T Consensus       119 ~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  195 (279)
T 3fdn_A          119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV  195 (279)
T ss_dssp             HHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred             HHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHH
Confidence            99999999   78999999999999999999999999999865432          234477777778899999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ++|||++|+.||....     ........        ..... ..+ .                  .....+.+++.+||
T Consensus       196 il~~l~~g~~p~~~~~-----~~~~~~~~--------~~~~~-~~~-~------------------~~~~~~~~li~~~l  242 (279)
T 3fdn_A          196 LCYEFLVGKPPFEANT-----YQETYKRI--------SRVEF-TFP-D------------------FVTEGARDLISRLL  242 (279)
T ss_dssp             HHHHHHHSSCTTCCSS-----HHHHHHHH--------HHTCC-CCC-T------------------TSCHHHHHHHHHHC
T ss_pred             HHHHHHHCCCCCCCCc-----HHHHHHHH--------HhCCC-CCC-C------------------cCCHHHHHHHHHHh
Confidence            9999999999986321     11111000        00000 000 0                  12235678888999


Q ss_pred             CCCccCCCCHHHHHHH
Q 040999          348 MESPQDRMKMTNVVHE  363 (382)
Q Consensus       348 ~~~p~~RPs~~evl~~  363 (382)
                      +.||++|||+.|+++.
T Consensus       243 ~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          243 KHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CSSGGGSCCHHHHHHC
T ss_pred             ccChhhCCCHHHHhhC
Confidence            9999999999999974

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=264.80  Aligned_cols=227  Identities=20%  Similarity=0.244  Sum_probs=155.3

Q ss_pred             HHHHHHHHHHhhcc---cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKALRNIR---HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ..+.+|+++++.++   ||||++++++|...........++||||+. |+|.+++...        ....+++..+..++
T Consensus        56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~~~~i~  126 (308)
T 3g33_A           56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA--------PPPGLPAETIKDLM  126 (308)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTC--------CTTCSCHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhc--------cCCCCCHHHHHHHH
Confidence            36778888887775   999999999986533223336799999996 6999988532        22348999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      .|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...+..++.++|||
T Consensus       127 ~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  203 (308)
T 3g33_A          127 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMW  203 (308)
T ss_dssp             HHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHH
T ss_pred             HHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHH
Confidence            99999999999   678999999999999999999999999999765432           2346666677889999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||||++|||++|+.||...... ..+..............+-.....  +.........   ........+....+.+++
T Consensus       204 slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~~~~~li  277 (308)
T 3g33_A          204 SVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWPRDVSL--PRGAFPPRGP---RPVQSVVPEMEESGAQLL  277 (308)
T ss_dssp             HHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSCSSCSS--CGGGSCCCCC---CCHHHHSCSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhccchhhc--cccccCCCCC---CcHHHhCccccHHHHHHH
Confidence            9999999999999998642111 111112111111000000000000  0000000000   000001112345678888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.||++|||+.|+++
T Consensus       278 ~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          278 LEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhcCCCccCCCHHHHhc
Confidence            8999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-33  Score=262.11  Aligned_cols=199  Identities=18%  Similarity=0.190  Sum_probs=154.9

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++.     .....++||||+++++|.+++.          ....+++..+..++.|
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~q  123 (321)
T 2a2a_A           59 REEIEREVSILRQVLHHNVITLHDVYE-----NRTDVVLILELVSGGELFDFLA----------QKESLSEEEATSFIKQ  123 (321)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------TCSCEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCEEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            367899999999999999999999964     3678999999999999999994          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCC----cEEEccccccccCCCC-----------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDM----TARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~D  261 (382)
                      ++.||.|||   +.+|+||||||+||+++.++    .+||+|||+++.....           ..+||...+..++.++|
T Consensus       124 i~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  200 (321)
T 2a2a_A          124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD  200 (321)
T ss_dssp             HHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred             HHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccc
Confidence            999999999   67999999999999999887    7999999999865432           22366666778899999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||+++|||+||+.||....    . ........        ........ .               ........+.+
T Consensus       201 i~slG~il~~l~~g~~pf~~~~----~-~~~~~~i~--------~~~~~~~~-~---------------~~~~~~~~~~~  251 (321)
T 2a2a_A          201 MWSIGVITYILLSGASPFLGDT----K-QETLANIT--------SVSYDFDE-E---------------FFSHTSELAKD  251 (321)
T ss_dssp             HHHHHHHHHHHHHSCCSSCCSS----H-HHHHHHHH--------TTCCCCCH-H---------------HHTTCCHHHHH
T ss_pred             cHHHHHHHHHHHHCCCCCCCCC----H-HHHHHHHH--------hcccccCh-h---------------hhcccCHHHHH
Confidence            9999999999999999986321    1 11111100        00000000 0               00022345778


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||++|||+.|+++
T Consensus       252 li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          252 FIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHhc
Confidence            888999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1e-33  Score=261.87  Aligned_cols=194  Identities=19%  Similarity=0.233  Sum_probs=154.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+.+++.++||||+++++++.     +....++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        51 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi  115 (318)
T 1fot_A           51 EHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQIFMIMDYIEGGELFSLLR----------KSQRFPNPVAKFYAAEV  115 (318)
T ss_dssp             HHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------HTSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCCceEeEEEE-----eCCEEEEEEeCCCCCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            56788999999999999999999954     4778999999999999999984          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------CCCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++....         ...+||...+..++.++|||||||+
T Consensus       116 ~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  192 (318)
T 1fot_A          116 CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGIL  192 (318)
T ss_dssp             HHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHH
T ss_pred             HHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHH
Confidence            99999999   78999999999999999999999999999986543         2334677677788999999999999


Q ss_pred             HHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCC
Q 040999          269 LLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSM  348 (382)
Q Consensus       269 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~  348 (382)
                      +|||++|+.||...    .....+ .        .++...... + .                  ....++.+++.+|++
T Consensus       193 l~ell~g~~pf~~~----~~~~~~-~--------~i~~~~~~~-p-~------------------~~~~~~~~li~~lL~  239 (318)
T 1fot_A          193 IYEMLAGYTPFYDS----NTMKTY-E--------KILNAELRF-P-P------------------FFNEDVKDLLSRLIT  239 (318)
T ss_dssp             HHHHHHSSCTTCCS----SHHHHH-H--------HHHHCCCCC-C-T------------------TSCHHHHHHHHHHTC
T ss_pred             HHHHHhCCCCCCCC----CHHHHH-H--------HHHhCCCCC-C-C------------------CCCHHHHHHHHHHhc
Confidence            99999999998632    111111 1        111110000 0 0                  112356778889999


Q ss_pred             CCccCCC-----CHHHHHH
Q 040999          349 ESPQDRM-----KMTNVVH  362 (382)
Q Consensus       349 ~~p~~RP-----s~~evl~  362 (382)
                      .||++||     +++|+++
T Consensus       240 ~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          240 RDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             SCTTTCTTSSTTTTHHHHT
T ss_pred             cCHHHcCCCcCCCHHHHhc
Confidence            9999999     8888874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.8e-33  Score=270.05  Aligned_cols=197  Identities=19%  Similarity=0.206  Sum_probs=150.5

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|+++|++++||||+++++++.      .+..++||||+++|+|.+++.          ....+++..+..++.|++
T Consensus       186 ~~~~E~~~l~~l~hpniv~l~~~~~------~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~~i~~qi~  249 (419)
T 3i6u_A          186 NVETEIEILKKLNHPCIIKIKNFFD------AEDYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQML  249 (419)
T ss_dssp             CHHHHHHHHHHCCCTTBCCCCEEEE------SSEEEEEEECCTTCBGGGGTS----------SSCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEe------cCceEEEEEcCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHH
Confidence            4789999999999999999999853      345789999999999999883          345689999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCC---CcEEEccccccccCCC-----------CCCCCcccc---CCCCCccch
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDD---MTARVGDFGLARFLPP-----------TRTQTKYGV---GNEVSTIGD  261 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfg~a~~~~~-----------~~~~~~~~~---~~~~~~~~D  261 (382)
                      .||+|||   +.+|+||||||+|||++.+   ..+||+|||+++....           ...+||...   ...++.++|
T Consensus       250 ~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D  326 (419)
T 3i6u_A          250 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD  326 (419)
T ss_dssp             HHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHH
T ss_pred             HHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhh
Confidence            9999999   6799999999999999754   4599999999986543           234477654   356788999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||+||+.||....... .+.............+                           ........+.+
T Consensus       327 iwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~~~~~~~---------------------------~~~~~~~~~~~  378 (419)
T 3i6u_A          327 CWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYNFIPE---------------------------VWAEVSEKALD  378 (419)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTCCCCCHH---------------------------HHTTSCHHHHH
T ss_pred             hHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCCCCCCch---------------------------hhcccCHHHHH
Confidence            9999999999999999987432211 1111111110000000                           00123346788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||++|||+.|+++
T Consensus       379 li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          379 LVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHhC
Confidence            888999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.5e-34  Score=258.29  Aligned_cols=197  Identities=21%  Similarity=0.231  Sum_probs=151.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     .....++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~~i  115 (277)
T 3f3z_A           51 DRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIYLVMELCTGGELFERVV----------HKRVFRESDAARIMKDV  115 (277)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEEEEEeccCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            67999999999999999999999964     3678999999999999998883          23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee---CCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+||++   +.++.+||+|||++......           ...||... ..++.++|||
T Consensus       116 ~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~  191 (277)
T 3f3z_A          116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEW  191 (277)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTTHHHH
T ss_pred             HHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhc-ccCCchhheh
Confidence            99999999   6799999999999999   78899999999999765432           22355443 3489999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||+++|||+||+.||.....  ........           ..... .+.               .........+.+++
T Consensus       192 slG~~l~~l~~g~~p~~~~~~--~~~~~~~~-----------~~~~~-~~~---------------~~~~~~~~~~~~li  242 (277)
T 3f3z_A          192 SAGVMMYVLLCGYPPFSAPTD--SEVMLKIR-----------EGTFT-FPE---------------KDWLNVSPQAESLI  242 (277)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSH--HHHHHHHH-----------HCCCC-CCH---------------HHHTTSCHHHHHHH
T ss_pred             hHHHHHHHHHHCCCCCCCCCH--HHHHHHHH-----------hCCCC-CCc---------------hhhhcCCHHHHHHH
Confidence            999999999999999864211  00000000           00000 000               00002234677888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.||++|||+.|+++
T Consensus       243 ~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          243 RRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            8999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3e-34  Score=266.52  Aligned_cols=210  Identities=21%  Similarity=0.347  Sum_probs=160.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .++.+|+.++++++||||+++++++..     ....++||||+++|+|.+++......   ......+++..++.++.|+
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~qi  149 (327)
T 2yfx_A           78 LDFLMEALIISKFNHQNIVRCIGVSLQ-----SLPRFILMELMAGGDLKSFLRETRPR---PSQPSSLAMLDLLHVARDI  149 (327)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHHTSCC---SSSTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCCCeEEEEEcC-----CCCcEEEEecCCCCcHHHHHHhhccc---ccccccccHHHHHHHHHHH
Confidence            678999999999999999999999643     66789999999999999999643211   1123468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCC---CCcEEEccccccccCCC--------------CCCCCccccCCCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDD---DMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~  260 (382)
                      +.||.|||   +.+|+||||||+|||++.   +..+||+|||+++....              ....||...+..++.++
T Consensus       150 ~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  226 (327)
T 2yfx_A          150 ACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKT  226 (327)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchh
Confidence            99999999   679999999999999984   44699999999864311              23446666677889999


Q ss_pred             hhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          261 DVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       261 Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      ||||||+++|||+| |+.||.....  ............            .....                  .+...+
T Consensus       227 Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~------------~~~~~------------------~~~~~l  274 (327)
T 2yfx_A          227 DTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGGR------------MDPPK------------------NCPGPV  274 (327)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCC------------CCCCT------------------TCCHHH
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcCCC------------CCCCC------------------CCCHHH
Confidence            99999999999998 9999763211  111111110000            00000                  223467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+++.+||+.||.+|||+.++++.|+.+...
T Consensus       275 ~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          275 YRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            7888899999999999999999999988663

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.3e-34  Score=264.79  Aligned_cols=212  Identities=20%  Similarity=0.217  Sum_probs=149.8

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++.++ +||||+++++++..     .+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        55 ~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~q  119 (316)
T 2ac3_A           55 SRVFREVEMLYQCQGHRNVLELIEFFEE-----EDRFYLVFEKMRGGSILSHIH----------KRRHFNELEASVVVQD  119 (316)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCEEEEEEEcCCCCcHHHHHh----------ccCCCCHHHHHHHHHH
Confidence            6789999999995 79999999999654     678999999999999999984          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCc---EEEccccccccCCCC-------------------CCCCccccC-
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT---ARVGDFGLARFLPPT-------------------RTQTKYGVG-  253 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~---~kl~Dfg~a~~~~~~-------------------~~~~~~~~~-  253 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.   +||+|||+++.....                   ..+||...+ 
T Consensus       120 i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  196 (316)
T 2ac3_A          120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF  196 (316)
T ss_dssp             HHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHT
T ss_pred             HHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcc
Confidence            999999999   679999999999999988776   999999998754311                   122444332 


Q ss_pred             ----CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCC-chhhhhhcccccchhhhhhccccchhhhh
Q 040999          254 ----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPN-HVKDIVDSILLNDDEKLVVRGDQKQTQAK  328 (382)
Q Consensus       254 ----~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (382)
                          ..++.++|||||||++|||+||+.||............   ..... ....+.+.......         ..+.  
T Consensus       197 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~~~---------~~~~--  262 (316)
T 2ac3_A          197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---GEACPACQNMLFESIQEGKY---------EFPD--  262 (316)
T ss_dssp             SHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCHHHHHHHHHHHHHCCC---------CCCH--
T ss_pred             cccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc---cccchhHHHHHHHHHhccCc---------ccCc--
Confidence                34688999999999999999999998754322111000   00000 00000000000000         0000  


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          329 INVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       329 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                       .........+.+++.+||+.||++|||+.|+++
T Consensus       263 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          263 -KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             -HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence             000123346788889999999999999999987

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.7e-34  Score=266.97  Aligned_cols=194  Identities=17%  Similarity=0.165  Sum_probs=154.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++.     +....++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        86 ~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~~~~qi  150 (350)
T 1rdq_E           86 EHTLNEKRILQAVNFPFLVKLEFSFK-----DNSNLYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQI  150 (350)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEE-----cCCEEEEEEcCCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            57889999999999999999999854     4778999999999999999984          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....         ..+||...+..++.++|||||||+
T Consensus       151 ~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  227 (350)
T 1rdq_E          151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVL  227 (350)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred             HHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHh
Confidence            99999999   779999999999999999999999999999866432         234676677788999999999999


Q ss_pred             HHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCC
Q 040999          269 LLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSM  348 (382)
Q Consensus       269 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~  348 (382)
                      +|||++|+.||...    .. ......        +...... .+ .                  .....+.+++.+||+
T Consensus       228 l~ell~g~~Pf~~~----~~-~~~~~~--------i~~~~~~-~p-~------------------~~~~~~~~li~~lL~  274 (350)
T 1rdq_E          228 IYEMAAGYPPFFAD----QP-IQIYEK--------IVSGKVR-FP-S------------------HFSSDLKDLLRNLLQ  274 (350)
T ss_dssp             HHHHHHSSCSSCCS----SH-HHHHHH--------HHHCCCC-CC-T------------------TCCHHHHHHHHHHSC
T ss_pred             HhHHhhCCCCCCCC----CH-HHHHHH--------HHcCCCC-CC-C------------------CCCHHHHHHHHHHhh
Confidence            99999999998632    11 111111        0000000 00 0                  122357788889999


Q ss_pred             CCccCCCC-----HHHHHH
Q 040999          349 ESPQDRMK-----MTNVVH  362 (382)
Q Consensus       349 ~~p~~RPs-----~~evl~  362 (382)
                      .||++||+     ++|+++
T Consensus       275 ~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          275 VDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             SCTTTCTTSSTTTTHHHHT
T ss_pred             cCHHhccCCccCCHHHHHh
Confidence            99999998     888874

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=269.39  Aligned_cols=196  Identities=20%  Similarity=0.333  Sum_probs=147.1

Q ss_pred             HHHHHHHHHHhhccc--ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRH--RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      +.+.+|+++|++++|  +||+++++++..     ....++||| +.+|+|.+++.          ....+++..+..++.
T Consensus        52 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~~~~~lv~e-~~~~~L~~~l~----------~~~~~~~~~~~~i~~  115 (343)
T 3dbq_A           52 DSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQYIYMVME-CGNIDLNSWLK----------KKKSIDPWERKSYWK  115 (343)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSEEEEEEC-CCSEEHHHHHH----------HSCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhhhcCCceEEEeeeEee-----CCEEEEEEe-CCCCCHHHHHH----------hcCCCCHHHHHHHHH
Confidence            678999999999986  999999999653     678999999 56889999984          345689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccC--------
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVG--------  253 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~--------  253 (382)
                      |++.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.....              ...||...+        
T Consensus       116 qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  191 (343)
T 3dbq_A          116 NMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG  191 (343)
T ss_dssp             HHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC------
T ss_pred             HHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccccccc
Confidence            9999999999   67999999999999997 578999999999765322              233555432        


Q ss_pred             ---CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhh
Q 040999          254 ---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN  330 (382)
Q Consensus       254 ---~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (382)
                         ..++.++|||||||++|||++|+.||.....   ......         .+++.........               
T Consensus       192 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~---------~~~~~~~~~~~~~---------------  244 (343)
T 3dbq_A          192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKLH---------AIIDPNHEIEFPD---------------  244 (343)
T ss_dssp             -----CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHHH---------HHHCTTSCCCCCC---------------
T ss_pred             ccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---HHHHHH---------HHhcCCcccCCcc---------------
Confidence               6678899999999999999999999864321   111111         1111110000000               


Q ss_pred             hHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          331 VIIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       331 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                         .....+.+++.+||+.||.+|||+.|+++.
T Consensus       245 ---~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          245 ---IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence               112356788889999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-33  Score=260.90  Aligned_cols=207  Identities=17%  Similarity=0.166  Sum_probs=154.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        79 ~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi  143 (309)
T 2h34_A           79 TRMQREARTAGRLQEPHVVPIHDFGEI-----DGQLYVDMRLINGVDLAAMLR----------RQGPLAPPRAVAIVRQI  143 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEEEEECCCCEEHHHHHH----------HHCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEee-----CCeEEEEEEecCCCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            678999999999999999999999754     678899999999999999984          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||++......             ...||...+..++.++||||
T Consensus       144 ~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  220 (309)
T 2h34_A          144 GSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYA  220 (309)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHH
T ss_pred             HHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHH
Confidence            99999999   679999999999999999999999999998755322             33477777788899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|||+||+.||......  .+........+. ... .                          ....+..+.+++.
T Consensus       221 lG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-~~~-~--------------------------~~~~~~~l~~li~  270 (309)
T 2h34_A          221 LTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR-PST-V--------------------------RPGIPVAFDAVIA  270 (309)
T ss_dssp             HHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC-GGG-T--------------------------STTCCTHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC-ccc-c--------------------------CCCCCHHHHHHHH
Confidence            999999999999998642110  011111000000 000 0                          0022336778888


Q ss_pred             ccCCCCccCCC-CHHHHHHHHHHhhhhhc
Q 040999          345 ACSMESPQDRM-KMTNVVHELQSIKNTLL  372 (382)
Q Consensus       345 ~Cl~~~p~~RP-s~~evl~~L~~i~~~~~  372 (382)
                      +||+.||++|| |++++++.|+++.....
T Consensus       271 ~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          271 RGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             HhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            99999999999 99999999998866543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.7e-34  Score=269.59  Aligned_cols=220  Identities=18%  Similarity=0.194  Sum_probs=155.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++...........++||||++ |+|.+++.         .....+++..+..++.|+
T Consensus        74 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi  143 (362)
T 3pg1_A           74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---------DQRIVISPQHIQYFMYHI  143 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---------CTTSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---------hcccCCCHHHHHHHHHHH
Confidence            78999999999999999999999986544344567899999997 68888774         234468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccC-CCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVG-NEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~-~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...+ ..++.++|||||
T Consensus       144 ~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  220 (362)
T 3pg1_A          144 LLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA  220 (362)
T ss_dssp             HHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHH
T ss_pred             HHHHHHHH---HCcCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhH
Confidence            99999999   679999999999999999999999999999754322           234665554 668999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhh-----------hhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKD-----------IVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ||++|||+||+.||..... ...+.............+           .+.......+.           .........
T Consensus       221 G~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~  288 (362)
T 3pg1_A          221 GCVMAEMFNRKALFRGSTF-YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA-----------RAWTAVVPT  288 (362)
T ss_dssp             HHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC-----------CCHHHHSTT
T ss_pred             HHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh-----------hhHHhhCCC
Confidence            9999999999999864211 111111111111111111           11111110000           000001112


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       289 ~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          289 ADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            2346788899999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-34  Score=269.45  Aligned_cols=228  Identities=17%  Similarity=0.202  Sum_probs=154.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +++.+|+++++.++||||+++++++.... .......++||||+ +++|.+++..           ..+++..+..++.|
T Consensus        69 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~q  136 (367)
T 1cm8_A           69 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQ  136 (367)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----------CCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHH
Confidence            67889999999999999999999975421 11224569999999 8899988832           35889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccC-CCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVG-NEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~-~~~~~~~Dv~S~G  266 (382)
                      |++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....         ..+||...+ ..++.++||||+|
T Consensus       137 i~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  213 (367)
T 1cm8_A          137 MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVG  213 (367)
T ss_dssp             HHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHH
T ss_pred             HHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHH
Confidence            999999999   679999999999999999999999999999875432         223665555 6789999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||..... ...+.......... ..+.+.................................+.+++.+|
T Consensus       214 ~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~m  291 (367)
T 1cm8_A          214 CIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTP-PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM  291 (367)
T ss_dssp             HHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCC-CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCC-CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence            999999999999864211 01111111111111 1111111000000000000000000000000112234677888899


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      |+.||++|||+.|+++
T Consensus       292 L~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          292 LVLDAEQRVTAGEALA  307 (367)
T ss_dssp             SCSSTTTSCCHHHHHH
T ss_pred             ccCChhHCCCHHHHhc
Confidence            9999999999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-33  Score=274.17  Aligned_cols=148  Identities=22%  Similarity=0.257  Sum_probs=122.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +++.+|+++|+.++|||||++++++.... .......++||||++++ |.+.+.            ..+++..+..++.|
T Consensus       106 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~------------~~l~~~~~~~~~~q  172 (464)
T 3ttj_A          106 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ------------MELDHERMSYLLYQ  172 (464)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT------------SCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHh------------hcCCHHHHHHHHHH
Confidence            67889999999999999999999975422 13346789999999764 555552            23889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      |+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....           ..+||...+..++.++||||+
T Consensus       173 il~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  249 (464)
T 3ttj_A          173 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  249 (464)
T ss_dssp             HHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             HHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHH
Confidence            999999999   679999999999999999999999999999865432           344777777889999999999


Q ss_pred             HHHHHHHHhcCCCCCc
Q 040999          266 GILLLELMIREKPSDI  281 (382)
Q Consensus       266 Gvil~elltg~~p~~~  281 (382)
                      ||++|||++|+.||..
T Consensus       250 G~il~ell~g~~pF~g  265 (464)
T 3ttj_A          250 GCIMGEMVRHKILFPG  265 (464)
T ss_dssp             HHHHHHHHHSSCSSCC
T ss_pred             HHHHHHHHhCCCCCCC
Confidence            9999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.9e-34  Score=267.97  Aligned_cols=197  Identities=24%  Similarity=0.316  Sum_probs=151.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++||||+++++++..     .+..++||||+. |+|.+++.         .....+++..+..++.|+
T Consensus        99 ~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~-g~l~~~l~---------~~~~~l~~~~~~~i~~qi  163 (348)
T 1u5q_A           99 QDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTAWLVMEYCL-GSASDLLE---------VHKKPLQEVEIAAVTHGA  163 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCS-EEHHHHHH---------HHTSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCeEEEEEecCC-CCHHHHHH---------HhcCCCCHHHHHHHHHHH
Confidence            578999999999999999999999764     678999999997 67877773         223568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------CCCCcccc---CCCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------RTQTKYGV---GNEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~---~~~~~~~~Dv~S~G  266 (382)
                      ++||.|||   +.+|+||||||+|||++.++.+||+|||+++.....        ..+||...   ...++.++||||||
T Consensus       164 ~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG  240 (348)
T 1u5q_A          164 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  240 (348)
T ss_dssp             HHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHH
T ss_pred             HHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHH
Confidence            99999999   679999999999999999999999999999865432        23356542   46789999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||+||+.||....    .......... ..     .+.....                     .....+.+++.+|
T Consensus       241 ~il~ell~g~~p~~~~~----~~~~~~~~~~-~~-----~~~~~~~---------------------~~~~~l~~li~~~  289 (348)
T 1u5q_A          241 ITCIELAERKPPLFNMN----AMSALYHIAQ-NE-----SPALQSG---------------------HWSEYFRNFVDSC  289 (348)
T ss_dssp             HHHHHHHHSSCTTTTSC----HHHHHHHHHH-SC-----CCCCCCT---------------------TSCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCC----hHHHHHHHHh-cC-----CCCCCCC---------------------CCCHHHHHHHHHH
Confidence            99999999999986321    1111111000 00     0000000                     1223567888899


Q ss_pred             CCCCccCCCCHHHHHHH
Q 040999          347 SMESPQDRMKMTNVVHE  363 (382)
Q Consensus       347 l~~~p~~RPs~~evl~~  363 (382)
                      |+.||++|||+.++++.
T Consensus       290 l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          290 LQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             TCSSGGGSCCHHHHTTC
T ss_pred             cccChhhCcCHHHHhhC
Confidence            99999999999998753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.4e-34  Score=267.68  Aligned_cols=223  Identities=19%  Similarity=0.275  Sum_probs=153.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        69 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~qi  133 (331)
T 4aaa_A           69 KIAMREIKLLKQLRHENLVNLLEVCKK-----KKRWYLVFEFVDHTILDDLEL----------FPNGLDYQVVQKYLFQI  133 (331)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHH----------STTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEeec-----CCEEEEEEecCCcchHHHHHh----------hccCCCHHHHHHHHHHH
Confidence            568899999999999999999999754     678899999999998888762          33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCC-CCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGN-EVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~-~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....            ...||...+. .++.++||||
T Consensus       134 ~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~s  210 (331)
T 4aaa_A          134 INGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWA  210 (331)
T ss_dssp             HHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHH
T ss_pred             HHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHH
Confidence            99999999   679999999999999999999999999999754321            2346655544 6789999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcC--CchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALP--NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||++|||++|+.||...... ..+.........  ..........-......   ....................+.++
T Consensus       211 lG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l  286 (331)
T 4aaa_A          211 IGCLVTEMFMGEPLFPGDSDI-DQLYHIMMCLGNLIPRHQELFNKNPVFAGVR---LPEIKEREPLERRYPKLSEVVIDL  286 (331)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC---CCCCSSCCCHHHHSTTSCHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhHhhhcccccccc---CccccccchhhhcccchhHHHHHH
Confidence            999999999999998642211 111111111100  00111111000000000   000000000000111234578889


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||+.|+++
T Consensus       287 i~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          287 AKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHhccCcccCCCHHHHhc
Confidence            99999999999999999885

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.5e-34  Score=257.54  Aligned_cols=195  Identities=21%  Similarity=0.283  Sum_probs=144.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     +.+..++||||+++++|.+++..         ....+++..+..++.|+
T Consensus        56 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~qi  121 (278)
T 3cok_A           56 QRVQNEVKIHCQLKHPSILELYNYFE-----DSNYVYLVLEMCHNGEMNRYLKN---------RVKPFSENEARHFMHQI  121 (278)
T ss_dssp             HHHHHHHHHHTTBCCTTBCCEEEEEE-----CSSEEEEEEECCTTEEHHHHHHT---------CSSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeEeEEEEEc-----cCCeEEEEEecCCCCcHHHHHhh---------ccCCCCHHHHHHHHHHH
Confidence            56889999999999999999999964     36789999999999999999842         33568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++||.|||   +.+|+||||||+||+++.++.+||+|||++.....            ....||...+..++.++|||||
T Consensus       122 ~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  198 (278)
T 3cok_A          122 ITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSL  198 (278)
T ss_dssp             HHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----------------------------CTHHHHH
T ss_pred             HHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHH
Confidence            99999999   67999999999999999999999999999986532            1334777777778999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|||+||+.||.......     ...        ........ .+ .                  ....++.+++.+
T Consensus       199 G~il~~l~~g~~p~~~~~~~~-----~~~--------~~~~~~~~-~~-~------------------~~~~~~~~li~~  245 (278)
T 3cok_A          199 GCMFYTLLIGRPPFDTDTVKN-----TLN--------KVVLADYE-MP-S------------------FLSIEAKDLIHQ  245 (278)
T ss_dssp             HHHHHHHHHSSCSSCCCSCC------------------CCSSCCC-CC-T------------------TSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCChhHHH-----HHH--------HHhhcccC-Cc-c------------------ccCHHHHHHHHH
Confidence            999999999999986421110     000        00000000 00 0                  122356788889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.||++|||+.++++
T Consensus       246 ~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          246 LLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HSCSSGGGSCCHHHHTT
T ss_pred             HcccCHhhCCCHHHHhc
Confidence            99999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=268.88  Aligned_cols=194  Identities=19%  Similarity=0.198  Sum_probs=150.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|.++++.+ +||||+++++++.     +.+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        68 ~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~q  132 (353)
T 3txo_A           68 ECTMTEKRILSLARNHPFLTQLFCCFQ-----TPDRLFFVMEFVNGGDLMFHIQ----------KSRRFDEARARFYAAE  132 (353)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCceeeEEEEEE-----eCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            4578899999998 7999999999954     4778999999999999999883          3356899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....            ...+||...+..++.++||||
T Consensus       133 i~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  209 (353)
T 3txo_A          133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWA  209 (353)
T ss_dssp             HHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHH
T ss_pred             HHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCc
Confidence            999999999   67999999999999999999999999999985322            123356555667899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....     .......        +....... + .                  .....+.+++.
T Consensus       210 lG~il~ell~G~~Pf~~~~-----~~~~~~~--------i~~~~~~~-p-~------------------~~~~~~~~li~  256 (353)
T 3txo_A          210 MGVLLYEMLCGHAPFEAEN-----EDDLFEA--------ILNDEVVY-P-T------------------WLHEDATGILK  256 (353)
T ss_dssp             HHHHHHHHHHSSCSSCCSS-----HHHHHHH--------HHHCCCCC-C-T------------------TSCHHHHHHHH
T ss_pred             chHHHHHHHhCCCCCCCCC-----HHHHHHH--------HHcCCCCC-C-C------------------CCCHHHHHHHH
Confidence            9999999999999986421     1111111        00100000 0 0                  11235677888


Q ss_pred             ccCCCCccCCCCH------HHHHH
Q 040999          345 ACSMESPQDRMKM------TNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~------~evl~  362 (382)
                      +||+.||++||++      .|+++
T Consensus       257 ~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          257 SFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHhhhCHHHccCCcccCCHHHHhh
Confidence            9999999999998      67764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.7e-34  Score=269.23  Aligned_cols=228  Identities=18%  Similarity=0.198  Sum_probs=156.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++...........++||||+. |+|.+++.           ...+++..+..++.|+
T Consensus        70 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~-----------~~~~~~~~~~~i~~qi  137 (364)
T 3qyz_A           70 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLK-----------TQHLSNDHICYFLYQI  137 (364)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHH-----------HCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHH-----------hCCCCHHHHHHHHHHH
Confidence            67899999999999999999999986544444567899999997 58888873           2358999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCcccc-CCCCCccch
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGV-GNEVSTIGD  261 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~-~~~~~~~~D  261 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....               ...||... +..++.++|
T Consensus       138 ~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  214 (364)
T 3qyz_A          138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID  214 (364)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHH
T ss_pred             HHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchh
Confidence            99999999   679999999999999999999999999999865422               12355433 345799999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||+||+.||..... ...+........... .+.+.................................+.+
T Consensus       215 iwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (364)
T 3qyz_A          215 IWSVGCILAEMLSNRPIFPGKHY-LDQLNHILGILGSPS-QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD  292 (364)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSG-GGHHHHHHHHHCSCC-HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCh-HHHHHHHHHHhCCCC-HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHH
Confidence            99999999999999999864321 111222222111111 1111100000000000000000000000001123346788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||++|||+.|+++
T Consensus       293 li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          293 LLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCChhhCCCHHHHhc
Confidence            899999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2e-33  Score=255.31  Aligned_cols=207  Identities=18%  Similarity=0.202  Sum_probs=158.9

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++..     ....++||||+++++|.+++.          ....+++..+..++.|
T Consensus        52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~~  116 (283)
T 3bhy_A           52 REEIEREVNILREIRHPNIITLHDIFEN-----KTDVVLILELVSGGELFDFLA----------EKESLTEDEATQFLKQ  116 (283)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCeeehhheecC-----CCeEEEEEeecCCCcHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            4678999999999999999999999653     678899999999999999983          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCC----cEEEccccccccCCCC-----------CCCCccccCCCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDM----TARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~D  261 (382)
                      ++.||.|||   +.+++||||||+||+++.++    .+||+|||.+......           ...||...+..++.++|
T Consensus       117 i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  193 (283)
T 3bhy_A          117 ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEAD  193 (283)
T ss_dssp             HHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHH
T ss_pred             HHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchh
Confidence            999999999   67999999999999998877    8999999999865332           23466666778899999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||+++|||++|+.||....    .. .......        ........                .........+.+
T Consensus       194 i~slG~il~~l~~g~~p~~~~~----~~-~~~~~~~--------~~~~~~~~----------------~~~~~~~~~~~~  244 (283)
T 3bhy_A          194 MWSIGVITYILLSGASPFLGET----KQ-ETLTNIS--------AVNYDFDE----------------EYFSNTSELAKD  244 (283)
T ss_dssp             HHHHHHHHHHHHHSSCTTCCSS----HH-HHHHHHH--------TTCCCCCH----------------HHHTTCCHHHHH
T ss_pred             hhhHHHHHHHHHHCCCCCCCcc----hH-HHHHHhH--------hcccCCcc----------------hhcccCCHHHHH
Confidence            9999999999999999986421    11 1111000        00000000                000122346778


Q ss_pred             HhhccCCCCccCCCCHHHHHH--HHHHhhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVH--ELQSIKNT  370 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~--~L~~i~~~  370 (382)
                      ++.+||+.||++|||+.|+++  .++.++..
T Consensus       245 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          245 FIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             HHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence            888999999999999999997  46665544

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.6e-34  Score=258.26  Aligned_cols=198  Identities=16%  Similarity=0.193  Sum_probs=152.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     .....++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~~~i  114 (284)
T 3kk8_A           50 QKLEREARICRKLQHPNIVRLHDSIQ-----EESFHYLVFDLVTGGELFEDIV----------AREFYSEADASHCIQQI  114 (284)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCEEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            67889999999999999999999964     3678899999999999988883          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCc---EEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT---ARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~---~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+||+++.++.   +||+|||.+......           ...||...+..++.++|||
T Consensus       115 ~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  191 (284)
T 3kk8_A          115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW  191 (284)
T ss_dssp             HHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHH
T ss_pred             HHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchH
Confidence            99999999   679999999999999987655   999999999765432           2336666677789999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||+++|||++|+.||.....  .............           ... .               ........+.+++
T Consensus       192 slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~-----------~~~-~---------------~~~~~~~~~~~li  242 (284)
T 3kk8_A          192 ACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYD-----------YPS-P---------------EWDTVTPEAKSLI  242 (284)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC-----------CCT-T---------------TTTTSCHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCch--hHHHHHHHhcccc-----------CCc-h---------------hhcccCHHHHHHH
Confidence            999999999999999863211  1111111000000           000 0               0001234577888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.||++|||+.|+++
T Consensus       243 ~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          243 DSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHcccChhhCCCHHHHhc
Confidence            8999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-33  Score=262.80  Aligned_cols=188  Identities=23%  Similarity=0.292  Sum_probs=151.3

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCC-CccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNR-SPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+.+|++++++++||||+++++++.     ..+..++||||+.+| +|.+++.          ....+++..+..++.|+
T Consensus        75 ~~~~E~~~l~~l~h~~Iv~~~~~~~-----~~~~~~lv~e~~~~g~~l~~~~~----------~~~~l~~~~~~~i~~qi  139 (335)
T 3dls_A           75 KVTLEIAILSRVEHANIIKVLDIFE-----NQGFFQLVMEKHGSGLDLFAFID----------RHPRLDEPLASYIFRQL  139 (335)
T ss_dssp             EEEHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECCTTSCBHHHHHH----------TCCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEe-----eCCEEEEEEEeCCCCccHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            5678999999999999999999964     377899999999777 9988883          34468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-----------CCCccccCCCC-CccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-----------TQTKYGVGNEV-STIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~~~~~-~~~~Dv~S~  265 (382)
                      +.||.|||   ..+|+||||||+|||++.++.+||+|||+++......           ..||...+..+ +.++|||||
T Consensus       140 ~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  216 (335)
T 3dls_A          140 VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSL  216 (335)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHH
T ss_pred             HHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhH
Confidence            99999999   6799999999999999999999999999998664432           23665555555 789999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||.....                   ..........                    ....++.+++.+
T Consensus       217 G~il~el~~g~~pf~~~~~-------------------~~~~~~~~~~--------------------~~~~~l~~li~~  257 (335)
T 3dls_A          217 GVTLYTLVFEENPFCELEE-------------------TVEAAIHPPY--------------------LVSKELMSLVSG  257 (335)
T ss_dssp             HHHHHHHHHSSCSCSSGGG-------------------GTTTCCCCSS--------------------CCCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCchhhHHH-------------------HHhhccCCCc--------------------ccCHHHHHHHHH
Confidence            9999999999999864211                   0111000000                    112357788889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.||++|||+.|+++.
T Consensus       258 ~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          258 LLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HTCSSGGGSCCHHHHHHC
T ss_pred             HccCChhhCcCHHHHhcC
Confidence            999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.6e-34  Score=268.29  Aligned_cols=229  Identities=17%  Similarity=0.188  Sum_probs=146.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeec-ccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGV-DYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++++.++||||+++++++... ........++|+||+ +++|.+++.           ...+++..+..++.|
T Consensus        73 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----------~~~l~~~~~~~i~~q  140 (367)
T 2fst_X           73 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-----------CQKLTDDHVQFLIYQ  140 (367)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC----------------CCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh-----------cCCCCHHHHHHHHHH
Confidence            6788999999999999999999997532 112235679999999 789988883           245899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccC-CCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVG-NEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~-~~~~~~~Dv~S~G  266 (382)
                      |++||.|||   +.+|+||||||+|||++.++.+||+|||+++.....         ..+||...+ ..++.++||||||
T Consensus       141 i~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  217 (367)
T 2fst_X          141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG  217 (367)
T ss_dssp             HHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHH
T ss_pred             HHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHH
Confidence            999999999   679999999999999999999999999999765322         334666555 6789999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||..... ...+.......... ..+.+..................+..............+.+|+.+|
T Consensus       218 ~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~m  295 (367)
T 2fst_X          218 CIMAELLTGRTLFPGTDH-IDQLKLILRLVGTP-GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM  295 (367)
T ss_dssp             HHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSC-CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCC-CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHh
Confidence            999999999999864211 01111111111111 1111111000000000000000000000001112234678888899


Q ss_pred             CCCCccCCCCHHHHHHH
Q 040999          347 SMESPQDRMKMTNVVHE  363 (382)
Q Consensus       347 l~~~p~~RPs~~evl~~  363 (382)
                      |+.||++|||+.|+++.
T Consensus       296 L~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          296 LVLDSDKRITAAQALAH  312 (367)
T ss_dssp             SCSSGGGSCCHHHHHTS
T ss_pred             CCCCcccCcCHHHHhcC
Confidence            99999999999999863

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.1e-35  Score=276.58  Aligned_cols=209  Identities=14%  Similarity=0.109  Sum_probs=148.8

Q ss_pred             HHHHHHH---HHHhhcccccceeeeeeeeecc--cCCC------------c-----eeEEEEecccCCCccccccCCCCC
Q 040999          118 KSFIAEC---KALRNIRHRNLIKVLTACLGVD--YQGN------------D-----FKALVYEFIHNRSPEKWLYPISKE  175 (382)
Q Consensus       118 ~~~~~E~---~~l~~l~h~niv~~~~~~~~~~--~~~~------------~-----~~~lv~e~~~~gsL~~~l~~~~~~  175 (382)
                      +.+.+|+   +++++++|||||++++.+....  +...            +     ..++||||+ +|+|.+++..... 
T Consensus       118 ~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~-  195 (377)
T 3byv_A          118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS-  195 (377)
T ss_dssp             HHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc-
Confidence            6789999   5556668999999984332100  1111            1     378999999 6899999953210 


Q ss_pred             CccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC--------CCCCC
Q 040999          176 DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP--------PTRTQ  247 (382)
Q Consensus       176 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~--------~~~~~  247 (382)
                        .......+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...        ....+
T Consensus       196 --~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~a  270 (377)
T 3byv_A          196 --HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEP  270 (377)
T ss_dssp             --TTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCC
T ss_pred             --cccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccC
Confidence              0112244667888999999999999999   6799999999999999999999999999998543        23445


Q ss_pred             CccccCC-----------CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhh
Q 040999          248 TKYGVGN-----------EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKL  316 (382)
Q Consensus       248 ~~~~~~~-----------~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (382)
                      ||...+.           .++.++|||||||++|||+||+.||.......             ....+... . .     
T Consensus       271 PE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~-------------~~~~~~~~-~-~-----  330 (377)
T 3byv_A          271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG-------------GSEWIFRS-C-K-----  330 (377)
T ss_dssp             HHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------C-------------CSGGGGSS-C-C-----
T ss_pred             hhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccccc-------------chhhhhhh-c-c-----
Confidence            7766665           78999999999999999999999986421110             00011100 0 0     


Q ss_pred             hhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH--HHHHhhhh
Q 040999          317 VVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH--ELQSIKNT  370 (382)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~--~L~~i~~~  370 (382)
                                       .....+.+++.+||+.||++|||+.|+++  .++++.+.
T Consensus       331 -----------------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  369 (377)
T 3byv_A          331 -----------------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE  369 (377)
T ss_dssp             -----------------CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred             -----------------CCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence                             12235778888999999999999999985  45555443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.5e-34  Score=259.09  Aligned_cols=208  Identities=20%  Similarity=0.227  Sum_probs=155.5

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++..   ......++||||+++++|.+++....      .....+++..++.++.|
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~  119 (279)
T 2w5a_A           49 KQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQ  119 (279)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTEEEEEEECCTTEEHHHHHHHHH------HTTCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCceEEEEEeCCCCCCHHHHHHhhc------ccCCCCCHHHHHHHHHH
Confidence            3678999999999999999999998754   23567899999999999999985321      12345899999999999


Q ss_pred             HHHHHhHHhhcC--CCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDC--QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~--~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||.|||...  ..+|+||||||+||+++.++.+||+|||.++....            ....||...+..++.++||
T Consensus       120 i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  199 (279)
T 2w5a_A          120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDI  199 (279)
T ss_dssp             HHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHH
T ss_pred             HHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhH
Confidence            999999999431  01299999999999999999999999999976532            2445777777788999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||+++|||+||+.||.....  ...........           ....+                   ......+.++
T Consensus       200 ~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~-----------~~~~~-------------------~~~~~~l~~l  247 (279)
T 2w5a_A          200 WSLGCLLYELCALMPPFTAFSQ--KELAGKIREGK-----------FRRIP-------------------YRYSDELNEI  247 (279)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC-----------CCCCC-------------------TTSCHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhcc-----------cccCC-------------------cccCHHHHHH
Confidence            9999999999999999864211  11111111000           00000                   0123467788


Q ss_pred             hhccCCCCccCCCCHHHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                      +.+||+.||++|||+.|+++.+.
T Consensus       248 i~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          248 ITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             HHHHcCCCcccCCCHHHHHhChh
Confidence            88999999999999999998653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.4e-34  Score=271.12  Aligned_cols=196  Identities=20%  Similarity=0.333  Sum_probs=146.1

Q ss_pred             HHHHHHHHHHhhcc--cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      +.+.+|+++|++++  ||||+++++++..     .+..++||| +.+++|.+++.          ....+++..+..++.
T Consensus        99 ~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~~~~lv~E-~~~~~L~~~l~----------~~~~~~~~~~~~i~~  162 (390)
T 2zmd_A           99 DSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQYIYMVME-CGNIDLNSWLK----------KKKSIDPWERKSYWK  162 (390)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSEEEEEEE-CCSEEHHHHHH----------HCSSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCeEEEEEEEEec-----CCEEEEEEe-cCCCCHHHHHH----------hcCCCCHHHHHHHHH
Confidence            67899999999996  5999999999654     667999999 56889999984          234688889999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccC--------
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVG--------  253 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~--------  253 (382)
                      ||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.....              ..+||...+        
T Consensus       163 qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  238 (390)
T 2zmd_A          163 NMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG  238 (390)
T ss_dssp             HHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC-------
T ss_pred             HHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcccccccc
Confidence            9999999999   78999999999999995 578999999999865332              122554432        


Q ss_pred             ---CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhh
Q 040999          254 ---NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN  330 (382)
Q Consensus       254 ---~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (382)
                         ..++.++|||||||++|||++|+.||.....   .....         ..+++.........               
T Consensus       239 ~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~---------~~~~~~~~~~~~~~---------------  291 (390)
T 2zmd_A          239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKL---------HAIIDPNHEIEFPD---------------  291 (390)
T ss_dssp             -----CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHH---------HHHHCTTSCCCCCC---------------
T ss_pred             ccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---HHHHH---------HHHhCccccCCCCc---------------
Confidence               3688999999999999999999999864221   11111         11111111000000               


Q ss_pred             hHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          331 VIIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       331 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                         .....+.+++.+||+.||++|||+.|+++.
T Consensus       292 ---~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          292 ---IPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence               012356788889999999999999999853

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.2e-34  Score=265.45  Aligned_cols=146  Identities=23%  Similarity=0.282  Sum_probs=127.5

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|.+++.++ +||||+++++++.     .....++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        54 ~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~~~~~lv~e~~~gg~L~~~l~----------~~~~l~~~~~~~~~~q  118 (345)
T 3a8x_A           54 DWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAE  118 (345)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCccCeEEEEEE-----eCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            5688999999988 8999999999954     4778999999999999999883          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....            ...+||...+..++.++||||
T Consensus       119 i~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  195 (345)
T 3a8x_A          119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA  195 (345)
T ss_dssp             HHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred             HHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHH
Confidence            999999999   67999999999999999999999999999985321            123366666778899999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      |||++|||++|+.||..
T Consensus       196 lG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          196 LGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             HHHHHHHHHHSSCTTTT
T ss_pred             HHHHHHHHHhCCCCcCC
Confidence            99999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4e-34  Score=271.61  Aligned_cols=146  Identities=23%  Similarity=0.282  Sum_probs=127.6

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|..++.++ +|||||++++++.     +....++||||+++|+|..++.          ....+++..+..++.|
T Consensus        97 ~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~~~~~lV~E~~~gg~L~~~l~----------~~~~l~~~~~~~~~~q  161 (396)
T 4dc2_A           97 DWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAE  161 (396)
T ss_dssp             CHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCcCeeEEEEE-----ECCEEEEEEEcCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            3578999999987 8999999999854     4788999999999999998883          3356899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....            ...+||...+..++.++||||
T Consensus       162 i~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diws  238 (396)
T 4dc2_A          162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA  238 (396)
T ss_dssp             HHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred             HHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHH
Confidence            999999999   67999999999999999999999999999985321            123467777788899999999


Q ss_pred             HHHHHHHHHhcCCCCCc
Q 040999          265 YGILLLELMIREKPSDI  281 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~  281 (382)
                      |||++|||++|+.||..
T Consensus       239 lGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          239 LGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             HHHHHHHHHHSSCSSTT
T ss_pred             HHHHHHHHHhCCCCCcc
Confidence            99999999999999964

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-33  Score=261.16  Aligned_cols=192  Identities=19%  Similarity=0.188  Sum_probs=146.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ..+.+|+..+.++ +||||++++++|..     .+..++||||+ +++|.+++.         .....+++..+..++.|
T Consensus       101 ~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~~~lv~e~~-~~~L~~~~~---------~~~~~l~~~~~~~i~~q  165 (311)
T 3p1a_A          101 ARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGILYLQTELC-GPSLQQHCE---------AWGASLPEAQVWGYLRD  165 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHH---------HHCSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCEEEEEEecc-CCCHHHHHH---------hcCCCCCHHHHHHHHHH
Confidence            3456666666666 89999999999754     77899999999 778888874         23346999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...+ .++.++|||||
T Consensus       166 i~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl  241 (311)
T 3p1a_A          166 TLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSL  241 (311)
T ss_dssp             HHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHH
T ss_pred             HHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHH
Confidence            999999999   679999999999999999999999999998765322           334776654 68999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|..|+...    ......            ........                  ........+.+++.+
T Consensus       242 G~il~el~~g~~~~~~~----~~~~~~------------~~~~~~~~------------------~~~~~~~~l~~li~~  287 (311)
T 3p1a_A          242 GLTILEVACNMELPHGG----EGWQQL------------RQGYLPPE------------------FTAGLSSELRSVLVM  287 (311)
T ss_dssp             HHHHHHHHHTCCCCSSH----HHHHHH------------TTTCCCHH------------------HHTTSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCc----cHHHHH------------hccCCCcc------------------cccCCCHHHHHHHHH
Confidence            99999999997765321    111111            00000000                  001233467888889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.||++|||+.|+++
T Consensus       288 ~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          288 MLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HSCSSTTTSCCHHHHHT
T ss_pred             HcCCChhhCcCHHHHHh
Confidence            99999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.4e-34  Score=265.93  Aligned_cols=193  Identities=18%  Similarity=0.219  Sum_probs=150.3

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|.+++..+ +||||+++++++.     +....++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        62 ~~~~~E~~il~~~~~hp~iv~l~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~q  126 (345)
T 1xjd_A           62 ECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAE  126 (345)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCCcEEEEEE-----eCCEEEEEEeCCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            4578899999987 8999999999854     4778999999999999999983          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....            ..+||...+..++.++||||
T Consensus       127 i~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  203 (345)
T 1xjd_A          127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWS  203 (345)
T ss_dssp             HHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred             HHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHH
Confidence            999999999   679999999999999999999999999999854221            23366666778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....    . .......        ...... .+ .                  .....+.+++.
T Consensus       204 lG~il~ell~g~~Pf~~~~----~-~~~~~~i--------~~~~~~-~p-~------------------~~s~~~~~li~  250 (345)
T 1xjd_A          204 FGVLLYEMLIGQSPFHGQD----E-EELFHSI--------RMDNPF-YP-R------------------WLEKEAKDLLV  250 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSS----H-HHHHHHH--------HHCCCC-CC-T------------------TSCHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCCC----H-HHHHHHH--------HhCCCC-CC-c------------------ccCHHHHHHHH
Confidence            9999999999999986421    1 1111100        000000 00 0                  11235677888


Q ss_pred             ccCCCCccCCCCHH-HHH
Q 040999          345 ACSMESPQDRMKMT-NVV  361 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~-evl  361 (382)
                      +||+.||++||++. |++
T Consensus       251 ~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          251 KLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHSCSSGGGSBTTBSCGG
T ss_pred             HHhcCCHhHcCCChHHHH
Confidence            99999999999997 664

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-33  Score=285.50  Aligned_cols=203  Identities=20%  Similarity=0.325  Sum_probs=160.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|+.++++++||||+++++++.      .+..++||||+++|+|.+++..         ....+++..++.++.|+
T Consensus       436 ~~~~~E~~~l~~l~HpnIv~l~~~~~------~~~~~lv~E~~~~g~L~~~l~~---------~~~~l~~~~~~~i~~qi  500 (656)
T 2j0j_A          436 EKFLQEALTMRQFDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQV---------RKFSLDLASLILYAYQL  500 (656)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEEEECCTTCBHHHHHHH---------TTTTCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEe------cCceEEEEEcCCCCcHHHHHHh---------ccCCCCHHHHHHHHHHH
Confidence            67999999999999999999999863      3557999999999999999942         33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....             ..+||...+..++.++||||
T Consensus       501 ~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS  577 (656)
T 2j0j_A          501 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM  577 (656)
T ss_dssp             HHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHH
Confidence            99999999   679999999999999999999999999999865332             33466666678899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||++|||++ |..||.....  ............           ...+                   ..++..+.+++
T Consensus       578 lG~il~ellt~g~~Pf~~~~~--~~~~~~i~~~~~-----------~~~~-------------------~~~~~~l~~li  625 (656)
T 2j0j_A          578 FGVCMWEILMHGVKPFQGVKN--NDVIGRIENGER-----------LPMP-------------------PNCPPTLYSLM  625 (656)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCH--HHHHHHHHHTCC-----------CCCC-------------------TTCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCCCH--HHHHHHHHcCCC-----------CCCC-------------------ccccHHHHHHH
Confidence            9999999997 9999864211  111111110000           0000                   02334678888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+||+.||++|||+.++++.|+++.+.
T Consensus       626 ~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          626 TKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            899999999999999999999998654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-33  Score=259.25  Aligned_cols=198  Identities=19%  Similarity=0.197  Sum_probs=154.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     .....++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  115 (304)
T 2jam_A           51 SSLENEIAVLKKIKHENIVTLEDIYE-----STTHYYLVMQLVSGGELFDRIL----------ERGVYTEKDASLVIQQV  115 (304)
T ss_dssp             -HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEEEEEEcCCCccHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            46889999999999999999999964     3678899999999999999883          23468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee---CCCCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      +.||.|||   +.+|+||||||+||++   +.++.+||+|||+++....          ....||...+..++.++||||
T Consensus       116 ~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  192 (304)
T 2jam_A          116 LSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWS  192 (304)
T ss_dssp             HHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHH
T ss_pred             HHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHH
Confidence            99999999   6799999999999999   7889999999999975433          244588888888999999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|||++|+.||.....  ...........           ......                ........+.+++.
T Consensus       193 lG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~-----------~~~~~~----------------~~~~~~~~~~~li~  243 (304)
T 2jam_A          193 IGVITYILLCGYPPFYEETE--SKLFEKIKEGY-----------YEFESP----------------FWDDISESAKDFIC  243 (304)
T ss_dssp             HHHHHHHHHHSSCTTTTSCH--HHHHHHHHHCC-----------CCCCTT----------------TTTTSCHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCC-----------CCCCcc----------------ccccCCHHHHHHHH
Confidence            99999999999999864211  11111110000           000000                00022346778888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||++|||+.|+++
T Consensus       244 ~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          244 HLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHCSSTTTSCCHHHHHT
T ss_pred             HHcCCChhHCcCHHHHhc
Confidence            999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.6e-34  Score=261.95  Aligned_cols=211  Identities=20%  Similarity=0.288  Sum_probs=146.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++||||+++++++..     .+..++||||+++++|.+++.......  ......+++..+..++.|+
T Consensus        58 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~i~~qi  130 (303)
T 2vwi_A           58 DELLKEIQAMSQCHHPNIVSYYTSFVV-----KDELWLVMKLLSGGSVLDIIKHIVAKG--EHKSGVLDESTIATILREV  130 (303)
T ss_dssp             --------CCCCCCCTTBCCEEEEEES-----SSCEEEEEECCTTCBHHHHHHHHHHTT--TTTTCSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCCEeeEEEEEee-----cCCcEEEehhccCCchHHHHHHHhhcc--ccccCCCCHHHHHHHHHHH
Confidence            568899999999999999999999654     567899999999999999885311000  0123568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------------CCCCccccC-CCCCcc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------------RTQTKYGVG-NEVSTI  259 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------------~~~~~~~~~-~~~~~~  259 (382)
                      +.||.|||   +.+|+||||||+||+++.++.+||+|||++......                 ...||...+ ..++.+
T Consensus       131 ~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  207 (303)
T 2vwi_A          131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK  207 (303)
T ss_dssp             HHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTH
T ss_pred             HHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCch
Confidence            99999999   679999999999999999999999999998754321                 223454433 457899


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhh-hhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKD-IVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +||||||+++|||+||+.||.......  .........+..... ..+....                      ......
T Consensus       208 ~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~  263 (303)
T 2vwi_A          208 ADIWSFGITAIELATGAAPYHKYPPMK--VLMLTLQNDPPSLETGVQDKEML----------------------KKYGKS  263 (303)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHHTSSCCCTTC-----CCC----------------------CCCCHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCccCchhh--HHHHHhccCCCccccccccchhh----------------------hhhhHH
Confidence            999999999999999999987432111  110000000000000 0000000                      012235


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+++.+||+.||.+|||+.|+++
T Consensus       264 ~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          264 FRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCcCHHHHhh
Confidence            778888999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.2e-33  Score=257.81  Aligned_cols=196  Identities=21%  Similarity=0.285  Sum_probs=155.1

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++..     ....++||||+++++|.+++.           ...+++..+..++.|
T Consensus        64 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~~~~~~~q  127 (303)
T 3a7i_A           64 IEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLWIIMEYLGGGSALDLLE-----------PGPLDETQIATILRE  127 (303)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHT-----------TSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEEEEeCCCCcHHHHHh-----------cCCCCHHHHHHHHHH
Confidence            4789999999999999999999999754     678899999999999999883           235899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++.||.|||   ..+|+||||||+||+++.++.+||+|||++......            ...||...+..++.++||||
T Consensus       128 i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  204 (303)
T 3a7i_A          128 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS  204 (303)
T ss_dssp             HHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred             HHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHH
Confidence            999999999   679999999999999999999999999999765332            23366666778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      ||+++|||++|+.||.....  ...........+        ..+..                      .....+.+++.
T Consensus       205 lG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~--------~~~~~----------------------~~~~~l~~li~  252 (303)
T 3a7i_A          205 LGITAIELARGEPPHSELHP--MKVLFLIPKNNP--------PTLEG----------------------NYSKPLKEFVE  252 (303)
T ss_dssp             HHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCC--------CCCCS----------------------SCCHHHHHHHH
T ss_pred             HHHHHHHHccCCCCCCCcCH--HHHHHHhhcCCC--------CCCcc----------------------ccCHHHHHHHH
Confidence            99999999999999864211  011111100000        00000                      12235778888


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.||++|||+.|+++.
T Consensus       253 ~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTC
T ss_pred             HHcCCChhhCcCHHHHhhC
Confidence            9999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=266.88  Aligned_cols=209  Identities=10%  Similarity=0.043  Sum_probs=161.7

Q ss_pred             chhhH-----HHHHHHHHHHhhcc---cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc
Q 040999          113 AFKIF-----KSFIAECKALRNIR---HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN  184 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~  184 (382)
                      |+|++     +++.+|+++++.++   |+||+++++++..     .+..++||||+++|+|.+++.....     .....
T Consensus        99 avK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~  168 (365)
T 3e7e_A           99 VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-----QNGSVLVGELYSYGTLLNAINLYKN-----TPEKV  168 (365)
T ss_dssp             EEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-----SSCEEEEECCCCSCBHHHHHHHHHT-----STTCS
T ss_pred             EEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-----CCCcEEEEeccCCCcHHHHHHHhhc-----ccccC
Confidence            77766     67888888888886   9999999999754     6778999999999999999953210     13456


Q ss_pred             cCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC-----------CCcEEEccccccccCC-----------
Q 040999          185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD-----------DMTARVGDFGLARFLP-----------  242 (382)
Q Consensus       185 l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-----------~~~~kl~Dfg~a~~~~-----------  242 (382)
                      +++..++.++.||+.||+|||   +.+|+||||||+|||++.           ++.+||+|||+|+.+.           
T Consensus       169 l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  245 (365)
T 3e7e_A          169 MPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK  245 (365)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeee
Confidence            999999999999999999999   789999999999999998           8999999999996432           


Q ss_pred             ---CCCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhc
Q 040999          243 ---PTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVR  319 (382)
Q Consensus       243 ---~~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (382)
                         ....+||...+..++.++|||||||++|||+||+.||.....+...                +...+...+      
T Consensus       246 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----------------~~~~~~~~~------  303 (365)
T 3e7e_A          246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----------------PEGLFRRLP------  303 (365)
T ss_dssp             SCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----------------ECSCCTTCS------
T ss_pred             cCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----------------echhccccC------
Confidence               2334577777888999999999999999999999998542211100                000000000      


Q ss_pred             cccchhhhhhhhHHHHHHHHHHHhhccCCCCccCC-CCHHHHHHHHHHhhhhh
Q 040999          320 GDQKQTQAKINVIIECVISMVRIGVACSMESPQDR-MKMTNVVHELQSIKNTL  371 (382)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~R-Ps~~evl~~L~~i~~~~  371 (382)
                                     ....+.+++..|++.+|.+| |++.++.+.|+++....
T Consensus       304 ---------------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          304 ---------------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ---------------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---------------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                           01234556668999999998 67889999998877653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-33  Score=266.96  Aligned_cols=146  Identities=21%  Similarity=0.336  Sum_probs=123.7

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+.++.++. ||||+++++++..   .+....++|||||+ |+|.+++.           ...+++..+..++.|
T Consensus        53 ~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~~~lv~e~~~-~~L~~~~~-----------~~~~~~~~~~~i~~q  117 (388)
T 3oz6_A           53 QRTFREIMILTELSGHENIVNLLNVLRA---DNDRDVYLVFDYME-TDLHAVIR-----------ANILEPVHKQYVVYQ  117 (388)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTSSCEEEEEECCS-EEHHHHHH-----------HTCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCCCeeeeEEec---CCCCEEEEEecccC-cCHHHHHH-----------cCCCCHHHHHHHHHH
Confidence            56889999999997 9999999999753   23457899999997 58888873           235889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------------------------------
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------------------------------  243 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------------------------------  243 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....                                 
T Consensus       118 i~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  194 (388)
T 3oz6_A          118 LIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATR  194 (388)
T ss_dssp             HHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGG
T ss_pred             HHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccC
Confidence            999999999   67999999999999999999999999999986432                                 


Q ss_pred             CCCCCccccC-CCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          244 TRTQTKYGVG-NEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       244 ~~~~~~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      ...+||...+ ..++.++||||+||++|||++|+.||..
T Consensus       195 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          195 WYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             GGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            0223555544 5789999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.9e-34  Score=258.23  Aligned_cols=200  Identities=21%  Similarity=0.246  Sum_probs=149.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     +....++||||+++|+|.+++....      .....+++..+..++.|+
T Consensus        65 ~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi  133 (285)
T 3is5_A           65 EQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMYIVMETCEGGELLERIVSAQ------ARGKALSEGYVAELMKQM  133 (285)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEEEEECCCSCCBHHHHHHHHH------HHTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEEEEEEeCCCCcHHHHHHhhh------hcccCCCHHHHHHHHHHH
Confidence            67899999999999999999999964     3678999999999999999884321      123568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee---CCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||+|||   +.+|+||||||+||++   +.++.+||+|||+++.....           ...||.. ...++.++|||
T Consensus       134 ~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~Di~  209 (285)
T 3is5_A          134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KRDVTFKCDIW  209 (285)
T ss_dssp             HHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHH-TTCCCHHHHHH
T ss_pred             HHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHh-ccCCCcccCee
Confidence            99999999   6799999999999999   45678999999999765332           2235543 35678999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||+++|||++|+.||.....  ...........+.         .....                   ......+.+++
T Consensus       210 slG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~---------~~~~~-------------------~~~~~~~~~li  259 (285)
T 3is5_A          210 SAGVVMYFLLTGCLPFTGTSL--EEVQQKATYKEPN---------YAVEC-------------------RPLTPQAVDLL  259 (285)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCC---------CCC---------------------CCCCHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCH--HHHHhhhccCCcc---------ccccc-------------------CcCCHHHHHHH
Confidence            999999999999999864211  0111110000000         00000                   01123567888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.||++|||+.|+++
T Consensus       260 ~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          260 KQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHTCSCTTTSCCHHHHHT
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            8999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.2e-34  Score=275.60  Aligned_cols=195  Identities=20%  Similarity=0.210  Sum_probs=146.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++..     .+..++||||+++|+|.+++.          ....+++..+..++.||
T Consensus       193 ~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  257 (446)
T 4ejn_A          193 AHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVMEYANGGELFFHLS----------RERVFSEDRARFYGAEI  257 (446)
T ss_dssp             --------CCCCCSCTTSCCEEEEEEE-----TTEEEEEECCCSSCBHHHHHH----------HHSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCeEeeEEEEEee-----CCEEEEEEeeCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            457789999999999999999999754     678999999999999998883          33568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||+  ..+|+||||||+|||++.++.+||+|||+|+.....            ..+||...+..++.++|||||
T Consensus       258 ~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  335 (446)
T 4ejn_A          258 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  335 (446)
T ss_dssp             HHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred             HHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhh
Confidence            999999993  168999999999999999999999999999753221            233666667888999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....     ........        ...... .+ .                  .....+.+++.+
T Consensus       336 G~il~ell~g~~Pf~~~~-----~~~~~~~i--------~~~~~~-~p-~------------------~~~~~~~~li~~  382 (446)
T 4ejn_A          336 GVVMYEMMCGRLPFYNQD-----HEKLFELI--------LMEEIR-FP-R------------------TLGPEAKSLLSG  382 (446)
T ss_dssp             HHHHHHHHHSSCSSCCSS-----HHHHHHHH--------HHCCCC-CC-T------------------TSCHHHHHHHHH
T ss_pred             HHHHHHHhhCCCCCCCCC-----HHHHHHHH--------HhCCCC-CC-c------------------cCCHHHHHHHHH
Confidence            999999999999986321     11111110        000000 00 0                  122356788889


Q ss_pred             cCCCCccCCC-----CHHHHHH
Q 040999          346 CSMESPQDRM-----KMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RP-----s~~evl~  362 (382)
                      ||+.||.+||     +++|+++
T Consensus       383 ~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          383 LLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HcccCHHHhCCCCCCCHHHHHh
Confidence            9999999999     9999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-33  Score=266.32  Aligned_cols=147  Identities=21%  Similarity=0.309  Sum_probs=129.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        76 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~~i  140 (360)
T 3eqc_A           76 NQIIRELQVLHECNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIAV  140 (360)
T ss_dssp             HHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEEEEEEECCCCCCHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            678999999999999999999999754     678999999999999999984          23468899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC----------CCCCCCCccccCCCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------PPTRTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~----------~~~~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      +.||.|||+.  .+|+||||||+|||++.++.+||+|||+++..          ......||...+..++.++|||||||
T Consensus       141 ~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  218 (360)
T 3eqc_A          141 IKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL  218 (360)
T ss_dssp             HHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHH
T ss_pred             HHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHH
Confidence            9999999941  38999999999999999999999999998642          23345577777888999999999999


Q ss_pred             HHHHHHhcCCCCCc
Q 040999          268 LLLELMIREKPSDI  281 (382)
Q Consensus       268 il~elltg~~p~~~  281 (382)
                      ++|||+||+.||..
T Consensus       219 il~~l~~g~~pf~~  232 (360)
T 3eqc_A          219 SLVEMAVGRYPIPP  232 (360)
T ss_dssp             HHHHHHHTSCCSSC
T ss_pred             HHHHHHhCCCCCCC
Confidence            99999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=266.31  Aligned_cols=211  Identities=21%  Similarity=0.233  Sum_probs=151.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     ....++||||+++++|.+++..         ....+++..+..++.|+
T Consensus        74 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~iv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~i~~qi  139 (319)
T 2y4i_B           74 KAFKREVMAYRQTRHENVVLFMGACMS-----PPHLAIITSLCKGRTLYSVVRD---------AKIVLDVNKTRQIAQEI  139 (319)
T ss_dssp             CCCCTTGGGGTTCCCTTBCCCCEEEEC-----SSCEEEECBCCCSEEHHHHTTS---------SCCCCCSHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEeEEEEEEec-----CCceEEEeecccCCcHHHHHHh---------cCCCCCHHHHHHHHHHH
Confidence            457789999999999999999999754     6678999999999999999942         23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------------CCCCCcccc--------
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------------TRTQTKYGV--------  252 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------------~~~~~~~~~--------  252 (382)
                      +.||+|||   +.+|+||||||+||+++ ++.+||+|||+++....                 ....||...        
T Consensus       140 ~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~  215 (319)
T 2y4i_B          140 VKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEE  215 (319)
T ss_dssp             HHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--C
T ss_pred             HHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccc
Confidence            99999999   67999999999999998 67999999999765421                 112344433        


Q ss_pred             -CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 -GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 -~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                       ...++.++||||||+++|||+||+.||....     ...........     ..+.....                   
T Consensus       216 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-----~~~~~~~~-------------------  266 (319)
T 2y4i_B          216 DKLPFSKHSDVFALGTIWYELHAREWPFKTQP-----AEAIIWQMGTG-----MKPNLSQI-------------------  266 (319)
T ss_dssp             CCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-----HHHHHHHHHTT-----CCCCCCCS-------------------
T ss_pred             cccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHhccC-----CCCCCCcC-------------------
Confidence             2357889999999999999999999986421     11111111000     00000000                   


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCCCCC
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPKNL  377 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~~~  377 (382)
                        .....+.+++.+||+.||++|||+.++++.|+++.........|
T Consensus       267 --~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~  310 (319)
T 2y4i_B          267 --GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP  310 (319)
T ss_dssp             --SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------
T ss_pred             --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCC
Confidence              11235678888999999999999999999999998876555444

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=259.81  Aligned_cols=203  Identities=20%  Similarity=0.246  Sum_probs=157.5

Q ss_pred             chhhH------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|.+      +.+.+|++++++++||||+++++++..     ....++||||+++++|.+++.         .....++
T Consensus        58 aiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~---------~~~~~~~  123 (314)
T 3com_A           58 AIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIIR---------LRNKTLT  123 (314)
T ss_dssp             EEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHH---------HHTCCCC
T ss_pred             EEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEEeecCCCCCHHHHHH---------hcCCCCC
Confidence            66654      779999999999999999999999754     677899999999999999984         1235689


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCC
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGN  254 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~  254 (382)
                      +..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||.+......            ...||...+.
T Consensus       124 ~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  200 (314)
T 3com_A          124 EDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI  200 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSS
T ss_pred             HHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCC
Confidence            9999999999999999999   679999999999999999999999999999765332            2336666667


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      .++.++||||||+++|||++|+.||....    ...........      ...... .+                   ..
T Consensus       201 ~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~------~~~~~~-~~-------------------~~  250 (314)
T 3com_A          201 GYNCVADIWSLGITAIEMAEGKPPYADIH----PMRAIFMIPTN------PPPTFR-KP-------------------EL  250 (314)
T ss_dssp             CBCTTHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHS------CCCCCS-SG-------------------GG
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcC------CCcccC-Cc-------------------cc
Confidence            78999999999999999999999986421    11111000000      000000 00                   01


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ....+.+++.+||+.||.+|||+.++++
T Consensus       251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          251 WSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            2346778888999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-33  Score=265.44  Aligned_cols=229  Identities=17%  Similarity=0.184  Sum_probs=154.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .++.+|++++++++||||+++++++....+......++||||+. |+|.+++.           ...+++..+..++.|+
T Consensus        54 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~~~~~~~~~~~~qi  121 (353)
T 2b9h_A           54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIS-----------TQMLSDDHIQYFIYQT  121 (353)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHH-----------HCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHh-----------hcCCCHHHHHHHHHHH
Confidence            56889999999999999999999976544455578899999997 58888873           2358999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------------CCCCcccc-CC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------------RTQTKYGV-GN  254 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------------~~~~~~~~-~~  254 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....                      ..+||... +.
T Consensus       122 ~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  198 (353)
T 2b9h_A          122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA  198 (353)
T ss_dssp             HHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCC
T ss_pred             HHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCC
Confidence            99999999   679999999999999999999999999999865321                      22355433 36


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      .++.++|||||||++|||++|+.||...... ..+.............................................
T Consensus       199 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (353)
T 2b9h_A          199 KYSRAMDVWSCGCILAELFLRRPIFPGRDYR-HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR  277 (353)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred             CccchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhccc
Confidence            7889999999999999999999998642110 011111111110000000000000000000000000000000000112


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ...++.+++.+||+.||++|||+.|+++
T Consensus       278 ~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          278 VNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            3456788899999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.2e-33  Score=259.61  Aligned_cols=201  Identities=16%  Similarity=0.188  Sum_probs=153.5

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++..+ +||||+++++++.     .....++||||+++|+|.+++..        .....+++..+..++.|
T Consensus        73 ~~~~~e~~~l~~l~~~~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~i~~q  139 (327)
T 3lm5_A           73 AEILHEIAVLELAKSCPRVINLHEVYE-----NTSEIILILEYAAGGEIFSLCLP--------ELAEMVSENDVIRLIKQ  139 (327)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEEECCTTEEGGGGGSS--------CC-CCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCEEEEEEEEE-----eCCeEEEEEEecCCCcHHHHHHH--------hcccCCCHHHHHHHHHH
Confidence            6789999999999 5699999999964     47789999999999999999843        22356899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCC---CCcEEEccccccccCCCC-----------CCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDD---DMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++.....           ...||...+..++.++||
T Consensus       140 l~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  216 (327)
T 3lm5_A          140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDM  216 (327)
T ss_dssp             HHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHH
T ss_pred             HHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhH
Confidence            999999999   679999999999999988   789999999999865432           234676677788999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||+||+.||....    .........         ........ .               ........+.++
T Consensus       217 wslG~il~~ll~g~~pf~~~~----~~~~~~~i~---------~~~~~~~~-~---------------~~~~~~~~~~~l  267 (327)
T 3lm5_A          217 WNIGIIAYMLLTHTSPFVGED----NQETYLNIS---------QVNVDYSE-E---------------TFSSVSQLATDF  267 (327)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSS----HHHHHHHHH---------HTCCCCCT-T---------------TTTTSCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCC----chHHHHHHH---------hcccccCc-h---------------hhcccCHHHHHH
Confidence            999999999999999986421    111111100         00000000 0               000223457788


Q ss_pred             hhccCCCCccCCCCHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +.+||+.||++|||++|+++.
T Consensus       268 i~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          268 IQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHHcCCChhhCcCHHHHhCC
Confidence            889999999999999999853

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.2e-33  Score=258.85  Aligned_cols=194  Identities=18%  Similarity=0.134  Sum_probs=146.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        66 ~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  130 (327)
T 3a62_A           66 AHTKAERNILEEVKHPFIVDLIYAFQ-----TGGKLYLILEYLSGGELFMQLE----------REGIFMEDTACFYLAEI  130 (327)
T ss_dssp             -----HHHHHHHCCCTTBCCEEEEEE-----CSSCEEEEEECCTTEEHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCccceeEEEE-----cCCEEEEEEeCCCCCcHHHHHH----------hCCCCCHHHHHHHHHHH
Confidence            45788999999999999999999964     3678999999999999999883          23458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++|||||
T Consensus       131 ~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  207 (327)
T 3a62_A          131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSL  207 (327)
T ss_dssp             HHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHH
T ss_pred             HHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhH
Confidence            99999999   6799999999999999999999999999987532            12344676667788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||++|+.||....    . .....        .+...... .+ .                  .....+.+++.+
T Consensus       208 G~il~el~~g~~pf~~~~----~-~~~~~--------~i~~~~~~-~p-~------------------~~~~~~~~li~~  254 (327)
T 3a62_A          208 GALMYDMLTGAPPFTGEN----R-KKTID--------KILKCKLN-LP-P------------------YLTQEARDLLKK  254 (327)
T ss_dssp             HHHHHHHHHSSCSCCCSS----H-HHHHH--------HHHHTCCC-CC-T------------------TSCHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCC----H-HHHHH--------HHHhCCCC-CC-C------------------CCCHHHHHHHHH
Confidence            999999999999986421    1 11111        01110000 00 0                  122356788889


Q ss_pred             cCCCCccCCC-----CHHHHHH
Q 040999          346 CSMESPQDRM-----KMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RP-----s~~evl~  362 (382)
                      ||+.||++||     ++.|+++
T Consensus       255 ~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          255 LLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHhcCHhhccCCCCCCHHHHHc
Confidence            9999999999     6777765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-33  Score=261.24  Aligned_cols=208  Identities=17%  Similarity=0.185  Sum_probs=151.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC---------------------
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED---------------------  176 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------  176 (382)
                      +.+.+|++++++++||||+++++++.     +.+..++||||+++|+|.+++.......                     
T Consensus        73 ~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (345)
T 3hko_A           73 ERIKTEVRLMKKLHHPNIARLYEVYE-----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE  147 (345)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceeehhhc-----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccc
Confidence            57899999999999999999999964     3678999999999999999884211000                     


Q ss_pred             ---------ccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC--cEEEccccccccCCC--
Q 040999          177 ---------ETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM--TARVGDFGLARFLPP--  243 (382)
Q Consensus       177 ---------~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~--~~kl~Dfg~a~~~~~--  243 (382)
                               ........+++..+..++.|+++||+|||   +.+|+||||||+||+++.++  .+||+|||+++....  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~  224 (345)
T 3hko_A          148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN  224 (345)
T ss_dssp             HHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTT
T ss_pred             cccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccC
Confidence                     00011223567788899999999999999   67999999999999998776  899999999975421  


Q ss_pred             --------------CCCCCccccC--CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhc
Q 040999          244 --------------TRTQTKYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDS  307 (382)
Q Consensus       244 --------------~~~~~~~~~~--~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (382)
                                    ...+||...+  ..++.++|||||||++|||++|+.||.....    .... .        .+...
T Consensus       225 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~-~--------~~~~~  291 (345)
T 3hko_A          225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND----ADTI-S--------QVLNK  291 (345)
T ss_dssp             CC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH-H--------HHHHC
T ss_pred             ccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh----HHHH-H--------HHHhc
Confidence                          1223565433  6788999999999999999999999864211    1111 1        11111


Q ss_pred             ccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          308 ILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ........                .......+.+++.+||+.||.+|||+.|+++
T Consensus       292 ~~~~~~~~----------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          292 KLCFENPN----------------YNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             CCCTTSGG----------------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             ccccCCcc----------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00000000                0012346778888999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.2e-33  Score=269.89  Aligned_cols=198  Identities=15%  Similarity=0.116  Sum_probs=150.5

Q ss_pred             HHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHH
Q 040999          120 FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVAS  199 (382)
Q Consensus       120 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~  199 (382)
                      +.+|+.++..++||||++++++|.     +.+..++|||||++|+|.+++..         ....+++..+..++.||+.
T Consensus       121 ~~~E~~il~~~~hp~Iv~l~~~~~-----~~~~~~lV~Ey~~gg~L~~~l~~---------~~~~l~e~~~~~~~~qi~~  186 (437)
T 4aw2_A          121 FREERDVLVNGDSKWITTLHYAFQ-----DDNNLYLVMDYYVGGDLLTLLSK---------FEDRLPEEMARFYLAEMVI  186 (437)
T ss_dssp             HHHHHHHHHHSCTTTBCCEEEEEE-----CSSEEEEEECCCTTCBHHHHHHT---------TTTCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEe-----eCCEEEEEEecCCCCcHHHHHHH---------ccCCCCHHHHHHHHHHHHH
Confidence            889999999999999999999964     47789999999999999999942         2356899999999999999


Q ss_pred             HHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCcccc-----CCCCCccch
Q 040999          200 ALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGV-----GNEVSTIGD  261 (382)
Q Consensus       200 ~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~-----~~~~~~~~D  261 (382)
                      ||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....             ..+||...     ...++.++|
T Consensus       187 aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~D  263 (437)
T 4aw2_A          187 AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECD  263 (437)
T ss_dssp             HHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHH
T ss_pred             HHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCe
Confidence            999999   779999999999999999999999999999765332             22355543     456889999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||+||+.||...    .....+ ....... ..   .......                   ......+.+
T Consensus       264 vwSlGvil~elltG~~Pf~~~----~~~~~~-~~i~~~~-~~---~~~p~~~-------------------~~~s~~~~d  315 (437)
T 4aw2_A          264 WWSLGVCMYEMLYGETPFYAE----SLVETY-GKIMNHK-ER---FQFPTQV-------------------TDVSENAKD  315 (437)
T ss_dssp             HHHHHHHHHHHHHSSCTTCCS----SHHHHH-HHHHTHH-HH---CCCCSSC-------------------CCSCHHHHH
T ss_pred             eHHHHHHHHHHHhCCCCCCCC----ChhHHH-Hhhhhcc-cc---ccCCccc-------------------ccCCHHHHH
Confidence            999999999999999998632    111111 1000000 00   0000000                   012235677


Q ss_pred             HhhccCCCCccC--CCCHHHHHH
Q 040999          342 IGVACSMESPQD--RMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~--RPs~~evl~  362 (382)
                      ++.+|+..+|++  ||+++|+++
T Consensus       316 Li~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          316 LIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             HHHHHhcccccccCCCCHHHHhC
Confidence            788999988888  999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6e-33  Score=252.45  Aligned_cols=194  Identities=19%  Similarity=0.223  Sum_probs=153.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     ..+..++||||+++|+|.+++.          ....+++..+..++.|+
T Consensus        59 ~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  123 (284)
T 2vgo_A           59 HQLRREIEIQSHLRHPNILRMYNYFH-----DRKRIYLMLEFAPRGELYKELQ----------KHGRFDEQRSATFMEEL  123 (284)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEeeEEEEEE-----cCCEEEEEEEeCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            56889999999999999999999964     3678999999999999999884          23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------CCCCccccCCCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------RTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      ++||.|||   +.+|+||||||+||+++.++.+||+|||++......          ...||...+..++.++||||||+
T Consensus       124 ~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  200 (284)
T 2vgo_A          124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGV  200 (284)
T ss_dssp             HHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHH
T ss_pred             HHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHH
Confidence            99999999   789999999999999999999999999998754332          23366666778899999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ++|||++|+.||....    .. ......        ...... .+ .                  .....+.+++.+||
T Consensus       201 il~~l~~g~~pf~~~~----~~-~~~~~~--------~~~~~~-~~-~------------------~~~~~~~~li~~~l  247 (284)
T 2vgo_A          201 LCYEFLVGMPPFDSPS----HT-ETHRRI--------VNVDLK-FP-P------------------FLSDGSKDLISKLL  247 (284)
T ss_dssp             HHHHHHHSSCTTCCSS----HH-HHHHHH--------HTTCCC-CC-T------------------TSCHHHHHHHHHHS
T ss_pred             HHHHHHHCCCCCCCCC----Hh-HHHHHH--------hccccC-CC-C------------------cCCHHHHHHHHHHh
Confidence            9999999999986421    11 111100        000000 00 0                  12235678888999


Q ss_pred             CCCccCCCCHHHHHH
Q 040999          348 MESPQDRMKMTNVVH  362 (382)
Q Consensus       348 ~~~p~~RPs~~evl~  362 (382)
                      +.||.+|||+.|+++
T Consensus       248 ~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          248 RYHPPQRLPLKGVME  262 (284)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             hcCHhhCCCHHHHhh
Confidence            999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.7e-33  Score=259.95  Aligned_cols=228  Identities=18%  Similarity=0.233  Sum_probs=152.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc---CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY---QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      ..+.+|++++++++||||+++++++.....   ...+..++||||+++ +|.+.+.         .....+++..+..++
T Consensus        61 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~---------~~~~~~~~~~~~~i~  130 (351)
T 3mi9_A           61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS---------NVLVKFTLSEIKRVM  130 (351)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHH---------CTTSCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHh---------hccCCCCHHHHHHHH
Confidence            578899999999999999999999765211   124578999999975 6776663         233468999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccC-CCCC
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVG-NEVS  257 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~-~~~~  257 (382)
                      .|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....                ..+||...+ ..++
T Consensus       131 ~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  207 (351)
T 3mi9_A          131 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG  207 (351)
T ss_dssp             HHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCC
T ss_pred             HHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCC
Confidence            99999999999   679999999999999999999999999999765311                223555444 4579


Q ss_pred             ccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhc--CC-chhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          258 TIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL--PN-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       258 ~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      .++|||||||++|||+||+.||...... ...........  +. .....-..........  ........... .....
T Consensus       208 ~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~  283 (351)
T 3mi9_A          208 PPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSITPEVWPNVDNYELYEKLEL--VKGQKRKVKDR-LKAYV  283 (351)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCC--CSSCCCCHHHH-HHHHH
T ss_pred             cHhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhccccccchhhccccc--ccccccCHHHH-hhhcc
Confidence            9999999999999999999998742111 11111111111  11 0010000000000000  00000000000 00001


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       284 ~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          284 RDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1345788999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=257.09  Aligned_cols=200  Identities=18%  Similarity=0.226  Sum_probs=150.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++..     .+..++||||+++++|.+++....       ....+++..+..++.|+
T Consensus        64 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi  131 (295)
T 2clq_A           64 QPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFMEQVPGGSLSALLRSKW-------GPLKDNEQTIGFYTKQI  131 (295)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEECCSEEEHHHHHHHTT-------CCCTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEEEeCCCCCHHHHHHhhc-------cCCCccHHHHHHHHHHH
Confidence            678999999999999999999999754     678899999999999999985321       22356788899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCCC------------CCCCccccCC--CCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPPT------------RTQTKYGVGN--EVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~--~~~~~~Dv  262 (382)
                      +.||.|||   +.+|+||||||+||+++. ++.+||+|||+++.....            ...||...+.  .++.++||
T Consensus       132 ~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di  208 (295)
T 2clq_A          132 LEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI  208 (295)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHH
T ss_pred             HHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHH
Confidence            99999999   679999999999999987 899999999999865432            1224443332  37889999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||+++|||+||+.||.......   ..........     ..+.+.                      ......+.++
T Consensus       209 ~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~-----~~~~~~----------------------~~~~~~~~~l  258 (295)
T 2clq_A          209 WSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMFK-----VHPEIP----------------------ESMSAEAKAF  258 (295)
T ss_dssp             HHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHHHC-----CCCCCC----------------------TTSCHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCccCCCchh---HHHHhhcccc-----cccccc----------------------ccCCHHHHHH
Confidence            999999999999999986321110   0110000000     000000                      0123467788


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||+.|+++
T Consensus       259 i~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          259 ILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHccCChhhCCCHHHHhc
Confidence            88999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5e-34  Score=266.55  Aligned_cols=206  Identities=18%  Similarity=0.216  Sum_probs=151.9

Q ss_pred             chhhH----HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCH
Q 040999          113 AFKIF----KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNL  187 (382)
Q Consensus       113 avK~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~  187 (382)
                      |+|.+    ....+|++++.++ +||||+++++++.     +....++||||+++|+|.+++.          ....+++
T Consensus        51 avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~i~----------~~~~~~~  115 (342)
T 2qr7_A           51 AVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYD-----DGKYVYVVTELMKGGELLDKIL----------RQKFFSE  115 (342)
T ss_dssp             EEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------TCTTCCH
T ss_pred             EEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCEEEEEEeCCCCCcHHHHHH----------HcCCCCH
Confidence            67665    3467899999998 7999999999954     4788999999999999999883          3346899


Q ss_pred             HHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC----CcEEEccccccccCCCC------------CCCCccc
Q 040999          188 LRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD----MTARVGDFGLARFLPPT------------RTQTKYG  251 (382)
Q Consensus       188 ~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~----~~~kl~Dfg~a~~~~~~------------~~~~~~~  251 (382)
                      ..+..++.||+.||+|||   +.+|+||||||+|||+..+    +.+||+|||+++.....            ..+||..
T Consensus       116 ~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~  192 (342)
T 2qr7_A          116 REASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL  192 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHh
Confidence            999999999999999999   6799999999999998443    35999999999865332            2234544


Q ss_pred             cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          252 VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       252 ~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      .+..++.++|||||||++|||++|+.||.....  ...........        .........                .
T Consensus       193 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~--------~~~~~~~~~----------------~  246 (342)
T 2qr7_A          193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILARIG--------SGKFSLSGG----------------Y  246 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHHHH--------HCCCCCCST----------------T
T ss_pred             cCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHHHc--------cCCcccCcc----------------c
Confidence            445578899999999999999999999864211  11111111110        000000000                0


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ......++.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0012345778888999999999999999885

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-33  Score=269.28  Aligned_cols=197  Identities=16%  Similarity=0.177  Sum_probs=149.7

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|+++++.++|||||++++++.     +....++||||+++|+|.+++..           ..+++..+..++.||+
T Consensus       115 ~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~~~lV~E~~~gg~L~~~l~~-----------~~~~e~~~~~~~~qi~  178 (410)
T 3v8s_A          115 FFWEERDIMAFANSPWVVQLFYAFQ-----DDRYLYMVMEYMPGGDLVNLMSN-----------YDVPEKWARFYTAEVV  178 (410)
T ss_dssp             THHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEECCCTTEEHHHHHHH-----------CCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeCCCCCcHHHHHHc-----------CCCCHHHHHHHHHHHH
Confidence            3789999999999999999999964     47889999999999999998832           3488999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-------------CCCccccCCC----CCccch
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-------------TQTKYGVGNE----VSTIGD  261 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~~~~----~~~~~D  261 (382)
                      .||+|||   +.+|+||||||+|||++.++.+||+|||+++......             .+||...+..    ++.++|
T Consensus       179 ~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~D  255 (410)
T 3v8s_A          179 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD  255 (410)
T ss_dssp             HHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHH
T ss_pred             HHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcce
Confidence            9999999   6799999999999999999999999999997654321             2355444333    788999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||+||+.||...    ... ..........     ........                   .....++.+
T Consensus       256 iwSlGvilyell~G~~Pf~~~----~~~-~~~~~i~~~~-----~~~~~p~~-------------------~~~s~~~~~  306 (410)
T 3v8s_A          256 WWSVGVFLYEMLVGDTPFYAD----SLV-GTYSKIMNHK-----NSLTFPDD-------------------NDISKEAKN  306 (410)
T ss_dssp             HHHHHHHHHHHHHSSCTTCCS----SHH-HHHHHHHTHH-----HHCCCCTT-------------------CCCCHHHHH
T ss_pred             EecchHHHHHHHhCCCCCCCC----Chh-hHHHHHHhcc-----ccccCCCc-------------------ccccHHHHH
Confidence            999999999999999998632    111 1111000000     00000000                   012235677


Q ss_pred             HhhccCCCCccC--CCCHHHHHHH
Q 040999          342 IGVACSMESPQD--RMKMTNVVHE  363 (382)
Q Consensus       342 l~~~Cl~~~p~~--RPs~~evl~~  363 (382)
                      ++.+||+.+|.+  ||+++||++.
T Consensus       307 li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          307 LICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HHHHHccChhhhCCCCCHHHHhcC
Confidence            888999999988  9999999863

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.6e-33  Score=261.68  Aligned_cols=194  Identities=16%  Similarity=0.165  Sum_probs=150.5

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|.+++..+ +||||+++++++.     +.+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        65 ~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~q  129 (353)
T 2i0e_A           65 ECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDRLYFVMEYVNGGDLMYHIQ----------QVGRFKEPHAVFYAAE  129 (353)
T ss_dssp             HHHHHHHHHHTCTTCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEEeeEEEEEE-----cCCEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            5678899999988 8999999999854     4778999999999999999983          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....            ...+||...+..++.++||||
T Consensus       130 i~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  206 (353)
T 2i0e_A          130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA  206 (353)
T ss_dssp             HHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHH
T ss_pred             HHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccc
Confidence            999999999   67999999999999999999999999999985321            123366666778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....     .......        +...... .+ .                  ....++.+++.
T Consensus       207 lG~il~ell~G~~Pf~~~~-----~~~~~~~--------i~~~~~~-~p-~------------------~~s~~~~~li~  253 (353)
T 2i0e_A          207 FGVLLYEMLAGQAPFEGED-----EDELFQS--------IMEHNVA-YP-K------------------SMSKEAVAICK  253 (353)
T ss_dssp             HHHHHHHHHHSSCSSCCSS-----HHHHHHH--------HHHCCCC-CC-T------------------TSCHHHHHHHH
T ss_pred             hHHHHHHHHcCCCCCCCCC-----HHHHHHH--------HHhCCCC-CC-C------------------CCCHHHHHHHH
Confidence            9999999999999986421     1111111        0110000 00 0                  12235778888


Q ss_pred             ccCCCCccCCCC-----HHHHHH
Q 040999          345 ACSMESPQDRMK-----MTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs-----~~evl~  362 (382)
                      +||+.||++||+     ++|+++
T Consensus       254 ~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          254 GLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhc
Confidence            999999999996     466654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-32  Score=255.37  Aligned_cols=197  Identities=19%  Similarity=0.196  Sum_probs=151.0

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|++++++++||||+++++++..      ...++||||+++++|.+++.          ....+++..+..++.||+
T Consensus        61 ~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~qi~  124 (322)
T 2ycf_A           61 NVETEIEILKKLNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVV----------GNKRLKEATCKLYFYQML  124 (322)
T ss_dssp             CHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEEECCTTEETHHHHS----------TTCCCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCceEeeEEcC------CceEEEEecCCCCcHHHHHh----------ccCCCCHHHHHHHHHHHH
Confidence            47899999999999999999998642      33799999999999999883          334689999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCc---EEEccccccccCCC-----------CCCCCccc---cCCCCCccch
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMT---ARVGDFGLARFLPP-----------TRTQTKYG---VGNEVSTIGD  261 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~---~kl~Dfg~a~~~~~-----------~~~~~~~~---~~~~~~~~~D  261 (382)
                      .||.|||   +.+|+||||||+|||++.++.   +||+|||+++....           ....||..   ....++.++|
T Consensus       125 ~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D  201 (322)
T 2ycf_A          125 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD  201 (322)
T ss_dssp             HHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHH
T ss_pred             HHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhh
Confidence            9999999   679999999999999987654   99999999986543           23446654   2466789999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||++|+.||....... .+.............+                           ........+.+
T Consensus       202 i~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~  253 (322)
T 2ycf_A          202 CWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYNFIPE---------------------------VWAEVSEKALD  253 (322)
T ss_dssp             HHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCCCCCHH---------------------------HHTTSCHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCccccCch---------------------------hhhhcCHHHHH
Confidence            9999999999999999987432221 1111111110000000                           00123346788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||++|||+.|+++
T Consensus       254 li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          254 LVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcccCHhhCCCHHHHhh
Confidence            888999999999999999984

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.9e-33  Score=272.16  Aligned_cols=197  Identities=19%  Similarity=0.219  Sum_probs=151.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     .....++||||+++|+|.+++.          ....+++..+..++.||
T Consensus        66 ~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi  130 (486)
T 3mwu_A           66 STILREVELLKKLDHPNIMKLFEILE-----DSSSFYIVGELYTGGELFDEII----------KRKRFSEHDAARIIKQV  130 (486)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCEEEEEEEcCCCCcHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            57899999999999999999999964     3778999999999999998883          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeC---CCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLD---DDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~---~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+|||++   .++.+||+|||+++.....           ..+||...+ .++.++|||
T Consensus       131 ~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diw  206 (486)
T 3mwu_A          131 FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVW  206 (486)
T ss_dssp             HHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHH
T ss_pred             HHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHH
Confidence            99999999   67999999999999995   4567999999999765332           233666554 589999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHH-HHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFA-KMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |+||++|||++|+.||.....  ....... ........           +                 ........+.++
T Consensus       207 slG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~-----------~-----------------~~~~~s~~~~~l  256 (486)
T 3mwu_A          207 SAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDL-----------P-----------------QWRTISDDAKDL  256 (486)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCSCS-----------G-----------------GGGGSCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCCC-----------c-----------------ccCCCCHHHHHH
Confidence            999999999999999864211  1111100 00000000           0                 000223457788


Q ss_pred             hhccCCCCccCCCCHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +.+||+.||++|||+.|+++.
T Consensus       257 i~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          257 IRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHHcCCChhhCcCHHHHhcC
Confidence            889999999999999999873

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.3e-33  Score=274.39  Aligned_cols=197  Identities=20%  Similarity=0.244  Sum_probs=152.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     .....++||||+.+|+|.+++.          ....+++..+..++.||
T Consensus        71 ~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi  135 (484)
T 3nyv_A           71 ESLLREVQLLKQLDHPNIMKLYEFFE-----DKGYFYLVGEVYTGGELFDEII----------SRKRFSEVDAARIIRQV  135 (484)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------TCSCCBHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEE-----eCCEEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            67999999999999999999999964     3778999999999999999883          33568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee---CCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.....           ..+||...+ .++.++|||
T Consensus       136 ~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diw  211 (484)
T 3nyv_A          136 LSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVW  211 (484)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHH
T ss_pred             HHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeH
Confidence            99999999   6799999999999999   56789999999999765433           234665544 689999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |+||++|||++|+.||....  ..........           ........                ........+.+++
T Consensus       212 slG~il~~ll~g~~pf~~~~--~~~~~~~i~~-----------~~~~~~~~----------------~~~~~s~~~~~li  262 (484)
T 3nyv_A          212 STGVILYILLSGCPPFNGAN--EYDILKKVEK-----------GKYTFELP----------------QWKKVSESAKDLI  262 (484)
T ss_dssp             HHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH-----------CCCCCCSG----------------GGGGSCHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCC--HHHHHHHHHc-----------CCCCCCCc----------------ccccCCHHHHHHH
Confidence            99999999999999986421  1111111100           00000000                0002234677888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.+|++|||+.|+++
T Consensus       263 ~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          263 RKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHTCSSGGGSCCHHHHHT
T ss_pred             HHHCCCChhHCcCHHHHhh
Confidence            8999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.7e-33  Score=271.49  Aligned_cols=215  Identities=19%  Similarity=0.215  Sum_probs=160.1

Q ss_pred             chhhH------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|++      +++.+|+++++.++|++.+..+.++.    ...+..++||||+ +++|.+++..         ....++
T Consensus        36 AvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~lvme~~-g~sL~~ll~~---------~~~~l~  101 (483)
T 3sv0_A           36 AIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNVLVMDLL-GPSLEDLFNF---------CSRKLS  101 (483)
T ss_dssp             EEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEEEEEECC-CCBHHHHHHH---------TTTCCC
T ss_pred             EEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEEEEEECC-CCCHHHHHHh---------hcCCCC
Confidence            66654      46899999999998755544444432    2367789999999 9999999842         235699


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceee---CCCCcEEEccccccccCCCC-------------------
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL---DDDMTARVGDFGLARFLPPT-------------------  244 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfg~a~~~~~~-------------------  244 (382)
                      +..++.++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.....                   
T Consensus       102 ~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~  178 (483)
T 3sv0_A          102 LKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR  178 (483)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTT
T ss_pred             HHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCcc
Confidence            9999999999999999999   6799999999999999   58899999999999765332                   


Q ss_pred             CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCch--HHHHHHHhcCCchhhhhhcccccchhhhhhcccc
Q 040999          245 RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMN--LHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQ  322 (382)
Q Consensus       245 ~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (382)
                      ...||...+..++.++|||||||++|||++|+.||.........  +..............                   
T Consensus       179 Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-------------------  239 (483)
T 3sv0_A          179 YASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA-------------------  239 (483)
T ss_dssp             TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH-------------------
T ss_pred             ccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH-------------------
Confidence            23356666778899999999999999999999999754222110  111111110000000                   


Q ss_pred             chhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          323 KQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                              ....++.++.+++..||+.+|++||++.+|++.|+++....
T Consensus       240 --------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          240 --------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             --------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             --------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence                    00123457888999999999999999999999999986543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.4e-33  Score=274.56  Aligned_cols=200  Identities=19%  Similarity=0.255  Sum_probs=154.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++.     +.+..++||||+++|+|.+++...        ....+++..+..++.||
T Consensus       229 ~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~~l~lVmEy~~gg~L~~~l~~~--------~~~~l~e~~~~~i~~qI  295 (576)
T 2acx_A          229 AMALNEKQILEKVNSRFVVSLAYAYE-----TKDALCLVLTLMNGGDLKFHIYHM--------GQAGFPEARAVFYAAEI  295 (576)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHHSS--------SSCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCEeeEEEEEe-----eCCEEEEEEEcCCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHH
Confidence            45789999999999999999999854     477899999999999999988532        22358999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...+..++.++||||||
T Consensus       296 l~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLG  372 (576)
T 2acx_A          296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALG  372 (576)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHH
T ss_pred             HHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHH
Confidence            99999999   679999999999999999999999999999876432           2336666677889999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||....... ........         +...-. ....                  .....+.+++.+|
T Consensus       373 vilyeLltG~~PF~~~~~~~-~~~~i~~~---------i~~~~~-~~p~------------------~~s~~~~dLI~~l  423 (576)
T 2acx_A          373 CLLYEMIAGQSPFQQRKKKI-KREEVERL---------VKEVPE-EYSE------------------RFSPQARSLCSQL  423 (576)
T ss_dssp             HHHHHHHHSSCSSSCSSSCC-CHHHHHHH---------HHHCCC-CCCT------------------TSCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCcccccch-hHHHHHHH---------hhcccc-cCCc------------------cCCHHHHHHHHHh
Confidence            99999999999987532211 11111110         000000 0000                  1223577888899


Q ss_pred             CCCCccCCC-----CHHHHHH
Q 040999          347 SMESPQDRM-----KMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RP-----s~~evl~  362 (382)
                      |+.||++||     ++.||++
T Consensus       424 L~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          424 LCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             TCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccCCHHHcCCCCCCCHHHHHh
Confidence            999999999     7788875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.9e-34  Score=268.83  Aligned_cols=243  Identities=16%  Similarity=0.178  Sum_probs=160.1

Q ss_pred             chhhH----HHHHHHHHHHhhcccccceeeeeeeeeccc---------------------------------CCCceeEE
Q 040999          113 AFKIF----KSFIAECKALRNIRHRNLIKVLTACLGVDY---------------------------------QGNDFKAL  155 (382)
Q Consensus       113 avK~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---------------------------------~~~~~~~l  155 (382)
                      |+|++    +...+|+++|+.++|||||++++++.....                                 .+..+.++
T Consensus        36 AiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  115 (383)
T 3eb0_A           36 ALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV  115 (383)
T ss_dssp             EEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEE
T ss_pred             EEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEE
Confidence            67765    345689999999999999999999754221                                 33456889


Q ss_pred             EEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeC-CCCcEEEcc
Q 040999          156 VYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVGD  234 (382)
Q Consensus       156 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~-~~~~~kl~D  234 (382)
                      ||||++ |+|.+.+....      .....+++..+..++.||++||+|||   +.+|+||||||+|||++ .++.+||+|
T Consensus       116 v~e~~~-~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~D  185 (383)
T 3eb0_A          116 IMEYVP-DTLHKVLKSFI------RSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCD  185 (383)
T ss_dssp             EECCCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECC
T ss_pred             EEecCC-ccHHHHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEE
Confidence            999998 57777764211      23457899999999999999999999   78999999999999997 688999999


Q ss_pred             ccccccCCCC-----------CCCCccccC-CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchh
Q 040999          235 FGLARFLPPT-----------RTQTKYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVK  302 (382)
Q Consensus       235 fg~a~~~~~~-----------~~~~~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (382)
                      ||+|+.....           ..+||...+ ..++.++||||+||++|||++|+.||..... ...+.............
T Consensus       186 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~p~~~  264 (383)
T 3eb0_A          186 FGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS-IDQLVRIIQIMGTPTKE  264 (383)
T ss_dssp             CTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHH
T ss_pred             CCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHH
Confidence            9999865332           233665554 3589999999999999999999999864211 11122222222221111


Q ss_pred             hhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH--HHHHhhh
Q 040999          303 DIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH--ELQSIKN  369 (382)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~--~L~~i~~  369 (382)
                      .+....-......   ....................+.+++.+||+.||++|||+.|+++  .++.++.
T Consensus       265 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          265 QMIRMNPHYTEVR---FPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHHCTTC--CC---CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             HHHHhCccccccc---CCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            1111000000000   00000000000000123346788888999999999999999984  3444443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.2e-33  Score=260.91  Aligned_cols=219  Identities=20%  Similarity=0.244  Sum_probs=149.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     ....++||||++ |+|.+++.          ....+++..+..++.||
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~L~~~~~----------~~~~~~~~~~~~i~~ql  141 (329)
T 3gbz_A           78 GTAIREVSLLKELQHRNIIELKSVIHH-----NHRLHLIFEYAE-NDLKKYMD----------KNPDVSMRVIKSFLYQL  141 (329)
T ss_dssp             --CHHHHHHGGGCCCTTBCCEEEEEEE-----TTEEEEEEECCS-EEHHHHHH----------HCTTCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHcCCCCcceEEEEEec-----CCEEEEEEecCC-CCHHHHHh----------hcCCCCHHHHHHHHHHH
Confidence            467899999999999999999999654     678999999997 58988883          23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceee-----CCCCcEEEccccccccCC------------CCCCCCccccC-CCCCcc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLL-----DDDMTARVGDFGLARFLP------------PTRTQTKYGVG-NEVSTI  259 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl-----~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~-~~~~~~  259 (382)
                      +.||+|||   +.+|+||||||+|||+     +.++.+||+|||+++...            .....||...+ ..++.+
T Consensus       142 ~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  218 (329)
T 3gbz_A          142 INGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTS  218 (329)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTH
T ss_pred             HHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcH
Confidence            99999999   6799999999999999     455669999999997543            22344666655 457999


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHh-cCC--chhhhhh-cccccchhhhhhccccchhhhhhhhHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMA-LPN--HVKDIVD-SILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      +|||||||++|||++|+.||...... ..+....... .+.  ....... +......      ................
T Consensus       219 ~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~  291 (329)
T 3gbz_A          219 VDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTWPGVTALPDWKQSF------PKFRGKTLKRVLGALL  291 (329)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC------CCCCCCCHHHHHGGGS
T ss_pred             HHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchhhhhhhhhhhhhhhhh------hhhccccHhhhccccc
Confidence            99999999999999999998642111 1111111111 111  0000000 0000000      0000000000000112


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ..++.+++.+||+.||++|||+.|+++
T Consensus       292 ~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          292 DDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            346788888999999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.4e-34  Score=268.62  Aligned_cols=196  Identities=22%  Similarity=0.218  Sum_probs=144.3

Q ss_pred             HHHHHHHHH-HhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKA-LRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|..+ ++.++||||+++++++.     +.+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus        83 ~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~~~~~~lv~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~q  147 (373)
T 2r5t_A           83 KHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVLDYINGGELFYHLQ----------RERCFLEPRARFYAAE  147 (373)
T ss_dssp             --------CCBCCCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCEEEEEE-----eCCEEEEEEeCCCCCcHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            456677776 56789999999999854     4778999999999999999883          2346889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...            ....+||...+..++.++||||
T Consensus       148 i~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  224 (373)
T 2r5t_A          148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC  224 (373)
T ss_dssp             HHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHH
T ss_pred             HHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHH
Confidence            999999999   7799999999999999999999999999997532            1233466667778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....     .......        ++........                    .....+.+++.
T Consensus       225 lG~il~ell~G~~Pf~~~~-----~~~~~~~--------i~~~~~~~~~--------------------~~~~~~~~li~  271 (373)
T 2r5t_A          225 LGAVLYEMLYGLPPFYSRN-----TAEMYDN--------ILNKPLQLKP--------------------NITNSARHLLE  271 (373)
T ss_dssp             HHHHHHHHHHSSCTTCCSB-----HHHHHHH--------HHHSCCCCCS--------------------SSCHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCCCC-----HHHHHHH--------HHhcccCCCC--------------------CCCHHHHHHHH
Confidence            9999999999999986321     1111111        1111000000                    11235677888


Q ss_pred             ccCCCCccCCCCHHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHEL  364 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~L  364 (382)
                      +||+.||.+||++.+.++.+
T Consensus       272 ~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          272 GLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             HHTCSSGGGSTTTTTTHHHH
T ss_pred             HHcccCHHhCCCCCCCHHHH
Confidence            99999999999986544444

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.5e-33  Score=271.72  Aligned_cols=202  Identities=21%  Similarity=0.254  Sum_probs=154.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     .....++||||+++|+|.+++....      .....+++..+..++.||
T Consensus       230 ~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~~l~lVmE~~~gg~L~~~l~~~~------~~~~~l~e~~~~~~~~qi  298 (543)
T 3c4z_A          230 QGAMVEKKILAKVHSRFIVSLAYAFE-----TKTDLCLVMTIMNGGDIRYHIYNVD------EDNPGFQEPRAIFYTAQI  298 (543)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEECCCTTCBHHHHHHTSS------TTSCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEe-----eCCEEEEEEEeccCCCHHHHHHHhh------cccccccHHHHHHHHHHH
Confidence            46889999999999999999999854     4778999999999999999885432      123468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....            ..+||...+..++.++|||||
T Consensus       299 ~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSl  375 (543)
T 3c4z_A          299 VSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFAL  375 (543)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHH
T ss_pred             HHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcc
Confidence            99999999   679999999999999999999999999999765322            233666677788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||....... .........        ...... .+ .                  .....+.+++.+
T Consensus       376 GvilyelltG~~PF~~~~~~~-~~~~~~~~i--------~~~~~~-~p-~------------------~~s~~~~~li~~  426 (543)
T 3c4z_A          376 GVTLYEMIAARGPFRARGEKV-ENKELKQRV--------LEQAVT-YP-D------------------KFSPASKDFCEA  426 (543)
T ss_dssp             HHHHHHHHHSSCSSCCTTCCC-CHHHHHHHH--------HHCCCC-CC-T------------------TSCHHHHHHHHH
T ss_pred             hHHHHHHHhCCCCCCCCccch-hHHHHHHHH--------hhcccC-CC-c------------------ccCHHHHHHHHH
Confidence            999999999999987532111 111111111        000000 00 0                  122356778889


Q ss_pred             cCCCCccCCCCH-----HHHHH
Q 040999          346 CSMESPQDRMKM-----TNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~-----~evl~  362 (382)
                      ||+.||++||++     .++++
T Consensus       427 lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          427 LLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HSCSSGGGSCCCBTTBSHHHHT
T ss_pred             hccCCHhHCCCCcccCHHHHHc
Confidence            999999999975     55653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1e-32  Score=258.22  Aligned_cols=221  Identities=16%  Similarity=0.211  Sum_probs=156.7

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++..     .+..++||||+++|+|.+++.....-.  ......+++..+..++.|
T Consensus        87 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~--~~~~~~~~~~~~~~i~~q  159 (348)
T 2pml_X           87 YDDFKNELQIITDIKNEYCLTCEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLD--KNYTCFIPIQVIKCIIKS  159 (348)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCCSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSC--SSSCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhh--hccccCCCHHHHHHHHHH
Confidence            3789999999999999999999999653     678999999999999999932110000  012467999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------CCCCccccCC-CCCc-cchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------RTQTKYGVGN-EVST-IGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~-~~~~-~~Dv~S  264 (382)
                      ++.||.|||+  ..+|+||||||+||+++.++.+||+|||.+......          ...||...+. .++. ++||||
T Consensus       160 i~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s  237 (348)
T 2pml_X          160 VLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS  237 (348)
T ss_dssp             HHHHHHHHHH--TSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHH
T ss_pred             HHHHHHHHhc--cCCEeecCCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHH
Confidence            9999999993  179999999999999999999999999999865322          3347766655 5655 999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHh---cCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMA---LPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||+++|||++|+.||...... ..........   .+.............               ............+.+
T Consensus       238 lG~il~~l~~g~~pf~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~l~~  301 (348)
T 2pml_X          238 LGICLYVMFYNVVPFSLKISL-VELFNNIRTKNIEYPLDRNHFLYPLTNK---------------KSTCSNNFLSNEDID  301 (348)
T ss_dssp             HHHHHHHHHHSSCSSCCSSCS-HHHHHHHTSCCCCCCCSSSSSTTTTCC-----------------------CCCHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCcCCccchhhhhcccccc---------------ccccchhhcCHHHHH
Confidence            999999999999998743221 1111111110   000000000000000               000000123446788


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||.+|||+.|+++
T Consensus       302 li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          302 FLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhhCCCHHHHhc
Confidence            888999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3e-33  Score=254.41  Aligned_cols=196  Identities=15%  Similarity=0.205  Sum_probs=148.9

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .++.+|+..+.++ +||||+++++++..     .+..++||||+++++|.+++....      .....+++..+..++.|
T Consensus        55 ~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~q  123 (289)
T 1x8b_A           55 QNALREVYAHAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENY------RIMSYFKEAELKDLLLQ  123 (289)
T ss_dssp             HHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHHH------HHTCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCeEEEEEEecCCCcHHHHHHhhc------ccccCCCHHHHHHHHHH
Confidence            6788999999999 99999999999754     678999999999999999994321      11246899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCC-------------------CcEEEccccccccCCCCC--------CCCc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDD-------------------MTARVGDFGLARFLPPTR--------TQTK  249 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-------------------~~~kl~Dfg~a~~~~~~~--------~~~~  249 (382)
                      |+.||.|||   +.+|+||||||+||+++.+                   ..+||+|||.+.......        ..||
T Consensus       124 i~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE  200 (289)
T 1x8b_A          124 VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANE  200 (289)
T ss_dssp             HHHHHHHHH---HTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSCCCCCCGGGCCHH
T ss_pred             HHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCccccCCCccccChh
Confidence            999999999   6799999999999999844                   479999999998764332        2355


Q ss_pred             cccCC-CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhh
Q 040999          250 YGVGN-EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAK  328 (382)
Q Consensus       250 ~~~~~-~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (382)
                      ...+. .++.++|||||||++|||++|.+++..    ............+            ..+ .             
T Consensus       201 ~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~----~~~~~~~~~~~~~------------~~~-~-------------  250 (289)
T 1x8b_A          201 VLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGRLP------------RIP-Q-------------  250 (289)
T ss_dssp             HHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS----SHHHHHHHTTCCC------------CCS-S-------------
T ss_pred             HhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc----hhHHHHHHcCCCC------------CCC-c-------------
Confidence            55444 566899999999999999999987532    1111111110000            000 0             


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          329 INVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       329 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                           .....+.+++.+||+.||++|||+.|+++
T Consensus       251 -----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          251 -----VLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                 12235778888999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-33  Score=257.71  Aligned_cols=199  Identities=19%  Similarity=0.247  Sum_probs=141.2

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.++...++.++||||+++++++..     .+..++||||++ |+|.+++....      .....+++..+..++.|++
T Consensus        52 ~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~i~~qi~  119 (290)
T 3fme_A           52 LLMDLDISMRTVDCPFTVTFYGALFR-----EGDVWICMELMD-TSLDKFYKQVI------DKGQTIPEDILGKIAVSIV  119 (290)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEC-----SSSEEEEEECCS-EEHHHHHHHHH------HTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCeEEEEeeeeec-----cCCEEEEEehhc-cchHHHHHHHH------hcCCCCCHHHHHHHHHHHH
Confidence            34455556888899999999999653     677899999997 58877764211      2345699999999999999


Q ss_pred             HHHhHHhhcCCC-ceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccc----cCCCCCccchh
Q 040999          199 SALNYLHHDCQP-VTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYG----VGNEVSTIGDV  262 (382)
Q Consensus       199 ~~L~~lH~~~~~-~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~----~~~~~~~~~Dv  262 (382)
                      .||+|||   +. +|+||||||+||+++.++.+||+|||+++....           ...+||..    .+..++.++||
T Consensus       120 ~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di  196 (290)
T 3fme_A          120 KALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDI  196 (290)
T ss_dssp             HHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHH
T ss_pred             HHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHH
Confidence            9999999   55 999999999999999999999999999975432           23346653    45667899999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||+||+.||+.................+            .....                  .....+.++
T Consensus       197 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------~~~~~------------------~~~~~~~~l  246 (290)
T 3fme_A          197 WSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP------------QLPAD------------------KFSAEFVDF  246 (290)
T ss_dssp             HHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC------------CCCTT------------------TSCHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC------------Ccccc------------------cCCHHHHHH
Confidence            999999999999999986421111111111110000            00000                  123457888


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||+.|+++
T Consensus       247 i~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          247 TSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHhhcChhhCcCHHHHHh
Confidence            88999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-32  Score=249.38  Aligned_cols=195  Identities=21%  Similarity=0.292  Sum_probs=152.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++||||+++++++..     .+..++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        56 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~qi  120 (276)
T 2h6d_A           56 GKIKREIQNLKLFRHPHIIKLYQVIST-----PTDFFMVMEYVSGGELFDYIC----------KHGRVEEMEARRLFQQI  120 (276)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHH----------HHCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEeEEEEEEec-----CCeEEEEEeccCCCcHHHHHh----------ccCCCCHHHHHHHHHHH
Confidence            578899999999999999999999643     678999999999999999984          23458899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCC-CccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEV-STIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~-~~~~Dv~S~  265 (382)
                      +.||.|||   +.+++||||||+||+++.++.+||+|||++......           ...||...+..+ +.++|||||
T Consensus       121 ~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  197 (276)
T 2h6d_A          121 LSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSC  197 (276)
T ss_dssp             HHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHH
T ss_pred             HHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHH
Confidence            99999999   669999999999999999999999999999865432           234676665544 689999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|||++|+.||+...     ........         .......+ .                  .....+.+++.+
T Consensus       198 G~~l~~l~~g~~p~~~~~-----~~~~~~~~---------~~~~~~~~-~------------------~~~~~l~~li~~  244 (276)
T 2h6d_A          198 GVILYALLCGTLPFDDEH-----VPTLFKKI---------RGGVFYIP-E------------------YLNRSVATLLMH  244 (276)
T ss_dssp             HHHHHHHHHSSCSSCCSS-----HHHHHHHH---------HHCCCCCC-T------------------TSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCc-----HHHHHHHh---------hcCcccCc-h------------------hcCHHHHHHHHH
Confidence            999999999999986421     11111100         00000000 0                  112356788889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.||++|||+.|+++.
T Consensus       245 ~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          245 MLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HTCSSGGGSCCHHHHHHS
T ss_pred             HccCChhhCCCHHHHHhC
Confidence            999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.2e-33  Score=273.18  Aligned_cols=197  Identities=19%  Similarity=0.207  Sum_probs=150.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++++.++|||||++++++.     .....++|||||++|+|.+++.          ....+++..+..++.||
T Consensus        81 ~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~~~----------~~~~~~~~~~~~i~~qi  145 (494)
T 3lij_A           81 SKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRNYYLVMECYKGGELFDEII----------HRMKFNEVDAAVIIKQV  145 (494)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHHH
Confidence            57899999999999999999999964     3778999999999999988883          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCC---CcEEEccccccccCCCC-----------CCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDD---MTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+|+||||||+|||++..   +.+||+|||+++.....           ..+||... ..++.++|||
T Consensus       146 ~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~Diw  221 (494)
T 3lij_A          146 LSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVW  221 (494)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHH
T ss_pred             HHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHH
Confidence            99999999   6799999999999999764   45999999999765322           23355543 5689999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |+||++|||++|+.||.....     .......        ..........                ........+.+++
T Consensus       222 slG~il~~ll~g~~pf~~~~~-----~~~~~~i--------~~~~~~~~~~----------------~~~~~s~~~~~li  272 (494)
T 3lij_A          222 SIGVILFILLAGYPPFGGQTD-----QEILRKV--------EKGKYTFDSP----------------EWKNVSEGAKDLI  272 (494)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSH-----HHHHHHH--------HHTCCCCCSG----------------GGTTSCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCH-----HHHHHHH--------HhCCCCCCch----------------hcccCCHHHHHHH
Confidence            999999999999999864211     1111100        0000000000                0002234577888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.||.+|||+.|+++
T Consensus       273 ~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          273 KQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHTCSSTTTSCCHHHHHT
T ss_pred             HHHCCCChhhCccHHHHhc
Confidence            8999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.9e-33  Score=252.30  Aligned_cols=195  Identities=19%  Similarity=0.249  Sum_probs=153.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        60 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~i~~qi  124 (294)
T 2rku_A           60 EKMSMEISIHRSLAHQHVVGFHGFFED-----NDFVFVVLELCRRRSLLELHK----------RRKALTEPEARYYLRQI  124 (294)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHH----------HHCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeeecc-----CCEEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            678899999999999999999999643     678999999999999998873          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....            ...||...+..++.++|||||
T Consensus       125 ~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  201 (294)
T 2rku_A          125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI  201 (294)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHH
T ss_pred             HHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHH
Confidence            99999999   679999999999999999999999999999765321            233666666778999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|||+||+.||....    ....+....         ..... .+ .                  .....+.+++.+
T Consensus       202 G~~l~~l~~g~~p~~~~~----~~~~~~~~~---------~~~~~-~~-~------------------~~~~~~~~li~~  248 (294)
T 2rku_A          202 GCIMYTLLVGKPPFETSC----LKETYLRIK---------KNEYS-IP-K------------------HINPVAASLIQK  248 (294)
T ss_dssp             HHHHHHHHHSSCTTCCSS----HHHHHHHHH---------TTCCC-CC-T------------------TSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCC----HHHHHHHHh---------hccCC-Cc-c------------------ccCHHHHHHHHH
Confidence            999999999999986421    111111100         00000 00 0                  112356778889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.||++|||+.|+++.
T Consensus       249 ~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          249 MLQTDPTARPTINELLND  266 (294)
T ss_dssp             HTCSSGGGSCCGGGGGGS
T ss_pred             HcccChhhCcCHHHHhhC
Confidence            999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.5e-32  Score=258.07  Aligned_cols=224  Identities=17%  Similarity=0.174  Sum_probs=152.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++++.++||||+++++++.... .......++||||+++ +|.+++.            ..+++..+..++.|
T Consensus        69 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~i~~q  135 (371)
T 2xrw_A           69 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQ  135 (371)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH------------SCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh------------hccCHHHHHHHHHH
Confidence            67889999999999999999999975421 1233478999999974 6777762            24788999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....           ..+||...+..++.++|||||
T Consensus       136 i~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  212 (371)
T 2xrw_A          136 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  212 (371)
T ss_dssp             HHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             HHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence            999999999   679999999999999999999999999999765332           344777777788999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHh--cCCchhhhhhcc-------cccchh----h-hhhccccchhhhhhhh
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMA--LPNHVKDIVDSI-------LLNDDE----K-LVVRGDQKQTQAKINV  331 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-------~~~~~~----~-~~~~~~~~~~~~~~~~  331 (382)
                      ||++|||+||+.||...    .....+....  ......+.....       ....+.    . ......... ......
T Consensus       213 G~il~el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  287 (371)
T 2xrw_A          213 GCIMGEMIKGGVLFPGT----DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLF-PADSEH  287 (371)
T ss_dssp             HHHHHHHHHSSCSSCCS----SHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGS-CCSSHH
T ss_pred             HHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccC-cccccc
Confidence            99999999999998642    2222221111  000011111000       000000    0 000000000 000011


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .......+.+++.+||+.||++|||++|+++
T Consensus       288 ~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          288 NKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            1234567889999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.7e-33  Score=254.18  Aligned_cols=203  Identities=18%  Similarity=0.233  Sum_probs=151.7

Q ss_pred             chhhH---HHHHHHHHHH-hhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHH
Q 040999          113 AFKIF---KSFIAECKAL-RNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLL  188 (382)
Q Consensus       113 avK~~---~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~  188 (382)
                      |+|.+   +.+.+|++++ +..+||||+++++++... ..+....++||||+++|+|.+++...        ....+++.
T Consensus        47 aiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~  117 (299)
T 3m2w_A           47 ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDR--------GDQAFTER  117 (299)
T ss_dssp             EEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEEEEEECCCCSCBHHHHHHHC--------TTCCCBHH
T ss_pred             EEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceEEEEEeecCCCcHHHHHHhc--------cCCCCCHH
Confidence            77776   6788999998 555899999999987532 23356789999999999999999531        23468999


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC---CCcEEEccccccccCCCCCCCCccccCCCCCccchhHHH
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD---DMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      .+..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||++....          +..++.++|||||
T Consensus       118 ~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------~~~~~~~~Diwsl  184 (299)
T 3m2w_A          118 EASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------GEKYDKSCDMWSL  184 (299)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----------TCGGGGHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----------cccCCchhhHHHH
Confidence            99999999999999999   679999999999999998   7889999999997553          3557889999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||.......          ........+.......+            .   .........+.+++.+
T Consensus       185 G~il~el~tg~~pf~~~~~~~----------~~~~~~~~~~~~~~~~~------------~---~~~~~~~~~~~~li~~  239 (299)
T 3m2w_A          185 GVIMYILLCGYPPFYSNHGLA----------ISPGMKTRIRMGQYEFP------------N---PEWSEVSEEVKMLIRN  239 (299)
T ss_dssp             HHHHHHHHHSSCSCCC-----------------CCSCCSSCTTCCSSC------------H---HHHTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCcchh----------hhHHHHHHHhhccccCC------------c---hhcccCCHHHHHHHHH
Confidence            999999999999986421110          00000000000000000            0   0001234567888889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.||++|||+.|+++
T Consensus       240 ~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          240 LLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             HTCSSTTTSCCHHHHHT
T ss_pred             HcccChhhCCCHHHHhc
Confidence            99999999999999997

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.5e-33  Score=257.66  Aligned_cols=195  Identities=19%  Similarity=0.249  Sum_probs=153.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|+||+++++++..     .+..++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        86 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~----------~~~~l~~~~~~~i~~qi  150 (335)
T 2owb_A           86 EKMSMEISIHRSLAHQHVVGFHGFFED-----NDFVFVVLELCRRRSLLELHK----------RRKALTEPEARYYLRQI  150 (335)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEEEEECCCTTCBHHHHHH----------HHCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEec-----CCeEEEEEecCCCCCHHHHHh----------ccCCCCHHHHHHHHHHH
Confidence            678999999999999999999999653     678999999999999999873          23468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      ++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....            ...||...+..++.++|||||
T Consensus       151 ~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  227 (335)
T 2owb_A          151 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI  227 (335)
T ss_dssp             HHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHH
T ss_pred             HHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHH
Confidence            99999999   679999999999999999999999999999865321            233666666778899999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      |+++|||++|+.||....    ....+....         ..... .+ .                  .....+.+++.+
T Consensus       228 G~il~~l~~g~~pf~~~~----~~~~~~~~~---------~~~~~-~~-~------------------~~~~~~~~li~~  274 (335)
T 2owb_A          228 GCIMYTLLVGKPPFETSC----LKETYLRIK---------KNEYS-IP-K------------------HINPVAASLIQK  274 (335)
T ss_dssp             HHHHHHHHHSSCTTCCSS----HHHHHHHHH---------HTCCC-CC-T------------------TSCHHHHHHHHH
T ss_pred             HHHHHHHHHCcCCCCCCC----HHHHHHHHh---------cCCCC-CC-c------------------cCCHHHHHHHHH
Confidence            999999999999986421    111111000         00000 00 0                  112356778889


Q ss_pred             cCCCCccCCCCHHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~~  363 (382)
                      ||+.||++|||+.|+++.
T Consensus       275 ~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          275 MLQTDPTARPTINELLND  292 (335)
T ss_dssp             HTCSSGGGSCCGGGGGGS
T ss_pred             HccCChhHCcCHHHHhcC
Confidence            999999999999999863

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.3e-33  Score=255.70  Aligned_cols=192  Identities=12%  Similarity=0.066  Sum_probs=146.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     .+..++||||+++++|.+++..           . .......+++.|+
T Consensus        76 ~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~-----------~-~~~~~~~~i~~ql  138 (286)
T 3uqc_A           76 QETLSRTLRLSRIDKPGVARVLDVVHT-----RAGGLVVAEWIRGGSLQEVADT-----------S-PSPVGAIRAMQSL  138 (286)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEECCCEEEHHHHHTT-----------C-CCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcceeeEEEEE-----CCcEEEEEEecCCCCHHHHHhc-----------C-CChHHHHHHHHHH
Confidence            679999999999999999999999654     6789999999999999999831           1 2445678899999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCCCccccCCCCCccchhHHHHHHHHHHHhcCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREK  277 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~  277 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+++|..               ..++.++|||||||++|||+||+.
T Consensus       139 ~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~---------------~~~~~~~Di~slG~il~elltg~~  200 (286)
T 3uqc_A          139 AAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATM---------------PDANPQDDIRGIGASLYALLVNRW  200 (286)
T ss_dssp             HHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCC---------------TTCCHHHHHHHHHHHHHHHHHSEE
T ss_pred             HHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecccc---------------CCCCchhHHHHHHHHHHHHHHCCC
Confidence            99999999   679999999999999999999999976543               246889999999999999999999


Q ss_pred             CCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCH
Q 040999          278 PSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKM  357 (382)
Q Consensus       278 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~  357 (382)
                      ||........             ... ...........            ......+.+..+.+++.+||+.||++| |+
T Consensus       201 Pf~~~~~~~~-------------~~~-~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~R-s~  253 (286)
T 3uqc_A          201 PLPEAGVRSG-------------LAP-AERDTAGQPIE------------PADIDRDIPFQISAVAARSVQGDGGIR-SA  253 (286)
T ss_dssp             CSCCCSBCCC-------------SEE-CCBCTTSCBCC------------HHHHCTTSCHHHHHHHHHHHCTTSSCC-CH
T ss_pred             CCCcCCcchh-------------hHH-HHHHhccCCCC------------hhhcccCCCHHHHHHHHHHcccCCccC-CH
Confidence            9874321110             000 00000000000            000001234467888889999999999 99


Q ss_pred             HHHHHHHHHhhhhh
Q 040999          358 TNVVHELQSIKNTL  371 (382)
Q Consensus       358 ~evl~~L~~i~~~~  371 (382)
                      .|+++.|+++....
T Consensus       254 ~el~~~L~~~~~~~  267 (286)
T 3uqc_A          254 STLLNLMQQATAVA  267 (286)
T ss_dssp             HHHHHHHHHHHC--
T ss_pred             HHHHHHHHHHhccC
Confidence            99999999987643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-32  Score=259.70  Aligned_cols=198  Identities=19%  Similarity=0.288  Sum_probs=151.5

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++++++ +||||+++++++..     ....++||||+++++|.+++.          ....+++..+..++.|
T Consensus       144 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~----------~~~~l~~~~~~~i~~q  208 (365)
T 2y7j_A          144 EATRRETHILRQVAGHPHIITLIDSYES-----SSFMFLVFDLMRKGELFDYLT----------EKVALSEKETRSIMRS  208 (365)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEEB-----SSEEEEEECCCTTCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEeEEEEEEee-----CCEEEEEEEeCCCCcHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            5688999999999 79999999999643     678999999999999999983          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-----------CCCcccc------CCCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-----------TQTKYGV------GNEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~------~~~~~~~  259 (382)
                      |+.||.|||   +.+|+||||||+||+++.++.+||+|||++..+....           ..||...      ...++.+
T Consensus       209 i~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  285 (365)
T 2y7j_A          209 LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE  285 (365)
T ss_dssp             HHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTT
T ss_pred             HHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCch
Confidence            999999999   6799999999999999999999999999998664322           2244432      2357889


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +|||||||++|||+||+.||....  .........           .........                ........+
T Consensus       286 ~Di~slG~il~ell~g~~pf~~~~--~~~~~~~i~-----------~~~~~~~~~----------------~~~~~~~~~  336 (365)
T 2y7j_A          286 VDLWACGVILFTLLAGSPPFWHRR--QILMLRMIM-----------EGQYQFSSP----------------EWDDRSSTV  336 (365)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHH-----------HTCCCCCHH----------------HHSSSCHHH
T ss_pred             hhHHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHH-----------hCCCCCCCc----------------ccccCCHHH
Confidence            999999999999999999986321  000101100           000000000                000223457


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+++.+||+.||++|||+.|+++
T Consensus       337 ~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          337 KDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHhc
Confidence            78888999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.98  E-value=8.1e-33  Score=255.50  Aligned_cols=227  Identities=19%  Similarity=0.245  Sum_probs=152.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc---------cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD---------YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLL  188 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~---------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~  188 (382)
                      +.+.+|++++++++||||+++++++....         .......++||||++ |+|.+++.           ...+++.
T Consensus        53 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----------~~~~~~~  120 (320)
T 2i6l_A           53 KHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-----------QGPLLEE  120 (320)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-----------TCCCCHH
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh-----------cCCccHH
Confidence            67899999999999999999999864211         134567899999997 69998883           2358899


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeC-CCCcEEEccccccccCCCC---------------CCCCcccc
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVGDFGLARFLPPT---------------RTQTKYGV  252 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~  252 (382)
                      .+..++.|++.||+|||   +.+|+||||||+||+++ .++.+||+|||+++.....               ...||...
T Consensus       121 ~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (320)
T 2i6l_A          121 HARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL  197 (320)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhc
Confidence            99999999999999999   67999999999999997 5679999999999865321               22355443


Q ss_pred             C-CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 G-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 ~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      + ..++.++|||||||++|||+||+.||.....  ...........+....+.........+........ .........
T Consensus       198 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  274 (320)
T 2i6l_A          198 SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMT-EPHKPLTQL  274 (320)
T ss_dssp             CTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTT-SCCCCHHHH
T ss_pred             CcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCchhhhhhhhhcCccccccccc-CCCCChhHh
Confidence            3 5788999999999999999999999864321  11111111111110000000000000000000000 000000000


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ......++.+++.+||+.||++|||+.|+++
T Consensus       275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          275 LPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             STTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            1123456888899999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.98  E-value=3.1e-33  Score=259.39  Aligned_cols=231  Identities=18%  Similarity=0.225  Sum_probs=155.6

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|++++++++||||+++++++..     .+..++||||++ |+|.+++.         .....+++..+..++.|++
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~~~~qi~  110 (324)
T 3mtl_A           46 TAIREVSLLKDLKHANIVTLHDIIHT-----EKSLTLVFEYLD-KDLKQYLD---------DCGNIINMHNVKLFLFQLL  110 (324)
T ss_dssp             CCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEEEEEECCS-EEHHHHHH---------HTTTCCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEEEEecccc-cCHHHHHH---------hcCCCCCHHHHHHHHHHHH
Confidence            35579999999999999999999643     678899999997 58888884         2344689999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYSY  265 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S~  265 (382)
                      .||.|||   +.+|+||||||+|||++.++.+||+|||+++.....            ..+||...+ ..++.++|||||
T Consensus       111 ~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  187 (324)
T 3mtl_A          111 RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGV  187 (324)
T ss_dssp             HHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred             HHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHH
Confidence            9999999   679999999999999999999999999999754321            233665544 567999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||...... ..+.......... ................. ....................+.+++.+
T Consensus       188 G~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~  264 (324)
T 3mtl_A          188 GCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTP-TEETWPGILSNEEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTK  264 (324)
T ss_dssp             HHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCC-CTTTSTTGGGCHHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC-ChHhchhhhcchhhccc-ccccccchhhhhhcCCCCHHHHHHHHH
Confidence            99999999999998642111 1111111111110 00000000000000000 000000000000011233467788889


Q ss_pred             cCCCCccCCCCHHHHHH--HHHHhhhh
Q 040999          346 CSMESPQDRMKMTNVVH--ELQSIKNT  370 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~--~L~~i~~~  370 (382)
                      ||+.||++|||++|+++  .+.++.+.
T Consensus       265 ~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          265 LLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             HcCcCcccCCCHHHHhcChhhhhcccc
Confidence            99999999999999986  45554443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.98  E-value=9.8e-33  Score=263.91  Aligned_cols=161  Identities=20%  Similarity=0.318  Sum_probs=125.7

Q ss_pred             chhhH------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|.+      +.+.+|+++|++++|||||++++++..   ......++||||+. |+|.+++....... .......++
T Consensus        52 aiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~l~  126 (405)
T 3rgf_A           52 ALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYAE-HDLWHIIKFHRASK-ANKKPVQLP  126 (405)
T ss_dssp             EEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEEEEEEECCS-EEHHHHHHHHHHHC--------CC
T ss_pred             EEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeEEEEEeCCC-CCHHHHHHHhcccc-ccccccCCC
Confidence            67765      578999999999999999999999753   34678999999996 47777763211000 001223589


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceee----CCCCcEEEccccccccCCC---------------CCCC
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL----DDDMTARVGDFGLARFLPP---------------TRTQ  247 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl----~~~~~~kl~Dfg~a~~~~~---------------~~~~  247 (382)
                      +..+..++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||+|+....               ...+
T Consensus       127 ~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  203 (405)
T 3rgf_A          127 RGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA  203 (405)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccC
Confidence            9999999999999999999   6799999999999999    6778999999999976532               1344


Q ss_pred             CccccC-CCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          248 TKYGVG-NEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       248 ~~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      ||...+ ..++.++|||||||++|||+||+.||..
T Consensus       204 PE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             HHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             chhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            666555 4589999999999999999999999964

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.98  E-value=5.1e-33  Score=262.80  Aligned_cols=228  Identities=16%  Similarity=0.159  Sum_probs=150.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++++.++||||+++++++..... ......++||||+. ++|.+++.            ..+++..+..++.|
T Consensus        86 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~q  152 (371)
T 4exu_A           86 KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------------MEFSEEKIQYLVYQ  152 (371)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT------------SCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh------------cCCCHHHHHHHHHH
Confidence            678899999999999999999999754211 11123499999997 57877662            24899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccC-CCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVG-NEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~-~~~~~~~Dv~S~G  266 (382)
                      ++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....         ..+||...+ ..++.++||||||
T Consensus       153 i~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (371)
T 4exu_A          153 MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVG  229 (371)
T ss_dssp             HHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHH
T ss_pred             HHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHH
Confidence            999999999   679999999999999999999999999999755322         334665555 6789999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||+||+.||..... ...+.......... ..+...................................+.+++.+|
T Consensus       230 ~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  307 (371)
T 4exu_A          230 CIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVP-GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM  307 (371)
T ss_dssp             HHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCC-CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC-cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHH
Confidence            999999999999864211 01111111111110 0111111000000000000000000000000112345678889999


Q ss_pred             CCCCccCCCCHHHHHHH
Q 040999          347 SMESPQDRMKMTNVVHE  363 (382)
Q Consensus       347 l~~~p~~RPs~~evl~~  363 (382)
                      |+.||++|||+.|+++.
T Consensus       308 L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          308 LELDVDKRLTAAQALTH  324 (371)
T ss_dssp             SCSCTTTSCCHHHHHTS
T ss_pred             CCCChhhcCCHHHHhcC
Confidence            99999999999999863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=4.1e-33  Score=261.88  Aligned_cols=200  Identities=19%  Similarity=0.186  Sum_probs=151.2

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++++++ +||||+++++++..     ....++||||+++|+|.+++.          ....+++..+..++.|
T Consensus       103 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~q  167 (355)
T 1vzo_A          103 EHTRTERQVLEHIRQSPFLVTLHYAFQT-----ETKLHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGE  167 (355)
T ss_dssp             GGCCCHHHHHHHHHTCTTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHccCCCceeEEEEEEee-----CceEEEEeecCCCCCHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            4577899999999 59999999998654     678899999999999999984          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC-------------CCCCCCccccC--CCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-------------PTRTQTKYGVG--NEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~-------------~~~~~~~~~~~--~~~~~~~D  261 (382)
                      |+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...             .....||...+  ..++.++|
T Consensus       168 i~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  244 (355)
T 1vzo_A          168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD  244 (355)
T ss_dssp             HHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHH
T ss_pred             HHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhh
Confidence            999999999   6799999999999999999999999999997542             22334665554  34688999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||+||+.||....... ..........        .... ..+                   .+....+.+
T Consensus       245 vwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~--------~~~~-~~~-------------------~~~~~~~~~  295 (355)
T 1vzo_A          245 WWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRIL--------KSEP-PYP-------------------QEMSALAKD  295 (355)
T ss_dssp             HHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHH--------HCCC-CCC-------------------TTSCHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHh--------ccCC-CCC-------------------cccCHHHHH
Confidence            9999999999999999986432211 1111111100        0000 000                   012235678


Q ss_pred             HhhccCCCCccCCC-----CHHHHHHHH
Q 040999          342 IGVACSMESPQDRM-----KMTNVVHEL  364 (382)
Q Consensus       342 l~~~Cl~~~p~~RP-----s~~evl~~L  364 (382)
                      ++.+||+.||++||     |+.|+++..
T Consensus       296 li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          296 LIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            88899999999999     999998643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.98  E-value=1.5e-33  Score=269.21  Aligned_cols=146  Identities=20%  Similarity=0.204  Sum_probs=125.6

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.+|.+++..++||||+++++++.     +.+..++||||+++|+|.+++..         ....+++..+..++.||+
T Consensus       107 ~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~~~~lVmE~~~gg~L~~~l~~---------~~~~l~~~~~~~~~~qi~  172 (412)
T 2vd5_A          107 CFREERDVLVNGDRRWITQLHFAFQ-----DENYLYLVMEYYVGGDLLTLLSK---------FGERIPAEMARFYLAEIV  172 (412)
T ss_dssp             CHHHHHHHHHHSCTTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHHH---------HSSCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCeeeEEEEEe-----eCCEEEEEEcCCCCCcHHHHHHh---------cCCCCCHHHHHHHHHHHH
Confidence            3788999999999999999999854     47889999999999999999942         224689999999999999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-------------CCCcccc-------CCCCCc
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-------------TQTKYGV-------GNEVST  258 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~-------~~~~~~  258 (382)
                      .||.|||   +.+|+||||||+|||++.++.+||+|||+++......             .+||...       +..++.
T Consensus       173 ~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~  249 (412)
T 2vd5_A          173 MAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP  249 (412)
T ss_dssp             HHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECT
T ss_pred             HHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCCh
Confidence            9999999   6799999999999999999999999999997654321             2244443       346789


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCc
Q 040999          259 IGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      ++|||||||++|||+||+.||..
T Consensus       250 ~~DiwSlGvilyelltG~~Pf~~  272 (412)
T 2vd5_A          250 ECDWWALGVFAYEMFYGQTPFYA  272 (412)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             HHhhhHHhHHHHHHHhCCCCCCC
Confidence            99999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.98  E-value=1.8e-32  Score=260.87  Aligned_cols=237  Identities=17%  Similarity=0.219  Sum_probs=159.3

Q ss_pred             chhhH-------HHHHHHHHHHhhcc--------cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCc
Q 040999          113 AFKIF-------KSFIAECKALRNIR--------HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE  177 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~  177 (382)
                      |+|++       +.+.+|+++++.++        |+||+++++++... .......++||||+ ++++.+++..      
T Consensus        66 avK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~-~~~~~~~~lv~e~~-~~~l~~~~~~------  137 (397)
T 1wak_A           66 AMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS-GVNGTHICMVFEVL-GHHLLKWIIK------  137 (397)
T ss_dssp             EEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE-ETTEEEEEEEECCC-CCBHHHHHHH------
T ss_pred             EEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec-CCCCceEEEEEecc-CccHHHHHHh------
Confidence            67665       67889999999996        78899999987531 12356789999999 5666666632      


Q ss_pred             cccCCcccCHHHHHHHHHHHHHHHhHHhhcCCC-ceeecCCCCCceeeCCCC----------------------------
Q 040999          178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQP-VTAHCDLKPSNVLLDDDM----------------------------  228 (382)
Q Consensus       178 ~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~-~ivH~dlkp~NILl~~~~----------------------------  228 (382)
                        .....+++..+..++.||+.||+|||   +. +|+||||||+|||++.++                            
T Consensus       138 --~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  212 (397)
T 1wak_A          138 --SNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST  212 (397)
T ss_dssp             --TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-----------------
T ss_pred             --cccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCcccc
Confidence              12346899999999999999999999   65 999999999999999775                            


Q ss_pred             ---------------------cEEEccccccccCCCC---------CCCCccccCCCCCccchhHHHHHHHHHHHhcCCC
Q 040999          229 ---------------------TARVGDFGLARFLPPT---------RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKP  278 (382)
Q Consensus       229 ---------------------~~kl~Dfg~a~~~~~~---------~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p  278 (382)
                                           .+||+|||+++.....         ...||...+..++.++|||||||++|||+||+.|
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  292 (397)
T 1wak_A          213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL  292 (397)
T ss_dssp             ----CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCC
Confidence                                 7999999999765332         2346766677889999999999999999999999


Q ss_pred             CCccccCCch-----HHHHHHHhcCCchhhhhhcccc-----cchhhhhh-cccc----chhhhhhhhHHHHHHHHHHHh
Q 040999          279 SDIMFEGDMN-----LHKFAKMALPNHVKDIVDSILL-----NDDEKLVV-RGDQ----KQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       279 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |.........     +..............+......     ........ ....    ...........+....+.+++
T Consensus       293 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  372 (397)
T 1wak_A          293 FEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFL  372 (397)
T ss_dssp             CCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHH
T ss_pred             CCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHH
Confidence            9754322211     1111111111000000000000     00000000 0000    000000011235567889999


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.||++|||+.|+++
T Consensus       373 ~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          373 LPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GGGGCSSGGGSCCHHHHHT
T ss_pred             HHHhccChhhcCCHHHHhh
Confidence            9999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.98  E-value=4.5e-33  Score=267.34  Aligned_cols=234  Identities=18%  Similarity=0.156  Sum_probs=155.3

Q ss_pred             chhhH----HHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCH
Q 040999          113 AFKIF----KSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNL  187 (382)
Q Consensus       113 avK~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~  187 (382)
                      |+|.+    +.+.+|+++|++++|||||++++++..... .+..+.++||||+++ ++.+.+....      .....+++
T Consensus        83 aiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~l~~  155 (420)
T 1j1b_A           83 AIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYS------RAKQTLPV  155 (420)
T ss_dssp             EEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHH------HTTCCCCH
T ss_pred             EEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHh------hccCCCCH
Confidence            77766    335579999999999999999999865322 223456799999976 5555542111      23456899


Q ss_pred             HHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC-CcEEEccccccccCCCC-----------CCCCccccCC-
Q 040999          188 LRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDFGLARFLPPT-----------RTQTKYGVGN-  254 (382)
Q Consensus       188 ~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~-  254 (382)
                      ..+..++.||++||+|||   +.+|+||||||+|||++.+ +.+||+|||+++.....           ...||...+. 
T Consensus       156 ~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~  232 (420)
T 1j1b_A          156 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT  232 (420)
T ss_dssp             HHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCC
Confidence            999999999999999999   7899999999999999965 57899999999865322           2346655443 


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhh--cccccchhhhhhccccchhhhhhhhH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVD--SILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      .++.++|||||||++|||++|+.||..... ...+..............+..  +......     ..............
T Consensus       233 ~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~-----~p~~~~~~~~~~~~  306 (420)
T 1j1b_A          233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNYTEFK-----FPQIKAHPWTKVFR  306 (420)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHHHHCSCCCCCC-----CCCCCCCCHHHHSC
T ss_pred             CCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhhChhhhhhc-----cCccCCCCHHHhcC
Confidence            689999999999999999999999864211 112222222221111111100  0000000     00000000000000


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .....++.+|+.+||+.||.+|||+.|+++
T Consensus       307 ~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          307 PRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            012346788888999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.98  E-value=8.8e-34  Score=268.01  Aligned_cols=208  Identities=7%  Similarity=-0.048  Sum_probs=135.0

Q ss_pred             HHHHHHHHHHhhc--ccccceeeee-------eeeeccc------C------CCceeEEEEecccCCCccccccCCCCCC
Q 040999          118 KSFIAECKALRNI--RHRNLIKVLT-------ACLGVDY------Q------GNDFKALVYEFIHNRSPEKWLYPISKED  176 (382)
Q Consensus       118 ~~~~~E~~~l~~l--~h~niv~~~~-------~~~~~~~------~------~~~~~~lv~e~~~~gsL~~~l~~~~~~~  176 (382)
                      +.+.+|+++++.+  +||||++++.       ++.....      .      .....++||||++ |+|.+++...    
T Consensus       107 ~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----  181 (371)
T 3q60_A          107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----  181 (371)
T ss_dssp             HHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----
T ss_pred             HHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----
Confidence            5677886555555  5999888553       3221000      0      0145799999998 8999999531    


Q ss_pred             ccccCCcccCHHHH------HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------
Q 040999          177 ETYERPRNLNLLRR------LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------  244 (382)
Q Consensus       177 ~~~~~~~~l~~~~~------~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------  244 (382)
                           ...+++..+      ..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....      
T Consensus       182 -----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~  253 (371)
T 3q60_A          182 -----DFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSV  253 (371)
T ss_dssp             -----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGS
T ss_pred             -----ccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccC
Confidence                 223455555      778899999999999   679999999999999999999999999999865432      


Q ss_pred             ---CCCCccccC--CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhc
Q 040999          245 ---RTQTKYGVG--NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVR  319 (382)
Q Consensus       245 ---~~~~~~~~~--~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (382)
                         ..+||...+  ..++.++|||||||++|||+||+.||.........       .+...   ...........     
T Consensus       254 t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------~~~~~---~~~~~~~~~~~-----  318 (371)
T 3q60_A          254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-------SWKRP---SLRVPGTDSLA-----  318 (371)
T ss_dssp             CGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-------CCCBC---CTTSCCCCSCC-----
T ss_pred             CcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-------chhhh---hhhhccccccc-----
Confidence               234676665  67899999999999999999999998754221100       00000   00000000000     


Q ss_pred             cccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          320 GDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                          .+     ........+.+++.+||+.||++|||+.|+++
T Consensus       319 ----~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          319 ----FG-----SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             ----CT-----TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             ----hh-----hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                00     00022346778888999999999999999974

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.98  E-value=4.8e-33  Score=255.22  Aligned_cols=199  Identities=21%  Similarity=0.283  Sum_probs=151.7

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|++++++++||||+++++++..     .+..++||||+++++|.+++..         ....+++..+..++.|
T Consensus        60 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~~~~~  125 (302)
T 2j7t_A           60 LEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKLWIMIEFCPGGAVDAIMLE---------LDRGLTEPQIQVVCRQ  125 (302)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CEEEEEECCTTEEHHHHHHH---------HTSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeEEEEEEeCCCCcHHHHHHh---------hccCCCHHHHHHHHHH
Confidence            3678999999999999999999999653     6688999999999999988842         2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC------------CCCCCCCccc-----cCCCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL------------PPTRTQTKYG-----VGNEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~------------~~~~~~~~~~-----~~~~~~~~  259 (382)
                      ++.||.|||   +.+++||||||+||+++.++.+||+|||++...            ......||..     .+..++.+
T Consensus       126 i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~  202 (302)
T 2j7t_A          126 MLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK  202 (302)
T ss_dssp             HHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTH
T ss_pred             HHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchh
Confidence            999999999   679999999999999999999999999987421            1123446654     35677899


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +||||||+++|||++|+.||.....    ........... .     +... .+                   ......+
T Consensus       203 ~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-~-----~~~~-~~-------------------~~~~~~l  252 (302)
T 2j7t_A          203 ADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSD-P-----PTLL-TP-------------------SKWSVEF  252 (302)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSC-C-----CCCS-SG-------------------GGSCHHH
T ss_pred             hhHHHHHHHHHHHhcCCCCCccCCH----HHHHHHHhccC-C-----cccC-Cc-------------------cccCHHH
Confidence            9999999999999999999864211    11111000000 0     0000 00                   0123467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+++.+||+.||++|||+.|+++
T Consensus       253 ~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          253 RDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHcccChhhCCCHHHHhc
Confidence            78888999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.98  E-value=1.6e-32  Score=251.16  Aligned_cols=198  Identities=21%  Similarity=0.278  Sum_probs=151.8

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|++++++++ ||||+++++++.     .....++||||+++++|.+++.          ....+++..+..++.|
T Consensus        68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~~~~q  132 (298)
T 1phk_A           68 EATLKEVDILRKVSGHPNIIQLKDTYE-----TNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETRKIMRA  132 (298)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeeec-----cCCeEEEEEeccCCCcHHHHHh----------ccCCCCHHHHHHHHHH
Confidence            67889999999996 999999999964     3678999999999999999984          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-----------CCCcccc------CCCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-----------TQTKYGV------GNEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~------~~~~~~~  259 (382)
                      ++.||.|||   +.+++||||||+||+++.++.+||+|||++.......           ..||...      ...++.+
T Consensus       133 i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~  209 (298)
T 1phk_A          133 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE  209 (298)
T ss_dssp             HHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH
T ss_pred             HHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcc
Confidence            999999999   6799999999999999999999999999998654322           2244332      3467889


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +||||||+++|||++|+.||....    .. .....        +..........                ........+
T Consensus       210 ~Di~slG~~l~~l~~g~~p~~~~~----~~-~~~~~--------~~~~~~~~~~~----------------~~~~~~~~l  260 (298)
T 1phk_A          210 VDMWSTGVIMYTLLAGSPPFWHRK----QM-LMLRM--------IMSGNYQFGSP----------------EWDDYSDTV  260 (298)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSS----HH-HHHHH--------HHHTCCCCCTT----------------TGGGSCHHH
T ss_pred             cccHhHHHHHHHHHHCCCCCcCcc----HH-HHHHH--------HhcCCcccCcc----------------cccccCHHH
Confidence            999999999999999999986321    11 11110        00000000000                000233467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+++.+||+.||++|||+.|+++
T Consensus       261 ~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          261 KDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHccCCcccCCCHHHHHh
Confidence            88888999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.98  E-value=1.6e-32  Score=269.74  Aligned_cols=198  Identities=19%  Similarity=0.240  Sum_probs=152.4

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.+.+|+++|++++||||+++++++.     +....++|||||++|+|.+++.          ....+++..+..++.|
T Consensus        90 ~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~----------~~~~~~~~~~~~i~~q  154 (504)
T 3q5i_A           90 HEEIYNEISLLKSLDHPNIIKLFDVFE-----DKKYFYLVTEFYEGGELFEQII----------NRHKFDECDAANIMKQ  154 (504)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCCEEEEEEecCCCCcHHHHHH----------HcCCCCHHHHHHHHHH
Confidence            357899999999999999999999964     4778999999999999998883          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCC---cEEEccccccccCCCC-----------CCCCccccCCCCCccchh
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDM---TARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv  262 (382)
                      |+.||.|||   +.+|+||||||+|||++.++   .+||+|||+++.....           ..+||... ..++.++||
T Consensus       155 i~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di  230 (504)
T 3q5i_A          155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDV  230 (504)
T ss_dssp             HHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHH
T ss_pred             HHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHH
Confidence            999999999   67999999999999998775   6999999999865432           22355543 468999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||+||++|+|++|+.||.....     .......        .........                .........+.++
T Consensus       231 wslG~il~~ll~g~~pf~~~~~-----~~~~~~i--------~~~~~~~~~----------------~~~~~~s~~~~~l  281 (504)
T 3q5i_A          231 WSCGVIMYILLCGYPPFGGQND-----QDIIKKV--------EKGKYYFDF----------------NDWKNISDEAKEL  281 (504)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH--------HHCCCCCCH----------------HHHTTSCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH--------HcCCCCCCc----------------cccCCCCHHHHHH
Confidence            9999999999999999864211     1111100        000000000                0001223467888


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||.+|||+.|+++
T Consensus       282 i~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          282 IKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCChhHCCCHHHHhc
Confidence            88999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.98  E-value=7.5e-33  Score=256.79  Aligned_cols=203  Identities=20%  Similarity=0.223  Sum_probs=149.8

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      +.+.+|+++++++ +||||+++++++..... ......++||||+++|+|.+++...        ....+++..+..++.
T Consensus        65 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~  136 (326)
T 2x7f_A           65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICR  136 (326)
T ss_dssp             HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--------GGGCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--------ccCCCCHHHHHHHHH
Confidence            6789999999999 79999999999765221 1246789999999999999998531        234688999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc-----CCCCCc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV-----GNEVST  258 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~-----~~~~~~  258 (382)
                      |++.||.|||   ..+|+||||||+||+++.++.+||+|||++......            ...||...     +..++.
T Consensus       137 qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~  213 (326)
T 2x7f_A          137 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF  213 (326)
T ss_dssp             HHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCT
T ss_pred             HHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCc
Confidence            9999999999   679999999999999999999999999998765322            22355543     456789


Q ss_pred             cchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          259 IGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       259 ~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      ++|||||||++|||+||+.||....    .......... ..     .+.....                     .....
T Consensus       214 ~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~-~~-----~~~~~~~---------------------~~~~~  262 (326)
T 2x7f_A          214 KSDLWSLGITAIEMAEGAPPLCDMH----PMRALFLIPR-NP-----APRLKSK---------------------KWSKK  262 (326)
T ss_dssp             THHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHH-SC-----CCCCSCS---------------------CSCHH
T ss_pred             cchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhc-Cc-----cccCCcc---------------------ccCHH
Confidence            9999999999999999999986321    1111100000 00     0000000                     12236


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHH
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+++.+||+.||++|||+.++++
T Consensus       263 l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          263 FQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhccChhhCCCHHHHhh
Confidence            778888999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.98  E-value=4e-32  Score=252.72  Aligned_cols=147  Identities=20%  Similarity=0.268  Sum_probs=125.6

Q ss_pred             HHHHHHHHHHhhccccc------ceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHH
Q 040999          118 KSFIAECKALRNIRHRN------LIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRL  191 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~  191 (382)
                      +.+.+|+++++.++|+|      ++++++++..     .+..++||||+ +++|.+++...        ....+++..+.
T Consensus        56 ~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~-~~~l~~~l~~~--------~~~~~~~~~~~  121 (339)
T 1z57_A           56 EAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-----HGHICIVFELL-GLSTYDFIKEN--------GFLPFRLDHIR  121 (339)
T ss_dssp             HHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHHT--------TTCCCCHHHHH
T ss_pred             HHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-----CCcEEEEEcCC-CCCHHHHHHhc--------CCCCCcHHHHH
Confidence            67889999999998876      8999998654     67899999999 88999988431        22468899999


Q ss_pred             HHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC-------------------CCcEEEccccccccCCCC--------
Q 040999          192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD-------------------DMTARVGDFGLARFLPPT--------  244 (382)
Q Consensus       192 ~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-------------------~~~~kl~Dfg~a~~~~~~--------  244 (382)
                      .++.|++.||+|||   +.+|+||||||+|||++.                   ++.+||+|||+++.....        
T Consensus       122 ~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~  198 (339)
T 1z57_A          122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTR  198 (339)
T ss_dssp             HHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCG
T ss_pred             HHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccccccccCCc
Confidence            99999999999999   679999999999999987                   668999999999865432        


Q ss_pred             -CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          245 -RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       245 -~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                       ...||...+..++.++|||||||++|||+||+.||..
T Consensus       199 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          199 HYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             GGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence             2346766677889999999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.98  E-value=2.2e-32  Score=257.14  Aligned_cols=247  Identities=17%  Similarity=0.229  Sum_probs=159.7

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeeccc--CCCceeEEEEecccCCCccccccCCCCCCccccCCc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDY--QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPR  183 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~  183 (382)
                      |+|.+       +.+.+|++.++.++||||+++++++.....  ......++||||+++ +|.+.+...      .....
T Consensus        52 avK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------~~~~~  124 (360)
T 3e3p_A           52 AIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNY------YRRQV  124 (360)
T ss_dssp             EEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHH------HTTTC
T ss_pred             EEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHH------hhccc
Confidence            77765       467888899999999999999999865322  223347899999976 444433211      12345


Q ss_pred             ccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCCCC-----------CCCccc
Q 040999          184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPPTR-----------TQTKYG  251 (382)
Q Consensus       184 ~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~-----------~~~~~~  251 (382)
                      .+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+||+|||+++......           .+||..
T Consensus       125 ~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~  203 (360)
T 3e3p_A          125 APPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELI  203 (360)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHH
Confidence            688999999999999999999943 569999999999999997 8999999999998664322           235554


Q ss_pred             cC-CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchh-hhhhccccchhhhhh
Q 040999          252 VG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDE-KLVVRGDQKQTQAKI  329 (382)
Q Consensus       252 ~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  329 (382)
                      .+ ..++.++|||||||++|||+||+.||..... ...+.......... ..+........... ...............
T Consensus       204 ~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (360)
T 3e3p_A          204 FGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRVLGCP-SREVLRKLNPSHTDVDLYNSKGIPWSNVFS  281 (360)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCC-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTT
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHHcCCC-CHHHHHhcccchhhccccccccCCcccccc
Confidence            44 3479999999999999999999999864211 11122222211111 11111110000000 000000000000000


Q ss_pred             hhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH--HHHhhh
Q 040999          330 NVIIECVISMVRIGVACSMESPQDRMKMTNVVHE--LQSIKN  369 (382)
Q Consensus       330 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~--L~~i~~  369 (382)
                      .........+.+++.+||+.||.+|||+.|+++.  ++++..
T Consensus       282 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          282 DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             hhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            0001234578889999999999999999999963  444433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=9.5e-33  Score=258.47  Aligned_cols=223  Identities=21%  Similarity=0.216  Sum_probs=153.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++.     .....++||||+++ +|.+++.         .....+++..+..++.|+
T Consensus        57 ~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~~~~qi  121 (346)
T 1ua2_A           57 RTALREIKLLQELSHPNIIGLLDAFG-----HKSNISLVFDFMET-DLEVIIK---------DNSLVLTPSHIKAYMLMT  121 (346)
T ss_dssp             THHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCEEEEECCSE-EHHHHHT---------TCCSSCCSSHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCCCeEEEEEe-----eCCceEEEEEcCCC-CHHHHHH---------hcCcCCCHHHHHHHHHHH
Confidence            36789999999999999999999964     36788999999976 7888774         233468889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....            ...||...+ ..++.++||||
T Consensus       122 ~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  198 (346)
T 1ua2_A          122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA  198 (346)
T ss_dssp             HHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred             HHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHh
Confidence            99999999   679999999999999999999999999999865322            233555544 34789999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|..||..... ...+..............+-+.....+...   ... .+..............+.+++.
T Consensus       199 lG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~li~  273 (346)
T 1ua2_A          199 VGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDMCSLPDYVT---FKS-FPGIPLHHIFSAAGDDLLDLIQ  273 (346)
T ss_dssp             HHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSSSTTSSTTCCC---CCC-CCCCCHHHHCTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCChhhhhhhccCccccc---ccc-cCCCChHHhhccCCHHHHHHHH
Confidence            99999999999999764211 111111111111100000000000000000   000 0000000001123356888889


Q ss_pred             ccCCCCccCCCCHHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~  363 (382)
                      +||+.||++|||+.|+++.
T Consensus       274 ~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          274 GLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHHCSSTTTSCCHHHHHTS
T ss_pred             HHhccChhhCCCHHHHhcC
Confidence            9999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.98  E-value=1.6e-32  Score=251.42  Aligned_cols=202  Identities=20%  Similarity=0.242  Sum_probs=149.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc--------cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD--------YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLR  189 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~  189 (382)
                      +.+.+|++++++++||||+++++++....        .......++||||+++|+|.+++..         ....+++..
T Consensus        47 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~  117 (303)
T 1zy4_A           47 STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---------ENLNQQRDE  117 (303)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---------SCGGGCHHH
T ss_pred             HHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---------cccccchHH
Confidence            67899999999999999999999875421        1235678999999999999999942         334578889


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------------------
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------------------  243 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------------------  243 (382)
                      ++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....                          
T Consensus       118 ~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (303)
T 1zy4_A          118 YWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA  194 (303)
T ss_dssp             HHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------C
T ss_pred             HHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcc
Confidence            9999999999999999   67999999999999999999999999999976532                          


Q ss_pred             CCCCCccccC-CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhcccc
Q 040999          244 TRTQTKYGVG-NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQ  322 (382)
Q Consensus       244 ~~~~~~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (382)
                      ...+||...+ ..++.++|||||||++|||++   ||...    .............      ........         
T Consensus       195 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----~~~~~~~~~~~~~------~~~~~~~~---------  252 (303)
T 1zy4_A          195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----MERVNILKKLRSV------SIEFPPDF---------  252 (303)
T ss_dssp             TTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHHHHHHHHHST------TCCCCTTC---------
T ss_pred             cccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----hhHHHHHHhcccc------ccccCccc---------
Confidence            1233555444 368899999999999999998   54321    1111111110000      00000000         


Q ss_pred             chhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          323 KQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                               .......+.+++.+||+.||.+|||+.|+++
T Consensus       253 ---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          253 ---------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ---------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                     0022345678888999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.98  E-value=1e-32  Score=279.22  Aligned_cols=194  Identities=17%  Similarity=0.200  Sum_probs=152.3

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|.+++..+ +||||++++++     +++.+..++||||+++|+|.+++.          ....+++..+..++.|
T Consensus       386 ~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~~~~~~lV~E~~~gg~L~~~l~----------~~~~~~~~~~~~~~~q  450 (674)
T 3pfq_A          386 ECTMVEKRVLALPGKPPFLTQLHSC-----FQTMDRLYFVMEYVNGGDLMYHIQ----------QVGRFKEPHAVFYAAE  450 (674)
T ss_dssp             HHHHHHHHHHTCTTCCTTBCCEEEE-----CBCSSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCeEEEEEEE-----EEeCCEEEEEEeCcCCCcHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            4578899999988 79999999998     445788999999999999999984          2346899999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC------------CCCCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP------------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~------------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...            ....+||...+..++.++||||
T Consensus       451 i~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwS  527 (674)
T 3pfq_A          451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA  527 (674)
T ss_dssp             HHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHH
T ss_pred             HHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEec
Confidence            999999999   6799999999999999999999999999998532            2234477777788999999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||++|+.||....     .........        ..... .+ .                  ....++.+++.
T Consensus       528 lGvilyelltG~~Pf~~~~-----~~~~~~~i~--------~~~~~-~p-~------------------~~s~~~~~li~  574 (674)
T 3pfq_A          528 FGVLLYEMLAGQAPFEGED-----EDELFQSIM--------EHNVA-YP-K------------------SMSKEAVAICK  574 (674)
T ss_dssp             HHHHHHHHHHSSCSSCCSS-----HHHHHHHHH--------SSCCC-CC-T------------------TSCHHHHHHHH
T ss_pred             hHHHHHHHHcCCCCCCCCC-----HHHHHHHHH--------hCCCC-CC-c------------------cCCHHHHHHHH
Confidence            9999999999999986421     111111111        10000 00 0                  12235778888


Q ss_pred             ccCCCCccCCCCH-----HHHHH
Q 040999          345 ACSMESPQDRMKM-----TNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~-----~evl~  362 (382)
                      +||+.||++||++     +||++
T Consensus       575 ~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          575 GLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHccCCHHHCCCCCCCcHHHHhc
Confidence            9999999999997     66653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.98  E-value=3e-32  Score=262.23  Aligned_cols=152  Identities=22%  Similarity=0.305  Sum_probs=128.2

Q ss_pred             chhhH-------HHHHHHHHHHhhcc------cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIR------HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY  179 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~  179 (382)
                      |+|++       +.+.+|+++++.++      |+||+++++++..     ....++||||+. ++|.+++...       
T Consensus       126 AvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-----~~~~~lv~e~~~-~~L~~~l~~~-------  192 (429)
T 3kvw_A          126 ALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-----RNHICMTFELLS-MNLYELIKKN-------  192 (429)
T ss_dssp             EEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----TTEEEEEECCCC-CBHHHHHHHT-------
T ss_pred             EEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----CCeEEEEEeccC-CCHHHHHHhc-------
Confidence            77766       56788999998884      6699999999654     678999999996 6898888532       


Q ss_pred             cCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCc--EEEccccccccCCCC---------CCCC
Q 040999          180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT--ARVGDFGLARFLPPT---------RTQT  248 (382)
Q Consensus       180 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~--~kl~Dfg~a~~~~~~---------~~~~  248 (382)
                       ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.  +||+|||+++.....         ..+|
T Consensus       193 -~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aP  268 (429)
T 3kvw_A          193 -KFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAP  268 (429)
T ss_dssp             -TTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCH
T ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecCCcccccCCCCCccCh
Confidence             2245899999999999999999999   669999999999999999887  999999999765432         2347


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          249 KYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       249 ~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      |...+..++.++|||||||++|||+||+.||..
T Consensus       269 E~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          269 EVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             HHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            777777899999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=1.7e-32  Score=257.37  Aligned_cols=227  Identities=16%  Similarity=0.157  Sum_probs=150.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+.++++++||||+++++++..... ......++||||+. ++|.+++.            ..+++..+..++.|
T Consensus        68 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------------~~~~~~~~~~i~~q  134 (353)
T 3coi_A           68 KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------------LKFSEEKIQYLVYQ  134 (353)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT------------SCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc------------CCCCHHHHHHHHHH
Confidence            678899999999999999999999753110 11124599999997 58887762            24889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccC-CCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVG-NEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~-~~~~~~~Dv~S~G  266 (382)
                      |+.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....         ...||...+ ..++.++||||||
T Consensus       135 i~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG  211 (353)
T 3coi_A          135 MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVG  211 (353)
T ss_dssp             HHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHH
T ss_pred             HHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHH
Confidence            999999999   679999999999999999999999999999765322         234665554 5788999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||...... ..+......... ...+...................................+.+++.+|
T Consensus       212 ~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  289 (353)
T 3coi_A          212 CIMAEMLTGKTLFKGKDYL-DQLTQILKVTGV-PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM  289 (353)
T ss_dssp             HHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCB-CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC-CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHH
Confidence            9999999999998642110 111111111100 00011100000000000000000000000000012345678888899


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      |+.||++|||+.|+++
T Consensus       290 L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          290 LELDVDKRLTAAQALT  305 (353)
T ss_dssp             SCSCTTTSCCHHHHHT
T ss_pred             cCCCcccCCCHHHHhc
Confidence            9999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=3.7e-32  Score=247.68  Aligned_cols=197  Identities=19%  Similarity=0.209  Sum_probs=150.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..     ....++||||+++++|.+++.          ....+++..+..++.|+
T Consensus        66 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~~i~~qi  130 (287)
T 2wei_A           66 STILREVELLKKLDHPNIMKLFEILED-----SSSFYIVGELYTGGELFDEII----------KRKRFSEHDAARIIKQV  130 (287)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCccEEEEEEeC-----CCeEEEEEEccCCCCHHHHHH----------hcCCCCHHHHHHHHHHH
Confidence            678999999999999999999999643     678899999999999988883          23458999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCC---CcEEEccccccccCCCCC-----------CCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDD---MTARVGDFGLARFLPPTR-----------TQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfg~a~~~~~~~-----------~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||   +.+++||||||+||+++.+   +.+||+|||++.......           ..||...+ .++.++|||
T Consensus       131 ~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~  206 (287)
T 2wei_A          131 FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVW  206 (287)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHH
T ss_pred             HHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhH
Confidence            99999999   6799999999999999764   469999999998654332           23554443 478999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||+++|||++|+.||.....     ......        +..........                ........+.+++
T Consensus       207 slG~~l~~l~~g~~p~~~~~~-----~~~~~~--------~~~~~~~~~~~----------------~~~~~~~~~~~li  257 (287)
T 2wei_A          207 SAGVILYILLSGTPPFYGKNE-----YDILKR--------VETGKYAFDLP----------------QWRTISDDAKDLI  257 (287)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSH-----HHHHHH--------HHHCCCCCCSG----------------GGTTSCHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------HHcCCCCCCch----------------hhhhcCHHHHHHH
Confidence            999999999999999864211     111110        00000000000                0002234678888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.||++|||+.|+++
T Consensus       258 ~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          258 RKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcccChhhCcCHHHHhc
Confidence            8999999999999999987

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=2e-32  Score=260.76  Aligned_cols=240  Identities=17%  Similarity=0.155  Sum_probs=157.0

Q ss_pred             chhhH----HHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCH
Q 040999          113 AFKIF----KSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNL  187 (382)
Q Consensus       113 avK~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~  187 (382)
                      |+|++    +...+|+++++.++||||+++++++..... .+....++||||++++.+......       ......+++
T Consensus        68 aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-------~~~~~~~~~  140 (394)
T 4e7w_A           68 AIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHY-------AKLKQTMPM  140 (394)
T ss_dssp             EEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHH-------HHTTSCCCH
T ss_pred             EEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHH-------HhhcCCCCH
Confidence            55544    234579999999999999999999865332 334457899999987533322210       012456899


Q ss_pred             HHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeC-CCCcEEEccccccccCCCC-----------CCCCccccC-C
Q 040999          188 LRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVGDFGLARFLPPT-----------RTQTKYGVG-N  254 (382)
Q Consensus       188 ~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~~-~  254 (382)
                      ..+..++.||++||+|||   +.+|+||||||+|||++ .++.+||+|||+|+.....           ..+||...+ .
T Consensus       141 ~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~  217 (394)
T 4e7w_A          141 LLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGAT  217 (394)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCC
Confidence            999999999999999999   67999999999999999 7899999999999865332           223555544 3


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhh--hcccccchhhhhhccccchhhhhhhhH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIV--DSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      .++.++|||||||++|||++|+.||..... ...+..............+.  .+........     ............
T Consensus       218 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~  291 (394)
T 4e7w_A          218 NYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFP-----QIRPHPFSKVFR  291 (394)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCC-----CCCCCCHHHHSC
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhhChhhhhhccc-----cccCCcHHHhcc
Confidence            589999999999999999999999864211 11122222221111111110  0000000000     000000000000


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHHH--HHHhh
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVHE--LQSIK  368 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~--L~~i~  368 (382)
                      .....++.+++.+||+.||++|||+.|+++.  +++++
T Consensus       292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          292 PRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             ccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            0133467888999999999999999999863  44443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=5.6e-32  Score=250.82  Aligned_cols=226  Identities=18%  Similarity=0.239  Sum_probs=155.0

Q ss_pred             HHHHHHHHHhhc---ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNI---RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+|+++++.+   +||||+++++++...........++||||+. |+|.+++...        ....+++..+..++.
T Consensus        57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~~~~  127 (326)
T 1blx_A           57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMF  127 (326)
T ss_dssp             THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS--------CTTCSCHHHHHHHHH
T ss_pred             hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc--------ccCCCCHHHHHHHHH
Confidence            567788877776   7999999999986433334677899999997 6999988532        223589999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....           ....||...+..++.++||||
T Consensus       128 qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  204 (326)
T 1blx_A          128 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS  204 (326)
T ss_dssp             HHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHH
T ss_pred             HHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHH
Confidence            9999999999   67999999999999999999999999999976532           233477667778899999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||...... ..+.............++-.......  .........   ............+.+++.
T Consensus       205 lG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~li~  278 (326)
T 1blx_A          205 VGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEEDWPRDVALPR--QAFHSKSAQ---PIEKFVTDIDELGKDLLL  278 (326)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGGGSCTTCSSCG--GGSCCCCCC---CGGGTCCSCCHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCcccCccccccch--hhhcccCcc---hhhhccccCCHHHHHHHH
Confidence            999999999999998642111 11111111111100000000000000  000000000   000000123346778888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||++|||+.|+++
T Consensus       279 ~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          279 KCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCCcccCCCHHHHhc
Confidence            999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=2.4e-32  Score=263.34  Aligned_cols=210  Identities=17%  Similarity=0.198  Sum_probs=148.1

Q ss_pred             chhhH-----HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF-----KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|.+     +.+.+|+++++++ +|||||++++++.     +....++|||||. |+|.+++.......   ......+
T Consensus        43 AvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~~~~lv~E~~~-gsL~~~l~~~~~~~---~~~~~~~  113 (434)
T 2rio_A           43 AVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSET-----TDRFLYIALELCN-LNLQDLVESKNVSD---ENLKLQK  113 (434)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEEEEECCCS-EEHHHHHHTC--------------
T ss_pred             EEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCeEEEEEecCC-CCHHHHHhccCCCc---hhhhhcc
Confidence            77764     5688999999987 8999999999854     4678999999995 69999995432110   0001123


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC-------------CcEEEccccccccCCCC---------
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-------------MTARVGDFGLARFLPPT---------  244 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~-------------~~~kl~Dfg~a~~~~~~---------  244 (382)
                      +..++.++.||+.||+|||   +.+|+||||||+|||++.+             +.+||+|||+++.....         
T Consensus       114 ~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~  190 (434)
T 2rio_A          114 EYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN  190 (434)
T ss_dssp             -CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC----------
T ss_pred             chhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeec
Confidence            4456789999999999999   6799999999999999654             48999999999865432         


Q ss_pred             -------CCCCccccC-------CCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhccc
Q 040999          245 -------RTQTKYGVG-------NEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSIL  309 (382)
Q Consensus       245 -------~~~~~~~~~-------~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (382)
                             ..+||...+       ..++.++|||||||++|||+| |+.||......   ............  .     .
T Consensus       191 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~i~~~~~~~~--~-----~  260 (434)
T 2rio_A          191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR---ESNIIRGIFSLD--E-----M  260 (434)
T ss_dssp             ----CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH---HHHHHHTCCCCC--C-----C
T ss_pred             CCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh---HHHHhcCCCCcc--c-----c
Confidence                   233555433       568999999999999999999 99998642211   111111111000  0     0


Q ss_pred             ccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          310 LNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      . ..                 .......++.+++.+||+.||++|||+.||++
T Consensus       261 ~-~~-----------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          261 K-CL-----------------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             T-TC-----------------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c-cc-----------------ccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            0 00                 00134557888999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=2e-32  Score=252.54  Aligned_cols=197  Identities=20%  Similarity=0.331  Sum_probs=146.7

Q ss_pred             HHHHHHHHHHHhhccc--ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRH--RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      .+.+.+|++++++++|  +||+++++++..     ....++||| +.+++|.+++.          ....+++..+..++
T Consensus        70 ~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~~~~~lv~e-~~~~~L~~~l~----------~~~~~~~~~~~~i~  133 (313)
T 3cek_A           70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQYIYMVME-CGNIDLNSWLK----------KKKSIDPWERKSYW  133 (313)
T ss_dssp             HHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-----SSEEEEEEC-CCSEEHHHHHH----------HCSSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHhccccCCceEEEEEEeec-----CCEEEEEEe-cCCCcHHHHHH----------hcCCCCHHHHHHHH
Confidence            3678999999999974  999999999654     678999999 66889999984          23468899999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccC-------
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVG-------  253 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~-------  253 (382)
                      .|+++||.|||   +.+|+||||||+||++++ +.+||+|||+++.....              ...||...+       
T Consensus       134 ~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  209 (313)
T 3cek_A          134 KNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN  209 (313)
T ss_dssp             HHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC-----
T ss_pred             HHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccccccc
Confidence            99999999999   679999999999999964 89999999999865322              223554433       


Q ss_pred             ----CCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhh
Q 040999          254 ----NEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKI  329 (382)
Q Consensus       254 ----~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (382)
                          ..++.++||||||+++|||++|+.||......   .....         ..++.........              
T Consensus       210 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~---------~~~~~~~~~~~~~--------------  263 (313)
T 3cek_A          210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLH---------AIIDPNHEIEFPD--------------  263 (313)
T ss_dssp             -----CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHH---------HHHCTTSCCCCCC--------------
T ss_pred             ccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---HHHHH---------HHHhcccccCCcc--------------
Confidence                46788999999999999999999998643211   11111         1111100000000              


Q ss_pred             hhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          330 NVIIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       330 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                          .....+.+++.+||+.||++|||+.|+++.
T Consensus       264 ----~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          264 ----IPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                112357788889999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=1.7e-31  Score=245.19  Aligned_cols=198  Identities=19%  Similarity=0.239  Sum_probs=147.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++||||+++++++..   ......++||||++++ |.+++..        .....+++..+..++.|+
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~~-l~~~~~~--------~~~~~~~~~~~~~~~~qi  118 (305)
T 2wtk_C           51 ANVKKEIQLLRRLRHKNVIQLVDVLYN---EEKQKMYMVMEYCVCG-MQEMLDS--------VPEKRFPVCQAHGYFCQL  118 (305)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEC---C---CEEEEEECCSEE-HHHHHHH--------STTCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEEEEc---CCCCeEEEEehhccCC-HHHHHHh--------CcccccCHHHHHHHHHHH
Confidence            568999999999999999999999743   3356789999999876 6666632        123568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCC--CCCccch
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGN--EVSTIGD  261 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~--~~~~~~D  261 (382)
                      ++||.|||   +.+|+||||||+||+++.++.+||+|||++......              ...||...+.  ..+.++|
T Consensus       119 ~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D  195 (305)
T 2wtk_C          119 IDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVD  195 (305)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHH
T ss_pred             HHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhh
Confidence            99999999   679999999999999999999999999999865421              1224444332  3377999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||+++|||++|+.||...     .........        ...... .+                   ..+...+.+
T Consensus       196 i~slG~il~~l~~g~~p~~~~-----~~~~~~~~i--------~~~~~~-~~-------------------~~~~~~l~~  242 (305)
T 2wtk_C          196 IWSAGVTLYNITTGLYPFEGD-----NIYKLFENI--------GKGSYA-IP-------------------GDCGPPLSD  242 (305)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHH--------HHCCCC-CC-------------------SSSCHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCc-----hHHHHHHHH--------hcCCCC-CC-------------------CccCHHHHH
Confidence            999999999999999998642     111111100        000000 00                   012335678


Q ss_pred             HhhccCCCCccCCCCHHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ++.+||+.||++|||+.|+++.
T Consensus       243 li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          243 LLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHHHccCChhhCCCHHHHhcC
Confidence            8889999999999999999964

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=2.2e-31  Score=249.44  Aligned_cols=147  Identities=21%  Similarity=0.280  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHhhccccc------ceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHH
Q 040999          118 KSFIAECKALRNIRHRN------LIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRL  191 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~  191 (382)
                      +.+.+|++++++++|++      ++.+++++..     .+..++||||+ ++++.+++..        .....+++..+.
T Consensus        61 ~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~lv~e~~-~~~l~~~l~~--------~~~~~~~~~~~~  126 (355)
T 2eu9_A           61 EAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-----HGHMCIAFELL-GKNTFEFLKE--------NNFQPYPLPHVR  126 (355)
T ss_dssp             HHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHH--------TTTCCCCHHHHH
T ss_pred             hHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-----CCeEEEEEecc-CCChHHHHHh--------ccCCCCCHHHHH
Confidence            57889999999999887      8888887543     67899999999 6677776632        122468999999


Q ss_pred             HHHHHHHHHHhHHhhcCCCceeecCCCCCceee-------------------CCCCcEEEccccccccCCCC--------
Q 040999          192 NIAIDVASALNYLHHDCQPVTAHCDLKPSNVLL-------------------DDDMTARVGDFGLARFLPPT--------  244 (382)
Q Consensus       192 ~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl-------------------~~~~~~kl~Dfg~a~~~~~~--------  244 (382)
                      .++.||+.||+|||   +.+|+||||||+|||+                   +.++.+||+|||+++.....        
T Consensus       127 ~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~  203 (355)
T 2eu9_A          127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATR  203 (355)
T ss_dssp             HHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCG
T ss_pred             HHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccccCCcCCC
Confidence            99999999999999   7899999999999999                   56789999999999865432        


Q ss_pred             -CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          245 -RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       245 -~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                       ...||...+..++.++|||||||++|||+||+.||..
T Consensus       204 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          204 HYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence             2346776777889999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=5.5e-32  Score=252.30  Aligned_cols=213  Identities=15%  Similarity=0.179  Sum_probs=143.7

Q ss_pred             chhhH---HHHHHHHH-HHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHH
Q 040999          113 AFKIF---KSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLL  188 (382)
Q Consensus       113 avK~~---~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~  188 (382)
                      |+|++   ....+|+. .++.++||||+++++++... ..+....++||||+++|+|.+++...        ....+++.
T Consensus        58 avK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~~lv~e~~~gg~L~~~l~~~--------~~~~l~~~  128 (336)
T 3fhr_A           58 ALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENM-HHGKRCLLIIMECMEGGELFSRIQER--------GDQAFTER  128 (336)
T ss_dssp             EEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEEEEEEECCTTEEHHHHHHTC---------CCCCBHH
T ss_pred             EEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCceEEEEEeccCCCCHHHHHHhc--------CCCCCCHH
Confidence            78876   33444444 45667899999999997542 12345689999999999999999532        23468999


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC---CCcEEEccccccccCCCC----------CCCCccccCCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD---DMTARVGDFGLARFLPPT----------RTQTKYGVGNE  255 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~  255 (382)
                      .+..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.....          ...||...+..
T Consensus       129 ~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  205 (336)
T 3fhr_A          129 EAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEK  205 (336)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------CH
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCC
Confidence            99999999999999999   679999999999999976   455999999999765332          33477777778


Q ss_pred             CCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          256 VSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      ++.++|||||||++|||++|+.||..........          .....+.......+..               .....
T Consensus       206 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~---------------~~~~~  260 (336)
T 3fhr_A          206 YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----------GMKRRIRLGQYGFPNP---------------EWSEV  260 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSSCCC-------------------------------CCCTT---------------TSTTC
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------hHHHhhhccccccCch---------------hhccC
Confidence            8999999999999999999999986432111000          0000000000000000               00022


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ...+.+++.+||+.||++|||+.|+++
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          261 SEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            346778888999999999999999997

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=7.1e-32  Score=259.63  Aligned_cols=202  Identities=19%  Similarity=0.212  Sum_probs=145.4

Q ss_pred             chhhH-----HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF-----KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|++     +.+.+|+++|+++ +|||||++++++..     ....++|||||. |+|.+++...         .....
T Consensus        52 AvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~~~lv~E~~~-g~L~~~l~~~---------~~~~~  116 (432)
T 3p23_A           52 AVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD-----RQFQYIAIELCA-ATLQEYVEQK---------DFAHL  116 (432)
T ss_dssp             EEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTEEEEEEECCS-EEHHHHHHSS---------SCCCC
T ss_pred             EEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCEEEEEEECCC-CCHHHHHHhc---------CCCcc
Confidence            78876     3467899999999 79999999998643     678899999996 6999988532         22344


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC-----CCcEEEccccccccCCC---------------CCC
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD-----DMTARVGDFGLARFLPP---------------TRT  246 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-----~~~~kl~Dfg~a~~~~~---------------~~~  246 (382)
                      +..+..++.||++||.|||   +.+|+||||||+|||++.     ...+||+|||+++....               ...
T Consensus       117 ~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~  193 (432)
T 3p23_A          117 GLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI  193 (432)
T ss_dssp             SSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSC
T ss_pred             chhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCcc
Confidence            4556789999999999999   679999999999999943     34688999999976532               223


Q ss_pred             CCcccc---CCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhcccc
Q 040999          247 QTKYGV---GNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQ  322 (382)
Q Consensus       247 ~~~~~~---~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (382)
                      +||...   ...++.++|||||||++|||+| |..||.....   .....   ...........      ..        
T Consensus       194 APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~~~~---~~~~~~~~~~~------~~--------  253 (432)
T 3p23_A          194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQANI---LLGACSLDCLH------PE--------  253 (432)
T ss_dssp             CGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HHHHH---HTTCCCCTTSC------TT--------
T ss_pred             ChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HHHHH---HhccCCccccC------cc--------
Confidence            477665   4566789999999999999999 8999753211   00000   00000000000      00        


Q ss_pred             chhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          323 KQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                                ......+.+++.+||+.||++|||+.||++
T Consensus       254 ----------~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          254 ----------KHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ----------CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----------ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                      022345678888999999999999999983

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=7.3e-32  Score=254.71  Aligned_cols=231  Identities=14%  Similarity=0.167  Sum_probs=153.8

Q ss_pred             HHHHHHHHHHhhcc-----------cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          118 KSFIAECKALRNIR-----------HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      +.+.+|++++++++           |+||+++++++.... ......++||||+ +++|.+++...        ....++
T Consensus        60 ~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~lv~e~~-~~~L~~~~~~~--------~~~~~~  129 (373)
T 1q8y_A           60 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG-PNGVHVVMVFEVL-GENLLALIKKY--------EHRGIP  129 (373)
T ss_dssp             HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE-TTEEEEEEEECCC-CEEHHHHHHHT--------TTSCCC
T ss_pred             hhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC-CCCceEEEEEecC-CCCHHHHHHHh--------hccCCc
Confidence            56889999999887           899999999976421 1234789999999 88999988532        234589


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCC-ceeecCCCCCceeeC------CCCcEEEccccccccCCCC---------CCCCcc
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQP-VTAHCDLKPSNVLLD------DDMTARVGDFGLARFLPPT---------RTQTKY  250 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~-~ivH~dlkp~NILl~------~~~~~kl~Dfg~a~~~~~~---------~~~~~~  250 (382)
                      +..+..++.||+.||+|||   +. +|+||||||+|||++      ..+.+||+|||+++.....         ..+||.
T Consensus       130 ~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~  206 (373)
T 1q8y_A          130 LIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEV  206 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHH
Confidence            9999999999999999999   65 999999999999994      4458999999999865432         234676


Q ss_pred             ccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCC-----chHHHHHHHhcCCchhhhhhc------ccccchhhhhhc
Q 040999          251 GVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD-----MNLHKFAKMALPNHVKDIVDS------ILLNDDEKLVVR  319 (382)
Q Consensus       251 ~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~  319 (382)
                      ..+..++.++|||||||++|||+||+.||.......     ..+........... ..+...      ............
T Consensus       207 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~  285 (373)
T 1q8y_A          207 LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP-SYLLRNGKYTRTFFNSRGLLRNIS  285 (373)
T ss_dssp             HHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCC-HHHHHHCTTHHHHBCC--CBSSCC
T ss_pred             HhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCC-HHHHhccchhhhhcCCcchhcccc
Confidence            677788999999999999999999999987432111     01111111111000 000000      000000000000


Q ss_pred             cccch-----hhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          320 GDQKQ-----TQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       320 ~~~~~-----~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .....     ..............+.+++.+||+.||++|||+.|+++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          286 KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             CCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             cccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            00000     00000111356678899999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=4.3e-31  Score=250.53  Aligned_cols=154  Identities=23%  Similarity=0.294  Sum_probs=127.2

Q ss_pred             chhhH-------HHHHHHHHHHhhcc-cc-----cceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIR-HR-----NLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETY  179 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~  179 (382)
                      |+|++       +++.+|+++++.++ |+     +|+++++++..     .+..++||||++ |+|.+++...       
T Consensus        83 aiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-----~~~~~lv~e~~~-~~L~~~l~~~-------  149 (382)
T 2vx3_A           83 AIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-----RNHLCLVFEMLS-YNLYDLLRNT-------  149 (382)
T ss_dssp             EEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----TTEEEEEEECCC-CBHHHHHHHT-------
T ss_pred             EEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----CCceEEEEecCC-CCHHHHHhhc-------
Confidence            77765       56778999998885 44     49999998654     678999999996 5999988532       


Q ss_pred             cCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeC--CCCcEEEccccccccCCCC---------CCCC
Q 040999          180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD--DDMTARVGDFGLARFLPPT---------RTQT  248 (382)
Q Consensus       180 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~--~~~~~kl~Dfg~a~~~~~~---------~~~~  248 (382)
                       ....+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.+||+|||+++.....         ..+|
T Consensus       150 -~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aP  227 (382)
T 2vx3_A          150 -NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSP  227 (382)
T ss_dssp             -TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCH
T ss_pred             -CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccccccccCCccccCh
Confidence             224589999999999999999999953 46899999999999994  5788999999999866432         2347


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          249 KYGVGNEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       249 ~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      |...+..++.++|||||||++|||+||+.||..
T Consensus       228 E~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            777777899999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=1.8e-32  Score=254.46  Aligned_cols=204  Identities=20%  Similarity=0.201  Sum_probs=139.8

Q ss_pred             HHHHHHHH-HHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECK-ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +++.+|+. +++.++||||+++++++..     .+..++||||+++ +|.+++....     ......+++..+..++.|
T Consensus        65 ~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~  133 (327)
T 3aln_A           65 KQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGDCWICMELMST-SFDKFYKYVY-----SVLDDVIPEEILGKITLA  133 (327)
T ss_dssp             HHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSEEEEEECCCSE-EHHHHHHHHH-----HTTCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCceEEEEeecCC-ChHHHHHHHH-----hhhcccCcHHHHHHHHHH
Confidence            45666666 6777899999999999653     6788999999975 7777663210     012456899999999999


Q ss_pred             HHHHHhHHhhcCCC-ceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------CCCCccc----cCCCCCccc
Q 040999          197 VASALNYLHHDCQP-VTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------RTQTKYG----VGNEVSTIG  260 (382)
Q Consensus       197 i~~~L~~lH~~~~~-~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~----~~~~~~~~~  260 (382)
                      ++.||.|||   .. +|+||||||+||+++.++.+||+|||+++.....           ...||..    .+..++.++
T Consensus       134 i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  210 (327)
T 3aln_A          134 TVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRS  210 (327)
T ss_dssp             HHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHH
T ss_pred             HHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchh
Confidence            999999999   55 8999999999999999999999999999765322           2346665    455688999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||||++|||++|+.||.......    ...........     +.+.....                  ......+.
T Consensus       211 Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~-----~~~~~~~~------------------~~~~~~l~  263 (327)
T 3aln_A          211 DVWSLGITLYELATGRFPYPKWNSVF----DQLTQVVKGDP-----PQLSNSEE------------------REFSPSFI  263 (327)
T ss_dssp             HHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCC-----CCCCCCSS------------------CCCCHHHH
T ss_pred             hHHHHHHHHHHHHHCCCCCCCcchHH----HHHHHHhcCCC-----CCCCCccc------------------ccCCHHHH
Confidence            99999999999999999986421100    00000000000     00000000                  01234678


Q ss_pred             HHhhccCCCCccCCCCHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +++.+||+.||++|||+.|+++
T Consensus       264 ~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          264 NFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhhCChhhCcCHHHHHh
Confidence            8888999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=248.02  Aligned_cols=197  Identities=19%  Similarity=0.219  Sum_probs=138.2

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      .+.++..+++.++||||+++++++..     .+..++||||+ ++.+..+..         .....+++..+..++.|++
T Consensus        70 ~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~-~~~~~~l~~---------~~~~~~~~~~~~~~~~~i~  134 (318)
T 2dyl_A           70 ILMDLDVVLKSHDCPYIVQCFGTFIT-----NTDVFIAMELM-GTCAEKLKK---------RMQGPIPERILGKMTVAIV  134 (318)
T ss_dssp             HHHHHHHHHHTTTCTTBCCEEEEEEC-----SSEEEEEECCC-SEEHHHHHH---------HHTSCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCceeeEEEEEec-----CCcEEEEEecc-CCcHHHHHH---------HhccCCCHHHHHHHHHHHH
Confidence            34455567888899999999999653     67899999999 444444331         1234689999999999999


Q ss_pred             HHHhHHhhcCCC-ceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccc-----cCCCCCccch
Q 040999          199 SALNYLHHDCQP-VTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYG-----VGNEVSTIGD  261 (382)
Q Consensus       199 ~~L~~lH~~~~~-~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~-----~~~~~~~~~D  261 (382)
                      +||.|||   .. +|+||||||+||+++.++.+||+|||+++....           ....||..     ....++.++|
T Consensus       135 ~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D  211 (318)
T 2dyl_A          135 KALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRAD  211 (318)
T ss_dssp             HHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHH
T ss_pred             HHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccc
Confidence            9999999   53 899999999999999999999999999975432           22345655     3456788999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      ||||||++|||++|+.||.........+...... .+.        .....                    ......+.+
T Consensus       212 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~--------~~~~~--------------------~~~~~~l~~  262 (318)
T 2dyl_A          212 VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPP--------LLPGH--------------------MGFSGDFQS  262 (318)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCC--------CCCSS--------------------SCCCHHHHH
T ss_pred             hhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCC--------CCCcc--------------------CCCCHHHHH
Confidence            9999999999999999986421111111111100 000        00000                    012235778


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||.+|||+.|+++
T Consensus       263 li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          263 FVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhh
Confidence            888999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=5.3e-31  Score=267.80  Aligned_cols=196  Identities=18%  Similarity=0.286  Sum_probs=149.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|||||++++++......+....++||||+++++|.+++.            ..+++..++.++.||
T Consensus       124 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~------------~~l~~~~~~~~~~qi  191 (681)
T 2pzi_A          124 AMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------------QKLPVAEAIAYLLEI  191 (681)
T ss_dssp             HHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----------------CCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh------------CCCCHHHHHHHHHHH
Confidence            57889999999999999999999987633322333799999999999988772            258999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------CCCCCccccCCCCCccchhHHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------TRTQTKYGVGNEVSTIGDVYSYGILL  269 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------~~~~~~~~~~~~~~~~~Dv~S~Gvil  269 (382)
                      +.||.|||   +.+|+||||||+|||++.+ .+||+|||+++....        ....||...+. .+.++|||||||++
T Consensus       192 ~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l  266 (681)
T 2pzi_A          192 LPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTL  266 (681)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHH
T ss_pred             HHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcccCCccCCCccccCHHHHcCC-CCCceehhhhHHHH
Confidence            99999999   6799999999999999886 899999999986543        23346655443 38899999999999


Q ss_pred             HHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCC
Q 040999          270 LELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSME  349 (382)
Q Consensus       270 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~  349 (382)
                      |||++|..||........          +.           ..+                  .......+.+++.+||+.
T Consensus       267 ~~l~~g~~~~~~~~~~~~----------~~-----------~~~------------------~~~~~~~l~~li~~~l~~  307 (681)
T 2pzi_A          267 AALTLDLPTRNGRYVDGL----------PE-----------DDP------------------VLKTYDSYGRLLRRAIDP  307 (681)
T ss_dssp             HHHHSCCCEETTEECSSC----------CT-----------TCH------------------HHHHCHHHHHHHHHHTCS
T ss_pred             HHHHhCCCCCcccccccc----------cc-----------ccc------------------ccccCHHHHHHHhhhccC
Confidence            999999888653221110          00           000                  002234677888899999


Q ss_pred             CccCCCC-HHHHHHHHHHhhh
Q 040999          350 SPQDRMK-MTNVVHELQSIKN  369 (382)
Q Consensus       350 ~p~~RPs-~~evl~~L~~i~~  369 (382)
                      ||++||+ ++++.+.|..+..
T Consensus       308 dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          308 DPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             SGGGSCSSHHHHHHHHHHHHH
T ss_pred             ChhhCCCHHHHHHHHHHHHHH
Confidence            9999995 6777777776643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=2.2e-31  Score=246.49  Aligned_cols=188  Identities=18%  Similarity=0.187  Sum_probs=147.2

Q ss_pred             HHHHHHHHHHhhcc--cccceeeeeeeeecccCCCceeEEEEecccC-CCccccccCCCCCCccccCCcccCHHHHHHHH
Q 040999          118 KSFIAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKALVYEFIHN-RSPEKWLYPISKEDETYERPRNLNLLRRLNIA  194 (382)
Q Consensus       118 ~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  194 (382)
                      +.+.+|++++++++  |+||+++++++..     .+..++|+|++.+ ++|.+++.          ....+++..+..++
T Consensus        91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~~L~~~l~----------~~~~l~~~~~~~i~  155 (320)
T 3a99_A           91 TRVPMEVVLLKKVSSGFSGVIRLLDWFER-----PDSFVLILERPEPVQDLFDFIT----------ERGALQEELARSFF  155 (320)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEEC-----SSEEEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHhhccCCCCceEEEEEEec-----CCcEEEEEEcCCCCccHHHHHh----------ccCCCCHHHHHHHH
Confidence            34678999999996  5999999999653     6788999999976 89999883          23468999999999


Q ss_pred             HHHHHHHhHHhhcCCCceeecCCCCCceeeC-CCCcEEEccccccccCCCC----------CCCCccccCCCC-Cccchh
Q 040999          195 IDVASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVGDFGLARFLPPT----------RTQTKYGVGNEV-STIGDV  262 (382)
Q Consensus       195 ~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~~-~~~~Dv  262 (382)
                      .|+++||+|||   +.+|+||||||+|||++ .++.+||+|||+++.....          ...||...+..+ +.++||
T Consensus       156 ~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  232 (320)
T 3a99_A          156 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV  232 (320)
T ss_dssp             HHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHH
T ss_pred             HHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchH
Confidence            99999999999   67999999999999999 7889999999999866433          223554444444 688999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||+||+.||....       ...            ........                    ....++.++
T Consensus       233 ~slG~il~el~~g~~pf~~~~-------~~~------------~~~~~~~~--------------------~~~~~~~~l  273 (320)
T 3a99_A          233 WSLGILLYDMVCGDIPFEHDE-------EII------------RGQVFFRQ--------------------RVSSECQHL  273 (320)
T ss_dssp             HHHHHHHHHHHHSSCSCCSHH-------HHH------------HCCCCCSS--------------------CCCHHHHHH
T ss_pred             HhHHHHHHHHHHCCCCCCChh-------hhh------------cccccccc--------------------cCCHHHHHH
Confidence            999999999999999986320       000            00000000                    122357788


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||+.|+++
T Consensus       274 i~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          274 IRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHccCChhhCcCHHHHhc
Confidence            88999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=246.40  Aligned_cols=187  Identities=18%  Similarity=0.211  Sum_probs=143.7

Q ss_pred             HHHHHHHHHhhc----ccccceeeeeeeeecccCCCceeEEEEec-ccCCCccccccCCCCCCccccCCcccCHHHHHHH
Q 040999          119 SFIAECKALRNI----RHRNLIKVLTACLGVDYQGNDFKALVYEF-IHNRSPEKWLYPISKEDETYERPRNLNLLRRLNI  193 (382)
Q Consensus       119 ~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i  193 (382)
                      .+.+|++++.++    +|+||+++++++.     ..+..++|+|| +.+++|.+++.          ....+++..++.+
T Consensus        80 ~~~~e~~~l~~l~~~~~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~~L~~~l~----------~~~~~~~~~~~~~  144 (312)
T 2iwi_A           80 TCPLEVALLWKVGAGGGHPGVIRLLDWFE-----TQEGFMLVLERPLPAQDLFDYIT----------EKGPLGEGPSRCF  144 (312)
T ss_dssp             CCCHHHHHHHHHHSSCCCSSBCCEEEEC----------CEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHH
T ss_pred             HHHHHHHHHHhhcccCCCCCeeeEEEEEe-----cCCeEEEEEEecCCCCCHHHHHH----------hcCCCCHHHHHHH
Confidence            356799999999    8999999999954     36778999999 78999999984          2345899999999


Q ss_pred             HHHHHHHHhHHhhcCCCceeecCCCCCceeeC-CCCcEEEccccccccCCCC----------CCCCccccCCCC-Cccch
Q 040999          194 AIDVASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVGDFGLARFLPPT----------RTQTKYGVGNEV-STIGD  261 (382)
Q Consensus       194 ~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~~-~~~~D  261 (382)
                      +.|+++||.|||   +.+|+||||||+||+++ .++.+||+|||+++.....          ...||...+..+ +.++|
T Consensus       145 ~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  221 (312)
T 2iwi_A          145 FGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPAT  221 (312)
T ss_dssp             HHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHH
T ss_pred             HHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccch
Confidence            999999999999   66999999999999999 8899999999999866432          223454444444 45899


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||+++|||++|+.||...       ....            ........                    .....+.+
T Consensus       222 i~slG~il~~l~~g~~pf~~~-------~~~~------------~~~~~~~~--------------------~~~~~~~~  262 (312)
T 2iwi_A          222 VWSLGILLYDMVCGDIPFERD-------QEIL------------EAELHFPA--------------------HVSPDCCA  262 (312)
T ss_dssp             HHHHHHHHHHHHHSSCSCCSH-------HHHH------------HTCCCCCT--------------------TSCHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCh-------HHHh------------hhccCCcc--------------------cCCHHHHH
Confidence            999999999999999998632       0110            10000000                    12235678


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ++.+||+.||++|||+.|+++
T Consensus       263 li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          263 LIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            888999999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=4.7e-31  Score=262.89  Aligned_cols=233  Identities=18%  Similarity=0.175  Sum_probs=158.7

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+.+|++++++++||||+++++++.... ....+..++||||+++|+|.+++....       ....+++..+..++.
T Consensus        56 ~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-------~~~~lse~~i~~I~~  128 (676)
T 3qa8_A           56 RERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-------NCCGLKEGPIRTLLS  128 (676)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-------CTTCCCSSHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-------cCCCCCHHHHHHHHH
Confidence            367899999999999999999999864321 123667899999999999999995422       223588899999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCc---EEEccccccccCCCC-----------CCCCccccCCCCCccch
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMT---ARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~---~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~D  261 (382)
                      |++.||+|||   +.+|+||||||+||+++.++.   +||+|||.++.....           ...||...+..++.++|
T Consensus       129 QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksD  205 (676)
T 3qa8_A          129 DISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVD  205 (676)
T ss_dssp             HHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHH
T ss_pred             HHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhH
Confidence            9999999999   679999999999999987664   999999999865432           34578877888999999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhh-hhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKD-IVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||+||+.||...    .....|........... ............   ......+..   ........+.
T Consensus       206 IwSLGviLyeLltG~~Pf~~~----~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~---~~~lp~p~~---l~~~ls~~L~  275 (676)
T 3qa8_A          206 YWSFGTLAFECITGFRPFLPN----WQPVQWHGKVREKSNEHIVVYDDLTGAVKF---SSVLPTPNH---LSGILAGKLE  275 (676)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSS----CHHHHSSTTCC------CCSCCCCSSSCCC---CSSSCCSCC---CCGGGHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCcc----cchhhhhhhhhcccchhhhhhhhhcccccc---ccccCCchh---hchhhhHHHH
Confidence            999999999999999998642    11111111110000000 000000000000   000000000   0112445778


Q ss_pred             HHhhccCCCCccCCCCHHH-----HHHHHHHhhh
Q 040999          341 RIGVACSMESPQDRMKMTN-----VVHELQSIKN  369 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~e-----vl~~L~~i~~  369 (382)
                      +++.+||+.||++|||+.|     ..+.++.+.+
T Consensus       276 dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          276 RWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             HHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             HHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            8888999999999999988     4466665544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=1.2e-29  Score=242.89  Aligned_cols=200  Identities=13%  Similarity=0.050  Sum_probs=136.8

Q ss_pred             HHHHHHHHHHhhccc-ccceeee---------eeee------------ecccCCCceeEEEEecccCCCccccccCCCCC
Q 040999          118 KSFIAECKALRNIRH-RNLIKVL---------TACL------------GVDYQGNDFKALVYEFIHNRSPEKWLYPISKE  175 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h-~niv~~~---------~~~~------------~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~  175 (382)
                      +.|.+|+.+++.++| +|...+.         ..+.            ..........+++|+++ +++|.+++......
T Consensus       123 ~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~  201 (413)
T 3dzo_A          123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH  201 (413)
T ss_dssp             HHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc
Confidence            678999999999976 2221111         1110            00000022356667655 67898887311000


Q ss_pred             CccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC--------CCCCC
Q 040999          176 DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP--------PTRTQ  247 (382)
Q Consensus       176 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~--------~~~~~  247 (382)
                         ......+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...        .....
T Consensus       202 ---~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~a  275 (413)
T 3dzo_A          202 ---SSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAP  275 (413)
T ss_dssp             ---TTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCC
T ss_pred             ---cccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcccceEEEecCCeEEEEeccceeecCCccccCCCCceeC
Confidence               012456889999999999999999999   7799999999999999999999999999987543        33445


Q ss_pred             Cccc----------cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhh
Q 040999          248 TKYG----------VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLV  317 (382)
Q Consensus       248 ~~~~----------~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (382)
                      ||..          .+..++.++|||||||++|||+||+.||.......                 ..+..+....    
T Consensus       276 PE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~-----------------~~~~~~~~~~----  334 (413)
T 3dzo_A          276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG-----------------GSEWIFRSCK----  334 (413)
T ss_dssp             HHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS-----------------CSGGGGSSCC----
T ss_pred             chhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh-----------------hHHHHHhhcc----
Confidence            6766          45567889999999999999999999986421110                 0111110000    


Q ss_pred             hccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHH
Q 040999          318 VRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVV  361 (382)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl  361 (382)
                                      ..+..+.+++.+||+.||++|||+.|++
T Consensus       335 ----------------~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          335 ----------------NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             ----------------CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             ----------------cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence                            1123578888899999999999977764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.94  E-value=6.3e-28  Score=224.72  Aligned_cols=149  Identities=16%  Similarity=0.121  Sum_probs=119.1

Q ss_pred             HHHHHHHHHHhhcc---------cccceeeeeeeeec-------------------------ccCCCceeEEEEecccCC
Q 040999          118 KSFIAECKALRNIR---------HRNLIKVLTACLGV-------------------------DYQGNDFKALVYEFIHNR  163 (382)
Q Consensus       118 ~~~~~E~~~l~~l~---------h~niv~~~~~~~~~-------------------------~~~~~~~~~lv~e~~~~g  163 (382)
                      +.+.+|+++++.++         |||||++.+++...                         ++.+....++||||+++|
T Consensus        68 ~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g  147 (336)
T 2vuw_A           68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG  147 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCC
T ss_pred             HHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCC
Confidence            67899999999986         77777766654311                         011367899999999999


Q ss_pred             CccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC---------------
Q 040999          164 SPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM---------------  228 (382)
Q Consensus       164 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~---------------  228 (382)
                      ++.+.+.           ...+++..+..++.||+.||+|||+  +.+|+||||||+|||++.++               
T Consensus       148 ~ll~~~~-----------~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~  214 (336)
T 2vuw_A          148 IDLEQMR-----------TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI  214 (336)
T ss_dssp             EETGGGT-----------TTCCCHHHHHHHHHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEE
T ss_pred             ccHHHHH-----------hcCCCHHHHHHHHHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccc
Confidence            8776662           1357899999999999999999993  24899999999999999887               


Q ss_pred             -----cEEEccccccccCC-------CCCCCCccccCCCCCccchhHHHHHH-HHHHHhcCCCCC
Q 040999          229 -----TARVGDFGLARFLP-------PTRTQTKYGVGNEVSTIGDVYSYGIL-LLELMIREKPSD  280 (382)
Q Consensus       229 -----~~kl~Dfg~a~~~~-------~~~~~~~~~~~~~~~~~~Dv~S~Gvi-l~elltg~~p~~  280 (382)
                           .+||+|||+|+...       ....+||...+.. +.++||||+|++ .+++++|..||.
T Consensus       215 ~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          215 PSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             ECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             cCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence                 89999999998653       3455688777665 899999998777 778888998864

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=7.9e-27  Score=231.37  Aligned_cols=136  Identities=21%  Similarity=0.111  Sum_probs=98.1

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ++|.+|+++|+++ .|+||+++++++     +++...||||||++|++|.+++.          ...+++..   +|+.|
T Consensus       286 ~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~~~yLVMEyv~G~~L~d~i~----------~~~~l~~~---~I~~Q  347 (569)
T 4azs_A          286 YELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQSGWLVMEKLPGRLLSDMLA----------AGEEIDRE---KILGS  347 (569)
T ss_dssp             HHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSSEEEEEEECCCSEEHHHHHH----------TTCCCCHH---HHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCeeEEEEEE-----EECCEEEEEEecCCCCcHHHHHH----------hCCCCCHH---HHHHH
Confidence            6799999999999 799999999994     45889999999999999999994          23445543   58899


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCC------------CccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ------------TKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~------------~~~~~~~~~~~~~Dv~S  264 (382)
                      |+.||+|+|   +++||||||||+|||++.++++||+|||+|+........            ||... +.+..++|+||
T Consensus       348 Il~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~-g~~~~~~d~~s  423 (569)
T 4azs_A          348 LLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFA-ENKSWNGFWRS  423 (569)
T ss_dssp             HHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------
T ss_pred             HHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhC-CCCCCcccccc
Confidence            999999999   789999999999999999999999999999876544321            34333 23456677777


Q ss_pred             HHHHHHHHHhc
Q 040999          265 YGILLLELMIR  275 (382)
Q Consensus       265 ~Gvil~elltg  275 (382)
                      +|++++++.++
T Consensus       424 ~g~~~~~l~~~  434 (569)
T 4azs_A          424 APVHPFNLPQP  434 (569)
T ss_dssp             -----CCCCTT
T ss_pred             cccchhhhccc
Confidence            77776665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.81  E-value=1.1e-20  Score=186.36  Aligned_cols=134  Identities=17%  Similarity=0.203  Sum_probs=108.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|++++++++||||+++..++..     .+..++||||+++++|.+++..                  +..++.|+
T Consensus       384 ~~~~~E~~il~~l~h~nIv~~~~~~~~-----~~~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi  440 (540)
T 3en9_A          384 SRTAREARYLALVKDFGIPAPYIFDVD-----LDNKRIMMSYINGKLAKDVIED------------------NLDIAYKI  440 (540)
T ss_dssp             HHHHHHHHHHHHGGGGTCCCCCEEEEE-----TTTTEEEEECCCSEEHHHHSTT------------------CTHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcCceEEEEEe-----CCccEEEEECCCCCCHHHHHHH------------------HHHHHHHH
Confidence            558999999999999999965555433     4556999999999999999831                  45799999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-------------------CCCccccC--CCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-------------------TQTKYGVG--NEV  256 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-------------------~~~~~~~~--~~~  256 (382)
                      ++||.|||   +.+|+||||||+|||++.  .+||+|||+|+......                   ..||....  ..|
T Consensus       441 ~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y  515 (540)
T 3en9_A          441 GEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGY  515 (540)
T ss_dssp             HHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHH
T ss_pred             HHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHH
Confidence            99999999   779999999999999998  99999999999775421                   12444433  345


Q ss_pred             CccchhHHHHHHHHHHHhcCCCC
Q 040999          257 STIGDVYSYGILLLELMIREKPS  279 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~elltg~~p~  279 (382)
                      +..+|+||..+-.++.+.++.+|
T Consensus       516 ~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          516 KSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHhHHHHHHHHHHHHHhcccc
Confidence            67789999998888888777765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.64  E-value=2.4e-16  Score=142.55  Aligned_cols=95  Identities=17%  Similarity=0.143  Sum_probs=78.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..+.+|+++|++++  | +++.+++.      .+..++||||+++|+|.+ +..                .....++.|+
T Consensus       149 ~~~~~E~~~l~~l~--~-~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~----------------~~~~~i~~qi  202 (282)
T 1zar_A          149 RSARNEFRALQKLQ--G-LAVPKVYA------WEGNAVLMELIDAKELYR-VRV----------------ENPDEVLDMI  202 (282)
T ss_dssp             HHHHHHHHHHHHTT--T-SSSCCEEE------EETTEEEEECCCCEEGGG-CCC----------------SCHHHHHHHH
T ss_pred             HHHHHHHHHHHhcc--C-CCcCeEEe------ccceEEEEEecCCCcHHH-cch----------------hhHHHHHHHH
Confidence            45889999999999  5 66666532      245699999999999988 421                1234699999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      +.||.|||   +.+|+||||||+|||++ ++.+||+|||+|+...
T Consensus       203 ~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~~  243 (282)
T 1zar_A          203 LEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG  243 (282)
T ss_dssp             HHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCTTCEETT
T ss_pred             HHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECCCCeECC
Confidence            99999999   77999999999999999 9999999999998553

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.49  E-value=2.8e-14  Score=127.37  Aligned_cols=101  Identities=25%  Similarity=0.239  Sum_probs=74.8

Q ss_pred             HHHHHHHHHhhcccccc--eeeeeeeeecccCCCceeEEEEecccC-CCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFIHN-RSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+|+++|..++|+++  ..++++         ...++||||+.+ |.+...+....         ...++.....++.
T Consensus       116 ~~~~E~~~l~~l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~---------~~~~~~~~~~i~~  177 (258)
T 1zth_A          116 WTEKEFRNLERAKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELG---------RELKELDVEGIFN  177 (258)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHG---------GGGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHh---------hccChHHHHHHHH
Confidence            68899999999999875  333332         346899999953 53322221100         1123456778999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      |++.||.|||.  ..+|+||||||+|||++.  .++|+|||+|...
T Consensus       178 qi~~~l~~lH~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          178 DVVENVKRLYQ--EAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHHHHHHHHH--TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHHHHHHHH--HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999994  348999999999999998  9999999999765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.16  E-value=8.6e-12  Score=116.31  Aligned_cols=69  Identities=13%  Similarity=0.131  Sum_probs=56.1

Q ss_pred             eEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC----
Q 040999          153 KALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM----  228 (382)
Q Consensus       153 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~----  228 (382)
                      .+|||||+++++|.++..              .  .....++.|++.+|.|||   ..+||||||||.|||+++++    
T Consensus       186 ~~LVME~i~G~~L~~l~~--------------~--~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          186 HTIVMSLVDALPMRQVSS--------------V--PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             TEEEEECCSCEEGGGCCC--------------C--SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSC
T ss_pred             ceEEEEecCCccHhhhcc--------------c--HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCccc
Confidence            379999999888766541              1  123467899999999999   66999999999999998776    


Q ss_pred             ------cEEEcccccccc
Q 040999          229 ------TARVGDFGLARF  240 (382)
Q Consensus       229 ------~~kl~Dfg~a~~  240 (382)
                            .+.|+||+-+..
T Consensus       247 ~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTSEEEEEEECCCTTCEE
T ss_pred             ccccccceEEEEeCCccc
Confidence                  389999998754

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.05  E-value=6.1e-11  Score=121.94  Aligned_cols=65  Identities=34%  Similarity=0.660  Sum_probs=57.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCccccccCCCCCCCCCCCCCcCCCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGISKFKLPKCGSK   69 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn~~lcg~~~~~~~~~c~~~   69 (382)
                      ||||+|+|+|.||..+.++ +|++||||+|+|+|+||. +.+..++..+|.||++|||.+.    +.|...
T Consensus       685 LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l----~~C~~~  751 (768)
T 3rgz_A          685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL----PRCDPS  751 (768)
T ss_dssp             EECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS----CCCCSC
T ss_pred             EECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC----cCCCCC
Confidence            6899999999999999999 899999999999999998 6788999999999999999753    468644

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.81  E-value=5.1e-09  Score=93.11  Aligned_cols=102  Identities=17%  Similarity=0.072  Sum_probs=78.1

Q ss_pred             HHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       119 ~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      .+.+|+++++.+. |..+.++++++..     .+..++||||++|.+|.+.+.               +......++.++
T Consensus        55 ~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e~i~G~~l~~~~~---------------~~~~~~~~~~~l  114 (263)
T 3tm0_A           55 DVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSNLLMSEADGVLCSEEYE---------------DEQSPEKIIELY  114 (263)
T ss_dssp             CHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCSSEEHHHHCC---------------TTTCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCeEEEEEec-----CCceEEEEEecCCeehhhccC---------------CcccHHHHHHHH
Confidence            4889999999985 6677788887543     567899999999988876531               111234678899


Q ss_pred             HHHHhHHhhc--------------------------------------------------------CCCceeecCCCCCc
Q 040999          198 ASALNYLHHD--------------------------------------------------------CQPVTAHCDLKPSN  221 (382)
Q Consensus       198 ~~~L~~lH~~--------------------------------------------------------~~~~ivH~dlkp~N  221 (382)
                      +++|+.||..                                                        ....++|+|++|.|
T Consensus       115 ~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~N  194 (263)
T 3tm0_A          115 AECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSN  194 (263)
T ss_dssp             HHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTS
T ss_pred             HHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCc
Confidence            9999999961                                                        01558999999999


Q ss_pred             eeeCCCCcEEEcccccccc
Q 040999          222 VLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       222 ILl~~~~~~kl~Dfg~a~~  240 (382)
                      |+++++..+.|+||+.+..
T Consensus       195 il~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          195 IFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEEETTEEEEECCCTTCEE
T ss_pred             EEEECCcEEEEEEchhccc
Confidence            9998765667999988753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.71  E-value=2.7e-08  Score=87.96  Aligned_cols=100  Identities=16%  Similarity=0.091  Sum_probs=71.6

Q ss_pred             HHHHHHHHHHhhcccccc--eeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNL--IKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+|+++++.+.+.++  .+++++..     ..+..++||||+++.++.  ...             .+   ...++.
T Consensus        58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~v~e~i~G~~l~--~~~-------------~~---~~~~~~  114 (264)
T 1nd4_A           58 NELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPGQDLL--SSH-------------LA---PAEKVS  114 (264)
T ss_dssp             SCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSSEETT--TSC-------------CC---HHHHHH
T ss_pred             hhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEEEEEecCCcccC--cCc-------------CC---HhHHHH
Confidence            357889999999976554  45777643     245689999999998874  210             11   125667


Q ss_pred             HHHHHHhHHhhcC-------------------------------------------------------CCceeecCCCCC
Q 040999          196 DVASALNYLHHDC-------------------------------------------------------QPVTAHCDLKPS  220 (382)
Q Consensus       196 ~i~~~L~~lH~~~-------------------------------------------------------~~~ivH~dlkp~  220 (382)
                      ++++.|+.||...                                                       ...++|+|++|.
T Consensus       115 ~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~  194 (264)
T 1nd4_A          115 IMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLP  194 (264)
T ss_dssp             HHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGG
T ss_pred             HHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCC
Confidence            7777777777421                                                       123999999999


Q ss_pred             ceeeCCCCcEEEcccccccc
Q 040999          221 NVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       221 NILl~~~~~~kl~Dfg~a~~  240 (382)
                      ||+++++..++|+||+.+..
T Consensus       195 Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          195 NIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GEEEETTEEEEECCCTTCEE
T ss_pred             cEEEECCcEEEEEcchhccc
Confidence            99998776677999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.66  E-value=8.4e-08  Score=89.36  Aligned_cols=109  Identities=14%  Similarity=0.152  Sum_probs=82.5

Q ss_pred             HHHHHHHHHHhhcc--cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       118 ~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..+.+|.++++.+.  +..+.+++.++...  ...+..++||||+++..+.+..            ...++...+..++.
T Consensus        81 ~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~~vme~v~G~~l~~~~------------~~~l~~~~~~~~~~  146 (359)
T 3dxp_A           81 HAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAFYIMEFVSGRVLWDQS------------LPGMSPAERTAIYD  146 (359)
T ss_dssp             -CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCEEEEECCCCBCCCCTT------------CTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeEEEEEecCCeecCCCc------------cccCCHHHHHHHHH
Confidence            46788999999997  44577888876431  1124578999999988775422            12367778889999


Q ss_pred             HHHHHHhHHhhcC-------------------------------------------------------CCceeecCCCCC
Q 040999          196 DVASALNYLHHDC-------------------------------------------------------QPVTAHCDLKPS  220 (382)
Q Consensus       196 ~i~~~L~~lH~~~-------------------------------------------------------~~~ivH~dlkp~  220 (382)
                      ++++.|+.||...                                                       ...++|+|++|.
T Consensus       147 ~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~  226 (359)
T 3dxp_A          147 EMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLD  226 (359)
T ss_dssp             HHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGG
T ss_pred             HHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCC
Confidence            9999999999620                                                       257999999999


Q ss_pred             ceeeCCCCc--EEEcccccccc
Q 040999          221 NVLLDDDMT--ARVGDFGLARF  240 (382)
Q Consensus       221 NILl~~~~~--~kl~Dfg~a~~  240 (382)
                      ||+++.++.  +.|.||+.+..
T Consensus       227 Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          227 NLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             GEEECSSSSCEEEECCCTTCEE
T ss_pred             cEEEeCCCCcEEEEECcccccc
Confidence            999987753  68999998864

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.56  E-value=7.9e-09  Score=100.50  Aligned_cols=55  Identities=22%  Similarity=0.240  Sum_probs=40.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCccccccCCCCCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGNSKLCGG   57 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn~~lcg~   57 (382)
                      ||||+|+|+| +|+.+..+ .|+.||+|+|+|+| +|..  ...++....+.||+..|+.
T Consensus       196 L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~  253 (487)
T 3oja_A          196 LDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGT  253 (487)
T ss_dssp             EECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred             EECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcc
Confidence            6788888887 44457788 89999999999986 6662  2345556667788777653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.54  E-value=1.2e-07  Score=86.27  Aligned_cols=149  Identities=17%  Similarity=0.163  Sum_probs=94.7

Q ss_pred             HHHHHHHHHHHhhcc-ccc--ceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHH
Q 040999          117 FKSFIAECKALRNIR-HRN--LIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNI  193 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i  193 (382)
                      ...+.+|.++|+.+. +..  +.+++..+..  .......|+||++++|.++....            ...++..++..+
T Consensus        54 ~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm~~i~G~~l~~~~------------~~~l~~~~~~~~  119 (304)
T 3sg8_A           54 STNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGFTKIKGVPLTPLL------------LNNLPKQSQNQA  119 (304)
T ss_dssp             HHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEEECCCCEECCHHH------------HHTSCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEEcccCCeECCccc------------cccCCHHHHHHH
Confidence            356889999999884 333  2333333211  11112457899999998775432            123556666777


Q ss_pred             HHHHHHHHhHHhhc-------------------------------------------------------CCCceeecCCC
Q 040999          194 AIDVASALNYLHHD-------------------------------------------------------CQPVTAHCDLK  218 (382)
Q Consensus       194 ~~~i~~~L~~lH~~-------------------------------------------------------~~~~ivH~dlk  218 (382)
                      +.++++.|+.||..                                                       ....++|+|++
T Consensus       120 ~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~  199 (304)
T 3sg8_A          120 AKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFS  199 (304)
T ss_dssp             HHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCC
T ss_pred             HHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCC
Confidence            77777777777741                                                       12468999999


Q ss_pred             CCceeeCC--CCcEEEccccccccCCCCC-----------CCCcccc-----CCCCC---------ccchhHHHHHHHHH
Q 040999          219 PSNVLLDD--DMTARVGDFGLARFLPPTR-----------TQTKYGV-----GNEVS---------TIGDVYSYGILLLE  271 (382)
Q Consensus       219 p~NILl~~--~~~~kl~Dfg~a~~~~~~~-----------~~~~~~~-----~~~~~---------~~~Dv~S~Gvil~e  271 (382)
                      |.||+++.  ...+.|+||+.+....+..           ..++...     .+..+         ...+.|++|.++|.
T Consensus       200 ~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~  279 (304)
T 3sg8_A          200 SDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYG  279 (304)
T ss_dssp             GGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHH
Confidence            99999988  4567899999987543310           1111000     01111         12589999999999


Q ss_pred             HHhcCCCC
Q 040999          272 LMIREKPS  279 (382)
Q Consensus       272 lltg~~p~  279 (382)
                      +.+|..+|
T Consensus       280 ~~~g~~~~  287 (304)
T 3sg8_A          280 KEYGYMDW  287 (304)
T ss_dssp             HHTTCHHH
T ss_pred             HHcCCHHH
Confidence            99998774

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=98.47  E-value=6e-08  Score=88.62  Aligned_cols=59  Identities=36%  Similarity=0.618  Sum_probs=53.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCccccccCCCCCCCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGIS   59 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn~~lcg~~~   59 (382)
                      |||++|+|+|.+|..+.++ .|++||+++|+|+|.+|. ..+.++....+.||+.+||.|.
T Consensus       249 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             EECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             EECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence            6899999999999999999 999999999999999998 4567777888999999999753

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=98.08  E-value=9.6e-07  Score=90.66  Aligned_cols=37  Identities=41%  Similarity=0.571  Sum_probs=23.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      ||||+|+|+|.||.+++++ .|+.||||+|+|+|.||.
T Consensus       637 LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~  674 (768)
T 3rgz_A          637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD  674 (768)
T ss_dssp             EECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred             EECcCCcccccCCHHHhccccCCEEeCcCCccCCCCCh
Confidence            4566666666666666666 666666666666666665

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.86  E-value=4.9e-05  Score=68.89  Aligned_cols=109  Identities=17%  Similarity=0.109  Sum_probs=69.4

Q ss_pred             HHHHHHHHHHHhhcccc---cceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHR---NLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNI  193 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i  193 (382)
                      ...+.+|.++|+.+.+.   .+.+.+.++.    ...+..++||||++|.++.....            ..++...+..+
T Consensus        53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~i~G~~l~~~~~------------~~l~~~~~~~~  116 (306)
T 3tdw_A           53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRKVQGQILGEDGM------------AVLPDDAKDRL  116 (306)
T ss_dssp             HHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEECCCSEECHHHHH------------TTSCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEeccCCeECchhhh------------hhCCHHHHHHH
Confidence            35789999999999753   2445555532    12456789999999987765210            01223333334


Q ss_pred             HHHHHHHHhHHhhc---------------------------------------------------------CCCceeecC
Q 040999          194 AIDVASALNYLHHD---------------------------------------------------------CQPVTAHCD  216 (382)
Q Consensus       194 ~~~i~~~L~~lH~~---------------------------------------------------------~~~~ivH~d  216 (382)
                      +.++++.|+.||..                                                         ....++|+|
T Consensus       117 ~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD  196 (306)
T 3tdw_A          117 ALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGD  196 (306)
T ss_dssp             HHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSC
T ss_pred             HHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCC
Confidence            44444444444321                                                         245679999


Q ss_pred             CCCCceeeCC---CCc-EEEccccccccC
Q 040999          217 LKPSNVLLDD---DMT-ARVGDFGLARFL  241 (382)
Q Consensus       217 lkp~NILl~~---~~~-~kl~Dfg~a~~~  241 (382)
                      ++|.||+++.   ++. ..|+||+.+...
T Consensus       197 ~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          197 LSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             CSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             CCcccEEEecCCCCCceEEEEehhhcCCC
Confidence            9999999987   455 589999988654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.85  E-value=3.5e-05  Score=68.35  Aligned_cols=105  Identities=19%  Similarity=0.102  Sum_probs=69.9

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      ..+.+|.+.|+.+. +--+-++++++..     .+..++|||++++.++.+....              .......+..+
T Consensus        64 ~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~~~~~~~~--------------~~~~~~~~~~~  124 (272)
T 4gkh_A           64 NDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKTAFQVLEE--------------YPDSGENIVDA  124 (272)
T ss_dssp             HHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEEHHHHHHH--------------CGGGHHHHHHH
T ss_pred             hHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCccccccccC--------------CHHHHHHHHHH
Confidence            46788999998884 2234566666543     5678999999998776554311              11122334455


Q ss_pred             HHHHHhHHhh-------------------------------------------------------cCCCceeecCCCCCc
Q 040999          197 VASALNYLHH-------------------------------------------------------DCQPVTAHCDLKPSN  221 (382)
Q Consensus       197 i~~~L~~lH~-------------------------------------------------------~~~~~ivH~dlkp~N  221 (382)
                      ++..|+-||.                                                       .....++|+|+.+.|
T Consensus       125 l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~N  204 (272)
T 4gkh_A          125 LAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDN  204 (272)
T ss_dssp             HHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTS
T ss_pred             HHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCe
Confidence            5555555553                                                       012347999999999


Q ss_pred             eeeCCCCcEEEccccccccC
Q 040999          222 VLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       222 ILl~~~~~~kl~Dfg~a~~~  241 (382)
                      |+++.++.+-|+||+.+...
T Consensus       205 il~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          205 LIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             EEEETTEEEEECCCTTCEEE
T ss_pred             EEEECCeEEEEEECcccccC
Confidence            99998777789999988643

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=97.59  E-value=2.6e-05  Score=65.57  Aligned_cols=51  Identities=14%  Similarity=0.218  Sum_probs=39.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|+|++.+|..+..+ .|++||||+|+|++..|..  ...++....+.+|
T Consensus        59 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  112 (192)
T 1w8a_A           59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN  112 (192)
T ss_dssp             EECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS
T ss_pred             EECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence            6899999999889999999 8999999999999877752  2344444445555

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=97.48  E-value=4.8e-05  Score=67.24  Aligned_cols=54  Identities=30%  Similarity=0.400  Sum_probs=41.3

Q ss_pred             CccCCCcccc--ccchhhhhc-cCCeeeccCCcccccCCc-cccc--CCCCccccccCCCCC
Q 040999            1 MDFSQNNLSG--EILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYK--NASATSVTGNSKLCG   56 (382)
Q Consensus         1 LdLs~N~lsG--~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~--~~~~~~~~gn~~lcg   56 (382)
                      ||||+|+|+|  .||..+..+ +|+.||||+|+|++. .. ..+.  .+....+.||+ +|+
T Consensus       175 L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Np-l~~  234 (267)
T 3rw6_A          175 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNS-LCD  234 (267)
T ss_dssp             EECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTST-TGG
T ss_pred             EECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCc-Ccc
Confidence            6899999999  888888889 999999999999985 22 2222  45555677776 665

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.46  E-value=0.00048  Score=63.55  Aligned_cols=32  Identities=28%  Similarity=0.342  Sum_probs=27.0

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      ...++|+|+.|.||+++++..+.|+||+.+..
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            46799999999999999644578999998864

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=97.45  E-value=7.7e-05  Score=61.28  Aligned_cols=51  Identities=20%  Similarity=0.197  Sum_probs=38.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|+|++-.|..+..+ .|++||||+|+|++-.|..  .+.++....+.+|
T Consensus        35 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           35 LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            6899999999889999999 9999999999999544431  2334444455555

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=97.42  E-value=8.1e-05  Score=68.53  Aligned_cols=51  Identities=22%  Similarity=0.185  Sum_probs=36.3

Q ss_pred             CccCC-Cccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQ-NNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~-N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++ |+|++-.|..+.++ .|+.||||+|+|+|..|..  -+.++....+.+|
T Consensus        36 L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             EECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            67885 88887777788888 8888888888888877752  2334444445555

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=97.39  E-value=6.5e-05  Score=64.57  Aligned_cols=51  Identities=20%  Similarity=0.163  Sum_probs=39.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|+|++..|..+..+ .|++||+|+|++++..|..  ...++....+.+|
T Consensus        86 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  139 (220)
T 2v70_A           86 ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN  139 (220)
T ss_dssp             EECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTS
T ss_pred             EECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCC
Confidence            6899999998888888889 9999999999999887762  2334444445555

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=97.31  E-value=0.00013  Score=60.09  Aligned_cols=50  Identities=22%  Similarity=0.343  Sum_probs=39.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCccc---ccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGV---YKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~---~~~~~~~~~~gn   51 (382)
                      |||++|+|++.+|..+.++ .|++||||+|+|++ +|...   +.++....+.+|
T Consensus        38 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           38 LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSS
T ss_pred             EEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCCC
Confidence            6899999999999999999 99999999999997 55533   344444556566

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=97.28  E-value=0.00012  Score=61.41  Aligned_cols=51  Identities=24%  Similarity=0.310  Sum_probs=39.1

Q ss_pred             CccCCCccccccch-hhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILK-FLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~-~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |+|++|+|++..|. .+..+ .|++||+++|+++|..|..  ...++....+.+|
T Consensus        34 L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A           34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            68999999977765 48889 9999999999999988862  2344444455555

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=97.26  E-value=0.00015  Score=59.79  Aligned_cols=49  Identities=14%  Similarity=0.108  Sum_probs=35.9

Q ss_pred             CccCCCccccccchhhhhccCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      ||+++|+| ++||..+. -.|++|||++|+|++..|.  ..+.++....+.+|
T Consensus        17 l~~~~n~l-~~iP~~~~-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   67 (174)
T 2r9u_A           17 VNCQNIRL-ASVPAGIP-TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSN   67 (174)
T ss_dssp             EECCSSCC-SSCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEeCCCCC-CccCCCcC-CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCC
Confidence            57899999 58997653 3799999999999988776  23445555556666

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=97.24  E-value=0.00016  Score=59.33  Aligned_cols=49  Identities=16%  Similarity=0.175  Sum_probs=34.3

Q ss_pred             CccCCCccccccchhhhhccCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      ||+|+|+|+ +||..+. -.|++|||++|++++..|.  ..+.++....+.+|
T Consensus        14 l~~s~n~l~-~ip~~~~-~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N   64 (170)
T 3g39_A           14 VDCSGKSLA-SVPTGIP-TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNN   64 (170)
T ss_dssp             EECTTSCCS-SCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred             EEeCCCCcC-ccCccCC-CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCC
Confidence            578999988 4887552 2789999999999987776  22344544555555

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=97.23  E-value=0.0001  Score=67.00  Aligned_cols=37  Identities=30%  Similarity=0.487  Sum_probs=29.9

Q ss_pred             CccCC-Cccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQ-NNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~-N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++ |+++|.+|..++++ .|++||+++|+++|.+|.
T Consensus        81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~  119 (313)
T 1ogq_A           81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD  119 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG
T ss_pred             eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCH
Confidence            56774 88888888888888 888888888888888886

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=97.18  E-value=0.00019  Score=60.31  Aligned_cols=52  Identities=31%  Similarity=0.360  Sum_probs=38.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn~   52 (382)
                      ||||+|+|++-.|..+..+ .|++||||+|++++-.|..  ...++....+.+|.
T Consensus        59 L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~  113 (193)
T 2wfh_A           59 IDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGND  113 (193)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCC
Confidence            6899999998877888899 9999999999999766642  23344444555553

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=97.16  E-value=0.00018  Score=61.71  Aligned_cols=50  Identities=22%  Similarity=0.238  Sum_probs=34.5

Q ss_pred             CccCCCccccccch-hhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILK-FLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~-~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      ||||+|+|+ .||. .+..+ .|++|||++|++++..|..  ...++....+.+|
T Consensus        85 L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  138 (220)
T 2v9t_B           85 LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN  138 (220)
T ss_dssp             EECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCC
Confidence            688999998 4554 45677 8999999999998877752  2334444445555

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=97.16  E-value=0.00022  Score=70.91  Aligned_cols=37  Identities=30%  Similarity=0.255  Sum_probs=27.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      ||||+|+|++.+|..+.++ +|++||||+|+|++-.|.
T Consensus       499 L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~  536 (635)
T 4g8a_A          499 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF  536 (635)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCG
T ss_pred             EECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChh
Confidence            5777777777777777777 777777777777765554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=97.15  E-value=0.00026  Score=61.06  Aligned_cols=50  Identities=24%  Similarity=0.393  Sum_probs=36.4

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCccc--ccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGV--YKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~--~~~~~~~~~~gn   51 (382)
                      ||||+|+|++-.|..+..+ .|++||+++|+|+ .||...  ..++....+.+|
T Consensus        93 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N  145 (229)
T 3e6j_A           93 LDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN  145 (229)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSS
T ss_pred             EECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCC
Confidence            6889999997666667788 8999999999998 788632  334444445555

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=97.12  E-value=0.00032  Score=72.68  Aligned_cols=56  Identities=23%  Similarity=0.318  Sum_probs=36.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc---------------------cccCCCCccccccCCCCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG---------------------VYKNASATSVTGNSKLCG   56 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~---------------------~~~~~~~~~~~gn~~lcg   56 (382)
                      ||||+|+|+|.+|..+..+ .|+.||||+|+|++-.|..                     .+..+....+.||+-.|.
T Consensus       485 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~  562 (844)
T 3j0a_A          485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE  562 (844)
T ss_dssp             CCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCS
T ss_pred             EECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccc
Confidence            6777777777777767666 6777777777666533321                     123444456778888884

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=97.10  E-value=0.00014  Score=57.98  Aligned_cols=49  Identities=24%  Similarity=0.266  Sum_probs=29.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|++++.  ..+.++ .|++||+|+|++++.+|..  ...++....+.+|
T Consensus        47 L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N   98 (149)
T 2je0_A           47 LSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN   98 (149)
T ss_dssp             EECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTS
T ss_pred             EECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCC
Confidence            46777777765  456666 6777777777777766651  1334444444444

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=97.09  E-value=0.00024  Score=64.98  Aligned_cols=36  Identities=19%  Similarity=0.210  Sum_probs=24.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|+|+| +|+.+..+ +|++||+++|++.|.+|.
T Consensus       211 L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~  247 (328)
T 4fcg_A          211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP  247 (328)
T ss_dssp             EEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCC
T ss_pred             EEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHH
Confidence            4667777774 56666666 677777777777777775

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=97.01  E-value=0.00043  Score=56.93  Aligned_cols=51  Identities=20%  Similarity=0.199  Sum_probs=37.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      |||++|+|++-.|..+..+ .|++||+++|++++..|.  ....++....+.+|
T Consensus        57 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N  110 (177)
T 2o6r_A           57 LSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN  110 (177)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCC
Confidence            6899999996666667888 999999999999976554  22344444455555

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=97.01  E-value=0.00034  Score=63.91  Aligned_cols=52  Identities=12%  Similarity=0.007  Sum_probs=42.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn~   52 (382)
                      |||++|++.|.+|..+..+ .|++|++++|++.|.+|..  ...++....+.+|+
T Consensus       234 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~  288 (328)
T 4fcg_A          234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV  288 (328)
T ss_dssp             EECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCT
T ss_pred             EECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCC
Confidence            6899999999999999999 9999999999999999973  34455555666765

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=97.01  E-value=0.00027  Score=64.94  Aligned_cols=54  Identities=22%  Similarity=0.270  Sum_probs=33.2

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccC--CCCccccccCCCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKN--ASATSVTGNSKLC   55 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~--~~~~~~~gn~~lc   55 (382)
                      ||||+|+|+|.+|..+.++ .|+.||||+|+|++ +|...+..  +....+.+|+--|
T Consensus        61 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~L~~l~l~~N~~~c  117 (347)
T 2ifg_A           61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHC  117 (347)
T ss_dssp             EECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCCCCEEECCSSCCCC
T ss_pred             EECCCCccceeCHHHhcCCcCCCEEeCCCCccce-eCHHHcccCCceEEEeeCCCccC
Confidence            5777777777777777777 77777777777774 44322222  3333444554433

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=96.93  E-value=0.00042  Score=68.33  Aligned_cols=53  Identities=28%  Similarity=0.306  Sum_probs=40.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCccccccCCCCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCG   56 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn~~lcg   56 (382)
                      ||||+|+|+ +||..++++ +|+.||||+|+|+| ||. +.+.++....+.+| .+.+
T Consensus       468 L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N-~l~~  522 (567)
T 1dce_A          468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNN-RLQQ  522 (567)
T ss_dssp             EECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSS-CCCS
T ss_pred             eecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCC-CCCC
Confidence            689999999 999999999 99999999999998 785 33444555555555 3444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=96.93  E-value=0.00048  Score=57.72  Aligned_cols=51  Identities=16%  Similarity=0.172  Sum_probs=38.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn~   52 (382)
                      |+|++|+|+ .||..+.++ .|++||+|+|++++-.|.  ....++....+.+|.
T Consensus        36 L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            689999998 899999999 999999999999976654  223344444455553

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=96.92  E-value=0.00054  Score=58.70  Aligned_cols=52  Identities=15%  Similarity=0.169  Sum_probs=40.2

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn~   52 (382)
                      |||++|+|++-.|..+..+ .|++|||++|++++..|.  ....++....+.+|.
T Consensus        62 L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  116 (220)
T 2v70_A           62 INFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNR  116 (220)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSC
T ss_pred             EECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCc
Confidence            6899999998888899999 999999999999977665  223444444555553

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=96.89  E-value=0.00047  Score=67.95  Aligned_cols=48  Identities=21%  Similarity=0.428  Sum_probs=38.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      ||||+|+|++ ||. ++++ .|+.||||+|+|+ .||..  .+.++....+.+|
T Consensus       446 L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N  496 (567)
T 1dce_A          446 LHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN  496 (567)
T ss_dssp             EECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred             EEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCC
Confidence            6899999997 887 8999 9999999999999 89973  3445555555555

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=96.88  E-value=0.00059  Score=59.65  Aligned_cols=51  Identities=24%  Similarity=0.272  Sum_probs=35.2

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      |||++|+|++-.|..+..+ .|++||+++|+|++..|.  ....++....+.+|
T Consensus       112 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  165 (251)
T 3m19_A          112 LYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN  165 (251)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence            6789999986666567788 899999999999865553  22334444455555

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=96.86  E-value=0.0007  Score=59.95  Aligned_cols=51  Identities=22%  Similarity=0.326  Sum_probs=33.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      |||++|+|++..|..+..+ .|++||+++|++++..|.  ....++....+.+|
T Consensus       138 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          138 LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            5788888886666667777 888888888888865553  12334444444455

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=96.80  E-value=0.00041  Score=69.50  Aligned_cols=52  Identities=15%  Similarity=0.076  Sum_probs=39.5

Q ss_pred             CccCCCccccc-----------------cchhhh--hc-cCCeeeccCCcccccCCcc--cccCCCCccccccC
Q 040999            1 MDFSQNNLSGE-----------------ILKFLT--RL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~-----------------iP~~l~--~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn~   52 (382)
                      ||||+|+|+|+                 ||.+++  ++ +|++|++++|+++|.+|..  .+.++....+.+|.
T Consensus       211 L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~  284 (636)
T 4eco_A          211 FYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR  284 (636)
T ss_dssp             EEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred             EECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence            68899999997                 999988  88 8999999999999999973  23344444455553

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=96.77  E-value=0.00054  Score=55.80  Aligned_cols=49  Identities=24%  Similarity=0.259  Sum_probs=27.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|+|++.  ..+..+ .|++||+++|++++.+|..  ...++....+.+|
T Consensus        54 L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  105 (168)
T 2ell_A           54 LSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN  105 (168)
T ss_dssp             EEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSS
T ss_pred             EeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCC
Confidence            46666666654  455566 6677777777776666551  1333443444444

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=96.76  E-value=0.00082  Score=67.26  Aligned_cols=51  Identities=18%  Similarity=0.186  Sum_probs=37.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeec------cCCcccccCCcc--cccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNL------SYNNLEGMVPTG--VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldl------s~N~lsG~iP~~--~~~~~~~~~~~gn~   52 (382)
                      |||++|+|+| ||..+.++ .|+.||+      |+|+++|.+|..  ...++....+.+|.
T Consensus       518 L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~  577 (636)
T 4eco_A          518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND  577 (636)
T ss_dssp             EECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred             EECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCc
Confidence            5788888888 88888888 8888888      567888888873  24445555555664

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=96.72  E-value=0.00098  Score=67.76  Aligned_cols=49  Identities=24%  Similarity=0.232  Sum_probs=37.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      ||||+|+|+ .||.+++++ .|++||||+|+|+ .||..  .+.++....+.+|
T Consensus       252 L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N  303 (727)
T 4b8c_D          252 LYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDN  303 (727)
T ss_dssp             CBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSS
T ss_pred             EEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCC
Confidence            688888888 888888888 8899999999888 88873  2344444455555

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=96.69  E-value=0.0007  Score=61.16  Aligned_cols=37  Identities=16%  Similarity=0.169  Sum_probs=26.4

Q ss_pred             CccCCCccc--cccchh-hhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLS--GEILKF-LTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~ls--G~iP~~-l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |+|++|+|+  +.+|.. +.++ .|++||+|+|++++.+|.
T Consensus       202 L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~  242 (310)
T 4glp_A          202 LALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNP  242 (310)
T ss_dssp             CBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCS
T ss_pred             EECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchh
Confidence            678888886  333333 3566 788888888888888775

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=96.68  E-value=0.0012  Score=55.72  Aligned_cols=51  Identities=20%  Similarity=0.236  Sum_probs=34.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      |||++|+|++..|..+.++ .|++||+++|++++..|.  ....++....+.+|
T Consensus        81 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  134 (208)
T 2o6s_A           81 LNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQN  134 (208)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCC
Confidence            5788898886655567788 889999999988865543  12233444444455

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=96.61  E-value=0.00064  Score=70.32  Aligned_cols=52  Identities=13%  Similarity=0.057  Sum_probs=38.2

Q ss_pred             CccCCCcccc-----------------ccchhhh--hc-cCCeeeccCCcccccCCcc--cccCCCCccccccC
Q 040999            1 MDFSQNNLSG-----------------EILKFLT--RL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG-----------------~iP~~l~--~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn~   52 (382)
                      ||||+|+|+|                 .||.+++  ++ +|++|+|++|+++|.+|..  .+.++....+.+|.
T Consensus       453 L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~  526 (876)
T 4ecn_A          453 IYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR  526 (876)
T ss_dssp             EEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred             EECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence            5788888888                 4888877  88 8999999999999998862  23444444455553

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=96.59  E-value=0.0011  Score=67.47  Aligned_cols=50  Identities=24%  Similarity=0.229  Sum_probs=38.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn~   52 (382)
                      ||||+|+|+ .||.++++| .|++|+|++|+|+ .||..  .+.++....+.+|.
T Consensus       275 L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~  327 (727)
T 4b8c_D          275 LDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNP  327 (727)
T ss_dssp             EECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSC
T ss_pred             EeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCc
Confidence            689999999 899999999 8999999999996 88873  23344444455553

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=96.58  E-value=0.00074  Score=60.13  Aligned_cols=51  Identities=20%  Similarity=0.170  Sum_probs=33.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCccc--ccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGV--YKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~--~~~~~~~~~~gn   51 (382)
                      |||++|+|++-.|..+..+ .|+.||+++|++++..|...  ..++....+.+|
T Consensus       158 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  211 (285)
T 1ozn_A          158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN  211 (285)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence            5778888886555567777 78888888888887777622  233444444444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=96.54  E-value=0.0012  Score=52.47  Aligned_cols=50  Identities=10%  Similarity=0.147  Sum_probs=37.3

Q ss_pred             CccCCCccc-cccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCcccccc
Q 040999            1 MDFSQNNLS-GEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~ls-G~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn   51 (382)
                      |||++|+++ |.+|..+..+ .|++|++++|++++. +. ..+.++....+.+|
T Consensus        22 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n   74 (149)
T 2je0_A           22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDN   74 (149)
T ss_dssp             EECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSS
T ss_pred             EEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCC
Confidence            689999999 9999988899 999999999999976 33 22333333344444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=96.52  E-value=0.0015  Score=53.68  Aligned_cols=51  Identities=18%  Similarity=0.227  Sum_probs=37.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |+|++|+|++-.|..+..+ .|++||+++|++++..|..  ...++....+.+|
T Consensus        33 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            6899999997666678889 9999999999999655432  2334444445555

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=96.51  E-value=0.0015  Score=67.47  Aligned_cols=51  Identities=22%  Similarity=0.197  Sum_probs=39.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccC------CcccccCCcc--cccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSY------NNLEGMVPTG--VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~------N~lsG~iP~~--~~~~~~~~~~~gn~   52 (382)
                      ||||+|+|+| ||.++.++ +|+.|||++      |+++|.+|..  ...++....+.+|.
T Consensus       758 L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~  817 (876)
T 4ecn_A          758 MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND  817 (876)
T ss_dssp             EECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred             EEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCC
Confidence            6889999998 89888888 899998866      8888999873  24455555566664

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=96.51  E-value=0.0015  Score=54.76  Aligned_cols=52  Identities=13%  Similarity=0.211  Sum_probs=36.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn~   52 (382)
                      |+|++|++++..|..++.+ .|++||+++|++++..|.  ....++....+.+|.
T Consensus        93 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A           93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             EEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred             EEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence            5788888888888888888 888888888888886665  223344444455553

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=96.50  E-value=0.00083  Score=66.60  Aligned_cols=37  Identities=24%  Similarity=0.237  Sum_probs=29.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|++++.+|..+.++ .|+.||+|+|+++|.+|.
T Consensus       481 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  518 (606)
T 3t6q_A          481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE  518 (606)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGG
T ss_pred             EECCCCccCccChhhhccccCCCEEECCCCccCcCChh
Confidence            5788888888778888888 788888888888887775

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=96.49  E-value=0.0016  Score=63.65  Aligned_cols=34  Identities=21%  Similarity=0.241  Sum_probs=16.6

Q ss_pred             ccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            2 DFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         2 dLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||+|+|+ .||. ...+ .|++||+|+|+|+|.+|.
T Consensus       457 ~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~  491 (549)
T 2z81_A          457 YISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDG  491 (549)
T ss_dssp             ECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTT
T ss_pred             ECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHH
Confidence            44555554 4544 2334 455555555555554443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=96.48  E-value=0.0013  Score=53.44  Aligned_cols=50  Identities=14%  Similarity=0.147  Sum_probs=38.3

Q ss_pred             CccCCCccc-cccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCcccccc
Q 040999            1 MDFSQNNLS-GEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~ls-G~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn   51 (382)
                      |||++|+++ |.||..+..+ .|++||+++|++++. +. ..+.++....+.+|
T Consensus        29 L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N   81 (168)
T 2ell_A           29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSEN   81 (168)
T ss_dssp             EECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESC
T ss_pred             EECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCC
Confidence            689999999 9999998899 999999999999976 43 22334444445555

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=96.47  E-value=0.0017  Score=61.77  Aligned_cols=51  Identities=25%  Similarity=0.339  Sum_probs=34.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|+|++..|..+.++ .|++||+|+|++++..|..  ...++....+.+|
T Consensus       328 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  381 (455)
T 3v47_A          328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTN  381 (455)
T ss_dssp             EECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCC
Confidence            5778888877777777777 7888888888887777752  2334444444454

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=96.46  E-value=0.0012  Score=65.52  Aligned_cols=37  Identities=30%  Similarity=0.268  Sum_probs=21.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|++++.+|..+.++ .|+.||+|+|++++.+|.
T Consensus       478 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  515 (606)
T 3vq2_A          478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS  515 (606)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGG
T ss_pred             EECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHH
Confidence            4556666665555555555 566666666666555554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=96.46  E-value=0.00072  Score=56.71  Aligned_cols=35  Identities=9%  Similarity=0.074  Sum_probs=22.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |+|++|.+  +.++.+..+ .|++|++++|++++..|.
T Consensus        71 L~l~~n~~--~~~~~l~~l~~L~~L~l~~n~l~~~~~~  106 (197)
T 4ezg_A           71 LTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIP  106 (197)
T ss_dssp             EEEESCCC--SCCGGGTTCTTCCEEEEECTTCBGGGSC
T ss_pred             EEccCCCC--CcchhhhcCCCCCEEEeECCccCcccCh
Confidence            46677744  334466677 777777777777775554

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=96.45  E-value=0.0017  Score=63.70  Aligned_cols=51  Identities=24%  Similarity=0.333  Sum_probs=33.5

Q ss_pred             CccCCCccc-cccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLS-GEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~ls-G~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |+|++|+++ |.+|..+..+ .|++||+++|++++..|..  ...++....+.+|
T Consensus       450 L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  504 (570)
T 2z63_A          450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN  504 (570)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence            567778777 6777777777 7888888888887776752  2233444444444

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=96.39  E-value=0.0019  Score=55.28  Aligned_cols=37  Identities=19%  Similarity=0.275  Sum_probs=25.4

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |+|++|+|++-.|..+..+ .|++|||++|++++..|.
T Consensus        37 L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~   74 (220)
T 2v9t_B           37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPD   74 (220)
T ss_dssp             EECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTT
T ss_pred             EECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHH
Confidence            4677777776555566666 777777777777766665

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=96.35  E-value=0.0017  Score=64.47  Aligned_cols=51  Identities=24%  Similarity=0.320  Sum_probs=30.9

Q ss_pred             CccCCCcccc-ccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSG-EILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG-~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |+|++|++.+ .+|..+..+ +|++||||+|+|++..|..  -..++....+.+|
T Consensus       474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N  528 (635)
T 4g8a_A          474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN  528 (635)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCC
Confidence            4677776444 456667777 7778888888777766652  2233333344444

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=96.33  E-value=0.0021  Score=55.26  Aligned_cols=50  Identities=22%  Similarity=0.335  Sum_probs=36.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccc---cCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVY---KNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~---~~~~~~~~~gn   51 (382)
                      |||++|+|++..|..+..+ .|++|+|++|+|+ .+|...+   .++....+.+|
T Consensus        45 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS
T ss_pred             EEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCC
Confidence            6889999998888888888 8999999999985 5554332   33333445455

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=96.29  E-value=0.0021  Score=57.70  Aligned_cols=52  Identities=23%  Similarity=0.169  Sum_probs=39.2

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn~   52 (382)
                      |||++|++++..|..+..+ .|+.||+++|++++..|..  ...++....+.+|.
T Consensus       180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  234 (306)
T 2z66_A          180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  234 (306)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred             EECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence            6899999999889899999 9999999999999765532  23344444555663

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.28  E-value=0.014  Score=52.21  Aligned_cols=32  Identities=22%  Similarity=0.291  Sum_probs=26.3

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      ...++|+|+.+.||+ ..++.+.++||..+..-
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            456899999999999 55667899999887643

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=96.20  E-value=0.0021  Score=61.35  Aligned_cols=51  Identities=12%  Similarity=0.064  Sum_probs=39.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      ||||+|+|++..|..+.++ +|+.|++++|++++..|..  ...++....+.+|
T Consensus       223 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  276 (452)
T 3zyi_A          223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN  276 (452)
T ss_dssp             EECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCC
Confidence            6899999999889999999 9999999999999877762  2344444455555

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=96.18  E-value=0.0029  Score=56.59  Aligned_cols=51  Identities=29%  Similarity=0.364  Sum_probs=36.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccc---cCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVY---KNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~---~~~~~~~~~gn~   52 (382)
                      |+|++|+|++-.|..+..+ .|+.||+++|+|+ .+|...+   .++....+.+|.
T Consensus       129 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~  183 (290)
T 1p9a_G          129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENS  183 (290)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCCCCccChhhcccccCCCEEECCCCcCC-ccCHHHhcCcCCCCEEECCCCc
Confidence            6899999997666667788 8999999999998 5665433   334444455553

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=96.18  E-value=0.0027  Score=55.34  Aligned_cols=51  Identities=22%  Similarity=0.237  Sum_probs=36.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|++++..|..+.++ .|++||+++|++++..|..  .+.++....+.+|
T Consensus        40 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n   93 (251)
T 3m19_A           40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN   93 (251)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             EEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCC
Confidence            5788888888888788888 8888899888888766642  2334444444444

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=96.13  E-value=0.0021  Score=61.03  Aligned_cols=51  Identities=18%  Similarity=0.185  Sum_probs=36.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      ||||+|+|++..|..+.++ .|+.|++++|++++..|..  ...++....+.+|
T Consensus       212 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  265 (440)
T 3zyj_A          212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN  265 (440)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTS
T ss_pred             EECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCC
Confidence            6888888888888888888 8888888888888766652  2233444444455

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=96.13  E-value=0.0014  Score=55.05  Aligned_cols=50  Identities=28%  Similarity=0.300  Sum_probs=39.7

Q ss_pred             CccCCCccccccch------hhhhc-cCCeeeccCCcccccCCc-ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILK------FLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~------~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn   51 (382)
                      ++|+.|+|+|.+|.      .+.++ .|++||+++|++++ +|. ..+.++....+.+|
T Consensus        23 l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n   80 (198)
T 1ds9_A           23 TEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRN   80 (198)
T ss_dssp             TTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEE
T ss_pred             cchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCC
Confidence            68999999999997      89999 99999999999998 884 22344554455555

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=96.09  E-value=0.0037  Score=60.66  Aligned_cols=35  Identities=26%  Similarity=0.469  Sum_probs=20.1

Q ss_pred             CccCCCccccccchhhhhccCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|+++|.+|..+. -.|+.||+++|+++ .||.
T Consensus       404 L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N~l~-~ip~  438 (520)
T 2z7x_B          404 LNMSSNILTDTIFRCLP-PRIKVLDLHSNKIK-SIPK  438 (520)
T ss_dssp             EECCSSCCCGGGGGSCC-TTCCEEECCSSCCC-CCCG
T ss_pred             EECcCCCCCcchhhhhc-ccCCEEECCCCccc-ccch
Confidence            45666666666665442 24566666666666 5555

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=96.08  E-value=0.0028  Score=51.97  Aligned_cols=48  Identities=23%  Similarity=0.303  Sum_probs=32.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCccc---ccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGV---YKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~---~~~~~~~~~~gn   51 (382)
                      ||||+|+|++-  ..+..+ .|++||+++|++++- |...   ..++....+.+|
T Consensus        47 L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N   98 (176)
T 1a9n_A           47 IDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRI-GEGLDQALPDLTELILTNN   98 (176)
T ss_dssp             EECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEE-CSCHHHHCTTCCEEECCSC
T ss_pred             EECCCCCCCcc--cccccCCCCCEEECCCCccccc-CcchhhcCCCCCEEECCCC
Confidence            67888888864  467777 888888888888854 4322   334444445555

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=96.08  E-value=0.0038  Score=55.06  Aligned_cols=51  Identities=18%  Similarity=0.212  Sum_probs=34.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|+|++-.|..+..+ .|+.|++++|++++..|..  ...++....+.+|
T Consensus       138 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (270)
T 2o6q_A          138 LSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN  191 (270)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence            6788999886555567788 8999999999888644431  1233444445555

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=96.06  E-value=0.0036  Score=52.76  Aligned_cols=51  Identities=22%  Similarity=0.207  Sum_probs=36.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|+|++-.|..+.++ +|++||+++|++++..|..  ...++....+.+|
T Consensus        57 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N  110 (208)
T 2o6s_A           57 LYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTN  110 (208)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCC
Confidence            6899999996655567888 9999999999999654431  2334444445555

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=96.04  E-value=0.0021  Score=62.08  Aligned_cols=37  Identities=35%  Similarity=0.251  Sum_probs=33.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      ||||+|+|++..|..+..+ .|++||||+|+++|.+|-
T Consensus        39 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~l   76 (487)
T 3oja_A           39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDL   76 (487)
T ss_dssp             EECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEEC
T ss_pred             EEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCccc
Confidence            6899999999888899999 999999999999987763

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=96.03  E-value=0.0017  Score=58.65  Aligned_cols=37  Identities=19%  Similarity=0.253  Sum_probs=26.3

Q ss_pred             CccCCCcccc--ccchhh-hhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSG--EILKFL-TRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG--~iP~~l-~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|+|++  .+|..+ .++ .|++||+|+|+++|.+|.
T Consensus       206 L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  246 (312)
T 1wwl_A          206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA  246 (312)
T ss_dssp             EECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC
T ss_pred             EECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch
Confidence            5788888883  555544 455 788888888888887754

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=96.03  E-value=0.0037  Score=61.37  Aligned_cols=36  Identities=25%  Similarity=0.481  Sum_probs=23.9

Q ss_pred             CccCCCccccccchhhhhccCCeeeccCCcccccCCcc
Q 040999            1 MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPTG   38 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l~L~~ldls~N~lsG~iP~~   38 (382)
                      |||++|+|+|.+|..+. -.|++||+|+|+++ .||..
T Consensus       433 L~l~~n~l~~~~~~~l~-~~L~~L~L~~N~l~-~ip~~  468 (562)
T 3a79_B          433 LNLSSNMLTGSVFRCLP-PKVKVLDLHNNRIM-SIPKD  468 (562)
T ss_dssp             EECCSSCCCGGGGSSCC-TTCSEEECCSSCCC-CCCTT
T ss_pred             EECCCCCCCcchhhhhc-CcCCEEECCCCcCc-ccChh
Confidence            46777777777776543 25677777777777 66663

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=95.97  E-value=0.0029  Score=57.27  Aligned_cols=34  Identities=26%  Similarity=0.234  Sum_probs=20.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP   36 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP   36 (382)
                      |||++|+|++- |.. ..+ .|++||+|+|++++-.|
T Consensus       174 L~L~~N~l~~~-~~~-~~l~~L~~L~Ls~N~l~~l~~  208 (317)
T 3o53_A          174 LNLQYNFIYDV-KGQ-VVFAKLKTLDLSSNKLAFMGP  208 (317)
T ss_dssp             EECTTSCCCEE-ECC-CCCTTCCEEECCSSCCCEECG
T ss_pred             EECCCCcCccc-ccc-cccccCCEEECCCCcCCcchh
Confidence            46677777644 332 235 67777777777775433

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=95.96  E-value=0.0014  Score=59.29  Aligned_cols=37  Identities=16%  Similarity=0.284  Sum_probs=22.6

Q ss_pred             CccCCCcc-ccccchhhh-------hc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNL-SGEILKFLT-------RL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~l-sG~iP~~l~-------~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|++ ++.+|..+.       ++ .|++||+++|+++|.+|.
T Consensus        68 L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  113 (312)
T 1wwl_A           68 LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP  113 (312)
T ss_dssp             CCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred             cccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence            45666666 456665554       45 566666666666666665

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=95.86  E-value=0.0038  Score=57.36  Aligned_cols=45  Identities=27%  Similarity=0.471  Sum_probs=33.5

Q ss_pred             ccchhhhhc-cCCeeeccCCcccccCCcccc---cCCCCccccccCCCCC
Q 040999           11 EILKFLTRL-FLDNLNLSYNNLEGMVPTGVY---KNASATSVTGNSKLCG   56 (382)
Q Consensus        11 ~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~---~~~~~~~~~gn~~lcg   56 (382)
                      .||..+.++ +|+.||+++|+++ .+|...+   .++....+.+|+-.|.
T Consensus       268 ~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~  316 (353)
T 2z80_A          268 QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS  316 (353)
T ss_dssp             HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCc
Confidence            478888888 9999999999999 7887543   3444456777775553

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=95.86  E-value=0.0046  Score=56.17  Aligned_cols=51  Identities=18%  Similarity=0.184  Sum_probs=38.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|++++..|..+.++ .|++||+++|++++..|..  ...++....+.+|
T Consensus        57 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n  110 (330)
T 1xku_A           57 LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN  110 (330)
T ss_dssp             EECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence            6899999998777788888 8999999999999887762  2334444445555

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=95.86  E-value=0.0048  Score=54.48  Aligned_cols=51  Identities=22%  Similarity=0.208  Sum_probs=38.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|++++..|..+..+ .|++||+++|++++..|..  ...++....+.+|
T Consensus       114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n  167 (272)
T 3rfs_A          114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN  167 (272)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCC
Confidence            6899999998888788999 9999999999999766542  2344444455555

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.85  E-value=0.036  Score=46.81  Aligned_cols=103  Identities=13%  Similarity=0.059  Sum_probs=64.0

Q ss_pred             CCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          163 RSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       163 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      -||.+.|.         ....++++.+++.++.|.+++|.-+-.. ... ..+=+.|..|++..+|.+...+ ..+..-.
T Consensus        33 vSL~eIL~---------~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~~~~  100 (229)
T 2yle_A           33 LSLEEILR---------LYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADDAGE  100 (229)
T ss_dssp             EEHHHHHH---------HHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C------
T ss_pred             ccHHHHHH---------HcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-ccccccc
Confidence            36677773         4467899999999999999998776211 011 1233456889999999988775 2221111


Q ss_pred             CCCCCCccccCCCCCccchhHHHHHHHHHHHhcCCC
Q 040999          243 PTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKP  278 (382)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p  278 (382)
                      .....|+.. ....+.+.=|||+|+++|.-+--..|
T Consensus       101 ~~~~~pe~~-~~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          101 PPPVAGKLG-YSQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------CCS-SSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCChhhc-cccchHHHHHHHHHHHHHHHhhcCCC
Confidence            111123332 23446788899999999998865544

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=95.83  E-value=0.0048  Score=56.12  Aligned_cols=37  Identities=22%  Similarity=0.229  Sum_probs=27.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|++++-.|..+.++ .|++||+++|++++..|.
T Consensus        59 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~   96 (332)
T 2ft3_A           59 LDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK   96 (332)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGG
T ss_pred             EECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHh
Confidence            5777777776666677777 777888887777776665

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=95.80  E-value=0.0072  Score=54.94  Aligned_cols=36  Identities=22%  Similarity=0.246  Sum_probs=20.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP   36 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP   36 (382)
                      |||++|++++..|..+..+ .|+.||+++|++++..|
T Consensus       198 L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  234 (332)
T 2ft3_A          198 LHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN  234 (332)
T ss_dssp             CBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCT
T ss_pred             EECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCCh
Confidence            4555565555555555555 55555555555555444

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=95.80  E-value=0.0047  Score=58.73  Aligned_cols=51  Identities=22%  Similarity=0.130  Sum_probs=39.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|++++..|..+.++ .|++||+++|++++..|..  ...++....+.+|
T Consensus       304 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  357 (455)
T 3v47_A          304 LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYN  357 (455)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSS
T ss_pred             EECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCC
Confidence            6899999999999999999 9999999999998777752  2344444455555

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=95.79  E-value=0.0035  Score=60.16  Aligned_cols=37  Identities=24%  Similarity=0.241  Sum_probs=24.4

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      ||||+|++++..|..+..+ .|+.|++++|++++..|.
T Consensus       253 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  290 (477)
T 2id5_A          253 LNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPY  290 (477)
T ss_dssp             EECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTT
T ss_pred             eECCCCcCCccChhhccccccCCEEECCCCccceECHH
Confidence            4667777776655566666 677777777777665554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=95.77  E-value=0.0029  Score=57.30  Aligned_cols=51  Identities=27%  Similarity=0.207  Sum_probs=37.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn   51 (382)
                      |||++|++++..|..+.++ .|++||+++|++++..|-..+.++....+.+|
T Consensus        39 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n   90 (317)
T 3o53_A           39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNN   90 (317)
T ss_dssp             EECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEEETTCTTCCEEECCSS
T ss_pred             EECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchhhhhcCCCCEEECcCC
Confidence            6899999999888899999 99999999999998766322333333334444

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=95.77  E-value=0.042  Score=49.57  Aligned_cols=113  Identities=18%  Similarity=0.170  Sum_probs=65.2

Q ss_pred             HHHHHHHHHHhhccc---ccceeeeeeeeecccCCCceeEEEEecccCCCccc-----------cccCCCC-CCcccc--
Q 040999          118 KSFIAECKALRNIRH---RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK-----------WLYPISK-EDETYE--  180 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-----------~l~~~~~-~~~~~~--  180 (382)
                      ..+.+|.+.|+.+..   ..+.+++.++..     .+..++||||+++..+..           .||.... ......  
T Consensus        73 ~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~  147 (312)
T 3jr1_A           73 SMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFD  147 (312)
T ss_dssp             HHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSC
T ss_pred             HHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC
Confidence            568899999999853   456777777432     467899999999876532           1222111 000000  


Q ss_pred             ---------CCcccCHHHHH---HHH--H--------------HHHHHH-hHHh-hcCCCceeecCCCCCceeeCCCCcE
Q 040999          181 ---------RPRNLNLLRRL---NIA--I--------------DVASAL-NYLH-HDCQPVTAHCDLKPSNVLLDDDMTA  230 (382)
Q Consensus       181 ---------~~~~l~~~~~~---~i~--~--------------~i~~~L-~~lH-~~~~~~ivH~dlkp~NILl~~~~~~  230 (382)
                               ....-+|....   ++.  .              .+...+ ..|. ....+.++|+|+.+.|++++.++ +
T Consensus       148 ~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~  226 (312)
T 3jr1_A          148 TWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-I  226 (312)
T ss_dssp             EEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-E
T ss_pred             CCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-e
Confidence                     00112343221   111  1              111111 2332 12257899999999999999887 8


Q ss_pred             EEcccc
Q 040999          231 RVGDFG  236 (382)
Q Consensus       231 kl~Dfg  236 (382)
                      .|.|+.
T Consensus       227 ~~iD~~  232 (312)
T 3jr1_A          227 FVCNPA  232 (312)
T ss_dssp             EECSCC
T ss_pred             EEEcCc
Confidence            899974

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=95.75  E-value=0.0032  Score=63.33  Aligned_cols=55  Identities=22%  Similarity=0.236  Sum_probs=25.6

Q ss_pred             ccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc---cccCCCCccccccCCCCC
Q 040999            2 DFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG---VYKNASATSVTGNSKLCG   56 (382)
Q Consensus         2 dLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~---~~~~~~~~~~~gn~~lcg   56 (382)
                      |||+|+|++-.|..+.++ +|+.||+++|+|++..|..   .+.++....+.||+-.|.
T Consensus       566 ~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             ECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            445555553222223444 4555555555555444331   233444445566666654

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=95.75  E-value=0.0035  Score=62.09  Aligned_cols=51  Identities=16%  Similarity=0.169  Sum_probs=38.6

Q ss_pred             CccCCCccccc-cchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGE-ILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~-iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |+|++|+++|. +|..+..+ .|+.||+|+|++++..|..  ...++....+.+|
T Consensus       453 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N  507 (606)
T 3vq2_A          453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN  507 (606)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCC
Confidence            58899999985 78888888 8999999999999888762  2344444455555

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=95.66  E-value=0.004  Score=61.73  Aligned_cols=35  Identities=31%  Similarity=0.503  Sum_probs=23.4

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |+|++|+|+|.  ..+.++ .|+.||||+|+++|.+|.
T Consensus       237 L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~  272 (597)
T 3oja_B          237 LKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH  272 (597)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESG
T ss_pred             EECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHH
Confidence            46677777762  456666 677777777777776665

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=95.63  E-value=0.0048  Score=60.67  Aligned_cols=32  Identities=25%  Similarity=0.353  Sum_probs=16.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      ||||+|+|+ +||   ..+ +|++||+|+|+|+| ||.
T Consensus        85 L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~  117 (571)
T 3cvr_A           85 LEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE  117 (571)
T ss_dssp             EECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC
T ss_pred             EECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch
Confidence            355555555 455   223 45555555555555 554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=95.61  E-value=0.0062  Score=54.59  Aligned_cols=52  Identities=23%  Similarity=0.319  Sum_probs=40.6

Q ss_pred             CccCCCcccc-ccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCccccccC
Q 040999            1 MDFSQNNLSG-EILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG-~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn~   52 (382)
                      |+|++|.+++ .+|..+..+ .|++||+++|++++..|..  ...++....+.+|.
T Consensus       155 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  210 (306)
T 2z66_A          155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN  210 (306)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCc
Confidence            6899999998 688899999 9999999999999987762  23444444555553

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=95.61  E-value=0.0055  Score=56.56  Aligned_cols=35  Identities=40%  Similarity=0.430  Sum_probs=17.4

Q ss_pred             CccCCCccccccchhhh-hc-cCCeeeccCCcccccC
Q 040999            1 MDFSQNNLSGEILKFLT-RL-FLDNLNLSYNNLEGMV   35 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~-~l-~L~~ldls~N~lsG~i   35 (382)
                      ||||+|+|++-.|..+. ++ +|++|+|++|++++-.
T Consensus        44 L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~   80 (361)
T 2xot_A           44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFIS   80 (361)
T ss_dssp             EECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEEC
T ss_pred             EECCCCCCCccChhhhhhcccccCEEECCCCcCCccC
Confidence            35555555544444443 44 5555555555555433

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.60  E-value=0.016  Score=52.66  Aligned_cols=32  Identities=28%  Similarity=0.378  Sum_probs=28.7

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            57899999999999998888899999998753

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=95.49  E-value=0.007  Score=57.65  Aligned_cols=49  Identities=20%  Similarity=0.241  Sum_probs=34.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|+|++ +| .+..+ +|+.||+|+|++++..|..  ...++....+.+|
T Consensus       201 L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  252 (452)
T 3zyi_A          201 LNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS  252 (452)
T ss_dssp             EECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTS
T ss_pred             EECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCC
Confidence            6899999985 56 47778 8999999999999877762  2333443444444

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=95.47  E-value=0.008  Score=54.54  Aligned_cols=50  Identities=26%  Similarity=0.242  Sum_probs=33.2

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn   51 (382)
                      |||++|++++..|..+.++ .|++||+++|+++ .+|...+.++....+.+|
T Consensus        81 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~~L~~L~l~~n  131 (330)
T 1xku_A           81 LILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHEN  131 (330)
T ss_dssp             EECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSS
T ss_pred             EECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhcccccEEECCCC
Confidence            5677777777777777777 7788888888777 566644444444444444

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=95.47  E-value=0.00072  Score=64.74  Aligned_cols=36  Identities=14%  Similarity=0.031  Sum_probs=16.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |++++|+| |+||++++++ .|++||+++|+++|.+|.
T Consensus        16 L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~   52 (454)
T 1jl5_A           16 PLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPP   52 (454)
T ss_dssp             -------------------CCHHHHHHHHHHHHHTSCT
T ss_pred             hhcccCch-hhCChhHhcccchhhhhccCCcccccCCc
Confidence            57889999 8999999888 899999999999998887

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=95.41  E-value=0.0049  Score=50.45  Aligned_cols=49  Identities=16%  Similarity=0.263  Sum_probs=33.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn   51 (382)
                      |+|++|+++ .||...... .|++||+|+|++++- +. ....++....+.+|
T Consensus        24 L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N   74 (176)
T 1a9n_A           24 LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNN   74 (176)
T ss_dssp             EECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSS
T ss_pred             EEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCC
Confidence            689999999 577533334 799999999999975 43 22334444445555

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=95.39  E-value=0.0073  Score=55.73  Aligned_cols=37  Identities=24%  Similarity=0.176  Sum_probs=29.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |+|++|+|++-.|..+.++ .|++||||+|+|++-.|.
T Consensus        69 L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~  106 (361)
T 2xot_A           69 LLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEF  106 (361)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             EECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHH
Confidence            5788888887777778888 888888888888865443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=95.32  E-value=0.0061  Score=59.44  Aligned_cols=35  Identities=20%  Similarity=0.203  Sum_probs=16.0

Q ss_pred             ccCCCccccccchhhhhc-cCCeeeccCCcccccCC
Q 040999            2 DFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP   36 (382)
Q Consensus         2 dLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP   36 (382)
                      ||++|++++..|..++++ .|++||+|+|++++..|
T Consensus        56 ~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~   91 (549)
T 2z81_A           56 ILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS   91 (549)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred             ECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence            444444444444444444 44444444444444333

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=95.31  E-value=0.0062  Score=59.02  Aligned_cols=35  Identities=26%  Similarity=0.128  Sum_probs=17.2

Q ss_pred             ccCCCccccccchhhhhc-cCCeeeccCCcccccCC
Q 040999            2 DFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP   36 (382)
Q Consensus         2 dLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP   36 (382)
                      |||+|++++..|..+.++ .|++||+|+|++++..|
T Consensus        27 ~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~   62 (520)
T 2z7x_B           27 NISQNYISELWTSDILSLSKLRILIISHNRIQYLDI   62 (520)
T ss_dssp             ECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEG
T ss_pred             ECCCCcccccChhhccccccccEEecCCCccCCcCh
Confidence            445555554444444444 45555555555554444

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=95.29  E-value=0.0095  Score=53.15  Aligned_cols=50  Identities=24%  Similarity=0.308  Sum_probs=36.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      ||||+|+|+ .||..+..+ .|++|++++|++++-.|.  ....++....+.+|
T Consensus        82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N  134 (290)
T 1p9a_G           82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN  134 (290)
T ss_dssp             EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred             EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence            689999998 889888888 899999999999965554  22334444445555

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=95.25  E-value=0.0089  Score=52.98  Aligned_cols=51  Identities=16%  Similarity=0.080  Sum_probs=37.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      |||++|++++..|..+..+ .|++||+++|++++-.|.  ....++....+.+|
T Consensus       134 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  187 (285)
T 1ozn_A          134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN  187 (285)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCC
Confidence            6899999997777778899 999999999999965443  12334444445555

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=95.20  E-value=0.0048  Score=63.83  Aligned_cols=37  Identities=24%  Similarity=0.284  Sum_probs=22.8

Q ss_pred             CccCCCccc-----cccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLS-----GEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~ls-----G~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|.|+     |..|..+..+ .|+.||||+|+|+|..|.
T Consensus       456 L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  498 (844)
T 3j0a_A          456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG  498 (844)
T ss_dssp             CEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTT
T ss_pred             ccCCCCccccccccccchhhhcCcccccEEECCCCcccccChh
Confidence            566667665     3344455566 666777777777665554

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=95.18  E-value=0.0039  Score=61.33  Aligned_cols=36  Identities=17%  Similarity=0.163  Sum_probs=30.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|+|+ .||..+.++ +|+.|||++|.|+|.+|.
T Consensus       212 L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          212 FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             EECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             EecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            578888888 688888888 888889999988888886

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=95.18  E-value=0.0021  Score=53.86  Aligned_cols=48  Identities=23%  Similarity=0.217  Sum_probs=35.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      ||||+|+|++ || .+..+ .|++||+++|+++ .+|..  ...++....+.+|
T Consensus        53 L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N  103 (198)
T 1ds9_A           53 LALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYN  103 (198)
T ss_dssp             EECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEE
T ss_pred             EECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCC
Confidence            6899999998 88 88888 9999999999998 68862  2234444444444

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=95.15  E-value=0.0081  Score=59.39  Aligned_cols=37  Identities=24%  Similarity=0.202  Sum_probs=20.2

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      ||||+|++++..|..+.++ .|++||+|+|++++..|.
T Consensus        38 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   75 (606)
T 3t6q_A           38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED   75 (606)
T ss_dssp             EECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTT
T ss_pred             EEccCCccCcCChhHhccCccceEEECCCCccceeChh
Confidence            4555555555555555555 555555555555554443

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=95.12  E-value=0.01  Score=58.20  Aligned_cols=37  Identities=27%  Similarity=0.237  Sum_probs=23.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|++++..|..+.++ .|++||+++|++++..|.
T Consensus        57 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~   94 (562)
T 3a79_B           57 LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFH   94 (562)
T ss_dssp             EECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTT
T ss_pred             EECCCCCccccChhhhccCCCccEEECCCCCCCcCCHH
Confidence            4666666666655666666 666666666666665554

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=95.11  E-value=0.011  Score=58.57  Aligned_cols=37  Identities=8%  Similarity=0.185  Sum_probs=25.4

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|+|++..|..++.+ .|++|||++|+++|..|.
T Consensus        80 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  117 (597)
T 3oja_B           80 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH  117 (597)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             EECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH
Confidence            5677777776666667777 777777777777765554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=95.06  E-value=0.0099  Score=56.38  Aligned_cols=35  Identities=43%  Similarity=0.572  Sum_probs=29.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|+|+ .||. +..+ .|+.||||+|++++..|.
T Consensus       190 L~L~~n~l~-~~~~-~~~l~~L~~L~Ls~N~l~~~~~~  225 (440)
T 3zyj_A          190 LNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPG  225 (440)
T ss_dssp             EECTTSCCS-SCCC-CTTCSSCCEEECTTSCCCEECTT
T ss_pred             ecCCCCcCc-cccc-cCCCcccCEEECCCCccCccChh
Confidence            688999998 6774 6777 899999999999987775

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=95.00  E-value=0.0055  Score=60.95  Aligned_cols=36  Identities=22%  Similarity=0.218  Sum_probs=25.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|+|+ .||..+.++ +|+.|||++|.|+|.+|.
T Consensus       266 L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~  302 (622)
T 3g06_A          266 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  302 (622)
T ss_dssp             EECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred             EeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence            466677776 667777777 677777777777776665

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=94.98  E-value=0.0078  Score=55.26  Aligned_cols=43  Identities=21%  Similarity=0.378  Sum_probs=35.4

Q ss_pred             CccCCCccccccch-hhhhc-cCCeeeccCCcccccCCcccccCCC
Q 040999            1 MDFSQNNLSGEILK-FLTRL-FLDNLNLSYNNLEGMVPTGVYKNAS   44 (382)
Q Consensus         1 LdLs~N~lsG~iP~-~l~~l-~L~~ldls~N~lsG~iP~~~~~~~~   44 (382)
                      |||++|+|+ +||+ .+.++ .|++||||+|++.+.||...|..+.
T Consensus        35 L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~   79 (350)
T 4ay9_X           35 LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP   79 (350)
T ss_dssp             EEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred             EEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence            689999998 6775 67889 9999999999999999986655443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=94.93  E-value=0.011  Score=56.46  Aligned_cols=37  Identities=19%  Similarity=0.320  Sum_probs=30.2

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|+|++..|..+.++ .|++|||++|++++..|.
T Consensus        37 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~   74 (477)
T 2id5_A           37 LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG   74 (477)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT
T ss_pred             EECCCCccceECHhHccCCCCCCEEECCCCccCEeChh
Confidence            5788888888777788888 888888888888877675

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=94.86  E-value=0.012  Score=51.74  Aligned_cols=51  Identities=24%  Similarity=0.165  Sum_probs=35.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      |||++|++++..|..+.++ .|++||+++|++++..|.  ....++....+.+|
T Consensus        33 L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n   86 (276)
T 2z62_A           33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN   86 (276)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             EECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence            6889999987777788888 899999999998865553  12233444444455

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=94.86  E-value=0.0097  Score=58.24  Aligned_cols=51  Identities=16%  Similarity=0.238  Sum_probs=39.2

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCccc-ccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLE-GMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~ls-G~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|++++.+|..+..+ .|++|++++|+++ |.+|..  ...++....+.+|
T Consensus       426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n  480 (570)
T 2z63_A          426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC  480 (570)
T ss_dssp             EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred             EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCC
Confidence            6899999999999999999 9999999999998 688862  2334444445455

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=94.86  E-value=0.0048  Score=58.95  Aligned_cols=33  Identities=30%  Similarity=0.392  Sum_probs=26.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccc--cCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEG--MVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG--~iP~   37 (382)
                      |||++|+|+ +||.   .+ +|++||+++|+++|  .+|.
T Consensus       342 L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~  377 (454)
T 1jl5_A          342 LIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPE  377 (454)
T ss_dssp             EECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCT
T ss_pred             EECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChH
Confidence            578888888 5887   36 88899999999988  7886

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=94.80  E-value=0.011  Score=54.20  Aligned_cols=37  Identities=24%  Similarity=0.235  Sum_probs=21.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|++++-.|..+.++ .|++||+++|++++..|.
T Consensus        57 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~   94 (353)
T 2z80_A           57 LDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED   94 (353)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT
T ss_pred             EECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHh
Confidence            4566666665434456666 666666666666654443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=94.80  E-value=0.015  Score=52.18  Aligned_cols=52  Identities=10%  Similarity=0.066  Sum_probs=39.5

Q ss_pred             CccCCCccccccchhh--hhc-cCCeeeccCCcccccCCc-c-----cccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFL--TRL-FLDNLNLSYNNLEGMVPT-G-----VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l--~~l-~L~~ldls~N~lsG~iP~-~-----~~~~~~~~~~~gn~   52 (382)
                      |||++|+++|.+|..+  .++ .|++||+++|++++.+|. .     ...++....+.+|.
T Consensus        96 L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~  156 (310)
T 4glp_A           96 LTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAH  156 (310)
T ss_dssp             EEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCS
T ss_pred             EEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCC
Confidence            6899999999999988  778 899999999999998774 1     13344444555553

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=94.76  E-value=0.017  Score=50.91  Aligned_cols=51  Identities=14%  Similarity=0.096  Sum_probs=37.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|++++..|..+.++ .|++||+++|++++..|..  ...++....+.+|
T Consensus        57 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n  110 (276)
T 2z62_A           57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET  110 (276)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             EECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCC
Confidence            6899999997777788889 9999999999999876652  2333333344444

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=94.74  E-value=0.014  Score=51.21  Aligned_cols=48  Identities=23%  Similarity=0.319  Sum_probs=32.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn   51 (382)
                      |||++|+|++ +| .+..+ .|+.||+|+|++++. |. ....++....+.+|
T Consensus       111 L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N  160 (263)
T 1xeu_A          111 LFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGN  160 (263)
T ss_dssp             EECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTS
T ss_pred             EEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCC
Confidence            6788999987 44 57788 899999999998874 43 23344444444455

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=94.73  E-value=0.012  Score=58.23  Aligned_cols=31  Identities=32%  Similarity=0.452  Sum_probs=16.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEG   33 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG   33 (382)
                      ||||+|+|++.+|  +..+ .|+.|||++|+|++
T Consensus       158 L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~  189 (605)
T 1m9s_A          158 LSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD  189 (605)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred             EECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence            4555555555444  4455 55555555555554

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=94.67  E-value=0.021  Score=44.25  Aligned_cols=54  Identities=20%  Similarity=0.339  Sum_probs=39.1

Q ss_pred             CccCCCccc-cccchhhhhccCCeeeccCCcccccCCccccc---CCCCccccccCCCCC
Q 040999            1 MDFSQNNLS-GEILKFLTRLFLDNLNLSYNNLEGMVPTGVYK---NASATSVTGNSKLCG   56 (382)
Q Consensus         1 LdLs~N~ls-G~iP~~l~~l~L~~ldls~N~lsG~iP~~~~~---~~~~~~~~gn~~lcg   56 (382)
                      +|.|+|+|+ -+||..|. -+|+.|||++|+|+ .||.+.|.   ++....+.|||-.|.
T Consensus        13 v~Cs~~~L~~~~vP~~lp-~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~Cd   70 (130)
T 3rfe_A           13 VDCGRRGLTWASLPTAFP-VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWRCD   70 (130)
T ss_dssp             EECCSSCCCTTTSCSCCC-TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred             EEeCCCCCccccCCCCCC-cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCeecc
Confidence            367889997 67886421 16899999999999 68875544   344456788987774

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=94.63  E-value=0.02  Score=50.33  Aligned_cols=51  Identities=22%  Similarity=0.262  Sum_probs=35.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      |||++|++++-.|..+..+ +|++|++++|++++..|.  ....++....+.+|
T Consensus        90 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n  143 (270)
T 2o6q_A           90 LWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYN  143 (270)
T ss_dssp             EECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCC
Confidence            6889999987666667788 899999999999876654  22334444445555

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=94.56  E-value=0.022  Score=49.94  Aligned_cols=32  Identities=19%  Similarity=0.289  Sum_probs=19.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGM   34 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~   34 (382)
                      |||++|+++ .+| .+..+ .|++|++++|++++.
T Consensus        46 L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~   78 (263)
T 1xeu_A           46 FNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL   78 (263)
T ss_dssp             EECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC
T ss_pred             EECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC
Confidence            456666666 455 45566 666666666666653

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=94.53  E-value=0.014  Score=52.10  Aligned_cols=49  Identities=24%  Similarity=0.378  Sum_probs=31.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn   51 (382)
                      |||++|++++-  +.+..+ .|+.||+++|++++..|-....++....+.+|
T Consensus       139 L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N  188 (291)
T 1h6t_A          139 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN  188 (291)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             EEccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCC
Confidence            57888888864  467777 88888888888887555222333333344444

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=94.51  E-value=0.0074  Score=54.77  Aligned_cols=36  Identities=8%  Similarity=0.083  Sum_probs=19.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCccccc-CCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGM-VPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~-iP~   37 (382)
                      |+|++|.++|.+|. +..+ .|++||+++|++++. +|.
T Consensus        75 L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~  112 (336)
T 2ast_B           75 FRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHG  112 (336)
T ss_dssp             EECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHH
T ss_pred             EEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHH
Confidence            35566666655554 3344 566666666665554 443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=94.51  E-value=0.018  Score=55.03  Aligned_cols=32  Identities=25%  Similarity=0.263  Sum_probs=16.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP   36 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP   36 (382)
                      |+|++|+|++. |  +..+ .|++||+++|+|+| +|
T Consensus       196 L~l~~N~l~~~-~--l~~l~~L~~L~Ls~N~l~~-ip  228 (457)
T 3bz5_A          196 LNCDTNNITKL-D--LNQNIQLTFLDCSSNKLTE-ID  228 (457)
T ss_dssp             EECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC
T ss_pred             EECcCCcCCee-c--cccCCCCCEEECcCCcccc-cC
Confidence            34555555543 2  4455 55555555555555 44

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=94.39  E-value=0.0099  Score=51.18  Aligned_cols=51  Identities=12%  Similarity=0.043  Sum_probs=32.6

Q ss_pred             CccCCCc-cccccchhhhhc-cCCeeeccC-CcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNN-LSGEILKFLTRL-FLDNLNLSY-NNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~-lsG~iP~~l~~l-~L~~ldls~-N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|+ +++-.|..+..+ .|++|++++ |++++--|..  ...++....+.+|
T Consensus        60 L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n  115 (239)
T 2xwt_C           60 IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT  115 (239)
T ss_dssp             EEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEE
T ss_pred             EeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCC
Confidence            5788887 664444477788 899999998 8888544431  2233444445555

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=94.31  E-value=0.019  Score=53.32  Aligned_cols=49  Identities=24%  Similarity=0.375  Sum_probs=34.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |+|++|++++.  +.+.++ .|+.||+|+|.+++..|..  ...++....+.+|
T Consensus       231 L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  282 (390)
T 3o6n_A          231 LKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN  282 (390)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSS
T ss_pred             EECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCC
Confidence            57888988874  467788 8999999999998877762  2334444445555

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=94.30  E-value=0.071  Score=49.45  Aligned_cols=47  Identities=21%  Similarity=0.279  Sum_probs=36.9

Q ss_pred             CCceeecCCCCCceeeCCC----CcEEEccccccccCCCCCCCCccccCCCCCccchhHHHHHHHHHHH
Q 040999          209 QPVTAHCDLKPSNVLLDDD----MTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM  273 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~ell  273 (382)
                      ...++|+|+.+.||+++.+    +.+.++||..+..-                  --.|-+|..+.+..
T Consensus       219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~------------------~~~~Dla~~~~~~~  269 (379)
T 3feg_A          219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN------------------YRGFDIGNHFCEWV  269 (379)
T ss_dssp             CEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE------------------EHHHHHHHHHHHTT
T ss_pred             CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC------------------ChHHHHHHHHHHHH
Confidence            4578999999999999876    68999999887532                  12577788777765

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=94.14  E-value=0.027  Score=56.51  Aligned_cols=36  Identities=22%  Similarity=0.433  Sum_probs=17.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP   36 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP   36 (382)
                      |||++|++++..|..+.++ .|++||+++|++++..|
T Consensus        30 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~   66 (680)
T 1ziw_A           30 LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP   66 (680)
T ss_dssp             EECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCT
T ss_pred             EECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCH
Confidence            3455555554444444444 45555555555554444

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.07  E-value=0.053  Score=51.04  Aligned_cols=33  Identities=24%  Similarity=0.343  Sum_probs=29.0

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      ...++|+|++|.||+++.++ ++++||+.+..-+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            67899999999999998876 9999999987543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=94.05  E-value=0.029  Score=52.11  Aligned_cols=37  Identities=8%  Similarity=0.185  Sum_probs=24.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|++++..|..+..+ .|++||+++|++++..|.
T Consensus        74 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  111 (390)
T 3o6n_A           74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH  111 (390)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             EECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHH
Confidence            4667777766555566666 677777777777665554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=94.05  E-value=0.0093  Score=55.45  Aligned_cols=51  Identities=20%  Similarity=0.254  Sum_probs=34.5

Q ss_pred             CccCCCccc--c---ccchhhhhc-cCCeeeccCCccc----ccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLS--G---EILKFLTRL-FLDNLNLSYNNLE----GMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~ls--G---~iP~~l~~l-~L~~ldls~N~ls----G~iP~~--~~~~~~~~~~~gn   51 (382)
                      |+|++|+++  |   -+|..+..+ .|++||||+|+++    +.+|..  ...++....+.+|
T Consensus       192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n  254 (386)
T 2ca6_A          192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC  254 (386)
T ss_dssp             EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTC
T ss_pred             EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCC
Confidence            578899888  4   455577788 8999999999987    667752  2233444444444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=93.84  E-value=0.034  Score=50.90  Aligned_cols=35  Identities=20%  Similarity=0.179  Sum_probs=16.2

Q ss_pred             ccCCCccccccchh-hhhc-cCCeeeccCCcccccCCc
Q 040999            2 DFSQNNLSGEILKF-LTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         2 dLs~N~lsG~iP~~-l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      +|++|+.-+.||.. +..+ +|++||||+|+|+ .||.
T Consensus       183 ~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~  219 (350)
T 4ay9_X          183 NLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS  219 (350)
T ss_dssp             ECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCS
T ss_pred             hhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccCh
Confidence            34444444444432 3444 5555555555555 3444

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=93.78  E-value=0.025  Score=53.97  Aligned_cols=51  Identities=24%  Similarity=0.167  Sum_probs=27.2

Q ss_pred             CccCCCccccccchhhhhc--------cCCeeeccCCcccccCCcccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL--------FLDNLNLSYNNLEGMVPTGVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l--------~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn   51 (382)
                      |||++|+|+|..+..+.++        .|+.||+++|.+.|.+|.+.+..+....+.+|
T Consensus       238 L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n  296 (457)
T 3bz5_A          238 FDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHN  296 (457)
T ss_dssp             EECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTC
T ss_pred             EEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCC
Confidence            4667777776544444433        24566666666666666533333443344444

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=93.47  E-value=0.038  Score=54.90  Aligned_cols=31  Identities=26%  Similarity=0.189  Sum_probs=16.5

Q ss_pred             ccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            2 DFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         2 dLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||+|+|+ .||.   .+ +|+.||+++|+|+ .||.
T Consensus       247 ~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~  278 (622)
T 3g06_A          247 MVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPE  278 (622)
T ss_dssp             ECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCG
T ss_pred             ECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCH
Confidence            44555554 3444   23 4566666666666 5554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=93.45  E-value=0.042  Score=48.89  Aligned_cols=48  Identities=23%  Similarity=0.326  Sum_probs=35.9

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn   51 (382)
                      |||++|++++ +| .+..+ .|+.||+++|++++. +. ....++....+.+|
T Consensus       117 L~L~~n~i~~-~~-~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N  166 (291)
T 1h6t_A          117 LSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDN  166 (291)
T ss_dssp             EECTTSCCCC-CG-GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSS
T ss_pred             EECCCCcCCC-Ch-hhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCC
Confidence            6899999997 44 68888 999999999999975 54 33444544555555

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=93.39  E-value=0.03  Score=50.25  Aligned_cols=49  Identities=18%  Similarity=0.296  Sum_probs=32.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn   51 (382)
                      |||++|++++ +|. +..+ .|+.||+++|++++..|-....++....+.+|
T Consensus       156 L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N  205 (308)
T 1h6u_A          156 LSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNN  205 (308)
T ss_dssp             EECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTS
T ss_pred             EEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCC
Confidence            5788888886 444 7778 88888888888886443233334444444455

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=93.29  E-value=0.04  Score=54.56  Aligned_cols=31  Identities=29%  Similarity=0.414  Sum_probs=16.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEG   33 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG   33 (382)
                      |||++|+|++ +| .+..+ .|+.|+||+|+|++
T Consensus       114 L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~  145 (605)
T 1m9s_A          114 LSLEHNGISD-IN-GLVHLPQLESLYLGNNKITD  145 (605)
T ss_dssp             EECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCC
T ss_pred             EEecCCCCCC-Cc-cccCCCccCEEECCCCccCC
Confidence            4555666554 22 34455 55555555555554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=93.22  E-value=0.026  Score=52.34  Aligned_cols=52  Identities=21%  Similarity=0.313  Sum_probs=40.0

Q ss_pred             CccCCCccccc----cchhhhh--c-cCCeeeccCCcccc----cCCccc---ccCCCCccccccC
Q 040999            1 MDFSQNNLSGE----ILKFLTR--L-FLDNLNLSYNNLEG----MVPTGV---YKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~----iP~~l~~--l-~L~~ldls~N~lsG----~iP~~~---~~~~~~~~~~gn~   52 (382)
                      |||++|++++.    ||..|..  + +|+.|||++|++++    .+|..+   +.++....+.+|+
T Consensus       249 L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~  314 (386)
T 2ca6_A          249 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR  314 (386)
T ss_dssp             EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred             EECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence            68999999988    7777754  7 89999999999999    588743   3455555566664

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=93.19  E-value=0.045  Score=52.18  Aligned_cols=49  Identities=31%  Similarity=0.352  Sum_probs=31.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn   51 (382)
                      |+|++|++++..|  +..+ .|+.|++++|++++..|-..+.++....+.+|
T Consensus       270 L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n  319 (466)
T 1o6v_A          270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN  319 (466)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSS
T ss_pred             EECCCCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCC
Confidence            5778888886544  6677 78888888888877544333344444444444

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.14  E-value=0.2  Score=42.11  Aligned_cols=92  Identities=14%  Similarity=0.208  Sum_probs=69.3

Q ss_pred             CcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCCCccccCCCCCccch
Q 040999          182 PRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       182 ~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~D  261 (382)
                      -+..+...+++++..|+....+++     .=+|--+.|+|++++.++.+++.-.|+-..+++...          +...=
T Consensus        75 ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f~~~~~p~i~~RGik~~l~P~~~----------~ee~f  139 (215)
T 4ann_A           75 IKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFFTRDGLPIAKTRGLQNVVDPLPV----------SEAEF  139 (215)
T ss_dssp             GGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEECTTSCEEESCCEETTTBSCCCC----------CHHHH
T ss_pred             HHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEEcCCCCEEEEEccCccCCCCCCC----------CHHHH
Confidence            356788899999999998887776     346778999999999999999999998665544322          22222


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCch
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMN  288 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~  288 (382)
                      .-.+=+++..+++++..|+....+...
T Consensus       140 L~qyKAliiall~~K~~Fe~l~~G~le  166 (215)
T 4ann_A          140 LTRYKALVICAFNEKQSFDALVEGNLE  166 (215)
T ss_dssp             HHHHHHHHHHHHCTTCCHHHHHHSCGG
T ss_pred             HHHHHHHHHHHHcCCCCHHHHHcChHh
Confidence            557788899999999998765554433

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=92.88  E-value=0.033  Score=51.23  Aligned_cols=36  Identities=22%  Similarity=0.233  Sum_probs=31.3

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP   36 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP   36 (382)
                      ++||+|+++|.+|..+... +|++||+|+|++++.-+
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~   39 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSIST   39 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHH
Confidence            3689999999999988777 69999999999987666

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=92.68  E-value=0.041  Score=48.34  Aligned_cols=52  Identities=23%  Similarity=0.227  Sum_probs=33.9

Q ss_pred             CccCCC---ccccccchhhhhc-cCCeeeccCCcccc--cCCc--ccccCCCCccccccC
Q 040999            1 MDFSQN---NLSGEILKFLTRL-FLDNLNLSYNNLEG--MVPT--GVYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N---~lsG~iP~~l~~l-~L~~ldls~N~lsG--~iP~--~~~~~~~~~~~~gn~   52 (382)
                      ++++.|   .+.+.++..-.++ .|+.||||+|+|+|  .+|.  ..+.++....+.+|.
T Consensus       148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~  207 (267)
T 3rw6_A          148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNE  207 (267)
T ss_dssp             CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSC
T ss_pred             ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCc
Confidence            466777   3344343333456 89999999999999  7775  234555555565553

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=92.39  E-value=0.055  Score=51.59  Aligned_cols=32  Identities=22%  Similarity=0.242  Sum_probs=24.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGM   34 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~   34 (382)
                      |||++|+++|..|  +..+ .|+.|++++|+++|.
T Consensus       314 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             EECcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence            5788888887766  5677 788888888887764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=92.38  E-value=0.17  Score=45.75  Aligned_cols=33  Identities=27%  Similarity=0.252  Sum_probs=28.5

Q ss_pred             CCceeecCCCCCceeeCCC----CcEEEccccccccC
Q 040999          209 QPVTAHCDLKPSNVLLDDD----MTARVGDFGLARFL  241 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~----~~~kl~Dfg~a~~~  241 (382)
                      ...++|+|+.+.||+++.+    ..+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            5689999999999999874    67899999988654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=92.34  E-value=0.07  Score=47.85  Aligned_cols=49  Identities=14%  Similarity=0.223  Sum_probs=35.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn   51 (382)
                      |+|++|++++..|  +..+ .|+.||+++|++++..|-....++....+.+|
T Consensus       134 L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n  183 (308)
T 1h6u_A          134 LYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN  183 (308)
T ss_dssp             EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             EECCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCC
Confidence            6899999997554  8888 99999999999997433222334444445555

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=91.98  E-value=0.24  Score=43.75  Aligned_cols=25  Identities=48%  Similarity=0.488  Sum_probs=21.2

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEcc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGD  234 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~D  234 (382)
                      .+.++|+|+.+.||+++.++ +.+.|
T Consensus       187 ~p~LvHGDlw~gNvl~~~~g-~~~iD  211 (288)
T 3f7w_A          187 PPARIHGDLWNGNVLWQDDG-AVVID  211 (288)
T ss_dssp             CCEEECSCCSGGGEEEETTE-EEECS
T ss_pred             CCeeeecCCCCCcEEEcCCC-eEEEe
Confidence            56899999999999999887 45666

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=91.82  E-value=0.058  Score=46.24  Aligned_cols=36  Identities=11%  Similarity=0.196  Sum_probs=29.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCc-ccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNN-LEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~-lsG~iP~   37 (382)
                      |||++|++++-.|..+.++ .|++||+++|+ ++ .||.
T Consensus        36 L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~   73 (239)
T 2xwt_C           36 LKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLES   73 (239)
T ss_dssp             EEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECT
T ss_pred             EEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCH
Confidence            6889999997666688888 89999999997 55 5554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=91.36  E-value=0.084  Score=47.64  Aligned_cols=37  Identities=22%  Similarity=0.313  Sum_probs=20.3

Q ss_pred             CccCCC-ccccc-cchhhhhc--cCCeeeccCC--ccc-ccCCc
Q 040999            1 MDFSQN-NLSGE-ILKFLTRL--FLDNLNLSYN--NLE-GMVPT   37 (382)
Q Consensus         1 LdLs~N-~lsG~-iP~~l~~l--~L~~ldls~N--~ls-G~iP~   37 (382)
                      |||++| ++++. +|..+..+  +|++|++++|  +++ +.+|.
T Consensus       173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~  216 (336)
T 2ast_B          173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST  216 (336)
T ss_dssp             EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHH
T ss_pred             EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHH
Confidence            456666 66654 55555555  4666666666  344 34443

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=91.35  E-value=0.061  Score=48.38  Aligned_cols=31  Identities=29%  Similarity=0.262  Sum_probs=26.6

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLAR  239 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~  239 (382)
                      ...++|+|+++.|||++.+..+.|+||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            4579999999999999887666899998875

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=91.29  E-value=0.1  Score=40.31  Aligned_cols=31  Identities=26%  Similarity=0.340  Sum_probs=26.1

Q ss_pred             CccCCCccccccch-hhhhc-cCCeeeccCCccc
Q 040999            1 MDFSQNNLSGEILK-FLTRL-FLDNLNLSYNNLE   32 (382)
Q Consensus         1 LdLs~N~lsG~iP~-~l~~l-~L~~ldls~N~ls   32 (382)
                      |||++|+|+ .||. .+..+ .|+.|+|++|.+.
T Consensus        36 L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           36 LVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            799999999 5665 56678 8999999999775

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.03  E-value=0.18  Score=47.12  Aligned_cols=45  Identities=24%  Similarity=0.329  Sum_probs=33.9

Q ss_pred             ceeecCCCCCceee------CCCCcEEEccccccccCCCCCCCCccccCCCCCccchhHHHHHHHHHHH
Q 040999          211 VTAHCDLKPSNVLL------DDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELM  273 (382)
Q Consensus       211 ~ivH~dlkp~NILl------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~ell  273 (382)
                      .++|+|+.+.|||+      +++..++++||..|..-.                  =.|-+|..+.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~------------------~~fDlan~f~ew~  295 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNY------------------RGFDIGNHFCEWM  295 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEE------------------HHHHHHHHHHHTT
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCCC------------------chHhHHHHHHHHh
Confidence            45799999999999      456779999998875321                  2566777777765

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=90.74  E-value=0.093  Score=47.60  Aligned_cols=31  Identities=26%  Similarity=0.383  Sum_probs=18.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEG   33 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG   33 (382)
                      |||++|++++ +| .+..+ +|++|++++|++++
T Consensus       248 L~l~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~  279 (347)
T 4fmz_A          248 LEIGTNQISD-IN-AVKDLTKLKMLNVGSNQISD  279 (347)
T ss_dssp             EECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC
T ss_pred             EECCCCccCC-Ch-hHhcCCCcCEEEccCCccCC
Confidence            4566666664 33 35555 66666666666665

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=90.67  E-value=0.29  Score=43.96  Aligned_cols=31  Identities=26%  Similarity=0.200  Sum_probs=26.6

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      ...++|+|+++.||+++ + .+.++||+.+..-
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            56789999999999999 4 8999999887643

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=90.66  E-value=0.077  Score=50.22  Aligned_cols=52  Identities=15%  Similarity=0.164  Sum_probs=37.9

Q ss_pred             CccCCCccccccchhhhh-----c-cCCeeeccCCcccc----cCCcc--cccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTR-----L-FLDNLNLSYNNLEG----MVPTG--VYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~-----l-~L~~ldls~N~lsG----~iP~~--~~~~~~~~~~~gn~   52 (382)
                      ||||+|++++..+..+.+     . .|++||+++|++++    .+|..  ...++....+.+|+
T Consensus       346 L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~  409 (461)
T 1z7x_W          346 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC  409 (461)
T ss_dssp             EECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred             EEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence            689999999887777664     5 79999999999997    77763  23444445555663

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=90.28  E-value=0.1  Score=47.91  Aligned_cols=37  Identities=30%  Similarity=0.223  Sum_probs=28.4

Q ss_pred             CccCCCccccccc----hhhhhc--cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEIL----KFLTRL--FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP----~~l~~l--~L~~ldls~N~lsG~iP~   37 (382)
                      ||||+|+|++.-+    ..+.++  .|++||+|+|++++..|.
T Consensus        27 L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~   69 (362)
T 3goz_A           27 LDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSD   69 (362)
T ss_dssp             EECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHH
T ss_pred             EEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHH
Confidence            6888888887777    555555  588888888888887765

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=88.96  E-value=0.076  Score=50.26  Aligned_cols=37  Identities=22%  Similarity=0.230  Sum_probs=32.5

Q ss_pred             CccCCCccccc----cchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGE----ILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~----iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |+|++|++++.    +|..+..+ .|+.||+|+|++++..+.
T Consensus       318 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  359 (461)
T 1z7x_W          318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR  359 (461)
T ss_dssp             EECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred             eEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence            68999999987    78888888 999999999999986554

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=88.91  E-value=0.41  Score=45.54  Aligned_cols=37  Identities=16%  Similarity=0.163  Sum_probs=25.0

Q ss_pred             HHHHHHHhhcccccc-eeeeeeeeecccCCCceeEEEEecccCCCcc
Q 040999          121 IAECKALRNIRHRNL-IKVLTACLGVDYQGNDFKALVYEFIHNRSPE  166 (382)
Q Consensus       121 ~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  166 (382)
                      .+|.++++.+...++ .++++.+       .+  .+||||+++.++.
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~-------~~--G~v~e~I~G~~l~  189 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFF-------TN--GRIEEFMDGYALS  189 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEE-------TT--EEEEECCCSEECC
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEe-------CC--eEEEEeeCCccCC
Confidence            589999999975555 3566653       11  2599999875553

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.83  E-value=0.44  Score=40.18  Aligned_cols=84  Identities=20%  Similarity=0.209  Sum_probs=63.4

Q ss_pred             cccCHHHHHHHHHHHHHHHh-HHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCCCccccCCCCCccch
Q 040999          183 RNLNLLRRLNIAIDVASALN-YLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~-~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~D  261 (382)
                      +.++...+++++.+|+.... +++     .-+|--+.|+||++|.++.+++.-.|+-..+++.....+          -=
T Consensus        80 ~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~lpP~e~~ee----------~f  144 (219)
T 4ano_A           80 RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKESLPPDEWDDE----------RL  144 (219)
T ss_dssp             HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTTBSSCSCCHH----------HH
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCcccCCCCCCCHH----------HH
Confidence            45788899999999988777 666     456778999999999999999999998766654332221          12


Q ss_pred             hHHHHHHHHHHHhcCCCCCc
Q 040999          262 VYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~  281 (382)
                      .-.+=+++..++.++..|+.
T Consensus       145 l~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          145 LREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             HHHHHHHHHHHTTCSSCHHH
T ss_pred             HHHHHHHHHHHHcCCCCHHH
Confidence            45677888888888887653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=88.47  E-value=0.27  Score=44.66  Aligned_cols=33  Identities=21%  Similarity=0.349  Sum_probs=28.8

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      ...++|+|+.+.||+++.++.+.++||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            457999999999999998888999999887654

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=88.38  E-value=0.27  Score=44.50  Aligned_cols=49  Identities=12%  Similarity=0.207  Sum_probs=30.4

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn   51 (382)
                      |++++|++++..|  +..+ .|+.|++++|++++.-|-....++....+.+|
T Consensus       204 L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n  253 (347)
T 4fmz_A          204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTN  253 (347)
T ss_dssp             EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             eecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECCCC
Confidence            4678888886555  6677 78888888888876443222333333334444

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=88.35  E-value=0.24  Score=46.03  Aligned_cols=32  Identities=19%  Similarity=0.246  Sum_probs=27.2

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccccC
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL  241 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~  241 (382)
                      ...++|+|+.|.||+++.+ .+++.||..+...
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G  257 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG  257 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence            5689999999999999876 4899999887643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=87.90  E-value=0.22  Score=45.81  Aligned_cols=30  Identities=27%  Similarity=0.381  Sum_probs=25.1

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLAR  239 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~  239 (382)
                      ...++|+|+++.|||++.+. +.++||..+.
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            45789999999999998655 8999998775

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=85.82  E-value=0.25  Score=45.59  Aligned_cols=33  Identities=27%  Similarity=0.422  Sum_probs=27.1

Q ss_pred             CccCCCccccc----cchhhhhc-cCCeeeccCCcccc
Q 040999            1 MDFSQNNLSGE----ILKFLTRL-FLDNLNLSYNNLEG   33 (382)
Q Consensus         1 LdLs~N~lsG~----iP~~l~~l-~L~~ldls~N~lsG   33 (382)
                      ||||+|+|+..    |+..|... .|+.||||+|+++.
T Consensus       188 L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~  225 (372)
T 3un9_A          188 LSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD  225 (372)
T ss_dssp             EECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred             EeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence            68999999864    46667777 89999999999975

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=84.58  E-value=0.33  Score=45.71  Aligned_cols=39  Identities=21%  Similarity=0.290  Sum_probs=26.1

Q ss_pred             HHHHHHHHHHhhcccccc-eeeeeeeeecccCCCceeEEEEecccCCCc
Q 040999          118 KSFIAECKALRNIRHRNL-IKVLTACLGVDYQGNDFKALVYEFIHNRSP  165 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL  165 (382)
                      ..+.+|..+++.+...++ .++++.+       .+  .+|+||+++.++
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~-------~~--g~v~e~l~G~~l  159 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIF-------SG--GRLEEYIPSRPL  159 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEE-------TT--EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEe-------CC--CEEEEEeCCccc
Confidence            456789999998865555 4556542       11  389999986554

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=84.07  E-value=0.17  Score=49.61  Aligned_cols=26  Identities=15%  Similarity=0.144  Sum_probs=13.7

Q ss_pred             cccccchhhhh-c-cCCeeeccCCcccc
Q 040999            8 LSGEILKFLTR-L-FLDNLNLSYNNLEG   33 (382)
Q Consensus         8 lsG~iP~~l~~-l-~L~~ldls~N~lsG   33 (382)
                      +++..+..+.. + .|++|++++|++++
T Consensus       450 l~~~~~~~~~~~~~~L~~L~L~~n~l~~  477 (592)
T 3ogk_B          450 LTDLGLSYIGQYSPNVRWMLLGYVGESD  477 (592)
T ss_dssp             CCHHHHHHHHHSCTTCCEEEECSCCSSH
T ss_pred             ccHHHHHHHHHhCccceEeeccCCCCCH
Confidence            55555555444 3 45555555555554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=83.17  E-value=0.36  Score=44.54  Aligned_cols=33  Identities=30%  Similarity=0.305  Sum_probs=25.5

Q ss_pred             CccCCCccccccchhhhh-----c-cCCeeeccCCcccc
Q 040999            1 MDFSQNNLSGEILKFLTR-----L-FLDNLNLSYNNLEG   33 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~-----l-~L~~ldls~N~lsG   33 (382)
                      ||||+|+|+..-...|+.     . .|+.||||+|+++.
T Consensus       131 L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~  169 (372)
T 3un9_A          131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTA  169 (372)
T ss_dssp             EECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHH
T ss_pred             hhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCCh
Confidence            689999998765555542     3 69999999999874

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=82.08  E-value=0.44  Score=43.77  Aligned_cols=34  Identities=12%  Similarity=0.254  Sum_probs=27.0

Q ss_pred             CccCCCccccccchhhhh---c-cCCeeeccCCccccc
Q 040999            1 MDFSQNNLSGEILKFLTR---L-FLDNLNLSYNNLEGM   34 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~---l-~L~~ldls~N~lsG~   34 (382)
                      |+|++|.+++.++..+..   + .|+.||||+|+|++.
T Consensus       257 L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~  294 (362)
T 2ra8_A          257 LGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE  294 (362)
T ss_dssp             EEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred             EeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence            578888888877766664   5 799999999998874

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=81.88  E-value=0.54  Score=38.46  Aligned_cols=33  Identities=6%  Similarity=0.142  Sum_probs=21.6

Q ss_pred             CccCCC-ccccc----cchhhhhc-cCCeeeccCCcccc
Q 040999            1 MDFSQN-NLSGE----ILKFLTRL-FLDNLNLSYNNLEG   33 (382)
Q Consensus         1 LdLs~N-~lsG~----iP~~l~~l-~L~~ldls~N~lsG   33 (382)
                      |||++| +++..    |...|... +|++||||+|+++.
T Consensus        41 L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~   79 (185)
T 1io0_A           41 VNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSND   79 (185)
T ss_dssp             EECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCH
T ss_pred             EEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCCh
Confidence            577777 77643    33344445 68888888887753

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=81.50  E-value=0.44  Score=46.53  Aligned_cols=52  Identities=13%  Similarity=0.034  Sum_probs=36.4

Q ss_pred             CccCCCcccc-ccchhhhhc-cCCeeeccCCcccccCCc---ccccCCCCccccccC
Q 040999            1 MDFSQNNLSG-EILKFLTRL-FLDNLNLSYNNLEGMVPT---GVYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG-~iP~~l~~l-~L~~ldls~N~lsG~iP~---~~~~~~~~~~~~gn~   52 (382)
                      |+|++|++++ .+|..+..+ +|++|||++|.+++..+.   ....++....+.+|.
T Consensus       468 L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~  524 (592)
T 3ogk_B          468 MLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR  524 (592)
T ss_dssp             EEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred             eeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence            6789999988 566667778 899999999998765333   123444445556664

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	382
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-35
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-29
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-29
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-29
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-28
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-28
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-28
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-26
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-26
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-25
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-25
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-25
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-24
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-24
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-24
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-24
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-24
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-23
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-23
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-23
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-22
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-22
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-22
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-22
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-22
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-21
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-21
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-21
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-21
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-20
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-20
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-20
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-19
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-18
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-18
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-18
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-18
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-17
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-17
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-17
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-17
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-16
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-16
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-16
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-16
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-16
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-15
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-15
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-14
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-14
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-14
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-13
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-13
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-13
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-13
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-13
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-12
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-12
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-12
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-11
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-09
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-09
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-07

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 9e-35
 Identities = 55/278 (19%), Positives = 100/278 (35%), Gaps = 64/278 (23%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           +  ++F  E   LR  RH N++  +       Y      A+V ++    S    L+    
Sbjct: 46  QQLQAFKNEVGVLRKTRHVNILLFM------GYSTAPQLAIVTQWCEGSSLYHHLH---- 95

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                       +++ ++IA   A  ++YLH        H DLK +N+ L +D+T ++GD
Sbjct: 96  -----IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 147

Query: 235 FGLARFLPPTRTQTKYGV-----------------GNEVSTIGDVYSYGILLLELMIREK 277
           FGLA          ++                    N  S   DVY++GI+L ELM  + 
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207

Query: 278 PSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI 337
           P    +    N  +   M    ++   +  +  N                       C  
Sbjct: 208 P----YSNINNRDQIIFMVGRGYLSPDLSKVRSN-----------------------CPK 240

Query: 338 SMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK 375
           +M R+   C  +   +R     ++  ++ +  +L  PK
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILASIELLARSL--PK 276

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-29
 Identities = 33/181 (18%), Positives = 66/181 (36%), Gaps = 27/181 (14%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           +  +    I    I E + L       ++    A        +   ++  E +   S ++
Sbjct: 39  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEISICMEHMDGGSLDQ 93

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
            L           +   +       ++I V   L YL    + +  H D+KPSN+L++  
Sbjct: 94  VLK----------KAGRIPEQILGKVSIAVIKGLTYLREKHKIM--HRDVKPSNILVNSR 141

Query: 228 MTARVGDFGLARFLPPTRTQTKYGV----------GNEVSTIGDVYSYGILLLELMIREK 277
              ++ DFG++  L  +   +  G           G   S   D++S G+ L+E+ +   
Sbjct: 142 GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201

Query: 278 P 278
           P
Sbjct: 202 P 202

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-29
 Identities = 50/291 (17%), Positives = 90/291 (30%), Gaps = 57/291 (19%)

Query: 113 AFKIFKS-------FIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSP 165
           A KIF S         AE      +RH N++  + A    +        LV ++  + S 
Sbjct: 30  AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHEHGSL 88

Query: 166 EKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDC-----QPVTAHCDLKPS 220
             +L               + +   + +A+  AS L +LH +      +P  AH DLK  
Sbjct: 89  FDYL-----------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137

Query: 221 NVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG-------------------- 260
           N+L+  + T  + D GLA               + V T                      
Sbjct: 138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 197

Query: 261 --DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVV 318
             D+Y+ G++  E+  R     I  +  +  +                   + +  K+V 
Sbjct: 198 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS-----------DPSVEEMRKVVC 246

Query: 319 RGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 369
               +          E +  M +I   C   +   R+    +   L  +  
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 7e-29
 Identities = 54/264 (20%), Positives = 89/264 (33%), Gaps = 55/264 (20%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
              ++F+AE   +  +RH NL+++L        +      +V E++   S   +L     
Sbjct: 42  ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRS--- 94

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                     L     L  ++DV  A+ YL  +      H DL   NVL+ +D  A+V D
Sbjct: 95  -----RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD 146

Query: 235 FGLARFLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 285
           FGL +    T+   K  V           + ST  DV+S+GILL E+    +        
Sbjct: 147 FGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYP 202

Query: 286 DMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA 345
            + L          +  D  D                            C  ++  +   
Sbjct: 203 RIPLKDVVPRVEKGYKMDAPD---------------------------GCPPAVYEVMKN 235

Query: 346 CSMESPQDRMKMTNVVHELQSIKN 369
           C       R     +  +L+ IK 
Sbjct: 236 CWHLDAAMRPSFLQLREQLEHIKT 259

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 5e-28
 Identities = 43/263 (16%), Positives = 96/263 (36%), Gaps = 61/263 (23%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
            +F+AE   ++ ++H+ L+++            +   ++ E++ N S   +L        
Sbjct: 53  DAFLAEANLMKQLQHQRLVRLY------AVVTQEPIYIITEYMENGSLVDFLK------- 99

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                  L + + L++A  +A  + ++         H DL+ +N+L+ D ++ ++ DFGL
Sbjct: 100 -TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGL 155

Query: 238 ARFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           AR +       + G                  +   DV+S+GILL E++   +       
Sbjct: 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP----- 210

Query: 285 GDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV 344
                  +  M  P  ++++     +   +                    C   + ++  
Sbjct: 211 -------YPGMTNPEVIQNLERGYRMVRPDN-------------------CPEELYQLMR 244

Query: 345 ACSMESPQDRMKMTNVVHELQSI 367
            C  E P+DR     +   L+  
Sbjct: 245 LCWKERPEDRPTFDYLRSVLEDF 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 5e-28
 Identities = 36/212 (16%), Positives = 82/212 (38%), Gaps = 26/212 (12%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F  E + L+ ++H N+++   +      +G     LV E + + + + +L        
Sbjct: 53  QRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYL-------- 103

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFG 236
             +R + + +    +    +   L +LH    P+  H DLK  N+ +     + ++GD G
Sbjct: 104 --KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI-IHRDLKCDNIFITGPTGSVKIGDLG 160

Query: 237 LARFLPPTRTQTKYG---------VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM 287
           LA     +  +   G            +     DVY++G+ +LE+   E P    +    
Sbjct: 161 LATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP----YSECQ 216

Query: 288 NLHKFAKMALPNHVKDIVDSILLNDDEKLVVR 319
           N  +  +           D + + + ++++  
Sbjct: 217 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 7e-28
 Identities = 45/218 (20%), Positives = 79/218 (36%), Gaps = 29/218 (13%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           +  ++E   LR ++H N+++     +    + N    +V E+         +   +KE +
Sbjct: 48  QMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQ 104

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLH--HDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
             +          L +   +  AL   H   D      H DLKP+NV LD     ++GDF
Sbjct: 105 YLDEEF------VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158

Query: 236 GLARFLPPTRTQTK------------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMF 283
           GLAR L    +  K                   +   D++S G LL EL     P     
Sbjct: 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218

Query: 284 EGDM--NLHKFAKMALPNHV----KDIVDSILLNDDEK 315
           + ++   + +     +P        +I+  +L   D  
Sbjct: 219 QKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYH 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  105 bits (262), Expect = 2e-26
 Identities = 44/277 (15%), Positives = 96/277 (34%), Gaps = 65/277 (23%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           L+     K  + F++E   +    H N+I +           +    ++ EF+ N S + 
Sbjct: 62  LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDS 116

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
           +           +      +++ + +   +A+ + YL         H DL   N+L++ +
Sbjct: 117 F---------LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV---HRDLAARNILVNSN 164

Query: 228 MTARVGDFGLARFLPPTRTQT-----------------KYGVGNEVSTIGDVYSYGILLL 270
           +  +V DFGL+RFL    +                   +     + ++  DV+SYGI++ 
Sbjct: 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 224

Query: 271 ELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKIN 330
           E+M   +              +  M   + +  I     L                    
Sbjct: 225 EVMSYGERP------------YWDMTNQDVINAIEQDYRLPPPM---------------- 256

Query: 331 VIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 367
              +C  ++ ++ + C  +    R K   +V+ L  +
Sbjct: 257 ---DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 5e-26
 Identities = 47/282 (16%), Positives = 87/282 (30%), Gaps = 63/282 (22%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           L           F+ E   +++  H N++ +L  C     +      +V  ++ +     
Sbjct: 63  LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEGSPLVVLPYMKHGDLRN 118

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
           +               N  +   +   + VA  +            H DL   N +LD+ 
Sbjct: 119 F---------IRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEK 166

Query: 228 MTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG----------------DVYSYGILLLE 271
            T +V DFGLAR +      + +        +                 DV+S+G+LL E
Sbjct: 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226

Query: 272 LMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV 331
           LM R  P       D+N               ++    L   E                 
Sbjct: 227 LMTRGAP----PYPDVNTFDITVY--------LLQGRRLLQPE----------------- 257

Query: 332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLG 373
              C   +  + + C     + R   + +V  + +I +T +G
Sbjct: 258 --YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  103 bits (256), Expect = 1e-25
 Identities = 52/288 (18%), Positives = 96/288 (33%), Gaps = 67/288 (23%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           L+ + +  +   F  E   +    + N++K+L  C            L++E++      +
Sbjct: 51  LKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNE 105

Query: 168 WLYPISKEDETY--------------ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA 213
           +L  +S                      P  L+   +L IA  VA+ + YL         
Sbjct: 106 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV--- 162

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV--------------GNEVSTI 259
           H DL   N L+ ++M  ++ DFGL+R +         G                N  +T 
Sbjct: 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 222

Query: 260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVR 319
            DV++YG++L E+                   +  MA    +  + D  +L   E     
Sbjct: 223 SDVWAYGVVLWEIFSYGLQP------------YYGMAHEEVIYYVRDGNILACPE----- 265

Query: 320 GDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 367
                          C + +  +   C  + P DR    ++   LQ +
Sbjct: 266 --------------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 6e-25
 Identities = 39/220 (17%), Positives = 84/220 (38%), Gaps = 41/220 (18%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
            +      E +   ++RH N++++                L+ E+    +  + L     
Sbjct: 48  GVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATRVYLILEYAPLGTVYREL----- 97

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                ++    +  R      ++A+AL+Y H   + V  H D+KP N+LL      ++ D
Sbjct: 98  -----QKLSKFDEQRTATYITELANALSYCHS--KRV-IHRDIKPENLLLGSAGELKIAD 149

Query: 235 FGLARFLPPTRTQTKYG----------VGNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           FG +   P +R  T  G           G       D++S G+L  E ++ + P    FE
Sbjct: 150 FGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FE 205

Query: 285 GDMNLHKFAKMA---------LPNHVKDIVDSILLNDDEK 315
            +     + +++         +    +D++  +L ++  +
Sbjct: 206 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQ 245

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  100 bits (251), Expect = 9e-25
 Identities = 45/223 (20%), Positives = 76/223 (34%), Gaps = 44/223 (19%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           + ++  I E + L+ +RH N I+                 LV E+    + +        
Sbjct: 57  EKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEV---- 107

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                   + L  +    +       L YLH     +  H D+K  N+LL +    ++GD
Sbjct: 108 ------HKKPLQEVEIAAVTHGALQGLAYLHS--HNM-IHRDVKAGNILLSEPGLVKLGD 158

Query: 235 FGLARFLPPTRTQ--TKYGVGNEV---------STIGDVYSYGILLLELMIREKPSDIMF 283
           FG A  + P  +   T Y +  EV             DV+S GI  +EL  R+ P     
Sbjct: 159 FGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----L 214

Query: 284 EGDMNLHKFAKMA-----------LPNHVKDIVDSILLNDDEK 315
                +     +A              + ++ VDS L    + 
Sbjct: 215 FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 1e-24
 Identities = 47/275 (17%), Positives = 100/275 (36%), Gaps = 63/275 (22%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           L+     K    F+ E   +    H N+I++                ++ E++ N + +K
Sbjct: 44  LKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDK 98

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
           +           E+    ++L+ + +   +A+ + YL +       H DL   N+L++ +
Sbjct: 99  F---------LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV---HRDLAARNILVNSN 146

Query: 228 MTARVGDFGLARFLPPTRTQTKYGVG---------------NEVSTIGDVYSYGILLLEL 272
           +  +V DFGL+R L      T    G                + ++  DV+S+GI++ E+
Sbjct: 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206

Query: 273 MIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI 332
           M   +        +++ H+  K         I D   L                      
Sbjct: 207 MTYGER----PYWELSNHEVMKA--------INDGFRLPTPM------------------ 236

Query: 333 IECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 367
            +C  ++ ++ + C  +    R K  ++V  L  +
Sbjct: 237 -DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.8 bits (248), Expect = 1e-24
 Identities = 48/271 (17%), Positives = 101/271 (37%), Gaps = 61/271 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++F+ E + ++ +RH  L+++            +   +V E++   S   +L        
Sbjct: 57  EAFLQEAQVMKKLRHEKLVQLY------AVVSEEPIYIVTEYMSKGSLLDFLK------- 103

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             E  + L L + +++A  +AS + Y+         H DL+ +N+L+ +++  +V DFGL
Sbjct: 104 -GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 159

Query: 238 ARFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           AR +       + G                  +   DV+S+GILL EL  + +     + 
Sbjct: 160 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYP 216

Query: 285 GDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV 344
           G +N             ++++D +                         EC  S+  +  
Sbjct: 217 GMVN-------------REVLDQVERGYRMPC---------------PPECPESLHDLMC 248

Query: 345 ACSMESPQDRMKMTNVVHELQSIKNTLLGPK 375
            C  + P++R     +   L+    +     
Sbjct: 249 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.0 bits (246), Expect = 2e-24
 Identities = 39/282 (13%), Positives = 83/282 (29%), Gaps = 64/282 (22%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           L+        +  + E + +  + +  +++++  C            LV E        K
Sbjct: 44  LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHK 97

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
           +L           +   + +     +   V+  + YL         H DL   NVLL + 
Sbjct: 98  FLV---------GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNR 145

Query: 228 MTARVGDFGLARFLPPTRTQTK---------------YGVGNEVSTIGDVYSYGILLLEL 272
             A++ DFGL++ L    +                       + S+  DV+SYG+ + E 
Sbjct: 146 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205

Query: 273 MIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI 332
           +   +     ++  M   +           +                             
Sbjct: 206 LSYGQKP---YKK-MKGPEVMAFIEQGKRMECPP-------------------------- 235

Query: 333 IECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP 374
            EC   +  +   C +   +DR     V   +++   +L   
Sbjct: 236 -ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.3 bits (247), Expect = 2e-24
 Identities = 44/227 (19%), Positives = 77/227 (33%), Gaps = 50/227 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + ++ E   L +  H N++K+L A         +   ++ EF    + +  +        
Sbjct: 54  EDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVML------- 101

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             E  R L   +   +      ALNYLH +      H DLK  N+L   D   ++ DFG+
Sbjct: 102 --ELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGV 156

Query: 238 ARFLPPTRTQTKYGVGN-----------------EVSTIGDVYSYGILLLELMIREKPSD 280
           +     T  +    +G                        DV+S GI L+E+   E P  
Sbjct: 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-- 214

Query: 281 IMFEGDMNLHKFAKMA------------LPNHVKDIVDSILLNDDEK 315
                   +    K+A              ++ KD +   L  + + 
Sbjct: 215 --HHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.0 bits (246), Expect = 3e-24
 Identities = 44/263 (16%), Positives = 94/263 (35%), Gaps = 60/263 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + F+ E   ++ I+H NL+++L  C            ++ EF+   +   +L        
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLR------- 105

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                + ++ +  L +A  ++SA+ YL    +    H DL   N L+ ++   +V DFGL
Sbjct: 106 -ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 161

Query: 238 ARFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           +R +         G               N+ S   DV+++G+LL E+            
Sbjct: 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----PY 217

Query: 285 GDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV 344
             ++L +  ++   ++  +  +                            C   +  +  
Sbjct: 218 PGIDLSQVYELLEKDYRMERPE---------------------------GCPEKVYELMR 250

Query: 345 ACSMESPQDRMKMTNVVHELQSI 367
           AC   +P DR     +    +++
Sbjct: 251 ACWQWNPSDRPSFAEIHQAFETM 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 2e-23
 Identities = 52/287 (18%), Positives = 84/287 (29%), Gaps = 66/287 (22%)

Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
           L+ +      ++ ++E K +  +  H N++ +L AC       +    L++E+       
Sbjct: 75  LKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLL 129

Query: 167 KWL-------------YPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTA 213
            +L             Y   K  E  E    L     L  A  VA  + +L    +    
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCV- 186

Query: 214 HCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV--------------GNEVSTI 259
           H DL   NVL+      ++ DFGLAR +         G                   +  
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246

Query: 260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVR 319
            DV+SYGILL E+          + G      F K+       D                
Sbjct: 247 SDVWSYGILLWEIFSLGVN---PYPGIPVDANFYKLIQNGFKMDQPF------------- 290

Query: 320 GDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQS 366
                              +  I  +C     + R    N+   L  
Sbjct: 291 --------------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 2e-23
 Identities = 48/283 (16%), Positives = 79/283 (27%), Gaps = 61/283 (21%)

Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
           L+        ++ ++E K L  +  H N++ +L AC            ++ E+       
Sbjct: 61  LKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC-----TIGGPTLVITEYCCYGDLL 115

Query: 167 KWL--------YPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLK 218
            +L           +      +    L+L   L+ +  VA  + +L         H DL 
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172

Query: 219 PSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGV--------------GNEVSTIGDVYS 264
             N+LL      ++ DFGLAR +         G                   +   DV+S
Sbjct: 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232

Query: 265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQ 324
           YGI L EL             D   +K  K        +                     
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE--------------------- 271

Query: 325 TQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 367
                         M  I   C    P  R     +V  ++  
Sbjct: 272 ---------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.9 bits (238), Expect = 2e-23
 Identities = 48/266 (18%), Positives = 90/266 (33%), Gaps = 61/266 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           + FI E + +  + H  L+++   C            LV+EF+ +     +         
Sbjct: 45  EDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPICLVFEFMEHGCLSDY--------- 90

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
              +         L + +DV   + YL   C     H DL   N L+ ++   +V DFG+
Sbjct: 91  LRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGM 147

Query: 238 ARFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
            RF+   +  +  G               +  S+  DV+S+G+L+ E+    K       
Sbjct: 148 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI----PY 203

Query: 285 GDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV 344
            + +  +         V+DI     L                            + +I  
Sbjct: 204 ENRSNSEV--------VEDISTGFRLYKPR-------------------LASTHVYQIMN 236

Query: 345 ACSMESPQDRMKMTNVVHELQSIKNT 370
            C  E P+DR   + ++ +L  I  +
Sbjct: 237 HCWKERPEDRPAFSRLLRQLAEIAES 262

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 1e-22
 Identities = 46/276 (16%), Positives = 82/276 (29%), Gaps = 63/276 (22%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           LR   + K  K  + E   + ++ + ++ ++L  CL           L+ + +       
Sbjct: 46  LREATSPKANKEILDEAYVMASVDNPHVCRLLGICL------TSTVQLITQLMPFGCLLD 99

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
           +           E   N+     LN  + +A  +NYL         H DL   NVL+   
Sbjct: 100 Y---------VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV---HRDLAARNVLVKTP 147

Query: 228 MTARVGDFGLARFLPPTRTQTK--------------YGVGNEVSTIGDVYSYGILLLELM 273
              ++ DFGLA+ L     +                  +    +   DV+SYG+ + ELM
Sbjct: 148 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207

Query: 274 IREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII 333
                        +   + + +                                      
Sbjct: 208 TFGSK----PYDGIPASEISSILEKGERLPQPP--------------------------- 236

Query: 334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN 369
            C I +  I V C M     R K   ++ E   +  
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 2e-22
 Identities = 49/278 (17%), Positives = 94/278 (33%), Gaps = 57/278 (20%)

Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
           ++   +    + F  E + L  +  H N+I +L AC     +   +  L  E+  + +  
Sbjct: 45  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLL 99

Query: 167 KWLYPISKEDE------TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPS 220
            +L      +              L+  + L+ A DVA  ++YL    Q    H DL   
Sbjct: 100 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAAR 156

Query: 221 NVLLDDDMTARVGDFGLARFLPPTRTQTKYGV-----------GNEVSTIGDVYSYGILL 269
           N+L+ ++  A++ DFGL+R       +T   +            +  +T  DV+SYG+LL
Sbjct: 157 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216

Query: 270 LELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKI 329
            E++             M   +  +     +  +                          
Sbjct: 217 WEIVSLGGT----PYCGMTCAELYEKLPQGYRLEKPL----------------------- 249

Query: 330 NVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 367
                C   +  +   C  E P +R     ++  L  +
Sbjct: 250 ----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.2 bits (231), Expect = 2e-22
 Identities = 44/263 (16%), Positives = 83/263 (31%), Gaps = 61/263 (23%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
             FI E K + N+ H  L+++   C            ++ E++ N     +L        
Sbjct: 44  DEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFIITEYMANGCLLNYLRE------ 92

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                      + L +  DV  A+ YL         H DL   N L++D    +V DFGL
Sbjct: 93  ---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGL 146

Query: 238 ARFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           +R++      +  G               ++ S+  D++++G+L+ E+    K     +E
Sbjct: 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YE 203

Query: 285 GDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV 344
              N               I   + L                            +  I  
Sbjct: 204 RFTNSETAEH---------IAQGLRLYRPH-------------------LASEKVYTIMY 235

Query: 345 ACSMESPQDRMKMTNVVHELQSI 367
           +C  E   +R     ++  +  +
Sbjct: 236 SCWHEKADERPTFKILLSNILDV 258

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.4 bits (229), Expect = 4e-22
 Identities = 36/233 (15%), Positives = 73/233 (31%), Gaps = 45/233 (19%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           +  + A    ++   E    + + H N++K          +  + + L  E+        
Sbjct: 38  VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQYLFLEYCSGGELFD 92

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
            +          E    +           + + + YLH        H D+KP N+LLD+ 
Sbjct: 93  RI----------EPDIGMPEPDAQRFFHQLMAGVVYLHGIGI---THRDIKPENLLLDER 139

Query: 228 MTARVGDFGLARFLPPTRTQTKYGVGNEVSTIG-----------------DVYSYGILLL 270
              ++ DFGLA        +          T+                  DV+S GI+L 
Sbjct: 140 DNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 197

Query: 271 ELMIREKPSDIMFEGDMNLHKFAKM--------ALPNHVKDIVDSILLNDDEK 315
            ++  E P D   +       + +          + +    ++  IL+ +   
Sbjct: 198 AMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSA 250

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.0 bits (228), Expect = 8e-22
 Identities = 41/222 (18%), Positives = 80/222 (36%), Gaps = 47/222 (21%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           +  I E   +R  ++ N++  L +         D   +V E++   S    +     ++ 
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEG 116

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                      +   +  +   AL +LH +      H D+K  N+LL  D + ++ DFG 
Sbjct: 117 -----------QIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162

Query: 238 ARFLPPTRTQTKYGVG------------NEVSTIGDVYSYGILLLELMIREKPSDIMFEG 285
              + P +++    VG                   D++S GI+ +E++  E P    +  
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLN 218

Query: 286 DMNLHKFAKMA------------LPNHVKDIVDSILLNDDEK 315
           +  L     +A            L    +D ++  L  D EK
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.8 bits (227), Expect = 1e-21
 Identities = 38/275 (13%), Positives = 92/275 (33%), Gaps = 53/275 (19%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           +    + +    F+ E   ++     +++++L               ++ E +     + 
Sbjct: 58  VNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKS 112

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
           +L  +             +L + + +A ++A  + YL+ +      H DL   N ++ +D
Sbjct: 113 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 169

Query: 228 MTARVGDFGLARFLPPTRTQTKYGVG--------------NEVSTIGDVYSYGILLLELM 273
            T ++GDFG+ R +  T    K G G                 +T  DV+S+G++L E+ 
Sbjct: 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229

Query: 274 IREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVII 333
              +         ++  +  +  +   + D  D                           
Sbjct: 230 TLAEQ----PYQGLSNEQVLRFVMEGGLLDKPD--------------------------- 258

Query: 334 ECVISMVRIGVACSMESPQDRMKMTNVVHELQSIK 368
            C   +  +   C   +P+ R     ++  ++   
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.6 bits (224), Expect = 2e-21
 Identities = 48/266 (18%), Positives = 79/266 (29%), Gaps = 63/266 (23%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
             FI E  A+ ++ HRNLI++    L           +V E     S             
Sbjct: 56  DDFIREVNAMHSLDHRNLIRLYGVVL------TPPMKMVTELAPLGSLLDR--------- 100

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
             +   +  L      A+ VA  + YL         H DL   N+LL      ++GDFGL
Sbjct: 101 LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGL 157

Query: 238 ARFLPPTRTQT---------------KYGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 282
            R LP                     +       S   D + +G+ L E+    +     
Sbjct: 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---P 214

Query: 283 FEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI 342
           + G              +   I+  I    +              ++    +C   +  +
Sbjct: 215 WIGL-------------NGSQILHKIDKEGE--------------RLPRPEDCPQDIYNV 247

Query: 343 GVACSMESPQDRMKMTNVVHELQSIK 368
            V C    P+DR     +   L   +
Sbjct: 248 MVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.2 bits (223), Expect = 3e-21
 Identities = 40/265 (15%), Positives = 82/265 (30%), Gaps = 65/265 (24%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
              +AE   ++ + +  +++++  C        +   LV E        K+L        
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGICE------AESWMLVMEMAELGPLNKYLQ------- 99

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
              + R++     + +   V+  + YL         H DL   NVLL     A++ DFGL
Sbjct: 100 ---QNRHVKDKNIIELVHQVSMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGL 153

Query: 238 ARFLPPTRTQTK---------------YGVGNEVSTIGDVYSYGILLLELMIREKPSDIM 282
           ++ L       K                    + S+  DV+S+G+L+ E     +     
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK---P 210

Query: 283 FEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI 342
           + G                 ++   +   +               ++     C   M  +
Sbjct: 211 YRGM-------------KGSEVTAMLEKGE---------------RMGCPAGCPREMYDL 242

Query: 343 GVACSMESPQDRMKMTNVVHELQSI 367
              C     ++R     V   L++ 
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNY 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.6 bits (221), Expect = 7e-21
 Identities = 45/266 (16%), Positives = 85/266 (31%), Gaps = 28/266 (10%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           L+        ++ ++E K L +I H   +  L    G   +      ++ EF    +   
Sbjct: 51  LKEGATHSEHRALMSELKILIHIGHHLNVVNLL---GACTKPGGPLMVIVEFCKFGNLST 107

Query: 168 WLYPISKEDETYE------RPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSN 221
           +L     E   Y+          L L   +  +  VA  + +L         H DL   N
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 164

Query: 222 VLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDI 281
           +LL +    ++ DFGLAR +       + G          +       +   +    SD+
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKG-----DARLPLKWMAPETIFDRVYTIQSDV 219

Query: 282 MFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR 341
              G +    F+  A P     I +        + +  G       ++         M +
Sbjct: 220 WSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRLKEGT------RMRAPDYTTPEMYQ 268

Query: 342 IGVACSMESPQDRMKMTNVVHELQSI 367
             + C    P  R   + +V  L ++
Sbjct: 269 TMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.3 bits (218), Expect = 1e-20
 Identities = 37/276 (13%), Positives = 91/276 (32%), Gaps = 68/276 (24%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
            ++  +  + + F+ E   +R   H +++K++           +   ++ E         
Sbjct: 43  CKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ENPVWIIMELCTLGELRS 96

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
           +            R  +L+L   +  A  +++AL YL         H D+   NVL+  +
Sbjct: 97  F---------LQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSN 144

Query: 228 MTARVGDFGLARFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMI 274
              ++GDFGL+R++  +                         ++  DV+ +G+ + E+++
Sbjct: 145 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 204

Query: 275 REKPSDIMFEGD---MNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV 331
                    + +     +    ++ +P +    + S++                      
Sbjct: 205 HGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT--------------------- 243

Query: 332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 367
                         C    P  R + T +  +L +I
Sbjct: 244 -------------KCWAYDPSRRPRFTELKAQLSTI 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 89.4 bits (221), Expect = 2e-20
 Identities = 38/224 (16%), Positives = 76/224 (33%), Gaps = 47/224 (20%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           ++   E + +  +RH  L+ +  A      + ++   ++YEF+      + +        
Sbjct: 68  ETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVA------- 115

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV--GDF 235
             +    ++    +     V   L ++H +      H DLKP N++     +  +   DF
Sbjct: 116 --DEHNKMSEDEAVEYMRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDF 170

Query: 236 GLARFLPPTRTQTKYGV-----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           GL   L P ++                 G  V    D++S G+L   L+    P    F 
Sbjct: 171 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FG 226

Query: 285 GDMNLHKFAKMA-------------LPNHVKDIVDSILLNDDEK 315
           G+ +      +              +    KD +  +LL D   
Sbjct: 227 GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.4 bits (216), Expect = 4e-20
 Identities = 41/221 (18%), Positives = 73/221 (33%), Gaps = 45/221 (20%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
                E   +  + H   +K+         Q ++       +  N    K++  I   DE
Sbjct: 53  PYVTRERDVMSRLDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDE 107

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
           T                   A  ++ L +       H DLKP N+LL++DM  ++ DFG 
Sbjct: 108 T-------------CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 154

Query: 238 ARFLPPTRTQTKYGV--------------GNEVSTIGDVYSYGILLLELMIREKPSDIMF 283
           A+ L P   Q +                         D+++ G ++ +L+    P    F
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----F 210

Query: 284 EGDMNLHKFAKMA---------LPNHVKDIVDSILLNDDEK 315
                   F K+               +D+V+ +L+ D  K
Sbjct: 211 RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATK 251

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 85.6 bits (211), Expect = 4e-19
 Identities = 32/229 (13%), Positives = 73/229 (31%), Gaps = 37/229 (16%)

Query: 106 SHLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSP 165
             ++ +    +  +       +       ++ +  A         D  + + + ++    
Sbjct: 40  KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDL 94

Query: 166 EKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD 225
              L           +    +       A ++   L ++H+       + DLKP+N+LLD
Sbjct: 95  HYHL----------SQHGVFSEADMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLD 141

Query: 226 DDMTARVGDFGLARFLPPTRTQTKYGV-----------GNEVSTIGDVYSYGILLLELMI 274
           +    R+ D GLA      +     G            G    +  D +S G +L +L+ 
Sbjct: 142 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 201

Query: 275 REKPSDIMFEGDM----NLHKFAKMALPNHV----KDIVDSILLNDDEK 315
              P       D      +     + LP+      + +++ +L  D  +
Sbjct: 202 GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 250

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 82.4 bits (203), Expect = 3e-18
 Identities = 36/224 (16%), Positives = 70/224 (31%), Gaps = 47/224 (20%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
            +   E   +  + H  LI +  A      +      L+ EF+        +        
Sbjct: 71  YTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRI-------- 117

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD--DDMTARVGDF 235
                  ++    +N        L ++H   +    H D+KP N++ +     + ++ DF
Sbjct: 118 -AAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDF 173

Query: 236 GLARFLPPTRTQTKYGV-----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           GLA  L P                       V    D+++ G+L   L+    P    F 
Sbjct: 174 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FA 229

Query: 285 GDMNLHKFAKMA-------------LPNHVKDIVDSILLNDDEK 315
           G+ +L     +              +    KD + ++L  +  K
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 273

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.0 bits (202), Expect = 4e-18
 Identities = 41/224 (18%), Positives = 75/224 (33%), Gaps = 47/224 (20%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
                E   L   RHRN++ +  +      +  +   +++EFI      + +        
Sbjct: 46  VLVKKEISILNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERIN------- 93

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARV--GDF 235
                  LN    ++    V  AL +LH        H D++P N++     ++ +   +F
Sbjct: 94  --TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEF 148

Query: 236 GLARFLPPTRTQTKYGV-----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           G AR L P                     + VST  D++S G L+  L+    P    F 
Sbjct: 149 GQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP----FL 204

Query: 285 GDMNLHKFAKMA-------------LPNHVKDIVDSILLNDDEK 315
            + N      +              +     D VD +L+ + + 
Sbjct: 205 AETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKS 248

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.4 bits (200), Expect = 5e-18
 Identities = 42/194 (21%), Positives = 73/194 (37%), Gaps = 35/194 (18%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
            I ++ + E K L+ + H N+I +L A            +LV++F+              
Sbjct: 42  GINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISLVFDFMETD----------L 86

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
           E    +    L         +     L YLH        H DLKP+N+LLD++   ++ D
Sbjct: 87  EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLAD 143

Query: 235 FGLARFLPPTRTQTKYGVG-------------NEVSTIGDVYSYGILLLELMIREKPSDI 281
           FGLA+          + V                     D+++ G +L EL++R      
Sbjct: 144 FGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF--- 200

Query: 282 MFEGDMNLHKFAKM 295
              GD +L +  ++
Sbjct: 201 -LPGDSDLDQLTRI 213

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.1 bits (199), Expect = 6e-18
 Identities = 51/281 (18%), Positives = 89/281 (31%), Gaps = 60/281 (21%)

Query: 108 LRHQGAFKIFKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
           L+     K     I+E + ++ I +H+N+I +L AC       +    ++ E+    +  
Sbjct: 53  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLR 107

Query: 167 KWLYPISKEDETYERP------RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPS 220
           ++L         Y           L+    ++ A  VA  + YL         H DL   
Sbjct: 108 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR 164

Query: 221 NVLLDDDMTARVGDFGLARFLPPTRTQTKYGV--------------GNEVSTIGDVYSYG 266
           NVL+ +D   ++ DFGLAR +       K                     +   DV+S+G
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224

Query: 267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQ 326
           +LL E+              + + +  K+    H  D                       
Sbjct: 225 VLLWEIFTLGGS----PYPGVPVEELFKLLKEGHRMDKPS-------------------- 260

Query: 327 AKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI 367
                   C   +  +   C    P  R     +V +L  I
Sbjct: 261 -------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 79.7 bits (196), Expect = 1e-17
 Identities = 47/247 (19%), Positives = 84/247 (34%), Gaps = 45/247 (18%)

Query: 96  ALSICFFFGFSHLRHQGAFKIFKSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKA 154
           A+ I    G      +   ++ ++ + E   LR +  H N+I++         + N F  
Sbjct: 32  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-----ETNTFFF 86

Query: 155 LVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAH 214
           LV++ +       +L               L+      I   +   +  LH        H
Sbjct: 87  LVFDLMKKGELFDYL----------TEKVTLSEKETRKIMRALLEVICALHKLNI---VH 133

Query: 215 CDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKY-----------------GVGNEVS 257
            DLKP N+LLDDDM  ++ DFG +  L P     +                         
Sbjct: 134 RDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYG 193

Query: 258 TIGDVYSYGILLLELMIREKPSD---------IMFEGDMNLHKFAKMALPNHVKDIVDSI 308
              D++S G+++  L+    P           ++  G+            + VKD+V   
Sbjct: 194 KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 253

Query: 309 LLNDDEK 315
           L+   +K
Sbjct: 254 LVVQPQK 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 80.1 bits (197), Expect = 2e-17
 Identities = 36/219 (16%), Positives = 69/219 (31%), Gaps = 40/219 (18%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           K  +    E   L  + H  +I++         Q      ++ ++I        L    +
Sbjct: 46  KQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQR 100

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                                  A     L +       + DLKP N+LLD +   ++ D
Sbjct: 101 FPNPV-------------AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITD 147

Query: 235 FGLARFLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 285
           FG A+++P                       +   D +S+GIL+ E++    P    F  
Sbjct: 148 FGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYD 203

Query: 286 DMNLHKFAKMA---------LPNHVKDIVDSILLNDDEK 315
              +  + K+              VKD++  ++  D  +
Sbjct: 204 SNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQ 242

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.1 bits (194), Expect = 5e-17
 Identities = 35/192 (18%), Positives = 75/192 (39%), Gaps = 28/192 (14%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGND-FKALVYEFIHNRSPEKWLYPISKED 176
           +    E + +R + H N++++         + ++ +  LV +++         +    + 
Sbjct: 58  RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK- 116

Query: 177 ETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD-MTARVGDF 235
                 + L ++        +  +L Y+H        H D+KP N+LLD D    ++ DF
Sbjct: 117 ------QTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF 167

Query: 236 GLARFLPPTRTQTKYGV------------GNEVSTIGDVYSYGILLLELMIREKPSDIMF 283
           G A+ L        Y                + ++  DV+S G +L EL++ +      F
Sbjct: 168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----F 223

Query: 284 EGDMNLHKFAKM 295
            GD  + +  ++
Sbjct: 224 PGDSGVDQLVEI 235

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.0 bits (191), Expect = 9e-17
 Identities = 35/200 (17%), Positives = 67/200 (33%), Gaps = 27/200 (13%)

Query: 107 HLRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
               +G        +A  + L    H N++++   C            LV+E +      
Sbjct: 44  QTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT 103

Query: 167 KWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD 226
                             +      ++   +   L++LH        H DLKP N+L+  
Sbjct: 104 YLDK---------VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTS 151

Query: 227 DMTARVGDFGLARFLPPTRTQT-----------KYGVGNEVSTIGDVYSYGILLLELMIR 275
               ++ DFGLAR        T           +  + +  +T  D++S G +  E+  R
Sbjct: 152 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211

Query: 276 EKPSDIMFEGDMNLHKFAKM 295
           +      F G  ++ +  K+
Sbjct: 212 KPL----FRGSSDVDQLGKI 227

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 75.9 bits (186), Expect = 3e-16
 Identities = 45/229 (19%), Positives = 79/229 (34%), Gaps = 46/229 (20%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
             +  F  E +    + H  ++ V          G     +V E++   +    ++    
Sbjct: 49  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVH---- 103

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                     +   R + +  D   ALN+ H +      H D+KP+N+++      +V D
Sbjct: 104 ------TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMD 154

Query: 235 FGLARFLPP-----TRTQTKYG----------VGNEVSTIGDVYSYGILLLELMIREKPS 279
           FG+AR +       T+T    G           G+ V    DVYS G +L E++  E P 
Sbjct: 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP- 213

Query: 280 DIMFEGDMNLHKFAKMA-------------LPNHVKDIVDSILLNDDEK 315
              F GD  +    +               L   +  +V   L  + E 
Sbjct: 214 ---FTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 259

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.9 bits (186), Expect = 4e-16
 Identities = 41/221 (18%), Positives = 78/221 (35%), Gaps = 44/221 (19%)

Query: 117 FKSFIAECKAL-RNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKE 175
            +  + E + L     H  L  +         Q  +    V E+++       +      
Sbjct: 46  VECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHI------ 94

Query: 176 DETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDF 235
               +     +L R    A ++   L +LH        + DLK  N+LLD D   ++ DF
Sbjct: 95  ----QSCHKFDLSRATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADF 147

Query: 236 GLARFLPPTRTQTKYGVG------------NEVSTIGDVYSYGILLLELMIREKPSDIMF 283
           G+ +       +T    G             + +   D +S+G+LL E++I + P    F
Sbjct: 148 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----F 203

Query: 284 EGD-----MNLHKFAKMALPNHV----KDIVDSILLNDDEK 315
            G       +  +      P  +    KD++  + + + EK
Sbjct: 204 HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEK 244

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 75.8 bits (186), Expect = 4e-16
 Identities = 35/232 (15%), Positives = 66/232 (28%), Gaps = 43/232 (18%)

Query: 108 LRHQGAFKIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEK 167
           +  +       S   E   L  I+H N++ +         +      L+ + +       
Sbjct: 42  IAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFD 96

Query: 168 WLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD 227
            +                       +   V  A+ YLH                  LD+D
Sbjct: 97  RIV----------EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDED 146

Query: 228 MTARVGDFGLARFL-PPTRTQTKYG----------VGNEVSTIGDVYSYGILLLELMIRE 276
               + DFGL++   P +   T  G               S   D +S G++   L+   
Sbjct: 147 SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206

Query: 277 KPSDIMFEGDMNLHKFAKMA-------------LPNHVKDIVDSILLNDDEK 315
            P    F  + +   F ++              + +  KD +  ++  D EK
Sbjct: 207 PP----FYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (187), Expect = 5e-16
 Identities = 38/202 (18%), Positives = 64/202 (31%), Gaps = 31/202 (15%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
              +  + E K L   RH N+I +         +      LV   +              
Sbjct: 48  TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG------------A 95

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
           +     + ++L+          +   L Y+H        H DLKPSN+LL+     ++ D
Sbjct: 96  DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICD 152

Query: 235 FGLARFLPPTRTQTKYGV----------------GNEVSTIGDVYSYGILLLELMIREKP 278
           FGLAR   P    T +                      +   D++S G +L E++     
Sbjct: 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

Query: 279 SDIMFEGDMNLHKFAKMALPNH 300
                  D   H    +  P+ 
Sbjct: 213 FPGKHYLDQLNHILGILGSPSQ 234

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.7 bits (185), Expect = 7e-16
 Identities = 39/201 (19%), Positives = 72/201 (35%), Gaps = 37/201 (18%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKA---LVYEFIHNRSPEKWLYP 171
               + + E K L+ ++H N++ ++  C       N  K    LV++F  +         
Sbjct: 51  GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 110

Query: 172 ISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR 231
           + K                  I   +   LN L++  +    H D+K +NVL+  D   +
Sbjct: 111 LVK-------------FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 157

Query: 232 VGDFGLARFLPPTRTQTKYGVGNEVSTIG-----------------DVYSYGILLLELMI 274
           + DFGLAR     +        N V T+                  D++  G ++ E+  
Sbjct: 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 217

Query: 275 REKPSDIMFEGDMNLHKFAKM 295
           R        +G+   H+ A +
Sbjct: 218 RSPI----MQGNTEQHQLALI 234

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.2 bits (184), Expect = 1e-15
 Identities = 36/220 (16%), Positives = 70/220 (31%), Gaps = 43/220 (19%)

Query: 117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
               + E + L+N RH  L  +  A    D            F+   +    L+     +
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALKYAFQTHDR---------LCFVMEYANGGELFFHLSRE 99

Query: 177 ETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
             +   R       +         ++ L +       + D+K  N++LD D   ++ DFG
Sbjct: 100 RVFTEERARFYGAEI---------VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150

Query: 237 LARFLPPTRTQTKYGVG------------NEVSTIGDVYSYGILLLELMIREKPSDIMFE 284
           L +         K   G            N+     D +  G+++ E+M    P    F 
Sbjct: 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----FY 206

Query: 285 GD-----MNLHKFAKMALPNHV----KDIVDSILLNDDEK 315
                    L    ++  P  +    K ++  +L  D ++
Sbjct: 207 NQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 246

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.7 bits (175), Expect = 9e-15
 Identities = 36/227 (15%), Positives = 66/227 (29%), Gaps = 38/227 (16%)

Query: 106 SHLRHQGAFKIFKSFIAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKALVYEFIHNR 163
             +   G          E   L+ +      +I++L        +  D   L+ E     
Sbjct: 40  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPV 94

Query: 164 SPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVL 223
                                L      +    V  A+ + H+       H D+K  N+L
Sbjct: 95  QDLFDFI---------TERGALQEELARSFFWQVLEAVRHCHNCGV---LHRDIKDENIL 142

Query: 224 LD-DDMTARVGDFGLARFLPPTRTQTKYG-----------VGNEVSTIGDVYSYGILLLE 271
           +D +    ++ DFG    L  T      G                     V+S GILL +
Sbjct: 143 IDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 202

Query: 272 LMIREKPSDIMFEGD---MNLHKFAKMALPNHVKDIVDSILLNDDEK 315
           ++  + P    FE D   +    F +  + +  + ++   L      
Sbjct: 203 MVCGDIP----FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 245

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 69.5 bits (169), Expect = 5e-14
 Identities = 41/259 (15%), Positives = 88/259 (33%), Gaps = 35/259 (13%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
            I  + I E   L+ ++H N++K+                LV+E +     +        
Sbjct: 42  GIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDV---- 92

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                     L  +   +  + + + + Y H        H DLKP N+L++ +   ++ D
Sbjct: 93  ------CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIAD 143

Query: 235 FGLARFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMIREKPSDI 281
           FGLAR       +  + +               + ST  D++S G +  E++        
Sbjct: 144 FGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203

Query: 282 MFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR 341
           + E D  L +  ++    + K+  +   L   +      +    ++ +  + E  I ++ 
Sbjct: 204 VSEADQ-LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262

Query: 342 IGVACSMESPQDRMKMTNV 360
                    P  R+     
Sbjct: 263 ---KMLKLDPNQRITAKQA 278

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.2 bits (171), Expect = 5e-14
 Identities = 46/276 (16%), Positives = 98/276 (35%), Gaps = 40/276 (14%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFK-ALVYEFIHNRSPEKWLYPISKED 176
           K    E + L+++RH N+I +L      +   +     LV  F+              + 
Sbjct: 62  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT------------DL 109

Query: 177 ETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFG 236
               +   L   R   +   +   L Y+H        H DLKP N+ +++D   ++ DFG
Sbjct: 110 GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFG 166

Query: 237 LARFLPPTRTQTKYGV----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD 286
           LAR      T                    +   D++S G ++ E++  +      F+G 
Sbjct: 167 LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGS 222

Query: 287 MNLHKFAKMA-----LPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR 341
            +L +  ++       P      + S    +  K +   ++K   + +       ++++ 
Sbjct: 223 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 282

Query: 342 IGVACSMESPQDRMKMTNVV-HE-LQSIKNTLLGPK 375
                 +   + R+     + H   +S+ +T   P+
Sbjct: 283 ---KMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 315

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.4 bits (169), Expect = 5e-14
 Identities = 42/226 (18%), Positives = 75/226 (33%), Gaps = 50/226 (22%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           +    E   L+ I+H N+I +         +      L+ E +        L+    E E
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVY-----ENKTDVILILELV----AGGELFDFLAEKE 108

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTAR----VG 233
           +         L+++         LN +++      AH DLKP N++L D    +    + 
Sbjct: 109 SLTEEEATEFLKQI---------LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 159

Query: 234 DFGLARFLPPTRTQTKYGV-----------GNEVSTIGDVYSYGILLLELMIREKPSDIM 282
           DFGLA  +                         +    D++S G++   L+    P    
Sbjct: 160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---- 215

Query: 283 FEGDMNLHKFAKMA-------------LPNHVKDIVDSILLNDDEK 315
           F GD      A ++                  KD +  +L+ D +K
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKK 261

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.4 bits (166), Expect = 1e-13
 Identities = 39/259 (15%), Positives = 81/259 (31%), Gaps = 34/259 (13%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
            +  S + E   L+ ++H+N++++           +    LV+EF      + +      
Sbjct: 43  GVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGD 97

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
            D               +    +   L + H        H DLKP N+L++ +   ++ +
Sbjct: 98  LDPE----------IVKSFLFQLLKGLGFCHSRNVL---HRDLKPQNLLINRNGELKLAN 144

Query: 235 FGLARFLPPTRTQTKYGV-------------GNEVSTIGDVYSYGILLLELMIREKPSDI 281
           FGLAR            V                 ST  D++S G +  EL    +P   
Sbjct: 145 FGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

Query: 282 MFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR 341
             + D  L +  ++      +       L D +   +          +  +      +++
Sbjct: 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ 264

Query: 342 IGVACSMESPQDRMKMTNV 360
                   +P  R+     
Sbjct: 265 ---NLLKCNPVQRISAEEA 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.0 bits (168), Expect = 1e-13
 Identities = 33/201 (16%), Positives = 65/201 (32%), Gaps = 34/201 (16%)

Query: 113 AFKIFK---SFIAECKAL-RNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKW 168
           A K+ +       E +   R  +  ++++++     + Y G     +V E +        
Sbjct: 41  ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSR 99

Query: 169 LYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD--- 225
           +             +         I   +  A+ YLH       AH D+KP N+L     
Sbjct: 100 IQ--------DRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKR 148

Query: 226 DDMTARVGDFGLARFLPPTRTQTKYGV-----------GNEVSTIGDVYSYGILLLELMI 274
            +   ++ DFG A+      + T                 +     D++S G+++  L+ 
Sbjct: 149 PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208

Query: 275 REKPSDIMFEGDMNLHKFAKM 295
              P    F  +  L     M
Sbjct: 209 GYPP----FYSNHGLAISPGM 225

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.4 bits (166), Expect = 2e-13
 Identities = 33/188 (17%), Positives = 63/188 (33%), Gaps = 28/188 (14%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
           K    E + L++++H N+I +L                +   +                 
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--------- 112

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
              + + L       +   +   L Y+H        H DLKPSN+ +++D   ++ DFGL
Sbjct: 113 --VKCQKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGL 167

Query: 238 ARFLPPTRTQTKYGV----------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDM 287
           AR      T                    +   D++S G ++ EL+         F G  
Sbjct: 168 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTD 223

Query: 288 NLHKFAKM 295
           ++ +   +
Sbjct: 224 HIDQLKLI 231

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.0 bits (165), Expect = 2e-13
 Identities = 40/194 (20%), Positives = 71/194 (36%), Gaps = 34/194 (17%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
            +  + I E   L+ + H N++K+L           +   LV+EF+H            K
Sbjct: 43  GVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLYLVFEFLHQDL---------K 88

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
           +         + L    +    +   L + H        H DLKP N+L++ +   ++ D
Sbjct: 89  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLAD 145

Query: 235 FGLARFLPPTRTQTKYGVG-------------NEVSTIGDVYSYGILLLELMIREKPSDI 281
           FGLAR          + V                 ST  D++S G +  E++ R      
Sbjct: 146 FGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL--- 202

Query: 282 MFEGDMNLHKFAKM 295
            F GD  + +  ++
Sbjct: 203 -FPGDSEIDQLFRI 215

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.4 bits (161), Expect = 7e-13
 Identities = 43/229 (18%), Positives = 79/229 (34%), Gaps = 49/229 (21%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           K  +    E + L +IR    +  L       +Q      L+ ++I+       L    +
Sbjct: 70  KTTEHTRTERQVLEHIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRER 125

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
             E               + I V   +  L H  +    + D+K  N+LLD +    + D
Sbjct: 126 FTEHE-------------VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 172

Query: 235 FGLARFLPPTRTQTKY---------------GVGNEVSTIGDVYSYGILLLELMIREKPS 279
           FGL++      T+  Y               G  +      D +S G+L+ EL+    P 
Sbjct: 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP- 231

Query: 280 DIMFEGDMNLHKFAKMA-------------LPNHVKDIVDSILLNDDEK 315
              F  D   +  A+++             +    KD++  +L+ D +K
Sbjct: 232 ---FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 277

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 66.0 bits (160), Expect = 1e-12
 Identities = 37/219 (16%), Positives = 68/219 (31%), Gaps = 40/219 (18%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
           K  +  + E + L+ +    L+K+           +         +        ++    
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLE---------FSFKDNSNLYMVMEYVAGGEMFSH-- 131

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
                 R    +       A  +     YLH        + DLKP N+L+D     +V D
Sbjct: 132 ----LRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTD 184

Query: 235 FGLARFLPPTRTQTKYGV---------GNEVSTIGDVYSYGILLLELMIREKPSDIMFEG 285
           FG A+ +                        +   D ++ G+L+ E+     P    F  
Sbjct: 185 FGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----FFA 240

Query: 286 D-----MNLHKFAKMALPNHV----KDIVDSILLNDDEK 315
           D            K+  P+H     KD++ ++L  D  K
Sbjct: 241 DQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTK 279

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 64.9 bits (157), Expect = 2e-12
 Identities = 38/215 (17%), Positives = 65/215 (30%), Gaps = 41/215 (19%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
                E K  + ++    I  +  C        D+  +V E +            S ED 
Sbjct: 47  PQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNVMVMELLGP----------SLEDL 92

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVL---LDDDMTARVGD 234
                R  +L   L +A  + S + Y+H        H D+KP N L           + D
Sbjct: 93  FNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIID 149

Query: 235 FGLARFLPPTRTQTKYGV-------------------GNEVSTIGDVYSYGILLLELMIR 275
           FGLA+     RT                         G E S   D+ S G +L+   + 
Sbjct: 150 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 209

Query: 276 EKPSDIMFEGD--MNLHKFAKMALPNHVKDIVDSI 308
             P   +          + ++  +   ++ +    
Sbjct: 210 SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 63.7 bits (154), Expect = 6e-12
 Identities = 46/223 (20%), Positives = 80/223 (35%), Gaps = 38/223 (17%)

Query: 113 AFKIFKS-----FIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPE 166
             KI K         E K L N+R   N+I +           +   ALV+E ++N   +
Sbjct: 64  VVKILKPVKKKKIKREIKILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFK 120

Query: 167 KWLYPISKEDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD- 225
           +               + L          ++  AL+Y H        H D+KP NV++D 
Sbjct: 121 QLY-------------QTLTDYDIRFYMYEILKALDYCHSMGIM---HRDVKPHNVMIDH 164

Query: 226 DDMTARVGDFGLARFLPPTRTQTKYGVG------------NEVSTIGDVYSYGILLLELM 273
           +    R+ D+GLA F  P +                           D++S G +L  ++
Sbjct: 165 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224

Query: 274 IREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKL 316
            R++P     +    L + AK+     + D +D   +  D + 
Sbjct: 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.0 bits (152), Expect = 1e-11
 Identities = 35/192 (18%), Positives = 69/192 (35%), Gaps = 30/192 (15%)

Query: 115 KIFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK 174
              K    E   ++ + H+N+I +L                +   + + +  + +     
Sbjct: 58  THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 117

Query: 175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGD 234
            +            R   +   +   + +LH        H DLKPSN+++  D T ++ D
Sbjct: 118 HE------------RMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILD 162

Query: 235 FGLARFLPPTRTQTKYGV-----------GNEVSTIGDVYSYGILLLELMIREKPSDIMF 283
           FGLAR    +   T Y V           G       D++S G ++ E++  +      F
Sbjct: 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----F 218

Query: 284 EGDMNLHKFAKM 295
            G   + ++ K+
Sbjct: 219 PGRDYIDQWNKV 230

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 61.7 bits (149), Expect = 2e-11
 Identities = 29/220 (13%), Positives = 57/220 (25%), Gaps = 45/220 (20%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
                E +  + +     I  +        Q      LV + +            S ED 
Sbjct: 45  PQLRDEYRTYKLLAGCTGIPNVYYF----GQEGLHNVLVIDLLGP----------SLEDL 90

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-----TARV 232
                R  ++      A  + + +  +H        + D+KP N L+            V
Sbjct: 91  LDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYV 147

Query: 233 GDFGLARFLPPTRTQTKYGVGNEVSTIG-------------------DVYSYGILLLELM 273
            DFG+ +F     T+       + +  G                   D+ + G + +  +
Sbjct: 148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 207

Query: 274 IREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDD 313
                  + ++G        K       K       L   
Sbjct: 208 RGS----LPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 55.9 bits (133), Expect = 2e-09
 Identities = 24/68 (35%), Positives = 36/68 (52%), Gaps = 6/68 (8%)

Query: 1   MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGI 58
           +D   N + G + + LT+L FL +LN+S+NNL G +P  G  +    ++   N  LCG  
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

Query: 59  SKFKLPKC 66
               LP C
Sbjct: 309 ----LPAC 312

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 54.7 bits (130), Expect = 6e-09
 Identities = 33/185 (17%), Positives = 60/185 (32%), Gaps = 22/185 (11%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACL-GVDYQGNDFKALVYEFIHNRSPEKWLYPISKED 176
           ++   E K L+ +   +  K  +     +    + F       +H     + L       
Sbjct: 54  EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113

Query: 177 ETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVGDF 235
                 R + L+    I+  +   L+Y+H  C  +  H D+KP NVL++  D    +   
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQI 171

Query: 236 GLARFLPPTRTQTKYGV--------------GNEVSTIGDVYSYGILLLELMIREKPSDI 281
            +A           Y                G       D++S   L+ EL+  +     
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL--- 228

Query: 282 MFEGD 286
            FE D
Sbjct: 229 -FEPD 232

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 47.5 bits (112), Expect = 4e-07
 Identities = 18/124 (14%), Positives = 33/124 (26%), Gaps = 22/124 (17%)

Query: 118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDE 177
             F            R L K+    +   Y      A++ E I  +   +       E  
Sbjct: 51  LHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN-AVLMELIDAKELYRVRVENPDE-- 107

Query: 178 TYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGL 237
                          +   +   +   +H       H DL   NVL+  +    + DF  
Sbjct: 108 ---------------VLDMILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQ 148

Query: 238 ARFL 241
           +  +
Sbjct: 149 SVEV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	382
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.68
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.04
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	97.65
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.52
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	97.23
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	97.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.2
d2ifga3	156	High affinity nerve growth factor receptor, N-term	97.09
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	97.05
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	96.97
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	96.32
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	96.05
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.04
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	96.03
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	95.98
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	95.95
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	95.76
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.47
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	94.33
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	94.18
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	93.94
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	93.7
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	93.09
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	92.85
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	92.51
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	92.47
d2ifga3	156	High affinity nerve growth factor receptor, N-term	92.43
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	91.81
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	91.8
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	91.56
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	90.63
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	90.46
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	89.55
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	88.48
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	87.45
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	86.79
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	86.1
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	85.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	84.16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=337.65  Aligned_cols=210  Identities=24%  Similarity=0.365  Sum_probs=162.6

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      .+.|.+|+++|++++|||||++++++.      .+..++|||||++|+|.+++..         ....+++..++.++.|
T Consensus        48 ~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~~~lv~Ey~~~g~L~~~l~~---------~~~~~~~~~~~~i~~q  112 (276)
T d1uwha_          48 LQAFKNEVGVLRKTRHVNILLFMGYST------APQLAIVTQWCEGSSLYHHLHI---------IETKFEMIKLIDIARQ  112 (276)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCEEEEECCCEEEHHHHHHT---------SCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeEEEe------ccEEEEEEecCCCCCHHHHHhh---------ccCCCCHHHHHHHHHH
Confidence            378999999999999999999999864      3467999999999999999942         3356999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccC---CCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVG---NEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~---~~~~~~  259 (382)
                      |++||+|||   +++|+||||||+|||++.++.+||+|||+|+.....              +.+||...+   ..++.+
T Consensus       113 i~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~  189 (276)
T d1uwha_         113 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ  189 (276)
T ss_dssp             HHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHH
T ss_pred             HHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCch
Confidence            999999999   679999999999999999999999999999765321              233665432   357899


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhc-CCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMAL-PNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +|||||||++|||+||+.||...... ..+........ +.....                           ...+++.+
T Consensus       190 sDiwS~Gv~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~p~~~~---------------------------~~~~~~~~  241 (276)
T d1uwha_         190 SDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYLSPDLSK---------------------------VRSNCPKA  241 (276)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHHTSCCCCGGG---------------------------SCTTCCHH
T ss_pred             hhhhhhHHHHHHHHHCCCCCCCCChH-HHHHHHHhcCCCCCcchh---------------------------ccccchHH
Confidence            99999999999999999998643111 11111111111 100000                           00133457


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhc
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  372 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~  372 (382)
                      +.+++.+||+.||++||||+||++.|+.+.++++
T Consensus       242 l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            8889999999999999999999999999988754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-45  Score=326.60  Aligned_cols=205  Identities=21%  Similarity=0.370  Sum_probs=158.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|++++++++|||||+++|+|..     ++..++|||||++|+|.+++.         .....+++..++.++.||
T Consensus        45 ~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~lv~E~~~~g~L~~~l~---------~~~~~~~~~~~~~i~~qi  110 (263)
T d1sm2a_          45 EDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDV  110 (263)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHH---------TTTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcccccceecc-----CCceEEEEEecCCCcHHHHhh---------ccccCCCHHHHHHHHHHH
Confidence            679999999999999999999999754     677899999999999999984         334568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-------------CCCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-------------TRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+||+|||   +.+|+||||||+|||++.++.+||+|||+|+....             ...+||...+..++.++||||
T Consensus       111 a~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS  187 (263)
T d1sm2a_         111 CEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS  187 (263)
T ss_dssp             HHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHH
T ss_pred             HHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcc
Confidence            99999999   67999999999999999999999999999986532             234577777888999999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+|+..|+.... ....+.........            ...+.                  .+..++.+++.
T Consensus       188 ~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~~~------------~~~p~------------------~~~~~l~~li~  236 (263)
T d1sm2a_         188 FGVLMWEVFSEGKIPYENR-SNSEVVEDISTGFR------------LYKPR------------------LASTHVYQIMN  236 (263)
T ss_dssp             HHHHHHHHHTTSCCTTCSC-CHHHHHHHHHHTCC------------CCCCT------------------TSCHHHHHHHH
T ss_pred             hHHHHHHHHHCCCCCCCCC-CHHHHHHHHHhcCC------------CCCcc------------------ccCHHHHHHHH
Confidence            9999999999654432111 11111111111100            00000                  22346788899


Q ss_pred             ccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          345 ACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +||+.||++||||+||++.|+++.++
T Consensus       237 ~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            99999999999999999999999764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-45  Score=334.55  Aligned_cols=205  Identities=21%  Similarity=0.381  Sum_probs=158.3

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..++|.+|+++|++++|||||+++|+|..     .+..++|||||++|+|.+++.         .....+++.+++.++.
T Consensus        70 ~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~~~~~iv~Ey~~~g~L~~~~~---------~~~~~l~~~~~~~i~~  135 (299)
T d1jpaa_          70 QRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLR---------QNDGQFTVIQLVGMLR  135 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHH---------TTTTCSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEee-----CCEEEEEEEecCCCcceeeec---------cccCCCCHHHHHHHHH
Confidence            34689999999999999999999999754     677899999999999999884         2345699999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-----------------CCCCccccCCCCCc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-----------------RTQTKYGVGNEVST  258 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-----------------~~~~~~~~~~~~~~  258 (382)
                      ||++||.|||   +++|+||||||+|||++.++.+||+|||+|+.+...                 ..+||...+..++.
T Consensus       136 qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  212 (299)
T d1jpaa_         136 GIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS  212 (299)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCH
T ss_pred             HHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCc
Confidence            9999999999   679999999999999999999999999999865322                 23466666788999


Q ss_pred             cchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHH
Q 040999          259 IGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVI  337 (382)
Q Consensus       259 ~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (382)
                      ++|||||||++|||+| |+.||.....  ..+...+...            ......                  .+++.
T Consensus       213 ~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~~------------~~~~~~------------------~~~~~  260 (299)
T d1jpaa_         213 ASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQD------------YRLPPP------------------MDCPS  260 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTT------------CCCCCC------------------TTCCH
T ss_pred             ccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC------------CCCCCC------------------ccchH
Confidence            9999999999999998 8999864211  1111111100            000000                  02345


Q ss_pred             HHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          338 SMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       338 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      ++.+++.+||+.||++||||.||++.|+++.+
T Consensus       261 ~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         261 ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            67889999999999999999999999998765

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-45  Score=327.67  Aligned_cols=208  Identities=20%  Similarity=0.304  Sum_probs=165.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|+++|++++|||||+++|+|.      .+..++|||||++|+|.+++.         .....+++..+..++.||
T Consensus        54 ~~~~~E~~il~~l~HpnIv~l~g~~~------~~~~~lvmE~~~~g~L~~~l~---------~~~~~l~~~~~~~i~~qi  118 (285)
T d1u59a_          54 EEMMREAQIMHQLDNPYIVRLIGVCQ------AEALMLVMEMAGGGPLHKFLV---------GKREEIPVSNVAELLHQV  118 (285)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEEECCTTEEHHHHHT---------TCTTTSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEeeeec------cCeEEEEEEeCCCCcHHHHhh---------ccccCCCHHHHHHHHHHH
Confidence            67999999999999999999999974      245799999999999999874         234569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++||+|||   +++|+||||||+|||++.++.+||+|||+|+.+...               +.+||...+..++.++||
T Consensus       119 ~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV  195 (285)
T d1u59a_         119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV  195 (285)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHH
T ss_pred             HHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchh
Confidence            99999999   679999999999999999999999999999865432               223666666788999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||+| |+.||....  ...+...+.....            ...+                  ..++.++.+
T Consensus       196 wS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i~~~~~------------~~~p------------------~~~~~~l~~  243 (285)
T d1u59a_         196 WSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKR------------MECP------------------PECPPELYA  243 (285)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTCC------------CCCC------------------TTCCHHHHH
T ss_pred             hcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC------------CCCC------------------CcCCHHHHH
Confidence            999999999998 899987431  1111111111000            0000                  023446788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhhhcCCC
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNTLLGPK  375 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~~  375 (382)
                      ++.+||+.||++||||.+|++.|+.+..++....
T Consensus       244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~  277 (285)
T d1u59a_         244 LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  277 (285)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhcc
Confidence            8999999999999999999999999887765544

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-44  Score=325.72  Aligned_cols=210  Identities=22%  Similarity=0.370  Sum_probs=166.3

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|++       ++|.+|+++|++++|||||+++++|..     .+..++|||||++|+|.+++..        .....+
T Consensus        46 AvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~iv~E~~~~g~l~~~l~~--------~~~~~~  112 (287)
T d1opja_          46 AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRE--------CNRQEV  112 (287)
T ss_dssp             EEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHH--------SCTTTS
T ss_pred             EEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee-----CCeeEEEeecccCcchHHHhhh--------ccccch
Confidence            67665       789999999999999999999999753     6788999999999999999853        224568


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-------------CCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-------------TQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~  252 (382)
                      ++..++.++.||++||.|||   +++|+||||||+|||++.++.+||+|||+|+......             .+||...
T Consensus       113 ~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~  189 (287)
T d1opja_         113 SAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA  189 (287)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHc
Confidence            99999999999999999999   6799999999999999999999999999998764332             2367777


Q ss_pred             CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      +..++.++|||||||++|||+||..|+...    ........         .+.........                  
T Consensus       190 ~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~----~~~~~~~~---------~i~~~~~~~~~------------------  238 (287)
T d1opja_         190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQVYE---------LLEKDYRMERP------------------  238 (287)
T ss_dssp             HCCCSHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHHHHH---------HHHTTCCCCCC------------------
T ss_pred             CCCCCchhhhhhHHHHHHHHHhCCCCCCCc----chHHHHHH---------HHhcCCCCCCC------------------
Confidence            788999999999999999999987775421    11111111         11111100000                  


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      ..++.++.+++.+||+.||++||||.||++.|+.+.+
T Consensus       239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            0233467889999999999999999999999988754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=324.17  Aligned_cols=202  Identities=20%  Similarity=0.284  Sum_probs=160.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|+++|++++|||||+++|+|.      .+..++|||||++|+|.+++.          ....+++..++.++.||
T Consensus        53 ~~~~~E~~il~~l~HpnIv~~~g~~~------~~~~~lvmE~~~~g~L~~~l~----------~~~~l~~~~~~~i~~qi  116 (277)
T d1xbba_          53 DELLAEANVMQQLDNPYIVRMIGICE------AESWMLVMEMAELGPLNKYLQ----------QNRHVKDKNIIELVHQV  116 (277)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEE------SSSEEEEEECCTTEEHHHHHH----------HCTTCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCceEEEEec------cCCEEEEEEcCCCCcHHHHHh----------hccCCCHHHHHHHHHHH
Confidence            57999999999999999999999974      235689999999999999984          34569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....               +.+||...+..++.++||
T Consensus       117 ~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDi  193 (277)
T d1xbba_         117 SMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV  193 (277)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHH
T ss_pred             HHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhh
Confidence            99999999   679999999999999999999999999999865332               234666667788999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||+| |+.||.....  ..+...+...            .....+                  ..++.++.+
T Consensus       194 wS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~------------~~~~~p------------------~~~~~~~~~  241 (277)
T d1xbba_         194 WSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKG------------ERMGCP------------------AGCPREMYD  241 (277)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTT------------CCCCCC------------------TTCCHHHHH
T ss_pred             ccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcC------------CCCCCC------------------cccCHHHHH
Confidence            999999999998 8999864211  1111111110            000000                  023446788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      ++.+||+.||++|||+.+|++.|+.....
T Consensus       242 li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         242 LMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            89999999999999999999999887543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-44  Score=321.32  Aligned_cols=209  Identities=21%  Similarity=0.356  Sum_probs=162.2

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |||++       +.|.+|+++|++++|||||+++|+|.      .+..++|||||++|+|.+++..        .....+
T Consensus        41 AvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~~~~~iv~Ey~~~g~L~~~~~~--------~~~~~l  106 (272)
T d1qpca_          41 AVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKT--------PSGIKL  106 (272)
T ss_dssp             EEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEEEECCTTCBHHHHTTS--------HHHHTC
T ss_pred             EEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec------cCCeEEEEEeCCCCcHHHHHhh--------cCCCCC
Confidence            67765       67999999999999999999999864      3457899999999999988742        223458


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~  252 (382)
                      ++..++.++.||++||.|||   +.+|+||||||+|||+++++.+||+|||+|+.+...             ..+||...
T Consensus       107 ~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~  183 (272)
T d1qpca_         107 TINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN  183 (272)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHh
Confidence            99999999999999999999   679999999999999999999999999999876432             23466666


Q ss_pred             CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      +..++.++|||||||++|||+||..|+....    .........         ........+.                 
T Consensus       184 ~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~----~~~~~~~~i---------~~~~~~~~p~-----------------  233 (272)
T d1qpca_         184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVIQNL---------ERGYRMVRPD-----------------  233 (272)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHH---------HTTCCCCCCT-----------------
T ss_pred             CCCCCchhhhhhhHHHHHHHHhCCCCCCCCC----CHHHHHHHH---------HhcCCCCCcc-----------------
Confidence            7788999999999999999999766643211    111111110         0000000000                 


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                       .++.++.+++.+||+.||++||||+||++.|+.+..
T Consensus       234 -~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         234 -NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence             233467888899999999999999999999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=317.36  Aligned_cols=197  Identities=18%  Similarity=0.213  Sum_probs=153.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++|++++|||||++++++..     ++..++|||||++|+|.+++.          ....+++..+..++.||
T Consensus        48 ~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~~ivmEy~~gg~L~~~l~----------~~~~l~e~~~~~i~~qi  112 (271)
T d1nvra_          48 ENIKKEICINKMLNHENVVKFYGHRRE-----GNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQL  112 (271)
T ss_dssp             -CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEGGGGSB----------TTTBCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEeeeecc-----CceeEEEEeccCCCcHHHHHh----------cCCCCCHHHHHHHHHHH
Confidence            568999999999999999999999654     778999999999999999993          34569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCC-Cccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEV-STIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~-~~~~Dv  262 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||+|+....              ...+||...+..+ +.++||
T Consensus       113 ~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~Di  189 (271)
T d1nvra_         113 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV  189 (271)
T ss_dssp             HHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHH
T ss_pred             HHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceee
Confidence            99999999   67999999999999999999999999999986421              2234776666665 678999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||+||++|||+||+.||............+.....            ...+.                  .....++.++
T Consensus       190 wSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~------------~~~~~------------------~~~s~~~~~l  239 (271)
T d1nvra_         190 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------YLNPW------------------KKIDSAPLAL  239 (271)
T ss_dssp             HHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT------------TSTTG------------------GGSCHHHHHH
T ss_pred             eHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------CCCcc------------------ccCCHHHHHH
Confidence            99999999999999998743222211111110000            00000                  0122356678


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||++|+++
T Consensus       240 i~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHcCCChhHCcCHHHHhc
Confidence            88999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-43  Score=315.10  Aligned_cols=194  Identities=18%  Similarity=0.234  Sum_probs=156.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|++++++++|||||++++++.     +++..++|||||++|+|.+++.          ....+++..+..++.||
T Consensus        51 ~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ivmEy~~~g~L~~~l~----------~~~~l~e~~~~~i~~qi  115 (263)
T d2j4za1          51 HQLRREVEIQSHLRHPNILRLYGYFH-----DATRVYLILEYAPLGTVYRELQ----------KLSKFDEQRTATYITEL  115 (263)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCEEEEEEeecCCCcHHHHHh----------hcCCCCHHHHHHHHHHH
Confidence            56889999999999999999999964     4788999999999999999983          34569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------CCCCccccCCCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------RTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....          ..+||...+..++.++|||||||
T Consensus       116 ~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGv  192 (263)
T d2j4za1         116 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGV  192 (263)
T ss_dssp             HHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred             HHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhH
Confidence            99999999   779999999999999999999999999999876543          23477777888999999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ++|||+||+.||...    . ............        .. .+ +                  ....++.+++.+||
T Consensus       193 ilyell~G~~Pf~~~----~-~~~~~~~i~~~~--------~~-~p-~------------------~~s~~~~~li~~~L  239 (263)
T d2j4za1         193 LCYEFLVGKPPFEAN----T-YQETYKRISRVE--------FT-FP-D------------------FVTEGARDLISRLL  239 (263)
T ss_dssp             HHHHHHHSSCTTCCS----S-HHHHHHHHHTTC--------CC-CC-T------------------TSCHHHHHHHHHHT
T ss_pred             HHHHHhcCCCCCCCC----C-HHHHHHHHHcCC--------CC-CC-c------------------cCCHHHHHHHHHHc
Confidence            999999999998632    1 111111110000        00 00 0                  12235677888999


Q ss_pred             CCCccCCCCHHHHHH
Q 040999          348 MESPQDRMKMTNVVH  362 (382)
Q Consensus       348 ~~~p~~RPs~~evl~  362 (382)
                      +.||++|||++|+++
T Consensus       240 ~~dp~~R~t~~eil~  254 (263)
T d2j4za1         240 KHNPSQRPMLREVLE  254 (263)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             cCCHhHCcCHHHHHc
Confidence            999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-43  Score=317.40  Aligned_cols=205  Identities=20%  Similarity=0.379  Sum_probs=159.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|+++|++++|||||+++|+|..     .+..++|||||.+|++.+++.         .....+++..++.++.||
T Consensus        54 ~~~~~E~~il~~l~H~nIv~~~g~~~~-----~~~~~~v~e~~~~~~l~~~~~---------~~~~~~~~~~~~~i~~~i  119 (283)
T d1mqba_          54 VDFLGEAGIMGQFSHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLR---------EKDGEFSVLQLVGMLRGI  119 (283)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEEEEEECCTTEEHHHHHH---------HTTTCSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeEEEec-----CCceEEEEEecccCcchhhhh---------cccccccHHHHHHHHHHH
Confidence            579999999999999999999999754     677899999999999988773         344579999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+...               +.+||...+..++.++||
T Consensus       120 ~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI  196 (283)
T d1mqba_         120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV  196 (283)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHH
T ss_pred             HHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccc
Confidence            99999999   779999999999999999999999999999865321               345777778899999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||+||..|+....    ...+....         +.........                  .+++..+.+|
T Consensus       197 ~S~Gvil~el~t~~~~~~~~~----~~~~~~~~---------i~~~~~~~~~------------------~~~~~~l~~l  245 (283)
T d1mqba_         197 WSFGIVMWEVMTYGERPYWEL----SNHEVMKA---------INDGFRLPTP------------------MDCPSAIYQL  245 (283)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTC----CHHHHHHH---------HHTTCCCCCC------------------TTCBHHHHHH
T ss_pred             cccHHHHHHHHhCCCCccccC----CHHHHHHH---------HhccCCCCCc------------------hhhHHHHHHH
Confidence            999999999999766643211    11111111         1110000000                  0234567889


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      +.+||+.||++||||.||++.|+++.+.
T Consensus       246 i~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         246 MMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            9999999999999999999999987653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=313.28  Aligned_cols=206  Identities=21%  Similarity=0.356  Sum_probs=163.5

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+       ++|.+|++++++++|||||+++|+|..     ++..++||||+++|+|.+++.         .....+
T Consensus        32 AvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~iv~Ey~~~g~l~~~~~---------~~~~~~   97 (258)
T d1k2pa_          32 AIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFIITEYMANGCLLNYLR---------EMRHRF   97 (258)
T ss_dssp             EEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEEEEEECCTTEEHHHHHH---------SGGGCC
T ss_pred             EEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceEEEEEccCCCcHHHhhh---------ccccCC
Confidence            66655       789999999999999999999999753     678999999999999999874         344568


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~  252 (382)
                      ++..+.+++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....             ..+||...
T Consensus        98 ~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~  174 (258)
T d1k2pa_          98 QTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM  174 (258)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhc
Confidence            99999999999999999999   679999999999999999999999999999765322             22366666


Q ss_pred             CCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          253 GNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      +..++.++|||||||++|||+| |+.||.....     .+.....         ........+.                
T Consensus       175 ~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----~~~~~~i---------~~~~~~~~p~----------------  224 (258)
T d1k2pa_         175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETAEHI---------AQGLRLYRPH----------------  224 (258)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HHHHHHH---------HTTCCCCCCT----------------
T ss_pred             CCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----HHHHHHH---------HhCCCCCCcc----------------
Confidence            7788999999999999999998 8999864321     1111110         0000000000                


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                        .++.++.+++.+||+.||++|||++++++.|.+|
T Consensus       225 --~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         225 --LASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             --TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             --cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence              2234678888999999999999999999998754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-43  Score=312.47  Aligned_cols=202  Identities=19%  Similarity=0.325  Sum_probs=154.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|+++|++++|||||++++++... ..+....++|||||++|+|.+++.          ....+++..+..++.||
T Consensus        53 ~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~ivmE~~~~g~L~~~l~----------~~~~~~~~~~~~~~~qi  121 (270)
T d1t4ha_          53 QRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQI  121 (270)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEEEeCCCCCcHHHHHh----------ccccccHHHHHHHHHHH
Confidence            6789999999999999999999997542 234567899999999999999983          33568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeC-CCCcEEEccccccccCCC----------CCCCCccccCCCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLD-DDMTARVGDFGLARFLPP----------TRTQTKYGVGNEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~~~~~~Dv~S~G  266 (382)
                      ++||+|||+. .++|+||||||+|||++ +++.+||+|||+|+....          ...+||... ..++.++||||||
T Consensus       122 ~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlG  199 (270)
T d1t4ha_         122 LKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFG  199 (270)
T ss_dssp             HHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHH
T ss_pred             HHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhC-CCCCCcCchhhHH
Confidence            9999999933 23399999999999996 578999999999986533          234477665 4689999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||+||+.||...    ...................+                          .....++.+++.+|
T Consensus       200 vilyel~~g~~Pf~~~----~~~~~~~~~i~~~~~~~~~~--------------------------~~~~~~~~~li~~~  249 (270)
T d1t4ha_         200 MCMLEMATSEYPYSEC----QNAAQIYRRVTSGVKPASFD--------------------------KVAIPEVKEIIEGC  249 (270)
T ss_dssp             HHHHHHHHSSCTTTTC----SSHHHHHHHHTTTCCCGGGG--------------------------GCCCHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCCc----ccHHHHHHHHHcCCCCcccC--------------------------ccCCHHHHHHHHHH
Confidence            9999999999998632    11222111111100000000                          01223567888899


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      |+.||++|||+.|+++
T Consensus       250 l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         250 IRQNKDERYSIKDLLN  265 (270)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             ccCCHhHCcCHHHHhC
Confidence            9999999999999975

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=316.09  Aligned_cols=212  Identities=22%  Similarity=0.373  Sum_probs=165.6

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..++|.+|+++|++++|||||+++|+|..    .+...++|||||++|+|.+++.         .....+++..+++++.
T Consensus        71 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv~E~~~~g~l~~~~~---------~~~~~~~~~~~~~i~~  137 (311)
T d1r0pa_          71 EVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIR---------NETHNPTVKDLIGFGL  137 (311)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEEEECCTTCBHHHHHH---------CTTCCCBHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEEEEEeecCchhhhhc---------cccccchHHHHHHHHH
Confidence            34789999999999999999999999864    2567899999999999999884         3445678889999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------CCCCccccCCCCCcc
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------RTQTKYGVGNEVSTI  259 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~~~~~~~~  259 (382)
                      |+++||.|||   +.+|+||||||+|||+++++.+||+|||+++.....                ...||...+..++.+
T Consensus       138 qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k  214 (311)
T d1r0pa_         138 QVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK  214 (311)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHH
T ss_pred             HHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCCh
Confidence            9999999999   779999999999999999999999999999865332                223555566788999


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +||||||+++|||+||..||....... ...........           ...+ .                  .++.++
T Consensus       215 sDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~-----------~~~p-~------------------~~~~~l  263 (311)
T d1r0pa_         215 SDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRR-----------LLQP-E------------------YCPDPL  263 (311)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC-----------CCCC-T------------------TCCHHH
T ss_pred             hHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCC-----------CCCc-c------------------cCcHHH
Confidence            999999999999999888865322111 11111111000           0000 0                  223467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHHHHHHhhhhhcCC
Q 040999          340 VRIGVACSMESPQDRMKMTNVVHELQSIKNTLLGP  374 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~~~  374 (382)
                      .+++.+||+.||++||||.||++.|+++.+.+...
T Consensus       264 ~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         264 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence            88889999999999999999999999999876554

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-43  Score=312.06  Aligned_cols=210  Identities=25%  Similarity=0.328  Sum_probs=161.7

Q ss_pred             chhhH------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|++      ++|.+|++++++++|||||+++|+|..    +.+..++||||+++|+|.+++..        .....++
T Consensus        34 AvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv~ey~~~g~L~~~l~~--------~~~~~l~  101 (262)
T d1byga_          34 AVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVTEYMAKGSLVDYLRS--------RGRSVLG  101 (262)
T ss_dssp             EEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEEEECCCTTEEHHHHHHH--------HHHHHCC
T ss_pred             EEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEEEEEeccCCCCHHHHHHh--------cCCCCCC
Confidence            66665      779999999999999999999999753    34567999999999999999942        1234589


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------CCCCCccccCCCCC
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQTKYGVGNEVS  257 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~~~~~  257 (382)
                      +..+++++.||+.||.|||   +.+|+||||||+|||++.++.+|++|||+++....         ...+||...+..++
T Consensus       102 ~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t  178 (262)
T d1byga_         102 GDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFS  178 (262)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCCccccccccCCChHHHhCCCCC
Confidence            9999999999999999999   67999999999999999999999999999986533         23457777778899


Q ss_pred             ccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHH
Q 040999          258 TIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECV  336 (382)
Q Consensus       258 ~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (382)
                      .++|||||||++|||+| |+.||...  ....+...+.....            ....                  ..+.
T Consensus       179 ~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~~------------~~~~------------------~~~~  226 (262)
T d1byga_         179 TKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYK------------MDAP------------------DGCP  226 (262)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCC------------CCCC------------------TTCC
T ss_pred             hHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCC------------CCCC------------------ccCC
Confidence            99999999999999998 67776532  11122222111000            0000                  0223


Q ss_pred             HHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          337 ISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       337 ~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      .++.+++.+||+.||++||||.|++++|++++.
T Consensus       227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            467788889999999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=314.09  Aligned_cols=196  Identities=19%  Similarity=0.237  Sum_probs=155.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++..     .+..++|||||++|+|.+++.           ...+++..+..++.||
T Consensus        62 ~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~ivmEy~~gg~L~~~~~-----------~~~l~~~~~~~i~~qi  125 (293)
T d1yhwa1          62 ELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCREC  125 (293)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHH-----------HSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEEEEEecCCCcHHHHhh-----------ccCCCHHHHHHHHHHH
Confidence            679999999999999999999999654     678999999999999998773           2358999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+...            ..+||...+..++.++||||+
T Consensus       126 ~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  202 (293)
T d1yhwa1         126 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (293)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHH
T ss_pred             HHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehH
Confidence            99999999   779999999999999999999999999999876432            234777777889999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||...... ..+........+.         . ..+                   ......+.+++.+
T Consensus       203 GvilyemltG~~Pf~~~~~~-~~~~~~~~~~~~~---------~-~~~-------------------~~~s~~~~~li~~  252 (293)
T d1yhwa1         203 GIMAIEMIEGEPPYLNENPL-RALYLIATNGTPE---------L-QNP-------------------EKLSAIFRDFLNR  252 (293)
T ss_dssp             HHHHHHHHHSSCTTTTSCHH-HHHHHHHHHCSCC---------C-SSG-------------------GGSCHHHHHHHHH
T ss_pred             hHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCC---------C-CCc-------------------ccCCHHHHHHHHH
Confidence            99999999999998632110 0011111100000         0 000                   0223457788889


Q ss_pred             cCCCCccCCCCHHHHHH
Q 040999          346 CSMESPQDRMKMTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs~~evl~  362 (382)
                      ||+.||++|||+.|+++
T Consensus       253 ~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HTCSSTTTSCCHHHHTT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=319.73  Aligned_cols=209  Identities=23%  Similarity=0.294  Sum_probs=160.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC-------------ccccCCc
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED-------------ETYERPR  183 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~  183 (382)
                      +.+.+|+++|.++ +|||||+++++|.     +.+..++|||||++|+|.+++.......             .......
T Consensus        85 ~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (325)
T d1rjba_          85 EALMSELKMMTQLGSHENIVNLLGACT-----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN  159 (325)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred             HHHHHHHHHHHHhcCCCcEeEEEEEEe-----eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccC
Confidence            5789999999998 8999999999965     3678899999999999999996533110             0001234


Q ss_pred             ccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCc
Q 040999          184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTK  249 (382)
Q Consensus       184 ~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~  249 (382)
                      .+++..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+....              ...+||
T Consensus       160 ~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  236 (325)
T d1rjba_         160 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  236 (325)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence            6899999999999999999999   67999999999999999999999999999976432              234477


Q ss_pred             cccCCCCCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhh
Q 040999          250 YGVGNEVSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAK  328 (382)
Q Consensus       250 ~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (382)
                      ...+..++.++|||||||++|||+| |+.||..... ...+.........            .+.+.             
T Consensus       237 ~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~-~~~~~~~~~~~~~------------~~~p~-------------  290 (325)
T d1rjba_         237 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-DANFYKLIQNGFK------------MDQPF-------------  290 (325)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHTTCC------------CCCCT-------------
T ss_pred             HHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCC------------CCCCC-------------
Confidence            7777889999999999999999998 8999864321 1112222211110            00000             


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHH
Q 040999          329 INVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQ  365 (382)
Q Consensus       329 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~  365 (382)
                           .++.++.+|+.+||+.||++||||+||++.|.
T Consensus       291 -----~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         291 -----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                 23346788899999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=313.96  Aligned_cols=198  Identities=23%  Similarity=0.284  Sum_probs=154.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++..     .+..++|||||++|+|.+++.         .....+++..+..++.||
T Consensus        54 ~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~lvmEy~~~g~L~~~~~---------~~~~~l~e~~~~~i~~qi  119 (288)
T d2jfla1          54 EDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVML---------ELERPLTESQIQVVCKQT  119 (288)
T ss_dssp             GGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHH---------HHTSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEEEEecCCCCcHHHHHH---------hcCCCCCHHHHHHHHHHH
Confidence            678999999999999999999999654     778999999999999999873         234569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC------------CCCCCCCccc-----cCCCCCccc
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL------------PPTRTQTKYG-----VGNEVSTIG  260 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~------------~~~~~~~~~~-----~~~~~~~~~  260 (382)
                      ++||.|||   +.+|+||||||+|||++.++.+||+|||+|+..            .+...+||..     .+..++.++
T Consensus       120 ~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~  196 (288)
T d2jfla1         120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA  196 (288)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHH
T ss_pred             HHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhh
Confidence            99999999   779999999999999999999999999999753            2234557764     345678999


Q ss_pred             hhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          261 DVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       261 Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      |||||||++|||+||+.||...... ..+........+         .+ ..+                   .....++.
T Consensus       197 DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~~~~~~---------~~-~~~-------------------~~~s~~~~  246 (288)
T d2jfla1         197 DVWSLGITLIEMAEIEPPHHELNPM-RVLLKIAKSEPP---------TL-AQP-------------------SRWSSNFK  246 (288)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHHSCCC---------CC-SSG-------------------GGSCHHHH
T ss_pred             hHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCCC---------CC-Ccc-------------------ccCCHHHH
Confidence            9999999999999999998643111 111111110000         00 000                   02234677


Q ss_pred             HHhhccCCCCccCCCCHHHHHH
Q 040999          341 RIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +++.+||+.||++|||+.|+++
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            8888999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-43  Score=314.46  Aligned_cols=212  Identities=22%  Similarity=0.360  Sum_probs=163.2

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|++       +.|.+|+.+|++++|||||+++|+|.      .+..++|||||++|+|..++..        .....+
T Consensus        45 AiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~~lv~Ey~~~g~l~~~~~~--------~~~~~l  110 (285)
T d1fmka3          45 AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKG--------ETGKYL  110 (285)
T ss_dssp             EEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEEECCCTTCBHHHHHSH--------HHHTTC
T ss_pred             EEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe------cCCeEEEEEecCCCchhhhhhh--------cccccc
Confidence            77766       68999999999999999999999863      3457899999999999988853        223469


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~  252 (382)
                      +|..++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....             ..+||+..
T Consensus       111 ~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  187 (285)
T d1fmka3         111 RLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL  187 (285)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHh
Confidence            99999999999999999999   679999999999999999999999999999865322             23467777


Q ss_pred             CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      ...++.++|||||||++|||+||..|+....    ...+.....         .........                  
T Consensus       188 ~~~~~~ksDI~S~Giil~el~t~~~p~~~~~----~~~~~~~~i---------~~~~~~~~~------------------  236 (285)
T d1fmka3         188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQV---------ERGYRMPCP------------------  236 (285)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHH---------HTTCCCCCC------------------
T ss_pred             CCCCCcHHhhhcchHHHHHHHhCCCCCCCCC----CHHHHHHHH---------HhcCCCCCC------------------
Confidence            7889999999999999999999777654211    111111111         000000000                  


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhhc
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTLL  372 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~~  372 (382)
                      ..++.++.+++.+||+.||++||||++|++.|+.......
T Consensus       237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            0233467888999999999999999999999998776543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-43  Score=313.40  Aligned_cols=204  Identities=20%  Similarity=0.243  Sum_probs=149.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++..   +..+..++|||||++|+|.+++....      .....+++..++.++.||
T Consensus        48 ~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~~ivmEy~~~g~L~~~i~~~~------~~~~~l~e~~~~~i~~qi  118 (269)
T d2java1          48 QMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGT------KERQYLDEEFVLRVMTQL  118 (269)
T ss_dssp             HHHHHHHHHTTSCCCTTBCCEEEEEEC-------CEEEEEECCTTEEHHHHHHHHH------HHTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEEEEEEecCCCCcHHHHHHhcc------ccCCCCCHHHHHHHHHHH
Confidence            568999999999999999999998753   23566899999999999999984321      224569999999999999


Q ss_pred             HHHHhHHhhcC--CCceeecCCCCCceeeCCCCcEEEccccccccCCC------------CCCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDC--QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~--~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||.|||+..  ..+|+||||||+|||++.++.+||+|||+|+....            ...+||...+..++.++|||
T Consensus       119 ~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIw  198 (269)
T d2java1         119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIW  198 (269)
T ss_dssp             HHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHH
Confidence            99999999642  24599999999999999999999999999986532            23447777788899999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      ||||++|||+||+.||....     ..+.....        ........+ .                  ....++.+++
T Consensus       199 SlGvilyel~tg~~Pf~~~~-----~~~~~~~i--------~~~~~~~~~-~------------------~~s~~l~~li  246 (269)
T d2java1         199 SLGCLLYELCALMPPFTAFS-----QKELAGKI--------REGKFRRIP-Y------------------RYSDELNEII  246 (269)
T ss_dssp             HHHHHHHHHHHSSCSCCCSS-----HHHHHHHH--------HHTCCCCCC-T------------------TSCHHHHHHH
T ss_pred             hhCHHHHHHhhCCCCCCCCC-----HHHHHHHH--------HcCCCCCCC-c------------------ccCHHHHHHH
Confidence            99999999999999986421     11111110        000000000 0                  1233577888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.||++|||+.|+++
T Consensus       247 ~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         247 TRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCChhHCcCHHHHHh
Confidence            8999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-42  Score=310.63  Aligned_cols=203  Identities=20%  Similarity=0.327  Sum_probs=154.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|+++|++++|||||+++++|.      .+..++||||+++|+|.+++.         .....+++..++.++.||
T Consensus        53 ~~~~~E~~~l~~l~HpnIv~l~~~~~------~~~~~iv~E~~~~g~l~~~~~---------~~~~~l~~~~~~~~~~qi  117 (273)
T d1mp8a_          53 EKFLQEALTMRQFDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQ---------VRKYSLDLASLILYAYQL  117 (273)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEC------SSSCEEEEECCTTEEHHHHHH---------HTTTTSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEe------cCeEEEEEEeccCCcHHhhhh---------ccCCCCCHHHHHHHHHHH
Confidence            67999999999999999999999863      356899999999999998873         334568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC-------------CCCCccccCCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT-------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      ++||.|||   +.+|+||||||+||+++.++.+||+|||+|+.....             ..+||...+..++.++||||
T Consensus       118 ~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwS  194 (273)
T d1mp8a_         118 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM  194 (273)
T ss_dssp             HHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHH
T ss_pred             HHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCcccccc
Confidence            99999999   779999999999999999999999999999865321             22356666778899999999


Q ss_pred             HHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          265 YGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       265 ~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |||++|||+| |.+||.....  ..+...+.....           ...+                   ..++.++.+++
T Consensus       195 lGvil~e~lt~g~~P~~~~~~--~~~~~~i~~~~~-----------~~~~-------------------~~~~~~~~~li  242 (273)
T d1mp8a_         195 FGVCMWEILMHGVKPFQGVKN--NDVIGRIENGER-----------LPMP-------------------PNCPPTLYSLM  242 (273)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCC-----------CCCC-------------------TTCCHHHHHHH
T ss_pred             chHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC-----------CCCC-------------------CCCCHHHHHHH
Confidence            9999999998 8899864321  111111111000           0000                   02334678888


Q ss_pred             hccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          344 VACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+||+.||++|||+.||++.|+++.+.
T Consensus       243 ~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         243 TKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            899999999999999999999998664

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-42  Score=317.50  Aligned_cols=147  Identities=21%  Similarity=0.309  Sum_probs=130.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++|++++|||||+++++|..     ++..++|||||++|+|.+++.          +...+++..+..++.|+
T Consensus        49 ~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~iVmEy~~gg~L~~~l~----------~~~~l~~~~~~~~~~qi  113 (322)
T d1s9ja_          49 NQIIRELQVLHECNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIAV  113 (322)
T ss_dssp             HHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSEEEEEEECCTTEEHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEEcCCCCcHHHHHh----------hcCCCCHHHHHHHHHHH
Confidence            678999999999999999999999653     778999999999999999994          33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccC----------CCCCCCCccccCCCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFL----------PPTRTQTKYGVGNEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~----------~~~~~~~~~~~~~~~~~~~Dv~S~Gv  267 (382)
                      ++||.|||+.  .+|+||||||+|||++.++.+||+|||+|+..          +....+||...+..++.++||||+||
T Consensus       114 l~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGv  191 (322)
T d1s9ja_         114 IKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL  191 (322)
T ss_dssp             HHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHH
T ss_pred             HHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHH
Confidence            9999999941  38999999999999999999999999999853          22345588888889999999999999


Q ss_pred             HHHHHHhcCCCCCc
Q 040999          268 LLLELMIREKPSDI  281 (382)
Q Consensus       268 il~elltg~~p~~~  281 (382)
                      ++|||+||+.||..
T Consensus       192 il~ell~G~~Pf~~  205 (322)
T d1s9ja_         192 SLVEMAVGRYPIPP  205 (322)
T ss_dssp             HHHHHHHSSCCSSC
T ss_pred             HHHHHHHCCCCCCC
Confidence            99999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-42  Score=308.65  Aligned_cols=201  Identities=24%  Similarity=0.307  Sum_probs=158.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ++|.+|+++|++++|||||+++|+|.      .+..++|||||++|++.+++.         .....+++..++.++.||
T Consensus        56 ~~~~~Ei~~l~~l~H~nIv~~~g~~~------~~~~~lv~e~~~~~~l~~~~~---------~~~~~l~~~~~~~~~~qi  120 (273)
T d1u46a_          56 DDFIREVNAMHSLDHRNLIRLYGVVL------TPPMKMVTELAPLGSLLDRLR---------KHQGHFLLGTLSRYAVQV  120 (273)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEEEECCTTCBHHHHHH---------HHGGGSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEe------ecchheeeeeecCcchhhhhh---------cccCCCCHHHHHHHHHHH
Confidence            68999999999999999999999974      245689999999999998874         334569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++||.|||   +++|+||||||+|||++.++.+||+|||+++.....               ..+||...+..++.++||
T Consensus       121 ~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  197 (273)
T d1u46a_         121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT  197 (273)
T ss_dssp             HHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHH
T ss_pred             HHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhh
Confidence            99999999   679999999999999999999999999999875332               223666667788999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          263 YSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       263 ~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||||++|||+| |+.||...     .............        ......                  ..++.++.+
T Consensus       198 ~S~Gvil~emlt~G~~Pf~~~-----~~~~~~~~i~~~~--------~~~~~~------------------~~~~~~l~~  246 (273)
T d1u46a_         198 WMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEG--------ERLPRP------------------EDCPQDIYN  246 (273)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTSC--------CCCCCC------------------TTCCHHHHH
T ss_pred             hhhHHHHHHHHhCCCCCCCCc-----CHHHHHHHHHhCC--------CCCCCc------------------ccccHHHHH
Confidence            999999999998 89998632     1111111111100        000000                  023346788


Q ss_pred             HhhccCCCCccCCCCHHHHHHHHHHh
Q 040999          342 IGVACSMESPQDRMKMTNVVHELQSI  367 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~L~~i  367 (382)
                      ++.+||+.||++||||.||.+.|++.
T Consensus       247 li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         247 VMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            99999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-42  Score=313.86  Aligned_cols=204  Identities=23%  Similarity=0.342  Sum_probs=162.6

Q ss_pred             hHHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          116 IFKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       116 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ..++|.+|+++|++++|||||+++|+|..      +..++++||+.+|+|.+++.         .....+++..+++++.
T Consensus        54 ~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------~~~~~v~e~~~~~~l~~~~~---------~~~~~~~~~~~~~i~~  118 (317)
T d1xkka_          54 ANKEILDEAYVMASVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVR---------EHKDNIGSQYLLNWCV  118 (317)
T ss_dssp             THHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEEECCTTCBHHHHHH---------HTSSSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCeeEEEEeccCCccccccc---------ccccCCCHHHHHHHHH
Confidence            34789999999999999999999999863      45688999999999998874         3456799999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccch
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGD  261 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~D  261 (382)
                      ||++||+|||   +++|+||||||+|||++.++.+||+|||+|+....              ...+||...+..++.++|
T Consensus       119 qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD  195 (317)
T d1xkka_         119 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD  195 (317)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHH
T ss_pred             HHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhh
Confidence            9999999999   67999999999999999999999999999986532              234477777788999999


Q ss_pred             hHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHH
Q 040999          262 VYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMV  340 (382)
Q Consensus       262 v~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
                      ||||||++|||+| |+.||+....  ..+.........            ....                  ..++..+.
T Consensus       196 vwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~~~~------------~~~p------------------~~~~~~~~  243 (317)
T d1xkka_         196 VWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGER------------LPQP------------------PICTIDVY  243 (317)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHHTCC------------CCCC------------------TTBCHHHH
T ss_pred             hhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCC------------CCCC------------------cccCHHHH
Confidence            9999999999999 7888764321  112222111110            0000                  02334678


Q ss_pred             HHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          341 RIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       341 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      +++.+||+.||++|||+.||++.|..+..
T Consensus       244 ~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         244 MIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            88999999999999999999999988754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-42  Score=312.56  Aligned_cols=213  Identities=23%  Similarity=0.358  Sum_probs=161.4

Q ss_pred             HHHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC--------------ccccCC
Q 040999          117 FKSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED--------------ETYERP  182 (382)
Q Consensus       117 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~  182 (382)
                      .++|.+|+++|++++||||++++++|..     ....++||||+++|+|.+++.......              ......
T Consensus        60 ~~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (301)
T d1lufa_          60 QADFQREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP  134 (301)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------
T ss_pred             HHHHHHHHHHHHhcCCCCcccceeeecc-----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCC
Confidence            3679999999999999999999999753     677899999999999999985432110              001223


Q ss_pred             cccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCC
Q 040999          183 RNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQT  248 (382)
Q Consensus       183 ~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~  248 (382)
                      ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....              ..+|
T Consensus       135 ~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP  211 (301)
T d1lufa_         135 PPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  211 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence            45899999999999999999999   779999999999999999999999999999754221              2336


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHHhcC-CCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhh
Q 040999          249 KYGVGNEVSTIGDVYSYGILLLELMIRE-KPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQA  327 (382)
Q Consensus       249 ~~~~~~~~~~~~Dv~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (382)
                      |...+..++.++|||||||++|||++|. +||...     ...+......        +......+              
T Consensus       212 E~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~-----~~~e~~~~v~--------~~~~~~~p--------------  264 (301)
T d1lufa_         212 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-----AHEEVIYYVR--------DGNILACP--------------  264 (301)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHH--------TTCCCCCC--------------
T ss_pred             HHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-----CHHHHHHHHH--------cCCCCCCC--------------
Confidence            6666778999999999999999999996 565432     1111111110        00000000              


Q ss_pred             hhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          328 KINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       328 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                           ..++.++.+|+.+||+.+|++||||.||++.|+++.+
T Consensus       265 -----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         265 -----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                 0233467889999999999999999999999998853

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-42  Score=312.50  Aligned_cols=196  Identities=22%  Similarity=0.285  Sum_probs=153.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++..     .+..++|||||++|+|..++.          ....+++..+..++.||
T Consensus        60 ~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~iv~E~~~~g~l~~~~~----------~~~~l~e~~~~~i~~qi  124 (309)
T d1u5ra_          60 QDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEV----------HKKPLQEVEIAAVTHGA  124 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHH----------HTSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEEEEEEEecCCCchHHHHH----------hCCCCCHHHHHHHHHHH
Confidence            679999999999999999999999754     678999999999999876652          34569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------CCCCccccC---CCCCccchhHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------RTQTKYGVG---NEVSTIGDVYSYG  266 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~~---~~~~~~~Dv~S~G  266 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....        ..+||...+   ..++.++||||||
T Consensus       125 ~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlG  201 (309)
T d1u5ra_         125 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  201 (309)
T ss_dssp             HHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHH
T ss_pred             HHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHH
Confidence            99999999   779999999999999999999999999999866432        334666532   4589999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||...    .....+...         ...........                  .....+.+++.+|
T Consensus       202 vilyel~~g~~Pf~~~----~~~~~~~~i---------~~~~~~~~~~~------------------~~s~~~~~li~~~  250 (309)
T d1u5ra_         202 ITCIELAERKPPLFNM----NAMSALYHI---------AQNESPALQSG------------------HWSEYFRNFVDSC  250 (309)
T ss_dssp             HHHHHHHHSSCTTTTS----CHHHHHHHH---------HHSCCCCCSCT------------------TSCHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCCC----CHHHHHHHH---------HhCCCCCCCCC------------------CCCHHHHHHHHHH
Confidence            9999999999998632    111111110         00000000000                  1233677888899


Q ss_pred             CCCCccCCCCHHHHHH
Q 040999          347 SMESPQDRMKMTNVVH  362 (382)
Q Consensus       347 l~~~p~~RPs~~evl~  362 (382)
                      |+.||++|||+.|+++
T Consensus       251 L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         251 LQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             TCSSGGGSCCHHHHTT
T ss_pred             CcCChhHCcCHHHHHh
Confidence            9999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-41  Score=309.54  Aligned_cols=203  Identities=19%  Similarity=0.197  Sum_probs=151.5

Q ss_pred             chhhH---------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCc
Q 040999          113 AFKIF---------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPR  183 (382)
Q Consensus       113 avK~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~  183 (382)
                      |+|.+         +.+.+|+++|++++|||||++++++.     +++..++|||||++|+|.+++.          ...
T Consensus        38 AvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~~lvmE~~~gg~L~~~l~----------~~~  102 (307)
T d1a06a_          38 AIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGHLYLIMQLVSGGELFDRIV----------EKG  102 (307)
T ss_dssp             EEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------TCS
T ss_pred             EEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEeccCCCcHHHhhh----------ccc
Confidence            77765         45789999999999999999999954     4788999999999999999994          345


Q ss_pred             ccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeC---CCCcEEEccccccccCCC-----------CCCCCc
Q 040999          184 NLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD---DDMTARVGDFGLARFLPP-----------TRTQTK  249 (382)
Q Consensus       184 ~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~---~~~~~kl~Dfg~a~~~~~-----------~~~~~~  249 (382)
                      .+++..+..++.||+.||+|||   +.+|+||||||+|||+.   +++.+||+|||+|+....           ...+||
T Consensus       103 ~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE  179 (307)
T d1a06a_         103 FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE  179 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcH
Confidence            6999999999999999999999   77999999999999994   578999999999986532           234577


Q ss_pred             cccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhh
Q 040999          250 YGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKI  329 (382)
Q Consensus       250 ~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (382)
                      ...+..++.++|||||||++|||+||+.||....    .. .........        .......               
T Consensus       180 ~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~-~~~~~i~~~--------~~~~~~~---------------  231 (307)
T d1a06a_         180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DA-KLFEQILKA--------EYEFDSP---------------  231 (307)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HH-HHHHHHHTT--------CCCCCTT---------------
T ss_pred             HHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC----HH-HHHHHHhcc--------CCCCCCc---------------
Confidence            7778889999999999999999999999986421    11 111111000        0000000               


Q ss_pred             hhHHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          330 NVIIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       330 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                       .......++.+++.+||+.||++|||+.|+++
T Consensus       232 -~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         232 -YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             -TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             00022346778888999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-42  Score=308.84  Aligned_cols=194  Identities=16%  Similarity=0.214  Sum_probs=154.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++.     +++..++|||||++|+|.+++.          ....+++..+..++.|+
T Consensus        53 ~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~ivmEy~~gg~L~~~~~----------~~~~l~e~~~~~~~~qi  117 (288)
T d1uu3a_          53 PYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEKLYFGLSYAKNGELLKYIR----------KIGSFDETCTRFYTAEI  117 (288)
T ss_dssp             HHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSEEEEEECCCTTEEHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCEEEEEEEccCCCCHHHhhh----------ccCCCCHHHHHHHHHHH
Confidence            56899999999999999999999954     4788999999999999999883          34569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      +.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+..              ...+||...+..++.++|||
T Consensus       118 ~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~Diw  194 (288)
T d1uu3a_         118 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW  194 (288)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHH
T ss_pred             HHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCccccee
Confidence            99999999   77999999999999999999999999999986532              12347777788899999999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |+||++|||+||+.||...    .. ...........        .. -+ .                  ....++.+++
T Consensus       195 SlGvilyell~g~~Pf~~~----~~-~~~~~~i~~~~--------~~-~p-~------------------~~s~~~~~li  241 (288)
T d1uu3a_         195 ALGCIIYQLVAGLPPFRAG----NE-YLIFQKIIKLE--------YD-FP-E------------------KFFPKARDLV  241 (288)
T ss_dssp             HHHHHHHHHHHSSCSSCCS----SH-HHHHHHHHTTC--------CC-CC-T------------------TCCHHHHHHH
T ss_pred             hhhHHHHHHhhCCCCCCCc----CH-HHHHHHHHcCC--------CC-CC-c------------------cCCHHHHHHH
Confidence            9999999999999998632    11 11111110000        00 00 0                  1123567888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.||++|||++|+++
T Consensus       242 ~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         242 EKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HTTSCSSGGGSTTSGGGTC
T ss_pred             HHHccCCHhHCcCHHHHcC
Confidence            8999999999999998754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-41  Score=308.66  Aligned_cols=214  Identities=23%  Similarity=0.324  Sum_probs=164.4

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC------ccccCCcccCHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED------ETYERPRNLNLLRR  190 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~  190 (382)
                      ++|.+|+++|+++ +|||||+++|+|..     ++..++||||+++|+|.++++......      ........+++..+
T Consensus        55 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  129 (309)
T d1fvra_          55 RDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL  129 (309)
T ss_dssp             CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred             HHHHHHHHHHHhccCCCCEeeEEEEEec-----CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHH
Confidence            5799999999999 79999999999765     678999999999999999996432100      00123457999999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCcc
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTI  259 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~  259 (382)
                      ..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+|+....           ....||...+..++.+
T Consensus       130 ~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~  206 (309)
T d1fvra_         130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN  206 (309)
T ss_dssp             HHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred             HHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCcc
Confidence            999999999999999   77999999999999999999999999999975432           2334666677888999


Q ss_pred             chhHHHHHHHHHHHhcCC-CCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREK-PSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVIS  338 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (382)
                      +|||||||++|||++|.. ||...     ..........        +. ......                  ..++.+
T Consensus       207 sDvwSfGvil~ell~~~~~p~~~~-----~~~~~~~~i~--------~~-~~~~~~------------------~~~~~~  254 (309)
T d1fvra_         207 SDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYEKLP--------QG-YRLEKP------------------LNCDDE  254 (309)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHGG--------GT-CCCCCC------------------TTBCHH
T ss_pred             ceeehhHHHHHHHHhcCCCCCCCC-----CHHHHHHHHH--------hc-CCCCCC------------------ccCCHH
Confidence            999999999999999765 55421     1111111110        00 000000                  023346


Q ss_pred             HHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          339 MVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       339 ~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                      +.+++.+||+.||++||||+||++.|+++.+..
T Consensus       255 ~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         255 VYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            788888999999999999999999999998654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-41  Score=304.99  Aligned_cols=214  Identities=21%  Similarity=0.275  Sum_probs=154.0

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC------ccccCCcccCHHHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED------ETYERPRNLNLLRR  190 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~  190 (382)
                      +.+.+|.+.+.++ +|+|||++++++..    .....++|||||++|+|.+++.......      ........+++..+
T Consensus        61 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~----~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  136 (299)
T d1ywna1          61 RALMSELKILIHIGHHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL  136 (299)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS----TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHH
T ss_pred             HHHHHHHHHHHhhcCCCeEEEeeeeecc----CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHH
Confidence            5688888888887 68999999998743    3567899999999999999996432110      00012346899999


Q ss_pred             HHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCCC
Q 040999          191 LNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNEV  256 (382)
Q Consensus       191 ~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~~  256 (382)
                      +.++.||++||.|||   +++|+||||||+|||++.++.+||+|||+|+.....              ..+||...+..+
T Consensus       137 ~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~  213 (299)
T d1ywna1         137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY  213 (299)
T ss_dssp             HHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence            999999999999999   779999999999999999999999999999754322              223666667788


Q ss_pred             CccchhHHHHHHHHHHHhcC-CCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          257 STIGDVYSYGILLLELMIRE-KPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       257 ~~~~Dv~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      +.++|||||||++|||+||. .||.... ....+...........            ...                  .+
T Consensus       214 ~~~sDiwS~Gvil~ellt~~~~p~~~~~-~~~~~~~~~~~~~~~~------------~~~------------------~~  262 (299)
T d1ywna1         214 TIQSDVWSFGVLLWEIFSLGASPYPGVK-IDEEFCRRLKEGTRMR------------APD------------------YT  262 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCC-CSHHHHHHHHHTCCCC------------CCT------------------TC
T ss_pred             CcccceeehHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCCCC------------CCc------------------cC
Confidence            99999999999999999975 5665321 1111222211111100            000                  22


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      +.++.+++.+||+.||++|||+.||+++|+++.+
T Consensus       263 ~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         263 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            3467888999999999999999999999998864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.8e-41  Score=310.88  Aligned_cols=204  Identities=17%  Similarity=0.219  Sum_probs=159.3

Q ss_pred             chhhH--------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc
Q 040999          113 AFKIF--------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN  184 (382)
Q Consensus       113 avK~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~  184 (382)
                      |+|++        +.+.+|+++|++++|||||++++++.     +++..++|||||++|+|.+++.         .....
T Consensus        58 AiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~ivmE~~~gg~L~~~~~---------~~~~~  123 (352)
T d1koba_          58 VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVLILEFLSGGELFDRIA---------AEDYK  123 (352)
T ss_dssp             EEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEEEEECCCCCBHHHHTT---------CTTCC
T ss_pred             EEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEEcCCCChHHHHHH---------hcCCC
Confidence            77765        56889999999999999999999954     4788999999999999988773         23456


Q ss_pred             cCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeC--CCCcEEEccccccccCCCCC-----------CCCccc
Q 040999          185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLD--DDMTARVGDFGLARFLPPTR-----------TQTKYG  251 (382)
Q Consensus       185 l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~--~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~  251 (382)
                      +++..+..++.||+.||.|||   +.+|+||||||+|||++  .++.+||+|||+|+.+....           .+||..
T Consensus       124 l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~  200 (352)
T d1koba_         124 MSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV  200 (352)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHH
Confidence            999999999999999999999   77999999999999998  57899999999998765432           247777


Q ss_pred             cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          252 VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       252 ~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      .+..++.++||||+||++|||+||+.||...    .....+....         ........ .               .
T Consensus       201 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~i~---------~~~~~~~~-~---------------~  251 (352)
T d1koba_         201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGE----DDLETLQNVK---------RCDWEFDE-D---------------A  251 (352)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHH---------HCCCCCCS-S---------------T
T ss_pred             cCCCCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHH---------hCCCCCCc-c---------------c
Confidence            7888999999999999999999999998632    1111111100         00000000 0               0


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ......++.+|+.+||+.||.+|||+.|+++
T Consensus       252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0012345778888999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-40  Score=302.10  Aligned_cols=231  Identities=21%  Similarity=0.256  Sum_probs=162.0

Q ss_pred             chhhH-----HHHHHHHH--HHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-----KSFIAECK--ALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-----~~~~~E~~--~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|++     +++.+|.+  .+.+++|||||+++++|.... ......++|||||++|+|.++++.           ..+
T Consensus        30 AvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~-----------~~l   97 (303)
T d1vjya_          30 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-----------YTV   97 (303)
T ss_dssp             EEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-----------CCB
T ss_pred             EEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEEecccCCCHHHHHhc-----------CCC
Confidence            77765     44444544  556789999999999987532 223468999999999999999942           358


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhc-----CCCceeecCCCCCceeeCCCCcEEEccccccccCCCC----------------
Q 040999          186 NLLRRLNIAIDVASALNYLHHD-----CQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT----------------  244 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~-----~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~----------------  244 (382)
                      +|..+++++.|+|.||+|+|+.     .+++|+||||||+|||++.++.+||+|||+++.....                
T Consensus        98 ~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~  177 (303)
T d1vjya_          98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR  177 (303)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccC
Confidence            9999999999999999999953     1369999999999999999999999999999865322                


Q ss_pred             CCCCccccCC------CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhh----hhhcccccchh
Q 040999          245 RTQTKYGVGN------EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKD----IVDSILLNDDE  314 (382)
Q Consensus       245 ~~~~~~~~~~------~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  314 (382)
                      ..+||...+.      .++.++|||||||++|||+||..||...............  .......    ..+..+.+...
T Consensus       178 y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~p~~~  255 (303)
T d1vjya_         178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP--SDPSVEEMRKVVCEQKLRPNIP  255 (303)
T ss_dssp             GCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC--SSCCHHHHHHHHTTSCCCCCCC
T ss_pred             cCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc--ccchHHHHHHHHhccccCCCCC
Confidence            1225544332      2577999999999999999999887542221111100000  0000011    11111111100


Q ss_pred             hhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          315 KLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                                   ......+.+..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus       256 -------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         256 -------------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             -------------GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence                         0001124566788999999999999999999999999998765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=303.07  Aligned_cols=198  Identities=18%  Similarity=0.195  Sum_probs=155.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++.     +.+..++|||||++|+|.+++.          ....+++..+..++.|+
T Consensus        58 ~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~iv~E~~~gg~L~~~i~----------~~~~l~~~~~~~~~~qi  122 (293)
T d1jksa_          58 EDIEREVSILKEIQHPNVITLHEVYE-----NKTDVILILELVAGGELFDFLA----------EKESLTEEEATEFLKQI  122 (293)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHH----------HHSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEEcCCCccccchhc----------cccccchhHHHHHHHHH
Confidence            67999999999999999999999964     4788999999999999999983          33469999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCC----cEEEccccccccCCCC-----------CCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDM----TARVGDFGLARFLPPT-----------RTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfg~a~~~~~~-----------~~~~~~~~~~~~~~~~Dv  262 (382)
                      +.||+|||   +.+|+||||||+|||++.++    .+|++|||+|+.....           ..+||...+..++.++||
T Consensus       123 ~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~Di  199 (293)
T d1jksa_         123 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADM  199 (293)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHH
T ss_pred             HHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccc
Confidence            99999999   77999999999999998776    4999999999876432           233666677789999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||+||+.||...    .... .......        .......                .........+.++
T Consensus       200 wSlGvilyell~g~~Pf~~~----~~~~-~~~~i~~--------~~~~~~~----------------~~~~~~s~~~~~l  250 (293)
T d1jksa_         200 WSIGVITYILLSGASPFLGD----TKQE-TLANVSA--------VNYEFED----------------EYFSNTSALAKDF  250 (293)
T ss_dssp             HHHHHHHHHHHHSSCSSCCS----SHHH-HHHHHHT--------TCCCCCH----------------HHHTTSCHHHHHH
T ss_pred             hhhhHHHHHHHcCCCCCCCC----CHHH-HHHHHHh--------cCCCCCc----------------hhcCCCCHHHHHH
Confidence            99999999999999998642    1111 1111000        0000000                0001223456788


Q ss_pred             hhccCCCCccCCCCHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~  362 (382)
                      +.+||+.||++|||++|+++
T Consensus       251 i~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         251 IRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHhc
Confidence            88999999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-41  Score=305.07  Aligned_cols=214  Identities=22%  Similarity=0.348  Sum_probs=163.4

Q ss_pred             HHHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC------ccccCCcccCHHH
Q 040999          117 FKSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED------ETYERPRNLNLLR  189 (382)
Q Consensus       117 ~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~  189 (382)
                      ..++.+|...+.++ +|||||+++++|..     ++..++|||||++|+|.+++.......      ........+++..
T Consensus        62 ~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~  136 (299)
T d1fgka_          62 LSDLISEMEMMKMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD  136 (299)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHH
T ss_pred             HHHHHHHHHHHHHhcCCCeEEeccccccc-----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHH
Confidence            37789999999998 89999999999754     677899999999999999996543211      1112345689999


Q ss_pred             HHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC--------------CCCCccccCCC
Q 040999          190 RLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT--------------RTQTKYGVGNE  255 (382)
Q Consensus       190 ~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~~~~~~  255 (382)
                      ++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....              ..+||...+..
T Consensus       137 ~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~  213 (299)
T d1fgka_         137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI  213 (299)
T ss_dssp             HHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC
Confidence            9999999999999999   779999999999999999999999999999865332              22356566788


Q ss_pred             CCccchhHHHHHHHHHHHh-cCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          256 VSTIGDVYSYGILLLELMI-REKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       256 ~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      ++.++|||||||++|||+| |..||....     ......         .+..........                  .
T Consensus       214 y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-----~~~~~~---------~i~~~~~~~~p~------------------~  261 (299)
T d1fgka_         214 YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----VEELFK---------LLKEGHRMDKPS------------------N  261 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHH---------HHHTTCCCCCCS------------------S
T ss_pred             CCchhhhHHhHHHHHHhccCCCCCCCCCC-----HHHHHH---------HHHcCCCCCCCc------------------c
Confidence            9999999999999999998 688875321     111111         111100000000                  2


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      ++.++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       262 ~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         262 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            234678899999999999999999999999998653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-40  Score=308.20  Aligned_cols=205  Identities=19%  Similarity=0.242  Sum_probs=159.5

Q ss_pred             chhhH--------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcc
Q 040999          113 AFKIF--------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRN  184 (382)
Q Consensus       113 avK~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~  184 (382)
                      |+|++        +.+.+|+++|++++|||||++++++..     .+..++|||||++|+|.+++.         .....
T Consensus        55 AvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~ivmE~~~gg~L~~~l~---------~~~~~  120 (350)
T d1koaa2          55 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVMIYEFMSGGELFEKVA---------DEHNK  120 (350)
T ss_dssp             EEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHT---------CTTSC
T ss_pred             EEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEEcCCCCCHHHHHH---------hhcCC
Confidence            77765        678999999999999999999999654     788999999999999999884         23456


Q ss_pred             cCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC--CCcEEEccccccccCCCC-----------CCCCccc
Q 040999          185 LNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD--DMTARVGDFGLARFLPPT-----------RTQTKYG  251 (382)
Q Consensus       185 l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~--~~~~kl~Dfg~a~~~~~~-----------~~~~~~~  251 (382)
                      +++..+..++.||+.||.|||   +.+|+||||||+|||++.  ++.+||+|||+|+.+...           ..+||..
T Consensus       121 l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~  197 (350)
T d1koaa2         121 MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA  197 (350)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHH
Confidence            999999999999999999999   779999999999999954  578999999999876432           3347777


Q ss_pred             cCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhh
Q 040999          252 VGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINV  331 (382)
Q Consensus       252 ~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (382)
                      .+..++.++||||+||++|||+||+.||...    .. .......        ..........                .
T Consensus       198 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~-~~~~~~i--------~~~~~~~~~~----------------~  248 (350)
T d1koaa2         198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----ND-DETLRNV--------KSCDWNMDDS----------------A  248 (350)
T ss_dssp             HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SH-HHHHHHH--------HHTCCCSCCG----------------G
T ss_pred             cCCCCChhHhhhhhhHHHHHHHhCCCCCCCC----CH-HHHHHHH--------HhCCCCCCcc----------------c
Confidence            7888999999999999999999999998632    11 1111110        0000000000                0


Q ss_pred             HHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          332 IIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       332 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ......++.+++.+||+.||++|||+.|+++.
T Consensus       249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00123356788889999999999999999873

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-40  Score=302.57  Aligned_cols=215  Identities=21%  Similarity=0.261  Sum_probs=162.6

Q ss_pred             HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCC--------ccccCCcccCHH
Q 040999          118 KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKED--------ETYERPRNLNLL  188 (382)
Q Consensus       118 ~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~~~l~~~  188 (382)
                      ..|.+|+.+++++ +|||||+++++|..     .+..++|||||++|+|.+++.......        ........+++.
T Consensus        71 ~~~~~E~~~~~~l~~HpnIv~~~g~~~~-----~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~  145 (311)
T d1t46a_          71 EALMSELKVLSYLGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE  145 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHH
T ss_pred             HHHHHHHHHHHhccCCCCEEEEEEEEee-----CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHH
Confidence            5799999999999 69999999999754     677899999999999999986433211        011233468999


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC--------------CCCccccCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR--------------TQTKYGVGN  254 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~--------------~~~~~~~~~  254 (382)
                      .+..++.||++||+|||   +++++||||||+|||++.++.+|++|||.++......              .+||...+.
T Consensus       146 ~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  222 (311)
T d1t46a_         146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC  222 (311)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC
Confidence            99999999999999999   7799999999999999999999999999998764322              225666677


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      .++.++|||||||++|||+|+..|+.........+........+.            ....                  .
T Consensus       223 ~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~------------~~~~------------------~  272 (311)
T d1t46a_         223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM------------LSPE------------------H  272 (311)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC------------CCCT------------------T
T ss_pred             CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC------------CCcc------------------c
Confidence            889999999999999999995555332222222222222221111            0000                  2


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                      .+..+.+|+.+||+.||++||||.||+++|+++..+
T Consensus       273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            234678889999999999999999999999887554

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-41  Score=307.50  Aligned_cols=212  Identities=17%  Similarity=0.321  Sum_probs=161.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      ..|.+|++++++++|||||+++++|..     .+..++|||||++|+|.+++...............+++..+.+++.|+
T Consensus        68 ~~~~~E~~il~~l~h~nIv~~~~~~~~-----~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  142 (308)
T d1p4oa_          68 IEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI  142 (308)
T ss_dssp             HHHHHHHHHGGGCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCEeeeeeEEec-----CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHH
Confidence            568999999999999999999999753     677899999999999999885322111111223457899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC--------------CCCCCccccCCCCCccchhH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP--------------TRTQTKYGVGNEVSTIGDVY  263 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~--------------~~~~~~~~~~~~~~~~~Dv~  263 (382)
                      ++||.|||   +.+|+||||||+|||+++++++||+|||+|+.+..              ....||...+..++.++|||
T Consensus       143 a~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~  219 (308)
T d1p4oa_         143 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW  219 (308)
T ss_dssp             HHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHh---hCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccc
Confidence            99999999   67999999999999999999999999999985532              22335666677889999999


Q ss_pred             HHHHHHHHHHhcC-CCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          264 SYGILLLELMIRE-KPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       264 S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      ||||++|||+||. .||...     ...+........        .....+ .                  .++..+.++
T Consensus       220 S~G~il~El~t~~~~p~~~~-----~~~~~~~~i~~~--------~~~~~p-~------------------~~~~~l~~l  267 (308)
T d1p4oa_         220 SFGVVLWEIATLAEQPYQGL-----SNEQVLRFVMEG--------GLLDKP-D------------------NCPDMLFEL  267 (308)
T ss_dssp             HHHHHHHHHHHTSCCTTTTS-----CHHHHHHHHHTT--------CCCCCC-T------------------TCCHHHHHH
T ss_pred             cHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhC--------CCCCCc-c------------------cchHHHHHH
Confidence            9999999999985 565421     112221111111        000000 0                  233468889


Q ss_pred             hhccCCCCccCCCCHHHHHHHHHHhhh
Q 040999          343 GVACSMESPQDRMKMTNVVHELQSIKN  369 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~L~~i~~  369 (382)
                      +.+||+.+|++||||.||++.|++..+
T Consensus       268 i~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         268 MRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            999999999999999999999987644

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.7e-40  Score=295.80  Aligned_cols=209  Identities=20%  Similarity=0.293  Sum_probs=161.9

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.|.+|+++|++++|||||++++++...+ ......|+|||||++|+|.+++.          ....+++.++..++.||
T Consensus        52 ~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~~~lvmE~~~g~~L~~~~~----------~~~~l~~~~~~~i~~qi  120 (277)
T d1o6ya_          52 LRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPLPYIVMEYVDGVTLRDIVH----------TEGPMTPKRAIEVIADA  120 (277)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCCEEEHHHHHH----------HHCSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCcccceeeecc-CCCceEEEEEECCCCCEehhhhc----------ccCCCCHHHHHHHHHHH
Confidence            57999999999999999999999976421 22345899999999999998883          34569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC---------------CCCCCCccccCCCCCccchh
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP---------------PTRTQTKYGVGNEVSTIGDV  262 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~---------------~~~~~~~~~~~~~~~~~~Dv  262 (382)
                      ++||+|||   +.+|+||||||+|||++.++..+++|||.++...               +...+||...+..++.++||
T Consensus       121 ~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~Di  197 (277)
T d1o6ya_         121 CQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV  197 (277)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHH
T ss_pred             HHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceec
Confidence            99999999   7799999999999999999999999999987542               22344787778889999999


Q ss_pred             HHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          263 YSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       263 ~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      |||||++|||+||+.||...    ........ ....            .+..         +..   ...+.+.++.++
T Consensus       198 wSlGvilyelltG~~Pf~~~----~~~~~~~~-~~~~------------~~~~---------~~~---~~~~~s~~l~~l  248 (277)
T d1o6ya_         198 YSLGCVLYEVLTGEPPFTGD----SPVSVAYQ-HVRE------------DPIP---------PSA---RHEGLSADLDAV  248 (277)
T ss_dssp             HHHHHHHHHHHHSSCSCCCS----SHHHHHHH-HHHC------------CCCC---------GGG---TSSSCCHHHHHH
T ss_pred             ccchHHHHHHHhCCCCCCCc----CHHHHHHH-HHhc------------CCCC---------Cch---hccCCCHHHHHH
Confidence            99999999999999998632    11111111 1000            0000         000   000223467788


Q ss_pred             hhccCCCCccCCC-CHHHHHHHHHHhhh
Q 040999          343 GVACSMESPQDRM-KMTNVVHELQSIKN  369 (382)
Q Consensus       343 ~~~Cl~~~p~~RP-s~~evl~~L~~i~~  369 (382)
                      +.+||+.||++|| |++++++.|.++++
T Consensus       249 i~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         249 VLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             HHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            8899999999999 89999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-39  Score=291.71  Aligned_cols=198  Identities=21%  Similarity=0.272  Sum_probs=152.7

Q ss_pred             HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++|++++ |||||++++++.     +++..++|||||++|+|.+++.          ....+++..+..++.|
T Consensus        54 ~~~~~E~~~l~~l~~hpnIv~~~~~~~-----~~~~~~ivmE~~~~g~L~~~l~----------~~~~l~e~~~~~~~~q  118 (277)
T d1phka_          54 EATLKEVDILRKVSGHPNIIQLKDTYE-----TNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETRKIMRA  118 (277)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEeecc-----cCcceEEEEEcCCCchHHHHHH----------hcCCCCHHHHHHHHHH
Confidence            56899999999997 999999999954     4789999999999999999994          3456999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCC-----------CCccc------cCCCCCcc
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRT-----------QTKYG------VGNEVSTI  259 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~------~~~~~~~~  259 (382)
                      |++||+|||   +.+|+||||||+|||++.++.+||+|||+++.......           .||..      ....++.+
T Consensus       119 i~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~  195 (277)
T d1phka_         119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE  195 (277)
T ss_dssp             HHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH
T ss_pred             HHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCch
Confidence            999999999   77999999999999999999999999999987654321           13322      23456889


Q ss_pred             chhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHH
Q 040999          260 GDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISM  339 (382)
Q Consensus       260 ~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (382)
                      +||||+||++|||+||+.||....    ... .....        ..........                .......++
T Consensus       196 ~DiwslGvilyeml~g~~Pf~~~~----~~~-~~~~i--------~~~~~~~~~~----------------~~~~~s~~~  246 (277)
T d1phka_         196 VDMWSTGVIMYTLLAGSPPFWHRK----QML-MLRMI--------MSGNYQFGSP----------------EWDDYSDTV  246 (277)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSS----HHH-HHHHH--------HHTCCCCCTT----------------TGGGSCHHH
T ss_pred             heEcccchhhhhhccCCCCCCCCC----HHH-HHHHH--------HhCCCCCCCc----------------ccccCCHHH
Confidence            999999999999999999986421    111 11100        0000000000                000223467


Q ss_pred             HHHhhccCCCCccCCCCHHHHHH
Q 040999          340 VRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       340 ~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+++.+||+.||++|||+.||++
T Consensus       247 ~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         247 KDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHccCChhHCcCHHHHHc
Confidence            88888999999999999999865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-39  Score=297.88  Aligned_cols=204  Identities=22%  Similarity=0.280  Sum_probs=156.7

Q ss_pred             chhhH-------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF-------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|.+       ..+.+|+++|++++|||||++++++.     +.+..|+|||||++|+|.+++.         .....+
T Consensus        34 AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~lvmE~~~gg~L~~~i~---------~~~~~l   99 (321)
T d1tkia_          34 MAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVMIFEFISGLDIFERIN---------TSAFEL   99 (321)
T ss_dssp             EEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEEEECCCCCCBHHHHHT---------SSSCCC
T ss_pred             EEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEecCCCCcHHHHHH---------hcCCCC
Confidence            77765       45889999999999999999999954     3788999999999999999994         233468


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCC--CcEEEccccccccCCCCC-----------CCCcccc
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDD--MTARVGDFGLARFLPPTR-----------TQTKYGV  252 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~--~~~kl~Dfg~a~~~~~~~-----------~~~~~~~  252 (382)
                      ++.++..++.||++||.|||   +.+|+||||||+|||++.+  ..+||+|||+++......           ..||...
T Consensus       100 ~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~  176 (321)
T d1tkia_         100 NEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ  176 (321)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHT
T ss_pred             CHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhcc
Confidence            99999999999999999999   7799999999999999854  579999999998764432           2255555


Q ss_pred             CCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhH
Q 040999          253 GNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVI  332 (382)
Q Consensus       253 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (382)
                      +..++.++||||+||++|||+||+.||....    . ......        +.........                ...
T Consensus       177 ~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~----~-~~~~~~--------i~~~~~~~~~----------------~~~  227 (321)
T d1tkia_         177 HDVVSTATDMWSLGTLVYVLLSGINPFLAET----N-QQIIEN--------IMNAEYTFDE----------------EAF  227 (321)
T ss_dssp             TCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----H-HHHHHH--------HHHTCCCCCH----------------HHH
T ss_pred             CCCCCchhhcccHHHHHHHHHhCCCCCCCCC----H-HHHHHH--------HHhCCCCCCh----------------hhc
Confidence            6778999999999999999999999986421    1 111110        0110000000                000


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          333 IECVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       333 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      .....++.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         228 KEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            012345678888999999999999999987

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-39  Score=298.42  Aligned_cols=194  Identities=20%  Similarity=0.209  Sum_probs=155.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++.     +.+..++|||||++|+|..++.          ....+++..+..++.||
T Consensus        49 ~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ivmE~~~gg~l~~~~~----------~~~~~~~~~~~~~~~qi  113 (316)
T d1fota_          49 EHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQIFMIMDYIEGGELFSLLR----------KSQRFPNPVAKFYAAEV  113 (316)
T ss_dssp             HHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------HTSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCcChhheeeeEe-----eCCeeeeEeeecCCcccccccc----------ccccccccHHHHHHHHH
Confidence            57889999999999999999999964     4788999999999999998883          34567888899999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC---------CCCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP---------TRTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....         ...+||...+..++.++||||+||+
T Consensus       114 ~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvi  190 (316)
T d1fota_         114 CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGIL  190 (316)
T ss_dssp             HHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHH
T ss_pred             HHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchh
Confidence            99999999   88999999999999999999999999999987643         2345787778889999999999999


Q ss_pred             HHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCC
Q 040999          269 LLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSM  348 (382)
Q Consensus       269 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~  348 (382)
                      +|||+||+.||...    .. ......        +...... .+ .                  ....++.+++.+||+
T Consensus       191 lyemltG~~Pf~~~----~~-~~~~~~--------i~~~~~~-~p-~------------------~~s~~~~~li~~~L~  237 (316)
T d1fota_         191 IYEMLAGYTPFYDS----NT-MKTYEK--------ILNAELR-FP-P------------------FFNEDVKDLLSRLIT  237 (316)
T ss_dssp             HHHHHHSSCTTCCS----SH-HHHHHH--------HHHCCCC-CC-T------------------TSCHHHHHHHHHHTC
T ss_pred             HHHHHhCCCCCCCc----CH-HHHHHH--------HHcCCCC-CC-C------------------CCCHHHHHHHHHHhh
Confidence            99999999998642    11 111111        0000000 00 0                  112356778889999


Q ss_pred             CCccCCC-----CHHHHHH
Q 040999          349 ESPQDRM-----KMTNVVH  362 (382)
Q Consensus       349 ~~p~~RP-----s~~evl~  362 (382)
                      .||++||     |++|+++
T Consensus       238 ~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         238 RDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             SCTTTCTTSSTTTTHHHHT
T ss_pred             hCHHhccccchhhHHHHHc
Confidence            9999996     8999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-39  Score=297.19  Aligned_cols=194  Identities=21%  Similarity=0.224  Sum_probs=154.8

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++.     +.+..++|||||++|+|.+++.          ....+++..+..++.||
T Consensus        50 ~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~~~iv~ey~~gg~L~~~~~----------~~~~~~e~~~~~~~~qi  114 (337)
T d1o6la_          50 AHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVMEYANGGELFFHLS----------RERVFTEERARFYGAEI  114 (337)
T ss_dssp             HHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEeeec-----cccccccceeccCCCchhhhhh----------cccCCcHHHHHHHHHHH
Confidence            56889999999999999999999954     4788999999999999999883          34568999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....            ..+||...+..++.++||||+
T Consensus       115 l~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSl  191 (337)
T d1o6la_         115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  191 (337)
T ss_dssp             HHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred             hhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccch
Confidence            99999999   779999999999999999999999999999865322            234788888899999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhc
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVA  345 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  345 (382)
                      ||++|||+||+.||....     .........        .... .-+ .                  ....++.+++.+
T Consensus       192 Gvilyeml~G~~pf~~~~-----~~~~~~~i~--------~~~~-~~p-~------------------~~s~~~~dli~~  238 (337)
T d1o6la_         192 GVVMYEMMCGRLPFYNQD-----HERLFELIL--------MEEI-RFP-R------------------TLSPEAKSLLAG  238 (337)
T ss_dssp             HHHHHHHHHSSCSSCCSS-----HHHHHHHHH--------HCCC-CCC-T------------------TSCHHHHHHHHH
T ss_pred             hhHHHHHHHCCCCCCCcC-----HHHHHHHHh--------cCCC-CCC-c------------------cCCHHHHHHHHh
Confidence            999999999999986421     111111100        0000 000 0                  122356778889


Q ss_pred             cCCCCccCCCC-----HHHHHH
Q 040999          346 CSMESPQDRMK-----MTNVVH  362 (382)
Q Consensus       346 Cl~~~p~~RPs-----~~evl~  362 (382)
                      ||+.||++||+     +.|+++
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHT
T ss_pred             hccCCchhhcccccccHHHHHc
Confidence            99999999995     778875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-39  Score=299.74  Aligned_cols=213  Identities=16%  Similarity=0.194  Sum_probs=159.6

Q ss_pred             chhhH---HHHHHHHHHHhhc-ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHH
Q 040999          113 AFKIF---KSFIAECKALRNI-RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLL  188 (382)
Q Consensus       113 avK~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~  188 (382)
                      |+|++   +.+.+|++++.++ +|||||++++++... .......|+|||||++|+|.+++..        .....+++.
T Consensus        41 AiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~~~ivmEy~~gg~L~~~i~~--------~~~~~l~e~  111 (335)
T d2ozaa1          41 ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQD--------RGDQAFTER  111 (335)
T ss_dssp             EEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEEEEEEECCCSEEHHHHHHS--------CSCCCEEHH
T ss_pred             EEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCEEEEEEECCCCCcHHHHHHh--------cCCCCcCHH
Confidence            88877   7889999997765 899999999986431 2335678999999999999999942        123469999


Q ss_pred             HHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC---CCcEEEccccccccCCC-----------CCCCCccccCC
Q 040999          189 RRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD---DMTARVGDFGLARFLPP-----------TRTQTKYGVGN  254 (382)
Q Consensus       189 ~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~  254 (382)
                      .+..++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||+|+....           ...+||...+.
T Consensus       112 ~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  188 (335)
T d2ozaa1         112 EASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE  188 (335)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGG
T ss_pred             HHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCC
Confidence            99999999999999999   779999999999999986   46799999999986533           23347887788


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      .++.++|||||||++|||+||+.||....... ......            ..........         +.   .....
T Consensus       189 ~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~------------~~i~~~~~~~---------~~---~~~~~  243 (335)
T d2ozaa1         189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMK------------TRIRMGQYEF---------PN---PEWSE  243 (335)
T ss_dssp             GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------------CCCSCSSSC---------CT---THHHH
T ss_pred             CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHHH------------HHHhcCCCCC---------CC---ccccc
Confidence            89999999999999999999999986421111 000000            0000000000         00   00113


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHH
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      ...++.+++.+||+.||++|||+.|+++
T Consensus       244 ~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         244 VSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            3456788899999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=296.57  Aligned_cols=222  Identities=20%  Similarity=0.205  Sum_probs=153.5

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|++++|||||++++++.     .++..++||||+.++++..+.          .....+++..+..++.||
T Consensus        45 ~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~ivmE~~~~~~~~~~~----------~~~~~l~~~~~~~~~~qi  109 (299)
T d1ua2a_          45 RTALREIKLLQELSHPNIIGLLDAFG-----HKSNISLVFDFMETDLEVIIK----------DNSLVLTPSHIKAYMLMT  109 (299)
T ss_dssp             THHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCEEEEECCSEEHHHHHT----------TCCSSCCSSHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEeeec-----cCCceeehhhhhcchHHhhhh----------hcccCCCHHHHHHHHHHH
Confidence            35889999999999999999999964     477899999999988776655          234568889999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc-CCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV-GNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~-~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....            ..+||... +..++.++||||
T Consensus       110 l~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  186 (299)
T d1ua2a_         110 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA  186 (299)
T ss_dssp             HHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred             HHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhh
Confidence            99999999   779999999999999999999999999999765432            22355543 345799999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||..... ...+................+..-......  ......  ............++.+++.
T Consensus       187 lGvil~el~~g~~pf~~~~~-~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~s~~~~dll~  261 (299)
T d1ua2a_         187 VGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDMCSLPDYVT--FKSFPG--IPLHHIFSAAGDDLLDLIQ  261 (299)
T ss_dssp             HHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSSSTTSSTTCCC--CCCCCC--CCHHHHCTTCCHHHHHHHH
T ss_pred             cchHHHHHHhCcCCCCCCCH-HHHHHHHHHhcCCCChhhccchhccchhhh--hccCCC--CChHHhcccCCHHHHHHHH
Confidence            99999999999999863211 111112222111111000000000000000  000000  0000000112346788888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||++|||++|+++
T Consensus       262 ~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         262 GLFLFNPCARITATQALK  279 (299)
T ss_dssp             HHHCSSTTTSCCHHHHHT
T ss_pred             HHccCChhhCcCHHHHhC
Confidence            999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.3e-39  Score=299.62  Aligned_cols=194  Identities=16%  Similarity=0.168  Sum_probs=149.0

Q ss_pred             HHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHHHH
Q 040999          121 IAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVASA  200 (382)
Q Consensus       121 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~  200 (382)
                      .+|+++++.++|||||++++++.     ..+..++|||||++|+|.+++.          ....+++..+..++.||+.|
T Consensus        55 ~~~~~~l~~~~hpnIv~l~~~~~-----~~~~~~ivmE~~~gg~L~~~l~----------~~~~~~e~~~~~~~~qi~~a  119 (364)
T d1omwa3          55 RIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFILDLMNGGDLHYHLS----------QHGVFSEADMRFYAAEIILG  119 (364)
T ss_dssp             HHHHHHHSSSCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHH----------HHCSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCcEEEEEEEEE-----ECCEEEEEEEecCCCcHHHHHH----------hcccccHHHHHHHHHHHHHH
Confidence            34467777888999999999954     4788999999999999999983          34568899999999999999


Q ss_pred             HhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC----------CCCcccc-CCCCCccchhHHHHHHH
Q 040999          201 LNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR----------TQTKYGV-GNEVSTIGDVYSYGILL  269 (382)
Q Consensus       201 L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~----------~~~~~~~-~~~~~~~~Dv~S~Gvil  269 (382)
                      |+|||   +.+|+||||||+|||++.++.+||+|||+|+......          .+||... +..++.++|||||||++
T Consensus       120 L~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvil  196 (364)
T d1omwa3         120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML  196 (364)
T ss_dssp             HHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHH
T ss_pred             HHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHH
Confidence            99999   7799999999999999999999999999998764332          2366654 45689999999999999


Q ss_pred             HHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCC
Q 040999          270 LELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSME  349 (382)
Q Consensus       270 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~  349 (382)
                      |||+||+.||......  ..............         ..+ .                  ....++.+++.+||+.
T Consensus       197 yemltG~~Pf~~~~~~--~~~~~~~~~~~~~~---------~~~-~------------------~~s~~~~~li~~~L~~  246 (364)
T d1omwa3         197 FKLLRGHSPFRQHKTK--DKHEIDRMTLTMAV---------ELP-D------------------SFSPELRSLLEGLLQR  246 (364)
T ss_dssp             HHHHHSSCSSCSSCSS--CHHHHHHHSSSCCC---------CCC-S------------------SSCHHHHHHHHHHTCS
T ss_pred             HHHHhCCCCCCCCCHH--HHHHHHHhcccCCC---------CCC-C------------------CCCHHHHHHHHHHccc
Confidence            9999999998753221  11111111111000         000 0                  1223567888899999


Q ss_pred             CccCCCC-----HHHHHH
Q 040999          350 SPQDRMK-----MTNVVH  362 (382)
Q Consensus       350 ~p~~RPs-----~~evl~  362 (382)
                      ||++|||     ++|+++
T Consensus       247 dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         247 DVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             STTTSTTTSSSTHHHHHT
T ss_pred             CHHHhCCCcccCHHHHHc
Confidence            9999999     577764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-38  Score=295.90  Aligned_cols=194  Identities=16%  Similarity=0.157  Sum_probs=155.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +.+.+|+++|+.++|||||++++++.     .....++||||+.+|+|.+++.          ..+.+++..+..++.||
T Consensus        86 ~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~~v~e~~~~g~l~~~l~----------~~~~l~e~~~~~i~~qi  150 (350)
T d1rdqe_          86 EHTLNEKRILQAVNFPFLVKLEFSFK-----DNSNLYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQI  150 (350)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCcEeecccccc-----cccccccccccccccchhhhHh----------hcCCCCHHHHHHHHHHH
Confidence            56889999999999999999999954     4778999999999999999883          33468999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------CCCCccccCCCCCccchhHHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------RTQTKYGVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~~~~~~~~~Dv~S~Gvi  268 (382)
                      +.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....         ..+||...+..++.++|||||||+
T Consensus       151 ~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvi  227 (350)
T d1rdqe_         151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVL  227 (350)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred             HHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHH
Confidence            99999999   779999999999999999999999999999876543         334777788889999999999999


Q ss_pred             HHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCC
Q 040999          269 LLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSM  348 (382)
Q Consensus       269 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~  348 (382)
                      +|||+||+.||...    .. .......        ...... .+ .                  ....++.+++.+||+
T Consensus       228 lyemltG~~Pf~~~----~~-~~~~~~i--------~~~~~~-~p-~------------------~~s~~~~~li~~~L~  274 (350)
T d1rdqe_         228 IYEMAAGYPPFFAD----QP-IQIYEKI--------VSGKVR-FP-S------------------HFSSDLKDLLRNLLQ  274 (350)
T ss_dssp             HHHHHHSSCSSCCS----SH-HHHHHHH--------HHCCCC-CC-T------------------TCCHHHHHHHHHHSC
T ss_pred             HHHHHhCCCCCCCc----CH-HHHHHHH--------hcCCCC-CC-c------------------cCCHHHHHHHHHHhh
Confidence            99999999998632    11 1111110        000000 00 0                  122356788889999


Q ss_pred             CCccCCC-----CHHHHHH
Q 040999          349 ESPQDRM-----KMTNVVH  362 (382)
Q Consensus       349 ~~p~~RP-----s~~evl~  362 (382)
                      .||.+|+     |++|+++
T Consensus       275 ~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         275 VDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             SCTTTCTTSSTTTTHHHHT
T ss_pred             hCHHhccccccccHHHHHc
Confidence            9999994     8999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=289.55  Aligned_cols=223  Identities=21%  Similarity=0.222  Sum_probs=151.4

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++|++++|||||++++++..     .+..++||||+.++ +.+++..        .....+++..+..++.||
T Consensus        46 ~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~~iv~e~~~~~-~~~~~~~--------~~~~~l~e~~~~~~~~qi  111 (298)
T d1gz8a_          46 STAIREISLLKELNHPNIVKLLDVIHT-----ENKLYLVFEFLHQD-LKKFMDA--------SALTGIPLPLIKSYLFQL  111 (298)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEEEEECCSEE-HHHHHHH--------TTTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCcEEEecccccc-----ccceeEEEeecCCc-hhhhhhh--------hcccCCCHHHHHHHHHHH
Confidence            678999999999999999999999654     78899999999765 4444321        234569999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC------------CCCccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR------------TQTKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~-~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+||+|||.|+......            .+||.... ..++.++||||
T Consensus       112 l~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwS  188 (298)
T d1gz8a_         112 LQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS  188 (298)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccc
Confidence            99999999   7799999999999999999999999999997654321            22443333 34588999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcC-C-chhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALP-N-HVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRI  342 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (382)
                      +||++|||++|+.||...... ..+......... . .....+.........   .......  ...........++.++
T Consensus       189 lGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~~~s~~~~dl  262 (298)
T d1gz8a_         189 LGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMPDYKPS---FPKWARQ--DFSKVVPPLDEDGRSL  262 (298)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTTCCTT---SCCCCCC--CHHHHSTTCCHHHHHH
T ss_pred             cchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhccccccccccccc---ccccccc--chhhhccCCCHHHHHH
Confidence            999999999999998642111 111111111111 1 000000000000000   0000000  0000011223467788


Q ss_pred             hhccCCCCccCCCCHHHHHHH
Q 040999          343 GVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       343 ~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +.+||+.||++|||+.|+++.
T Consensus       263 l~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         263 LSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHccCChhHCcCHHHHhCC
Confidence            889999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-38  Score=288.42  Aligned_cols=226  Identities=18%  Similarity=0.219  Sum_probs=156.8

Q ss_pred             HHHHHHHHHhhc---ccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNI---RHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      .+.+|+++|+.+   +|||||+++++|...........+++|||+.++++.....         .....+++..+..++.
T Consensus        53 ~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~  123 (305)
T d1blxa_          53 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMF  123 (305)
T ss_dssp             THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH---------SCTTCSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh---------ccCCCCCHHHHHHHHH
Confidence            567888887776   7999999999987654555678899999998887654442         2345689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCC-----------CCCCCCccccCCCCCccchhHH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP-----------PTRTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~-----------~~~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...           ....+||...+..++.++||||
T Consensus       124 qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwS  200 (305)
T d1blxa_         124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS  200 (305)
T ss_dssp             HHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHH
T ss_pred             HHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhc
Confidence            9999999999   7799999999999999999999999999997542           2344588888889999999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      +||++|||+||+.||..... ...+..............+-........ . ...........   ........+.+|+.
T Consensus       201 lG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~---~~~~~s~~~~dli~  274 (305)
T d1blxa_         201 VGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVALPRQ-A-FHSKSAQPIEK---FVTDIDELGKDLLL  274 (305)
T ss_dssp             HHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGGGSCTTCSSCGG-G-SCCCCCCCGGG---TCCSCCHHHHHHHH
T ss_pred             hHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCchhcccccccchhh-h-hccccccchhh---ccccCCHHHHHHHH
Confidence            99999999999999864211 1112222222111111110000000000 0 00000000000   00112235677888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||++|||+.|+++
T Consensus       275 ~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         275 KCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHSCSSTTTSCCHHHHHT
T ss_pred             HHCcCChhHCcCHHHHhc
Confidence            999999999999999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-38  Score=289.67  Aligned_cols=194  Identities=18%  Similarity=0.246  Sum_probs=151.2

Q ss_pred             HHHHHHHHHHh-hcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALR-NIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|..++. .++|||||++++++.     +.+..|+|||||++|+|.+++.          ....+++..+..++.|
T Consensus        47 ~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~~~yivmEy~~~g~L~~~i~----------~~~~~~e~~~~~~~~q  111 (320)
T d1xjda_          47 ECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAE  111 (320)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHH----------HHSSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCCceeEEEeecCCCcHHHHhh----------ccCCCCHHHHHHHHHH
Confidence            45777887766 589999999999954     4788999999999999999994          3446889999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCccccCCCCCccchhHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGVGNEVSTIGDVYS  264 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~~~~~~~~~Dv~S  264 (382)
                      |+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.....            ..+||...+..++.++||||
T Consensus       112 i~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  188 (320)
T d1xjda_         112 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWS  188 (320)
T ss_dssp             HHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred             HHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhh
Confidence            999999999   779999999999999999999999999999864321            22377777888999999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      |||++|||+||+.||...    .. ..........      ....   + .                  ....++.+|+.
T Consensus       189 lGvilyemltG~~PF~~~----~~-~~~~~~i~~~------~~~~---p-~------------------~~s~~~~dli~  235 (320)
T d1xjda_         189 FGVLLYEMLIGQSPFHGQ----DE-EELFHSIRMD------NPFY---P-R------------------WLEKEAKDLLV  235 (320)
T ss_dssp             HHHHHHHHHHSSCSSCCS----SH-HHHHHHHHHC------CCCC---C-T------------------TSCHHHHHHHH
T ss_pred             hhHHHHHHHhCCCCCCCC----CH-HHHHHHHHcC------CCCC---C-c------------------cCCHHHHHHHH
Confidence            999999999999998642    11 1111110000      0000   0 0                  12235778888


Q ss_pred             ccCCCCccCCCCHH-HHHH
Q 040999          345 ACSMESPQDRMKMT-NVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~-evl~  362 (382)
                      +||+.||++|||+. |+++
T Consensus       236 ~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         236 KLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHSCSSGGGSBTTBSCGGG
T ss_pred             HhcccCCCCCcCHHHHHHh
Confidence            99999999999995 6753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.9e-38  Score=282.71  Aligned_cols=223  Identities=17%  Similarity=0.195  Sum_probs=153.1

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+.+|++++|||||++++++..     .+..++++||+.++.+..+.          .....+++..+..++.||
T Consensus        45 ~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~i~~e~~~~~~~~~~~----------~~~~~l~~~~~~~i~~qi  109 (286)
T d1ob3a_          45 STTIREISILKELKHSNIVKLYDVIHT-----KKRLVLVFEHLDQDLKKLLD----------VCEGGLESVTAKSFLLQL  109 (286)
T ss_dssp             HHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCEEEEEECCSEEHHHHHH----------TSTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCcEEeeeeeccc-----CCceeEEEEeehhhhHHHHH----------hhcCCcchhhhHHHHHHH
Confidence            689999999999999999999999654     77899999999887766665          334679999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC------------CCCCcccc-CCCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT------------RTQTKYGV-GNEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~------------~~~~~~~~-~~~~~~~~Dv~S  264 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+|++|||.|......            ...||... ...++.++||||
T Consensus       110 ~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~Diws  186 (286)
T d1ob3a_         110 LNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS  186 (286)
T ss_dssp             HHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHH
T ss_pred             HHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehh
Confidence            99999999   679999999999999999999999999999765332            12244333 345689999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhh
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGV  344 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (382)
                      +||++|||++|+.||..... ...+................+......... .......  .............+.+++.
T Consensus       187 lGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~s~~~~dli~  262 (286)
T d1ob3a_         187 VGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPKYDP-NFTVYEP--LPWESFLKGLDESGIDLLS  262 (286)
T ss_dssp             HHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-TCCCCCC--CCGGGTCCSCCHHHHHHHH
T ss_pred             cCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCChhhccchhhhhhccc-ccccccC--cchhhhcccCCHHHHHHHH
Confidence            99999999999999864321 111122222211111110000000000000 0000000  0000000112345678888


Q ss_pred             ccCCCCccCCCCHHHHHH
Q 040999          345 ACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       345 ~Cl~~~p~~RPs~~evl~  362 (382)
                      +||+.||++|||++|+++
T Consensus       263 ~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         263 KMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             HHTCSSTTTSCCHHHHHT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-37  Score=286.66  Aligned_cols=229  Identities=19%  Similarity=0.196  Sum_probs=152.6

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++++|+++|++++|||||++++++...........+++ +|+.+|+|.+++.           ...+++..+..++.|+
T Consensus        51 ~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~-----------~~~l~~~~i~~i~~qi  118 (345)
T d1pmea_          51 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLK-----------TQHLSNDHICYFLYQI  118 (345)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHH-----------HCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhh-----------cCCCCHHHHHHHHHHH
Confidence            578999999999999999999999865433334445555 5566999999983           2358999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCC---------------CCCCccc-cCCCCCccch
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPT---------------RTQTKYG-VGNEVSTIGD  261 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~-~~~~~~~~~D  261 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....               ..+||.. .+..++.++|
T Consensus       119 l~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~D  195 (345)
T d1pmea_         119 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID  195 (345)
T ss_dssp             HHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHH
T ss_pred             HHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhh
Confidence            99999999   779999999999999999999999999999754321               1235554 3456688999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||+||++|||++|+.||....... ..................................... ............++.+
T Consensus       196 iwSlG~il~eml~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~  273 (345)
T d1pmea_         196 IWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK-VPWNRLFPNADSKALD  273 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC-CCHHHHCTTSCHHHHH
T ss_pred             hhccCceehHHhhCCCCCCCCCHHH-HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCC-CCHHHhCCCCCHHHHH
Confidence            9999999999999999986432111 1111111111111111000000000000000000000 0000000112235778


Q ss_pred             HhhccCCCCccCCCCHHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ++.+||+.||++|||+.|+++.
T Consensus       274 li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         274 LLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHccCChhHCcCHHHHhcC
Confidence            8899999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-37  Score=284.02  Aligned_cols=234  Identities=17%  Similarity=0.212  Sum_probs=156.0

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++|++++|||||+++++|.... .......++||||+ +.+|..+..           ...+++..+..++.|
T Consensus        62 ~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----------~~~l~~~~~~~~~~q  129 (346)
T d1cm8a_          62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-----------HEKLGEDRIQFLVYQ  129 (346)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-----------HCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-----------hccccHHHHHHHHHH
Confidence            57899999999999999999999976422 12344679999999 556666552           345999999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC---------CCCccccC-CCCCccchhHHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR---------TQTKYGVG-NEVSTIGDVYSYG  266 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~~~-~~~~~~~Dv~S~G  266 (382)
                      |+.||.|||   +.+|+||||||+|||++.++.+|++|||+|+......         .+||...+ ..++.++||||+|
T Consensus       130 i~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG  206 (346)
T d1cm8a_         130 MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVG  206 (346)
T ss_dssp             HHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHH
T ss_pred             HHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcch
Confidence            999999999   7799999999999999999999999999998765432         23665544 4568999999999


Q ss_pred             HHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhcc
Q 040999          267 ILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVAC  346 (382)
Q Consensus       267 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  346 (382)
                      |++|||++|+.||..... ...+........... .+...................................+.+|+.+|
T Consensus       207 vil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m  284 (346)
T d1cm8a_         207 CIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPP-AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM  284 (346)
T ss_dssp             HHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCC-HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCc-HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHH
Confidence            999999999999864211 111111111111110 001100000000000000000000000000011223567888899


Q ss_pred             CCCCccCCCCHHHHHHH--HHHhh
Q 040999          347 SMESPQDRMKMTNVVHE--LQSIK  368 (382)
Q Consensus       347 l~~~p~~RPs~~evl~~--L~~i~  368 (382)
                      |+.||++|||+.|+++.  ++.+.
T Consensus       285 L~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         285 LVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             SCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CcCChhHCcCHHHHhcChhhCcCC
Confidence            99999999999999974  55543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-37  Score=276.63  Aligned_cols=187  Identities=18%  Similarity=0.188  Sum_probs=145.3

Q ss_pred             HHHHHHHHHhhcc--cccceeeeeeeeecccCCCceeEEEEecccC-CCccccccCCCCCCccccCCcccCHHHHHHHHH
Q 040999          119 SFIAECKALRNIR--HRNLIKVLTACLGVDYQGNDFKALVYEFIHN-RSPEKWLYPISKEDETYERPRNLNLLRRLNIAI  195 (382)
Q Consensus       119 ~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~  195 (382)
                      ++.+|+++|++++  |||||++++++.     +.+..++||||+.+ +++.+++.          ....+++..+..++.
T Consensus        53 ~~~~E~~il~~l~~~h~nIv~~~~~~~-----~~~~~~lv~e~~~~~~~l~~~~~----------~~~~l~e~~~~~~~~  117 (273)
T d1xwsa_          53 RVPMEVVLLKKVSSGFSGVIRLLDWFE-----RPDSFVLILERPEPVQDLFDFIT----------ERGALQEELARSFFW  117 (273)
T ss_dssp             EEEHHHHHHHHHCSSSCSBCCEEEEEE-----CSSEEEEEEECCSSEEEHHHHHH----------HHCSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCccEEEEEEe-----eCCeEEEEEEeccCcchHHHHHh----------ccCCCCHHHHHHHHH
Confidence            3678999999996  899999999954     47889999999976 56666662          345689999999999


Q ss_pred             HHHHHHhHHhhcCCCceeecCCCCCceeeCC-CCcEEEccccccccCCCCC----------CCCccccCCC-CCccchhH
Q 040999          196 DVASALNYLHHDCQPVTAHCDLKPSNVLLDD-DMTARVGDFGLARFLPPTR----------TQTKYGVGNE-VSTIGDVY  263 (382)
Q Consensus       196 ~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~----------~~~~~~~~~~-~~~~~Dv~  263 (382)
                      ||++||+|||   +.+|+||||||+|||++. ++.+||+|||+|+......          .+||...+.. ++.++|||
T Consensus       118 qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~Diw  194 (273)
T d1xwsa_         118 QVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVW  194 (273)
T ss_dssp             HHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHH
T ss_pred             HHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccc
Confidence            9999999999   779999999999999985 4799999999998654332          2255554444 46779999


Q ss_pred             HHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHh
Q 040999          264 SYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIG  343 (382)
Q Consensus       264 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (382)
                      |+||++|||+||+.||...       .....            .......                    ....++.+++
T Consensus       195 SlGvilyell~g~~Pf~~~-------~~i~~------------~~~~~~~--------------------~~s~~~~~li  235 (273)
T d1xwsa_         195 SLGILLYDMVCGDIPFEHD-------EEIIR------------GQVFFRQ--------------------RVSSECQHLI  235 (273)
T ss_dssp             HHHHHHHHHHHSSCSCCSH-------HHHHH------------CCCCCSS--------------------CCCHHHHHHH
T ss_pred             cceeeehhHhhCCCCCCCc-------hHHhh------------cccCCCC--------------------CCCHHHHHHH
Confidence            9999999999999998631       01111            0000000                    1123567888


Q ss_pred             hccCCCCccCCCCHHHHHH
Q 040999          344 VACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       344 ~~Cl~~~p~~RPs~~evl~  362 (382)
                      .+||+.||++|||++|+++
T Consensus       236 ~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         236 RWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHTCSSGGGSCCHHHHHT
T ss_pred             HHHccCCHhHCcCHHHHhc
Confidence            8999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-36  Score=277.52  Aligned_cols=156  Identities=21%  Similarity=0.317  Sum_probs=125.4

Q ss_pred             chhhH----------HHHHHHHHHHhhcccccceeeeeeeeecc---cCCCceeEEEEecccCCCccccccCCCCCCccc
Q 040999          113 AFKIF----------KSFIAECKALRNIRHRNLIKVLTACLGVD---YQGNDFKALVYEFIHNRSPEKWLYPISKEDETY  179 (382)
Q Consensus       113 avK~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~  179 (382)
                      |+|++          +++.+|+++|++++||||+++++++....   ...++..++||||++++.+..+.          
T Consensus        39 AvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~----------  108 (318)
T d3blha1          39 ALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----------  108 (318)
T ss_dssp             EEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT----------
T ss_pred             EEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh----------
Confidence            77765          57899999999999999999999975422   12346789999999887766544          


Q ss_pred             cCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC--------------
Q 040999          180 ERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR--------------  245 (382)
Q Consensus       180 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~--------------  245 (382)
                      .....++...+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++......              
T Consensus       109 ~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~  185 (318)
T d3blha1         109 NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL  185 (318)
T ss_dssp             CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCG
T ss_pred             hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCH
Confidence            23456888999999999999999999   7799999999999999999999999999997553211              


Q ss_pred             --CCCccccC-CCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          246 --TQTKYGVG-NEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       246 --~~~~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                        .+||...+ ..+++++||||+||++|||+||+.||..
T Consensus       186 ~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             GGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             HHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence              22444443 3678999999999999999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-36  Score=275.97  Aligned_cols=221  Identities=18%  Similarity=0.188  Sum_probs=153.3

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++|+.++|||||++++++..     ....++|++++.++++..++.          ..+.+++..+..++.|+
T Consensus        46 ~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~~iv~~~~~~~~l~~~~~----------~~~~~~~~~~~~~~~q~  110 (292)
T d1unla_          46 SSALREICLLKELKHKNIVRLHDVLHS-----DKKLTLVFEFCDQDLKKYFDS----------CNGDLDPEIVKSFLFQL  110 (292)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEEECCSEEHHHHHHH----------TTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCcCCEEeecccccc-----ccceeEEeeeccccccccccc----------cccccchhHHHHHHHHH
Confidence            789999999999999999999999654     778899999999998887773          34568899999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCC------------CccccC-CCCCccchhHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQ------------TKYGVG-NEVSTIGDVYS  264 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~------------~~~~~~-~~~~~~~Dv~S  264 (382)
                      ++||+|||   +.+|+||||||+|||++.++.+||+|||.|+........            ||.... ..++.++||||
T Consensus       111 ~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwS  187 (292)
T d1unla_         111 LKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS  187 (292)
T ss_dssp             HHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred             HHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccc
Confidence            99999999   679999999999999999999999999999876543221            233333 34689999999


Q ss_pred             HHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCc---hhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          265 YGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNH---VKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       265 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      +||++|||++|+.||.........+...........   ...............   ......   ...........+.+
T Consensus       188 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~s~~~~d  261 (292)
T d1unla_         188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM---YPATTS---LVNVVPKLNATGRD  261 (292)
T ss_dssp             HHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC---CCTTCC---CTTTSTTCCHHHHH
T ss_pred             cchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccc---ccccch---hhhccccCCHHHHH
Confidence            999999999999997432111111222222111111   000000000000000   000000   00000112235677


Q ss_pred             HhhccCCCCccCCCCHHHHHH
Q 040999          342 IGVACSMESPQDRMKMTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs~~evl~  362 (382)
                      |+.+|++.||++|||++|+++
T Consensus       262 ll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         262 LLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            888999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-36  Score=280.98  Aligned_cols=243  Identities=16%  Similarity=0.145  Sum_probs=157.9

Q ss_pred             chhhH----HHHHHHHHHHhhcccccceeeeeeeeecc-cCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCH
Q 040999          113 AFKIF----KSFIAECKALRNIRHRNLIKVLTACLGVD-YQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNL  187 (382)
Q Consensus       113 avK~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~  187 (382)
                      |+|++    +.+.+|+++|++++|||||++++++.... ..+..+.++|||||+++.+..+...       ......+++
T Consensus        49 AiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~-------~~~~~~l~~  121 (350)
T d1q5ka_          49 AIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-------SRAKQTLPV  121 (350)
T ss_dssp             EEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHH-------HHTTCCCCH
T ss_pred             EEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhh-------hhccCCCCH
Confidence            78876    34568999999999999999999986532 2345568999999987643333211       123456999


Q ss_pred             HHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC-cEEEccccccccCCCCC-----------CCCcccc-CC
Q 040999          188 LRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPPTR-----------TQTKYGV-GN  254 (382)
Q Consensus       188 ~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~-----------~~~~~~~-~~  254 (382)
                      ..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++......           ..||... ..
T Consensus       122 ~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  198 (350)
T d1q5ka_         122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT  198 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhccc
Confidence            999999999999999999   78999999999999999775 89999999998664322           2244433 35


Q ss_pred             CCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHH
Q 040999          255 EVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIE  334 (382)
Q Consensus       255 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (382)
                      .++.++||||+||++|||++|+.||..... ...+....+....... +.+................. .+ ........
T Consensus       199 ~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~-~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~  274 (350)
T d1q5ka_         199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTR-EQIREMNPNYTEFKFPQIKA-HP-WTKVFRPR  274 (350)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCH-HHHHHHCC---CCCCCCCCC-CC-GGGTSCTT
T ss_pred             CCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHHHHhCCChH-Hhhhhhccchhhcccccccc-Cc-hhhhcccC
Confidence            689999999999999999999999864211 1111222221111110 00100000000000000000 00 00000001


Q ss_pred             HHHHHHHHhhccCCCCccCCCCHHHHHHH--HHHhhh
Q 040999          335 CVISMVRIGVACSMESPQDRMKMTNVVHE--LQSIKN  369 (382)
Q Consensus       335 ~~~~~~~l~~~Cl~~~p~~RPs~~evl~~--L~~i~~  369 (382)
                      ...++.+|+.+||+.||++|||+.|+++.  ++++.+
T Consensus       275 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         275 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            23356788889999999999999999863  555544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.3e-36  Score=275.35  Aligned_cols=150  Identities=27%  Similarity=0.379  Sum_probs=126.4

Q ss_pred             chhhH-----HHHHHHHHHHhhcc-cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF-----KSFIAECKALRNIR-HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|++     +++.+|+++|++++ ||||+++++++..   ......++|||||.+++|..+.             +.++
T Consensus        64 AiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~v~e~~~~~~L~~~~-------------~~l~  127 (328)
T d3bqca1          64 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALVFEHVNNTDFKQLY-------------QTLT  127 (328)
T ss_dssp             EEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEEEEECCCSCBGGGTT-------------TSCC
T ss_pred             EEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeEEEeecCCCcHHHHh-------------cCCC
Confidence            88875     78999999999995 9999999998653   3456789999999999987654             3488


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC-cEEEccccccccCCCCC-----------CCCccccC-
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM-TARVGDFGLARFLPPTR-----------TQTKYGVG-  253 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfg~a~~~~~~~-----------~~~~~~~~-  253 (382)
                      +..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+|+......           .+||...+ 
T Consensus       128 e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~  204 (328)
T d3bqca1         128 DYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY  204 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCC
Confidence            9999999999999999999   77999999999999998655 69999999998764432           22555444 


Q ss_pred             CCCCccchhHHHHHHHHHHHhcCCCCCc
Q 040999          254 NEVSTIGDVYSYGILLLELMIREKPSDI  281 (382)
Q Consensus       254 ~~~~~~~Dv~S~Gvil~elltg~~p~~~  281 (382)
                      ..++.++||||+||++|||++|+.||..
T Consensus       205 ~~~~~~~DiwslG~~l~e~~~g~~pf~~  232 (328)
T d3bqca1         205 QMYDYSLDMWSLGCMLASMIFRKEPFFH  232 (328)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCCCcccchhhhhhhhHHhccCCCCCCC
Confidence            3579999999999999999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-36  Score=279.22  Aligned_cols=229  Identities=17%  Similarity=0.170  Sum_probs=149.2

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDV  197 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i  197 (382)
                      +++.+|+++|++++|||||++++++...........+++++|+.+|+|.+++.           ...+++..+..++.||
T Consensus        62 ~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-----------~~~l~e~~~~~i~~qi  130 (348)
T d2gfsa1          62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----------CQKLTDDHVQFLIYQI  130 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-----------TCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-----------cccccHHHHHHHHHHH
Confidence            57889999999999999999999875432222344566677888999999883           2359999999999999


Q ss_pred             HHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC---------CCCccccC-CCCCccchhHHHHH
Q 040999          198 ASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR---------TQTKYGVG-NEVSTIGDVYSYGI  267 (382)
Q Consensus       198 ~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~~~-~~~~~~~Dv~S~Gv  267 (382)
                      +.||+|||   +.+|+||||||+|||++.++.+|++|||.+.......         .+||...+ ..++.++||||+||
T Consensus       131 l~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv  207 (348)
T d2gfsa1         131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC  207 (348)
T ss_dssp             HHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHH
T ss_pred             HHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhH
Confidence            99999999   7799999999999999999999999999997654332         22554444 35688999999999


Q ss_pred             HHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccC
Q 040999          268 LLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACS  347 (382)
Q Consensus       268 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  347 (382)
                      ++|||++|+.||..... .............. ..+...................................+.+|+.+||
T Consensus       208 ~l~~ll~g~~pF~~~~~-~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL  285 (348)
T d2gfsa1         208 IMAELLTGRTLFPGTDH-IDQLKLILRLVGTP-GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML  285 (348)
T ss_dssp             HHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCC-CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHS
T ss_pred             HHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCC-ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHC
Confidence            99999999999864211 00111111111110 00100000000000000000000000000001122345678888999


Q ss_pred             CCCccCCCCHHHHHH
Q 040999          348 MESPQDRMKMTNVVH  362 (382)
Q Consensus       348 ~~~p~~RPs~~evl~  362 (382)
                      +.||++|||+.|+++
T Consensus       286 ~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         286 VLDSDKRITAAQALA  300 (348)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             cCChhhCcCHHHHhc
Confidence            999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-36  Score=275.34  Aligned_cols=198  Identities=19%  Similarity=0.192  Sum_probs=148.8

Q ss_pred             HHHHHHHHHHhhccc-ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRH-RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +.+.+|+++|++++| |||+++++++..     ....+++|||+.+|+|.+++.          ....++......++.|
T Consensus        73 ~~~~~E~~il~~l~h~pnIv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~i~----------~~~~~~e~~~~~~~~Q  137 (322)
T d1vzoa_          73 EHTRTERQVLEHIRQSPFLVTLHYAFQT-----ETKLHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGE  137 (322)
T ss_dssp             GGCCCHHHHHHHHHTCTTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHH----------HHSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCeEEEeeeeecc-----CCceeeeeecccccHHHHHHH----------hcccccHHHHHHHHHH
Confidence            468899999999977 799999998543     778999999999999999984          3345778889999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCC-------------CCCccccC--CCCCccch
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTR-------------TQTKYGVG--NEVSTIGD  261 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~~--~~~~~~~D  261 (382)
                      |+.||.|+|   +.+|+||||||+|||++.++.+||+|||+|+.+....             ..||...+  ..++.++|
T Consensus       138 i~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksD  214 (322)
T d1vzoa_         138 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD  214 (322)
T ss_dssp             HHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHH
T ss_pred             HHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhh
Confidence            999999999   7799999999999999999999999999998653321             12333333  24678999


Q ss_pred             hHHHHHHHHHHHhcCCCCCccccCCchHHHHHHHhcCCchhhhhhcccccchhhhhhccccchhhhhhhhHHHHHHHHHH
Q 040999          262 VYSYGILLLELMIREKPSDIMFEGDMNLHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIECVISMVR  341 (382)
Q Consensus       262 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (382)
                      |||+||++|||+||+.||........ ............        . ..+                   .....++.+
T Consensus       215 IWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~~--------~-~~~-------------------~~~s~~~~~  265 (322)
T d1vzoa_         215 WWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE--------P-PYP-------------------QEMSALAKD  265 (322)
T ss_dssp             HHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC--------C-CCC-------------------TTSCHHHHH
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccCC--------C-CCc-------------------ccCCHHHHH
Confidence            99999999999999999975432221 111111110000        0 000                   022346778


Q ss_pred             HhhccCCCCccCCCC-----HHHHHH
Q 040999          342 IGVACSMESPQDRMK-----MTNVVH  362 (382)
Q Consensus       342 l~~~Cl~~~p~~RPs-----~~evl~  362 (382)
                      ++.+||+.||++|||     ++|+++
T Consensus       266 li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         266 LIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHHHcccCHHHcCCCCcccHHHHHc
Confidence            888999999999994     788875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-35  Score=270.75  Aligned_cols=214  Identities=18%  Similarity=0.218  Sum_probs=156.7

Q ss_pred             chhhH------HHHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccC
Q 040999          113 AFKIF------KSFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLN  186 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~  186 (382)
                      |+|++      +++.+|+++++.++|+|+|..++.|..    ..+..++||||+ ++++.+.+.         .....++
T Consensus        36 AvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~ivme~~-~~~l~~~~~---------~~~~~~~  101 (299)
T d1ckia_          36 AIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMVMELL-GPSLEDLFN---------FCSRKFS  101 (299)
T ss_dssp             EEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEEEEECC-CCBHHHHHH---------HTTTCCC
T ss_pred             EEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEEEEEEc-CCchhhhhh---------hccCCCc
Confidence            67754      568899999999998887777666543    367889999999 456665552         2345699


Q ss_pred             HHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC---CCcEEEccccccccCCCC-------------------
Q 040999          187 LLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD---DMTARVGDFGLARFLPPT-------------------  244 (382)
Q Consensus       187 ~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfg~a~~~~~~-------------------  244 (382)
                      +..+..++.|++.||+|||   +++|+||||||+|||++.   +..+||+|||+|+.....                   
T Consensus       102 ~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~  178 (299)
T d1ckia_         102 LKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR  178 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSS
T ss_pred             HHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCcc
Confidence            9999999999999999999   779999999999999864   457999999999865322                   


Q ss_pred             CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCch--HHHHHHHhcCCchhhhhhcccccchhhhhhcccc
Q 040999          245 RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMN--LHKFAKMALPNHVKDIVDSILLNDDEKLVVRGDQ  322 (382)
Q Consensus       245 ~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (382)
                      ..+||...+..++.++|||||||++|||+||+.||.........  .........+.....                   
T Consensus       179 y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  239 (299)
T d1ckia_         179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-------------------  239 (299)
T ss_dssp             SCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH-------------------
T ss_pred             ccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH-------------------
Confidence            22366666777899999999999999999999998753222111  111110000000000                   


Q ss_pred             chhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhh
Q 040999          323 KQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNT  370 (382)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~  370 (382)
                              ....++.++.+++..||+.+|++||++.++.+.|+.+...
T Consensus       240 --------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         240 --------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             --------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                    0012345678888899999999999999999999887543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-35  Score=272.55  Aligned_cols=229  Identities=17%  Similarity=0.121  Sum_probs=153.7

Q ss_pred             HHHHHHHHHHhhcccccceeeeeeeeeccc-CCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHH
Q 040999          118 KSFIAECKALRNIRHRNLIKVLTACLGVDY-QGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAID  196 (382)
Q Consensus       118 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~  196 (382)
                      +++.+|+++|++++|||||++++++..... +.....|+|||||.++.+. .+.            ..+++..+..++.|
T Consensus        61 ~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~~------------~~~~~~~i~~~~~q  127 (355)
T d2b1pa1          61 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VIQ------------MELDHERMSYLLYQ  127 (355)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HHT------------SCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHH-hhh------------cCCCHHHHHHHHHH
Confidence            468899999999999999999999764322 3457899999999765443 331            34789999999999


Q ss_pred             HHHHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCC-----------CCCCCccccCCCCCccchhHHH
Q 040999          197 VASALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPP-----------TRTQTKYGVGNEVSTIGDVYSY  265 (382)
Q Consensus       197 i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~~Dv~S~  265 (382)
                      |+.||.|||   +.+|+||||||+|||++.++.+|++|||+++....           ...+||...+..+++++||||+
T Consensus       128 il~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSl  204 (355)
T d2b1pa1         128 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  204 (355)
T ss_dssp             HHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             HHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccc
Confidence            999999999   77999999999999999999999999999875432           3345787788889999999999


Q ss_pred             HHHHHHHHhcCCCCCccccCCchHHHHHHHhcC----------CchhhhhhcccccchhhhhhccccchhhhhhhhHHHH
Q 040999          266 GILLLELMIREKPSDIMFEGDMNLHKFAKMALP----------NHVKDIVDSILLNDDEKLVVRGDQKQTQAKINVIIEC  335 (382)
Q Consensus       266 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (382)
                      ||++|||++|+.||..... .............          ....+................................
T Consensus       205 G~~l~ell~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (355)
T d2b1pa1         205 GCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK  283 (355)
T ss_dssp             HHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHH
T ss_pred             cchHHHHhhCCCCCCCCCH-HHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccC
Confidence            9999999999999863211 0111111111111          0111111111100000000000000000001112234


Q ss_pred             HHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          336 VISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       336 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      ...+.+|+.+|++.||++|||++|+++.
T Consensus       284 s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         284 ASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            5578889999999999999999999853

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-34  Score=261.98  Aligned_cols=213  Identities=14%  Similarity=0.138  Sum_probs=162.2

Q ss_pred             chhhH------HHHHHHHHHHhhccc-ccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCccc
Q 040999          113 AFKIF------KSFIAECKALRNIRH-RNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNL  185 (382)
Q Consensus       113 avK~~------~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l  185 (382)
                      |+|++      +.+.+|++.++.++| +|++.+++++..     ....++||||+ +++|.+++.         .....+
T Consensus        34 AvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~~vme~~-~~~l~~~~~---------~~~~~~   98 (293)
T d1csna_          34 AIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNVLVIDLL-GPSLEDLLD---------LCGRKF   98 (293)
T ss_dssp             EEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHH---------HTTTCC
T ss_pred             EEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCccEEEEEec-CCCHHHHHH---------hhccch
Confidence            77765      457889999999965 899999988543     67889999999 689988884         234568


Q ss_pred             CHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCC-----CCcEEEccccccccCCC-----------------
Q 040999          186 NLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDD-----DMTARVGDFGLARFLPP-----------------  243 (382)
Q Consensus       186 ~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~-----~~~~kl~Dfg~a~~~~~-----------------  243 (382)
                      ++..+..++.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||+|+....                 
T Consensus        99 ~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~G  175 (293)
T d1csna_          99 SVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG  175 (293)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCS
T ss_pred             hhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEE
Confidence            99999999999999999999   889999999999999974     56899999999986432                 


Q ss_pred             --CCCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCCchHHHHH---HHhcCCchhhhhhcccccchhhhhh
Q 040999          244 --TRTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGDMNLHKFA---KMALPNHVKDIVDSILLNDDEKLVV  318 (382)
Q Consensus       244 --~~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  318 (382)
                        ...+||...+..++.++|||||||++|||+||+.||........ .....   .........++              
T Consensus       176 T~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l--------------  240 (293)
T d1csna_         176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEKKQSTPLREL--------------  240 (293)
T ss_dssp             CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHHHHHHHHSCHHHH--------------
T ss_pred             chhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH-HHHHHHHHhccCCCChHHh--------------
Confidence              23346777778899999999999999999999999974322211 11110   00000000110              


Q ss_pred             ccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHHHHHhhhhh
Q 040999          319 RGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHELQSIKNTL  371 (382)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~  371 (382)
                                   ...++.++.+++..|++.+|++||+++.+.+.|+++.+..
T Consensus       241 -------------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         241 -------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             -------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -------------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence                         0123446788888999999999999999999998886654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=6.4e-30  Score=238.45  Aligned_cols=239  Identities=18%  Similarity=0.175  Sum_probs=151.5

Q ss_pred             chhhH-------HHHHHHHHHHhhcc-----------cccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCC
Q 040999          113 AFKIF-------KSFIAECKALRNIR-----------HRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISK  174 (382)
Q Consensus       113 avK~~-------~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~  174 (382)
                      |+|++       +.+.+|+++++.++           |+|||++++++..   .+....+++++++..+........   
T Consensus        42 AvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~---  115 (362)
T d1q8ya_          42 AMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH---KGPNGVHVVMVFEVLGENLLALIK---  115 (362)
T ss_dssp             EEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE---EETTEEEEEEEECCCCEEHHHHHH---
T ss_pred             EEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee---ccccceeeeeeecccccccccccc---
Confidence            88875       66788999998886           4789999988653   335566777777655543222211   


Q ss_pred             CCccccCCcccCHHHHHHHHHHHHHHHhHHhhcCCCceeecCCCCCceeeCCCC------cEEEccccccccCCCC----
Q 040999          175 EDETYERPRNLNLLRRLNIAIDVASALNYLHHDCQPVTAHCDLKPSNVLLDDDM------TARVGDFGLARFLPPT----  244 (382)
Q Consensus       175 ~~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~~~~ivH~dlkp~NILl~~~~------~~kl~Dfg~a~~~~~~----  244 (382)
                          ......+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++      .+|++|||.|......    
T Consensus       116 ----~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~  189 (362)
T d1q8ya_         116 ----KYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS  189 (362)
T ss_dssp             ----HTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSC
T ss_pred             ----cccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeEeecccccccccccccc
Confidence                1234568889999999999999999995  36999999999999997654      3899999999765332    


Q ss_pred             -----CCCCccccCCCCCccchhHHHHHHHHHHHhcCCCCCccccCC--c---hHHHHHHHhcCCch---------hhhh
Q 040999          245 -----RTQTKYGVGNEVSTIGDVYSYGILLLELMIREKPSDIMFEGD--M---NLHKFAKMALPNHV---------KDIV  305 (382)
Q Consensus       245 -----~~~~~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~--~---~~~~~~~~~~~~~~---------~~~~  305 (382)
                           ..+||......++.++||||+||+++||++|+.||.......  .   .+....+.......         ....
T Consensus       190 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  269 (362)
T d1q8ya_         190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFF  269 (362)
T ss_dssp             CSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHB
T ss_pred             cccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhccccccccc
Confidence                 234676677888999999999999999999999987432211  0   11111111111000         0000


Q ss_pred             hcc-cccchhhhhhccccchhhhhhhhHHHHHHHHHHHhhccCCCCccCCCCHHHHHHH
Q 040999          306 DSI-LLNDDEKLVVRGDQKQTQAKINVIIECVISMVRIGVACSMESPQDRMKMTNVVHE  363 (382)
Q Consensus       306 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~  363 (382)
                      +.. .............................++.+|+.+|++.||.+|||++|+++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         270 NSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             CC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             ccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000 0000000000000000000111123556688999999999999999999999863

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.68  E-value=6e-18  Score=142.15  Aligned_cols=120  Identities=17%  Similarity=0.091  Sum_probs=89.9

Q ss_pred             HHHHHHHHHhhcccccceeeeeeeeecccCCCceeEEEEecccCCCccccccCCCCCCccccCCcccCHHHHHHHHHHHH
Q 040999          119 SFIAECKALRNIRHRNLIKVLTACLGVDYQGNDFKALVYEFIHNRSPEKWLYPISKEDETYERPRNLNLLRRLNIAIDVA  198 (382)
Q Consensus       119 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  198 (382)
                      ...+|.+.+.++.|.+++..+++.         ..+++|||+++..+.+                 ++......++.|++
T Consensus        60 ~~~~e~~~l~~l~~~~v~~~~~~~---------~~~lvme~~~~~~~~~-----------------l~~~~~~~i~~ql~  113 (191)
T d1zara2          60 SARNEFRALQKLQGLAVPKVYAWE---------GNAVLMELIDAKELYR-----------------VRVENPDEVLDMIL  113 (191)
T ss_dssp             HHHHHHHHHHHTTTSSSCCEEEEE---------TTEEEEECCCCEEGGG-----------------CCCSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHccCCCcceEEEec---------CCEEEEEeeccccccc-----------------hhhHHHHHHHHHHH
Confidence            456789999999999999887762         1379999998754332                 33344567899999


Q ss_pred             HHHhHHhhcCCCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCCCcc----------ccCCCCCccchhHHHHHH
Q 040999          199 SALNYLHHDCQPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKY----------GVGNEVSTIGDVYSYGIL  268 (382)
Q Consensus       199 ~~L~~lH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~----------~~~~~~~~~~Dv~S~Gvi  268 (382)
                      ++|+|||   ..+|+||||||+|||++++ .++|+|||.|......... ++          .....++.++|+||..--
T Consensus       114 ~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~-~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         114 EEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR-EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             HHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH-HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             HHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            9999999   6799999999999999865 5899999999866433221 11          123456788999997544


Q ss_pred             H
Q 040999          269 L  269 (382)
Q Consensus       269 l  269 (382)
                      +
T Consensus       189 ~  189 (191)
T d1zara2         189 I  189 (191)
T ss_dssp             H
T ss_pred             H
Confidence            3

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.04  E-value=3.2e-11  Score=108.26  Aligned_cols=62  Identities=37%  Similarity=0.688  Sum_probs=55.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCccccccCCCCCCCCCCCCCcC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNSKLCGGISKFKLPKC   66 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn~~lcg~~~~~~~~~c   66 (382)
                      ||||+|+|+|.||.+|+++ +|++||||+|+|+|.||. +.+.++....+.||+.|||.|.    |.|
T Consensus       249 L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl----p~c  312 (313)
T d1ogqa_         249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL----PAC  312 (313)
T ss_dssp             EECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS----SCC
T ss_pred             ccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC----CCC
Confidence            6899999999999999999 999999999999999998 4567888888999999999753    566

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=97.65  E-value=6e-06  Score=72.87  Aligned_cols=51  Identities=29%  Similarity=0.357  Sum_probs=40.6

Q ss_pred             CccCCCcccc--ccchhhhhc-cCCeeeccC-CcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSG--EILKFLTRL-FLDNLNLSY-NNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG--~iP~~l~~l-~L~~ldls~-N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      |||++|+++|  +||++|+++ +|++||||+ |+|+|.||..  -..++....+.+|
T Consensus        55 L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N  111 (313)
T d1ogqa_          55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT  111 (313)
T ss_dssp             EEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEE
T ss_pred             EECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccc
Confidence            6899999999  689999999 999999986 8999999983  2344444455555

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.52  E-value=8.7e-05  Score=63.23  Aligned_cols=30  Identities=30%  Similarity=0.376  Sum_probs=25.9

Q ss_pred             ceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          211 VTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       211 ~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      .++|+|+.|.||++++++..-|.||+.+..
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhccc
Confidence            479999999999999876677999988864

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.23  E-value=9.2e-05  Score=55.54  Aligned_cols=48  Identities=21%  Similarity=0.433  Sum_probs=31.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      ||||+|+|+ .+| .+.++ .|++||+|+|.++ .+|..  .+.++....+.+|
T Consensus         3 L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N   53 (124)
T d1dcea3           3 LHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN   53 (124)
T ss_dssp             EECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred             EEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccc
Confidence            678888887 665 37777 7888888888887 57752  2334444444444

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.22  E-value=8.2e-05  Score=63.73  Aligned_cols=55  Identities=31%  Similarity=0.454  Sum_probs=43.4

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccc--cCCCCccccccCCCCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVY--KNASATSVTGNSKLCG   56 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~--~~~~~~~~~gn~~lcg   56 (382)
                      ||+++|+|++-.|..+..+ .|++|||++|+|+ .||.+.+  ..+....+.|||-.|.
T Consensus       153 l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             cccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence            5789999998777778888 8999999999999 8998543  3445566778887774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.20  E-value=0.00034  Score=59.01  Aligned_cols=31  Identities=19%  Similarity=0.206  Sum_probs=26.6

Q ss_pred             CceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          210 PVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       210 ~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      ..++|+|+.|.||+++.+..+-|+||+.+..
T Consensus       175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            3489999999999999876678999988864

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.09  E-value=0.00018  Score=56.25  Aligned_cols=54  Identities=22%  Similarity=0.259  Sum_probs=34.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccC--CCCccccccCCCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKN--ASATSVTGNSKLC   55 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~--~~~~~~~gn~~lc   55 (382)
                      |+|++|+|++--|..+..+ .|++||||+|+|+ .||.+.+..  +....+.||+--|
T Consensus        61 L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C  117 (156)
T d2ifga3          61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC  117 (156)
T ss_dssp             EECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCC
T ss_pred             ceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCcccC
Confidence            5677777775556667777 7788888888877 666644433  3334455666544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.05  E-value=0.00018  Score=53.88  Aligned_cols=50  Identities=28%  Similarity=0.301  Sum_probs=38.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn~   52 (382)
                      ||||+|+|+ +||+.++.+ .|+.||+++|.+++ +|. ..+.++....+.+|.
T Consensus        25 L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3          25 LDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSC
T ss_pred             EECCCCccC-cchhhhhhhhcccccccccccccc-cCccccccccCeEECCCCc
Confidence            699999998 799999999 99999999999995 565 333444444555553

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=96.97  E-value=0.00016  Score=58.66  Aligned_cols=50  Identities=14%  Similarity=0.308  Sum_probs=34.5

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCccccc---CCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYK---NASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~---~~~~~~~~gn   51 (382)
                      |||++|++++.+|..+..+ .|++|++|+|++++ ||...|.   ++....+.+|
T Consensus        59 L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~-l~~~~F~~l~~L~~L~L~~N  112 (192)
T d1w8aa_          59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDN  112 (192)
T ss_dssp             EECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCE-ECSSSSTTCTTCCEEECCSS
T ss_pred             eeccccccccccccccccccccceeeeccccccc-cCHHHHhCCCcccccccCCc
Confidence            5788888888888888888 88888888888885 4443333   3333344455

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.32  E-value=0.0006  Score=58.62  Aligned_cols=37  Identities=24%  Similarity=0.247  Sum_probs=25.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |||++|+|++-.|..+..+ +|+.+++++|++++..|.
T Consensus       158 L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~  195 (284)
T d1ozna_         158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH  195 (284)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             cccccCcccccchhhhccccccchhhhhhccccccChh
Confidence            4677777776666666667 777777777777766665

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=96.05  E-value=0.0015  Score=56.47  Aligned_cols=36  Identities=31%  Similarity=0.317  Sum_probs=23.4

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |++++|++++-.|..+.++ +|++|+|++|+|+ .||.
T Consensus       200 L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~  236 (305)
T d1xkua_         200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG  236 (305)
T ss_dssp             EECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred             cccccccccccccccccccccceeeeccccccc-cccc
Confidence            4566666766666666666 6777777777666 4554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.04  E-value=0.0061  Score=54.80  Aligned_cols=33  Identities=21%  Similarity=0.296  Sum_probs=27.6

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccccCC
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLP  242 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~  242 (382)
                      ...++|+|+.|.|||++++. ++|+||..|.+-+
T Consensus       222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G~  254 (392)
T d2pula1         222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFYGP  254 (392)
T ss_dssp             CCEEECSCCCGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CcceeccCCcCCceeEcCCc-eEEechhhcccCC
Confidence            45799999999999998764 8999998886543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=96.03  E-value=0.0015  Score=52.45  Aligned_cols=51  Identities=24%  Similarity=0.310  Sum_probs=38.6

Q ss_pred             CccCCCccccccch-hhhhc-cCCeeeccCCcccccCCcc--cccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILK-FLTRL-FLDNLNLSYNNLEGMVPTG--VYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~-~l~~l-~L~~ldls~N~lsG~iP~~--~~~~~~~~~~~gn   51 (382)
                      ||||+|+|++.++. .+..+ .|+.|++++|++++..|..  ....+....+.+|
T Consensus        34 L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            68999999987754 66788 9999999999999887762  2334444445555

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.98  E-value=0.0016  Score=50.84  Aligned_cols=49  Identities=16%  Similarity=0.254  Sum_probs=32.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn   51 (382)
                      |||++|+++ .||.....+ .|+.||+|+|+++ .++. ..+.++....+.+|
T Consensus        23 L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~~~~l~~L~~L~ls~N   73 (162)
T d1a9na_          23 LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNN   73 (162)
T ss_dssp             EECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECCCCCCSSCCEEECCSS
T ss_pred             EECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCCcccCcchhhhhcccc
Confidence            689999997 567655667 8999999999988 4554 22333333344444

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.95  E-value=0.0021  Score=50.14  Aligned_cols=51  Identities=25%  Similarity=0.266  Sum_probs=33.0

Q ss_pred             CccCCCcccc--ccchhhhhc-cCCeeeccCCcccccCCc-cc--ccCCCCccccccC
Q 040999            1 MDFSQNNLSG--EILKFLTRL-FLDNLNLSYNNLEGMVPT-GV--YKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG--~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~--~~~~~~~~~~gn~   52 (382)
                      ||||+|+|+.  .++..+..+ +|+.||+|+|+++- ++. ..  ...+....+.|||
T Consensus        70 L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Np  126 (162)
T d1koha1          70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNS  126 (162)
T ss_dssp             CCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTST
T ss_pred             eeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCC
Confidence            6888888875  345556677 88888888888883 443 11  1233445566775

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.76  E-value=0.0017  Score=55.03  Aligned_cols=50  Identities=24%  Similarity=0.230  Sum_probs=33.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn   51 (382)
                      |||++|+|++--|..+.++ .|++|+|++|+|+ .||. +...++....+.+|
T Consensus        36 L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~~~l~~L~~L~Ls~N   87 (266)
T d1p9ag_          36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHN   87 (266)
T ss_dssp             EECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECCSCCTTCCEEECCSS
T ss_pred             EECcCCcCCCcCHHHhhcccccccccccccccc-ccccccccccccccccccc
Confidence            6888888886555678888 8888888888887 4554 33334444444444

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.47  E-value=0.026  Score=50.47  Aligned_cols=37  Identities=22%  Similarity=0.289  Sum_probs=25.4

Q ss_pred             HHHHHHHHhhcccccce-eeeeeeeecccCCCceeEEEEecccCCCc
Q 040999          120 FIAECKALRNIRHRNLI-KVLTACLGVDYQGNDFKALVYEFIHNRSP  165 (382)
Q Consensus       120 ~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~~~gsL  165 (382)
                      ..+|.++++.+.-.+++ ++++++       ++  .+|+||+++.++
T Consensus        91 r~~E~~i~~~ls~~gl~Pkll~~~-------~~--g~I~efi~g~~l  128 (395)
T d1nw1a_          91 LVAESVIFTLLSERHLGPKLYGIF-------SG--GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHTTSSSCEEEEE-------TT--EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHhCCCCCeEEEEc-------CC--ceEEEEeccccC
Confidence            46788888888644554 666663       11  589999987554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.33  E-value=0.01  Score=46.07  Aligned_cols=50  Identities=22%  Similarity=0.245  Sum_probs=35.4

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn~   52 (382)
                      ||||+|+++ +|+ .+..+ .|++|++|+|+++.--|.  .....+....+.+|.
T Consensus        46 L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~   98 (162)
T d1a9na_          46 IDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS   98 (162)
T ss_dssp             EECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCC
T ss_pred             EECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccc
Confidence            689999998 675 47788 899999999999863332  123444455555664

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.18  E-value=0.011  Score=50.23  Aligned_cols=37  Identities=19%  Similarity=0.138  Sum_probs=30.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      +++++|+|++..|..+..+ .|+.||+++|+|++-.|.
T Consensus       134 l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~  171 (284)
T d1ozna_         134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER  171 (284)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             hhhccccccccChhHhccccchhhcccccCcccccchh
Confidence            5799999997666778888 899999999999965554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=93.94  E-value=0.017  Score=49.50  Aligned_cols=37  Identities=22%  Similarity=0.285  Sum_probs=23.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      |+|++|+.++.+|..+..+ .+++|++++|++++-.|.
T Consensus       176 L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~  213 (305)
T d1xkua_         176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG  213 (305)
T ss_dssp             EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred             EECCCCcCCCCChhHhhccccccccccccccccccccc
Confidence            4566666666666666666 666677776666654443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.70  E-value=0.01  Score=48.97  Aligned_cols=39  Identities=21%  Similarity=0.390  Sum_probs=27.6

Q ss_pred             CccCCCccccccch-hhhhc-cCCeeeccCCcccccCCcccc
Q 040999            1 MDFSQNNLSGEILK-FLTRL-FLDNLNLSYNNLEGMVPTGVY   40 (382)
Q Consensus         1 LdLs~N~lsG~iP~-~l~~l-~L~~ldls~N~lsG~iP~~~~   40 (382)
                      |||++|+++ +||. .+.++ .|++||+|+|.+...+|...+
T Consensus        34 L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f   74 (242)
T d1xwdc1          34 LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVF   74 (242)
T ss_dssp             EEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSE
T ss_pred             EECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccc
Confidence            577888876 4554 56777 788888888888777766443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=93.09  E-value=0.0059  Score=49.23  Aligned_cols=37  Identities=30%  Similarity=0.310  Sum_probs=22.1

Q ss_pred             hhhhhc-cCCeeeccCCcccccCCc-ccccCCCCcccccc
Q 040999           14 KFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGN   51 (382)
Q Consensus        14 ~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn   51 (382)
                      .++.++ .|+.||+|+|+++ .||. ..+.++....+.+|
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~-~i~~l~~l~~L~~L~Ls~N   80 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRN   80 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEES-CCCCHHHHTTCCEEECCEE
T ss_pred             hHHhcccccceeECcccCCC-CcccccCCccccChhhccc
Confidence            456677 7777777777776 5554 23344444445554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=92.85  E-value=0.015  Score=50.23  Aligned_cols=48  Identities=25%  Similarity=0.136  Sum_probs=37.8

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEccccccccCCCCCCCCccccCCCCCccchhHHHHHHHHHHHh
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARFLPPTRTQTKYGVGNEVSTIGDVYSYGILLLELMI  274 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~Dv~S~Gvil~ellt  274 (382)
                      ..+++|+|+.++||+++.+...-|.||+.+..-                  -=+|-+++++..++.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~------------------~~~~DLAi~~~~~~~  229 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACND------------------LLAYDVSICLNAWCF  229 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEEE------------------EHHHHHHHHHHHHSB
T ss_pred             ccccccCCcchhhhhcccccceeEecccccccc------------------hhhhhHHHHHHHHhh
Confidence            568999999999999998877789999988521                  125667887777654

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=92.51  E-value=0.034  Score=48.85  Aligned_cols=31  Identities=23%  Similarity=0.265  Sum_probs=18.6

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEG   33 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG   33 (382)
                      |||++|++++-.|  +..+ .|+.|++++|++++
T Consensus       312 L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~  343 (384)
T d2omza2         312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSD  343 (384)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             EECCCCCCCCCcc--cccCCCCCEEECCCCCCCC
Confidence            4566666665322  5556 66666666666664

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=92.47  E-value=0.031  Score=45.06  Aligned_cols=49  Identities=18%  Similarity=0.167  Sum_probs=29.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn   51 (382)
                      |++++|.++. ++ .|..+ .|++||+++|++++--|-+...++....+.+|
T Consensus        51 L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n  100 (210)
T d1h6ta2          51 IIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDEN  100 (210)
T ss_dssp             EECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             EECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCccccccCccccccccccc
Confidence            4677777764 33 36677 78888888888876332233344444444444

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.43  E-value=0.031  Score=42.79  Aligned_cols=35  Identities=23%  Similarity=0.292  Sum_probs=23.5

Q ss_pred             CccCCCc-cccccc-hhhhhc-cCCeeeccCCcccccCC
Q 040999            1 MDFSQNN-LSGEIL-KFLTRL-FLDNLNLSYNNLEGMVP   36 (382)
Q Consensus         1 LdLs~N~-lsG~iP-~~l~~l-~L~~ldls~N~lsG~iP   36 (382)
                      |+|++|+ |+ .|| ..+.++ .|+.|++++|+|++--|
T Consensus        36 L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~   73 (156)
T d2ifga3          36 LYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAP   73 (156)
T ss_dssp             EECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred             eecCCCcccc-ccCchhhccccccCcceeeccccCCccc
Confidence            4566664 55 454 457777 88888888888875433

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=91.81  E-value=0.04  Score=47.60  Aligned_cols=47  Identities=30%  Similarity=0.326  Sum_probs=29.7

Q ss_pred             CccCCCccccccchhhhhccCCeeeccCCcccccCCcccccCCCCccccccC
Q 040999            1 MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPTGVYKNASATSVTGNS   52 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn~   52 (382)
                      |||++|+|+ +||+.+.  +|+.|++++|+|+ .||.. ..++....+.+|+
T Consensus       289 L~Ls~N~l~-~lp~~~~--~L~~L~L~~N~L~-~l~~~-~~~L~~L~L~~N~  335 (353)
T d1jl5a_         289 LNVSNNKLI-ELPALPP--RLERLIASFNHLA-EVPEL-PQNLKQLHVEYNP  335 (353)
T ss_dssp             EECCSSCCS-CCCCCCT--TCCEEECCSSCCS-CCCCC-CTTCCEEECCSSC
T ss_pred             EECCCCccC-ccccccC--CCCEEECCCCcCC-ccccc-cCCCCEEECcCCc
Confidence            577888887 6775422  6778888888887 67752 2334444455664

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=91.80  E-value=0.04  Score=47.63  Aligned_cols=33  Identities=24%  Similarity=0.406  Sum_probs=27.4

Q ss_pred             CccCCCccccccchhhhhccCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRLFLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l~L~~ldls~N~lsG~iP~   37 (382)
                      ||||+|.|+ +||+.+.  .|++||+|+|+|+ .||.
T Consensus        43 LdLs~~~L~-~lp~~~~--~L~~L~Ls~N~l~-~lp~   75 (353)
T d1jl5a_          43 LELNNLGLS-SLPELPP--HLESLVASCNSLT-ELPE   75 (353)
T ss_dssp             EECTTSCCS-CCCSCCT--TCSEEECCSSCCS-SCCC
T ss_pred             EEeCCCCCC-CCCCCCC--CCCEEECCCCCCc-cccc
Confidence            689999998 6996432  6899999999999 8886

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=91.56  E-value=0.044  Score=48.11  Aligned_cols=31  Identities=29%  Similarity=0.481  Sum_probs=18.7

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEG   33 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG   33 (382)
                      ||||+|+|++ ||+ +.++ .|++|++++|++++
T Consensus        71 L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~  102 (384)
T d2omza2          71 INFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD  102 (384)
T ss_dssp             EECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC
T ss_pred             EeCcCCcCCC-Ccc-ccCCccccccccccccccc
Confidence            4666666664 332 5666 66666666666664

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.63  E-value=0.068  Score=43.68  Aligned_cols=40  Identities=20%  Similarity=0.105  Sum_probs=24.2

Q ss_pred             ccCCCccccccchh-hhhc-cCCeeeccCCcccccCCcccccCC
Q 040999            2 DFSQNNLSGEILKF-LTRL-FLDNLNLSYNNLEGMVPTGVYKNA   43 (382)
Q Consensus         2 dLs~N~lsG~iP~~-l~~l-~L~~ldls~N~lsG~iP~~~~~~~   43 (382)
                      ++++|+|+ +||.. +..+ +|++|||++|+++ .+|...+.++
T Consensus       183 ~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l  224 (242)
T d1xwdc1         183 LSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENL  224 (242)
T ss_dssp             CTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTC
T ss_pred             cccccccc-cccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCC
Confidence            45556665 56553 4556 7777777777776 5665444443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=90.46  E-value=0.076  Score=43.05  Aligned_cols=48  Identities=17%  Similarity=0.227  Sum_probs=26.8

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc-ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT-GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~-~~~~~~~~~~~~gn   51 (382)
                      |++++|.+++..+  +.++ .|+.||+|+|++++ +|. ..+.++....+.+|
T Consensus       156 L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N  205 (227)
T d1h6ua2         156 LSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNN  205 (227)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccchh--hcccccceecccCCCccCC-ChhhcCCCCCCEEECcCC
Confidence            4566676664332  6667 77777777777775 443 22333333334444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=89.55  E-value=0.096  Score=41.53  Aligned_cols=30  Identities=23%  Similarity=0.216  Sum_probs=16.0

Q ss_pred             ccCCCccccccchhhhhc-cCCeeeccCCcccc
Q 040999            2 DFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEG   33 (382)
Q Consensus         2 dLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG   33 (382)
                      ++++|+++ +|+ .+..+ .|++||+|+|++++
T Consensus        46 ~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~   76 (199)
T d2omxa2          46 QADRLGIK-SID-GVEYLNNLTQINFSNNQLTD   76 (199)
T ss_dssp             ECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC
T ss_pred             ECCCCCCC-Ccc-ccccCCCcCcCccccccccC
Confidence            45555554 332 24455 56666666666665

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=88.48  E-value=0.14  Score=40.56  Aligned_cols=34  Identities=24%  Similarity=0.396  Sum_probs=28.0

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT   37 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~   37 (382)
                      ||||+|+|++--|  +.++ .|++|++++|.+.. +|.
T Consensus        67 L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~~  101 (199)
T d2omxa2          67 INFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITP  101 (199)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG
T ss_pred             CccccccccCccc--ccCCccccccccccccccc-ccc
Confidence            6899999997544  8889 99999999998874 443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=87.45  E-value=0.16  Score=41.06  Aligned_cols=34  Identities=21%  Similarity=0.225  Sum_probs=21.2

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCC
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVP   36 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP   36 (382)
                      |++++|+++ +++ .+.++ +|++||+++|++++..|
T Consensus        46 L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~   80 (227)
T d1h6ua2          46 LSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP   80 (227)
T ss_dssp             EECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG
T ss_pred             EECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc
Confidence            356666666 453 46666 67777777777766444

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=86.79  E-value=0.18  Score=40.21  Aligned_cols=48  Identities=10%  Similarity=0.273  Sum_probs=25.4

Q ss_pred             ccCCCccccccchhhhhc-cCCeeeccCCcccccCCcccccCCCCcccccc
Q 040999            2 DFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPTGVYKNASATSVTGN   51 (382)
Q Consensus         2 dLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~~~~~~~~~~~~~gn   51 (382)
                      +++.+.+++.|+.  .++ +|+.|++++|+++.--+-..+.++....+.+|
T Consensus        30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~l~~l~~L~~L~L~~n   78 (210)
T d1h6ta2          30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGN   78 (210)
T ss_dssp             HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSS
T ss_pred             HhCcCccCCccCH--HHhcCccEEECcCCCCCCchhHhhCCCCCEEeCCCc
Confidence            3556666666653  355 66777777777664222123334444444444

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=86.10  E-value=0.074  Score=42.35  Aligned_cols=48  Identities=23%  Similarity=0.267  Sum_probs=35.1

Q ss_pred             CccCCCccccccchhhhhc-cCCeeeccCCcccccCCc--ccccCCCCcccccc
Q 040999            1 MDFSQNNLSGEILKFLTRL-FLDNLNLSYNNLEGMVPT--GVYKNASATSVTGN   51 (382)
Q Consensus         1 LdLs~N~lsG~iP~~l~~l-~L~~ldls~N~lsG~iP~--~~~~~~~~~~~~gn   51 (382)
                      ||||+|+++ .|| .|..+ +|++||||+|.++ .||.  .....+....+.+|
T Consensus        53 L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N  103 (198)
T d1m9la_          53 LALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYN  103 (198)
T ss_dssp             EECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEE
T ss_pred             eECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccc
Confidence            689999998 786 58889 9999999999997 6775  22233444445555

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=85.78  E-value=0.17  Score=43.46  Aligned_cols=30  Identities=27%  Similarity=0.268  Sum_probs=24.9

Q ss_pred             CCceeecCCCCCceeeCCCCcEEEcccccccc
Q 040999          209 QPVTAHCDLKPSNVLLDDDMTARVGDFGLARF  240 (382)
Q Consensus       209 ~~~ivH~dlkp~NILl~~~~~~kl~Dfg~a~~  240 (382)
                      ..+++|+|+.+.|||++++  ..+.||+-+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            4678999999999999754  45899998864

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.16  E-value=0.17  Score=45.03  Aligned_cols=33  Identities=21%  Similarity=0.208  Sum_probs=25.3

Q ss_pred             CccCCCccccc----cchhhhh-c-cCCeeeccCCcccc
Q 040999            1 MDFSQNNLSGE----ILKFLTR-L-FLDNLNLSYNNLEG   33 (382)
Q Consensus         1 LdLs~N~lsG~----iP~~l~~-l-~L~~ldls~N~lsG   33 (382)
                      ||||+|+++.+    ++..+.. . .|++|||++|+++.
T Consensus       345 L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~  383 (460)
T d1z7xw1         345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD  383 (460)
T ss_dssp             EECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred             hheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence            68999999864    4555543 3 69999999999975